data_2mgy_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2mgy _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 1.2 t-105 . . . . . 0 CA--C 1.531 0.219 0 N-CA-C 110.167 -0.308 . . . . 0.0 110.167 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.566 ' N ' ' CD ' ' A' ' 7' ' ' PRO . 0.9 OUTLIER -62.02 -44.97 91.34 Favored Pre-proline 0 CA--C 1.533 0.319 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.316 -179.796 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.566 ' CD ' ' N ' ' A' ' 6' ' ' VAL . 21.3 Cg_exo -57.14 -65.42 0.1 Allowed 'Trans proline' 0 C--N 1.307 -1.655 0 C-N-CA 121.671 1.58 . . . . 0.0 111.585 179.673 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.552 ' O ' ' CG2' ' A' ' 12' ' ' THR . . . -49.23 -41.44 37.38 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.226 -179.632 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.445 ' O ' ' OG1' ' A' ' 12' ' ' THR . 49.7 t -60.53 -62.75 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 120.824 0.345 . . . . 0.0 111.533 -179.07 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -57.78 -52.33 52.74 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 111.456 -0.658 . . . . 0.0 111.456 -179.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 9.5 mp -57.99 -30.38 66.02 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.474 0.178 . . . . 0.0 110.961 -179.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.552 ' CG2' ' O ' ' A' ' 8' ' ' ALA . 20.8 p -79.93 -20.74 44.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.087 0.47 . . . . 0.0 109.766 179.295 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.7 mt -82.0 -22.86 36.32 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.499 179.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 5.4 t -54.35 -54.63 45.99 Favored Pre-proline 0 CA--C 1.535 0.398 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.655 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -57.55 -8.59 4.2 Favored 'Trans proline' 0 N--CA 1.495 1.572 0 C-N-CA 120.935 1.09 . . . . 0.0 111.642 179.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.4 t -75.08 -27.62 60.0 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.124 179.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 63.8 mt -79.45 -43.67 22.84 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.767 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -77.63 -31.74 48.9 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 111.012 -0.835 . . . . 0.0 111.012 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -78.36 -34.76 35.36 Favored Glycine 0 CA--C 1.52 0.379 0 N-CA-C 110.305 -1.118 . . . . 0.0 110.305 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 41.4 t80 -72.01 -58.99 2.98 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 179.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 48.8 tpp -64.61 -28.02 69.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.625 179.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.541 ' C ' ' CZ2' ' A' ' 95' ' ' TRP . . . -65.66 -63.12 4.27 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 111.674 -0.571 . . . . 0.0 111.674 -179.462 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -69.34 -18.2 63.78 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.891 -0.324 . . . . 0.0 111.03 -179.388 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 80.7 t80 -50.6 -24.64 3.41 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.959 0.409 . . . . 0.0 110.045 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 63.5 t80 -69.2 -48.26 62.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.979 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 32.9 m -75.55 -14.24 15.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 C-N-CA 120.73 -0.388 . . . . 0.0 110.768 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.542 ' O ' ' CD1' ' A' ' 31' ' ' LEU . 0.0 OUTLIER -57.79 -44.03 85.98 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.626 179.879 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -112.16 -54.56 0.48 Allowed Glycine 0 CA--C 1.525 0.667 0 N-CA-C 110.978 -0.849 . . . . 0.0 110.978 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -58.99 -27.61 65.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.836 0.351 . . . . 0.0 110.495 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -78.52 -49.05 6.89 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 111.062 -0.815 . . . . 0.0 111.062 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.542 ' CD1' ' O ' ' A' ' 27' ' ' ARG . 95.0 mt -56.7 -34.51 67.5 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.769 0.319 . . . . 0.0 110.541 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 49.4 mtp180 -77.06 -54.21 6.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.669 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -44.96 -41.65 7.48 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.298 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 56.2 t80 -49.44 -31.43 9.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.879 -179.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -66.28 -25.24 66.77 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.678 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -92.67 -67.36 1.1 Allowed Glycine 0 CA--C 1.523 0.573 0 N-CA-C 111.049 -0.82 . . . . 0.0 111.049 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -95.2 166.96 11.65 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.827 0.346 . . . . 0.0 110.561 179.666 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -87.1 112.82 22.29 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.704 -179.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.688 ' NZ ' ' CH2' ' A' ' 107' ' ' TRP . 17.3 mtpt -129.42 153.31 80.57 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.193 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo . . . . . 0 C--N 1.305 -1.725 0 C-N-CA 121.438 1.425 . . . . 0.0 110.668 178.843 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.534 0.359 0 N-CA-C 111.804 0.298 . . . . 0.0 111.804 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.638 ' C ' ' H ' ' A' ' 52' ' ' ILE . . . -40.13 -29.17 0.2 Allowed Pre-proline 0 N--CA 1.466 0.339 0 N-CA-C 112.129 0.418 . . . . 0.0 112.129 -178.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -52.82 3.0 0.04 OUTLIER 'Trans proline' 0 C--N 1.312 -1.363 0 CA-C-N 119.336 0.799 . . . . 0.0 112.441 178.287 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.638 ' H ' ' C ' ' A' ' 50' ' ' ALA . 7.9 pt -52.51 -40.36 32.77 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.238 0 CA-C-O 121.22 0.534 . . . . 0.0 109.842 179.258 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.456 ' N ' ' CG1' ' A' ' 52' ' ' ILE . 69.7 m95 -73.4 -22.41 60.25 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.157 -179.328 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -67.43 -49.28 52.51 Favored Glycine 0 CA--C 1.527 0.833 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 179.015 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 3.3 m -65.54 -56.95 9.54 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.909 0.385 . . . . 0.0 110.209 179.464 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 83.3 mt -57.18 -26.52 60.76 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.503 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.509 ' C ' ' CD1' ' A' ' 57' ' ' TYR . 2.3 t80 -67.17 -47.63 70.41 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 179.464 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 15.1 m -56.43 -53.62 55.22 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.957 179.331 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -57.98 -41.06 82.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.34 179.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 8.3 mtm -56.71 -58.28 8.78 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.092 179.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -46.95 -44.07 17.92 Favored Glycine 0 CA--C 1.523 0.573 0 N-CA-C 110.696 -0.961 . . . . 0.0 110.696 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -61.72 -59.22 5.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.708 0.29 . . . . 0.0 110.468 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -49.79 -57.34 9.81 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.88 -0.888 . . . . 0.0 110.88 179.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.714 ' HG ' ' HE1' ' A' ' 68' ' ' TRP . 0.3 OUTLIER -45.68 -55.51 6.34 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.958 0.408 . . . . 0.0 110.526 179.803 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.703 ' HH ' ' HZ3' ' A' ' 69' ' ' LYS . 50.0 t80 -48.54 -42.23 32.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.965 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 93.4 mt -66.73 -49.25 76.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.176 -179.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 9.1 t -51.43 -54.54 11.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.907 0.384 . . . . 0.0 111.162 -179.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' TRP . . . . . 0.714 ' HE1' ' HG ' ' A' ' 64' ' ' SER . 1.7 m95 -65.81 -35.01 79.5 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.097 -179.458 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.703 ' HZ3' ' HH ' ' A' ' 65' ' ' TYR . 7.1 mmmt -65.63 -22.93 66.7 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.653 -0.419 . . . . 0.0 110.349 179.369 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -81.95 -62.68 1.57 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.542 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.492 ' C ' ' CD1' ' A' ' 71' ' ' LEU . 3.1 pp -65.68 -8.96 23.5 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.643 -0.423 . . . . 0.0 110.839 -179.814 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.488 ' O ' ' O ' ' A' ' 73' ' ' GLY . . . 104.6 84.38 1.76 Allowed Glycine 0 CA--C 1.526 0.767 0 C-N-CA 120.994 -0.622 . . . . 0.0 111.77 179.19 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.554 ' N ' ' O ' ' A' ' 68' ' ' TRP . . . 41.91 -174.16 0.01 OUTLIER Glycine 0 CA--C 1.526 0.75 0 N-CA-C 111.795 -0.522 . . . . 0.0 111.795 179.212 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 46.6 t80 -78.7 114.21 17.43 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.866 0.365 . . . . 0.0 110.563 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.58 ' OG1' ' N ' ' A' ' 76' ' ' GLU . 0.0 OUTLIER -142.04 -175.48 4.43 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.423 -179.966 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.58 ' N ' ' OG1' ' A' ' 75' ' ' THR . 4.7 pt-20 -51.3 -25.8 6.42 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.601 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 64.3 t0 -76.12 -31.35 58.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.081 -179.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -83.71 -19.11 35.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.937 -179.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 24.6 mtp -68.24 -27.38 66.31 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.847 -179.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 6.4 t -67.07 -49.39 46.3 Favored Pre-proline 0 CA--C 1.534 0.352 0 CA-C-N 116.438 -0.347 . . . . 0.0 110.729 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_endo -71.77 -58.85 0.07 OUTLIER 'Trans proline' 0 N--CA 1.498 1.74 0 C-N-CA 120.985 1.123 . . . . 0.0 111.721 179.166 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.405 ' HG ' ' CH2' ' A' ' 68' ' ' TRP . 2.8 mt -51.74 -47.59 63.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.781 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -67.88 -64.16 3.3 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 111.204 -0.758 . . . . 0.0 111.204 -179.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 31.4 tp -46.04 -26.71 0.78 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.988 0.423 . . . . 0.0 110.169 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 12.2 t80 -77.23 -41.98 39.12 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.245 179.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 1.3 m -69.52 -43.44 73.04 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.842 -179.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -69.84 -56.79 7.78 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 110.986 -0.846 . . . . 0.0 110.986 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.433 ' O ' ' CB ' ' A' ' 92' ' ' ASN . 3.5 tp60 -53.84 -45.2 70.83 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.9 0.381 . . . . 0.0 110.514 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 11.4 tp -66.19 -33.16 75.14 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.834 -179.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.432 ' O ' ' CB ' ' A' ' 94' ' ' ALA . . . -64.11 -65.68 0.65 Allowed 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 120.256 -0.578 . . . . 0.0 111.291 -179.324 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.9 pp -68.04 -33.37 74.46 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 -178.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.433 ' CB ' ' O ' ' A' ' 88' ' ' GLN . 32.2 t-20 -81.13 -55.11 4.97 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.249 0.463 . . . . 0.0 112.249 -178.444 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . 0.614 ' O ' ' N ' ' A' ' 95' ' ' TRP . 0.0 OUTLIER -73.54 -17.43 61.21 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.699 -0.4 . . . . 0.0 111.773 -178.371 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.432 ' CB ' ' O ' ' A' ' 90' ' ' ALA . . . -52.82 82.04 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 120.473 -0.491 . . . . 0.0 109.911 179.505 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.704 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 38.4 p-90 -97.08 -15.47 0.2 Allowed Pre-proline 0 CA--C 1.536 0.437 0 N-CA-C 112.635 0.605 . . . . 0.0 112.635 -179.16 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.704 ' CD ' ' N ' ' A' ' 95' ' ' TRP . 47.4 Cg_exo -60.39 -18.76 55.09 Favored 'Trans proline' 0 N--CA 1.498 1.744 0 C-N-CA 120.675 0.917 . . . . 0.0 113.663 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . 0.562 ' CD ' ' N ' ' A' ' 96' ' ' PRO . 71.5 Cg_exo -76.76 0.69 9.34 Favored 'Trans proline' 0 N--CA 1.498 1.788 0 C-N-CA 120.534 0.822 . . . . 0.0 113.183 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.486 ' O ' ' N ' ' A' ' 101' ' ' GLY . 1.9 pp -91.76 9.37 3.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 C-N-CA 120.739 -0.385 . . . . 0.0 110.632 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.535 ' CD1' ' O ' ' A' ' 96' ' ' PRO . 2.8 m-30 -40.44 -36.32 0.54 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.678 179.716 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . 0.547 ' CD1' ' N ' ' A' ' 100' ' ' PHE . 0.1 OUTLIER -66.9 -35.41 79.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.203 -179.334 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 0.486 ' N ' ' O ' ' A' ' 98' ' ' ILE . . . -92.89 -4.27 65.28 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 111.402 -0.679 . . . . 0.0 111.402 -179.538 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -65.85 -13.96 60.56 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.683 0.278 . . . . 0.0 110.925 -179.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 16.2 ptt180 -89.26 3.35 52.34 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.832 0.348 . . . . 0.0 110.81 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 9.4 mt-30 -120.61 158.74 26.72 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.362 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' MET . . . . . 0.409 ' N ' ' SD ' ' A' ' 105' ' ' MET . 0.0 OUTLIER -49.31 -18.37 0.36 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.232 179.907 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.566 ' O ' ' N ' ' A' ' 108' ' ' ALA . . . -64.48 -15.68 59.66 Favored Glycine 0 CA--C 1.526 0.764 0 N-CA-C 111.022 -0.831 . . . . 0.0 111.022 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' TRP . . . . . 0.688 ' CH2' ' NZ ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -41.8 -16.59 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 120.619 0.247 . . . . 0.0 111.241 -179.533 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.566 ' N ' ' O ' ' A' ' 106' ' ' GLY . . . -64.0 -17.3 63.18 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.96 0.409 . . . . 0.0 110.514 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 9.9 mt -51.64 -29.99 19.83 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.591 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -58.96 -62.78 1.62 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.644 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.573 ' OD1' ' N ' ' A' ' 112' ' ' LEU . 1.4 p30 -54.72 -53.86 49.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.453 -179.456 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.573 ' N ' ' OD1' ' A' ' 111' ' ' ASP . 31.3 tp -55.94 -40.78 73.66 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.918 -0.313 . . . . 0.0 111.662 -179.112 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 24.9 mt -68.35 -61.3 1.9 Allowed 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.363 0.505 . . . . 0.0 112.363 -178.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.0 pp -61.89 -32.86 73.26 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 120.435 -0.506 . . . . 0.0 111.41 -178.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.55 ' CG2' ' O ' ' A' ' 111' ' ' ASP . 41.8 t -61.86 -55.98 20.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.15 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' SER . . . . . 0.506 ' O ' ' OG1' ' A' ' 120' ' ' THR . 14.8 m -74.56 -22.9 58.76 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.447 -179.222 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -65.2 -62.48 4.87 Favored Glycine 0 CA--C 1.526 0.72 0 C-N-CA 120.809 -0.71 . . . . 0.0 111.419 -179.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.518 ' O ' ' OG1' ' A' ' 122' ' ' THR . 5.4 p -73.64 -35.5 44.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 C-N-CA 121.134 -0.226 . . . . 0.0 111.418 -179.507 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . 0.509 ' O ' ' OG1' ' A' ' 123' ' ' THR . . . -69.76 -60.32 2.39 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.484 -0.487 . . . . 0.0 111.045 -179.457 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.506 ' OG1' ' O ' ' A' ' 116' ' ' SER . 1.9 m -59.28 -50.36 74.28 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.775 0.322 . . . . 0.0 111.34 -179.478 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -56.56 -41.75 77.39 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.464 -179.284 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.518 ' OG1' ' O ' ' A' ' 118' ' ' VAL . 33.9 p -72.44 -25.53 61.49 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.849 -0.34 . . . . 0.0 111.658 -179.238 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 0.509 ' OG1' ' O ' ' A' ' 119' ' ' ALA . 0.1 OUTLIER -69.55 -47.39 63.82 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.645 -0.422 . . . . 0.0 110.456 -179.747 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.8 pp -83.26 -18.32 39.56 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.18 -179.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -91.91 -65.01 1.04 Allowed 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -178.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 40.3 m0 -85.77 -57.63 2.97 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 113.032 0.753 . . . . 0.0 113.032 -177.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . 0.467 ' CD2' ' N ' ' A' ' 127' ' ' HIS . 15.2 m170 -56.6 -22.6 35.04 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 111.762 0.282 . . . . 0.0 111.762 -178.324 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.51 -37.32 87.14 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 120.897 -0.321 . . . . 0.0 110.798 -179.574 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 47.9 t -101.16 -48.48 11.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.51 -179.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 6.2 t -113.15 108.13 53.25 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.585 -178.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . 0.663 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 73.1 Cg_exo -76.41 -26.6 8.59 Favored 'Trans proline' 0 C--N 1.31 -1.47 0 C-N-CA 121.788 1.659 . . . . 0.0 112.393 178.592 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . 0.663 ' CD ' ' N ' ' A' ' 131' ' ' PRO . 51.0 Cg_exo -61.15 -44.87 21.62 Favored 'Trans proline' 0 N--CA 1.497 1.682 0 C-N-CA 121.485 1.457 . . . . 0.0 112.248 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . 0.405 ' O ' ' N ' ' A' ' 136' ' ' LEU . . . -59.05 -43.25 91.68 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.02 0.438 . . . . 0.0 110.321 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -49.61 -27.28 4.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.039 179.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 7.0 tpt180 -77.96 -29.53 49.84 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.345 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.405 ' N ' ' O ' ' A' ' 133' ' ' ALA . 39.0 mt -74.16 -21.74 59.71 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 178.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 0.49 ' O ' ' N ' ' A' ' 140' ' ' TYR . 3.3 mt -93.7 -28.29 16.04 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.278 -0.873 . . . . 0.0 110.232 179.455 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.513 ' C ' ' CD1' ' A' ' 138' ' ' TYR . 0.6 OUTLIER -32.3 -50.41 0.55 Allowed Pre-proline 0 CA--C 1.537 0.462 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.586 -179.929 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.412 ' HD2' ' N ' ' A' ' 138' ' ' TYR . 2.7 Cg_endo -61.91 5.94 0.19 Allowed 'Trans proline' 0 N--CA 1.498 1.773 0 C-N-CA 121.476 1.451 . . . . 0.0 112.972 -179.5 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . 0.49 ' N ' ' O ' ' A' ' 137' ' ' LEU . 0.1 OUTLIER -90.41 -15.18 31.45 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.904 0.383 . . . . 0.0 110.891 179.866 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.401 HD23 ' CE1' ' A' ' 140' ' ' TYR . 98.7 mt -59.38 -35.89 74.76 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.216 -0.447 . . . . 0.0 109.922 178.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -56.06 -41.48 75.15 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.768 179.286 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' TRP . . . . . . . . . . . . . 8.4 t-105 -64.65 -44.49 90.26 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.606 179.266 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 19.2 mt -57.33 -43.3 83.27 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.802 179.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -70.26 -26.69 63.94 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.007 179.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 11.1 t80 -60.65 -61.73 2.37 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.647 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . 0.491 ' O ' ' OD1' ' A' ' 151' ' ' ASN . . . -66.55 -50.34 63.47 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 120.696 -0.401 . . . . 0.0 110.615 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' THR . . . . . 0.576 ' O ' ' ND2' ' A' ' 151' ' ' ASN . 17.0 m -48.99 -55.43 11.96 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.626 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 73.1 t -59.46 -35.86 61.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.613 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -51.73 -61.23 2.38 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.628 -0.429 . . . . 0.0 110.083 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . 0.576 ' ND2' ' O ' ' A' ' 148' ' ' THR . 1.3 p-10 -54.34 -47.15 72.87 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.766 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 38.1 t80 -53.23 -40.73 64.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.766 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 37.1 t80 -63.92 -45.92 87.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.912 -179.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 14.6 t -56.6 -51.69 62.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.926 0.393 . . . . 0.0 110.806 -179.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' TRP . . . . . . . . . . . . . 15.9 m0 -52.28 -55.33 22.06 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.225 -179.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -66.65 -19.73 65.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.28 -179.066 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 37.8 t0 -71.1 -52.7 17.84 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.73 0.3 . . . . 0.0 111.164 -179.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 19.6 p30 . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.861 -179.483 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . 0.422 ' O ' ' CG2' ' A' ' 9' ' ' VAL . 0.5 OUTLIER . . . . . 0 CA--C 1.528 0.125 0 N-CA-C 110.23 -0.285 . . . . 0.0 110.23 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.571 ' N ' ' CD ' ' A' ' 7' ' ' PRO . 0.9 OUTLIER -61.43 -42.86 86.99 Favored Pre-proline 0 CA--C 1.532 0.266 0 C-N-CA 120.938 -0.305 . . . . 0.0 110.26 -179.819 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.571 ' CD ' ' N ' ' A' ' 6' ' ' VAL . 24.1 Cg_exo -58.88 -65.1 0.09 OUTLIER 'Trans proline' 0 C--N 1.307 -1.623 0 C-N-CA 121.472 1.448 . . . . 0.0 111.52 179.585 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.553 ' O ' ' CG2' ' A' ' 12' ' ' THR . . . -50.42 -37.74 39.54 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.201 -179.765 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.471 ' O ' ' OG1' ' A' ' 12' ' ' THR . 46.1 t -59.9 -62.45 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.831 0.348 . . . . 0.0 111.376 -179.28 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -61.67 -48.28 85.29 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 111.316 -0.714 . . . . 0.0 111.316 -179.431 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 9.0 mp -60.26 -24.96 65.33 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.49 0.186 . . . . 0.0 111.153 -179.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.553 ' CG2' ' O ' ' A' ' 8' ' ' ALA . 14.4 p -83.92 -29.11 27.39 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.77 -0.372 . . . . 0.0 110.539 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.422 ' O ' ' CB ' ' A' ' 16' ' ' SER . 6.4 mp -78.47 -20.87 49.98 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 179.661 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.473 ' C ' ' H ' ' A' ' 16' ' ' SER . 3.5 t -49.73 -57.63 11.67 Favored Pre-proline 0 CA--C 1.534 0.349 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.739 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.409 ' HD2' ' N ' ' A' ' 14' ' ' VAL . 11.3 Cg_endo -56.5 -4.19 0.75 Allowed 'Trans proline' 0 N--CA 1.497 1.725 0 C-N-CA 120.81 1.007 . . . . 0.0 111.974 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.473 ' H ' ' C ' ' A' ' 14' ' ' VAL . 1.6 t -81.46 -27.81 34.44 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.832 0.348 . . . . 0.0 110.464 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 13.4 mt -71.56 -54.93 8.86 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.671 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -74.02 -35.8 53.08 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 111.035 -0.826 . . . . 0.0 111.035 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -67.27 -33.69 83.34 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 111.011 -0.836 . . . . 0.0 111.011 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -78.14 -60.09 2.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.74 0.305 . . . . 0.0 111.002 -179.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 3.3 ttt -61.95 -23.19 66.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.777 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.405 ' C ' ' CZ2' ' A' ' 95' ' ' TRP . . . -77.94 -60.43 2.75 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 111.681 -0.567 . . . . 0.0 111.681 -179.565 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -66.79 -22.42 66.03 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.857 -179.146 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 88.5 t80 -49.86 -24.15 2.3 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.192 179.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 65.3 t80 -70.56 -52.09 24.05 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.007 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 31.9 m -64.57 -22.59 31.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 C-N-CA 120.826 -0.35 . . . . 0.0 110.697 -179.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 16.3 ttt180 -67.66 -31.77 71.98 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.518 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -106.17 -61.41 0.6 Allowed Glycine 0 CA--C 1.525 0.706 0 N-CA-C 111.522 -0.631 . . . . 0.0 111.522 -179.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.45 ' C ' ' OE1' ' A' ' 29' ' ' GLU . 4.2 tm-20 -66.52 -34.48 78.01 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 121.032 -0.267 . . . . 0.0 111.304 -179.471 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -64.73 -58.23 10.56 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 110.932 -0.867 . . . . 0.0 110.932 -179.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 10.9 mp -51.67 -30.11 20.61 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.665 0.269 . . . . 0.0 110.511 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 16.1 tpp180 -78.61 -49.93 12.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.888 -179.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . 0.41 ' O ' ' N ' ' A' ' 36' ' ' GLY . 0.3 OUTLIER -51.4 -29.96 17.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.357 -179.652 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 39.1 t80 -46.28 -35.94 5.76 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.232 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -61.4 -29.03 69.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.486 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.41 ' N ' ' O ' ' A' ' 33' ' ' TRP . . . -89.13 -70.64 1.26 Allowed Glycine 0 CA--C 1.525 0.668 0 N-CA-C 110.851 -0.9 . . . . 0.0 110.851 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -95.21 167.15 11.53 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.912 0.387 . . . . 0.0 110.687 179.606 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 20.1 mt-30 -92.77 114.04 26.48 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.062 -179.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 18.8 mtpt -107.27 160.03 27.95 Favored Pre-proline 0 C--N 1.331 -0.2 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.907 179.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo . . . . . 0 C--N 1.307 -1.641 0 C-N-CA 122.147 1.898 . . . . 0.0 111.535 179.595 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.533 0.326 0 N-CA-C 112.133 0.419 . . . . 0.0 112.133 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.659 ' C ' ' H ' ' A' ' 52' ' ' ILE . . . -39.37 -30.09 0.2 Allowed Pre-proline 0 C--N 1.33 -0.263 0 C-N-CA 120.961 -0.296 . . . . 0.0 111.436 -179.171 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.404 ' HD2' ' N ' ' A' ' 50' ' ' ALA . 28.6 Cg_exo -54.79 7.67 0.03 OUTLIER 'Trans proline' 0 C--N 1.311 -1.44 0 CA-C-N 118.916 0.649 . . . . 0.0 112.57 178.388 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.659 ' H ' ' C ' ' A' ' 50' ' ' ALA . 9.8 pt -56.35 -31.23 32.45 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.242 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 178.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 3.6 m0 -64.58 -24.15 67.5 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.616 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -71.62 -46.59 38.58 Favored Glycine 0 CA--C 1.523 0.551 0 N-CA-C 110.629 -0.988 . . . . 0.0 110.629 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 87.0 m -62.09 -50.21 72.85 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.875 0.369 . . . . 0.0 110.447 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 36.9 mt -69.08 -24.9 64.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.692 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.42 ' C ' ' CD1' ' A' ' 57' ' ' TYR . 1.6 t80 -65.34 -48.43 73.03 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 179.769 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -64.91 -46.13 82.98 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.32 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.61 -48.15 82.81 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.695 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 55.1 mtm -63.22 -36.45 83.7 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.713 -179.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -59.21 -47.29 91.55 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 111.423 -0.671 . . . . 0.0 111.423 -179.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 3.3 m-30 -66.84 -59.85 3.18 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.991 -0.284 . . . . 0.0 110.77 -179.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -50.84 -59.12 8.35 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 110.972 -0.851 . . . . 0.0 110.972 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.584 ' OG ' ' NE1' ' A' ' 68' ' ' TRP . 34.5 t -45.11 -52.04 9.61 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-O 120.986 0.422 . . . . 0.0 110.783 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 70.6 t80 -56.16 -36.64 68.53 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.116 -179.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 70.5 mt -70.83 -48.44 57.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.775 0.321 . . . . 0.0 110.798 -179.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.405 ' CG1' ' CZ3' ' A' ' 68' ' ' TRP . 18.3 t -48.9 -54.69 4.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.0 -179.711 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' TRP . . . . . 0.586 ' O ' ' N ' ' A' ' 73' ' ' GLY . 0.9 OUTLIER -64.15 -45.22 89.46 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.76 -0.376 . . . . 0.0 111.047 -179.587 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 14.6 mmmt -57.22 -23.28 46.91 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.888 -0.325 . . . . 0.0 110.913 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 24.1 tp10 -82.34 -63.33 1.4 Allowed 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.799 -0.361 . . . . 0.0 110.848 -179.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.503 ' C ' ' CD1' ' A' ' 71' ' ' LEU . 3.0 pp -64.82 -4.36 4.32 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.965 -179.652 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.488 ' O ' ' O ' ' A' ' 73' ' ' GLY . . . 110.95 71.68 0.65 Allowed Glycine 0 CA--C 1.526 0.777 0 C-N-CA 121.177 -0.535 . . . . 0.0 111.817 179.454 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.586 ' N ' ' O ' ' A' ' 68' ' ' TRP . . . 40.93 -173.83 0.01 OUTLIER Glycine 0 CA--C 1.525 0.667 0 CA-C-O 121.365 0.425 . . . . 0.0 112.281 179.077 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 39.4 t80 -70.45 109.84 5.02 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.316 -0.442 . . . . 0.0 110.7 -179.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.526 ' OG1' ' N ' ' A' ' 76' ' ' GLU . 1.5 t -142.89 -173.56 3.93 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.231 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.526 ' N ' ' OG1' ' A' ' 75' ' ' THR . 16.6 mp0 -56.73 -23.17 40.63 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.301 179.625 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -78.48 -29.01 46.5 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.785 -179.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -86.85 -30.67 21.28 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.546 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 66.8 mmm -60.46 -27.11 67.27 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.905 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 17.6 t -65.97 -48.11 61.96 Favored Pre-proline 0 CA--C 1.534 0.33 0 C-N-CA 120.711 -0.396 . . . . 0.0 110.817 -179.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_endo -73.22 -52.87 0.14 Allowed 'Trans proline' 0 N--CA 1.495 1.615 0 C-N-CA 120.727 0.951 . . . . 0.0 111.355 178.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 3.6 mt -51.49 -52.8 43.58 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.333 179.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.5 ' O ' ' N ' ' A' ' 86' ' ' THR . . . -66.65 -64.54 3.26 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 111.332 -0.707 . . . . 0.0 111.332 -179.237 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 34.3 tp -42.01 -28.08 0.16 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.065 0.46 . . . . 0.0 109.994 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.414 ' N ' ' O ' ' A' ' 83' ' ' GLY . 4.3 t80 -77.29 -43.11 34.41 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.061 179.543 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.5 ' N ' ' O ' ' A' ' 83' ' ' GLY . 3.0 m -68.02 -52.78 31.58 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.744 179.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -60.56 -55.9 27.36 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 111.163 -0.775 . . . . 0.0 111.163 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.427 ' O ' ' CB ' ' A' ' 92' ' ' ASN . 52.2 tp60 -55.99 -42.87 77.03 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.799 0.333 . . . . 0.0 110.471 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 10.5 tp -66.01 -28.61 69.0 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.879 0.371 . . . . 0.0 110.125 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.462 ' O ' ' CB ' ' A' ' 94' ' ' ALA . . . -69.35 -65.82 0.66 Allowed 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.095 -0.642 . . . . 0.0 111.225 -179.814 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.7 pp -66.19 -29.16 69.38 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.149 0.426 . . . . 0.0 112.149 -179.01 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.427 ' CB ' ' O ' ' A' ' 88' ' ' GLN . 36.3 t-20 -85.22 -60.91 1.9 Allowed 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 -178.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . 0.609 ' O ' ' N ' ' A' ' 95' ' ' TRP . 0.0 OUTLIER -68.25 -14.78 63.24 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.69 -0.404 . . . . 0.0 111.403 -178.486 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.462 ' CB ' ' O ' ' A' ' 90' ' ' ALA . . . -54.04 80.25 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.137 0 C-N-CA 120.439 -0.505 . . . . 0.0 109.995 179.498 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.711 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 33.8 p-90 -94.44 -16.42 0.21 Allowed Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.24 -0.437 . . . . 0.0 112.061 -179.633 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.711 ' CD ' ' N ' ' A' ' 95' ' ' TRP . 46.9 Cg_exo -56.96 -31.99 91.46 Favored 'Trans proline' 0 N--CA 1.494 1.504 0 CA-C-N 118.921 0.65 . . . . 0.0 112.789 179.366 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . 0.546 ' C ' ' H ' ' A' ' 99' ' ' PHE . 59.6 Cg_exo -50.33 -30.55 26.97 Favored 'Trans proline' 0 N--CA 1.493 1.479 0 CA-C-N 118.969 0.668 . . . . 0.0 112.838 179.736 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.492 ' O ' ' N ' ' A' ' 101' ' ' GLY . 1.2 pp -74.01 20.87 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.022 0.439 . . . . 0.0 110.187 179.662 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.546 ' H ' ' C ' ' A' ' 97' ' ' PRO . 0.9 OUTLIER -39.29 -58.18 1.25 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.038 -179.666 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 4.2 p90 -66.89 -18.04 65.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.143 -179.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 0.492 ' N ' ' O ' ' A' ' 98' ' ' ILE . . . -86.99 -10.7 71.45 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 111.17 -0.772 . . . . 0.0 111.17 -179.815 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -70.74 -9.4 57.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.56 0.219 . . . . 0.0 111.093 -179.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 10.6 ptm180 -91.97 -5.39 53.16 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.8 0.333 . . . . 0.0 110.734 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 10.0 mt-30 -109.11 160.45 16.05 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.554 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -53.76 -19.25 3.99 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.049 0.452 . . . . 0.0 110.237 179.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.605 ' O ' ' N ' ' A' ' 108' ' ' ALA . . . -65.4 -14.93 60.59 Favored Glycine 0 CA--C 1.523 0.592 0 N-CA-C 111.073 -0.811 . . . . 0.0 111.073 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' TRP . . . . . 0.505 ' NE1' ' OD1' ' A' ' 151' ' ' ASN . 0.0 OUTLIER -42.41 -15.12 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.791 0.329 . . . . 0.0 110.517 -179.663 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.605 ' N ' ' O ' ' A' ' 106' ' ' GLY . . . -58.76 -16.83 18.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.136 0.493 . . . . 0.0 109.85 179.427 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 12.1 mt -58.74 -33.92 70.79 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.569 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -53.8 -61.04 2.56 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.936 0.398 . . . . 0.0 110.898 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.477 ' OD1' ' O ' ' A' ' 108' ' ' ALA . 2.3 p-10 -58.83 -54.89 41.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.733 -179.392 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 43.5 tp -52.82 -43.52 66.01 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.351 -0.386 . . . . 0.0 112.01 -178.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 8.6 mt -66.96 -61.37 1.97 Allowed 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -178.17 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.3 pp -61.23 -35.18 76.52 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.304 -0.558 . . . . 0.0 111.499 -178.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.404 ' CG2' ' O ' ' A' ' 111' ' ' ASP . 41.5 t -60.07 -56.64 16.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.596 -0.274 . . . . 0.0 111.116 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' SER . . . . . 0.498 ' O ' ' OG1' ' A' ' 120' ' ' THR . 58.1 m -72.92 -24.1 60.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.615 -0.266 . . . . 0.0 111.58 -178.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . 0.406 ' O ' ' CB ' ' A' ' 121' ' ' ALA . . . -63.69 -62.73 5.02 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 111.537 -0.625 . . . . 0.0 111.537 -179.285 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.504 ' O ' ' OG1' ' A' ' 122' ' ' THR . 8.7 p -74.03 -34.59 39.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 C-N-CA 120.883 -0.327 . . . . 0.0 111.231 -179.481 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . 0.524 ' O ' ' OG1' ' A' ' 123' ' ' THR . . . -68.95 -60.57 2.27 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.781 -0.367 . . . . 0.0 111.201 -179.429 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.498 ' OG1' ' O ' ' A' ' 116' ' ' SER . 1.4 m -61.47 -48.66 80.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.397 -179.252 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.407 ' O ' ' CB ' ' A' ' 125' ' ' ALA . . . -56.68 -42.01 78.31 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.173 -179.4 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.504 ' OG1' ' O ' ' A' ' 118' ' ' VAL . 35.3 p -71.7 -29.22 64.32 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.948 -0.301 . . . . 0.0 111.567 -179.317 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 0.524 ' OG1' ' O ' ' A' ' 119' ' ' ALA . 0.1 OUTLIER -67.41 -50.7 58.37 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.584 -0.446 . . . . 0.0 110.577 -179.749 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.0 pp -79.71 -20.39 46.61 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.625 -179.085 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . 0.407 ' CB ' ' O ' ' A' ' 121' ' ' ALA . . . -91.47 -64.72 1.08 Allowed 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.678 0.621 . . . . 0.0 112.678 -178.351 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' TRP . . . . . 0.433 ' N ' ' CD1' ' A' ' 126' ' ' TRP . 40.2 m0 -85.69 -57.08 3.19 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 -177.587 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . 0.471 ' CD2' ' N ' ' A' ' 127' ' ' HIS . 11.3 m170 -57.2 -31.58 65.59 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.795 -0.362 . . . . 0.0 111.919 -178.577 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 18.6 ttt180 -56.98 -38.51 73.11 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.709 -0.396 . . . . 0.0 111.367 -179.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 48.5 t -97.22 -49.56 11.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.793 0.33 . . . . 0.0 111.403 -179.244 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 15.0 t -113.91 108.31 51.25 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.748 -179.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . 0.635 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 82.3 Cg_exo -75.26 -28.07 9.07 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 C-N-CA 121.755 1.637 . . . . 0.0 112.72 179.338 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . 0.635 ' CD ' ' N ' ' A' ' 131' ' ' PRO . 53.5 Cg_exo -57.77 -55.45 2.36 Favored 'Trans proline' 0 N--CA 1.497 1.68 0 C-N-CA 121.142 1.228 . . . . 0.0 111.968 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -49.26 -38.48 27.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.463 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -57.08 -29.04 63.14 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.337 179.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 9.7 tpp85 -76.36 -24.5 54.2 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.335 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 84.6 mt -76.04 -39.73 54.95 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 179.42 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 0.612 ' O ' ' N ' ' A' ' 140' ' ' TYR . 9.7 mt -77.0 -37.42 55.15 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.791 -0.641 . . . . 0.0 109.823 179.166 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.493 ' C ' ' O ' ' A' ' 137' ' ' LEU . 2.9 t80 -21.0 -44.41 0.04 OUTLIER Pre-proline 0 N--CA 1.467 0.375 0 O-C-N 123.918 0.761 . . . . 0.0 111.828 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.564 ' N ' ' O ' ' A' ' 137' ' ' LEU . 2.0 Cg_endo -67.75 11.55 0.23 Allowed 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 121.026 1.151 . . . . 0.0 112.296 179.554 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . 0.612 ' N ' ' O ' ' A' ' 137' ' ' LEU . 2.4 p90 -93.14 -14.15 27.56 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 121.188 0.518 . . . . 0.0 110.118 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.605 ' CD1' ' CE1' ' A' ' 140' ' ' TYR . 5.2 mp -57.05 -25.91 59.45 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 178.522 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -66.66 -44.51 81.68 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.826 179.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' TRP . . . . . . . . . . . . . 7.9 t-105 -59.77 -48.08 83.13 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 179.358 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.459 ' O ' ' OG1' ' A' ' 148' ' ' THR . 9.1 mt -53.22 -50.96 63.64 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 179.09 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . 0.502 ' O ' ' CG2' ' A' ' 149' ' ' VAL . . . -61.33 -26.58 67.9 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.667 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 25.4 t80 -65.01 -62.43 1.55 Allowed 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.812 -0.355 . . . . 0.0 110.775 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -66.25 -43.38 86.68 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.612 -0.435 . . . . 0.0 110.492 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' THR . . . . . 0.459 ' OG1' ' O ' ' A' ' 144' ' ' LEU . 16.2 m -57.06 -57.62 11.78 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.765 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.502 ' CG2' ' O ' ' A' ' 145' ' ' ALA . 85.4 t -56.95 -32.77 40.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 C-N-CA 120.836 -0.346 . . . . 0.0 110.731 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 1.8 tp -58.39 -48.62 80.03 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.523 -0.471 . . . . 0.0 109.813 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . 0.505 ' OD1' ' NE1' ' A' ' 107' ' ' TRP . 21.1 t30 -69.62 -55.68 9.4 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.528 179.701 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 84.8 t80 -47.49 -39.53 16.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.818 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 25.8 t80 -67.82 -46.59 71.45 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.765 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 93.7 t -61.88 -33.06 56.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.742 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' TRP . . . . . . . . . . . . . 6.3 m0 -67.02 -58.48 4.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.511 179.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -62.94 -19.43 64.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.553 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -80.09 -51.66 8.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.169 -179.547 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 33.5 m-20 . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.084 -179.449 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.233 0.207 0 CA-C-O 120.732 0.301 . . . . 0.0 110.308 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.589 ' N ' ' CD ' ' A' ' 7' ' ' PRO . 0.9 OUTLIER -61.0 -40.77 77.17 Favored Pre-proline 0 C--N 1.33 -0.269 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 -179.919 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.589 ' CD ' ' N ' ' A' ' 6' ' ' VAL . 23.4 Cg_exo -62.82 -64.59 0.07 OUTLIER 'Trans proline' 0 C--N 1.307 -1.649 0 C-N-CA 121.683 1.589 . . . . 0.0 111.388 179.526 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.536 ' O ' ' CG2' ' A' ' 12' ' ' THR . . . -48.9 -30.09 5.47 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.84 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 43.5 t -74.18 -62.8 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.709 0.29 . . . . 0.0 111.658 -179.258 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -58.13 -35.21 76.23 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 111.598 -0.601 . . . . 0.0 111.598 -179.268 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 6.9 mp -73.52 -38.17 65.39 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.621 0.248 . . . . 0.0 110.567 -179.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.536 ' CG2' ' O ' ' A' ' 8' ' ' ALA . 12.3 p -70.16 -20.59 63.13 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.017 0.436 . . . . 0.0 109.86 179.456 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.418 ' O ' ' C ' ' A' ' 14' ' ' VAL . 7.8 mt -80.95 -42.76 20.76 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.695 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.418 ' C ' ' O ' ' A' ' 13' ' ' LEU . 3.1 t -35.71 -66.08 0.27 Allowed Pre-proline 0 CA--C 1.534 0.35 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.997 -179.766 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.421 ' O ' ' N ' ' A' ' 17' ' ' LEU . 27.7 Cg_endo -51.23 -48.04 23.04 Favored 'Trans proline' 0 N--CA 1.498 1.754 0 C-N-CA 120.712 0.941 . . . . 0.0 112.126 -179.515 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 7.5 t -45.06 -21.32 0.06 Allowed 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.793 -0.363 . . . . 0.0 110.726 -179.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.421 ' N ' ' O ' ' A' ' 15' ' ' PRO . 73.2 mt -74.22 -53.37 9.94 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.395 179.77 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -72.01 -23.82 77.42 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 111.11 -0.796 . . . . 0.0 111.11 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -72.1 -49.2 22.64 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 110.952 -0.859 . . . . 0.0 110.952 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 11.2 t80 -67.94 -59.02 3.6 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.831 0.348 . . . . 0.0 110.566 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 8.0 tpp -62.88 -26.95 69.03 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.156 -179.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -77.68 -62.55 2.37 Favored Glycine 0 CA--C 1.526 0.753 0 C-N-CA 120.963 -0.637 . . . . 0.0 111.913 -179.316 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -57.57 -24.79 58.15 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.834 -0.347 . . . . 0.0 110.666 -179.085 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 54.2 t80 -47.82 -24.5 1.0 Allowed 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.769 -0.372 . . . . 0.0 110.11 179.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 21.7 t80 -69.45 -55.78 9.28 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.777 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 33.7 m -60.44 -23.99 29.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 C-N-CA 120.699 -0.4 . . . . 0.0 110.344 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 2.9 tmt_? -66.09 -20.86 66.29 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.631 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -116.29 -75.22 0.57 Allowed Glycine 0 CA--C 1.523 0.569 0 N-CA-C 111.021 -0.832 . . . . 0.0 111.021 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -50.36 -31.68 15.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.654 0.264 . . . . 0.0 110.774 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -72.82 -53.39 8.21 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.81 -0.916 . . . . 0.0 110.81 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 11.0 mp -57.58 -29.94 64.86 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.84 0.352 . . . . 0.0 110.317 179.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 45.0 mtp180 -79.94 -48.92 12.63 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.549 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -52.15 -29.97 24.52 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.013 -0.539 . . . . 0.0 109.923 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 51.1 t80 -48.54 -40.03 25.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.61 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -58.9 -22.52 59.67 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.461 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -94.95 -73.5 1.2 Allowed Glycine 0 CA--C 1.524 0.638 0 N-CA-C 110.721 -0.951 . . . . 0.0 110.721 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -95.52 167.14 11.49 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.711 0.291 . . . . 0.0 110.424 179.494 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 33.3 mt-30 -85.02 115.72 23.0 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.887 0.375 . . . . 0.0 111.168 -179.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 12.0 mtpt -122.78 164.66 25.51 Favored Pre-proline 0 N--CA 1.462 0.168 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 179.276 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo . . . . . 0 C--N 1.306 -1.678 0 C-N-CA 121.743 1.628 . . . . 0.0 111.159 179.358 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.417 ' O ' ' CG2' ' A' ' 52' ' ' ILE . 1.5 mm? . . . . . 0 CA--C 1.531 0.249 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.59 ' C ' ' H ' ' A' ' 52' ' ' ILE . . . -40.42 -34.97 0.48 Allowed Pre-proline 0 C--N 1.326 -0.416 0 C-N-CA 120.427 -0.509 . . . . 0.0 111.42 -179.143 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.413 ' HD2' ' N ' ' A' ' 50' ' ' ALA . 69.6 Cg_exo -54.26 3.0 0.05 OUTLIER 'Trans proline' 0 C--N 1.314 -1.283 0 C-N-CA 120.644 0.896 . . . . 0.0 112.954 179.257 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.59 ' H ' ' C ' ' A' ' 50' ' ' ALA . 42.1 pt -55.55 -30.27 26.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 121.133 0.492 . . . . 0.0 110.032 179.624 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.413 ' O ' ' CB ' ' A' ' 57' ' ' TYR . 45.7 m95 -81.51 -22.51 37.9 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.413 -179.606 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -72.01 -47.51 31.04 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 109.709 -1.356 . . . . 0.0 109.709 178.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 5.0 m -67.12 -54.98 16.25 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 178.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 92.8 mt -53.76 -39.63 65.52 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.848 -0.614 . . . . 0.0 109.5 179.119 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.42 ' CD1' ' C ' ' A' ' 57' ' ' TYR . 1.3 t80 -54.6 -50.75 67.28 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 179.394 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 5.7 m -52.22 -50.22 62.42 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.223 179.608 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.55 -47.95 82.51 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.574 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 15.4 mtt -56.07 -44.14 78.66 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.461 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -54.59 -55.91 24.82 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 111.155 -0.778 . . . . 0.0 111.155 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -53.65 -54.66 34.59 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.727 0.299 . . . . 0.0 110.448 -179.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -52.53 -56.97 15.18 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 110.824 -0.91 . . . . 0.0 110.824 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.592 ' O ' ' CD1' ' A' ' 68' ' ' TRP . 0.0 OUTLIER -49.19 -50.13 39.48 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.897 0.379 . . . . 0.0 110.324 179.957 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.527 ' HH ' ' HZ3' ' A' ' 69' ' ' LYS . 83.9 t80 -51.43 -38.33 53.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.709 -179.758 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 51.9 mt -71.59 -48.67 51.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.166 -179.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 15.9 t -51.51 -61.35 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.867 0.365 . . . . 0.0 111.334 -179.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' TRP . . . . . 0.592 ' CD1' ' O ' ' A' ' 64' ' ' SER . 1.5 m95 -60.72 -40.67 93.18 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.339 -179.179 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.527 ' HZ3' ' HH ' ' A' ' 65' ' ' TYR . 10.6 mmmt -64.2 -22.68 67.03 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.847 0.356 . . . . 0.0 110.706 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -82.89 -62.36 1.62 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.671 -179.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.488 ' C ' ' CD1' ' A' ' 71' ' ' LEU . 3.6 pp -65.22 -9.73 25.95 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.962 -179.775 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.484 ' O ' ' O ' ' A' ' 73' ' ' GLY . . . 106.09 85.69 1.83 Allowed Glycine 0 CA--C 1.527 0.788 0 C-N-CA 121.221 -0.514 . . . . 0.0 111.939 179.234 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.484 ' O ' ' O ' ' A' ' 72' ' ' GLY . . . 42.06 -173.72 0.01 OUTLIER Glycine 0 CA--C 1.526 0.719 0 N-CA-C 111.838 -0.505 . . . . 0.0 111.838 179.078 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -85.02 110.93 19.28 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.527 -0.336 . . . . 0.0 110.773 -179.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.524 ' OG1' ' N ' ' A' ' 76' ' ' GLU . 1.7 t -142.53 -173.81 3.97 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.665 179.751 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.524 ' N ' ' OG1' ' A' ' 75' ' ' THR . 6.9 pt-20 -45.45 -34.9 3.4 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.889 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -67.91 -32.65 73.28 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.071 -179.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -83.98 -22.69 31.32 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.844 0.354 . . . . 0.0 110.816 -179.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 4.8 mtp -62.99 -26.63 68.94 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.775 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.2 t -68.67 -52.92 17.4 Favored Pre-proline 0 CA--C 1.534 0.35 0 C-N-CA 120.608 -0.437 . . . . 0.0 110.749 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -65.86 -60.78 0.11 Allowed 'Trans proline' 0 N--CA 1.497 1.678 0 C-N-CA 121.07 1.18 . . . . 0.0 111.703 179.137 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.7 mt -56.77 -56.43 21.55 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.391 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -47.82 -51.37 18.37 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 111.168 -0.773 . . . . 0.0 111.168 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 16.0 tp -62.58 -30.13 71.1 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 121.019 -0.273 . . . . 0.0 110.753 -179.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 23.0 t80 -71.51 -39.11 71.01 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.963 -0.295 . . . . 0.0 110.468 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 8.8 p -64.49 -53.54 46.49 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.802 -0.359 . . . . 0.0 110.656 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -68.04 -58.09 7.85 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 111.527 -0.629 . . . . 0.0 111.527 -179.266 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 52.4 tp60 -49.47 -54.61 16.84 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-O 121.039 0.447 . . . . 0.0 110.551 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.434 ' O ' ' C ' ' A' ' 90' ' ' ALA . 27.1 tp -51.03 -64.4 0.82 Allowed 'General case' 0 C--O 1.209 -1.027 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.906 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.434 ' C ' ' O ' ' A' ' 89' ' ' LEU . . . -38.05 -48.85 1.25 Allowed 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 120.434 -0.506 . . . . 0.0 111.916 -179.561 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 94.1 mt -56.6 -57.17 13.54 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 -178.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.411 ' O ' ' CD2' ' A' ' 113' ' ' LEU . 2.8 m120 -74.21 -55.11 6.43 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 121.415 0.626 . . . . 0.0 111.301 -178.621 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . 0.623 ' O ' ' N ' ' A' ' 95' ' ' TRP . 7.4 t-105 -52.84 -21.92 4.8 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.114 -0.948 . . . . 0.0 111.273 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -60.05 69.27 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.929 0.395 . . . . 0.0 109.948 179.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.685 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 9.9 p-90 -99.94 -17.39 0.2 Allowed Pre-proline 0 CA--C 1.536 0.439 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.73 -179.363 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.685 ' CD ' ' N ' ' A' ' 95' ' ' TRP . 31.8 Cg_exo -62.86 -26.24 74.57 Favored 'Trans proline' 0 N--CA 1.494 1.522 0 C-N-CA 120.442 0.762 . . . . 0.0 112.659 179.193 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . 0.544 ' CD ' ' N ' ' A' ' 96' ' ' PRO . 84.2 Cg_exo -60.1 -25.69 80.49 Favored 'Trans proline' 0 N--CA 1.496 1.638 0 C-N-CA 120.744 0.963 . . . . 0.0 112.781 179.83 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -80.74 33.03 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 121.003 0.43 . . . . 0.0 110.427 179.82 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.443 ' H ' ' C ' ' A' ' 97' ' ' PRO . 1.6 t80 -44.7 -52.92 7.82 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.488 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -73.63 -40.33 63.86 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.673 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -57.14 -15.47 14.69 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 111.135 -0.786 . . . . 0.0 111.135 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -74.64 -7.88 54.62 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.69 0.281 . . . . 0.0 110.837 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.41 -17.12 52.75 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.657 -179.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . 0.536 ' O ' ' N ' ' A' ' 106' ' ' GLY . 5.4 pt20 -110.95 158.06 19.19 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.599 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 6.0 mmt -43.26 -17.32 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.669 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.536 ' N ' ' O ' ' A' ' 104' ' ' GLN . . . -62.78 -15.82 55.32 Favored Glycine 0 CA--C 1.526 0.77 0 N-CA-C 111.122 -0.791 . . . . 0.0 111.122 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' TRP . . . . . 0.481 ' C ' ' CD1' ' A' ' 107' ' ' TRP . 0.0 OUTLIER -47.68 -12.09 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.887 0.375 . . . . 0.0 110.664 -179.881 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.535 ' H ' ' C ' ' A' ' 106' ' ' GLY . . . -62.7 -22.51 66.56 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.082 179.754 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 8.2 mt -53.39 -29.68 35.96 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.297 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -54.91 -64.4 0.85 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.957 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.549 ' OD1' ' N ' ' A' ' 112' ' ' LEU . 1.4 p30 -58.82 -51.1 71.45 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.457 -179.477 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.549 ' N ' ' OD1' ' A' ' 111' ' ' ASP . 39.6 tp -52.48 -47.79 66.31 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.813 -178.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.411 ' CD2' ' O ' ' A' ' 92' ' ' ASN . 17.3 mt -65.81 -62.07 1.71 Allowed 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 -178.002 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.1 pp -58.36 -35.32 71.77 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 120.369 -0.533 . . . . 0.0 111.48 -178.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.535 ' CG2' ' O ' ' A' ' 111' ' ' ASP . 40.2 t -59.56 -61.27 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.132 -179.675 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' SER . . . . . 0.499 ' O ' ' OG1' ' A' ' 120' ' ' THR . 9.0 p -69.22 -22.24 63.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.291 -179.082 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -63.3 -63.02 4.85 Favored Glycine 0 CA--C 1.527 0.841 0 C-N-CA 120.838 -0.696 . . . . 0.0 111.597 -179.284 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.507 ' O ' ' CG2' ' A' ' 122' ' ' THR . 9.9 p -73.07 -37.04 52.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 C-N-CA 120.88 -0.328 . . . . 0.0 111.239 -179.415 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . 0.531 ' O ' ' OG1' ' A' ' 123' ' ' THR . . . -67.58 -60.75 2.31 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.692 -0.403 . . . . 0.0 111.212 -179.563 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.499 ' OG1' ' O ' ' A' ' 116' ' ' SER . 2.3 m -58.42 -53.52 57.36 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.432 -179.339 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.428 ' O ' ' CB ' ' A' ' 125' ' ' ALA . . . -53.76 -41.36 67.06 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.253 -179.345 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.507 ' CG2' ' O ' ' A' ' 118' ' ' VAL . 42.1 p -73.73 -34.05 64.6 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 120.783 -0.367 . . . . 0.0 111.889 -179.12 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 0.531 ' OG1' ' O ' ' A' ' 119' ' ' ALA . 0.0 OUTLIER -60.27 -56.04 26.38 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 120.555 -0.458 . . . . 0.0 110.938 -179.453 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -79.06 -20.28 49.24 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.323 0.49 . . . . 0.0 112.323 -178.653 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . 0.428 ' CB ' ' O ' ' A' ' 121' ' ' ALA . . . -87.91 -67.83 0.8 Allowed 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 -178.716 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' TRP . . . . . 0.522 ' N ' ' CD1' ' A' ' 126' ' ' TRP . 22.9 m0 -84.61 -57.27 3.2 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 -177.789 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . 0.551 ' CD2' ' N ' ' A' ' 127' ' ' HIS . 5.2 m170 -56.09 -22.3 27.16 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.916 -0.314 . . . . 0.0 111.569 -178.755 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.42 -37.21 84.7 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.856 0.36 . . . . 0.0 110.69 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 74.1 t -96.33 -49.47 12.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.209 -179.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 6.0 t -111.88 108.41 55.7 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.958 -179.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . 0.67 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 73.0 Cg_exo -75.27 -22.11 14.68 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 121.611 1.541 . . . . 0.0 112.379 178.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . 0.67 ' CD ' ' N ' ' A' ' 131' ' ' PRO . 58.8 Cg_exo -67.12 -45.01 4.29 Favored 'Trans proline' 0 N--CA 1.496 1.632 0 C-N-CA 121.42 1.414 . . . . 0.0 112.184 179.782 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -56.3 -37.01 69.31 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.884 0.373 . . . . 0.0 110.459 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -59.72 -24.84 64.33 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.711 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 15.5 ttp-105 -79.32 -30.61 42.9 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.664 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 86.3 mt -71.49 -36.09 71.02 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 179.556 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 0.58 ' O ' ' N ' ' A' ' 139' ' ' PRO . 6.4 mt -81.47 -39.93 24.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.312 179.548 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.602 ' C ' ' H ' ' A' ' 140' ' ' TYR . 0.7 OUTLIER -17.45 -48.7 0.04 OUTLIER Pre-proline 0 N--CA 1.468 0.47 0 O-C-N 123.921 0.763 . . . . 0.0 111.882 -179.65 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.58 ' N ' ' O ' ' A' ' 137' ' ' LEU . 2.1 Cg_endo -63.74 14.93 0.07 OUTLIER 'Trans proline' 0 C--N 1.308 -1.564 0 C-N-CA 120.91 1.073 . . . . 0.0 111.809 179.518 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . 0.637 ' CE1' ' CD1' ' A' ' 141' ' ' LEU . 7.0 p90 -92.77 -14.34 28.02 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 121.208 0.528 . . . . 0.0 110.26 179.702 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.637 ' CD1' ' CE1' ' A' ' 140' ' ' TYR . 6.7 mp -59.96 -36.76 77.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.301 178.629 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -55.5 -45.42 77.04 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.091 179.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' TRP . . . . . 0.428 ' CZ2' ' CD1' ' A' ' 52' ' ' ILE . 9.1 t-105 -60.63 -51.57 68.84 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 179.537 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 11.4 mt -50.27 -53.58 27.45 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 120.23 -0.588 . . . . 0.0 109.594 179.366 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . 0.544 ' O ' ' CG2' ' A' ' 149' ' ' VAL . . . -59.22 -23.01 61.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.269 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 5.1 t80 -67.07 -63.44 1.06 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.693 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -66.51 -35.6 80.64 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.65 -179.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 9.7 m -65.58 -39.58 91.78 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.868 -0.333 . . . . 0.0 110.371 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.544 ' CG2' ' O ' ' A' ' 145' ' ' ALA . 37.7 t -69.17 -36.55 73.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.198 179.733 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 2.1 tp -58.62 -54.26 49.11 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.044 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . 0.441 ' OD1' ' NE1' ' A' ' 107' ' ' TRP . 14.3 t30 -58.58 -55.21 37.99 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.62 179.688 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 69.6 t80 -50.38 -47.27 56.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.214 -179.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 14.4 t80 -56.08 -43.49 78.07 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.953 -179.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 84.4 t -68.35 -41.28 83.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.486 -0.324 . . . . 0.0 111.141 -179.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' TRP . . . . . . . . . . . . . 5.3 m0 -58.55 -38.17 77.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.617 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . 0.404 ' HE ' ' HA ' ' A' ' 156' ' ' ARG . 0.0 OUTLIER -81.07 -54.91 5.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.931 -179.51 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 33.2 t0 -51.58 -43.91 62.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.191 -179.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' ASN . . . . . 0.533 ' O ' ' ND2' ' A' ' 158' ' ' ASN . 0.4 OUTLIER . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.163 -179.444 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . 0.438 ' NE1' ' CD1' ' A' ' 68' ' ' TRP . 0.5 OUTLIER . . . . . 0 C--O 1.232 0.153 0 N-CA-C 110.165 -0.309 . . . . 0.0 110.165 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.575 ' N ' ' CD ' ' A' ' 7' ' ' PRO . 0.9 OUTLIER -61.1 -41.81 82.97 Favored Pre-proline 0 CA--C 1.533 0.304 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 179.932 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.575 ' CD ' ' N ' ' A' ' 6' ' ' VAL . 17.3 Cg_exo -62.62 -66.41 0.05 OUTLIER 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 121.579 1.519 . . . . 0.0 111.733 179.478 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.554 ' O ' ' CG2' ' A' ' 12' ' ' THR . . . -48.5 -33.56 9.68 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.339 -179.422 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 39.5 t -69.51 -63.24 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 111.76 0.281 . . . . 0.0 111.76 -178.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -60.53 -45.97 95.28 Favored Glycine 0 CA--C 1.526 0.73 0 C-N-CA 121.195 -0.526 . . . . 0.0 111.84 -179.101 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.402 ' N ' ' CD1' ' A' ' 11' ' ' LEU . 9.3 mp -62.25 -38.31 88.75 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 122.873 -0.193 . . . . 0.0 111.09 -179.264 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.554 ' CG2' ' O ' ' A' ' 8' ' ' ALA . 36.1 p -73.42 -22.55 60.19 Favored 'General case' 0 C--N 1.332 -0.166 0 C-N-CA 120.298 -0.561 . . . . 0.0 109.924 179.268 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.401 ' O ' ' N ' ' A' ' 16' ' ' SER . 5.6 mt -76.5 -30.97 57.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.228 179.671 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.9 t -43.53 -55.09 9.04 Favored Pre-proline 0 CA--C 1.534 0.363 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.788 -179.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -66.19 -17.06 54.03 Favored 'Trans proline' 0 N--CA 1.499 1.796 0 C-N-CA 120.925 1.083 . . . . 0.0 111.825 179.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.401 ' N ' ' O ' ' A' ' 13' ' ' LEU . 1.6 t -75.07 -28.74 60.46 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.551 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 56.5 mt -72.36 -57.82 3.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.433 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -69.78 -21.17 76.46 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 110.865 -0.894 . . . . 0.0 110.865 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -70.59 -54.07 11.08 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 111.008 -0.837 . . . . 0.0 111.008 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 37.7 t80 -70.17 -58.24 4.02 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.787 0.327 . . . . 0.0 110.518 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 20.5 ttp -57.21 -35.99 70.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.762 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -69.78 -62.23 3.94 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 111.121 -0.792 . . . . 0.0 111.121 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -55.55 -17.14 4.83 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.906 0.384 . . . . 0.0 110.31 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 47.4 t80 -51.26 -25.47 5.72 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.277 179.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 71.8 t80 -67.17 -47.29 71.41 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.507 179.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 32.6 m -77.52 -13.94 14.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.379 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.4 tmt_? -67.43 -30.57 70.35 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.743 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -119.45 -69.9 0.32 Allowed Glycine 0 CA--C 1.525 0.691 0 N-CA-C 110.996 -0.841 . . . . 0.0 110.996 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -47.57 -22.63 0.51 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.744 0.307 . . . . 0.0 110.659 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -76.29 -52.15 6.32 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 111.119 -0.792 . . . . 0.0 111.119 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 72.6 mt -53.45 -36.28 61.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.758 0.313 . . . . 0.0 110.625 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 11.3 mmt180 -78.0 -49.89 13.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.809 -179.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -47.53 -31.54 4.45 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 110.101 -0.333 . . . . 0.0 110.101 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.445 ' CD1' ' C ' ' A' ' 34' ' ' TYR . 23.8 t80 -52.82 -39.03 62.09 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.486 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -56.94 -20.77 25.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.28 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -98.01 -73.34 1.11 Allowed Glycine 0 CA--C 1.526 0.749 0 N-CA-C 110.858 -0.897 . . . . 0.0 110.858 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -96.05 166.9 11.54 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 120.938 0.399 . . . . 0.0 110.898 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 6.6 mp0 -84.1 117.08 23.22 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.636 -179.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 6.7 mtpt -126.1 149.57 66.97 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.797 179.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo . . . . . 0 C--N 1.307 -1.62 0 C-N-CA 121.328 1.352 . . . . 0.0 111.387 179.296 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.466 0.354 0 N-CA-C 112.505 0.557 . . . . 0.0 112.505 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.633 ' C ' ' H ' ' A' ' 52' ' ' ILE . . . -39.85 -33.46 0.33 Allowed Pre-proline 0 C--N 1.327 -0.394 0 C-N-CA 120.675 -0.41 . . . . 0.0 111.539 -179.033 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.408 ' HD2' ' N ' ' A' ' 50' ' ' ALA . 56.9 Cg_exo -54.23 4.1 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.522 0 CA-C-N 118.615 0.541 . . . . 0.0 112.587 178.82 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.633 ' H ' ' C ' ' A' ' 50' ' ' ALA . 45.6 pt -53.52 -31.74 19.65 Favored 'Isoleucine or valine' 0 C--O 1.232 0.151 0 CA-C-O 121.211 0.529 . . . . 0.0 109.766 179.423 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.442 ' O ' ' CB ' ' A' ' 57' ' ' TYR . 48.2 m95 -81.35 -25.6 36.23 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.814 -179.361 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -69.44 -43.52 69.07 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 178.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 17.3 m -69.15 -59.05 3.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.87 0.367 . . . . 0.0 110.115 179.298 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 96.9 mt -54.19 -33.84 59.11 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.208 -0.451 . . . . 0.0 109.99 179.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.442 ' CB ' ' O ' ' A' ' 53' ' ' TRP . 1.7 t80 -59.2 -55.32 36.38 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.751 179.528 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 4.9 t -49.53 -49.66 45.09 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.097 179.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -57.21 -48.38 78.92 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.335 179.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.498 ' O ' ' OG ' ' A' ' 64' ' ' SER . 23.5 mtm -58.17 -33.61 69.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.513 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.501 ' O ' ' OG ' ' A' ' 64' ' ' SER . . . -65.21 -43.23 95.71 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 111.197 -0.761 . . . . 0.0 111.197 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -66.41 -59.99 3.16 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.676 -0.409 . . . . 0.0 110.282 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -52.48 -50.08 49.43 Favored Glycine 0 CA--C 1.522 0.507 0 N-CA-C 110.32 -1.112 . . . . 0.0 110.32 179.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.577 ' O ' ' CE2' ' A' ' 68' ' ' TRP . 6.2 p -45.96 -50.6 14.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.099 0.476 . . . . 0.0 110.321 179.575 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.508 ' H ' ' HG ' ' A' ' 64' ' ' SER . 67.2 t80 -56.48 -40.24 74.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.507 179.745 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 91.5 mt -65.45 -41.87 92.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.926 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 23.4 t -56.56 -53.67 38.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.047 -179.621 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' TRP . . . . . 0.585 ' O ' ' N ' ' A' ' 73' ' ' GLY . 0.6 OUTLIER -65.27 -35.98 82.71 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 120.577 -0.449 . . . . 0.0 110.839 -179.702 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.42 ' CE ' ' HH ' ' A' ' 65' ' ' TYR . 13.4 mmmt -63.73 -25.85 68.38 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.798 -0.361 . . . . 0.0 110.677 -179.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 23.1 tp10 -82.65 -62.34 1.63 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.471 -179.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.504 ' C ' ' CD1' ' A' ' 71' ' ' LEU . 3.8 pp -68.59 -8.55 42.85 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.834 -0.347 . . . . 0.0 111.489 -179.222 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.479 ' O ' ' O ' ' A' ' 73' ' ' GLY . . . 102.1 83.61 1.74 Allowed Glycine 0 CA--C 1.528 0.891 0 C-N-CA 121.208 -0.52 . . . . 0.0 111.873 179.32 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.585 ' N ' ' O ' ' A' ' 68' ' ' TRP . . . 42.37 -174.08 0.01 OUTLIER Glycine 0 CA--C 1.525 0.683 0 N-CA-C 111.782 -0.527 . . . . 0.0 111.782 179.46 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 38.4 t80 -80.87 110.59 16.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.867 0.365 . . . . 0.0 110.663 -179.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.482 ' OG1' ' N ' ' A' ' 76' ' ' GLU . 2.8 t -142.29 -173.86 3.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.488 179.797 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.482 ' N ' ' OG1' ' A' ' 75' ' ' THR . 2.8 mp0 -47.42 -32.15 4.77 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.679 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 12.8 t0 -71.0 -28.35 64.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.977 -179.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -88.51 -22.92 23.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.8 0.333 . . . . 0.0 110.886 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -66.34 -27.72 68.1 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.723 -179.807 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 8.8 t -68.34 -47.23 37.95 Favored Pre-proline 0 CA--C 1.534 0.338 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.864 -179.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -73.95 -57.03 0.07 OUTLIER 'Trans proline' 0 N--CA 1.499 1.797 0 C-N-CA 121.165 1.243 . . . . 0.0 111.738 179.021 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 7.7 mt -56.02 -51.43 67.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.543 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -60.95 -61.66 6.75 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 110.805 -0.918 . . . . 0.0 110.805 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 58.7 tp -46.96 -33.51 4.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.929 0.395 . . . . 0.0 110.269 179.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.454 ' C ' ' CD1' ' A' ' 85' ' ' TYR . 2.0 t80 -73.89 -47.27 39.23 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.703 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 1.3 m -60.82 -49.0 79.23 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.91 -0.316 . . . . 0.0 111.146 -179.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -69.84 -58.33 6.39 Favored Glycine 0 CA--C 1.527 0.798 0 C-N-CA 120.95 -0.643 . . . . 0.0 111.615 -179.421 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 37.7 tp60 -51.99 -46.28 64.83 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 120.728 -0.389 . . . . 0.0 110.374 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.415 ' O ' ' C ' ' A' ' 90' ' ' ALA . 25.4 tp -53.71 -65.32 0.59 Allowed 'General case' 0 C--O 1.214 -0.803 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 179.566 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.415 ' C ' ' O ' ' A' ' 89' ' ' LEU . . . -38.58 -44.32 0.96 Allowed 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 120.533 -0.467 . . . . 0.0 111.637 -179.64 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 80.3 mt -59.57 -56.86 16.6 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 -178.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 8.7 m-20 -75.89 -54.37 7.01 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 121.286 0.565 . . . . 0.0 111.428 -178.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . 0.677 ' O ' ' N ' ' A' ' 95' ' ' TRP . 3.6 t-105 -52.5 -28.98 22.7 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.265 -0.879 . . . . 0.0 111.583 -179.665 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -52.06 73.38 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.846 0.355 . . . . 0.0 110.727 -179.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.683 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 13.9 p-90 -102.32 -18.7 0.19 Allowed Pre-proline 0 CA--C 1.534 0.332 0 CA-C-N 115.991 -0.55 . . . . 0.0 112.049 -179.621 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.683 ' CD ' ' N ' ' A' ' 95' ' ' TRP . 31.6 Cg_exo -59.79 -31.08 93.47 Favored 'Trans proline' 0 N--CA 1.494 1.502 0 C-N-CA 120.353 0.702 . . . . 0.0 112.819 179.785 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . 0.513 ' C ' ' H ' ' A' ' 99' ' ' PHE . 75.5 Cg_exo -53.36 -28.11 42.2 Favored 'Trans proline' 0 N--CA 1.492 1.436 0 C-N-CA 120.431 0.754 . . . . 0.0 112.583 179.671 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 1.2 pp -75.42 18.79 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 121.167 0.508 . . . . 0.0 110.173 179.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.513 ' H ' ' C ' ' A' ' 97' ' ' PRO . 4.5 t80 -38.98 -41.74 0.79 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.814 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . 0.423 ' C ' ' H ' ' A' ' 102' ' ' ALA . 1.6 m-85 -84.59 -44.49 13.46 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.829 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -59.8 -5.37 3.98 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 111.368 -0.693 . . . . 0.0 111.368 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.423 ' H ' ' C ' ' A' ' 100' ' ' PHE . . . -75.95 -13.46 60.25 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 121.016 -0.274 . . . . 0.0 110.971 -179.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 24.2 ptt180 -80.25 3.31 21.27 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.775 0.321 . . . . 0.0 110.639 -179.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 5.2 mt-30 -120.92 160.29 23.79 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.321 179.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -49.4 -19.82 0.59 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.822 0.344 . . . . 0.0 110.205 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.538 ' O ' ' N ' ' A' ' 108' ' ' ALA . . . -65.38 -15.6 61.54 Favored Glycine 0 CA--C 1.527 0.788 0 N-CA-C 111.305 -0.718 . . . . 0.0 111.305 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' TRP . . . . . 0.49 ' CD1' ' N ' ' A' ' 108' ' ' ALA . 0.0 OUTLIER -45.29 -13.6 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.789 0.328 . . . . 0.0 110.844 -179.665 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.538 ' N ' ' O ' ' A' ' 106' ' ' GLY . . . -64.64 -21.84 66.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.511 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 12.1 mt -52.18 -27.16 13.46 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.405 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -55.84 -63.82 1.05 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.345 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.581 ' OD1' ' N ' ' A' ' 112' ' ' LEU . 2.0 p30 -60.37 -51.65 68.6 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.598 -179.609 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.581 ' N ' ' OD1' ' A' ' 111' ' ' ASP . 43.3 tp -52.51 -42.35 64.24 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.552 -178.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 81.5 mt -71.66 -61.93 1.6 Allowed 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.701 0.63 . . . . 0.0 112.701 -178.269 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.8 pp -57.39 -35.18 69.67 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 120.117 -0.633 . . . . 0.0 111.116 -178.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.517 ' CG2' ' O ' ' A' ' 111' ' ' ASP . 54.6 t -62.13 -58.47 7.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.262 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' SER . . . . . 0.412 ' O ' ' OG1' ' A' ' 120' ' ' THR . 3.5 t -68.73 -22.37 64.33 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.79 -178.852 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -68.56 -62.71 3.93 Favored Glycine 0 CA--C 1.526 0.746 0 C-N-CA 121.011 -0.614 . . . . 0.0 111.745 -179.03 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.512 ' O ' ' OG1' ' A' ' 122' ' ' THR . 7.4 p -70.47 -37.73 71.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 C-N-CA 120.967 -0.293 . . . . 0.0 111.354 -179.421 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . 0.527 ' O ' ' OG1' ' A' ' 123' ' ' THR . . . -66.47 -60.78 2.43 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 120.54 -0.464 . . . . 0.0 111.533 -179.21 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.412 ' OG1' ' O ' ' A' ' 116' ' ' SER . 5.0 m -58.38 -55.01 40.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.696 -179.202 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -52.48 -41.69 63.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.349 -179.248 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.512 ' OG1' ' O ' ' A' ' 118' ' ' VAL . 36.5 p -72.19 -32.59 66.94 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.823 -0.351 . . . . 0.0 111.615 -179.156 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 0.527 ' OG1' ' O ' ' A' ' 119' ' ' ALA . 0.2 OUTLIER -61.55 -50.16 73.79 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.908 0.385 . . . . 0.0 110.868 -179.489 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.6 pp -82.56 -20.0 37.44 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.701 -179.014 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -86.49 -70.69 0.59 Allowed 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 112.659 0.614 . . . . 0.0 112.659 -178.567 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' TRP . . . . . 0.403 ' N ' ' CD1' ' A' ' 126' ' ' TRP . 41.8 m0 -85.18 -58.8 2.54 Favored 'General case' 0 N--CA 1.465 0.325 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 -177.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . 0.433 ' CD2' ' N ' ' A' ' 127' ' ' HIS . 20.2 m170 -47.99 -21.52 0.46 Allowed 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 120.719 -0.392 . . . . 0.0 111.522 -178.546 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 29.6 ttt85 -73.1 -42.48 62.91 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.974 -0.29 . . . . 0.0 111.456 -179.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 6.3 t -92.07 -47.88 13.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.717 0.294 . . . . 0.0 111.332 -179.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 46.2 p -109.59 102.77 51.11 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.817 -179.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . 0.657 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 75.7 Cg_exo -71.05 -26.26 21.77 Favored 'Trans proline' 0 C--N 1.311 -1.444 0 C-N-CA 121.733 1.622 . . . . 0.0 112.465 179.43 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . 0.657 ' CD ' ' N ' ' A' ' 131' ' ' PRO . 38.2 Cg_exo -68.62 -49.43 0.81 Allowed 'Trans proline' 0 N--CA 1.494 1.523 0 C-N-CA 121.496 1.464 . . . . 0.0 111.877 179.796 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . 0.406 ' C ' ' N ' ' A' ' 135' ' ' ARG . . . -46.67 -49.02 19.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.191 179.774 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -46.7 -22.35 0.29 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.031 179.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . 0.406 ' N ' ' C ' ' A' ' 133' ' ' ALA . 5.7 tpp85 -78.41 -39.2 39.63 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.541 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 93.1 mt -68.87 -25.94 64.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.259 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 0.571 ' O ' ' N ' ' A' ' 140' ' ' TYR . 3.2 mt -89.11 -41.8 12.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.935 179.477 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.549 ' C ' ' H ' ' A' ' 140' ' ' TYR . 0.7 OUTLIER -22.11 -47.68 0.06 OUTLIER Pre-proline 0 N--CA 1.464 0.261 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.782 -179.776 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.483 ' N ' ' O ' ' A' ' 137' ' ' LEU . 3.1 Cg_exo -59.66 5.57 0.12 Allowed 'Trans proline' 0 C--N 1.307 -1.621 0 C-N-CA 121.071 1.18 . . . . 0.0 112.256 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . 0.571 ' N ' ' O ' ' A' ' 137' ' ' LEU . 1.9 p90 -90.78 -15.33 30.31 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 120.705 -0.398 . . . . 0.0 110.644 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.44 ' CD2' ' CE1' ' A' ' 140' ' ' TYR . 2.9 mm? -54.17 -36.0 62.91 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 179.216 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -57.47 -53.98 52.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.378 179.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' TRP . . . . . 0.404 ' CZ2' ' CD1' ' A' ' 52' ' ' ILE . 11.7 t-105 -51.06 -48.9 61.46 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 116.318 -0.401 . . . . 0.0 109.939 179.793 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.457 ' O ' ' OG1' ' A' ' 148' ' ' THR . 11.4 mt -50.09 -48.29 53.35 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 120.533 -0.467 . . . . 0.0 109.832 179.558 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . 0.482 ' O ' ' CG2' ' A' ' 149' ' ' VAL . . . -65.12 -30.52 71.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.699 -179.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 21.0 t80 -58.93 -62.19 2.07 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.73 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . 0.49 ' O ' ' OD1' ' A' ' 151' ' ' ASN . . . -67.74 -50.4 57.51 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.6 -0.44 . . . . 0.0 110.648 -179.708 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' THR . . . . . 0.457 ' OG1' ' O ' ' A' ' 144' ' ' LEU . 27.0 m -48.91 -44.61 40.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.842 -179.854 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.482 ' CG2' ' O ' ' A' ' 145' ' ' ALA . 68.7 t -69.08 -36.11 71.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.127 -179.683 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -56.24 -51.5 67.9 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.535 -0.466 . . . . 0.0 110.696 -179.334 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . 0.49 ' OD1' ' O ' ' A' ' 147' ' ' ALA . 4.6 p-10 -65.3 -48.83 71.73 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.945 -0.302 . . . . 0.0 111.055 -179.741 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 82.7 t80 -53.86 -49.17 69.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.931 -179.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . 0.56 ' CE2' ' OD2' ' A' ' 157' ' ' ASP . 79.5 t80 -57.35 -45.56 84.22 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.644 -179.719 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 94.4 t -63.7 -33.68 63.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.096 -179.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' TRP . . . . . 0.517 ' C ' ' HE ' ' A' ' 156' ' ' ARG . 9.5 m0 -62.3 -49.69 74.64 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.647 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . 0.584 ' HE ' ' N ' ' A' ' 156' ' ' ARG . 0.0 OUTLIER -71.02 -32.63 69.44 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.871 -179.639 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . 0.56 ' OD2' ' CE2' ' A' ' 153' ' ' TYR . 2.6 m-20 -74.85 -47.85 28.12 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.823 -179.785 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 1.5 t30 . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.61 -179.947 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . 0.406 ' O ' ' CG2' ' A' ' 9' ' ' VAL . 1.3 t-105 . . . . . 0 CA--C 1.528 0.101 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.465 ' N ' ' CD ' ' A' ' 7' ' ' PRO . 1.0 OUTLIER -59.38 -42.08 90.59 Favored Pre-proline 0 CA--C 1.537 0.464 0 C-N-CA 120.564 -0.454 . . . . 0.0 110.492 -179.439 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.465 ' CD ' ' N ' ' A' ' 6' ' ' VAL . 23.0 Cg_exo -64.9 -65.91 0.05 OUTLIER 'Trans proline' 0 N--CA 1.493 1.498 0 C-N-CA 120.909 1.072 . . . . 0.0 111.611 179.498 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.546 ' O ' ' CG2' ' A' ' 12' ' ' THR . . . -47.46 -37.74 12.29 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.208 -179.581 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.492 ' O ' ' OG1' ' A' ' 12' ' ' THR . 42.4 t -63.12 -62.08 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 C-N-CA 121.048 -0.261 . . . . 0.0 111.404 -179.337 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -58.25 -49.85 72.0 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 110.858 -0.897 . . . . 0.0 110.858 -179.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 10.8 mp -59.08 -27.8 65.88 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.596 0.236 . . . . 0.0 110.65 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.546 ' CG2' ' O ' ' A' ' 8' ' ' ALA . 13.5 p -83.0 -20.73 34.54 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.783 -0.367 . . . . 0.0 110.238 179.566 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 9.3 mt -80.35 -26.42 38.7 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 179.343 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 18.9 t -54.95 -57.38 19.77 Favored Pre-proline 0 CA--C 1.533 0.305 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.033 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -55.84 -10.46 4.04 Favored 'Trans proline' 0 N--CA 1.497 1.711 0 C-N-CA 120.754 0.969 . . . . 0.0 111.651 179.503 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.488 ' N ' ' OH ' ' A' ' 57' ' ' TYR . 1.8 t -74.61 -33.63 62.63 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.19 179.708 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 32.1 mt -73.58 -39.42 64.67 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.63 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -77.04 -49.91 7.23 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 111.263 -0.735 . . . . 0.0 111.263 -179.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -62.58 -34.69 90.28 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 111.306 -0.717 . . . . 0.0 111.306 -179.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 81.8 t80 -73.36 -60.1 2.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.742 0.306 . . . . 0.0 111.102 -179.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 32.4 tpp -61.6 -20.9 63.84 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.74 -179.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.525 ' C ' ' CZ2' ' A' ' 95' ' ' TRP . . . -75.13 -63.76 2.45 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 111.656 -0.577 . . . . 0.0 111.656 -179.533 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -66.3 -16.43 64.03 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.706 -0.397 . . . . 0.0 110.817 -179.474 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 54.2 t80 -48.67 -24.41 1.36 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.111 0.481 . . . . 0.0 110.004 179.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 55.2 t80 -70.1 -50.73 37.91 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.947 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 22.8 m -74.6 -13.29 15.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.877 -179.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 8.9 ttt85 -55.7 -41.45 73.78 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.893 -179.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -122.51 -57.99 0.2 Allowed Glycine 0 CA--C 1.526 0.746 0 N-CA-C 111.444 -0.663 . . . . 0.0 111.444 -179.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 20.8 tp10 -56.35 -23.0 34.62 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.709 0.29 . . . . 0.0 110.796 -179.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -76.62 -53.69 5.34 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 111.072 -0.811 . . . . 0.0 111.072 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 9.9 mp -56.39 -24.94 48.01 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.774 0.321 . . . . 0.0 110.424 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 71.1 ttt180 -81.55 -52.57 7.07 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.352 179.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -46.59 -36.06 6.51 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.962 179.709 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 27.1 t80 -47.81 -38.82 16.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.599 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -63.51 -24.61 67.89 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.797 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -89.32 -72.08 1.26 Allowed Glycine 0 CA--C 1.526 0.728 0 N-CA-C 110.981 -0.848 . . . . 0.0 110.981 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -95.69 167.17 11.44 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.761 0.315 . . . . 0.0 110.672 179.602 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 47.2 mm-40 -80.91 112.65 18.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.0 -179.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.571 ' NZ ' ' CZ3' ' A' ' 107' ' ' TRP . 12.0 mtpt -129.79 156.54 78.76 Favored Pre-proline 0 N--CA 1.463 0.213 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.214 179.535 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo . . . . . 0 C--N 1.309 -1.531 0 C-N-CA 121.578 1.518 . . . . 0.0 111.189 179.072 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.418 ' O ' ' C ' ' A' ' 50' ' ' ALA . 0.2 OUTLIER . . . . . 0 C--O 1.224 -0.241 0 N-CA-C 111.884 0.327 . . . . 0.0 111.884 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.644 ' C ' ' H ' ' A' ' 52' ' ' ILE . . . -38.74 -31.04 0.19 Allowed Pre-proline 0 C--O 1.234 0.257 0 C-N-CA 120.751 -0.38 . . . . 0.0 111.311 -179.133 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.419 ' HD2' ' N ' ' A' ' 50' ' ' ALA . 46.6 Cg_exo -54.19 5.18 0.04 OUTLIER 'Trans proline' 0 C--N 1.31 -1.471 0 CA-C-N 118.691 0.568 . . . . 0.0 112.422 178.2 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.644 ' H ' ' C ' ' A' ' 50' ' ' ALA . 10.4 pt -54.29 -39.2 42.49 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.258 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 179.344 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.621 ' O ' ' CD1' ' A' ' 57' ' ' TYR . 65.7 m95 -69.32 -24.45 63.92 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.746 -179.583 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -67.83 -53.2 24.65 Favored Glycine 0 CA--C 1.527 0.836 0 N-CA-C 110.013 -1.235 . . . . 0.0 110.013 179.002 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 18.6 m -60.02 -54.73 42.56 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.623 0.249 . . . . 0.0 110.581 179.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.408 ' O ' ' SD ' ' A' ' 60' ' ' MET . 88.5 mt -55.82 -47.96 76.27 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.254 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.621 ' CD1' ' O ' ' A' ' 53' ' ' TRP . 3.6 m-30 -46.19 -47.13 17.79 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 179.31 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 7.0 t -56.77 -57.28 13.14 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.215 179.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -48.7 -50.06 35.1 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.183 179.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.408 ' SD ' ' O ' ' A' ' 56' ' ' LEU . 0.0 OUTLIER -52.05 -50.56 61.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.368 179.828 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -49.13 -48.96 31.46 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 111.338 -0.705 . . . . 0.0 111.338 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -62.17 -59.93 4.32 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.849 0.357 . . . . 0.0 110.85 -179.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -47.47 -56.02 8.67 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 110.93 -0.868 . . . . 0.0 110.93 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.66 ' HG ' ' HE1' ' A' ' 68' ' ' TRP . 0.0 OUTLIER -45.64 -55.28 6.57 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.898 0.38 . . . . 0.0 110.664 -179.929 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.532 ' OH ' ' NZ ' ' A' ' 69' ' ' LYS . 69.1 t80 -49.73 -40.0 39.27 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.804 -179.674 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 77.4 mt -69.3 -54.84 17.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.257 -179.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.509 ' CG1' ' CZ3' ' A' ' 68' ' ' TRP . 18.8 t -46.16 -61.23 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.857 0.36 . . . . 0.0 111.257 -179.39 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' TRP . . . . . 0.66 ' HE1' ' HG ' ' A' ' 64' ' ' SER . 0.9 OUTLIER -60.68 -42.31 96.84 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.485 -179.124 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.532 ' NZ ' ' OH ' ' A' ' 65' ' ' TYR . 5.8 mmmt -59.13 -31.92 69.39 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.979 -0.288 . . . . 0.0 111.052 -179.697 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 24.2 tp10 -74.81 -62.28 1.59 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.037 -179.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.498 ' C ' ' CD1' ' A' ' 71' ' ' LEU . 3.4 pp -64.33 -8.58 13.54 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.239 -179.344 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.48 ' O ' ' O ' ' A' ' 73' ' ' GLY . . . 110.35 77.51 0.93 Allowed Glycine 0 CA--C 1.527 0.826 0 C-N-CA 121.014 -0.612 . . . . 0.0 111.98 179.359 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.511 ' N ' ' O ' ' A' ' 68' ' ' TRP . . . 41.56 -173.57 0.01 OUTLIER Glycine 0 CA--C 1.526 0.749 0 C-N-CA 121.504 -0.379 . . . . 0.0 112.165 178.842 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 36.0 t80 -74.48 113.05 11.27 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.382 -0.409 . . . . 0.0 110.715 -179.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.569 ' OG1' ' N ' ' A' ' 76' ' ' GLU . 0.4 OUTLIER -142.38 -175.02 4.29 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.256 179.713 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.569 ' N ' ' OG1' ' A' ' 75' ' ' THR . 2.7 mp0 -55.08 -34.22 63.45 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.916 0.389 . . . . 0.0 110.4 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -66.29 -33.06 74.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.67 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -83.91 -19.09 35.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.046 0.45 . . . . 0.0 110.748 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 65.0 mmm -68.93 -27.07 65.43 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.22 -179.344 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 6.0 t -67.45 -43.51 42.48 Favored Pre-proline 0 C--N 1.329 -0.322 0 C-N-CA 120.673 -0.411 . . . . 0.0 110.413 179.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -76.31 -52.18 0.09 OUTLIER 'Trans proline' 0 N--CA 1.496 1.673 0 C-N-CA 121.047 1.165 . . . . 0.0 111.508 178.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 5.5 mt -56.03 -47.14 78.39 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.277 179.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -68.28 -63.83 3.4 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 111.318 -0.713 . . . . 0.0 111.318 -179.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 38.5 tp -47.91 -23.79 0.86 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.941 0.4 . . . . 0.0 110.57 -179.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 11.8 t80 -74.8 -55.57 5.68 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.009 -179.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 1.9 t -68.53 -33.22 73.73 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.903 -0.319 . . . . 0.0 111.479 -179.282 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -71.6 -57.85 5.74 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 111.205 -0.758 . . . . 0.0 111.205 -179.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 29.2 tp60 -59.57 -43.85 93.49 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 11.1 tp -58.13 -38.57 76.8 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 179.241 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.48 ' O ' ' CB ' ' A' ' 94' ' ' ALA . . . -58.36 -64.48 0.9 Allowed 'General case' 0 C--N 1.319 -0.754 0 C-N-CA 120.062 -0.655 . . . . 0.0 110.435 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.401 HD22 ' N ' ' A' ' 91' ' ' LEU . 6.2 mt -58.69 -56.48 21.64 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 -178.688 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -66.43 -62.12 1.63 Allowed 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -177.755 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . 0.596 ' C ' ' CD1' ' A' ' 93' ' ' TRP . 0.0 OUTLIER -63.54 -16.89 62.05 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 -177.913 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.48 ' CB ' ' O ' ' A' ' 90' ' ' ALA . . . -54.63 82.19 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 120.286 -0.566 . . . . 0.0 109.868 179.155 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.688 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 19.8 p-90 -100.81 -15.71 0.18 Allowed Pre-proline 0 CA--C 1.533 0.307 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -179.488 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.688 ' CD ' ' N ' ' A' ' 95' ' ' TRP . 52.9 Cg_exo -61.08 -15.22 37.97 Favored 'Trans proline' 0 N--CA 1.497 1.7 0 C-N-CA 120.471 0.781 . . . . 0.0 113.403 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . 0.614 ' CD ' ' N ' ' A' ' 96' ' ' PRO . 31.6 Cg_exo -87.08 -0.38 7.77 Favored 'Trans proline' 0 N--CA 1.5 1.867 0 C-N-CA 120.659 0.906 . . . . 0.0 112.928 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.413 ' O ' ' N ' ' A' ' 101' ' ' GLY . 1.3 pp -91.86 25.19 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 C-N-CA 120.73 -0.388 . . . . 0.0 110.833 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.528 ' CD1' ' O ' ' A' ' 96' ' ' PRO . 3.0 m-85 -46.8 -34.46 5.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.167 179.687 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -63.13 -27.39 69.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.786 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 0.413 ' N ' ' O ' ' A' ' 98' ' ' ILE . . . -95.73 -13.52 50.19 Favored Glycine 0 CA--C 1.526 0.743 0 N-CA-C 110.902 -0.879 . . . . 0.0 110.902 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -70.49 -6.73 38.2 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.613 0.244 . . . . 0.0 111.018 -179.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 15.5 ptt180 -97.97 -10.08 25.08 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.065 -179.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . 0.438 ' C ' ' N ' ' A' ' 106' ' ' GLY . 3.2 pt20 -125.49 168.94 12.93 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.832 0.348 . . . . 0.0 110.781 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 9.8 mmt -45.19 -20.2 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.679 -179.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.446 ' C ' ' H ' ' A' ' 108' ' ' ALA . . . -62.26 -15.69 51.94 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 111.102 -0.799 . . . . 0.0 111.102 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' TRP . . . . . 0.571 ' CZ3' ' NZ ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -50.2 -13.42 0.11 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.742 0.306 . . . . 0.0 110.702 -179.596 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.468 ' N ' ' CD1' ' A' ' 107' ' ' TRP . . . -64.73 -19.58 65.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.075 0.464 . . . . 0.0 110.105 179.638 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 8.2 mt -57.04 -26.04 59.64 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.531 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -59.4 -58.66 7.62 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.569 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.553 ' O ' ' CG2' ' A' ' 115' ' ' VAL . 1.3 p30 -62.07 -52.21 64.84 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.303 -179.617 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.524 ' N ' ' CG ' ' A' ' 111' ' ' ASP . 31.7 tp -54.95 -37.4 66.42 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.919 -0.313 . . . . 0.0 111.618 -179.099 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 49.4 mt -72.8 -61.57 1.76 Allowed 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -178.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.5 pp -59.66 -32.52 70.54 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 120.24 -0.584 . . . . 0.0 110.955 -179.047 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.553 ' CG2' ' O ' ' A' ' 111' ' ' ASP . 53.5 t -64.16 -60.14 3.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.405 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' SER . . . . . 0.485 ' O ' ' OG1' ' A' ' 120' ' ' THR . 50.3 m -68.41 -28.31 66.97 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.555 -178.84 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -63.08 -62.24 5.63 Favored Glycine 0 CA--C 1.526 0.759 0 C-N-CA 120.973 -0.632 . . . . 0.0 111.769 -179.348 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.502 ' O ' ' OG1' ' A' ' 122' ' ' THR . 9.3 p -70.94 -37.99 70.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 111.667 0.247 . . . . 0.0 111.667 -179.231 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . 0.522 ' O ' ' OG1' ' A' ' 123' ' ' THR . . . -68.25 -60.8 2.19 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.446 -0.502 . . . . 0.0 111.002 -179.404 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.485 ' OG1' ' O ' ' A' ' 116' ' ' SER . 3.7 m -56.35 -55.87 28.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.44 -179.49 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -51.58 -43.92 62.61 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.404 -179.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.502 ' OG1' ' O ' ' A' ' 118' ' ' VAL . 41.4 p -71.91 -25.25 61.84 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.054 0.39 . . . . 0.0 112.054 -178.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 0.522 ' OG1' ' O ' ' A' ' 119' ' ' ALA . 0.2 OUTLIER -69.28 -49.99 51.0 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.631 -0.428 . . . . 0.0 110.516 -179.636 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.4 pp -79.34 -19.94 49.05 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.246 -179.475 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -89.77 -67.37 0.85 Allowed 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.734 0.642 . . . . 0.0 112.734 -178.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' TRP . . . . . 0.458 ' N ' ' CD1' ' A' ' 126' ' ' TRP . 34.1 m0 -84.82 -57.54 3.07 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 112.87 0.693 . . . . 0.0 112.87 -177.785 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . 0.477 ' CD2' ' N ' ' A' ' 127' ' ' HIS . 9.6 m170 -53.98 -22.29 10.08 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.731 -0.388 . . . . 0.0 111.517 -178.703 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 29.2 ttt85 -73.76 -46.47 45.5 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.822 -0.351 . . . . 0.0 111.416 -179.474 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 39.1 t -81.36 -40.62 18.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.73 0.3 . . . . 0.0 111.313 -179.229 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 3.6 t -138.38 121.66 11.15 Favored Pre-proline 0 CA--C 1.536 0.428 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.541 -179.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . 0.612 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 83.4 Cg_exo -73.61 -48.35 0.25 Allowed 'Trans proline' 0 N--CA 1.493 1.488 0 C-N-CA 121.32 1.347 . . . . 0.0 113.212 179.529 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . 0.612 ' CD ' ' N ' ' A' ' 131' ' ' PRO . 31.2 Cg_exo -33.63 -55.97 0.41 Allowed 'Trans proline' 0 N--CA 1.497 1.73 0 C-N-CA 121.583 1.522 . . . . 0.0 112.177 -179.222 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -47.48 -46.69 27.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.862 0.363 . . . . 0.0 110.384 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . 0.413 ' N ' ' O ' ' A' ' 131' ' ' PRO . . . -55.21 -22.72 18.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.406 179.815 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 10.2 tpt180 -77.28 -29.63 53.88 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-O 120.937 0.399 . . . . 0.0 110.342 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 39.4 mt -75.92 -33.97 59.88 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 179.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 0.461 ' O ' ' CD1' ' A' ' 140' ' ' TYR . 4.3 mt -85.56 -23.31 27.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.341 179.778 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.551 ' C ' ' CD1' ' A' ' 138' ' ' TYR . 0.3 OUTLIER -36.65 -53.9 1.74 Allowed Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.323 -179.881 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.418 ' HD2' ' N ' ' A' ' 138' ' ' TYR . 8.2 Cg_endo -60.79 3.41 0.29 Allowed 'Trans proline' 0 N--CA 1.498 1.755 0 C-N-CA 121.481 1.454 . . . . 0.0 113.057 -179.415 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . 0.461 ' CD1' ' O ' ' A' ' 137' ' ' LEU . 0.1 OUTLIER -82.79 -14.3 54.67 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.489 -0.484 . . . . 0.0 110.954 -179.96 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 86.8 mt -59.14 -25.25 63.72 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 178.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -64.13 -39.84 94.89 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.631 179.224 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' TRP . . . . . 0.507 ' CZ2' ' CD1' ' A' ' 52' ' ' ILE . 11.6 t-105 -70.08 -40.78 74.81 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.723 179.441 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.401 HD12 ' CZ ' ' A' ' 140' ' ' TYR . 10.3 mt -62.48 -42.02 99.2 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 120.403 -0.519 . . . . 0.0 109.712 179.739 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . 0.537 ' O ' ' CG2' ' A' ' 149' ' ' VAL . . . -73.03 -21.91 60.73 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.776 179.268 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 32.2 t80 -64.85 -58.58 5.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.481 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . 0.558 ' O ' ' ND2' ' A' ' 151' ' ' ASN . . . -68.5 -44.15 75.34 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.567 179.867 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' THR . . . . . 0.478 ' O ' ' OD1' ' A' ' 151' ' ' ASN . 51.3 m -57.27 -37.3 72.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.411 179.851 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.537 ' CG2' ' O ' ' A' ' 145' ' ' ALA . 55.0 t -75.8 -30.2 21.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.416 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 2.3 tp -61.39 -57.49 12.04 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 179.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . 0.558 ' ND2' ' O ' ' A' ' 147' ' ' ALA . 1.8 p30 -63.81 -42.36 97.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.632 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 60.8 t80 -56.65 -45.86 81.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.552 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 9.5 t80 -63.18 -36.72 84.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.477 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 55.5 t -67.36 -34.0 66.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.632 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' TRP . . . . . . . . . . . . . 10.9 m0 -68.7 -41.12 79.57 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.791 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -72.63 -35.61 67.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.865 -179.659 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -75.18 -43.03 54.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.878 -179.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' ASN . . . . . 0.402 ' OD1' ' N ' ' A' ' 158' ' ' ASN . 1.5 m-20 . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.872 -179.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . 0.473 ' O ' ' CG2' ' A' ' 9' ' ' VAL . 0.5 OUTLIER . . . . . 0 CA--C 1.53 0.192 0 CA-C-O 120.651 0.262 . . . . 0.0 110.301 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.619 ' N ' ' CD ' ' A' ' 7' ' ' PRO . 1.0 OUTLIER -63.68 -38.71 40.53 Favored Pre-proline 0 CA--C 1.533 0.289 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 179.927 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.619 ' CD ' ' N ' ' A' ' 6' ' ' VAL . 15.4 Cg_exo -66.9 -66.18 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 121.891 1.727 . . . . 0.0 111.735 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.54 ' O ' ' CG2' ' A' ' 12' ' ' THR . . . -47.65 -40.63 20.28 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.173 -179.76 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.488 ' O ' ' OG1' ' A' ' 12' ' ' THR . 59.2 t -61.11 -61.86 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.238 -179.354 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -57.88 -51.75 56.34 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 111.495 -0.642 . . . . 0.0 111.495 -179.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 9.4 mp -57.78 -31.81 66.91 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.572 0.225 . . . . 0.0 110.96 -179.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.54 ' CG2' ' O ' ' A' ' 8' ' ' ALA . 16.8 p -77.33 -24.81 50.75 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.862 0.363 . . . . 0.0 110.121 179.639 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.427 ' O ' ' CB ' ' A' ' 16' ' ' SER . 6.2 mt -80.12 -27.32 39.17 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.363 179.811 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 4.5 t -48.55 -59.64 5.81 Favored Pre-proline 0 CA--C 1.535 0.38 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.718 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -54.98 -12.38 4.85 Favored 'Trans proline' 0 N--CA 1.498 1.746 0 C-N-CA 121.056 1.171 . . . . 0.0 111.96 179.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.427 ' CB ' ' O ' ' A' ' 13' ' ' LEU . 1.6 t -73.5 -30.49 63.16 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.66 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 59.5 mt -74.3 -56.73 4.54 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.664 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -64.83 -34.3 89.52 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 110.802 -0.919 . . . . 0.0 110.802 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -74.88 -28.51 62.59 Favored Glycine 0 CA--C 1.521 0.433 0 N-CA-C 110.614 -0.994 . . . . 0.0 110.614 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 48.8 t80 -74.99 -60.43 2.29 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 110.177 -0.305 . . . . 0.0 110.177 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 19.2 ttp -65.53 -25.1 67.29 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.397 179.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.471 ' C ' ' CZ2' ' A' ' 95' ' ' TRP . . . -68.2 -62.13 4.39 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 110.819 -0.912 . . . . 0.0 110.819 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -70.62 -16.62 62.85 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.993 -0.283 . . . . 0.0 110.397 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 68.5 t80 -47.81 -24.49 0.99 Allowed 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 179.403 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.451 ' CD1' ' C ' ' A' ' 25' ' ' PHE . 22.8 t80 -67.99 -53.57 25.01 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.667 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 34.1 m -71.43 -13.46 16.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.702 -179.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.3 ttp180 -63.31 -46.16 87.97 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.992 -179.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -105.42 -77.99 1.17 Allowed Glycine 0 CA--C 1.525 0.696 0 N-CA-C 111.197 -0.761 . . . . 0.0 111.197 -179.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 53.3 tt0 -44.42 -23.08 0.09 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.698 0.285 . . . . 0.0 110.808 -179.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -66.51 -58.49 8.48 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 110.989 -0.845 . . . . 0.0 110.989 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 11.1 mt -51.99 -21.74 3.36 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.836 0.35 . . . . 0.0 110.365 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 16.2 tpp180 -84.79 -54.03 4.95 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.524 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . 0.432 ' O ' ' N ' ' A' ' 36' ' ' GLY . 0.4 OUTLIER -44.95 -46.77 11.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.551 -179.756 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 46.5 t80 -47.23 -35.58 7.82 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.9 0.381 . . . . 0.0 110.373 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.61 -25.33 68.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.354 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.432 ' N ' ' O ' ' A' ' 33' ' ' TRP . . . -92.72 -68.74 1.12 Allowed Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.892 -0.883 . . . . 0.0 110.892 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -95.75 166.18 11.94 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.793 0.33 . . . . 0.0 110.583 179.712 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.559 ' H ' ' CD ' ' A' ' 38' ' ' GLN . 0.5 OUTLIER -86.63 113.0 22.15 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.861 -179.578 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.643 ' NZ ' ' CH2' ' A' ' 107' ' ' TRP . 22.1 mtpt -129.13 156.71 77.79 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.197 179.812 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo . . . . . 0 C--N 1.307 -1.654 0 C-N-CA 121.814 1.676 . . . . 0.0 110.803 178.822 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.425 ' O ' ' N ' ' A' ' 51' ' ' PRO . 0.1 OUTLIER . . . . . 0 N--CA 1.466 0.372 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.67 ' C ' ' H ' ' A' ' 52' ' ' ILE . . . -37.83 -31.0 0.15 Allowed Pre-proline 0 C--O 1.237 0.402 0 C-N-CA 121.113 -0.235 . . . . 0.0 111.218 -179.04 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.425 ' N ' ' O ' ' A' ' 49' ' ' LEU . 32.9 Cg_exo -55.62 8.99 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.659 0 CA-C-N 118.425 0.473 . . . . 0.0 112.204 178.11 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.67 ' H ' ' C ' ' A' ' 50' ' ' ALA . 12.1 pt -55.71 -27.36 21.73 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 178.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 3.2 m0 -64.62 -30.02 71.03 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.783 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -72.98 -46.93 26.72 Favored Glycine 0 CA--C 1.522 0.519 0 N-CA-C 111.027 -0.829 . . . . 0.0 111.027 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 91.2 m -61.53 -53.37 57.28 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.74 0.305 . . . . 0.0 110.59 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 57.5 mt -64.91 -28.68 69.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.506 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.528 ' C ' ' CD1' ' A' ' 57' ' ' TYR . 1.6 t80 -63.6 -41.62 98.32 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 179.455 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 26.1 t -68.02 -49.43 61.55 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.42 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.67 -46.07 88.02 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.758 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.496 ' O ' ' OG ' ' A' ' 64' ' ' SER . 21.3 mtm -65.45 -33.14 75.25 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.31 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -63.35 -49.68 68.49 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 111.324 -0.71 . . . . 0.0 111.324 -179.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -63.15 -60.06 3.93 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 121.07 -0.252 . . . . 0.0 110.739 -179.652 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -52.58 -52.08 39.94 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 110.811 -0.916 . . . . 0.0 110.811 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.496 ' OG ' ' O ' ' A' ' 60' ' ' MET . 34.2 p -48.14 -56.64 7.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.087 0.47 . . . . 0.0 110.831 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 68.0 t80 -51.38 -37.4 48.0 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.196 -179.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 56.6 mt -71.44 -37.09 63.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.165 -179.548 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.481 ' CG1' ' CZ3' ' A' ' 68' ' ' TRP . 49.1 t -59.48 -52.09 65.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 C-N-CA 120.735 -0.386 . . . . 0.0 110.598 -179.694 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' TRP . . . . . 0.59 ' O ' ' N ' ' A' ' 73' ' ' GLY . 0.9 OUTLIER -64.7 -44.72 89.36 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.859 -179.878 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.469 ' CB ' ' HZ3' ' A' ' 69' ' ' LYS . 0.1 OUTLIER -60.25 -23.08 63.81 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.862 -0.335 . . . . 0.0 110.725 179.894 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -79.67 -62.81 1.57 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.667 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.498 ' C ' ' CD1' ' A' ' 71' ' ' LEU . 2.8 pp -65.67 -6.8 12.45 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.161 -179.661 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 109.69 72.09 0.7 Allowed Glycine 0 CA--C 1.527 0.822 0 N-CA-C 111.511 -0.636 . . . . 0.0 111.511 179.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.59 ' N ' ' O ' ' A' ' 68' ' ' TRP . . . 46.58 -174.15 0.01 OUTLIER Glycine 0 CA--C 1.526 0.768 0 N-CA-C 111.761 -0.536 . . . . 0.0 111.761 179.532 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 41.2 t80 -77.28 111.99 13.52 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.884 0.373 . . . . 0.0 111.03 -179.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.547 ' OG1' ' N ' ' A' ' 76' ' ' GLU . 0.0 OUTLIER -142.54 -179.99 6.63 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.254 179.468 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.547 ' N ' ' OG1' ' A' ' 75' ' ' THR . 7.4 pt-20 -51.57 -23.53 4.29 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.401 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -72.9 -36.95 67.41 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.757 -179.878 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -81.63 -22.1 37.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.975 0.417 . . . . 0.0 110.824 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 73.0 mmm -61.56 -26.07 67.72 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.177 -179.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 14.8 t -68.09 -46.36 41.09 Favored Pre-proline 0 CA--C 1.534 0.338 0 C-N-CA 120.511 -0.476 . . . . 0.0 110.619 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_endo -74.66 -54.76 0.09 OUTLIER 'Trans proline' 0 N--CA 1.497 1.717 0 C-N-CA 120.953 1.102 . . . . 0.0 111.517 178.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 3.2 mt -50.99 -55.25 18.26 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.534 179.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.455 ' O ' ' N ' ' A' ' 86' ' ' THR . . . -64.51 -63.87 3.98 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 111.488 -0.645 . . . . 0.0 111.488 -179.157 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 43.2 tp -43.91 -29.71 0.6 Allowed 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.664 -0.415 . . . . 0.0 109.92 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 13.3 t80 -75.4 -42.83 52.87 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.843 179.518 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.455 ' N ' ' O ' ' A' ' 83' ' ' GLY . 1.4 m -66.86 -56.65 9.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.799 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -58.92 -55.36 31.33 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 111.401 -0.679 . . . . 0.0 111.401 -179.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.424 ' O ' ' CB ' ' A' ' 92' ' ' ASN . 9.6 tp-100 -55.47 -42.87 74.91 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 121.001 -0.28 . . . . 0.0 110.89 -179.572 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.42 ' O ' ' CD1' ' A' ' 93' ' ' TRP . 10.4 tp -66.04 -31.38 72.24 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.903 -0.319 . . . . 0.0 110.383 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.458 ' O ' ' CB ' ' A' ' 94' ' ' ALA . . . -65.87 -65.83 0.63 Allowed 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 120.314 -0.554 . . . . 0.0 111.182 -179.561 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.4 pp -66.0 -34.35 77.88 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.157 0.428 . . . . 0.0 112.157 -179.001 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.424 ' CB ' ' O ' ' A' ' 88' ' ' GLN . 47.5 t30 -78.39 -61.34 2.04 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.862 -0.335 . . . . 0.0 111.826 -178.811 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . 0.613 ' O ' ' N ' ' A' ' 95' ' ' TRP . 0.0 OUTLIER -68.96 -13.32 62.37 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.906 -0.318 . . . . 0.0 111.527 -178.543 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.458 ' CB ' ' O ' ' A' ' 90' ' ' ALA . . . -52.77 80.76 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 120.663 -0.415 . . . . 0.0 109.913 179.38 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.706 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 32.8 p-90 -98.18 -16.95 0.2 Allowed Pre-proline 0 CA--C 1.535 0.39 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -179.389 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.706 ' CD ' ' N ' ' A' ' 95' ' ' TRP . 51.4 Cg_exo -54.51 -40.86 81.69 Favored 'Trans proline' 0 N--CA 1.496 1.632 0 C-N-CA 120.537 0.825 . . . . 0.0 113.03 179.562 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . 0.43 ' HD2' ' N ' ' A' ' 96' ' ' PRO . 41.9 Cg_exo -36.69 -31.31 0.1 Allowed 'Trans proline' 0 N--CA 1.492 1.41 0 CA-C-N 118.98 0.671 . . . . 0.0 112.777 -179.776 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.45 ' N ' ' O ' ' A' ' 96' ' ' PRO . 1.1 pp -83.63 22.19 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.427 179.797 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.581 ' N ' ' O ' ' A' ' 96' ' ' PRO . 22.3 t80 -44.71 -41.63 6.96 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.463 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 48.9 m-85 -83.89 -40.92 18.0 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.529 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -58.0 -14.1 16.24 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 111.006 -0.838 . . . . 0.0 111.006 -179.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -65.05 -7.26 11.22 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.801 0.334 . . . . 0.0 110.472 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 15.3 ptt180 -82.14 4.78 21.9 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.602 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 5.6 mt-30 -122.41 164.92 17.16 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.247 179.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -59.94 -17.06 34.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.328 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.608 ' O ' ' N ' ' A' ' 108' ' ' ALA . . . -66.62 -14.62 62.88 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 111.203 -0.759 . . . . 0.0 111.203 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' TRP . . . . . 0.643 ' CH2' ' NZ ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -41.25 -15.37 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.716 0.294 . . . . 0.0 111.031 -179.366 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.608 ' N ' ' O ' ' A' ' 106' ' ' GLY . . . -58.77 -27.2 64.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.935 0.398 . . . . 0.0 110.435 179.72 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 9.3 mt -46.46 -29.01 1.55 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.444 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -60.22 -63.63 1.23 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.759 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.585 ' OD1' ' N ' ' A' ' 112' ' ' LEU . 1.4 p30 -55.07 -51.88 64.97 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.781 -179.269 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.585 ' N ' ' OD1' ' A' ' 111' ' ' ASP . 0.2 OUTLIER -58.52 -45.11 89.49 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.103 0.409 . . . . 0.0 112.103 -178.539 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 57.2 mt -64.74 -55.27 20.91 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -178.202 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.3 pp -68.06 -33.55 74.78 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 120.455 -0.498 . . . . 0.0 111.703 -178.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.524 ' CG2' ' O ' ' A' ' 111' ' ' ASP . 38.7 t -62.22 -54.37 35.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.736 0.303 . . . . 0.0 111.186 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' SER . . . . . 0.486 ' O ' ' OG1' ' A' ' 120' ' ' THR . 39.0 t -75.3 -23.93 57.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.093 -179.353 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -62.74 -62.46 5.51 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 111.186 -0.765 . . . . 0.0 111.186 -179.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.518 ' O ' ' OG1' ' A' ' 122' ' ' THR . 7.3 p -71.93 -37.92 62.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 111.57 0.211 . . . . 0.0 111.57 -179.547 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . 0.529 ' O ' ' OG1' ' A' ' 123' ' ' THR . . . -68.41 -61.0 2.03 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.281 -0.568 . . . . 0.0 111.075 -179.234 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.486 ' OG1' ' O ' ' A' ' 116' ' ' SER . 2.7 m -56.7 -53.33 58.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.257 -179.541 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.41 ' O ' ' CB ' ' A' ' 125' ' ' ALA . . . -54.36 -40.84 68.47 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.455 -179.256 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.518 ' OG1' ' O ' ' A' ' 118' ' ' VAL . 37.6 p -74.88 -29.17 60.92 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 111.872 0.323 . . . . 0.0 111.872 -179.034 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 0.529 ' OG1' ' O ' ' A' ' 119' ' ' ALA . 0.1 OUTLIER -65.71 -47.59 74.85 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.594 -0.442 . . . . 0.0 110.683 -179.639 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.4 pp -83.98 -19.4 34.64 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.373 -179.15 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . 0.41 ' CB ' ' O ' ' A' ' 121' ' ' ALA . . . -89.74 -67.55 0.84 Allowed 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.497 0.555 . . . . 0.0 112.497 -178.589 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' TRP . . . . . 0.433 ' N ' ' CD1' ' A' ' 126' ' ' TRP . 39.3 m0 -84.36 -57.66 3.07 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 112.662 0.616 . . . . 0.0 112.662 -177.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . 0.462 ' CD2' ' N ' ' A' ' 127' ' ' HIS . 9.3 m170 -54.51 -22.48 13.06 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.865 -0.334 . . . . 0.0 111.115 -178.702 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 22.4 ttt180 -68.44 -38.97 81.65 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.755 0.312 . . . . 0.0 110.994 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 25.9 t -92.67 -47.89 13.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.31 -179.388 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -125.57 117.33 24.75 Favored Pre-proline 0 CA--C 1.535 0.374 0 CA-C-N 116.575 -0.284 . . . . 0.0 111.048 -179.385 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . 0.647 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 88.4 Cg_exo -75.03 -38.43 1.58 Allowed 'Trans proline' 0 N--CA 1.492 1.424 0 C-N-CA 121.454 1.436 . . . . 0.0 112.646 179.074 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . 0.647 ' CD ' ' N ' ' A' ' 131' ' ' PRO . 37.9 Cg_exo -46.98 -46.24 19.22 Favored 'Trans proline' 0 N--CA 1.497 1.688 0 C-N-CA 121.646 1.564 . . . . 0.0 111.983 -179.699 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -57.15 -38.22 73.21 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 179.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -62.69 -23.07 66.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.196 179.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 9.3 tpp180 -78.5 -37.3 43.51 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.234 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 12.6 mt -69.61 -29.52 67.04 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.241 -0.436 . . . . 0.0 109.867 179.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 0.583 ' O ' ' N ' ' A' ' 140' ' ' TYR . 8.2 mt -84.14 -42.39 16.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.025 179.489 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.513 ' C ' ' H ' ' A' ' 140' ' ' TYR . 1.9 t80 -23.15 -41.39 0.04 OUTLIER Pre-proline 0 N--CA 1.464 0.252 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.753 -179.686 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.574 ' N ' ' O ' ' A' ' 137' ' ' LEU . 12.3 Cg_exo -64.37 7.29 0.24 Allowed 'Trans proline' 0 C--N 1.307 -1.643 0 C-N-CA 120.699 0.933 . . . . 0.0 112.0 179.45 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . 0.583 ' N ' ' O ' ' A' ' 137' ' ' LEU . 1.9 p90 -93.13 -13.67 28.19 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.903 -179.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.417 HD22 ' CE1' ' A' ' 140' ' ' TYR . 4.1 mm? -55.94 -26.63 48.74 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 178.299 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -64.28 -49.14 73.0 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.833 179.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' TRP . . . . . . . . . . . . . 10.7 t-105 -56.91 -45.84 82.39 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.103 -0.498 . . . . 0.0 109.659 179.375 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 11.5 mt -54.63 -51.15 66.29 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.199 -0.455 . . . . 0.0 109.962 179.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . 0.522 ' O ' ' CG2' ' A' ' 149' ' ' VAL . . . -63.72 -22.16 66.77 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.413 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -67.25 -64.82 0.78 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.61 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -63.94 -41.9 97.48 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.615 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 59.9 m -57.16 -58.68 7.14 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.499 179.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.522 ' CG2' ' O ' ' A' ' 145' ' ' ALA . 89.5 t -55.61 -39.49 54.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.708 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 1.6 tp -50.84 -57.49 8.31 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.696 -0.402 . . . . 0.0 110.069 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . 0.516 HD21 ' HE1' ' A' ' 107' ' ' TRP . 2.9 t-20 -53.7 -57.02 12.32 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.706 179.73 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . 0.467 ' CZ ' ' NE ' ' A' ' 156' ' ' ARG . 46.5 t80 -48.53 -36.14 14.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.519 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . 0.49 ' CE2' ' OD2' ' A' ' 157' ' ' ASP . 8.8 t80 -65.96 -39.52 90.51 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.688 -179.799 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 15.7 t -66.21 -38.02 81.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.002 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' TRP . . . . . . . . . . . . . 7.9 m0 -68.17 -39.15 82.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.964 -179.579 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . 0.467 ' NE ' ' CZ ' ' A' ' 152' ' ' TYR . 0.9 OUTLIER -77.15 -24.04 51.59 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.808 -0.357 . . . . 0.0 110.071 179.999 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . 0.49 ' OD2' ' CE2' ' A' ' 153' ' ' TYR . 98.2 m-20 -86.9 -51.08 6.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.661 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' ASN . . . . . 0.485 ' C ' HD21 ' A' ' 158' ' ' ASN . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.831 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . 0.595 ' CD1' ' CE2' ' A' ' 68' ' ' TRP . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.746 0.307 . . . . 0.0 110.238 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.62 ' N ' ' CD ' ' A' ' 7' ' ' PRO . 1.0 OUTLIER -64.2 -33.88 10.33 Favored Pre-proline 0 C--N 1.329 -0.309 0 N-CA-C 109.916 -0.402 . . . . 0.0 109.916 179.942 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.62 ' CD ' ' N ' ' A' ' 6' ' ' VAL . 21.3 Cg_exo -71.61 -67.51 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.626 0 C-N-CA 121.709 1.606 . . . . 0.0 111.899 179.63 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.537 ' O ' ' CG2' ' A' ' 12' ' ' THR . . . -48.31 -39.16 20.92 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.19 -179.513 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.418 ' CG2' ' O ' ' A' ' 5' ' ' TRP . 95.9 t -69.98 -62.48 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -179.049 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -55.32 -47.34 75.81 Favored Glycine 0 CA--C 1.526 0.764 0 C-N-CA 121.207 -0.52 . . . . 0.0 111.834 -179.108 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.411 ' N ' ' CD1' ' A' ' 11' ' ' LEU . 6.8 mp -62.5 -38.47 90.05 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.485 0.183 . . . . 0.0 110.805 -179.584 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.537 ' CG2' ' O ' ' A' ' 8' ' ' ALA . 22.3 p -73.34 -23.53 60.24 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.801 -0.36 . . . . 0.0 110.871 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 7.0 mp -82.97 -24.88 32.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.297 -179.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.413 ' N ' ' HD2' ' A' ' 15' ' ' PRO . 2.7 t -50.02 -63.16 1.92 Allowed Pre-proline 0 CA--C 1.536 0.442 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.723 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.413 ' HD2' ' N ' ' A' ' 14' ' ' VAL . 24.5 Cg_endo -53.78 -40.08 81.48 Favored 'Trans proline' 0 N--CA 1.498 1.788 0 C-N-CA 120.876 1.05 . . . . 0.0 112.366 -179.462 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.1 t -46.19 -25.68 0.65 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.811 0.338 . . . . 0.0 110.664 -179.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 83.1 mt -70.03 -57.94 4.4 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.726 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -68.35 -20.71 73.67 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 111.163 -0.775 . . . . 0.0 111.163 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -72.92 -45.53 32.78 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 37.7 t80 -69.89 -57.63 4.82 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.79 0.329 . . . . 0.0 110.707 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -66.83 -21.55 66.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.07 -179.743 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -77.5 -63.5 2.22 Favored Glycine 0 CA--C 1.524 0.608 0 C-N-CA 120.842 -0.694 . . . . 0.0 111.572 -179.504 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.15 -20.98 66.37 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.671 -0.412 . . . . 0.0 110.245 -179.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.461 ' CD1' ' C ' ' A' ' 24' ' ' TYR . 11.0 t80 -48.77 -23.7 1.15 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.278 -0.419 . . . . 0.0 109.912 179.357 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 83.3 t80 -70.78 -52.63 19.44 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.765 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 35.3 m -66.53 -17.21 22.16 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 C-N-CA 120.535 -0.466 . . . . 0.0 110.41 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.9 tmt_? -58.08 -43.41 87.0 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.854 0.359 . . . . 0.0 110.32 179.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -101.41 -46.9 1.61 Allowed Glycine 0 CA--C 1.526 0.738 0 N-CA-C 110.957 -0.857 . . . . 0.0 110.957 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -59.91 -38.59 82.75 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.759 0.314 . . . . 0.0 110.64 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -58.68 -44.93 95.4 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.857 -0.897 . . . . 0.0 110.857 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 81.0 mt -58.47 -31.95 68.3 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.944 -0.302 . . . . 0.0 110.392 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.41 ' O ' ' N ' ' A' ' 35' ' ' ALA . 14.6 mmm180 -76.68 -50.03 14.69 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.464 179.793 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 13.0 m0 -44.84 -48.14 11.05 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.289 -0.414 . . . . 0.0 109.998 179.489 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.452 ' O ' ' CD1' ' A' ' 34' ' ' TYR . 26.3 t80 -50.62 -27.05 6.14 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.751 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.41 ' N ' ' O ' ' A' ' 32' ' ' ARG . . . -65.95 -45.83 80.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.763 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -91.87 -69.67 1.16 Allowed Glycine 0 CA--C 1.524 0.601 0 N-CA-C 110.992 -0.843 . . . . 0.0 110.992 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.497 ' C ' ' CD1' ' A' ' 37' ' ' LEU . 3.9 pp -87.66 162.78 16.91 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.677 0.275 . . . . 0.0 110.359 179.722 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 29.5 mt-30 -97.32 123.23 41.07 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.71 -179.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 13.9 mtpp -90.41 163.23 31.8 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.21 179.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_exo . . . . . 0 C--N 1.307 -1.628 0 C-N-CA 122.153 1.902 . . . . 0.0 112.198 -179.709 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.535 0.388 0 N-CA-C 112.411 0.523 . . . . 0.0 112.411 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.63 ' C ' ' H ' ' A' ' 52' ' ' ILE . . . -39.91 -31.63 0.26 Allowed Pre-proline 0 CA--C 1.534 0.344 0 N-CA-C 111.952 0.353 . . . . 0.0 111.952 -179.085 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.401 ' HD2' ' N ' ' A' ' 50' ' ' ALA . 28.2 Cg_exo -52.87 6.37 0.03 OUTLIER 'Trans proline' 0 C--N 1.311 -1.417 0 CA-C-N 118.928 0.653 . . . . 0.0 112.984 178.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.63 ' H ' ' C ' ' A' ' 50' ' ' ALA . 10.9 pt -55.59 -28.5 23.15 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.178 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 179.04 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.414 ' O ' ' CB ' ' A' ' 57' ' ' TYR . 3.0 m0 -67.68 -28.53 67.77 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.484 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -69.41 -60.94 4.76 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 111.464 -0.654 . . . . 0.0 111.464 -179.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.42 ' CG2' ' N ' ' A' ' 56' ' ' LEU . 7.3 t -57.56 -53.37 58.93 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.897 -0.321 . . . . 0.0 111.125 -179.343 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.42 ' N ' ' CG2' ' A' ' 55' ' ' THR . 73.2 mt -58.24 -39.41 79.04 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.524 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.414 ' CB ' ' O ' ' A' ' 53' ' ' TRP . 6.1 t80 -54.79 -57.89 9.73 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 179.747 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 7.1 t -48.63 -50.39 33.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.552 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -57.18 -42.55 81.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.606 -179.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 14.6 mtt -63.0 -55.09 28.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.525 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -44.73 -47.44 9.15 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 111.16 -0.776 . . . . 0.0 111.16 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -61.17 -49.37 77.47 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.845 0.355 . . . . 0.0 110.279 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -54.87 -45.06 81.59 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 110.187 -1.165 . . . . 0.0 110.187 179.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.592 ' O ' ' NE1' ' A' ' 68' ' ' TRP . 0.7 OUTLIER -60.52 -42.35 96.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.906 0.384 . . . . 0.0 110.221 179.642 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.426 ' OH ' ' NZ ' ' A' ' 69' ' ' LYS . 87.3 t80 -53.11 -43.47 66.88 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 179.361 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 79.4 mt -72.15 -25.81 24.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.024 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 55.1 t -66.15 -60.05 3.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 C-N-CA 120.664 -0.414 . . . . 0.0 111.333 -179.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' TRP . . . . . 0.595 ' CE2' ' CD1' ' A' ' 5' ' ' TRP . 0.0 OUTLIER -70.37 -29.39 66.04 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 119.974 -0.69 . . . . 0.0 110.725 -179.601 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.426 ' NZ ' ' OH ' ' A' ' 65' ' ' TYR . 10.8 mmmt -72.79 -26.55 61.56 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.336 -0.546 . . . . 0.0 110.616 179.825 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -78.42 -60.98 2.16 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.85 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.7 pp -70.38 -19.17 63.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.087 -179.482 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.502 ' O ' ' O ' ' A' ' 73' ' ' GLY . . . 110.24 95.43 2.33 Favored Glycine 0 CA--C 1.53 0.985 0 C-N-CA 121.257 -0.496 . . . . 0.0 112.043 179.218 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.594 ' N ' ' O ' ' A' ' 68' ' ' TRP . . . 41.51 -174.33 0.01 OUTLIER Glycine 0 CA--C 1.525 0.691 0 N-CA-C 111.944 -0.462 . . . . 0.0 111.944 178.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 49.3 t80 -79.78 111.05 15.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.675 0.274 . . . . 0.0 110.408 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.427 ' OG1' ' N ' ' A' ' 76' ' ' GLU . 2.1 t -139.35 177.31 8.01 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 120.993 0.425 . . . . 0.0 110.949 -179.641 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.427 ' N ' ' OG1' ' A' ' 75' ' ' THR . 2.3 mp0 -50.05 -40.84 46.41 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.795 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 27.7 m-20 -62.39 -22.03 65.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.505 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -93.64 -24.82 17.75 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.663 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 13.2 mtp -69.14 -29.57 67.63 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.535 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.406 ' O ' ' CB ' ' A' ' 84' ' ' LEU . 6.5 t -65.56 -45.74 68.11 Favored Pre-proline 0 CA--C 1.535 0.372 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.505 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -76.33 -63.87 0.03 OUTLIER 'Trans proline' 0 N--CA 1.498 1.749 0 C-N-CA 120.903 1.069 . . . . 0.0 111.563 178.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 4.2 mt -47.19 -46.73 24.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.439 179.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.499 ' O ' ' N ' ' A' ' 86' ' ' THR . . . -68.38 -64.13 3.25 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 111.015 -0.834 . . . . 0.0 111.015 -179.852 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.406 ' CB ' ' O ' ' A' ' 80' ' ' VAL . 65.3 tp -41.9 -28.18 0.15 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.03 0.443 . . . . 0.0 109.88 179.751 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.465 ' CD1' ' C ' ' A' ' 85' ' ' TYR . 0.6 OUTLIER -76.85 -43.6 35.54 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.029 179.663 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.499 ' N ' ' O ' ' A' ' 83' ' ' GLY . 0.3 OUTLIER -61.56 -43.95 97.92 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.164 -179.57 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -73.62 -58.17 4.65 Favored Glycine 0 CA--C 1.527 0.808 0 C-N-CA 120.9 -0.667 . . . . 0.0 111.466 -179.455 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -51.14 -48.61 61.77 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-O 121.052 0.453 . . . . 0.0 109.943 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.435 ' O ' ' C ' ' A' ' 90' ' ' ALA . 23.3 tp -54.85 -63.39 1.17 Allowed 'General case' 0 C--O 1.211 -0.927 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.814 179.593 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.435 ' C ' ' O ' ' A' ' 89' ' ' LEU . . . -37.86 -42.87 0.64 Allowed 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 120.568 -0.453 . . . . 0.0 111.522 -179.497 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 90.8 mt -63.38 -56.98 11.87 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -178.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -72.62 -53.85 10.73 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.346 0.593 . . . . 0.0 111.33 -178.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . 0.606 ' O ' ' N ' ' A' ' 95' ' ' TRP . 30.7 t-105 -51.86 -33.31 35.85 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.152 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -60.01 72.11 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 120.611 -0.436 . . . . 0.0 109.89 179.228 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.694 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 22.2 p-90 -99.42 -15.91 0.19 Allowed Pre-proline 0 CA--C 1.538 0.505 0 N-CA-C 112.581 0.586 . . . . 0.0 112.581 -179.113 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.694 ' CD ' ' N ' ' A' ' 95' ' ' TRP . 49.3 Cg_exo -58.87 -31.14 94.79 Favored 'Trans proline' 0 N--CA 1.497 1.717 0 C-N-CA 120.645 0.897 . . . . 0.0 113.808 -179.731 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . 0.494 ' CD ' ' N ' ' A' ' 96' ' ' PRO . 89.0 Cg_exo -56.99 -13.91 12.99 Favored 'Trans proline' 0 N--CA 1.499 1.825 0 C-N-CA 120.642 0.895 . . . . 0.0 113.654 -179.152 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 1.1 pp -90.05 29.96 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 C-N-CA 120.453 -0.499 . . . . 0.0 110.779 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.585 ' CD2' ' O ' ' A' ' 96' ' ' PRO . 42.6 m-85 -50.37 -40.09 48.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.213 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . 0.598 ' CD1' ' N ' ' A' ' 100' ' ' PHE . 0.1 OUTLIER -70.05 -58.84 3.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.318 -179.311 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -55.56 -14.82 7.42 Favored Glycine 0 CA--C 1.522 0.489 0 N-CA-C 110.847 -0.901 . . . . 0.0 110.847 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -59.76 -12.14 6.63 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.587 0.232 . . . . 0.0 111.203 -179.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 -94.78 10.3 35.7 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 121.005 -0.278 . . . . 0.0 110.862 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 16.6 mt-30 -117.21 -175.35 2.78 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.732 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' MET . . . . . 0.495 ' CE ' ' CZ3' ' A' ' 155' ' ' TRP . 17.5 mmt -74.78 -18.31 60.49 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.094 0.473 . . . . 0.0 109.78 179.662 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.613 ' O ' ' N ' ' A' ' 108' ' ' ALA . . . -74.23 -14.77 80.39 Favored Glycine 0 CA--C 1.524 0.653 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.355 -179.702 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' TRP . . . . . 0.606 ' NE1' ' OD1' ' A' ' 151' ' ' ASN . 0.0 OUTLIER -41.6 -14.96 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.252 0 CA-C-O 120.749 0.309 . . . . 0.0 110.879 -179.468 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.613 ' N ' ' O ' ' A' ' 106' ' ' GLY . . . -62.49 -17.57 59.9 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.983 0.421 . . . . 0.0 110.172 179.53 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 6.8 mp -47.5 -30.7 3.65 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.358 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -57.81 -63.98 1.06 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.935 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.54 ' CG ' ' N ' ' A' ' 112' ' ' LEU . 1.9 p30 -57.82 -54.34 48.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.764 -179.224 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.54 ' N ' ' CG ' ' A' ' 111' ' ' ASP . 38.1 tp -52.84 -41.49 64.31 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.506 -0.316 . . . . 0.0 111.727 -178.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 57.2 mt -70.33 -62.12 1.51 Allowed 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.616 0.599 . . . . 0.0 112.616 -178.333 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.0 pp -59.0 -29.84 67.53 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 120.431 -0.508 . . . . 0.0 111.066 -178.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.532 ' CG2' ' O ' ' A' ' 111' ' ' ASP . 38.8 t -65.12 -60.61 2.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.221 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' SER . . . . . 0.499 ' O ' ' OG1' ' A' ' 120' ' ' THR . 9.8 p -68.81 -22.29 64.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.954 -179.55 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . 0.405 ' O ' ' CB ' ' A' ' 121' ' ' ALA . . . -65.34 -62.66 4.69 Favored Glycine 0 CA--C 1.525 0.693 0 C-N-CA 120.903 -0.665 . . . . 0.0 111.496 -179.474 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.493 ' O ' ' OG1' ' A' ' 122' ' ' THR . 9.6 p -73.24 -37.5 52.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 C-N-CA 120.957 -0.297 . . . . 0.0 111.233 -179.531 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . 0.526 ' O ' ' OG1' ' A' ' 123' ' ' THR . . . -67.02 -60.86 2.27 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.596 -0.442 . . . . 0.0 111.145 -179.393 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.499 ' OG1' ' O ' ' A' ' 116' ' ' SER . 1.6 m -60.36 -53.23 60.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.412 -179.455 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.405 ' CB ' ' O ' ' A' ' 117' ' ' GLY . . . -51.83 -42.38 62.5 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.916 -0.314 . . . . 0.0 111.044 -179.391 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.493 ' OG1' ' O ' ' A' ' 118' ' ' VAL . 35.6 p -71.55 -40.15 70.19 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.769 -179.09 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 0.526 ' OG1' ' O ' ' A' ' 119' ' ' ALA . 0.1 OUTLIER -54.77 -49.29 71.24 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 120.761 0.315 . . . . 0.0 110.897 -179.143 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.9 pp -84.11 -20.21 32.93 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.202 -0.454 . . . . 0.0 112.089 -178.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -90.17 -71.19 0.63 Allowed 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.821 0.675 . . . . 0.0 112.821 -178.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 41.6 m0 -80.46 -57.13 3.73 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 -177.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . 0.446 ' CD2' ' N ' ' A' ' 127' ' ' HIS . 10.4 m170 -55.48 -23.57 26.53 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.826 -0.35 . . . . 0.0 111.54 -178.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.77 -39.56 87.89 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.756 -0.377 . . . . 0.0 110.666 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 98.7 t -90.6 -49.54 13.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.942 -179.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 1.9 p -114.06 109.34 49.63 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.468 -179.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . 0.629 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 71.4 Cg_exo -69.68 -35.91 12.01 Favored 'Trans proline' 0 C--N 1.311 -1.418 0 C-N-CA 121.38 1.386 . . . . 0.0 112.422 179.472 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . 0.629 ' CD ' ' N ' ' A' ' 131' ' ' PRO . 29.8 Cg_exo -56.28 -40.64 83.41 Favored 'Trans proline' 0 N--CA 1.495 1.58 0 C-N-CA 121.374 1.383 . . . . 0.0 111.679 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -51.89 -44.54 63.79 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.265 179.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -58.65 -22.64 57.28 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.511 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 7.7 tpt85 -79.32 -29.42 42.35 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.535 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 12.8 mt -79.01 -28.96 43.42 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.389 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 0.477 ' O ' ' CD1' ' A' ' 140' ' ' TYR . 13.2 mt -93.74 -18.64 21.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.091 179.686 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.54 ' C ' ' CD1' ' A' ' 138' ' ' TYR . 0.3 OUTLIER -37.43 -52.19 2.46 Favored Pre-proline 0 CA--C 1.537 0.461 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.715 -179.764 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_endo -62.65 1.54 1.01 Allowed 'Trans proline' 0 N--CA 1.499 1.797 0 C-N-CA 121.734 1.622 . . . . 0.0 113.38 -179.281 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . 0.477 ' CD1' ' O ' ' A' ' 137' ' ' LEU . 0.1 OUTLIER -80.0 -13.7 59.13 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-O 120.921 0.391 . . . . 0.0 111.53 -179.679 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 74.8 mt -57.64 -34.05 68.93 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.072 179.099 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -53.45 -47.2 69.91 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 179.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' TRP . . . . . . . . . . . . . 8.8 t-105 -63.37 -44.2 95.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.74 179.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 25.3 mt -55.19 -54.97 36.61 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.334 -0.547 . . . . 0.0 110.281 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . 0.408 ' O ' ' CG2' ' A' ' 149' ' ' VAL . . . -64.68 -23.57 67.3 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.636 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 25.9 t80 -61.35 -59.16 5.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.771 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -64.33 -50.38 68.0 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.005 -179.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 10.9 m -52.62 -55.83 19.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.904 0.383 . . . . 0.0 110.769 -179.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.408 ' CG2' ' O ' ' A' ' 145' ' ' ALA . 80.9 t -58.25 -35.05 51.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.726 -179.772 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 4.8 tp -54.7 -58.11 8.82 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.471 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . 0.733 HD21 ' N ' ' A' ' 152' ' ' TYR . 0.2 OUTLIER -56.4 -58.89 6.08 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-O 120.988 0.423 . . . . 0.0 110.783 179.94 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . 0.733 ' N ' HD21 ' A' ' 151' ' ' ASN . 50.5 t80 -47.42 -39.65 16.03 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.83 -179.383 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 31.5 t80 -72.12 -35.83 69.25 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.401 -179.53 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 45.1 t -59.15 -47.04 91.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 C-N-CA 120.791 -0.364 . . . . 0.0 111.395 -179.291 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' TRP . . . . . 0.495 ' CZ3' ' CE ' ' A' ' 105' ' ' MET . 22.9 m95 -79.95 -28.68 39.63 Favored 'General case' 0 N--CA 1.464 0.225 0 C-N-CA 119.818 -0.753 . . . . 0.0 111.521 -179.279 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.41 -21.66 61.23 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.461 -0.495 . . . . 0.0 110.164 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -83.57 -40.06 19.58 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.918 -179.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 18.2 t30 . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.084 -179.587 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . 0.413 ' NE1' ' CD1' ' A' ' 68' ' ' TRP . 0.7 OUTLIER . . . . . 0 CA--C 1.528 0.127 0 CA-C-O 120.784 0.326 . . . . 0.0 110.275 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.585 ' N ' ' CD ' ' A' ' 7' ' ' PRO . 0.9 OUTLIER -60.84 -33.62 15.03 Favored Pre-proline 0 CA--C 1.533 0.306 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.144 -179.759 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.585 ' CD ' ' N ' ' A' ' 6' ' ' VAL . 24.2 Cg_exo -73.34 -62.64 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 121.613 1.542 . . . . 0.0 111.518 179.282 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.552 ' O ' ' CG2' ' A' ' 12' ' ' THR . . . -50.78 -36.51 37.29 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.849 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.477 ' O ' ' OG1' ' A' ' 12' ' ' THR . 56.0 t -68.27 -62.17 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.511 -179.442 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -55.6 -47.73 75.42 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 111.484 -0.646 . . . . 0.0 111.484 -179.33 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.416 ' N ' ' CD1' ' A' ' 11' ' ' LEU . 8.5 mp -64.84 -30.86 71.88 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 121.177 -0.209 . . . . 0.0 110.968 -179.514 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.552 ' CG2' ' O ' ' A' ' 8' ' ' ALA . 6.1 p -74.47 -22.95 58.84 Favored 'General case' 0 C--N 1.333 -0.135 0 C-N-CA 120.569 -0.453 . . . . 0.0 110.016 179.439 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 52.5 mt -80.18 -34.77 37.24 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.213 179.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.409 ' N ' ' HD2' ' A' ' 15' ' ' PRO . 11.9 t -43.63 -55.21 9.05 Favored Pre-proline 0 CA--C 1.536 0.423 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.45 -179.722 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.409 ' HD2' ' N ' ' A' ' 14' ' ' VAL . 13.8 Cg_endo -58.92 -21.92 60.26 Favored 'Trans proline' 0 N--CA 1.498 1.754 0 C-N-CA 120.672 0.915 . . . . 0.0 112.303 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 5.7 t -62.08 -30.59 71.1 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.825 -179.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 71.5 mt -71.62 -57.1 4.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.817 0.342 . . . . 0.0 110.893 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -61.16 -36.97 93.18 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 111.287 -0.725 . . . . 0.0 111.287 -179.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -75.44 -25.94 66.9 Favored Glycine 0 CA--C 1.521 0.461 0 N-CA-C 110.694 -0.962 . . . . 0.0 110.694 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 62.0 t80 -75.54 -60.62 2.23 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.528 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 3.9 ttt -70.16 -22.29 62.99 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.17 179.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -69.47 -62.31 3.97 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.825 -0.91 . . . . 0.0 110.825 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -68.55 -21.28 64.56 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.831 -0.348 . . . . 0.0 110.635 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 40.2 t80 -47.45 -24.0 0.73 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.013 0.435 . . . . 0.0 109.984 179.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 25.6 t80 -69.72 -52.26 27.07 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.966 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 36.0 m -72.14 -15.89 18.2 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.894 -179.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -59.82 -28.88 67.85 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.258 -179.388 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -123.39 -59.39 0.19 Allowed Glycine 0 CA--C 1.524 0.643 0 N-CA-C 111.199 -0.76 . . . . 0.0 111.199 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 27.7 tp10 -53.92 -28.99 40.18 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.745 0.307 . . . . 0.0 110.686 -179.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -73.78 -40.98 43.73 Favored Glycine 0 CA--C 1.526 0.754 0 N-CA-C 111.134 -0.786 . . . . 0.0 111.134 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 85.6 mt -62.98 -33.2 74.9 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.881 0.372 . . . . 0.0 110.482 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 18.6 mmm-85 -81.0 -40.01 24.98 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.35 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . 0.489 ' O ' ' N ' ' A' ' 36' ' ' GLY . 0.0 OUTLIER -56.11 -40.41 73.67 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.802 179.624 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 91.4 t80 -44.5 -42.11 6.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.518 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -60.27 -29.32 68.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.145 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.489 ' N ' ' O ' ' A' ' 33' ' ' TRP . . . -84.86 -76.72 1.19 Allowed Glycine 0 CA--C 1.524 0.602 0 N-CA-C 110.437 -1.065 . . . . 0.0 110.437 179.679 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -95.65 166.94 11.58 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.791 0.329 . . . . 0.0 110.221 179.277 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.415 ' N ' ' CD ' ' A' ' 38' ' ' GLN . 3.7 mp0 -81.54 113.02 19.29 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.483 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.417 ' NZ ' ' CZ3' ' A' ' 107' ' ' TRP . 8.9 mtpt -122.18 146.63 47.25 Favored Pre-proline 0 N--CA 1.464 0.265 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.05 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo . . . . . 0 C--N 1.309 -1.503 0 C-N-CA 121.28 1.32 . . . . 0.0 111.386 179.406 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.533 0.301 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.657 ' C ' ' H ' ' A' ' 52' ' ' ILE . . . -40.94 -28.92 0.23 Allowed Pre-proline 0 N--CA 1.465 0.281 0 N-CA-C 111.892 0.33 . . . . 0.0 111.892 -179.057 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_exo -54.03 7.36 0.03 OUTLIER 'Trans proline' 0 C--N 1.312 -1.359 0 CA-C-N 119.126 0.724 . . . . 0.0 112.78 178.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.657 ' H ' ' C ' ' A' ' 50' ' ' ALA . 8.1 pt -55.19 -31.35 26.05 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.133 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 178.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.403 ' O ' ' CB ' ' A' ' 57' ' ' TYR . 72.8 m95 -80.98 -22.21 39.7 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.124 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -69.92 -52.12 20.78 Favored Glycine 0 CA--C 1.527 0.828 0 N-CA-C 109.987 -1.245 . . . . 0.0 109.987 178.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.471 ' CG2' ' N ' ' A' ' 56' ' ' LEU . 9.3 t -67.23 -50.2 61.58 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 179.321 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.471 ' N ' ' CG2' ' A' ' 55' ' ' THR . 90.4 mt -58.4 -33.77 70.01 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 120.655 -0.418 . . . . 0.0 109.89 179.389 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.403 ' CB ' ' O ' ' A' ' 53' ' ' TRP . 3.6 t80 -59.16 -55.93 28.7 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 179.42 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 34.6 t -48.01 -50.33 27.95 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.347 -0.541 . . . . 0.0 109.88 179.339 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -55.63 -52.59 63.28 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.57 179.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.456 ' O ' ' OG ' ' A' ' 64' ' ' SER . 16.2 mtm -55.09 -37.68 67.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.036 -179.715 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -62.87 -41.2 99.92 Favored Glycine 0 CA--C 1.523 0.55 0 N-CA-C 111.216 -0.754 . . . . 0.0 111.216 -179.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -68.61 -60.25 2.55 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.695 0.283 . . . . 0.0 110.869 -179.487 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -55.48 -56.58 22.83 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 110.749 -0.94 . . . . 0.0 110.749 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.477 ' O ' ' NE1' ' A' ' 68' ' ' TRP . 92.7 p -45.77 -49.53 14.87 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.004 0.43 . . . . 0.0 110.473 179.699 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 73.5 t80 -58.16 -34.4 70.26 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.835 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 96.2 mt -74.25 -39.13 49.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.882 -179.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.411 ' CG1' ' CZ3' ' A' ' 68' ' ' TRP . 37.4 t -56.98 -58.17 6.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.616 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' TRP . . . . . 0.578 ' O ' ' N ' ' A' ' 73' ' ' GLY . 1.0 OUTLIER -60.82 -45.04 96.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.692 -179.837 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 2.7 mmmt -56.65 -25.73 54.25 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.02 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 23.5 tp10 -82.41 -63.06 1.45 Allowed 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.827 -0.349 . . . . 0.0 111.317 -179.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.5 ' C ' ' CD1' ' A' ' 71' ' ' LEU . 3.3 pp -62.93 -7.12 4.58 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.777 -0.369 . . . . 0.0 111.023 -179.478 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.498 ' O ' ' O ' ' A' ' 73' ' ' GLY . . . 108.45 71.69 0.73 Allowed Glycine 0 CA--C 1.527 0.791 0 N-CA-C 111.402 -0.679 . . . . 0.0 111.402 179.697 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.578 ' N ' ' O ' ' A' ' 68' ' ' TRP . . . 42.15 -174.03 0.01 OUTLIER Glycine 0 CA--C 1.525 0.698 0 N-CA-C 111.748 -0.541 . . . . 0.0 111.748 179.496 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 63.4 t80 -69.33 111.42 5.22 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.372 -0.414 . . . . 0.0 110.432 -179.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.477 ' OG1' ' N ' ' A' ' 76' ' ' GLU . 1.7 t -140.0 -178.6 5.52 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.538 -179.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.477 ' N ' ' OG1' ' A' ' 75' ' ' THR . 96.3 mt-10 -55.51 -23.24 25.09 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.632 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -79.97 -18.84 49.34 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.664 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -94.09 -24.42 17.59 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.927 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 13.1 mtp -62.19 -26.98 68.65 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.813 -0.355 . . . . 0.0 110.439 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 10.8 t -68.49 -52.99 18.4 Favored Pre-proline 0 CA--C 1.535 0.386 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.953 -179.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -66.42 -59.53 0.13 Allowed 'Trans proline' 0 N--CA 1.497 1.733 0 C-N-CA 120.97 1.113 . . . . 0.0 111.77 179.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.2 mt -55.27 -51.49 66.47 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.492 179.714 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -57.82 -51.08 60.22 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 111.153 -0.779 . . . . 0.0 111.153 -179.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.427 ' O ' ' CB ' ' A' ' 88' ' ' GLN . 44.3 tp -60.15 -29.74 68.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.834 0.349 . . . . 0.0 110.61 -179.832 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 11.6 t80 -71.25 -43.51 67.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.627 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 1.5 m -67.29 -48.03 68.86 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.888 -179.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -68.75 -57.27 8.14 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 111.162 -0.775 . . . . 0.0 111.162 -179.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.427 ' CB ' ' O ' ' A' ' 84' ' ' LEU . 53.1 tp60 -52.13 -46.01 65.19 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.826 0.346 . . . . 0.0 110.711 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 11.7 tp -66.12 -31.94 73.1 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.94 -179.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.417 ' O ' ' CB ' ' A' ' 94' ' ' ALA . . . -64.4 -65.64 0.65 Allowed 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 120.272 -0.571 . . . . 0.0 111.183 -179.547 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.8 pp -67.65 -36.96 81.72 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 -178.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.423 ' CB ' ' O ' ' A' ' 88' ' ' GLN . 34.7 t30 -75.03 -59.13 2.88 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 -178.768 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . 0.62 ' O ' ' N ' ' A' ' 95' ' ' TRP . 0.0 OUTLIER -69.95 -17.15 63.3 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 120.681 -0.408 . . . . 0.0 111.499 -178.576 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.417 ' CB ' ' O ' ' A' ' 90' ' ' ALA . . . -49.0 83.23 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 120.739 -0.385 . . . . 0.0 110.206 179.512 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.696 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 34.8 p-90 -101.42 -15.75 0.18 Allowed Pre-proline 0 CA--C 1.536 0.419 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 -179.278 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.696 ' CD ' ' N ' ' A' ' 95' ' ' TRP . 32.0 Cg_exo -60.24 -27.79 85.58 Favored 'Trans proline' 0 N--CA 1.495 1.564 0 C-N-CA 120.484 0.79 . . . . 0.0 113.126 179.654 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . 0.52 ' CD ' ' N ' ' A' ' 96' ' ' PRO . 97.2 Cg_exo -58.96 -17.53 37.93 Favored 'Trans proline' 0 N--CA 1.496 1.671 0 C-N-CA 120.592 0.861 . . . . 0.0 113.127 -179.81 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.531 ' O ' ' N ' ' A' ' 101' ' ' GLY . 1.2 pp -82.24 17.26 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 121.105 0.479 . . . . 0.0 110.304 179.699 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -40.22 -31.7 0.14 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.789 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -80.85 -30.32 35.67 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.246 -179.36 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 0.531 ' N ' ' O ' ' A' ' 98' ' ' ILE . . . -83.66 -11.97 78.67 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 111.372 -0.691 . . . . 0.0 111.372 -179.742 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -63.55 -33.06 74.77 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.673 0.273 . . . . 0.0 111.033 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -75.91 9.65 2.29 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.98 -179.654 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . 0.416 ' C ' ' N ' ' A' ' 106' ' ' GLY . 5.3 mt-30 -126.09 158.83 34.45 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.748 0.308 . . . . 0.0 110.574 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 6.7 mmt -48.79 -18.91 0.31 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.097 0.475 . . . . 0.0 110.348 179.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.593 ' O ' ' N ' ' A' ' 108' ' ' ALA . . . -66.51 -14.59 62.59 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 111.351 -0.7 . . . . 0.0 111.351 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' TRP . . . . . 0.526 ' CZ2' ' ND2' ' A' ' 151' ' ' ASN . 0.0 OUTLIER -42.33 -14.52 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.287 0 CA-C-O 120.561 0.22 . . . . 0.0 111.137 -179.368 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.593 ' N ' ' O ' ' A' ' 106' ' ' GLY . . . -64.78 -24.1 67.45 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.092 0.472 . . . . 0.0 110.321 179.686 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 6.6 mt -49.98 -27.99 6.2 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.59 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.24 -58.51 7.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.733 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.544 ' O ' ' CG2' ' A' ' 115' ' ' VAL . 1.0 OUTLIER -59.2 -52.32 66.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.558 -179.422 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.538 ' N ' ' CG ' ' A' ' 111' ' ' ASP . 57.4 tp -55.07 -43.17 73.66 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.43 -179.137 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 51.6 mt -67.12 -61.55 1.87 Allowed 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 -178.487 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.0 pp -60.94 -34.04 74.12 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.337 -0.545 . . . . 0.0 111.413 -178.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.544 ' CG2' ' O ' ' A' ' 111' ' ' ASP . 40.7 t -59.87 -56.82 14.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.763 179.877 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' SER . . . . . 0.491 ' O ' ' OG1' ' A' ' 120' ' ' THR . 41.5 t -72.09 -22.54 61.34 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.54 -179.208 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . 0.401 ' HA2' HD21 ' A' ' 92' ' ' ASN . . . -64.98 -62.74 4.7 Favored Glycine 0 CA--C 1.526 0.75 0 C-N-CA 120.938 -0.648 . . . . 0.0 111.674 -179.357 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.538 ' O ' ' OG1' ' A' ' 122' ' ' THR . 10.3 p -73.01 -37.62 53.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 C-N-CA 121.08 -0.248 . . . . 0.0 111.408 -179.476 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . 0.527 ' O ' ' OG1' ' A' ' 123' ' ' THR . . . -65.53 -60.24 3.14 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.684 -0.406 . . . . 0.0 111.149 -179.344 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.491 ' OG1' ' O ' ' A' ' 116' ' ' SER . 1.9 m -60.43 -52.77 63.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.673 -179.237 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -54.6 -39.93 68.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.601 -0.272 . . . . 0.0 111.417 -179.166 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.538 ' OG1' ' O ' ' A' ' 118' ' ' VAL . 22.9 p -71.48 -39.11 71.09 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.994 -0.283 . . . . 0.0 111.728 -179.195 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 0.527 ' OG1' ' O ' ' A' ' 119' ' ' ALA . 0.1 OUTLIER -58.46 -49.44 77.33 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.782 -0.367 . . . . 0.0 111.08 -179.286 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.2 pp -79.97 -20.48 45.47 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.581 -179.057 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -87.42 -70.88 0.59 Allowed 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 112.515 0.561 . . . . 0.0 112.515 -178.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' TRP . . . . . 0.469 ' N ' ' CD1' ' A' ' 126' ' ' TRP . 32.0 m0 -83.57 -57.36 3.27 Favored 'General case' 0 N--CA 1.465 0.275 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -177.687 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . 0.494 ' CD2' ' N ' ' A' ' 127' ' ' HIS . 7.0 m170 -54.52 -22.68 13.68 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.642 -0.423 . . . . 0.0 111.419 -178.672 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 17.1 ttt-85 -66.35 -39.62 89.28 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.877 -0.329 . . . . 0.0 111.137 -179.563 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 21.5 t -96.18 -49.77 11.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.149 -179.543 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 16.8 m -114.72 110.35 46.84 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.699 -179.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . 0.64 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 77.7 Cg_exo -75.19 -33.11 4.64 Favored 'Trans proline' 0 C--N 1.31 -1.479 0 C-N-CA 121.73 1.62 . . . . 0.0 112.871 179.544 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . 0.64 ' CD ' ' N ' ' A' ' 131' ' ' PRO . 53.1 Cg_exo -52.97 -49.91 15.92 Favored 'Trans proline' 0 N--CA 1.497 1.687 0 C-N-CA 121.587 1.525 . . . . 0.0 112.572 -179.536 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -53.27 -38.98 63.55 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.908 0.385 . . . . 0.0 110.666 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -56.18 -28.06 56.79 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.596 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 11.4 tpp180 -75.98 -29.66 58.3 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.653 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 54.3 mt -72.43 -35.74 68.39 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.878 0.37 . . . . 0.0 110.118 179.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 0.589 ' O ' ' N ' ' A' ' 140' ' ' TYR . 6.2 mt -82.46 -36.81 26.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.211 179.571 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.553 ' C ' ' H ' ' A' ' 140' ' ' TYR . 0.8 OUTLIER -21.04 -45.48 0.04 OUTLIER Pre-proline 0 N--CA 1.467 0.399 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.811 -179.725 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.559 ' N ' ' O ' ' A' ' 137' ' ' LEU . 5.5 Cg_exo -66.08 14.33 0.11 Allowed 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 120.986 1.124 . . . . 0.0 112.001 179.593 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . 0.656 ' CE1' ' CD1' ' A' ' 141' ' ' LEU . 3.7 p90 -93.25 -14.64 26.78 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.197 0.522 . . . . 0.0 110.341 179.684 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.656 ' CD1' ' CE1' ' A' ' 140' ' ' TYR . 5.9 mp -58.79 -30.63 67.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.268 178.578 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -60.92 -45.37 94.91 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.983 179.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' TRP . . . . . . . . . . . . . 7.7 t-105 -60.33 -49.57 77.06 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 179.415 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 11.9 mt -51.37 -54.61 24.75 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.743 179.322 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . 0.475 ' O ' ' CG2' ' A' ' 149' ' ' VAL . . . -59.72 -24.79 64.29 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.792 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 23.0 t80 -65.1 -59.16 4.42 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.741 -0.383 . . . . 0.0 110.711 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -67.18 -43.41 82.24 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.622 -0.431 . . . . 0.0 110.633 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 5.2 m -57.3 -55.13 38.79 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.579 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.475 ' CG2' ' O ' ' A' ' 145' ' ' ALA . 91.2 t -59.19 -31.66 46.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.59 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -58.33 -53.94 52.6 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.796 -0.362 . . . . 0.0 110.068 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . 0.526 ' ND2' ' CZ2' ' A' ' 107' ' ' TRP . 8.3 m120 -64.16 -53.37 50.49 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.939 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . 0.424 ' HH ' ' NH2' ' A' ' 156' ' ' ARG . 31.5 t80 -51.4 -37.53 48.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.867 -179.682 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 90.8 t80 -67.93 -42.68 80.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.949 -179.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 86.7 t -63.61 -38.27 81.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 C-N-CA 120.945 -0.302 . . . . 0.0 110.79 -179.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' TRP . . . . . . . . . . . . . 4.8 m0 -64.06 -45.96 86.49 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.536 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . 0.424 ' NH2' ' HH ' ' A' ' 152' ' ' TYR . 7.5 mpt_? -70.62 -34.31 71.97 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.954 -179.605 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -74.64 -37.79 62.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.111 -179.314 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' ASN . . . . . 0.476 ' O ' ' ND2' ' A' ' 158' ' ' ASN . 0.6 OUTLIER . . . . . 0 C--N 1.33 -0.256 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.918 -179.745 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . 0.426 ' O ' ' CG2' ' A' ' 9' ' ' VAL . 0.7 OUTLIER . . . . . 0 CA--C 1.528 0.102 0 CA-C-O 120.786 0.327 . . . . 0.0 110.282 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.594 ' N ' ' CD ' ' A' ' 7' ' ' PRO . 0.9 OUTLIER -62.36 -35.76 22.72 Favored Pre-proline 0 CA--C 1.534 0.35 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.43 -179.715 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.594 ' CD ' ' N ' ' A' ' 6' ' ' VAL . 35.2 Cg_exo -65.99 -64.59 0.05 OUTLIER 'Trans proline' 0 C--N 1.306 -1.665 0 C-N-CA 121.668 1.579 . . . . 0.0 111.827 179.624 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.547 ' O ' ' CG2' ' A' ' 12' ' ' THR . . . -51.65 -32.76 30.63 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.973 -179.706 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.426 ' CG2' ' O ' ' A' ' 5' ' ' TRP . 58.5 t -69.87 -61.37 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.94 0.4 . . . . 0.0 111.304 -179.447 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -57.89 -43.36 94.85 Favored Glycine 0 CA--C 1.528 0.853 0 N-CA-C 111.215 -0.754 . . . . 0.0 111.215 -179.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 8.1 mp -65.92 -62.95 1.21 Allowed 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 111.544 0.202 . . . . 0.0 111.544 -179.166 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.574 ' OG1' ' SD ' ' A' ' 60' ' ' MET . 6.9 t -54.38 -20.55 7.57 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.449 -0.5 . . . . 0.0 110.572 -179.395 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.431 ' O ' ' C ' ' A' ' 14' ' ' VAL . 17.6 mt -78.79 -38.12 39.17 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.779 0.324 . . . . 0.0 110.371 179.611 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.431 ' C ' ' O ' ' A' ' 13' ' ' LEU . 28.1 t -35.55 -56.72 1.01 Allowed Pre-proline 0 CA--C 1.534 0.342 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.63 -179.774 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.416 ' HD2' ' N ' ' A' ' 14' ' ' VAL . 15.4 Cg_endo -54.6 -32.59 75.46 Favored 'Trans proline' 0 N--CA 1.498 1.772 0 C-N-CA 120.475 0.783 . . . . 0.0 112.501 -179.488 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.421 ' N ' ' O ' ' A' ' 13' ' ' LEU . 2.3 t -45.05 -25.96 0.39 Allowed 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 120.396 -0.522 . . . . 0.0 110.341 -179.586 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 74.5 mt -72.85 -53.69 10.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.128 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -68.61 -34.48 78.69 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 111.594 -0.602 . . . . 0.0 111.594 -179.399 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -75.14 -29.61 60.21 Favored Glycine 0 CA--C 1.517 0.184 0 N-CA-C 110.651 -0.98 . . . . 0.0 110.651 -179.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 36.9 t80 -74.79 -60.71 2.16 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.506 -0.478 . . . . 0.0 110.64 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 9.4 ttt -69.7 -22.85 63.38 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.809 -179.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -73.59 -63.23 2.8 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 111.081 -0.808 . . . . 0.0 111.081 -179.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.83 -23.49 67.38 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.424 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 76.2 t80 -47.83 -23.5 0.76 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.936 0.398 . . . . 0.0 109.95 179.235 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 46.8 t80 -69.49 -52.65 24.56 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.703 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 31.1 m -71.14 -16.2 19.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.864 -179.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 2.4 tmt_? -58.04 -46.38 85.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.79 0.328 . . . . 0.0 110.568 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -100.73 -60.51 0.81 Allowed Glycine 0 CA--C 1.526 0.749 0 N-CA-C 110.916 -0.873 . . . . 0.0 110.916 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -49.84 -31.69 12.51 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.753 0.311 . . . . 0.0 110.546 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.468 ' CA ' ' HZ2' ' A' ' 39' ' ' LYS . . . -68.7 -53.6 19.26 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 110.826 -0.91 . . . . 0.0 110.826 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 71.2 mt -51.24 -38.68 53.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.831 0.348 . . . . 0.0 110.51 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 20.1 mmm-85 -75.13 -46.85 31.7 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.035 -179.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 4.8 m95 -47.12 -39.35 13.17 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 120.853 -0.339 . . . . 0.0 110.269 -179.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 77.6 t80 -53.33 -26.11 17.63 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.312 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -75.89 -16.38 60.05 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.377 179.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -111.37 -76.47 0.83 Allowed Glycine 0 CA--C 1.523 0.568 0 N-CA-C 110.727 -0.949 . . . . 0.0 110.727 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.518 ' C ' ' CD1' ' A' ' 37' ' ' LEU . 3.6 pp -95.27 165.41 12.4 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 110.245 -0.28 . . . . 0.0 110.245 179.708 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 77.0 mm-40 -75.55 113.08 12.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.93 0.395 . . . . 0.0 111.624 -179.121 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.468 ' HZ2' ' CA ' ' A' ' 30' ' ' GLY . 0.7 OUTLIER -129.59 135.48 27.61 Favored Pre-proline 0 CA--C 1.536 0.424 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 179.313 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo . . . . . 0 N--CA 1.496 1.671 0 C-N-CA 120.386 0.724 . . . . 0.0 111.617 179.582 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.533 0.289 0 N-CA-C 111.867 0.321 . . . . 0.0 111.867 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.656 ' C ' ' H ' ' A' ' 52' ' ' ILE . . . -39.96 -29.57 0.21 Allowed Pre-proline 0 C--O 1.234 0.281 0 N-CA-C 111.88 0.326 . . . . 0.0 111.88 -178.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -53.19 4.5 0.03 OUTLIER 'Trans proline' 0 C--N 1.312 -1.379 0 CA-C-N 119.179 0.742 . . . . 0.0 112.439 178.158 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.656 ' H ' ' C ' ' A' ' 50' ' ' ALA . 8.1 pt -52.49 -33.45 17.84 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.174 0 CA-C-O 121.101 0.477 . . . . 0.0 109.961 179.214 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.439 ' O ' ' CB ' ' A' ' 57' ' ' TYR . 72.6 m95 -79.72 -23.38 42.37 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.45 -179.002 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -71.76 -46.22 39.52 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 110.12 -1.192 . . . . 0.0 110.12 179.08 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 5.9 m -68.36 -52.22 35.66 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 179.321 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 96.0 mt -60.02 -28.72 67.97 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.887 179.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.512 ' C ' ' CD1' ' A' ' 57' ' ' TYR . 0.4 OUTLIER -63.76 -51.53 64.43 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 179.454 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.411 ' HB2' ' HH ' ' A' ' 62' ' ' TYR . 5.8 p -53.98 -50.73 65.91 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.152 179.467 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.71 -42.03 87.7 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.329 179.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.574 ' SD ' ' OG1' ' A' ' 12' ' ' THR . 11.3 mtm -59.27 -40.87 87.41 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.926 179.579 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -58.83 -45.09 95.47 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 110.526 -1.03 . . . . 0.0 110.526 179.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.481 ' N ' ' CD1' ' A' ' 62' ' ' TYR . 2.9 m-30 -62.15 -60.0 4.23 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 121.06 -0.256 . . . . 0.0 110.951 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -54.04 -60.89 7.76 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 110.986 -0.845 . . . . 0.0 110.986 -179.593 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.521 ' O ' ' CD1' ' A' ' 68' ' ' TRP . 56.0 p -45.5 -48.27 14.09 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.012 0.434 . . . . 0.0 110.465 179.804 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 57.6 t80 -56.47 -41.05 75.91 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.945 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 79.4 mt -67.8 -43.44 86.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.952 -179.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.496 ' CG1' ' CZ3' ' A' ' 68' ' ' TRP . 21.5 t -52.54 -56.33 7.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.86 -179.774 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' TRP . . . . . 0.591 ' O ' ' N ' ' A' ' 73' ' ' GLY . 1.0 OUTLIER -66.29 -46.85 75.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.089 -179.391 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.07 -24.46 40.0 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.947 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -81.19 -62.1 1.76 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.348 -179.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.2 pp -69.3 -2.15 9.99 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.46 -179.101 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.491 ' O ' ' O ' ' A' ' 73' ' ' GLY . . . 108.4 71.13 0.71 Allowed Glycine 0 CA--C 1.527 0.817 0 N-CA-C 111.572 -0.611 . . . . 0.0 111.572 179.557 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.591 ' N ' ' O ' ' A' ' 68' ' ' TRP . . . 42.03 -173.53 0.01 OUTLIER Glycine 0 CA--C 1.525 0.701 0 N-CA-C 111.94 -0.464 . . . . 0.0 111.94 179.286 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 57.6 t80 -69.81 111.21 5.4 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.203 -0.498 . . . . 0.0 111.009 -179.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.516 ' OG1' ' N ' ' A' ' 76' ' ' GLU . 1.3 t -139.4 -175.44 4.18 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.226 179.664 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.516 ' N ' ' OG1' ' A' ' 75' ' ' THR . 73.4 mt-10 -52.92 -24.4 9.18 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.086 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -79.92 -17.71 52.39 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.001 -179.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -96.78 -15.6 21.26 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.04 -179.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 7.0 mtp -70.05 -28.27 65.32 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.484 -0.326 . . . . 0.0 110.885 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 5.1 t -70.47 -54.99 8.02 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.758 -179.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -62.93 -54.61 1.08 Allowed 'Trans proline' 0 N--CA 1.498 1.764 0 C-N-CA 120.993 1.129 . . . . 0.0 111.802 179.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.5 mt -61.05 -55.91 27.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.533 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -53.33 -60.32 8.34 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 111.084 -0.807 . . . . 0.0 111.084 -179.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.6 tt -48.54 -40.82 28.34 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.781 0.324 . . . . 0.0 110.631 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.4 ' O ' ' CB ' ' A' ' 89' ' ' LEU . 11.0 t80 -63.02 -36.15 82.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.597 -179.747 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.449 ' H ' ' HG1' ' A' ' 86' ' ' THR . 0.2 OUTLIER -68.74 -63.05 1.14 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.197 -179.556 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -60.11 -55.59 29.39 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 111.378 -0.689 . . . . 0.0 111.378 -179.547 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.423 ' O ' ' CB ' ' A' ' 92' ' ' ASN . 6.5 tp-100 -50.84 -47.25 60.28 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.652 0.263 . . . . 0.0 111.029 -179.669 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.4 ' CB ' ' O ' ' A' ' 85' ' ' TYR . 11.4 tp -65.3 -28.83 69.59 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.98 0.419 . . . . 0.0 110.313 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.433 ' O ' ' CB ' ' A' ' 94' ' ' ALA . . . -64.7 -65.57 0.66 Allowed 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 120.429 -0.509 . . . . 0.0 111.404 -179.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.3 pp -71.59 -26.11 62.46 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -178.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.423 ' CB ' ' O ' ' A' ' 88' ' ' GLN . 19.1 t-20 -83.53 -57.23 3.32 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.68 -0.408 . . . . 0.0 111.75 -178.847 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . 0.621 ' O ' ' N ' ' A' ' 95' ' ' TRP . 0.0 OUTLIER -72.08 -20.58 61.63 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.693 -0.403 . . . . 0.0 111.091 -178.851 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.433 ' CB ' ' O ' ' A' ' 90' ' ' ALA . . . -46.94 85.31 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.115 0 C-N-CA 120.703 -0.399 . . . . 0.0 110.207 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.707 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 34.4 p-90 -99.77 -16.9 0.2 Allowed Pre-proline 0 CA--C 1.537 0.445 0 CA-C-N 116.2 -0.455 . . . . 0.0 112.119 -179.653 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.707 ' CD ' ' N ' ' A' ' 95' ' ' TRP . 50.1 Cg_exo -55.15 -36.61 93.49 Favored 'Trans proline' 0 N--CA 1.496 1.639 0 C-N-CA 120.424 0.749 . . . . 0.0 113.106 179.483 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . 0.443 ' HD2' ' N ' ' A' ' 96' ' ' PRO . 26.7 Cg_exo -39.74 -29.5 0.29 Allowed 'Trans proline' 0 N--CA 1.491 1.364 0 CA-C-N 118.979 0.671 . . . . 0.0 113.261 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 1.1 pt -83.87 26.45 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 121.109 0.48 . . . . 0.0 110.341 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.444 ' N ' ' O ' ' A' ' 96' ' ' PRO . 11.1 t80 -40.82 -43.52 2.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.794 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -81.53 -42.8 19.66 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.859 -179.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -61.09 -7.01 7.94 Favored Glycine 0 CA--C 1.527 0.791 0 N-CA-C 111.21 -0.756 . . . . 0.0 111.21 -179.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -76.01 -7.32 54.38 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 121.015 -0.274 . . . . 0.0 110.884 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 39.7 ptt85 -89.34 2.04 54.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.77 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 9.4 mt-30 -119.47 164.34 15.92 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.492 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' MET . . . . . 0.586 ' O ' ' NE1' ' A' ' 155' ' ' TRP . 0.0 OUTLIER -52.44 -17.46 1.22 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.296 179.78 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.577 ' O ' ' N ' ' A' ' 108' ' ' ALA . . . -68.11 -15.34 67.33 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 111.058 -0.817 . . . . 0.0 111.058 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' TRP . . . . . 0.416 ' CD1' ' C ' ' A' ' 107' ' ' TRP . 0.0 OUTLIER -44.87 -11.71 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.726 0.298 . . . . 0.0 110.802 -179.727 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.577 ' N ' ' O ' ' A' ' 106' ' ' GLY . . . -66.99 -23.28 65.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.998 0.428 . . . . 0.0 110.485 179.765 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 8.3 mp -52.44 -29.82 26.43 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.023 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -55.87 -64.02 0.99 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.396 179.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.586 ' OD1' ' N ' ' A' ' 112' ' ' LEU . 1.6 p30 -55.62 -52.46 63.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.917 -179.418 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.586 ' N ' ' OD1' ' A' ' 111' ' ' ASP . 8.1 tp -55.55 -40.88 72.47 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.884 -0.327 . . . . 0.0 111.714 -178.66 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 50.5 mt -68.68 -61.36 1.85 Allowed 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.678 -0.409 . . . . 0.0 111.912 -178.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.5 pp -57.95 -34.51 69.98 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 120.361 -0.536 . . . . 0.0 111.122 -178.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.537 ' CG2' ' O ' ' A' ' 111' ' ' ASP . 41.0 t -59.96 -54.52 33.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.912 179.745 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' SER . . . . . 0.443 ' O ' ' OG1' ' A' ' 120' ' ' THR . 58.7 m -71.68 -24.01 61.75 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.573 -179.286 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -65.22 -63.05 4.39 Favored Glycine 0 CA--C 1.527 0.821 0 C-N-CA 120.824 -0.703 . . . . 0.0 111.762 -179.32 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.519 ' O ' ' OG1' ' A' ' 122' ' ' THR . 8.0 p -71.78 -37.87 63.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 O-C-N 122.834 -0.215 . . . . 0.0 111.429 -179.404 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . 0.483 ' O ' ' OG1' ' A' ' 123' ' ' THR . . . -66.22 -60.85 2.4 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.623 -0.431 . . . . 0.0 111.192 -179.171 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.454 ' H ' ' HG1' ' A' ' 120' ' ' THR . 3.0 m -59.1 -54.28 48.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.408 -179.241 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.411 ' O ' ' CB ' ' A' ' 125' ' ' ALA . . . -52.31 -40.35 61.74 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.414 -179.24 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.519 ' OG1' ' O ' ' A' ' 118' ' ' VAL . 33.4 p -73.71 -35.53 65.12 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 111.918 0.34 . . . . 0.0 111.918 -178.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 0.483 ' OG1' ' O ' ' A' ' 119' ' ' ALA . 0.1 OUTLIER -59.94 -48.51 81.41 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.821 -0.352 . . . . 0.0 110.947 -179.458 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.6 pp -83.79 -19.98 34.09 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.616 -179.011 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . 0.411 ' CB ' ' O ' ' A' ' 121' ' ' ALA . . . -87.66 -68.03 0.78 Allowed 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -178.606 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' TRP . . . . . 0.44 ' N ' ' CD1' ' A' ' 126' ' ' TRP . 38.0 m0 -85.22 -57.44 3.08 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 112.762 0.653 . . . . 0.0 112.762 -177.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . 0.494 ' CD2' ' N ' ' A' ' 127' ' ' HIS . 8.5 m170 -54.37 -22.46 12.32 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.903 -0.319 . . . . 0.0 111.374 -178.58 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . 0.409 ' C ' ' CD ' ' A' ' 128' ' ' ARG . 0.0 OUTLIER -70.84 -48.49 53.66 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.877 -0.329 . . . . 0.0 111.058 -179.665 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 44.2 t -80.82 -49.83 17.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.207 -179.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 5.7 t -129.85 115.6 17.94 Favored Pre-proline 0 CA--C 1.532 0.281 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.827 -179.487 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . 0.565 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 82.7 Cg_exo -72.12 -43.34 1.16 Allowed 'Trans proline' 0 N--CA 1.491 1.371 0 C-N-CA 121.294 1.329 . . . . 0.0 113.077 179.436 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . 0.565 ' CD ' ' N ' ' A' ' 131' ' ' PRO . 68.8 Cg_exo -36.91 -48.82 1.5 Allowed 'Trans proline' 0 N--CA 1.497 1.684 0 C-N-CA 121.038 1.159 . . . . 0.0 112.099 -179.392 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -54.94 -34.98 63.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.042 0.448 . . . . 0.0 110.028 179.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . 0.554 ' N ' ' O ' ' A' ' 131' ' ' PRO . . . -61.64 -22.36 65.2 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.316 179.609 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 12.1 tpp180 -77.69 -34.58 52.83 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.844 -179.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 29.9 mt -73.9 -33.52 64.04 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.63 -0.428 . . . . 0.0 109.922 179.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 0.586 ' O ' ' N ' ' A' ' 139' ' ' PRO . 10.1 mt -80.16 -40.37 27.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.276 -0.42 . . . . 0.0 109.973 179.315 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.493 ' O ' ' CD1' ' A' ' 138' ' ' TYR . 1.1 t80 -23.02 -40.61 0.03 OUTLIER Pre-proline 0 CA--C 1.534 0.335 0 CA-C-N 115.251 -0.886 . . . . 0.0 112.0 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.586 ' N ' ' O ' ' A' ' 137' ' ' LEU . 3.0 Cg_exo -70.59 13.51 0.35 Allowed 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 121.037 1.158 . . . . 0.0 112.237 179.698 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . 0.64 ' CE1' ' CD1' ' A' ' 141' ' ' LEU . 2.6 p90 -94.18 -14.81 25.21 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-O 121.27 0.557 . . . . 0.0 110.438 179.833 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.64 ' CD1' ' CE1' ' A' ' 140' ' ' TYR . 5.2 mp -56.41 -27.8 57.55 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.266 178.805 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -63.78 -46.43 85.28 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.002 179.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' TRP . . . . . . . . . . . . . 13.6 t-105 -59.61 -46.82 87.84 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 179.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.484 ' O ' ' OG1' ' A' ' 148' ' ' THR . 10.8 mt -52.48 -52.34 54.82 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.263 -0.575 . . . . 0.0 109.871 179.625 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . 0.526 ' O ' ' CG2' ' A' ' 149' ' ' VAL . . . -64.14 -21.76 66.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.664 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 13.5 t80 -66.09 -63.0 1.18 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.828 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -68.9 -36.48 78.08 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.882 -179.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' THR . . . . . 0.498 ' O ' ' OD1' ' A' ' 151' ' ' ASN . 14.8 m -63.32 -50.01 71.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.735 0.302 . . . . 0.0 110.684 -179.828 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.526 ' CG2' ' O ' ' A' ' 145' ' ' ALA . 88.3 t -65.84 -30.69 50.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.567 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 1.4 tp -60.53 -52.9 63.22 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.9 -0.32 . . . . 0.0 110.209 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . 0.498 ' OD1' ' O ' ' A' ' 148' ' ' THR . 0.8 OUTLIER -64.53 -44.04 92.12 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.905 -179.959 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . 0.495 ' N ' ' ND2' ' A' ' 151' ' ' ASN . 26.0 t80 -56.64 -44.51 81.37 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.653 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . 0.428 ' CD2' ' OD2' ' A' ' 157' ' ' ASP . 20.5 t80 -59.08 -55.07 39.85 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.574 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 64.8 t -57.35 -46.09 85.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.75 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' TRP . . . . . 0.586 ' NE1' ' O ' ' A' ' 105' ' ' MET . 5.1 m0 -48.07 -52.06 21.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.818 0.342 . . . . 0.0 110.173 179.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . 0.409 ' HE ' ' HA ' ' A' ' 156' ' ' ARG . 0.0 OUTLIER -64.7 -52.2 58.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.685 -179.83 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . 0.428 ' OD2' ' CD2' ' A' ' 153' ' ' TYR . 80.0 m-20 -50.02 -48.14 52.76 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.854 -179.689 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 29.2 t-20 . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.777 -179.991 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . 0.711 ' CE2' ' CE3' ' A' ' 68' ' ' TRP . 0.4 OUTLIER . . . . . 0 CA--C 1.528 0.13 0 CA-C-O 120.663 0.268 . . . . 0.0 110.595 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.638 ' N ' ' CD ' ' A' ' 7' ' ' PRO . 1.0 OUTLIER -64.26 -33.32 8.96 Favored Pre-proline 0 C--N 1.328 -0.329 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 179.662 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.638 ' CD ' ' N ' ' A' ' 6' ' ' VAL . 18.9 Cg_exo -72.78 -67.12 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 121.855 1.703 . . . . 0.0 111.867 179.613 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.544 ' O ' ' CG2' ' A' ' 12' ' ' THR . . . -47.74 -41.89 24.12 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.319 -179.537 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.488 ' O ' ' OG1' ' A' ' 12' ' ' THR . 74.7 t -67.94 -62.41 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -178.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -53.78 -47.53 64.74 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 111.567 -0.613 . . . . 0.0 111.567 -179.163 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.415 ' N ' ' CD1' ' A' ' 11' ' ' LEU . 7.6 mp -65.34 -30.53 71.37 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.533 0.206 . . . . 0.0 111.105 -179.519 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.544 ' CG2' ' O ' ' A' ' 8' ' ' ALA . 6.6 p -76.14 -25.18 55.08 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.749 -0.381 . . . . 0.0 110.786 -179.831 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.425 ' O ' ' C ' ' A' ' 14' ' ' VAL . 9.3 mt -81.72 -36.3 28.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.673 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.425 ' C ' ' O ' ' A' ' 13' ' ' LEU . 4.9 t -37.08 -55.08 1.74 Allowed Pre-proline 0 CA--C 1.535 0.398 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.784 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.417 ' HD2' ' N ' ' A' ' 14' ' ' VAL . 19.3 Cg_endo -60.98 -47.82 11.84 Favored 'Trans proline' 0 N--CA 1.5 1.868 0 C-N-CA 120.678 0.919 . . . . 0.0 112.125 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.9 m -46.01 -22.14 0.19 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.662 -179.556 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 83.9 mt -71.02 -55.9 7.32 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.85 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -74.84 -21.57 78.33 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 111.157 -0.777 . . . . 0.0 111.157 -179.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -69.79 -52.69 18.71 Favored Glycine 0 CA--C 1.522 0.483 0 N-CA-C 110.573 -1.011 . . . . 0.0 110.573 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 68.9 t80 -71.14 -57.88 4.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.721 0.296 . . . . 0.0 110.595 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 8.1 tpp -59.95 -25.69 65.39 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.278 -179.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -82.55 -62.98 1.81 Allowed Glycine 0 CA--C 1.525 0.718 0 C-N-CA 120.839 -0.696 . . . . 0.0 111.485 -179.421 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -59.6 -15.64 20.14 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.798 -0.361 . . . . 0.0 110.659 -179.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 61.6 t80 -46.7 -26.19 0.88 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.981 0.42 . . . . 0.0 110.389 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 70.5 t80 -67.73 -50.65 56.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.661 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 31.3 m -72.57 -21.03 19.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.671 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -61.24 -41.09 96.28 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.381 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -110.17 -73.44 0.74 Allowed Glycine 0 CA--C 1.525 0.702 0 N-CA-C 111.034 -0.826 . . . . 0.0 111.034 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.422 ' O ' ' CD ' ' A' ' 29' ' ' GLU . 13.0 tm-20 -46.01 -26.51 0.74 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.753 0.311 . . . . 0.0 110.57 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -65.28 -53.25 33.96 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 111.185 -0.766 . . . . 0.0 111.185 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 24.7 mt -48.5 -28.93 3.66 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.916 0.389 . . . . 0.0 110.211 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 82.8 mtt180 -84.1 -53.75 5.32 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.567 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -44.74 -35.92 2.92 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.19 -0.459 . . . . 0.0 109.96 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.443 ' O ' ' O ' ' A' ' 37' ' ' LEU . 2.8 t80 -64.42 -46.62 82.42 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.938 179.558 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -51.18 -22.88 2.86 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.124 179.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -90.59 -73.9 1.27 Allowed Glycine 0 CA--C 1.524 0.614 0 N-CA-C 110.569 -1.013 . . . . 0.0 110.569 179.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.493 ' CB ' HD22 ' A' ' 158' ' ' ASN . 0.6 OUTLIER -96.2 167.23 11.32 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 120.791 0.329 . . . . 0.0 110.238 179.171 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -77.57 116.09 17.86 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.963 0.411 . . . . 0.0 111.55 -178.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 8.0 mtpt -128.93 149.12 71.54 Favored Pre-proline 0 CA--C 1.532 0.275 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.562 179.385 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo . . . . . 0 C--N 1.308 -1.564 0 C-N-CA 121.199 1.266 . . . . 0.0 111.022 179.304 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 44.1 tp . . . . . 0 CA--C 1.531 0.235 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.644 ' C ' ' H ' ' A' ' 52' ' ' ILE . . . -41.74 -28.92 0.27 Allowed Pre-proline 0 N--CA 1.466 0.358 0 C-N-CA 120.22 -0.592 . . . . 0.0 111.46 -179.138 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.409 ' HD2' ' N ' ' A' ' 50' ' ' ALA . 23.2 Cg_exo -53.05 4.06 0.03 OUTLIER 'Trans proline' 0 C--N 1.312 -1.364 0 CA-C-N 118.847 0.624 . . . . 0.0 112.123 177.829 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.644 ' H ' ' C ' ' A' ' 50' ' ' ALA . 7.1 pt -48.44 -29.61 2.55 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.177 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 179.054 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 6.5 m0 -58.97 -45.44 90.54 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.465 -0.788 . . . . 0.0 110.89 -179.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -68.84 -42.53 78.48 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 110.901 -0.879 . . . . 0.0 110.901 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.494 ' O ' ' OG ' ' A' ' 58' ' ' SER . 51.9 m -59.04 -56.31 23.93 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.798 0.332 . . . . 0.0 110.709 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 70.4 mt -67.32 -30.45 70.29 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.665 -179.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.493 ' C ' ' CD1' ' A' ' 57' ' ' TYR . 13.7 t80 -60.8 -36.31 78.7 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.132 179.572 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.579 ' HG ' ' H ' ' A' ' 59' ' ' ALA . 7.7 p -74.07 -57.92 3.64 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.047 179.587 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.579 ' H ' ' HG ' ' A' ' 58' ' ' SER . . . -48.53 -52.29 23.29 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.022 179.645 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 70.6 mtm -55.09 -47.88 74.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.072 179.608 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -46.82 -59.56 5.44 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 110.717 -0.953 . . . . 0.0 110.717 179.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 3.4 m-30 -51.84 -52.18 51.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.924 0.392 . . . . 0.0 110.116 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -47.83 -46.76 25.33 Favored Glycine 0 CA--C 1.522 0.53 0 N-CA-C 110.487 -1.045 . . . . 0.0 110.487 179.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.537 ' O ' ' NE1' ' A' ' 68' ' ' TRP . 1.1 t -60.53 -45.04 95.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.793 0.33 . . . . 0.0 110.577 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.402 ' HA ' ' CZ2' ' A' ' 68' ' ' TRP . 84.6 t80 -48.55 -45.85 38.19 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 179.58 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 37.9 mt -72.27 -26.06 24.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.136 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 55.8 t -65.21 -59.94 3.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 C-N-CA 120.584 -0.446 . . . . 0.0 111.09 -179.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' TRP . . . . . 0.711 ' CE3' ' CE2' ' A' ' 5' ' ' TRP . 0.0 OUTLIER -67.51 -33.83 75.88 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 119.9 -0.72 . . . . 0.0 110.563 -179.753 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 5.8 mmmt -69.56 -23.41 63.56 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.517 -0.473 . . . . 0.0 111.035 -179.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 19.9 tp10 -80.95 -55.61 4.67 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.941 -0.304 . . . . 0.0 111.226 -179.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.6 pp -77.04 -11.77 59.85 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.93 -0.308 . . . . 0.0 111.184 -179.301 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.491 ' O ' ' O ' ' A' ' 73' ' ' GLY . . . 107.0 87.29 1.93 Allowed Glycine 0 CA--C 1.527 0.835 0 N-CA-C 111.604 -0.598 . . . . 0.0 111.604 179.398 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.596 ' N ' ' O ' ' A' ' 68' ' ' TRP . . . 41.56 -173.82 0.01 OUTLIER Glycine 0 CA--C 1.525 0.714 0 N-CA-C 111.797 -0.521 . . . . 0.0 111.797 179.207 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 82.7 t80 -79.94 113.39 18.07 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.841 0.353 . . . . 0.0 110.548 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.548 ' OG1' ' N ' ' A' ' 76' ' ' GLU . 0.0 OUTLIER -141.89 -178.85 5.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.626 -179.86 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.548 ' N ' ' OG1' ' A' ' 75' ' ' THR . 31.8 mt-10 -54.93 -20.12 8.23 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.623 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 76.0 m-20 -83.1 -18.57 39.1 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.921 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -93.32 -20.21 20.61 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.862 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 11.7 mtp -69.01 -27.22 65.49 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.846 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 5.9 t -67.56 -46.9 47.3 Favored Pre-proline 0 CA--C 1.536 0.432 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.534 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -75.18 -61.65 0.04 OUTLIER 'Trans proline' 0 N--CA 1.499 1.845 0 C-N-CA 121.106 1.204 . . . . 0.0 111.656 178.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 4.6 mt -52.33 -50.66 61.84 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.363 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.406 ' O ' ' N ' ' A' ' 86' ' ' THR . . . -61.93 -64.04 4.27 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 111.262 -0.735 . . . . 0.0 111.262 -179.705 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 40.3 tp -46.83 -29.61 2.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.823 0.344 . . . . 0.0 110.233 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.423 ' CD1' ' C ' ' A' ' 85' ' ' TYR . 1.1 t80 -75.27 -37.68 60.82 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.033 179.744 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.406 ' N ' ' O ' ' A' ' 83' ' ' GLY . 0.8 OUTLIER -67.91 -48.92 64.63 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.094 -179.648 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -69.15 -58.04 7.06 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 111.492 -0.643 . . . . 0.0 111.492 -179.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 34.0 tp60 -51.45 -49.23 62.14 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-O 120.991 0.424 . . . . 0.0 110.414 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.427 ' O ' ' C ' ' A' ' 90' ' ' ALA . 27.3 tp -54.65 -62.62 1.54 Allowed 'General case' 0 C--O 1.212 -0.869 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 179.525 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.431 ' O ' ' CB ' ' A' ' 94' ' ' ALA . . . -38.24 -42.81 0.72 Allowed 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 120.537 -0.465 . . . . 0.0 111.426 -179.683 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 92.1 mt -63.16 -56.81 13.57 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 -178.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 15.8 m-20 -72.24 -54.63 9.02 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 121.431 0.634 . . . . 0.0 111.058 -178.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . 0.61 ' O ' ' N ' ' A' ' 95' ' ' TRP . 16.6 t-105 -52.75 -30.0 30.23 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.049 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.431 ' CB ' ' O ' ' A' ' 90' ' ' ALA . . . -60.38 71.8 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 121.084 0.469 . . . . 0.0 109.753 179.376 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.71 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 23.8 p-90 -98.49 -17.18 0.2 Allowed Pre-proline 0 CA--C 1.537 0.478 0 CA-C-N 115.852 -0.613 . . . . 0.0 112.336 -179.255 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.71 ' CD ' ' N ' ' A' ' 95' ' ' TRP . 52.6 Cg_exo -53.4 -39.84 80.31 Favored 'Trans proline' 0 N--CA 1.497 1.684 0 C-N-CA 120.556 0.837 . . . . 0.0 113.341 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . 0.467 ' C ' ' H ' ' A' ' 99' ' ' PHE . 31.7 Cg_exo -36.52 -34.94 0.17 Allowed 'Trans proline' 0 N--CA 1.491 1.327 0 CA-C-N 119.143 0.73 . . . . 0.0 113.185 -179.727 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -79.58 24.27 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 121.024 0.44 . . . . 0.0 110.386 179.696 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.537 ' N ' ' O ' ' A' ' 96' ' ' PRO . 27.0 t80 -44.31 -34.93 2.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.666 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -86.19 -42.97 13.39 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.893 -179.762 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -61.42 -9.59 18.12 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 111.07 -0.812 . . . . 0.0 111.07 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -61.55 -13.27 20.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.748 0.309 . . . . 0.0 110.935 -179.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 25.3 ptt180 -90.68 4.56 51.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.809 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 12.1 mt-30 -115.28 154.2 29.53 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.435 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -52.71 -18.26 1.73 Allowed 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 179.559 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.586 ' C ' ' H ' ' A' ' 108' ' ' ALA . . . -69.43 -15.96 71.01 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' TRP . . . . . 0.452 ' CD1' ' N ' ' A' ' 108' ' ' ALA . 0.1 OUTLIER -45.36 -11.67 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.9 0.381 . . . . 0.0 110.54 -179.865 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.586 ' H ' ' C ' ' A' ' 106' ' ' GLY . . . -59.32 -23.15 62.24 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.193 179.657 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 13.9 mt -53.7 -28.66 35.05 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.383 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -56.71 -61.37 2.48 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.862 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.546 ' O ' ' CG2' ' A' ' 115' ' ' VAL . 1.4 p30 -61.53 -52.29 65.08 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.785 -179.293 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.531 ' N ' ' CG ' ' A' ' 111' ' ' ASP . 56.1 tp -55.42 -38.41 68.93 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.716 -178.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 51.7 mt -71.4 -61.81 1.64 Allowed 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.36 0.504 . . . . 0.0 112.36 -178.611 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.6 pp -59.75 -32.84 70.95 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.213 -0.595 . . . . 0.0 110.95 -178.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.546 ' CG2' ' O ' ' A' ' 111' ' ' ASP . 41.3 t -61.7 -59.47 4.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.752 179.767 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' SER . . . . . 0.49 ' O ' ' OG1' ' A' ' 120' ' ' THR . 49.4 m -68.84 -22.1 64.25 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.428 -179.261 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -66.51 -62.58 4.49 Favored Glycine 0 CA--C 1.527 0.823 0 C-N-CA 121.039 -0.601 . . . . 0.0 111.934 -179.124 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.496 ' O ' ' OG1' ' A' ' 122' ' ' THR . 7.0 p -72.43 -36.91 56.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 C-N-CA 120.915 -0.314 . . . . 0.0 111.411 -179.23 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . 0.545 ' O ' ' OG1' ' A' ' 123' ' ' THR . . . -67.41 -61.01 2.11 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.593 -0.443 . . . . 0.0 110.953 -179.362 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.49 ' OG1' ' O ' ' A' ' 116' ' ' SER . 2.8 m -58.64 -55.33 36.53 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.234 -179.584 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.419 ' O ' ' CB ' ' A' ' 125' ' ' ALA . . . -50.53 -41.95 54.45 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.304 -179.352 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.496 ' OG1' ' O ' ' A' ' 118' ' ' VAL . 38.9 p -73.32 -39.72 65.04 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 111.844 0.313 . . . . 0.0 111.844 -179.095 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 0.545 ' OG1' ' O ' ' A' ' 119' ' ' ALA . 0.1 OUTLIER -54.09 -50.28 67.17 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.91 -179.268 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.6 pp -84.11 -20.32 32.76 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.198 -0.455 . . . . 0.0 112.077 -178.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . 0.419 ' CB ' ' O ' ' A' ' 121' ' ' ALA . . . -88.68 -70.68 0.63 Allowed 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 -178.47 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' TRP . . . . . 0.55 ' N ' ' CD1' ' A' ' 126' ' ' TRP . 18.6 m0 -83.93 -58.0 2.97 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 112.84 0.681 . . . . 0.0 112.84 -177.862 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 18.9 m170 -49.77 -22.23 1.35 Allowed 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.458 -0.497 . . . . 0.0 110.932 -179.128 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 1.4 tmt_? -73.44 -29.47 62.57 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.023 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 14.6 t -99.76 -49.85 11.07 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 CA-C-O 120.942 0.401 . . . . 0.0 110.763 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -115.56 105.83 51.36 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.202 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . 0.64 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 76.9 Cg_exo -72.77 -24.34 18.22 Favored 'Trans proline' 0 C--N 1.311 -1.398 0 C-N-CA 121.59 1.526 . . . . 0.0 112.686 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . 0.64 ' CD ' ' N ' ' A' ' 131' ' ' PRO . 51.2 Cg_exo -66.21 -47.47 3.34 Favored 'Trans proline' 0 N--CA 1.496 1.627 0 C-N-CA 121.292 1.328 . . . . 0.0 112.084 179.624 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -50.41 -39.39 47.03 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.568 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -53.92 -23.48 13.02 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.404 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 11.0 tpp180 -78.25 -32.4 49.63 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.545 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 47.0 mt -72.77 -33.47 66.34 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.32 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 0.58 ' O ' ' N ' ' A' ' 140' ' ' TYR . 5.6 mt -84.09 -39.26 19.74 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.002 -0.545 . . . . 0.0 109.855 179.519 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.477 ' C ' ' O ' ' A' ' 137' ' ' LEU . 2.0 t80 -23.72 -43.67 0.05 OUTLIER Pre-proline 0 CA--C 1.534 0.338 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.82 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.516 ' N ' ' O ' ' A' ' 137' ' ' LEU . 3.4 Cg_exo -67.61 10.96 0.24 Allowed 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 120.984 1.123 . . . . 0.0 112.561 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . 0.618 ' CE1' ' CD1' ' A' ' 141' ' ' LEU . 1.5 p90 -93.83 -14.88 25.65 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 121.083 0.468 . . . . 0.0 110.483 179.819 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.618 ' CD1' ' CE1' ' A' ' 140' ' ' TYR . 4.1 mp -53.63 -32.45 51.36 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 179.004 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -60.33 -52.46 65.17 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.217 179.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' TRP . . . . . . . . . . . . . 7.7 t-105 -53.08 -49.66 65.95 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 179.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 10.5 mt -49.99 -59.6 3.72 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.015 179.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . 0.491 ' O ' ' CG2' ' A' ' 149' ' ' VAL . . . -58.73 -20.71 51.49 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.056 -179.684 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -67.18 -57.6 6.43 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.805 -0.358 . . . . 0.0 110.402 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -66.08 -47.4 74.38 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.216 179.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 7.1 m -55.68 -51.35 67.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.709 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.491 ' CG2' ' O ' ' A' ' 145' ' ' ALA . 90.7 t -64.68 -26.53 40.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 C-N-CA 120.895 -0.322 . . . . 0.0 110.278 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -60.72 -55.0 38.38 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.313 -0.555 . . . . 0.0 109.794 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . 0.495 ' ND2' ' OD2' ' A' ' 111' ' ' ASP . 1.9 m-80 -65.85 -39.89 91.19 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.694 -0.403 . . . . 0.0 110.357 179.429 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . 0.518 ' HH ' HH21 ' A' ' 156' ' ' ARG . 29.3 t80 -56.05 -46.19 78.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.569 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . 0.408 ' O ' ' OD1' ' A' ' 157' ' ' ASP . 5.5 t80 -63.56 -44.66 93.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.479 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 79.5 t -57.74 -45.15 86.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.653 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' TRP . . . . . . . . . . . . . 10.2 m0 -56.45 -56.98 14.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.518 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . 0.518 HH21 ' HH ' ' A' ' 152' ' ' TYR . 0.9 OUTLIER -49.16 -38.71 26.4 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.589 -179.962 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . 0.408 ' OD1' ' O ' ' A' ' 153' ' ' TYR . 1.5 m-20 -75.41 -52.04 11.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.803 0.335 . . . . 0.0 110.675 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' ASN . . . . . 0.493 HD22 ' CB ' ' A' ' 37' ' ' LEU . 4.7 m120 . . . . . 0 C--N 1.327 -0.409 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.648 -179.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . 0.69 ' CE2' ' CE3' ' A' ' 68' ' ' TRP . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.094 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 . . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.609 ' N ' ' CD ' ' A' ' 7' ' ' PRO . 0.9 OUTLIER -61.66 -35.5 22.96 Favored Pre-proline 0 CA--C 1.532 0.277 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 -179.914 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.609 ' CD ' ' N ' ' A' ' 6' ' ' VAL . 18.6 Cg_exo -70.83 -67.53 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.509 0 C-N-CA 121.686 1.59 . . . . 0.0 111.835 179.541 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.5 ' O ' ' CG2' ' A' ' 12' ' ' THR . . . -46.79 -40.27 13.37 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.202 -179.652 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.506 ' O ' ' OG1' ' A' ' 12' ' ' THR . 73.8 t -65.24 -61.97 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 112.062 0.393 . . . . 0.0 112.062 -178.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -58.38 -49.49 75.81 Favored Glycine 0 CA--C 1.527 0.837 0 N-CA-C 111.269 -0.732 . . . . 0.0 111.269 -179.158 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 9.3 mp -58.87 -30.54 67.81 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.538 0.209 . . . . 0.0 110.755 -179.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.506 ' OG1' ' O ' ' A' ' 9' ' ' VAL . 7.5 p -78.66 -31.18 46.64 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 120.801 -0.36 . . . . 0.0 110.191 179.548 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 81.2 mt -73.53 -22.17 60.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.117 179.656 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.498 ' O ' ' N ' ' A' ' 16' ' ' SER . 9.7 t -58.22 -66.6 1.26 Allowed Pre-proline 0 CA--C 1.536 0.434 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.312 -179.798 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -45.49 -14.87 0.11 Allowed 'Trans proline' 0 N--CA 1.499 1.799 0 C-N-CA 120.778 0.985 . . . . 0.0 112.074 -179.625 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.498 ' N ' ' O ' ' A' ' 14' ' ' VAL . 1.1 t -76.17 -35.99 58.9 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.866 0.365 . . . . 0.0 110.6 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 8.9 mt -69.75 -45.12 68.8 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.172 -179.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -73.6 -48.86 16.25 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 111.631 -0.588 . . . . 0.0 111.631 -179.545 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -63.24 -30.16 76.67 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 111.18 -0.768 . . . . 0.0 111.18 -179.576 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 64.4 t80 -75.95 -60.77 2.18 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.838 -0.345 . . . . 0.0 111.107 -179.528 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 28.0 ttp -61.59 -21.31 64.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.908 0.385 . . . . 0.0 110.324 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.515 ' C ' ' CZ2' ' A' ' 95' ' ' TRP . . . -73.45 -62.9 2.92 Favored Glycine 0 CA--C 1.524 0.615 0 N-CA-C 111.135 -0.786 . . . . 0.0 111.135 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.94 -16.49 63.92 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.54 -179.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 42.8 t80 -49.93 -24.15 2.37 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 179.264 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 9.7 t80 -72.11 -53.41 12.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.862 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 16.4 m -72.09 -14.58 17.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.81 -179.668 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.64 -42.69 75.35 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.255 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -121.45 -49.86 0.26 Allowed Glycine 0 CA--C 1.525 0.709 0 N-CA-C 110.693 -0.963 . . . . 0.0 110.693 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -56.01 -32.03 63.61 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.887 0.375 . . . . 0.0 110.417 179.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -75.46 -58.23 3.96 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.874 -0.89 . . . . 0.0 110.874 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 11.0 mp -53.49 -21.89 7.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.903 0.382 . . . . 0.0 110.06 179.676 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 38.9 mtp180 -84.86 -54.98 4.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.526 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -48.52 -30.57 5.36 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.182 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 52.1 t80 -50.3 -40.02 47.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.877 0.37 . . . . 0.0 110.31 179.723 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -58.91 -17.42 24.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.393 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -100.44 -72.15 0.99 Allowed Glycine 0 CA--C 1.527 0.796 0 N-CA-C 111.003 -0.839 . . . . 0.0 111.003 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -95.45 167.08 11.54 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.838 0.352 . . . . 0.0 110.828 179.861 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.489 ' NE2' ' H ' ' A' ' 38' ' ' GLN . 2.4 mp0 -81.62 113.38 19.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.126 -179.673 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.403 ' NZ ' ' CZ3' ' A' ' 107' ' ' TRP . 15.4 mtpt -129.05 160.19 64.91 Favored Pre-proline 0 CA--C 1.531 0.248 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.718 179.489 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo . . . . . 0 C--N 1.309 -1.538 0 C-N-CA 121.806 1.671 . . . . 0.0 111.381 179.356 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.41 ' O ' ' C ' ' A' ' 50' ' ' ALA . 0.2 OUTLIER . . . . . 0 CA--C 1.533 0.297 0 N-CA-C 112.243 0.46 . . . . 0.0 112.243 . . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.63 ' C ' ' H ' ' A' ' 52' ' ' ILE . . . -38.3 -33.78 0.25 Allowed Pre-proline 0 C--O 1.235 0.337 0 C-N-CA 120.771 -0.372 . . . . 0.0 111.431 -179.03 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.409 ' HD2' ' N ' ' A' ' 50' ' ' ALA . 34.4 Cg_exo -53.69 4.93 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.613 0 C-N-CA 120.355 0.703 . . . . 0.0 112.773 178.816 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.63 ' H ' ' C ' ' A' ' 50' ' ' ALA . 10.5 pt -54.08 -35.65 29.57 Favored 'Isoleucine or valine' 0 C--O 1.232 0.169 0 CA-C-O 121.248 0.547 . . . . 0.0 109.542 179.157 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.421 ' O ' ' CB ' ' A' ' 57' ' ' TYR . 62.3 m95 -73.17 -22.95 60.38 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.244 -0.889 . . . . 0.0 111.35 -179.285 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -70.49 -48.15 38.33 Favored Glycine 0 CA--C 1.527 0.812 0 N-CA-C 110.481 -1.048 . . . . 0.0 110.481 179.503 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 11.0 m -65.75 -55.28 18.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.969 0.414 . . . . 0.0 109.909 179.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.562 ' O ' ' SD ' ' A' ' 60' ' ' MET . 94.8 mt -56.71 -36.29 69.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.954 179.463 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.548 ' C ' ' CD1' ' A' ' 57' ' ' TYR . 0.4 OUTLIER -54.76 -52.03 63.84 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 179.109 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 3.1 m -52.23 -47.26 65.8 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 178.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -56.26 -46.24 79.74 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.343 179.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.562 ' SD ' ' O ' ' A' ' 56' ' ' LEU . 0.0 OUTLIER -61.87 -40.74 96.44 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.334 179.926 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -52.46 -52.89 34.69 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 110.641 -0.984 . . . . 0.0 110.641 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.46 ' CD1' ' N ' ' A' ' 62' ' ' TYR . 1.1 m-85 -65.78 -40.86 92.38 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.925 0.393 . . . . 0.0 110.376 179.762 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -54.19 -52.55 43.13 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 110.342 -1.103 . . . . 0.0 110.342 179.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.587 ' O ' ' CD1' ' A' ' 68' ' ' TRP . 1.0 OUTLIER -56.47 -44.56 80.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.86 0.362 . . . . 0.0 110.42 179.684 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.431 ' HA ' ' CZ2' ' A' ' 68' ' ' TRP . 85.4 t80 -48.45 -47.35 38.27 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.674 -0.41 . . . . 0.0 110.083 179.651 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 53.3 mt -70.7 -25.95 27.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.041 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 68.8 t -66.02 -58.79 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 C-N-CA 120.582 -0.447 . . . . 0.0 111.578 -179.41 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' TRP . . . . . 0.69 ' CE3' ' CE2' ' A' ' 5' ' ' TRP . 0.0 OUTLIER -71.79 -27.8 63.18 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 119.656 -0.818 . . . . 0.0 110.69 -179.643 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 9.4 mmmt -72.25 -24.2 61.33 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.468 -0.493 . . . . 0.0 110.352 179.658 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -82.31 -59.18 2.63 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.949 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.5 pp -71.67 -16.77 62.26 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.02 -179.548 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.5 ' O ' ' O ' ' A' ' 73' ' ' GLY . . . 108.39 94.53 2.34 Favored Glycine 0 CA--C 1.527 0.826 0 N-CA-C 111.703 -0.559 . . . . 0.0 111.703 179.459 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.585 ' N ' ' O ' ' A' ' 68' ' ' TRP . . . 42.02 -174.1 0.01 OUTLIER Glycine 0 CA--C 1.525 0.704 0 N-CA-C 111.799 -0.52 . . . . 0.0 111.799 179.198 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 32.4 t80 -87.22 113.21 22.75 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.547 -0.327 . . . . 0.0 110.595 -179.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.528 ' OG1' ' N ' ' A' ' 76' ' ' GLU . 0.8 OUTLIER -142.13 -177.41 5.22 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.686 -179.909 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.528 ' N ' ' OG1' ' A' ' 75' ' ' THR . 29.5 mt-10 -51.78 -23.14 4.27 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.796 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -79.72 -24.58 41.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.939 -179.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -90.33 -20.59 22.7 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.003 -179.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 14.9 mtp -69.49 -28.66 66.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.806 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.416 ' O ' ' CB ' ' A' ' 84' ' ' LEU . 5.9 t -67.16 -50.77 39.01 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.507 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_endo -69.52 -60.45 0.07 OUTLIER 'Trans proline' 0 N--CA 1.499 1.846 0 C-N-CA 121.065 1.177 . . . . 0.0 111.81 179.031 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.3 mt -53.37 -51.95 60.84 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.614 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -62.84 -63.33 4.7 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 111.383 -0.687 . . . . 0.0 111.383 -179.485 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.416 ' CB ' ' O ' ' A' ' 80' ' ' VAL . 52.6 tp -45.87 -31.64 2.23 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.749 0.309 . . . . 0.0 110.647 -179.845 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 7.0 t80 -67.96 -58.51 4.42 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.274 -179.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 3.5 m -61.89 -60.35 3.77 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.841 -179.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -45.56 -57.11 6.04 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 111.112 -0.795 . . . . 0.0 111.112 -179.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 11.1 tp-100 -58.94 -32.85 69.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.759 0.314 . . . . 0.0 110.679 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.445 ' O ' ' CD1' ' A' ' 93' ' ' TRP . 11.8 tp -67.73 -36.59 80.85 Favored 'General case' 0 C--O 1.222 -0.379 0 C-N-CA 120.685 -0.406 . . . . 0.0 110.306 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.49 ' O ' ' CB ' ' A' ' 94' ' ' ALA . . . -65.81 -59.91 3.41 Favored 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 120.268 -0.573 . . . . 0.0 110.379 179.833 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 7.9 mt -55.31 -53.89 50.44 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.786 -0.643 . . . . 0.0 112.21 -179.085 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -75.2 -60.83 2.12 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -177.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . 0.611 ' O ' ' N ' ' A' ' 95' ' ' TRP . 0.0 OUTLIER -63.78 -11.74 29.4 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.192 0.441 . . . . 0.0 112.192 -177.688 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.49 ' CB ' ' O ' ' A' ' 90' ' ' ALA . . . -54.12 80.5 0.0 OUTLIER 'General case' 0 CA--C 1.528 0.126 0 C-N-CA 120.399 -0.521 . . . . 0.0 109.76 179.224 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.689 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 14.6 p-90 -101.22 -15.23 0.18 Allowed Pre-proline 0 CA--C 1.534 0.338 0 CA-C-N 116.208 -0.451 . . . . 0.0 112.086 -179.312 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.689 ' CD ' ' N ' ' A' ' 95' ' ' TRP . 64.8 Cg_exo -64.12 -12.65 33.48 Favored 'Trans proline' 0 N--CA 1.498 1.768 0 C-N-CA 120.875 1.05 . . . . 0.0 113.558 179.634 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . 0.621 ' CD ' ' N ' ' A' ' 96' ' ' PRO . 51.2 Cg_exo -85.33 -8.79 8.55 Favored 'Trans proline' 0 N--CA 1.502 1.978 0 C-N-CA 120.753 0.968 . . . . 0.0 113.519 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.416 ' O ' ' N ' ' A' ' 101' ' ' GLY . 1.5 pp -84.18 18.62 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 C-N-CA 120.608 -0.437 . . . . 0.0 110.932 -179.661 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.565 ' CD1' ' O ' ' A' ' 96' ' ' PRO . 2.7 m-30 -39.85 -34.12 0.25 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.211 179.673 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . 0.457 ' O ' ' NE ' ' A' ' 103' ' ' ARG . 0.9 OUTLIER -76.36 -45.08 33.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.745 -179.902 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 0.416 ' N ' ' O ' ' A' ' 98' ' ' ILE . . . -65.98 -9.98 49.36 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 110.97 -0.852 . . . . 0.0 110.97 -179.921 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -78.35 -7.17 56.98 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.749 0.309 . . . . 0.0 110.724 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.457 ' NE ' ' O ' ' A' ' 100' ' ' PHE . 1.2 ptp180 -79.16 -14.8 58.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.867 -179.769 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . 0.407 ' C ' ' N ' ' A' ' 106' ' ' GLY . 1.4 pt20 -125.82 172.58 9.74 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.826 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' MET . . . . . 0.493 ' N ' ' SD ' ' A' ' 105' ' ' MET . 0.0 OUTLIER -49.37 -16.88 0.21 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.457 179.822 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.437 ' C ' ' N ' ' A' ' 108' ' ' ALA . . . -60.6 -15.79 41.84 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 111.1 -0.8 . . . . 0.0 111.1 -179.892 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' TRP . . . . . 0.481 ' CD1' ' N ' ' A' ' 108' ' ' ALA . 0.0 OUTLIER -50.48 -14.46 0.18 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.848 0.356 . . . . 0.0 110.432 -179.779 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.481 ' N ' ' CD1' ' A' ' 107' ' ' TRP . . . -61.11 -17.55 53.3 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.212 179.621 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 6.0 mp -56.67 -28.56 60.96 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.671 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -58.71 -62.63 1.72 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.845 0.355 . . . . 0.0 110.672 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.53 ' O ' ' CG2' ' A' ' 115' ' ' VAL . 4.4 p-10 -57.29 -53.67 55.53 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.358 -179.429 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 29.9 tp -54.45 -43.13 71.37 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.773 -179.034 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 53.7 mt -67.54 -61.3 1.96 Allowed 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.584 0.587 . . . . 0.0 112.584 -178.387 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.9 pp -61.09 -34.36 74.82 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 120.445 -0.502 . . . . 0.0 111.572 -178.555 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.53 ' CG2' ' O ' ' A' ' 111' ' ' ASP . 48.1 t -61.49 -58.0 9.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.383 -0.372 . . . . 0.0 111.385 -179.856 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 23.4 p -71.9 -23.59 61.51 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.603 -179.091 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -64.61 -62.14 5.31 Favored Glycine 0 CA--C 1.525 0.67 0 C-N-CA 120.842 -0.694 . . . . 0.0 111.472 -179.389 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.492 ' O ' ' OG1' ' A' ' 122' ' ' THR . 9.8 p -70.71 -37.18 68.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 111.874 0.324 . . . . 0.0 111.874 -179.336 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . 0.512 ' O ' ' OG1' ' A' ' 123' ' ' THR . . . -67.96 -60.91 2.14 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.545 -0.462 . . . . 0.0 111.63 -179.087 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.404 ' HA ' ' HG1' ' A' ' 123' ' ' THR . 6.4 m -59.47 -51.84 68.16 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.909 0.385 . . . . 0.0 111.464 -179.299 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -53.92 -43.37 69.71 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.272 -179.203 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.492 ' OG1' ' O ' ' A' ' 118' ' ' VAL . 38.0 p -71.13 -30.81 66.95 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 111.971 0.36 . . . . 0.0 111.971 -179.135 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 0.512 ' OG1' ' O ' ' A' ' 119' ' ' ALA . 0.1 OUTLIER -64.72 -48.79 73.32 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 120.851 -0.34 . . . . 0.0 111.074 -179.141 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.8 pp -82.79 -19.92 36.8 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.763 -0.375 . . . . 0.0 111.531 -179.021 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -88.93 -69.59 0.7 Allowed 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.594 0.591 . . . . 0.0 112.594 -178.689 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' TRP . . . . . 0.445 ' N ' ' CD1' ' A' ' 126' ' ' TRP . 36.9 m0 -83.14 -57.53 3.23 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 -177.751 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . 0.47 ' CD2' ' N ' ' A' ' 127' ' ' HIS . 10.0 m170 -52.12 -22.18 3.95 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.418 -0.513 . . . . 0.0 111.06 -178.661 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 2.8 tmt_? -71.07 -43.39 67.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.504 -0.317 . . . . 0.0 111.225 -179.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 14.9 t -86.92 -49.6 14.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 C-N-CA 120.922 -0.311 . . . . 0.0 111.054 -179.523 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 7.5 m -120.11 110.83 35.92 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.434 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . 0.627 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 73.6 Cg_exo -71.34 -33.78 10.68 Favored 'Trans proline' 0 N--CA 1.491 1.345 0 C-N-CA 121.373 1.382 . . . . 0.0 112.387 179.488 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . 0.627 ' CD ' ' N ' ' A' ' 131' ' ' PRO . 37.1 Cg_exo -55.36 -39.09 92.91 Favored 'Trans proline' 0 N--CA 1.495 1.595 0 C-N-CA 121.31 1.34 . . . . 0.0 111.75 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -55.91 -34.66 65.78 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.334 179.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -64.83 -24.97 67.71 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.38 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 13.5 tpt180 -77.12 -29.12 54.59 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.362 179.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 18.4 mt -74.9 -41.05 60.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.379 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 0.574 ' O ' ' N ' ' A' ' 140' ' ' TYR . 5.0 mt -78.82 -35.49 44.06 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.152 179.624 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.481 ' C ' ' O ' ' A' ' 137' ' ' LEU . 2.0 t80 -23.4 -44.75 0.05 OUTLIER Pre-proline 0 CA--C 1.535 0.372 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.853 -179.865 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.515 ' N ' ' O ' ' A' ' 137' ' ' LEU . 1.7 Cg_endo -67.91 12.6 0.21 Allowed 'Trans proline' 0 C--N 1.309 -1.5 0 C-N-CA 121.188 1.259 . . . . 0.0 112.57 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . 0.574 ' N ' ' O ' ' A' ' 137' ' ' LEU . 1.7 p90 -93.41 -14.2 27.08 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-O 121.008 0.432 . . . . 0.0 110.633 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.403 HD23 ' CE1' ' A' ' 140' ' ' TYR . 4.1 mm? -53.37 -38.64 63.54 Favored 'General case' 0 C--N 1.333 -0.122 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 178.754 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -54.99 -46.58 75.14 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.549 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' TRP . . . . . 0.405 ' CZ2' ' CD1' ' A' ' 52' ' ' ILE . 9.5 t-105 -59.21 -49.36 78.16 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.773 -0.455 . . . . 0.0 109.773 179.807 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 12.2 mt -51.89 -54.5 28.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.086 179.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . 0.487 ' O ' ' CG2' ' A' ' 149' ' ' VAL . . . -60.5 -27.01 67.26 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.536 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -60.99 -64.56 0.91 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.533 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -63.83 -49.14 74.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.694 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 73.8 m -51.21 -47.22 62.33 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.911 -179.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.487 ' CG2' ' O ' ' A' ' 145' ' ' ALA . 53.3 t -65.24 -34.47 70.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.882 -179.738 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 1.7 tp -57.15 -55.56 33.22 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.837 0.351 . . . . 0.0 110.307 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -58.12 -57.12 14.22 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.413 179.697 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 18.5 t80 -46.76 -47.26 20.8 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.589 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 43.6 t80 -55.79 -42.98 76.38 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.611 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 89.1 t -66.53 -40.42 86.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.826 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' TRP . . . . . 0.479 ' C ' ' HE ' ' A' ' 156' ' ' ARG . 8.8 m0 -58.61 -39.74 81.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.801 -179.707 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . 0.479 ' HE ' ' C ' ' A' ' 155' ' ' TRP . 0.0 OUTLIER -79.29 -45.93 18.75 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.504 -179.885 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -64.19 -50.11 69.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.445 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.524 -179.945 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . 0.663 ' CE2' ' CE3' ' A' ' 68' ' ' TRP . 0.4 OUTLIER . . . . . 0 N--CA 1.46 0.067 0 CA-C-O 120.781 0.324 . . . . 0.0 110.287 . . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.626 ' N ' ' CD ' ' A' ' 7' ' ' PRO . 0.9 OUTLIER -64.61 -32.79 7.52 Favored Pre-proline 0 CA--C 1.534 0.335 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 179.743 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.626 ' CD ' ' N ' ' A' ' 6' ' ' VAL . 23.8 Cg_exo -72.61 -67.02 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 121.888 1.726 . . . . 0.0 112.156 179.654 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.538 ' O ' ' CG2' ' A' ' 12' ' ' THR . . . -50.93 -38.24 49.09 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.541 -0.3 . . . . 0.0 111.278 -179.565 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.49 ' O ' ' OG1' ' A' ' 12' ' ' THR . 75.5 t -67.63 -62.25 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.756 -179.14 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -56.74 -47.61 84.16 Favored Glycine 0 CA--C 1.527 0.79 0 N-CA-C 111.743 -0.543 . . . . 0.0 111.743 -179.192 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.414 ' N ' ' CD1' ' A' ' 11' ' ' LEU . 7.7 mp -64.02 -30.91 71.95 Favored 'General case' 0 C--N 1.326 -0.433 0 O-C-N 122.921 -0.164 . . . . 0.0 111.052 -179.498 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.582 ' O ' ' CZ ' ' A' ' 57' ' ' TYR . 7.5 p -74.96 -25.15 58.66 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.621 -0.432 . . . . 0.0 110.129 179.549 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.454 ' O ' ' CB ' ' A' ' 16' ' ' SER . 9.4 mt -80.65 -32.26 36.21 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.133 179.563 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.409 ' N ' ' HD2' ' A' ' 15' ' ' PRO . 17.9 t -44.65 -53.29 15.5 Favored Pre-proline 0 CA--C 1.536 0.414 0 CA-C-N 115.894 -0.593 . . . . 0.0 111.237 -179.806 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.409 ' HD2' ' N ' ' A' ' 14' ' ' VAL . 18.6 Cg_endo -62.56 -7.53 10.97 Favored 'Trans proline' 0 N--CA 1.499 1.82 0 C-N-CA 120.591 0.861 . . . . 0.0 111.882 179.582 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.454 ' CB ' ' O ' ' A' ' 13' ' ' LEU . 3.7 t -77.69 -26.37 50.15 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.543 -179.866 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 15.9 mt -76.73 -49.66 15.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.85 -179.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -77.79 -29.27 55.21 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 111.329 -0.708 . . . . 0.0 111.329 -179.652 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -76.72 -37.49 34.3 Favored Glycine 0 CA--C 1.523 0.539 0 N-CA-C 110.877 -0.889 . . . . 0.0 110.877 -179.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 77.9 t80 -72.85 -55.81 6.12 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.875 0.369 . . . . 0.0 110.295 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 32.5 ttp -69.81 -22.09 63.34 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.464 179.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.462 ' C ' ' CZ2' ' A' ' 95' ' ' TRP . . . -69.99 -63.38 3.33 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 111.159 -0.776 . . . . 0.0 111.159 -179.804 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -68.86 -20.77 64.29 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 120.999 -0.281 . . . . 0.0 110.793 -179.623 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 56.5 t80 -47.27 -25.15 0.88 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.872 0.367 . . . . 0.0 110.479 179.706 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.412 ' CZ ' ' OE1' ' A' ' 29' ' ' GLU . 24.8 t80 -67.55 -55.55 13.01 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.797 -179.871 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 27.5 m -68.08 -16.79 21.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.867 -179.663 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 3.3 ttm180 -60.5 -41.13 93.68 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.037 -179.613 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -104.74 -74.32 0.96 Allowed Glycine 0 CA--C 1.525 0.686 0 N-CA-C 111.393 -0.683 . . . . 0.0 111.393 -179.57 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.412 ' OE1' ' CZ ' ' A' ' 25' ' ' PHE . 22.8 tt0 -44.38 -33.02 1.51 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.641 0.258 . . . . 0.0 110.965 -179.515 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -63.38 -51.61 53.27 Favored Glycine 0 CA--C 1.526 0.757 0 N-CA-C 111.222 -0.751 . . . . 0.0 111.222 -179.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 83.6 mt -49.43 -47.24 48.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.728 0.299 . . . . 0.0 110.851 -179.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 67.8 mtm180 -68.79 -49.38 59.1 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.86 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -45.13 -43.61 9.92 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.429 -179.717 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 75.9 t80 -46.11 -45.13 16.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.802 -179.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -57.42 -25.91 60.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.811 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -87.64 -73.8 1.28 Allowed Glycine 0 CA--C 1.526 0.74 0 N-CA-C 110.901 -0.88 . . . . 0.0 110.901 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -95.89 167.63 11.13 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.873 0.368 . . . . 0.0 110.673 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.524 ' NE2' ' C ' ' A' ' 38' ' ' GLN . 0.0 OUTLIER -81.74 114.76 20.61 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.778 -179.725 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.44 ' NZ ' ' CH2' ' A' ' 107' ' ' TRP . 11.0 mtpt -128.77 148.78 70.04 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.076 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo . . . . . 0 C--N 1.308 -1.566 0 C-N-CA 121.445 1.43 . . . . 0.0 110.968 179.293 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 27.6 tp . . . . . 0 CA--C 1.532 0.265 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.656 ' C ' ' H ' ' A' ' 52' ' ' ILE . . . -41.22 -28.46 0.24 Allowed Pre-proline 0 C--O 1.234 0.27 0 C-N-CA 120.141 -0.623 . . . . 0.0 111.516 -179.021 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.4 ' HD2' ' N ' ' A' ' 50' ' ' ALA . 22.3 Cg_exo -53.63 5.16 0.03 OUTLIER 'Trans proline' 0 C--N 1.313 -1.317 0 CA-C-N 118.955 0.663 . . . . 0.0 112.085 177.903 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.656 ' H ' ' C ' ' A' ' 50' ' ' ALA . 7.2 pt -49.37 -29.27 3.73 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.144 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 178.841 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.605 ' O ' ' CD1' ' A' ' 57' ' ' TYR . 2.8 m0 -66.06 -45.91 79.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.799 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -59.34 -60.26 9.14 Favored Glycine 0 CA--C 1.527 0.82 0 N-CA-C 111.593 -0.603 . . . . 0.0 111.593 -179.609 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.524 ' CG2' ' H ' ' A' ' 56' ' ' LEU . 5.3 t -56.21 -60.71 3.11 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 121.033 -0.267 . . . . 0.0 111.329 -179.279 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.524 ' H ' ' CG2' ' A' ' 55' ' ' THR . 82.6 mt -50.82 -44.68 59.23 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 120.59 -0.444 . . . . 0.0 110.478 -179.744 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.605 ' CD1' ' O ' ' A' ' 53' ' ' TRP . 3.7 m-30 -50.93 -46.96 61.08 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 75.7 m -57.89 -42.15 84.05 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.187 -0.46 . . . . 0.0 109.911 179.584 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.78 -37.24 86.65 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.203 179.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 41.5 mtt -67.69 -49.18 64.07 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.462 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -52.09 -48.57 52.27 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 111.108 -0.797 . . . . 0.0 111.108 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -60.97 -56.69 18.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.868 0.366 . . . . 0.0 110.512 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -49.55 -48.47 35.11 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.504 -1.038 . . . . 0.0 110.504 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.523 ' O ' ' NE1' ' A' ' 68' ' ' TRP . 1.2 t -57.7 -44.92 86.22 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.667 0.27 . . . . 0.0 110.707 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.434 ' HA ' ' CZ2' ' A' ' 68' ' ' TRP . 87.3 t80 -50.79 -44.52 58.9 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 179.301 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 69.9 mt -70.79 -25.16 25.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.787 179.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 77.9 t -68.8 -59.04 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.155 0 C-N-CA 120.69 -0.404 . . . . 0.0 111.192 -179.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' TRP . . . . . 0.663 ' CE3' ' CE2' ' A' ' 5' ' ' TRP . 0.0 OUTLIER -67.65 -28.1 67.43 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 119.973 -0.691 . . . . 0.0 110.646 -179.666 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -73.22 -28.18 62.02 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.532 -0.467 . . . . 0.0 110.526 -179.885 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 32.0 tp10 -76.85 -59.99 2.54 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.79 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.3 pp -69.11 -22.14 63.99 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.717 -179.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.497 ' O ' ' O ' ' A' ' 73' ' ' GLY . . . 110.68 97.58 2.43 Favored Glycine 0 CA--C 1.526 0.775 0 N-CA-C 111.585 -0.606 . . . . 0.0 111.585 179.586 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.557 ' N ' ' O ' ' A' ' 68' ' ' TRP . . . 41.88 -173.86 0.01 OUTLIER Glycine 0 CA--C 1.523 0.557 0 N-CA-C 111.667 -0.573 . . . . 0.0 111.667 179.389 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 51.5 t80 -87.54 111.64 21.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.819 0.342 . . . . 0.0 110.741 -179.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.576 ' OG1' ' N ' ' A' ' 76' ' ' GLU . 0.8 OUTLIER -141.73 -174.03 3.95 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.672 179.73 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.576 ' N ' ' OG1' ' A' ' 75' ' ' THR . 46.1 mt-10 -47.98 -44.29 30.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.174 -179.768 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -60.49 -24.4 65.26 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.502 -179.239 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -91.09 -25.34 19.68 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.82 -0.352 . . . . 0.0 111.234 -179.424 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 12.5 mtp -66.79 -27.78 67.86 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.814 -0.354 . . . . 0.0 111.354 -179.283 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 4.7 t -68.72 -50.89 22.78 Favored Pre-proline 0 C--N 1.328 -0.335 0 C-N-CA 120.673 -0.411 . . . . 0.0 110.364 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_endo -69.43 -62.38 0.05 OUTLIER 'Trans proline' 0 N--CA 1.498 1.764 0 C-N-CA 120.955 1.103 . . . . 0.0 111.616 179.007 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.0 mt -52.12 -52.45 51.45 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.271 179.592 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.504 ' O ' ' N ' ' A' ' 86' ' ' THR . . . -60.46 -63.88 4.61 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 111.367 -0.693 . . . . 0.0 111.367 -179.549 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 59.3 tp -43.15 -38.74 2.56 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.9 0.381 . . . . 0.0 110.114 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 6.3 t80 -68.22 -34.33 76.05 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.242 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.504 ' N ' ' O ' ' A' ' 83' ' ' GLY . 1.3 m -70.42 -57.97 4.23 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.917 -179.683 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -62.51 -49.23 75.64 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 111.463 -0.655 . . . . 0.0 111.463 -179.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.416 ' O ' ' CB ' ' A' ' 92' ' ' ASN . 51.6 tp60 -57.26 -45.54 83.91 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.739 0.304 . . . . 0.0 110.952 -179.583 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 11.6 tp -65.4 -29.12 69.79 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.475 -179.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.467 ' O ' ' CB ' ' A' ' 94' ' ' ALA . . . -67.04 -66.08 0.6 Allowed 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.393 -0.523 . . . . 0.0 111.176 -179.723 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.2 pp -67.64 -29.79 69.19 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 -178.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.416 ' CB ' ' O ' ' A' ' 88' ' ' GLN . 11.1 t-20 -84.12 -54.52 4.77 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 -178.441 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . 0.609 ' O ' ' N ' ' A' ' 95' ' ' TRP . 0.0 OUTLIER -76.57 -12.53 60.04 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.516 -0.474 . . . . 0.0 111.491 -178.478 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.467 ' CB ' ' O ' ' A' ' 90' ' ' ALA . . . -55.69 78.73 0.0 OUTLIER 'General case' 0 C--O 1.231 0.129 0 C-N-CA 120.448 -0.501 . . . . 0.0 109.852 179.174 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.708 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 44.1 p-90 -93.11 -16.87 0.21 Allowed Pre-proline 0 CA--C 1.533 0.302 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -179.444 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.708 ' CD ' ' N ' ' A' ' 95' ' ' TRP . 46.5 Cg_exo -55.66 -34.49 90.6 Favored 'Trans proline' 0 N--CA 1.495 1.576 0 C-N-CA 120.422 0.748 . . . . 0.0 113.021 179.502 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . 0.595 ' C ' ' H ' ' A' ' 99' ' ' PHE . 33.6 Cg_exo -44.08 -30.84 3.58 Favored 'Trans proline' 0 N--CA 1.492 1.386 0 CA-C-N 118.969 0.668 . . . . 0.0 112.994 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.577 ' O ' ' N ' ' A' ' 101' ' ' GLY . 1.3 pp -72.61 20.22 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 121.076 0.465 . . . . 0.0 110.059 179.66 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.595 ' H ' ' C ' ' A' ' 97' ' ' PRO . 0.8 OUTLIER -39.72 -36.67 0.44 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.889 -179.968 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . 0.401 ' O ' ' CG ' ' A' ' 103' ' ' ARG . 1.6 m-85 -85.98 -21.0 28.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.045 -179.518 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 0.577 ' N ' ' O ' ' A' ' 98' ' ' ILE . . . -89.16 -5.45 72.97 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 111.153 -0.779 . . . . 0.0 111.153 -179.718 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -73.16 -11.26 60.47 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.778 0.323 . . . . 0.0 110.753 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.401 ' CG ' ' O ' ' A' ' 100' ' ' PHE . 5.4 ptp180 -94.94 11.61 31.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.586 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -123.97 162.62 23.02 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.63 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 21.2 mmm -57.18 -17.13 9.83 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.234 179.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.589 ' O ' ' N ' ' A' ' 108' ' ' ALA . . . -70.42 -15.01 72.48 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 111.214 -0.755 . . . . 0.0 111.214 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' TRP . . . . . 0.444 ' CD1' ' N ' ' A' ' 108' ' ' ALA . 0.1 OUTLIER -43.14 -12.51 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.521 0.2 . . . . 0.0 111.113 -179.468 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.589 ' N ' ' O ' ' A' ' 106' ' ' GLY . . . -63.01 -23.44 67.46 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-O 121.132 0.491 . . . . 0.0 110.075 179.417 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 54.6 mt -52.71 -29.45 26.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.107 179.726 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -56.19 -60.76 3.04 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.548 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.578 ' OD1' ' N ' ' A' ' 112' ' ' LEU . 1.2 p30 -57.46 -51.24 70.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.323 -179.673 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.578 ' N ' ' OD1' ' A' ' 111' ' ' ASP . 0.2 OUTLIER -55.29 -40.26 70.85 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.474 -178.944 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 11.3 mt -70.18 -61.51 1.75 Allowed 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 -178.655 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.4 pp -58.38 -30.55 66.88 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 120.292 -0.563 . . . . 0.0 110.866 -179.052 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.55 ' CG2' ' O ' ' A' ' 111' ' ' ASP . 38.7 t -65.49 -55.78 18.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.264 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' SER . . . . . 0.443 ' O ' ' OG1' ' A' ' 120' ' ' THR . 4.9 m -71.45 -24.57 62.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.4 -179.009 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . 0.411 ' O ' ' CB ' ' A' ' 121' ' ' ALA . . . -68.02 -62.49 4.2 Favored Glycine 0 CA--C 1.527 0.794 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.051 -179.218 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.506 ' O ' ' OG1' ' A' ' 122' ' ' THR . 8.5 p -70.62 -36.93 67.64 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 O-C-N 122.738 -0.272 . . . . 0.0 111.572 -179.14 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . 0.526 ' O ' ' OG1' ' A' ' 123' ' ' THR . . . -66.67 -60.54 2.61 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.493 -0.483 . . . . 0.0 111.201 -179.288 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.473 ' H ' ' HG1' ' A' ' 120' ' ' THR . 1.9 m -61.56 -53.68 53.11 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.334 -179.446 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.411 ' CB ' ' O ' ' A' ' 117' ' ' GLY . . . -50.12 -42.41 50.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.411 -0.358 . . . . 0.0 111.152 -179.494 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.506 ' OG1' ' O ' ' A' ' 118' ' ' VAL . 27.7 p -70.65 -39.32 73.69 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.64 -179.28 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 0.526 ' OG1' ' O ' ' A' ' 119' ' ' ALA . 0.2 OUTLIER -55.29 -52.2 64.23 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.921 0.391 . . . . 0.0 111.197 -179.312 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.7 pp -80.49 -20.33 43.91 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.752 -178.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -86.06 -73.88 0.44 Allowed 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -178.179 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' TRP . . . . . 0.571 ' N ' ' CD1' ' A' ' 126' ' ' TRP . 15.7 m0 -84.88 -57.37 3.14 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 112.762 0.653 . . . . 0.0 112.762 -177.444 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . 0.492 ' CD2' ' N ' ' A' ' 127' ' ' HIS . 9.7 m170 -47.71 -22.12 0.48 Allowed 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.686 -0.405 . . . . 0.0 111.121 -179.027 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 19.2 ttt85 -72.59 -40.84 66.25 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.063 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 86.4 t -88.37 -50.01 13.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.788 0.328 . . . . 0.0 111.076 -179.514 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 6.0 m -115.69 105.28 51.98 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.502 -179.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . 0.631 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 73.5 Cg_exo -70.98 -36.43 7.58 Favored 'Trans proline' 0 C--N 1.312 -1.364 0 C-N-CA 121.557 1.505 . . . . 0.0 112.726 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . 0.631 ' CD ' ' N ' ' A' ' 131' ' ' PRO . 32.4 Cg_exo -55.8 -35.48 93.72 Favored 'Trans proline' 0 N--CA 1.496 1.675 0 C-N-CA 121.678 1.585 . . . . 0.0 111.946 -179.847 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -62.6 -43.2 99.41 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.66 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -50.47 -24.77 3.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.764 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 14.9 ttp180 -80.93 -28.39 35.78 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.786 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 26.7 mt -72.84 -39.18 66.75 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.779 -0.368 . . . . 0.0 110.068 179.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 0.583 ' O ' ' N ' ' A' ' 139' ' ' PRO . 4.8 mt -81.04 -35.78 31.38 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 179.126 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.473 ' C ' ' O ' ' A' ' 137' ' ' LEU . 14.3 t80 -24.23 -38.9 0.03 OUTLIER Pre-proline 0 CA--C 1.534 0.356 0 CA-C-N 115.368 -0.833 . . . . 0.0 112.118 -179.888 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.583 ' N ' ' O ' ' A' ' 137' ' ' LEU . 5.8 Cg_exo -66.62 5.54 0.73 Allowed 'Trans proline' 0 C--N 1.31 -1.479 0 C-N-CA 120.897 1.065 . . . . 0.0 112.771 179.508 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . 0.521 ' N ' ' O ' ' A' ' 137' ' ' LEU . 2.5 p90 -88.62 -14.55 37.22 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 120.54 -0.464 . . . . 0.0 111.074 -179.842 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.416 HD22 ' CE1' ' A' ' 140' ' ' TYR . 4.1 mm? -53.55 -33.45 54.72 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 178.568 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -60.63 -50.01 75.21 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.473 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' TRP . . . . . . . . . . . . . 8.8 t-105 -55.13 -46.1 75.62 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.226 -0.443 . . . . 0.0 109.844 179.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 9.3 mt -53.35 -55.96 20.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.267 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . 0.486 ' O ' ' CG2' ' A' ' 149' ' ' VAL . . . -62.86 -18.85 63.5 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.94 -179.786 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -69.45 -63.34 1.09 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.682 -179.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -60.37 -47.42 86.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.414 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 89.0 m -53.93 -49.67 68.14 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.495 179.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.486 ' CG2' ' O ' ' A' ' 145' ' ' ALA . 45.0 t -62.42 -28.54 44.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.594 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -63.53 -54.85 29.81 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.704 -0.398 . . . . 0.0 110.415 -179.598 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . 0.608 ' ND2' ' H ' ' A' ' 152' ' ' TYR . 1.4 p-10 -67.47 -54.65 18.37 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.96 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . 0.608 ' H ' ' ND2' ' A' ' 151' ' ' ASN . 15.6 t80 -50.5 -43.26 55.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.681 -179.69 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . 0.481 ' C ' ' CD1' ' A' ' 153' ' ' TYR . 17.5 t80 -61.86 -43.75 98.22 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.188 179.72 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 49.4 t -60.27 -35.25 60.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.597 179.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' TRP . . . . . . . . . . . . . 8.1 m0 -62.99 -53.32 55.86 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.413 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . 0.436 ' CZ ' ' OH ' ' A' ' 152' ' ' TYR . 0.5 OUTLIER -64.73 -31.61 72.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.414 -179.899 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -71.33 -52.59 17.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.678 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 22.3 m-20 . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.646 -179.903 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . 0.471 ' CD1' ' CD1' ' A' ' 68' ' ' TRP . 2.2 t-105 . . . . . 0 CA--C 1.528 0.128 0 CA-C-O 121.001 0.429 . . . . 0.0 110.038 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.0 t -56.69 -69.45 0.44 Allowed Pre-proline 0 CA--C 1.537 0.471 0 CA-C-N 115.717 -0.674 . . . . 0.0 112.285 -178.375 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -46.3 -53.49 5.87 Favored 'Trans proline' 0 N--CA 1.494 1.519 0 C-N-CA 120.349 0.699 . . . . 0.0 112.343 -178.618 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.495 ' O ' ' OG1' ' A' ' 12' ' ' THR . . . -49.14 -43.92 42.16 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.595 -0.442 . . . . 0.0 111.195 -179.74 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.497 ' O ' ' OG1' ' A' ' 12' ' ' THR . 63.3 t -60.85 -60.97 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.775 -179.04 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -58.05 -53.95 41.42 Favored Glycine 0 CA--C 1.527 0.808 0 N-CA-C 111.369 -0.692 . . . . 0.0 111.369 -179.398 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 9.0 mp -54.53 -31.36 56.2 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.605 0.241 . . . . 0.0 110.775 -179.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.497 ' OG1' ' O ' ' A' ' 9' ' ' VAL . 8.9 p -79.03 -24.39 43.66 Favored 'General case' 0 C--N 1.333 -0.145 0 C-N-CA 120.783 -0.367 . . . . 0.0 110.41 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 41.3 mt -76.84 -26.48 54.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.152 179.49 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.486 ' O ' ' N ' ' A' ' 16' ' ' SER . 13.7 t -52.05 -64.22 1.64 Allowed Pre-proline 0 CA--C 1.536 0.42 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.593 -179.519 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_endo -44.6 -16.29 0.11 Allowed 'Trans proline' 0 N--CA 1.497 1.726 0 C-N-CA 120.941 1.094 . . . . 0.0 112.137 -179.434 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.486 ' N ' ' O ' ' A' ' 14' ' ' VAL . 0.5 OUTLIER -75.49 -29.12 59.46 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.641 -179.915 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 81.7 mt -68.22 -56.17 9.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.002 -179.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -66.96 -38.55 92.89 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 111.558 -0.617 . . . . 0.0 111.558 -179.362 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -74.12 -26.2 69.2 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 111.378 -0.689 . . . . 0.0 111.378 -179.433 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.441 ' CB ' ' O ' ' A' ' 16' ' ' SER . 34.3 t80 -78.0 -60.7 2.26 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.78 -0.368 . . . . 0.0 110.998 -179.665 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 19.9 tpp -71.53 -21.26 61.93 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.34 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.422 ' C ' ' CZ2' ' A' ' 95' ' ' TRP . . . -75.51 -53.59 5.92 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 111.302 -0.719 . . . . 0.0 111.302 -179.802 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -73.56 -20.81 60.53 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.963 0.411 . . . . 0.0 110.461 -179.702 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.43 ' O ' ' CD1' ' A' ' 24' ' ' TYR . 27.2 t80 -51.08 -23.9 3.49 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.862 179.298 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 52.1 t80 -71.27 -55.46 8.02 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.02 -179.779 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 34.6 m -58.46 -26.06 29.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 C-N-CA 120.599 -0.441 . . . . 0.0 110.306 -179.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.519 ' O ' ' CD1' ' A' ' 31' ' ' LEU . 0.0 OUTLIER -87.95 -15.08 37.53 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.338 179.851 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -101.33 -71.66 0.94 Allowed Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.835 -0.906 . . . . 0.0 110.835 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.403 ' OE2' ' O ' ' A' ' 29' ' ' GLU . 3.3 tm-20 -76.88 -36.89 56.39 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.739 0.304 . . . . 0.0 110.567 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -51.3 -36.12 36.38 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 110.89 -0.884 . . . . 0.0 110.89 -179.79 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.519 ' CD1' ' O ' ' A' ' 27' ' ' ARG . 86.3 mt -55.35 -32.17 62.34 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.737 0.303 . . . . 0.0 110.348 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.434 ' O ' ' N ' ' A' ' 35' ' ' ALA . 37.6 ttm180 -81.28 -48.96 11.33 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.252 179.728 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -44.76 -36.13 3.05 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 179.473 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 26.6 t80 -55.66 -40.52 72.36 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.287 179.452 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.434 ' N ' ' O ' ' A' ' 32' ' ' ARG . . . -53.29 -26.96 20.46 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.169 179.784 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -90.37 -72.32 1.25 Allowed Glycine 0 CA--C 1.524 0.615 0 N-CA-C 110.921 -0.872 . . . . 0.0 110.921 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.406 ' C ' ' CD1' ' A' ' 37' ' ' LEU . 0.3 OUTLIER -96.1 167.64 11.09 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 120.947 0.404 . . . . 0.0 110.88 179.614 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 43.8 mm-40 -84.79 122.93 29.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.241 -179.256 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 16.0 mtpt -129.28 153.34 80.47 Favored Pre-proline 0 N--CA 1.464 0.24 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.048 179.443 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo . . . . . 0 C--N 1.31 -1.47 0 C-N-CA 121.549 1.499 . . . . 0.0 111.372 179.417 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.537 0.455 0 N-CA-C 112.686 0.624 . . . . 0.0 112.686 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.632 ' C ' ' H ' ' A' ' 52' ' ' ILE . . . -40.34 -30.26 0.24 Allowed Pre-proline 0 N--CA 1.468 0.427 0 C-N-CA 120.857 -0.337 . . . . 0.0 111.818 -178.699 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -53.76 4.53 0.04 OUTLIER 'Trans proline' 0 C--N 1.312 -1.382 0 CA-C-N 119.163 0.737 . . . . 0.0 112.547 178.498 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.632 ' H ' ' C ' ' A' ' 50' ' ' ALA . 44.0 pt -53.52 -32.42 20.51 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 C-N-CA 120.515 -0.474 . . . . 0.0 109.779 179.52 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.457 ' O ' ' CB ' ' A' ' 57' ' ' TYR . 60.9 m95 -78.94 -23.08 44.87 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.267 -179.145 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -68.54 -45.47 67.24 Favored Glycine 0 CA--C 1.527 0.793 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 178.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 16.5 m -69.27 -58.45 4.02 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-O 120.991 0.424 . . . . 0.0 110.0 179.408 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 96.6 mt -54.55 -28.62 46.99 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.033 179.511 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.521 ' C ' ' CD1' ' A' ' 57' ' ' TYR . 0.6 OUTLIER -63.51 -58.98 5.27 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 179.523 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 11.0 m -46.16 -49.29 17.01 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.406 -0.518 . . . . 0.0 109.909 179.515 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.55 -51.49 69.65 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.856 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 12.3 mtm -55.81 -35.59 66.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.78 -179.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -61.88 -49.31 77.05 Favored Glycine 0 CA--C 1.522 0.491 0 N-CA-C 110.59 -1.004 . . . . 0.0 110.59 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -56.83 -60.27 3.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.817 0.341 . . . . 0.0 110.501 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -52.21 -49.74 49.15 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 110.66 -0.976 . . . . 0.0 110.66 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.585 ' OG ' ' NE1' ' A' ' 68' ' ' TRP . 1.4 t -48.1 -54.24 13.87 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.108 0.48 . . . . 0.0 110.396 179.617 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 59.0 t80 -51.28 -41.48 60.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.51 179.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 84.9 mt -67.72 -45.58 84.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.329 -179.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 39.0 t -50.72 -55.81 5.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 C-N-CA 121.043 -0.263 . . . . 0.0 111.277 -179.327 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' TRP . . . . . 0.585 ' NE1' ' OG ' ' A' ' 64' ' ' SER . 0.7 OUTLIER -59.97 -52.56 64.89 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.686 -179.542 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 24.3 mmtt -53.64 -22.67 9.22 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.993 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 43.0 tp10 -79.6 -62.46 1.68 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.441 -179.312 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.0 pp -71.22 -1.17 11.72 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.2 -179.297 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 104.43 64.98 0.68 Allowed Glycine 0 CA--C 1.526 0.778 0 N-CA-C 111.43 -0.668 . . . . 0.0 111.43 179.51 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.585 ' N ' ' O ' ' A' ' 68' ' ' TRP . . . 51.75 -174.46 0.15 Allowed Glycine 0 CA--C 1.525 0.679 0 N-CA-C 111.325 -0.71 . . . . 0.0 111.325 179.661 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 89.8 t80 -76.62 110.72 11.42 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.86 0.362 . . . . 0.0 110.604 -179.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.591 ' OG1' ' N ' ' A' ' 76' ' ' GLU . 0.0 OUTLIER -139.17 -174.94 4.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.13 179.804 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.591 ' N ' ' OG1' ' A' ' 75' ' ' THR . 3.1 pt-20 -50.55 -21.62 1.61 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.839 -179.838 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -83.95 -18.47 37.16 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.105 -179.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -89.32 -18.25 27.32 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.874 -0.33 . . . . 0.0 110.838 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 15.4 mtp -69.32 -27.4 65.35 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.871 -0.332 . . . . 0.0 110.573 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 5.0 t -67.73 -47.94 43.26 Favored Pre-proline 0 CA--C 1.535 0.4 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.582 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -71.83 -58.12 0.08 OUTLIER 'Trans proline' 0 N--CA 1.498 1.786 0 C-N-CA 121.187 1.258 . . . . 0.0 112.087 179.277 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 13.0 mt -60.08 -53.4 58.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.985 0.421 . . . . 0.0 110.678 -179.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -55.86 -55.19 30.28 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 111.268 -0.733 . . . . 0.0 111.268 -179.537 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.404 ' O ' ' CB ' ' A' ' 88' ' ' GLN . 33.0 tp -61.01 -24.23 66.0 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.687 0.279 . . . . 0.0 110.936 -179.702 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -74.7 -56.49 4.74 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.884 -179.685 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 14.2 t -66.13 -38.35 87.97 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.799 -0.361 . . . . 0.0 110.977 -179.64 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -68.77 -57.26 8.14 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.932 -0.867 . . . . 0.0 110.932 -179.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.45 ' O ' ' CB ' ' A' ' 92' ' ' ASN . 36.3 tp60 -58.09 -40.5 81.28 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.859 0.362 . . . . 0.0 110.149 179.756 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 12.3 tp -67.37 -30.54 70.35 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.292 179.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.455 ' O ' ' CB ' ' A' ' 94' ' ' ALA . . . -66.95 -66.09 0.6 Allowed 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 120.13 -0.628 . . . . 0.0 110.944 -179.746 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.0 pp -66.51 -29.68 69.83 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.389 0.514 . . . . 0.0 112.389 -178.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.553 ' C ' HD21 ' A' ' 92' ' ' ASN . 0.2 OUTLIER -85.2 -62.2 1.59 Allowed 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.551 -0.46 . . . . 0.0 111.815 -178.827 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . 0.631 ' O ' ' N ' ' A' ' 95' ' ' TRP . 0.0 OUTLIER -64.57 -17.57 64.08 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.552 -0.459 . . . . 0.0 110.834 -179.007 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.455 ' CB ' ' O ' ' A' ' 90' ' ' ALA . . . -48.76 83.81 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 179.313 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.698 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 23.2 p-90 -100.95 -16.13 0.19 Allowed Pre-proline 0 CA--C 1.535 0.377 0 CA-C-N 116.107 -0.497 . . . . 0.0 112.334 -179.235 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.698 ' CD ' ' N ' ' A' ' 95' ' ' TRP . 37.2 Cg_exo -60.65 -31.52 92.21 Favored 'Trans proline' 0 N--CA 1.495 1.582 0 CA-C-N 119.067 0.703 . . . . 0.0 112.718 179.691 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . 0.518 ' CD ' ' N ' ' A' ' 96' ' ' PRO . 83.8 Cg_exo -56.76 -16.92 21.23 Favored 'Trans proline' 0 N--CA 1.496 1.647 0 C-N-CA 120.803 1.002 . . . . 0.0 113.15 -179.775 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.423 ' O ' ' N ' ' A' ' 101' ' ' GLY . 1.1 pp -88.34 20.36 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 C-N-CA 120.713 -0.395 . . . . 0.0 110.732 -179.718 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.597 ' CD2' ' O ' ' A' ' 96' ' ' PRO . 29.7 m-85 -39.36 -36.96 0.4 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.326 179.649 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . 0.557 ' CD1' ' N ' ' A' ' 100' ' ' PHE . 0.5 OUTLIER -76.71 -43.87 35.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.697 179.948 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 0.423 ' N ' ' O ' ' A' ' 98' ' ' ILE . . . -62.23 -11.28 32.29 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 111.083 -0.807 . . . . 0.0 111.083 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -62.17 -38.47 89.17 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.637 0.256 . . . . 0.0 111.198 -179.615 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.16 17.97 2.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.078 -179.607 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 11.5 mt-30 -124.4 160.15 28.81 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.888 0.375 . . . . 0.0 110.638 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' MET . . . . . 0.547 ' N ' ' SD ' ' A' ' 105' ' ' MET . 0.0 OUTLIER -51.12 -17.06 0.57 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.416 179.813 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.601 ' O ' ' N ' ' A' ' 108' ' ' ALA . . . -75.48 -14.13 82.27 Favored Glycine 0 CA--C 1.529 0.919 0 CA-C-N 115.938 -0.573 . . . . 0.0 111.722 -179.554 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' TRP . . . . . 0.617 ' CD1' ' CZ2' ' A' ' 155' ' ' TRP . 0.0 OUTLIER -36.62 -21.84 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.417 0 CA-C-O 120.529 0.204 . . . . 0.0 111.366 -179.165 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.601 ' N ' ' O ' ' A' ' 106' ' ' GLY . . . -63.35 -16.67 61.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.669 0.271 . . . . 0.0 111.168 -179.322 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 6.2 mp -54.5 -32.95 58.95 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.776 -179.632 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.427 ' O ' ' CD2' ' A' ' 114' ' ' LEU . . . -55.82 -62.33 1.76 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.858 0.361 . . . . 0.0 111.138 -179.628 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.529 ' O ' ' CG2' ' A' ' 115' ' ' VAL . 3.8 p-10 -58.92 -54.43 47.24 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.033 -0.53 . . . . 0.0 112.005 -179.155 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 34.3 tp -55.76 -44.36 77.59 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 -178.56 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 52.1 mt -64.24 -60.68 2.9 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.254 0.465 . . . . 0.0 112.254 -178.482 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.427 ' CD2' ' O ' ' A' ' 110' ' ' ALA . 2.3 pp -62.89 -35.32 79.64 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.494 -0.483 . . . . 0.0 111.68 -178.565 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.529 ' CG2' ' O ' ' A' ' 111' ' ' ASP . 27.2 t -57.91 -60.12 2.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.136 -179.687 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' SER . . . . . 0.488 ' O ' ' OG1' ' A' ' 120' ' ' THR . 4.5 m -74.18 -22.44 59.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.427 -0.352 . . . . 0.0 111.592 -178.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -62.93 -62.71 5.22 Favored Glycine 0 CA--C 1.526 0.721 0 C-N-CA 120.783 -0.723 . . . . 0.0 111.475 -179.418 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.51 ' O ' ' OG1' ' A' ' 122' ' ' THR . 8.6 p -75.58 -35.1 30.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 C-N-CA 121.035 -0.266 . . . . 0.0 111.046 -179.579 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . 0.526 ' O ' ' OG1' ' A' ' 123' ' ' THR . . . -66.69 -60.4 2.73 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.635 -0.426 . . . . 0.0 110.56 -179.742 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.488 ' OG1' ' O ' ' A' ' 116' ' ' SER . 2.4 m -60.32 -54.57 44.15 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.408 -179.589 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.408 ' O ' ' CB ' ' A' ' 125' ' ' ALA . . . -51.25 -41.12 60.14 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.314 -179.153 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.51 ' OG1' ' O ' ' A' ' 118' ' ' VAL . 36.0 p -73.19 -29.95 63.2 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.625 -179.19 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 0.526 ' OG1' ' O ' ' A' ' 119' ' ' ALA . 0.2 OUTLIER -66.84 -49.89 64.3 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.714 -0.394 . . . . 0.0 110.864 -179.412 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.8 pp -81.44 -19.05 43.27 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.57 -179.04 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . 0.408 ' CB ' ' O ' ' A' ' 121' ' ' ALA . . . -93.61 -65.28 1.0 Allowed 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.427 0.529 . . . . 0.0 112.427 -178.824 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 42.1 m0 -83.59 -56.98 3.42 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 113.056 0.762 . . . . 0.0 113.056 -177.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . 0.403 ' CD2' ' N ' ' A' ' 127' ' ' HIS . 11.1 m170 -59.6 -25.62 64.77 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.586 -0.445 . . . . 0.0 111.569 -178.535 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 15.9 ttt180 -61.76 -41.17 97.34 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.31 -179.455 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 33.4 t -93.34 -48.88 13.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.517 -0.311 . . . . 0.0 110.964 -179.611 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 2.1 p -113.07 107.94 53.63 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.884 -179.301 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . 0.646 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 73.8 Cg_exo -74.69 -26.52 11.49 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 C-N-CA 121.702 1.601 . . . . 0.0 112.741 179.355 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . 0.646 ' CD ' ' N ' ' A' ' 131' ' ' PRO . 52.0 Cg_exo -62.09 -54.97 1.17 Allowed 'Trans proline' 0 N--CA 1.496 1.666 0 C-N-CA 121.357 1.372 . . . . 0.0 112.194 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . 0.524 ' O ' ' N ' ' A' ' 136' ' ' LEU . . . -45.97 -46.07 16.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.879 0.371 . . . . 0.0 110.42 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -45.12 -27.31 0.57 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.109 179.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 10.1 tpp180 -76.3 -30.7 57.85 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.299 179.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.524 ' N ' ' O ' ' A' ' 133' ' ' ALA . 36.6 mt -74.16 -24.9 59.47 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 179.303 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 0.573 ' O ' ' N ' ' A' ' 140' ' ' TYR . 3.7 mt -89.81 -33.26 16.58 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.075 179.511 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.529 ' C ' ' H ' ' A' ' 140' ' ' TYR . 0.5 OUTLIER -27.68 -51.13 0.23 Allowed Pre-proline 0 CA--C 1.536 0.416 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.554 179.727 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.424 ' HD2' ' N ' ' A' ' 138' ' ' TYR . 2.2 Cg_endo -58.76 4.69 0.11 Allowed 'Trans proline' 0 N--CA 1.497 1.687 0 C-N-CA 121.374 1.383 . . . . 0.0 112.689 -179.823 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . 0.573 ' N ' ' O ' ' A' ' 137' ' ' LEU . 0.3 OUTLIER -90.66 -15.41 30.45 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.904 0.383 . . . . 0.0 110.724 179.764 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 97.6 mt -60.09 -36.5 77.55 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 178.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -56.61 -41.8 77.67 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.689 179.161 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' TRP . . . . . . . . . . . . . 7.5 t-105 -62.74 -43.66 98.22 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 115.771 -0.65 . . . . 0.0 109.472 179.227 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 22.0 mt -58.44 -37.59 75.73 Favored 'General case' 0 CA--C 1.521 -0.163 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.707 179.268 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . 0.535 ' O ' ' CG2' ' A' ' 149' ' ' VAL . . . -73.28 -27.84 61.78 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.496 179.848 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 28.7 t80 -64.75 -62.32 1.64 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.781 -179.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . 0.489 ' O ' ' OD1' ' A' ' 151' ' ' ASN . . . -64.15 -43.84 93.95 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.432 -0.507 . . . . 0.0 110.45 -179.815 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' THR . . . . . 0.499 ' O ' ' OD1' ' A' ' 151' ' ' ASN . 52.4 m -57.89 -36.71 72.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.475 179.807 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.535 ' CG2' ' O ' ' A' ' 145' ' ' ALA . 39.3 t -74.65 -27.5 20.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.686 179.82 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -66.41 -52.64 44.45 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.426 -0.509 . . . . 0.0 110.209 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . 0.499 ' OD1' ' O ' ' A' ' 148' ' ' THR . 8.1 p-10 -65.35 -43.42 90.93 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.25 -179.837 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . 0.455 ' C ' ' CD1' ' A' ' 152' ' ' TYR . 22.6 t80 -64.78 -42.44 95.09 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.988 -0.285 . . . . 0.0 111.006 -179.562 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 77.1 t80 -61.18 -41.16 96.29 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.181 -179.376 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 42.9 t -75.44 -50.46 23.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.38 -179.348 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' TRP . . . . . 0.617 ' CZ2' ' CD1' ' A' ' 107' ' ' TRP . 0.1 OUTLIER -55.4 -29.4 58.45 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.826 -178.889 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -85.41 -45.93 11.4 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.952 -0.299 . . . . 0.0 110.625 -179.639 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -69.02 -44.02 73.58 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.897 -179.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 16.3 t30 . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.79 -179.971 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . 0.694 ' CE2' ' CE3' ' A' ' 68' ' ' TRP . 1.0 OUTLIER . . . . . 0 CA--C 1.529 0.141 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 . . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.576 ' N ' ' CD ' ' A' ' 7' ' ' PRO . 0.9 OUTLIER -60.52 -33.01 12.86 Favored Pre-proline 0 CA--C 1.534 0.362 0 C-N-CA 120.858 -0.337 . . . . 0.0 110.274 -179.653 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.576 ' CD ' ' N ' ' A' ' 6' ' ' VAL . 24.6 Cg_exo -73.14 -66.23 0.03 OUTLIER 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 121.517 1.478 . . . . 0.0 112.069 179.577 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.455 ' O ' ' OG1' ' A' ' 12' ' ' THR . . . -50.11 -36.58 30.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.261 -179.485 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.41 ' CG2' ' O ' ' A' ' 5' ' ' TRP . 78.7 t -69.53 -61.96 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.552 -179.292 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -56.11 -34.71 62.71 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 111.51 -0.636 . . . . 0.0 111.51 -179.347 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 6.9 mp -74.44 -30.29 61.83 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.57 0.224 . . . . 0.0 110.737 -179.532 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.455 ' OG1' ' O ' ' A' ' 8' ' ' ALA . 3.1 p -81.21 -21.02 39.9 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.876 0.37 . . . . 0.0 110.578 179.83 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.423 ' O ' ' N ' ' A' ' 16' ' ' SER . 69.8 mt -82.9 -38.12 23.3 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.517 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 5.1 t -43.07 -58.9 3.55 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.717 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -56.8 -13.96 12.57 Favored 'Trans proline' 0 N--CA 1.497 1.71 0 C-N-CA 121.02 1.147 . . . . 0.0 111.789 179.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.423 ' N ' ' O ' ' A' ' 13' ' ' LEU . 1.9 t -79.52 -24.73 42.01 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.506 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 55.0 mt -74.24 -58.16 3.48 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.323 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -75.72 -23.24 73.13 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 110.685 -0.966 . . . . 0.0 110.685 179.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -70.38 -52.49 16.86 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 111.259 -0.736 . . . . 0.0 111.259 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 86.9 t80 -74.07 -55.14 6.47 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.682 0.277 . . . . 0.0 111.184 -179.597 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 16.2 ttm -62.97 -30.12 71.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.26 -179.365 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -72.76 -59.54 4.34 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 111.277 -0.729 . . . . 0.0 111.277 -179.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.22 -16.43 62.0 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.784 -0.366 . . . . 0.0 110.62 -179.434 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 63.4 t80 -48.14 -23.99 1.0 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.104 179.56 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 48.5 t80 -72.08 -53.54 12.54 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.953 -179.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 33.3 m -65.52 -16.32 20.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 C-N-CA 120.835 -0.346 . . . . 0.0 110.672 -179.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.458 ' O ' ' CD1' ' A' ' 31' ' ' LEU . 0.0 OUTLIER -56.57 -47.51 79.34 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.741 -179.813 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -105.51 -62.98 0.63 Allowed Glycine 0 CA--C 1.525 0.7 0 N-CA-C 111.191 -0.764 . . . . 0.0 111.191 -179.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 6.1 tm-20 -45.09 -33.89 2.36 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.722 0.296 . . . . 0.0 110.626 -179.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -71.66 -51.11 17.05 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 111.023 -0.831 . . . . 0.0 111.023 -179.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.458 ' CD1' ' O ' ' A' ' 27' ' ' ARG . 86.6 mt -57.61 -35.04 69.93 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.752 0.31 . . . . 0.0 110.609 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 62.8 mtp180 -76.07 -42.72 46.56 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.36 179.796 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -51.71 -40.61 60.46 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.372 179.845 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.506 ' C ' ' CD1' ' A' ' 34' ' ' TYR . 9.8 t80 -48.23 -40.6 24.96 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.67 -179.797 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -57.73 -24.95 59.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.449 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -95.55 -75.18 1.26 Allowed Glycine 0 CA--C 1.525 0.663 0 N-CA-C 110.974 -0.85 . . . . 0.0 110.974 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.402 ' C ' ' CD1' ' A' ' 37' ' ' LEU . 0.4 OUTLIER -95.79 167.54 11.21 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.971 0.415 . . . . 0.0 110.739 179.823 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 47.2 mm-40 -79.91 113.21 17.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.888 -179.568 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 8.3 mtpt -128.86 150.72 75.86 Favored Pre-proline 0 CA--C 1.532 0.281 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.068 179.637 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo . . . . . 0 C--N 1.31 -1.492 0 C-N-CA 121.871 1.714 . . . . 0.0 111.636 179.526 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 31.5 tp . . . . . 0 CA--C 1.531 0.249 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.67 ' C ' ' H ' ' A' ' 52' ' ' ILE . . . -40.43 -29.08 0.21 Allowed Pre-proline 0 N--CA 1.466 0.327 0 C-N-CA 120.069 -0.652 . . . . 0.0 111.569 -178.872 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_exo -54.93 7.39 0.03 OUTLIER 'Trans proline' 0 C--N 1.312 -1.355 0 CA-C-N 119.058 0.699 . . . . 0.0 112.205 177.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.67 ' H ' ' C ' ' A' ' 50' ' ' ALA . 11.6 pt -54.37 -35.19 29.98 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.203 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 178.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 63.0 m95 -81.79 -24.12 36.16 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.359 179.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -71.43 -47.07 37.23 Favored Glycine 0 CA--C 1.527 0.792 0 N-CA-C 110.36 -1.096 . . . . 0.0 110.36 179.275 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.517 ' CG2' ' N ' ' A' ' 56' ' ' LEU . 13.3 t -70.65 -48.15 56.38 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 179.408 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.517 ' N ' ' CG2' ' A' ' 55' ' ' THR . 93.5 mt -60.92 -27.9 68.54 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 178.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.46 ' C ' ' CD1' ' A' ' 57' ' ' TYR . 0.8 OUTLIER -65.94 -53.64 36.54 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 179.375 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.479 ' H ' ' HG ' ' A' ' 58' ' ' SER . 0.1 OUTLIER -48.88 -47.56 42.89 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 178.928 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.11 -48.21 82.44 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.062 179.177 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 27.1 mtt -52.67 -50.55 63.02 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.876 179.652 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -48.37 -53.63 15.38 Favored Glycine 0 CA--C 1.522 0.526 0 N-CA-C 110.399 -1.081 . . . . 0.0 110.399 179.638 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.538 ' N ' ' CD1' ' A' ' 62' ' ' TYR . 1.4 m-30 -56.55 -50.31 72.25 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.8 0.333 . . . . 0.0 110.527 179.68 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -52.06 -54.13 27.42 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 110.475 -1.05 . . . . 0.0 110.475 179.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.592 ' O ' ' CD1' ' A' ' 68' ' ' TRP . 1.4 t -54.88 -47.23 74.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.834 0.349 . . . . 0.0 110.281 179.672 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.57 ' OH ' ' NZ ' ' A' ' 69' ' ' LYS . 74.7 t80 -46.27 -45.17 17.04 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.647 -0.421 . . . . 0.0 109.899 179.69 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 59.0 mt -71.38 -27.1 27.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.902 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 73.6 t -67.34 -57.71 8.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 C-N-CA 120.732 -0.387 . . . . 0.0 111.6 -179.3 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' TRP . . . . . 0.694 ' CE3' ' CE2' ' A' ' 5' ' ' TRP . 0.0 OUTLIER -72.82 -24.61 60.93 Favored 'General case' 0 CA--C 1.528 0.11 0 C-N-CA 119.814 -0.754 . . . . 0.0 110.73 -179.654 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.57 ' NZ ' ' OH ' ' A' ' 65' ' ' TYR . 6.5 mmmt -76.73 -26.74 54.98 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.427 -0.509 . . . . 0.0 110.181 179.341 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 33.6 tp10 -79.96 -58.4 3.18 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.817 -179.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.2 pp -73.34 -21.72 60.48 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.878 -179.597 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.499 ' O ' ' O ' ' A' ' 73' ' ' GLY . . . 109.32 98.57 2.54 Favored Glycine 0 CA--C 1.528 0.844 0 C-N-CA 121.088 -0.577 . . . . 0.0 112.248 178.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.577 ' N ' ' O ' ' A' ' 68' ' ' TRP . . . 41.52 -173.99 0.01 OUTLIER Glycine 0 CA--C 1.525 0.691 0 N-CA-C 111.975 -0.45 . . . . 0.0 111.975 178.878 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 84.0 t80 -90.42 110.64 21.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.724 0.297 . . . . 0.0 110.483 -179.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.568 ' OG1' ' N ' ' A' ' 76' ' ' GLU . 0.8 OUTLIER -142.43 -173.6 3.9 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.909 0.385 . . . . 0.0 110.893 -179.839 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.568 ' N ' ' OG1' ' A' ' 75' ' ' THR . 26.0 mt-10 -53.27 -21.68 5.83 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.692 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 24.3 m-20 -79.67 -33.07 41.5 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.778 -179.796 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -87.02 -15.62 38.12 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.821 -179.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 8.1 mtp -70.99 -27.24 63.56 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.763 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 8.4 t -66.85 -45.12 54.36 Favored Pre-proline 0 C--N 1.328 -0.331 0 C-N-CA 120.783 -0.367 . . . . 0.0 110.52 -179.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -77.1 -61.7 0.03 OUTLIER 'Trans proline' 0 N--CA 1.499 1.816 0 C-N-CA 121.227 1.284 . . . . 0.0 111.799 178.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 12.7 mt -55.39 -44.41 76.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.759 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -65.92 -55.85 17.43 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.972 -0.851 . . . . 0.0 110.972 -179.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 60.3 tp -55.28 -21.87 16.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.812 0.339 . . . . 0.0 110.37 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 30.7 t80 -78.03 -51.89 9.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.063 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -61.84 -38.58 88.75 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.8 -0.36 . . . . 0.0 111.277 -179.059 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -73.67 -58.14 4.65 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 111.277 -0.729 . . . . 0.0 111.277 -179.571 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 5.0 tp-100 -53.45 -47.74 69.45 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-O 121.127 0.489 . . . . 0.0 109.778 179.714 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.445 ' O ' ' C ' ' A' ' 90' ' ' ALA . 19.5 tp -52.81 -66.02 0.46 Allowed 'General case' 0 C--O 1.211 -0.961 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.904 179.823 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.445 ' C ' ' O ' ' A' ' 89' ' ' LEU . . . -38.17 -48.7 1.29 Allowed 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 120.267 -0.573 . . . . 0.0 111.771 -179.496 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 95.3 mt -55.22 -57.03 13.45 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 113.415 0.894 . . . . 0.0 113.415 -178.407 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.402 ' O ' ' CD2' ' A' ' 113' ' ' LEU . 4.8 m-20 -78.05 -53.42 7.43 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 121.284 0.564 . . . . 0.0 111.604 -178.223 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . 0.645 ' O ' ' N ' ' A' ' 95' ' ' TRP . 5.6 t-105 -52.13 -25.11 8.12 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.568 -179.679 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -55.74 71.35 0.0 OUTLIER 'General case' 0 CA--C 1.528 0.133 0 CA-C-O 120.829 0.347 . . . . 0.0 110.675 -179.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.681 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 7.0 p-90 -101.62 -17.73 0.19 Allowed Pre-proline 0 CA--C 1.534 0.35 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.891 -179.784 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.681 ' CD ' ' N ' ' A' ' 95' ' ' TRP . 44.5 Cg_exo -61.16 -24.78 79.85 Favored 'Trans proline' 0 C--N 1.311 -1.396 0 C-N-CA 120.248 0.632 . . . . 0.0 112.412 179.034 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . 0.529 ' CD ' ' N ' ' A' ' 96' ' ' PRO . 63.8 Cg_exo -59.82 -31.82 94.51 Favored 'Trans proline' 0 N--CA 1.493 1.474 0 C-N-CA 120.339 0.693 . . . . 0.0 112.803 179.547 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 1.4 pt -77.2 44.01 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 C-N-CA 120.342 -0.543 . . . . 0.0 110.259 179.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.421 ' H ' ' C ' ' A' ' 97' ' ' PRO . 0.1 OUTLIER -61.57 -35.59 78.23 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.302 179.986 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -82.62 -20.01 37.2 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.399 179.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -87.28 -14.73 63.57 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.912 -0.875 . . . . 0.0 110.912 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -62.04 -34.18 75.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.783 0.325 . . . . 0.0 110.672 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 15.8 ptt180 -76.4 11.24 1.65 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.78 -179.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 14.8 mt-30 -121.89 154.56 36.93 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.564 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 6.0 mmt -51.49 -18.59 1.12 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.413 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.606 ' O ' ' N ' ' A' ' 108' ' ' ALA . . . -71.13 -14.98 74.19 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 111.18 -0.768 . . . . 0.0 111.18 179.874 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' TRP . . . . . 0.461 ' CD1' ' N ' ' A' ' 108' ' ' ALA . 0.1 OUTLIER -42.55 -14.12 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.683 0.278 . . . . 0.0 110.822 -179.498 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.606 ' N ' ' O ' ' A' ' 106' ' ' GLY . . . -58.49 -28.68 65.6 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 179.416 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 12.2 mt -47.02 -31.68 3.42 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.889 179.49 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -54.55 -60.47 3.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.39 179.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.589 ' OD1' ' N ' ' A' ' 112' ' ' LEU . 1.6 p30 -59.0 -53.68 55.72 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.76 -179.44 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.589 ' N ' ' OD1' ' A' ' 111' ' ' ASP . 40.5 tp -55.43 -39.81 70.72 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -178.414 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.402 ' CD2' ' O ' ' A' ' 92' ' ' ASN . 17.9 mt -70.47 -61.69 1.67 Allowed 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.124 0.416 . . . . 0.0 112.124 -178.506 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.9 pp -59.6 -34.02 72.21 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 120.339 -0.544 . . . . 0.0 111.064 -179.006 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.55 ' CG2' ' O ' ' A' ' 111' ' ' ASP . 42.3 t -61.68 -60.86 2.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.102 -179.863 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 13.0 m -68.0 -22.62 64.99 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.546 -178.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -66.35 -62.75 4.39 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 120.696 -0.764 . . . . 0.0 111.856 -179.252 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.494 ' O ' ' OG1' ' A' ' 122' ' ' THR . 9.1 p -72.46 -35.86 52.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 111.614 0.227 . . . . 0.0 111.614 -179.183 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . 0.557 ' O ' ' OG1' ' A' ' 123' ' ' THR . . . -67.96 -61.31 1.92 Allowed 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.387 -0.525 . . . . 0.0 111.289 -179.326 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 8.1 m -59.64 -50.43 73.9 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.561 -0.291 . . . . 0.0 111.492 -179.184 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.433 ' O ' ' CB ' ' A' ' 125' ' ' ALA . . . -55.29 -40.49 71.13 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.79 0.329 . . . . 0.0 111.019 -179.461 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.494 ' OG1' ' O ' ' A' ' 118' ' ' VAL . 40.4 p -74.79 -33.44 62.24 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.803 -0.359 . . . . 0.0 111.713 -179.253 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 0.557 ' OG1' ' O ' ' A' ' 119' ' ' ALA . 0.2 OUTLIER -60.07 -56.48 21.15 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.559 -0.456 . . . . 0.0 110.784 -179.521 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -79.19 -20.16 49.07 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 -178.584 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . 0.433 ' CB ' ' O ' ' A' ' 121' ' ' ALA . . . -91.17 -66.73 0.9 Allowed 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 112.789 0.663 . . . . 0.0 112.789 -178.818 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 43.4 m0 -83.0 -57.42 3.3 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -177.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . 0.401 ' CD2' ' N ' ' A' ' 127' ' ' HIS . 11.5 m170 -55.69 -22.18 22.08 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.584 -0.446 . . . . 0.0 111.129 -179.004 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 19.2 ttt85 -69.66 -48.79 58.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.148 -179.624 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 10.3 t -81.39 -47.46 19.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.993 -179.453 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 61.0 p -116.28 104.98 51.39 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.51 -179.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . 0.639 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 57.2 Cg_exo -70.79 -29.43 18.99 Favored 'Trans proline' 0 C--N 1.31 -1.477 0 C-N-CA 121.537 1.491 . . . . 0.0 112.367 179.639 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . 0.639 ' CD ' ' N ' ' A' ' 131' ' ' PRO . 41.4 Cg_exo -62.58 -42.81 24.51 Favored 'Trans proline' 0 N--CA 1.496 1.663 0 C-N-CA 121.391 1.394 . . . . 0.0 111.787 179.7 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -54.44 -41.52 69.5 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.311 179.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -57.18 -22.66 42.06 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.309 179.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 11.2 tpp180 -77.06 -31.7 56.32 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.61 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 82.8 mt -72.56 -43.54 63.3 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.857 0.361 . . . . 0.0 110.082 179.571 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 0.556 ' O ' ' N ' ' A' ' 140' ' ' TYR . 3.4 mt -75.31 -37.68 60.68 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.442 179.79 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.588 ' C ' ' H ' ' A' ' 140' ' ' TYR . 0.8 OUTLIER -19.4 -48.64 0.04 OUTLIER Pre-proline 0 N--CA 1.466 0.352 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.948 -179.608 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.527 ' N ' ' O ' ' A' ' 137' ' ' LEU . 1.6 Cg_endo -64.45 16.08 0.08 OUTLIER 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 120.968 1.112 . . . . 0.0 112.142 179.617 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . 0.653 ' CE1' ' CD1' ' A' ' 141' ' ' LEU . 5.3 p90 -93.35 -15.17 26.01 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-O 121.153 0.501 . . . . 0.0 110.22 179.634 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.653 ' CD1' ' CE1' ' A' ' 140' ' ' TYR . 5.8 mp -57.43 -26.74 61.62 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.273 178.773 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -66.49 -48.93 68.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.08 179.651 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' TRP . . . . . . . . . . . . . 12.0 t-105 -55.81 -48.7 74.96 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 179.499 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 8.8 mt -50.37 -56.58 10.76 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 120.444 -0.502 . . . . 0.0 109.968 179.714 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . 0.426 ' O ' ' CG2' ' A' ' 149' ' ' VAL . . . -61.41 -18.28 58.09 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.709 -179.815 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 6.5 t80 -70.93 -65.04 0.79 Allowed 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.843 -0.343 . . . . 0.0 110.829 -179.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . 0.494 ' O ' ' OD1' ' A' ' 151' ' ' ASN . . . -62.95 -40.23 97.03 Favored 'General case' 0 C--N 1.332 -0.154 0 C-N-CA 120.769 -0.372 . . . . 0.0 110.309 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 13.9 m -58.77 -49.83 76.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.46 179.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.426 ' CG2' ' O ' ' A' ' 145' ' ' ALA . 53.6 t -66.9 -29.38 46.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.334 179.831 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -58.33 -59.6 5.08 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.506 -0.478 . . . . 0.0 109.935 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . 0.494 ' OD1' ' O ' ' A' ' 147' ' ' ALA . 6.7 p-10 -60.6 -51.29 70.02 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.543 179.624 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . 0.665 ' CZ ' ' NE ' ' A' ' 156' ' ' ARG . 53.8 t80 -50.13 -34.74 23.18 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.283 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . 0.552 ' CE2' ' OD2' ' A' ' 157' ' ' ASP . 41.0 t80 -68.06 -46.07 72.09 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.529 179.826 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 19.0 t -58.14 -36.8 58.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.305 179.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' TRP . . . . . . . . . . . . . 15.3 m0 -65.57 -46.02 81.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.624 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . 0.665 ' NE ' ' CZ ' ' A' ' 152' ' ' TYR . 7.2 mpt_? -68.4 -29.27 67.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.579 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . 0.552 ' OD2' ' CE2' ' A' ' 153' ' ' TYR . 17.0 m-20 -72.3 -51.71 19.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.819 -179.78 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 . . . . . 0 C--N 1.328 -0.341 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.602 -179.917 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.702 0.287 . . . . 0.0 110.354 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.589 ' N ' ' CD ' ' A' ' 7' ' ' PRO . 0.9 OUTLIER -62.28 -37.52 37.86 Favored Pre-proline 0 CA--C 1.534 0.352 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.114 -179.999 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.589 ' CD ' ' N ' ' A' ' 6' ' ' VAL . 33.5 Cg_exo -63.68 -64.21 0.07 OUTLIER 'Trans proline' 0 C--N 1.307 -1.621 0 C-N-CA 121.704 1.603 . . . . 0.0 111.525 179.638 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.533 ' O ' ' CG2' ' A' ' 12' ' ' THR . . . -52.77 -38.84 61.64 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.695 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 24.8 t -59.3 -62.02 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.848 -179.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -59.86 -56.67 23.48 Favored Glycine 0 CA--C 1.527 0.81 0 N-CA-C 111.516 -0.634 . . . . 0.0 111.516 -179.628 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 10.1 mp -50.15 -37.77 36.19 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.563 0.22 . . . . 0.0 110.888 -179.643 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.533 ' CG2' ' O ' ' A' ' 8' ' ' ALA . 35.9 p -75.57 -25.18 56.85 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.858 -0.337 . . . . 0.0 110.625 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 4.1 mp -75.81 -25.11 56.06 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.196 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.2 t -54.54 -61.87 4.94 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.428 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -55.8 -46.16 33.67 Favored 'Trans proline' 0 N--CA 1.496 1.672 0 C-N-CA 120.662 0.908 . . . . 0.0 111.808 179.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.2 t -46.13 -28.37 1.2 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.236 -179.474 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 92.7 mt -70.2 -56.02 7.86 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.645 -0.422 . . . . 0.0 110.742 -179.705 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -68.0 -23.2 74.42 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 111.316 -0.714 . . . . 0.0 111.316 -179.659 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -69.93 -54.66 11.13 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 110.881 -0.888 . . . . 0.0 110.881 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 52.3 t80 -65.94 -60.29 2.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.833 0.349 . . . . 0.0 110.675 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 17.3 tpp -59.09 -27.67 65.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.04 -179.726 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -74.71 -62.91 2.71 Favored Glycine 0 CA--C 1.523 0.536 0 N-CA-C 111.011 -0.836 . . . . 0.0 111.011 -179.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -55.48 -19.54 9.9 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.947 0.403 . . . . 0.0 109.994 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 9.5 t80 -47.83 -24.39 0.98 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.409 179.713 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.466 ' CE2' ' O ' ' A' ' 99' ' ' PHE . 50.0 t80 -69.34 -48.32 61.74 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.417 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 35.6 m -75.23 -16.37 15.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.634 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -56.31 -47.28 79.01 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.834 -179.77 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -107.14 -42.2 1.55 Allowed Glycine 0 CA--C 1.525 0.7 0 N-CA-C 111.055 -0.818 . . . . 0.0 111.055 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.44 ' OE2' ' CZ3' ' A' ' 33' ' ' TRP . 16.8 tp10 -71.45 -29.63 65.09 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.701 0.286 . . . . 0.0 110.693 -179.845 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -73.99 -57.36 4.87 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.913 -0.875 . . . . 0.0 110.913 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 10.0 mp -56.83 -25.42 56.02 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.973 -0.381 . . . . 0.0 109.973 179.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 55.4 ttt180 -81.2 -49.89 10.24 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.088 -0.506 . . . . 0.0 109.989 179.432 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . 0.44 ' CZ3' ' OE2' ' A' ' 29' ' ' GLU . 0.2 OUTLIER -45.83 -39.94 9.14 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.688 179.252 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 42.2 t80 -47.37 -38.67 13.55 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.774 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -55.97 -35.18 66.43 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.262 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -84.31 -72.27 1.29 Allowed Glycine 0 CA--C 1.524 0.634 0 N-CA-C 110.804 -0.918 . . . . 0.0 110.804 179.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.411 ' C ' ' CD1' ' A' ' 37' ' ' LEU . 0.4 OUTLIER -96.67 167.89 10.85 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.798 0.333 . . . . 0.0 110.611 179.622 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 42.3 mm-40 -83.71 118.53 23.95 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.512 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 15.0 mtpt -127.47 150.15 71.97 Favored Pre-proline 0 N--CA 1.465 0.277 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.255 -179.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo . . . . . 0 C--N 1.309 -1.509 0 C-N-CA 121.747 1.632 . . . . 0.0 111.045 179.177 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 15.5 tp . . . . . 0 CA--C 1.535 0.398 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.689 ' C ' ' H ' ' A' ' 52' ' ' ILE . . . -43.41 -27.84 0.33 Allowed Pre-proline 0 N--CA 1.468 0.431 0 N-CA-C 112.141 0.422 . . . . 0.0 112.141 -179.141 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.414 ' HD2' ' N ' ' A' ' 50' ' ' ALA . 26.6 Cg_exo -53.41 6.46 0.03 OUTLIER 'Trans proline' 0 C--N 1.313 -1.309 0 CA-C-N 119.003 0.68 . . . . 0.0 112.476 178.214 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.689 ' H ' ' C ' ' A' ' 50' ' ' ALA . 7.0 pt -51.85 -36.81 19.84 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.19 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 178.827 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.403 ' CH2' ' CZ3' ' A' ' 93' ' ' TRP . 66.1 m95 -80.74 -25.0 38.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.143 -179.752 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -73.1 -50.75 11.64 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 110.326 -1.109 . . . . 0.0 110.326 179.326 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.54 ' CG2' ' N ' ' A' ' 56' ' ' LEU . 6.8 t -66.28 -49.16 68.04 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.983 -0.287 . . . . 0.0 110.287 179.713 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.54 ' N ' ' CG2' ' A' ' 55' ' ' THR . 77.7 mt -60.33 -36.53 78.17 Favored 'General case' 0 CA--C 1.521 -0.16 0 C-N-CA 120.403 -0.519 . . . . 0.0 109.608 179.317 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.485 ' C ' ' CD1' ' A' ' 57' ' ' TYR . 0.8 OUTLIER -56.46 -48.29 77.38 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.61 179.334 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.7 p -55.87 -48.06 76.23 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.022 179.5 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.0 -38.82 80.09 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.315 179.558 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 22.2 mtt -63.16 -37.91 89.1 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.479 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -63.38 -47.02 91.28 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 111.245 -0.742 . . . . 0.0 111.245 -179.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 3.3 m-30 -61.49 -59.13 5.71 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.574 -179.662 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -53.94 -60.06 8.95 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 111.02 -0.832 . . . . 0.0 111.02 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.534 ' OG ' ' CH2' ' A' ' 126' ' ' TRP . 44.7 m -45.51 -48.47 14.12 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.001 0.429 . . . . 0.0 110.726 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 62.6 t80 -56.51 -41.45 76.74 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.697 -179.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 74.7 mt -65.43 -37.56 80.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.923 -179.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.413 ' CG1' ' CZ3' ' A' ' 68' ' ' TRP . 21.3 t -59.85 -60.83 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.721 -179.801 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' TRP . . . . . 0.576 ' O ' ' N ' ' A' ' 73' ' ' GLY . 0.7 OUTLIER -57.3 -41.51 79.96 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.655 -0.418 . . . . 0.0 110.325 179.933 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 13.9 mmmt -61.44 -24.77 66.77 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.498 179.622 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 17.7 tp10 -82.34 -62.47 1.61 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.187 -179.473 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.497 ' C ' ' CD1' ' A' ' 71' ' ' LEU . 3.4 pp -65.25 -8.88 19.7 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.831 -0.348 . . . . 0.0 111.377 -179.152 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.468 ' O ' ' O ' ' A' ' 73' ' ' GLY . . . 108.87 76.43 0.93 Allowed Glycine 0 CA--C 1.527 0.801 0 C-N-CA 120.939 -0.648 . . . . 0.0 111.592 179.561 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.576 ' N ' ' O ' ' A' ' 68' ' ' TRP . . . 42.84 -174.03 0.01 OUTLIER Glycine 0 CA--C 1.524 0.595 0 N-CA-C 111.947 -0.461 . . . . 0.0 111.947 179.219 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 43.8 t80 -76.33 110.71 11.07 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.262 -0.469 . . . . 0.0 110.837 -179.671 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 7.4 t -142.37 -178.21 5.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.428 179.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -46.8 -26.57 0.98 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.179 -179.66 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 51.7 m-20 -79.05 -28.78 43.21 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.268 -179.422 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -86.4 -18.34 32.05 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.955 -0.298 . . . . 0.0 110.937 -179.681 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 9.1 mtp -68.96 -27.38 65.68 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.604 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.0 t -68.37 -47.77 36.5 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.9 -179.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -72.03 -58.56 0.07 OUTLIER 'Trans proline' 0 N--CA 1.498 1.792 0 C-N-CA 121.113 1.208 . . . . 0.0 111.843 179.253 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.6 mt -57.07 -43.71 82.34 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.48 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -66.84 -63.77 3.67 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 111.142 -0.783 . . . . 0.0 111.142 -179.475 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 57.7 tp -49.66 -23.07 1.55 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.924 0.393 . . . . 0.0 110.137 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.413 ' O ' ' CB ' ' A' ' 89' ' ' LEU . 12.9 t80 -76.61 -48.58 18.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.54 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.44 -42.45 95.99 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.8 -0.36 . . . . 0.0 111.056 -179.442 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -70.05 -57.97 6.55 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 111.149 -0.78 . . . . 0.0 111.149 -179.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 36.5 tp60 -54.71 -47.52 73.64 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-O 121.012 0.434 . . . . 0.0 110.104 179.731 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.441 ' O ' ' C ' ' A' ' 90' ' ' ALA . 17.4 tp -56.55 -65.04 0.68 Allowed 'General case' 0 C--O 1.21 -0.991 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.936 179.581 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.441 ' C ' ' O ' ' A' ' 89' ' ' LEU . . . -37.86 -44.33 0.75 Allowed 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 120.407 -0.517 . . . . 0.0 111.649 -179.407 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 78.2 mt -60.97 -56.89 15.81 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 113.102 0.778 . . . . 0.0 113.102 -178.664 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 41.7 m-20 -75.9 -53.11 8.93 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.392 0.615 . . . . 0.0 111.697 -178.369 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . 0.628 ' O ' ' N ' ' A' ' 95' ' ' TRP . 9.8 t-105 -52.05 -33.68 40.07 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.055 -0.975 . . . . 0.0 111.594 -179.938 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -57.03 72.3 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.892 0.377 . . . . 0.0 110.076 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.705 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 22.1 p-90 -97.47 -17.0 0.2 Allowed Pre-proline 0 CA--C 1.532 0.264 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.966 -179.387 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.705 ' CD ' ' N ' ' A' ' 95' ' ' TRP . 52.8 Cg_exo -60.14 -32.23 94.32 Favored 'Trans proline' 0 N--CA 1.493 1.493 0 C-N-CA 120.357 0.705 . . . . 0.0 112.635 179.387 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . 0.484 ' CD ' ' N ' ' A' ' 96' ' ' PRO . 70.1 Cg_exo -50.35 -23.31 9.98 Favored 'Trans proline' 0 N--CA 1.493 1.458 0 C-N-CA 120.254 0.636 . . . . 0.0 112.443 179.785 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.588 ' O ' ' N ' ' A' ' 101' ' ' GLY . 1.1 pp -84.5 19.77 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 121.087 0.47 . . . . 0.0 110.135 179.531 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.466 ' O ' ' CE2' ' A' ' 25' ' ' PHE . 4.4 t80 -39.13 -35.41 0.23 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.843 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 30.6 m-85 -86.59 -25.79 24.79 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.82 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 0.588 ' N ' ' O ' ' A' ' 98' ' ' ILE . . . -82.8 -4.4 90.07 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 111.195 -0.762 . . . . 0.0 111.195 -179.886 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -72.24 -9.63 58.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.637 0.256 . . . . 0.0 111.081 -179.704 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 3.7 ptm180 -105.25 4.3 30.95 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.755 0.312 . . . . 0.0 110.779 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . 0.406 ' C ' ' N ' ' A' ' 106' ' ' GLY . 9.6 mt-30 -113.69 167.54 10.53 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.475 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' MET . . . . . 0.486 ' N ' ' SD ' ' A' ' 105' ' ' MET . 0.0 OUTLIER -49.64 -17.38 0.32 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.532 179.979 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.578 ' O ' ' N ' ' A' ' 108' ' ' ALA . . . -72.77 -15.12 78.0 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 111.37 -0.692 . . . . 0.0 111.37 -179.751 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' TRP . . . . . 0.665 ' CD1' ' CZ2' ' A' ' 155' ' ' TRP . 0.0 OUTLIER -38.15 -21.32 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 120.548 0.213 . . . . 0.0 111.239 -179.473 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.578 ' N ' ' O ' ' A' ' 106' ' ' GLY . . . -66.81 -16.15 64.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.912 0.387 . . . . 0.0 111.291 -179.531 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 13.5 mt -60.31 -36.79 78.73 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.479 -179.246 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -53.66 -63.59 1.1 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.967 0.413 . . . . 0.0 110.721 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.493 ' OD1' ' O ' ' A' ' 108' ' ' ALA . 5.6 p-10 -56.76 -60.69 3.2 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.826 -179.297 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.43 ' H ' ' CG ' ' A' ' 111' ' ' ASP . 51.9 tp -49.83 -41.9 46.06 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -178.477 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 71.4 mt -68.49 -61.72 1.7 Allowed 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 -178.144 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.3 pp -59.76 -33.29 71.48 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 120.581 -0.448 . . . . 0.0 111.281 -178.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.49 ' CG2' ' O ' ' A' ' 111' ' ' ASP . 53.3 t -62.04 -60.93 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.148 -179.838 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' SER . . . . . 0.496 ' O ' ' OG1' ' A' ' 120' ' ' THR . 11.4 t -68.57 -22.12 64.49 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.1 -179.373 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -64.8 -62.92 4.58 Favored Glycine 0 CA--C 1.526 0.764 0 C-N-CA 120.883 -0.675 . . . . 0.0 111.742 -179.284 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.496 ' O ' ' OG1' ' A' ' 122' ' ' THR . 9.9 p -73.38 -36.57 49.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 C-N-CA 120.948 -0.301 . . . . 0.0 111.286 -179.389 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . 0.543 ' O ' ' OG1' ' A' ' 123' ' ' THR . . . -67.41 -61.21 2.02 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.529 -0.469 . . . . 0.0 111.019 -179.462 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.496 ' OG1' ' O ' ' A' ' 116' ' ' SER . 2.0 m -59.27 -54.59 45.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.351 -179.431 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.437 ' O ' ' CB ' ' A' ' 125' ' ' ALA . . . -49.5 -45.89 47.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.854 -179.513 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.496 ' OG1' ' O ' ' A' ' 118' ' ' VAL . 40.9 p -69.75 -35.29 74.84 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.996 -179.06 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 0.543 ' OG1' ' O ' ' A' ' 119' ' ' ALA . 0.2 OUTLIER -58.2 -52.07 67.1 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.633 -0.427 . . . . 0.0 111.139 -179.218 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.7 pp -83.96 -19.73 34.11 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.705 -0.398 . . . . 0.0 111.721 -178.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . 0.437 ' CB ' ' O ' ' A' ' 121' ' ' ALA . . . -88.02 -70.11 0.65 Allowed 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.584 0.587 . . . . 0.0 112.584 -178.796 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' TRP . . . . . 0.534 ' CH2' ' OG ' ' A' ' 64' ' ' SER . 35.9 m0 -83.23 -57.82 3.1 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 -177.702 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . 0.449 ' CD2' ' N ' ' A' ' 127' ' ' HIS . 12.3 m170 -52.22 -21.82 3.76 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.663 -0.415 . . . . 0.0 111.295 -178.825 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 28.3 ttt180 -70.05 -47.01 63.75 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.667 -179.337 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 4.1 t -94.44 -9.58 9.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 111.861 0.319 . . . . 0.0 111.861 -178.674 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -149.56 106.39 3.29 Favored Pre-proline 0 C--N 1.328 -0.368 0 C-N-CA 120.872 -0.331 . . . . 0.0 111.183 -179.364 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . 0.665 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 74.4 Cg_exo -76.05 -23.27 12.28 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 121.759 1.639 . . . . 0.0 112.656 179.058 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . 0.665 ' CD ' ' N ' ' A' ' 131' ' ' PRO . 52.4 Cg_exo -65.89 -56.85 0.28 Allowed 'Trans proline' 0 N--CA 1.496 1.652 0 C-N-CA 121.322 1.348 . . . . 0.0 112.347 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -46.76 -40.73 14.07 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.64 -179.793 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -52.35 -24.39 7.54 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.533 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 6.1 tpt180 -76.93 -36.71 56.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.432 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 41.3 mt -67.19 -37.06 83.05 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.353 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 0.568 ' O ' ' N ' ' A' ' 140' ' ' TYR . 5.8 mt -81.86 -39.63 23.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.487 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.534 ' C ' ' H ' ' A' ' 140' ' ' TYR . 4.2 t80 -22.58 -43.57 0.04 OUTLIER Pre-proline 0 CA--C 1.532 0.274 0 O-C-N 123.664 0.602 . . . . 0.0 111.819 -179.601 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.552 ' N ' ' O ' ' A' ' 137' ' ' LEU . 6.3 Cg_exo -65.36 12.66 0.12 Allowed 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 120.852 1.034 . . . . 0.0 111.975 179.291 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . 0.568 ' N ' ' O ' ' A' ' 137' ' ' LEU . 3.1 p90 -93.15 -14.42 27.21 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-O 120.892 0.377 . . . . 0.0 110.852 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.42 ' CD2' ' CE1' ' A' ' 140' ' ' TYR . 4.3 mm? -55.94 -33.48 64.77 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 178.536 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -56.21 -55.43 33.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.005 179.604 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' TRP . . . . . . . . . . . . . 10.8 t-105 -52.08 -50.49 61.46 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 179.643 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 13.3 mt -49.68 -54.92 15.83 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 120.348 -0.541 . . . . 0.0 109.91 179.599 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . 0.494 ' O ' ' CG2' ' A' ' 149' ' ' VAL . . . -60.44 -21.35 62.19 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.852 -179.779 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 6.2 t80 -69.48 -63.18 1.12 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.837 -179.582 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -64.91 -33.4 75.94 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.728 -0.389 . . . . 0.0 110.436 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 68.9 m -67.13 -35.35 79.53 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.2 179.673 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.494 ' CG2' ' O ' ' A' ' 145' ' ' ALA . 43.5 t -79.5 -26.87 12.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.179 179.79 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -66.55 -48.7 68.83 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.827 -0.435 . . . . 0.0 109.827 179.747 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . 0.507 ' CG ' ' HE1' ' A' ' 107' ' ' TRP . 0.9 OUTLIER -72.92 -51.23 19.34 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.627 179.81 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . 0.414 ' CD1' ' C ' ' A' ' 152' ' ' TYR . 27.8 t80 -56.16 -43.31 78.22 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.855 -179.77 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . 0.437 ' CB ' ' O ' ' A' ' 149' ' ' VAL . 63.9 t80 -62.46 -54.38 40.98 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.299 -179.548 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 72.7 t -60.44 -54.81 29.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.151 -179.291 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' TRP . . . . . 0.665 ' CZ2' ' CD1' ' A' ' 107' ' ' TRP . 0.4 OUTLIER -48.92 -37.6 20.36 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.206 -0.452 . . . . 0.0 109.978 -179.564 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -77.51 -28.98 52.23 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.296 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 12.5 t0 -75.44 -52.82 9.82 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.826 -179.595 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' ASN . . . . . 0.484 ' OD1' ' O ' ' A' ' 158' ' ' ASN . 48.9 t-20 . . . . . 0 N--CA 1.452 -0.354 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.731 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . 0.497 ' CE2' ' CE3' ' A' ' 68' ' ' TRP . 0.3 OUTLIER . . . . . 0 CA--C 1.528 0.127 0 CA-C-O 120.719 0.295 . . . . 0.0 110.239 . . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.648 ' N ' ' CD ' ' A' ' 7' ' ' PRO . 1.0 OUTLIER -62.64 -33.73 12.4 Favored Pre-proline 0 C--N 1.328 -0.326 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 179.788 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.648 ' CD ' ' N ' ' A' ' 6' ' ' VAL . 21.6 Cg_exo -72.37 -66.97 0.03 OUTLIER 'Trans proline' 0 C--N 1.308 -1.557 0 C-N-CA 121.957 1.772 . . . . 0.0 111.895 179.516 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.505 ' O ' ' CG2' ' A' ' 12' ' ' THR . . . -49.65 -31.32 10.67 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.153 -179.683 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.469 ' CG2' ' O ' ' A' ' 5' ' ' TRP . 47.4 t -71.36 -62.2 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.425 -179.182 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -59.02 -43.82 96.67 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 111.262 -0.735 . . . . 0.0 111.262 -179.419 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 8.0 mp -61.87 -39.03 90.5 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.697 0.284 . . . . 0.0 110.637 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.505 ' CG2' ' O ' ' A' ' 8' ' ' ALA . 8.0 p -69.73 -28.48 65.84 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.786 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.427 ' O ' ' CB ' ' A' ' 16' ' ' SER . 10.7 mt -78.27 -33.38 49.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.669 -179.843 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.439 ' C ' ' H ' ' A' ' 16' ' ' SER . 20.3 t -42.0 -59.48 2.58 Favored Pre-proline 0 CA--C 1.535 0.38 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.561 -179.681 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.43 ' HD2' ' N ' ' A' ' 14' ' ' VAL . 17.1 Cg_endo -51.69 -9.46 0.4 Allowed 'Trans proline' 0 N--CA 1.5 1.869 0 C-N-CA 120.616 0.877 . . . . 0.0 112.317 -179.471 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.439 ' H ' ' C ' ' A' ' 14' ' ' VAL . 3.1 t -79.35 -30.99 42.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.74 -179.865 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 16.6 mt -69.63 -54.44 13.95 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.998 -179.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -73.38 -38.55 52.75 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 111.632 -0.587 . . . . 0.0 111.632 -179.374 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -68.94 -29.84 72.42 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 111.066 -0.813 . . . . 0.0 111.066 -179.546 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.412 ' CB ' ' O ' ' A' ' 16' ' ' SER . 64.0 t80 -78.73 -60.32 2.42 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.815 -0.354 . . . . 0.0 110.934 -179.672 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 23.8 ttm -64.88 -21.1 66.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.66 -179.805 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -79.09 -63.02 2.12 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 111.309 -0.716 . . . . 0.0 111.309 -179.628 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.93 -22.19 66.6 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.594 -179.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 64.4 t80 -50.9 -23.91 3.19 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.989 0.424 . . . . 0.0 109.892 179.31 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.446 ' CD1' ' C ' ' A' ' 25' ' ' PHE . 25.4 t80 -67.08 -55.01 16.14 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.964 -179.84 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 27.2 m -65.87 -22.13 30.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.966 -179.509 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.7 tmt_? -75.56 -17.54 60.03 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.698 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -116.06 -67.3 0.41 Allowed Glycine 0 CA--C 1.525 0.7 0 N-CA-C 111.239 -0.744 . . . . 0.0 111.239 -179.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -67.97 -29.72 68.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.751 0.31 . . . . 0.0 110.94 -179.69 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -69.27 -45.91 59.33 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 111.31 -0.716 . . . . 0.0 111.31 -179.737 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 11.1 mp -60.34 -28.53 68.24 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.692 0.282 . . . . 0.0 110.677 -179.789 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 76.7 mtm180 -80.38 -43.03 21.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.829 0.347 . . . . 0.0 110.36 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . 0.502 ' O ' ' N ' ' A' ' 36' ' ' GLY . 0.2 OUTLIER -59.91 -27.2 66.54 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 179.751 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.487 ' C ' ' CD1' ' A' ' 34' ' ' TYR . 10.3 t80 -49.02 -37.02 19.33 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.894 179.496 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -70.87 -21.66 62.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.902 179.447 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.502 ' N ' ' O ' ' A' ' 33' ' ' TRP . . . -87.95 -76.89 1.28 Allowed Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.442 -1.063 . . . . 0.0 110.442 179.591 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -96.04 163.7 13.01 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 109.889 -0.411 . . . . 0.0 109.889 179.011 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.455 ' H ' ' CD ' ' A' ' 38' ' ' GLN . 11.2 mp0 -81.79 122.64 27.95 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.932 0.396 . . . . 0.0 111.432 -179.066 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 20.3 mtpt -119.02 160.01 42.58 Favored Pre-proline 0 C--N 1.332 -0.176 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.575 179.182 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo . . . . . 0 C--N 1.305 -1.714 0 C-N-CA 122.023 1.815 . . . . 0.0 111.972 -179.936 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.405 ' O ' ' C ' ' A' ' 50' ' ' ALA . 2.1 mm? . . . . . 0 CA--C 1.534 0.344 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.619 ' C ' ' H ' ' A' ' 52' ' ' ILE . . . -39.87 -29.12 0.19 Allowed Pre-proline 0 N--CA 1.466 0.346 0 C-N-CA 120.14 -0.624 . . . . 0.0 111.849 -178.266 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.409 ' HD2' ' N ' ' A' ' 50' ' ' ALA . 95.5 Cg_exo -57.01 5.85 0.06 OUTLIER 'Trans proline' 0 C--N 1.313 -1.323 0 CA-C-N 119.114 0.719 . . . . 0.0 112.273 178.125 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.619 ' H ' ' C ' ' A' ' 50' ' ' ALA . 33.5 pt -55.29 -31.37 26.65 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.295 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 179.514 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.459 ' O ' ' CB ' ' A' ' 57' ' ' TYR . 72.7 m95 -78.73 -22.81 45.98 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.892 -179.497 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -69.22 -48.23 47.52 Favored Glycine 0 CA--C 1.526 0.772 0 N-CA-C 110.064 -1.214 . . . . 0.0 110.064 178.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 14.5 m -66.77 -55.63 14.12 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.783 0.325 . . . . 0.0 110.142 179.431 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 86.1 mt -58.62 -26.98 64.26 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.44 179.713 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.526 ' C ' ' CD1' ' A' ' 57' ' ' TYR . 0.5 OUTLIER -64.98 -54.1 35.79 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 179.509 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 37.2 t -51.19 -50.49 58.92 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 179.126 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -56.6 -45.18 81.58 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.319 179.435 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 12.3 mtt -57.72 -49.03 77.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.365 179.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -51.49 -43.98 52.98 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 110.994 -0.842 . . . . 0.0 110.994 -179.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 3.2 m-30 -65.26 -56.3 13.54 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.762 0.315 . . . . 0.0 110.943 -179.456 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -52.06 -48.53 52.21 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.37 -1.092 . . . . 0.0 110.37 179.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.488 ' O ' ' CD1' ' A' ' 68' ' ' TRP . 1.7 t -58.83 -41.9 87.98 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.652 -0.274 . . . . 0.0 110.571 179.889 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.406 ' O ' ' CG ' ' A' ' 69' ' ' LYS . 14.5 t80 -54.58 -37.97 66.14 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 109.138 -0.689 . . . . 0.0 109.138 179.038 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 97.3 mt -73.34 -27.29 23.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.096 179.223 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 61.2 t -69.52 -61.69 1.58 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.252 0 C-N-CA 120.746 -0.382 . . . . 0.0 110.763 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' TRP . . . . . 0.516 ' CD1' ' N ' ' A' ' 68' ' ' TRP . 0.0 OUTLIER -57.9 -38.07 75.17 Favored 'General case' 0 C--O 1.221 -0.402 0 C-N-CA 119.388 -0.925 . . . . 0.0 109.622 179.758 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.406 ' CG ' ' O ' ' A' ' 65' ' ' TYR . 0.2 OUTLIER -58.39 -40.52 82.56 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.889 0.376 . . . . 0.0 110.458 179.956 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 55.8 tt0 -64.35 -41.67 96.64 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.344 -179.555 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.6 mt -78.78 -17.64 55.45 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.955 0.407 . . . . 0.0 111.053 -179.347 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 97.84 43.16 2.93 Favored Glycine 0 CA--C 1.526 0.771 0 N-CA-C 110.345 -1.102 . . . . 0.0 110.345 -178.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 96.98 -175.09 30.76 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 111.03 -0.828 . . . . 0.0 111.03 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -71.8 112.44 7.91 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.844 0.354 . . . . 0.0 110.533 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.433 ' OG1' ' N ' ' A' ' 76' ' ' GLU . 3.0 t -139.4 179.51 6.5 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.855 -179.801 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.433 ' N ' ' OG1' ' A' ' 75' ' ' THR . 5.0 mm-40 -54.56 -50.06 68.85 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.595 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -55.0 -16.11 2.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.454 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -95.56 -30.7 13.68 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.392 179.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 3.5 mtp -64.9 -27.06 68.6 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.495 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.427 ' O ' ' CB ' ' A' ' 84' ' ' LEU . 9.1 t -68.9 -49.64 25.67 Favored Pre-proline 0 CA--C 1.534 0.345 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.643 -179.694 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -72.13 -61.48 0.05 OUTLIER 'Trans proline' 0 N--CA 1.497 1.728 0 C-N-CA 121.127 1.218 . . . . 0.0 111.523 178.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.7 mt -51.3 -46.32 62.5 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.384 179.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.452 ' O ' ' N ' ' A' ' 86' ' ' THR . . . -67.6 -63.56 3.65 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.672 -0.971 . . . . 0.0 110.672 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.427 ' CB ' ' O ' ' A' ' 80' ' ' VAL . 56.9 tp -43.73 -24.75 0.14 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.892 0.377 . . . . 0.0 110.014 179.727 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.424 ' N ' ' C ' ' A' ' 83' ' ' GLY . 7.2 t80 -80.62 -40.48 25.59 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.442 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.452 ' N ' ' O ' ' A' ' 83' ' ' GLY . 0.7 OUTLIER -71.63 -39.07 70.65 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 120.599 -0.44 . . . . 0.0 110.854 -179.787 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -74.7 -56.92 4.74 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 110.758 -0.937 . . . . 0.0 110.758 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.454 ' O ' ' CB ' ' A' ' 92' ' ' ASN . 9.4 tp-100 -52.7 -43.88 65.93 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.723 0.296 . . . . 0.0 110.236 179.747 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 11.1 tp -67.59 -34.9 77.95 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.605 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -59.73 -65.75 0.63 Allowed 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 120.279 -0.568 . . . . 0.0 111.343 -179.633 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.0 pp -70.71 -39.01 73.67 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -178.479 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.454 ' CB ' ' O ' ' A' ' 88' ' ' GLN . 36.7 t-20 -72.42 -50.33 27.14 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 -178.6 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . 0.622 ' O ' ' N ' ' A' ' 95' ' ' TRP . 0.0 OUTLIER -79.63 -16.63 55.45 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.536 -0.466 . . . . 0.0 111.832 -178.374 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -52.02 81.83 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 120.31 -0.556 . . . . 0.0 109.965 179.336 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.704 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 33.8 p-90 -98.97 -16.14 0.19 Allowed Pre-proline 0 CA--C 1.537 0.451 0 N-CA-C 112.564 0.579 . . . . 0.0 112.564 -179.103 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.704 ' CD ' ' N ' ' A' ' 95' ' ' TRP . 36.6 Cg_exo -57.31 -31.5 91.09 Favored 'Trans proline' 0 N--CA 1.495 1.609 0 C-N-CA 120.526 0.818 . . . . 0.0 113.125 179.777 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . 0.455 ' CD ' ' N ' ' A' ' 96' ' ' PRO . 80.4 Cg_exo -53.14 -20.28 13.87 Favored 'Trans proline' 0 N--CA 1.495 1.601 0 C-N-CA 120.352 0.701 . . . . 0.0 113.271 -179.873 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.463 ' O ' ' N ' ' A' ' 101' ' ' GLY . 1.3 pp -82.61 19.21 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 C-N-CA 120.586 -0.446 . . . . 0.0 110.469 -179.897 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -40.76 -41.48 1.56 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.933 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . 0.4 ' CD1' ' N ' ' A' ' 100' ' ' PHE . 2.5 p90 -85.5 -23.75 27.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.914 -179.698 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 0.463 ' N ' ' O ' ' A' ' 98' ' ' ILE . . . -78.82 -7.7 88.15 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 111.194 -0.762 . . . . 0.0 111.194 -179.851 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -80.14 -7.11 58.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.774 0.321 . . . . 0.0 110.729 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -74.36 -12.18 60.45 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.846 -179.727 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . 0.429 ' C ' ' N ' ' A' ' 106' ' ' GLY . 6.7 pt20 -117.39 164.62 14.59 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.804 -179.862 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 8.6 mmt -47.92 -17.15 0.1 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.536 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.595 ' O ' ' N ' ' A' ' 108' ' ' ALA . . . -62.09 -15.56 50.58 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' TRP . . . . . 0.512 ' C ' ' CD1' ' A' ' 107' ' ' TRP . 0.0 OUTLIER -44.04 -12.62 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.758 0.313 . . . . 0.0 110.725 -179.687 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.595 ' N ' ' O ' ' A' ' 106' ' ' GLY . . . -65.27 -28.52 69.4 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.363 179.743 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 9.1 mp -45.76 -26.43 0.65 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.231 179.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -60.82 -63.97 1.12 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.595 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.545 ' O ' ' CG2' ' A' ' 115' ' ' VAL . 4.1 p30 -57.66 -50.75 72.15 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.464 -179.614 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.438 ' N ' ' OD1' ' A' ' 111' ' ' ASP . 53.2 tp -55.14 -44.27 74.92 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.875 -0.33 . . . . 0.0 111.587 -178.968 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 54.2 mt -66.7 -61.39 1.99 Allowed 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -178.515 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.3 pp -61.51 -32.64 72.67 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 120.567 -0.453 . . . . 0.0 111.842 -178.391 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.545 ' CG2' ' O ' ' A' ' 111' ' ' ASP . 46.0 t -63.32 -54.44 32.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.24 -179.9 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' SER . . . . . 0.447 ' O ' ' OG1' ' A' ' 120' ' ' THR . 28.9 t -72.46 -24.12 61.15 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.316 -179.059 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -66.2 -62.66 4.49 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 120.944 -0.646 . . . . 0.0 111.749 -179.278 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.516 ' O ' ' OG1' ' A' ' 122' ' ' THR . 7.5 p -71.79 -38.48 65.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 C-N-CA 120.961 -0.296 . . . . 0.0 111.709 -179.246 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . 0.53 ' O ' ' OG1' ' A' ' 123' ' ' THR . . . -64.54 -60.92 2.58 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.697 -0.401 . . . . 0.0 111.221 -179.286 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.447 ' OG1' ' O ' ' A' ' 116' ' ' SER . 2.1 m -60.28 -55.16 37.12 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.56 -179.275 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -51.11 -40.65 58.95 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.204 -179.268 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.516 ' OG1' ' O ' ' A' ' 118' ' ' VAL . 30.9 p -72.25 -35.54 68.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.3 -179.363 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 0.53 ' OG1' ' O ' ' A' ' 119' ' ' ALA . 0.2 OUTLIER -58.28 -50.66 72.81 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.812 0.339 . . . . 0.0 111.148 -179.221 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.6 pp -82.42 -20.19 37.54 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.669 -178.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -88.12 -72.72 0.52 Allowed 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 -178.511 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 43.7 m0 -81.83 -57.93 3.21 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 112.662 0.616 . . . . 0.0 112.662 -177.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . 0.533 ' CD2' ' N ' ' A' ' 127' ' ' HIS . 5.3 m170 -53.18 -22.23 6.28 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.63 -0.428 . . . . 0.0 111.14 -178.823 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 14.0 ttt180 -76.31 -30.49 57.74 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.146 -179.61 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 73.8 t -95.64 -49.9 12.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.769 0.319 . . . . 0.0 111.29 -179.422 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 67.7 p -117.6 109.23 41.99 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.511 -179.707 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . 0.657 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 50.5 Cg_exo -71.68 -18.13 29.04 Favored 'Trans proline' 0 N--CA 1.493 1.461 0 C-N-CA 121.458 1.439 . . . . 0.0 112.584 179.638 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . 0.657 ' CD ' ' N ' ' A' ' 131' ' ' PRO . 54.3 Cg_exo -74.43 -35.57 3.68 Favored 'Trans proline' 0 N--CA 1.496 1.653 0 C-N-CA 121.262 1.308 . . . . 0.0 112.0 179.365 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -63.49 -39.64 94.97 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.348 179.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -57.33 -26.56 61.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.2 179.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 15.9 tpt180 -77.66 -31.09 52.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.373 179.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 20.5 mt -75.5 -25.83 57.63 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.261 -0.427 . . . . 0.0 109.849 179.506 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 0.486 ' O ' ' N ' ' A' ' 140' ' ' TYR . 68.6 mt -92.47 -23.81 19.01 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.165 179.505 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.518 ' C ' ' CD1' ' A' ' 138' ' ' TYR . 0.3 OUTLIER -35.43 -50.19 1.33 Allowed Pre-proline 0 CA--C 1.535 0.395 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.977 179.715 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.43 ' HD2' ' N ' ' A' ' 138' ' ' TYR . 0.9 OUTLIER -61.28 4.89 0.2 Allowed 'Trans proline' 0 N--CA 1.496 1.667 0 C-N-CA 121.64 1.56 . . . . 0.0 112.958 -179.471 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . 0.486 ' N ' ' O ' ' A' ' 137' ' ' LEU . 0.1 OUTLIER -88.88 -14.32 37.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.0 0.429 . . . . 0.0 110.562 179.657 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.411 ' N ' ' CD1' ' A' ' 140' ' ' TYR . 97.5 mt -60.02 -33.6 72.22 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.685 178.582 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -57.15 -41.39 79.06 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.584 179.304 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' TRP . . . . . . . . . . . . . 8.6 t-105 -66.11 -43.64 86.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.591 179.24 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 30.0 mt -59.08 -41.97 89.27 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.174 179.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . 0.489 ' O ' ' CG2' ' A' ' 149' ' ' VAL . . . -72.65 -23.4 60.9 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.419 179.855 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 24.4 t80 -65.91 -57.11 8.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.804 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -68.08 -43.37 78.69 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 120.91 -0.316 . . . . 0.0 110.886 -179.727 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 63.6 m -58.99 -45.68 90.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.831 0.348 . . . . 0.0 110.754 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.489 ' CG2' ' O ' ' A' ' 145' ' ' ALA . 69.4 t -68.49 -29.43 43.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.632 -179.885 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 1.6 tp -62.51 -47.09 85.44 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.293 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . 0.596 ' ND2' ' N ' ' A' ' 152' ' ' TYR . 0.3 OUTLIER -69.27 -37.2 77.77 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.568 179.934 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . 0.596 ' N ' ' ND2' ' A' ' 151' ' ' ASN . 26.0 t80 -64.15 -48.82 74.53 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.593 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 31.1 t80 -59.27 -43.51 92.49 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.872 -179.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 75.8 t -61.7 -36.04 71.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.81 -179.757 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' TRP . . . . . . . . . . . . . 8.0 m0 -64.44 -59.19 4.63 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.74 -179.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . 0.411 ' NE ' ' CZ ' ' A' ' 152' ' ' TYR . 3.3 mpt_? -60.62 -51.29 70.05 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.829 -179.571 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 31.3 t0 -53.82 -43.79 69.7 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.791 -179.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 16.5 t-20 . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.55 -179.933 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 1.3 t-105 . . . . . 0 CA--C 1.528 0.128 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.576 ' N ' ' CD ' ' A' ' 7' ' ' PRO . 0.9 OUTLIER -62.23 -40.43 66.78 Favored Pre-proline 0 CA--C 1.533 0.313 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.479 -179.479 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.576 ' CD ' ' N ' ' A' ' 6' ' ' VAL . 25.1 Cg_exo -61.24 -60.29 0.24 Allowed 'Trans proline' 0 C--N 1.306 -1.66 0 C-N-CA 121.627 1.551 . . . . 0.0 111.874 179.904 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.538 ' O ' ' CG2' ' A' ' 12' ' ' THR . . . -56.88 -32.94 66.37 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.42 -179.465 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.487 ' O ' ' OG1' ' A' ' 12' ' ' THR . 55.3 t -67.22 -62.03 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 C-N-CA 120.897 -0.321 . . . . 0.0 111.397 -179.263 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -57.52 -41.23 93.33 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 111.354 -0.698 . . . . 0.0 111.354 -179.509 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 7.7 mp -69.64 -30.14 67.78 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 121.043 -0.263 . . . . 0.0 110.758 -179.641 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.538 ' CG2' ' O ' ' A' ' 8' ' ' ALA . 4.8 p -74.81 -25.24 58.89 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.842 -0.343 . . . . 0.0 110.406 179.802 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.441 ' O ' ' CB ' ' A' ' 16' ' ' SER . 6.4 mp -81.48 -33.79 31.74 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.023 179.688 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.407 ' N ' ' HD2' ' A' ' 15' ' ' PRO . 7.9 t -40.25 -60.66 1.4 Allowed Pre-proline 0 CA--C 1.535 0.366 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.061 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.407 ' HD2' ' N ' ' A' ' 14' ' ' VAL . 10.5 Cg_endo -51.49 -17.15 4.14 Favored 'Trans proline' 0 N--CA 1.499 1.8 0 C-N-CA 120.949 1.099 . . . . 0.0 112.091 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.441 ' CB ' ' O ' ' A' ' 13' ' ' LEU . 4.0 t -70.0 -33.3 71.86 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.886 0.374 . . . . 0.0 110.512 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 27.9 mt -72.11 -55.17 7.77 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.336 179.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -60.75 -46.36 94.63 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 110.857 -0.897 . . . . 0.0 110.857 179.784 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -65.35 -29.45 75.28 Favored Glycine 0 CA--C 1.526 0.756 0 N-CA-C 111.051 -0.82 . . . . 0.0 111.051 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 31.9 t80 -74.23 -59.98 2.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.696 0.284 . . . . 0.0 110.66 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 6.7 ttp -63.31 -22.47 66.9 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.621 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.479 ' C ' ' CZ2' ' A' ' 95' ' ' TRP . . . -77.2 -62.65 2.41 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 111.093 -0.803 . . . . 0.0 111.093 -179.874 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.51 -17.54 63.99 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.006 0.431 . . . . 0.0 110.314 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 41.4 t80 -48.91 -24.73 1.58 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.143 179.634 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 33.9 t80 -67.64 -54.72 17.31 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.761 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 22.2 m -71.64 -17.2 19.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.761 -179.724 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -62.17 -39.84 94.0 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.623 -179.885 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -114.65 -72.42 0.55 Allowed Glycine 0 CA--C 1.525 0.681 0 N-CA-C 110.824 -0.91 . . . . 0.0 110.824 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -45.92 -28.23 1.07 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.82 0.343 . . . . 0.0 110.431 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -68.26 -45.16 71.91 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 84.2 mt -54.95 -36.43 65.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.887 0.375 . . . . 0.0 110.274 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 56.2 mtp180 -77.69 -50.53 12.26 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.637 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . 0.422 ' O ' ' N ' ' A' ' 36' ' ' GLY . 0.6 OUTLIER -46.73 -30.68 2.52 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 116.3 -0.409 . . . . 0.0 109.909 -179.996 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 37.7 t80 -47.75 -33.62 7.33 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.424 179.723 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -74.9 -30.64 61.35 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.263 179.731 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.422 ' N ' ' O ' ' A' ' 33' ' ' TRP . . . -77.72 -77.39 0.83 Allowed Glycine 0 CA--C 1.524 0.64 0 N-CA-C 110.793 -0.923 . . . . 0.0 110.793 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -96.45 166.23 11.8 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 120.791 0.329 . . . . 0.0 110.739 179.712 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.579 HE21 ' C ' ' A' ' 39' ' ' LYS . 2.3 tm0? -83.17 113.41 20.63 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.767 -179.739 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.579 ' C ' HE21 ' A' ' 38' ' ' GLN . 7.8 mtpt -97.24 157.28 35.16 Favored Pre-proline 0 CA--C 1.532 0.267 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 179.893 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo . . . . . 0 N--CA 1.495 1.568 0 C-N-CA 120.924 1.083 . . . . 0.0 112.104 -178.714 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.406 ' O ' ' C ' ' A' ' 50' ' ' ALA . 0.2 OUTLIER . . . . . 0 CA--C 1.533 0.309 0 N-CA-C 112.808 0.669 . . . . 0.0 112.808 . . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.655 ' C ' ' H ' ' A' ' 52' ' ' ILE . . . -39.08 -30.98 0.21 Allowed Pre-proline 0 C--O 1.235 0.305 0 C-N-CA 120.614 -0.435 . . . . 0.0 111.73 -178.391 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo -53.53 5.55 0.03 OUTLIER 'Trans proline' 0 C--N 1.311 -1.417 0 CA-C-N 118.99 0.675 . . . . 0.0 112.456 178.253 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.655 ' H ' ' C ' ' A' ' 50' ' ' ALA . 9.9 pt -53.34 -34.86 23.3 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.201 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 179.114 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.454 ' O ' ' CB ' ' A' ' 57' ' ' TYR . 72.6 m95 -78.83 -23.24 45.19 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.151 -179.415 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -68.96 -45.12 64.33 Favored Glycine 0 CA--C 1.527 0.797 0 N-CA-C 109.909 -1.276 . . . . 0.0 109.909 179.047 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 6.2 m -68.8 -56.89 6.58 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 179.282 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 95.8 mt -57.32 -26.0 60.25 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.094 179.733 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.543 ' C ' ' CD1' ' A' ' 57' ' ' TYR . 0.5 OUTLIER -66.27 -54.65 22.37 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 179.482 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 61.5 m -51.13 -53.85 30.59 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.539 -0.464 . . . . 0.0 109.92 179.369 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -54.51 -41.07 69.2 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.485 179.772 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 10.1 mtt -62.45 -58.2 8.46 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.354 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -42.31 -41.99 4.17 Favored Glycine 0 CA--C 1.521 0.445 0 N-CA-C 110.641 -0.984 . . . . 0.0 110.641 179.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -63.55 -57.64 9.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.896 0.379 . . . . 0.0 110.412 179.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -52.1 -57.0 14.11 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 110.682 -0.967 . . . . 0.0 110.682 179.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.455 ' O ' ' CD1' ' A' ' 68' ' ' TRP . 0.3 OUTLIER -46.26 -51.64 14.09 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.927 0.394 . . . . 0.0 110.176 179.574 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 70.6 t80 -49.84 -41.07 44.24 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.447 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 40.9 mt -69.63 -44.68 79.3 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.023 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.465 ' CG1' ' CZ3' ' A' ' 68' ' ' TRP . 23.3 t -53.83 -58.61 3.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 120.962 0.411 . . . . 0.0 110.815 -179.722 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' TRP . . . . . 0.526 ' O ' ' N ' ' A' ' 73' ' ' GLY . 1.5 m95 -64.06 -39.48 94.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.196 -179.526 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 4.9 mmmt -63.0 -23.96 67.69 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.847 0.356 . . . . 0.0 110.543 179.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -83.0 -62.67 1.53 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.08 -179.47 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.497 ' C ' ' CD1' ' A' ' 71' ' ' LEU . 3.6 pp -64.92 -9.29 20.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.179 -179.487 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.487 ' O ' ' O ' ' A' ' 73' ' ' GLY . . . 106.05 81.99 1.49 Allowed Glycine 0 CA--C 1.525 0.707 0 C-N-CA 121.071 -0.585 . . . . 0.0 111.783 179.335 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.526 ' N ' ' O ' ' A' ' 68' ' ' TRP . . . 42.03 -174.13 0.01 OUTLIER Glycine 0 CA--C 1.526 0.722 0 N-CA-C 111.933 -0.467 . . . . 0.0 111.933 179.097 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 69.8 t80 -76.98 110.8 11.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.871 0.367 . . . . 0.0 110.884 -179.718 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.576 ' HG1' ' N ' ' A' ' 76' ' ' GLU . 1.1 t -142.05 -173.66 3.88 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.326 179.781 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.576 ' N ' ' HG1' ' A' ' 75' ' ' THR . 9.1 mm-40 -49.25 -34.71 15.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.779 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -69.64 -24.29 63.61 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.027 -179.729 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -91.53 -24.22 19.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.861 0.362 . . . . 0.0 110.642 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 9.2 mtp -63.05 -26.72 68.98 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.576 179.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 6.8 t -70.41 -53.9 9.54 Favored Pre-proline 0 CA--C 1.536 0.405 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.838 -179.617 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -64.34 -56.32 0.46 Allowed 'Trans proline' 0 N--CA 1.498 1.753 0 C-N-CA 121.053 1.169 . . . . 0.0 112.097 179.551 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.2 mt -61.41 -46.56 89.64 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.911 0.386 . . . . 0.0 110.569 -179.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -61.03 -53.96 40.7 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 111.241 -0.743 . . . . 0.0 111.241 -179.64 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 54.9 tp -62.69 -26.58 68.73 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.885 0.374 . . . . 0.0 110.603 -179.707 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 20.9 t80 -68.65 -50.88 47.67 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.783 -179.732 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 9.7 t -70.98 -33.82 70.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.268 -179.468 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -70.52 -57.2 6.8 Favored Glycine 0 CA--C 1.523 0.587 0 N-CA-C 110.947 -0.861 . . . . 0.0 110.947 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.428 ' O ' ' CB ' ' A' ' 92' ' ' ASN . 1.8 tp-100 -59.51 -40.54 87.42 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.818 0.342 . . . . 0.0 110.397 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.405 ' O ' ' CD1' ' A' ' 93' ' ' TRP . 11.4 tp -66.52 -34.91 78.98 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.41 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.439 ' O ' ' CB ' ' A' ' 94' ' ' ALA . . . -64.52 -65.73 0.64 Allowed 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 120.254 -0.578 . . . . 0.0 111.489 -179.398 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.6 pp -66.42 -34.48 78.04 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.714 0.635 . . . . 0.0 112.714 -178.493 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.428 ' CB ' ' O ' ' A' ' 88' ' ' GLN . 7.5 t-20 -82.04 -57.6 3.33 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 -178.461 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . 0.6 ' O ' ' N ' ' A' ' 95' ' ' TRP . 0.0 OUTLIER -69.94 -17.04 63.3 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 111.838 0.31 . . . . 0.0 111.838 -178.265 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.439 ' CB ' ' O ' ' A' ' 90' ' ' ALA . . . -52.51 82.95 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.14 0 C-N-CA 120.349 -0.54 . . . . 0.0 110.068 179.637 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.702 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 30.8 p-90 -99.32 -16.31 0.19 Allowed Pre-proline 0 CA--C 1.535 0.375 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 -179.449 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.702 ' CD ' ' N ' ' A' ' 95' ' ' TRP . 48.8 Cg_exo -58.91 -32.92 98.31 Favored 'Trans proline' 0 N--CA 1.495 1.579 0 C-N-CA 120.692 0.928 . . . . 0.0 112.977 179.393 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . 0.466 ' CD ' ' N ' ' A' ' 96' ' ' PRO . 66.4 Cg_exo -49.41 -18.55 2.37 Favored 'Trans proline' 0 N--CA 1.495 1.559 0 C-N-CA 120.389 0.726 . . . . 0.0 112.971 -179.903 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.549 ' O ' ' N ' ' A' ' 101' ' ' GLY . 1.1 pp -92.06 20.97 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.934 0.397 . . . . 0.0 110.466 179.758 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 10.3 t80 -40.41 -48.42 2.73 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.488 179.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -77.5 -19.73 55.41 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.546 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 0.549 ' N ' ' O ' ' A' ' 98' ' ' ILE . . . -78.34 -15.17 81.35 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 110.892 -0.883 . . . . 0.0 110.892 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -67.73 -12.95 61.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.772 0.32 . . . . 0.0 110.468 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.56 -8.44 59.72 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.467 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . 0.523 ' O ' ' N ' ' A' ' 106' ' ' GLY . 19.1 pt20 -123.87 173.8 7.95 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.838 179.852 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' MET . . . . . 0.55 ' N ' ' SD ' ' A' ' 105' ' ' MET . 0.0 OUTLIER -42.83 -17.02 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.125 -179.748 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.523 ' N ' ' O ' ' A' ' 104' ' ' GLN . . . -63.34 -16.84 58.74 Favored Glycine 0 CA--C 1.527 0.836 0 C-N-CA 121.324 -0.465 . . . . 0.0 111.979 -179.233 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' TRP . . . . . 0.686 ' CD1' ' CH2' ' A' ' 155' ' ' TRP . 0.0 OUTLIER -51.11 -15.87 0.4 Allowed 'General case' 0 C--N 1.329 -0.314 0 O-C-N 122.626 -0.338 . . . . 0.0 110.554 -179.581 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.492 ' O ' ' OD1' ' A' ' 111' ' ' ASP . . . -76.2 -25.05 54.78 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.855 0.359 . . . . 0.0 110.621 -179.825 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 84.2 mt -59.24 -29.72 67.73 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.923 -179.716 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.4 ' O ' ' CD2' ' A' ' 114' ' ' LEU . . . -54.1 -62.02 1.92 Allowed 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.728 -0.389 . . . . 0.0 110.502 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.522 ' O ' ' CG2' ' A' ' 115' ' ' VAL . 5.5 p-10 -62.02 -53.73 51.42 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.108 -0.496 . . . . 0.0 112.024 -179.432 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 31.8 tp -52.95 -45.13 67.57 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 -178.458 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 60.3 mt -67.67 -61.7 1.76 Allowed 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.624 0.601 . . . . 0.0 112.624 -178.322 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.4 ' CD2' ' O ' ' A' ' 110' ' ' ALA . 2.9 pp -58.62 -35.1 71.94 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 120.157 -0.617 . . . . 0.0 111.251 -178.736 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.522 ' CG2' ' O ' ' A' ' 111' ' ' ASP . 37.2 t -58.86 -59.27 3.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.963 179.801 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' SER . . . . . 0.494 ' O ' ' OG1' ' A' ' 120' ' ' THR . 5.6 t -70.45 -22.34 62.71 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.658 -179.009 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -64.93 -62.84 4.62 Favored Glycine 0 CA--C 1.526 0.778 0 C-N-CA 120.963 -0.637 . . . . 0.0 111.84 -179.058 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.532 ' O ' ' OG1' ' A' ' 122' ' ' THR . 8.9 p -72.16 -37.51 59.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 C-N-CA 120.975 -0.29 . . . . 0.0 111.39 -179.404 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . 0.523 ' O ' ' OG1' ' A' ' 123' ' ' THR . . . -67.07 -60.21 2.81 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.338 -0.545 . . . . 0.0 111.038 -179.549 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.494 ' OG1' ' O ' ' A' ' 116' ' ' SER . 3.3 m -57.92 -56.46 21.75 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.754 0.311 . . . . 0.0 111.393 -179.638 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -50.68 -41.15 55.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.305 -179.302 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.532 ' OG1' ' O ' ' A' ' 118' ' ' VAL . 31.4 p -73.53 -30.16 62.92 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.855 -0.338 . . . . 0.0 111.817 -179.144 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 0.523 ' OG1' ' O ' ' A' ' 119' ' ' ALA . 0.2 OUTLIER -64.96 -49.04 71.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.942 0.401 . . . . 0.0 110.759 -179.559 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.0 pp -81.59 -20.18 40.38 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.488 -179.274 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -90.8 -67.04 0.88 Allowed 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 -178.552 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 34.8 m0 -83.73 -57.15 3.34 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 112.962 0.727 . . . . 0.0 112.962 -177.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . 0.492 ' CD2' ' N ' ' A' ' 127' ' ' HIS . 9.1 m170 -55.88 -22.21 24.24 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.715 -0.394 . . . . 0.0 111.707 -178.565 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 33.5 ttt-85 -72.91 -47.25 47.37 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.783 -0.367 . . . . 0.0 111.178 -179.592 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 64.3 t -79.47 -41.49 22.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.168 -179.449 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -130.2 118.22 18.23 Favored Pre-proline 0 CA--C 1.536 0.405 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.578 -179.543 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . 0.647 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 70.9 Cg_exo -75.26 -26.6 10.36 Favored 'Trans proline' 0 N--CA 1.493 1.476 0 C-N-CA 121.238 1.292 . . . . 0.0 112.857 179.276 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . 0.647 ' CD ' ' N ' ' A' ' 131' ' ' PRO . 53.8 Cg_exo -60.4 -55.22 1.6 Allowed 'Trans proline' 0 N--CA 1.497 1.73 0 C-N-CA 121.517 1.478 . . . . 0.0 112.492 -179.731 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -46.28 -37.36 7.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.857 0.361 . . . . 0.0 110.315 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -57.57 -29.45 64.45 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.366 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 25.5 ttp180 -74.44 -30.47 61.91 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.319 179.788 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 48.5 mt -73.28 -28.91 62.38 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 179.405 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 0.519 ' O ' ' N ' ' A' ' 140' ' ' TYR . 5.7 mt -86.45 -31.01 21.61 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.413 179.614 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.496 ' C ' ' H ' ' A' ' 140' ' ' TYR . 1.5 t80 -31.52 -49.72 0.45 Allowed Pre-proline 0 CA--C 1.538 0.506 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.508 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.417 ' HD2' ' N ' ' A' ' 138' ' ' TYR . 4.1 Cg_endo -62.65 7.42 0.15 Allowed 'Trans proline' 0 N--CA 1.498 1.764 0 C-N-CA 121.526 1.484 . . . . 0.0 112.807 -179.689 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . 0.519 ' N ' ' O ' ' A' ' 137' ' ' LEU . 0.1 OUTLIER -93.08 -14.41 27.32 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 121.013 0.435 . . . . 0.0 111.096 179.806 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 97.7 mt -59.73 -26.53 65.72 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.16 -0.473 . . . . 0.0 109.942 178.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -64.38 -39.3 93.6 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 179.256 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' TRP . . . . . . . . . . . . . 10.5 t-105 -67.19 -42.45 84.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.521 179.115 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.42 ' O ' ' OG1' ' A' ' 148' ' ' THR . 17.9 mt -58.73 -45.66 89.13 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.226 179.8 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . 0.481 ' O ' ' CG2' ' A' ' 149' ' ' VAL . . . -70.35 -23.29 62.78 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.27 179.715 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 33.8 t80 -64.83 -64.34 0.89 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.776 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -64.96 -43.82 91.4 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.977 -179.571 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' THR . . . . . 0.42 ' OG1' ' O ' ' A' ' 144' ' ' LEU . 37.4 m -56.89 -49.86 74.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.804 -179.781 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.481 ' CG2' ' O ' ' A' ' 145' ' ' ALA . 90.5 t -68.57 -31.78 52.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.935 -179.56 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 1.9 tp -57.07 -46.46 82.48 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.983 0.42 . . . . 0.0 109.912 179.738 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . 0.601 ' OD1' ' NE1' ' A' ' 107' ' ' TRP . 7.3 t30 -70.08 -54.53 12.67 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.922 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 65.8 t80 -51.58 -39.09 57.25 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.4 -179.397 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . 0.578 ' CE1' ' OD2' ' A' ' 157' ' ' ASP . 53.2 t80 -68.22 -52.43 34.2 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.63 -179.08 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 86.6 t -65.16 -28.07 43.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.596 -178.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' TRP . . . . . 0.686 ' CH2' ' CD1' ' A' ' 107' ' ' TRP . 0.6 OUTLIER -78.32 -40.64 36.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.773 0.32 . . . . 0.0 110.445 -179.334 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 6.0 mpt_? -76.52 -23.22 53.67 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 110.051 -0.351 . . . . 0.0 110.051 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . 0.578 ' OD2' ' CE1' ' A' ' 153' ' ' TYR . 2.1 m-20 -79.53 -39.89 30.89 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.537 179.79 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' ASN . . . . . 0.5 ' OD1' ' O ' ' A' ' 155' ' ' TRP . 43.1 p30 . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.501 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . 0.548 ' CD1' ' NE1' ' A' ' 68' ' ' TRP . 0.9 OUTLIER . . . . . 0 CA--C 1.529 0.136 0 N-CA-C 110.148 -0.316 . . . . 0.0 110.148 . . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.538 ' N ' ' CD ' ' A' ' 7' ' ' PRO . 0.9 OUTLIER -57.94 -45.1 99.81 Favored Pre-proline 0 CA--C 1.534 0.346 0 C-N-CA 120.855 -0.338 . . . . 0.0 110.297 -179.577 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.538 ' CD ' ' N ' ' A' ' 6' ' ' VAL . 20.6 Cg_exo -58.02 -65.36 0.1 OUTLIER 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 121.416 1.411 . . . . 0.0 111.646 179.559 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.544 ' O ' ' CG2' ' A' ' 12' ' ' THR . . . -45.32 -36.32 4.06 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.366 -179.701 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 69.0 t -70.04 -62.59 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 C-N-CA 120.866 -0.334 . . . . 0.0 111.775 -178.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -57.23 -43.59 93.53 Favored Glycine 0 CA--C 1.527 0.822 0 C-N-CA 121.275 -0.488 . . . . 0.0 112.0 -179.051 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.415 ' N ' ' CD1' ' A' ' 11' ' ' LEU . 8.5 mp -67.13 -35.53 79.94 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.569 0.223 . . . . 0.0 111.324 -179.166 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.544 ' CG2' ' O ' ' A' ' 8' ' ' ALA . 10.6 p -69.66 -29.83 67.38 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.733 -0.387 . . . . 0.0 110.635 -179.9 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.445 ' O ' ' C ' ' A' ' 14' ' ' VAL . 6.0 mp -78.58 -32.13 47.53 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.738 -179.758 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.445 ' C ' ' O ' ' A' ' 13' ' ' LEU . 6.0 t -35.97 -55.91 1.23 Allowed Pre-proline 0 CA--C 1.534 0.35 0 C-N-CA 120.891 -0.323 . . . . 0.0 110.867 -179.704 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -61.03 -41.27 45.25 Favored 'Trans proline' 0 N--CA 1.5 1.87 0 C-N-CA 120.936 1.091 . . . . 0.0 112.026 179.644 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 7.8 t -45.54 -28.34 0.92 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.665 -179.57 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 87.4 mt -66.0 -57.89 6.75 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.72 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -64.55 -24.92 69.83 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 111.291 -0.724 . . . . 0.0 111.291 -179.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -77.32 -27.82 59.01 Favored Glycine 0 CA--C 1.518 0.256 0 N-CA-C 110.432 -1.067 . . . . 0.0 110.432 -179.709 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 19.7 t80 -76.08 -60.75 2.19 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.785 0.326 . . . . 0.0 110.617 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 48.6 ttm -73.17 -21.08 60.76 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.216 -179.673 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -79.39 -57.04 3.24 Favored Glycine 0 CA--C 1.526 0.769 0 C-N-CA 120.956 -0.64 . . . . 0.0 111.664 -179.478 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -69.65 -26.74 64.54 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 120.59 -0.444 . . . . 0.0 110.794 -179.466 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 45.1 t80 -46.92 -23.89 0.52 Allowed 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.516 -0.474 . . . . 0.0 109.848 179.443 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.566 ' CD1' ' CE1' ' A' ' 99' ' ' PHE . 56.6 t80 -72.71 -54.99 7.49 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.086 -179.769 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 29.1 m -57.15 -25.83 23.91 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.107 0 C-N-CA 120.392 -0.523 . . . . 0.0 110.291 -179.528 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.75 -37.38 81.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.709 179.592 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -101.07 -56.03 0.9 Allowed Glycine 0 CA--C 1.525 0.693 0 N-CA-C 111.447 -0.661 . . . . 0.0 111.447 -179.596 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 6.0 tm-20 -65.63 -34.72 78.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.603 0.24 . . . . 0.0 111.107 -179.589 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -71.74 -55.02 7.72 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 111.076 -0.81 . . . . 0.0 111.076 -179.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 11.0 mp -59.32 -28.33 66.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.744 0.307 . . . . 0.0 110.508 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 40.3 ttm180 -79.02 -52.79 7.75 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.814 0.34 . . . . 0.0 110.466 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -50.51 -33.74 22.63 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 179.87 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.427 ' CD1' ' C ' ' A' ' 34' ' ' TYR . 25.8 t80 -45.51 -35.2 3.7 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.216 179.641 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -56.42 -36.94 69.52 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.58 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -85.67 -66.26 1.42 Allowed Glycine 0 CA--C 1.525 0.657 0 N-CA-C 111.033 -0.827 . . . . 0.0 111.033 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.436 ' CD2' ' ND2' ' A' ' 158' ' ' ASN . 0.4 OUTLIER -96.49 167.2 11.3 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.843 0.354 . . . . 0.0 110.532 179.564 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 6.3 tt0 -90.05 113.58 25.31 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.635 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.632 ' NZ ' ' CH2' ' A' ' 107' ' ' TRP . 17.9 mtpt -125.65 156.23 71.18 Favored Pre-proline 0 C--N 1.331 -0.211 0 CA-C-N 116.174 -0.466 . . . . 0.0 109.862 179.727 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo . . . . . 0 C--N 1.305 -1.712 0 C-N-CA 121.984 1.789 . . . . 0.0 111.497 179.672 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.412 ' O ' ' N ' ' A' ' 51' ' ' PRO . 0.1 OUTLIER . . . . . 0 CA--C 1.533 0.303 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 . . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.671 ' C ' ' H ' ' A' ' 52' ' ' ILE . . . -39.19 -29.23 0.17 Allowed Pre-proline 0 C--O 1.237 0.407 0 C-N-CA 120.745 -0.382 . . . . 0.0 111.44 -178.618 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.412 ' N ' ' O ' ' A' ' 49' ' ' LEU . 35.1 Cg_exo -52.92 3.71 0.04 OUTLIER 'Trans proline' 0 C--N 1.313 -1.32 0 CA-C-N 118.852 0.626 . . . . 0.0 111.877 177.516 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.671 ' H ' ' C ' ' A' ' 50' ' ' ALA . 5.7 pt -51.12 -45.23 30.3 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.233 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 178.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.534 ' N ' ' CG1' ' A' ' 52' ' ' ILE . 87.6 m95 -57.66 -23.41 51.22 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.789 -179.094 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -68.48 -45.33 68.6 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 109.411 -1.476 . . . . 0.0 109.411 178.399 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 6.0 m -69.1 -57.6 5.2 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 179.133 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.443 ' CD1' ' CE3' ' A' ' 143' ' ' TRP . 34.6 mt -48.52 -49.58 35.45 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 179.112 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 6.9 t80 -46.37 -58.48 3.69 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.696 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.486 ' OG ' ' OH ' ' A' ' 62' ' ' TYR . 0.2 OUTLIER -48.05 -58.88 3.87 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.881 0.372 . . . . 0.0 110.686 -179.556 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -51.68 -61.46 2.24 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.852 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.433 ' SD ' ' C ' ' A' ' 56' ' ' LEU . 0.2 OUTLIER -46.1 -38.93 8.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.396 -179.957 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -56.6 -54.29 37.37 Favored Glycine 0 CA--C 1.522 0.493 0 N-CA-C 110.905 -0.878 . . . . 0.0 110.905 -179.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.6 ' N ' ' CD1' ' A' ' 62' ' ' TYR . 0.6 OUTLIER -55.85 -59.81 4.36 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.876 -0.33 . . . . 0.0 110.847 -179.814 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -48.33 -56.14 9.69 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 110.75 -0.94 . . . . 0.0 110.75 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.59 ' OG ' ' NE1' ' A' ' 68' ' ' TRP . 0.6 OUTLIER -45.6 -56.07 5.59 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.963 0.411 . . . . 0.0 111.025 179.967 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 59.7 t80 -47.51 -47.11 27.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.023 -179.723 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 53.6 mt -59.62 -40.01 81.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.009 -179.588 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.447 ' CG1' ' CZ3' ' A' ' 68' ' ' TRP . 43.0 t -57.74 -52.12 61.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 C-N-CA 120.862 -0.335 . . . . 0.0 110.849 -179.612 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' TRP . . . . . 0.59 ' NE1' ' OG ' ' A' ' 64' ' ' SER . 0.6 OUTLIER -64.19 -28.94 70.09 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 120.643 -0.423 . . . . 0.0 110.778 -179.978 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.404 ' HZ1' ' HB3' ' A' ' 69' ' ' LYS . 0.1 OUTLIER -74.06 -22.46 59.52 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.816 0.341 . . . . 0.0 110.374 179.828 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -81.35 -61.36 1.96 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.053 -179.72 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.8 pp -74.43 -20.67 59.95 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.788 -0.365 . . . . 0.0 111.209 -179.294 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.509 ' O ' ' O ' ' A' ' 73' ' ' GLY . . . 109.44 99.11 2.56 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 121.135 -0.555 . . . . 0.0 112.268 178.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.509 ' O ' ' O ' ' A' ' 72' ' ' GLY . . . 40.64 -173.55 0.01 OUTLIER Glycine 0 CA--C 1.525 0.671 0 N-CA-C 112.195 -0.362 . . . . 0.0 112.195 178.684 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 25.4 t80 -90.2 110.88 21.9 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.538 -0.331 . . . . 0.0 110.53 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.587 ' OG1' ' N ' ' A' ' 76' ' ' GLU . 0.1 OUTLIER -142.2 -177.43 5.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.592 179.796 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.587 ' N ' ' OG1' ' A' ' 75' ' ' THR . 35.8 mt-10 -47.92 -29.6 3.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.636 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -70.04 -27.57 64.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.895 -179.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -95.64 -17.74 21.09 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.917 -179.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 25.9 mtp -68.7 -28.63 67.01 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.836 -0.346 . . . . 0.0 110.786 -179.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 9.1 t -66.78 -49.29 49.77 Favored Pre-proline 0 CA--C 1.533 0.292 0 C-N-CA 120.782 -0.367 . . . . 0.0 110.536 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -69.52 -59.7 0.08 OUTLIER 'Trans proline' 0 N--CA 1.497 1.692 0 C-N-CA 121.051 1.167 . . . . 0.0 111.61 179.094 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 5.0 mt -52.47 -52.4 54.49 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.411 179.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -58.37 -57.67 18.64 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 110.484 -1.046 . . . . 0.0 110.484 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.425 ' O ' ' CB ' ' A' ' 88' ' ' GLN . 57.0 tp -48.22 -32.98 7.86 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 179.534 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -74.56 -47.53 32.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.827 -179.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -60.08 -48.74 80.44 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.742 -0.383 . . . . 0.0 110.919 -179.597 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -70.73 -58.33 5.88 Favored Glycine 0 CA--C 1.527 0.822 0 N-CA-C 111.477 -0.649 . . . . 0.0 111.477 -179.611 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.425 ' CB ' ' O ' ' A' ' 84' ' ' LEU . 12.4 tp-100 -50.45 -40.66 51.27 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.092 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.419 ' O ' ' C ' ' A' ' 90' ' ' ALA . 50.6 tp -58.51 -65.84 0.59 Allowed 'General case' 0 C--O 1.215 -0.719 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.927 179.717 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.419 ' C ' ' O ' ' A' ' 89' ' ' LEU . . . -38.56 -46.13 1.15 Allowed 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 120.349 -0.54 . . . . 0.0 111.622 -179.448 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 83.8 mt -57.86 -56.43 22.11 Favored 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 112.815 0.672 . . . . 0.0 112.815 -178.694 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -75.2 -57.07 4.12 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.185 0.517 . . . . 0.0 111.742 -178.396 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . 0.676 ' O ' ' N ' ' A' ' 95' ' ' TRP . 0.1 OUTLIER -53.92 -23.44 12.84 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.454 -0.793 . . . . 0.0 111.49 -179.468 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -52.34 73.64 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.818 0.342 . . . . 0.0 110.757 -179.549 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.682 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 13.5 p-90 -101.96 -17.48 0.19 Allowed Pre-proline 0 CA--C 1.532 0.266 0 CA-C-N 116.279 -0.418 . . . . 0.0 112.127 -179.522 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.682 ' CD ' ' N ' ' A' ' 95' ' ' TRP . 39.5 Cg_exo -62.43 -24.81 75.76 Favored 'Trans proline' 0 N--CA 1.495 1.577 0 C-N-CA 120.404 0.736 . . . . 0.0 112.812 179.401 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . 0.562 ' C ' ' H ' ' A' ' 99' ' ' PHE . 92.5 Cg_exo -62.02 -26.94 78.93 Favored 'Trans proline' 0 N--CA 1.496 1.628 0 C-N-CA 120.496 0.798 . . . . 0.0 112.675 179.679 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 1.2 pp -72.79 17.49 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-O 121.086 0.47 . . . . 0.0 110.107 179.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.566 ' CE1' ' CD1' ' A' ' 25' ' ' PHE . 2.4 t80 -39.49 -31.65 0.1 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.191 -179.802 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . 0.488 ' CE1' ' O ' ' A' ' 97' ' ' PRO . 3.4 p90 -84.69 -50.37 7.69 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.942 -0.303 . . . . 0.0 110.869 -179.633 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 0.417 ' N ' ' CD2' ' A' ' 100' ' ' PHE . . . -64.22 -4.58 12.48 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 111.171 -0.772 . . . . 0.0 111.171 -179.739 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -75.07 -14.17 60.56 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.643 0.258 . . . . 0.0 110.939 -179.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 4.3 ptm180 -86.68 5.35 36.49 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.915 -0.314 . . . . 0.0 110.677 -179.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -121.57 171.01 9.13 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.565 179.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 4.7 mmt -59.37 -17.68 32.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.419 179.737 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.588 ' O ' ' N ' ' A' ' 108' ' ' ALA . . . -69.46 -15.37 70.47 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 111.455 -0.658 . . . . 0.0 111.455 -179.571 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' TRP . . . . . 0.632 ' CH2' ' NZ ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -43.49 -13.86 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.749 0.309 . . . . 0.0 110.725 -179.604 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.588 ' N ' ' O ' ' A' ' 106' ' ' GLY . . . -57.96 -18.68 25.18 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.431 179.718 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 13.4 mt -54.45 -32.13 56.92 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.386 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.439 ' O ' ' CD2' ' A' ' 114' ' ' LEU . . . -52.85 -63.05 1.27 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.544 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.463 ' O ' ' CG2' ' A' ' 115' ' ' VAL . 0.9 OUTLIER -59.67 -57.79 11.38 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.495 -179.545 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.418 ' N ' ' OD1' ' A' ' 111' ' ' ASP . 50.8 tp -47.82 -41.72 24.43 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.115 -0.493 . . . . 0.0 112.025 -178.87 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 64.5 mt -71.84 -61.84 1.64 Allowed 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -178.14 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.439 ' CD2' ' O ' ' A' ' 110' ' ' ALA . 1.1 pp -57.22 -32.8 66.88 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 120.037 -0.665 . . . . 0.0 111.432 -178.178 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.463 ' CG2' ' O ' ' A' ' 111' ' ' ASP . 98.0 t -67.06 -51.36 54.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.84 0.353 . . . . 0.0 110.925 179.777 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 18.0 m -68.53 -27.72 66.35 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.393 -179.312 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -68.07 -59.96 6.0 Favored Glycine 0 CA--C 1.528 0.867 0 C-N-CA 121.045 -0.598 . . . . 0.0 111.899 -179.036 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.523 ' O ' ' OG1' ' A' ' 122' ' ' THR . 7.5 p -65.27 -38.51 82.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 -178.831 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . 0.489 ' O ' ' OG1' ' A' ' 123' ' ' THR . . . -71.12 -60.76 2.06 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.518 -0.473 . . . . 0.0 111.52 -178.687 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 43.7 m -52.23 -52.97 49.28 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.918 0.39 . . . . 0.0 110.975 -179.594 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -57.47 -50.91 71.51 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.115 -0.493 . . . . 0.0 112.226 -179.161 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.63 ' HG1' ' H ' ' A' ' 123' ' ' THR . 40.0 p -64.75 -64.54 0.85 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.969 0.414 . . . . 0.0 111.745 -178.72 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 0.63 ' H ' ' HG1' ' A' ' 122' ' ' THR . 0.2 OUTLIER -44.06 -41.31 5.41 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.892 -0.595 . . . . 0.0 112.295 -178.448 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.528 ' CD1' ' C ' ' A' ' 124' ' ' LEU . 1.5 pp -84.34 -19.93 32.87 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.393 -0.523 . . . . 0.0 111.643 -179.117 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -94.77 -71.3 0.67 Allowed 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 113.053 0.761 . . . . 0.0 113.053 -178.433 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' TRP . . . . . 0.467 ' N ' ' CD1' ' A' ' 126' ' ' TRP . 25.6 m0 -76.71 -57.09 4.06 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 -177.411 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . 0.409 ' CD2' ' N ' ' A' ' 127' ' ' HIS . 18.1 m170 -48.79 -22.58 0.84 Allowed 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.558 -0.457 . . . . 0.0 111.332 -178.63 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 23.0 ttt180 -69.11 -48.1 63.41 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.838 -0.345 . . . . 0.0 111.06 -179.628 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 15.0 t -79.77 -49.33 19.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.962 -179.62 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' SER . . . . . 0.455 ' O ' ' OG ' ' A' ' 130' ' ' SER . 0.4 OUTLIER -118.71 108.92 40.47 Favored Pre-proline 0 CA--C 1.532 0.258 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.673 -179.701 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . 0.654 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 82.1 Cg_exo -74.38 -32.52 6.33 Favored 'Trans proline' 0 C--N 1.311 -1.447 0 C-N-CA 121.577 1.518 . . . . 0.0 112.794 179.451 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . 0.654 ' CD ' ' N ' ' A' ' 131' ' ' PRO . 27.5 Cg_exo -58.67 -44.43 36.66 Favored 'Trans proline' 0 N--CA 1.494 1.558 0 C-N-CA 121.706 1.604 . . . . 0.0 112.199 -179.82 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . 0.413 ' O ' ' N ' ' A' ' 136' ' ' LEU . . . -50.24 -49.51 52.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.672 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -44.19 -23.07 0.08 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.665 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . 0.401 ' N ' ' O ' ' A' ' 133' ' ' ALA . 14.1 tpp180 -76.66 -37.11 56.82 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.17 -179.528 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.413 ' N ' ' O ' ' A' ' 133' ' ' ALA . 9.4 mt -76.26 -22.13 55.5 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 179.777 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 0.547 ' O ' ' N ' ' A' ' 140' ' ' TYR . 0.7 OUTLIER -85.44 -43.64 13.43 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 179.147 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.589 ' C ' ' H ' ' A' ' 140' ' ' TYR . 0.2 OUTLIER -21.32 -50.66 0.06 OUTLIER Pre-proline 0 N--CA 1.466 0.341 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.871 179.71 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.434 ' N ' ' O ' ' A' ' 137' ' ' LEU . 17.2 Cg_exo -51.21 -3.33 0.07 OUTLIER 'Trans proline' 0 C--N 1.308 -1.598 0 C-N-CA 121.247 1.298 . . . . 0.0 112.051 179.824 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . 0.589 ' H ' ' C ' ' A' ' 138' ' ' TYR . 1.9 p90 -83.45 -17.55 41.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.779 -179.836 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 93.4 mt -61.35 -36.59 80.61 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 179.154 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -56.95 -40.29 76.16 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 179.08 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' TRP . . . . . 0.55 ' CD1' ' C ' ' A' ' 143' ' ' TRP . 0.4 OUTLIER -63.54 -45.14 91.93 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.647 179.414 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.464 ' O ' ' OG1' ' A' ' 148' ' ' THR . 13.7 mt -60.81 -41.53 95.85 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 179.354 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . 0.54 ' O ' ' CG2' ' A' ' 149' ' ' VAL . . . -70.42 -18.98 63.02 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.103 -0.499 . . . . 0.0 109.766 179.217 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -71.14 -63.09 1.17 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.823 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -68.64 -31.74 71.09 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 120.607 -0.437 . . . . 0.0 110.583 -179.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' THR . . . . . 0.464 ' OG1' ' O ' ' A' ' 144' ' ' LEU . 85.0 m -67.7 -45.48 74.99 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.851 -0.34 . . . . 0.0 110.217 179.772 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.54 ' CG2' ' O ' ' A' ' 145' ' ' ALA . 45.7 t -64.64 -33.71 64.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.047 179.731 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.59 -58.9 6.53 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.033 179.859 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 11.1 t30 -55.8 -54.43 44.54 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.56 179.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 16.6 t80 -52.42 -34.36 48.1 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.649 -179.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . 0.583 ' CE2' ' OD2' ' A' ' 157' ' ' ASP . 59.4 t80 -66.53 -47.1 73.98 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.821 -179.729 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 13.0 t -55.9 -42.16 69.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.659 -179.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' TRP . . . . . . . . . . . . . 16.5 m0 -62.5 -59.45 4.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.151 -179.657 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.63 -25.93 63.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.047 -179.43 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . 0.583 ' OD2' ' CE2' ' A' ' 153' ' ' TYR . 0.8 OUTLIER -86.74 -42.67 13.15 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.885 -0.326 . . . . 0.0 111.333 -179.393 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' ASN . . . . . 0.436 ' ND2' ' CD2' ' A' ' 37' ' ' LEU . 2.4 m-20 . . . . . 0 C--N 1.328 -0.359 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.208 -179.43 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . 0.668 ' CD2' ' CZ3' ' A' ' 68' ' ' TRP . 0.3 OUTLIER . . . . . 0 C--O 1.232 0.167 0 CA-C-O 120.697 0.284 . . . . 0.0 110.624 . . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.59 ' N ' ' CD ' ' A' ' 7' ' ' PRO . 0.9 OUTLIER -61.05 -32.66 11.44 Favored Pre-proline 0 C--N 1.329 -0.291 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 179.7 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.59 ' CD ' ' N ' ' A' ' 6' ' ' VAL . 22.7 Cg_exo -74.71 -67.81 0.02 OUTLIER 'Trans proline' 0 N--CA 1.492 1.423 0 C-N-CA 121.531 1.488 . . . . 0.0 111.953 179.168 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.514 ' O ' ' CG2' ' A' ' 12' ' ' THR . . . -48.13 -38.95 19.09 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.965 -0.294 . . . . 0.0 111.178 -179.569 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.406 ' CG2' ' O ' ' A' ' 5' ' ' TRP . 89.2 t -69.96 -62.21 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.802 -179.255 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -53.9 -50.94 52.65 Favored Glycine 0 CA--C 1.526 0.773 0 N-CA-C 111.486 -0.646 . . . . 0.0 111.486 -179.307 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 8.8 mp -58.47 -40.9 83.94 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.615 0.245 . . . . 0.0 111.134 -179.603 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.514 ' CG2' ' O ' ' A' ' 8' ' ' ALA . 18.2 p -69.39 -28.71 66.42 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.843 -0.343 . . . . 0.0 110.998 -179.643 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 7.1 mp -80.2 -26.31 39.25 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.737 -179.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 14.2 t -44.58 -60.15 3.26 Favored Pre-proline 0 CA--C 1.534 0.342 0 C-N-CA 120.89 -0.324 . . . . 0.0 110.934 -179.64 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -52.7 -20.65 13.01 Favored 'Trans proline' 0 N--CA 1.498 1.761 0 C-N-CA 121.025 1.15 . . . . 0.0 111.749 179.746 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.587 ' OG ' ' CE3' ' A' ' 53' ' ' TRP . 1.6 t -73.79 -27.39 61.11 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.857 -179.744 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 87.7 mt -73.77 -58.16 3.49 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.477 -179.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -68.95 -22.06 75.59 Favored Glycine 0 CA--C 1.523 0.539 0 N-CA-C 110.449 -1.06 . . . . 0.0 110.449 179.694 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -74.12 -39.1 45.96 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 110.517 -1.033 . . . . 0.0 110.517 179.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 67.4 t80 -70.82 -60.09 2.44 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.676 0.274 . . . . 0.0 110.668 179.797 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 16.2 ttm -67.27 -21.21 65.72 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.951 -179.703 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -81.42 -62.68 1.93 Allowed Glycine 0 CA--C 1.525 0.672 0 N-CA-C 111.43 -0.668 . . . . 0.0 111.43 -179.671 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.88 -24.96 67.69 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.77 0.319 . . . . 0.0 111.129 -179.386 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 27.8 t80 -47.36 -23.2 0.54 Allowed 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 179.558 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 21.3 t80 -72.72 -51.21 20.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.916 -0.583 . . . . 0.0 111.25 -179.769 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.459 ' O ' ' N ' ' A' ' 30' ' ' GLY . 34.9 m -62.79 -26.88 41.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 C-N-CA 120.541 -0.464 . . . . 0.0 110.522 -179.745 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -66.72 -24.9 66.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.223 179.799 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -106.03 -35.36 2.98 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 110.377 -1.089 . . . . 0.0 110.377 179.531 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.419 ' O ' ' N ' ' A' ' 32' ' ' ARG . 18.8 tt0 -84.95 -47.42 10.29 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.753 0.311 . . . . 0.0 110.227 179.644 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.459 ' N ' ' O ' ' A' ' 26' ' ' VAL . . . -48.39 -46.5 28.87 Favored Glycine 0 CA--C 1.523 0.567 0 N-CA-C 110.567 -1.013 . . . . 0.0 110.567 179.787 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 10.5 mp -60.0 -25.12 65.02 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 179.612 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.419 ' N ' ' O ' ' A' ' 29' ' ' GLU . 56.6 ttt180 -78.33 -50.96 10.84 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.131 179.344 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 11.9 m0 -47.26 -45.24 23.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.231 179.745 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 88.3 t80 -52.52 -23.99 7.29 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.438 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -67.73 -42.16 82.31 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.696 -179.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -97.1 -68.83 0.97 Allowed Glycine 0 CA--C 1.525 0.683 0 N-CA-C 111.076 -0.809 . . . . 0.0 111.076 -179.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.506 ' C ' ' CD1' ' A' ' 37' ' ' LEU . 3.6 pp -90.52 166.2 13.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.875 0.369 . . . . 0.0 110.592 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 48.5 mm-40 -85.46 129.8 34.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.608 -179.16 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 14.2 mtpt -118.63 165.02 17.78 Favored Pre-proline 0 CA--C 1.532 0.25 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 179.013 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo . . . . . 0 C--N 1.307 -1.612 0 C-N-CA 122.164 1.909 . . . . 0.0 111.75 179.917 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.535 0.403 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.679 ' C ' ' H ' ' A' ' 52' ' ' ILE . . . -40.8 -28.34 0.21 Allowed Pre-proline 0 N--CA 1.465 0.287 0 N-CA-C 111.934 0.346 . . . . 0.0 111.934 -179.107 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -54.48 8.28 0.03 OUTLIER 'Trans proline' 0 C--N 1.311 -1.401 0 CA-C-N 119.005 0.68 . . . . 0.0 112.533 178.352 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.679 ' H ' ' C ' ' A' ' 50' ' ' ALA . 9.2 pt -55.62 -35.56 39.12 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 178.673 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.587 ' CE3' ' OG ' ' A' ' 16' ' ' SER . 3.5 m0 -55.11 -25.01 28.79 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.433 179.615 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -69.89 -61.51 4.3 Favored Glycine 0 CA--C 1.528 0.845 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.906 -179.371 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.49 ' CG2' ' N ' ' A' ' 56' ' ' LEU . 1.9 t -56.39 -46.69 79.99 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 120.729 -0.389 . . . . 0.0 110.706 -179.351 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.49 ' N ' ' CG2' ' A' ' 55' ' ' THR . 57.9 mt -62.31 -41.57 98.65 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.365 -0.534 . . . . 0.0 109.639 179.313 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.532 ' C ' ' CD1' ' A' ' 57' ' ' TYR . 4.2 t80 -56.69 -40.27 75.29 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.678 -179.707 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.431 ' OG ' ' N ' ' A' ' 59' ' ' ALA . 1.3 p -62.85 -53.63 51.26 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 179.62 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.431 ' N ' ' OG ' ' A' ' 58' ' ' SER . . . -55.78 -62.3 1.79 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.503 179.713 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 36.5 mtm -51.72 -32.35 29.99 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.447 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -57.93 -56.06 27.22 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 111.19 -0.764 . . . . 0.0 111.19 -179.774 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 3.4 m-30 -65.46 -42.67 92.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.05 0.452 . . . . 0.0 110.301 -179.834 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -53.35 -56.27 20.4 Favored Glycine 0 CA--C 1.524 0.615 0 N-CA-C 110.44 -1.064 . . . . 0.0 110.44 179.68 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.582 ' O ' ' CD1' ' A' ' 68' ' ' TRP . 0.9 OUTLIER -54.97 -45.12 74.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.774 0.321 . . . . 0.0 110.539 179.815 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.42 ' HA ' ' CZ2' ' A' ' 68' ' ' TRP . 74.7 t80 -47.01 -47.21 22.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.019 0.438 . . . . 0.0 110.01 179.668 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 62.4 mt -70.56 -28.14 33.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.058 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 59.3 t -63.42 -59.22 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 C-N-CA 120.617 -0.433 . . . . 0.0 111.647 -179.399 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' TRP . . . . . 0.668 ' CZ3' ' CD2' ' A' ' 5' ' ' TRP . 0.0 OUTLIER -70.78 -29.56 65.8 Favored 'General case' 0 N--CA 1.462 0.152 0 C-N-CA 119.84 -0.744 . . . . 0.0 110.822 -179.327 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -70.89 -22.38 62.28 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.517 -0.473 . . . . 0.0 110.207 179.524 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -82.22 -60.75 2.1 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.924 -179.677 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.8 pp -72.92 -11.19 60.49 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.99 -179.395 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.515 ' O ' ' O ' ' A' ' 73' ' ' GLY . . . 104.86 92.57 2.27 Favored Glycine 0 CA--C 1.527 0.814 0 C-N-CA 121.163 -0.541 . . . . 0.0 112.149 179.101 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.586 ' N ' ' O ' ' A' ' 68' ' ' TRP . . . 40.94 -173.52 0.01 OUTLIER Glycine 0 CA--C 1.524 0.652 0 N-CA-C 111.973 -0.451 . . . . 0.0 111.973 179.009 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 42.9 t80 -86.98 110.18 19.87 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.85 0.357 . . . . 0.0 110.341 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.576 ' OG1' ' N ' ' A' ' 76' ' ' GLU . 0.1 OUTLIER -142.57 -174.12 4.05 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.788 -179.822 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.576 ' N ' ' OG1' ' A' ' 75' ' ' THR . 92.2 mt-10 -49.89 -24.43 2.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.884 179.881 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -78.63 -31.68 47.03 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.893 -179.804 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -85.8 -20.57 29.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.831 0.348 . . . . 0.0 110.716 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 8.3 mtp -65.43 -27.1 68.29 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.658 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.409 ' O ' ' CB ' ' A' ' 84' ' ' LEU . 6.9 t -69.4 -48.74 24.75 Favored Pre-proline 0 C--N 1.328 -0.33 0 C-N-CA 120.839 -0.345 . . . . 0.0 110.728 -179.768 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -71.23 -60.85 0.05 OUTLIER 'Trans proline' 0 N--CA 1.497 1.715 0 C-N-CA 120.961 1.107 . . . . 0.0 111.829 179.179 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 5.0 mt -57.6 -48.73 78.61 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.618 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -61.2 -61.45 6.91 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 110.938 -0.865 . . . . 0.0 110.938 -179.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.409 ' CB ' ' O ' ' A' ' 80' ' ' VAL . 33.2 tp -53.54 -24.05 12.37 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.902 0.382 . . . . 0.0 110.494 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.409 ' HH ' HG22 ' A' ' 118' ' ' VAL . 13.5 t80 -77.33 -47.99 18.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.433 179.85 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -66.71 -37.0 83.81 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.603 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -71.21 -57.44 6.18 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 110.612 -0.995 . . . . 0.0 110.612 179.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 49.3 tp60 -53.38 -45.29 69.2 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 179.61 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.424 ' O ' ' C ' ' A' ' 90' ' ' ALA . 24.3 tp -53.35 -66.14 0.44 Allowed 'General case' 0 C--O 1.21 -0.994 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.63 179.603 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.424 ' C ' ' O ' ' A' ' 89' ' ' LEU . . . -38.65 -48.64 1.48 Allowed 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 120.637 -0.425 . . . . 0.0 111.85 -179.575 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 94.6 mt -55.04 -57.28 12.33 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 112.9 0.704 . . . . 0.0 112.9 -178.277 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -74.84 -55.88 5.35 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 121.316 0.579 . . . . 0.0 111.419 -178.717 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . 0.642 ' O ' ' N ' ' A' ' 95' ' ' TRP . 4.9 t-105 -53.19 -19.45 3.06 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.124 -0.943 . . . . 0.0 111.209 -179.781 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -59.19 69.37 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.161 0 CA-C-O 120.992 0.425 . . . . 0.0 109.86 179.629 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.688 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 11.9 p-90 -101.95 -17.04 0.19 Allowed Pre-proline 0 CA--C 1.536 0.418 0 CA-C-N 115.729 -0.668 . . . . 0.0 112.142 -179.106 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.688 ' CD ' ' N ' ' A' ' 95' ' ' TRP . 31.9 Cg_exo -60.89 -30.57 90.28 Favored 'Trans proline' 0 N--CA 1.495 1.573 0 C-N-CA 120.383 0.722 . . . . 0.0 112.618 179.638 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . 0.535 ' C ' ' H ' ' A' ' 99' ' ' PHE . 91.8 Cg_exo -55.24 -27.55 57.42 Favored 'Trans proline' 0 N--CA 1.494 1.526 0 C-N-CA 120.495 0.796 . . . . 0.0 112.607 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 1.1 pp -76.79 22.73 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.152 0 CA-C-O 121.335 0.588 . . . . 0.0 109.933 179.537 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.535 ' H ' ' C ' ' A' ' 97' ' ' PRO . 2.4 t80 -39.53 -45.74 1.62 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.043 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . 0.475 ' C ' ' H ' ' A' ' 102' ' ' ALA . 4.7 m-85 -83.11 -49.65 9.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.195 -179.361 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -54.81 -7.75 1.12 Allowed Glycine 0 CA--C 1.526 0.726 0 N-CA-C 111.372 -0.691 . . . . 0.0 111.372 -179.506 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.475 ' H ' ' C ' ' A' ' 100' ' ' PHE . . . -75.06 -13.43 60.49 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 121.079 -0.248 . . . . 0.0 110.964 -179.707 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -75.77 6.98 4.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.768 0.318 . . . . 0.0 110.82 -179.848 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -125.63 165.95 17.62 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.326 179.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 8.4 mmt -56.07 -17.12 6.15 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.924 0.392 . . . . 0.0 110.183 179.602 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.536 ' C ' ' H ' ' A' ' 108' ' ' ALA . . . -63.36 -15.85 57.44 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 110.611 -0.996 . . . . 0.0 110.611 179.718 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' TRP . . . . . 0.483 ' C ' ' CD1' ' A' ' 107' ' ' TRP . 0.0 OUTLIER -47.47 -11.8 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.762 0.315 . . . . 0.0 110.525 -179.776 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.536 ' H ' ' C ' ' A' ' 106' ' ' GLY . . . -63.58 -20.7 65.86 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-O 121.118 0.485 . . . . 0.0 109.816 179.432 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 7.1 mt -55.36 -30.76 60.95 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.717 179.491 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.427 ' O ' ' CD2' ' A' ' 114' ' ' LEU . . . -53.86 -61.87 2.02 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.548 179.718 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.526 ' OD1' ' N ' ' A' ' 112' ' ' LEU . 1.4 p30 -60.69 -57.97 10.46 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.769 -179.351 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.526 ' N ' ' OD1' ' A' ' 111' ' ' ASP . 9.1 tp -50.46 -38.12 41.96 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 -178.733 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 62.6 mt -72.7 -62.24 1.52 Allowed 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -178.409 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.427 ' CD2' ' O ' ' A' ' 110' ' ' ALA . 1.3 pp -58.29 -35.45 71.82 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 120.063 -0.655 . . . . 0.0 110.912 -178.724 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.495 ' CG2' ' O ' ' A' ' 111' ' ' ASP . 87.7 t -63.46 -52.66 55.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.746 -179.708 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 39.0 t -69.81 -32.31 70.69 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.428 -178.704 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -61.22 -59.96 9.13 Favored Glycine 0 CA--C 1.526 0.753 0 C-N-CA 121.05 -0.595 . . . . 0.0 111.924 -179.262 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.506 ' O ' ' OG1' ' A' ' 122' ' ' THR . 4.4 p -68.78 -38.05 78.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -178.789 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . 0.503 ' O ' ' OG1' ' A' ' 123' ' ' THR . . . -65.99 -60.19 3.08 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.625 -0.43 . . . . 0.0 111.339 -178.746 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 28.1 m -59.73 -57.26 13.67 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.366 -179.285 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -49.07 -43.93 41.45 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.42 -179.29 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.506 ' OG1' ' O ' ' A' ' 118' ' ' VAL . 27.9 p -68.32 -38.06 81.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.511 -179.197 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 0.503 ' OG1' ' O ' ' A' ' 119' ' ' ALA . 0.1 OUTLIER -56.77 -49.81 74.18 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.845 0.355 . . . . 0.0 111.134 -179.191 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.6 pp -83.76 -19.82 34.45 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.886 -178.745 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -86.48 -71.32 0.55 Allowed 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -178.433 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' TRP . . . . . 0.456 ' N ' ' CD1' ' A' ' 126' ' ' TRP . 37.0 m0 -85.01 -57.23 3.18 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 112.767 0.654 . . . . 0.0 112.767 -177.881 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . 0.514 ' CD2' ' N ' ' A' ' 127' ' ' HIS . 8.7 m170 -50.4 -23.97 2.74 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.874 -0.33 . . . . 0.0 111.549 -178.7 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 40.4 ttt-85 -76.34 -37.08 57.82 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.918 -0.313 . . . . 0.0 110.99 -179.721 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 60.2 t -83.94 -48.88 16.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.783 0.325 . . . . 0.0 110.88 -179.575 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -128.2 112.82 19.9 Favored Pre-proline 0 CA--C 1.532 0.274 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.573 -179.624 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . 0.625 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 67.1 Cg_exo -70.71 -34.28 11.67 Favored 'Trans proline' 0 N--CA 1.492 1.423 0 C-N-CA 121.092 1.195 . . . . 0.0 112.307 179.473 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . 0.625 ' CD ' ' N ' ' A' ' 131' ' ' PRO . 32.3 Cg_exo -56.34 -35.0 95.56 Favored 'Trans proline' 0 N--CA 1.495 1.607 0 C-N-CA 121.52 1.48 . . . . 0.0 111.877 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -63.66 -38.68 92.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.321 179.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -54.51 -25.39 25.36 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.194 -0.457 . . . . 0.0 109.994 179.697 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 9.5 tpt85 -77.37 -29.82 53.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.002 179.63 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 79.1 mt -80.02 -31.34 39.64 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.829 179.362 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 0.579 ' O ' ' N ' ' A' ' 140' ' ' TYR . 0.7 OUTLIER -79.39 -44.61 21.13 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 179.344 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.579 ' C ' ' H ' ' A' ' 140' ' ' TYR . 0.4 OUTLIER -19.97 -51.24 0.05 OUTLIER Pre-proline 0 N--CA 1.466 0.327 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.913 179.916 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.457 ' N ' ' O ' ' A' ' 137' ' ' LEU . 16.9 Cg_exo -53.08 -1.69 0.09 OUTLIER 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 121.11 1.207 . . . . 0.0 112.015 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . 0.579 ' H ' ' C ' ' A' ' 138' ' ' TYR . 2.2 p90 -84.24 -19.5 33.82 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 120.919 0.39 . . . . 0.0 110.638 -179.781 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 95.6 mt -59.98 -49.92 75.79 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.63 -0.428 . . . . 0.0 109.986 179.253 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -45.55 -44.92 13.15 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 179.37 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' TRP . . . . . 0.575 ' C ' ' CD1' ' A' ' 143' ' ' TRP . 0.3 OUTLIER -58.34 -48.74 79.59 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.423 179.37 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.479 ' O ' ' OG1' ' A' ' 148' ' ' THR . 16.1 mt -55.46 -46.7 76.78 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.32 -0.552 . . . . 0.0 109.59 179.567 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . 0.476 ' O ' ' CG2' ' A' ' 149' ' ' VAL . . . -63.44 -20.91 65.97 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.902 179.3 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -68.99 -62.91 1.18 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.504 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -67.8 -45.61 74.28 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 120.57 -0.452 . . . . 0.0 110.414 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' THR . . . . . 0.479 ' OG1' ' O ' ' A' ' 144' ' ' LEU . 19.2 m -52.28 -60.29 3.39 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.756 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.476 ' CG2' ' O ' ' A' ' 145' ' ' ALA . 93.2 t -54.16 -41.64 52.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 C-N-CA 120.878 -0.329 . . . . 0.0 110.798 -179.725 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 3.5 tp -50.39 -56.05 13.1 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.819 0.342 . . . . 0.0 110.548 -179.679 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . 0.414 ' ND2' ' CB ' ' A' ' 108' ' ' ALA . 9.8 t30 -61.7 -54.76 38.24 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.672 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . 0.443 ' CZ ' ' NE ' ' A' ' 156' ' ' ARG . 40.5 t80 -46.36 -38.09 8.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.616 -179.702 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 32.0 t80 -65.9 -53.39 40.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.699 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 62.8 t -49.22 -48.13 18.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 C-N-CA 120.614 -0.435 . . . . 0.0 110.365 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' TRP . . . . . . . . . . . . . 13.5 m0 -53.67 -55.56 24.99 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.363 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . 0.443 ' NE ' ' CZ ' ' A' ' 152' ' ' TYR . 0.7 OUTLIER -54.79 -52.14 63.55 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.362 179.949 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -49.19 -46.89 46.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.743 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' ASN . . . . . 0.478 ' O ' ' ND2' ' A' ' 158' ' ' ASN . 1.7 t30 . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.73 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . 0.436 ' CE2' ' CD2' ' A' ' 68' ' ' TRP . 0.5 OUTLIER . . . . . 0 CA--C 1.527 0.094 0 CA-C-O 120.761 0.315 . . . . 0.0 110.234 . . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.633 ' N ' ' CD ' ' A' ' 7' ' ' PRO . 1.0 OUTLIER -63.8 -36.56 22.04 Favored Pre-proline 0 C--N 1.328 -0.328 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 179.875 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.633 ' CD ' ' N ' ' A' ' 6' ' ' VAL . 15.0 Cg_exo -70.09 -68.23 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 121.987 1.792 . . . . 0.0 112.251 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.446 ' CB ' ' HG ' ' A' ' 64' ' ' SER . . . -47.41 -42.8 22.88 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.538 -179.35 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.485 ' O ' ' OG1' ' A' ' 12' ' ' THR . 60.6 t -65.1 -62.51 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 111.852 0.316 . . . . 0.0 111.852 -179.126 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -53.92 -40.03 64.14 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 111.462 -0.655 . . . . 0.0 111.462 -179.355 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 6.7 mp -68.61 -28.7 67.15 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.646 0.26 . . . . 0.0 110.862 -179.575 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.485 ' OG1' ' O ' ' A' ' 9' ' ' VAL . 2.2 p -81.25 -24.0 37.63 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.844 -0.342 . . . . 0.0 110.901 -179.933 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 84.6 mt -81.4 -33.39 32.28 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.517 -0.31 . . . . 0.0 110.695 -179.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.407 ' N ' ' HD2' ' A' ' 15' ' ' PRO . 3.9 t -47.11 -57.89 8.35 Favored Pre-proline 0 CA--C 1.535 0.373 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.907 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.407 ' HD2' ' N ' ' A' ' 14' ' ' VAL . 11.6 Cg_endo -56.66 -30.9 85.58 Favored 'Trans proline' 0 N--CA 1.498 1.754 0 C-N-CA 121.169 1.246 . . . . 0.0 112.3 -179.857 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.1 t -67.84 -27.16 66.46 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.694 -179.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 96.2 mt -69.54 -58.16 4.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.861 -179.687 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -68.92 -20.27 74.36 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 110.816 -0.913 . . . . 0.0 110.816 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -71.02 -46.07 46.57 Favored Glycine 0 CA--C 1.522 0.502 0 N-CA-C 110.909 -0.876 . . . . 0.0 110.909 -179.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -74.44 -59.64 2.64 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.737 0.303 . . . . 0.0 110.796 -179.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 1.1 tpt -60.9 -26.78 67.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.108 -179.509 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -79.26 -59.84 2.64 Favored Glycine 0 CA--C 1.527 0.8 0 N-CA-C 111.602 -0.599 . . . . 0.0 111.602 -179.462 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -61.35 -17.13 52.4 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.812 0.339 . . . . 0.0 110.843 -179.264 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 28.7 t80 -50.01 -24.0 2.37 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.935 0.398 . . . . 0.0 110.223 179.69 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.409 ' CE2' ' CB ' ' A' ' 102' ' ' ALA . 53.9 t80 -69.38 -48.6 60.67 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.904 -179.775 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 27.6 m -72.12 -19.52 19.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.805 -179.624 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.55 -44.38 86.97 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.764 -179.751 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -102.37 -43.9 1.94 Allowed Glycine 0 CA--C 1.525 0.711 0 N-CA-C 111.503 -0.639 . . . . 0.0 111.503 -179.472 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -73.78 -24.62 59.87 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.95 -0.3 . . . . 0.0 111.019 -179.605 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -81.33 -58.77 2.52 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 111.24 -0.744 . . . . 0.0 111.24 -179.659 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 10.3 mp -51.69 -29.05 16.73 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.853 -0.339 . . . . 0.0 110.122 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 33.3 ttt180 -82.55 -47.84 11.69 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.217 179.52 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -49.09 -27.67 3.57 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.294 -0.412 . . . . 0.0 109.921 179.748 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.52 ' C ' ' CD1' ' A' ' 34' ' ' TYR . 9.0 t80 -46.83 -43.31 18.42 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.241 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -54.37 -24.4 19.42 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.489 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -96.09 -72.6 1.13 Allowed Glycine 0 CA--C 1.525 0.706 0 N-CA-C 110.986 -0.845 . . . . 0.0 110.986 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -95.95 166.87 11.57 Favored 'General case' 0 N--CA 1.462 0.173 0 C-N-CA 120.863 -0.335 . . . . 0.0 110.431 179.546 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 31.2 tp60 -85.92 118.67 25.55 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.947 -179.471 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 7.6 mtpt -105.13 162.28 20.23 Favored Pre-proline 0 CA--C 1.535 0.392 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.73 179.7 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo . . . . . 0 N--CA 1.494 1.503 0 C-N-CA 121.369 1.379 . . . . 0.0 112.408 -179.353 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.406 ' O ' ' CG2' ' A' ' 52' ' ' ILE . 0.3 OUTLIER . . . . . 0 CA--C 1.534 0.327 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 . . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.637 ' C ' ' H ' ' A' ' 52' ' ' ILE . . . -40.37 -32.17 0.3 Allowed Pre-proline 0 CA--C 1.534 0.348 0 C-N-CA 120.425 -0.51 . . . . 0.0 111.835 -178.922 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_exo -54.24 4.26 0.04 OUTLIER 'Trans proline' 0 C--N 1.316 -1.182 0 CA-C-N 119.052 0.697 . . . . 0.0 112.342 178.23 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.637 ' H ' ' C ' ' A' ' 50' ' ' ALA . 46.9 pt -54.24 -30.75 21.11 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.113 0 CA-C-O 121.167 0.508 . . . . 0.0 110.066 179.662 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 52.9 m95 -80.1 -23.41 41.27 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.898 -179.44 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -70.85 -45.0 54.66 Favored Glycine 0 CA--C 1.523 0.585 0 N-CA-C 109.916 -1.274 . . . . 0.0 109.916 178.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 5.3 m -68.52 -51.8 39.07 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 179.294 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 94.5 mt -60.8 -26.53 67.36 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.044 179.586 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.543 ' C ' ' CD1' ' A' ' 57' ' ' TYR . 0.4 OUTLIER -65.61 -56.72 10.69 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 179.615 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 40.3 t -52.2 -44.01 64.5 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.775 -0.37 . . . . 0.0 110.288 179.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.76 -47.15 82.14 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.789 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 30.3 mtm -60.47 -35.65 76.38 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.563 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -64.53 -43.15 97.0 Favored Glycine 0 CA--C 1.523 0.538 0 N-CA-C 110.815 -0.914 . . . . 0.0 110.815 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -63.18 -53.41 53.63 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -57.32 -37.08 79.31 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 179.032 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.586 ' O ' ' NE1' ' A' ' 68' ' ' TRP . 23.3 t -62.33 -44.62 96.08 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 179.278 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 21.1 t80 -54.16 -44.06 71.12 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 179.155 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 65.7 mt -65.05 -30.52 50.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.603 179.625 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 73.1 t -65.49 -58.8 5.46 Favored 'Isoleucine or valine' 0 C--O 1.233 0.186 0 C-N-CA 120.501 -0.479 . . . . 0.0 111.125 -179.711 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' TRP . . . . . 0.631 ' N ' ' CD1' ' A' ' 68' ' ' TRP . 0.0 OUTLIER -56.17 -37.17 69.21 Favored 'General case' 0 CA--C 1.528 0.104 0 C-N-CA 119.96 -0.696 . . . . 0.0 110.119 -179.78 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 16.5 mmmt -73.17 -21.62 60.66 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.416 -0.514 . . . . 0.0 110.917 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 15.8 tp10 -76.83 -40.64 47.14 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 -178.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.44 ' C ' ' CD1' ' A' ' 71' ' ' LEU . 0.5 OUTLIER -105.03 -0.11 27.1 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 120.32 -0.552 . . . . 0.0 111.44 -179.506 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.417 ' O ' ' O ' ' A' ' 73' ' ' GLY . . . 96.3 84.62 1.71 Allowed Glycine 0 CA--C 1.525 0.662 0 C-N-CA 120.992 -0.623 . . . . 0.0 111.628 179.222 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.578 ' N ' ' O ' ' A' ' 68' ' ' TRP . . . 44.81 -173.88 0.01 OUTLIER Glycine 0 CA--C 1.525 0.691 0 N-CA-C 111.652 -0.579 . . . . 0.0 111.652 179.31 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 77.7 t80 -81.71 110.46 17.06 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.875 0.369 . . . . 0.0 110.651 -179.663 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.503 ' OG1' ' N ' ' A' ' 76' ' ' GLU . 2.6 t -142.65 -173.77 3.97 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.646 179.849 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.503 ' N ' ' OG1' ' A' ' 75' ' ' THR . 22.0 mt-10 -51.97 -24.56 6.68 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.649 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -79.29 -24.69 42.72 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.901 -179.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -93.28 -16.83 24.3 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.838 0.352 . . . . 0.0 111.031 -179.663 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 14.1 mtp -69.54 -30.46 68.28 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.871 -179.782 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.41 ' N ' ' HD2' ' A' ' 81' ' ' PRO . 6.3 t -68.16 -46.57 40.29 Favored Pre-proline 0 CA--C 1.533 0.291 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.749 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.41 ' HD2' ' N ' ' A' ' 80' ' ' VAL . 13.4 Cg_endo -71.76 -61.18 0.05 OUTLIER 'Trans proline' 0 N--CA 1.498 1.786 0 C-N-CA 120.841 1.027 . . . . 0.0 111.916 179.397 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 8.4 mt -56.22 -51.9 66.4 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 121.014 0.435 . . . . 0.0 109.906 179.54 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -52.03 -53.96 28.09 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 111.167 -0.773 . . . . 0.0 111.167 -179.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 29.6 tp -58.42 -33.09 69.28 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.554 0.216 . . . . 0.0 110.954 -179.512 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 31.1 t80 -68.42 -37.08 79.97 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.801 -0.36 . . . . 0.0 110.86 -179.645 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.428 ' OG1' ' N ' ' A' ' 87' ' ' GLY . 5.1 p -68.44 -58.73 3.89 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.742 -0.383 . . . . 0.0 110.747 -179.46 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.428 ' N ' ' OG1' ' A' ' 86' ' ' THR . . . -58.69 -57.46 19.76 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 111.268 -0.733 . . . . 0.0 111.268 -179.799 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 54.1 tp60 -50.6 -55.36 16.66 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-O 120.88 0.371 . . . . 0.0 110.922 -179.758 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.424 ' O ' ' C ' ' A' ' 90' ' ' ALA . 26.3 tp -47.88 -66.27 0.43 Allowed 'General case' 0 C--O 1.209 -1.051 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.06 -179.731 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.424 ' C ' ' O ' ' A' ' 89' ' ' LEU . . . -38.37 -50.51 1.5 Allowed 'General case' 0 C--N 1.319 -0.759 0 C-N-CA 120.633 -0.427 . . . . 0.0 112.026 -179.309 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 95.2 mt -53.64 -56.75 14.54 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 -178.312 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -76.97 -53.7 7.51 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.275 0.559 . . . . 0.0 111.615 -178.312 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . 0.64 ' O ' ' N ' ' A' ' 95' ' ' TRP . 3.9 t-105 -53.11 -20.76 4.04 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.364 -0.835 . . . . 0.0 111.63 -179.595 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -57.01 70.48 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 120.793 0.33 . . . . 0.0 110.608 -179.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.68 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 5.6 p-90 -102.38 -17.32 0.19 Allowed Pre-proline 0 CA--C 1.537 0.472 0 CA-C-N 116.051 -0.522 . . . . 0.0 112.036 -179.543 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.68 ' CD ' ' N ' ' A' ' 95' ' ' TRP . 32.5 Cg_exo -63.28 -24.2 72.06 Favored 'Trans proline' 0 N--CA 1.495 1.614 0 C-N-CA 120.629 0.886 . . . . 0.0 112.831 179.466 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . 0.558 ' CD ' ' N ' ' A' ' 96' ' ' PRO . 97.3 Cg_exo -62.93 -24.87 74.14 Favored 'Trans proline' 0 N--CA 1.495 1.563 0 C-N-CA 120.833 1.022 . . . . 0.0 112.832 179.856 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 1.1 pp -78.58 22.53 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 121.015 0.436 . . . . 0.0 110.1 179.751 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.481 ' H ' ' C ' ' A' ' 97' ' ' PRO . 2.5 t80 -40.21 -42.78 1.55 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.531 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -86.23 -33.1 20.83 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.724 -179.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -68.46 -5.12 41.8 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 111.231 -0.748 . . . . 0.0 111.231 -179.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.409 ' CB ' ' CE2' ' A' ' 25' ' ' PHE . . . -74.63 -9.45 58.58 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.74 0.305 . . . . 0.0 110.908 -179.76 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.488 ' C ' ' CD ' ' A' ' 103' ' ' ARG . 0.0 OUTLIER -88.56 -11.73 44.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.828 -179.792 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -109.7 -178.92 3.67 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.914 0.387 . . . . 0.0 110.801 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' MET . . . . . 0.66 ' N ' ' SD ' ' A' ' 105' ' ' MET . 0.0 OUTLIER -55.45 -23.0 22.99 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.123 -179.826 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -62.22 -15.42 51.0 Favored Glycine 0 CA--C 1.528 0.847 0 CA-C-N 116.193 -0.458 . . . . 0.0 112.08 -179.287 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' TRP . . . . . 0.688 ' CD1' ' CZ2' ' A' ' 155' ' ' TRP . 0.0 OUTLIER -48.75 -18.98 0.31 Allowed 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 116.812 0.306 . . . . 0.0 110.972 -179.329 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -70.8 -23.76 62.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.991 0.424 . . . . 0.0 110.647 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 7.5 mt -54.21 -28.68 42.46 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.635 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -53.29 -63.01 1.29 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.087 0.47 . . . . 0.0 110.334 179.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.545 ' OD1' ' N ' ' A' ' 112' ' ' LEU . 2.1 p30 -62.26 -53.38 56.06 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.838 -0.619 . . . . 0.0 112.039 -179.376 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.545 ' N ' ' OD1' ' A' ' 111' ' ' ASP . 0.2 OUTLIER -53.49 -40.46 65.36 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.268 0.47 . . . . 0.0 112.268 -178.194 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 61.4 mt -71.4 -61.69 1.68 Allowed 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.281 0.475 . . . . 0.0 112.281 -178.479 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.5 pp -58.3 -33.67 69.71 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 120.15 -0.62 . . . . 0.0 110.9 -178.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.536 ' CG2' ' O ' ' A' ' 111' ' ' ASP . 41.2 t -62.16 -60.91 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.462 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 57.3 p -68.87 -22.24 64.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.474 -178.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -66.17 -62.22 4.85 Favored Glycine 0 CA--C 1.526 0.723 0 C-N-CA 120.952 -0.642 . . . . 0.0 111.549 -179.27 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.509 ' O ' ' OG1' ' A' ' 122' ' ' THR . 10.0 p -71.12 -37.54 67.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 C-N-CA 120.872 -0.331 . . . . 0.0 111.694 -179.258 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . 0.51 ' O ' ' OG1' ' A' ' 123' ' ' THR . . . -68.39 -60.64 2.29 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.564 -0.454 . . . . 0.0 111.522 -179.204 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 3.7 m -58.7 -51.73 68.7 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.892 0.377 . . . . 0.0 111.372 -179.34 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.423 ' O ' ' CB ' ' A' ' 125' ' ' ALA . . . -55.58 -39.7 71.04 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.381 -179.384 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.509 ' OG1' ' O ' ' A' ' 118' ' ' VAL . 36.2 p -75.01 -28.94 60.7 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.638 -0.425 . . . . 0.0 111.601 -179.279 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 0.51 ' OG1' ' O ' ' A' ' 119' ' ' ALA . 0.1 OUTLIER -65.11 -54.55 28.23 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.631 -0.428 . . . . 0.0 110.717 -179.669 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -79.45 -19.73 49.16 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.576 -0.449 . . . . 0.0 111.73 -179.043 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . 0.423 ' CB ' ' O ' ' A' ' 121' ' ' ALA . . . -88.33 -68.28 0.77 Allowed 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 -179.083 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' TRP . . . . . 0.4 ' N ' ' CD1' ' A' ' 126' ' ' TRP . 41.8 m0 -84.17 -57.23 3.26 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -177.87 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . 0.505 ' CD2' ' N ' ' A' ' 127' ' ' HIS . 7.1 m170 -54.69 -22.11 12.83 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.581 -0.448 . . . . 0.0 111.289 -178.718 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 26.8 ttt180 -68.34 -42.98 78.49 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.863 -0.335 . . . . 0.0 110.821 -179.694 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 23.2 t -87.51 -49.64 14.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.807 -179.796 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 26.6 p -116.23 108.32 46.03 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.523 -179.793 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . 0.642 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 79.5 Cg_exo -74.22 -25.71 13.3 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 121.554 1.503 . . . . 0.0 112.663 179.471 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . 0.642 ' CD ' ' N ' ' A' ' 131' ' ' PRO . 51.4 Cg_exo -63.16 -43.31 19.28 Favored 'Trans proline' 0 N--CA 1.495 1.609 0 C-N-CA 121.371 1.38 . . . . 0.0 111.961 179.797 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -54.83 -38.75 67.78 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.251 179.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -55.06 -26.28 36.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.256 179.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 13.4 tpp180 -76.07 -32.23 59.16 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.248 179.658 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 95.9 mt -72.53 -26.78 61.88 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 179.314 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 0.512 ' O ' ' N ' ' A' ' 140' ' ' TYR . 2.6 mt -88.69 -29.25 20.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.376 179.757 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.516 ' C ' ' CD1' ' A' ' 138' ' ' TYR . 0.4 OUTLIER -33.59 -49.3 0.75 Allowed Pre-proline 0 CA--C 1.537 0.458 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.381 -179.819 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.408 ' HD2' ' N ' ' A' ' 138' ' ' TYR . 3.9 Cg_exo -60.96 4.96 0.17 Allowed 'Trans proline' 0 N--CA 1.494 1.535 0 C-N-CA 121.402 1.401 . . . . 0.0 112.591 -179.688 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . 0.512 ' N ' ' O ' ' A' ' 137' ' ' LEU . 0.1 OUTLIER -90.07 -16.65 29.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.709 0.29 . . . . 0.0 111.125 179.88 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.405 ' N ' ' CD1' ' A' ' 140' ' ' TYR . 94.8 mt -58.42 -26.19 63.0 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 178.831 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -63.41 -42.3 98.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.628 179.266 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' TRP . . . . . 0.429 ' CZ2' ' CD1' ' A' ' 52' ' ' ILE . 12.3 t-105 -66.72 -38.72 87.27 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.7 179.387 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.409 HD11 ' CZ ' ' A' ' 140' ' ' TYR . 18.0 mt -62.55 -37.64 86.93 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 120.539 -0.465 . . . . 0.0 110.035 179.616 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . 0.489 ' O ' ' CG2' ' A' ' 149' ' ' VAL . . . -76.91 -25.92 53.52 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.389 179.746 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 26.4 t80 -64.28 -57.96 7.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.744 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -70.4 -49.38 49.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.794 -179.74 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 99.2 m -51.38 -47.46 62.86 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.906 -179.667 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.489 ' CG2' ' O ' ' A' ' 145' ' ' ALA . 94.2 t -69.54 -34.06 59.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.176 -179.502 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -56.18 -52.9 62.71 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.917 0.389 . . . . 0.0 110.383 -179.683 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . 0.494 ' OD1' ' NE1' ' A' ' 107' ' ' TRP . 3.4 t30 -63.88 -51.25 65.41 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.843 -179.841 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 58.9 t80 -56.27 -29.8 61.6 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.454 -179.282 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . 0.436 ' O ' ' CG ' ' A' ' 157' ' ' ASP . 55.8 t80 -73.02 -52.58 13.84 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.827 -0.349 . . . . 0.0 111.296 -179.464 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . 0.486 ' O ' ' OD1' ' A' ' 157' ' ' ASP . 54.3 t -65.1 -32.44 58.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.593 -179.353 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' TRP . . . . . 0.688 ' CZ2' ' CD1' ' A' ' 107' ' ' TRP . 0.2 OUTLIER -73.4 -42.14 62.46 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.177 -178.559 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . 0.403 ' NE ' ' CA ' ' A' ' 156' ' ' ARG . 0.0 OUTLIER -77.61 -57.04 4.03 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.855 -0.338 . . . . 0.0 110.751 -179.753 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . 0.579 ' OD1' ' N ' ' A' ' 158' ' ' ASN . 39.7 p-10 -48.24 -36.31 13.66 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.962 -0.295 . . . . 0.0 110.76 -179.688 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' ASN . . . . . 0.579 ' N ' ' OD1' ' A' ' 157' ' ' ASP . 8.7 t-20 . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.773 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.4 mtp . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.96 0.409 . . . . 0.0 110.541 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -40.73 140.93 0.97 Allowed 'Trans proline' 0 C--N 1.305 -1.727 0 C-N-CA 122.69 2.26 . . . . 0.0 112.28 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 82.6 mt-10 -73.78 -33.54 64.29 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.441 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 23.3 p -74.25 172.53 11.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.93 -179.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 1.2 t-105 -63.56 112.07 2.64 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.167 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.566 ' N ' ' CD ' ' A' ' 7' ' ' PRO . 0.9 OUTLIER -62.02 -44.97 91.34 Favored Pre-proline 0 CA--C 1.533 0.319 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.316 -179.796 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.566 ' CD ' ' N ' ' A' ' 6' ' ' VAL . 21.3 Cg_exo -57.14 -65.42 0.1 Allowed 'Trans proline' 0 C--N 1.307 -1.655 0 C-N-CA 121.671 1.58 . . . . 0.0 111.585 179.673 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.552 ' O ' ' CG2' ' A' ' 12' ' ' THR . . . -49.23 -41.44 37.38 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.226 -179.632 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.445 ' O ' ' OG1' ' A' ' 12' ' ' THR . 49.7 t -60.53 -62.75 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 120.824 0.345 . . . . 0.0 111.533 -179.07 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -57.78 -52.33 52.74 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 111.456 -0.658 . . . . 0.0 111.456 -179.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 9.5 mp -57.99 -30.38 66.02 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.474 0.178 . . . . 0.0 110.961 -179.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.552 ' CG2' ' O ' ' A' ' 8' ' ' ALA . 20.8 p -79.93 -20.74 44.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.087 0.47 . . . . 0.0 109.766 179.295 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.7 mt -82.0 -22.86 36.32 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.499 179.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 5.4 t -54.35 -54.63 45.99 Favored Pre-proline 0 CA--C 1.535 0.398 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.655 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -57.55 -8.59 4.2 Favored 'Trans proline' 0 N--CA 1.495 1.572 0 C-N-CA 120.935 1.09 . . . . 0.0 111.642 179.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.4 t -75.08 -27.62 60.0 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.124 179.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 63.8 mt -79.45 -43.67 22.84 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.767 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -77.63 -31.74 48.9 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 111.012 -0.835 . . . . 0.0 111.012 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -78.36 -34.76 35.36 Favored Glycine 0 CA--C 1.52 0.379 0 N-CA-C 110.305 -1.118 . . . . 0.0 110.305 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 41.4 t80 -72.01 -58.99 2.98 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 179.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 48.8 tpp -64.61 -28.02 69.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.625 179.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.541 ' C ' ' CZ2' ' A' ' 95' ' ' TRP . . . -65.66 -63.12 4.27 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 111.674 -0.571 . . . . 0.0 111.674 -179.462 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -69.34 -18.2 63.78 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.891 -0.324 . . . . 0.0 111.03 -179.388 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 80.7 t80 -50.6 -24.64 3.41 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.959 0.409 . . . . 0.0 110.045 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 63.5 t80 -69.2 -48.26 62.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.979 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 32.9 m -75.55 -14.24 15.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 C-N-CA 120.73 -0.388 . . . . 0.0 110.768 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.542 ' O ' ' CD1' ' A' ' 31' ' ' LEU . 0.0 OUTLIER -57.79 -44.03 85.98 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.626 179.879 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -112.16 -54.56 0.48 Allowed Glycine 0 CA--C 1.525 0.667 0 N-CA-C 110.978 -0.849 . . . . 0.0 110.978 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -58.99 -27.61 65.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.836 0.351 . . . . 0.0 110.495 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -78.52 -49.05 6.89 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 111.062 -0.815 . . . . 0.0 111.062 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.542 ' CD1' ' O ' ' A' ' 27' ' ' ARG . 95.0 mt -56.7 -34.51 67.5 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.769 0.319 . . . . 0.0 110.541 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 49.4 mtp180 -77.06 -54.21 6.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.669 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -44.96 -41.65 7.48 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.298 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 56.2 t80 -49.44 -31.43 9.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.879 -179.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -66.28 -25.24 66.77 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.678 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -92.67 -67.36 1.1 Allowed Glycine 0 CA--C 1.523 0.573 0 N-CA-C 111.049 -0.82 . . . . 0.0 111.049 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -95.2 166.96 11.65 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.827 0.346 . . . . 0.0 110.561 179.666 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -87.1 112.82 22.29 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.704 -179.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.688 ' NZ ' ' CH2' ' A' ' 107' ' ' TRP . 17.3 mtpt -129.42 153.31 80.57 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.193 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.63 ' C ' ' H ' ' A' ' 42' ' ' TRP . 71.8 Cg_endo -72.82 18.85 0.35 Allowed 'Trans proline' 0 C--N 1.305 -1.725 0 C-N-CA 121.438 1.425 . . . . 0.0 110.668 178.843 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.547 ' H ' ' C ' ' A' ' 39' ' ' LYS . 39.0 t -49.09 -2.53 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.186 -0.915 . . . . 0.0 111.46 -179.784 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . 0.696 ' CZ2' ' CE1' ' A' ' 43' ' ' HIS . 47.7 p-90 -76.35 -15.03 60.06 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.46 -0.496 . . . . 0.0 110.448 -179.587 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.696 ' CE1' ' CZ2' ' A' ' 42' ' ' TRP . 37.4 m80 -61.32 143.91 92.33 Favored Pre-proline 0 C--N 1.332 -0.171 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 178.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.455 ' C ' ' O ' ' A' ' 43' ' ' HIS . 47.1 Cg_exo -34.65 130.09 0.2 Allowed 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 121.237 1.291 . . . . 0.0 111.273 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.567 ' O ' ' N ' ' A' ' 47' ' ' TRP . 16.0 Cg_exo -52.86 155.89 10.22 Favored 'Trans proline' 0 C--N 1.311 -1.398 0 C-N-CA 120.599 0.866 . . . . 0.0 111.929 -179.481 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.45 ' O ' ' CB ' ' A' ' 50' ' ' ALA . 2.1 ppt_? -41.75 -17.24 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.834 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.626 ' CD1' ' N ' ' A' ' 48' ' ' THR . 0.7 OUTLIER -61.14 -50.18 74.24 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 120.658 -0.417 . . . . 0.0 110.94 -179.391 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.626 ' N ' ' CD1' ' A' ' 47' ' ' TRP . 1.0 OUTLIER -90.56 -27.0 19.42 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.632 -179.146 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -83.01 -51.35 7.64 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 120.46 -0.496 . . . . 0.0 111.804 -178.677 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.638 ' C ' ' H ' ' A' ' 52' ' ' ILE . . . -40.13 -29.17 0.2 Allowed Pre-proline 0 N--CA 1.466 0.339 0 N-CA-C 112.129 0.418 . . . . 0.0 112.129 -178.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -52.82 3.0 0.04 OUTLIER 'Trans proline' 0 C--N 1.312 -1.363 0 CA-C-N 119.336 0.799 . . . . 0.0 112.441 178.287 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.638 ' H ' ' C ' ' A' ' 50' ' ' ALA . 7.9 pt -52.51 -40.36 32.77 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.238 0 CA-C-O 121.22 0.534 . . . . 0.0 109.842 179.258 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.456 ' N ' ' CG1' ' A' ' 52' ' ' ILE . 69.7 m95 -73.4 -22.41 60.25 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.157 -179.328 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -67.43 -49.28 52.51 Favored Glycine 0 CA--C 1.527 0.833 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 179.015 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 3.3 m -65.54 -56.95 9.54 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.909 0.385 . . . . 0.0 110.209 179.464 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 83.3 mt -57.18 -26.52 60.76 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.503 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.509 ' C ' ' CD1' ' A' ' 57' ' ' TYR . 2.3 t80 -67.17 -47.63 70.41 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 179.464 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 15.1 m -56.43 -53.62 55.22 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.957 179.331 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -57.98 -41.06 82.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.34 179.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 8.3 mtm -56.71 -58.28 8.78 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.092 179.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -46.95 -44.07 17.92 Favored Glycine 0 CA--C 1.523 0.573 0 N-CA-C 110.696 -0.961 . . . . 0.0 110.696 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -61.72 -59.22 5.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.708 0.29 . . . . 0.0 110.468 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -49.79 -57.34 9.81 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.88 -0.888 . . . . 0.0 110.88 179.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.714 ' HG ' ' HE1' ' A' ' 68' ' ' TRP . 0.3 OUTLIER -45.68 -55.51 6.34 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.958 0.408 . . . . 0.0 110.526 179.803 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.703 ' HH ' ' HZ3' ' A' ' 69' ' ' LYS . 50.0 t80 -48.54 -42.23 32.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.965 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 93.4 mt -66.73 -49.25 76.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.176 -179.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 9.1 t -51.43 -54.54 11.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.907 0.384 . . . . 0.0 111.162 -179.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . 0.714 ' HE1' ' HG ' ' A' ' 64' ' ' SER . 1.7 m95 -65.81 -35.01 79.5 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.097 -179.458 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.703 ' HZ3' ' HH ' ' A' ' 65' ' ' TYR . 7.1 mmmt -65.63 -22.93 66.7 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.653 -0.419 . . . . 0.0 110.349 179.369 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -81.95 -62.68 1.57 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.542 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.492 ' C ' ' CD1' ' A' ' 71' ' ' LEU . 3.1 pp -65.68 -8.96 23.5 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.643 -0.423 . . . . 0.0 110.839 -179.814 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.488 ' O ' ' O ' ' A' ' 73' ' ' GLY . . . 104.6 84.38 1.76 Allowed Glycine 0 CA--C 1.526 0.767 0 C-N-CA 120.994 -0.622 . . . . 0.0 111.77 179.19 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.554 ' N ' ' O ' ' A' ' 68' ' ' TRP . . . 41.91 -174.16 0.01 OUTLIER Glycine 0 CA--C 1.526 0.75 0 N-CA-C 111.795 -0.522 . . . . 0.0 111.795 179.212 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 46.6 t80 -78.7 114.21 17.43 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.866 0.365 . . . . 0.0 110.563 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.58 ' OG1' ' N ' ' A' ' 76' ' ' GLU . 0.0 OUTLIER -142.04 -175.48 4.43 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.423 -179.966 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.58 ' N ' ' OG1' ' A' ' 75' ' ' THR . 4.7 pt-20 -51.3 -25.8 6.42 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.601 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 64.3 t0 -76.12 -31.35 58.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.081 -179.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -83.71 -19.11 35.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.937 -179.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 24.6 mtp -68.24 -27.38 66.31 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.847 -179.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 6.4 t -67.07 -49.39 46.3 Favored Pre-proline 0 CA--C 1.534 0.352 0 CA-C-N 116.438 -0.347 . . . . 0.0 110.729 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_endo -71.77 -58.85 0.07 OUTLIER 'Trans proline' 0 N--CA 1.498 1.74 0 C-N-CA 120.985 1.123 . . . . 0.0 111.721 179.166 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.405 ' HG ' ' CH2' ' A' ' 68' ' ' TRP . 2.8 mt -51.74 -47.59 63.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.781 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -67.88 -64.16 3.3 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 111.204 -0.758 . . . . 0.0 111.204 -179.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 31.4 tp -46.04 -26.71 0.78 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.988 0.423 . . . . 0.0 110.169 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 12.2 t80 -77.23 -41.98 39.12 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.245 179.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 1.3 m -69.52 -43.44 73.04 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.842 -179.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -69.84 -56.79 7.78 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 110.986 -0.846 . . . . 0.0 110.986 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.433 ' O ' ' CB ' ' A' ' 92' ' ' ASN . 3.5 tp60 -53.84 -45.2 70.83 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.9 0.381 . . . . 0.0 110.514 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 11.4 tp -66.19 -33.16 75.14 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.834 -179.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.432 ' O ' ' CB ' ' A' ' 94' ' ' ALA . . . -64.11 -65.68 0.65 Allowed 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 120.256 -0.578 . . . . 0.0 111.291 -179.324 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.9 pp -68.04 -33.37 74.46 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 -178.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.433 ' CB ' ' O ' ' A' ' 88' ' ' GLN . 32.2 t-20 -81.13 -55.11 4.97 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.249 0.463 . . . . 0.0 112.249 -178.444 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . 0.614 ' O ' ' N ' ' A' ' 95' ' ' TRP . 0.0 OUTLIER -73.54 -17.43 61.21 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.699 -0.4 . . . . 0.0 111.773 -178.371 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.432 ' CB ' ' O ' ' A' ' 90' ' ' ALA . . . -52.82 82.04 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 120.473 -0.491 . . . . 0.0 109.911 179.505 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.704 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 38.4 p-90 -97.08 -15.47 0.2 Allowed Pre-proline 0 CA--C 1.536 0.437 0 N-CA-C 112.635 0.605 . . . . 0.0 112.635 -179.16 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.704 ' CD ' ' N ' ' A' ' 95' ' ' TRP . 47.4 Cg_exo -60.39 -18.76 55.09 Favored 'Trans proline' 0 N--CA 1.498 1.744 0 C-N-CA 120.675 0.917 . . . . 0.0 113.663 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.562 ' CD ' ' N ' ' A' ' 96' ' ' PRO . 71.5 Cg_exo -76.76 0.69 9.34 Favored 'Trans proline' 0 N--CA 1.498 1.788 0 C-N-CA 120.534 0.822 . . . . 0.0 113.183 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.486 ' O ' ' N ' ' A' ' 101' ' ' GLY . 1.9 pp -91.76 9.37 3.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 C-N-CA 120.739 -0.385 . . . . 0.0 110.632 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.535 ' CD1' ' O ' ' A' ' 96' ' ' PRO . 2.8 m-30 -40.44 -36.32 0.54 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.678 179.716 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 0.547 ' CD1' ' N ' ' A' ' 100' ' ' PHE . 0.1 OUTLIER -66.9 -35.41 79.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.203 -179.334 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.486 ' N ' ' O ' ' A' ' 98' ' ' ILE . . . -92.89 -4.27 65.28 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 111.402 -0.679 . . . . 0.0 111.402 -179.538 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -65.85 -13.96 60.56 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.683 0.278 . . . . 0.0 110.925 -179.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 16.2 ptt180 -89.26 3.35 52.34 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.832 0.348 . . . . 0.0 110.81 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 9.4 mt-30 -120.61 158.74 26.72 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.362 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' MET . . . . . 0.409 ' N ' ' SD ' ' A' ' 105' ' ' MET . 0.0 OUTLIER -49.31 -18.37 0.36 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.232 179.907 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.566 ' O ' ' N ' ' A' ' 108' ' ' ALA . . . -64.48 -15.68 59.66 Favored Glycine 0 CA--C 1.526 0.764 0 N-CA-C 111.022 -0.831 . . . . 0.0 111.022 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' TRP . . . . . 0.688 ' CH2' ' NZ ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -41.8 -16.59 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 120.619 0.247 . . . . 0.0 111.241 -179.533 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.566 ' N ' ' O ' ' A' ' 106' ' ' GLY . . . -64.0 -17.3 63.18 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.96 0.409 . . . . 0.0 110.514 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 9.9 mt -51.64 -29.99 19.83 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.591 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -58.96 -62.78 1.62 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.644 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.573 ' OD1' ' N ' ' A' ' 112' ' ' LEU . 1.4 p30 -54.72 -53.86 49.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.453 -179.456 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.573 ' N ' ' OD1' ' A' ' 111' ' ' ASP . 31.3 tp -55.94 -40.78 73.66 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.918 -0.313 . . . . 0.0 111.662 -179.112 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 24.9 mt -68.35 -61.3 1.9 Allowed 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.363 0.505 . . . . 0.0 112.363 -178.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.0 pp -61.89 -32.86 73.26 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 120.435 -0.506 . . . . 0.0 111.41 -178.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.55 ' CG2' ' O ' ' A' ' 111' ' ' ASP . 41.8 t -61.86 -55.98 20.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.15 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' SER . . . . . 0.506 ' O ' ' OG1' ' A' ' 120' ' ' THR . 14.8 m -74.56 -22.9 58.76 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.447 -179.222 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -65.2 -62.48 4.87 Favored Glycine 0 CA--C 1.526 0.72 0 C-N-CA 120.809 -0.71 . . . . 0.0 111.419 -179.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.518 ' O ' ' OG1' ' A' ' 122' ' ' THR . 5.4 p -73.64 -35.5 44.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 C-N-CA 121.134 -0.226 . . . . 0.0 111.418 -179.507 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . 0.509 ' O ' ' OG1' ' A' ' 123' ' ' THR . . . -69.76 -60.32 2.39 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.484 -0.487 . . . . 0.0 111.045 -179.457 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.506 ' OG1' ' O ' ' A' ' 116' ' ' SER . 1.9 m -59.28 -50.36 74.28 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.775 0.322 . . . . 0.0 111.34 -179.478 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -56.56 -41.75 77.39 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.464 -179.284 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.518 ' OG1' ' O ' ' A' ' 118' ' ' VAL . 33.9 p -72.44 -25.53 61.49 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.849 -0.34 . . . . 0.0 111.658 -179.238 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.509 ' OG1' ' O ' ' A' ' 119' ' ' ALA . 0.1 OUTLIER -69.55 -47.39 63.82 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.645 -0.422 . . . . 0.0 110.456 -179.747 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.8 pp -83.26 -18.32 39.56 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.18 -179.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -91.91 -65.01 1.04 Allowed 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -178.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 40.3 m0 -85.77 -57.63 2.97 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 113.032 0.753 . . . . 0.0 113.032 -177.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . 0.467 ' CD2' ' N ' ' A' ' 127' ' ' HIS . 15.2 m170 -56.6 -22.6 35.04 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 111.762 0.282 . . . . 0.0 111.762 -178.324 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.51 -37.32 87.14 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 120.897 -0.321 . . . . 0.0 110.798 -179.574 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 47.9 t -101.16 -48.48 11.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.51 -179.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 6.2 t -113.15 108.13 53.25 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.585 -178.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . 0.663 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 73.1 Cg_exo -76.41 -26.6 8.59 Favored 'Trans proline' 0 C--N 1.31 -1.47 0 C-N-CA 121.788 1.659 . . . . 0.0 112.393 178.592 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.663 ' CD ' ' N ' ' A' ' 131' ' ' PRO . 51.0 Cg_exo -61.15 -44.87 21.62 Favored 'Trans proline' 0 N--CA 1.497 1.682 0 C-N-CA 121.485 1.457 . . . . 0.0 112.248 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . 0.405 ' O ' ' N ' ' A' ' 136' ' ' LEU . . . -59.05 -43.25 91.68 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.02 0.438 . . . . 0.0 110.321 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -49.61 -27.28 4.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.039 179.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 7.0 tpt180 -77.96 -29.53 49.84 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.345 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.405 ' N ' ' O ' ' A' ' 133' ' ' ALA . 39.0 mt -74.16 -21.74 59.71 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 178.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.49 ' O ' ' N ' ' A' ' 140' ' ' TYR . 3.3 mt -93.7 -28.29 16.04 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.278 -0.873 . . . . 0.0 110.232 179.455 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.513 ' C ' ' CD1' ' A' ' 138' ' ' TYR . 0.6 OUTLIER -32.3 -50.41 0.55 Allowed Pre-proline 0 CA--C 1.537 0.462 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.586 -179.929 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.412 ' HD2' ' N ' ' A' ' 138' ' ' TYR . 2.7 Cg_endo -61.91 5.94 0.19 Allowed 'Trans proline' 0 N--CA 1.498 1.773 0 C-N-CA 121.476 1.451 . . . . 0.0 112.972 -179.5 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . 0.49 ' N ' ' O ' ' A' ' 137' ' ' LEU . 0.1 OUTLIER -90.41 -15.18 31.45 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.904 0.383 . . . . 0.0 110.891 179.866 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.401 HD23 ' CE1' ' A' ' 140' ' ' TYR . 98.7 mt -59.38 -35.89 74.76 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.216 -0.447 . . . . 0.0 109.922 178.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -56.06 -41.48 75.15 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.768 179.286 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' TRP . . . . . . . . . . . . . 8.4 t-105 -64.65 -44.49 90.26 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.606 179.266 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 19.2 mt -57.33 -43.3 83.27 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.802 179.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -70.26 -26.69 63.94 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.007 179.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 11.1 t80 -60.65 -61.73 2.37 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.647 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.491 ' O ' ' OD1' ' A' ' 151' ' ' ASN . . . -66.55 -50.34 63.47 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 120.696 -0.401 . . . . 0.0 110.615 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' THR . . . . . 0.576 ' O ' ' ND2' ' A' ' 151' ' ' ASN . 17.0 m -48.99 -55.43 11.96 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.626 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 73.1 t -59.46 -35.86 61.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.613 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -51.73 -61.23 2.38 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.628 -0.429 . . . . 0.0 110.083 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . 0.576 ' ND2' ' O ' ' A' ' 148' ' ' THR . 1.3 p-10 -54.34 -47.15 72.87 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.766 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 38.1 t80 -53.23 -40.73 64.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.766 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 37.1 t80 -63.92 -45.92 87.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.912 -179.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 14.6 t -56.6 -51.69 62.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.926 0.393 . . . . 0.0 110.806 -179.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' TRP . . . . . . . . . . . . . 15.9 m0 -52.28 -55.33 22.06 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.225 -179.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -66.65 -19.73 65.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.28 -179.066 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 37.8 t0 -71.1 -52.7 17.84 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.73 0.3 . . . . 0.0 111.164 -179.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . 0.49 ' OD1' ' OG ' ' A' ' 159' ' ' SER . 19.6 p30 -83.1 -25.3 32.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.861 -179.483 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' SER . . . . . 0.49 ' OG ' ' OD1' ' A' ' 158' ' ' ASN . 2.6 p -144.41 100.36 3.52 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.599 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . 0.44 ' O ' ' C ' ' A' ' 161' ' ' ARG . . . -152.73 168.62 31.72 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 111.147 -0.781 . . . . 0.0 111.147 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . 0.44 ' C ' ' O ' ' A' ' 160' ' ' GLY . 87.7 mtt180 36.63 74.25 0.08 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.841 0.353 . . . . 0.0 110.682 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 66.9 mtm180 -104.28 141.37 36.41 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.484 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 147.98 76.85 0.02 OUTLIER Glycine 0 CA--C 1.524 0.635 0 N-CA-C 110.948 -0.861 . . . . 0.0 110.948 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -135.86 -167.18 11.2 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 110.817 -0.913 . . . . 0.0 110.817 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 17.5 m -86.02 179.32 7.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.868 0.366 . . . . 0.0 110.597 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 90.4 mtt180 -107.07 -102.88 0.35 Allowed 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.403 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.451 ' O ' ' O ' ' A' ' 168' ' ' ALA . 11.1 mp -106.83 -66.79 0.99 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.466 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.451 ' O ' ' O ' ' A' ' 167' ' ' LEU . . . 53.83 108.33 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.276 -179.772 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 48.3 mm-40 . . . . . 0 C--O 1.221 -0.422 0 CA-C-O 117.941 -1.028 . . . . 0.0 110.584 -179.865 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' PKA . . . . . 0.553 ' N18' ' H3 ' ' A' ' 201' ' ' PKA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.508 ' O ' ' SD ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.148 0 CA-C-O 120.878 0.371 . . . . 0.0 110.439 . . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -60.14 -165.46 0.03 OUTLIER 'Trans proline' 0 C--N 1.304 -1.796 0 C-N-CA 122.436 2.091 . . . . 0.0 112.033 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -151.02 -19.59 0.21 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.558 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 23.2 t -83.84 130.64 34.92 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.401 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.422 ' O ' ' CG2' ' A' ' 9' ' ' VAL . 0.5 OUTLIER -90.88 117.11 29.23 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.23 -179.953 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.571 ' N ' ' CD ' ' A' ' 7' ' ' PRO . 0.9 OUTLIER -61.43 -42.86 86.99 Favored Pre-proline 0 CA--C 1.532 0.266 0 C-N-CA 120.938 -0.305 . . . . 0.0 110.26 -179.819 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.571 ' CD ' ' N ' ' A' ' 6' ' ' VAL . 24.1 Cg_exo -58.88 -65.1 0.09 OUTLIER 'Trans proline' 0 C--N 1.307 -1.623 0 C-N-CA 121.472 1.448 . . . . 0.0 111.52 179.585 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.553 ' O ' ' CG2' ' A' ' 12' ' ' THR . . . -50.42 -37.74 39.54 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.201 -179.765 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.471 ' O ' ' OG1' ' A' ' 12' ' ' THR . 46.1 t -59.9 -62.45 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.831 0.348 . . . . 0.0 111.376 -179.28 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -61.67 -48.28 85.29 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 111.316 -0.714 . . . . 0.0 111.316 -179.431 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 9.0 mp -60.26 -24.96 65.33 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.49 0.186 . . . . 0.0 111.153 -179.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.553 ' CG2' ' O ' ' A' ' 8' ' ' ALA . 14.4 p -83.92 -29.11 27.39 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.77 -0.372 . . . . 0.0 110.539 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.422 ' O ' ' CB ' ' A' ' 16' ' ' SER . 6.4 mp -78.47 -20.87 49.98 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 179.661 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.473 ' C ' ' H ' ' A' ' 16' ' ' SER . 3.5 t -49.73 -57.63 11.67 Favored Pre-proline 0 CA--C 1.534 0.349 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.739 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.409 ' HD2' ' N ' ' A' ' 14' ' ' VAL . 11.3 Cg_endo -56.5 -4.19 0.75 Allowed 'Trans proline' 0 N--CA 1.497 1.725 0 C-N-CA 120.81 1.007 . . . . 0.0 111.974 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.473 ' H ' ' C ' ' A' ' 14' ' ' VAL . 1.6 t -81.46 -27.81 34.44 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.832 0.348 . . . . 0.0 110.464 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 13.4 mt -71.56 -54.93 8.86 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.671 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -74.02 -35.8 53.08 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 111.035 -0.826 . . . . 0.0 111.035 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -67.27 -33.69 83.34 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 111.011 -0.836 . . . . 0.0 111.011 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -78.14 -60.09 2.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.74 0.305 . . . . 0.0 111.002 -179.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 3.3 ttt -61.95 -23.19 66.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.777 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.405 ' C ' ' CZ2' ' A' ' 95' ' ' TRP . . . -77.94 -60.43 2.75 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 111.681 -0.567 . . . . 0.0 111.681 -179.565 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -66.79 -22.42 66.03 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.857 -179.146 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 88.5 t80 -49.86 -24.15 2.3 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.192 179.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 65.3 t80 -70.56 -52.09 24.05 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.007 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 31.9 m -64.57 -22.59 31.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 C-N-CA 120.826 -0.35 . . . . 0.0 110.697 -179.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.409 ' NH2' ' HE ' ' A' ' 46' ' ' ARG . 16.3 ttt180 -67.66 -31.77 71.98 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.518 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -106.17 -61.41 0.6 Allowed Glycine 0 CA--C 1.525 0.706 0 N-CA-C 111.522 -0.631 . . . . 0.0 111.522 -179.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.45 ' C ' ' OE1' ' A' ' 29' ' ' GLU . 4.2 tm-20 -66.52 -34.48 78.01 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 121.032 -0.267 . . . . 0.0 111.304 -179.471 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -64.73 -58.23 10.56 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 110.932 -0.867 . . . . 0.0 110.932 -179.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 10.9 mp -51.67 -30.11 20.61 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.665 0.269 . . . . 0.0 110.511 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 16.1 tpp180 -78.61 -49.93 12.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.888 -179.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . 0.41 ' O ' ' N ' ' A' ' 36' ' ' GLY . 0.3 OUTLIER -51.4 -29.96 17.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.357 -179.652 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 39.1 t80 -46.28 -35.94 5.76 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.232 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -61.4 -29.03 69.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.486 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.41 ' N ' ' O ' ' A' ' 33' ' ' TRP . . . -89.13 -70.64 1.26 Allowed Glycine 0 CA--C 1.525 0.668 0 N-CA-C 110.851 -0.9 . . . . 0.0 110.851 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -95.21 167.15 11.53 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.912 0.387 . . . . 0.0 110.687 179.606 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 20.1 mt-30 -92.77 114.04 26.48 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.062 -179.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 18.8 mtpt -107.27 160.03 27.95 Favored Pre-proline 0 C--N 1.331 -0.2 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.907 179.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.564 ' O ' ' CD2' ' A' ' 43' ' ' HIS . 10.9 Cg_endo -65.12 96.33 0.27 Allowed 'Trans proline' 0 C--N 1.307 -1.641 0 C-N-CA 122.147 1.898 . . . . 0.0 111.535 179.595 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 4.1 t -60.97 -1.45 0.43 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.474 -0.785 . . . . 0.0 111.54 -179.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . 0.592 ' CD2' ' N ' ' A' ' 42' ' ' TRP . 0.0 OUTLIER -78.17 -15.06 59.18 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.421 -0.512 . . . . 0.0 110.123 -179.405 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.661 ' HD1' ' C2 ' ' A' ' 201' ' ' PKA . 0.3 OUTLIER -79.48 118.88 74.82 Favored Pre-proline 0 CA--C 1.535 0.391 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.38 -179.753 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.446 ' O ' ' C ' ' A' ' 45' ' ' PRO . 71.8 Cg_endo -87.02 150.71 8.29 Favored 'Trans proline' 0 C--N 1.312 -1.381 0 C-N-CA 120.787 0.991 . . . . 0.0 111.084 179.123 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.512 ' O ' ' N ' ' A' ' 47' ' ' TRP . 35.8 Cg_exo -37.4 137.1 0.36 Allowed 'Trans proline' 0 C--N 1.309 -1.534 0 C-N-CA 120.68 0.92 . . . . 0.0 111.435 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.409 ' HE ' ' NH2' ' A' ' 27' ' ' ARG . 1.3 ppt_? -42.31 -17.45 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.545 -179.347 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.563 ' CD1' ' N ' ' A' ' 48' ' ' THR . 0.1 OUTLIER -49.24 -51.58 32.41 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 120.623 -0.431 . . . . 0.0 111.809 -178.841 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.563 ' N ' ' CD1' ' A' ' 47' ' ' TRP . 15.0 t -91.25 -27.26 18.56 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 112.918 0.71 . . . . 0.0 112.918 -179.246 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -80.94 -53.74 6.19 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.447 -0.501 . . . . 0.0 112.133 -177.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.659 ' C ' ' H ' ' A' ' 52' ' ' ILE . . . -39.37 -30.09 0.2 Allowed Pre-proline 0 C--N 1.33 -0.263 0 C-N-CA 120.961 -0.296 . . . . 0.0 111.436 -179.171 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.404 ' HD2' ' N ' ' A' ' 50' ' ' ALA . 28.6 Cg_exo -54.79 7.67 0.03 OUTLIER 'Trans proline' 0 C--N 1.311 -1.44 0 CA-C-N 118.916 0.649 . . . . 0.0 112.57 178.388 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.659 ' H ' ' C ' ' A' ' 50' ' ' ALA . 9.8 pt -56.35 -31.23 32.45 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.242 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 178.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 3.6 m0 -64.58 -24.15 67.5 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.616 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -71.62 -46.59 38.58 Favored Glycine 0 CA--C 1.523 0.551 0 N-CA-C 110.629 -0.988 . . . . 0.0 110.629 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 87.0 m -62.09 -50.21 72.85 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.875 0.369 . . . . 0.0 110.447 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 36.9 mt -69.08 -24.9 64.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.692 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.42 ' C ' ' CD1' ' A' ' 57' ' ' TYR . 1.6 t80 -65.34 -48.43 73.03 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 179.769 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -64.91 -46.13 82.98 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.32 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.61 -48.15 82.81 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.695 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 55.1 mtm -63.22 -36.45 83.7 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.713 -179.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -59.21 -47.29 91.55 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 111.423 -0.671 . . . . 0.0 111.423 -179.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 3.3 m-30 -66.84 -59.85 3.18 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.991 -0.284 . . . . 0.0 110.77 -179.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -50.84 -59.12 8.35 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 110.972 -0.851 . . . . 0.0 110.972 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.584 ' OG ' ' NE1' ' A' ' 68' ' ' TRP . 34.5 t -45.11 -52.04 9.61 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-O 120.986 0.422 . . . . 0.0 110.783 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 70.6 t80 -56.16 -36.64 68.53 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.116 -179.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 70.5 mt -70.83 -48.44 57.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.775 0.321 . . . . 0.0 110.798 -179.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.405 ' CG1' ' CZ3' ' A' ' 68' ' ' TRP . 18.3 t -48.9 -54.69 4.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.0 -179.711 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . 0.586 ' O ' ' N ' ' A' ' 73' ' ' GLY . 0.9 OUTLIER -64.15 -45.22 89.46 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.76 -0.376 . . . . 0.0 111.047 -179.587 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 14.6 mmmt -57.22 -23.28 46.91 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.888 -0.325 . . . . 0.0 110.913 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 24.1 tp10 -82.34 -63.33 1.4 Allowed 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.799 -0.361 . . . . 0.0 110.848 -179.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.503 ' C ' ' CD1' ' A' ' 71' ' ' LEU . 3.0 pp -64.82 -4.36 4.32 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.965 -179.652 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.488 ' O ' ' O ' ' A' ' 73' ' ' GLY . . . 110.95 71.68 0.65 Allowed Glycine 0 CA--C 1.526 0.777 0 C-N-CA 121.177 -0.535 . . . . 0.0 111.817 179.454 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.586 ' N ' ' O ' ' A' ' 68' ' ' TRP . . . 40.93 -173.83 0.01 OUTLIER Glycine 0 CA--C 1.525 0.667 0 CA-C-O 121.365 0.425 . . . . 0.0 112.281 179.077 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 39.4 t80 -70.45 109.84 5.02 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.316 -0.442 . . . . 0.0 110.7 -179.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.526 ' OG1' ' N ' ' A' ' 76' ' ' GLU . 1.5 t -142.89 -173.56 3.93 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.231 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.526 ' N ' ' OG1' ' A' ' 75' ' ' THR . 16.6 mp0 -56.73 -23.17 40.63 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.301 179.625 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -78.48 -29.01 46.5 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.785 -179.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -86.85 -30.67 21.28 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.546 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 66.8 mmm -60.46 -27.11 67.27 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.905 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 17.6 t -65.97 -48.11 61.96 Favored Pre-proline 0 CA--C 1.534 0.33 0 C-N-CA 120.711 -0.396 . . . . 0.0 110.817 -179.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_endo -73.22 -52.87 0.14 Allowed 'Trans proline' 0 N--CA 1.495 1.615 0 C-N-CA 120.727 0.951 . . . . 0.0 111.355 178.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 3.6 mt -51.49 -52.8 43.58 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.333 179.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.5 ' O ' ' N ' ' A' ' 86' ' ' THR . . . -66.65 -64.54 3.26 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 111.332 -0.707 . . . . 0.0 111.332 -179.237 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 34.3 tp -42.01 -28.08 0.16 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.065 0.46 . . . . 0.0 109.994 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.414 ' N ' ' O ' ' A' ' 83' ' ' GLY . 4.3 t80 -77.29 -43.11 34.41 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.061 179.543 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.5 ' N ' ' O ' ' A' ' 83' ' ' GLY . 3.0 m -68.02 -52.78 31.58 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.744 179.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -60.56 -55.9 27.36 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 111.163 -0.775 . . . . 0.0 111.163 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.427 ' O ' ' CB ' ' A' ' 92' ' ' ASN . 52.2 tp60 -55.99 -42.87 77.03 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.799 0.333 . . . . 0.0 110.471 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 10.5 tp -66.01 -28.61 69.0 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.879 0.371 . . . . 0.0 110.125 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.462 ' O ' ' CB ' ' A' ' 94' ' ' ALA . . . -69.35 -65.82 0.66 Allowed 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.095 -0.642 . . . . 0.0 111.225 -179.814 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.7 pp -66.19 -29.16 69.38 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.149 0.426 . . . . 0.0 112.149 -179.01 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.427 ' CB ' ' O ' ' A' ' 88' ' ' GLN . 36.3 t-20 -85.22 -60.91 1.9 Allowed 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 -178.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . 0.609 ' O ' ' N ' ' A' ' 95' ' ' TRP . 0.0 OUTLIER -68.25 -14.78 63.24 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.69 -0.404 . . . . 0.0 111.403 -178.486 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.462 ' CB ' ' O ' ' A' ' 90' ' ' ALA . . . -54.04 80.25 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.137 0 C-N-CA 120.439 -0.505 . . . . 0.0 109.995 179.498 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.711 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 33.8 p-90 -94.44 -16.42 0.21 Allowed Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.24 -0.437 . . . . 0.0 112.061 -179.633 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.711 ' CD ' ' N ' ' A' ' 95' ' ' TRP . 46.9 Cg_exo -56.96 -31.99 91.46 Favored 'Trans proline' 0 N--CA 1.494 1.504 0 CA-C-N 118.921 0.65 . . . . 0.0 112.789 179.366 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.546 ' C ' ' H ' ' A' ' 99' ' ' PHE . 59.6 Cg_exo -50.33 -30.55 26.97 Favored 'Trans proline' 0 N--CA 1.493 1.479 0 CA-C-N 118.969 0.668 . . . . 0.0 112.838 179.736 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.492 ' O ' ' N ' ' A' ' 101' ' ' GLY . 1.2 pp -74.01 20.87 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.022 0.439 . . . . 0.0 110.187 179.662 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.546 ' H ' ' C ' ' A' ' 97' ' ' PRO . 0.9 OUTLIER -39.29 -58.18 1.25 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.038 -179.666 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 4.2 p90 -66.89 -18.04 65.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.143 -179.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.492 ' N ' ' O ' ' A' ' 98' ' ' ILE . . . -86.99 -10.7 71.45 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 111.17 -0.772 . . . . 0.0 111.17 -179.815 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -70.74 -9.4 57.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.56 0.219 . . . . 0.0 111.093 -179.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 10.6 ptm180 -91.97 -5.39 53.16 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.8 0.333 . . . . 0.0 110.734 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 10.0 mt-30 -109.11 160.45 16.05 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.554 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -53.76 -19.25 3.99 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.049 0.452 . . . . 0.0 110.237 179.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.605 ' O ' ' N ' ' A' ' 108' ' ' ALA . . . -65.4 -14.93 60.59 Favored Glycine 0 CA--C 1.523 0.592 0 N-CA-C 111.073 -0.811 . . . . 0.0 111.073 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' TRP . . . . . 0.505 ' NE1' ' OD1' ' A' ' 151' ' ' ASN . 0.0 OUTLIER -42.41 -15.12 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.791 0.329 . . . . 0.0 110.517 -179.663 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.605 ' N ' ' O ' ' A' ' 106' ' ' GLY . . . -58.76 -16.83 18.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.136 0.493 . . . . 0.0 109.85 179.427 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 12.1 mt -58.74 -33.92 70.79 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.569 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -53.8 -61.04 2.56 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.936 0.398 . . . . 0.0 110.898 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.477 ' OD1' ' O ' ' A' ' 108' ' ' ALA . 2.3 p-10 -58.83 -54.89 41.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.733 -179.392 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 43.5 tp -52.82 -43.52 66.01 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.351 -0.386 . . . . 0.0 112.01 -178.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 8.6 mt -66.96 -61.37 1.97 Allowed 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -178.17 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.3 pp -61.23 -35.18 76.52 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.304 -0.558 . . . . 0.0 111.499 -178.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.404 ' CG2' ' O ' ' A' ' 111' ' ' ASP . 41.5 t -60.07 -56.64 16.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.596 -0.274 . . . . 0.0 111.116 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' SER . . . . . 0.498 ' O ' ' OG1' ' A' ' 120' ' ' THR . 58.1 m -72.92 -24.1 60.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.615 -0.266 . . . . 0.0 111.58 -178.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . 0.406 ' O ' ' CB ' ' A' ' 121' ' ' ALA . . . -63.69 -62.73 5.02 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 111.537 -0.625 . . . . 0.0 111.537 -179.285 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.504 ' O ' ' OG1' ' A' ' 122' ' ' THR . 8.7 p -74.03 -34.59 39.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 C-N-CA 120.883 -0.327 . . . . 0.0 111.231 -179.481 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . 0.524 ' O ' ' OG1' ' A' ' 123' ' ' THR . . . -68.95 -60.57 2.27 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.781 -0.367 . . . . 0.0 111.201 -179.429 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.498 ' OG1' ' O ' ' A' ' 116' ' ' SER . 1.4 m -61.47 -48.66 80.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.397 -179.252 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.407 ' O ' ' CB ' ' A' ' 125' ' ' ALA . . . -56.68 -42.01 78.31 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.173 -179.4 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.504 ' OG1' ' O ' ' A' ' 118' ' ' VAL . 35.3 p -71.7 -29.22 64.32 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.948 -0.301 . . . . 0.0 111.567 -179.317 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.524 ' OG1' ' O ' ' A' ' 119' ' ' ALA . 0.1 OUTLIER -67.41 -50.7 58.37 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.584 -0.446 . . . . 0.0 110.577 -179.749 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.0 pp -79.71 -20.39 46.61 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.625 -179.085 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . 0.407 ' CB ' ' O ' ' A' ' 121' ' ' ALA . . . -91.47 -64.72 1.08 Allowed 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.678 0.621 . . . . 0.0 112.678 -178.351 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' TRP . . . . . 0.433 ' N ' ' CD1' ' A' ' 126' ' ' TRP . 40.2 m0 -85.69 -57.08 3.19 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 -177.587 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . 0.471 ' CD2' ' N ' ' A' ' 127' ' ' HIS . 11.3 m170 -57.2 -31.58 65.59 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.795 -0.362 . . . . 0.0 111.919 -178.577 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 18.6 ttt180 -56.98 -38.51 73.11 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.709 -0.396 . . . . 0.0 111.367 -179.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 48.5 t -97.22 -49.56 11.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.793 0.33 . . . . 0.0 111.403 -179.244 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 15.0 t -113.91 108.31 51.25 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.748 -179.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . 0.635 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 82.3 Cg_exo -75.26 -28.07 9.07 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 C-N-CA 121.755 1.637 . . . . 0.0 112.72 179.338 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.635 ' CD ' ' N ' ' A' ' 131' ' ' PRO . 53.5 Cg_exo -57.77 -55.45 2.36 Favored 'Trans proline' 0 N--CA 1.497 1.68 0 C-N-CA 121.142 1.228 . . . . 0.0 111.968 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -49.26 -38.48 27.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.463 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -57.08 -29.04 63.14 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.337 179.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 9.7 tpp85 -76.36 -24.5 54.2 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.335 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 84.6 mt -76.04 -39.73 54.95 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 179.42 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.612 ' O ' ' N ' ' A' ' 140' ' ' TYR . 9.7 mt -77.0 -37.42 55.15 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.791 -0.641 . . . . 0.0 109.823 179.166 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.493 ' C ' ' O ' ' A' ' 137' ' ' LEU . 2.9 t80 -21.0 -44.41 0.04 OUTLIER Pre-proline 0 N--CA 1.467 0.375 0 O-C-N 123.918 0.761 . . . . 0.0 111.828 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.564 ' N ' ' O ' ' A' ' 137' ' ' LEU . 2.0 Cg_endo -67.75 11.55 0.23 Allowed 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 121.026 1.151 . . . . 0.0 112.296 179.554 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . 0.612 ' N ' ' O ' ' A' ' 137' ' ' LEU . 2.4 p90 -93.14 -14.15 27.56 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 121.188 0.518 . . . . 0.0 110.118 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.605 ' CD1' ' CE1' ' A' ' 140' ' ' TYR . 5.2 mp -57.05 -25.91 59.45 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 178.522 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -66.66 -44.51 81.68 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.826 179.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' TRP . . . . . . . . . . . . . 7.9 t-105 -59.77 -48.08 83.13 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 179.358 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.459 ' O ' ' OG1' ' A' ' 148' ' ' THR . 9.1 mt -53.22 -50.96 63.64 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 179.09 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . 0.502 ' O ' ' CG2' ' A' ' 149' ' ' VAL . . . -61.33 -26.58 67.9 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.667 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 25.4 t80 -65.01 -62.43 1.55 Allowed 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.812 -0.355 . . . . 0.0 110.775 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -66.25 -43.38 86.68 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.612 -0.435 . . . . 0.0 110.492 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' THR . . . . . 0.459 ' OG1' ' O ' ' A' ' 144' ' ' LEU . 16.2 m -57.06 -57.62 11.78 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.765 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.502 ' CG2' ' O ' ' A' ' 145' ' ' ALA . 85.4 t -56.95 -32.77 40.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 C-N-CA 120.836 -0.346 . . . . 0.0 110.731 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 1.8 tp -58.39 -48.62 80.03 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.523 -0.471 . . . . 0.0 109.813 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . 0.505 ' OD1' ' NE1' ' A' ' 107' ' ' TRP . 21.1 t30 -69.62 -55.68 9.4 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.528 179.701 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 84.8 t80 -47.49 -39.53 16.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.818 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 25.8 t80 -67.82 -46.59 71.45 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.765 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 93.7 t -61.88 -33.06 56.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.742 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' TRP . . . . . . . . . . . . . 6.3 m0 -67.02 -58.48 4.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.511 179.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -62.94 -19.43 64.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.553 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -80.09 -51.66 8.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.169 -179.547 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 33.5 m-20 -87.15 -40.47 14.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.084 -179.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -79.22 110.34 14.39 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.543 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 120.85 -152.72 16.77 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 111.011 -0.836 . . . . 0.0 111.011 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 19.0 ttt85 48.45 51.73 14.8 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.835 0.35 . . . . 0.0 110.535 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 42.0 mtm180 -81.03 138.87 36.01 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.591 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . 0.485 ' O ' ' O ' ' A' ' 164' ' ' GLY . . . 171.52 -176.17 44.81 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 111.014 -0.834 . . . . 0.0 111.014 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . 0.485 ' O ' ' O ' ' A' ' 163' ' ' GLY . . . 51.6 108.96 0.01 OUTLIER Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.944 -0.862 . . . . 0.0 110.944 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' SER . . . . . 0.406 ' C ' ' OE2' ' A' ' 169' ' ' GLU . 46.3 t -93.25 18.16 9.97 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.91 0.386 . . . . 0.0 110.462 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . 0.462 ' O ' ' N ' ' A' ' 168' ' ' ALA . 94.0 mtt180 -52.72 -176.96 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.575 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.464 ' N ' ' CD1' ' A' ' 167' ' ' LEU . 9.4 mp 59.28 -80.45 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.713 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.462 ' N ' ' O ' ' A' ' 166' ' ' ARG . . . -40.22 -33.61 0.25 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.761 -179.814 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . 0.406 ' OE2' ' C ' ' A' ' 165' ' ' SER . 11.2 mt-10 . . . . . 0 C--O 1.22 -0.455 0 CA-C-O 118.026 -0.987 . . . . 0.0 110.549 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' PKA . . . . . 0.661 ' C2 ' ' HD1' ' A' ' 43' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.65 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 CA--C 1.527 0.089 0 CA-C-O 120.901 0.381 . . . . 0.0 110.64 . . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.467 ' O ' ' CB ' ' A' ' 3' ' ' GLU . 37.3 Cg_endo -98.83 -73.7 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.609 0 C-N-CA 122.343 2.029 . . . . 0.0 112.146 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.467 ' CB ' ' O ' ' A' ' 2' ' ' PRO . 13.0 tt0 80.88 -19.41 0.44 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.416 -179.764 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.405 ' H ' ' C ' ' A' ' 2' ' ' PRO . 30.2 p 53.29 99.0 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.504 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -45.44 116.97 1.27 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.308 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.589 ' N ' ' CD ' ' A' ' 7' ' ' PRO . 0.9 OUTLIER -61.0 -40.77 77.17 Favored Pre-proline 0 C--N 1.33 -0.269 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 -179.919 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.589 ' CD ' ' N ' ' A' ' 6' ' ' VAL . 23.4 Cg_exo -62.82 -64.59 0.07 OUTLIER 'Trans proline' 0 C--N 1.307 -1.649 0 C-N-CA 121.683 1.589 . . . . 0.0 111.388 179.526 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.536 ' O ' ' CG2' ' A' ' 12' ' ' THR . . . -48.9 -30.09 5.47 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.84 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 43.5 t -74.18 -62.8 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.709 0.29 . . . . 0.0 111.658 -179.258 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -58.13 -35.21 76.23 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 111.598 -0.601 . . . . 0.0 111.598 -179.268 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 6.9 mp -73.52 -38.17 65.39 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.621 0.248 . . . . 0.0 110.567 -179.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.536 ' CG2' ' O ' ' A' ' 8' ' ' ALA . 12.3 p -70.16 -20.59 63.13 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.017 0.436 . . . . 0.0 109.86 179.456 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.418 ' O ' ' C ' ' A' ' 14' ' ' VAL . 7.8 mt -80.95 -42.76 20.76 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.695 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.418 ' C ' ' O ' ' A' ' 13' ' ' LEU . 3.1 t -35.71 -66.08 0.27 Allowed Pre-proline 0 CA--C 1.534 0.35 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.997 -179.766 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.421 ' O ' ' N ' ' A' ' 17' ' ' LEU . 27.7 Cg_endo -51.23 -48.04 23.04 Favored 'Trans proline' 0 N--CA 1.498 1.754 0 C-N-CA 120.712 0.941 . . . . 0.0 112.126 -179.515 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 7.5 t -45.06 -21.32 0.06 Allowed 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.793 -0.363 . . . . 0.0 110.726 -179.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.421 ' N ' ' O ' ' A' ' 15' ' ' PRO . 73.2 mt -74.22 -53.37 9.94 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.395 179.77 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -72.01 -23.82 77.42 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 111.11 -0.796 . . . . 0.0 111.11 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -72.1 -49.2 22.64 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 110.952 -0.859 . . . . 0.0 110.952 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 11.2 t80 -67.94 -59.02 3.6 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.831 0.348 . . . . 0.0 110.566 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 8.0 tpp -62.88 -26.95 69.03 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.156 -179.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -77.68 -62.55 2.37 Favored Glycine 0 CA--C 1.526 0.753 0 C-N-CA 120.963 -0.637 . . . . 0.0 111.913 -179.316 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -57.57 -24.79 58.15 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.834 -0.347 . . . . 0.0 110.666 -179.085 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 54.2 t80 -47.82 -24.5 1.0 Allowed 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.769 -0.372 . . . . 0.0 110.11 179.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 21.7 t80 -69.45 -55.78 9.28 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.777 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 33.7 m -60.44 -23.99 29.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 C-N-CA 120.699 -0.4 . . . . 0.0 110.344 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 2.9 tmt_? -66.09 -20.86 66.29 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.631 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -116.29 -75.22 0.57 Allowed Glycine 0 CA--C 1.523 0.569 0 N-CA-C 111.021 -0.832 . . . . 0.0 111.021 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -50.36 -31.68 15.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.654 0.264 . . . . 0.0 110.774 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -72.82 -53.39 8.21 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.81 -0.916 . . . . 0.0 110.81 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 11.0 mp -57.58 -29.94 64.86 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.84 0.352 . . . . 0.0 110.317 179.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 45.0 mtp180 -79.94 -48.92 12.63 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.549 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -52.15 -29.97 24.52 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.013 -0.539 . . . . 0.0 109.923 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 51.1 t80 -48.54 -40.03 25.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.61 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -58.9 -22.52 59.67 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.461 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -94.95 -73.5 1.2 Allowed Glycine 0 CA--C 1.524 0.638 0 N-CA-C 110.721 -0.951 . . . . 0.0 110.721 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -95.52 167.14 11.49 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.711 0.291 . . . . 0.0 110.424 179.494 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 33.3 mt-30 -85.02 115.72 23.0 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.887 0.375 . . . . 0.0 111.168 -179.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 12.0 mtpt -122.78 164.66 25.51 Favored Pre-proline 0 N--CA 1.462 0.168 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 179.276 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.643 ' C ' ' H ' ' A' ' 42' ' ' TRP . 20.4 Cg_endo -80.5 43.53 1.55 Allowed 'Trans proline' 0 C--N 1.306 -1.678 0 C-N-CA 121.743 1.628 . . . . 0.0 111.159 179.358 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -50.89 0.73 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.106 -0.952 . . . . 0.0 111.695 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . 0.643 ' H ' ' C ' ' A' ' 40' ' ' PRO . 39.9 p-90 -76.22 -15.26 60.07 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.479 -0.488 . . . . 0.0 110.923 -178.641 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.595 ' CD2' ' O ' ' A' ' 40' ' ' PRO . 2.9 p80 -77.3 137.09 64.5 Favored Pre-proline 0 C--N 1.326 -0.415 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 179.26 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -55.58 160.51 9.16 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 121.398 1.398 . . . . 0.0 111.793 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -52.01 162.8 1.71 Allowed 'Trans proline' 0 C--N 1.306 -1.69 0 C-N-CA 121.986 1.791 . . . . 0.0 111.79 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.42 ' O ' ' CB ' ' A' ' 50' ' ' ALA . 0.1 OUTLIER -57.82 -25.37 60.54 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.768 -179.171 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.484 ' CD1' ' N ' ' A' ' 48' ' ' THR . 0.0 OUTLIER -66.41 -13.4 60.66 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.348 -0.541 . . . . 0.0 110.77 -179.192 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.484 ' N ' ' CD1' ' A' ' 47' ' ' TRP . 29.5 m -91.79 -57.75 2.64 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.046 -0.525 . . . . 0.0 112.204 -179.236 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.417 ' O ' ' CG2' ' A' ' 52' ' ' ILE . 1.5 mm? -81.18 -28.68 34.88 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 -177.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.59 ' C ' ' H ' ' A' ' 52' ' ' ILE . . . -40.42 -34.97 0.48 Allowed Pre-proline 0 C--N 1.326 -0.416 0 C-N-CA 120.427 -0.509 . . . . 0.0 111.42 -179.143 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.413 ' HD2' ' N ' ' A' ' 50' ' ' ALA . 69.6 Cg_exo -54.26 3.0 0.05 OUTLIER 'Trans proline' 0 C--N 1.314 -1.283 0 C-N-CA 120.644 0.896 . . . . 0.0 112.954 179.257 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.59 ' H ' ' C ' ' A' ' 50' ' ' ALA . 42.1 pt -55.55 -30.27 26.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 121.133 0.492 . . . . 0.0 110.032 179.624 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.413 ' O ' ' CB ' ' A' ' 57' ' ' TYR . 45.7 m95 -81.51 -22.51 37.9 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.413 -179.606 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -72.01 -47.51 31.04 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 109.709 -1.356 . . . . 0.0 109.709 178.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 5.0 m -67.12 -54.98 16.25 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 178.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 92.8 mt -53.76 -39.63 65.52 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.848 -0.614 . . . . 0.0 109.5 179.119 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.42 ' CD1' ' C ' ' A' ' 57' ' ' TYR . 1.3 t80 -54.6 -50.75 67.28 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 179.394 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 5.7 m -52.22 -50.22 62.42 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.223 179.608 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.55 -47.95 82.51 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.574 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 15.4 mtt -56.07 -44.14 78.66 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.461 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -54.59 -55.91 24.82 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 111.155 -0.778 . . . . 0.0 111.155 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -53.65 -54.66 34.59 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.727 0.299 . . . . 0.0 110.448 -179.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -52.53 -56.97 15.18 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 110.824 -0.91 . . . . 0.0 110.824 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.592 ' O ' ' CD1' ' A' ' 68' ' ' TRP . 0.0 OUTLIER -49.19 -50.13 39.48 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.897 0.379 . . . . 0.0 110.324 179.957 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.527 ' HH ' ' HZ3' ' A' ' 69' ' ' LYS . 83.9 t80 -51.43 -38.33 53.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.709 -179.758 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 51.9 mt -71.59 -48.67 51.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.166 -179.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 15.9 t -51.51 -61.35 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.867 0.365 . . . . 0.0 111.334 -179.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . 0.592 ' CD1' ' O ' ' A' ' 64' ' ' SER . 1.5 m95 -60.72 -40.67 93.18 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.339 -179.179 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.527 ' HZ3' ' HH ' ' A' ' 65' ' ' TYR . 10.6 mmmt -64.2 -22.68 67.03 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.847 0.356 . . . . 0.0 110.706 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -82.89 -62.36 1.62 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.671 -179.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.488 ' C ' ' CD1' ' A' ' 71' ' ' LEU . 3.6 pp -65.22 -9.73 25.95 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.962 -179.775 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.484 ' O ' ' O ' ' A' ' 73' ' ' GLY . . . 106.09 85.69 1.83 Allowed Glycine 0 CA--C 1.527 0.788 0 C-N-CA 121.221 -0.514 . . . . 0.0 111.939 179.234 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.484 ' O ' ' O ' ' A' ' 72' ' ' GLY . . . 42.06 -173.72 0.01 OUTLIER Glycine 0 CA--C 1.526 0.719 0 N-CA-C 111.838 -0.505 . . . . 0.0 111.838 179.078 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -85.02 110.93 19.28 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.527 -0.336 . . . . 0.0 110.773 -179.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.524 ' OG1' ' N ' ' A' ' 76' ' ' GLU . 1.7 t -142.53 -173.81 3.97 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.665 179.751 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.524 ' N ' ' OG1' ' A' ' 75' ' ' THR . 6.9 pt-20 -45.45 -34.9 3.4 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.889 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -67.91 -32.65 73.28 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.071 -179.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -83.98 -22.69 31.32 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.844 0.354 . . . . 0.0 110.816 -179.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 4.8 mtp -62.99 -26.63 68.94 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.775 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.2 t -68.67 -52.92 17.4 Favored Pre-proline 0 CA--C 1.534 0.35 0 C-N-CA 120.608 -0.437 . . . . 0.0 110.749 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -65.86 -60.78 0.11 Allowed 'Trans proline' 0 N--CA 1.497 1.678 0 C-N-CA 121.07 1.18 . . . . 0.0 111.703 179.137 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.7 mt -56.77 -56.43 21.55 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.391 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -47.82 -51.37 18.37 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 111.168 -0.773 . . . . 0.0 111.168 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 16.0 tp -62.58 -30.13 71.1 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 121.019 -0.273 . . . . 0.0 110.753 -179.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 23.0 t80 -71.51 -39.11 71.01 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.963 -0.295 . . . . 0.0 110.468 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 8.8 p -64.49 -53.54 46.49 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.802 -0.359 . . . . 0.0 110.656 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -68.04 -58.09 7.85 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 111.527 -0.629 . . . . 0.0 111.527 -179.266 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 52.4 tp60 -49.47 -54.61 16.84 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-O 121.039 0.447 . . . . 0.0 110.551 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.434 ' O ' ' C ' ' A' ' 90' ' ' ALA . 27.1 tp -51.03 -64.4 0.82 Allowed 'General case' 0 C--O 1.209 -1.027 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.906 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.434 ' C ' ' O ' ' A' ' 89' ' ' LEU . . . -38.05 -48.85 1.25 Allowed 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 120.434 -0.506 . . . . 0.0 111.916 -179.561 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 94.1 mt -56.6 -57.17 13.54 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 -178.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.411 ' O ' ' CD2' ' A' ' 113' ' ' LEU . 2.8 m120 -74.21 -55.11 6.43 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 121.415 0.626 . . . . 0.0 111.301 -178.621 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . 0.623 ' O ' ' N ' ' A' ' 95' ' ' TRP . 7.4 t-105 -52.84 -21.92 4.8 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.114 -0.948 . . . . 0.0 111.273 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -60.05 69.27 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.929 0.395 . . . . 0.0 109.948 179.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.685 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 9.9 p-90 -99.94 -17.39 0.2 Allowed Pre-proline 0 CA--C 1.536 0.439 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.73 -179.363 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.685 ' CD ' ' N ' ' A' ' 95' ' ' TRP . 31.8 Cg_exo -62.86 -26.24 74.57 Favored 'Trans proline' 0 N--CA 1.494 1.522 0 C-N-CA 120.442 0.762 . . . . 0.0 112.659 179.193 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.544 ' CD ' ' N ' ' A' ' 96' ' ' PRO . 84.2 Cg_exo -60.1 -25.69 80.49 Favored 'Trans proline' 0 N--CA 1.496 1.638 0 C-N-CA 120.744 0.963 . . . . 0.0 112.781 179.83 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -80.74 33.03 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 121.003 0.43 . . . . 0.0 110.427 179.82 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.443 ' H ' ' C ' ' A' ' 97' ' ' PRO . 1.6 t80 -44.7 -52.92 7.82 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.488 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -73.63 -40.33 63.86 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.673 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -57.14 -15.47 14.69 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 111.135 -0.786 . . . . 0.0 111.135 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -74.64 -7.88 54.62 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.69 0.281 . . . . 0.0 110.837 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.41 -17.12 52.75 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.657 -179.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . 0.536 ' O ' ' N ' ' A' ' 106' ' ' GLY . 5.4 pt20 -110.95 158.06 19.19 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.599 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 6.0 mmt -43.26 -17.32 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.669 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.536 ' N ' ' O ' ' A' ' 104' ' ' GLN . . . -62.78 -15.82 55.32 Favored Glycine 0 CA--C 1.526 0.77 0 N-CA-C 111.122 -0.791 . . . . 0.0 111.122 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' TRP . . . . . 0.481 ' C ' ' CD1' ' A' ' 107' ' ' TRP . 0.0 OUTLIER -47.68 -12.09 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.887 0.375 . . . . 0.0 110.664 -179.881 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.535 ' H ' ' C ' ' A' ' 106' ' ' GLY . . . -62.7 -22.51 66.56 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.082 179.754 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 8.2 mt -53.39 -29.68 35.96 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.297 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -54.91 -64.4 0.85 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.957 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.549 ' OD1' ' N ' ' A' ' 112' ' ' LEU . 1.4 p30 -58.82 -51.1 71.45 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.457 -179.477 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.549 ' N ' ' OD1' ' A' ' 111' ' ' ASP . 39.6 tp -52.48 -47.79 66.31 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.813 -178.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.411 ' CD2' ' O ' ' A' ' 92' ' ' ASN . 17.3 mt -65.81 -62.07 1.71 Allowed 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 -178.002 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.1 pp -58.36 -35.32 71.77 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 120.369 -0.533 . . . . 0.0 111.48 -178.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.535 ' CG2' ' O ' ' A' ' 111' ' ' ASP . 40.2 t -59.56 -61.27 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.132 -179.675 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' SER . . . . . 0.499 ' O ' ' OG1' ' A' ' 120' ' ' THR . 9.0 p -69.22 -22.24 63.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.291 -179.082 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -63.3 -63.02 4.85 Favored Glycine 0 CA--C 1.527 0.841 0 C-N-CA 120.838 -0.696 . . . . 0.0 111.597 -179.284 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.507 ' O ' ' CG2' ' A' ' 122' ' ' THR . 9.9 p -73.07 -37.04 52.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 C-N-CA 120.88 -0.328 . . . . 0.0 111.239 -179.415 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . 0.531 ' O ' ' OG1' ' A' ' 123' ' ' THR . . . -67.58 -60.75 2.31 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.692 -0.403 . . . . 0.0 111.212 -179.563 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.499 ' OG1' ' O ' ' A' ' 116' ' ' SER . 2.3 m -58.42 -53.52 57.36 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.432 -179.339 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.428 ' O ' ' CB ' ' A' ' 125' ' ' ALA . . . -53.76 -41.36 67.06 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.253 -179.345 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.507 ' CG2' ' O ' ' A' ' 118' ' ' VAL . 42.1 p -73.73 -34.05 64.6 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 120.783 -0.367 . . . . 0.0 111.889 -179.12 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.531 ' OG1' ' O ' ' A' ' 119' ' ' ALA . 0.0 OUTLIER -60.27 -56.04 26.38 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 120.555 -0.458 . . . . 0.0 110.938 -179.453 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -79.06 -20.28 49.24 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.323 0.49 . . . . 0.0 112.323 -178.653 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . 0.428 ' CB ' ' O ' ' A' ' 121' ' ' ALA . . . -87.91 -67.83 0.8 Allowed 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 -178.716 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' TRP . . . . . 0.522 ' N ' ' CD1' ' A' ' 126' ' ' TRP . 22.9 m0 -84.61 -57.27 3.2 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 -177.789 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . 0.551 ' CD2' ' N ' ' A' ' 127' ' ' HIS . 5.2 m170 -56.09 -22.3 27.16 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.916 -0.314 . . . . 0.0 111.569 -178.755 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.42 -37.21 84.7 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.856 0.36 . . . . 0.0 110.69 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 74.1 t -96.33 -49.47 12.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.209 -179.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 6.0 t -111.88 108.41 55.7 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.958 -179.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . 0.67 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 73.0 Cg_exo -75.27 -22.11 14.68 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 121.611 1.541 . . . . 0.0 112.379 178.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.67 ' CD ' ' N ' ' A' ' 131' ' ' PRO . 58.8 Cg_exo -67.12 -45.01 4.29 Favored 'Trans proline' 0 N--CA 1.496 1.632 0 C-N-CA 121.42 1.414 . . . . 0.0 112.184 179.782 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -56.3 -37.01 69.31 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.884 0.373 . . . . 0.0 110.459 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -59.72 -24.84 64.33 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.711 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 15.5 ttp-105 -79.32 -30.61 42.9 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.664 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 86.3 mt -71.49 -36.09 71.02 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 179.556 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.58 ' O ' ' N ' ' A' ' 139' ' ' PRO . 6.4 mt -81.47 -39.93 24.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.312 179.548 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.602 ' C ' ' H ' ' A' ' 140' ' ' TYR . 0.7 OUTLIER -17.45 -48.7 0.04 OUTLIER Pre-proline 0 N--CA 1.468 0.47 0 O-C-N 123.921 0.763 . . . . 0.0 111.882 -179.65 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.58 ' N ' ' O ' ' A' ' 137' ' ' LEU . 2.1 Cg_endo -63.74 14.93 0.07 OUTLIER 'Trans proline' 0 C--N 1.308 -1.564 0 C-N-CA 120.91 1.073 . . . . 0.0 111.809 179.518 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . 0.637 ' CE1' ' CD1' ' A' ' 141' ' ' LEU . 7.0 p90 -92.77 -14.34 28.02 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 121.208 0.528 . . . . 0.0 110.26 179.702 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.637 ' CD1' ' CE1' ' A' ' 140' ' ' TYR . 6.7 mp -59.96 -36.76 77.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.301 178.629 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -55.5 -45.42 77.04 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.091 179.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' TRP . . . . . 0.428 ' CZ2' ' CD1' ' A' ' 52' ' ' ILE . 9.1 t-105 -60.63 -51.57 68.84 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 179.537 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 11.4 mt -50.27 -53.58 27.45 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 120.23 -0.588 . . . . 0.0 109.594 179.366 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . 0.544 ' O ' ' CG2' ' A' ' 149' ' ' VAL . . . -59.22 -23.01 61.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.269 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 5.1 t80 -67.07 -63.44 1.06 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.693 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -66.51 -35.6 80.64 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.65 -179.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 9.7 m -65.58 -39.58 91.78 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.868 -0.333 . . . . 0.0 110.371 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.544 ' CG2' ' O ' ' A' ' 145' ' ' ALA . 37.7 t -69.17 -36.55 73.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.198 179.733 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 2.1 tp -58.62 -54.26 49.11 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.044 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . 0.441 ' OD1' ' NE1' ' A' ' 107' ' ' TRP . 14.3 t30 -58.58 -55.21 37.99 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.62 179.688 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 69.6 t80 -50.38 -47.27 56.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.214 -179.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 14.4 t80 -56.08 -43.49 78.07 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.953 -179.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 84.4 t -68.35 -41.28 83.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.486 -0.324 . . . . 0.0 111.141 -179.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' TRP . . . . . . . . . . . . . 5.3 m0 -58.55 -38.17 77.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.617 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . 0.404 ' HE ' ' HA ' ' A' ' 156' ' ' ARG . 0.0 OUTLIER -81.07 -54.91 5.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.931 -179.51 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 33.2 t0 -51.58 -43.91 62.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.191 -179.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . 0.533 ' O ' ' ND2' ' A' ' 158' ' ' ASN . 0.4 OUTLIER -80.7 -10.85 59.7 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.163 -179.444 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' SER . . . . . 0.42 ' C ' ' O ' ' A' ' 158' ' ' ASN . 7.2 m 40.05 85.25 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.792 0.329 . . . . 0.0 110.253 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -77.96 95.23 1.26 Allowed Glycine 0 CA--C 1.525 0.701 0 N-CA-C 111.299 -0.72 . . . . 0.0 111.299 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 77.0 ttt180 -68.01 119.86 13.32 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.77 0.319 . . . . 0.0 110.188 179.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 39.7 ttt180 -91.63 126.69 36.8 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.781 -179.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -171.63 -172.63 37.85 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 110.905 -0.878 . . . . 0.0 110.905 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 151.64 -40.04 0.78 Allowed Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.875 -0.89 . . . . 0.0 110.875 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 16.5 t -178.16 121.54 0.1 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.825 0.345 . . . . 0.0 110.531 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 78.8 mtt-85 -83.98 173.07 11.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.684 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.577 ' N ' ' CD1' ' A' ' 167' ' ' LEU . 0.0 OUTLIER -150.69 22.98 0.79 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.624 179.597 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -102.7 106.48 17.13 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.536 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 . . . . . 0 C--O 1.22 -0.495 0 CA-C-O 118.085 -0.96 . . . . 0.0 110.63 179.934 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' PKA . . . . . 0.54 'CL ' ' C15' ' A' ' 201' ' ' PKA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.5 ttm . . . . . 0 C--O 1.232 0.145 0 CA-C-O 120.863 0.364 . . . . 0.0 110.644 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -60.19 -150.07 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 122.488 2.125 . . . . 0.0 112.027 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -158.53 -51.62 0.06 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.918 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 80.1 p -75.94 135.21 40.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.128 -179.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.438 ' NE1' ' CD1' ' A' ' 68' ' ' TRP . 0.5 OUTLIER -54.21 119.07 4.63 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.165 179.717 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.575 ' N ' ' CD ' ' A' ' 7' ' ' PRO . 0.9 OUTLIER -61.1 -41.81 82.97 Favored Pre-proline 0 CA--C 1.533 0.304 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 179.932 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.575 ' CD ' ' N ' ' A' ' 6' ' ' VAL . 17.3 Cg_exo -62.62 -66.41 0.05 OUTLIER 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 121.579 1.519 . . . . 0.0 111.733 179.478 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.554 ' O ' ' CG2' ' A' ' 12' ' ' THR . . . -48.5 -33.56 9.68 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.339 -179.422 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 39.5 t -69.51 -63.24 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 111.76 0.281 . . . . 0.0 111.76 -178.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -60.53 -45.97 95.28 Favored Glycine 0 CA--C 1.526 0.73 0 C-N-CA 121.195 -0.526 . . . . 0.0 111.84 -179.101 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.402 ' N ' ' CD1' ' A' ' 11' ' ' LEU . 9.3 mp -62.25 -38.31 88.75 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 122.873 -0.193 . . . . 0.0 111.09 -179.264 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.554 ' CG2' ' O ' ' A' ' 8' ' ' ALA . 36.1 p -73.42 -22.55 60.19 Favored 'General case' 0 C--N 1.332 -0.166 0 C-N-CA 120.298 -0.561 . . . . 0.0 109.924 179.268 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.401 ' O ' ' N ' ' A' ' 16' ' ' SER . 5.6 mt -76.5 -30.97 57.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.228 179.671 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.9 t -43.53 -55.09 9.04 Favored Pre-proline 0 CA--C 1.534 0.363 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.788 -179.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -66.19 -17.06 54.03 Favored 'Trans proline' 0 N--CA 1.499 1.796 0 C-N-CA 120.925 1.083 . . . . 0.0 111.825 179.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.401 ' N ' ' O ' ' A' ' 13' ' ' LEU . 1.6 t -75.07 -28.74 60.46 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.551 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 56.5 mt -72.36 -57.82 3.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.433 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -69.78 -21.17 76.46 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 110.865 -0.894 . . . . 0.0 110.865 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -70.59 -54.07 11.08 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 111.008 -0.837 . . . . 0.0 111.008 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 37.7 t80 -70.17 -58.24 4.02 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.787 0.327 . . . . 0.0 110.518 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 20.5 ttp -57.21 -35.99 70.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.762 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -69.78 -62.23 3.94 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 111.121 -0.792 . . . . 0.0 111.121 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -55.55 -17.14 4.83 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.906 0.384 . . . . 0.0 110.31 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 47.4 t80 -51.26 -25.47 5.72 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.277 179.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 71.8 t80 -67.17 -47.29 71.41 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.507 179.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 32.6 m -77.52 -13.94 14.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.379 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.4 tmt_? -67.43 -30.57 70.35 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.743 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -119.45 -69.9 0.32 Allowed Glycine 0 CA--C 1.525 0.691 0 N-CA-C 110.996 -0.841 . . . . 0.0 110.996 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -47.57 -22.63 0.51 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.744 0.307 . . . . 0.0 110.659 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -76.29 -52.15 6.32 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 111.119 -0.792 . . . . 0.0 111.119 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 72.6 mt -53.45 -36.28 61.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.758 0.313 . . . . 0.0 110.625 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 11.3 mmt180 -78.0 -49.89 13.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.809 -179.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -47.53 -31.54 4.45 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 110.101 -0.333 . . . . 0.0 110.101 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.445 ' CD1' ' C ' ' A' ' 34' ' ' TYR . 23.8 t80 -52.82 -39.03 62.09 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.486 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -56.94 -20.77 25.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.28 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -98.01 -73.34 1.11 Allowed Glycine 0 CA--C 1.526 0.749 0 N-CA-C 110.858 -0.897 . . . . 0.0 110.858 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -96.05 166.9 11.54 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 120.938 0.399 . . . . 0.0 110.898 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 6.6 mp0 -84.1 117.08 23.22 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.636 -179.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.539 ' C ' ' H ' ' A' ' 41' ' ' SER . 6.7 mtpt -126.1 149.57 66.97 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.797 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.638 ' C ' ' H ' ' A' ' 42' ' ' TRP . 59.4 Cg_endo -73.23 23.69 0.31 Allowed 'Trans proline' 0 C--N 1.307 -1.62 0 C-N-CA 121.328 1.352 . . . . 0.0 111.387 179.296 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.539 ' H ' ' C ' ' A' ' 39' ' ' LYS . 1.2 t -51.23 -1.69 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.959 179.816 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . 0.638 ' H ' ' C ' ' A' ' 40' ' ' PRO . 41.5 p-90 -77.54 -15.99 58.94 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.564 -0.454 . . . . 0.0 111.093 -179.014 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.494 ' O ' ' ND1' ' A' ' 43' ' ' HIS . 0.0 OUTLIER -80.41 147.86 65.08 Favored Pre-proline 0 C--N 1.328 -0.346 0 C-N-CA 120.209 -0.596 . . . . 0.0 109.475 179.419 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.468 ' C ' ' O ' ' A' ' 43' ' ' HIS . 12.6 Cg_exo -32.95 131.04 0.11 Allowed 'Trans proline' 0 C--N 1.311 -1.396 0 C-N-CA 121.423 1.416 . . . . 0.0 111.877 -179.018 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.48 ' O ' ' N ' ' A' ' 47' ' ' TRP . 72.9 Cg_exo -64.98 163.67 27.63 Favored 'Trans proline' 0 C--N 1.312 -1.347 0 C-N-CA 120.888 1.058 . . . . 0.0 112.681 179.722 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 2.7 ppt_? -44.25 -16.18 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.433 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.55 ' CG ' ' N ' ' A' ' 48' ' ' THR . 3.3 p-90 -52.69 -54.08 38.51 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.166 -0.614 . . . . 0.0 111.609 -177.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.55 ' N ' ' CG ' ' A' ' 47' ' ' TRP . 15.0 t -93.86 -21.49 19.23 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 120.25 -0.58 . . . . 0.0 112.076 179.44 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -81.14 -47.12 13.91 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 112.505 0.557 . . . . 0.0 112.505 -177.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.633 ' C ' ' H ' ' A' ' 52' ' ' ILE . . . -39.85 -33.46 0.33 Allowed Pre-proline 0 C--N 1.327 -0.394 0 C-N-CA 120.675 -0.41 . . . . 0.0 111.539 -179.033 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.408 ' HD2' ' N ' ' A' ' 50' ' ' ALA . 56.9 Cg_exo -54.23 4.1 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.522 0 CA-C-N 118.615 0.541 . . . . 0.0 112.587 178.82 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.633 ' H ' ' C ' ' A' ' 50' ' ' ALA . 45.6 pt -53.52 -31.74 19.65 Favored 'Isoleucine or valine' 0 C--O 1.232 0.151 0 CA-C-O 121.211 0.529 . . . . 0.0 109.766 179.423 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.442 ' O ' ' CB ' ' A' ' 57' ' ' TYR . 48.2 m95 -81.35 -25.6 36.23 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.814 -179.361 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -69.44 -43.52 69.07 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 178.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 17.3 m -69.15 -59.05 3.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.87 0.367 . . . . 0.0 110.115 179.298 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 96.9 mt -54.19 -33.84 59.11 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.208 -0.451 . . . . 0.0 109.99 179.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.442 ' CB ' ' O ' ' A' ' 53' ' ' TRP . 1.7 t80 -59.2 -55.32 36.38 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.751 179.528 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 4.9 t -49.53 -49.66 45.09 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.097 179.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -57.21 -48.38 78.92 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.335 179.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.498 ' O ' ' OG ' ' A' ' 64' ' ' SER . 23.5 mtm -58.17 -33.61 69.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.513 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.501 ' O ' ' OG ' ' A' ' 64' ' ' SER . . . -65.21 -43.23 95.71 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 111.197 -0.761 . . . . 0.0 111.197 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -66.41 -59.99 3.16 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.676 -0.409 . . . . 0.0 110.282 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -52.48 -50.08 49.43 Favored Glycine 0 CA--C 1.522 0.507 0 N-CA-C 110.32 -1.112 . . . . 0.0 110.32 179.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.577 ' O ' ' CE2' ' A' ' 68' ' ' TRP . 6.2 p -45.96 -50.6 14.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.099 0.476 . . . . 0.0 110.321 179.575 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.508 ' H ' ' HG ' ' A' ' 64' ' ' SER . 67.2 t80 -56.48 -40.24 74.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.507 179.745 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 91.5 mt -65.45 -41.87 92.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.926 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 23.4 t -56.56 -53.67 38.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.047 -179.621 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . 0.585 ' O ' ' N ' ' A' ' 73' ' ' GLY . 0.6 OUTLIER -65.27 -35.98 82.71 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 120.577 -0.449 . . . . 0.0 110.839 -179.702 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.42 ' CE ' ' HH ' ' A' ' 65' ' ' TYR . 13.4 mmmt -63.73 -25.85 68.38 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.798 -0.361 . . . . 0.0 110.677 -179.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 23.1 tp10 -82.65 -62.34 1.63 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.471 -179.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.504 ' C ' ' CD1' ' A' ' 71' ' ' LEU . 3.8 pp -68.59 -8.55 42.85 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.834 -0.347 . . . . 0.0 111.489 -179.222 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.479 ' O ' ' O ' ' A' ' 73' ' ' GLY . . . 102.1 83.61 1.74 Allowed Glycine 0 CA--C 1.528 0.891 0 C-N-CA 121.208 -0.52 . . . . 0.0 111.873 179.32 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.585 ' N ' ' O ' ' A' ' 68' ' ' TRP . . . 42.37 -174.08 0.01 OUTLIER Glycine 0 CA--C 1.525 0.683 0 N-CA-C 111.782 -0.527 . . . . 0.0 111.782 179.46 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 38.4 t80 -80.87 110.59 16.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.867 0.365 . . . . 0.0 110.663 -179.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.482 ' OG1' ' N ' ' A' ' 76' ' ' GLU . 2.8 t -142.29 -173.86 3.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.488 179.797 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.482 ' N ' ' OG1' ' A' ' 75' ' ' THR . 2.8 mp0 -47.42 -32.15 4.77 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.679 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 12.8 t0 -71.0 -28.35 64.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.977 -179.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -88.51 -22.92 23.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.8 0.333 . . . . 0.0 110.886 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -66.34 -27.72 68.1 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.723 -179.807 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 8.8 t -68.34 -47.23 37.95 Favored Pre-proline 0 CA--C 1.534 0.338 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.864 -179.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -73.95 -57.03 0.07 OUTLIER 'Trans proline' 0 N--CA 1.499 1.797 0 C-N-CA 121.165 1.243 . . . . 0.0 111.738 179.021 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 7.7 mt -56.02 -51.43 67.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.543 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -60.95 -61.66 6.75 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 110.805 -0.918 . . . . 0.0 110.805 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 58.7 tp -46.96 -33.51 4.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.929 0.395 . . . . 0.0 110.269 179.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.454 ' C ' ' CD1' ' A' ' 85' ' ' TYR . 2.0 t80 -73.89 -47.27 39.23 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.703 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 1.3 m -60.82 -49.0 79.23 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.91 -0.316 . . . . 0.0 111.146 -179.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -69.84 -58.33 6.39 Favored Glycine 0 CA--C 1.527 0.798 0 C-N-CA 120.95 -0.643 . . . . 0.0 111.615 -179.421 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 37.7 tp60 -51.99 -46.28 64.83 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 120.728 -0.389 . . . . 0.0 110.374 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.415 ' O ' ' C ' ' A' ' 90' ' ' ALA . 25.4 tp -53.71 -65.32 0.59 Allowed 'General case' 0 C--O 1.214 -0.803 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 179.566 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.415 ' C ' ' O ' ' A' ' 89' ' ' LEU . . . -38.58 -44.32 0.96 Allowed 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 120.533 -0.467 . . . . 0.0 111.637 -179.64 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 80.3 mt -59.57 -56.86 16.6 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 -178.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 8.7 m-20 -75.89 -54.37 7.01 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 121.286 0.565 . . . . 0.0 111.428 -178.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . 0.677 ' O ' ' N ' ' A' ' 95' ' ' TRP . 3.6 t-105 -52.5 -28.98 22.7 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.265 -0.879 . . . . 0.0 111.583 -179.665 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -52.06 73.38 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.846 0.355 . . . . 0.0 110.727 -179.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.683 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 13.9 p-90 -102.32 -18.7 0.19 Allowed Pre-proline 0 CA--C 1.534 0.332 0 CA-C-N 115.991 -0.55 . . . . 0.0 112.049 -179.621 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.683 ' CD ' ' N ' ' A' ' 95' ' ' TRP . 31.6 Cg_exo -59.79 -31.08 93.47 Favored 'Trans proline' 0 N--CA 1.494 1.502 0 C-N-CA 120.353 0.702 . . . . 0.0 112.819 179.785 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.513 ' C ' ' H ' ' A' ' 99' ' ' PHE . 75.5 Cg_exo -53.36 -28.11 42.2 Favored 'Trans proline' 0 N--CA 1.492 1.436 0 C-N-CA 120.431 0.754 . . . . 0.0 112.583 179.671 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 1.2 pp -75.42 18.79 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 121.167 0.508 . . . . 0.0 110.173 179.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.513 ' H ' ' C ' ' A' ' 97' ' ' PRO . 4.5 t80 -38.98 -41.74 0.79 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.814 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 0.423 ' C ' ' H ' ' A' ' 102' ' ' ALA . 1.6 m-85 -84.59 -44.49 13.46 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.829 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -59.8 -5.37 3.98 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 111.368 -0.693 . . . . 0.0 111.368 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.423 ' H ' ' C ' ' A' ' 100' ' ' PHE . . . -75.95 -13.46 60.25 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 121.016 -0.274 . . . . 0.0 110.971 -179.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 24.2 ptt180 -80.25 3.31 21.27 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.775 0.321 . . . . 0.0 110.639 -179.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 5.2 mt-30 -120.92 160.29 23.79 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.321 179.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -49.4 -19.82 0.59 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.822 0.344 . . . . 0.0 110.205 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.538 ' O ' ' N ' ' A' ' 108' ' ' ALA . . . -65.38 -15.6 61.54 Favored Glycine 0 CA--C 1.527 0.788 0 N-CA-C 111.305 -0.718 . . . . 0.0 111.305 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' TRP . . . . . 0.49 ' CD1' ' N ' ' A' ' 108' ' ' ALA . 0.0 OUTLIER -45.29 -13.6 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.789 0.328 . . . . 0.0 110.844 -179.665 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.538 ' N ' ' O ' ' A' ' 106' ' ' GLY . . . -64.64 -21.84 66.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.511 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 12.1 mt -52.18 -27.16 13.46 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.405 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -55.84 -63.82 1.05 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.345 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.581 ' OD1' ' N ' ' A' ' 112' ' ' LEU . 2.0 p30 -60.37 -51.65 68.6 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.598 -179.609 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.581 ' N ' ' OD1' ' A' ' 111' ' ' ASP . 43.3 tp -52.51 -42.35 64.24 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.552 -178.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 81.5 mt -71.66 -61.93 1.6 Allowed 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.701 0.63 . . . . 0.0 112.701 -178.269 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.8 pp -57.39 -35.18 69.67 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 120.117 -0.633 . . . . 0.0 111.116 -178.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.517 ' CG2' ' O ' ' A' ' 111' ' ' ASP . 54.6 t -62.13 -58.47 7.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.262 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' SER . . . . . 0.412 ' O ' ' OG1' ' A' ' 120' ' ' THR . 3.5 t -68.73 -22.37 64.33 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.79 -178.852 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -68.56 -62.71 3.93 Favored Glycine 0 CA--C 1.526 0.746 0 C-N-CA 121.011 -0.614 . . . . 0.0 111.745 -179.03 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.512 ' O ' ' OG1' ' A' ' 122' ' ' THR . 7.4 p -70.47 -37.73 71.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 C-N-CA 120.967 -0.293 . . . . 0.0 111.354 -179.421 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . 0.527 ' O ' ' OG1' ' A' ' 123' ' ' THR . . . -66.47 -60.78 2.43 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 120.54 -0.464 . . . . 0.0 111.533 -179.21 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.412 ' OG1' ' O ' ' A' ' 116' ' ' SER . 5.0 m -58.38 -55.01 40.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.696 -179.202 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -52.48 -41.69 63.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.349 -179.248 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.512 ' OG1' ' O ' ' A' ' 118' ' ' VAL . 36.5 p -72.19 -32.59 66.94 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.823 -0.351 . . . . 0.0 111.615 -179.156 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.527 ' OG1' ' O ' ' A' ' 119' ' ' ALA . 0.2 OUTLIER -61.55 -50.16 73.79 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.908 0.385 . . . . 0.0 110.868 -179.489 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.6 pp -82.56 -20.0 37.44 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.701 -179.014 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -86.49 -70.69 0.59 Allowed 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 112.659 0.614 . . . . 0.0 112.659 -178.567 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' TRP . . . . . 0.403 ' N ' ' CD1' ' A' ' 126' ' ' TRP . 41.8 m0 -85.18 -58.8 2.54 Favored 'General case' 0 N--CA 1.465 0.325 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 -177.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . 0.433 ' CD2' ' N ' ' A' ' 127' ' ' HIS . 20.2 m170 -47.99 -21.52 0.46 Allowed 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 120.719 -0.392 . . . . 0.0 111.522 -178.546 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 29.6 ttt85 -73.1 -42.48 62.91 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.974 -0.29 . . . . 0.0 111.456 -179.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 6.3 t -92.07 -47.88 13.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.717 0.294 . . . . 0.0 111.332 -179.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 46.2 p -109.59 102.77 51.11 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.817 -179.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . 0.657 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 75.7 Cg_exo -71.05 -26.26 21.77 Favored 'Trans proline' 0 C--N 1.311 -1.444 0 C-N-CA 121.733 1.622 . . . . 0.0 112.465 179.43 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.657 ' CD ' ' N ' ' A' ' 131' ' ' PRO . 38.2 Cg_exo -68.62 -49.43 0.81 Allowed 'Trans proline' 0 N--CA 1.494 1.523 0 C-N-CA 121.496 1.464 . . . . 0.0 111.877 179.796 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . 0.406 ' C ' ' N ' ' A' ' 135' ' ' ARG . . . -46.67 -49.02 19.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.191 179.774 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -46.7 -22.35 0.29 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.031 179.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . 0.406 ' N ' ' C ' ' A' ' 133' ' ' ALA . 5.7 tpp85 -78.41 -39.2 39.63 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.541 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 93.1 mt -68.87 -25.94 64.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.259 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.571 ' O ' ' N ' ' A' ' 140' ' ' TYR . 3.2 mt -89.11 -41.8 12.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.935 179.477 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.549 ' C ' ' H ' ' A' ' 140' ' ' TYR . 0.7 OUTLIER -22.11 -47.68 0.06 OUTLIER Pre-proline 0 N--CA 1.464 0.261 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.782 -179.776 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.483 ' N ' ' O ' ' A' ' 137' ' ' LEU . 3.1 Cg_exo -59.66 5.57 0.12 Allowed 'Trans proline' 0 C--N 1.307 -1.621 0 C-N-CA 121.071 1.18 . . . . 0.0 112.256 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . 0.571 ' N ' ' O ' ' A' ' 137' ' ' LEU . 1.9 p90 -90.78 -15.33 30.31 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 120.705 -0.398 . . . . 0.0 110.644 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.44 ' CD2' ' CE1' ' A' ' 140' ' ' TYR . 2.9 mm? -54.17 -36.0 62.91 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 179.216 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -57.47 -53.98 52.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.378 179.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' TRP . . . . . 0.404 ' CZ2' ' CD1' ' A' ' 52' ' ' ILE . 11.7 t-105 -51.06 -48.9 61.46 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 116.318 -0.401 . . . . 0.0 109.939 179.793 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.457 ' O ' ' OG1' ' A' ' 148' ' ' THR . 11.4 mt -50.09 -48.29 53.35 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 120.533 -0.467 . . . . 0.0 109.832 179.558 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . 0.482 ' O ' ' CG2' ' A' ' 149' ' ' VAL . . . -65.12 -30.52 71.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.699 -179.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 21.0 t80 -58.93 -62.19 2.07 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.73 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.49 ' O ' ' OD1' ' A' ' 151' ' ' ASN . . . -67.74 -50.4 57.51 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.6 -0.44 . . . . 0.0 110.648 -179.708 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' THR . . . . . 0.457 ' OG1' ' O ' ' A' ' 144' ' ' LEU . 27.0 m -48.91 -44.61 40.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.842 -179.854 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.482 ' CG2' ' O ' ' A' ' 145' ' ' ALA . 68.7 t -69.08 -36.11 71.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.127 -179.683 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.406 HD21 ' HE2' ' A' ' 43' ' ' HIS . 0.8 OUTLIER -56.24 -51.5 67.9 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.535 -0.466 . . . . 0.0 110.696 -179.334 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . 0.49 ' OD1' ' O ' ' A' ' 147' ' ' ALA . 4.6 p-10 -65.3 -48.83 71.73 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.945 -0.302 . . . . 0.0 111.055 -179.741 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 82.7 t80 -53.86 -49.17 69.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.931 -179.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . 0.56 ' CE2' ' OD2' ' A' ' 157' ' ' ASP . 79.5 t80 -57.35 -45.56 84.22 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.644 -179.719 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 94.4 t -63.7 -33.68 63.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.096 -179.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' TRP . . . . . 0.517 ' C ' ' HE ' ' A' ' 156' ' ' ARG . 9.5 m0 -62.3 -49.69 74.64 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.647 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . 0.584 ' HE ' ' N ' ' A' ' 156' ' ' ARG . 0.0 OUTLIER -71.02 -32.63 69.44 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.871 -179.639 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . 0.56 ' OD2' ' CE2' ' A' ' 153' ' ' TYR . 2.6 m-20 -74.85 -47.85 28.12 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.823 -179.785 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -70.17 -39.29 75.37 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.61 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 96.6 p -70.89 96.5 1.28 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.471 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -71.15 68.7 0.85 Allowed Glycine 0 CA--C 1.525 0.715 0 N-CA-C 111.199 -0.76 . . . . 0.0 111.199 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 7.3 tpm_? -56.87 -36.58 70.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.867 0.365 . . . . 0.0 110.418 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.2 123.62 12.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.302 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -175.75 176.46 47.49 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 111.02 -0.832 . . . . 0.0 111.02 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . 0.545 ' O ' ' N ' ' A' ' 166' ' ' ARG . . . 57.06 111.5 0.01 OUTLIER Glycine 0 CA--C 1.526 0.779 0 N-CA-C 111.022 -0.831 . . . . 0.0 111.022 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 13.1 t -61.48 70.83 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.766 0.317 . . . . 0.0 110.551 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . 0.545 ' N ' ' O ' ' A' ' 164' ' ' GLY . 68.8 mtp180 58.02 170.0 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.545 -179.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.581 ' N ' ' CD1' ' A' ' 167' ' ' LEU . 0.0 OUTLIER -150.06 17.99 0.87 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.804 179.621 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.467 ' O ' ' C ' ' A' ' 169' ' ' GLU . . . -97.34 88.04 4.31 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.421 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . 0.467 ' C ' ' O ' ' A' ' 168' ' ' ALA . 4.4 pt-20 . . . . . 0 C--O 1.22 -0.459 0 CA-C-O 117.956 -1.021 . . . . 0.0 110.912 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' PKA . . . . . 0.569 'CL ' ' C15' ' A' ' 201' ' ' PKA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 35.1 mtt . . . . . 0 CA--C 1.529 0.14 0 CA-C-O 120.751 0.31 . . . . 0.0 110.446 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -78.4 80.84 2.91 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.05 1.833 . . . . 0.0 112.005 179.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -130.12 -23.86 2.68 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.55 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 20.1 p -143.56 121.59 12.1 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.677 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.406 ' O ' ' CG2' ' A' ' 9' ' ' VAL . 1.3 t-105 -61.53 118.18 6.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.861 179.676 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.465 ' N ' ' CD ' ' A' ' 7' ' ' PRO . 1.0 OUTLIER -59.38 -42.08 90.59 Favored Pre-proline 0 CA--C 1.537 0.464 0 C-N-CA 120.564 -0.454 . . . . 0.0 110.492 -179.439 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.465 ' CD ' ' N ' ' A' ' 6' ' ' VAL . 23.0 Cg_exo -64.9 -65.91 0.05 OUTLIER 'Trans proline' 0 N--CA 1.493 1.498 0 C-N-CA 120.909 1.072 . . . . 0.0 111.611 179.498 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.546 ' O ' ' CG2' ' A' ' 12' ' ' THR . . . -47.46 -37.74 12.29 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.208 -179.581 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.492 ' O ' ' OG1' ' A' ' 12' ' ' THR . 42.4 t -63.12 -62.08 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 C-N-CA 121.048 -0.261 . . . . 0.0 111.404 -179.337 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -58.25 -49.85 72.0 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 110.858 -0.897 . . . . 0.0 110.858 -179.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 10.8 mp -59.08 -27.8 65.88 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.596 0.236 . . . . 0.0 110.65 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.546 ' CG2' ' O ' ' A' ' 8' ' ' ALA . 13.5 p -83.0 -20.73 34.54 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.783 -0.367 . . . . 0.0 110.238 179.566 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 9.3 mt -80.35 -26.42 38.7 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 179.343 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 18.9 t -54.95 -57.38 19.77 Favored Pre-proline 0 CA--C 1.533 0.305 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.033 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -55.84 -10.46 4.04 Favored 'Trans proline' 0 N--CA 1.497 1.711 0 C-N-CA 120.754 0.969 . . . . 0.0 111.651 179.503 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.488 ' N ' ' OH ' ' A' ' 57' ' ' TYR . 1.8 t -74.61 -33.63 62.63 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.19 179.708 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 32.1 mt -73.58 -39.42 64.67 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.63 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -77.04 -49.91 7.23 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 111.263 -0.735 . . . . 0.0 111.263 -179.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -62.58 -34.69 90.28 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 111.306 -0.717 . . . . 0.0 111.306 -179.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 81.8 t80 -73.36 -60.1 2.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.742 0.306 . . . . 0.0 111.102 -179.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 32.4 tpp -61.6 -20.9 63.84 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.74 -179.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.525 ' C ' ' CZ2' ' A' ' 95' ' ' TRP . . . -75.13 -63.76 2.45 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 111.656 -0.577 . . . . 0.0 111.656 -179.533 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -66.3 -16.43 64.03 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.706 -0.397 . . . . 0.0 110.817 -179.474 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 54.2 t80 -48.67 -24.41 1.36 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.111 0.481 . . . . 0.0 110.004 179.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 55.2 t80 -70.1 -50.73 37.91 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.947 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 22.8 m -74.6 -13.29 15.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.877 -179.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.61 ' NE ' ' HE ' ' A' ' 46' ' ' ARG . 8.9 ttt85 -55.7 -41.45 73.78 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.893 -179.795 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -122.51 -57.99 0.2 Allowed Glycine 0 CA--C 1.526 0.746 0 N-CA-C 111.444 -0.663 . . . . 0.0 111.444 -179.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 20.8 tp10 -56.35 -23.0 34.62 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.709 0.29 . . . . 0.0 110.796 -179.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -76.62 -53.69 5.34 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 111.072 -0.811 . . . . 0.0 111.072 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 9.9 mp -56.39 -24.94 48.01 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.774 0.321 . . . . 0.0 110.424 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 71.1 ttt180 -81.55 -52.57 7.07 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.352 179.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -46.59 -36.06 6.51 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.962 179.709 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 27.1 t80 -47.81 -38.82 16.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.599 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -63.51 -24.61 67.89 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.797 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -89.32 -72.08 1.26 Allowed Glycine 0 CA--C 1.526 0.728 0 N-CA-C 110.981 -0.848 . . . . 0.0 110.981 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -95.69 167.17 11.44 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.761 0.315 . . . . 0.0 110.672 179.602 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 47.2 mm-40 -80.91 112.65 18.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.0 -179.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.571 ' NZ ' ' CZ3' ' A' ' 107' ' ' TRP . 12.0 mtpt -129.79 156.54 78.76 Favored Pre-proline 0 N--CA 1.463 0.213 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.214 179.535 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.632 ' C ' ' H ' ' A' ' 42' ' ' TRP . 73.9 Cg_endo -81.43 23.45 0.75 Allowed 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 121.578 1.518 . . . . 0.0 111.189 179.072 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.4 ' H ' ' C ' ' A' ' 39' ' ' LYS . 30.4 m -49.96 -1.27 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.193 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . 0.632 ' H ' ' C ' ' A' ' 40' ' ' PRO . 2.7 p90 -76.19 -15.4 60.06 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.558 -0.457 . . . . 0.0 111.171 -178.787 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.469 ' O ' ' O ' ' A' ' 44' ' ' PRO . 22.5 m-70 -62.95 144.04 97.19 Favored Pre-proline 0 C--N 1.33 -0.262 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 178.836 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.469 ' O ' ' O ' ' A' ' 43' ' ' HIS . 50.7 Cg_exo -32.2 153.74 0.02 OUTLIER 'Trans proline' 0 N--CA 1.492 1.419 0 C-N-CA 121.444 1.429 . . . . 0.0 111.708 -179.199 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -60.68 153.16 64.04 Favored 'Trans proline' 0 C--N 1.308 -1.565 0 C-N-CA 120.644 0.896 . . . . 0.0 111.344 179.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.61 ' HE ' ' NE ' ' A' ' 27' ' ' ARG . 0.0 OUTLIER -50.01 -15.84 0.24 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.307 -179.727 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.556 ' CD1' ' N ' ' A' ' 48' ' ' THR . 0.7 OUTLIER -54.34 -47.87 72.05 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.664 -0.414 . . . . 0.0 111.793 -178.309 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.556 ' N ' ' CD1' ' A' ' 47' ' ' TRP . 8.9 t -91.2 -25.96 19.27 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -179.472 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.418 ' O ' ' C ' ' A' ' 50' ' ' ALA . 0.2 OUTLIER -80.53 -58.84 2.93 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.623 -0.431 . . . . 0.0 111.884 -178.412 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.644 ' C ' ' H ' ' A' ' 52' ' ' ILE . . . -38.74 -31.04 0.19 Allowed Pre-proline 0 C--O 1.234 0.257 0 C-N-CA 120.751 -0.38 . . . . 0.0 111.311 -179.133 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.419 ' HD2' ' N ' ' A' ' 50' ' ' ALA . 46.6 Cg_exo -54.19 5.18 0.04 OUTLIER 'Trans proline' 0 C--N 1.31 -1.471 0 CA-C-N 118.691 0.568 . . . . 0.0 112.422 178.2 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.644 ' H ' ' C ' ' A' ' 50' ' ' ALA . 10.4 pt -54.29 -39.2 42.49 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.258 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 179.344 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.621 ' O ' ' CD1' ' A' ' 57' ' ' TYR . 65.7 m95 -69.32 -24.45 63.92 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.746 -179.583 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -67.83 -53.2 24.65 Favored Glycine 0 CA--C 1.527 0.836 0 N-CA-C 110.013 -1.235 . . . . 0.0 110.013 179.002 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 18.6 m -60.02 -54.73 42.56 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.623 0.249 . . . . 0.0 110.581 179.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.408 ' O ' ' SD ' ' A' ' 60' ' ' MET . 88.5 mt -55.82 -47.96 76.27 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.254 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.621 ' CD1' ' O ' ' A' ' 53' ' ' TRP . 3.6 m-30 -46.19 -47.13 17.79 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 179.31 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 7.0 t -56.77 -57.28 13.14 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.215 179.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -48.7 -50.06 35.1 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.183 179.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.408 ' SD ' ' O ' ' A' ' 56' ' ' LEU . 0.0 OUTLIER -52.05 -50.56 61.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.368 179.828 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -49.13 -48.96 31.46 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 111.338 -0.705 . . . . 0.0 111.338 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -62.17 -59.93 4.32 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.849 0.357 . . . . 0.0 110.85 -179.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -47.47 -56.02 8.67 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 110.93 -0.868 . . . . 0.0 110.93 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.66 ' HG ' ' HE1' ' A' ' 68' ' ' TRP . 0.0 OUTLIER -45.64 -55.28 6.57 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.898 0.38 . . . . 0.0 110.664 -179.929 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.532 ' OH ' ' NZ ' ' A' ' 69' ' ' LYS . 69.1 t80 -49.73 -40.0 39.27 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.804 -179.674 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 77.4 mt -69.3 -54.84 17.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.257 -179.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.509 ' CG1' ' CZ3' ' A' ' 68' ' ' TRP . 18.8 t -46.16 -61.23 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.857 0.36 . . . . 0.0 111.257 -179.39 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . 0.66 ' HE1' ' HG ' ' A' ' 64' ' ' SER . 0.9 OUTLIER -60.68 -42.31 96.84 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.485 -179.124 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.532 ' NZ ' ' OH ' ' A' ' 65' ' ' TYR . 5.8 mmmt -59.13 -31.92 69.39 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.979 -0.288 . . . . 0.0 111.052 -179.697 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 24.2 tp10 -74.81 -62.28 1.59 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.037 -179.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.498 ' C ' ' CD1' ' A' ' 71' ' ' LEU . 3.4 pp -64.33 -8.58 13.54 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.239 -179.344 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.48 ' O ' ' O ' ' A' ' 73' ' ' GLY . . . 110.35 77.51 0.93 Allowed Glycine 0 CA--C 1.527 0.826 0 C-N-CA 121.014 -0.612 . . . . 0.0 111.98 179.359 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.511 ' N ' ' O ' ' A' ' 68' ' ' TRP . . . 41.56 -173.57 0.01 OUTLIER Glycine 0 CA--C 1.526 0.749 0 C-N-CA 121.504 -0.379 . . . . 0.0 112.165 178.842 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 36.0 t80 -74.48 113.05 11.27 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.382 -0.409 . . . . 0.0 110.715 -179.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.569 ' OG1' ' N ' ' A' ' 76' ' ' GLU . 0.4 OUTLIER -142.38 -175.02 4.29 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.256 179.713 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.569 ' N ' ' OG1' ' A' ' 75' ' ' THR . 2.7 mp0 -55.08 -34.22 63.45 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.916 0.389 . . . . 0.0 110.4 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -66.29 -33.06 74.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.67 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -83.91 -19.09 35.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.046 0.45 . . . . 0.0 110.748 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 65.0 mmm -68.93 -27.07 65.43 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.22 -179.344 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 6.0 t -67.45 -43.51 42.48 Favored Pre-proline 0 C--N 1.329 -0.322 0 C-N-CA 120.673 -0.411 . . . . 0.0 110.413 179.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -76.31 -52.18 0.09 OUTLIER 'Trans proline' 0 N--CA 1.496 1.673 0 C-N-CA 121.047 1.165 . . . . 0.0 111.508 178.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 5.5 mt -56.03 -47.14 78.39 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.277 179.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -68.28 -63.83 3.4 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 111.318 -0.713 . . . . 0.0 111.318 -179.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 38.5 tp -47.91 -23.79 0.86 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.941 0.4 . . . . 0.0 110.57 -179.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 11.8 t80 -74.8 -55.57 5.68 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.009 -179.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 1.9 t -68.53 -33.22 73.73 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.903 -0.319 . . . . 0.0 111.479 -179.282 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -71.6 -57.85 5.74 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 111.205 -0.758 . . . . 0.0 111.205 -179.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 29.2 tp60 -59.57 -43.85 93.49 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 11.1 tp -58.13 -38.57 76.8 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 179.241 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.48 ' O ' ' CB ' ' A' ' 94' ' ' ALA . . . -58.36 -64.48 0.9 Allowed 'General case' 0 C--N 1.319 -0.754 0 C-N-CA 120.062 -0.655 . . . . 0.0 110.435 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.401 HD22 ' N ' ' A' ' 91' ' ' LEU . 6.2 mt -58.69 -56.48 21.64 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 -178.688 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -66.43 -62.12 1.63 Allowed 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -177.755 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . 0.596 ' C ' ' CD1' ' A' ' 93' ' ' TRP . 0.0 OUTLIER -63.54 -16.89 62.05 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 -177.913 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.48 ' CB ' ' O ' ' A' ' 90' ' ' ALA . . . -54.63 82.19 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 120.286 -0.566 . . . . 0.0 109.868 179.155 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.688 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 19.8 p-90 -100.81 -15.71 0.18 Allowed Pre-proline 0 CA--C 1.533 0.307 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -179.488 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.688 ' CD ' ' N ' ' A' ' 95' ' ' TRP . 52.9 Cg_exo -61.08 -15.22 37.97 Favored 'Trans proline' 0 N--CA 1.497 1.7 0 C-N-CA 120.471 0.781 . . . . 0.0 113.403 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.614 ' CD ' ' N ' ' A' ' 96' ' ' PRO . 31.6 Cg_exo -87.08 -0.38 7.77 Favored 'Trans proline' 0 N--CA 1.5 1.867 0 C-N-CA 120.659 0.906 . . . . 0.0 112.928 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.413 ' O ' ' N ' ' A' ' 101' ' ' GLY . 1.3 pp -91.86 25.19 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 C-N-CA 120.73 -0.388 . . . . 0.0 110.833 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.528 ' CD1' ' O ' ' A' ' 96' ' ' PRO . 3.0 m-85 -46.8 -34.46 5.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.167 179.687 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -63.13 -27.39 69.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.786 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.413 ' N ' ' O ' ' A' ' 98' ' ' ILE . . . -95.73 -13.52 50.19 Favored Glycine 0 CA--C 1.526 0.743 0 N-CA-C 110.902 -0.879 . . . . 0.0 110.902 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -70.49 -6.73 38.2 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.613 0.244 . . . . 0.0 111.018 -179.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 15.5 ptt180 -97.97 -10.08 25.08 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.065 -179.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . 0.438 ' C ' ' N ' ' A' ' 106' ' ' GLY . 3.2 pt20 -125.49 168.94 12.93 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.832 0.348 . . . . 0.0 110.781 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 9.8 mmt -45.19 -20.2 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.679 -179.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.446 ' C ' ' H ' ' A' ' 108' ' ' ALA . . . -62.26 -15.69 51.94 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 111.102 -0.799 . . . . 0.0 111.102 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' TRP . . . . . 0.571 ' CZ3' ' NZ ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -50.2 -13.42 0.11 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.742 0.306 . . . . 0.0 110.702 -179.596 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.468 ' N ' ' CD1' ' A' ' 107' ' ' TRP . . . -64.73 -19.58 65.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.075 0.464 . . . . 0.0 110.105 179.638 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 8.2 mt -57.04 -26.04 59.64 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.531 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -59.4 -58.66 7.62 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.569 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.553 ' O ' ' CG2' ' A' ' 115' ' ' VAL . 1.3 p30 -62.07 -52.21 64.84 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.303 -179.617 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.524 ' N ' ' CG ' ' A' ' 111' ' ' ASP . 31.7 tp -54.95 -37.4 66.42 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.919 -0.313 . . . . 0.0 111.618 -179.099 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 49.4 mt -72.8 -61.57 1.76 Allowed 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -178.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.5 pp -59.66 -32.52 70.54 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 120.24 -0.584 . . . . 0.0 110.955 -179.047 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.553 ' CG2' ' O ' ' A' ' 111' ' ' ASP . 53.5 t -64.16 -60.14 3.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.405 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' SER . . . . . 0.485 ' O ' ' OG1' ' A' ' 120' ' ' THR . 50.3 m -68.41 -28.31 66.97 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.555 -178.84 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -63.08 -62.24 5.63 Favored Glycine 0 CA--C 1.526 0.759 0 C-N-CA 120.973 -0.632 . . . . 0.0 111.769 -179.348 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.502 ' O ' ' OG1' ' A' ' 122' ' ' THR . 9.3 p -70.94 -37.99 70.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 111.667 0.247 . . . . 0.0 111.667 -179.231 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . 0.522 ' O ' ' OG1' ' A' ' 123' ' ' THR . . . -68.25 -60.8 2.19 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.446 -0.502 . . . . 0.0 111.002 -179.404 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.485 ' OG1' ' O ' ' A' ' 116' ' ' SER . 3.7 m -56.35 -55.87 28.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.44 -179.49 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -51.58 -43.92 62.61 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.404 -179.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.502 ' OG1' ' O ' ' A' ' 118' ' ' VAL . 41.4 p -71.91 -25.25 61.84 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.054 0.39 . . . . 0.0 112.054 -178.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.522 ' OG1' ' O ' ' A' ' 119' ' ' ALA . 0.2 OUTLIER -69.28 -49.99 51.0 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.631 -0.428 . . . . 0.0 110.516 -179.636 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.4 pp -79.34 -19.94 49.05 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.246 -179.475 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -89.77 -67.37 0.85 Allowed 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.734 0.642 . . . . 0.0 112.734 -178.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' TRP . . . . . 0.458 ' N ' ' CD1' ' A' ' 126' ' ' TRP . 34.1 m0 -84.82 -57.54 3.07 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 112.87 0.693 . . . . 0.0 112.87 -177.785 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . 0.477 ' CD2' ' N ' ' A' ' 127' ' ' HIS . 9.6 m170 -53.98 -22.29 10.08 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.731 -0.388 . . . . 0.0 111.517 -178.703 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 29.2 ttt85 -73.76 -46.47 45.5 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.822 -0.351 . . . . 0.0 111.416 -179.474 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 39.1 t -81.36 -40.62 18.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.73 0.3 . . . . 0.0 111.313 -179.229 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 3.6 t -138.38 121.66 11.15 Favored Pre-proline 0 CA--C 1.536 0.428 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.541 -179.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . 0.612 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 83.4 Cg_exo -73.61 -48.35 0.25 Allowed 'Trans proline' 0 N--CA 1.493 1.488 0 C-N-CA 121.32 1.347 . . . . 0.0 113.212 179.529 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.612 ' CD ' ' N ' ' A' ' 131' ' ' PRO . 31.2 Cg_exo -33.63 -55.97 0.41 Allowed 'Trans proline' 0 N--CA 1.497 1.73 0 C-N-CA 121.583 1.522 . . . . 0.0 112.177 -179.222 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -47.48 -46.69 27.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.862 0.363 . . . . 0.0 110.384 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . 0.413 ' N ' ' O ' ' A' ' 131' ' ' PRO . . . -55.21 -22.72 18.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.406 179.815 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 10.2 tpt180 -77.28 -29.63 53.88 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-O 120.937 0.399 . . . . 0.0 110.342 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 39.4 mt -75.92 -33.97 59.88 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 179.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.461 ' O ' ' CD1' ' A' ' 140' ' ' TYR . 4.3 mt -85.56 -23.31 27.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.341 179.778 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.551 ' C ' ' CD1' ' A' ' 138' ' ' TYR . 0.3 OUTLIER -36.65 -53.9 1.74 Allowed Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.323 -179.881 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.418 ' HD2' ' N ' ' A' ' 138' ' ' TYR . 8.2 Cg_endo -60.79 3.41 0.29 Allowed 'Trans proline' 0 N--CA 1.498 1.755 0 C-N-CA 121.481 1.454 . . . . 0.0 113.057 -179.415 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . 0.461 ' CD1' ' O ' ' A' ' 137' ' ' LEU . 0.1 OUTLIER -82.79 -14.3 54.67 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.489 -0.484 . . . . 0.0 110.954 -179.96 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 86.8 mt -59.14 -25.25 63.72 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 178.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -64.13 -39.84 94.89 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.631 179.224 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' TRP . . . . . 0.507 ' CZ2' ' CD1' ' A' ' 52' ' ' ILE . 11.6 t-105 -70.08 -40.78 74.81 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.723 179.441 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.401 HD12 ' CZ ' ' A' ' 140' ' ' TYR . 10.3 mt -62.48 -42.02 99.2 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 120.403 -0.519 . . . . 0.0 109.712 179.739 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . 0.537 ' O ' ' CG2' ' A' ' 149' ' ' VAL . . . -73.03 -21.91 60.73 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.776 179.268 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 32.2 t80 -64.85 -58.58 5.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.481 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.558 ' O ' ' ND2' ' A' ' 151' ' ' ASN . . . -68.5 -44.15 75.34 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.567 179.867 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' THR . . . . . 0.478 ' O ' ' OD1' ' A' ' 151' ' ' ASN . 51.3 m -57.27 -37.3 72.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.411 179.851 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.537 ' CG2' ' O ' ' A' ' 145' ' ' ALA . 55.0 t -75.8 -30.2 21.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.416 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 2.3 tp -61.39 -57.49 12.04 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 179.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . 0.558 ' ND2' ' O ' ' A' ' 147' ' ' ALA . 1.8 p30 -63.81 -42.36 97.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.632 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 60.8 t80 -56.65 -45.86 81.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.552 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 9.5 t80 -63.18 -36.72 84.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.477 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 55.5 t -67.36 -34.0 66.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.632 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' TRP . . . . . . . . . . . . . 10.9 m0 -68.7 -41.12 79.57 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.791 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . 0.487 ' O ' ' O ' ' A' ' 159' ' ' SER . 0.3 OUTLIER -72.63 -35.61 67.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.865 -179.659 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -75.18 -43.03 54.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.878 -179.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . 0.402 ' OD1' ' N ' ' A' ' 158' ' ' ASN . 1.5 m-20 -79.07 -4.02 48.18 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.872 -179.711 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' SER . . . . . 0.487 ' O ' ' O ' ' A' ' 156' ' ' ARG . 6.6 t -149.49 -161.5 1.36 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.534 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 81.35 47.18 6.56 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 110.98 -0.848 . . . . 0.0 110.98 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 24.5 ttt-85 -42.67 122.82 2.44 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.795 0.331 . . . . 0.0 110.612 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 15.6 mtm180 -99.08 145.55 27.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.508 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -79.44 145.52 27.95 Favored Glycine 0 CA--C 1.524 0.602 0 N-CA-C 111.025 -0.83 . . . . 0.0 111.025 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 75.95 -176.8 50.87 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 111.123 -0.791 . . . . 0.0 111.123 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 25.7 t -147.13 113.54 5.95 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.808 0.337 . . . . 0.0 110.429 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . 0.523 ' O ' ' N ' ' A' ' 168' ' ' ALA . 3.5 tpt180 -49.98 167.05 0.06 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.548 -179.795 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 10.8 mp 58.48 -77.72 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.657 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.523 ' N ' ' O ' ' A' ' 166' ' ' ARG . . . -55.65 -15.17 2.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.667 -179.82 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 . . . . . 0 C--O 1.219 -0.526 0 CA-C-O 118.007 -0.997 . . . . 0.0 110.595 179.965 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' PKA . . . . . 0.562 ' N18' ' H3 ' ' A' ' 201' ' ' PKA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.641 ' N ' ' CD ' ' A' ' 2' ' ' PRO . 0.4 OUTLIER . . . . . 0 CA--C 1.53 0.206 0 CA-C-O 120.63 0.252 . . . . 0.0 110.783 . . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.641 ' CD ' ' N ' ' A' ' 1' ' ' MET . 43.3 Cg_exo -70.11 123.51 10.05 Favored 'Trans proline' 0 N--CA 1.495 1.56 0 C-N-CA 121.969 1.779 . . . . 0.0 112.385 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.429 ' C ' ' HG ' ' A' ' 4' ' ' SER . 65.8 mt-10 -87.73 -26.29 23.01 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.143 179.603 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.429 ' HG ' ' C ' ' A' ' 3' ' ' GLU . 44.4 m -150.03 -175.78 5.19 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.612 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.473 ' O ' ' CG2' ' A' ' 9' ' ' VAL . 0.5 OUTLIER -49.39 117.98 2.49 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.301 -179.975 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.619 ' N ' ' CD ' ' A' ' 7' ' ' PRO . 1.0 OUTLIER -63.68 -38.71 40.53 Favored Pre-proline 0 CA--C 1.533 0.289 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 179.927 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.619 ' CD ' ' N ' ' A' ' 6' ' ' VAL . 15.4 Cg_exo -66.9 -66.18 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 121.891 1.727 . . . . 0.0 111.735 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.54 ' O ' ' CG2' ' A' ' 12' ' ' THR . . . -47.65 -40.63 20.28 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.173 -179.76 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.488 ' O ' ' OG1' ' A' ' 12' ' ' THR . 59.2 t -61.11 -61.86 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.238 -179.354 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -57.88 -51.75 56.34 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 111.495 -0.642 . . . . 0.0 111.495 -179.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 9.4 mp -57.78 -31.81 66.91 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.572 0.225 . . . . 0.0 110.96 -179.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.54 ' CG2' ' O ' ' A' ' 8' ' ' ALA . 16.8 p -77.33 -24.81 50.75 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.862 0.363 . . . . 0.0 110.121 179.639 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.427 ' O ' ' CB ' ' A' ' 16' ' ' SER . 6.2 mt -80.12 -27.32 39.17 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.363 179.811 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 4.5 t -48.55 -59.64 5.81 Favored Pre-proline 0 CA--C 1.535 0.38 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.718 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -54.98 -12.38 4.85 Favored 'Trans proline' 0 N--CA 1.498 1.746 0 C-N-CA 121.056 1.171 . . . . 0.0 111.96 179.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.427 ' CB ' ' O ' ' A' ' 13' ' ' LEU . 1.6 t -73.5 -30.49 63.16 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.66 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 59.5 mt -74.3 -56.73 4.54 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.664 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -64.83 -34.3 89.52 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 110.802 -0.919 . . . . 0.0 110.802 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -74.88 -28.51 62.59 Favored Glycine 0 CA--C 1.521 0.433 0 N-CA-C 110.614 -0.994 . . . . 0.0 110.614 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 48.8 t80 -74.99 -60.43 2.29 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 110.177 -0.305 . . . . 0.0 110.177 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 19.2 ttp -65.53 -25.1 67.29 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.397 179.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.471 ' C ' ' CZ2' ' A' ' 95' ' ' TRP . . . -68.2 -62.13 4.39 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 110.819 -0.912 . . . . 0.0 110.819 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -70.62 -16.62 62.85 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.993 -0.283 . . . . 0.0 110.397 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 68.5 t80 -47.81 -24.49 0.99 Allowed 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 179.403 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.451 ' CD1' ' C ' ' A' ' 25' ' ' PHE . 22.8 t80 -67.99 -53.57 25.01 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.667 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 34.1 m -71.43 -13.46 16.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.702 -179.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.3 ttp180 -63.31 -46.16 87.97 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.992 -179.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -105.42 -77.99 1.17 Allowed Glycine 0 CA--C 1.525 0.696 0 N-CA-C 111.197 -0.761 . . . . 0.0 111.197 -179.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 53.3 tt0 -44.42 -23.08 0.09 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.698 0.285 . . . . 0.0 110.808 -179.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -66.51 -58.49 8.48 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 110.989 -0.845 . . . . 0.0 110.989 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 11.1 mt -51.99 -21.74 3.36 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.836 0.35 . . . . 0.0 110.365 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 16.2 tpp180 -84.79 -54.03 4.95 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.524 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . 0.432 ' O ' ' N ' ' A' ' 36' ' ' GLY . 0.4 OUTLIER -44.95 -46.77 11.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.551 -179.756 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 46.5 t80 -47.23 -35.58 7.82 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.9 0.381 . . . . 0.0 110.373 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.61 -25.33 68.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.354 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.432 ' N ' ' O ' ' A' ' 33' ' ' TRP . . . -92.72 -68.74 1.12 Allowed Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.892 -0.883 . . . . 0.0 110.892 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -95.75 166.18 11.94 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.793 0.33 . . . . 0.0 110.583 179.712 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.559 ' H ' ' CD ' ' A' ' 38' ' ' GLN . 0.5 OUTLIER -86.63 113.0 22.15 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.861 -179.578 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.643 ' NZ ' ' CH2' ' A' ' 107' ' ' TRP . 22.1 mtpt -129.13 156.71 77.79 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.197 179.812 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.656 ' C ' ' H ' ' A' ' 42' ' ' TRP . 89.6 Cg_endo -73.46 18.13 0.42 Allowed 'Trans proline' 0 C--N 1.307 -1.654 0 C-N-CA 121.814 1.676 . . . . 0.0 110.803 178.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.54 ' H ' ' C ' ' A' ' 39' ' ' LYS . 21.7 t -48.52 -1.12 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.246 -0.888 . . . . 0.0 111.442 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . 0.656 ' H ' ' C ' ' A' ' 40' ' ' PRO . 44.6 p-90 -75.24 -15.12 60.56 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.341 -0.543 . . . . 0.0 110.318 -179.297 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.643 ' NE2' ' CH2' ' A' ' 42' ' ' TRP . 6.6 m-70 -61.49 140.69 94.85 Favored Pre-proline 0 C--N 1.331 -0.206 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 178.218 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.468 ' C ' ' O ' ' A' ' 43' ' ' HIS . 11.0 Cg_endo -32.51 149.01 0.02 OUTLIER 'Trans proline' 0 N--CA 1.496 1.635 0 C-N-CA 121.405 1.403 . . . . 0.0 111.683 -179.227 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -59.39 155.61 40.23 Favored 'Trans proline' 0 C--N 1.312 -1.344 0 C-N-CA 121.12 1.213 . . . . 0.0 112.088 -179.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -53.14 -18.37 2.16 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.675 -179.296 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.566 ' CD1' ' N ' ' A' ' 48' ' ' THR . 1.0 OUTLIER -49.46 -47.5 48.32 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.092 -0.643 . . . . 0.0 110.897 -178.898 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.566 ' N ' ' CD1' ' A' ' 47' ' ' TRP . 13.2 t -91.95 -24.82 19.14 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.052 0.39 . . . . 0.0 112.052 -179.732 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.425 ' O ' ' N ' ' A' ' 51' ' ' PRO . 0.1 OUTLIER -80.23 -62.35 1.7 Allowed 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -178.215 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.67 ' C ' ' H ' ' A' ' 52' ' ' ILE . . . -37.83 -31.0 0.15 Allowed Pre-proline 0 C--O 1.237 0.402 0 C-N-CA 121.113 -0.235 . . . . 0.0 111.218 -179.04 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.425 ' N ' ' O ' ' A' ' 49' ' ' LEU . 32.9 Cg_exo -55.62 8.99 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.659 0 CA-C-N 118.425 0.473 . . . . 0.0 112.204 178.11 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.67 ' H ' ' C ' ' A' ' 50' ' ' ALA . 12.1 pt -55.71 -27.36 21.73 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 178.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 3.2 m0 -64.62 -30.02 71.03 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.783 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -72.98 -46.93 26.72 Favored Glycine 0 CA--C 1.522 0.519 0 N-CA-C 111.027 -0.829 . . . . 0.0 111.027 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 91.2 m -61.53 -53.37 57.28 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.74 0.305 . . . . 0.0 110.59 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 57.5 mt -64.91 -28.68 69.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.506 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.528 ' C ' ' CD1' ' A' ' 57' ' ' TYR . 1.6 t80 -63.6 -41.62 98.32 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 179.455 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 26.1 t -68.02 -49.43 61.55 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.42 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.67 -46.07 88.02 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.758 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.496 ' O ' ' OG ' ' A' ' 64' ' ' SER . 21.3 mtm -65.45 -33.14 75.25 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.31 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -63.35 -49.68 68.49 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 111.324 -0.71 . . . . 0.0 111.324 -179.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -63.15 -60.06 3.93 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 121.07 -0.252 . . . . 0.0 110.739 -179.652 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -52.58 -52.08 39.94 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 110.811 -0.916 . . . . 0.0 110.811 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.496 ' OG ' ' O ' ' A' ' 60' ' ' MET . 34.2 p -48.14 -56.64 7.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.087 0.47 . . . . 0.0 110.831 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 68.0 t80 -51.38 -37.4 48.0 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.196 -179.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 56.6 mt -71.44 -37.09 63.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.165 -179.548 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.481 ' CG1' ' CZ3' ' A' ' 68' ' ' TRP . 49.1 t -59.48 -52.09 65.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 C-N-CA 120.735 -0.386 . . . . 0.0 110.598 -179.694 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . 0.59 ' O ' ' N ' ' A' ' 73' ' ' GLY . 0.9 OUTLIER -64.7 -44.72 89.36 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.859 -179.878 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.469 ' CB ' ' HZ3' ' A' ' 69' ' ' LYS . 0.1 OUTLIER -60.25 -23.08 63.81 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.862 -0.335 . . . . 0.0 110.725 179.894 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -79.67 -62.81 1.57 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.667 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.498 ' C ' ' CD1' ' A' ' 71' ' ' LEU . 2.8 pp -65.67 -6.8 12.45 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.161 -179.661 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 109.69 72.09 0.7 Allowed Glycine 0 CA--C 1.527 0.822 0 N-CA-C 111.511 -0.636 . . . . 0.0 111.511 179.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.59 ' N ' ' O ' ' A' ' 68' ' ' TRP . . . 46.58 -174.15 0.01 OUTLIER Glycine 0 CA--C 1.526 0.768 0 N-CA-C 111.761 -0.536 . . . . 0.0 111.761 179.532 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 41.2 t80 -77.28 111.99 13.52 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.884 0.373 . . . . 0.0 111.03 -179.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.547 ' OG1' ' N ' ' A' ' 76' ' ' GLU . 0.0 OUTLIER -142.54 -179.99 6.63 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.254 179.468 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.547 ' N ' ' OG1' ' A' ' 75' ' ' THR . 7.4 pt-20 -51.57 -23.53 4.29 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.401 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -72.9 -36.95 67.41 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.757 -179.878 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -81.63 -22.1 37.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.975 0.417 . . . . 0.0 110.824 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 73.0 mmm -61.56 -26.07 67.72 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.177 -179.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 14.8 t -68.09 -46.36 41.09 Favored Pre-proline 0 CA--C 1.534 0.338 0 C-N-CA 120.511 -0.476 . . . . 0.0 110.619 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_endo -74.66 -54.76 0.09 OUTLIER 'Trans proline' 0 N--CA 1.497 1.717 0 C-N-CA 120.953 1.102 . . . . 0.0 111.517 178.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 3.2 mt -50.99 -55.25 18.26 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.534 179.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.455 ' O ' ' N ' ' A' ' 86' ' ' THR . . . -64.51 -63.87 3.98 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 111.488 -0.645 . . . . 0.0 111.488 -179.157 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 43.2 tp -43.91 -29.71 0.6 Allowed 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.664 -0.415 . . . . 0.0 109.92 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 13.3 t80 -75.4 -42.83 52.87 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.843 179.518 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.455 ' N ' ' O ' ' A' ' 83' ' ' GLY . 1.4 m -66.86 -56.65 9.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.799 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -58.92 -55.36 31.33 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 111.401 -0.679 . . . . 0.0 111.401 -179.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.424 ' O ' ' CB ' ' A' ' 92' ' ' ASN . 9.6 tp-100 -55.47 -42.87 74.91 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 121.001 -0.28 . . . . 0.0 110.89 -179.572 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.42 ' O ' ' CD1' ' A' ' 93' ' ' TRP . 10.4 tp -66.04 -31.38 72.24 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.903 -0.319 . . . . 0.0 110.383 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.458 ' O ' ' CB ' ' A' ' 94' ' ' ALA . . . -65.87 -65.83 0.63 Allowed 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 120.314 -0.554 . . . . 0.0 111.182 -179.561 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.4 pp -66.0 -34.35 77.88 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.157 0.428 . . . . 0.0 112.157 -179.001 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.424 ' CB ' ' O ' ' A' ' 88' ' ' GLN . 47.5 t30 -78.39 -61.34 2.04 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.862 -0.335 . . . . 0.0 111.826 -178.811 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . 0.613 ' O ' ' N ' ' A' ' 95' ' ' TRP . 0.0 OUTLIER -68.96 -13.32 62.37 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.906 -0.318 . . . . 0.0 111.527 -178.543 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.458 ' CB ' ' O ' ' A' ' 90' ' ' ALA . . . -52.77 80.76 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 120.663 -0.415 . . . . 0.0 109.913 179.38 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.706 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 32.8 p-90 -98.18 -16.95 0.2 Allowed Pre-proline 0 CA--C 1.535 0.39 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -179.389 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.706 ' CD ' ' N ' ' A' ' 95' ' ' TRP . 51.4 Cg_exo -54.51 -40.86 81.69 Favored 'Trans proline' 0 N--CA 1.496 1.632 0 C-N-CA 120.537 0.825 . . . . 0.0 113.03 179.562 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.43 ' HD2' ' N ' ' A' ' 96' ' ' PRO . 41.9 Cg_exo -36.69 -31.31 0.1 Allowed 'Trans proline' 0 N--CA 1.492 1.41 0 CA-C-N 118.98 0.671 . . . . 0.0 112.777 -179.776 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.45 ' N ' ' O ' ' A' ' 96' ' ' PRO . 1.1 pp -83.63 22.19 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.427 179.797 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.581 ' N ' ' O ' ' A' ' 96' ' ' PRO . 22.3 t80 -44.71 -41.63 6.96 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.463 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 48.9 m-85 -83.89 -40.92 18.0 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.529 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -58.0 -14.1 16.24 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 111.006 -0.838 . . . . 0.0 111.006 -179.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -65.05 -7.26 11.22 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.801 0.334 . . . . 0.0 110.472 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 15.3 ptt180 -82.14 4.78 21.9 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.602 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 5.6 mt-30 -122.41 164.92 17.16 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.247 179.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -59.94 -17.06 34.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.328 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.608 ' O ' ' N ' ' A' ' 108' ' ' ALA . . . -66.62 -14.62 62.88 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 111.203 -0.759 . . . . 0.0 111.203 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' TRP . . . . . 0.643 ' CH2' ' NZ ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -41.25 -15.37 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.716 0.294 . . . . 0.0 111.031 -179.366 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.608 ' N ' ' O ' ' A' ' 106' ' ' GLY . . . -58.77 -27.2 64.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.935 0.398 . . . . 0.0 110.435 179.72 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 9.3 mt -46.46 -29.01 1.55 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.444 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -60.22 -63.63 1.23 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.759 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.585 ' OD1' ' N ' ' A' ' 112' ' ' LEU . 1.4 p30 -55.07 -51.88 64.97 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.781 -179.269 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.585 ' N ' ' OD1' ' A' ' 111' ' ' ASP . 0.2 OUTLIER -58.52 -45.11 89.49 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.103 0.409 . . . . 0.0 112.103 -178.539 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 57.2 mt -64.74 -55.27 20.91 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -178.202 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.3 pp -68.06 -33.55 74.78 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 120.455 -0.498 . . . . 0.0 111.703 -178.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.524 ' CG2' ' O ' ' A' ' 111' ' ' ASP . 38.7 t -62.22 -54.37 35.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.736 0.303 . . . . 0.0 111.186 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' SER . . . . . 0.486 ' O ' ' OG1' ' A' ' 120' ' ' THR . 39.0 t -75.3 -23.93 57.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.093 -179.353 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -62.74 -62.46 5.51 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 111.186 -0.765 . . . . 0.0 111.186 -179.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.518 ' O ' ' OG1' ' A' ' 122' ' ' THR . 7.3 p -71.93 -37.92 62.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 111.57 0.211 . . . . 0.0 111.57 -179.547 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . 0.529 ' O ' ' OG1' ' A' ' 123' ' ' THR . . . -68.41 -61.0 2.03 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.281 -0.568 . . . . 0.0 111.075 -179.234 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.486 ' OG1' ' O ' ' A' ' 116' ' ' SER . 2.7 m -56.7 -53.33 58.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.257 -179.541 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.41 ' O ' ' CB ' ' A' ' 125' ' ' ALA . . . -54.36 -40.84 68.47 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.455 -179.256 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.518 ' OG1' ' O ' ' A' ' 118' ' ' VAL . 37.6 p -74.88 -29.17 60.92 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 111.872 0.323 . . . . 0.0 111.872 -179.034 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.529 ' OG1' ' O ' ' A' ' 119' ' ' ALA . 0.1 OUTLIER -65.71 -47.59 74.85 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.594 -0.442 . . . . 0.0 110.683 -179.639 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.4 pp -83.98 -19.4 34.64 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.373 -179.15 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . 0.41 ' CB ' ' O ' ' A' ' 121' ' ' ALA . . . -89.74 -67.55 0.84 Allowed 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.497 0.555 . . . . 0.0 112.497 -178.589 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' TRP . . . . . 0.433 ' N ' ' CD1' ' A' ' 126' ' ' TRP . 39.3 m0 -84.36 -57.66 3.07 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 112.662 0.616 . . . . 0.0 112.662 -177.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . 0.462 ' CD2' ' N ' ' A' ' 127' ' ' HIS . 9.3 m170 -54.51 -22.48 13.06 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.865 -0.334 . . . . 0.0 111.115 -178.702 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 22.4 ttt180 -68.44 -38.97 81.65 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.755 0.312 . . . . 0.0 110.994 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 25.9 t -92.67 -47.89 13.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.31 -179.388 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -125.57 117.33 24.75 Favored Pre-proline 0 CA--C 1.535 0.374 0 CA-C-N 116.575 -0.284 . . . . 0.0 111.048 -179.385 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . 0.647 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 88.4 Cg_exo -75.03 -38.43 1.58 Allowed 'Trans proline' 0 N--CA 1.492 1.424 0 C-N-CA 121.454 1.436 . . . . 0.0 112.646 179.074 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.647 ' CD ' ' N ' ' A' ' 131' ' ' PRO . 37.9 Cg_exo -46.98 -46.24 19.22 Favored 'Trans proline' 0 N--CA 1.497 1.688 0 C-N-CA 121.646 1.564 . . . . 0.0 111.983 -179.699 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -57.15 -38.22 73.21 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 179.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -62.69 -23.07 66.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.196 179.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 9.3 tpp180 -78.5 -37.3 43.51 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.234 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 12.6 mt -69.61 -29.52 67.04 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.241 -0.436 . . . . 0.0 109.867 179.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.583 ' O ' ' N ' ' A' ' 140' ' ' TYR . 8.2 mt -84.14 -42.39 16.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.025 179.489 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.513 ' C ' ' H ' ' A' ' 140' ' ' TYR . 1.9 t80 -23.15 -41.39 0.04 OUTLIER Pre-proline 0 N--CA 1.464 0.252 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.753 -179.686 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.574 ' N ' ' O ' ' A' ' 137' ' ' LEU . 12.3 Cg_exo -64.37 7.29 0.24 Allowed 'Trans proline' 0 C--N 1.307 -1.643 0 C-N-CA 120.699 0.933 . . . . 0.0 112.0 179.45 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . 0.583 ' N ' ' O ' ' A' ' 137' ' ' LEU . 1.9 p90 -93.13 -13.67 28.19 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.903 -179.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.417 HD22 ' CE1' ' A' ' 140' ' ' TYR . 4.1 mm? -55.94 -26.63 48.74 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 178.299 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -64.28 -49.14 73.0 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.833 179.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' TRP . . . . . . . . . . . . . 10.7 t-105 -56.91 -45.84 82.39 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.103 -0.498 . . . . 0.0 109.659 179.375 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 11.5 mt -54.63 -51.15 66.29 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.199 -0.455 . . . . 0.0 109.962 179.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . 0.522 ' O ' ' CG2' ' A' ' 149' ' ' VAL . . . -63.72 -22.16 66.77 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.413 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -67.25 -64.82 0.78 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.61 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -63.94 -41.9 97.48 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.615 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 59.9 m -57.16 -58.68 7.14 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.499 179.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.522 ' CG2' ' O ' ' A' ' 145' ' ' ALA . 89.5 t -55.61 -39.49 54.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.708 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 1.6 tp -50.84 -57.49 8.31 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.696 -0.402 . . . . 0.0 110.069 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . 0.516 HD21 ' HE1' ' A' ' 107' ' ' TRP . 2.9 t-20 -53.7 -57.02 12.32 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.706 179.73 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . 0.467 ' CZ ' ' NE ' ' A' ' 156' ' ' ARG . 46.5 t80 -48.53 -36.14 14.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.519 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . 0.49 ' CE2' ' OD2' ' A' ' 157' ' ' ASP . 8.8 t80 -65.96 -39.52 90.51 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.688 -179.799 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 15.7 t -66.21 -38.02 81.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.002 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' TRP . . . . . . . . . . . . . 7.9 m0 -68.17 -39.15 82.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.964 -179.579 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . 0.467 ' NE ' ' CZ ' ' A' ' 152' ' ' TYR . 0.9 OUTLIER -77.15 -24.04 51.59 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.808 -0.357 . . . . 0.0 110.071 179.999 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . 0.49 ' OD2' ' CE2' ' A' ' 153' ' ' TYR . 98.2 m-20 -86.9 -51.08 6.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.661 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . 0.485 ' C ' HD21 ' A' ' 158' ' ' ASN . 0.2 OUTLIER -77.47 -29.08 52.53 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.831 -179.809 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 9.8 t 46.89 -166.63 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.438 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 157.31 19.79 0.03 OUTLIER Glycine 0 CA--C 1.525 0.69 0 N-CA-C 110.997 -0.841 . . . . 0.0 110.997 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 6.2 mtm180 -56.59 -175.0 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.744 0.307 . . . . 0.0 110.576 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 43.1 ttm-85 -91.53 149.93 21.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.673 -179.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 102.11 53.71 0.94 Allowed Glycine 0 CA--C 1.525 0.669 0 N-CA-C 111.084 -0.806 . . . . 0.0 111.084 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -65.38 -39.17 95.67 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 110.769 -0.932 . . . . 0.0 110.769 179.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 3.3 m -155.37 144.76 21.06 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.742 0.306 . . . . 0.0 110.388 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? -90.82 -65.92 0.97 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.547 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -94.15 173.48 7.63 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 179.446 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -163.72 131.18 3.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.612 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 15.3 mm-40 . . . . . 0 C--O 1.22 -0.457 0 CA-C-O 117.998 -1.001 . . . . 0.0 110.529 -179.98 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' PKA . . . . . 0.55 ' N18' ' H3 ' ' A' ' 201' ' ' PKA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 44.6 mmm . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.959 0.409 . . . . 0.0 110.52 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -70.12 144.0 50.8 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 C-N-CA 122.562 2.175 . . . . 0.0 112.183 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 59.0 mt-10 -47.32 -25.77 1.08 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.921 -179.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 28.7 m -164.04 160.71 22.03 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.734 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.595 ' CD1' ' CE2' ' A' ' 68' ' ' TRP . 0.2 OUTLIER -76.22 120.24 21.22 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.238 -179.922 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.62 ' N ' ' CD ' ' A' ' 7' ' ' PRO . 1.0 OUTLIER -64.2 -33.88 10.33 Favored Pre-proline 0 C--N 1.329 -0.309 0 N-CA-C 109.916 -0.402 . . . . 0.0 109.916 179.942 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.62 ' CD ' ' N ' ' A' ' 6' ' ' VAL . 21.3 Cg_exo -71.61 -67.51 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.626 0 C-N-CA 121.709 1.606 . . . . 0.0 111.899 179.63 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.537 ' O ' ' CG2' ' A' ' 12' ' ' THR . . . -48.31 -39.16 20.92 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.19 -179.513 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.418 ' CG2' ' O ' ' A' ' 5' ' ' TRP . 95.9 t -69.98 -62.48 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -179.049 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -55.32 -47.34 75.81 Favored Glycine 0 CA--C 1.526 0.764 0 C-N-CA 121.207 -0.52 . . . . 0.0 111.834 -179.108 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.411 ' N ' ' CD1' ' A' ' 11' ' ' LEU . 6.8 mp -62.5 -38.47 90.05 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.485 0.183 . . . . 0.0 110.805 -179.584 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.537 ' CG2' ' O ' ' A' ' 8' ' ' ALA . 22.3 p -73.34 -23.53 60.24 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.801 -0.36 . . . . 0.0 110.871 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 7.0 mp -82.97 -24.88 32.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.297 -179.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.413 ' N ' ' HD2' ' A' ' 15' ' ' PRO . 2.7 t -50.02 -63.16 1.92 Allowed Pre-proline 0 CA--C 1.536 0.442 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.723 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.413 ' HD2' ' N ' ' A' ' 14' ' ' VAL . 24.5 Cg_endo -53.78 -40.08 81.48 Favored 'Trans proline' 0 N--CA 1.498 1.788 0 C-N-CA 120.876 1.05 . . . . 0.0 112.366 -179.462 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.1 t -46.19 -25.68 0.65 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.811 0.338 . . . . 0.0 110.664 -179.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 83.1 mt -70.03 -57.94 4.4 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.726 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -68.35 -20.71 73.67 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 111.163 -0.775 . . . . 0.0 111.163 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -72.92 -45.53 32.78 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 37.7 t80 -69.89 -57.63 4.82 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.79 0.329 . . . . 0.0 110.707 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -66.83 -21.55 66.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.07 -179.743 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -77.5 -63.5 2.22 Favored Glycine 0 CA--C 1.524 0.608 0 C-N-CA 120.842 -0.694 . . . . 0.0 111.572 -179.504 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.15 -20.98 66.37 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.671 -0.412 . . . . 0.0 110.245 -179.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.461 ' CD1' ' C ' ' A' ' 24' ' ' TYR . 11.0 t80 -48.77 -23.7 1.15 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.278 -0.419 . . . . 0.0 109.912 179.357 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 83.3 t80 -70.78 -52.63 19.44 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.765 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 35.3 m -66.53 -17.21 22.16 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 C-N-CA 120.535 -0.466 . . . . 0.0 110.41 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.9 tmt_? -58.08 -43.41 87.0 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.854 0.359 . . . . 0.0 110.32 179.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -101.41 -46.9 1.61 Allowed Glycine 0 CA--C 1.526 0.738 0 N-CA-C 110.957 -0.857 . . . . 0.0 110.957 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -59.91 -38.59 82.75 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.759 0.314 . . . . 0.0 110.64 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -58.68 -44.93 95.4 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.857 -0.897 . . . . 0.0 110.857 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 81.0 mt -58.47 -31.95 68.3 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.944 -0.302 . . . . 0.0 110.392 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.41 ' O ' ' N ' ' A' ' 35' ' ' ALA . 14.6 mmm180 -76.68 -50.03 14.69 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.464 179.793 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 13.0 m0 -44.84 -48.14 11.05 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.289 -0.414 . . . . 0.0 109.998 179.489 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.452 ' O ' ' CD1' ' A' ' 34' ' ' TYR . 26.3 t80 -50.62 -27.05 6.14 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.751 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.41 ' N ' ' O ' ' A' ' 32' ' ' ARG . . . -65.95 -45.83 80.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.763 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -91.87 -69.67 1.16 Allowed Glycine 0 CA--C 1.524 0.601 0 N-CA-C 110.992 -0.843 . . . . 0.0 110.992 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.497 ' C ' ' CD1' ' A' ' 37' ' ' LEU . 3.9 pp -87.66 162.78 16.91 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.677 0.275 . . . . 0.0 110.359 179.722 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 29.5 mt-30 -97.32 123.23 41.07 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.71 -179.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 13.9 mtpp -90.41 163.23 31.8 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.21 179.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.592 ' O ' ' ND1' ' A' ' 43' ' ' HIS . 15.7 Cg_exo -45.93 146.54 4.04 Favored 'Trans proline' 0 C--N 1.307 -1.628 0 C-N-CA 122.153 1.902 . . . . 0.0 112.198 -179.709 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 11.6 t -81.84 -2.16 50.05 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.653 -179.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 13.5 p90 -117.87 9.91 13.03 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 120.484 -0.486 . . . . 0.0 111.623 -178.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.599 ' O ' ' CG ' ' A' ' 43' ' ' HIS . 3.5 p-80 -88.96 117.6 68.42 Favored Pre-proline 0 CA--C 1.535 0.374 0 C-N-CA 121.078 -0.249 . . . . 0.0 111.028 179.757 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.421 ' O ' ' C ' ' A' ' 45' ' ' PRO . 65.9 Cg_endo -101.29 148.54 0.32 Allowed 'Trans proline' 0 C--N 1.313 -1.334 0 C-N-CA 120.427 0.751 . . . . 0.0 111.112 178.646 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.421 ' C ' ' O ' ' A' ' 44' ' ' PRO . 5.7 Cg_endo -40.62 137.4 1.67 Allowed 'Trans proline' 0 C--N 1.3 -1.98 0 C-N-CA 120.543 0.829 . . . . 0.0 110.419 179.631 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 4.8 ppt_? -48.09 -17.01 0.1 Allowed 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 113.125 0.787 . . . . 0.0 113.125 -178.109 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.562 ' CD1' ' N ' ' A' ' 48' ' ' THR . 0.7 OUTLIER -56.48 -44.63 80.83 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.267 -0.573 . . . . 0.0 112.239 -178.201 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.562 ' N ' ' CD1' ' A' ' 47' ' ' TRP . 13.3 t -91.5 -30.74 16.27 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 -178.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -82.42 -45.4 14.86 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 112.411 0.523 . . . . 0.0 112.411 -177.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.63 ' C ' ' H ' ' A' ' 52' ' ' ILE . . . -39.91 -31.63 0.26 Allowed Pre-proline 0 CA--C 1.534 0.344 0 N-CA-C 111.952 0.353 . . . . 0.0 111.952 -179.085 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.401 ' HD2' ' N ' ' A' ' 50' ' ' ALA . 28.2 Cg_exo -52.87 6.37 0.03 OUTLIER 'Trans proline' 0 C--N 1.311 -1.417 0 CA-C-N 118.928 0.653 . . . . 0.0 112.984 178.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.63 ' H ' ' C ' ' A' ' 50' ' ' ALA . 10.9 pt -55.59 -28.5 23.15 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.178 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 179.04 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.414 ' O ' ' CB ' ' A' ' 57' ' ' TYR . 3.0 m0 -67.68 -28.53 67.77 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.484 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -69.41 -60.94 4.76 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 111.464 -0.654 . . . . 0.0 111.464 -179.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.42 ' CG2' ' N ' ' A' ' 56' ' ' LEU . 7.3 t -57.56 -53.37 58.93 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.897 -0.321 . . . . 0.0 111.125 -179.343 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.42 ' N ' ' CG2' ' A' ' 55' ' ' THR . 73.2 mt -58.24 -39.41 79.04 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.524 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.414 ' CB ' ' O ' ' A' ' 53' ' ' TRP . 6.1 t80 -54.79 -57.89 9.73 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 179.747 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 7.1 t -48.63 -50.39 33.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.552 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -57.18 -42.55 81.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.606 -179.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 14.6 mtt -63.0 -55.09 28.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.525 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -44.73 -47.44 9.15 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 111.16 -0.776 . . . . 0.0 111.16 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -61.17 -49.37 77.47 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.845 0.355 . . . . 0.0 110.279 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -54.87 -45.06 81.59 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 110.187 -1.165 . . . . 0.0 110.187 179.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.592 ' O ' ' NE1' ' A' ' 68' ' ' TRP . 0.7 OUTLIER -60.52 -42.35 96.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.906 0.384 . . . . 0.0 110.221 179.642 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.426 ' OH ' ' NZ ' ' A' ' 69' ' ' LYS . 87.3 t80 -53.11 -43.47 66.88 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 179.361 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 79.4 mt -72.15 -25.81 24.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.024 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 55.1 t -66.15 -60.05 3.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 C-N-CA 120.664 -0.414 . . . . 0.0 111.333 -179.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . 0.595 ' CE2' ' CD1' ' A' ' 5' ' ' TRP . 0.0 OUTLIER -70.37 -29.39 66.04 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 119.974 -0.69 . . . . 0.0 110.725 -179.601 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.426 ' NZ ' ' OH ' ' A' ' 65' ' ' TYR . 10.8 mmmt -72.79 -26.55 61.56 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.336 -0.546 . . . . 0.0 110.616 179.825 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -78.42 -60.98 2.16 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.85 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.7 pp -70.38 -19.17 63.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.087 -179.482 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.502 ' O ' ' O ' ' A' ' 73' ' ' GLY . . . 110.24 95.43 2.33 Favored Glycine 0 CA--C 1.53 0.985 0 C-N-CA 121.257 -0.496 . . . . 0.0 112.043 179.218 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.594 ' N ' ' O ' ' A' ' 68' ' ' TRP . . . 41.51 -174.33 0.01 OUTLIER Glycine 0 CA--C 1.525 0.691 0 N-CA-C 111.944 -0.462 . . . . 0.0 111.944 178.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 49.3 t80 -79.78 111.05 15.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.675 0.274 . . . . 0.0 110.408 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.427 ' OG1' ' N ' ' A' ' 76' ' ' GLU . 2.1 t -139.35 177.31 8.01 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 120.993 0.425 . . . . 0.0 110.949 -179.641 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.427 ' N ' ' OG1' ' A' ' 75' ' ' THR . 2.3 mp0 -50.05 -40.84 46.41 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.795 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 27.7 m-20 -62.39 -22.03 65.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.505 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -93.64 -24.82 17.75 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.663 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 13.2 mtp -69.14 -29.57 67.63 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.535 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.406 ' O ' ' CB ' ' A' ' 84' ' ' LEU . 6.5 t -65.56 -45.74 68.11 Favored Pre-proline 0 CA--C 1.535 0.372 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.505 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -76.33 -63.87 0.03 OUTLIER 'Trans proline' 0 N--CA 1.498 1.749 0 C-N-CA 120.903 1.069 . . . . 0.0 111.563 178.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 4.2 mt -47.19 -46.73 24.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.439 179.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.499 ' O ' ' N ' ' A' ' 86' ' ' THR . . . -68.38 -64.13 3.25 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 111.015 -0.834 . . . . 0.0 111.015 -179.852 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.406 ' CB ' ' O ' ' A' ' 80' ' ' VAL . 65.3 tp -41.9 -28.18 0.15 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.03 0.443 . . . . 0.0 109.88 179.751 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.465 ' CD1' ' C ' ' A' ' 85' ' ' TYR . 0.6 OUTLIER -76.85 -43.6 35.54 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.029 179.663 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.499 ' N ' ' O ' ' A' ' 83' ' ' GLY . 0.3 OUTLIER -61.56 -43.95 97.92 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.164 -179.57 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -73.62 -58.17 4.65 Favored Glycine 0 CA--C 1.527 0.808 0 C-N-CA 120.9 -0.667 . . . . 0.0 111.466 -179.455 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -51.14 -48.61 61.77 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-O 121.052 0.453 . . . . 0.0 109.943 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.435 ' O ' ' C ' ' A' ' 90' ' ' ALA . 23.3 tp -54.85 -63.39 1.17 Allowed 'General case' 0 C--O 1.211 -0.927 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.814 179.593 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.435 ' C ' ' O ' ' A' ' 89' ' ' LEU . . . -37.86 -42.87 0.64 Allowed 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 120.568 -0.453 . . . . 0.0 111.522 -179.497 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 90.8 mt -63.38 -56.98 11.87 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -178.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -72.62 -53.85 10.73 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.346 0.593 . . . . 0.0 111.33 -178.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . 0.606 ' O ' ' N ' ' A' ' 95' ' ' TRP . 30.7 t-105 -51.86 -33.31 35.85 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.152 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -60.01 72.11 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 120.611 -0.436 . . . . 0.0 109.89 179.228 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.694 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 22.2 p-90 -99.42 -15.91 0.19 Allowed Pre-proline 0 CA--C 1.538 0.505 0 N-CA-C 112.581 0.586 . . . . 0.0 112.581 -179.113 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.694 ' CD ' ' N ' ' A' ' 95' ' ' TRP . 49.3 Cg_exo -58.87 -31.14 94.79 Favored 'Trans proline' 0 N--CA 1.497 1.717 0 C-N-CA 120.645 0.897 . . . . 0.0 113.808 -179.731 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.494 ' CD ' ' N ' ' A' ' 96' ' ' PRO . 89.0 Cg_exo -56.99 -13.91 12.99 Favored 'Trans proline' 0 N--CA 1.499 1.825 0 C-N-CA 120.642 0.895 . . . . 0.0 113.654 -179.152 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 1.1 pp -90.05 29.96 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 C-N-CA 120.453 -0.499 . . . . 0.0 110.779 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.585 ' CD2' ' O ' ' A' ' 96' ' ' PRO . 42.6 m-85 -50.37 -40.09 48.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.213 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 0.598 ' CD1' ' N ' ' A' ' 100' ' ' PHE . 0.1 OUTLIER -70.05 -58.84 3.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.318 -179.311 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -55.56 -14.82 7.42 Favored Glycine 0 CA--C 1.522 0.489 0 N-CA-C 110.847 -0.901 . . . . 0.0 110.847 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -59.76 -12.14 6.63 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.587 0.232 . . . . 0.0 111.203 -179.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 -94.78 10.3 35.7 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 121.005 -0.278 . . . . 0.0 110.862 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 16.6 mt-30 -117.21 -175.35 2.78 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.732 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' MET . . . . . 0.495 ' CE ' ' CZ3' ' A' ' 155' ' ' TRP . 17.5 mmt -74.78 -18.31 60.49 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.094 0.473 . . . . 0.0 109.78 179.662 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.613 ' O ' ' N ' ' A' ' 108' ' ' ALA . . . -74.23 -14.77 80.39 Favored Glycine 0 CA--C 1.524 0.653 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.355 -179.702 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' TRP . . . . . 0.606 ' NE1' ' OD1' ' A' ' 151' ' ' ASN . 0.0 OUTLIER -41.6 -14.96 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.252 0 CA-C-O 120.749 0.309 . . . . 0.0 110.879 -179.468 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.613 ' N ' ' O ' ' A' ' 106' ' ' GLY . . . -62.49 -17.57 59.9 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.983 0.421 . . . . 0.0 110.172 179.53 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 6.8 mp -47.5 -30.7 3.65 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.358 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -57.81 -63.98 1.06 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.935 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.54 ' CG ' ' N ' ' A' ' 112' ' ' LEU . 1.9 p30 -57.82 -54.34 48.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.764 -179.224 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.54 ' N ' ' CG ' ' A' ' 111' ' ' ASP . 38.1 tp -52.84 -41.49 64.31 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.506 -0.316 . . . . 0.0 111.727 -178.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 57.2 mt -70.33 -62.12 1.51 Allowed 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.616 0.599 . . . . 0.0 112.616 -178.333 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.0 pp -59.0 -29.84 67.53 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 120.431 -0.508 . . . . 0.0 111.066 -178.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.532 ' CG2' ' O ' ' A' ' 111' ' ' ASP . 38.8 t -65.12 -60.61 2.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.221 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' SER . . . . . 0.499 ' O ' ' OG1' ' A' ' 120' ' ' THR . 9.8 p -68.81 -22.29 64.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.954 -179.55 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . 0.405 ' O ' ' CB ' ' A' ' 121' ' ' ALA . . . -65.34 -62.66 4.69 Favored Glycine 0 CA--C 1.525 0.693 0 C-N-CA 120.903 -0.665 . . . . 0.0 111.496 -179.474 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.493 ' O ' ' OG1' ' A' ' 122' ' ' THR . 9.6 p -73.24 -37.5 52.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 C-N-CA 120.957 -0.297 . . . . 0.0 111.233 -179.531 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . 0.526 ' O ' ' OG1' ' A' ' 123' ' ' THR . . . -67.02 -60.86 2.27 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.596 -0.442 . . . . 0.0 111.145 -179.393 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.499 ' OG1' ' O ' ' A' ' 116' ' ' SER . 1.6 m -60.36 -53.23 60.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.412 -179.455 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.405 ' CB ' ' O ' ' A' ' 117' ' ' GLY . . . -51.83 -42.38 62.5 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.916 -0.314 . . . . 0.0 111.044 -179.391 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.493 ' OG1' ' O ' ' A' ' 118' ' ' VAL . 35.6 p -71.55 -40.15 70.19 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.769 -179.09 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.526 ' OG1' ' O ' ' A' ' 119' ' ' ALA . 0.1 OUTLIER -54.77 -49.29 71.24 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 120.761 0.315 . . . . 0.0 110.897 -179.143 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.9 pp -84.11 -20.21 32.93 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.202 -0.454 . . . . 0.0 112.089 -178.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -90.17 -71.19 0.63 Allowed 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.821 0.675 . . . . 0.0 112.821 -178.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 41.6 m0 -80.46 -57.13 3.73 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 -177.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . 0.446 ' CD2' ' N ' ' A' ' 127' ' ' HIS . 10.4 m170 -55.48 -23.57 26.53 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.826 -0.35 . . . . 0.0 111.54 -178.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.77 -39.56 87.89 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.756 -0.377 . . . . 0.0 110.666 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 98.7 t -90.6 -49.54 13.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.942 -179.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 1.9 p -114.06 109.34 49.63 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.468 -179.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . 0.629 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 71.4 Cg_exo -69.68 -35.91 12.01 Favored 'Trans proline' 0 C--N 1.311 -1.418 0 C-N-CA 121.38 1.386 . . . . 0.0 112.422 179.472 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.629 ' CD ' ' N ' ' A' ' 131' ' ' PRO . 29.8 Cg_exo -56.28 -40.64 83.41 Favored 'Trans proline' 0 N--CA 1.495 1.58 0 C-N-CA 121.374 1.383 . . . . 0.0 111.679 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -51.89 -44.54 63.79 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.265 179.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -58.65 -22.64 57.28 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.511 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 7.7 tpt85 -79.32 -29.42 42.35 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.535 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 12.8 mt -79.01 -28.96 43.42 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.389 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.477 ' O ' ' CD1' ' A' ' 140' ' ' TYR . 13.2 mt -93.74 -18.64 21.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.091 179.686 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.54 ' C ' ' CD1' ' A' ' 138' ' ' TYR . 0.3 OUTLIER -37.43 -52.19 2.46 Favored Pre-proline 0 CA--C 1.537 0.461 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.715 -179.764 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_endo -62.65 1.54 1.01 Allowed 'Trans proline' 0 N--CA 1.499 1.797 0 C-N-CA 121.734 1.622 . . . . 0.0 113.38 -179.281 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . 0.477 ' CD1' ' O ' ' A' ' 137' ' ' LEU . 0.1 OUTLIER -80.0 -13.7 59.13 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-O 120.921 0.391 . . . . 0.0 111.53 -179.679 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 74.8 mt -57.64 -34.05 68.93 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.072 179.099 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -53.45 -47.2 69.91 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 179.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' TRP . . . . . . . . . . . . . 8.8 t-105 -63.37 -44.2 95.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.74 179.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 25.3 mt -55.19 -54.97 36.61 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.334 -0.547 . . . . 0.0 110.281 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . 0.408 ' O ' ' CG2' ' A' ' 149' ' ' VAL . . . -64.68 -23.57 67.3 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.636 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 25.9 t80 -61.35 -59.16 5.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.771 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -64.33 -50.38 68.0 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.005 -179.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 10.9 m -52.62 -55.83 19.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.904 0.383 . . . . 0.0 110.769 -179.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.408 ' CG2' ' O ' ' A' ' 145' ' ' ALA . 80.9 t -58.25 -35.05 51.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.726 -179.772 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 4.8 tp -54.7 -58.11 8.82 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.471 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . 0.733 HD21 ' N ' ' A' ' 152' ' ' TYR . 0.2 OUTLIER -56.4 -58.89 6.08 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-O 120.988 0.423 . . . . 0.0 110.783 179.94 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . 0.733 ' N ' HD21 ' A' ' 151' ' ' ASN . 50.5 t80 -47.42 -39.65 16.03 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.83 -179.383 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 31.5 t80 -72.12 -35.83 69.25 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.401 -179.53 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 45.1 t -59.15 -47.04 91.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 C-N-CA 120.791 -0.364 . . . . 0.0 111.395 -179.291 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' TRP . . . . . 0.495 ' CZ3' ' CE ' ' A' ' 105' ' ' MET . 22.9 m95 -79.95 -28.68 39.63 Favored 'General case' 0 N--CA 1.464 0.225 0 C-N-CA 119.818 -0.753 . . . . 0.0 111.521 -179.279 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.41 -21.66 61.23 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.461 -0.495 . . . . 0.0 110.164 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -83.57 -40.06 19.58 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.918 -179.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 18.2 t30 -90.53 -24.24 20.69 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.084 -179.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 63.69 148.33 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.34 -179.754 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -95.13 -170.08 36.46 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 111.31 -0.716 . . . . 0.0 111.31 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 69.1 mtt180 -80.6 39.17 0.46 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.69 0.281 . . . . 0.0 110.771 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 32.8 mtt180 -63.92 153.63 36.38 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.66 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -72.7 177.21 41.49 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 110.97 -0.852 . . . . 0.0 110.97 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -96.58 -3.35 59.7 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 111.035 -0.826 . . . . 0.0 111.035 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -160.69 170.9 19.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.784 0.326 . . . . 0.0 110.641 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 89.6 mtt180 -101.7 -132.29 0.27 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.305 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.516 ' N ' ' CD1' ' A' ' 167' ' ' LEU . 8.8 mp -89.28 -171.9 3.42 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.884 0.373 . . . . 0.0 110.63 -179.849 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -163.49 125.59 2.5 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.329 179.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 . . . . . 0 C--O 1.22 -0.455 0 CA-C-O 117.943 -1.027 . . . . 0.0 110.572 -179.959 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' PKA . . . . . 0.579 ' N18' ' H3 ' ' A' ' 201' ' ' PKA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.552 ' N ' ' SD ' ' A' ' 1' ' ' MET . 9.3 mmm . . . . . 0 CA--C 1.529 0.148 0 N-CA-C 110.451 -0.203 . . . . 0.0 110.451 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -75.51 39.36 0.62 Allowed 'Trans proline' 0 N--CA 1.493 1.488 0 C-N-CA 121.778 1.652 . . . . 0.0 112.034 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -56.98 -42.48 80.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.715 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.8 t 53.61 179.31 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.463 -179.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.413 ' NE1' ' CD1' ' A' ' 68' ' ' TRP . 0.7 OUTLIER -79.58 116.84 20.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.275 -179.826 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.585 ' N ' ' CD ' ' A' ' 7' ' ' PRO . 0.9 OUTLIER -60.84 -33.62 15.03 Favored Pre-proline 0 CA--C 1.533 0.306 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.144 -179.759 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.585 ' CD ' ' N ' ' A' ' 6' ' ' VAL . 24.2 Cg_exo -73.34 -62.64 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 121.613 1.542 . . . . 0.0 111.518 179.282 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.552 ' O ' ' CG2' ' A' ' 12' ' ' THR . . . -50.78 -36.51 37.29 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.849 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.477 ' O ' ' OG1' ' A' ' 12' ' ' THR . 56.0 t -68.27 -62.17 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.511 -179.442 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -55.6 -47.73 75.42 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 111.484 -0.646 . . . . 0.0 111.484 -179.33 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.416 ' N ' ' CD1' ' A' ' 11' ' ' LEU . 8.5 mp -64.84 -30.86 71.88 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 121.177 -0.209 . . . . 0.0 110.968 -179.514 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.552 ' CG2' ' O ' ' A' ' 8' ' ' ALA . 6.1 p -74.47 -22.95 58.84 Favored 'General case' 0 C--N 1.333 -0.135 0 C-N-CA 120.569 -0.453 . . . . 0.0 110.016 179.439 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 52.5 mt -80.18 -34.77 37.24 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.213 179.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.409 ' N ' ' HD2' ' A' ' 15' ' ' PRO . 11.9 t -43.63 -55.21 9.05 Favored Pre-proline 0 CA--C 1.536 0.423 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.45 -179.722 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.409 ' HD2' ' N ' ' A' ' 14' ' ' VAL . 13.8 Cg_endo -58.92 -21.92 60.26 Favored 'Trans proline' 0 N--CA 1.498 1.754 0 C-N-CA 120.672 0.915 . . . . 0.0 112.303 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 5.7 t -62.08 -30.59 71.1 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.825 -179.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 71.5 mt -71.62 -57.1 4.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.817 0.342 . . . . 0.0 110.893 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -61.16 -36.97 93.18 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 111.287 -0.725 . . . . 0.0 111.287 -179.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -75.44 -25.94 66.9 Favored Glycine 0 CA--C 1.521 0.461 0 N-CA-C 110.694 -0.962 . . . . 0.0 110.694 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 62.0 t80 -75.54 -60.62 2.23 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.528 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 3.9 ttt -70.16 -22.29 62.99 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.17 179.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -69.47 -62.31 3.97 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.825 -0.91 . . . . 0.0 110.825 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -68.55 -21.28 64.56 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.831 -0.348 . . . . 0.0 110.635 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 40.2 t80 -47.45 -24.0 0.73 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.013 0.435 . . . . 0.0 109.984 179.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 25.6 t80 -69.72 -52.26 27.07 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.966 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 36.0 m -72.14 -15.89 18.2 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.894 -179.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -59.82 -28.88 67.85 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.258 -179.388 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -123.39 -59.39 0.19 Allowed Glycine 0 CA--C 1.524 0.643 0 N-CA-C 111.199 -0.76 . . . . 0.0 111.199 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 27.7 tp10 -53.92 -28.99 40.18 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.745 0.307 . . . . 0.0 110.686 -179.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -73.78 -40.98 43.73 Favored Glycine 0 CA--C 1.526 0.754 0 N-CA-C 111.134 -0.786 . . . . 0.0 111.134 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 85.6 mt -62.98 -33.2 74.9 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.881 0.372 . . . . 0.0 110.482 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 18.6 mmm-85 -81.0 -40.01 24.98 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.35 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . 0.489 ' O ' ' N ' ' A' ' 36' ' ' GLY . 0.0 OUTLIER -56.11 -40.41 73.67 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.802 179.624 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 91.4 t80 -44.5 -42.11 6.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.518 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -60.27 -29.32 68.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.145 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.489 ' N ' ' O ' ' A' ' 33' ' ' TRP . . . -84.86 -76.72 1.19 Allowed Glycine 0 CA--C 1.524 0.602 0 N-CA-C 110.437 -1.065 . . . . 0.0 110.437 179.679 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -95.65 166.94 11.58 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.791 0.329 . . . . 0.0 110.221 179.277 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.415 ' N ' ' CD ' ' A' ' 38' ' ' GLN . 3.7 mp0 -81.54 113.02 19.29 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.483 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.53 ' C ' ' H ' ' A' ' 41' ' ' SER . 8.9 mtpt -122.18 146.63 47.25 Favored Pre-proline 0 N--CA 1.464 0.265 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.05 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.628 ' C ' ' H ' ' A' ' 42' ' ' TRP . 85.5 Cg_endo -74.13 30.19 0.33 Allowed 'Trans proline' 0 C--N 1.309 -1.503 0 C-N-CA 121.28 1.32 . . . . 0.0 111.386 179.406 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.53 ' H ' ' C ' ' A' ' 39' ' ' LYS . 53.7 p -52.37 -0.1 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.94 179.565 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . 0.628 ' H ' ' C ' ' A' ' 40' ' ' PRO . 1.2 p90 -75.72 -14.0 60.32 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.398 -0.521 . . . . 0.0 110.758 -178.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.481 ' O ' ' C ' ' A' ' 44' ' ' PRO . 30.5 m-70 -74.59 140.32 75.13 Favored Pre-proline 0 C--N 1.328 -0.359 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 178.759 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.481 ' C ' ' O ' ' A' ' 43' ' ' HIS . 51.9 Cg_exo -32.55 131.54 0.1 OUTLIER 'Trans proline' 0 N--CA 1.492 1.439 0 C-N-CA 121.204 1.27 . . . . 0.0 111.346 -179.343 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.431 ' O ' ' N ' ' A' ' 47' ' ' TRP . 5.8 Cg_exo -54.82 162.94 4.45 Favored 'Trans proline' 0 C--N 1.311 -1.402 0 CA-C-N 118.791 0.604 . . . . 0.0 111.676 -179.191 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.462 ' O ' ' CB ' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -45.47 -17.73 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.202 -179.482 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.594 ' CD1' ' N ' ' A' ' 48' ' ' THR . 1.6 p-90 -63.74 -48.6 76.35 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.851 -0.34 . . . . 0.0 111.587 -179.03 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.594 ' N ' ' CD1' ' A' ' 47' ' ' TRP . 1.1 m -90.16 -27.45 19.57 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.555 -178.854 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -83.39 -45.92 13.15 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.473 -0.491 . . . . 0.0 112.029 -178.733 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.657 ' C ' ' H ' ' A' ' 52' ' ' ILE . . . -40.94 -28.92 0.23 Allowed Pre-proline 0 N--CA 1.465 0.281 0 N-CA-C 111.892 0.33 . . . . 0.0 111.892 -179.057 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_exo -54.03 7.36 0.03 OUTLIER 'Trans proline' 0 C--N 1.312 -1.359 0 CA-C-N 119.126 0.724 . . . . 0.0 112.78 178.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.657 ' H ' ' C ' ' A' ' 50' ' ' ALA . 8.1 pt -55.19 -31.35 26.05 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.133 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 178.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.403 ' O ' ' CB ' ' A' ' 57' ' ' TYR . 72.8 m95 -80.98 -22.21 39.7 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.124 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -69.92 -52.12 20.78 Favored Glycine 0 CA--C 1.527 0.828 0 N-CA-C 109.987 -1.245 . . . . 0.0 109.987 178.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.471 ' CG2' ' N ' ' A' ' 56' ' ' LEU . 9.3 t -67.23 -50.2 61.58 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 179.321 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.471 ' N ' ' CG2' ' A' ' 55' ' ' THR . 90.4 mt -58.4 -33.77 70.01 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 120.655 -0.418 . . . . 0.0 109.89 179.389 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.403 ' CB ' ' O ' ' A' ' 53' ' ' TRP . 3.6 t80 -59.16 -55.93 28.7 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 179.42 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 34.6 t -48.01 -50.33 27.95 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.347 -0.541 . . . . 0.0 109.88 179.339 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -55.63 -52.59 63.28 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.57 179.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.456 ' O ' ' OG ' ' A' ' 64' ' ' SER . 16.2 mtm -55.09 -37.68 67.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.036 -179.715 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -62.87 -41.2 99.92 Favored Glycine 0 CA--C 1.523 0.55 0 N-CA-C 111.216 -0.754 . . . . 0.0 111.216 -179.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -68.61 -60.25 2.55 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.695 0.283 . . . . 0.0 110.869 -179.487 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -55.48 -56.58 22.83 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 110.749 -0.94 . . . . 0.0 110.749 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.477 ' O ' ' NE1' ' A' ' 68' ' ' TRP . 92.7 p -45.77 -49.53 14.87 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.004 0.43 . . . . 0.0 110.473 179.699 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 73.5 t80 -58.16 -34.4 70.26 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.835 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 96.2 mt -74.25 -39.13 49.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.882 -179.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.411 ' CG1' ' CZ3' ' A' ' 68' ' ' TRP . 37.4 t -56.98 -58.17 6.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.616 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . 0.578 ' O ' ' N ' ' A' ' 73' ' ' GLY . 1.0 OUTLIER -60.82 -45.04 96.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.692 -179.837 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 2.7 mmmt -56.65 -25.73 54.25 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.02 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 23.5 tp10 -82.41 -63.06 1.45 Allowed 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.827 -0.349 . . . . 0.0 111.317 -179.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.5 ' C ' ' CD1' ' A' ' 71' ' ' LEU . 3.3 pp -62.93 -7.12 4.58 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.777 -0.369 . . . . 0.0 111.023 -179.478 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.498 ' O ' ' O ' ' A' ' 73' ' ' GLY . . . 108.45 71.69 0.73 Allowed Glycine 0 CA--C 1.527 0.791 0 N-CA-C 111.402 -0.679 . . . . 0.0 111.402 179.697 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.578 ' N ' ' O ' ' A' ' 68' ' ' TRP . . . 42.15 -174.03 0.01 OUTLIER Glycine 0 CA--C 1.525 0.698 0 N-CA-C 111.748 -0.541 . . . . 0.0 111.748 179.496 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 63.4 t80 -69.33 111.42 5.22 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.372 -0.414 . . . . 0.0 110.432 -179.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.477 ' OG1' ' N ' ' A' ' 76' ' ' GLU . 1.7 t -140.0 -178.6 5.52 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.538 -179.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.477 ' N ' ' OG1' ' A' ' 75' ' ' THR . 96.3 mt-10 -55.51 -23.24 25.09 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.632 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -79.97 -18.84 49.34 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.664 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -94.09 -24.42 17.59 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.927 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 13.1 mtp -62.19 -26.98 68.65 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.813 -0.355 . . . . 0.0 110.439 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 10.8 t -68.49 -52.99 18.4 Favored Pre-proline 0 CA--C 1.535 0.386 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.953 -179.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -66.42 -59.53 0.13 Allowed 'Trans proline' 0 N--CA 1.497 1.733 0 C-N-CA 120.97 1.113 . . . . 0.0 111.77 179.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.2 mt -55.27 -51.49 66.47 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.492 179.714 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -57.82 -51.08 60.22 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 111.153 -0.779 . . . . 0.0 111.153 -179.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.427 ' O ' ' CB ' ' A' ' 88' ' ' GLN . 44.3 tp -60.15 -29.74 68.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.834 0.349 . . . . 0.0 110.61 -179.832 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 11.6 t80 -71.25 -43.51 67.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.627 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 1.5 m -67.29 -48.03 68.86 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.888 -179.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -68.75 -57.27 8.14 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 111.162 -0.775 . . . . 0.0 111.162 -179.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.427 ' CB ' ' O ' ' A' ' 84' ' ' LEU . 53.1 tp60 -52.13 -46.01 65.19 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.826 0.346 . . . . 0.0 110.711 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 11.7 tp -66.12 -31.94 73.1 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.94 -179.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.417 ' O ' ' CB ' ' A' ' 94' ' ' ALA . . . -64.4 -65.64 0.65 Allowed 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 120.272 -0.571 . . . . 0.0 111.183 -179.547 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.8 pp -67.65 -36.96 81.72 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 -178.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.423 ' CB ' ' O ' ' A' ' 88' ' ' GLN . 34.7 t30 -75.03 -59.13 2.88 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 -178.768 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . 0.62 ' O ' ' N ' ' A' ' 95' ' ' TRP . 0.0 OUTLIER -69.95 -17.15 63.3 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 120.681 -0.408 . . . . 0.0 111.499 -178.576 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.417 ' CB ' ' O ' ' A' ' 90' ' ' ALA . . . -49.0 83.23 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 120.739 -0.385 . . . . 0.0 110.206 179.512 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.696 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 34.8 p-90 -101.42 -15.75 0.18 Allowed Pre-proline 0 CA--C 1.536 0.419 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 -179.278 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.696 ' CD ' ' N ' ' A' ' 95' ' ' TRP . 32.0 Cg_exo -60.24 -27.79 85.58 Favored 'Trans proline' 0 N--CA 1.495 1.564 0 C-N-CA 120.484 0.79 . . . . 0.0 113.126 179.654 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.52 ' CD ' ' N ' ' A' ' 96' ' ' PRO . 97.2 Cg_exo -58.96 -17.53 37.93 Favored 'Trans proline' 0 N--CA 1.496 1.671 0 C-N-CA 120.592 0.861 . . . . 0.0 113.127 -179.81 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.531 ' O ' ' N ' ' A' ' 101' ' ' GLY . 1.2 pp -82.24 17.26 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 121.105 0.479 . . . . 0.0 110.304 179.699 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -40.22 -31.7 0.14 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.789 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -80.85 -30.32 35.67 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.246 -179.36 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.531 ' N ' ' O ' ' A' ' 98' ' ' ILE . . . -83.66 -11.97 78.67 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 111.372 -0.691 . . . . 0.0 111.372 -179.742 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -63.55 -33.06 74.77 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.673 0.273 . . . . 0.0 111.033 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -75.91 9.65 2.29 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.98 -179.654 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . 0.416 ' C ' ' N ' ' A' ' 106' ' ' GLY . 5.3 mt-30 -126.09 158.83 34.45 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.748 0.308 . . . . 0.0 110.574 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 6.7 mmt -48.79 -18.91 0.31 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.097 0.475 . . . . 0.0 110.348 179.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.593 ' O ' ' N ' ' A' ' 108' ' ' ALA . . . -66.51 -14.59 62.59 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 111.351 -0.7 . . . . 0.0 111.351 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' TRP . . . . . 0.526 ' CZ2' ' ND2' ' A' ' 151' ' ' ASN . 0.0 OUTLIER -42.33 -14.52 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.287 0 CA-C-O 120.561 0.22 . . . . 0.0 111.137 -179.368 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.593 ' N ' ' O ' ' A' ' 106' ' ' GLY . . . -64.78 -24.1 67.45 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.092 0.472 . . . . 0.0 110.321 179.686 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 6.6 mt -49.98 -27.99 6.2 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.59 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.24 -58.51 7.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.733 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.544 ' O ' ' CG2' ' A' ' 115' ' ' VAL . 1.0 OUTLIER -59.2 -52.32 66.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.558 -179.422 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.538 ' N ' ' CG ' ' A' ' 111' ' ' ASP . 57.4 tp -55.07 -43.17 73.66 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.43 -179.137 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 51.6 mt -67.12 -61.55 1.87 Allowed 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 -178.487 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.0 pp -60.94 -34.04 74.12 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.337 -0.545 . . . . 0.0 111.413 -178.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.544 ' CG2' ' O ' ' A' ' 111' ' ' ASP . 40.7 t -59.87 -56.82 14.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.763 179.877 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' SER . . . . . 0.491 ' O ' ' OG1' ' A' ' 120' ' ' THR . 41.5 t -72.09 -22.54 61.34 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.54 -179.208 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . 0.401 ' HA2' HD21 ' A' ' 92' ' ' ASN . . . -64.98 -62.74 4.7 Favored Glycine 0 CA--C 1.526 0.75 0 C-N-CA 120.938 -0.648 . . . . 0.0 111.674 -179.357 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.538 ' O ' ' OG1' ' A' ' 122' ' ' THR . 10.3 p -73.01 -37.62 53.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 C-N-CA 121.08 -0.248 . . . . 0.0 111.408 -179.476 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . 0.527 ' O ' ' OG1' ' A' ' 123' ' ' THR . . . -65.53 -60.24 3.14 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.684 -0.406 . . . . 0.0 111.149 -179.344 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.491 ' OG1' ' O ' ' A' ' 116' ' ' SER . 1.9 m -60.43 -52.77 63.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.673 -179.237 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -54.6 -39.93 68.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.601 -0.272 . . . . 0.0 111.417 -179.166 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.538 ' OG1' ' O ' ' A' ' 118' ' ' VAL . 22.9 p -71.48 -39.11 71.09 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.994 -0.283 . . . . 0.0 111.728 -179.195 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.527 ' OG1' ' O ' ' A' ' 119' ' ' ALA . 0.1 OUTLIER -58.46 -49.44 77.33 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.782 -0.367 . . . . 0.0 111.08 -179.286 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.2 pp -79.97 -20.48 45.47 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.581 -179.057 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -87.42 -70.88 0.59 Allowed 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 112.515 0.561 . . . . 0.0 112.515 -178.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' TRP . . . . . 0.469 ' N ' ' CD1' ' A' ' 126' ' ' TRP . 32.0 m0 -83.57 -57.36 3.27 Favored 'General case' 0 N--CA 1.465 0.275 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -177.687 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . 0.494 ' CD2' ' N ' ' A' ' 127' ' ' HIS . 7.0 m170 -54.52 -22.68 13.68 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.642 -0.423 . . . . 0.0 111.419 -178.672 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 17.1 ttt-85 -66.35 -39.62 89.28 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.877 -0.329 . . . . 0.0 111.137 -179.563 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 21.5 t -96.18 -49.77 11.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.149 -179.543 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 16.8 m -114.72 110.35 46.84 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.699 -179.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . 0.64 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 77.7 Cg_exo -75.19 -33.11 4.64 Favored 'Trans proline' 0 C--N 1.31 -1.479 0 C-N-CA 121.73 1.62 . . . . 0.0 112.871 179.544 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.64 ' CD ' ' N ' ' A' ' 131' ' ' PRO . 53.1 Cg_exo -52.97 -49.91 15.92 Favored 'Trans proline' 0 N--CA 1.497 1.687 0 C-N-CA 121.587 1.525 . . . . 0.0 112.572 -179.536 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -53.27 -38.98 63.55 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.908 0.385 . . . . 0.0 110.666 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -56.18 -28.06 56.79 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.596 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 11.4 tpp180 -75.98 -29.66 58.3 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.653 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 54.3 mt -72.43 -35.74 68.39 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.878 0.37 . . . . 0.0 110.118 179.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.589 ' O ' ' N ' ' A' ' 140' ' ' TYR . 6.2 mt -82.46 -36.81 26.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.211 179.571 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.553 ' C ' ' H ' ' A' ' 140' ' ' TYR . 0.8 OUTLIER -21.04 -45.48 0.04 OUTLIER Pre-proline 0 N--CA 1.467 0.399 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.811 -179.725 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.559 ' N ' ' O ' ' A' ' 137' ' ' LEU . 5.5 Cg_exo -66.08 14.33 0.11 Allowed 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 120.986 1.124 . . . . 0.0 112.001 179.593 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . 0.656 ' CE1' ' CD1' ' A' ' 141' ' ' LEU . 3.7 p90 -93.25 -14.64 26.78 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.197 0.522 . . . . 0.0 110.341 179.684 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.656 ' CD1' ' CE1' ' A' ' 140' ' ' TYR . 5.9 mp -58.79 -30.63 67.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.268 178.578 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -60.92 -45.37 94.91 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.983 179.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' TRP . . . . . . . . . . . . . 7.7 t-105 -60.33 -49.57 77.06 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 179.415 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 11.9 mt -51.37 -54.61 24.75 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.743 179.322 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . 0.475 ' O ' ' CG2' ' A' ' 149' ' ' VAL . . . -59.72 -24.79 64.29 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.792 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 23.0 t80 -65.1 -59.16 4.42 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.741 -0.383 . . . . 0.0 110.711 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -67.18 -43.41 82.24 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.622 -0.431 . . . . 0.0 110.633 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 5.2 m -57.3 -55.13 38.79 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.579 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.475 ' CG2' ' O ' ' A' ' 145' ' ' ALA . 91.2 t -59.19 -31.66 46.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.59 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -58.33 -53.94 52.6 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.796 -0.362 . . . . 0.0 110.068 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . 0.6 HD22 ' C21' ' A' ' 201' ' ' PKA . 8.3 m120 -64.16 -53.37 50.49 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.939 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . 0.424 ' HH ' ' NH2' ' A' ' 156' ' ' ARG . 31.5 t80 -51.4 -37.53 48.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.867 -179.682 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 90.8 t80 -67.93 -42.68 80.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.949 -179.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 86.7 t -63.61 -38.27 81.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 C-N-CA 120.945 -0.302 . . . . 0.0 110.79 -179.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' TRP . . . . . . . . . . . . . 4.8 m0 -64.06 -45.96 86.49 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.536 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . 0.424 ' NH2' ' HH ' ' A' ' 152' ' ' TYR . 7.5 mpt_? -70.62 -34.31 71.97 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.954 -179.605 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -74.64 -37.79 62.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.111 -179.314 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . 0.476 ' O ' ' ND2' ' A' ' 158' ' ' ASN . 0.6 OUTLIER -84.45 -23.42 29.95 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.918 -179.745 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 9.4 p 52.33 -160.1 0.11 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.342 -179.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 165.56 80.19 0.04 OUTLIER Glycine 0 CA--C 1.525 0.694 0 N-CA-C 111.102 -0.799 . . . . 0.0 111.102 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 24.4 ttm180 -98.44 -56.58 2.42 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.771 0.32 . . . . 0.0 110.552 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 67.1 mtt85 -76.96 147.04 37.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.611 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 169.94 165.52 27.44 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 111.064 -0.815 . . . . 0.0 111.064 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -90.88 48.26 3.0 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.904 -0.878 . . . . 0.0 110.904 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 5.7 t -92.77 123.3 35.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.783 0.325 . . . . 0.0 110.61 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 8.4 mtp180 -141.57 -141.67 0.14 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.165 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.571 ' N ' ' CD1' ' A' ' 167' ' ' LEU . 0.0 OUTLIER -173.76 -10.08 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.834 -0.347 . . . . 0.0 111.217 179.781 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -43.71 117.13 1.09 Allowed 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.912 -0.315 . . . . 0.0 110.416 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 . . . . . 0 C--O 1.22 -0.464 0 CA-C-O 117.985 -1.007 . . . . 0.0 110.64 -179.938 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' PKA . . . . . 0.6 ' C21' HD22 ' A' ' 151' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 56.3 mmm . . . . . 0 CA--C 1.528 0.129 0 CA-C-O 120.546 0.212 . . . . 0.0 110.442 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_exo -39.86 125.85 1.66 Allowed 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 121.819 1.679 . . . . 0.0 112.123 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.466 ' CD ' ' H ' ' A' ' 3' ' ' GLU . 10.3 mp0 -49.71 -52.12 33.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.806 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.407 ' C ' ' O ' ' A' ' 3' ' ' GLU . 34.8 t -38.99 116.78 0.61 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.544 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.426 ' O ' ' CG2' ' A' ' 9' ' ' VAL . 0.7 OUTLIER -63.97 116.93 6.33 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.282 -179.816 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.594 ' N ' ' CD ' ' A' ' 7' ' ' PRO . 0.9 OUTLIER -62.36 -35.76 22.72 Favored Pre-proline 0 CA--C 1.534 0.35 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.43 -179.715 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.594 ' CD ' ' N ' ' A' ' 6' ' ' VAL . 35.2 Cg_exo -65.99 -64.59 0.05 OUTLIER 'Trans proline' 0 C--N 1.306 -1.665 0 C-N-CA 121.668 1.579 . . . . 0.0 111.827 179.624 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.547 ' O ' ' CG2' ' A' ' 12' ' ' THR . . . -51.65 -32.76 30.63 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.973 -179.706 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.426 ' CG2' ' O ' ' A' ' 5' ' ' TRP . 58.5 t -69.87 -61.37 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.94 0.4 . . . . 0.0 111.304 -179.447 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -57.89 -43.36 94.85 Favored Glycine 0 CA--C 1.528 0.853 0 N-CA-C 111.215 -0.754 . . . . 0.0 111.215 -179.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 8.1 mp -65.92 -62.95 1.21 Allowed 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 111.544 0.202 . . . . 0.0 111.544 -179.166 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.574 ' OG1' ' SD ' ' A' ' 60' ' ' MET . 6.9 t -54.38 -20.55 7.57 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.449 -0.5 . . . . 0.0 110.572 -179.395 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.431 ' O ' ' C ' ' A' ' 14' ' ' VAL . 17.6 mt -78.79 -38.12 39.17 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.779 0.324 . . . . 0.0 110.371 179.611 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.431 ' C ' ' O ' ' A' ' 13' ' ' LEU . 28.1 t -35.55 -56.72 1.01 Allowed Pre-proline 0 CA--C 1.534 0.342 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.63 -179.774 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.416 ' HD2' ' N ' ' A' ' 14' ' ' VAL . 15.4 Cg_endo -54.6 -32.59 75.46 Favored 'Trans proline' 0 N--CA 1.498 1.772 0 C-N-CA 120.475 0.783 . . . . 0.0 112.501 -179.488 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.421 ' N ' ' O ' ' A' ' 13' ' ' LEU . 2.3 t -45.05 -25.96 0.39 Allowed 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 120.396 -0.522 . . . . 0.0 110.341 -179.586 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 74.5 mt -72.85 -53.69 10.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.128 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -68.61 -34.48 78.69 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 111.594 -0.602 . . . . 0.0 111.594 -179.399 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -75.14 -29.61 60.21 Favored Glycine 0 CA--C 1.517 0.184 0 N-CA-C 110.651 -0.98 . . . . 0.0 110.651 -179.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 36.9 t80 -74.79 -60.71 2.16 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.506 -0.478 . . . . 0.0 110.64 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 9.4 ttt -69.7 -22.85 63.38 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.809 -179.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -73.59 -63.23 2.8 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 111.081 -0.808 . . . . 0.0 111.081 -179.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.83 -23.49 67.38 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.424 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 76.2 t80 -47.83 -23.5 0.76 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.936 0.398 . . . . 0.0 109.95 179.235 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 46.8 t80 -69.49 -52.65 24.56 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.703 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 31.1 m -71.14 -16.2 19.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.864 -179.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 2.4 tmt_? -58.04 -46.38 85.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.79 0.328 . . . . 0.0 110.568 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -100.73 -60.51 0.81 Allowed Glycine 0 CA--C 1.526 0.749 0 N-CA-C 110.916 -0.873 . . . . 0.0 110.916 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -49.84 -31.69 12.51 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.753 0.311 . . . . 0.0 110.546 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.468 ' CA ' ' HZ2' ' A' ' 39' ' ' LYS . . . -68.7 -53.6 19.26 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 110.826 -0.91 . . . . 0.0 110.826 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 71.2 mt -51.24 -38.68 53.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.831 0.348 . . . . 0.0 110.51 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 20.1 mmm-85 -75.13 -46.85 31.7 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.035 -179.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 4.8 m95 -47.12 -39.35 13.17 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 120.853 -0.339 . . . . 0.0 110.269 -179.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 77.6 t80 -53.33 -26.11 17.63 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.312 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -75.89 -16.38 60.05 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.377 179.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -111.37 -76.47 0.83 Allowed Glycine 0 CA--C 1.523 0.568 0 N-CA-C 110.727 -0.949 . . . . 0.0 110.727 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.518 ' C ' ' CD1' ' A' ' 37' ' ' LEU . 3.6 pp -95.27 165.41 12.4 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 110.245 -0.28 . . . . 0.0 110.245 179.708 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 77.0 mm-40 -75.55 113.08 12.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.93 0.395 . . . . 0.0 111.624 -179.121 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.564 ' C ' ' H ' ' A' ' 41' ' ' SER . 0.7 OUTLIER -129.59 135.48 27.61 Favored Pre-proline 0 CA--C 1.536 0.424 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 179.313 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.58 ' C ' ' H ' ' A' ' 42' ' ' TRP . 43.1 Cg_endo -70.39 25.54 0.19 Allowed 'Trans proline' 0 N--CA 1.496 1.671 0 C-N-CA 120.386 0.724 . . . . 0.0 111.617 179.582 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.564 ' H ' ' C ' ' A' ' 39' ' ' LYS . 2.9 t -53.54 -2.28 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.154 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . 0.692 ' CH2' ' NE2' ' A' ' 43' ' ' HIS . 48.4 p-90 -77.49 -16.12 58.91 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.365 -0.534 . . . . 0.0 110.708 -179.367 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.692 ' NE2' ' CH2' ' A' ' 42' ' ' TRP . 6.9 m-70 -65.6 147.16 98.84 Favored Pre-proline 0 C--N 1.33 -0.267 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 178.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.474 ' C ' ' O ' ' A' ' 43' ' ' HIS . 53.0 Cg_exo -31.45 114.39 0.05 OUTLIER 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 121.762 1.642 . . . . 0.0 111.441 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.598 ' O ' ' N ' ' A' ' 47' ' ' TRP . 33.1 Cg_exo -41.89 154.24 0.11 Allowed 'Trans proline' 0 C--N 1.308 -1.555 0 CA-C-N 118.796 0.606 . . . . 0.0 111.844 -179.356 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.443 ' O ' ' CB ' ' A' ' 50' ' ' ALA . 3.0 ppt_? -40.19 -16.77 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.034 -179.83 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.622 ' CD1' ' N ' ' A' ' 48' ' ' THR . 0.7 OUTLIER -60.81 -50.41 73.56 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.77 -0.372 . . . . 0.0 111.005 -179.175 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.622 ' N ' ' CD1' ' A' ' 47' ' ' TRP . 0.9 OUTLIER -90.34 -27.24 19.51 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.621 -178.922 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -83.13 -51.97 7.03 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.524 -0.47 . . . . 0.0 111.867 -178.659 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.656 ' C ' ' H ' ' A' ' 52' ' ' ILE . . . -39.96 -29.57 0.21 Allowed Pre-proline 0 C--O 1.234 0.281 0 N-CA-C 111.88 0.326 . . . . 0.0 111.88 -178.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -53.19 4.5 0.03 OUTLIER 'Trans proline' 0 C--N 1.312 -1.379 0 CA-C-N 119.179 0.742 . . . . 0.0 112.439 178.158 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.656 ' H ' ' C ' ' A' ' 50' ' ' ALA . 8.1 pt -52.49 -33.45 17.84 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.174 0 CA-C-O 121.101 0.477 . . . . 0.0 109.961 179.214 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.439 ' O ' ' CB ' ' A' ' 57' ' ' TYR . 72.6 m95 -79.72 -23.38 42.37 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.45 -179.002 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -71.76 -46.22 39.52 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 110.12 -1.192 . . . . 0.0 110.12 179.08 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 5.9 m -68.36 -52.22 35.66 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 179.321 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 96.0 mt -60.02 -28.72 67.97 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.887 179.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.512 ' C ' ' CD1' ' A' ' 57' ' ' TYR . 0.4 OUTLIER -63.76 -51.53 64.43 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 179.454 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.411 ' HB2' ' HH ' ' A' ' 62' ' ' TYR . 5.8 p -53.98 -50.73 65.91 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.152 179.467 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.71 -42.03 87.7 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.329 179.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.574 ' SD ' ' OG1' ' A' ' 12' ' ' THR . 11.3 mtm -59.27 -40.87 87.41 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.926 179.579 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -58.83 -45.09 95.47 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 110.526 -1.03 . . . . 0.0 110.526 179.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.481 ' N ' ' CD1' ' A' ' 62' ' ' TYR . 2.9 m-30 -62.15 -60.0 4.23 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 121.06 -0.256 . . . . 0.0 110.951 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -54.04 -60.89 7.76 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 110.986 -0.845 . . . . 0.0 110.986 -179.593 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.521 ' O ' ' CD1' ' A' ' 68' ' ' TRP . 56.0 p -45.5 -48.27 14.09 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.012 0.434 . . . . 0.0 110.465 179.804 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 57.6 t80 -56.47 -41.05 75.91 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.945 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 79.4 mt -67.8 -43.44 86.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.952 -179.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.496 ' CG1' ' CZ3' ' A' ' 68' ' ' TRP . 21.5 t -52.54 -56.33 7.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.86 -179.774 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . 0.591 ' O ' ' N ' ' A' ' 73' ' ' GLY . 1.0 OUTLIER -66.29 -46.85 75.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.089 -179.391 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.07 -24.46 40.0 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.947 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -81.19 -62.1 1.76 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.348 -179.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.2 pp -69.3 -2.15 9.99 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.46 -179.101 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.491 ' O ' ' O ' ' A' ' 73' ' ' GLY . . . 108.4 71.13 0.71 Allowed Glycine 0 CA--C 1.527 0.817 0 N-CA-C 111.572 -0.611 . . . . 0.0 111.572 179.557 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.591 ' N ' ' O ' ' A' ' 68' ' ' TRP . . . 42.03 -173.53 0.01 OUTLIER Glycine 0 CA--C 1.525 0.701 0 N-CA-C 111.94 -0.464 . . . . 0.0 111.94 179.286 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 57.6 t80 -69.81 111.21 5.4 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.203 -0.498 . . . . 0.0 111.009 -179.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.516 ' OG1' ' N ' ' A' ' 76' ' ' GLU . 1.3 t -139.4 -175.44 4.18 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.226 179.664 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.516 ' N ' ' OG1' ' A' ' 75' ' ' THR . 73.4 mt-10 -52.92 -24.4 9.18 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.086 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -79.92 -17.71 52.39 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.001 -179.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -96.78 -15.6 21.26 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.04 -179.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 7.0 mtp -70.05 -28.27 65.32 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.484 -0.326 . . . . 0.0 110.885 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 5.1 t -70.47 -54.99 8.02 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.758 -179.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -62.93 -54.61 1.08 Allowed 'Trans proline' 0 N--CA 1.498 1.764 0 C-N-CA 120.993 1.129 . . . . 0.0 111.802 179.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.5 mt -61.05 -55.91 27.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.533 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -53.33 -60.32 8.34 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 111.084 -0.807 . . . . 0.0 111.084 -179.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.6 tt -48.54 -40.82 28.34 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.781 0.324 . . . . 0.0 110.631 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.4 ' O ' ' CB ' ' A' ' 89' ' ' LEU . 11.0 t80 -63.02 -36.15 82.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.597 -179.747 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.449 ' H ' ' HG1' ' A' ' 86' ' ' THR . 0.2 OUTLIER -68.74 -63.05 1.14 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.197 -179.556 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -60.11 -55.59 29.39 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 111.378 -0.689 . . . . 0.0 111.378 -179.547 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.423 ' O ' ' CB ' ' A' ' 92' ' ' ASN . 6.5 tp-100 -50.84 -47.25 60.28 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.652 0.263 . . . . 0.0 111.029 -179.669 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.4 ' CB ' ' O ' ' A' ' 85' ' ' TYR . 11.4 tp -65.3 -28.83 69.59 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.98 0.419 . . . . 0.0 110.313 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.433 ' O ' ' CB ' ' A' ' 94' ' ' ALA . . . -64.7 -65.57 0.66 Allowed 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 120.429 -0.509 . . . . 0.0 111.404 -179.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.3 pp -71.59 -26.11 62.46 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -178.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.423 ' CB ' ' O ' ' A' ' 88' ' ' GLN . 19.1 t-20 -83.53 -57.23 3.32 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.68 -0.408 . . . . 0.0 111.75 -178.847 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . 0.621 ' O ' ' N ' ' A' ' 95' ' ' TRP . 0.0 OUTLIER -72.08 -20.58 61.63 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.693 -0.403 . . . . 0.0 111.091 -178.851 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.433 ' CB ' ' O ' ' A' ' 90' ' ' ALA . . . -46.94 85.31 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.115 0 C-N-CA 120.703 -0.399 . . . . 0.0 110.207 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.707 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 34.4 p-90 -99.77 -16.9 0.2 Allowed Pre-proline 0 CA--C 1.537 0.445 0 CA-C-N 116.2 -0.455 . . . . 0.0 112.119 -179.653 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.707 ' CD ' ' N ' ' A' ' 95' ' ' TRP . 50.1 Cg_exo -55.15 -36.61 93.49 Favored 'Trans proline' 0 N--CA 1.496 1.639 0 C-N-CA 120.424 0.749 . . . . 0.0 113.106 179.483 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.443 ' HD2' ' N ' ' A' ' 96' ' ' PRO . 26.7 Cg_exo -39.74 -29.5 0.29 Allowed 'Trans proline' 0 N--CA 1.491 1.364 0 CA-C-N 118.979 0.671 . . . . 0.0 113.261 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 1.1 pt -83.87 26.45 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 121.109 0.48 . . . . 0.0 110.341 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.444 ' N ' ' O ' ' A' ' 96' ' ' PRO . 11.1 t80 -40.82 -43.52 2.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.794 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -81.53 -42.8 19.66 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.859 -179.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -61.09 -7.01 7.94 Favored Glycine 0 CA--C 1.527 0.791 0 N-CA-C 111.21 -0.756 . . . . 0.0 111.21 -179.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -76.01 -7.32 54.38 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 121.015 -0.274 . . . . 0.0 110.884 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 39.7 ptt85 -89.34 2.04 54.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.77 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 9.4 mt-30 -119.47 164.34 15.92 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.492 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' MET . . . . . 0.586 ' O ' ' NE1' ' A' ' 155' ' ' TRP . 0.0 OUTLIER -52.44 -17.46 1.22 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.296 179.78 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.577 ' O ' ' N ' ' A' ' 108' ' ' ALA . . . -68.11 -15.34 67.33 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 111.058 -0.817 . . . . 0.0 111.058 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' TRP . . . . . 0.416 ' CD1' ' C ' ' A' ' 107' ' ' TRP . 0.0 OUTLIER -44.87 -11.71 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.726 0.298 . . . . 0.0 110.802 -179.727 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.577 ' N ' ' O ' ' A' ' 106' ' ' GLY . . . -66.99 -23.28 65.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.998 0.428 . . . . 0.0 110.485 179.765 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 8.3 mp -52.44 -29.82 26.43 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.023 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -55.87 -64.02 0.99 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.396 179.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.586 ' OD1' ' N ' ' A' ' 112' ' ' LEU . 1.6 p30 -55.62 -52.46 63.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.917 -179.418 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.586 ' N ' ' OD1' ' A' ' 111' ' ' ASP . 8.1 tp -55.55 -40.88 72.47 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.884 -0.327 . . . . 0.0 111.714 -178.66 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 50.5 mt -68.68 -61.36 1.85 Allowed 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.678 -0.409 . . . . 0.0 111.912 -178.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.5 pp -57.95 -34.51 69.98 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 120.361 -0.536 . . . . 0.0 111.122 -178.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.537 ' CG2' ' O ' ' A' ' 111' ' ' ASP . 41.0 t -59.96 -54.52 33.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.912 179.745 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' SER . . . . . 0.443 ' O ' ' OG1' ' A' ' 120' ' ' THR . 58.7 m -71.68 -24.01 61.75 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.573 -179.286 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -65.22 -63.05 4.39 Favored Glycine 0 CA--C 1.527 0.821 0 C-N-CA 120.824 -0.703 . . . . 0.0 111.762 -179.32 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.519 ' O ' ' OG1' ' A' ' 122' ' ' THR . 8.0 p -71.78 -37.87 63.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 O-C-N 122.834 -0.215 . . . . 0.0 111.429 -179.404 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . 0.483 ' O ' ' OG1' ' A' ' 123' ' ' THR . . . -66.22 -60.85 2.4 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.623 -0.431 . . . . 0.0 111.192 -179.171 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.454 ' H ' ' HG1' ' A' ' 120' ' ' THR . 3.0 m -59.1 -54.28 48.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.408 -179.241 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.411 ' O ' ' CB ' ' A' ' 125' ' ' ALA . . . -52.31 -40.35 61.74 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.414 -179.24 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.519 ' OG1' ' O ' ' A' ' 118' ' ' VAL . 33.4 p -73.71 -35.53 65.12 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 111.918 0.34 . . . . 0.0 111.918 -178.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.483 ' OG1' ' O ' ' A' ' 119' ' ' ALA . 0.1 OUTLIER -59.94 -48.51 81.41 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.821 -0.352 . . . . 0.0 110.947 -179.458 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.6 pp -83.79 -19.98 34.09 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.616 -179.011 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . 0.411 ' CB ' ' O ' ' A' ' 121' ' ' ALA . . . -87.66 -68.03 0.78 Allowed 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -178.606 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' TRP . . . . . 0.44 ' N ' ' CD1' ' A' ' 126' ' ' TRP . 38.0 m0 -85.22 -57.44 3.08 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 112.762 0.653 . . . . 0.0 112.762 -177.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . 0.494 ' CD2' ' N ' ' A' ' 127' ' ' HIS . 8.5 m170 -54.37 -22.46 12.32 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.903 -0.319 . . . . 0.0 111.374 -178.58 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.409 ' C ' ' CD ' ' A' ' 128' ' ' ARG . 0.0 OUTLIER -70.84 -48.49 53.66 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.877 -0.329 . . . . 0.0 111.058 -179.665 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 44.2 t -80.82 -49.83 17.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.207 -179.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 5.7 t -129.85 115.6 17.94 Favored Pre-proline 0 CA--C 1.532 0.281 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.827 -179.487 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . 0.565 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 82.7 Cg_exo -72.12 -43.34 1.16 Allowed 'Trans proline' 0 N--CA 1.491 1.371 0 C-N-CA 121.294 1.329 . . . . 0.0 113.077 179.436 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.565 ' CD ' ' N ' ' A' ' 131' ' ' PRO . 68.8 Cg_exo -36.91 -48.82 1.5 Allowed 'Trans proline' 0 N--CA 1.497 1.684 0 C-N-CA 121.038 1.159 . . . . 0.0 112.099 -179.392 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -54.94 -34.98 63.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.042 0.448 . . . . 0.0 110.028 179.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . 0.554 ' N ' ' O ' ' A' ' 131' ' ' PRO . . . -61.64 -22.36 65.2 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.316 179.609 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 12.1 tpp180 -77.69 -34.58 52.83 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.844 -179.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 29.9 mt -73.9 -33.52 64.04 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.63 -0.428 . . . . 0.0 109.922 179.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.586 ' O ' ' N ' ' A' ' 139' ' ' PRO . 10.1 mt -80.16 -40.37 27.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.276 -0.42 . . . . 0.0 109.973 179.315 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.493 ' O ' ' CD1' ' A' ' 138' ' ' TYR . 1.1 t80 -23.02 -40.61 0.03 OUTLIER Pre-proline 0 CA--C 1.534 0.335 0 CA-C-N 115.251 -0.886 . . . . 0.0 112.0 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.586 ' N ' ' O ' ' A' ' 137' ' ' LEU . 3.0 Cg_exo -70.59 13.51 0.35 Allowed 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 121.037 1.158 . . . . 0.0 112.237 179.698 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . 0.64 ' CE1' ' CD1' ' A' ' 141' ' ' LEU . 2.6 p90 -94.18 -14.81 25.21 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-O 121.27 0.557 . . . . 0.0 110.438 179.833 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.64 ' CD1' ' CE1' ' A' ' 140' ' ' TYR . 5.2 mp -56.41 -27.8 57.55 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.266 178.805 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -63.78 -46.43 85.28 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.002 179.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' TRP . . . . . . . . . . . . . 13.6 t-105 -59.61 -46.82 87.84 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 179.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.484 ' O ' ' OG1' ' A' ' 148' ' ' THR . 10.8 mt -52.48 -52.34 54.82 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.263 -0.575 . . . . 0.0 109.871 179.625 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . 0.526 ' O ' ' CG2' ' A' ' 149' ' ' VAL . . . -64.14 -21.76 66.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.664 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 13.5 t80 -66.09 -63.0 1.18 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.828 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -68.9 -36.48 78.08 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.882 -179.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' THR . . . . . 0.498 ' O ' ' OD1' ' A' ' 151' ' ' ASN . 14.8 m -63.32 -50.01 71.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.735 0.302 . . . . 0.0 110.684 -179.828 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.526 ' CG2' ' O ' ' A' ' 145' ' ' ALA . 88.3 t -65.84 -30.69 50.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.567 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 1.4 tp -60.53 -52.9 63.22 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.9 -0.32 . . . . 0.0 110.209 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . 0.498 ' OD1' ' O ' ' A' ' 148' ' ' THR . 0.8 OUTLIER -64.53 -44.04 92.12 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.905 -179.959 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . 0.495 ' N ' ' ND2' ' A' ' 151' ' ' ASN . 26.0 t80 -56.64 -44.51 81.37 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.653 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . 0.428 ' CD2' ' OD2' ' A' ' 157' ' ' ASP . 20.5 t80 -59.08 -55.07 39.85 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.574 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 64.8 t -57.35 -46.09 85.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.75 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' TRP . . . . . 0.586 ' NE1' ' O ' ' A' ' 105' ' ' MET . 5.1 m0 -48.07 -52.06 21.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.818 0.342 . . . . 0.0 110.173 179.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . 0.409 ' HE ' ' HA ' ' A' ' 156' ' ' ARG . 0.0 OUTLIER -64.7 -52.2 58.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.685 -179.83 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . 0.428 ' OD2' ' CD2' ' A' ' 153' ' ' TYR . 80.0 m-20 -50.02 -48.14 52.76 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.854 -179.689 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 29.2 t-20 -67.83 -30.88 70.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.777 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 31.4 t -73.67 157.69 36.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.699 -179.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -162.36 -169.42 25.71 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 111.013 -0.835 . . . . 0.0 111.013 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 39.4 mtm105 -141.61 -107.08 0.14 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.745 0.307 . . . . 0.0 110.47 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 85.8 mtt180 -92.86 149.58 21.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.589 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -166.11 -70.04 0.03 OUTLIER Glycine 0 CA--C 1.526 0.746 0 N-CA-C 110.941 -0.864 . . . . 0.0 110.941 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 68.04 95.98 0.04 OUTLIER Glycine 0 CA--C 1.525 0.678 0 N-CA-C 111.183 -0.767 . . . . 0.0 111.183 179.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 2.3 p -97.27 115.25 27.28 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.753 0.311 . . . . 0.0 110.538 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 38.5 ttm-85 -86.83 42.23 1.01 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.703 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.537 ' C ' ' H ' ' A' ' 169' ' ' GLU . 2.2 mp -139.37 179.32 6.61 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.93 0.395 . . . . 0.0 110.743 -179.684 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . 69.41 -38.86 0.41 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.884 179.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . 0.537 ' H ' ' C ' ' A' ' 167' ' ' LEU . 42.6 mm-40 . . . . . 0 C--O 1.219 -0.505 0 CA-C-O 117.963 -1.018 . . . . 0.0 110.655 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' PKA . . . . . 0.556 ' N18' ' H3 ' ' A' ' 201' ' ' PKA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.425 ' O ' ' N ' ' A' ' 3' ' ' GLU . 5.1 mmt . . . . . 0 CA--C 1.528 0.115 0 N-CA-C 110.406 -0.22 . . . . 0.0 110.406 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_exo -48.81 89.99 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 121.687 1.591 . . . . 0.0 112.147 179.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.425 ' N ' ' O ' ' A' ' 1' ' ' MET . 20.8 mt-10 -66.55 -16.75 64.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.457 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.1 t 62.65 -162.55 0.28 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.919 179.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.711 ' CE2' ' CE3' ' A' ' 68' ' ' TRP . 0.4 OUTLIER -55.38 117.87 3.93 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.595 -179.738 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.638 ' N ' ' CD ' ' A' ' 7' ' ' PRO . 1.0 OUTLIER -64.26 -33.32 8.96 Favored Pre-proline 0 C--N 1.328 -0.329 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 179.662 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.638 ' CD ' ' N ' ' A' ' 6' ' ' VAL . 18.9 Cg_exo -72.78 -67.12 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 121.855 1.703 . . . . 0.0 111.867 179.613 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.544 ' O ' ' CG2' ' A' ' 12' ' ' THR . . . -47.74 -41.89 24.12 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.319 -179.537 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.488 ' O ' ' OG1' ' A' ' 12' ' ' THR . 74.7 t -67.94 -62.41 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -178.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -53.78 -47.53 64.74 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 111.567 -0.613 . . . . 0.0 111.567 -179.163 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.415 ' N ' ' CD1' ' A' ' 11' ' ' LEU . 7.6 mp -65.34 -30.53 71.37 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.533 0.206 . . . . 0.0 111.105 -179.519 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.544 ' CG2' ' O ' ' A' ' 8' ' ' ALA . 6.6 p -76.14 -25.18 55.08 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.749 -0.381 . . . . 0.0 110.786 -179.831 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.425 ' O ' ' C ' ' A' ' 14' ' ' VAL . 9.3 mt -81.72 -36.3 28.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.673 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.425 ' C ' ' O ' ' A' ' 13' ' ' LEU . 4.9 t -37.08 -55.08 1.74 Allowed Pre-proline 0 CA--C 1.535 0.398 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.784 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.417 ' HD2' ' N ' ' A' ' 14' ' ' VAL . 19.3 Cg_endo -60.98 -47.82 11.84 Favored 'Trans proline' 0 N--CA 1.5 1.868 0 C-N-CA 120.678 0.919 . . . . 0.0 112.125 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.9 m -46.01 -22.14 0.19 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.662 -179.556 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 83.9 mt -71.02 -55.9 7.32 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.85 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -74.84 -21.57 78.33 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 111.157 -0.777 . . . . 0.0 111.157 -179.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -69.79 -52.69 18.71 Favored Glycine 0 CA--C 1.522 0.483 0 N-CA-C 110.573 -1.011 . . . . 0.0 110.573 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 68.9 t80 -71.14 -57.88 4.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.721 0.296 . . . . 0.0 110.595 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 8.1 tpp -59.95 -25.69 65.39 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.278 -179.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -82.55 -62.98 1.81 Allowed Glycine 0 CA--C 1.525 0.718 0 C-N-CA 120.839 -0.696 . . . . 0.0 111.485 -179.421 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -59.6 -15.64 20.14 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.798 -0.361 . . . . 0.0 110.659 -179.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 61.6 t80 -46.7 -26.19 0.88 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.981 0.42 . . . . 0.0 110.389 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 70.5 t80 -67.73 -50.65 56.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.661 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.402 ' CG2' 'CL ' ' A' ' 201' ' ' PKA . 31.3 m -72.57 -21.03 19.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.671 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -61.24 -41.09 96.28 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.381 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -110.17 -73.44 0.74 Allowed Glycine 0 CA--C 1.525 0.702 0 N-CA-C 111.034 -0.826 . . . . 0.0 111.034 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.422 ' O ' ' CD ' ' A' ' 29' ' ' GLU . 13.0 tm-20 -46.01 -26.51 0.74 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.753 0.311 . . . . 0.0 110.57 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -65.28 -53.25 33.96 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 111.185 -0.766 . . . . 0.0 111.185 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 24.7 mt -48.5 -28.93 3.66 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.916 0.389 . . . . 0.0 110.211 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 82.8 mtt180 -84.1 -53.75 5.32 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.567 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -44.74 -35.92 2.92 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.19 -0.459 . . . . 0.0 109.96 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.443 ' O ' ' O ' ' A' ' 37' ' ' LEU . 2.8 t80 -64.42 -46.62 82.42 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.938 179.558 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -51.18 -22.88 2.86 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.124 179.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -90.59 -73.9 1.27 Allowed Glycine 0 CA--C 1.524 0.614 0 N-CA-C 110.569 -1.013 . . . . 0.0 110.569 179.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.493 ' CB ' HD22 ' A' ' 158' ' ' ASN . 0.6 OUTLIER -96.2 167.23 11.32 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 120.791 0.329 . . . . 0.0 110.238 179.171 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -77.57 116.09 17.86 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.963 0.411 . . . . 0.0 111.55 -178.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.537 ' C ' ' H ' ' A' ' 41' ' ' SER . 8.0 mtpt -128.93 149.12 71.54 Favored Pre-proline 0 CA--C 1.532 0.275 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.562 179.385 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.664 ' C ' ' H ' ' A' ' 42' ' ' TRP . 93.5 Cg_endo -74.05 20.2 0.41 Allowed 'Trans proline' 0 C--N 1.308 -1.564 0 C-N-CA 121.199 1.266 . . . . 0.0 111.022 179.304 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.537 ' H ' ' C ' ' A' ' 39' ' ' LYS . 11.9 p -49.28 -0.67 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.212 179.743 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . 0.664 ' H ' ' C ' ' A' ' 40' ' ' PRO . 1.8 p90 -75.56 -15.53 60.36 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.568 -0.453 . . . . 0.0 110.662 -179.076 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.455 ' O ' ' C ' ' A' ' 44' ' ' PRO . 3.6 m-70 -62.7 147.28 93.38 Favored Pre-proline 0 C--N 1.329 -0.3 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 179.095 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.474 ' O ' ' O ' ' A' ' 45' ' ' PRO . 6.7 Cg_endo -32.76 120.42 0.1 OUTLIER 'Trans proline' 0 N--CA 1.493 1.46 0 C-N-CA 121.483 1.455 . . . . 0.0 110.837 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.474 ' O ' ' O ' ' A' ' 44' ' ' PRO . 1.5 Cg_endo -37.89 160.99 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.398 0 C-N-CA 120.342 0.694 . . . . 0.0 111.997 -178.411 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.451 ' O ' ' CB ' ' A' ' 50' ' ' ALA . 7.1 ppt_? -49.37 -22.83 1.23 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.277 -0.874 . . . . 0.0 112.134 -178.889 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.585 ' CD1' ' N ' ' A' ' 48' ' ' THR . 1.2 p-90 -58.94 -41.5 87.55 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.93 0.715 . . . . 0.0 112.93 -178.487 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.585 ' N ' ' CD1' ' A' ' 47' ' ' TRP . 0.9 OUTLIER -88.86 -43.44 11.21 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.477 0.547 . . . . 0.0 112.477 -177.6 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 44.1 tp -82.81 -51.59 7.52 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.134 -0.626 . . . . 0.0 112.471 -178.051 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.644 ' C ' ' H ' ' A' ' 52' ' ' ILE . . . -41.74 -28.92 0.27 Allowed Pre-proline 0 N--CA 1.466 0.358 0 C-N-CA 120.22 -0.592 . . . . 0.0 111.46 -179.138 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.409 ' HD2' ' N ' ' A' ' 50' ' ' ALA . 23.2 Cg_exo -53.05 4.06 0.03 OUTLIER 'Trans proline' 0 C--N 1.312 -1.364 0 CA-C-N 118.847 0.624 . . . . 0.0 112.123 177.829 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.644 ' H ' ' C ' ' A' ' 50' ' ' ALA . 7.1 pt -48.44 -29.61 2.55 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.177 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 179.054 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 6.5 m0 -58.97 -45.44 90.54 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.465 -0.788 . . . . 0.0 110.89 -179.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -68.84 -42.53 78.48 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 110.901 -0.879 . . . . 0.0 110.901 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.494 ' O ' ' OG ' ' A' ' 58' ' ' SER . 51.9 m -59.04 -56.31 23.93 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.798 0.332 . . . . 0.0 110.709 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 70.4 mt -67.32 -30.45 70.29 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.665 -179.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.493 ' C ' ' CD1' ' A' ' 57' ' ' TYR . 13.7 t80 -60.8 -36.31 78.7 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.132 179.572 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.579 ' HG ' ' H ' ' A' ' 59' ' ' ALA . 7.7 p -74.07 -57.92 3.64 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.047 179.587 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.579 ' H ' ' HG ' ' A' ' 58' ' ' SER . . . -48.53 -52.29 23.29 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.022 179.645 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 70.6 mtm -55.09 -47.88 74.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.072 179.608 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -46.82 -59.56 5.44 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 110.717 -0.953 . . . . 0.0 110.717 179.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 3.4 m-30 -51.84 -52.18 51.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.924 0.392 . . . . 0.0 110.116 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -47.83 -46.76 25.33 Favored Glycine 0 CA--C 1.522 0.53 0 N-CA-C 110.487 -1.045 . . . . 0.0 110.487 179.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.537 ' O ' ' NE1' ' A' ' 68' ' ' TRP . 1.1 t -60.53 -45.04 95.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.793 0.33 . . . . 0.0 110.577 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.402 ' HA ' ' CZ2' ' A' ' 68' ' ' TRP . 84.6 t80 -48.55 -45.85 38.19 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 179.58 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 37.9 mt -72.27 -26.06 24.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.136 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 55.8 t -65.21 -59.94 3.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 C-N-CA 120.584 -0.446 . . . . 0.0 111.09 -179.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . 0.711 ' CE3' ' CE2' ' A' ' 5' ' ' TRP . 0.0 OUTLIER -67.51 -33.83 75.88 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 119.9 -0.72 . . . . 0.0 110.563 -179.753 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 5.8 mmmt -69.56 -23.41 63.56 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.517 -0.473 . . . . 0.0 111.035 -179.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 19.9 tp10 -80.95 -55.61 4.67 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.941 -0.304 . . . . 0.0 111.226 -179.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.6 pp -77.04 -11.77 59.85 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.93 -0.308 . . . . 0.0 111.184 -179.301 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.491 ' O ' ' O ' ' A' ' 73' ' ' GLY . . . 107.0 87.29 1.93 Allowed Glycine 0 CA--C 1.527 0.835 0 N-CA-C 111.604 -0.598 . . . . 0.0 111.604 179.398 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.596 ' N ' ' O ' ' A' ' 68' ' ' TRP . . . 41.56 -173.82 0.01 OUTLIER Glycine 0 CA--C 1.525 0.714 0 N-CA-C 111.797 -0.521 . . . . 0.0 111.797 179.207 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 82.7 t80 -79.94 113.39 18.07 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.841 0.353 . . . . 0.0 110.548 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.548 ' OG1' ' N ' ' A' ' 76' ' ' GLU . 0.0 OUTLIER -141.89 -178.85 5.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.626 -179.86 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.548 ' N ' ' OG1' ' A' ' 75' ' ' THR . 31.8 mt-10 -54.93 -20.12 8.23 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.623 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 76.0 m-20 -83.1 -18.57 39.1 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.921 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -93.32 -20.21 20.61 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.862 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 11.7 mtp -69.01 -27.22 65.49 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.846 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 5.9 t -67.56 -46.9 47.3 Favored Pre-proline 0 CA--C 1.536 0.432 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.534 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -75.18 -61.65 0.04 OUTLIER 'Trans proline' 0 N--CA 1.499 1.845 0 C-N-CA 121.106 1.204 . . . . 0.0 111.656 178.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 4.6 mt -52.33 -50.66 61.84 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.363 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.406 ' O ' ' N ' ' A' ' 86' ' ' THR . . . -61.93 -64.04 4.27 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 111.262 -0.735 . . . . 0.0 111.262 -179.705 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 40.3 tp -46.83 -29.61 2.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.823 0.344 . . . . 0.0 110.233 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.423 ' CD1' ' C ' ' A' ' 85' ' ' TYR . 1.1 t80 -75.27 -37.68 60.82 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.033 179.744 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.406 ' N ' ' O ' ' A' ' 83' ' ' GLY . 0.8 OUTLIER -67.91 -48.92 64.63 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.094 -179.648 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -69.15 -58.04 7.06 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 111.492 -0.643 . . . . 0.0 111.492 -179.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 34.0 tp60 -51.45 -49.23 62.14 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-O 120.991 0.424 . . . . 0.0 110.414 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.427 ' O ' ' C ' ' A' ' 90' ' ' ALA . 27.3 tp -54.65 -62.62 1.54 Allowed 'General case' 0 C--O 1.212 -0.869 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 179.525 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.431 ' O ' ' CB ' ' A' ' 94' ' ' ALA . . . -38.24 -42.81 0.72 Allowed 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 120.537 -0.465 . . . . 0.0 111.426 -179.683 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 92.1 mt -63.16 -56.81 13.57 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 -178.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 15.8 m-20 -72.24 -54.63 9.02 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 121.431 0.634 . . . . 0.0 111.058 -178.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . 0.61 ' O ' ' N ' ' A' ' 95' ' ' TRP . 16.6 t-105 -52.75 -30.0 30.23 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.049 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.431 ' CB ' ' O ' ' A' ' 90' ' ' ALA . . . -60.38 71.8 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 121.084 0.469 . . . . 0.0 109.753 179.376 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.71 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 23.8 p-90 -98.49 -17.18 0.2 Allowed Pre-proline 0 CA--C 1.537 0.478 0 CA-C-N 115.852 -0.613 . . . . 0.0 112.336 -179.255 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.71 ' CD ' ' N ' ' A' ' 95' ' ' TRP . 52.6 Cg_exo -53.4 -39.84 80.31 Favored 'Trans proline' 0 N--CA 1.497 1.684 0 C-N-CA 120.556 0.837 . . . . 0.0 113.341 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.467 ' C ' ' H ' ' A' ' 99' ' ' PHE . 31.7 Cg_exo -36.52 -34.94 0.17 Allowed 'Trans proline' 0 N--CA 1.491 1.327 0 CA-C-N 119.143 0.73 . . . . 0.0 113.185 -179.727 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -79.58 24.27 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 121.024 0.44 . . . . 0.0 110.386 179.696 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.537 ' N ' ' O ' ' A' ' 96' ' ' PRO . 27.0 t80 -44.31 -34.93 2.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.666 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -86.19 -42.97 13.39 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.893 -179.762 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -61.42 -9.59 18.12 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 111.07 -0.812 . . . . 0.0 111.07 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -61.55 -13.27 20.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.748 0.309 . . . . 0.0 110.935 -179.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 25.3 ptt180 -90.68 4.56 51.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.809 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 12.1 mt-30 -115.28 154.2 29.53 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.435 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -52.71 -18.26 1.73 Allowed 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 179.559 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.586 ' C ' ' H ' ' A' ' 108' ' ' ALA . . . -69.43 -15.96 71.01 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' TRP . . . . . 0.452 ' CD1' ' N ' ' A' ' 108' ' ' ALA . 0.1 OUTLIER -45.36 -11.67 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.9 0.381 . . . . 0.0 110.54 -179.865 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.586 ' H ' ' C ' ' A' ' 106' ' ' GLY . . . -59.32 -23.15 62.24 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.193 179.657 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 13.9 mt -53.7 -28.66 35.05 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.383 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -56.71 -61.37 2.48 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.862 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.546 ' O ' ' CG2' ' A' ' 115' ' ' VAL . 1.4 p30 -61.53 -52.29 65.08 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.785 -179.293 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.531 ' N ' ' CG ' ' A' ' 111' ' ' ASP . 56.1 tp -55.42 -38.41 68.93 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.716 -178.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 51.7 mt -71.4 -61.81 1.64 Allowed 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.36 0.504 . . . . 0.0 112.36 -178.611 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.6 pp -59.75 -32.84 70.95 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.213 -0.595 . . . . 0.0 110.95 -178.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.546 ' CG2' ' O ' ' A' ' 111' ' ' ASP . 41.3 t -61.7 -59.47 4.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.752 179.767 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' SER . . . . . 0.49 ' O ' ' OG1' ' A' ' 120' ' ' THR . 49.4 m -68.84 -22.1 64.25 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.428 -179.261 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -66.51 -62.58 4.49 Favored Glycine 0 CA--C 1.527 0.823 0 C-N-CA 121.039 -0.601 . . . . 0.0 111.934 -179.124 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.496 ' O ' ' OG1' ' A' ' 122' ' ' THR . 7.0 p -72.43 -36.91 56.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 C-N-CA 120.915 -0.314 . . . . 0.0 111.411 -179.23 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . 0.545 ' O ' ' OG1' ' A' ' 123' ' ' THR . . . -67.41 -61.01 2.11 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.593 -0.443 . . . . 0.0 110.953 -179.362 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.49 ' OG1' ' O ' ' A' ' 116' ' ' SER . 2.8 m -58.64 -55.33 36.53 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.234 -179.584 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.419 ' O ' ' CB ' ' A' ' 125' ' ' ALA . . . -50.53 -41.95 54.45 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.304 -179.352 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.496 ' OG1' ' O ' ' A' ' 118' ' ' VAL . 38.9 p -73.32 -39.72 65.04 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 111.844 0.313 . . . . 0.0 111.844 -179.095 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.545 ' OG1' ' O ' ' A' ' 119' ' ' ALA . 0.1 OUTLIER -54.09 -50.28 67.17 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.91 -179.268 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.6 pp -84.11 -20.32 32.76 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.198 -0.455 . . . . 0.0 112.077 -178.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . 0.419 ' CB ' ' O ' ' A' ' 121' ' ' ALA . . . -88.68 -70.68 0.63 Allowed 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 -178.47 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' TRP . . . . . 0.55 ' N ' ' CD1' ' A' ' 126' ' ' TRP . 18.6 m0 -83.93 -58.0 2.97 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 112.84 0.681 . . . . 0.0 112.84 -177.862 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 18.9 m170 -49.77 -22.23 1.35 Allowed 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.458 -0.497 . . . . 0.0 110.932 -179.128 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 1.4 tmt_? -73.44 -29.47 62.57 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.023 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 14.6 t -99.76 -49.85 11.07 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 CA-C-O 120.942 0.401 . . . . 0.0 110.763 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -115.56 105.83 51.36 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.202 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . 0.64 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 76.9 Cg_exo -72.77 -24.34 18.22 Favored 'Trans proline' 0 C--N 1.311 -1.398 0 C-N-CA 121.59 1.526 . . . . 0.0 112.686 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.64 ' CD ' ' N ' ' A' ' 131' ' ' PRO . 51.2 Cg_exo -66.21 -47.47 3.34 Favored 'Trans proline' 0 N--CA 1.496 1.627 0 C-N-CA 121.292 1.328 . . . . 0.0 112.084 179.624 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -50.41 -39.39 47.03 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.568 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -53.92 -23.48 13.02 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.404 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 11.0 tpp180 -78.25 -32.4 49.63 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.545 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 47.0 mt -72.77 -33.47 66.34 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.32 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.58 ' O ' ' N ' ' A' ' 140' ' ' TYR . 5.6 mt -84.09 -39.26 19.74 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.002 -0.545 . . . . 0.0 109.855 179.519 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.477 ' C ' ' O ' ' A' ' 137' ' ' LEU . 2.0 t80 -23.72 -43.67 0.05 OUTLIER Pre-proline 0 CA--C 1.534 0.338 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.82 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.516 ' N ' ' O ' ' A' ' 137' ' ' LEU . 3.4 Cg_exo -67.61 10.96 0.24 Allowed 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 120.984 1.123 . . . . 0.0 112.561 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . 0.618 ' CE1' ' CD1' ' A' ' 141' ' ' LEU . 1.5 p90 -93.83 -14.88 25.65 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 121.083 0.468 . . . . 0.0 110.483 179.819 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.618 ' CD1' ' CE1' ' A' ' 140' ' ' TYR . 4.1 mp -53.63 -32.45 51.36 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 179.004 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -60.33 -52.46 65.17 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.217 179.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' TRP . . . . . . . . . . . . . 7.7 t-105 -53.08 -49.66 65.95 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 179.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 10.5 mt -49.99 -59.6 3.72 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.015 179.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . 0.491 ' O ' ' CG2' ' A' ' 149' ' ' VAL . . . -58.73 -20.71 51.49 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.056 -179.684 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -67.18 -57.6 6.43 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.805 -0.358 . . . . 0.0 110.402 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -66.08 -47.4 74.38 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.216 179.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 7.1 m -55.68 -51.35 67.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.709 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.491 ' CG2' ' O ' ' A' ' 145' ' ' ALA . 90.7 t -64.68 -26.53 40.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 C-N-CA 120.895 -0.322 . . . . 0.0 110.278 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -60.72 -55.0 38.38 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.313 -0.555 . . . . 0.0 109.794 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . 0.495 ' ND2' ' OD2' ' A' ' 111' ' ' ASP . 1.9 m-80 -65.85 -39.89 91.19 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.694 -0.403 . . . . 0.0 110.357 179.429 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . 0.518 ' HH ' HH21 ' A' ' 156' ' ' ARG . 29.3 t80 -56.05 -46.19 78.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.569 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . 0.408 ' O ' ' OD1' ' A' ' 157' ' ' ASP . 5.5 t80 -63.56 -44.66 93.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.479 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 79.5 t -57.74 -45.15 86.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.653 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' TRP . . . . . 0.588 ' O ' ' N ' ' A' ' 159' ' ' SER . 10.2 m0 -56.45 -56.98 14.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.518 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . 0.518 HH21 ' HH ' ' A' ' 152' ' ' TYR . 0.9 OUTLIER -49.16 -38.71 26.4 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.589 -179.962 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . 0.408 ' OD1' ' O ' ' A' ' 153' ' ' TYR . 1.5 m-20 -75.41 -52.04 11.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.803 0.335 . . . . 0.0 110.675 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . 0.493 HD22 ' CB ' ' A' ' 37' ' ' LEU . 4.7 m120 -74.79 -6.12 47.2 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.648 -179.772 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' SER . . . . . 0.588 ' N ' ' O ' ' A' ' 155' ' ' TRP . 7.6 t -149.03 131.52 15.75 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.808 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -175.32 71.51 0.09 OUTLIER Glycine 0 CA--C 1.526 0.759 0 N-CA-C 111.176 -0.77 . . . . 0.0 111.176 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 10.5 mtm-85 -95.17 90.38 5.87 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.752 0.31 . . . . 0.0 110.505 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 54.9 mtm180 -87.67 124.64 33.77 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.681 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 90.48 -165.5 31.2 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 111.128 -0.789 . . . . 0.0 111.128 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 176.48 11.76 0.02 OUTLIER Glycine 0 CA--C 1.525 0.707 0 N-CA-C 111.017 -0.833 . . . . 0.0 111.017 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 3.5 t 63.27 -172.26 0.17 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.837 0.351 . . . . 0.0 110.569 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 83.4 mtt180 -89.23 173.41 8.42 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.656 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.51 ' CD2' ' N ' ' A' ' 167' ' ' LEU . 1.5 mm? -108.13 62.12 0.61 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.113 179.608 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -74.23 -0.84 18.17 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.676 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 . . . . . 0 C--O 1.219 -0.503 0 CA-C-O 118.008 -0.996 . . . . 0.0 110.473 179.852 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' PKA . . . . . 0.553 ' N18' ' H3 ' ' A' ' 201' ' ' PKA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.529 0.151 0 CA-C-O 120.74 0.305 . . . . 0.0 110.463 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -73.9 150.14 43.42 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 C-N-CA 122.095 1.863 . . . . 0.0 112.118 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -133.93 -30.94 1.18 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.291 179.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.6 p 73.36 133.8 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.694 179.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.69 ' CE2' ' CE3' ' A' ' 68' ' ' TRP . 0.3 OUTLIER -61.43 118.41 6.94 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.001 179.806 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.609 ' N ' ' CD ' ' A' ' 7' ' ' PRO . 0.9 OUTLIER -61.66 -35.5 22.96 Favored Pre-proline 0 CA--C 1.532 0.277 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 -179.914 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.609 ' CD ' ' N ' ' A' ' 6' ' ' VAL . 18.6 Cg_exo -70.83 -67.53 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.509 0 C-N-CA 121.686 1.59 . . . . 0.0 111.835 179.541 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.5 ' O ' ' CG2' ' A' ' 12' ' ' THR . . . -46.79 -40.27 13.37 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.202 -179.652 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.506 ' O ' ' OG1' ' A' ' 12' ' ' THR . 73.8 t -65.24 -61.97 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 112.062 0.393 . . . . 0.0 112.062 -178.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -58.38 -49.49 75.81 Favored Glycine 0 CA--C 1.527 0.837 0 N-CA-C 111.269 -0.732 . . . . 0.0 111.269 -179.158 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 9.3 mp -58.87 -30.54 67.81 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.538 0.209 . . . . 0.0 110.755 -179.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.506 ' OG1' ' O ' ' A' ' 9' ' ' VAL . 7.5 p -78.66 -31.18 46.64 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 120.801 -0.36 . . . . 0.0 110.191 179.548 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 81.2 mt -73.53 -22.17 60.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.117 179.656 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.498 ' O ' ' N ' ' A' ' 16' ' ' SER . 9.7 t -58.22 -66.6 1.26 Allowed Pre-proline 0 CA--C 1.536 0.434 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.312 -179.798 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -45.49 -14.87 0.11 Allowed 'Trans proline' 0 N--CA 1.499 1.799 0 C-N-CA 120.778 0.985 . . . . 0.0 112.074 -179.625 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.498 ' N ' ' O ' ' A' ' 14' ' ' VAL . 1.1 t -76.17 -35.99 58.9 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.866 0.365 . . . . 0.0 110.6 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 8.9 mt -69.75 -45.12 68.8 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.172 -179.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -73.6 -48.86 16.25 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 111.631 -0.588 . . . . 0.0 111.631 -179.545 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -63.24 -30.16 76.67 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 111.18 -0.768 . . . . 0.0 111.18 -179.576 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 64.4 t80 -75.95 -60.77 2.18 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.838 -0.345 . . . . 0.0 111.107 -179.528 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 28.0 ttp -61.59 -21.31 64.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.908 0.385 . . . . 0.0 110.324 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.515 ' C ' ' CZ2' ' A' ' 95' ' ' TRP . . . -73.45 -62.9 2.92 Favored Glycine 0 CA--C 1.524 0.615 0 N-CA-C 111.135 -0.786 . . . . 0.0 111.135 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.94 -16.49 63.92 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.54 -179.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 42.8 t80 -49.93 -24.15 2.37 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 179.264 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 9.7 t80 -72.11 -53.41 12.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.862 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 16.4 m -72.09 -14.58 17.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.81 -179.668 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.64 -42.69 75.35 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.255 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -121.45 -49.86 0.26 Allowed Glycine 0 CA--C 1.525 0.709 0 N-CA-C 110.693 -0.963 . . . . 0.0 110.693 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -56.01 -32.03 63.61 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.887 0.375 . . . . 0.0 110.417 179.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -75.46 -58.23 3.96 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.874 -0.89 . . . . 0.0 110.874 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 11.0 mp -53.49 -21.89 7.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.903 0.382 . . . . 0.0 110.06 179.676 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 38.9 mtp180 -84.86 -54.98 4.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.526 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -48.52 -30.57 5.36 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.182 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 52.1 t80 -50.3 -40.02 47.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.877 0.37 . . . . 0.0 110.31 179.723 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -58.91 -17.42 24.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.393 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -100.44 -72.15 0.99 Allowed Glycine 0 CA--C 1.527 0.796 0 N-CA-C 111.003 -0.839 . . . . 0.0 111.003 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -95.45 167.08 11.54 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.838 0.352 . . . . 0.0 110.828 179.861 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.489 ' NE2' ' H ' ' A' ' 38' ' ' GLN . 2.4 mp0 -81.62 113.38 19.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.126 -179.673 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.403 ' NZ ' ' CZ3' ' A' ' 107' ' ' TRP . 15.4 mtpt -129.05 160.19 64.91 Favored Pre-proline 0 CA--C 1.531 0.248 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.718 179.489 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.625 ' C ' ' H ' ' A' ' 42' ' ' TRP . 56.3 Cg_endo -82.55 30.48 0.53 Allowed 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 121.806 1.671 . . . . 0.0 111.381 179.356 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -51.12 -1.29 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.486 -179.896 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . 0.673 ' CH2' ' NE2' ' A' ' 43' ' ' HIS . 43.6 p-90 -76.38 -11.3 59.87 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.331 -0.548 . . . . 0.0 110.326 -179.247 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.673 ' NE2' ' CH2' ' A' ' 42' ' ' TRP . 5.6 m80 -63.71 133.16 95.44 Favored Pre-proline 0 C--N 1.328 -0.354 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 178.352 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.447 ' C ' ' O ' ' A' ' 43' ' ' HIS . 30.2 Cg_endo -34.94 149.82 0.03 OUTLIER 'Trans proline' 0 N--CA 1.496 1.622 0 C-N-CA 121.034 1.156 . . . . 0.0 111.464 -179.158 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -53.68 151.1 26.3 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 120.896 1.064 . . . . 0.0 111.823 -179.48 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.556 ' C ' ' HE ' ' A' ' 46' ' ' ARG . 0.0 OUTLIER -52.4 -17.71 1.31 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.997 -179.812 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.56 ' CD1' ' N ' ' A' ' 48' ' ' THR . 0.8 OUTLIER -49.71 -48.68 49.67 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.876 -0.33 . . . . 0.0 111.608 -179.105 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.56 ' N ' ' CD1' ' A' ' 47' ' ' TRP . 12.9 t -91.79 -27.47 17.98 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 -179.496 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.41 ' O ' ' C ' ' A' ' 50' ' ' ALA . 0.2 OUTLIER -77.73 -56.77 4.24 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 112.243 0.46 . . . . 0.0 112.243 -178.05 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.63 ' C ' ' H ' ' A' ' 52' ' ' ILE . . . -38.3 -33.78 0.25 Allowed Pre-proline 0 C--O 1.235 0.337 0 C-N-CA 120.771 -0.372 . . . . 0.0 111.431 -179.03 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.409 ' HD2' ' N ' ' A' ' 50' ' ' ALA . 34.4 Cg_exo -53.69 4.93 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.613 0 C-N-CA 120.355 0.703 . . . . 0.0 112.773 178.816 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.63 ' H ' ' C ' ' A' ' 50' ' ' ALA . 10.5 pt -54.08 -35.65 29.57 Favored 'Isoleucine or valine' 0 C--O 1.232 0.169 0 CA-C-O 121.248 0.547 . . . . 0.0 109.542 179.157 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.421 ' O ' ' CB ' ' A' ' 57' ' ' TYR . 62.3 m95 -73.17 -22.95 60.38 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.244 -0.889 . . . . 0.0 111.35 -179.285 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -70.49 -48.15 38.33 Favored Glycine 0 CA--C 1.527 0.812 0 N-CA-C 110.481 -1.048 . . . . 0.0 110.481 179.503 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 11.0 m -65.75 -55.28 18.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.969 0.414 . . . . 0.0 109.909 179.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.562 ' O ' ' SD ' ' A' ' 60' ' ' MET . 94.8 mt -56.71 -36.29 69.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.954 179.463 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.548 ' C ' ' CD1' ' A' ' 57' ' ' TYR . 0.4 OUTLIER -54.76 -52.03 63.84 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 179.109 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 3.1 m -52.23 -47.26 65.8 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 178.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -56.26 -46.24 79.74 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.343 179.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.562 ' SD ' ' O ' ' A' ' 56' ' ' LEU . 0.0 OUTLIER -61.87 -40.74 96.44 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.334 179.926 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -52.46 -52.89 34.69 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 110.641 -0.984 . . . . 0.0 110.641 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.46 ' CD1' ' N ' ' A' ' 62' ' ' TYR . 1.1 m-85 -65.78 -40.86 92.38 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.925 0.393 . . . . 0.0 110.376 179.762 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -54.19 -52.55 43.13 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 110.342 -1.103 . . . . 0.0 110.342 179.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.587 ' O ' ' CD1' ' A' ' 68' ' ' TRP . 1.0 OUTLIER -56.47 -44.56 80.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.86 0.362 . . . . 0.0 110.42 179.684 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.431 ' HA ' ' CZ2' ' A' ' 68' ' ' TRP . 85.4 t80 -48.45 -47.35 38.27 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.674 -0.41 . . . . 0.0 110.083 179.651 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 53.3 mt -70.7 -25.95 27.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.041 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 68.8 t -66.02 -58.79 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 C-N-CA 120.582 -0.447 . . . . 0.0 111.578 -179.41 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . 0.69 ' CE3' ' CE2' ' A' ' 5' ' ' TRP . 0.0 OUTLIER -71.79 -27.8 63.18 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 119.656 -0.818 . . . . 0.0 110.69 -179.643 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 9.4 mmmt -72.25 -24.2 61.33 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.468 -0.493 . . . . 0.0 110.352 179.658 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -82.31 -59.18 2.63 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.949 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.5 pp -71.67 -16.77 62.26 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.02 -179.548 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.5 ' O ' ' O ' ' A' ' 73' ' ' GLY . . . 108.39 94.53 2.34 Favored Glycine 0 CA--C 1.527 0.826 0 N-CA-C 111.703 -0.559 . . . . 0.0 111.703 179.459 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.585 ' N ' ' O ' ' A' ' 68' ' ' TRP . . . 42.02 -174.1 0.01 OUTLIER Glycine 0 CA--C 1.525 0.704 0 N-CA-C 111.799 -0.52 . . . . 0.0 111.799 179.198 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 32.4 t80 -87.22 113.21 22.75 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.547 -0.327 . . . . 0.0 110.595 -179.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.528 ' OG1' ' N ' ' A' ' 76' ' ' GLU . 0.8 OUTLIER -142.13 -177.41 5.22 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.686 -179.909 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.528 ' N ' ' OG1' ' A' ' 75' ' ' THR . 29.5 mt-10 -51.78 -23.14 4.27 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.796 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -79.72 -24.58 41.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.939 -179.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -90.33 -20.59 22.7 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.003 -179.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 14.9 mtp -69.49 -28.66 66.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.806 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.416 ' O ' ' CB ' ' A' ' 84' ' ' LEU . 5.9 t -67.16 -50.77 39.01 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.507 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_endo -69.52 -60.45 0.07 OUTLIER 'Trans proline' 0 N--CA 1.499 1.846 0 C-N-CA 121.065 1.177 . . . . 0.0 111.81 179.031 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.3 mt -53.37 -51.95 60.84 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.614 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -62.84 -63.33 4.7 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 111.383 -0.687 . . . . 0.0 111.383 -179.485 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.416 ' CB ' ' O ' ' A' ' 80' ' ' VAL . 52.6 tp -45.87 -31.64 2.23 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.749 0.309 . . . . 0.0 110.647 -179.845 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 7.0 t80 -67.96 -58.51 4.42 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.274 -179.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 3.5 m -61.89 -60.35 3.77 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.841 -179.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -45.56 -57.11 6.04 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 111.112 -0.795 . . . . 0.0 111.112 -179.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 11.1 tp-100 -58.94 -32.85 69.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.759 0.314 . . . . 0.0 110.679 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.445 ' O ' ' CD1' ' A' ' 93' ' ' TRP . 11.8 tp -67.73 -36.59 80.85 Favored 'General case' 0 C--O 1.222 -0.379 0 C-N-CA 120.685 -0.406 . . . . 0.0 110.306 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.49 ' O ' ' CB ' ' A' ' 94' ' ' ALA . . . -65.81 -59.91 3.41 Favored 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 120.268 -0.573 . . . . 0.0 110.379 179.833 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 7.9 mt -55.31 -53.89 50.44 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.786 -0.643 . . . . 0.0 112.21 -179.085 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -75.2 -60.83 2.12 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -177.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . 0.611 ' O ' ' N ' ' A' ' 95' ' ' TRP . 0.0 OUTLIER -63.78 -11.74 29.4 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.192 0.441 . . . . 0.0 112.192 -177.688 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.49 ' CB ' ' O ' ' A' ' 90' ' ' ALA . . . -54.12 80.5 0.0 OUTLIER 'General case' 0 CA--C 1.528 0.126 0 C-N-CA 120.399 -0.521 . . . . 0.0 109.76 179.224 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.689 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 14.6 p-90 -101.22 -15.23 0.18 Allowed Pre-proline 0 CA--C 1.534 0.338 0 CA-C-N 116.208 -0.451 . . . . 0.0 112.086 -179.312 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.689 ' CD ' ' N ' ' A' ' 95' ' ' TRP . 64.8 Cg_exo -64.12 -12.65 33.48 Favored 'Trans proline' 0 N--CA 1.498 1.768 0 C-N-CA 120.875 1.05 . . . . 0.0 113.558 179.634 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.621 ' CD ' ' N ' ' A' ' 96' ' ' PRO . 51.2 Cg_exo -85.33 -8.79 8.55 Favored 'Trans proline' 0 N--CA 1.502 1.978 0 C-N-CA 120.753 0.968 . . . . 0.0 113.519 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.416 ' O ' ' N ' ' A' ' 101' ' ' GLY . 1.5 pp -84.18 18.62 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 C-N-CA 120.608 -0.437 . . . . 0.0 110.932 -179.661 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.565 ' CD1' ' O ' ' A' ' 96' ' ' PRO . 2.7 m-30 -39.85 -34.12 0.25 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.211 179.673 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 0.457 ' O ' ' NE ' ' A' ' 103' ' ' ARG . 0.9 OUTLIER -76.36 -45.08 33.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.745 -179.902 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.416 ' N ' ' O ' ' A' ' 98' ' ' ILE . . . -65.98 -9.98 49.36 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 110.97 -0.852 . . . . 0.0 110.97 -179.921 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -78.35 -7.17 56.98 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.749 0.309 . . . . 0.0 110.724 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.457 ' NE ' ' O ' ' A' ' 100' ' ' PHE . 1.2 ptp180 -79.16 -14.8 58.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.867 -179.769 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . 0.407 ' C ' ' N ' ' A' ' 106' ' ' GLY . 1.4 pt20 -125.82 172.58 9.74 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.826 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' MET . . . . . 0.493 ' N ' ' SD ' ' A' ' 105' ' ' MET . 0.0 OUTLIER -49.37 -16.88 0.21 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.457 179.822 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.437 ' C ' ' N ' ' A' ' 108' ' ' ALA . . . -60.6 -15.79 41.84 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 111.1 -0.8 . . . . 0.0 111.1 -179.892 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' TRP . . . . . 0.481 ' CD1' ' N ' ' A' ' 108' ' ' ALA . 0.0 OUTLIER -50.48 -14.46 0.18 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.848 0.356 . . . . 0.0 110.432 -179.779 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.481 ' N ' ' CD1' ' A' ' 107' ' ' TRP . . . -61.11 -17.55 53.3 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.212 179.621 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 6.0 mp -56.67 -28.56 60.96 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.671 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -58.71 -62.63 1.72 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.845 0.355 . . . . 0.0 110.672 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.53 ' O ' ' CG2' ' A' ' 115' ' ' VAL . 4.4 p-10 -57.29 -53.67 55.53 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.358 -179.429 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 29.9 tp -54.45 -43.13 71.37 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.773 -179.034 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 53.7 mt -67.54 -61.3 1.96 Allowed 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.584 0.587 . . . . 0.0 112.584 -178.387 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.9 pp -61.09 -34.36 74.82 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 120.445 -0.502 . . . . 0.0 111.572 -178.555 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.53 ' CG2' ' O ' ' A' ' 111' ' ' ASP . 48.1 t -61.49 -58.0 9.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.383 -0.372 . . . . 0.0 111.385 -179.856 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 23.4 p -71.9 -23.59 61.51 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.603 -179.091 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -64.61 -62.14 5.31 Favored Glycine 0 CA--C 1.525 0.67 0 C-N-CA 120.842 -0.694 . . . . 0.0 111.472 -179.389 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.492 ' O ' ' OG1' ' A' ' 122' ' ' THR . 9.8 p -70.71 -37.18 68.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 111.874 0.324 . . . . 0.0 111.874 -179.336 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . 0.512 ' O ' ' OG1' ' A' ' 123' ' ' THR . . . -67.96 -60.91 2.14 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.545 -0.462 . . . . 0.0 111.63 -179.087 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.404 ' HA ' ' HG1' ' A' ' 123' ' ' THR . 6.4 m -59.47 -51.84 68.16 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.909 0.385 . . . . 0.0 111.464 -179.299 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -53.92 -43.37 69.71 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.272 -179.203 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.492 ' OG1' ' O ' ' A' ' 118' ' ' VAL . 38.0 p -71.13 -30.81 66.95 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 111.971 0.36 . . . . 0.0 111.971 -179.135 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.512 ' OG1' ' O ' ' A' ' 119' ' ' ALA . 0.1 OUTLIER -64.72 -48.79 73.32 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 120.851 -0.34 . . . . 0.0 111.074 -179.141 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.8 pp -82.79 -19.92 36.8 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.763 -0.375 . . . . 0.0 111.531 -179.021 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -88.93 -69.59 0.7 Allowed 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.594 0.591 . . . . 0.0 112.594 -178.689 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' TRP . . . . . 0.445 ' N ' ' CD1' ' A' ' 126' ' ' TRP . 36.9 m0 -83.14 -57.53 3.23 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 -177.751 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . 0.47 ' CD2' ' N ' ' A' ' 127' ' ' HIS . 10.0 m170 -52.12 -22.18 3.95 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.418 -0.513 . . . . 0.0 111.06 -178.661 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 2.8 tmt_? -71.07 -43.39 67.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.504 -0.317 . . . . 0.0 111.225 -179.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 14.9 t -86.92 -49.6 14.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 C-N-CA 120.922 -0.311 . . . . 0.0 111.054 -179.523 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 7.5 m -120.11 110.83 35.92 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.434 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . 0.627 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 73.6 Cg_exo -71.34 -33.78 10.68 Favored 'Trans proline' 0 N--CA 1.491 1.345 0 C-N-CA 121.373 1.382 . . . . 0.0 112.387 179.488 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.627 ' CD ' ' N ' ' A' ' 131' ' ' PRO . 37.1 Cg_exo -55.36 -39.09 92.91 Favored 'Trans proline' 0 N--CA 1.495 1.595 0 C-N-CA 121.31 1.34 . . . . 0.0 111.75 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -55.91 -34.66 65.78 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.334 179.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -64.83 -24.97 67.71 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.38 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 13.5 tpt180 -77.12 -29.12 54.59 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.362 179.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 18.4 mt -74.9 -41.05 60.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.379 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.574 ' O ' ' N ' ' A' ' 140' ' ' TYR . 5.0 mt -78.82 -35.49 44.06 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.152 179.624 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.481 ' C ' ' O ' ' A' ' 137' ' ' LEU . 2.0 t80 -23.4 -44.75 0.05 OUTLIER Pre-proline 0 CA--C 1.535 0.372 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.853 -179.865 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.515 ' N ' ' O ' ' A' ' 137' ' ' LEU . 1.7 Cg_endo -67.91 12.6 0.21 Allowed 'Trans proline' 0 C--N 1.309 -1.5 0 C-N-CA 121.188 1.259 . . . . 0.0 112.57 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . 0.574 ' N ' ' O ' ' A' ' 137' ' ' LEU . 1.7 p90 -93.41 -14.2 27.08 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-O 121.008 0.432 . . . . 0.0 110.633 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.403 HD23 ' CE1' ' A' ' 140' ' ' TYR . 4.1 mm? -53.37 -38.64 63.54 Favored 'General case' 0 C--N 1.333 -0.122 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 178.754 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -54.99 -46.58 75.14 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.549 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' TRP . . . . . 0.405 ' CZ2' ' CD1' ' A' ' 52' ' ' ILE . 9.5 t-105 -59.21 -49.36 78.16 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.773 -0.455 . . . . 0.0 109.773 179.807 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 12.2 mt -51.89 -54.5 28.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.086 179.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . 0.487 ' O ' ' CG2' ' A' ' 149' ' ' VAL . . . -60.5 -27.01 67.26 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.536 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -60.99 -64.56 0.91 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.533 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -63.83 -49.14 74.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.694 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 73.8 m -51.21 -47.22 62.33 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.911 -179.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.487 ' CG2' ' O ' ' A' ' 145' ' ' ALA . 53.3 t -65.24 -34.47 70.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.882 -179.738 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 1.7 tp -57.15 -55.56 33.22 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.837 0.351 . . . . 0.0 110.307 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -58.12 -57.12 14.22 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.413 179.697 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 18.5 t80 -46.76 -47.26 20.8 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.589 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 43.6 t80 -55.79 -42.98 76.38 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.611 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 89.1 t -66.53 -40.42 86.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.826 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' TRP . . . . . 0.479 ' C ' ' HE ' ' A' ' 156' ' ' ARG . 8.8 m0 -58.61 -39.74 81.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.801 -179.707 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . 0.479 ' HE ' ' C ' ' A' ' 155' ' ' TRP . 0.0 OUTLIER -79.29 -45.93 18.75 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.504 -179.885 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -64.19 -50.11 69.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.445 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -79.72 -12.39 59.8 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.524 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 92.6 p 49.19 98.36 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.597 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -71.13 -89.01 0.11 Allowed Glycine 0 CA--C 1.524 0.619 0 N-CA-C 110.804 -0.918 . . . . 0.0 110.804 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 13.8 mtm180 -70.39 80.5 0.55 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.828 0.347 . . . . 0.0 110.346 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 43.8 ttt180 -67.9 139.36 56.47 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.594 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 103.22 -72.51 0.28 Allowed Glycine 0 CA--C 1.526 0.738 0 N-CA-C 111.111 -0.795 . . . . 0.0 111.111 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 66.79 -109.52 2.95 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 110.809 -0.917 . . . . 0.0 110.809 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 48.0 t -67.04 153.06 44.59 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.875 0.369 . . . . 0.0 110.566 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . 0.462 ' O ' ' O ' ' A' ' 167' ' ' LEU . 93.0 mtt180 -44.27 159.28 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.675 -179.88 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.462 ' O ' ' O ' ' A' ' 166' ' ' ARG . 2.2 mp 54.02 161.58 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.779 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -158.01 -46.28 0.06 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.674 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 15.1 tt0 . . . . . 0 C--O 1.219 -0.522 0 CA-C-O 118.006 -0.997 . . . . 0.0 110.373 -179.797 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 201' ' ' PKA . . . . . 0.548 ' N18' ' H3 ' ' A' ' 201' ' ' PKA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.547 ' O ' ' SD ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.888 0.375 . . . . 0.0 110.552 . . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.43 ' CD ' ' N ' ' A' ' 1' ' ' MET . 41.0 Cg_endo -76.66 155.94 35.53 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 C-N-CA 122.299 1.999 . . . . 0.0 112.01 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 -74.61 -47.51 31.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.64 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.1 p -176.59 132.64 0.21 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.494 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.663 ' CE2' ' CE3' ' A' ' 68' ' ' TRP . 0.4 OUTLIER -67.14 118.0 9.95 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.287 -179.86 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.626 ' N ' ' CD ' ' A' ' 7' ' ' PRO . 0.9 OUTLIER -64.61 -32.79 7.52 Favored Pre-proline 0 CA--C 1.534 0.335 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 179.743 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.626 ' CD ' ' N ' ' A' ' 6' ' ' VAL . 23.8 Cg_exo -72.61 -67.02 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 121.888 1.726 . . . . 0.0 112.156 179.654 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.538 ' O ' ' CG2' ' A' ' 12' ' ' THR . . . -50.93 -38.24 49.09 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.541 -0.3 . . . . 0.0 111.278 -179.565 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.49 ' O ' ' OG1' ' A' ' 12' ' ' THR . 75.5 t -67.63 -62.25 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.756 -179.14 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -56.74 -47.61 84.16 Favored Glycine 0 CA--C 1.527 0.79 0 N-CA-C 111.743 -0.543 . . . . 0.0 111.743 -179.192 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.414 ' N ' ' CD1' ' A' ' 11' ' ' LEU . 7.7 mp -64.02 -30.91 71.95 Favored 'General case' 0 C--N 1.326 -0.433 0 O-C-N 122.921 -0.164 . . . . 0.0 111.052 -179.498 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.582 ' O ' ' CZ ' ' A' ' 57' ' ' TYR . 7.5 p -74.96 -25.15 58.66 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.621 -0.432 . . . . 0.0 110.129 179.549 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.454 ' O ' ' CB ' ' A' ' 16' ' ' SER . 9.4 mt -80.65 -32.26 36.21 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.133 179.563 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.409 ' N ' ' HD2' ' A' ' 15' ' ' PRO . 17.9 t -44.65 -53.29 15.5 Favored Pre-proline 0 CA--C 1.536 0.414 0 CA-C-N 115.894 -0.593 . . . . 0.0 111.237 -179.806 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.409 ' HD2' ' N ' ' A' ' 14' ' ' VAL . 18.6 Cg_endo -62.56 -7.53 10.97 Favored 'Trans proline' 0 N--CA 1.499 1.82 0 C-N-CA 120.591 0.861 . . . . 0.0 111.882 179.582 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.454 ' CB ' ' O ' ' A' ' 13' ' ' LEU . 3.7 t -77.69 -26.37 50.15 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.543 -179.866 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 15.9 mt -76.73 -49.66 15.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.85 -179.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -77.79 -29.27 55.21 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 111.329 -0.708 . . . . 0.0 111.329 -179.652 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -76.72 -37.49 34.3 Favored Glycine 0 CA--C 1.523 0.539 0 N-CA-C 110.877 -0.889 . . . . 0.0 110.877 -179.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 77.9 t80 -72.85 -55.81 6.12 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.875 0.369 . . . . 0.0 110.295 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 32.5 ttp -69.81 -22.09 63.34 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.464 179.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.462 ' C ' ' CZ2' ' A' ' 95' ' ' TRP . . . -69.99 -63.38 3.33 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 111.159 -0.776 . . . . 0.0 111.159 -179.804 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -68.86 -20.77 64.29 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 120.999 -0.281 . . . . 0.0 110.793 -179.623 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 56.5 t80 -47.27 -25.15 0.88 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.872 0.367 . . . . 0.0 110.479 179.706 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.412 ' CZ ' ' OE1' ' A' ' 29' ' ' GLU . 24.8 t80 -67.55 -55.55 13.01 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.797 -179.871 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 27.5 m -68.08 -16.79 21.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.867 -179.663 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 3.3 ttm180 -60.5 -41.13 93.68 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.037 -179.613 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -104.74 -74.32 0.96 Allowed Glycine 0 CA--C 1.525 0.686 0 N-CA-C 111.393 -0.683 . . . . 0.0 111.393 -179.57 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.412 ' OE1' ' CZ ' ' A' ' 25' ' ' PHE . 22.8 tt0 -44.38 -33.02 1.51 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.641 0.258 . . . . 0.0 110.965 -179.515 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -63.38 -51.61 53.27 Favored Glycine 0 CA--C 1.526 0.757 0 N-CA-C 111.222 -0.751 . . . . 0.0 111.222 -179.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 83.6 mt -49.43 -47.24 48.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.728 0.299 . . . . 0.0 110.851 -179.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 67.8 mtm180 -68.79 -49.38 59.1 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.86 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -45.13 -43.61 9.92 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.429 -179.717 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 75.9 t80 -46.11 -45.13 16.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.802 -179.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -57.42 -25.91 60.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.811 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -87.64 -73.8 1.28 Allowed Glycine 0 CA--C 1.526 0.74 0 N-CA-C 110.901 -0.88 . . . . 0.0 110.901 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -95.89 167.63 11.13 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.873 0.368 . . . . 0.0 110.673 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.524 ' NE2' ' C ' ' A' ' 38' ' ' GLN . 0.0 OUTLIER -81.74 114.76 20.61 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.778 -179.725 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.549 ' C ' ' H ' ' A' ' 41' ' ' SER . 11.0 mtpt -128.77 148.78 70.04 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.076 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.644 ' C ' ' H ' ' A' ' 42' ' ' TRP . 93.2 Cg_endo -72.71 19.49 0.33 Allowed 'Trans proline' 0 C--N 1.308 -1.566 0 C-N-CA 121.445 1.43 . . . . 0.0 110.968 179.293 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.549 ' H ' ' C ' ' A' ' 39' ' ' LYS . 15.7 t -49.63 -1.7 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.386 -0.824 . . . . 0.0 110.972 179.781 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . 0.644 ' H ' ' C ' ' A' ' 40' ' ' PRO . 2.3 p90 -76.53 -15.21 59.93 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.744 -0.382 . . . . 0.0 110.369 -179.472 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.489 ' O ' ' C ' ' A' ' 44' ' ' PRO . 23.0 m80 -65.05 143.55 98.9 Favored Pre-proline 0 C--N 1.328 -0.353 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 179.071 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.489 ' C ' ' O ' ' A' ' 43' ' ' HIS . 68.6 Cg_exo -31.26 125.45 0.08 OUTLIER 'Trans proline' 0 N--CA 1.492 1.422 0 C-N-CA 121.441 1.427 . . . . 0.0 111.319 -179.461 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.6 ' O ' ' N ' ' A' ' 47' ' ' TRP . 11.4 Cg_endo -45.92 151.35 1.44 Allowed 'Trans proline' 0 C--N 1.31 -1.488 0 C-N-CA 120.22 0.614 . . . . 0.0 111.883 -178.906 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.724 ' NE ' ' H ' ' A' ' 46' ' ' ARG . 0.0 OUTLIER -38.66 -18.16 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.595 -179.008 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.6 ' N ' ' O ' ' A' ' 45' ' ' PRO . 0.0 OUTLIER -60.58 -37.54 81.68 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.705 0.288 . . . . 0.0 111.696 -179.05 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.585 ' N ' ' CD1' ' A' ' 47' ' ' TRP . 1.0 OUTLIER -91.01 -44.88 9.04 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 -178.399 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.52 ' CD2' ' O8 ' ' A' ' 201' ' ' PKA . 27.6 tp -83.02 -50.74 8.22 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -177.61 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.656 ' C ' ' H ' ' A' ' 52' ' ' ILE . . . -41.22 -28.46 0.24 Allowed Pre-proline 0 C--O 1.234 0.27 0 C-N-CA 120.141 -0.623 . . . . 0.0 111.516 -179.021 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.4 ' HD2' ' N ' ' A' ' 50' ' ' ALA . 22.3 Cg_exo -53.63 5.16 0.03 OUTLIER 'Trans proline' 0 C--N 1.313 -1.317 0 CA-C-N 118.955 0.663 . . . . 0.0 112.085 177.903 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.656 ' H ' ' C ' ' A' ' 50' ' ' ALA . 7.2 pt -49.37 -29.27 3.73 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.144 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 178.841 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.605 ' O ' ' CD1' ' A' ' 57' ' ' TYR . 2.8 m0 -66.06 -45.91 79.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.799 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -59.34 -60.26 9.14 Favored Glycine 0 CA--C 1.527 0.82 0 N-CA-C 111.593 -0.603 . . . . 0.0 111.593 -179.609 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.524 ' CG2' ' H ' ' A' ' 56' ' ' LEU . 5.3 t -56.21 -60.71 3.11 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 121.033 -0.267 . . . . 0.0 111.329 -179.279 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.524 ' H ' ' CG2' ' A' ' 55' ' ' THR . 82.6 mt -50.82 -44.68 59.23 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 120.59 -0.444 . . . . 0.0 110.478 -179.744 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.605 ' CD1' ' O ' ' A' ' 53' ' ' TRP . 3.7 m-30 -50.93 -46.96 61.08 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 75.7 m -57.89 -42.15 84.05 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.187 -0.46 . . . . 0.0 109.911 179.584 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.78 -37.24 86.65 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.203 179.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 41.5 mtt -67.69 -49.18 64.07 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.462 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -52.09 -48.57 52.27 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 111.108 -0.797 . . . . 0.0 111.108 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -60.97 -56.69 18.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.868 0.366 . . . . 0.0 110.512 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -49.55 -48.47 35.11 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.504 -1.038 . . . . 0.0 110.504 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.523 ' O ' ' NE1' ' A' ' 68' ' ' TRP . 1.2 t -57.7 -44.92 86.22 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.667 0.27 . . . . 0.0 110.707 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.434 ' HA ' ' CZ2' ' A' ' 68' ' ' TRP . 87.3 t80 -50.79 -44.52 58.9 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 179.301 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 69.9 mt -70.79 -25.16 25.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.787 179.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 77.9 t -68.8 -59.04 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.155 0 C-N-CA 120.69 -0.404 . . . . 0.0 111.192 -179.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . 0.663 ' CE3' ' CE2' ' A' ' 5' ' ' TRP . 0.0 OUTLIER -67.65 -28.1 67.43 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 119.973 -0.691 . . . . 0.0 110.646 -179.666 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -73.22 -28.18 62.02 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.532 -0.467 . . . . 0.0 110.526 -179.885 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 32.0 tp10 -76.85 -59.99 2.54 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.79 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.3 pp -69.11 -22.14 63.99 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.717 -179.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.497 ' O ' ' O ' ' A' ' 73' ' ' GLY . . . 110.68 97.58 2.43 Favored Glycine 0 CA--C 1.526 0.775 0 N-CA-C 111.585 -0.606 . . . . 0.0 111.585 179.586 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.557 ' N ' ' O ' ' A' ' 68' ' ' TRP . . . 41.88 -173.86 0.01 OUTLIER Glycine 0 CA--C 1.523 0.557 0 N-CA-C 111.667 -0.573 . . . . 0.0 111.667 179.389 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 51.5 t80 -87.54 111.64 21.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.819 0.342 . . . . 0.0 110.741 -179.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.576 ' OG1' ' N ' ' A' ' 76' ' ' GLU . 0.8 OUTLIER -141.73 -174.03 3.95 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.672 179.73 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.576 ' N ' ' OG1' ' A' ' 75' ' ' THR . 46.1 mt-10 -47.98 -44.29 30.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.174 -179.768 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -60.49 -24.4 65.26 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.502 -179.239 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -91.09 -25.34 19.68 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.82 -0.352 . . . . 0.0 111.234 -179.424 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 12.5 mtp -66.79 -27.78 67.86 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.814 -0.354 . . . . 0.0 111.354 -179.283 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 4.7 t -68.72 -50.89 22.78 Favored Pre-proline 0 C--N 1.328 -0.335 0 C-N-CA 120.673 -0.411 . . . . 0.0 110.364 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_endo -69.43 -62.38 0.05 OUTLIER 'Trans proline' 0 N--CA 1.498 1.764 0 C-N-CA 120.955 1.103 . . . . 0.0 111.616 179.007 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.0 mt -52.12 -52.45 51.45 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.271 179.592 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.504 ' O ' ' N ' ' A' ' 86' ' ' THR . . . -60.46 -63.88 4.61 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 111.367 -0.693 . . . . 0.0 111.367 -179.549 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 59.3 tp -43.15 -38.74 2.56 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.9 0.381 . . . . 0.0 110.114 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 6.3 t80 -68.22 -34.33 76.05 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.242 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.504 ' N ' ' O ' ' A' ' 83' ' ' GLY . 1.3 m -70.42 -57.97 4.23 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.917 -179.683 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -62.51 -49.23 75.64 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 111.463 -0.655 . . . . 0.0 111.463 -179.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.416 ' O ' ' CB ' ' A' ' 92' ' ' ASN . 51.6 tp60 -57.26 -45.54 83.91 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.739 0.304 . . . . 0.0 110.952 -179.583 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 11.6 tp -65.4 -29.12 69.79 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.475 -179.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.467 ' O ' ' CB ' ' A' ' 94' ' ' ALA . . . -67.04 -66.08 0.6 Allowed 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.393 -0.523 . . . . 0.0 111.176 -179.723 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.2 pp -67.64 -29.79 69.19 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 -178.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.416 ' CB ' ' O ' ' A' ' 88' ' ' GLN . 11.1 t-20 -84.12 -54.52 4.77 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 -178.441 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . 0.609 ' O ' ' N ' ' A' ' 95' ' ' TRP . 0.0 OUTLIER -76.57 -12.53 60.04 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.516 -0.474 . . . . 0.0 111.491 -178.478 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.467 ' CB ' ' O ' ' A' ' 90' ' ' ALA . . . -55.69 78.73 0.0 OUTLIER 'General case' 0 C--O 1.231 0.129 0 C-N-CA 120.448 -0.501 . . . . 0.0 109.852 179.174 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.708 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 44.1 p-90 -93.11 -16.87 0.21 Allowed Pre-proline 0 CA--C 1.533 0.302 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -179.444 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.708 ' CD ' ' N ' ' A' ' 95' ' ' TRP . 46.5 Cg_exo -55.66 -34.49 90.6 Favored 'Trans proline' 0 N--CA 1.495 1.576 0 C-N-CA 120.422 0.748 . . . . 0.0 113.021 179.502 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.595 ' C ' ' H ' ' A' ' 99' ' ' PHE . 33.6 Cg_exo -44.08 -30.84 3.58 Favored 'Trans proline' 0 N--CA 1.492 1.386 0 CA-C-N 118.969 0.668 . . . . 0.0 112.994 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.577 ' O ' ' N ' ' A' ' 101' ' ' GLY . 1.3 pp -72.61 20.22 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 121.076 0.465 . . . . 0.0 110.059 179.66 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.595 ' H ' ' C ' ' A' ' 97' ' ' PRO . 0.8 OUTLIER -39.72 -36.67 0.44 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.889 -179.968 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 0.401 ' O ' ' CG ' ' A' ' 103' ' ' ARG . 1.6 m-85 -85.98 -21.0 28.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.045 -179.518 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.577 ' N ' ' O ' ' A' ' 98' ' ' ILE . . . -89.16 -5.45 72.97 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 111.153 -0.779 . . . . 0.0 111.153 -179.718 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -73.16 -11.26 60.47 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.778 0.323 . . . . 0.0 110.753 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.401 ' CG ' ' O ' ' A' ' 100' ' ' PHE . 5.4 ptp180 -94.94 11.61 31.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.586 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -123.97 162.62 23.02 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.63 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 21.2 mmm -57.18 -17.13 9.83 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.234 179.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.589 ' O ' ' N ' ' A' ' 108' ' ' ALA . . . -70.42 -15.01 72.48 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 111.214 -0.755 . . . . 0.0 111.214 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' TRP . . . . . 0.444 ' CD1' ' N ' ' A' ' 108' ' ' ALA . 0.1 OUTLIER -43.14 -12.51 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.521 0.2 . . . . 0.0 111.113 -179.468 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.589 ' N ' ' O ' ' A' ' 106' ' ' GLY . . . -63.01 -23.44 67.46 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-O 121.132 0.491 . . . . 0.0 110.075 179.417 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 54.6 mt -52.71 -29.45 26.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.107 179.726 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -56.19 -60.76 3.04 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.548 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.578 ' OD1' ' N ' ' A' ' 112' ' ' LEU . 1.2 p30 -57.46 -51.24 70.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.323 -179.673 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.578 ' N ' ' OD1' ' A' ' 111' ' ' ASP . 0.2 OUTLIER -55.29 -40.26 70.85 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.474 -178.944 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 11.3 mt -70.18 -61.51 1.75 Allowed 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 -178.655 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.4 pp -58.38 -30.55 66.88 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 120.292 -0.563 . . . . 0.0 110.866 -179.052 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.55 ' CG2' ' O ' ' A' ' 111' ' ' ASP . 38.7 t -65.49 -55.78 18.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.264 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' SER . . . . . 0.443 ' O ' ' OG1' ' A' ' 120' ' ' THR . 4.9 m -71.45 -24.57 62.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.4 -179.009 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . 0.411 ' O ' ' CB ' ' A' ' 121' ' ' ALA . . . -68.02 -62.49 4.2 Favored Glycine 0 CA--C 1.527 0.794 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.051 -179.218 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.506 ' O ' ' OG1' ' A' ' 122' ' ' THR . 8.5 p -70.62 -36.93 67.64 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 O-C-N 122.738 -0.272 . . . . 0.0 111.572 -179.14 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . 0.526 ' O ' ' OG1' ' A' ' 123' ' ' THR . . . -66.67 -60.54 2.61 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.493 -0.483 . . . . 0.0 111.201 -179.288 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.473 ' H ' ' HG1' ' A' ' 120' ' ' THR . 1.9 m -61.56 -53.68 53.11 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.334 -179.446 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.411 ' CB ' ' O ' ' A' ' 117' ' ' GLY . . . -50.12 -42.41 50.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.411 -0.358 . . . . 0.0 111.152 -179.494 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.506 ' OG1' ' O ' ' A' ' 118' ' ' VAL . 27.7 p -70.65 -39.32 73.69 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.64 -179.28 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.526 ' OG1' ' O ' ' A' ' 119' ' ' ALA . 0.2 OUTLIER -55.29 -52.2 64.23 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.921 0.391 . . . . 0.0 111.197 -179.312 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.7 pp -80.49 -20.33 43.91 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.752 -178.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -86.06 -73.88 0.44 Allowed 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -178.179 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' TRP . . . . . 0.571 ' N ' ' CD1' ' A' ' 126' ' ' TRP . 15.7 m0 -84.88 -57.37 3.14 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 112.762 0.653 . . . . 0.0 112.762 -177.444 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . 0.492 ' CD2' ' N ' ' A' ' 127' ' ' HIS . 9.7 m170 -47.71 -22.12 0.48 Allowed 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.686 -0.405 . . . . 0.0 111.121 -179.027 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 19.2 ttt85 -72.59 -40.84 66.25 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.063 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 86.4 t -88.37 -50.01 13.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.788 0.328 . . . . 0.0 111.076 -179.514 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 6.0 m -115.69 105.28 51.98 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.502 -179.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . 0.631 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 73.5 Cg_exo -70.98 -36.43 7.58 Favored 'Trans proline' 0 C--N 1.312 -1.364 0 C-N-CA 121.557 1.505 . . . . 0.0 112.726 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.631 ' CD ' ' N ' ' A' ' 131' ' ' PRO . 32.4 Cg_exo -55.8 -35.48 93.72 Favored 'Trans proline' 0 N--CA 1.496 1.675 0 C-N-CA 121.678 1.585 . . . . 0.0 111.946 -179.847 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -62.6 -43.2 99.41 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.66 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -50.47 -24.77 3.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.764 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 14.9 ttp180 -80.93 -28.39 35.78 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.786 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 26.7 mt -72.84 -39.18 66.75 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.779 -0.368 . . . . 0.0 110.068 179.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.583 ' O ' ' N ' ' A' ' 139' ' ' PRO . 4.8 mt -81.04 -35.78 31.38 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 179.126 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.473 ' C ' ' O ' ' A' ' 137' ' ' LEU . 14.3 t80 -24.23 -38.9 0.03 OUTLIER Pre-proline 0 CA--C 1.534 0.356 0 CA-C-N 115.368 -0.833 . . . . 0.0 112.118 -179.888 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.583 ' N ' ' O ' ' A' ' 137' ' ' LEU . 5.8 Cg_exo -66.62 5.54 0.73 Allowed 'Trans proline' 0 C--N 1.31 -1.479 0 C-N-CA 120.897 1.065 . . . . 0.0 112.771 179.508 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . 0.521 ' N ' ' O ' ' A' ' 137' ' ' LEU . 2.5 p90 -88.62 -14.55 37.22 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 120.54 -0.464 . . . . 0.0 111.074 -179.842 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.416 HD22 ' CE1' ' A' ' 140' ' ' TYR . 4.1 mm? -53.55 -33.45 54.72 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 178.568 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -60.63 -50.01 75.21 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.473 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' TRP . . . . . . . . . . . . . 8.8 t-105 -55.13 -46.1 75.62 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.226 -0.443 . . . . 0.0 109.844 179.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 9.3 mt -53.35 -55.96 20.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.267 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . 0.486 ' O ' ' CG2' ' A' ' 149' ' ' VAL . . . -62.86 -18.85 63.5 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.94 -179.786 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -69.45 -63.34 1.09 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.682 -179.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -60.37 -47.42 86.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.414 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 89.0 m -53.93 -49.67 68.14 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.495 179.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.486 ' CG2' ' O ' ' A' ' 145' ' ' ALA . 45.0 t -62.42 -28.54 44.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.594 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -63.53 -54.85 29.81 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.704 -0.398 . . . . 0.0 110.415 -179.598 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . 0.608 ' ND2' ' H ' ' A' ' 152' ' ' TYR . 1.4 p-10 -67.47 -54.65 18.37 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.96 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . 0.608 ' H ' ' ND2' ' A' ' 151' ' ' ASN . 15.6 t80 -50.5 -43.26 55.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.681 -179.69 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . 0.481 ' C ' ' CD1' ' A' ' 153' ' ' TYR . 17.5 t80 -61.86 -43.75 98.22 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.188 179.72 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 49.4 t -60.27 -35.25 60.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.597 179.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' TRP . . . . . 0.519 ' O ' ' N ' ' A' ' 159' ' ' SER . 8.1 m0 -62.99 -53.32 55.86 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.413 179.895 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . 0.436 ' CZ ' ' OH ' ' A' ' 152' ' ' TYR . 0.5 OUTLIER -64.73 -31.61 72.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.414 -179.899 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -71.33 -52.59 17.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.678 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 22.3 m-20 -83.92 -12.27 55.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.646 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' SER . . . . . 0.519 ' N ' ' O ' ' A' ' 155' ' ' TRP . 10.9 m 53.44 24.78 4.18 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.447 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 85.22 -105.62 2.91 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.784 -0.926 . . . . 0.0 110.784 -179.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 73.9 mtt85 -94.19 -111.78 0.12 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.757 0.313 . . . . 0.0 110.441 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . 0.403 ' O ' ' CG ' ' A' ' 162' ' ' ARG . 25.1 ptt-85 -82.37 128.45 34.24 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 120.869 -0.333 . . . . 0.0 110.443 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -91.02 79.74 1.35 Allowed Glycine 0 CA--C 1.524 0.613 0 N-CA-C 110.946 -0.862 . . . . 0.0 110.946 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -147.15 34.28 1.31 Allowed Glycine 0 CA--C 1.526 0.719 0 N-CA-C 111.202 -0.759 . . . . 0.0 111.202 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 24.0 p -89.06 169.85 11.15 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.784 0.326 . . . . 0.0 110.634 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 11.0 mmp_? -107.16 178.81 4.44 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.536 179.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.58 ' N ' ' CD1' ' A' ' 167' ' ' LEU . 0.0 OUTLIER -150.8 -179.92 7.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.619 179.656 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -167.77 47.83 0.05 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.378 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 33.8 mm-40 . . . . . 0 C--O 1.221 -0.425 0 CA-C-O 118.011 -0.995 . . . . 0.0 110.573 179.946 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 201' ' ' PKA . . . . . 0.555 ' N18' ' H3 ' ' A' ' 201' ' ' PKA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.484 ' C ' ' SD ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.183 0 CA-C-O 120.888 0.375 . . . . 0.0 110.518 . . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -70.82 120.87 7.4 Favored 'Trans proline' 0 C--N 1.303 -1.823 0 C-N-CA 122.528 2.152 . . . . 0.0 112.228 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -55.98 -25.22 43.08 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.451 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.0 m 65.39 175.09 0.21 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.501 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.471 ' CD1' ' CD1' ' A' ' 68' ' ' TRP . 2.2 t-105 -57.25 119.84 7.09 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.001 0.429 . . . . 0.0 110.038 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.0 t -56.69 -69.45 0.44 Allowed Pre-proline 0 CA--C 1.537 0.471 0 CA-C-N 115.717 -0.674 . . . . 0.0 112.285 -178.375 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -46.3 -53.49 5.87 Favored 'Trans proline' 0 N--CA 1.494 1.519 0 C-N-CA 120.349 0.699 . . . . 0.0 112.343 -178.618 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.495 ' O ' ' OG1' ' A' ' 12' ' ' THR . . . -49.14 -43.92 42.16 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.595 -0.442 . . . . 0.0 111.195 -179.74 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.497 ' O ' ' OG1' ' A' ' 12' ' ' THR . 63.3 t -60.85 -60.97 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.775 -179.04 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -58.05 -53.95 41.42 Favored Glycine 0 CA--C 1.527 0.808 0 N-CA-C 111.369 -0.692 . . . . 0.0 111.369 -179.398 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 9.0 mp -54.53 -31.36 56.2 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.605 0.241 . . . . 0.0 110.775 -179.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.497 ' OG1' ' O ' ' A' ' 9' ' ' VAL . 8.9 p -79.03 -24.39 43.66 Favored 'General case' 0 C--N 1.333 -0.145 0 C-N-CA 120.783 -0.367 . . . . 0.0 110.41 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 41.3 mt -76.84 -26.48 54.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.152 179.49 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.486 ' O ' ' N ' ' A' ' 16' ' ' SER . 13.7 t -52.05 -64.22 1.64 Allowed Pre-proline 0 CA--C 1.536 0.42 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.593 -179.519 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_endo -44.6 -16.29 0.11 Allowed 'Trans proline' 0 N--CA 1.497 1.726 0 C-N-CA 120.941 1.094 . . . . 0.0 112.137 -179.434 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.486 ' N ' ' O ' ' A' ' 14' ' ' VAL . 0.5 OUTLIER -75.49 -29.12 59.46 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.641 -179.915 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 81.7 mt -68.22 -56.17 9.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.002 -179.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -66.96 -38.55 92.89 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 111.558 -0.617 . . . . 0.0 111.558 -179.362 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -74.12 -26.2 69.2 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 111.378 -0.689 . . . . 0.0 111.378 -179.433 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.441 ' CB ' ' O ' ' A' ' 16' ' ' SER . 34.3 t80 -78.0 -60.7 2.26 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.78 -0.368 . . . . 0.0 110.998 -179.665 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 19.9 tpp -71.53 -21.26 61.93 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.34 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.422 ' C ' ' CZ2' ' A' ' 95' ' ' TRP . . . -75.51 -53.59 5.92 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 111.302 -0.719 . . . . 0.0 111.302 -179.802 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -73.56 -20.81 60.53 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.963 0.411 . . . . 0.0 110.461 -179.702 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.43 ' O ' ' CD1' ' A' ' 24' ' ' TYR . 27.2 t80 -51.08 -23.9 3.49 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.862 179.298 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 52.1 t80 -71.27 -55.46 8.02 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.02 -179.779 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 34.6 m -58.46 -26.06 29.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 C-N-CA 120.599 -0.441 . . . . 0.0 110.306 -179.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.519 ' O ' ' CD1' ' A' ' 31' ' ' LEU . 0.0 OUTLIER -87.95 -15.08 37.53 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.338 179.851 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -101.33 -71.66 0.94 Allowed Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.835 -0.906 . . . . 0.0 110.835 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.403 ' OE2' ' O ' ' A' ' 29' ' ' GLU . 3.3 tm-20 -76.88 -36.89 56.39 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.739 0.304 . . . . 0.0 110.567 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -51.3 -36.12 36.38 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 110.89 -0.884 . . . . 0.0 110.89 -179.79 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.519 ' CD1' ' O ' ' A' ' 27' ' ' ARG . 86.3 mt -55.35 -32.17 62.34 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.737 0.303 . . . . 0.0 110.348 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.434 ' O ' ' N ' ' A' ' 35' ' ' ALA . 37.6 ttm180 -81.28 -48.96 11.33 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.252 179.728 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -44.76 -36.13 3.05 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 179.473 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 26.6 t80 -55.66 -40.52 72.36 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.287 179.452 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.434 ' N ' ' O ' ' A' ' 32' ' ' ARG . . . -53.29 -26.96 20.46 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.169 179.784 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -90.37 -72.32 1.25 Allowed Glycine 0 CA--C 1.524 0.615 0 N-CA-C 110.921 -0.872 . . . . 0.0 110.921 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.406 ' C ' ' CD1' ' A' ' 37' ' ' LEU . 0.3 OUTLIER -96.1 167.64 11.09 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 120.947 0.404 . . . . 0.0 110.88 179.614 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 43.8 mm-40 -84.79 122.93 29.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.241 -179.256 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.528 ' C ' ' H ' ' A' ' 41' ' ' SER . 16.0 mtpt -129.28 153.34 80.47 Favored Pre-proline 0 N--CA 1.464 0.24 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.048 179.443 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.651 ' C ' ' H ' ' A' ' 42' ' ' TRP . 56.8 Cg_endo -73.17 26.23 0.3 Allowed 'Trans proline' 0 C--N 1.31 -1.47 0 C-N-CA 121.549 1.499 . . . . 0.0 111.372 179.417 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.528 ' H ' ' C ' ' A' ' 39' ' ' LYS . 1.5 t -50.13 -0.65 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.105 179.689 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . 0.651 ' H ' ' C ' ' A' ' 40' ' ' PRO . 44.6 p-90 -76.27 -15.07 60.08 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.517 -0.473 . . . . 0.0 111.144 -178.875 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.454 ' O ' ' C ' ' A' ' 44' ' ' PRO . 0.3 OUTLIER -82.07 143.13 48.75 Favored Pre-proline 0 C--N 1.329 -0.292 0 C-N-CA 120.157 -0.617 . . . . 0.0 109.419 178.622 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.454 ' C ' ' O ' ' A' ' 43' ' ' HIS . 52.2 Cg_exo -33.88 143.04 0.06 OUTLIER 'Trans proline' 0 C--N 1.311 -1.41 0 C-N-CA 121.399 1.4 . . . . 0.0 111.717 -179.463 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -69.49 169.91 17.47 Favored 'Trans proline' 0 C--N 1.313 -1.29 0 C-N-CA 120.595 0.864 . . . . 0.0 111.322 179.748 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.467 ' O ' ' CB ' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -47.7 -17.9 0.12 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.771 -179.149 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.599 ' CD1' ' N ' ' A' ' 48' ' ' THR . 1.4 p-90 -61.81 -45.05 95.5 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 120.151 -0.62 . . . . 0.0 111.159 -179.188 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.599 ' N ' ' CD1' ' A' ' 47' ' ' TRP . 1.2 m -91.43 -33.79 15.1 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.983 -178.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -83.28 -43.86 15.58 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 112.686 0.624 . . . . 0.0 112.686 -177.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.632 ' C ' ' H ' ' A' ' 52' ' ' ILE . . . -40.34 -30.26 0.24 Allowed Pre-proline 0 N--CA 1.468 0.427 0 C-N-CA 120.857 -0.337 . . . . 0.0 111.818 -178.699 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -53.76 4.53 0.04 OUTLIER 'Trans proline' 0 C--N 1.312 -1.382 0 CA-C-N 119.163 0.737 . . . . 0.0 112.547 178.498 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.632 ' H ' ' C ' ' A' ' 50' ' ' ALA . 44.0 pt -53.52 -32.42 20.51 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 C-N-CA 120.515 -0.474 . . . . 0.0 109.779 179.52 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.457 ' O ' ' CB ' ' A' ' 57' ' ' TYR . 60.9 m95 -78.94 -23.08 44.87 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.267 -179.145 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -68.54 -45.47 67.24 Favored Glycine 0 CA--C 1.527 0.793 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 178.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 16.5 m -69.27 -58.45 4.02 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-O 120.991 0.424 . . . . 0.0 110.0 179.408 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 96.6 mt -54.55 -28.62 46.99 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.033 179.511 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.521 ' C ' ' CD1' ' A' ' 57' ' ' TYR . 0.6 OUTLIER -63.51 -58.98 5.27 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 179.523 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 11.0 m -46.16 -49.29 17.01 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.406 -0.518 . . . . 0.0 109.909 179.515 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.55 -51.49 69.65 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.856 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 12.3 mtm -55.81 -35.59 66.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.78 -179.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -61.88 -49.31 77.05 Favored Glycine 0 CA--C 1.522 0.491 0 N-CA-C 110.59 -1.004 . . . . 0.0 110.59 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -56.83 -60.27 3.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.817 0.341 . . . . 0.0 110.501 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -52.21 -49.74 49.15 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 110.66 -0.976 . . . . 0.0 110.66 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.585 ' OG ' ' NE1' ' A' ' 68' ' ' TRP . 1.4 t -48.1 -54.24 13.87 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.108 0.48 . . . . 0.0 110.396 179.617 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 59.0 t80 -51.28 -41.48 60.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.51 179.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 84.9 mt -67.72 -45.58 84.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.329 -179.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 39.0 t -50.72 -55.81 5.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 C-N-CA 121.043 -0.263 . . . . 0.0 111.277 -179.327 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . 0.585 ' NE1' ' OG ' ' A' ' 64' ' ' SER . 0.7 OUTLIER -59.97 -52.56 64.89 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.686 -179.542 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 24.3 mmtt -53.64 -22.67 9.22 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.993 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 43.0 tp10 -79.6 -62.46 1.68 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.441 -179.312 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.0 pp -71.22 -1.17 11.72 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.2 -179.297 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 104.43 64.98 0.68 Allowed Glycine 0 CA--C 1.526 0.778 0 N-CA-C 111.43 -0.668 . . . . 0.0 111.43 179.51 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.585 ' N ' ' O ' ' A' ' 68' ' ' TRP . . . 51.75 -174.46 0.15 Allowed Glycine 0 CA--C 1.525 0.679 0 N-CA-C 111.325 -0.71 . . . . 0.0 111.325 179.661 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 89.8 t80 -76.62 110.72 11.42 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.86 0.362 . . . . 0.0 110.604 -179.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.591 ' OG1' ' N ' ' A' ' 76' ' ' GLU . 0.0 OUTLIER -139.17 -174.94 4.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.13 179.804 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.591 ' N ' ' OG1' ' A' ' 75' ' ' THR . 3.1 pt-20 -50.55 -21.62 1.61 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.839 -179.838 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -83.95 -18.47 37.16 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.105 -179.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -89.32 -18.25 27.32 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.874 -0.33 . . . . 0.0 110.838 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 15.4 mtp -69.32 -27.4 65.35 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.871 -0.332 . . . . 0.0 110.573 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 5.0 t -67.73 -47.94 43.26 Favored Pre-proline 0 CA--C 1.535 0.4 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.582 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -71.83 -58.12 0.08 OUTLIER 'Trans proline' 0 N--CA 1.498 1.786 0 C-N-CA 121.187 1.258 . . . . 0.0 112.087 179.277 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 13.0 mt -60.08 -53.4 58.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.985 0.421 . . . . 0.0 110.678 -179.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -55.86 -55.19 30.28 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 111.268 -0.733 . . . . 0.0 111.268 -179.537 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.404 ' O ' ' CB ' ' A' ' 88' ' ' GLN . 33.0 tp -61.01 -24.23 66.0 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.687 0.279 . . . . 0.0 110.936 -179.702 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -74.7 -56.49 4.74 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.884 -179.685 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 14.2 t -66.13 -38.35 87.97 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.799 -0.361 . . . . 0.0 110.977 -179.64 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -68.77 -57.26 8.14 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.932 -0.867 . . . . 0.0 110.932 -179.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.45 ' O ' ' CB ' ' A' ' 92' ' ' ASN . 36.3 tp60 -58.09 -40.5 81.28 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.859 0.362 . . . . 0.0 110.149 179.756 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 12.3 tp -67.37 -30.54 70.35 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.292 179.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.455 ' O ' ' CB ' ' A' ' 94' ' ' ALA . . . -66.95 -66.09 0.6 Allowed 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 120.13 -0.628 . . . . 0.0 110.944 -179.746 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.0 pp -66.51 -29.68 69.83 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.389 0.514 . . . . 0.0 112.389 -178.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.553 ' C ' HD21 ' A' ' 92' ' ' ASN . 0.2 OUTLIER -85.2 -62.2 1.59 Allowed 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.551 -0.46 . . . . 0.0 111.815 -178.827 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . 0.631 ' O ' ' N ' ' A' ' 95' ' ' TRP . 0.0 OUTLIER -64.57 -17.57 64.08 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.552 -0.459 . . . . 0.0 110.834 -179.007 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.455 ' CB ' ' O ' ' A' ' 90' ' ' ALA . . . -48.76 83.81 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 179.313 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.698 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 23.2 p-90 -100.95 -16.13 0.19 Allowed Pre-proline 0 CA--C 1.535 0.377 0 CA-C-N 116.107 -0.497 . . . . 0.0 112.334 -179.235 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.698 ' CD ' ' N ' ' A' ' 95' ' ' TRP . 37.2 Cg_exo -60.65 -31.52 92.21 Favored 'Trans proline' 0 N--CA 1.495 1.582 0 CA-C-N 119.067 0.703 . . . . 0.0 112.718 179.691 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.518 ' CD ' ' N ' ' A' ' 96' ' ' PRO . 83.8 Cg_exo -56.76 -16.92 21.23 Favored 'Trans proline' 0 N--CA 1.496 1.647 0 C-N-CA 120.803 1.002 . . . . 0.0 113.15 -179.775 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.423 ' O ' ' N ' ' A' ' 101' ' ' GLY . 1.1 pp -88.34 20.36 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 C-N-CA 120.713 -0.395 . . . . 0.0 110.732 -179.718 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.597 ' CD2' ' O ' ' A' ' 96' ' ' PRO . 29.7 m-85 -39.36 -36.96 0.4 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.326 179.649 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 0.557 ' CD1' ' N ' ' A' ' 100' ' ' PHE . 0.5 OUTLIER -76.71 -43.87 35.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.697 179.948 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.423 ' N ' ' O ' ' A' ' 98' ' ' ILE . . . -62.23 -11.28 32.29 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 111.083 -0.807 . . . . 0.0 111.083 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -62.17 -38.47 89.17 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.637 0.256 . . . . 0.0 111.198 -179.615 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.16 17.97 2.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.078 -179.607 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 11.5 mt-30 -124.4 160.15 28.81 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.888 0.375 . . . . 0.0 110.638 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' MET . . . . . 0.547 ' N ' ' SD ' ' A' ' 105' ' ' MET . 0.0 OUTLIER -51.12 -17.06 0.57 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.416 179.813 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.601 ' O ' ' N ' ' A' ' 108' ' ' ALA . . . -75.48 -14.13 82.27 Favored Glycine 0 CA--C 1.529 0.919 0 CA-C-N 115.938 -0.573 . . . . 0.0 111.722 -179.554 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' TRP . . . . . 0.617 ' CD1' ' CZ2' ' A' ' 155' ' ' TRP . 0.0 OUTLIER -36.62 -21.84 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.417 0 CA-C-O 120.529 0.204 . . . . 0.0 111.366 -179.165 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.601 ' N ' ' O ' ' A' ' 106' ' ' GLY . . . -63.35 -16.67 61.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.669 0.271 . . . . 0.0 111.168 -179.322 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 6.2 mp -54.5 -32.95 58.95 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.776 -179.632 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.427 ' O ' ' CD2' ' A' ' 114' ' ' LEU . . . -55.82 -62.33 1.76 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.858 0.361 . . . . 0.0 111.138 -179.628 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.529 ' O ' ' CG2' ' A' ' 115' ' ' VAL . 3.8 p-10 -58.92 -54.43 47.24 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.033 -0.53 . . . . 0.0 112.005 -179.155 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 34.3 tp -55.76 -44.36 77.59 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 -178.56 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 52.1 mt -64.24 -60.68 2.9 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.254 0.465 . . . . 0.0 112.254 -178.482 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.427 ' CD2' ' O ' ' A' ' 110' ' ' ALA . 2.3 pp -62.89 -35.32 79.64 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.494 -0.483 . . . . 0.0 111.68 -178.565 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.529 ' CG2' ' O ' ' A' ' 111' ' ' ASP . 27.2 t -57.91 -60.12 2.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.136 -179.687 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' SER . . . . . 0.488 ' O ' ' OG1' ' A' ' 120' ' ' THR . 4.5 m -74.18 -22.44 59.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.427 -0.352 . . . . 0.0 111.592 -178.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -62.93 -62.71 5.22 Favored Glycine 0 CA--C 1.526 0.721 0 C-N-CA 120.783 -0.723 . . . . 0.0 111.475 -179.418 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.51 ' O ' ' OG1' ' A' ' 122' ' ' THR . 8.6 p -75.58 -35.1 30.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 C-N-CA 121.035 -0.266 . . . . 0.0 111.046 -179.579 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . 0.526 ' O ' ' OG1' ' A' ' 123' ' ' THR . . . -66.69 -60.4 2.73 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.635 -0.426 . . . . 0.0 110.56 -179.742 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.488 ' OG1' ' O ' ' A' ' 116' ' ' SER . 2.4 m -60.32 -54.57 44.15 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.408 -179.589 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.408 ' O ' ' CB ' ' A' ' 125' ' ' ALA . . . -51.25 -41.12 60.14 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.314 -179.153 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.51 ' OG1' ' O ' ' A' ' 118' ' ' VAL . 36.0 p -73.19 -29.95 63.2 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.625 -179.19 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.526 ' OG1' ' O ' ' A' ' 119' ' ' ALA . 0.2 OUTLIER -66.84 -49.89 64.3 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.714 -0.394 . . . . 0.0 110.864 -179.412 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.8 pp -81.44 -19.05 43.27 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.57 -179.04 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . 0.408 ' CB ' ' O ' ' A' ' 121' ' ' ALA . . . -93.61 -65.28 1.0 Allowed 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.427 0.529 . . . . 0.0 112.427 -178.824 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 42.1 m0 -83.59 -56.98 3.42 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 113.056 0.762 . . . . 0.0 113.056 -177.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . 0.403 ' CD2' ' N ' ' A' ' 127' ' ' HIS . 11.1 m170 -59.6 -25.62 64.77 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.586 -0.445 . . . . 0.0 111.569 -178.535 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 15.9 ttt180 -61.76 -41.17 97.34 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.31 -179.455 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 33.4 t -93.34 -48.88 13.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.517 -0.311 . . . . 0.0 110.964 -179.611 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 2.1 p -113.07 107.94 53.63 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.884 -179.301 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . 0.646 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 73.8 Cg_exo -74.69 -26.52 11.49 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 C-N-CA 121.702 1.601 . . . . 0.0 112.741 179.355 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.646 ' CD ' ' N ' ' A' ' 131' ' ' PRO . 52.0 Cg_exo -62.09 -54.97 1.17 Allowed 'Trans proline' 0 N--CA 1.496 1.666 0 C-N-CA 121.357 1.372 . . . . 0.0 112.194 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . 0.524 ' O ' ' N ' ' A' ' 136' ' ' LEU . . . -45.97 -46.07 16.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.879 0.371 . . . . 0.0 110.42 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -45.12 -27.31 0.57 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.109 179.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 10.1 tpp180 -76.3 -30.7 57.85 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.299 179.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.524 ' N ' ' O ' ' A' ' 133' ' ' ALA . 36.6 mt -74.16 -24.9 59.47 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 179.303 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.573 ' O ' ' N ' ' A' ' 140' ' ' TYR . 3.7 mt -89.81 -33.26 16.58 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.075 179.511 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.529 ' C ' ' H ' ' A' ' 140' ' ' TYR . 0.5 OUTLIER -27.68 -51.13 0.23 Allowed Pre-proline 0 CA--C 1.536 0.416 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.554 179.727 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.424 ' HD2' ' N ' ' A' ' 138' ' ' TYR . 2.2 Cg_endo -58.76 4.69 0.11 Allowed 'Trans proline' 0 N--CA 1.497 1.687 0 C-N-CA 121.374 1.383 . . . . 0.0 112.689 -179.823 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . 0.573 ' N ' ' O ' ' A' ' 137' ' ' LEU . 0.3 OUTLIER -90.66 -15.41 30.45 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.904 0.383 . . . . 0.0 110.724 179.764 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 97.6 mt -60.09 -36.5 77.55 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 178.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -56.61 -41.8 77.67 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.689 179.161 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' TRP . . . . . . . . . . . . . 7.5 t-105 -62.74 -43.66 98.22 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 115.771 -0.65 . . . . 0.0 109.472 179.227 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 22.0 mt -58.44 -37.59 75.73 Favored 'General case' 0 CA--C 1.521 -0.163 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.707 179.268 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . 0.535 ' O ' ' CG2' ' A' ' 149' ' ' VAL . . . -73.28 -27.84 61.78 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.496 179.848 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 28.7 t80 -64.75 -62.32 1.64 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.781 -179.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.489 ' O ' ' OD1' ' A' ' 151' ' ' ASN . . . -64.15 -43.84 93.95 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.432 -0.507 . . . . 0.0 110.45 -179.815 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' THR . . . . . 0.499 ' O ' ' OD1' ' A' ' 151' ' ' ASN . 52.4 m -57.89 -36.71 72.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.475 179.807 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.535 ' CG2' ' O ' ' A' ' 145' ' ' ALA . 39.3 t -74.65 -27.5 20.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.686 179.82 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -66.41 -52.64 44.45 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.426 -0.509 . . . . 0.0 110.209 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . 0.499 ' OD1' ' O ' ' A' ' 148' ' ' THR . 8.1 p-10 -65.35 -43.42 90.93 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.25 -179.837 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . 0.455 ' C ' ' CD1' ' A' ' 152' ' ' TYR . 22.6 t80 -64.78 -42.44 95.09 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.988 -0.285 . . . . 0.0 111.006 -179.562 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 77.1 t80 -61.18 -41.16 96.29 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.181 -179.376 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 42.9 t -75.44 -50.46 23.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.38 -179.348 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' TRP . . . . . 0.617 ' CZ2' ' CD1' ' A' ' 107' ' ' TRP . 0.1 OUTLIER -55.4 -29.4 58.45 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.826 -178.889 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -85.41 -45.93 11.4 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.952 -0.299 . . . . 0.0 110.625 -179.639 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -69.02 -44.02 73.58 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.897 -179.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 16.3 t30 -69.74 -10.22 57.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.79 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 27.0 t -62.22 -28.51 69.74 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.71 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 83.0 -162.01 40.32 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 110.842 -0.903 . . . . 0.0 110.842 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 83.0 mtt-85 -139.06 167.93 20.95 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.828 0.347 . . . . 0.0 110.526 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 89.3 mtt180 -89.05 141.83 28.16 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.7 -179.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 82.09 118.66 0.52 Allowed Glycine 0 CA--C 1.524 0.62 0 N-CA-C 111.106 -0.798 . . . . 0.0 111.106 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 160.15 -106.31 0.28 Allowed Glycine 0 CA--C 1.524 0.624 0 N-CA-C 111.223 -0.751 . . . . 0.0 111.223 179.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 9.5 p -56.43 159.14 3.84 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.891 0.377 . . . . 0.0 110.846 -179.744 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 43.9 ttp85 -139.74 128.03 22.62 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.453 179.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.492 ' CD2' ' N ' ' A' ' 167' ' ' LEU . 1.3 mm? -108.38 172.19 6.98 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.044 179.785 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -139.64 139.81 36.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.598 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 . . . . . 0 C--O 1.219 -0.511 0 CA-C-O 117.999 -1.001 . . . . 0.0 110.453 179.929 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 201' ' ' PKA . . . . . 0.521 'CL ' ' C15' ' A' ' 201' ' ' PKA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.492 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.903 0.382 . . . . 0.0 110.636 . . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_exo -62.09 -45.25 16.54 Favored 'Trans proline' 0 C--N 1.304 -1.765 0 C-N-CA 122.515 2.143 . . . . 0.0 112.266 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -166.53 -21.86 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.57 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 67.5 p -54.14 124.66 16.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.734 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.694 ' CE2' ' CE3' ' A' ' 68' ' ' TRP . 1.0 OUTLIER -76.57 117.81 18.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.898 179.748 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.576 ' N ' ' CD ' ' A' ' 7' ' ' PRO . 0.9 OUTLIER -60.52 -33.01 12.86 Favored Pre-proline 0 CA--C 1.534 0.362 0 C-N-CA 120.858 -0.337 . . . . 0.0 110.274 -179.653 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.576 ' CD ' ' N ' ' A' ' 6' ' ' VAL . 24.6 Cg_exo -73.14 -66.23 0.03 OUTLIER 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 121.517 1.478 . . . . 0.0 112.069 179.577 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.455 ' O ' ' OG1' ' A' ' 12' ' ' THR . . . -50.11 -36.58 30.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.261 -179.485 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.41 ' CG2' ' O ' ' A' ' 5' ' ' TRP . 78.7 t -69.53 -61.96 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.552 -179.292 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -56.11 -34.71 62.71 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 111.51 -0.636 . . . . 0.0 111.51 -179.347 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 6.9 mp -74.44 -30.29 61.83 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.57 0.224 . . . . 0.0 110.737 -179.532 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.455 ' OG1' ' O ' ' A' ' 8' ' ' ALA . 3.1 p -81.21 -21.02 39.9 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.876 0.37 . . . . 0.0 110.578 179.83 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.423 ' O ' ' N ' ' A' ' 16' ' ' SER . 69.8 mt -82.9 -38.12 23.3 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.517 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 5.1 t -43.07 -58.9 3.55 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.717 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -56.8 -13.96 12.57 Favored 'Trans proline' 0 N--CA 1.497 1.71 0 C-N-CA 121.02 1.147 . . . . 0.0 111.789 179.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.423 ' N ' ' O ' ' A' ' 13' ' ' LEU . 1.9 t -79.52 -24.73 42.01 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.506 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 55.0 mt -74.24 -58.16 3.48 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.323 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -75.72 -23.24 73.13 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 110.685 -0.966 . . . . 0.0 110.685 179.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -70.38 -52.49 16.86 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 111.259 -0.736 . . . . 0.0 111.259 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 86.9 t80 -74.07 -55.14 6.47 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.682 0.277 . . . . 0.0 111.184 -179.597 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 16.2 ttm -62.97 -30.12 71.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.26 -179.365 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -72.76 -59.54 4.34 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 111.277 -0.729 . . . . 0.0 111.277 -179.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.22 -16.43 62.0 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.784 -0.366 . . . . 0.0 110.62 -179.434 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 63.4 t80 -48.14 -23.99 1.0 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.104 179.56 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 48.5 t80 -72.08 -53.54 12.54 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.953 -179.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 33.3 m -65.52 -16.32 20.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 C-N-CA 120.835 -0.346 . . . . 0.0 110.672 -179.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.458 ' O ' ' CD1' ' A' ' 31' ' ' LEU . 0.0 OUTLIER -56.57 -47.51 79.34 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.741 -179.813 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -105.51 -62.98 0.63 Allowed Glycine 0 CA--C 1.525 0.7 0 N-CA-C 111.191 -0.764 . . . . 0.0 111.191 -179.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 6.1 tm-20 -45.09 -33.89 2.36 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.722 0.296 . . . . 0.0 110.626 -179.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -71.66 -51.11 17.05 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 111.023 -0.831 . . . . 0.0 111.023 -179.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.458 ' CD1' ' O ' ' A' ' 27' ' ' ARG . 86.6 mt -57.61 -35.04 69.93 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.752 0.31 . . . . 0.0 110.609 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 62.8 mtp180 -76.07 -42.72 46.56 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.36 179.796 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -51.71 -40.61 60.46 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.372 179.845 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.506 ' C ' ' CD1' ' A' ' 34' ' ' TYR . 9.8 t80 -48.23 -40.6 24.96 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.67 -179.797 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -57.73 -24.95 59.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.449 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -95.55 -75.18 1.26 Allowed Glycine 0 CA--C 1.525 0.663 0 N-CA-C 110.974 -0.85 . . . . 0.0 110.974 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.402 ' C ' ' CD1' ' A' ' 37' ' ' LEU . 0.4 OUTLIER -95.79 167.54 11.21 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.971 0.415 . . . . 0.0 110.739 179.823 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 47.2 mm-40 -79.91 113.21 17.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.888 -179.568 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.463 ' C ' ' H ' ' A' ' 41' ' ' SER . 8.3 mtpt -128.86 150.72 75.86 Favored Pre-proline 0 CA--C 1.532 0.281 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.068 179.637 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.603 ' C ' ' H ' ' A' ' 42' ' ' TRP . 72.4 Cg_endo -75.7 23.8 0.43 Allowed 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 121.871 1.714 . . . . 0.0 111.636 179.526 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.463 ' H ' ' C ' ' A' ' 39' ' ' LYS . 98.1 p -51.66 -1.72 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.264 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . 0.695 ' CH2' ' NE2' ' A' ' 43' ' ' HIS . 55.7 p-90 -76.81 -14.2 59.93 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.397 -0.521 . . . . 0.0 110.558 -179.308 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.695 ' NE2' ' CH2' ' A' ' 42' ' ' TRP . 19.0 m80 -64.45 139.14 97.65 Favored Pre-proline 0 C--N 1.33 -0.267 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 178.438 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.48 ' C ' ' O ' ' A' ' 43' ' ' HIS . 71.2 Cg_exo -31.37 116.12 0.06 OUTLIER 'Trans proline' 0 N--CA 1.494 1.537 0 C-N-CA 121.215 1.276 . . . . 0.0 111.349 -179.771 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.596 ' O ' ' N ' ' A' ' 47' ' ' TRP . 38.5 Cg_exo -39.65 152.82 0.06 OUTLIER 'Trans proline' 0 C--N 1.308 -1.588 0 CA-C-N 118.776 0.599 . . . . 0.0 111.774 -179.194 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.467 ' O ' ' CB ' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -40.57 -17.74 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.726 -179.812 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.602 ' CD1' ' N ' ' A' ' 48' ' ' THR . 0.2 OUTLIER -60.12 -45.78 91.84 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.899 -0.32 . . . . 0.0 111.685 -179.247 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.602 ' N ' ' CD1' ' A' ' 47' ' ' TRP . 1.0 OUTLIER -91.21 -39.78 11.91 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 112.824 0.675 . . . . 0.0 112.824 -178.268 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.434 ' CD2' ' O8 ' ' A' ' 201' ' ' PKA . 31.5 tp -83.0 -39.67 20.98 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -177.097 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.67 ' C ' ' H ' ' A' ' 52' ' ' ILE . . . -40.43 -29.08 0.21 Allowed Pre-proline 0 N--CA 1.466 0.327 0 C-N-CA 120.069 -0.652 . . . . 0.0 111.569 -178.872 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_exo -54.93 7.39 0.03 OUTLIER 'Trans proline' 0 C--N 1.312 -1.355 0 CA-C-N 119.058 0.699 . . . . 0.0 112.205 177.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.67 ' H ' ' C ' ' A' ' 50' ' ' ALA . 11.6 pt -54.37 -35.19 29.98 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.203 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 178.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 63.0 m95 -81.79 -24.12 36.16 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.359 179.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -71.43 -47.07 37.23 Favored Glycine 0 CA--C 1.527 0.792 0 N-CA-C 110.36 -1.096 . . . . 0.0 110.36 179.275 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.517 ' CG2' ' N ' ' A' ' 56' ' ' LEU . 13.3 t -70.65 -48.15 56.38 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 179.408 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.517 ' N ' ' CG2' ' A' ' 55' ' ' THR . 93.5 mt -60.92 -27.9 68.54 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 178.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.46 ' C ' ' CD1' ' A' ' 57' ' ' TYR . 0.8 OUTLIER -65.94 -53.64 36.54 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 179.375 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.479 ' H ' ' HG ' ' A' ' 58' ' ' SER . 0.1 OUTLIER -48.88 -47.56 42.89 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 178.928 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.11 -48.21 82.44 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.062 179.177 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 27.1 mtt -52.67 -50.55 63.02 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.876 179.652 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -48.37 -53.63 15.38 Favored Glycine 0 CA--C 1.522 0.526 0 N-CA-C 110.399 -1.081 . . . . 0.0 110.399 179.638 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.538 ' N ' ' CD1' ' A' ' 62' ' ' TYR . 1.4 m-30 -56.55 -50.31 72.25 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.8 0.333 . . . . 0.0 110.527 179.68 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -52.06 -54.13 27.42 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 110.475 -1.05 . . . . 0.0 110.475 179.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.592 ' O ' ' CD1' ' A' ' 68' ' ' TRP . 1.4 t -54.88 -47.23 74.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.834 0.349 . . . . 0.0 110.281 179.672 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.57 ' OH ' ' NZ ' ' A' ' 69' ' ' LYS . 74.7 t80 -46.27 -45.17 17.04 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.647 -0.421 . . . . 0.0 109.899 179.69 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 59.0 mt -71.38 -27.1 27.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.902 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 73.6 t -67.34 -57.71 8.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 C-N-CA 120.732 -0.387 . . . . 0.0 111.6 -179.3 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . 0.694 ' CE3' ' CE2' ' A' ' 5' ' ' TRP . 0.0 OUTLIER -72.82 -24.61 60.93 Favored 'General case' 0 CA--C 1.528 0.11 0 C-N-CA 119.814 -0.754 . . . . 0.0 110.73 -179.654 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.57 ' NZ ' ' OH ' ' A' ' 65' ' ' TYR . 6.5 mmmt -76.73 -26.74 54.98 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.427 -0.509 . . . . 0.0 110.181 179.341 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 33.6 tp10 -79.96 -58.4 3.18 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.817 -179.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.2 pp -73.34 -21.72 60.48 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.878 -179.597 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.499 ' O ' ' O ' ' A' ' 73' ' ' GLY . . . 109.32 98.57 2.54 Favored Glycine 0 CA--C 1.528 0.844 0 C-N-CA 121.088 -0.577 . . . . 0.0 112.248 178.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.577 ' N ' ' O ' ' A' ' 68' ' ' TRP . . . 41.52 -173.99 0.01 OUTLIER Glycine 0 CA--C 1.525 0.691 0 N-CA-C 111.975 -0.45 . . . . 0.0 111.975 178.878 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 84.0 t80 -90.42 110.64 21.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.724 0.297 . . . . 0.0 110.483 -179.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.568 ' OG1' ' N ' ' A' ' 76' ' ' GLU . 0.8 OUTLIER -142.43 -173.6 3.9 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.909 0.385 . . . . 0.0 110.893 -179.839 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.568 ' N ' ' OG1' ' A' ' 75' ' ' THR . 26.0 mt-10 -53.27 -21.68 5.83 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.692 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 24.3 m-20 -79.67 -33.07 41.5 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.778 -179.796 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -87.02 -15.62 38.12 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.821 -179.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 8.1 mtp -70.99 -27.24 63.56 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.763 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 8.4 t -66.85 -45.12 54.36 Favored Pre-proline 0 C--N 1.328 -0.331 0 C-N-CA 120.783 -0.367 . . . . 0.0 110.52 -179.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -77.1 -61.7 0.03 OUTLIER 'Trans proline' 0 N--CA 1.499 1.816 0 C-N-CA 121.227 1.284 . . . . 0.0 111.799 178.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 12.7 mt -55.39 -44.41 76.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.759 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -65.92 -55.85 17.43 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.972 -0.851 . . . . 0.0 110.972 -179.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 60.3 tp -55.28 -21.87 16.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.812 0.339 . . . . 0.0 110.37 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 30.7 t80 -78.03 -51.89 9.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.063 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -61.84 -38.58 88.75 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.8 -0.36 . . . . 0.0 111.277 -179.059 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -73.67 -58.14 4.65 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 111.277 -0.729 . . . . 0.0 111.277 -179.571 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 5.0 tp-100 -53.45 -47.74 69.45 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-O 121.127 0.489 . . . . 0.0 109.778 179.714 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.445 ' O ' ' C ' ' A' ' 90' ' ' ALA . 19.5 tp -52.81 -66.02 0.46 Allowed 'General case' 0 C--O 1.211 -0.961 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.904 179.823 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.445 ' C ' ' O ' ' A' ' 89' ' ' LEU . . . -38.17 -48.7 1.29 Allowed 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 120.267 -0.573 . . . . 0.0 111.771 -179.496 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 95.3 mt -55.22 -57.03 13.45 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 113.415 0.894 . . . . 0.0 113.415 -178.407 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.402 ' O ' ' CD2' ' A' ' 113' ' ' LEU . 4.8 m-20 -78.05 -53.42 7.43 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 121.284 0.564 . . . . 0.0 111.604 -178.223 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . 0.645 ' O ' ' N ' ' A' ' 95' ' ' TRP . 5.6 t-105 -52.13 -25.11 8.12 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.568 -179.679 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -55.74 71.35 0.0 OUTLIER 'General case' 0 CA--C 1.528 0.133 0 CA-C-O 120.829 0.347 . . . . 0.0 110.675 -179.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.681 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 7.0 p-90 -101.62 -17.73 0.19 Allowed Pre-proline 0 CA--C 1.534 0.35 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.891 -179.784 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.681 ' CD ' ' N ' ' A' ' 95' ' ' TRP . 44.5 Cg_exo -61.16 -24.78 79.85 Favored 'Trans proline' 0 C--N 1.311 -1.396 0 C-N-CA 120.248 0.632 . . . . 0.0 112.412 179.034 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.529 ' CD ' ' N ' ' A' ' 96' ' ' PRO . 63.8 Cg_exo -59.82 -31.82 94.51 Favored 'Trans proline' 0 N--CA 1.493 1.474 0 C-N-CA 120.339 0.693 . . . . 0.0 112.803 179.547 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 1.4 pt -77.2 44.01 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 C-N-CA 120.342 -0.543 . . . . 0.0 110.259 179.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.421 ' H ' ' C ' ' A' ' 97' ' ' PRO . 0.1 OUTLIER -61.57 -35.59 78.23 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.302 179.986 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -82.62 -20.01 37.2 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.399 179.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -87.28 -14.73 63.57 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.912 -0.875 . . . . 0.0 110.912 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -62.04 -34.18 75.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.783 0.325 . . . . 0.0 110.672 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 15.8 ptt180 -76.4 11.24 1.65 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.78 -179.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 14.8 mt-30 -121.89 154.56 36.93 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.564 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 6.0 mmt -51.49 -18.59 1.12 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.413 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.606 ' O ' ' N ' ' A' ' 108' ' ' ALA . . . -71.13 -14.98 74.19 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 111.18 -0.768 . . . . 0.0 111.18 179.874 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' TRP . . . . . 0.461 ' CD1' ' N ' ' A' ' 108' ' ' ALA . 0.1 OUTLIER -42.55 -14.12 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.683 0.278 . . . . 0.0 110.822 -179.498 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.606 ' N ' ' O ' ' A' ' 106' ' ' GLY . . . -58.49 -28.68 65.6 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 179.416 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 12.2 mt -47.02 -31.68 3.42 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.889 179.49 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -54.55 -60.47 3.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.39 179.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.589 ' OD1' ' N ' ' A' ' 112' ' ' LEU . 1.6 p30 -59.0 -53.68 55.72 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.76 -179.44 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.589 ' N ' ' OD1' ' A' ' 111' ' ' ASP . 40.5 tp -55.43 -39.81 70.72 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -178.414 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.402 ' CD2' ' O ' ' A' ' 92' ' ' ASN . 17.9 mt -70.47 -61.69 1.67 Allowed 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.124 0.416 . . . . 0.0 112.124 -178.506 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.9 pp -59.6 -34.02 72.21 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 120.339 -0.544 . . . . 0.0 111.064 -179.006 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.55 ' CG2' ' O ' ' A' ' 111' ' ' ASP . 42.3 t -61.68 -60.86 2.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.102 -179.863 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 13.0 m -68.0 -22.62 64.99 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.546 -178.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -66.35 -62.75 4.39 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 120.696 -0.764 . . . . 0.0 111.856 -179.252 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.494 ' O ' ' OG1' ' A' ' 122' ' ' THR . 9.1 p -72.46 -35.86 52.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 111.614 0.227 . . . . 0.0 111.614 -179.183 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . 0.557 ' O ' ' OG1' ' A' ' 123' ' ' THR . . . -67.96 -61.31 1.92 Allowed 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.387 -0.525 . . . . 0.0 111.289 -179.326 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 8.1 m -59.64 -50.43 73.9 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.561 -0.291 . . . . 0.0 111.492 -179.184 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.433 ' O ' ' CB ' ' A' ' 125' ' ' ALA . . . -55.29 -40.49 71.13 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.79 0.329 . . . . 0.0 111.019 -179.461 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.494 ' OG1' ' O ' ' A' ' 118' ' ' VAL . 40.4 p -74.79 -33.44 62.24 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.803 -0.359 . . . . 0.0 111.713 -179.253 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.557 ' OG1' ' O ' ' A' ' 119' ' ' ALA . 0.2 OUTLIER -60.07 -56.48 21.15 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.559 -0.456 . . . . 0.0 110.784 -179.521 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -79.19 -20.16 49.07 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 -178.584 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . 0.433 ' CB ' ' O ' ' A' ' 121' ' ' ALA . . . -91.17 -66.73 0.9 Allowed 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 112.789 0.663 . . . . 0.0 112.789 -178.818 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 43.4 m0 -83.0 -57.42 3.3 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -177.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . 0.401 ' CD2' ' N ' ' A' ' 127' ' ' HIS . 11.5 m170 -55.69 -22.18 22.08 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.584 -0.446 . . . . 0.0 111.129 -179.004 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 19.2 ttt85 -69.66 -48.79 58.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.148 -179.624 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 10.3 t -81.39 -47.46 19.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.993 -179.453 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 61.0 p -116.28 104.98 51.39 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.51 -179.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . 0.639 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 57.2 Cg_exo -70.79 -29.43 18.99 Favored 'Trans proline' 0 C--N 1.31 -1.477 0 C-N-CA 121.537 1.491 . . . . 0.0 112.367 179.639 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.639 ' CD ' ' N ' ' A' ' 131' ' ' PRO . 41.4 Cg_exo -62.58 -42.81 24.51 Favored 'Trans proline' 0 N--CA 1.496 1.663 0 C-N-CA 121.391 1.394 . . . . 0.0 111.787 179.7 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -54.44 -41.52 69.5 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.311 179.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -57.18 -22.66 42.06 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.309 179.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 11.2 tpp180 -77.06 -31.7 56.32 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.61 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 82.8 mt -72.56 -43.54 63.3 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.857 0.361 . . . . 0.0 110.082 179.571 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.556 ' O ' ' N ' ' A' ' 140' ' ' TYR . 3.4 mt -75.31 -37.68 60.68 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.442 179.79 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.588 ' C ' ' H ' ' A' ' 140' ' ' TYR . 0.8 OUTLIER -19.4 -48.64 0.04 OUTLIER Pre-proline 0 N--CA 1.466 0.352 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.948 -179.608 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.527 ' N ' ' O ' ' A' ' 137' ' ' LEU . 1.6 Cg_endo -64.45 16.08 0.08 OUTLIER 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 120.968 1.112 . . . . 0.0 112.142 179.617 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . 0.653 ' CE1' ' CD1' ' A' ' 141' ' ' LEU . 5.3 p90 -93.35 -15.17 26.01 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-O 121.153 0.501 . . . . 0.0 110.22 179.634 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.653 ' CD1' ' CE1' ' A' ' 140' ' ' TYR . 5.8 mp -57.43 -26.74 61.62 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.273 178.773 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -66.49 -48.93 68.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.08 179.651 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' TRP . . . . . . . . . . . . . 12.0 t-105 -55.81 -48.7 74.96 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 179.499 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 8.8 mt -50.37 -56.58 10.76 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 120.444 -0.502 . . . . 0.0 109.968 179.714 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . 0.426 ' O ' ' CG2' ' A' ' 149' ' ' VAL . . . -61.41 -18.28 58.09 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.709 -179.815 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 6.5 t80 -70.93 -65.04 0.79 Allowed 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.843 -0.343 . . . . 0.0 110.829 -179.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.494 ' O ' ' OD1' ' A' ' 151' ' ' ASN . . . -62.95 -40.23 97.03 Favored 'General case' 0 C--N 1.332 -0.154 0 C-N-CA 120.769 -0.372 . . . . 0.0 110.309 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 13.9 m -58.77 -49.83 76.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.46 179.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.426 ' CG2' ' O ' ' A' ' 145' ' ' ALA . 53.6 t -66.9 -29.38 46.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.334 179.831 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -58.33 -59.6 5.08 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.506 -0.478 . . . . 0.0 109.935 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . 0.494 ' OD1' ' O ' ' A' ' 147' ' ' ALA . 6.7 p-10 -60.6 -51.29 70.02 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.543 179.624 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . 0.665 ' CZ ' ' NE ' ' A' ' 156' ' ' ARG . 53.8 t80 -50.13 -34.74 23.18 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.283 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . 0.552 ' CE2' ' OD2' ' A' ' 157' ' ' ASP . 41.0 t80 -68.06 -46.07 72.09 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.529 179.826 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 19.0 t -58.14 -36.8 58.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.305 179.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' TRP . . . . . 0.575 ' O ' ' N ' ' A' ' 159' ' ' SER . 15.3 m0 -65.57 -46.02 81.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.624 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . 0.665 ' NE ' ' CZ ' ' A' ' 152' ' ' TYR . 7.2 mpt_? -68.4 -29.27 67.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.579 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . 0.552 ' OD2' ' CE2' ' A' ' 153' ' ' TYR . 17.0 m-20 -72.3 -51.71 19.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.819 -179.78 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 -89.2 -40.02 13.15 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.602 -179.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' SER . . . . . 0.575 ' N ' ' O ' ' A' ' 155' ' ' TRP . 23.0 t -115.78 -170.12 1.72 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.632 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 84.81 25.53 41.28 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 110.974 -0.851 . . . . 0.0 110.974 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 69.6 mtt180 -48.77 -24.92 1.58 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.766 0.317 . . . . 0.0 110.721 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 11.9 ttt85 -61.92 153.7 28.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.968 0.413 . . . . 0.0 110.616 -179.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -153.87 179.32 30.22 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 110.713 -0.955 . . . . 0.0 110.713 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -176.7 -90.98 0.08 OUTLIER Glycine 0 CA--C 1.525 0.709 0 N-CA-C 111.1 -0.8 . . . . 0.0 111.1 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' SER . . . . . 0.561 ' OG ' ' N ' ' A' ' 166' ' ' ARG . 5.6 t -76.91 -174.32 3.04 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.705 0.288 . . . . 0.0 110.759 -179.853 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . 0.561 ' N ' ' OG ' ' A' ' 165' ' ' SER . 22.0 ttp180 83.52 137.09 0.06 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.319 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.522 ' CD2' ' N ' ' A' ' 167' ' ' LEU . 1.4 mm? -111.19 54.16 0.69 Allowed 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.401 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.433 ' CB ' HH21 ' A' ' 166' ' ' ARG . . . -50.47 -39.13 47.19 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.617 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 . . . . . 0 C--O 1.221 -0.431 0 CA-C-O 118.011 -0.995 . . . . 0.0 110.444 179.855 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 201' ' ' PKA . . . . . 0.542 ' N18' ' H3 ' ' A' ' 201' ' ' PKA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 37.9 mtt . . . . . 0 C--O 1.231 0.08 0 CA-C-O 120.689 0.28 . . . . 0.0 110.41 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -81.72 -15.15 9.76 Favored 'Trans proline' 0 N--CA 1.494 1.538 0 C-N-CA 121.84 1.693 . . . . 0.0 111.944 179.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.428 ' O ' ' OG ' ' A' ' 4' ' ' SER . 34.8 tt0 -62.75 -26.56 68.76 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.481 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.428 ' OG ' ' O ' ' A' ' 3' ' ' GLU . 4.3 m -177.99 145.22 0.37 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.522 179.854 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -65.68 117.03 7.53 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.354 -179.872 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.589 ' N ' ' CD ' ' A' ' 7' ' ' PRO . 0.9 OUTLIER -62.28 -37.52 37.86 Favored Pre-proline 0 CA--C 1.534 0.352 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.114 -179.999 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.589 ' CD ' ' N ' ' A' ' 6' ' ' VAL . 33.5 Cg_exo -63.68 -64.21 0.07 OUTLIER 'Trans proline' 0 C--N 1.307 -1.621 0 C-N-CA 121.704 1.603 . . . . 0.0 111.525 179.638 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.533 ' O ' ' CG2' ' A' ' 12' ' ' THR . . . -52.77 -38.84 61.64 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.695 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 24.8 t -59.3 -62.02 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.848 -179.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -59.86 -56.67 23.48 Favored Glycine 0 CA--C 1.527 0.81 0 N-CA-C 111.516 -0.634 . . . . 0.0 111.516 -179.628 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 10.1 mp -50.15 -37.77 36.19 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.563 0.22 . . . . 0.0 110.888 -179.643 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.533 ' CG2' ' O ' ' A' ' 8' ' ' ALA . 35.9 p -75.57 -25.18 56.85 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.858 -0.337 . . . . 0.0 110.625 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 4.1 mp -75.81 -25.11 56.06 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.196 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.2 t -54.54 -61.87 4.94 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.428 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -55.8 -46.16 33.67 Favored 'Trans proline' 0 N--CA 1.496 1.672 0 C-N-CA 120.662 0.908 . . . . 0.0 111.808 179.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.2 t -46.13 -28.37 1.2 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.236 -179.474 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 92.7 mt -70.2 -56.02 7.86 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.645 -0.422 . . . . 0.0 110.742 -179.705 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -68.0 -23.2 74.42 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 111.316 -0.714 . . . . 0.0 111.316 -179.659 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -69.93 -54.66 11.13 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 110.881 -0.888 . . . . 0.0 110.881 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 52.3 t80 -65.94 -60.29 2.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.833 0.349 . . . . 0.0 110.675 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 17.3 tpp -59.09 -27.67 65.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.04 -179.726 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -74.71 -62.91 2.71 Favored Glycine 0 CA--C 1.523 0.536 0 N-CA-C 111.011 -0.836 . . . . 0.0 111.011 -179.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -55.48 -19.54 9.9 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.947 0.403 . . . . 0.0 109.994 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 9.5 t80 -47.83 -24.39 0.98 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.409 179.713 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.466 ' CE2' ' O ' ' A' ' 99' ' ' PHE . 50.0 t80 -69.34 -48.32 61.74 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.417 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 35.6 m -75.23 -16.37 15.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.634 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -56.31 -47.28 79.01 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.834 -179.77 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -107.14 -42.2 1.55 Allowed Glycine 0 CA--C 1.525 0.7 0 N-CA-C 111.055 -0.818 . . . . 0.0 111.055 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.44 ' OE2' ' CZ3' ' A' ' 33' ' ' TRP . 16.8 tp10 -71.45 -29.63 65.09 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.701 0.286 . . . . 0.0 110.693 -179.845 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -73.99 -57.36 4.87 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.913 -0.875 . . . . 0.0 110.913 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 10.0 mp -56.83 -25.42 56.02 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.973 -0.381 . . . . 0.0 109.973 179.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 55.4 ttt180 -81.2 -49.89 10.24 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.088 -0.506 . . . . 0.0 109.989 179.432 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . 0.44 ' CZ3' ' OE2' ' A' ' 29' ' ' GLU . 0.2 OUTLIER -45.83 -39.94 9.14 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.688 179.252 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 42.2 t80 -47.37 -38.67 13.55 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.774 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -55.97 -35.18 66.43 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.262 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -84.31 -72.27 1.29 Allowed Glycine 0 CA--C 1.524 0.634 0 N-CA-C 110.804 -0.918 . . . . 0.0 110.804 179.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.411 ' C ' ' CD1' ' A' ' 37' ' ' LEU . 0.4 OUTLIER -96.67 167.89 10.85 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.798 0.333 . . . . 0.0 110.611 179.622 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 42.3 mm-40 -83.71 118.53 23.95 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.512 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.523 ' C ' ' H ' ' A' ' 41' ' ' SER . 15.0 mtpt -127.47 150.15 71.97 Favored Pre-proline 0 N--CA 1.465 0.277 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.255 -179.804 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.652 ' C ' ' H ' ' A' ' 42' ' ' TRP . 99.0 Cg_endo -72.61 17.23 0.37 Allowed 'Trans proline' 0 C--N 1.309 -1.509 0 C-N-CA 121.747 1.632 . . . . 0.0 111.045 179.177 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.523 ' H ' ' C ' ' A' ' 39' ' ' LYS . 95.1 p -49.28 -2.04 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.397 -0.82 . . . . 0.0 111.447 -179.861 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . 0.652 ' H ' ' C ' ' A' ' 40' ' ' PRO . 48.7 p-90 -77.19 -15.14 59.63 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.448 -0.501 . . . . 0.0 110.557 -179.381 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.587 ' CE1' ' CH2' ' A' ' 42' ' ' TRP . 6.9 m-70 -60.71 146.07 86.84 Favored Pre-proline 0 C--N 1.33 -0.265 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 178.587 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.455 ' C ' ' O ' ' A' ' 43' ' ' HIS . 9.7 Cg_endo -34.18 139.79 0.08 OUTLIER 'Trans proline' 0 C--N 1.309 -1.515 0 C-N-CA 121.377 1.385 . . . . 0.0 111.145 -179.645 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -59.94 163.18 14.4 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 C-N-CA 120.148 0.565 . . . . 0.0 112.003 -179.347 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.468 ' O ' ' CB ' ' A' ' 50' ' ' ALA . 1.6 ptm180 -46.19 -26.88 0.85 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.832 -179.066 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.597 ' CD1' ' N ' ' A' ' 48' ' ' THR . 1.4 p-90 -55.42 -46.23 76.68 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 120.805 -0.358 . . . . 0.0 111.872 -178.678 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.597 ' N ' ' CD1' ' A' ' 47' ' ' TRP . 1.1 m -91.41 -40.92 11.16 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -178.499 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 15.5 tp -83.19 -47.43 11.59 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -177.188 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.689 ' C ' ' H ' ' A' ' 52' ' ' ILE . . . -43.41 -27.84 0.33 Allowed Pre-proline 0 N--CA 1.468 0.431 0 N-CA-C 112.141 0.422 . . . . 0.0 112.141 -179.141 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.414 ' HD2' ' N ' ' A' ' 50' ' ' ALA . 26.6 Cg_exo -53.41 6.46 0.03 OUTLIER 'Trans proline' 0 C--N 1.313 -1.309 0 CA-C-N 119.003 0.68 . . . . 0.0 112.476 178.214 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.689 ' H ' ' C ' ' A' ' 50' ' ' ALA . 7.0 pt -51.85 -36.81 19.84 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.19 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 178.827 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.403 ' CH2' ' CZ3' ' A' ' 93' ' ' TRP . 66.1 m95 -80.74 -25.0 38.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.143 -179.752 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -73.1 -50.75 11.64 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 110.326 -1.109 . . . . 0.0 110.326 179.326 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.54 ' CG2' ' N ' ' A' ' 56' ' ' LEU . 6.8 t -66.28 -49.16 68.04 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.983 -0.287 . . . . 0.0 110.287 179.713 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.54 ' N ' ' CG2' ' A' ' 55' ' ' THR . 77.7 mt -60.33 -36.53 78.17 Favored 'General case' 0 CA--C 1.521 -0.16 0 C-N-CA 120.403 -0.519 . . . . 0.0 109.608 179.317 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.485 ' C ' ' CD1' ' A' ' 57' ' ' TYR . 0.8 OUTLIER -56.46 -48.29 77.38 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.61 179.334 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.7 p -55.87 -48.06 76.23 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.022 179.5 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.0 -38.82 80.09 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.315 179.558 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 22.2 mtt -63.16 -37.91 89.1 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.479 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -63.38 -47.02 91.28 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 111.245 -0.742 . . . . 0.0 111.245 -179.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 3.3 m-30 -61.49 -59.13 5.71 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.574 -179.662 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -53.94 -60.06 8.95 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 111.02 -0.832 . . . . 0.0 111.02 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.534 ' OG ' ' CH2' ' A' ' 126' ' ' TRP . 44.7 m -45.51 -48.47 14.12 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.001 0.429 . . . . 0.0 110.726 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 62.6 t80 -56.51 -41.45 76.74 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.697 -179.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 74.7 mt -65.43 -37.56 80.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.923 -179.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.413 ' CG1' ' CZ3' ' A' ' 68' ' ' TRP . 21.3 t -59.85 -60.83 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.721 -179.801 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . 0.576 ' O ' ' N ' ' A' ' 73' ' ' GLY . 0.7 OUTLIER -57.3 -41.51 79.96 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.655 -0.418 . . . . 0.0 110.325 179.933 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 13.9 mmmt -61.44 -24.77 66.77 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.498 179.622 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 17.7 tp10 -82.34 -62.47 1.61 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.187 -179.473 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.497 ' C ' ' CD1' ' A' ' 71' ' ' LEU . 3.4 pp -65.25 -8.88 19.7 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.831 -0.348 . . . . 0.0 111.377 -179.152 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.468 ' O ' ' O ' ' A' ' 73' ' ' GLY . . . 108.87 76.43 0.93 Allowed Glycine 0 CA--C 1.527 0.801 0 C-N-CA 120.939 -0.648 . . . . 0.0 111.592 179.561 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.576 ' N ' ' O ' ' A' ' 68' ' ' TRP . . . 42.84 -174.03 0.01 OUTLIER Glycine 0 CA--C 1.524 0.595 0 N-CA-C 111.947 -0.461 . . . . 0.0 111.947 179.219 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 43.8 t80 -76.33 110.71 11.07 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.262 -0.469 . . . . 0.0 110.837 -179.671 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 7.4 t -142.37 -178.21 5.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.428 179.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -46.8 -26.57 0.98 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.179 -179.66 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 51.7 m-20 -79.05 -28.78 43.21 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.268 -179.422 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -86.4 -18.34 32.05 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.955 -0.298 . . . . 0.0 110.937 -179.681 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 9.1 mtp -68.96 -27.38 65.68 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.604 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.0 t -68.37 -47.77 36.5 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.9 -179.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -72.03 -58.56 0.07 OUTLIER 'Trans proline' 0 N--CA 1.498 1.792 0 C-N-CA 121.113 1.208 . . . . 0.0 111.843 179.253 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.6 mt -57.07 -43.71 82.34 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.48 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -66.84 -63.77 3.67 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 111.142 -0.783 . . . . 0.0 111.142 -179.475 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 57.7 tp -49.66 -23.07 1.55 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.924 0.393 . . . . 0.0 110.137 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.413 ' O ' ' CB ' ' A' ' 89' ' ' LEU . 12.9 t80 -76.61 -48.58 18.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.54 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.44 -42.45 95.99 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.8 -0.36 . . . . 0.0 111.056 -179.442 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -70.05 -57.97 6.55 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 111.149 -0.78 . . . . 0.0 111.149 -179.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 36.5 tp60 -54.71 -47.52 73.64 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-O 121.012 0.434 . . . . 0.0 110.104 179.731 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.441 ' O ' ' C ' ' A' ' 90' ' ' ALA . 17.4 tp -56.55 -65.04 0.68 Allowed 'General case' 0 C--O 1.21 -0.991 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.936 179.581 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.441 ' C ' ' O ' ' A' ' 89' ' ' LEU . . . -37.86 -44.33 0.75 Allowed 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 120.407 -0.517 . . . . 0.0 111.649 -179.407 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 78.2 mt -60.97 -56.89 15.81 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 113.102 0.778 . . . . 0.0 113.102 -178.664 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 41.7 m-20 -75.9 -53.11 8.93 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.392 0.615 . . . . 0.0 111.697 -178.369 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . 0.628 ' O ' ' N ' ' A' ' 95' ' ' TRP . 9.8 t-105 -52.05 -33.68 40.07 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.055 -0.975 . . . . 0.0 111.594 -179.938 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -57.03 72.3 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.892 0.377 . . . . 0.0 110.076 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.705 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 22.1 p-90 -97.47 -17.0 0.2 Allowed Pre-proline 0 CA--C 1.532 0.264 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.966 -179.387 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.705 ' CD ' ' N ' ' A' ' 95' ' ' TRP . 52.8 Cg_exo -60.14 -32.23 94.32 Favored 'Trans proline' 0 N--CA 1.493 1.493 0 C-N-CA 120.357 0.705 . . . . 0.0 112.635 179.387 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.484 ' CD ' ' N ' ' A' ' 96' ' ' PRO . 70.1 Cg_exo -50.35 -23.31 9.98 Favored 'Trans proline' 0 N--CA 1.493 1.458 0 C-N-CA 120.254 0.636 . . . . 0.0 112.443 179.785 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.588 ' O ' ' N ' ' A' ' 101' ' ' GLY . 1.1 pp -84.5 19.77 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 121.087 0.47 . . . . 0.0 110.135 179.531 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.466 ' O ' ' CE2' ' A' ' 25' ' ' PHE . 4.4 t80 -39.13 -35.41 0.23 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.843 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 30.6 m-85 -86.59 -25.79 24.79 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.82 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.588 ' N ' ' O ' ' A' ' 98' ' ' ILE . . . -82.8 -4.4 90.07 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 111.195 -0.762 . . . . 0.0 111.195 -179.886 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -72.24 -9.63 58.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.637 0.256 . . . . 0.0 111.081 -179.704 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 3.7 ptm180 -105.25 4.3 30.95 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.755 0.312 . . . . 0.0 110.779 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . 0.406 ' C ' ' N ' ' A' ' 106' ' ' GLY . 9.6 mt-30 -113.69 167.54 10.53 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.475 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' MET . . . . . 0.486 ' N ' ' SD ' ' A' ' 105' ' ' MET . 0.0 OUTLIER -49.64 -17.38 0.32 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.532 179.979 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.578 ' O ' ' N ' ' A' ' 108' ' ' ALA . . . -72.77 -15.12 78.0 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 111.37 -0.692 . . . . 0.0 111.37 -179.751 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' TRP . . . . . 0.665 ' CD1' ' CZ2' ' A' ' 155' ' ' TRP . 0.0 OUTLIER -38.15 -21.32 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 120.548 0.213 . . . . 0.0 111.239 -179.473 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.578 ' N ' ' O ' ' A' ' 106' ' ' GLY . . . -66.81 -16.15 64.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.912 0.387 . . . . 0.0 111.291 -179.531 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 13.5 mt -60.31 -36.79 78.73 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.479 -179.246 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -53.66 -63.59 1.1 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.967 0.413 . . . . 0.0 110.721 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.493 ' OD1' ' O ' ' A' ' 108' ' ' ALA . 5.6 p-10 -56.76 -60.69 3.2 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.826 -179.297 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.43 ' H ' ' CG ' ' A' ' 111' ' ' ASP . 51.9 tp -49.83 -41.9 46.06 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -178.477 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 71.4 mt -68.49 -61.72 1.7 Allowed 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 -178.144 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.3 pp -59.76 -33.29 71.48 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 120.581 -0.448 . . . . 0.0 111.281 -178.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.49 ' CG2' ' O ' ' A' ' 111' ' ' ASP . 53.3 t -62.04 -60.93 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.148 -179.838 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' SER . . . . . 0.496 ' O ' ' OG1' ' A' ' 120' ' ' THR . 11.4 t -68.57 -22.12 64.49 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.1 -179.373 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -64.8 -62.92 4.58 Favored Glycine 0 CA--C 1.526 0.764 0 C-N-CA 120.883 -0.675 . . . . 0.0 111.742 -179.284 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.496 ' O ' ' OG1' ' A' ' 122' ' ' THR . 9.9 p -73.38 -36.57 49.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 C-N-CA 120.948 -0.301 . . . . 0.0 111.286 -179.389 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . 0.543 ' O ' ' OG1' ' A' ' 123' ' ' THR . . . -67.41 -61.21 2.02 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.529 -0.469 . . . . 0.0 111.019 -179.462 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.496 ' OG1' ' O ' ' A' ' 116' ' ' SER . 2.0 m -59.27 -54.59 45.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.351 -179.431 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.437 ' O ' ' CB ' ' A' ' 125' ' ' ALA . . . -49.5 -45.89 47.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.854 -179.513 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.496 ' OG1' ' O ' ' A' ' 118' ' ' VAL . 40.9 p -69.75 -35.29 74.84 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.996 -179.06 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.543 ' OG1' ' O ' ' A' ' 119' ' ' ALA . 0.2 OUTLIER -58.2 -52.07 67.1 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.633 -0.427 . . . . 0.0 111.139 -179.218 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.7 pp -83.96 -19.73 34.11 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.705 -0.398 . . . . 0.0 111.721 -178.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . 0.437 ' CB ' ' O ' ' A' ' 121' ' ' ALA . . . -88.02 -70.11 0.65 Allowed 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.584 0.587 . . . . 0.0 112.584 -178.796 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' TRP . . . . . 0.534 ' CH2' ' OG ' ' A' ' 64' ' ' SER . 35.9 m0 -83.23 -57.82 3.1 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 -177.702 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . 0.449 ' CD2' ' N ' ' A' ' 127' ' ' HIS . 12.3 m170 -52.22 -21.82 3.76 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.663 -0.415 . . . . 0.0 111.295 -178.825 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 28.3 ttt180 -70.05 -47.01 63.75 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.667 -179.337 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 4.1 t -94.44 -9.58 9.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 111.861 0.319 . . . . 0.0 111.861 -178.674 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -149.56 106.39 3.29 Favored Pre-proline 0 C--N 1.328 -0.368 0 C-N-CA 120.872 -0.331 . . . . 0.0 111.183 -179.364 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . 0.665 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 74.4 Cg_exo -76.05 -23.27 12.28 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 121.759 1.639 . . . . 0.0 112.656 179.058 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.665 ' CD ' ' N ' ' A' ' 131' ' ' PRO . 52.4 Cg_exo -65.89 -56.85 0.28 Allowed 'Trans proline' 0 N--CA 1.496 1.652 0 C-N-CA 121.322 1.348 . . . . 0.0 112.347 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -46.76 -40.73 14.07 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.64 -179.793 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -52.35 -24.39 7.54 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.533 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 6.1 tpt180 -76.93 -36.71 56.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.432 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 41.3 mt -67.19 -37.06 83.05 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.353 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.568 ' O ' ' N ' ' A' ' 140' ' ' TYR . 5.8 mt -81.86 -39.63 23.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.487 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.534 ' C ' ' H ' ' A' ' 140' ' ' TYR . 4.2 t80 -22.58 -43.57 0.04 OUTLIER Pre-proline 0 CA--C 1.532 0.274 0 O-C-N 123.664 0.602 . . . . 0.0 111.819 -179.601 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.552 ' N ' ' O ' ' A' ' 137' ' ' LEU . 6.3 Cg_exo -65.36 12.66 0.12 Allowed 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 120.852 1.034 . . . . 0.0 111.975 179.291 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . 0.568 ' N ' ' O ' ' A' ' 137' ' ' LEU . 3.1 p90 -93.15 -14.42 27.21 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-O 120.892 0.377 . . . . 0.0 110.852 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.42 ' CD2' ' CE1' ' A' ' 140' ' ' TYR . 4.3 mm? -55.94 -33.48 64.77 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 178.536 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -56.21 -55.43 33.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.005 179.604 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' TRP . . . . . . . . . . . . . 10.8 t-105 -52.08 -50.49 61.46 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 179.643 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 13.3 mt -49.68 -54.92 15.83 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 120.348 -0.541 . . . . 0.0 109.91 179.599 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . 0.494 ' O ' ' CG2' ' A' ' 149' ' ' VAL . . . -60.44 -21.35 62.19 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.852 -179.779 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 6.2 t80 -69.48 -63.18 1.12 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.837 -179.582 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -64.91 -33.4 75.94 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.728 -0.389 . . . . 0.0 110.436 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 68.9 m -67.13 -35.35 79.53 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.2 179.673 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.494 ' CG2' ' O ' ' A' ' 145' ' ' ALA . 43.5 t -79.5 -26.87 12.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.179 179.79 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -66.55 -48.7 68.83 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.827 -0.435 . . . . 0.0 109.827 179.747 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . 0.507 ' CG ' ' HE1' ' A' ' 107' ' ' TRP . 0.9 OUTLIER -72.92 -51.23 19.34 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.627 179.81 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . 0.414 ' CD1' ' C ' ' A' ' 152' ' ' TYR . 27.8 t80 -56.16 -43.31 78.22 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.855 -179.77 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . 0.437 ' CB ' ' O ' ' A' ' 149' ' ' VAL . 63.9 t80 -62.46 -54.38 40.98 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.299 -179.548 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 72.7 t -60.44 -54.81 29.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.151 -179.291 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' TRP . . . . . 0.665 ' CZ2' ' CD1' ' A' ' 107' ' ' TRP . 0.4 OUTLIER -48.92 -37.6 20.36 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.206 -0.452 . . . . 0.0 109.978 -179.564 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -77.51 -28.98 52.23 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.296 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 12.5 t0 -75.44 -52.82 9.82 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.826 -179.595 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . 0.484 ' OD1' ' O ' ' A' ' 158' ' ' ASN . 48.9 t-20 -68.03 -31.28 70.85 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.731 -179.861 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' SER . . . . . 0.46 ' OG ' ' O ' ' A' ' 155' ' ' TRP . 3.8 m -54.46 174.46 0.06 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.636 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 175.88 177.09 44.65 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 111.217 -0.753 . . . . 0.0 111.217 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . 0.4 ' HD2' ' H ' ' A' ' 162' ' ' ARG . 15.3 tpt85 -100.68 146.27 27.4 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.82 0.343 . . . . 0.0 110.253 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . 0.4 ' H ' ' HD2' ' A' ' 161' ' ' ARG . 66.9 ttp85 -75.15 125.2 28.45 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.664 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -147.93 35.04 1.2 Allowed Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.76 -0.936 . . . . 0.0 110.76 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 60.19 151.26 0.01 OUTLIER Glycine 0 CA--C 1.523 0.569 0 N-CA-C 110.774 -0.93 . . . . 0.0 110.774 -179.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' SER . . . . . 0.571 ' HG ' ' HE ' ' A' ' 166' ' ' ARG . 0.8 OUTLIER -64.37 -12.45 42.79 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.825 0.345 . . . . 0.0 110.42 -179.97 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . 0.571 ' HE ' ' HG ' ' A' ' 165' ' ' SER . 2.7 mpt_? -137.95 -122.67 0.13 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.026 179.834 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.506 ' N ' ' CD1' ' A' ' 167' ' ' LEU . 8.4 mp -92.87 -79.43 0.4 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.803 0.335 . . . . 0.0 110.205 179.77 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . 64.52 118.89 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.718 179.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 . . . . . 0 C--O 1.221 -0.426 0 CA-C-O 117.988 -1.006 . . . . 0.0 110.303 179.822 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 201' ' ' PKA . . . . . 0.548 ' N18' ' H3 ' ' A' ' 201' ' ' PKA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.563 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.085 0 CA-C-O 121.009 0.433 . . . . 0.0 110.472 . . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -66.4 -12.71 36.82 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 C-N-CA 122.679 2.252 . . . . 0.0 112.213 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.435 ' O ' ' C ' ' A' ' 4' ' ' SER . 47.4 mm-40 -43.22 -29.86 0.43 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.648 -179.887 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.435 ' C ' ' O ' ' A' ' 3' ' ' GLU . 32.5 p 36.59 87.98 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.539 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.497 ' CE2' ' CE3' ' A' ' 68' ' ' TRP . 0.3 OUTLIER -66.97 117.51 9.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.239 -179.938 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.648 ' N ' ' CD ' ' A' ' 7' ' ' PRO . 1.0 OUTLIER -62.64 -33.73 12.4 Favored Pre-proline 0 C--N 1.328 -0.326 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 179.788 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.648 ' CD ' ' N ' ' A' ' 6' ' ' VAL . 21.6 Cg_exo -72.37 -66.97 0.03 OUTLIER 'Trans proline' 0 C--N 1.308 -1.557 0 C-N-CA 121.957 1.772 . . . . 0.0 111.895 179.516 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.505 ' O ' ' CG2' ' A' ' 12' ' ' THR . . . -49.65 -31.32 10.67 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.153 -179.683 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.469 ' CG2' ' O ' ' A' ' 5' ' ' TRP . 47.4 t -71.36 -62.2 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.425 -179.182 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -59.02 -43.82 96.67 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 111.262 -0.735 . . . . 0.0 111.262 -179.419 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 8.0 mp -61.87 -39.03 90.5 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.697 0.284 . . . . 0.0 110.637 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.505 ' CG2' ' O ' ' A' ' 8' ' ' ALA . 8.0 p -69.73 -28.48 65.84 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.786 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.427 ' O ' ' CB ' ' A' ' 16' ' ' SER . 10.7 mt -78.27 -33.38 49.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.669 -179.843 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.439 ' C ' ' H ' ' A' ' 16' ' ' SER . 20.3 t -42.0 -59.48 2.58 Favored Pre-proline 0 CA--C 1.535 0.38 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.561 -179.681 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.43 ' HD2' ' N ' ' A' ' 14' ' ' VAL . 17.1 Cg_endo -51.69 -9.46 0.4 Allowed 'Trans proline' 0 N--CA 1.5 1.869 0 C-N-CA 120.616 0.877 . . . . 0.0 112.317 -179.471 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.439 ' H ' ' C ' ' A' ' 14' ' ' VAL . 3.1 t -79.35 -30.99 42.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.74 -179.865 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 16.6 mt -69.63 -54.44 13.95 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.998 -179.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -73.38 -38.55 52.75 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 111.632 -0.587 . . . . 0.0 111.632 -179.374 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -68.94 -29.84 72.42 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 111.066 -0.813 . . . . 0.0 111.066 -179.546 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.412 ' CB ' ' O ' ' A' ' 16' ' ' SER . 64.0 t80 -78.73 -60.32 2.42 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.815 -0.354 . . . . 0.0 110.934 -179.672 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 23.8 ttm -64.88 -21.1 66.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.66 -179.805 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -79.09 -63.02 2.12 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 111.309 -0.716 . . . . 0.0 111.309 -179.628 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.93 -22.19 66.6 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.594 -179.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 64.4 t80 -50.9 -23.91 3.19 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.989 0.424 . . . . 0.0 109.892 179.31 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.446 ' CD1' ' C ' ' A' ' 25' ' ' PHE . 25.4 t80 -67.08 -55.01 16.14 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.964 -179.84 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 27.2 m -65.87 -22.13 30.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.966 -179.509 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.7 tmt_? -75.56 -17.54 60.03 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.698 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -116.06 -67.3 0.41 Allowed Glycine 0 CA--C 1.525 0.7 0 N-CA-C 111.239 -0.744 . . . . 0.0 111.239 -179.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -67.97 -29.72 68.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.751 0.31 . . . . 0.0 110.94 -179.69 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -69.27 -45.91 59.33 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 111.31 -0.716 . . . . 0.0 111.31 -179.737 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 11.1 mp -60.34 -28.53 68.24 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.692 0.282 . . . . 0.0 110.677 -179.789 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 76.7 mtm180 -80.38 -43.03 21.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.829 0.347 . . . . 0.0 110.36 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . 0.502 ' O ' ' N ' ' A' ' 36' ' ' GLY . 0.2 OUTLIER -59.91 -27.2 66.54 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 179.751 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.487 ' C ' ' CD1' ' A' ' 34' ' ' TYR . 10.3 t80 -49.02 -37.02 19.33 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.894 179.496 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -70.87 -21.66 62.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.902 179.447 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.502 ' N ' ' O ' ' A' ' 33' ' ' TRP . . . -87.95 -76.89 1.28 Allowed Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.442 -1.063 . . . . 0.0 110.442 179.591 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -96.04 163.7 13.01 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 109.889 -0.411 . . . . 0.0 109.889 179.011 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.455 ' H ' ' CD ' ' A' ' 38' ' ' GLN . 11.2 mp0 -81.79 122.64 27.95 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.932 0.396 . . . . 0.0 111.432 -179.066 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 20.3 mtpt -119.02 160.01 42.58 Favored Pre-proline 0 C--N 1.332 -0.176 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.575 179.182 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -41.97 131.79 4.37 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 C-N-CA 122.023 1.815 . . . . 0.0 111.972 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.6 t -80.57 -2.53 46.67 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.021 -179.631 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 6.1 p90 -111.42 22.85 14.66 Favored 'General case' 0 N--CA 1.463 0.187 0 C-N-CA 120.959 -0.297 . . . . 0.0 110.845 -179.364 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.567 ' O ' ' CG ' ' A' ' 43' ' ' HIS . 1.7 p80 -90.27 122.92 66.92 Favored Pre-proline 0 CA--C 1.538 0.519 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.821 -179.891 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -105.44 -175.83 0.07 OUTLIER 'Trans proline' 0 N--CA 1.496 1.662 0 C-N-CA 120.933 1.089 . . . . 0.0 111.13 177.713 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -77.45 155.8 32.25 Favored 'Trans proline' 0 C--N 1.303 -1.839 0 C-N-CA 121.359 1.372 . . . . 0.0 110.698 178.659 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.457 ' O ' ' CB ' ' A' ' 50' ' ' ALA . 40.7 ptt85 -48.14 -32.28 6.73 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 112.2 0.444 . . . . 0.0 112.2 -178.693 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.507 ' CD1' ' OG1' ' A' ' 48' ' ' THR . 0.0 OUTLIER -61.86 -17.0 54.85 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 120.618 -0.433 . . . . 0.0 111.551 -178.596 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.507 ' OG1' ' CD1' ' A' ' 47' ' ' TRP . 8.9 m -92.39 -63.5 1.22 Allowed 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 -178.666 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.405 ' O ' ' C ' ' A' ' 50' ' ' ALA . 2.1 mm? -85.02 -35.49 21.88 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 -177.657 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.619 ' C ' ' H ' ' A' ' 52' ' ' ILE . . . -39.87 -29.12 0.19 Allowed Pre-proline 0 N--CA 1.466 0.346 0 C-N-CA 120.14 -0.624 . . . . 0.0 111.849 -178.266 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.409 ' HD2' ' N ' ' A' ' 50' ' ' ALA . 95.5 Cg_exo -57.01 5.85 0.06 OUTLIER 'Trans proline' 0 C--N 1.313 -1.323 0 CA-C-N 119.114 0.719 . . . . 0.0 112.273 178.125 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.619 ' H ' ' C ' ' A' ' 50' ' ' ALA . 33.5 pt -55.29 -31.37 26.65 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.295 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 179.514 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.459 ' O ' ' CB ' ' A' ' 57' ' ' TYR . 72.7 m95 -78.73 -22.81 45.98 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.892 -179.497 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -69.22 -48.23 47.52 Favored Glycine 0 CA--C 1.526 0.772 0 N-CA-C 110.064 -1.214 . . . . 0.0 110.064 178.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 14.5 m -66.77 -55.63 14.12 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.783 0.325 . . . . 0.0 110.142 179.431 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 86.1 mt -58.62 -26.98 64.26 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.44 179.713 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.526 ' C ' ' CD1' ' A' ' 57' ' ' TYR . 0.5 OUTLIER -64.98 -54.1 35.79 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 179.509 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 37.2 t -51.19 -50.49 58.92 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 179.126 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -56.6 -45.18 81.58 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.319 179.435 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 12.3 mtt -57.72 -49.03 77.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.365 179.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -51.49 -43.98 52.98 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 110.994 -0.842 . . . . 0.0 110.994 -179.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 3.2 m-30 -65.26 -56.3 13.54 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.762 0.315 . . . . 0.0 110.943 -179.456 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -52.06 -48.53 52.21 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.37 -1.092 . . . . 0.0 110.37 179.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.488 ' O ' ' CD1' ' A' ' 68' ' ' TRP . 1.7 t -58.83 -41.9 87.98 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.652 -0.274 . . . . 0.0 110.571 179.889 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.406 ' O ' ' CG ' ' A' ' 69' ' ' LYS . 14.5 t80 -54.58 -37.97 66.14 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 109.138 -0.689 . . . . 0.0 109.138 179.038 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 97.3 mt -73.34 -27.29 23.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.096 179.223 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 61.2 t -69.52 -61.69 1.58 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.252 0 C-N-CA 120.746 -0.382 . . . . 0.0 110.763 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . 0.516 ' CD1' ' N ' ' A' ' 68' ' ' TRP . 0.0 OUTLIER -57.9 -38.07 75.17 Favored 'General case' 0 C--O 1.221 -0.402 0 C-N-CA 119.388 -0.925 . . . . 0.0 109.622 179.758 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.406 ' CG ' ' O ' ' A' ' 65' ' ' TYR . 0.2 OUTLIER -58.39 -40.52 82.56 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.889 0.376 . . . . 0.0 110.458 179.956 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 55.8 tt0 -64.35 -41.67 96.64 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.344 -179.555 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.6 mt -78.78 -17.64 55.45 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.955 0.407 . . . . 0.0 111.053 -179.347 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 97.84 43.16 2.93 Favored Glycine 0 CA--C 1.526 0.771 0 N-CA-C 110.345 -1.102 . . . . 0.0 110.345 -178.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 96.98 -175.09 30.76 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 111.03 -0.828 . . . . 0.0 111.03 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -71.8 112.44 7.91 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.844 0.354 . . . . 0.0 110.533 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.433 ' OG1' ' N ' ' A' ' 76' ' ' GLU . 3.0 t -139.4 179.51 6.5 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.855 -179.801 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.433 ' N ' ' OG1' ' A' ' 75' ' ' THR . 5.0 mm-40 -54.56 -50.06 68.85 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.595 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -55.0 -16.11 2.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.454 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -95.56 -30.7 13.68 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.392 179.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 3.5 mtp -64.9 -27.06 68.6 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.495 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.427 ' O ' ' CB ' ' A' ' 84' ' ' LEU . 9.1 t -68.9 -49.64 25.67 Favored Pre-proline 0 CA--C 1.534 0.345 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.643 -179.694 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -72.13 -61.48 0.05 OUTLIER 'Trans proline' 0 N--CA 1.497 1.728 0 C-N-CA 121.127 1.218 . . . . 0.0 111.523 178.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.7 mt -51.3 -46.32 62.5 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.384 179.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.452 ' O ' ' N ' ' A' ' 86' ' ' THR . . . -67.6 -63.56 3.65 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.672 -0.971 . . . . 0.0 110.672 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.427 ' CB ' ' O ' ' A' ' 80' ' ' VAL . 56.9 tp -43.73 -24.75 0.14 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.892 0.377 . . . . 0.0 110.014 179.727 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.424 ' N ' ' C ' ' A' ' 83' ' ' GLY . 7.2 t80 -80.62 -40.48 25.59 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.442 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.452 ' N ' ' O ' ' A' ' 83' ' ' GLY . 0.7 OUTLIER -71.63 -39.07 70.65 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 120.599 -0.44 . . . . 0.0 110.854 -179.787 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -74.7 -56.92 4.74 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 110.758 -0.937 . . . . 0.0 110.758 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.454 ' O ' ' CB ' ' A' ' 92' ' ' ASN . 9.4 tp-100 -52.7 -43.88 65.93 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.723 0.296 . . . . 0.0 110.236 179.747 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 11.1 tp -67.59 -34.9 77.95 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.605 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -59.73 -65.75 0.63 Allowed 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 120.279 -0.568 . . . . 0.0 111.343 -179.633 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.0 pp -70.71 -39.01 73.67 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -178.479 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.454 ' CB ' ' O ' ' A' ' 88' ' ' GLN . 36.7 t-20 -72.42 -50.33 27.14 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 -178.6 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . 0.622 ' O ' ' N ' ' A' ' 95' ' ' TRP . 0.0 OUTLIER -79.63 -16.63 55.45 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.536 -0.466 . . . . 0.0 111.832 -178.374 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -52.02 81.83 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 120.31 -0.556 . . . . 0.0 109.965 179.336 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.704 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 33.8 p-90 -98.97 -16.14 0.19 Allowed Pre-proline 0 CA--C 1.537 0.451 0 N-CA-C 112.564 0.579 . . . . 0.0 112.564 -179.103 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.704 ' CD ' ' N ' ' A' ' 95' ' ' TRP . 36.6 Cg_exo -57.31 -31.5 91.09 Favored 'Trans proline' 0 N--CA 1.495 1.609 0 C-N-CA 120.526 0.818 . . . . 0.0 113.125 179.777 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.455 ' CD ' ' N ' ' A' ' 96' ' ' PRO . 80.4 Cg_exo -53.14 -20.28 13.87 Favored 'Trans proline' 0 N--CA 1.495 1.601 0 C-N-CA 120.352 0.701 . . . . 0.0 113.271 -179.873 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.463 ' O ' ' N ' ' A' ' 101' ' ' GLY . 1.3 pp -82.61 19.21 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 C-N-CA 120.586 -0.446 . . . . 0.0 110.469 -179.897 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -40.76 -41.48 1.56 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.933 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 0.4 ' CD1' ' N ' ' A' ' 100' ' ' PHE . 2.5 p90 -85.5 -23.75 27.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.914 -179.698 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.463 ' N ' ' O ' ' A' ' 98' ' ' ILE . . . -78.82 -7.7 88.15 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 111.194 -0.762 . . . . 0.0 111.194 -179.851 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -80.14 -7.11 58.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.774 0.321 . . . . 0.0 110.729 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -74.36 -12.18 60.45 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.846 -179.727 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . 0.429 ' C ' ' N ' ' A' ' 106' ' ' GLY . 6.7 pt20 -117.39 164.62 14.59 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.804 -179.862 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 8.6 mmt -47.92 -17.15 0.1 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.536 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.595 ' O ' ' N ' ' A' ' 108' ' ' ALA . . . -62.09 -15.56 50.58 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' TRP . . . . . 0.512 ' C ' ' CD1' ' A' ' 107' ' ' TRP . 0.0 OUTLIER -44.04 -12.62 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.758 0.313 . . . . 0.0 110.725 -179.687 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.595 ' N ' ' O ' ' A' ' 106' ' ' GLY . . . -65.27 -28.52 69.4 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.363 179.743 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 9.1 mp -45.76 -26.43 0.65 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.231 179.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -60.82 -63.97 1.12 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.595 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.545 ' O ' ' CG2' ' A' ' 115' ' ' VAL . 4.1 p30 -57.66 -50.75 72.15 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.464 -179.614 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.438 ' N ' ' OD1' ' A' ' 111' ' ' ASP . 53.2 tp -55.14 -44.27 74.92 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.875 -0.33 . . . . 0.0 111.587 -178.968 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 54.2 mt -66.7 -61.39 1.99 Allowed 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -178.515 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.3 pp -61.51 -32.64 72.67 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 120.567 -0.453 . . . . 0.0 111.842 -178.391 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.545 ' CG2' ' O ' ' A' ' 111' ' ' ASP . 46.0 t -63.32 -54.44 32.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.24 -179.9 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' SER . . . . . 0.447 ' O ' ' OG1' ' A' ' 120' ' ' THR . 28.9 t -72.46 -24.12 61.15 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.316 -179.059 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -66.2 -62.66 4.49 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 120.944 -0.646 . . . . 0.0 111.749 -179.278 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.516 ' O ' ' OG1' ' A' ' 122' ' ' THR . 7.5 p -71.79 -38.48 65.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 C-N-CA 120.961 -0.296 . . . . 0.0 111.709 -179.246 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . 0.53 ' O ' ' OG1' ' A' ' 123' ' ' THR . . . -64.54 -60.92 2.58 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.697 -0.401 . . . . 0.0 111.221 -179.286 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.447 ' OG1' ' O ' ' A' ' 116' ' ' SER . 2.1 m -60.28 -55.16 37.12 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.56 -179.275 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -51.11 -40.65 58.95 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.204 -179.268 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.516 ' OG1' ' O ' ' A' ' 118' ' ' VAL . 30.9 p -72.25 -35.54 68.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.3 -179.363 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.53 ' OG1' ' O ' ' A' ' 119' ' ' ALA . 0.2 OUTLIER -58.28 -50.66 72.81 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.812 0.339 . . . . 0.0 111.148 -179.221 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.6 pp -82.42 -20.19 37.54 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.669 -178.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -88.12 -72.72 0.52 Allowed 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 -178.511 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 43.7 m0 -81.83 -57.93 3.21 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 112.662 0.616 . . . . 0.0 112.662 -177.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . 0.533 ' CD2' ' N ' ' A' ' 127' ' ' HIS . 5.3 m170 -53.18 -22.23 6.28 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.63 -0.428 . . . . 0.0 111.14 -178.823 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 14.0 ttt180 -76.31 -30.49 57.74 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.146 -179.61 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 73.8 t -95.64 -49.9 12.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.769 0.319 . . . . 0.0 111.29 -179.422 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 67.7 p -117.6 109.23 41.99 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.511 -179.707 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . 0.657 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 50.5 Cg_exo -71.68 -18.13 29.04 Favored 'Trans proline' 0 N--CA 1.493 1.461 0 C-N-CA 121.458 1.439 . . . . 0.0 112.584 179.638 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.657 ' CD ' ' N ' ' A' ' 131' ' ' PRO . 54.3 Cg_exo -74.43 -35.57 3.68 Favored 'Trans proline' 0 N--CA 1.496 1.653 0 C-N-CA 121.262 1.308 . . . . 0.0 112.0 179.365 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -63.49 -39.64 94.97 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.348 179.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -57.33 -26.56 61.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.2 179.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 15.9 tpt180 -77.66 -31.09 52.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.373 179.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 20.5 mt -75.5 -25.83 57.63 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.261 -0.427 . . . . 0.0 109.849 179.506 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.486 ' O ' ' N ' ' A' ' 140' ' ' TYR . 68.6 mt -92.47 -23.81 19.01 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.165 179.505 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.518 ' C ' ' CD1' ' A' ' 138' ' ' TYR . 0.3 OUTLIER -35.43 -50.19 1.33 Allowed Pre-proline 0 CA--C 1.535 0.395 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.977 179.715 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.43 ' HD2' ' N ' ' A' ' 138' ' ' TYR . 0.9 OUTLIER -61.28 4.89 0.2 Allowed 'Trans proline' 0 N--CA 1.496 1.667 0 C-N-CA 121.64 1.56 . . . . 0.0 112.958 -179.471 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . 0.486 ' N ' ' O ' ' A' ' 137' ' ' LEU . 0.1 OUTLIER -88.88 -14.32 37.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.0 0.429 . . . . 0.0 110.562 179.657 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.411 ' N ' ' CD1' ' A' ' 140' ' ' TYR . 97.5 mt -60.02 -33.6 72.22 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.685 178.582 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -57.15 -41.39 79.06 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.584 179.304 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' TRP . . . . . . . . . . . . . 8.6 t-105 -66.11 -43.64 86.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.591 179.24 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 30.0 mt -59.08 -41.97 89.27 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.174 179.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . 0.489 ' O ' ' CG2' ' A' ' 149' ' ' VAL . . . -72.65 -23.4 60.9 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.419 179.855 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 24.4 t80 -65.91 -57.11 8.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.804 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -68.08 -43.37 78.69 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 120.91 -0.316 . . . . 0.0 110.886 -179.727 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 63.6 m -58.99 -45.68 90.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.831 0.348 . . . . 0.0 110.754 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.489 ' CG2' ' O ' ' A' ' 145' ' ' ALA . 69.4 t -68.49 -29.43 43.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.632 -179.885 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 1.6 tp -62.51 -47.09 85.44 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.293 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . 0.596 ' ND2' ' N ' ' A' ' 152' ' ' TYR . 0.3 OUTLIER -69.27 -37.2 77.77 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.568 179.934 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . 0.596 ' N ' ' ND2' ' A' ' 151' ' ' ASN . 26.0 t80 -64.15 -48.82 74.53 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.593 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 31.1 t80 -59.27 -43.51 92.49 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.872 -179.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 75.8 t -61.7 -36.04 71.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.81 -179.757 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' TRP . . . . . . . . . . . . . 8.0 m0 -64.44 -59.19 4.63 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.74 -179.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . 0.411 ' NE ' ' CZ ' ' A' ' 152' ' ' TYR . 3.3 mpt_? -60.62 -51.29 70.05 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.829 -179.571 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 31.3 t0 -53.82 -43.79 69.7 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.791 -179.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 16.5 t-20 -76.18 -31.41 58.48 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.55 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 86.2 p -128.65 116.44 19.58 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.439 179.671 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . 0.476 ' O ' ' O ' ' A' ' 161' ' ' ARG . . . -93.09 130.41 10.32 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 110.999 -0.841 . . . . 0.0 110.999 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . 0.476 ' O ' ' O ' ' A' ' 160' ' ' GLY . 46.9 mtt180 45.67 -177.22 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.826 0.346 . . . . 0.0 110.742 179.872 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 34.9 ttp180 -94.66 129.8 41.39 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.504 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -79.67 -169.17 37.96 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 110.827 -0.909 . . . . 0.0 110.827 179.805 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 71.3 -123.82 10.63 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.809 -0.916 . . . . 0.0 110.809 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 6.0 t 63.4 158.34 0.08 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.759 0.314 . . . . 0.0 110.512 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 4.1 ttm105 -80.35 -70.63 0.51 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.336 -0.393 . . . . 0.0 109.977 179.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 3.8 mp -141.73 -113.94 0.12 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.351 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -91.59 107.09 18.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.578 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 . . . . . 0 C--O 1.219 -0.525 0 CA-C-O 117.974 -1.013 . . . . 0.0 110.525 -179.98 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 201' ' ' PKA . . . . . 0.574 ' N18' ' H3 ' ' A' ' 201' ' ' PKA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.644 ' N ' ' CD ' ' A' ' 2' ' ' PRO . 1.6 mmt . . . . . 0 CA--C 1.53 0.179 0 CA-C-O 120.511 0.196 . . . . 0.0 110.99 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.644 ' CD ' ' N ' ' A' ' 1' ' ' MET . 52.5 Cg_exo -60.42 139.12 84.88 Favored 'Trans proline' 0 N--CA 1.495 1.602 0 C-N-CA 121.602 1.535 . . . . 0.0 112.13 -179.823 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.4 ' O ' ' CB ' ' A' ' 4' ' ' SER . 92.1 mt-10 -145.54 -25.63 0.47 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.459 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.4 ' CB ' ' O ' ' A' ' 3' ' ' GLU . 1.3 p 73.98 137.56 0.06 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.379 -179.814 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 1.3 t-105 -60.2 109.12 0.9 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.096 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.576 ' N ' ' CD ' ' A' ' 7' ' ' PRO . 0.9 OUTLIER -62.23 -40.43 66.78 Favored Pre-proline 0 CA--C 1.533 0.313 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.479 -179.479 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.576 ' CD ' ' N ' ' A' ' 6' ' ' VAL . 25.1 Cg_exo -61.24 -60.29 0.24 Allowed 'Trans proline' 0 C--N 1.306 -1.66 0 C-N-CA 121.627 1.551 . . . . 0.0 111.874 179.904 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.538 ' O ' ' CG2' ' A' ' 12' ' ' THR . . . -56.88 -32.94 66.37 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.42 -179.465 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.487 ' O ' ' OG1' ' A' ' 12' ' ' THR . 55.3 t -67.22 -62.03 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 C-N-CA 120.897 -0.321 . . . . 0.0 111.397 -179.263 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -57.52 -41.23 93.33 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 111.354 -0.698 . . . . 0.0 111.354 -179.509 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 7.7 mp -69.64 -30.14 67.78 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 121.043 -0.263 . . . . 0.0 110.758 -179.641 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.538 ' CG2' ' O ' ' A' ' 8' ' ' ALA . 4.8 p -74.81 -25.24 58.89 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.842 -0.343 . . . . 0.0 110.406 179.802 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.441 ' O ' ' CB ' ' A' ' 16' ' ' SER . 6.4 mp -81.48 -33.79 31.74 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.023 179.688 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.407 ' N ' ' HD2' ' A' ' 15' ' ' PRO . 7.9 t -40.25 -60.66 1.4 Allowed Pre-proline 0 CA--C 1.535 0.366 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.061 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.407 ' HD2' ' N ' ' A' ' 14' ' ' VAL . 10.5 Cg_endo -51.49 -17.15 4.14 Favored 'Trans proline' 0 N--CA 1.499 1.8 0 C-N-CA 120.949 1.099 . . . . 0.0 112.091 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.441 ' CB ' ' O ' ' A' ' 13' ' ' LEU . 4.0 t -70.0 -33.3 71.86 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.886 0.374 . . . . 0.0 110.512 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 27.9 mt -72.11 -55.17 7.77 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.336 179.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -60.75 -46.36 94.63 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 110.857 -0.897 . . . . 0.0 110.857 179.784 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -65.35 -29.45 75.28 Favored Glycine 0 CA--C 1.526 0.756 0 N-CA-C 111.051 -0.82 . . . . 0.0 111.051 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 31.9 t80 -74.23 -59.98 2.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.696 0.284 . . . . 0.0 110.66 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 6.7 ttp -63.31 -22.47 66.9 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.621 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.479 ' C ' ' CZ2' ' A' ' 95' ' ' TRP . . . -77.2 -62.65 2.41 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 111.093 -0.803 . . . . 0.0 111.093 -179.874 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.51 -17.54 63.99 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.006 0.431 . . . . 0.0 110.314 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 41.4 t80 -48.91 -24.73 1.58 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.143 179.634 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 33.9 t80 -67.64 -54.72 17.31 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.761 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 22.2 m -71.64 -17.2 19.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.761 -179.724 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -62.17 -39.84 94.0 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.623 -179.885 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -114.65 -72.42 0.55 Allowed Glycine 0 CA--C 1.525 0.681 0 N-CA-C 110.824 -0.91 . . . . 0.0 110.824 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -45.92 -28.23 1.07 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.82 0.343 . . . . 0.0 110.431 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -68.26 -45.16 71.91 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 84.2 mt -54.95 -36.43 65.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.887 0.375 . . . . 0.0 110.274 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 56.2 mtp180 -77.69 -50.53 12.26 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.637 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . 0.422 ' O ' ' N ' ' A' ' 36' ' ' GLY . 0.6 OUTLIER -46.73 -30.68 2.52 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 116.3 -0.409 . . . . 0.0 109.909 -179.996 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 37.7 t80 -47.75 -33.62 7.33 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.424 179.723 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -74.9 -30.64 61.35 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.263 179.731 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.422 ' N ' ' O ' ' A' ' 33' ' ' TRP . . . -77.72 -77.39 0.83 Allowed Glycine 0 CA--C 1.524 0.64 0 N-CA-C 110.793 -0.923 . . . . 0.0 110.793 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -96.45 166.23 11.8 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 120.791 0.329 . . . . 0.0 110.739 179.712 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.579 HE21 ' C ' ' A' ' 39' ' ' LYS . 2.3 tm0? -83.17 113.41 20.63 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.767 -179.739 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.579 ' C ' HE21 ' A' ' 38' ' ' GLN . 7.8 mtpt -97.24 157.28 35.16 Favored Pre-proline 0 CA--C 1.532 0.267 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 179.893 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.428 ' O ' ' CD2' ' A' ' 43' ' ' HIS . 2.9 Cg_exo -49.79 139.85 31.35 Favored 'Trans proline' 0 N--CA 1.495 1.568 0 C-N-CA 120.924 1.083 . . . . 0.0 112.104 -178.714 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 6.0 t -80.86 -2.83 49.02 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.841 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 4.5 p90 -114.27 15.96 18.01 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.256 -179.257 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.59 ' CD2' ' O ' ' A' ' 43' ' ' HIS . 0.4 OUTLIER -88.68 119.67 70.06 Favored Pre-proline 0 CA--C 1.537 0.459 0 CA-C-N 116.742 -0.208 . . . . 0.0 111.484 -179.684 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -102.77 152.42 0.26 Allowed 'Trans proline' 0 N--CA 1.491 1.367 0 C-N-CA 120.763 0.975 . . . . 0.0 111.049 178.47 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.481 ' O ' ' N ' ' A' ' 47' ' ' TRP . 2.0 Cg_endo -47.85 135.47 22.94 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 C-N-CA 120.615 0.877 . . . . 0.0 111.088 179.877 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.45 ' C ' ' HE ' ' A' ' 46' ' ' ARG . 0.0 OUTLIER -41.87 -18.43 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.904 -0.589 . . . . 0.0 112.258 -178.879 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.564 ' CD1' ' N ' ' A' ' 48' ' ' THR . 0.2 OUTLIER -53.91 -47.44 71.15 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 112.508 0.559 . . . . 0.0 112.508 -178.412 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.564 ' N ' ' CD1' ' A' ' 47' ' ' TRP . 4.7 t -90.43 -32.65 16.32 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 113.256 0.836 . . . . 0.0 113.256 -178.124 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.406 ' O ' ' C ' ' A' ' 50' ' ' ALA . 0.2 OUTLIER -83.63 -46.32 12.48 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.808 0.669 . . . . 0.0 112.808 -177.658 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.655 ' C ' ' H ' ' A' ' 52' ' ' ILE . . . -39.08 -30.98 0.21 Allowed Pre-proline 0 C--O 1.235 0.305 0 C-N-CA 120.614 -0.435 . . . . 0.0 111.73 -178.391 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo -53.53 5.55 0.03 OUTLIER 'Trans proline' 0 C--N 1.311 -1.417 0 CA-C-N 118.99 0.675 . . . . 0.0 112.456 178.253 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.655 ' H ' ' C ' ' A' ' 50' ' ' ALA . 9.9 pt -53.34 -34.86 23.3 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.201 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 179.114 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.454 ' O ' ' CB ' ' A' ' 57' ' ' TYR . 72.6 m95 -78.83 -23.24 45.19 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.151 -179.415 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -68.96 -45.12 64.33 Favored Glycine 0 CA--C 1.527 0.797 0 N-CA-C 109.909 -1.276 . . . . 0.0 109.909 179.047 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 6.2 m -68.8 -56.89 6.58 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 179.282 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 95.8 mt -57.32 -26.0 60.25 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.094 179.733 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.543 ' C ' ' CD1' ' A' ' 57' ' ' TYR . 0.5 OUTLIER -66.27 -54.65 22.37 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 179.482 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 61.5 m -51.13 -53.85 30.59 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.539 -0.464 . . . . 0.0 109.92 179.369 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -54.51 -41.07 69.2 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.485 179.772 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 10.1 mtt -62.45 -58.2 8.46 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.354 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -42.31 -41.99 4.17 Favored Glycine 0 CA--C 1.521 0.445 0 N-CA-C 110.641 -0.984 . . . . 0.0 110.641 179.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -63.55 -57.64 9.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.896 0.379 . . . . 0.0 110.412 179.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -52.1 -57.0 14.11 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 110.682 -0.967 . . . . 0.0 110.682 179.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.455 ' O ' ' CD1' ' A' ' 68' ' ' TRP . 0.3 OUTLIER -46.26 -51.64 14.09 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.927 0.394 . . . . 0.0 110.176 179.574 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 70.6 t80 -49.84 -41.07 44.24 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.447 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 40.9 mt -69.63 -44.68 79.3 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.023 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.465 ' CG1' ' CZ3' ' A' ' 68' ' ' TRP . 23.3 t -53.83 -58.61 3.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 120.962 0.411 . . . . 0.0 110.815 -179.722 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . 0.526 ' O ' ' N ' ' A' ' 73' ' ' GLY . 1.5 m95 -64.06 -39.48 94.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.196 -179.526 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 4.9 mmmt -63.0 -23.96 67.69 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.847 0.356 . . . . 0.0 110.543 179.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -83.0 -62.67 1.53 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.08 -179.47 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.497 ' C ' ' CD1' ' A' ' 71' ' ' LEU . 3.6 pp -64.92 -9.29 20.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.179 -179.487 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.487 ' O ' ' O ' ' A' ' 73' ' ' GLY . . . 106.05 81.99 1.49 Allowed Glycine 0 CA--C 1.525 0.707 0 C-N-CA 121.071 -0.585 . . . . 0.0 111.783 179.335 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.526 ' N ' ' O ' ' A' ' 68' ' ' TRP . . . 42.03 -174.13 0.01 OUTLIER Glycine 0 CA--C 1.526 0.722 0 N-CA-C 111.933 -0.467 . . . . 0.0 111.933 179.097 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 69.8 t80 -76.98 110.8 11.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.871 0.367 . . . . 0.0 110.884 -179.718 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.576 ' HG1' ' N ' ' A' ' 76' ' ' GLU . 1.1 t -142.05 -173.66 3.88 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.326 179.781 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.576 ' N ' ' HG1' ' A' ' 75' ' ' THR . 9.1 mm-40 -49.25 -34.71 15.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.779 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -69.64 -24.29 63.61 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.027 -179.729 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -91.53 -24.22 19.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.861 0.362 . . . . 0.0 110.642 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 9.2 mtp -63.05 -26.72 68.98 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.576 179.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 6.8 t -70.41 -53.9 9.54 Favored Pre-proline 0 CA--C 1.536 0.405 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.838 -179.617 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -64.34 -56.32 0.46 Allowed 'Trans proline' 0 N--CA 1.498 1.753 0 C-N-CA 121.053 1.169 . . . . 0.0 112.097 179.551 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.2 mt -61.41 -46.56 89.64 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.911 0.386 . . . . 0.0 110.569 -179.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -61.03 -53.96 40.7 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 111.241 -0.743 . . . . 0.0 111.241 -179.64 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 54.9 tp -62.69 -26.58 68.73 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.885 0.374 . . . . 0.0 110.603 -179.707 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 20.9 t80 -68.65 -50.88 47.67 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.783 -179.732 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 9.7 t -70.98 -33.82 70.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.268 -179.468 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -70.52 -57.2 6.8 Favored Glycine 0 CA--C 1.523 0.587 0 N-CA-C 110.947 -0.861 . . . . 0.0 110.947 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.428 ' O ' ' CB ' ' A' ' 92' ' ' ASN . 1.8 tp-100 -59.51 -40.54 87.42 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.818 0.342 . . . . 0.0 110.397 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.405 ' O ' ' CD1' ' A' ' 93' ' ' TRP . 11.4 tp -66.52 -34.91 78.98 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.41 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.439 ' O ' ' CB ' ' A' ' 94' ' ' ALA . . . -64.52 -65.73 0.64 Allowed 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 120.254 -0.578 . . . . 0.0 111.489 -179.398 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.6 pp -66.42 -34.48 78.04 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.714 0.635 . . . . 0.0 112.714 -178.493 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.428 ' CB ' ' O ' ' A' ' 88' ' ' GLN . 7.5 t-20 -82.04 -57.6 3.33 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 -178.461 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . 0.6 ' O ' ' N ' ' A' ' 95' ' ' TRP . 0.0 OUTLIER -69.94 -17.04 63.3 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 111.838 0.31 . . . . 0.0 111.838 -178.265 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.439 ' CB ' ' O ' ' A' ' 90' ' ' ALA . . . -52.51 82.95 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.14 0 C-N-CA 120.349 -0.54 . . . . 0.0 110.068 179.637 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.702 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 30.8 p-90 -99.32 -16.31 0.19 Allowed Pre-proline 0 CA--C 1.535 0.375 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 -179.449 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.702 ' CD ' ' N ' ' A' ' 95' ' ' TRP . 48.8 Cg_exo -58.91 -32.92 98.31 Favored 'Trans proline' 0 N--CA 1.495 1.579 0 C-N-CA 120.692 0.928 . . . . 0.0 112.977 179.393 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.466 ' CD ' ' N ' ' A' ' 96' ' ' PRO . 66.4 Cg_exo -49.41 -18.55 2.37 Favored 'Trans proline' 0 N--CA 1.495 1.559 0 C-N-CA 120.389 0.726 . . . . 0.0 112.971 -179.903 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.549 ' O ' ' N ' ' A' ' 101' ' ' GLY . 1.1 pp -92.06 20.97 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.934 0.397 . . . . 0.0 110.466 179.758 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 10.3 t80 -40.41 -48.42 2.73 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.488 179.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -77.5 -19.73 55.41 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.546 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.549 ' N ' ' O ' ' A' ' 98' ' ' ILE . . . -78.34 -15.17 81.35 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 110.892 -0.883 . . . . 0.0 110.892 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -67.73 -12.95 61.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.772 0.32 . . . . 0.0 110.468 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.56 -8.44 59.72 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.467 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . 0.523 ' O ' ' N ' ' A' ' 106' ' ' GLY . 19.1 pt20 -123.87 173.8 7.95 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.838 179.852 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' MET . . . . . 0.55 ' N ' ' SD ' ' A' ' 105' ' ' MET . 0.0 OUTLIER -42.83 -17.02 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.125 -179.748 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.523 ' N ' ' O ' ' A' ' 104' ' ' GLN . . . -63.34 -16.84 58.74 Favored Glycine 0 CA--C 1.527 0.836 0 C-N-CA 121.324 -0.465 . . . . 0.0 111.979 -179.233 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' TRP . . . . . 0.686 ' CD1' ' CH2' ' A' ' 155' ' ' TRP . 0.0 OUTLIER -51.11 -15.87 0.4 Allowed 'General case' 0 C--N 1.329 -0.314 0 O-C-N 122.626 -0.338 . . . . 0.0 110.554 -179.581 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.492 ' O ' ' OD1' ' A' ' 111' ' ' ASP . . . -76.2 -25.05 54.78 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.855 0.359 . . . . 0.0 110.621 -179.825 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 84.2 mt -59.24 -29.72 67.73 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.923 -179.716 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.4 ' O ' ' CD2' ' A' ' 114' ' ' LEU . . . -54.1 -62.02 1.92 Allowed 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.728 -0.389 . . . . 0.0 110.502 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.522 ' O ' ' CG2' ' A' ' 115' ' ' VAL . 5.5 p-10 -62.02 -53.73 51.42 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.108 -0.496 . . . . 0.0 112.024 -179.432 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 31.8 tp -52.95 -45.13 67.57 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 -178.458 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 60.3 mt -67.67 -61.7 1.76 Allowed 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.624 0.601 . . . . 0.0 112.624 -178.322 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.4 ' CD2' ' O ' ' A' ' 110' ' ' ALA . 2.9 pp -58.62 -35.1 71.94 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 120.157 -0.617 . . . . 0.0 111.251 -178.736 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.522 ' CG2' ' O ' ' A' ' 111' ' ' ASP . 37.2 t -58.86 -59.27 3.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.963 179.801 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' SER . . . . . 0.494 ' O ' ' OG1' ' A' ' 120' ' ' THR . 5.6 t -70.45 -22.34 62.71 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.658 -179.009 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -64.93 -62.84 4.62 Favored Glycine 0 CA--C 1.526 0.778 0 C-N-CA 120.963 -0.637 . . . . 0.0 111.84 -179.058 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.532 ' O ' ' OG1' ' A' ' 122' ' ' THR . 8.9 p -72.16 -37.51 59.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 C-N-CA 120.975 -0.29 . . . . 0.0 111.39 -179.404 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . 0.523 ' O ' ' OG1' ' A' ' 123' ' ' THR . . . -67.07 -60.21 2.81 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.338 -0.545 . . . . 0.0 111.038 -179.549 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.494 ' OG1' ' O ' ' A' ' 116' ' ' SER . 3.3 m -57.92 -56.46 21.75 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.754 0.311 . . . . 0.0 111.393 -179.638 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -50.68 -41.15 55.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.305 -179.302 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.532 ' OG1' ' O ' ' A' ' 118' ' ' VAL . 31.4 p -73.53 -30.16 62.92 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.855 -0.338 . . . . 0.0 111.817 -179.144 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.523 ' OG1' ' O ' ' A' ' 119' ' ' ALA . 0.2 OUTLIER -64.96 -49.04 71.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.942 0.401 . . . . 0.0 110.759 -179.559 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.0 pp -81.59 -20.18 40.38 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.488 -179.274 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -90.8 -67.04 0.88 Allowed 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 -178.552 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 34.8 m0 -83.73 -57.15 3.34 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 112.962 0.727 . . . . 0.0 112.962 -177.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . 0.492 ' CD2' ' N ' ' A' ' 127' ' ' HIS . 9.1 m170 -55.88 -22.21 24.24 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.715 -0.394 . . . . 0.0 111.707 -178.565 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 33.5 ttt-85 -72.91 -47.25 47.37 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.783 -0.367 . . . . 0.0 111.178 -179.592 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 64.3 t -79.47 -41.49 22.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.168 -179.449 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -130.2 118.22 18.23 Favored Pre-proline 0 CA--C 1.536 0.405 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.578 -179.543 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . 0.647 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 70.9 Cg_exo -75.26 -26.6 10.36 Favored 'Trans proline' 0 N--CA 1.493 1.476 0 C-N-CA 121.238 1.292 . . . . 0.0 112.857 179.276 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.647 ' CD ' ' N ' ' A' ' 131' ' ' PRO . 53.8 Cg_exo -60.4 -55.22 1.6 Allowed 'Trans proline' 0 N--CA 1.497 1.73 0 C-N-CA 121.517 1.478 . . . . 0.0 112.492 -179.731 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -46.28 -37.36 7.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.857 0.361 . . . . 0.0 110.315 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -57.57 -29.45 64.45 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.366 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 25.5 ttp180 -74.44 -30.47 61.91 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.319 179.788 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 48.5 mt -73.28 -28.91 62.38 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 179.405 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.519 ' O ' ' N ' ' A' ' 140' ' ' TYR . 5.7 mt -86.45 -31.01 21.61 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.413 179.614 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.496 ' C ' ' H ' ' A' ' 140' ' ' TYR . 1.5 t80 -31.52 -49.72 0.45 Allowed Pre-proline 0 CA--C 1.538 0.506 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.508 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.417 ' HD2' ' N ' ' A' ' 138' ' ' TYR . 4.1 Cg_endo -62.65 7.42 0.15 Allowed 'Trans proline' 0 N--CA 1.498 1.764 0 C-N-CA 121.526 1.484 . . . . 0.0 112.807 -179.689 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . 0.519 ' N ' ' O ' ' A' ' 137' ' ' LEU . 0.1 OUTLIER -93.08 -14.41 27.32 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 121.013 0.435 . . . . 0.0 111.096 179.806 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 97.7 mt -59.73 -26.53 65.72 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.16 -0.473 . . . . 0.0 109.942 178.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -64.38 -39.3 93.6 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 179.256 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' TRP . . . . . . . . . . . . . 10.5 t-105 -67.19 -42.45 84.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.521 179.115 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.42 ' O ' ' OG1' ' A' ' 148' ' ' THR . 17.9 mt -58.73 -45.66 89.13 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.226 179.8 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . 0.481 ' O ' ' CG2' ' A' ' 149' ' ' VAL . . . -70.35 -23.29 62.78 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.27 179.715 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 33.8 t80 -64.83 -64.34 0.89 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.776 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -64.96 -43.82 91.4 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.977 -179.571 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' THR . . . . . 0.42 ' OG1' ' O ' ' A' ' 144' ' ' LEU . 37.4 m -56.89 -49.86 74.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.804 -179.781 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.481 ' CG2' ' O ' ' A' ' 145' ' ' ALA . 90.5 t -68.57 -31.78 52.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.935 -179.56 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 1.9 tp -57.07 -46.46 82.48 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.983 0.42 . . . . 0.0 109.912 179.738 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . 0.601 ' OD1' ' NE1' ' A' ' 107' ' ' TRP . 7.3 t30 -70.08 -54.53 12.67 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.922 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 65.8 t80 -51.58 -39.09 57.25 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.4 -179.397 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . 0.578 ' CE1' ' OD2' ' A' ' 157' ' ' ASP . 53.2 t80 -68.22 -52.43 34.2 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.63 -179.08 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 86.6 t -65.16 -28.07 43.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.596 -178.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' TRP . . . . . 0.686 ' CH2' ' CD1' ' A' ' 107' ' ' TRP . 0.6 OUTLIER -78.32 -40.64 36.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.773 0.32 . . . . 0.0 110.445 -179.334 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 6.0 mpt_? -76.52 -23.22 53.67 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 110.051 -0.351 . . . . 0.0 110.051 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . 0.578 ' OD2' ' CE1' ' A' ' 153' ' ' TYR . 2.1 m-20 -79.53 -39.89 30.89 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.537 179.79 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . 0.583 ' OD1' ' N ' ' A' ' 159' ' ' SER . 43.1 p30 -86.82 -18.42 31.04 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.501 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' SER . . . . . 0.583 ' N ' ' OD1' ' A' ' 158' ' ' ASN . 19.0 p 54.17 -157.39 0.19 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.734 179.837 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . 0.474 ' N ' ' HG ' ' A' ' 159' ' ' SER . . . -172.68 -73.11 0.05 OUTLIER Glycine 0 CA--C 1.526 0.733 0 N-CA-C 110.864 -0.895 . . . . 0.0 110.864 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 41.4 ttm180 -160.79 90.92 0.87 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.8 0.334 . . . . 0.0 110.514 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 27.1 ttm180 -65.88 143.01 57.71 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.451 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -82.97 -171.52 47.46 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 111.061 -0.816 . . . . 0.0 111.061 -179.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -159.11 -167.76 20.24 Favored Glycine 0 CA--C 1.526 0.733 0 N-CA-C 110.869 -0.893 . . . . 0.0 110.869 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 3.1 t -79.74 -74.12 0.31 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.749 0.309 . . . . 0.0 110.596 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 75.3 mtm180 57.2 179.86 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.647 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.51 ' N ' ' CD1' ' A' ' 167' ' ' LEU . 8.9 mp 57.27 -102.93 0.16 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.488 -179.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -56.41 90.94 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.531 179.827 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.22 -0.496 0 CA-C-O 118.021 -0.99 . . . . 0.0 110.509 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 201' ' ' PKA . . . . . 0.551 ' N18' ' H3 ' ' A' ' 201' ' ' PKA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 81.4 mmm . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.971 0.415 . . . . 0.0 110.571 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -59.3 -69.81 0.04 OUTLIER 'Trans proline' 0 C--N 1.306 -1.677 0 C-N-CA 122.565 2.176 . . . . 0.0 112.275 179.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 19.6 pt-20 -167.71 -32.03 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.793 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 12.9 m -154.17 -178.43 7.1 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.89 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.548 ' CD1' ' NE1' ' A' ' 68' ' ' TRP . 0.9 OUTLIER -88.87 116.8 27.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.148 -179.983 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.538 ' N ' ' CD ' ' A' ' 7' ' ' PRO . 0.9 OUTLIER -57.94 -45.1 99.81 Favored Pre-proline 0 CA--C 1.534 0.346 0 C-N-CA 120.855 -0.338 . . . . 0.0 110.297 -179.577 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.538 ' CD ' ' N ' ' A' ' 6' ' ' VAL . 20.6 Cg_exo -58.02 -65.36 0.1 OUTLIER 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 121.416 1.411 . . . . 0.0 111.646 179.559 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.544 ' O ' ' CG2' ' A' ' 12' ' ' THR . . . -45.32 -36.32 4.06 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.366 -179.701 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 69.0 t -70.04 -62.59 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 C-N-CA 120.866 -0.334 . . . . 0.0 111.775 -178.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -57.23 -43.59 93.53 Favored Glycine 0 CA--C 1.527 0.822 0 C-N-CA 121.275 -0.488 . . . . 0.0 112.0 -179.051 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.415 ' N ' ' CD1' ' A' ' 11' ' ' LEU . 8.5 mp -67.13 -35.53 79.94 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.569 0.223 . . . . 0.0 111.324 -179.166 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.544 ' CG2' ' O ' ' A' ' 8' ' ' ALA . 10.6 p -69.66 -29.83 67.38 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.733 -0.387 . . . . 0.0 110.635 -179.9 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.445 ' O ' ' C ' ' A' ' 14' ' ' VAL . 6.0 mp -78.58 -32.13 47.53 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.738 -179.758 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.445 ' C ' ' O ' ' A' ' 13' ' ' LEU . 6.0 t -35.97 -55.91 1.23 Allowed Pre-proline 0 CA--C 1.534 0.35 0 C-N-CA 120.891 -0.323 . . . . 0.0 110.867 -179.704 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -61.03 -41.27 45.25 Favored 'Trans proline' 0 N--CA 1.5 1.87 0 C-N-CA 120.936 1.091 . . . . 0.0 112.026 179.644 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 7.8 t -45.54 -28.34 0.92 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.665 -179.57 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 87.4 mt -66.0 -57.89 6.75 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.72 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -64.55 -24.92 69.83 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 111.291 -0.724 . . . . 0.0 111.291 -179.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -77.32 -27.82 59.01 Favored Glycine 0 CA--C 1.518 0.256 0 N-CA-C 110.432 -1.067 . . . . 0.0 110.432 -179.709 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 19.7 t80 -76.08 -60.75 2.19 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.785 0.326 . . . . 0.0 110.617 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 48.6 ttm -73.17 -21.08 60.76 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.216 -179.673 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -79.39 -57.04 3.24 Favored Glycine 0 CA--C 1.526 0.769 0 C-N-CA 120.956 -0.64 . . . . 0.0 111.664 -179.478 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -69.65 -26.74 64.54 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 120.59 -0.444 . . . . 0.0 110.794 -179.466 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 45.1 t80 -46.92 -23.89 0.52 Allowed 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.516 -0.474 . . . . 0.0 109.848 179.443 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.566 ' CD1' ' CE1' ' A' ' 99' ' ' PHE . 56.6 t80 -72.71 -54.99 7.49 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.086 -179.769 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 29.1 m -57.15 -25.83 23.91 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.107 0 C-N-CA 120.392 -0.523 . . . . 0.0 110.291 -179.528 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.75 -37.38 81.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.709 179.592 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -101.07 -56.03 0.9 Allowed Glycine 0 CA--C 1.525 0.693 0 N-CA-C 111.447 -0.661 . . . . 0.0 111.447 -179.596 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 6.0 tm-20 -65.63 -34.72 78.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.603 0.24 . . . . 0.0 111.107 -179.589 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -71.74 -55.02 7.72 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 111.076 -0.81 . . . . 0.0 111.076 -179.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 11.0 mp -59.32 -28.33 66.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.744 0.307 . . . . 0.0 110.508 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 40.3 ttm180 -79.02 -52.79 7.75 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.814 0.34 . . . . 0.0 110.466 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -50.51 -33.74 22.63 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 179.87 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.427 ' CD1' ' C ' ' A' ' 34' ' ' TYR . 25.8 t80 -45.51 -35.2 3.7 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.216 179.641 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -56.42 -36.94 69.52 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.58 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -85.67 -66.26 1.42 Allowed Glycine 0 CA--C 1.525 0.657 0 N-CA-C 111.033 -0.827 . . . . 0.0 111.033 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.436 ' CD2' ' ND2' ' A' ' 158' ' ' ASN . 0.4 OUTLIER -96.49 167.2 11.3 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.843 0.354 . . . . 0.0 110.532 179.564 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 6.3 tt0 -90.05 113.58 25.31 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.635 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.632 ' NZ ' ' CH2' ' A' ' 107' ' ' TRP . 17.9 mtpt -125.65 156.23 71.18 Favored Pre-proline 0 C--N 1.331 -0.211 0 CA-C-N 116.174 -0.466 . . . . 0.0 109.862 179.727 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.599 ' C ' ' H ' ' A' ' 42' ' ' TRP . 62.8 Cg_endo -74.72 29.06 0.35 Allowed 'Trans proline' 0 C--N 1.305 -1.712 0 C-N-CA 121.984 1.789 . . . . 0.0 111.497 179.672 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.496 ' H ' ' C ' ' A' ' 39' ' ' LYS . 87.4 p -52.41 -1.85 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.139 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . 0.599 ' H ' ' C ' ' A' ' 40' ' ' PRO . 3.5 p90 -76.9 -11.8 59.87 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.798 -0.361 . . . . 0.0 110.928 -179.259 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.457 ' O ' ' C ' ' A' ' 44' ' ' PRO . 24.2 m80 -68.52 135.56 90.68 Favored Pre-proline 0 C--N 1.329 -0.295 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 179.097 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.457 ' C ' ' O ' ' A' ' 43' ' ' HIS . 74.6 Cg_exo -33.79 148.52 0.03 OUTLIER 'Trans proline' 0 N--CA 1.495 1.566 0 C-N-CA 121.312 1.341 . . . . 0.0 111.683 -179.69 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.469 ' O ' ' N ' ' A' ' 47' ' ' TRP . 5.0 Cg_exo -64.13 157.83 51.37 Favored 'Trans proline' 0 C--N 1.311 -1.432 0 C-N-CA 120.627 0.885 . . . . 0.0 111.475 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.45 ' O ' ' CB ' ' A' ' 50' ' ' ALA . 3.1 ptm180 -43.51 -18.51 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.59 -179.188 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.588 ' CD1' ' N ' ' A' ' 48' ' ' THR . 1.0 OUTLIER -64.7 -42.41 95.31 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.658 -0.417 . . . . 0.0 111.012 -179.469 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.588 ' N ' ' CD1' ' A' ' 47' ' ' TRP . 1.7 m -90.58 -34.34 15.53 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.438 -179.257 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.412 ' O ' ' N ' ' A' ' 51' ' ' PRO . 0.1 OUTLIER -83.3 -56.31 3.84 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 120.454 -0.498 . . . . 0.0 112.05 -178.635 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.671 ' C ' ' H ' ' A' ' 52' ' ' ILE . . . -39.19 -29.23 0.17 Allowed Pre-proline 0 C--O 1.237 0.407 0 C-N-CA 120.745 -0.382 . . . . 0.0 111.44 -178.618 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.412 ' N ' ' O ' ' A' ' 49' ' ' LEU . 35.1 Cg_exo -52.92 3.71 0.04 OUTLIER 'Trans proline' 0 C--N 1.313 -1.32 0 CA-C-N 118.852 0.626 . . . . 0.0 111.877 177.516 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.671 ' H ' ' C ' ' A' ' 50' ' ' ALA . 5.7 pt -51.12 -45.23 30.3 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.233 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 178.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.534 ' N ' ' CG1' ' A' ' 52' ' ' ILE . 87.6 m95 -57.66 -23.41 51.22 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.789 -179.094 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -68.48 -45.33 68.6 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 109.411 -1.476 . . . . 0.0 109.411 178.399 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 6.0 m -69.1 -57.6 5.2 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 179.133 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.443 ' CD1' ' CE3' ' A' ' 143' ' ' TRP . 34.6 mt -48.52 -49.58 35.45 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 179.112 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 6.9 t80 -46.37 -58.48 3.69 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.696 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.486 ' OG ' ' OH ' ' A' ' 62' ' ' TYR . 0.2 OUTLIER -48.05 -58.88 3.87 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.881 0.372 . . . . 0.0 110.686 -179.556 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -51.68 -61.46 2.24 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.852 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.433 ' SD ' ' C ' ' A' ' 56' ' ' LEU . 0.2 OUTLIER -46.1 -38.93 8.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.396 -179.957 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -56.6 -54.29 37.37 Favored Glycine 0 CA--C 1.522 0.493 0 N-CA-C 110.905 -0.878 . . . . 0.0 110.905 -179.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.6 ' N ' ' CD1' ' A' ' 62' ' ' TYR . 0.6 OUTLIER -55.85 -59.81 4.36 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.876 -0.33 . . . . 0.0 110.847 -179.814 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -48.33 -56.14 9.69 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 110.75 -0.94 . . . . 0.0 110.75 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.59 ' OG ' ' NE1' ' A' ' 68' ' ' TRP . 0.6 OUTLIER -45.6 -56.07 5.59 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.963 0.411 . . . . 0.0 111.025 179.967 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 59.7 t80 -47.51 -47.11 27.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.023 -179.723 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 53.6 mt -59.62 -40.01 81.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.009 -179.588 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.447 ' CG1' ' CZ3' ' A' ' 68' ' ' TRP . 43.0 t -57.74 -52.12 61.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 C-N-CA 120.862 -0.335 . . . . 0.0 110.849 -179.612 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . 0.59 ' NE1' ' OG ' ' A' ' 64' ' ' SER . 0.6 OUTLIER -64.19 -28.94 70.09 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 120.643 -0.423 . . . . 0.0 110.778 -179.978 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.404 ' HZ1' ' HB3' ' A' ' 69' ' ' LYS . 0.1 OUTLIER -74.06 -22.46 59.52 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.816 0.341 . . . . 0.0 110.374 179.828 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -81.35 -61.36 1.96 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.053 -179.72 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.8 pp -74.43 -20.67 59.95 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.788 -0.365 . . . . 0.0 111.209 -179.294 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.509 ' O ' ' O ' ' A' ' 73' ' ' GLY . . . 109.44 99.11 2.56 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 121.135 -0.555 . . . . 0.0 112.268 178.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.509 ' O ' ' O ' ' A' ' 72' ' ' GLY . . . 40.64 -173.55 0.01 OUTLIER Glycine 0 CA--C 1.525 0.671 0 N-CA-C 112.195 -0.362 . . . . 0.0 112.195 178.684 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 25.4 t80 -90.2 110.88 21.9 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.538 -0.331 . . . . 0.0 110.53 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.587 ' OG1' ' N ' ' A' ' 76' ' ' GLU . 0.1 OUTLIER -142.2 -177.43 5.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.592 179.796 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.587 ' N ' ' OG1' ' A' ' 75' ' ' THR . 35.8 mt-10 -47.92 -29.6 3.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.636 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -70.04 -27.57 64.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.895 -179.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -95.64 -17.74 21.09 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.917 -179.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 25.9 mtp -68.7 -28.63 67.01 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.836 -0.346 . . . . 0.0 110.786 -179.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 9.1 t -66.78 -49.29 49.77 Favored Pre-proline 0 CA--C 1.533 0.292 0 C-N-CA 120.782 -0.367 . . . . 0.0 110.536 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -69.52 -59.7 0.08 OUTLIER 'Trans proline' 0 N--CA 1.497 1.692 0 C-N-CA 121.051 1.167 . . . . 0.0 111.61 179.094 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 5.0 mt -52.47 -52.4 54.49 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.411 179.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -58.37 -57.67 18.64 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 110.484 -1.046 . . . . 0.0 110.484 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.425 ' O ' ' CB ' ' A' ' 88' ' ' GLN . 57.0 tp -48.22 -32.98 7.86 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 179.534 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -74.56 -47.53 32.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.827 -179.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -60.08 -48.74 80.44 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.742 -0.383 . . . . 0.0 110.919 -179.597 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -70.73 -58.33 5.88 Favored Glycine 0 CA--C 1.527 0.822 0 N-CA-C 111.477 -0.649 . . . . 0.0 111.477 -179.611 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.425 ' CB ' ' O ' ' A' ' 84' ' ' LEU . 12.4 tp-100 -50.45 -40.66 51.27 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.092 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.419 ' O ' ' C ' ' A' ' 90' ' ' ALA . 50.6 tp -58.51 -65.84 0.59 Allowed 'General case' 0 C--O 1.215 -0.719 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.927 179.717 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.419 ' C ' ' O ' ' A' ' 89' ' ' LEU . . . -38.56 -46.13 1.15 Allowed 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 120.349 -0.54 . . . . 0.0 111.622 -179.448 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 83.8 mt -57.86 -56.43 22.11 Favored 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 112.815 0.672 . . . . 0.0 112.815 -178.694 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -75.2 -57.07 4.12 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.185 0.517 . . . . 0.0 111.742 -178.396 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . 0.676 ' O ' ' N ' ' A' ' 95' ' ' TRP . 0.1 OUTLIER -53.92 -23.44 12.84 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.454 -0.793 . . . . 0.0 111.49 -179.468 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -52.34 73.64 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.818 0.342 . . . . 0.0 110.757 -179.549 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.682 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 13.5 p-90 -101.96 -17.48 0.19 Allowed Pre-proline 0 CA--C 1.532 0.266 0 CA-C-N 116.279 -0.418 . . . . 0.0 112.127 -179.522 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.682 ' CD ' ' N ' ' A' ' 95' ' ' TRP . 39.5 Cg_exo -62.43 -24.81 75.76 Favored 'Trans proline' 0 N--CA 1.495 1.577 0 C-N-CA 120.404 0.736 . . . . 0.0 112.812 179.401 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.562 ' C ' ' H ' ' A' ' 99' ' ' PHE . 92.5 Cg_exo -62.02 -26.94 78.93 Favored 'Trans proline' 0 N--CA 1.496 1.628 0 C-N-CA 120.496 0.798 . . . . 0.0 112.675 179.679 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 1.2 pp -72.79 17.49 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-O 121.086 0.47 . . . . 0.0 110.107 179.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.566 ' CE1' ' CD1' ' A' ' 25' ' ' PHE . 2.4 t80 -39.49 -31.65 0.1 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.191 -179.802 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 0.488 ' CE1' ' O ' ' A' ' 97' ' ' PRO . 3.4 p90 -84.69 -50.37 7.69 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.942 -0.303 . . . . 0.0 110.869 -179.633 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.417 ' N ' ' CD2' ' A' ' 100' ' ' PHE . . . -64.22 -4.58 12.48 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 111.171 -0.772 . . . . 0.0 111.171 -179.739 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -75.07 -14.17 60.56 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.643 0.258 . . . . 0.0 110.939 -179.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 4.3 ptm180 -86.68 5.35 36.49 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.915 -0.314 . . . . 0.0 110.677 -179.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -121.57 171.01 9.13 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.565 179.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 4.7 mmt -59.37 -17.68 32.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.419 179.737 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.588 ' O ' ' N ' ' A' ' 108' ' ' ALA . . . -69.46 -15.37 70.47 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 111.455 -0.658 . . . . 0.0 111.455 -179.571 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' TRP . . . . . 0.632 ' CH2' ' NZ ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -43.49 -13.86 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.749 0.309 . . . . 0.0 110.725 -179.604 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.588 ' N ' ' O ' ' A' ' 106' ' ' GLY . . . -57.96 -18.68 25.18 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.431 179.718 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 13.4 mt -54.45 -32.13 56.92 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.386 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.439 ' O ' ' CD2' ' A' ' 114' ' ' LEU . . . -52.85 -63.05 1.27 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.544 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.463 ' O ' ' CG2' ' A' ' 115' ' ' VAL . 0.9 OUTLIER -59.67 -57.79 11.38 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.495 -179.545 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.418 ' N ' ' OD1' ' A' ' 111' ' ' ASP . 50.8 tp -47.82 -41.72 24.43 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.115 -0.493 . . . . 0.0 112.025 -178.87 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 64.5 mt -71.84 -61.84 1.64 Allowed 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -178.14 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.439 ' CD2' ' O ' ' A' ' 110' ' ' ALA . 1.1 pp -57.22 -32.8 66.88 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 120.037 -0.665 . . . . 0.0 111.432 -178.178 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.463 ' CG2' ' O ' ' A' ' 111' ' ' ASP . 98.0 t -67.06 -51.36 54.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.84 0.353 . . . . 0.0 110.925 179.777 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 18.0 m -68.53 -27.72 66.35 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.393 -179.312 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -68.07 -59.96 6.0 Favored Glycine 0 CA--C 1.528 0.867 0 C-N-CA 121.045 -0.598 . . . . 0.0 111.899 -179.036 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.523 ' O ' ' OG1' ' A' ' 122' ' ' THR . 7.5 p -65.27 -38.51 82.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 -178.831 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . 0.489 ' O ' ' OG1' ' A' ' 123' ' ' THR . . . -71.12 -60.76 2.06 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.518 -0.473 . . . . 0.0 111.52 -178.687 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 43.7 m -52.23 -52.97 49.28 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.918 0.39 . . . . 0.0 110.975 -179.594 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -57.47 -50.91 71.51 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.115 -0.493 . . . . 0.0 112.226 -179.161 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.63 ' HG1' ' H ' ' A' ' 123' ' ' THR . 40.0 p -64.75 -64.54 0.85 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.969 0.414 . . . . 0.0 111.745 -178.72 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.63 ' H ' ' HG1' ' A' ' 122' ' ' THR . 0.2 OUTLIER -44.06 -41.31 5.41 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.892 -0.595 . . . . 0.0 112.295 -178.448 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.528 ' CD1' ' C ' ' A' ' 124' ' ' LEU . 1.5 pp -84.34 -19.93 32.87 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.393 -0.523 . . . . 0.0 111.643 -179.117 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -94.77 -71.3 0.67 Allowed 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 113.053 0.761 . . . . 0.0 113.053 -178.433 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' TRP . . . . . 0.467 ' N ' ' CD1' ' A' ' 126' ' ' TRP . 25.6 m0 -76.71 -57.09 4.06 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 -177.411 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . 0.409 ' CD2' ' N ' ' A' ' 127' ' ' HIS . 18.1 m170 -48.79 -22.58 0.84 Allowed 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.558 -0.457 . . . . 0.0 111.332 -178.63 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 23.0 ttt180 -69.11 -48.1 63.41 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.838 -0.345 . . . . 0.0 111.06 -179.628 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 15.0 t -79.77 -49.33 19.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.962 -179.62 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' SER . . . . . 0.455 ' O ' ' OG ' ' A' ' 130' ' ' SER . 0.4 OUTLIER -118.71 108.92 40.47 Favored Pre-proline 0 CA--C 1.532 0.258 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.673 -179.701 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . 0.654 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 82.1 Cg_exo -74.38 -32.52 6.33 Favored 'Trans proline' 0 C--N 1.311 -1.447 0 C-N-CA 121.577 1.518 . . . . 0.0 112.794 179.451 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.654 ' CD ' ' N ' ' A' ' 131' ' ' PRO . 27.5 Cg_exo -58.67 -44.43 36.66 Favored 'Trans proline' 0 N--CA 1.494 1.558 0 C-N-CA 121.706 1.604 . . . . 0.0 112.199 -179.82 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . 0.413 ' O ' ' N ' ' A' ' 136' ' ' LEU . . . -50.24 -49.51 52.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.672 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -44.19 -23.07 0.08 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.665 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . 0.401 ' N ' ' O ' ' A' ' 133' ' ' ALA . 14.1 tpp180 -76.66 -37.11 56.82 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.17 -179.528 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.413 ' N ' ' O ' ' A' ' 133' ' ' ALA . 9.4 mt -76.26 -22.13 55.5 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 179.777 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.547 ' O ' ' N ' ' A' ' 140' ' ' TYR . 0.7 OUTLIER -85.44 -43.64 13.43 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 179.147 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.589 ' C ' ' H ' ' A' ' 140' ' ' TYR . 0.2 OUTLIER -21.32 -50.66 0.06 OUTLIER Pre-proline 0 N--CA 1.466 0.341 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.871 179.71 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.434 ' N ' ' O ' ' A' ' 137' ' ' LEU . 17.2 Cg_exo -51.21 -3.33 0.07 OUTLIER 'Trans proline' 0 C--N 1.308 -1.598 0 C-N-CA 121.247 1.298 . . . . 0.0 112.051 179.824 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . 0.589 ' H ' ' C ' ' A' ' 138' ' ' TYR . 1.9 p90 -83.45 -17.55 41.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.779 -179.836 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 93.4 mt -61.35 -36.59 80.61 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 179.154 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -56.95 -40.29 76.16 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 179.08 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' TRP . . . . . 0.55 ' CD1' ' C ' ' A' ' 143' ' ' TRP . 0.4 OUTLIER -63.54 -45.14 91.93 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.647 179.414 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.464 ' O ' ' OG1' ' A' ' 148' ' ' THR . 13.7 mt -60.81 -41.53 95.85 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 179.354 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . 0.54 ' O ' ' CG2' ' A' ' 149' ' ' VAL . . . -70.42 -18.98 63.02 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.103 -0.499 . . . . 0.0 109.766 179.217 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -71.14 -63.09 1.17 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.823 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -68.64 -31.74 71.09 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 120.607 -0.437 . . . . 0.0 110.583 -179.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' THR . . . . . 0.464 ' OG1' ' O ' ' A' ' 144' ' ' LEU . 85.0 m -67.7 -45.48 74.99 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.851 -0.34 . . . . 0.0 110.217 179.772 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.54 ' CG2' ' O ' ' A' ' 145' ' ' ALA . 45.7 t -64.64 -33.71 64.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.047 179.731 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.59 -58.9 6.53 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.033 179.859 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 11.1 t30 -55.8 -54.43 44.54 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.56 179.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 16.6 t80 -52.42 -34.36 48.1 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.649 -179.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . 0.583 ' CE2' ' OD2' ' A' ' 157' ' ' ASP . 59.4 t80 -66.53 -47.1 73.98 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.821 -179.729 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 13.0 t -55.9 -42.16 69.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.659 -179.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' TRP . . . . . . . . . . . . . 16.5 m0 -62.5 -59.45 4.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.151 -179.657 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.63 -25.93 63.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.047 -179.43 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . 0.583 ' OD2' ' CE2' ' A' ' 153' ' ' TYR . 0.8 OUTLIER -86.74 -42.67 13.15 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.885 -0.326 . . . . 0.0 111.333 -179.393 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . 0.436 ' ND2' ' CD2' ' A' ' 37' ' ' LEU . 2.4 m-20 -78.02 -40.78 37.85 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.208 -179.43 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' SER . . . . . 0.473 ' O ' ' OG ' ' A' ' 159' ' ' SER . 22.8 p -67.57 90.5 0.26 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.476 -179.893 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 161.92 58.42 0.02 OUTLIER Glycine 0 CA--C 1.526 0.719 0 N-CA-C 111.176 -0.769 . . . . 0.0 111.176 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 27.8 mmt180 -89.19 -49.48 6.71 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.849 0.357 . . . . 0.0 110.586 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 36.7 ttt180 -52.34 143.96 13.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.632 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -139.44 -95.65 0.31 Allowed Glycine 0 CA--C 1.525 0.66 0 N-CA-C 111.024 -0.83 . . . . 0.0 111.024 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -159.73 45.81 0.43 Allowed Glycine 0 CA--C 1.524 0.629 0 N-CA-C 110.845 -0.902 . . . . 0.0 110.845 179.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' SER . . . . . 0.426 ' O ' ' O ' ' A' ' 166' ' ' ARG . 1.1 t 56.97 18.74 4.11 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.803 0.335 . . . . 0.0 110.502 -179.816 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . 0.426 ' O ' ' O ' ' A' ' 165' ' ' SER . 0.3 OUTLIER 48.88 -178.97 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.439 179.89 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.528 ' CD2' ' N ' ' A' ' 167' ' ' LEU . 2.0 mm? -107.49 31.35 5.49 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.795 179.661 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -48.73 -37.87 20.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.869 -179.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 66.9 mm-40 . . . . . 0 C--O 1.22 -0.497 0 CA-C-O 117.98 -1.01 . . . . 0.0 110.511 179.882 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 201' ' ' PKA . . . . . 0.481 ' N18' ' H3 ' ' A' ' 201' ' ' PKA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 42.0 mtt . . . . . 0 CA--C 1.529 0.145 0 CA-C-O 120.593 0.235 . . . . 0.0 110.495 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_exo -45.01 148.58 1.53 Allowed 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 121.997 1.798 . . . . 0.0 112.182 179.759 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.408 ' CD ' ' N ' ' A' ' 3' ' ' GLU . 4.5 mp0 -109.42 -20.26 12.97 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.416 179.853 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 22.7 t -79.84 65.67 5.07 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.485 179.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.668 ' CD2' ' CZ3' ' A' ' 68' ' ' TRP . 0.3 OUTLIER -49.31 119.75 3.56 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.624 -179.858 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.59 ' N ' ' CD ' ' A' ' 7' ' ' PRO . 0.9 OUTLIER -61.05 -32.66 11.44 Favored Pre-proline 0 C--N 1.329 -0.291 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 179.7 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.59 ' CD ' ' N ' ' A' ' 6' ' ' VAL . 22.7 Cg_exo -74.71 -67.81 0.02 OUTLIER 'Trans proline' 0 N--CA 1.492 1.423 0 C-N-CA 121.531 1.488 . . . . 0.0 111.953 179.168 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.514 ' O ' ' CG2' ' A' ' 12' ' ' THR . . . -48.13 -38.95 19.09 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.965 -0.294 . . . . 0.0 111.178 -179.569 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.406 ' CG2' ' O ' ' A' ' 5' ' ' TRP . 89.2 t -69.96 -62.21 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.802 -179.255 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -53.9 -50.94 52.65 Favored Glycine 0 CA--C 1.526 0.773 0 N-CA-C 111.486 -0.646 . . . . 0.0 111.486 -179.307 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 8.8 mp -58.47 -40.9 83.94 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.615 0.245 . . . . 0.0 111.134 -179.603 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.514 ' CG2' ' O ' ' A' ' 8' ' ' ALA . 18.2 p -69.39 -28.71 66.42 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.843 -0.343 . . . . 0.0 110.998 -179.643 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 7.1 mp -80.2 -26.31 39.25 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.737 -179.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 14.2 t -44.58 -60.15 3.26 Favored Pre-proline 0 CA--C 1.534 0.342 0 C-N-CA 120.89 -0.324 . . . . 0.0 110.934 -179.64 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -52.7 -20.65 13.01 Favored 'Trans proline' 0 N--CA 1.498 1.761 0 C-N-CA 121.025 1.15 . . . . 0.0 111.749 179.746 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.587 ' OG ' ' CE3' ' A' ' 53' ' ' TRP . 1.6 t -73.79 -27.39 61.11 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.857 -179.744 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 87.7 mt -73.77 -58.16 3.49 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.477 -179.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -68.95 -22.06 75.59 Favored Glycine 0 CA--C 1.523 0.539 0 N-CA-C 110.449 -1.06 . . . . 0.0 110.449 179.694 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -74.12 -39.1 45.96 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 110.517 -1.033 . . . . 0.0 110.517 179.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 67.4 t80 -70.82 -60.09 2.44 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.676 0.274 . . . . 0.0 110.668 179.797 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 16.2 ttm -67.27 -21.21 65.72 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.951 -179.703 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -81.42 -62.68 1.93 Allowed Glycine 0 CA--C 1.525 0.672 0 N-CA-C 111.43 -0.668 . . . . 0.0 111.43 -179.671 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.88 -24.96 67.69 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.77 0.319 . . . . 0.0 111.129 -179.386 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 27.8 t80 -47.36 -23.2 0.54 Allowed 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 179.558 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 21.3 t80 -72.72 -51.21 20.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.916 -0.583 . . . . 0.0 111.25 -179.769 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.459 ' O ' ' N ' ' A' ' 30' ' ' GLY . 34.9 m -62.79 -26.88 41.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 C-N-CA 120.541 -0.464 . . . . 0.0 110.522 -179.745 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -66.72 -24.9 66.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.223 179.799 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -106.03 -35.36 2.98 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 110.377 -1.089 . . . . 0.0 110.377 179.531 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.419 ' O ' ' N ' ' A' ' 32' ' ' ARG . 18.8 tt0 -84.95 -47.42 10.29 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.753 0.311 . . . . 0.0 110.227 179.644 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.459 ' N ' ' O ' ' A' ' 26' ' ' VAL . . . -48.39 -46.5 28.87 Favored Glycine 0 CA--C 1.523 0.567 0 N-CA-C 110.567 -1.013 . . . . 0.0 110.567 179.787 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 10.5 mp -60.0 -25.12 65.02 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 179.612 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.419 ' N ' ' O ' ' A' ' 29' ' ' GLU . 56.6 ttt180 -78.33 -50.96 10.84 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.131 179.344 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 11.9 m0 -47.26 -45.24 23.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.231 179.745 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 88.3 t80 -52.52 -23.99 7.29 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.438 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -67.73 -42.16 82.31 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.696 -179.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -97.1 -68.83 0.97 Allowed Glycine 0 CA--C 1.525 0.683 0 N-CA-C 111.076 -0.809 . . . . 0.0 111.076 -179.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.506 ' C ' ' CD1' ' A' ' 37' ' ' LEU . 3.6 pp -90.52 166.2 13.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.875 0.369 . . . . 0.0 110.592 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 48.5 mm-40 -85.46 129.8 34.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.608 -179.16 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 14.2 mtpt -118.63 165.02 17.78 Favored Pre-proline 0 CA--C 1.532 0.25 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 179.013 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.527 ' C ' ' H ' ' A' ' 42' ' ' TRP . 2.8 Cg_endo -63.77 92.36 0.17 Allowed 'Trans proline' 0 C--N 1.307 -1.612 0 C-N-CA 122.164 1.909 . . . . 0.0 111.75 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.2 m -56.02 -1.68 0.05 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.324 -179.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . 0.527 ' H ' ' C ' ' A' ' 40' ' ' PRO . 2.8 p90 -95.07 -9.24 34.29 Favored 'General case' 0 C--O 1.231 0.113 0 C-N-CA 120.295 -0.562 . . . . 0.0 110.772 -179.386 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.583 ' O ' ' ND1' ' A' ' 43' ' ' HIS . 0.9 OUTLIER -87.86 121.2 70.91 Favored Pre-proline 0 CA--C 1.537 0.471 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.813 -179.985 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -95.11 156.98 1.72 Allowed 'Trans proline' 0 N--CA 1.492 1.429 0 C-N-CA 120.844 1.029 . . . . 0.0 111.562 179.13 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.425 ' C ' ' N ' ' A' ' 47' ' ' TRP . 2.9 Cg_endo -43.01 140.3 3.22 Favored 'Trans proline' 0 C--N 1.306 -1.694 0 C-N-CA 121.511 1.474 . . . . 0.0 111.59 -179.764 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -45.82 -16.96 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.231 -179.528 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.593 ' CD1' ' N ' ' A' ' 48' ' ' THR . 0.3 OUTLIER -53.06 -49.66 65.92 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 120.407 -0.517 . . . . 0.0 111.818 -178.653 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.593 ' N ' ' CD1' ' A' ' 47' ' ' TRP . 6.6 t -91.29 -30.09 16.79 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 113.341 0.867 . . . . 0.0 113.341 -178.606 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -83.14 -43.01 16.69 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -177.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.679 ' C ' ' H ' ' A' ' 52' ' ' ILE . . . -40.8 -28.34 0.21 Allowed Pre-proline 0 N--CA 1.465 0.287 0 N-CA-C 111.934 0.346 . . . . 0.0 111.934 -179.107 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -54.48 8.28 0.03 OUTLIER 'Trans proline' 0 C--N 1.311 -1.401 0 CA-C-N 119.005 0.68 . . . . 0.0 112.533 178.352 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.679 ' H ' ' C ' ' A' ' 50' ' ' ALA . 9.2 pt -55.62 -35.56 39.12 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 178.673 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.587 ' CE3' ' OG ' ' A' ' 16' ' ' SER . 3.5 m0 -55.11 -25.01 28.79 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.433 179.615 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -69.89 -61.51 4.3 Favored Glycine 0 CA--C 1.528 0.845 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.906 -179.371 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.49 ' CG2' ' N ' ' A' ' 56' ' ' LEU . 1.9 t -56.39 -46.69 79.99 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 120.729 -0.389 . . . . 0.0 110.706 -179.351 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.49 ' N ' ' CG2' ' A' ' 55' ' ' THR . 57.9 mt -62.31 -41.57 98.65 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.365 -0.534 . . . . 0.0 109.639 179.313 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.532 ' C ' ' CD1' ' A' ' 57' ' ' TYR . 4.2 t80 -56.69 -40.27 75.29 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.678 -179.707 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.431 ' OG ' ' N ' ' A' ' 59' ' ' ALA . 1.3 p -62.85 -53.63 51.26 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 179.62 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.431 ' N ' ' OG ' ' A' ' 58' ' ' SER . . . -55.78 -62.3 1.79 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.503 179.713 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 36.5 mtm -51.72 -32.35 29.99 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.447 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -57.93 -56.06 27.22 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 111.19 -0.764 . . . . 0.0 111.19 -179.774 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 3.4 m-30 -65.46 -42.67 92.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.05 0.452 . . . . 0.0 110.301 -179.834 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -53.35 -56.27 20.4 Favored Glycine 0 CA--C 1.524 0.615 0 N-CA-C 110.44 -1.064 . . . . 0.0 110.44 179.68 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.582 ' O ' ' CD1' ' A' ' 68' ' ' TRP . 0.9 OUTLIER -54.97 -45.12 74.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.774 0.321 . . . . 0.0 110.539 179.815 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.42 ' HA ' ' CZ2' ' A' ' 68' ' ' TRP . 74.7 t80 -47.01 -47.21 22.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.019 0.438 . . . . 0.0 110.01 179.668 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 62.4 mt -70.56 -28.14 33.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.058 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 59.3 t -63.42 -59.22 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 C-N-CA 120.617 -0.433 . . . . 0.0 111.647 -179.399 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . 0.668 ' CZ3' ' CD2' ' A' ' 5' ' ' TRP . 0.0 OUTLIER -70.78 -29.56 65.8 Favored 'General case' 0 N--CA 1.462 0.152 0 C-N-CA 119.84 -0.744 . . . . 0.0 110.822 -179.327 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -70.89 -22.38 62.28 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.517 -0.473 . . . . 0.0 110.207 179.524 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -82.22 -60.75 2.1 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.924 -179.677 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.8 pp -72.92 -11.19 60.49 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.99 -179.395 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.515 ' O ' ' O ' ' A' ' 73' ' ' GLY . . . 104.86 92.57 2.27 Favored Glycine 0 CA--C 1.527 0.814 0 C-N-CA 121.163 -0.541 . . . . 0.0 112.149 179.101 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.586 ' N ' ' O ' ' A' ' 68' ' ' TRP . . . 40.94 -173.52 0.01 OUTLIER Glycine 0 CA--C 1.524 0.652 0 N-CA-C 111.973 -0.451 . . . . 0.0 111.973 179.009 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 42.9 t80 -86.98 110.18 19.87 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.85 0.357 . . . . 0.0 110.341 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.576 ' OG1' ' N ' ' A' ' 76' ' ' GLU . 0.1 OUTLIER -142.57 -174.12 4.05 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.788 -179.822 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.576 ' N ' ' OG1' ' A' ' 75' ' ' THR . 92.2 mt-10 -49.89 -24.43 2.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.884 179.881 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -78.63 -31.68 47.03 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.893 -179.804 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -85.8 -20.57 29.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.831 0.348 . . . . 0.0 110.716 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 8.3 mtp -65.43 -27.1 68.29 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.658 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.409 ' O ' ' CB ' ' A' ' 84' ' ' LEU . 6.9 t -69.4 -48.74 24.75 Favored Pre-proline 0 C--N 1.328 -0.33 0 C-N-CA 120.839 -0.345 . . . . 0.0 110.728 -179.768 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -71.23 -60.85 0.05 OUTLIER 'Trans proline' 0 N--CA 1.497 1.715 0 C-N-CA 120.961 1.107 . . . . 0.0 111.829 179.179 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 5.0 mt -57.6 -48.73 78.61 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.618 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -61.2 -61.45 6.91 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 110.938 -0.865 . . . . 0.0 110.938 -179.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.409 ' CB ' ' O ' ' A' ' 80' ' ' VAL . 33.2 tp -53.54 -24.05 12.37 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.902 0.382 . . . . 0.0 110.494 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.409 ' HH ' HG22 ' A' ' 118' ' ' VAL . 13.5 t80 -77.33 -47.99 18.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.433 179.85 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -66.71 -37.0 83.81 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.603 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -71.21 -57.44 6.18 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 110.612 -0.995 . . . . 0.0 110.612 179.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 49.3 tp60 -53.38 -45.29 69.2 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 179.61 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.424 ' O ' ' C ' ' A' ' 90' ' ' ALA . 24.3 tp -53.35 -66.14 0.44 Allowed 'General case' 0 C--O 1.21 -0.994 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.63 179.603 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.424 ' C ' ' O ' ' A' ' 89' ' ' LEU . . . -38.65 -48.64 1.48 Allowed 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 120.637 -0.425 . . . . 0.0 111.85 -179.575 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 94.6 mt -55.04 -57.28 12.33 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 112.9 0.704 . . . . 0.0 112.9 -178.277 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -74.84 -55.88 5.35 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 121.316 0.579 . . . . 0.0 111.419 -178.717 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . 0.642 ' O ' ' N ' ' A' ' 95' ' ' TRP . 4.9 t-105 -53.19 -19.45 3.06 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.124 -0.943 . . . . 0.0 111.209 -179.781 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -59.19 69.37 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.161 0 CA-C-O 120.992 0.425 . . . . 0.0 109.86 179.629 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.688 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 11.9 p-90 -101.95 -17.04 0.19 Allowed Pre-proline 0 CA--C 1.536 0.418 0 CA-C-N 115.729 -0.668 . . . . 0.0 112.142 -179.106 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.688 ' CD ' ' N ' ' A' ' 95' ' ' TRP . 31.9 Cg_exo -60.89 -30.57 90.28 Favored 'Trans proline' 0 N--CA 1.495 1.573 0 C-N-CA 120.383 0.722 . . . . 0.0 112.618 179.638 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.535 ' C ' ' H ' ' A' ' 99' ' ' PHE . 91.8 Cg_exo -55.24 -27.55 57.42 Favored 'Trans proline' 0 N--CA 1.494 1.526 0 C-N-CA 120.495 0.796 . . . . 0.0 112.607 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 1.1 pp -76.79 22.73 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.152 0 CA-C-O 121.335 0.588 . . . . 0.0 109.933 179.537 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.535 ' H ' ' C ' ' A' ' 97' ' ' PRO . 2.4 t80 -39.53 -45.74 1.62 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.043 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 0.475 ' C ' ' H ' ' A' ' 102' ' ' ALA . 4.7 m-85 -83.11 -49.65 9.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.195 -179.361 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -54.81 -7.75 1.12 Allowed Glycine 0 CA--C 1.526 0.726 0 N-CA-C 111.372 -0.691 . . . . 0.0 111.372 -179.506 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.475 ' H ' ' C ' ' A' ' 100' ' ' PHE . . . -75.06 -13.43 60.49 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 121.079 -0.248 . . . . 0.0 110.964 -179.707 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -75.77 6.98 4.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.768 0.318 . . . . 0.0 110.82 -179.848 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -125.63 165.95 17.62 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.326 179.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 8.4 mmt -56.07 -17.12 6.15 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.924 0.392 . . . . 0.0 110.183 179.602 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.536 ' C ' ' H ' ' A' ' 108' ' ' ALA . . . -63.36 -15.85 57.44 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 110.611 -0.996 . . . . 0.0 110.611 179.718 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' TRP . . . . . 0.483 ' C ' ' CD1' ' A' ' 107' ' ' TRP . 0.0 OUTLIER -47.47 -11.8 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.762 0.315 . . . . 0.0 110.525 -179.776 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.536 ' H ' ' C ' ' A' ' 106' ' ' GLY . . . -63.58 -20.7 65.86 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-O 121.118 0.485 . . . . 0.0 109.816 179.432 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 7.1 mt -55.36 -30.76 60.95 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.717 179.491 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.427 ' O ' ' CD2' ' A' ' 114' ' ' LEU . . . -53.86 -61.87 2.02 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.548 179.718 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.526 ' OD1' ' N ' ' A' ' 112' ' ' LEU . 1.4 p30 -60.69 -57.97 10.46 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.769 -179.351 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.526 ' N ' ' OD1' ' A' ' 111' ' ' ASP . 9.1 tp -50.46 -38.12 41.96 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 -178.733 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 62.6 mt -72.7 -62.24 1.52 Allowed 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -178.409 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.427 ' CD2' ' O ' ' A' ' 110' ' ' ALA . 1.3 pp -58.29 -35.45 71.82 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 120.063 -0.655 . . . . 0.0 110.912 -178.724 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.495 ' CG2' ' O ' ' A' ' 111' ' ' ASP . 87.7 t -63.46 -52.66 55.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.746 -179.708 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 39.0 t -69.81 -32.31 70.69 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.428 -178.704 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -61.22 -59.96 9.13 Favored Glycine 0 CA--C 1.526 0.753 0 C-N-CA 121.05 -0.595 . . . . 0.0 111.924 -179.262 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.506 ' O ' ' OG1' ' A' ' 122' ' ' THR . 4.4 p -68.78 -38.05 78.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -178.789 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . 0.503 ' O ' ' OG1' ' A' ' 123' ' ' THR . . . -65.99 -60.19 3.08 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.625 -0.43 . . . . 0.0 111.339 -178.746 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 28.1 m -59.73 -57.26 13.67 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.366 -179.285 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -49.07 -43.93 41.45 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.42 -179.29 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.506 ' OG1' ' O ' ' A' ' 118' ' ' VAL . 27.9 p -68.32 -38.06 81.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.511 -179.197 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.503 ' OG1' ' O ' ' A' ' 119' ' ' ALA . 0.1 OUTLIER -56.77 -49.81 74.18 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.845 0.355 . . . . 0.0 111.134 -179.191 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.6 pp -83.76 -19.82 34.45 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.886 -178.745 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -86.48 -71.32 0.55 Allowed 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -178.433 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' TRP . . . . . 0.456 ' N ' ' CD1' ' A' ' 126' ' ' TRP . 37.0 m0 -85.01 -57.23 3.18 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 112.767 0.654 . . . . 0.0 112.767 -177.881 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . 0.514 ' CD2' ' N ' ' A' ' 127' ' ' HIS . 8.7 m170 -50.4 -23.97 2.74 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.874 -0.33 . . . . 0.0 111.549 -178.7 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 40.4 ttt-85 -76.34 -37.08 57.82 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.918 -0.313 . . . . 0.0 110.99 -179.721 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 60.2 t -83.94 -48.88 16.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.783 0.325 . . . . 0.0 110.88 -179.575 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -128.2 112.82 19.9 Favored Pre-proline 0 CA--C 1.532 0.274 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.573 -179.624 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . 0.625 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 67.1 Cg_exo -70.71 -34.28 11.67 Favored 'Trans proline' 0 N--CA 1.492 1.423 0 C-N-CA 121.092 1.195 . . . . 0.0 112.307 179.473 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.625 ' CD ' ' N ' ' A' ' 131' ' ' PRO . 32.3 Cg_exo -56.34 -35.0 95.56 Favored 'Trans proline' 0 N--CA 1.495 1.607 0 C-N-CA 121.52 1.48 . . . . 0.0 111.877 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -63.66 -38.68 92.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.321 179.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -54.51 -25.39 25.36 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.194 -0.457 . . . . 0.0 109.994 179.697 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 9.5 tpt85 -77.37 -29.82 53.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.002 179.63 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 79.1 mt -80.02 -31.34 39.64 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.829 179.362 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.579 ' O ' ' N ' ' A' ' 140' ' ' TYR . 0.7 OUTLIER -79.39 -44.61 21.13 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 179.344 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.579 ' C ' ' H ' ' A' ' 140' ' ' TYR . 0.4 OUTLIER -19.97 -51.24 0.05 OUTLIER Pre-proline 0 N--CA 1.466 0.327 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.913 179.916 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.457 ' N ' ' O ' ' A' ' 137' ' ' LEU . 16.9 Cg_exo -53.08 -1.69 0.09 OUTLIER 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 121.11 1.207 . . . . 0.0 112.015 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . 0.579 ' H ' ' C ' ' A' ' 138' ' ' TYR . 2.2 p90 -84.24 -19.5 33.82 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 120.919 0.39 . . . . 0.0 110.638 -179.781 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 95.6 mt -59.98 -49.92 75.79 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.63 -0.428 . . . . 0.0 109.986 179.253 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -45.55 -44.92 13.15 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 179.37 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' TRP . . . . . 0.575 ' C ' ' CD1' ' A' ' 143' ' ' TRP . 0.3 OUTLIER -58.34 -48.74 79.59 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.423 179.37 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.479 ' O ' ' OG1' ' A' ' 148' ' ' THR . 16.1 mt -55.46 -46.7 76.78 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.32 -0.552 . . . . 0.0 109.59 179.567 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . 0.476 ' O ' ' CG2' ' A' ' 149' ' ' VAL . . . -63.44 -20.91 65.97 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.902 179.3 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -68.99 -62.91 1.18 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.504 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -67.8 -45.61 74.28 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 120.57 -0.452 . . . . 0.0 110.414 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' THR . . . . . 0.479 ' OG1' ' O ' ' A' ' 144' ' ' LEU . 19.2 m -52.28 -60.29 3.39 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.756 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.476 ' CG2' ' O ' ' A' ' 145' ' ' ALA . 93.2 t -54.16 -41.64 52.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 C-N-CA 120.878 -0.329 . . . . 0.0 110.798 -179.725 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 3.5 tp -50.39 -56.05 13.1 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.819 0.342 . . . . 0.0 110.548 -179.679 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . 0.414 ' ND2' ' CB ' ' A' ' 108' ' ' ALA . 9.8 t30 -61.7 -54.76 38.24 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.672 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . 0.443 ' CZ ' ' NE ' ' A' ' 156' ' ' ARG . 40.5 t80 -46.36 -38.09 8.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.616 -179.702 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 32.0 t80 -65.9 -53.39 40.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.699 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 62.8 t -49.22 -48.13 18.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 C-N-CA 120.614 -0.435 . . . . 0.0 110.365 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' TRP . . . . . . . . . . . . . 13.5 m0 -53.67 -55.56 24.99 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.363 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . 0.443 ' NE ' ' CZ ' ' A' ' 152' ' ' TYR . 0.7 OUTLIER -54.79 -52.14 63.55 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.362 179.949 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -49.19 -46.89 46.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.743 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . 0.478 ' O ' ' ND2' ' A' ' 158' ' ' ASN . 1.7 t30 -79.2 -12.92 59.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.73 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' SER . . . . . 0.532 ' OG ' ' N ' ' A' ' 160' ' ' GLY . 1.6 t 57.73 -95.4 0.05 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.603 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . 0.532 ' N ' ' OG ' ' A' ' 159' ' ' SER . . . 85.43 16.33 64.51 Favored Glycine 0 CA--C 1.525 0.705 0 N-CA-C 111.102 -0.799 . . . . 0.0 111.102 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 15.5 mmt180 -56.74 -55.07 38.92 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.772 0.32 . . . . 0.0 110.66 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . 0.475 ' CD ' ' H ' ' A' ' 162' ' ' ARG . 0.0 OUTLIER -91.17 125.13 35.86 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.618 -179.958 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 95.22 -95.8 1.91 Allowed Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.896 -0.882 . . . . 0.0 110.896 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -170.67 -106.92 0.19 Allowed Glycine 0 CA--C 1.523 0.552 0 N-CA-C 110.873 -0.891 . . . . 0.0 110.873 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 40.0 m -73.03 -24.5 60.73 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.866 0.365 . . . . 0.0 110.426 179.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 19.5 ttp180 63.36 140.41 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.552 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.511 ' CD2' ' N ' ' A' ' 167' ' ' LEU . 1.6 mm? -108.72 63.64 0.61 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.108 179.739 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -43.97 93.58 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.728 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . 0.461 ' N ' ' O ' ' A' ' 167' ' ' LEU . 27.8 mm-40 . . . . . 0 C--O 1.22 -0.479 0 CA-C-O 117.943 -1.027 . . . . 0.0 110.689 179.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 201' ' ' PKA . . . . . 0.525 ' N18' ' H3 ' ' A' ' 201' ' ' PKA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 29.3 mtt . . . . . 0 CA--C 1.529 0.156 0 N-CA-C 110.404 -0.221 . . . . 0.0 110.404 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_exo -41.33 124.95 2.45 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 121.593 1.529 . . . . 0.0 112.129 179.758 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 52.3 tt0 -80.96 -63.4 1.41 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.354 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 79.9 p -102.14 154.44 19.0 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.439 179.707 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.436 ' CE2' ' CD2' ' A' ' 68' ' ' TRP . 0.5 OUTLIER -60.1 116.2 4.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.234 -179.931 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.633 ' N ' ' CD ' ' A' ' 7' ' ' PRO . 1.0 OUTLIER -63.8 -36.56 22.04 Favored Pre-proline 0 C--N 1.328 -0.328 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 179.875 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.633 ' CD ' ' N ' ' A' ' 6' ' ' VAL . 15.0 Cg_exo -70.09 -68.23 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 121.987 1.792 . . . . 0.0 112.251 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.446 ' CB ' ' HG ' ' A' ' 64' ' ' SER . . . -47.41 -42.8 22.88 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.538 -179.35 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.485 ' O ' ' OG1' ' A' ' 12' ' ' THR . 60.6 t -65.1 -62.51 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 111.852 0.316 . . . . 0.0 111.852 -179.126 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -53.92 -40.03 64.14 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 111.462 -0.655 . . . . 0.0 111.462 -179.355 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 6.7 mp -68.61 -28.7 67.15 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.646 0.26 . . . . 0.0 110.862 -179.575 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.485 ' OG1' ' O ' ' A' ' 9' ' ' VAL . 2.2 p -81.25 -24.0 37.63 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.844 -0.342 . . . . 0.0 110.901 -179.933 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 84.6 mt -81.4 -33.39 32.28 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.517 -0.31 . . . . 0.0 110.695 -179.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.407 ' N ' ' HD2' ' A' ' 15' ' ' PRO . 3.9 t -47.11 -57.89 8.35 Favored Pre-proline 0 CA--C 1.535 0.373 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.907 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.407 ' HD2' ' N ' ' A' ' 14' ' ' VAL . 11.6 Cg_endo -56.66 -30.9 85.58 Favored 'Trans proline' 0 N--CA 1.498 1.754 0 C-N-CA 121.169 1.246 . . . . 0.0 112.3 -179.857 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.1 t -67.84 -27.16 66.46 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.694 -179.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 96.2 mt -69.54 -58.16 4.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.861 -179.687 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -68.92 -20.27 74.36 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 110.816 -0.913 . . . . 0.0 110.816 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -71.02 -46.07 46.57 Favored Glycine 0 CA--C 1.522 0.502 0 N-CA-C 110.909 -0.876 . . . . 0.0 110.909 -179.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -74.44 -59.64 2.64 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.737 0.303 . . . . 0.0 110.796 -179.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 1.1 tpt -60.9 -26.78 67.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.108 -179.509 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -79.26 -59.84 2.64 Favored Glycine 0 CA--C 1.527 0.8 0 N-CA-C 111.602 -0.599 . . . . 0.0 111.602 -179.462 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -61.35 -17.13 52.4 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.812 0.339 . . . . 0.0 110.843 -179.264 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 28.7 t80 -50.01 -24.0 2.37 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.935 0.398 . . . . 0.0 110.223 179.69 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.409 ' CE2' ' CB ' ' A' ' 102' ' ' ALA . 53.9 t80 -69.38 -48.6 60.67 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.904 -179.775 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.458 ' CG2' 'CL ' ' A' ' 201' ' ' PKA . 27.6 m -72.12 -19.52 19.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.805 -179.624 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.55 -44.38 86.97 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.764 -179.751 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -102.37 -43.9 1.94 Allowed Glycine 0 CA--C 1.525 0.711 0 N-CA-C 111.503 -0.639 . . . . 0.0 111.503 -179.472 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -73.78 -24.62 59.87 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.95 -0.3 . . . . 0.0 111.019 -179.605 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -81.33 -58.77 2.52 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 111.24 -0.744 . . . . 0.0 111.24 -179.659 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 10.3 mp -51.69 -29.05 16.73 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.853 -0.339 . . . . 0.0 110.122 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 33.3 ttt180 -82.55 -47.84 11.69 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.217 179.52 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -49.09 -27.67 3.57 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.294 -0.412 . . . . 0.0 109.921 179.748 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.52 ' C ' ' CD1' ' A' ' 34' ' ' TYR . 9.0 t80 -46.83 -43.31 18.42 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.241 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -54.37 -24.4 19.42 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.489 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -96.09 -72.6 1.13 Allowed Glycine 0 CA--C 1.525 0.706 0 N-CA-C 110.986 -0.845 . . . . 0.0 110.986 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -95.95 166.87 11.57 Favored 'General case' 0 N--CA 1.462 0.173 0 C-N-CA 120.863 -0.335 . . . . 0.0 110.431 179.546 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 31.2 tp60 -85.92 118.67 25.55 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.947 -179.471 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.467 ' HZ2' ' C1 ' ' A' ' 201' ' ' PKA . 7.6 mtpt -105.13 162.28 20.23 Favored Pre-proline 0 CA--C 1.535 0.392 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.73 179.7 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.426 ' O ' ' ND1' ' A' ' 43' ' ' HIS . 8.2 Cg_exo -53.05 139.5 61.47 Favored 'Trans proline' 0 N--CA 1.494 1.503 0 C-N-CA 121.369 1.379 . . . . 0.0 112.408 -179.353 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 35.9 t -81.71 -2.81 51.87 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.69 179.632 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 2.6 p90 -112.41 20.25 16.86 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.656 -0.247 . . . . 0.0 110.98 -179.213 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.673 ' H ' ' HD1' ' A' ' 43' ' ' HIS . 2.0 p-80 -88.65 117.2 68.08 Favored Pre-proline 0 CA--C 1.535 0.375 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.369 -179.66 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -99.35 -175.19 0.16 Allowed 'Trans proline' 0 N--CA 1.489 1.248 0 C-N-CA 120.836 1.024 . . . . 0.0 111.13 178.457 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.479 ' O ' ' N ' ' A' ' 47' ' ' TRP . 3.0 Cg_endo -80.3 140.97 14.07 Favored 'Trans proline' 0 C--N 1.302 -1.893 0 C-N-CA 121.573 1.515 . . . . 0.0 111.62 179.665 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.41 ' O ' ' CB ' ' A' ' 50' ' ' ALA . 23.6 ptt180 -41.2 -18.57 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.725 -0.671 . . . . 0.0 112.557 -178.758 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.586 ' CD1' ' N ' ' A' ' 48' ' ' THR . 0.4 OUTLIER -58.7 -48.58 80.64 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 112.48 0.548 . . . . 0.0 112.48 -178.335 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.586 ' N ' ' CD1' ' A' ' 47' ' ' TRP . 5.1 t -89.72 -34.3 16.27 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 113.196 0.813 . . . . 0.0 113.196 -178.019 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.406 ' O ' ' CG2' ' A' ' 52' ' ' ILE . 0.3 OUTLIER -82.71 -49.33 9.89 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.212 -0.595 . . . . 0.0 112.263 -178.016 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.637 ' C ' ' H ' ' A' ' 52' ' ' ILE . . . -40.37 -32.17 0.3 Allowed Pre-proline 0 CA--C 1.534 0.348 0 C-N-CA 120.425 -0.51 . . . . 0.0 111.835 -178.922 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_exo -54.24 4.26 0.04 OUTLIER 'Trans proline' 0 C--N 1.316 -1.182 0 CA-C-N 119.052 0.697 . . . . 0.0 112.342 178.23 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.637 ' H ' ' C ' ' A' ' 50' ' ' ALA . 46.9 pt -54.24 -30.75 21.11 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.113 0 CA-C-O 121.167 0.508 . . . . 0.0 110.066 179.662 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 52.9 m95 -80.1 -23.41 41.27 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.898 -179.44 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -70.85 -45.0 54.66 Favored Glycine 0 CA--C 1.523 0.585 0 N-CA-C 109.916 -1.274 . . . . 0.0 109.916 178.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 5.3 m -68.52 -51.8 39.07 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 179.294 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 94.5 mt -60.8 -26.53 67.36 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.044 179.586 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.543 ' C ' ' CD1' ' A' ' 57' ' ' TYR . 0.4 OUTLIER -65.61 -56.72 10.69 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 179.615 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 40.3 t -52.2 -44.01 64.5 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.775 -0.37 . . . . 0.0 110.288 179.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.76 -47.15 82.14 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.789 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 30.3 mtm -60.47 -35.65 76.38 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.563 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -64.53 -43.15 97.0 Favored Glycine 0 CA--C 1.523 0.538 0 N-CA-C 110.815 -0.914 . . . . 0.0 110.815 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -63.18 -53.41 53.63 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -57.32 -37.08 79.31 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 179.032 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.586 ' O ' ' NE1' ' A' ' 68' ' ' TRP . 23.3 t -62.33 -44.62 96.08 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 179.278 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 21.1 t80 -54.16 -44.06 71.12 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 179.155 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 65.7 mt -65.05 -30.52 50.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.603 179.625 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 73.1 t -65.49 -58.8 5.46 Favored 'Isoleucine or valine' 0 C--O 1.233 0.186 0 C-N-CA 120.501 -0.479 . . . . 0.0 111.125 -179.711 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . 0.631 ' N ' ' CD1' ' A' ' 68' ' ' TRP . 0.0 OUTLIER -56.17 -37.17 69.21 Favored 'General case' 0 CA--C 1.528 0.104 0 C-N-CA 119.96 -0.696 . . . . 0.0 110.119 -179.78 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 16.5 mmmt -73.17 -21.62 60.66 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.416 -0.514 . . . . 0.0 110.917 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 15.8 tp10 -76.83 -40.64 47.14 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 -178.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.44 ' C ' ' CD1' ' A' ' 71' ' ' LEU . 0.5 OUTLIER -105.03 -0.11 27.1 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 120.32 -0.552 . . . . 0.0 111.44 -179.506 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.417 ' O ' ' O ' ' A' ' 73' ' ' GLY . . . 96.3 84.62 1.71 Allowed Glycine 0 CA--C 1.525 0.662 0 C-N-CA 120.992 -0.623 . . . . 0.0 111.628 179.222 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.578 ' N ' ' O ' ' A' ' 68' ' ' TRP . . . 44.81 -173.88 0.01 OUTLIER Glycine 0 CA--C 1.525 0.691 0 N-CA-C 111.652 -0.579 . . . . 0.0 111.652 179.31 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 77.7 t80 -81.71 110.46 17.06 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.875 0.369 . . . . 0.0 110.651 -179.663 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.503 ' OG1' ' N ' ' A' ' 76' ' ' GLU . 2.6 t -142.65 -173.77 3.97 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.646 179.849 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.503 ' N ' ' OG1' ' A' ' 75' ' ' THR . 22.0 mt-10 -51.97 -24.56 6.68 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.649 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -79.29 -24.69 42.72 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.901 -179.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -93.28 -16.83 24.3 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.838 0.352 . . . . 0.0 111.031 -179.663 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 14.1 mtp -69.54 -30.46 68.28 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.871 -179.782 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.41 ' N ' ' HD2' ' A' ' 81' ' ' PRO . 6.3 t -68.16 -46.57 40.29 Favored Pre-proline 0 CA--C 1.533 0.291 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.749 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.41 ' HD2' ' N ' ' A' ' 80' ' ' VAL . 13.4 Cg_endo -71.76 -61.18 0.05 OUTLIER 'Trans proline' 0 N--CA 1.498 1.786 0 C-N-CA 120.841 1.027 . . . . 0.0 111.916 179.397 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 8.4 mt -56.22 -51.9 66.4 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 121.014 0.435 . . . . 0.0 109.906 179.54 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -52.03 -53.96 28.09 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 111.167 -0.773 . . . . 0.0 111.167 -179.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 29.6 tp -58.42 -33.09 69.28 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.554 0.216 . . . . 0.0 110.954 -179.512 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 31.1 t80 -68.42 -37.08 79.97 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.801 -0.36 . . . . 0.0 110.86 -179.645 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.428 ' OG1' ' N ' ' A' ' 87' ' ' GLY . 5.1 p -68.44 -58.73 3.89 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.742 -0.383 . . . . 0.0 110.747 -179.46 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.428 ' N ' ' OG1' ' A' ' 86' ' ' THR . . . -58.69 -57.46 19.76 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 111.268 -0.733 . . . . 0.0 111.268 -179.799 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 54.1 tp60 -50.6 -55.36 16.66 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-O 120.88 0.371 . . . . 0.0 110.922 -179.758 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.424 ' O ' ' C ' ' A' ' 90' ' ' ALA . 26.3 tp -47.88 -66.27 0.43 Allowed 'General case' 0 C--O 1.209 -1.051 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.06 -179.731 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.424 ' C ' ' O ' ' A' ' 89' ' ' LEU . . . -38.37 -50.51 1.5 Allowed 'General case' 0 C--N 1.319 -0.759 0 C-N-CA 120.633 -0.427 . . . . 0.0 112.026 -179.309 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 95.2 mt -53.64 -56.75 14.54 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 -178.312 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -76.97 -53.7 7.51 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.275 0.559 . . . . 0.0 111.615 -178.312 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . 0.64 ' O ' ' N ' ' A' ' 95' ' ' TRP . 3.9 t-105 -53.11 -20.76 4.04 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.364 -0.835 . . . . 0.0 111.63 -179.595 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -57.01 70.48 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 120.793 0.33 . . . . 0.0 110.608 -179.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.68 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 5.6 p-90 -102.38 -17.32 0.19 Allowed Pre-proline 0 CA--C 1.537 0.472 0 CA-C-N 116.051 -0.522 . . . . 0.0 112.036 -179.543 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.68 ' CD ' ' N ' ' A' ' 95' ' ' TRP . 32.5 Cg_exo -63.28 -24.2 72.06 Favored 'Trans proline' 0 N--CA 1.495 1.614 0 C-N-CA 120.629 0.886 . . . . 0.0 112.831 179.466 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.558 ' CD ' ' N ' ' A' ' 96' ' ' PRO . 97.3 Cg_exo -62.93 -24.87 74.14 Favored 'Trans proline' 0 N--CA 1.495 1.563 0 C-N-CA 120.833 1.022 . . . . 0.0 112.832 179.856 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 1.1 pp -78.58 22.53 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 121.015 0.436 . . . . 0.0 110.1 179.751 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.481 ' H ' ' C ' ' A' ' 97' ' ' PRO . 2.5 t80 -40.21 -42.78 1.55 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.531 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -86.23 -33.1 20.83 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.724 -179.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -68.46 -5.12 41.8 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 111.231 -0.748 . . . . 0.0 111.231 -179.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.409 ' CB ' ' CE2' ' A' ' 25' ' ' PHE . . . -74.63 -9.45 58.58 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.74 0.305 . . . . 0.0 110.908 -179.76 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.488 ' C ' ' CD ' ' A' ' 103' ' ' ARG . 0.0 OUTLIER -88.56 -11.73 44.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.828 -179.792 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -109.7 -178.92 3.67 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.914 0.387 . . . . 0.0 110.801 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' MET . . . . . 0.66 ' N ' ' SD ' ' A' ' 105' ' ' MET . 0.0 OUTLIER -55.45 -23.0 22.99 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.123 -179.826 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -62.22 -15.42 51.0 Favored Glycine 0 CA--C 1.528 0.847 0 CA-C-N 116.193 -0.458 . . . . 0.0 112.08 -179.287 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' TRP . . . . . 0.688 ' CD1' ' CZ2' ' A' ' 155' ' ' TRP . 0.0 OUTLIER -48.75 -18.98 0.31 Allowed 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 116.812 0.306 . . . . 0.0 110.972 -179.329 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -70.8 -23.76 62.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.991 0.424 . . . . 0.0 110.647 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 7.5 mt -54.21 -28.68 42.46 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.635 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -53.29 -63.01 1.29 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.087 0.47 . . . . 0.0 110.334 179.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.545 ' OD1' ' N ' ' A' ' 112' ' ' LEU . 2.1 p30 -62.26 -53.38 56.06 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.838 -0.619 . . . . 0.0 112.039 -179.376 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.545 ' N ' ' OD1' ' A' ' 111' ' ' ASP . 0.2 OUTLIER -53.49 -40.46 65.36 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.268 0.47 . . . . 0.0 112.268 -178.194 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 61.4 mt -71.4 -61.69 1.68 Allowed 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.281 0.475 . . . . 0.0 112.281 -178.479 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.5 pp -58.3 -33.67 69.71 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 120.15 -0.62 . . . . 0.0 110.9 -178.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.536 ' CG2' ' O ' ' A' ' 111' ' ' ASP . 41.2 t -62.16 -60.91 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.462 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 57.3 p -68.87 -22.24 64.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.474 -178.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -66.17 -62.22 4.85 Favored Glycine 0 CA--C 1.526 0.723 0 C-N-CA 120.952 -0.642 . . . . 0.0 111.549 -179.27 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.509 ' O ' ' OG1' ' A' ' 122' ' ' THR . 10.0 p -71.12 -37.54 67.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 C-N-CA 120.872 -0.331 . . . . 0.0 111.694 -179.258 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . 0.51 ' O ' ' OG1' ' A' ' 123' ' ' THR . . . -68.39 -60.64 2.29 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.564 -0.454 . . . . 0.0 111.522 -179.204 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 3.7 m -58.7 -51.73 68.7 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.892 0.377 . . . . 0.0 111.372 -179.34 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.423 ' O ' ' CB ' ' A' ' 125' ' ' ALA . . . -55.58 -39.7 71.04 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.381 -179.384 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.509 ' OG1' ' O ' ' A' ' 118' ' ' VAL . 36.2 p -75.01 -28.94 60.7 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.638 -0.425 . . . . 0.0 111.601 -179.279 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.51 ' OG1' ' O ' ' A' ' 119' ' ' ALA . 0.1 OUTLIER -65.11 -54.55 28.23 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.631 -0.428 . . . . 0.0 110.717 -179.669 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -79.45 -19.73 49.16 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.576 -0.449 . . . . 0.0 111.73 -179.043 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . 0.423 ' CB ' ' O ' ' A' ' 121' ' ' ALA . . . -88.33 -68.28 0.77 Allowed 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 -179.083 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' TRP . . . . . 0.4 ' N ' ' CD1' ' A' ' 126' ' ' TRP . 41.8 m0 -84.17 -57.23 3.26 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -177.87 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . 0.505 ' CD2' ' N ' ' A' ' 127' ' ' HIS . 7.1 m170 -54.69 -22.11 12.83 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.581 -0.448 . . . . 0.0 111.289 -178.718 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 26.8 ttt180 -68.34 -42.98 78.49 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.863 -0.335 . . . . 0.0 110.821 -179.694 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 23.2 t -87.51 -49.64 14.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.807 -179.796 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 26.6 p -116.23 108.32 46.03 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.523 -179.793 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . 0.642 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 79.5 Cg_exo -74.22 -25.71 13.3 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 121.554 1.503 . . . . 0.0 112.663 179.471 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.642 ' CD ' ' N ' ' A' ' 131' ' ' PRO . 51.4 Cg_exo -63.16 -43.31 19.28 Favored 'Trans proline' 0 N--CA 1.495 1.609 0 C-N-CA 121.371 1.38 . . . . 0.0 111.961 179.797 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -54.83 -38.75 67.78 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.251 179.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -55.06 -26.28 36.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.256 179.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 13.4 tpp180 -76.07 -32.23 59.16 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.248 179.658 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 95.9 mt -72.53 -26.78 61.88 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 179.314 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.512 ' O ' ' N ' ' A' ' 140' ' ' TYR . 2.6 mt -88.69 -29.25 20.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.376 179.757 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.516 ' C ' ' CD1' ' A' ' 138' ' ' TYR . 0.4 OUTLIER -33.59 -49.3 0.75 Allowed Pre-proline 0 CA--C 1.537 0.458 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.381 -179.819 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.408 ' HD2' ' N ' ' A' ' 138' ' ' TYR . 3.9 Cg_exo -60.96 4.96 0.17 Allowed 'Trans proline' 0 N--CA 1.494 1.535 0 C-N-CA 121.402 1.401 . . . . 0.0 112.591 -179.688 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . 0.512 ' N ' ' O ' ' A' ' 137' ' ' LEU . 0.1 OUTLIER -90.07 -16.65 29.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.709 0.29 . . . . 0.0 111.125 179.88 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.405 ' N ' ' CD1' ' A' ' 140' ' ' TYR . 94.8 mt -58.42 -26.19 63.0 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 178.831 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -63.41 -42.3 98.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.628 179.266 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' TRP . . . . . 0.429 ' CZ2' ' CD1' ' A' ' 52' ' ' ILE . 12.3 t-105 -66.72 -38.72 87.27 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.7 179.387 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.409 HD11 ' CZ ' ' A' ' 140' ' ' TYR . 18.0 mt -62.55 -37.64 86.93 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 120.539 -0.465 . . . . 0.0 110.035 179.616 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . 0.489 ' O ' ' CG2' ' A' ' 149' ' ' VAL . . . -76.91 -25.92 53.52 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.389 179.746 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 26.4 t80 -64.28 -57.96 7.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.744 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -70.4 -49.38 49.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.794 -179.74 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 99.2 m -51.38 -47.46 62.86 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.906 -179.667 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.489 ' CG2' ' O ' ' A' ' 145' ' ' ALA . 94.2 t -69.54 -34.06 59.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.176 -179.502 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -56.18 -52.9 62.71 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.917 0.389 . . . . 0.0 110.383 -179.683 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . 0.494 ' OD1' ' NE1' ' A' ' 107' ' ' TRP . 3.4 t30 -63.88 -51.25 65.41 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.843 -179.841 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 58.9 t80 -56.27 -29.8 61.6 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.454 -179.282 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . 0.436 ' O ' ' CG ' ' A' ' 157' ' ' ASP . 55.8 t80 -73.02 -52.58 13.84 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.827 -0.349 . . . . 0.0 111.296 -179.464 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . 0.486 ' O ' ' OD1' ' A' ' 157' ' ' ASP . 54.3 t -65.1 -32.44 58.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.593 -179.353 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' TRP . . . . . 0.688 ' CZ2' ' CD1' ' A' ' 107' ' ' TRP . 0.2 OUTLIER -73.4 -42.14 62.46 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.177 -178.559 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . 0.403 ' NE ' ' CA ' ' A' ' 156' ' ' ARG . 0.0 OUTLIER -77.61 -57.04 4.03 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.855 -0.338 . . . . 0.0 110.751 -179.753 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . 0.579 ' OD1' ' N ' ' A' ' 158' ' ' ASN . 39.7 p-10 -48.24 -36.31 13.66 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.962 -0.295 . . . . 0.0 110.76 -179.688 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . 0.579 ' N ' ' OD1' ' A' ' 157' ' ' ASP . 8.7 t-20 -89.03 -22.34 23.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.773 -179.715 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' SER . . . . . 0.446 ' O ' ' O ' ' A' ' 158' ' ' ASN . 8.7 t 53.83 165.51 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.726 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 160.16 98.53 0.14 Allowed Glycine 0 CA--C 1.524 0.656 0 N-CA-C 110.731 -0.948 . . . . 0.0 110.731 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 26.7 ttt85 -166.9 -33.12 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.833 0.349 . . . . 0.0 110.728 -179.642 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 62.2 mtt85 -74.98 140.5 43.69 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.757 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -74.39 2.61 45.05 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 111.208 -0.757 . . . . 0.0 111.208 -179.687 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 105.97 -149.96 16.8 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 111.077 -0.809 . . . . 0.0 111.077 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 4.9 t -78.17 -159.57 0.17 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.844 0.354 . . . . 0.0 110.686 -179.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 16.4 mmt85 -66.62 -95.28 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.366 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 7.6 mp -113.12 -75.73 0.6 Allowed 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.294 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . 59.04 111.08 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.554 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.22 -0.481 0 CA-C-O 117.97 -1.014 . . . . 0.0 110.564 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 201' ' ' PKA . . . . . 0.549 ' N18' ' H3 ' ' A' ' 201' ' ' PKA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.624 ' O ' HG23 ' A' ' 9' ' ' VAL . 1.2 t-105 . . . . . 0 CA--C 1.531 0.219 0 N-CA-C 110.167 -0.308 . . . . 0.0 110.167 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.566 ' N ' ' CD ' ' A' ' 7' ' ' PRO . 0.9 OUTLIER -62.02 -44.97 91.34 Favored Pre-proline 0 CA--C 1.533 0.319 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.316 -179.796 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.566 ' CD ' ' N ' ' A' ' 6' ' ' VAL . 21.3 Cg_exo -57.14 -65.42 0.1 Allowed 'Trans proline' 0 C--N 1.307 -1.655 0 C-N-CA 121.671 1.58 . . . . 0.0 111.585 179.673 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.727 ' O ' HG23 ' A' ' 12' ' ' THR . . . -49.23 -41.44 37.38 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.226 -179.632 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.624 HG23 ' O ' ' A' ' 5' ' ' TRP . 49.7 t -60.53 -62.75 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 120.824 0.345 . . . . 0.0 111.533 -179.07 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -57.78 -52.33 52.74 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 111.456 -0.658 . . . . 0.0 111.456 -179.406 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 9.5 mp -57.99 -30.38 66.02 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.474 0.178 . . . . 0.0 110.961 -179.535 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.727 HG23 ' O ' ' A' ' 8' ' ' ALA . 20.8 p -79.93 -20.74 44.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.087 0.47 . . . . 0.0 109.766 179.295 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.7 mt -82.0 -22.86 36.32 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.499 179.404 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.405 ' N ' ' HD2' ' A' ' 15' ' ' PRO . 5.4 t -54.35 -54.63 45.99 Favored Pre-proline 0 CA--C 1.535 0.398 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.655 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.405 ' HD2' ' N ' ' A' ' 14' ' ' VAL . 6.4 Cg_endo -57.55 -8.59 4.2 Favored 'Trans proline' 0 N--CA 1.495 1.572 0 C-N-CA 120.935 1.09 . . . . 0.0 111.642 179.657 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.4 t -75.08 -27.62 60.0 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.124 179.766 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 63.8 mt -79.45 -43.67 22.84 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.767 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -77.63 -31.74 48.9 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 111.012 -0.835 . . . . 0.0 111.012 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -78.36 -34.76 35.36 Favored Glycine 0 CA--C 1.52 0.379 0 N-CA-C 110.305 -1.118 . . . . 0.0 110.305 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 41.4 t80 -72.01 -58.99 2.98 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 179.459 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 48.8 tpp -64.61 -28.02 69.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.625 179.587 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.541 ' C ' ' CZ2' ' A' ' 95' ' ' TRP . . . -65.66 -63.12 4.27 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 111.674 -0.571 . . . . 0.0 111.674 -179.462 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.496 ' O ' HG22 ' A' ' 26' ' ' VAL . . . -69.34 -18.2 63.78 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.891 -0.324 . . . . 0.0 111.03 -179.388 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 80.7 t80 -50.6 -24.64 3.41 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.959 0.409 . . . . 0.0 110.045 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.461 ' CE2' ' HB1' ' A' ' 102' ' ' ALA . 63.5 t80 -69.2 -48.26 62.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.979 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.496 HG22 ' O ' ' A' ' 23' ' ' ALA . 32.9 m -75.55 -14.24 15.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 C-N-CA 120.73 -0.388 . . . . 0.0 110.768 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.542 ' O ' ' CD1' ' A' ' 31' ' ' LEU . 0.0 OUTLIER -57.79 -44.03 85.98 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.626 179.879 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -112.16 -54.56 0.48 Allowed Glycine 0 CA--C 1.525 0.667 0 N-CA-C 110.978 -0.849 . . . . 0.0 110.978 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -58.99 -27.61 65.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.836 0.351 . . . . 0.0 110.495 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -78.52 -49.05 6.89 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 111.062 -0.815 . . . . 0.0 111.062 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.542 ' CD1' ' O ' ' A' ' 27' ' ' ARG . 95.0 mt -56.7 -34.51 67.5 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.769 0.319 . . . . 0.0 110.541 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 49.4 mtp180 -77.06 -54.21 6.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.669 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -44.96 -41.65 7.48 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.298 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 56.2 t80 -49.44 -31.43 9.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.879 -179.697 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -66.28 -25.24 66.77 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.678 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -92.67 -67.36 1.1 Allowed Glycine 0 CA--C 1.523 0.573 0 N-CA-C 111.049 -0.82 . . . . 0.0 111.049 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.571 ' O ' HD12 ' A' ' 37' ' ' LEU . 0.3 OUTLIER -95.2 166.96 11.65 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.827 0.346 . . . . 0.0 110.561 179.666 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -87.1 112.82 22.29 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.704 -179.681 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.688 ' NZ ' ' CH2' ' A' ' 107' ' ' TRP . 17.3 mtpt -129.42 153.31 80.57 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.193 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo . . . . . 0 C--N 1.305 -1.725 0 C-N-CA 121.438 1.425 . . . . 0.0 110.668 178.843 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.74 ' O ' HG23 ' A' ' 52' ' ' ILE . 0.1 OUTLIER . . . . . 0 CA--C 1.534 0.359 0 N-CA-C 111.804 0.298 . . . . 0.0 111.804 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.602 ' C ' ' H ' ' A' ' 52' ' ' ILE . . . -40.13 -29.17 0.2 Allowed Pre-proline 0 N--CA 1.466 0.339 0 N-CA-C 112.129 0.418 . . . . 0.0 112.129 -178.898 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.407 ' HD2' ' N ' ' A' ' 50' ' ' ALA . 26.3 Cg_exo -52.82 3.0 0.04 OUTLIER 'Trans proline' 0 C--N 1.312 -1.363 0 CA-C-N 119.336 0.799 . . . . 0.0 112.441 178.287 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.74 HG23 ' O ' ' A' ' 49' ' ' LEU . 7.9 pt -52.51 -40.36 32.77 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.238 0 CA-C-O 121.22 0.534 . . . . 0.0 109.842 179.258 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.456 ' N ' ' CG1' ' A' ' 52' ' ' ILE . 69.7 m95 -73.4 -22.41 60.25 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.157 -179.328 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -67.43 -49.28 52.51 Favored Glycine 0 CA--C 1.527 0.833 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 179.015 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 3.3 m -65.54 -56.95 9.54 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.909 0.385 . . . . 0.0 110.209 179.464 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 83.3 mt -57.18 -26.52 60.76 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.503 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.509 ' CD1' ' C ' ' A' ' 57' ' ' TYR . 2.3 t80 -67.17 -47.63 70.41 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 179.464 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 15.1 m -56.43 -53.62 55.22 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.957 179.331 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -57.98 -41.06 82.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.34 179.524 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 8.3 mtm -56.71 -58.28 8.78 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.092 179.765 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -46.95 -44.07 17.92 Favored Glycine 0 CA--C 1.523 0.573 0 N-CA-C 110.696 -0.961 . . . . 0.0 110.696 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -61.72 -59.22 5.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.708 0.29 . . . . 0.0 110.468 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.539 ' O ' HG23 ' A' ' 67' ' ' VAL . . . -49.79 -57.34 9.81 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.88 -0.888 . . . . 0.0 110.88 179.792 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.592 ' O ' ' CD1' ' A' ' 68' ' ' TRP . 0.3 OUTLIER -45.68 -55.51 6.34 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.958 0.408 . . . . 0.0 110.526 179.803 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.415 ' N ' ' OG ' ' A' ' 64' ' ' SER . 50.0 t80 -48.54 -42.23 32.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.965 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 93.4 mt -66.73 -49.25 76.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.176 -179.577 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.539 HG23 ' O ' ' A' ' 63' ' ' GLY . 9.1 t -51.43 -54.54 11.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.907 0.384 . . . . 0.0 111.162 -179.47 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' TRP . . . . . 0.592 ' CD1' ' O ' ' A' ' 64' ' ' SER . 1.7 m95 -65.81 -35.01 79.5 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.097 -179.458 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 7.1 mmmt -65.63 -22.93 66.7 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.653 -0.419 . . . . 0.0 110.349 179.369 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -81.95 -62.68 1.57 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.542 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.729 ' C ' HD12 ' A' ' 71' ' ' LEU . 3.1 pp -65.68 -8.96 23.5 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.643 -0.423 . . . . 0.0 110.839 -179.814 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.687 ' N ' HD12 ' A' ' 71' ' ' LEU . . . 104.6 84.38 1.76 Allowed Glycine 0 CA--C 1.526 0.767 0 C-N-CA 120.994 -0.622 . . . . 0.0 111.77 179.19 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.554 ' N ' ' O ' ' A' ' 68' ' ' TRP . . . 41.91 -174.16 0.01 OUTLIER Glycine 0 CA--C 1.526 0.75 0 N-CA-C 111.795 -0.522 . . . . 0.0 111.795 179.212 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 46.6 t80 -78.7 114.21 17.43 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.866 0.365 . . . . 0.0 110.563 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.58 ' OG1' ' N ' ' A' ' 76' ' ' GLU . 0.0 OUTLIER -142.04 -175.48 4.43 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.423 -179.966 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.58 ' N ' ' OG1' ' A' ' 75' ' ' THR . 4.7 pt-20 -51.3 -25.8 6.42 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.601 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 64.3 t0 -76.12 -31.35 58.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.081 -179.696 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.41 ' O ' HD12 ' A' ' 82' ' ' LEU . . . -83.71 -19.11 35.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.937 -179.764 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 24.6 mtp -68.24 -27.38 66.31 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.847 -179.823 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 6.4 t -67.07 -49.39 46.3 Favored Pre-proline 0 CA--C 1.534 0.352 0 CA-C-N 116.438 -0.347 . . . . 0.0 110.729 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_endo -71.77 -58.85 0.07 OUTLIER 'Trans proline' 0 N--CA 1.498 1.74 0 C-N-CA 120.985 1.123 . . . . 0.0 111.721 179.166 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.414 HD11 ' CE2' ' A' ' 68' ' ' TRP . 2.8 mt -51.74 -47.59 63.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.781 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -67.88 -64.16 3.3 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 111.204 -0.758 . . . . 0.0 111.204 -179.471 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 31.4 tp -46.04 -26.71 0.78 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.988 0.423 . . . . 0.0 110.169 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 12.2 t80 -77.23 -41.98 39.12 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.245 179.767 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 1.3 m -69.52 -43.44 73.04 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.842 -179.824 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -69.84 -56.79 7.78 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 110.986 -0.846 . . . . 0.0 110.986 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.433 ' O ' ' CB ' ' A' ' 92' ' ' ASN . 3.5 tp60 -53.84 -45.2 70.83 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.9 0.381 . . . . 0.0 110.514 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 11.4 tp -66.19 -33.16 75.14 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.834 -179.722 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.761 ' O ' ' HB2' ' A' ' 94' ' ' ALA . . . -64.11 -65.68 0.65 Allowed 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 120.256 -0.578 . . . . 0.0 111.291 -179.324 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.9 pp -68.04 -33.37 74.46 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 -178.611 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.433 ' CB ' ' O ' ' A' ' 88' ' ' GLN . 32.2 t-20 -81.13 -55.11 4.97 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.249 0.463 . . . . 0.0 112.249 -178.444 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' TRP . . . . . 0.614 ' O ' ' N ' ' A' ' 95' ' ' TRP . 0.0 OUTLIER -73.54 -17.43 61.21 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.699 -0.4 . . . . 0.0 111.773 -178.371 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.761 ' HB2' ' O ' ' A' ' 90' ' ' ALA . . . -52.82 82.04 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 120.473 -0.491 . . . . 0.0 109.911 179.505 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.704 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 38.4 p-90 -97.08 -15.47 0.2 Allowed Pre-proline 0 CA--C 1.536 0.437 0 N-CA-C 112.635 0.605 . . . . 0.0 112.635 -179.16 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.704 ' CD ' ' N ' ' A' ' 95' ' ' TRP . 47.4 Cg_exo -60.39 -18.76 55.09 Favored 'Trans proline' 0 N--CA 1.498 1.744 0 C-N-CA 120.675 0.917 . . . . 0.0 113.663 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.562 ' CD ' ' N ' ' A' ' 96' ' ' PRO . 71.5 Cg_exo -76.76 0.69 9.34 Favored 'Trans proline' 0 N--CA 1.498 1.788 0 C-N-CA 120.534 0.822 . . . . 0.0 113.183 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.486 ' O ' ' N ' ' A' ' 101' ' ' GLY . 1.9 pp -91.76 9.37 3.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 C-N-CA 120.739 -0.385 . . . . 0.0 110.632 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.535 ' CD1' ' O ' ' A' ' 96' ' ' PRO . 2.8 m-30 -40.44 -36.32 0.54 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.678 179.716 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.547 ' CD1' ' N ' ' A' ' 100' ' ' PHE . 0.1 OUTLIER -66.9 -35.41 79.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.203 -179.334 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.486 ' N ' ' O ' ' A' ' 98' ' ' ILE . . . -92.89 -4.27 65.28 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 111.402 -0.679 . . . . 0.0 111.402 -179.538 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.461 ' HB1' ' CE2' ' A' ' 25' ' ' PHE . . . -65.85 -13.96 60.56 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.683 0.278 . . . . 0.0 110.925 -179.764 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 16.2 ptt180 -89.26 3.35 52.34 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.832 0.348 . . . . 0.0 110.81 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 8.5 mt-30 -120.61 158.74 26.72 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.362 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.409 ' N ' ' SD ' ' A' ' 105' ' ' MET . 0.0 OUTLIER -49.31 -18.37 0.36 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.232 179.907 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.566 ' O ' ' N ' ' A' ' 108' ' ' ALA . . . -64.48 -15.68 59.66 Favored Glycine 0 CA--C 1.526 0.764 0 N-CA-C 111.022 -0.831 . . . . 0.0 111.022 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' TRP . . . . . 0.688 ' CH2' ' NZ ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -41.8 -16.59 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 120.619 0.247 . . . . 0.0 111.241 -179.533 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.566 ' N ' ' O ' ' A' ' 106' ' ' GLY . . . -64.0 -17.3 63.18 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.96 0.409 . . . . 0.0 110.514 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 9.9 mt -51.64 -29.99 19.83 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.591 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.436 ' HB2' ' CE3' ' A' ' 95' ' ' TRP . . . -58.96 -62.78 1.62 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.644 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.71 ' O ' HG23 ' A' ' 115' ' ' VAL . 1.4 p30 -54.72 -53.86 49.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.453 -179.456 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.573 ' N ' ' OD1' ' A' ' 111' ' ' ASP . 31.3 tp -55.94 -40.78 73.66 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.918 -0.313 . . . . 0.0 111.662 -179.112 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 24.9 mt -68.35 -61.3 1.9 Allowed 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.363 0.505 . . . . 0.0 112.363 -178.598 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.0 pp -61.89 -32.86 73.26 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 120.435 -0.506 . . . . 0.0 111.41 -178.606 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.71 HG23 ' O ' ' A' ' 111' ' ' ASP . 41.8 t -61.86 -55.98 20.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.15 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' SER . . . . . 0.499 ' O ' ' OG1' ' A' ' 120' ' ' THR . 14.8 m -74.56 -22.9 58.76 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.447 -179.222 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -65.2 -62.48 4.87 Favored Glycine 0 CA--C 1.526 0.72 0 C-N-CA 120.809 -0.71 . . . . 0.0 111.419 -179.326 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.557 ' O ' HG23 ' A' ' 122' ' ' THR . 5.4 p -73.64 -35.5 44.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 C-N-CA 121.134 -0.226 . . . . 0.0 111.418 -179.507 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.508 ' O ' ' OG1' ' A' ' 123' ' ' THR . . . -69.76 -60.32 2.39 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.484 -0.487 . . . . 0.0 111.045 -179.457 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.499 ' OG1' ' O ' ' A' ' 116' ' ' SER . 1.9 m -59.28 -50.36 74.28 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.775 0.322 . . . . 0.0 111.34 -179.478 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -56.56 -41.75 77.39 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.464 -179.284 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.557 HG23 ' O ' ' A' ' 118' ' ' VAL . 33.9 p -72.44 -25.53 61.49 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.849 -0.34 . . . . 0.0 111.658 -179.238 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.508 ' OG1' ' O ' ' A' ' 119' ' ' ALA . 0.1 OUTLIER -69.55 -47.39 63.82 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.645 -0.422 . . . . 0.0 110.456 -179.747 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.8 pp -83.26 -18.32 39.56 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.18 -179.47 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -91.91 -65.01 1.04 Allowed 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -178.644 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 40.3 m0 -85.77 -57.63 2.97 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 113.032 0.753 . . . . 0.0 113.032 -177.791 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' HIS . . . . . 0.514 ' CD2' ' HB2' ' A' ' 134' ' ' ALA . 15.2 m170 -56.6 -22.6 35.04 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 111.762 0.282 . . . . 0.0 111.762 -178.324 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.51 -37.32 87.14 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 120.897 -0.321 . . . . 0.0 110.798 -179.574 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 47.9 t -101.16 -48.48 11.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.51 -179.466 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' SER . . . . . 0.523 ' HB3' HG22 ' A' ' 67' ' ' VAL . 6.2 t -113.15 108.13 53.25 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.585 -178.983 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' PRO . . . . . 0.663 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 73.1 Cg_exo -76.41 -26.6 8.59 Favored 'Trans proline' 0 C--N 1.31 -1.47 0 C-N-CA 121.788 1.659 . . . . 0.0 112.393 178.592 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 132' ' ' PRO . . . . . 0.663 ' CD ' ' N ' ' A' ' 131' ' ' PRO . 51.0 Cg_exo -61.15 -44.87 21.62 Favored 'Trans proline' 0 N--CA 1.497 1.682 0 C-N-CA 121.485 1.457 . . . . 0.0 112.248 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.405 ' O ' ' N ' ' A' ' 136' ' ' LEU . . . -59.05 -43.25 91.68 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.02 0.438 . . . . 0.0 110.321 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 134' ' ' ALA . . . . . 0.514 ' HB2' ' CD2' ' A' ' 127' ' ' HIS . . . -49.61 -27.28 4.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.039 179.713 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 7.0 tpt180 -77.96 -29.53 49.84 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.345 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.405 ' N ' ' O ' ' A' ' 133' ' ' ALA . 39.0 mt -74.16 -21.74 59.71 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 178.955 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.49 ' O ' ' N ' ' A' ' 140' ' ' TYR . 3.3 mt -93.7 -28.29 16.04 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.278 -0.873 . . . . 0.0 110.232 179.455 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.513 ' CD1' ' C ' ' A' ' 138' ' ' TYR . 0.6 OUTLIER -32.3 -50.41 0.55 Allowed Pre-proline 0 CA--C 1.537 0.462 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.586 -179.929 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.42 ' HD2' ' N ' ' A' ' 138' ' ' TYR . 2.7 Cg_endo -61.91 5.94 0.19 Allowed 'Trans proline' 0 N--CA 1.498 1.773 0 C-N-CA 121.476 1.451 . . . . 0.0 112.972 -179.5 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 140' ' ' TYR . . . . . 0.49 ' N ' ' O ' ' A' ' 137' ' ' LEU . 0.1 OUTLIER -90.41 -15.18 31.45 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.904 0.383 . . . . 0.0 110.891 179.866 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.511 HD23 HD12 ' A' ' 144' ' ' LEU . 98.7 mt -59.38 -35.89 74.76 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.216 -0.447 . . . . 0.0 109.922 178.992 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -56.06 -41.48 75.15 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.768 179.286 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' TRP . . . . . 0.502 ' CE2' HD12 ' A' ' 52' ' ' ILE . 8.4 t-105 -64.65 -44.49 90.26 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.606 179.266 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.511 HD12 HD23 ' A' ' 141' ' ' LEU . 19.2 mt -57.33 -43.3 83.27 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.802 179.573 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.5 ' O ' HG23 ' A' ' 149' ' ' VAL . . . -70.26 -26.69 63.94 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.007 179.644 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 11.1 t80 -60.65 -61.73 2.37 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.647 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 147' ' ' ALA . . . . . 0.491 ' O ' ' OD1' ' A' ' 151' ' ' ASN . . . -66.55 -50.34 63.47 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 120.696 -0.401 . . . . 0.0 110.615 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 148' ' ' THR . . . . . 0.576 ' O ' ' ND2' ' A' ' 151' ' ' ASN . 17.0 m -48.99 -55.43 11.96 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.626 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.5 HG23 ' O ' ' A' ' 145' ' ' ALA . 73.1 t -59.46 -35.86 61.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.613 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.42 ' O ' HG23 ' A' ' 154' ' ' VAL . 0.8 OUTLIER -51.73 -61.23 2.38 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.628 -0.429 . . . . 0.0 110.083 -179.873 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 151' ' ' ASN . . . . . 0.576 ' ND2' ' O ' ' A' ' 148' ' ' THR . 1.3 p-10 -54.34 -47.15 72.87 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.766 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 38.1 t80 -53.23 -40.73 64.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.766 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 37.1 t80 -63.92 -45.92 87.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.912 -179.696 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.42 HG23 ' O ' ' A' ' 150' ' ' LEU . 14.6 t -56.6 -51.69 62.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.926 0.393 . . . . 0.0 110.806 -179.792 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 155' ' ' TRP . . . . . . . . . . . . . 15.9 m0 -52.28 -55.33 22.06 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.225 -179.642 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -66.65 -19.73 65.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.28 -179.066 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 37.8 t0 -71.1 -52.7 17.84 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.73 0.3 . . . . 0.0 111.164 -179.456 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 19.6 p30 . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.861 -179.483 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.761 ' O ' HG23 ' A' ' 9' ' ' VAL . 0.5 OUTLIER . . . . . 0 CA--C 1.528 0.125 0 N-CA-C 110.23 -0.285 . . . . 0.0 110.23 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.571 ' N ' ' CD ' ' A' ' 7' ' ' PRO . 0.9 OUTLIER -61.43 -42.86 86.99 Favored Pre-proline 0 CA--C 1.532 0.266 0 C-N-CA 120.938 -0.305 . . . . 0.0 110.26 -179.819 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.571 ' CD ' ' N ' ' A' ' 6' ' ' VAL . 24.1 Cg_exo -58.88 -65.1 0.09 OUTLIER 'Trans proline' 0 C--N 1.307 -1.623 0 C-N-CA 121.472 1.448 . . . . 0.0 111.52 179.585 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.732 ' O ' HG23 ' A' ' 12' ' ' THR . . . -50.42 -37.74 39.54 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.201 -179.765 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.761 HG23 ' O ' ' A' ' 5' ' ' TRP . 46.1 t -59.9 -62.45 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.831 0.348 . . . . 0.0 111.376 -179.28 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -61.67 -48.28 85.29 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 111.316 -0.714 . . . . 0.0 111.316 -179.431 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 9.0 mp -60.26 -24.96 65.33 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.49 0.186 . . . . 0.0 111.153 -179.609 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.732 HG23 ' O ' ' A' ' 8' ' ' ALA . 14.4 p -83.92 -29.11 27.39 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.77 -0.372 . . . . 0.0 110.539 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.422 ' O ' ' CB ' ' A' ' 16' ' ' SER . 6.4 mp -78.47 -20.87 49.98 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 179.661 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.421 ' C ' ' H ' ' A' ' 16' ' ' SER . 3.5 t -49.73 -57.63 11.67 Favored Pre-proline 0 CA--C 1.534 0.349 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.739 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.418 ' HD2' ' N ' ' A' ' 14' ' ' VAL . 11.3 Cg_endo -56.5 -4.19 0.75 Allowed 'Trans proline' 0 N--CA 1.497 1.725 0 C-N-CA 120.81 1.007 . . . . 0.0 111.974 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.422 ' CB ' ' O ' ' A' ' 13' ' ' LEU . 1.6 t -81.46 -27.81 34.44 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.832 0.348 . . . . 0.0 110.464 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 13.4 mt -71.56 -54.93 8.86 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.671 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -74.02 -35.8 53.08 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 111.035 -0.826 . . . . 0.0 111.035 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -67.27 -33.69 83.34 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 111.011 -0.836 . . . . 0.0 111.011 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -78.14 -60.09 2.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.74 0.305 . . . . 0.0 111.002 -179.739 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 3.3 ttt -61.95 -23.19 66.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.777 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.405 ' C ' ' CZ2' ' A' ' 95' ' ' TRP . . . -77.94 -60.43 2.75 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 111.681 -0.567 . . . . 0.0 111.681 -179.565 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.646 ' O ' HG22 ' A' ' 26' ' ' VAL . . . -66.79 -22.42 66.03 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.857 -179.146 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 88.5 t80 -49.86 -24.15 2.3 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.192 179.741 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 65.3 t80 -70.56 -52.09 24.05 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.007 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.646 HG22 ' O ' ' A' ' 23' ' ' ALA . 31.9 m -64.57 -22.59 31.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 C-N-CA 120.826 -0.35 . . . . 0.0 110.697 -179.725 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 16.3 ttt180 -67.66 -31.77 71.98 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.518 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -106.17 -61.41 0.6 Allowed Glycine 0 CA--C 1.525 0.706 0 N-CA-C 111.522 -0.631 . . . . 0.0 111.522 -179.503 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.45 ' C ' ' OE1' ' A' ' 29' ' ' GLU . 4.2 tm-20 -66.52 -34.48 78.01 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 121.032 -0.267 . . . . 0.0 111.304 -179.471 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -64.73 -58.23 10.56 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 110.932 -0.867 . . . . 0.0 110.932 -179.757 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 10.9 mp -51.67 -30.11 20.61 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.665 0.269 . . . . 0.0 110.511 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 16.1 tpp180 -78.61 -49.93 12.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.888 -179.746 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -51.4 -29.96 17.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.357 -179.652 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 39.1 t80 -46.28 -35.94 5.76 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.232 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -61.4 -29.03 69.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.486 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -89.13 -70.64 1.26 Allowed Glycine 0 CA--C 1.525 0.668 0 N-CA-C 110.851 -0.9 . . . . 0.0 110.851 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.572 ' O ' HD12 ' A' ' 37' ' ' LEU . 0.3 OUTLIER -95.21 167.15 11.53 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.912 0.387 . . . . 0.0 110.687 179.606 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 20.1 mt-30 -92.77 114.04 26.48 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.062 -179.542 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 18.8 mtpt -107.27 160.03 27.95 Favored Pre-proline 0 C--N 1.331 -0.2 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.907 179.493 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo . . . . . 0 C--N 1.307 -1.641 0 C-N-CA 122.147 1.898 . . . . 0.0 111.535 179.595 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.774 ' O ' HG23 ' A' ' 52' ' ' ILE . 0.2 OUTLIER . . . . . 0 CA--C 1.533 0.326 0 N-CA-C 112.133 0.419 . . . . 0.0 112.133 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.62 ' C ' ' H ' ' A' ' 52' ' ' ILE . . . -39.37 -30.09 0.2 Allowed Pre-proline 0 C--N 1.33 -0.263 0 C-N-CA 120.961 -0.296 . . . . 0.0 111.436 -179.171 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.423 ' HD2' ' N ' ' A' ' 50' ' ' ALA . 28.6 Cg_exo -54.79 7.67 0.03 OUTLIER 'Trans proline' 0 C--N 1.311 -1.44 0 CA-C-N 118.916 0.649 . . . . 0.0 112.57 178.388 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.774 HG23 ' O ' ' A' ' 49' ' ' LEU . 9.8 pt -56.35 -31.23 32.45 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.242 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 178.989 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.429 ' CH2' ' HB1' ' A' ' 50' ' ' ALA . 3.6 m0 -64.58 -24.15 67.5 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.616 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -71.62 -46.59 38.58 Favored Glycine 0 CA--C 1.523 0.551 0 N-CA-C 110.629 -0.988 . . . . 0.0 110.629 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 87.0 m -62.09 -50.21 72.85 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.875 0.369 . . . . 0.0 110.447 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 36.9 mt -69.08 -24.9 64.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.692 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.42 ' CD1' ' C ' ' A' ' 57' ' ' TYR . 1.6 t80 -65.34 -48.43 73.03 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 179.769 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -64.91 -46.13 82.98 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.32 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.61 -48.15 82.81 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.695 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 55.1 mtm -63.22 -36.45 83.7 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.713 -179.781 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -59.21 -47.29 91.55 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 111.423 -0.671 . . . . 0.0 111.423 -179.474 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 3.3 m-30 -66.84 -59.85 3.18 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.991 -0.284 . . . . 0.0 110.77 -179.496 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.517 ' O ' HG23 ' A' ' 67' ' ' VAL . . . -50.84 -59.12 8.35 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 110.972 -0.851 . . . . 0.0 110.972 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.511 ' O ' ' CD1' ' A' ' 68' ' ' TRP . 34.5 t -45.11 -52.04 9.61 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-O 120.986 0.422 . . . . 0.0 110.783 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 70.6 t80 -56.16 -36.64 68.53 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.116 -179.794 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 70.5 mt -70.83 -48.44 57.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.775 0.321 . . . . 0.0 110.798 -179.716 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.517 HG23 ' O ' ' A' ' 63' ' ' GLY . 18.3 t -48.9 -54.69 4.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.0 -179.711 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' TRP . . . . . 0.586 ' O ' ' N ' ' A' ' 73' ' ' GLY . 0.9 OUTLIER -64.15 -45.22 89.46 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.76 -0.376 . . . . 0.0 111.047 -179.587 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 14.6 mmmt -57.22 -23.28 46.91 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.888 -0.325 . . . . 0.0 110.913 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 24.1 tp10 -82.34 -63.33 1.4 Allowed 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.799 -0.361 . . . . 0.0 110.848 -179.636 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.742 ' C ' HD12 ' A' ' 71' ' ' LEU . 3.0 pp -64.82 -4.36 4.32 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.965 -179.652 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.618 ' N ' HD12 ' A' ' 71' ' ' LEU . . . 110.95 71.68 0.65 Allowed Glycine 0 CA--C 1.526 0.777 0 C-N-CA 121.177 -0.535 . . . . 0.0 111.817 179.454 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.586 ' N ' ' O ' ' A' ' 68' ' ' TRP . . . 40.93 -173.83 0.01 OUTLIER Glycine 0 CA--C 1.525 0.667 0 CA-C-O 121.365 0.425 . . . . 0.0 112.281 179.077 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 39.4 t80 -70.45 109.84 5.02 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.316 -0.442 . . . . 0.0 110.7 -179.691 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.532 ' OG1' ' N ' ' A' ' 76' ' ' GLU . 1.5 t -142.89 -173.56 3.93 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.231 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.532 ' N ' ' OG1' ' A' ' 75' ' ' THR . 16.6 mp0 -56.73 -23.17 40.63 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.301 179.625 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -78.48 -29.01 46.5 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.785 -179.748 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.437 ' O ' HD12 ' A' ' 82' ' ' LEU . . . -86.85 -30.67 21.28 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.546 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 66.8 mmm -60.46 -27.11 67.27 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.905 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 17.6 t -65.97 -48.11 61.96 Favored Pre-proline 0 CA--C 1.534 0.33 0 C-N-CA 120.711 -0.396 . . . . 0.0 110.817 -179.688 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_endo -73.22 -52.87 0.14 Allowed 'Trans proline' 0 N--CA 1.495 1.615 0 C-N-CA 120.727 0.951 . . . . 0.0 111.355 178.551 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.437 HD12 ' O ' ' A' ' 78' ' ' ALA . 3.6 mt -51.49 -52.8 43.58 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.333 179.769 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.5 ' O ' ' N ' ' A' ' 86' ' ' THR . . . -66.65 -64.54 3.26 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 111.332 -0.707 . . . . 0.0 111.332 -179.237 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 34.3 tp -42.01 -28.08 0.16 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.065 0.46 . . . . 0.0 109.994 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.414 ' N ' ' O ' ' A' ' 83' ' ' GLY . 4.3 t80 -77.29 -43.11 34.41 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.061 179.543 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.5 ' N ' ' O ' ' A' ' 83' ' ' GLY . 3.0 m -68.02 -52.78 31.58 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.744 179.883 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -60.56 -55.9 27.36 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 111.163 -0.775 . . . . 0.0 111.163 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.427 ' O ' ' CB ' ' A' ' 92' ' ' ASN . 8.1 tp-100 -55.99 -42.87 77.03 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.799 0.333 . . . . 0.0 110.471 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 10.5 tp -66.01 -28.61 69.0 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.879 0.371 . . . . 0.0 110.125 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.783 ' O ' ' HB2' ' A' ' 94' ' ' ALA . . . -69.35 -65.82 0.66 Allowed 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.095 -0.642 . . . . 0.0 111.225 -179.814 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.7 pp -66.19 -29.16 69.38 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.149 0.426 . . . . 0.0 112.149 -179.01 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.427 ' CB ' ' O ' ' A' ' 88' ' ' GLN . 36.3 t-20 -85.22 -60.91 1.9 Allowed 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 -178.848 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' TRP . . . . . 0.609 ' O ' ' N ' ' A' ' 95' ' ' TRP . 0.0 OUTLIER -68.25 -14.78 63.24 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.69 -0.404 . . . . 0.0 111.403 -178.486 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.783 ' HB2' ' O ' ' A' ' 90' ' ' ALA . . . -54.04 80.25 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.137 0 C-N-CA 120.439 -0.505 . . . . 0.0 109.995 179.498 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.711 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 33.8 p-90 -94.44 -16.42 0.21 Allowed Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.24 -0.437 . . . . 0.0 112.061 -179.633 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.711 ' CD ' ' N ' ' A' ' 95' ' ' TRP . 46.9 Cg_exo -56.96 -31.99 91.46 Favored 'Trans proline' 0 N--CA 1.494 1.504 0 CA-C-N 118.921 0.65 . . . . 0.0 112.789 179.366 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.524 ' C ' ' H ' ' A' ' 99' ' ' PHE . 59.6 Cg_exo -50.33 -30.55 26.97 Favored 'Trans proline' 0 N--CA 1.493 1.479 0 CA-C-N 118.969 0.668 . . . . 0.0 112.838 179.736 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.492 ' O ' ' N ' ' A' ' 101' ' ' GLY . 1.2 pp -74.01 20.87 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.022 0.439 . . . . 0.0 110.187 179.662 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.524 ' H ' ' C ' ' A' ' 97' ' ' PRO . 0.9 OUTLIER -39.29 -58.18 1.25 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.038 -179.666 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 4.2 p90 -66.89 -18.04 65.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.143 -179.595 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.492 ' N ' ' O ' ' A' ' 98' ' ' ILE . . . -86.99 -10.7 71.45 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 111.17 -0.772 . . . . 0.0 111.17 -179.815 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -70.74 -9.4 57.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.56 0.219 . . . . 0.0 111.093 -179.673 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 10.6 ptm180 -91.97 -5.39 53.16 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.8 0.333 . . . . 0.0 110.734 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 10.0 mt-30 -109.11 160.45 16.05 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.554 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -53.76 -19.25 3.99 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.049 0.452 . . . . 0.0 110.237 179.883 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.605 ' O ' ' N ' ' A' ' 108' ' ' ALA . . . -65.4 -14.93 60.59 Favored Glycine 0 CA--C 1.523 0.592 0 N-CA-C 111.073 -0.811 . . . . 0.0 111.073 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' TRP . . . . . 0.505 ' NE1' ' OD1' ' A' ' 151' ' ' ASN . 0.0 OUTLIER -42.41 -15.12 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.791 0.329 . . . . 0.0 110.517 -179.663 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.605 ' N ' ' O ' ' A' ' 106' ' ' GLY . . . -58.76 -16.83 18.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.136 0.493 . . . . 0.0 109.85 179.427 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 12.1 mt -58.74 -33.92 70.79 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.569 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -53.8 -61.04 2.56 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.936 0.398 . . . . 0.0 110.898 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.571 ' O ' HG23 ' A' ' 115' ' ' VAL . 2.3 p-10 -58.83 -54.89 41.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.733 -179.392 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 43.5 tp -52.82 -43.52 66.01 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.351 -0.386 . . . . 0.0 112.01 -178.83 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 8.6 mt -66.96 -61.37 1.97 Allowed 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -178.17 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.3 pp -61.23 -35.18 76.52 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.304 -0.558 . . . . 0.0 111.499 -178.496 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.571 HG23 ' O ' ' A' ' 111' ' ' ASP . 41.5 t -60.07 -56.64 16.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.596 -0.274 . . . . 0.0 111.116 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' SER . . . . . 0.489 ' O ' ' OG1' ' A' ' 120' ' ' THR . 58.1 m -72.92 -24.1 60.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.615 -0.266 . . . . 0.0 111.58 -178.939 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' GLY . . . . . 0.406 ' O ' ' CB ' ' A' ' 121' ' ' ALA . . . -63.69 -62.73 5.02 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 111.537 -0.625 . . . . 0.0 111.537 -179.285 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.585 ' O ' HG23 ' A' ' 122' ' ' THR . 8.7 p -74.03 -34.59 39.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 C-N-CA 120.883 -0.327 . . . . 0.0 111.231 -179.481 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.524 ' O ' ' OG1' ' A' ' 123' ' ' THR . . . -68.95 -60.57 2.27 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.781 -0.367 . . . . 0.0 111.201 -179.429 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.489 ' OG1' ' O ' ' A' ' 116' ' ' SER . 1.4 m -61.47 -48.66 80.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.397 -179.252 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.407 ' O ' ' CB ' ' A' ' 125' ' ' ALA . . . -56.68 -42.01 78.31 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.173 -179.4 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.585 HG23 ' O ' ' A' ' 118' ' ' VAL . 35.3 p -71.7 -29.22 64.32 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.948 -0.301 . . . . 0.0 111.567 -179.317 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.524 ' OG1' ' O ' ' A' ' 119' ' ' ALA . 0.1 OUTLIER -67.41 -50.7 58.37 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.584 -0.446 . . . . 0.0 110.577 -179.749 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.0 pp -79.71 -20.39 46.61 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.625 -179.085 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.407 ' CB ' ' O ' ' A' ' 121' ' ' ALA . . . -91.47 -64.72 1.08 Allowed 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.678 0.621 . . . . 0.0 112.678 -178.351 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' TRP . . . . . 0.433 ' CD1' ' N ' ' A' ' 126' ' ' TRP . 40.2 m0 -85.69 -57.08 3.19 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 -177.587 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' HIS . . . . . 0.532 ' CG ' ' HB2' ' A' ' 134' ' ' ALA . 11.3 m170 -57.2 -31.58 65.59 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.795 -0.362 . . . . 0.0 111.919 -178.577 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 18.6 ttt180 -56.98 -38.51 73.11 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.709 -0.396 . . . . 0.0 111.367 -179.237 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 48.5 t -97.22 -49.56 11.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.793 0.33 . . . . 0.0 111.403 -179.244 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' SER . . . . . 0.509 ' HB3' HG22 ' A' ' 67' ' ' VAL . 15.0 t -113.91 108.31 51.25 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.748 -179.546 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 131' ' ' PRO . . . . . 0.635 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 82.3 Cg_exo -75.26 -28.07 9.07 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 C-N-CA 121.755 1.637 . . . . 0.0 112.72 179.338 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 132' ' ' PRO . . . . . 0.635 ' CD ' ' N ' ' A' ' 131' ' ' PRO . 53.5 Cg_exo -57.77 -55.45 2.36 Favored 'Trans proline' 0 N--CA 1.497 1.68 0 C-N-CA 121.142 1.228 . . . . 0.0 111.968 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -49.26 -38.48 27.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.463 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' ALA . . . . . 0.532 ' HB2' ' CG ' ' A' ' 127' ' ' HIS . . . -57.08 -29.04 63.14 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.337 179.786 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 9.7 tpp85 -76.36 -24.5 54.2 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.335 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 84.6 mt -76.04 -39.73 54.95 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 179.42 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.608 ' O ' ' N ' ' A' ' 140' ' ' TYR . 9.7 mt -77.0 -37.42 55.15 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.791 -0.641 . . . . 0.0 109.823 179.166 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.493 ' C ' ' O ' ' A' ' 137' ' ' LEU . 2.9 t80 -21.0 -44.41 0.04 OUTLIER Pre-proline 0 N--CA 1.467 0.375 0 O-C-N 123.918 0.761 . . . . 0.0 111.828 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.564 ' N ' ' O ' ' A' ' 137' ' ' LEU . 2.0 Cg_endo -67.75 11.55 0.23 Allowed 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 121.026 1.151 . . . . 0.0 112.296 179.554 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 140' ' ' TYR . . . . . 0.756 ' CE2' HD11 ' A' ' 144' ' ' LEU . 2.4 p90 -93.14 -14.15 27.56 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 121.188 0.518 . . . . 0.0 110.118 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.605 ' CD1' ' CE1' ' A' ' 140' ' ' TYR . 5.2 mp -57.05 -25.91 59.45 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 178.522 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -66.66 -44.51 81.68 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.826 179.495 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' TRP . . . . . 0.453 ' CZ2' HD12 ' A' ' 52' ' ' ILE . 7.9 t-105 -59.77 -48.08 83.13 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 179.358 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.756 HD11 ' CE2' ' A' ' 140' ' ' TYR . 9.1 mt -53.22 -50.96 63.64 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 179.09 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.645 ' O ' HG23 ' A' ' 149' ' ' VAL . . . -61.33 -26.58 67.9 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.667 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 25.4 t80 -65.01 -62.43 1.55 Allowed 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.812 -0.355 . . . . 0.0 110.775 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -66.25 -43.38 86.68 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.612 -0.435 . . . . 0.0 110.492 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 16.2 m -57.06 -57.62 11.78 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.765 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.645 HG23 ' O ' ' A' ' 145' ' ' ALA . 85.4 t -56.95 -32.77 40.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 C-N-CA 120.836 -0.346 . . . . 0.0 110.731 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.541 ' O ' HG23 ' A' ' 154' ' ' VAL . 1.8 tp -58.39 -48.62 80.03 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.523 -0.471 . . . . 0.0 109.813 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 151' ' ' ASN . . . . . 0.505 ' OD1' ' NE1' ' A' ' 107' ' ' TRP . 21.1 t30 -69.62 -55.68 9.4 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.528 179.701 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 84.8 t80 -47.49 -39.53 16.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.818 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 25.8 t80 -67.82 -46.59 71.45 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.765 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.541 HG23 ' O ' ' A' ' 150' ' ' LEU . 93.7 t -61.88 -33.06 56.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.742 -179.853 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 155' ' ' TRP . . . . . . . . . . . . . 6.3 m0 -67.02 -58.48 4.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.511 179.778 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -62.94 -19.43 64.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.553 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -80.09 -51.66 8.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.169 -179.547 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 7.4 m120 . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.084 -179.449 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.605 ' O ' HG23 ' A' ' 9' ' ' VAL . 0.5 OUTLIER . . . . . 0 C--O 1.233 0.207 0 CA-C-O 120.732 0.301 . . . . 0.0 110.308 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.589 ' N ' ' CD ' ' A' ' 7' ' ' PRO . 0.9 OUTLIER -61.0 -40.77 77.17 Favored Pre-proline 0 C--N 1.33 -0.269 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 -179.919 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.589 ' CD ' ' N ' ' A' ' 6' ' ' VAL . 23.4 Cg_exo -62.82 -64.59 0.07 OUTLIER 'Trans proline' 0 C--N 1.307 -1.649 0 C-N-CA 121.683 1.589 . . . . 0.0 111.388 179.526 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.681 ' O ' HG23 ' A' ' 12' ' ' THR . . . -48.9 -30.09 5.47 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.84 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.605 HG23 ' O ' ' A' ' 5' ' ' TRP . 43.5 t -74.18 -62.8 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.709 0.29 . . . . 0.0 111.658 -179.258 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -58.13 -35.21 76.23 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 111.598 -0.601 . . . . 0.0 111.598 -179.268 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.528 ' HG ' HG22 ' A' ' 86' ' ' THR . 6.9 mp -73.52 -38.17 65.39 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.621 0.248 . . . . 0.0 110.567 -179.663 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.681 HG23 ' O ' ' A' ' 8' ' ' ALA . 12.3 p -70.16 -20.59 63.13 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.017 0.436 . . . . 0.0 109.86 179.456 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.418 ' O ' ' C ' ' A' ' 14' ' ' VAL . 7.8 mt -80.95 -42.76 20.76 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.695 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.439 HG12 ' N ' ' A' ' 15' ' ' PRO . 3.1 t -35.71 -66.08 0.27 Allowed Pre-proline 0 CA--C 1.534 0.35 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.997 -179.766 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.439 ' N ' HG12 ' A' ' 14' ' ' VAL . 27.7 Cg_endo -51.23 -48.04 23.04 Favored 'Trans proline' 0 N--CA 1.498 1.754 0 C-N-CA 120.712 0.941 . . . . 0.0 112.126 -179.515 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 7.5 t -45.06 -21.32 0.06 Allowed 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.793 -0.363 . . . . 0.0 110.726 -179.468 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.421 ' N ' ' O ' ' A' ' 15' ' ' PRO . 73.2 mt -74.22 -53.37 9.94 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.395 179.77 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -72.01 -23.82 77.42 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 111.11 -0.796 . . . . 0.0 111.11 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -72.1 -49.2 22.64 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 110.952 -0.859 . . . . 0.0 110.952 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 11.2 t80 -67.94 -59.02 3.6 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.831 0.348 . . . . 0.0 110.566 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 8.0 tpp -62.88 -26.95 69.03 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.156 -179.634 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -77.68 -62.55 2.37 Favored Glycine 0 CA--C 1.526 0.753 0 C-N-CA 120.963 -0.637 . . . . 0.0 111.913 -179.316 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.626 ' O ' HG22 ' A' ' 26' ' ' VAL . . . -57.57 -24.79 58.15 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.834 -0.347 . . . . 0.0 110.666 -179.085 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 54.2 t80 -47.82 -24.5 1.0 Allowed 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.769 -0.372 . . . . 0.0 110.11 179.546 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.4 ' CE2' ' HB3' ' A' ' 102' ' ' ALA . 21.7 t80 -69.45 -55.78 9.28 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.777 -179.801 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.626 HG22 ' O ' ' A' ' 23' ' ' ALA . 33.7 m -60.44 -23.99 29.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 C-N-CA 120.699 -0.4 . . . . 0.0 110.344 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 2.9 tmt_? -66.09 -20.86 66.29 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.631 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -116.29 -75.22 0.57 Allowed Glycine 0 CA--C 1.523 0.569 0 N-CA-C 111.021 -0.832 . . . . 0.0 111.021 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -50.36 -31.68 15.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.654 0.264 . . . . 0.0 110.774 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -72.82 -53.39 8.21 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.81 -0.916 . . . . 0.0 110.81 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 11.0 mp -57.58 -29.94 64.86 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.84 0.352 . . . . 0.0 110.317 179.83 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 45.0 mtp180 -79.94 -48.92 12.63 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.549 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -52.15 -29.97 24.52 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.013 -0.539 . . . . 0.0 109.923 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 51.1 t80 -48.54 -40.03 25.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.61 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -58.9 -22.52 59.67 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.461 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -94.95 -73.5 1.2 Allowed Glycine 0 CA--C 1.524 0.638 0 N-CA-C 110.721 -0.951 . . . . 0.0 110.721 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.568 ' O ' HD12 ' A' ' 37' ' ' LEU . 0.3 OUTLIER -95.52 167.14 11.49 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.711 0.291 . . . . 0.0 110.424 179.494 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 33.3 mt-30 -85.02 115.72 23.0 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.887 0.375 . . . . 0.0 111.168 -179.421 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 12.0 mtpt -122.78 164.66 25.51 Favored Pre-proline 0 N--CA 1.462 0.168 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 179.276 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo . . . . . 0 C--N 1.306 -1.678 0 C-N-CA 121.743 1.628 . . . . 0.0 111.159 179.358 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.957 ' O ' HG23 ' A' ' 52' ' ' ILE . 1.5 mm? . . . . . 0 CA--C 1.531 0.249 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.543 ' C ' ' H ' ' A' ' 52' ' ' ILE . . . -40.42 -34.97 0.48 Allowed Pre-proline 0 C--N 1.326 -0.416 0 C-N-CA 120.427 -0.509 . . . . 0.0 111.42 -179.143 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.43 ' HD2' ' N ' ' A' ' 50' ' ' ALA . 69.6 Cg_exo -54.26 3.0 0.05 OUTLIER 'Trans proline' 0 C--N 1.314 -1.283 0 C-N-CA 120.644 0.896 . . . . 0.0 112.954 179.257 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.957 HG23 ' O ' ' A' ' 49' ' ' LEU . 42.1 pt -55.55 -30.27 26.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 121.133 0.492 . . . . 0.0 110.032 179.624 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.484 ' CE2' HD11 ' A' ' 52' ' ' ILE . 45.7 m95 -81.51 -22.51 37.9 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.413 -179.606 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -72.01 -47.51 31.04 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 109.709 -1.356 . . . . 0.0 109.709 178.792 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 5.0 m -67.12 -54.98 16.25 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 178.983 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.41 HD23 ' HA ' ' A' ' 56' ' ' LEU . 92.8 mt -53.76 -39.63 65.52 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.848 -0.614 . . . . 0.0 109.5 179.119 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.42 ' CD1' ' C ' ' A' ' 57' ' ' TYR . 1.3 t80 -54.6 -50.75 67.28 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 179.394 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 5.7 m -52.22 -50.22 62.42 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.223 179.608 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.55 -47.95 82.51 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.574 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 15.4 mtt -56.07 -44.14 78.66 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.461 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -54.59 -55.91 24.82 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 111.155 -0.778 . . . . 0.0 111.155 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -53.65 -54.66 34.59 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.727 0.299 . . . . 0.0 110.448 -179.724 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.487 ' O ' HG23 ' A' ' 67' ' ' VAL . . . -52.53 -56.97 15.18 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 110.824 -0.91 . . . . 0.0 110.824 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.592 ' O ' ' CD1' ' A' ' 68' ' ' TRP . 0.0 OUTLIER -49.19 -50.13 39.48 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.897 0.379 . . . . 0.0 110.324 179.957 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.487 ' O ' ' CG ' ' A' ' 69' ' ' LYS . 83.9 t80 -51.43 -38.33 53.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.709 -179.758 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 51.9 mt -71.59 -48.67 51.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.166 -179.693 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.487 HG23 ' O ' ' A' ' 63' ' ' GLY . 15.9 t -51.51 -61.35 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.867 0.365 . . . . 0.0 111.334 -179.46 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' TRP . . . . . 0.592 ' CD1' ' O ' ' A' ' 64' ' ' SER . 1.5 m95 -60.72 -40.67 93.18 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.339 -179.179 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.487 ' CG ' ' O ' ' A' ' 65' ' ' TYR . 10.6 mmmt -64.2 -22.68 67.03 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.847 0.356 . . . . 0.0 110.706 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -82.89 -62.36 1.62 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.671 -179.785 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.74 ' C ' HD12 ' A' ' 71' ' ' LEU . 3.6 pp -65.22 -9.73 25.95 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.962 -179.775 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.668 ' N ' HD12 ' A' ' 71' ' ' LEU . . . 106.09 85.69 1.83 Allowed Glycine 0 CA--C 1.527 0.788 0 C-N-CA 121.221 -0.514 . . . . 0.0 111.939 179.234 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.493 ' O ' HD11 ' A' ' 71' ' ' LEU . . . 42.06 -173.72 0.01 OUTLIER Glycine 0 CA--C 1.526 0.719 0 N-CA-C 111.838 -0.505 . . . . 0.0 111.838 179.078 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -85.02 110.93 19.28 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.527 -0.336 . . . . 0.0 110.773 -179.758 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.524 ' OG1' ' N ' ' A' ' 76' ' ' GLU . 1.7 t -142.53 -173.81 3.97 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.665 179.751 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.524 ' N ' ' OG1' ' A' ' 75' ' ' THR . 6.9 pt-20 -45.45 -34.9 3.4 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.889 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -67.91 -32.65 73.28 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.071 -179.584 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -83.98 -22.69 31.32 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.844 0.354 . . . . 0.0 110.816 -179.747 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 4.8 mtp -62.99 -26.63 68.94 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.775 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.2 t -68.67 -52.92 17.4 Favored Pre-proline 0 CA--C 1.534 0.35 0 C-N-CA 120.608 -0.437 . . . . 0.0 110.749 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -65.86 -60.78 0.11 Allowed 'Trans proline' 0 N--CA 1.497 1.678 0 C-N-CA 121.07 1.18 . . . . 0.0 111.703 179.137 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.624 ' O ' HG23 ' A' ' 86' ' ' THR . 2.7 mt -56.77 -56.43 21.55 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.391 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -47.82 -51.37 18.37 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 111.168 -0.773 . . . . 0.0 111.168 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 16.0 tp -62.58 -30.13 71.1 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 121.019 -0.273 . . . . 0.0 110.753 -179.698 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.597 ' CZ ' HD22 ' A' ' 89' ' ' LEU . 23.0 t80 -71.51 -39.11 71.01 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.963 -0.295 . . . . 0.0 110.468 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.624 HG23 ' O ' ' A' ' 82' ' ' LEU . 8.8 p -64.49 -53.54 46.49 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.802 -0.359 . . . . 0.0 110.656 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -68.04 -58.09 7.85 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 111.527 -0.629 . . . . 0.0 111.527 -179.266 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 52.4 tp60 -49.47 -54.61 16.84 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-O 121.039 0.447 . . . . 0.0 110.551 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.597 HD22 ' CZ ' ' A' ' 85' ' ' TYR . 27.1 tp -51.03 -64.4 0.82 Allowed 'General case' 0 C--O 1.209 -1.027 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.906 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.622 ' O ' ' HB2' ' A' ' 94' ' ' ALA . . . -38.05 -48.85 1.25 Allowed 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 120.434 -0.506 . . . . 0.0 111.916 -179.561 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 94.1 mt -56.6 -57.17 13.54 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 -178.438 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.798 ' O ' HD22 ' A' ' 113' ' ' LEU . 2.8 m120 -74.21 -55.11 6.43 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 121.415 0.626 . . . . 0.0 111.301 -178.621 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' TRP . . . . . 0.623 ' O ' ' N ' ' A' ' 95' ' ' TRP . 7.4 t-105 -52.84 -21.92 4.8 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.114 -0.948 . . . . 0.0 111.273 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.622 ' HB2' ' O ' ' A' ' 90' ' ' ALA . . . -60.05 69.27 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.929 0.395 . . . . 0.0 109.948 179.623 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.685 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 9.9 p-90 -99.94 -17.39 0.2 Allowed Pre-proline 0 CA--C 1.536 0.439 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.73 -179.363 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.685 ' CD ' ' N ' ' A' ' 95' ' ' TRP . 31.8 Cg_exo -62.86 -26.24 74.57 Favored 'Trans proline' 0 N--CA 1.494 1.522 0 C-N-CA 120.442 0.762 . . . . 0.0 112.659 179.193 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.544 ' CD ' ' N ' ' A' ' 96' ' ' PRO . 84.2 Cg_exo -60.1 -25.69 80.49 Favored 'Trans proline' 0 N--CA 1.496 1.638 0 C-N-CA 120.744 0.963 . . . . 0.0 112.781 179.83 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -80.74 33.03 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 121.003 0.43 . . . . 0.0 110.427 179.82 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.402 ' H ' ' C ' ' A' ' 97' ' ' PRO . 1.6 t80 -44.7 -52.92 7.82 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.488 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -73.63 -40.33 63.86 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.673 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -57.14 -15.47 14.69 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 111.135 -0.786 . . . . 0.0 111.135 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.4 ' HB3' ' CE2' ' A' ' 25' ' ' PHE . . . -74.64 -7.88 54.62 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.69 0.281 . . . . 0.0 110.837 -179.831 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.41 -17.12 52.75 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.657 -179.857 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' GLN . . . . . 0.536 ' O ' ' N ' ' A' ' 106' ' ' GLY . 2.2 pt20 -110.95 158.06 19.19 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.599 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 6.0 mmt -43.26 -17.32 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.669 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.536 ' N ' ' O ' ' A' ' 104' ' ' GLN . . . -62.78 -15.82 55.32 Favored Glycine 0 CA--C 1.526 0.77 0 N-CA-C 111.122 -0.791 . . . . 0.0 111.122 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' TRP . . . . . 0.481 ' CD1' ' C ' ' A' ' 107' ' ' TRP . 0.0 OUTLIER -47.68 -12.09 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.887 0.375 . . . . 0.0 110.664 -179.881 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.498 ' H ' ' C ' ' A' ' 106' ' ' GLY . . . -62.7 -22.51 66.56 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.082 179.754 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 8.2 mt -53.39 -29.68 35.96 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.297 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -54.91 -64.4 0.85 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.957 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.707 ' O ' HG23 ' A' ' 115' ' ' VAL . 1.4 p30 -58.82 -51.1 71.45 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.457 -179.477 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.549 ' N ' ' OD1' ' A' ' 111' ' ' ASP . 39.6 tp -52.48 -47.79 66.31 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.813 -178.986 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.798 HD22 ' O ' ' A' ' 92' ' ' ASN . 17.3 mt -65.81 -62.07 1.71 Allowed 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 -178.002 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.1 pp -58.36 -35.32 71.77 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 120.369 -0.533 . . . . 0.0 111.48 -178.478 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.707 HG23 ' O ' ' A' ' 111' ' ' ASP . 40.2 t -59.56 -61.27 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.132 -179.675 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' SER . . . . . 0.49 ' O ' ' OG1' ' A' ' 120' ' ' THR . 9.0 p -69.22 -22.24 63.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.291 -179.082 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -63.3 -63.02 4.85 Favored Glycine 0 CA--C 1.527 0.841 0 C-N-CA 120.838 -0.696 . . . . 0.0 111.597 -179.284 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.614 ' O ' HG23 ' A' ' 122' ' ' THR . 9.9 p -73.07 -37.04 52.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 C-N-CA 120.88 -0.328 . . . . 0.0 111.239 -179.415 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.515 ' O ' ' OG1' ' A' ' 123' ' ' THR . . . -67.58 -60.75 2.31 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.692 -0.403 . . . . 0.0 111.212 -179.563 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.49 ' OG1' ' O ' ' A' ' 116' ' ' SER . 2.3 m -58.42 -53.52 57.36 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.432 -179.339 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.439 ' O ' HD23 ' A' ' 124' ' ' LEU . . . -53.76 -41.36 67.06 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.253 -179.345 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.614 HG23 ' O ' ' A' ' 118' ' ' VAL . 42.1 p -73.73 -34.05 64.6 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 120.783 -0.367 . . . . 0.0 111.889 -179.12 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.515 ' OG1' ' O ' ' A' ' 119' ' ' ALA . 0.0 OUTLIER -60.27 -56.04 26.38 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 120.555 -0.458 . . . . 0.0 110.938 -179.453 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.579 HD23 ' N ' ' A' ' 125' ' ' ALA . 0.6 OUTLIER -79.06 -20.28 49.24 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.323 0.49 . . . . 0.0 112.323 -178.653 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.579 ' N ' HD23 ' A' ' 124' ' ' LEU . . . -87.91 -67.83 0.8 Allowed 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 -178.716 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' TRP . . . . . 0.522 ' CD1' ' N ' ' A' ' 126' ' ' TRP . 22.9 m0 -84.61 -57.27 3.2 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 -177.789 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' HIS . . . . . 0.551 ' CD2' ' N ' ' A' ' 127' ' ' HIS . 5.2 m170 -56.09 -22.3 27.16 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.916 -0.314 . . . . 0.0 111.569 -178.755 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.42 -37.21 84.7 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.856 0.36 . . . . 0.0 110.69 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 74.1 t -96.33 -49.47 12.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.209 -179.45 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 6.0 t -111.88 108.41 55.7 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.958 -179.432 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' PRO . . . . . 0.67 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 73.0 Cg_exo -75.27 -22.11 14.68 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 121.611 1.541 . . . . 0.0 112.379 178.946 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 132' ' ' PRO . . . . . 0.67 ' CD ' ' N ' ' A' ' 131' ' ' PRO . 58.8 Cg_exo -67.12 -45.01 4.29 Favored 'Trans proline' 0 N--CA 1.496 1.632 0 C-N-CA 121.42 1.414 . . . . 0.0 112.184 179.782 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -56.3 -37.01 69.31 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.884 0.373 . . . . 0.0 110.459 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -59.72 -24.84 64.33 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.711 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 15.5 ttp-105 -79.32 -30.61 42.9 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.664 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 86.3 mt -71.49 -36.09 71.02 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 179.556 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.58 ' O ' ' N ' ' A' ' 139' ' ' PRO . 6.4 mt -81.47 -39.93 24.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.312 179.548 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.574 ' C ' ' H ' ' A' ' 140' ' ' TYR . 0.7 OUTLIER -17.45 -48.7 0.04 OUTLIER Pre-proline 0 N--CA 1.468 0.47 0 O-C-N 123.921 0.763 . . . . 0.0 111.882 -179.65 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.58 ' N ' ' O ' ' A' ' 137' ' ' LEU . 2.1 Cg_endo -63.74 14.93 0.07 OUTLIER 'Trans proline' 0 C--N 1.308 -1.564 0 C-N-CA 120.91 1.073 . . . . 0.0 111.809 179.518 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 140' ' ' TYR . . . . . 0.698 ' CE2' HD11 ' A' ' 144' ' ' LEU . 7.0 p90 -92.77 -14.34 28.02 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 121.208 0.528 . . . . 0.0 110.26 179.702 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.637 ' CD1' ' CE1' ' A' ' 140' ' ' TYR . 6.7 mp -59.96 -36.76 77.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.301 178.629 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -55.5 -45.42 77.04 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.091 179.634 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' TRP . . . . . 0.442 ' CE2' HD12 ' A' ' 52' ' ' ILE . 9.1 t-105 -60.63 -51.57 68.84 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 179.537 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.698 HD11 ' CE2' ' A' ' 140' ' ' TYR . 11.4 mt -50.27 -53.58 27.45 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 120.23 -0.588 . . . . 0.0 109.594 179.366 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.681 ' O ' HG23 ' A' ' 149' ' ' VAL . . . -59.22 -23.01 61.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.269 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 5.1 t80 -67.07 -63.44 1.06 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.693 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -66.51 -35.6 80.64 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.65 -179.698 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 9.7 m -65.58 -39.58 91.78 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.868 -0.333 . . . . 0.0 110.371 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.681 HG23 ' O ' ' A' ' 145' ' ' ALA . 37.7 t -69.17 -36.55 73.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.198 179.733 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 2.1 tp -58.62 -54.26 49.11 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.044 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 151' ' ' ASN . . . . . 0.441 ' OD1' ' NE1' ' A' ' 107' ' ' TRP . 14.3 t30 -58.58 -55.21 37.99 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.62 179.688 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 69.6 t80 -50.38 -47.27 56.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.214 -179.714 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 14.4 t80 -56.08 -43.49 78.07 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.953 -179.576 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 84.4 t -68.35 -41.28 83.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.486 -0.324 . . . . 0.0 111.141 -179.715 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 155' ' ' TRP . . . . . . . . . . . . . 5.3 m0 -58.55 -38.17 77.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.617 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 156' ' ' ARG . . . . . 0.433 ' HA ' ' HE ' ' A' ' 156' ' ' ARG . 0.0 OUTLIER -81.07 -54.91 5.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.931 -179.51 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 33.2 t0 -51.58 -43.91 62.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.191 -179.489 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 158' ' ' ASN . . . . . 0.533 ' ND2' ' O ' ' A' ' 158' ' ' ASN . 0.4 OUTLIER . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.163 -179.444 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.574 ' O ' HG23 ' A' ' 9' ' ' VAL . 0.5 OUTLIER . . . . . 0 C--O 1.232 0.153 0 N-CA-C 110.165 -0.309 . . . . 0.0 110.165 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.575 ' N ' ' CD ' ' A' ' 7' ' ' PRO . 0.9 OUTLIER -61.1 -41.81 82.97 Favored Pre-proline 0 CA--C 1.533 0.304 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 179.932 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.575 ' CD ' ' N ' ' A' ' 6' ' ' VAL . 17.3 Cg_exo -62.62 -66.41 0.05 OUTLIER 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 121.579 1.519 . . . . 0.0 111.733 179.478 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.675 ' O ' HG23 ' A' ' 12' ' ' THR . . . -48.5 -33.56 9.68 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.339 -179.422 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.574 HG23 ' O ' ' A' ' 5' ' ' TRP . 39.5 t -69.51 -63.24 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 111.76 0.281 . . . . 0.0 111.76 -178.991 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -60.53 -45.97 95.28 Favored Glycine 0 CA--C 1.526 0.73 0 C-N-CA 121.195 -0.526 . . . . 0.0 111.84 -179.101 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.445 HD12 ' N ' ' A' ' 11' ' ' LEU . 9.3 mp -62.25 -38.31 88.75 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 122.873 -0.193 . . . . 0.0 111.09 -179.264 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.675 HG23 ' O ' ' A' ' 8' ' ' ALA . 36.1 p -73.42 -22.55 60.19 Favored 'General case' 0 C--N 1.332 -0.166 0 C-N-CA 120.298 -0.561 . . . . 0.0 109.924 179.268 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 5.6 mt -76.5 -30.97 57.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.228 179.671 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.9 t -43.53 -55.09 9.04 Favored Pre-proline 0 CA--C 1.534 0.363 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.788 -179.829 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -66.19 -17.06 54.03 Favored 'Trans proline' 0 N--CA 1.499 1.796 0 C-N-CA 120.925 1.083 . . . . 0.0 111.825 179.554 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.6 t -75.07 -28.74 60.46 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.551 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 56.5 mt -72.36 -57.82 3.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.433 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -69.78 -21.17 76.46 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 110.865 -0.894 . . . . 0.0 110.865 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -70.59 -54.07 11.08 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 111.008 -0.837 . . . . 0.0 111.008 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 37.7 t80 -70.17 -58.24 4.02 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.787 0.327 . . . . 0.0 110.518 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 20.5 ttp -57.21 -35.99 70.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.762 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -69.78 -62.23 3.94 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 111.121 -0.792 . . . . 0.0 111.121 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.555 ' O ' HG22 ' A' ' 26' ' ' VAL . . . -55.55 -17.14 4.83 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.906 0.384 . . . . 0.0 110.31 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 47.4 t80 -51.26 -25.47 5.72 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.277 179.72 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 71.8 t80 -67.17 -47.29 71.41 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.507 179.797 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.555 HG22 ' O ' ' A' ' 23' ' ' ALA . 32.6 m -77.52 -13.94 14.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.379 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.4 tmt_? -67.43 -30.57 70.35 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.743 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -119.45 -69.9 0.32 Allowed Glycine 0 CA--C 1.525 0.691 0 N-CA-C 110.996 -0.841 . . . . 0.0 110.996 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -47.57 -22.63 0.51 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.744 0.307 . . . . 0.0 110.659 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -76.29 -52.15 6.32 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 111.119 -0.792 . . . . 0.0 111.119 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 72.6 mt -53.45 -36.28 61.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.758 0.313 . . . . 0.0 110.625 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 11.3 mmt180 -78.0 -49.89 13.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.809 -179.736 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -47.53 -31.54 4.45 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 110.101 -0.333 . . . . 0.0 110.101 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.445 ' CD1' ' C ' ' A' ' 34' ' ' TYR . 23.8 t80 -52.82 -39.03 62.09 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.486 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -56.94 -20.77 25.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.28 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -98.01 -73.34 1.11 Allowed Glycine 0 CA--C 1.526 0.749 0 N-CA-C 110.858 -0.897 . . . . 0.0 110.858 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.572 ' O ' HD12 ' A' ' 37' ' ' LEU . 0.3 OUTLIER -96.05 166.9 11.54 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 120.938 0.399 . . . . 0.0 110.898 179.806 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 6.6 mp0 -84.1 117.08 23.22 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.636 -179.713 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 6.7 mtpt -126.1 149.57 66.97 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.797 179.808 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo . . . . . 0 C--N 1.307 -1.62 0 C-N-CA 121.328 1.352 . . . . 0.0 111.387 179.296 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.898 ' O ' HG23 ' A' ' 52' ' ' ILE . 1.0 OUTLIER . . . . . 0 N--CA 1.466 0.354 0 N-CA-C 112.505 0.557 . . . . 0.0 112.505 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.584 ' C ' ' H ' ' A' ' 52' ' ' ILE . . . -39.85 -33.46 0.33 Allowed Pre-proline 0 C--N 1.327 -0.394 0 C-N-CA 120.675 -0.41 . . . . 0.0 111.539 -179.033 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.421 ' HD2' ' N ' ' A' ' 50' ' ' ALA . 56.9 Cg_exo -54.23 4.1 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.522 0 CA-C-N 118.615 0.541 . . . . 0.0 112.587 178.82 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.898 HG23 ' O ' ' A' ' 49' ' ' LEU . 45.6 pt -53.52 -31.74 19.65 Favored 'Isoleucine or valine' 0 C--O 1.232 0.151 0 CA-C-O 121.211 0.529 . . . . 0.0 109.766 179.423 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.518 ' CE2' HD11 ' A' ' 52' ' ' ILE . 48.2 m95 -81.35 -25.6 36.23 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.814 -179.361 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -69.44 -43.52 69.07 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 178.876 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 17.3 m -69.15 -59.05 3.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.87 0.367 . . . . 0.0 110.115 179.298 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.422 ' HA ' HD23 ' A' ' 56' ' ' LEU . 96.9 mt -54.19 -33.84 59.11 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.208 -0.451 . . . . 0.0 109.99 179.661 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.442 ' CB ' ' O ' ' A' ' 53' ' ' TRP . 1.7 t80 -59.2 -55.32 36.38 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.751 179.528 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 4.9 t -49.53 -49.66 45.09 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.097 179.632 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -57.21 -48.38 78.92 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.335 179.728 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.407 ' O ' ' OG ' ' A' ' 64' ' ' SER . 23.5 mtm -58.17 -33.61 69.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.513 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.501 ' O ' ' OG ' ' A' ' 64' ' ' SER . . . -65.21 -43.23 95.71 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 111.197 -0.761 . . . . 0.0 111.197 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -66.41 -59.99 3.16 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.676 -0.409 . . . . 0.0 110.282 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.439 ' O ' HG23 ' A' ' 67' ' ' VAL . . . -52.48 -50.08 49.43 Favored Glycine 0 CA--C 1.522 0.507 0 N-CA-C 110.32 -1.112 . . . . 0.0 110.32 179.541 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.577 ' O ' ' CE2' ' A' ' 68' ' ' TRP . 6.2 p -45.96 -50.6 14.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.099 0.476 . . . . 0.0 110.321 179.575 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 67.2 t80 -56.48 -40.24 74.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.507 179.745 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 91.5 mt -65.45 -41.87 92.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.926 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.48 HG22 ' OG ' ' A' ' 130' ' ' SER . 23.4 t -56.56 -53.67 38.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.047 -179.621 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' TRP . . . . . 0.585 ' O ' ' N ' ' A' ' 73' ' ' GLY . 0.6 OUTLIER -65.27 -35.98 82.71 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 120.577 -0.449 . . . . 0.0 110.839 -179.702 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 13.4 mmmt -63.73 -25.85 68.38 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.798 -0.361 . . . . 0.0 110.677 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 23.1 tp10 -82.65 -62.34 1.63 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.471 -179.369 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.752 ' C ' HD12 ' A' ' 71' ' ' LEU . 3.8 pp -68.59 -8.55 42.85 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.834 -0.347 . . . . 0.0 111.489 -179.222 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.605 ' N ' HD12 ' A' ' 71' ' ' LEU . . . 102.1 83.61 1.74 Allowed Glycine 0 CA--C 1.528 0.891 0 C-N-CA 121.208 -0.52 . . . . 0.0 111.873 179.32 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.585 ' N ' ' O ' ' A' ' 68' ' ' TRP . . . 42.37 -174.08 0.01 OUTLIER Glycine 0 CA--C 1.525 0.683 0 N-CA-C 111.782 -0.527 . . . . 0.0 111.782 179.46 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 38.4 t80 -80.87 110.59 16.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.867 0.365 . . . . 0.0 110.663 -179.676 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.482 ' OG1' ' N ' ' A' ' 76' ' ' GLU . 2.8 t -142.29 -173.86 3.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.488 179.797 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.482 ' N ' ' OG1' ' A' ' 75' ' ' THR . 2.8 mp0 -47.42 -32.15 4.77 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.679 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 12.8 t0 -71.0 -28.35 64.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.977 -179.679 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -88.51 -22.92 23.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.8 0.333 . . . . 0.0 110.886 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -66.34 -27.72 68.1 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.723 -179.807 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 8.8 t -68.34 -47.23 37.95 Favored Pre-proline 0 CA--C 1.534 0.338 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.864 -179.759 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -73.95 -57.03 0.07 OUTLIER 'Trans proline' 0 N--CA 1.499 1.797 0 C-N-CA 121.165 1.243 . . . . 0.0 111.738 179.021 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.491 HD21 ' CZ2' ' A' ' 68' ' ' TRP . 7.7 mt -56.02 -51.43 67.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.543 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -60.95 -61.66 6.75 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 110.805 -0.918 . . . . 0.0 110.805 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 58.7 tp -46.96 -33.51 4.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.929 0.395 . . . . 0.0 110.269 179.733 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.454 ' C ' ' CD1' ' A' ' 85' ' ' TYR . 2.0 t80 -73.89 -47.27 39.23 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.703 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 1.3 m -60.82 -49.0 79.23 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.91 -0.316 . . . . 0.0 111.146 -179.49 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -69.84 -58.33 6.39 Favored Glycine 0 CA--C 1.527 0.798 0 C-N-CA 120.95 -0.643 . . . . 0.0 111.615 -179.421 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 37.7 tp60 -51.99 -46.28 64.83 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 120.728 -0.389 . . . . 0.0 110.374 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.415 ' O ' ' C ' ' A' ' 90' ' ' ALA . 25.4 tp -53.71 -65.32 0.59 Allowed 'General case' 0 C--O 1.214 -0.803 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 179.566 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.663 ' O ' ' HB2' ' A' ' 94' ' ' ALA . . . -38.58 -44.32 0.96 Allowed 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 120.533 -0.467 . . . . 0.0 111.637 -179.64 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 80.3 mt -59.57 -56.86 16.6 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 -178.529 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 8.7 m-20 -75.89 -54.37 7.01 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 121.286 0.565 . . . . 0.0 111.428 -178.588 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' TRP . . . . . 0.677 ' O ' ' N ' ' A' ' 95' ' ' TRP . 3.6 t-105 -52.5 -28.98 22.7 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.265 -0.879 . . . . 0.0 111.583 -179.665 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.663 ' HB2' ' O ' ' A' ' 90' ' ' ALA . . . -52.06 73.38 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.846 0.355 . . . . 0.0 110.727 -179.494 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.683 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 13.9 p-90 -102.32 -18.7 0.19 Allowed Pre-proline 0 CA--C 1.534 0.332 0 CA-C-N 115.991 -0.55 . . . . 0.0 112.049 -179.621 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.683 ' CD ' ' N ' ' A' ' 95' ' ' TRP . 31.6 Cg_exo -59.79 -31.08 93.47 Favored 'Trans proline' 0 N--CA 1.494 1.502 0 C-N-CA 120.353 0.702 . . . . 0.0 112.819 179.785 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.491 ' C ' ' H ' ' A' ' 99' ' ' PHE . 75.5 Cg_exo -53.36 -28.11 42.2 Favored 'Trans proline' 0 N--CA 1.492 1.436 0 C-N-CA 120.431 0.754 . . . . 0.0 112.583 179.671 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 1.2 pp -75.42 18.79 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 121.167 0.508 . . . . 0.0 110.173 179.735 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.491 ' H ' ' C ' ' A' ' 97' ' ' PRO . 4.5 t80 -38.98 -41.74 0.79 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.814 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -84.59 -44.49 13.46 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.829 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -59.8 -5.37 3.98 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 111.368 -0.693 . . . . 0.0 111.368 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -75.95 -13.46 60.25 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 121.016 -0.274 . . . . 0.0 110.971 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 24.2 ptt180 -80.25 3.31 21.27 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.775 0.321 . . . . 0.0 110.639 -179.747 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 5.2 mt-30 -120.92 160.29 23.79 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.321 179.72 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -49.4 -19.82 0.59 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.822 0.344 . . . . 0.0 110.205 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.538 ' O ' ' N ' ' A' ' 108' ' ' ALA . . . -65.38 -15.6 61.54 Favored Glycine 0 CA--C 1.527 0.788 0 N-CA-C 111.305 -0.718 . . . . 0.0 111.305 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' TRP . . . . . 0.49 ' CD1' ' N ' ' A' ' 108' ' ' ALA . 0.0 OUTLIER -45.29 -13.6 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.789 0.328 . . . . 0.0 110.844 -179.665 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.538 ' N ' ' O ' ' A' ' 106' ' ' GLY . . . -64.64 -21.84 66.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.511 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 12.1 mt -52.18 -27.16 13.46 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.405 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -55.84 -63.82 1.05 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.345 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.683 ' O ' HG23 ' A' ' 115' ' ' VAL . 2.0 p30 -60.37 -51.65 68.6 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.598 -179.609 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.581 ' N ' ' OD1' ' A' ' 111' ' ' ASP . 43.3 tp -52.51 -42.35 64.24 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.552 -178.975 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 81.5 mt -71.66 -61.93 1.6 Allowed 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.701 0.63 . . . . 0.0 112.701 -178.269 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.403 ' HB2' ' CZ3' ' A' ' 93' ' ' TRP . 1.8 pp -57.39 -35.18 69.67 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 120.117 -0.633 . . . . 0.0 111.116 -178.811 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.683 HG23 ' O ' ' A' ' 111' ' ' ASP . 54.6 t -62.13 -58.47 7.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.262 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 3.5 t -68.73 -22.37 64.33 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.79 -178.852 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -68.56 -62.71 3.93 Favored Glycine 0 CA--C 1.526 0.746 0 C-N-CA 121.011 -0.614 . . . . 0.0 111.745 -179.03 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.563 ' O ' HG23 ' A' ' 122' ' ' THR . 7.4 p -70.47 -37.73 71.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 C-N-CA 120.967 -0.293 . . . . 0.0 111.354 -179.421 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.515 ' O ' ' OG1' ' A' ' 123' ' ' THR . . . -66.47 -60.78 2.43 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 120.54 -0.464 . . . . 0.0 111.533 -179.21 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 5.0 m -58.38 -55.01 40.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.696 -179.202 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -52.48 -41.69 63.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.349 -179.248 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.563 HG23 ' O ' ' A' ' 118' ' ' VAL . 36.5 p -72.19 -32.59 66.94 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.823 -0.351 . . . . 0.0 111.615 -179.156 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.515 ' OG1' ' O ' ' A' ' 119' ' ' ALA . 0.2 OUTLIER -61.55 -50.16 73.79 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.908 0.385 . . . . 0.0 110.868 -179.489 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.6 pp -82.56 -20.0 37.44 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.701 -179.014 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -86.49 -70.69 0.59 Allowed 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 112.659 0.614 . . . . 0.0 112.659 -178.567 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' TRP . . . . . 0.403 ' N ' ' CD1' ' A' ' 126' ' ' TRP . 41.8 m0 -85.18 -58.8 2.54 Favored 'General case' 0 N--CA 1.465 0.325 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 -177.866 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' HIS . . . . . 0.433 ' CD2' ' N ' ' A' ' 127' ' ' HIS . 20.2 m170 -47.99 -21.52 0.46 Allowed 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 120.719 -0.392 . . . . 0.0 111.522 -178.546 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 29.6 ttt85 -73.1 -42.48 62.91 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.974 -0.29 . . . . 0.0 111.456 -179.589 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 6.3 t -92.07 -47.88 13.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.717 0.294 . . . . 0.0 111.332 -179.309 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' SER . . . . . 0.48 ' OG ' HG22 ' A' ' 67' ' ' VAL . 46.2 p -109.59 102.77 51.11 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.817 -179.764 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 131' ' ' PRO . . . . . 0.657 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 75.7 Cg_exo -71.05 -26.26 21.77 Favored 'Trans proline' 0 C--N 1.311 -1.444 0 C-N-CA 121.733 1.622 . . . . 0.0 112.465 179.43 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 132' ' ' PRO . . . . . 0.657 ' CD ' ' N ' ' A' ' 131' ' ' PRO . 38.2 Cg_exo -68.62 -49.43 0.81 Allowed 'Trans proline' 0 N--CA 1.494 1.523 0 C-N-CA 121.496 1.464 . . . . 0.0 111.877 179.796 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.406 ' C ' ' N ' ' A' ' 135' ' ' ARG . . . -46.67 -49.02 19.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.191 179.774 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' ALA . . . . . 0.428 ' HB2' ' CD2' ' A' ' 127' ' ' HIS . . . -46.7 -22.35 0.29 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.031 179.628 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 135' ' ' ARG . . . . . 0.406 ' N ' ' C ' ' A' ' 133' ' ' ALA . 5.7 tpp85 -78.41 -39.2 39.63 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.541 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 93.1 mt -68.87 -25.94 64.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.259 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.571 ' O ' ' N ' ' A' ' 140' ' ' TYR . 3.2 mt -89.11 -41.8 12.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.935 179.477 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.516 ' C ' ' H ' ' A' ' 140' ' ' TYR . 0.7 OUTLIER -22.11 -47.68 0.06 OUTLIER Pre-proline 0 N--CA 1.464 0.261 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.782 -179.776 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.483 ' N ' ' O ' ' A' ' 137' ' ' LEU . 3.1 Cg_exo -59.66 5.57 0.12 Allowed 'Trans proline' 0 C--N 1.307 -1.621 0 C-N-CA 121.071 1.18 . . . . 0.0 112.256 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 140' ' ' TYR . . . . . 0.817 ' CE2' HD11 ' A' ' 144' ' ' LEU . 1.9 p90 -90.78 -15.33 30.31 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 120.705 -0.398 . . . . 0.0 110.644 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.637 HD22 ' CE1' ' A' ' 140' ' ' TYR . 2.9 mm? -54.17 -36.0 62.91 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 179.216 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -57.47 -53.98 52.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.378 179.67 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' TRP . . . . . 0.44 ' CE2' HD12 ' A' ' 52' ' ' ILE . 11.7 t-105 -51.06 -48.9 61.46 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 116.318 -0.401 . . . . 0.0 109.939 179.793 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.817 HD11 ' CE2' ' A' ' 140' ' ' TYR . 11.4 mt -50.09 -48.29 53.35 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 120.533 -0.467 . . . . 0.0 109.832 179.558 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.619 ' O ' HG23 ' A' ' 149' ' ' VAL . . . -65.12 -30.52 71.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.699 -179.838 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 21.0 t80 -58.93 -62.19 2.07 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.73 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' ALA . . . . . 0.49 ' O ' ' OD1' ' A' ' 151' ' ' ASN . . . -67.74 -50.4 57.51 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.6 -0.44 . . . . 0.0 110.648 -179.708 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 148' ' ' THR . . . . . 0.401 ' OG1' ' O ' ' A' ' 144' ' ' LEU . 27.0 m -48.91 -44.61 40.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.842 -179.854 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.619 HG23 ' O ' ' A' ' 145' ' ' ALA . 68.7 t -69.08 -36.11 71.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.127 -179.683 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.471 ' O ' HG23 ' A' ' 154' ' ' VAL . 0.8 OUTLIER -56.24 -51.5 67.9 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.535 -0.466 . . . . 0.0 110.696 -179.334 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 151' ' ' ASN . . . . . 0.49 ' OD1' ' O ' ' A' ' 147' ' ' ALA . 4.6 p-10 -65.3 -48.83 71.73 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.945 -0.302 . . . . 0.0 111.055 -179.741 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 82.7 t80 -53.86 -49.17 69.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.931 -179.649 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 153' ' ' TYR . . . . . 0.56 ' CE2' ' OD2' ' A' ' 157' ' ' ASP . 79.5 t80 -57.35 -45.56 84.22 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.644 -179.719 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.471 HG23 ' O ' ' A' ' 150' ' ' LEU . 94.4 t -63.7 -33.68 63.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.096 -179.699 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 155' ' ' TRP . . . . . 0.551 ' C ' ' HE ' ' A' ' 156' ' ' ARG . 9.5 m0 -62.3 -49.69 74.64 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.647 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 156' ' ' ARG . . . . . 0.601 ' HE ' ' N ' ' A' ' 156' ' ' ARG . 0.0 OUTLIER -71.02 -32.63 69.44 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.871 -179.639 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 157' ' ' ASP . . . . . 0.56 ' OD2' ' CE2' ' A' ' 153' ' ' TYR . 2.6 m-20 -74.85 -47.85 28.12 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.823 -179.785 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 1.5 t30 . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.61 -179.947 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.644 ' O ' HG23 ' A' ' 9' ' ' VAL . 1.3 t-105 . . . . . 0 CA--C 1.528 0.101 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.465 ' N ' ' CD ' ' A' ' 7' ' ' PRO . 1.0 OUTLIER -59.38 -42.08 90.59 Favored Pre-proline 0 CA--C 1.537 0.464 0 C-N-CA 120.564 -0.454 . . . . 0.0 110.492 -179.439 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.465 ' CD ' ' N ' ' A' ' 6' ' ' VAL . 23.0 Cg_exo -64.9 -65.91 0.05 OUTLIER 'Trans proline' 0 N--CA 1.493 1.498 0 C-N-CA 120.909 1.072 . . . . 0.0 111.611 179.498 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.728 ' O ' HG23 ' A' ' 12' ' ' THR . . . -47.46 -37.74 12.29 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.208 -179.581 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.644 HG23 ' O ' ' A' ' 5' ' ' TRP . 42.4 t -63.12 -62.08 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 C-N-CA 121.048 -0.261 . . . . 0.0 111.404 -179.337 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -58.25 -49.85 72.0 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 110.858 -0.897 . . . . 0.0 110.858 -179.667 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 10.8 mp -59.08 -27.8 65.88 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.596 0.236 . . . . 0.0 110.65 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.728 HG23 ' O ' ' A' ' 8' ' ' ALA . 13.5 p -83.0 -20.73 34.54 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.783 -0.367 . . . . 0.0 110.238 179.566 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 9.3 mt -80.35 -26.42 38.7 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 179.343 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 18.9 t -54.95 -57.38 19.77 Favored Pre-proline 0 CA--C 1.533 0.305 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.033 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -55.84 -10.46 4.04 Favored 'Trans proline' 0 N--CA 1.497 1.711 0 C-N-CA 120.754 0.969 . . . . 0.0 111.651 179.503 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.488 ' N ' ' OH ' ' A' ' 57' ' ' TYR . 1.8 t -74.61 -33.63 62.63 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.19 179.708 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 32.1 mt -73.58 -39.42 64.67 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.63 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -77.04 -49.91 7.23 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 111.263 -0.735 . . . . 0.0 111.263 -179.685 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -62.58 -34.69 90.28 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 111.306 -0.717 . . . . 0.0 111.306 -179.774 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 81.8 t80 -73.36 -60.1 2.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.742 0.306 . . . . 0.0 111.102 -179.462 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 32.4 tpp -61.6 -20.9 63.84 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.74 -179.768 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.525 ' C ' ' CZ2' ' A' ' 95' ' ' TRP . . . -75.13 -63.76 2.45 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 111.656 -0.577 . . . . 0.0 111.656 -179.533 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.44 ' O ' HG22 ' A' ' 26' ' ' VAL . . . -66.3 -16.43 64.03 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.706 -0.397 . . . . 0.0 110.817 -179.474 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 54.2 t80 -48.67 -24.41 1.36 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.111 0.481 . . . . 0.0 110.004 179.472 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 55.2 t80 -70.1 -50.73 37.91 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.947 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.44 HG22 ' O ' ' A' ' 23' ' ' ALA . 22.8 m -74.6 -13.29 15.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.877 -179.664 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 8.9 ttt85 -55.7 -41.45 73.78 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.893 -179.795 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -122.51 -57.99 0.2 Allowed Glycine 0 CA--C 1.526 0.746 0 N-CA-C 111.444 -0.663 . . . . 0.0 111.444 -179.585 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 20.8 tp10 -56.35 -23.0 34.62 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.709 0.29 . . . . 0.0 110.796 -179.664 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -76.62 -53.69 5.34 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 111.072 -0.811 . . . . 0.0 111.072 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.414 HD12 ' N ' ' A' ' 31' ' ' LEU . 9.9 mp -56.39 -24.94 48.01 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.774 0.321 . . . . 0.0 110.424 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 71.1 ttt180 -81.55 -52.57 7.07 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.352 179.704 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -46.59 -36.06 6.51 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.962 179.709 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 27.1 t80 -47.81 -38.82 16.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.599 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -63.51 -24.61 67.89 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.797 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -89.32 -72.08 1.26 Allowed Glycine 0 CA--C 1.526 0.728 0 N-CA-C 110.981 -0.848 . . . . 0.0 110.981 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.573 ' O ' HD12 ' A' ' 37' ' ' LEU . 0.3 OUTLIER -95.69 167.17 11.44 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.761 0.315 . . . . 0.0 110.672 179.602 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 47.2 mm-40 -80.91 112.65 18.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.0 -179.502 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.543 ' NZ ' ' CZ3' ' A' ' 107' ' ' TRP . 12.0 mtpt -129.79 156.54 78.76 Favored Pre-proline 0 N--CA 1.463 0.213 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.214 179.535 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo . . . . . 0 C--N 1.309 -1.531 0 C-N-CA 121.578 1.518 . . . . 0.0 111.189 179.072 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.81 ' O ' HG23 ' A' ' 52' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--O 1.224 -0.241 0 N-CA-C 111.884 0.327 . . . . 0.0 111.884 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.609 ' C ' ' H ' ' A' ' 52' ' ' ILE . . . -38.74 -31.04 0.19 Allowed Pre-proline 0 C--O 1.234 0.257 0 C-N-CA 120.751 -0.38 . . . . 0.0 111.311 -179.133 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.439 ' HD2' ' N ' ' A' ' 50' ' ' ALA . 46.6 Cg_exo -54.19 5.18 0.04 OUTLIER 'Trans proline' 0 C--N 1.31 -1.471 0 CA-C-N 118.691 0.568 . . . . 0.0 112.422 178.2 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.81 HG23 ' O ' ' A' ' 49' ' ' LEU . 10.4 pt -54.29 -39.2 42.49 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.258 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 179.344 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.621 ' O ' ' CD1' ' A' ' 57' ' ' TYR . 65.7 m95 -69.32 -24.45 63.92 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.746 -179.583 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -67.83 -53.2 24.65 Favored Glycine 0 CA--C 1.527 0.836 0 N-CA-C 110.013 -1.235 . . . . 0.0 110.013 179.002 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 18.6 m -60.02 -54.73 42.56 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.623 0.249 . . . . 0.0 110.581 179.611 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.408 ' O ' ' SD ' ' A' ' 60' ' ' MET . 88.5 mt -55.82 -47.96 76.27 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.254 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.621 ' CD1' ' O ' ' A' ' 53' ' ' TRP . 3.6 m-30 -46.19 -47.13 17.79 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 179.31 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 7.0 t -56.77 -57.28 13.14 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.215 179.479 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -48.7 -50.06 35.1 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.183 179.682 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.408 ' SD ' ' O ' ' A' ' 56' ' ' LEU . 0.0 OUTLIER -52.05 -50.56 61.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.368 179.828 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -49.13 -48.96 31.46 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 111.338 -0.705 . . . . 0.0 111.338 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -62.17 -59.93 4.32 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.849 0.357 . . . . 0.0 110.85 -179.631 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.452 ' O ' HG23 ' A' ' 67' ' ' VAL . . . -47.47 -56.02 8.67 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 110.93 -0.868 . . . . 0.0 110.93 -179.841 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.588 ' O ' ' CD1' ' A' ' 68' ' ' TRP . 0.0 OUTLIER -45.64 -55.28 6.57 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.898 0.38 . . . . 0.0 110.664 -179.929 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.501 ' OH ' ' NZ ' ' A' ' 69' ' ' LYS . 69.1 t80 -49.73 -40.0 39.27 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.804 -179.674 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 77.4 mt -69.3 -54.84 17.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.257 -179.473 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.509 ' CG1' ' CZ3' ' A' ' 68' ' ' TRP . 18.8 t -46.16 -61.23 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.857 0.36 . . . . 0.0 111.257 -179.39 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' TRP . . . . . 0.588 ' CD1' ' O ' ' A' ' 64' ' ' SER . 0.9 OUTLIER -60.68 -42.31 96.84 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.485 -179.124 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.501 ' NZ ' ' OH ' ' A' ' 65' ' ' TYR . 5.8 mmmt -59.13 -31.92 69.39 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.979 -0.288 . . . . 0.0 111.052 -179.697 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 24.2 tp10 -74.81 -62.28 1.59 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.037 -179.366 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.739 ' C ' HD12 ' A' ' 71' ' ' LEU . 3.4 pp -64.33 -8.58 13.54 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.239 -179.344 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.655 ' N ' HD12 ' A' ' 71' ' ' LEU . . . 110.35 77.51 0.93 Allowed Glycine 0 CA--C 1.527 0.826 0 C-N-CA 121.014 -0.612 . . . . 0.0 111.98 179.359 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.511 ' N ' ' O ' ' A' ' 68' ' ' TRP . . . 41.56 -173.57 0.01 OUTLIER Glycine 0 CA--C 1.526 0.749 0 C-N-CA 121.504 -0.379 . . . . 0.0 112.165 178.842 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 36.0 t80 -74.48 113.05 11.27 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.382 -0.409 . . . . 0.0 110.715 -179.679 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.569 ' OG1' ' N ' ' A' ' 76' ' ' GLU . 0.4 OUTLIER -142.38 -175.02 4.29 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.256 179.713 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.569 ' N ' ' OG1' ' A' ' 75' ' ' THR . 2.7 mp0 -55.08 -34.22 63.45 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.916 0.389 . . . . 0.0 110.4 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -66.29 -33.06 74.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.67 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.494 ' O ' HD12 ' A' ' 82' ' ' LEU . . . -83.91 -19.09 35.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.046 0.45 . . . . 0.0 110.748 -179.82 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 65.0 mmm -68.93 -27.07 65.43 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.22 -179.344 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.4 ' N ' ' HD2' ' A' ' 81' ' ' PRO . 6.0 t -67.45 -43.51 42.48 Favored Pre-proline 0 C--N 1.329 -0.322 0 C-N-CA 120.673 -0.411 . . . . 0.0 110.413 179.781 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.4 ' HD2' ' N ' ' A' ' 80' ' ' VAL . 9.3 Cg_endo -76.31 -52.18 0.09 OUTLIER 'Trans proline' 0 N--CA 1.496 1.673 0 C-N-CA 121.047 1.165 . . . . 0.0 111.508 178.643 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.494 HD12 ' O ' ' A' ' 78' ' ' ALA . 5.5 mt -56.03 -47.14 78.39 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.277 179.71 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -68.28 -63.83 3.4 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 111.318 -0.713 . . . . 0.0 111.318 -179.517 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.4 HD23 ' CD1' ' A' ' 124' ' ' LEU . 38.5 tp -47.91 -23.79 0.86 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.941 0.4 . . . . 0.0 110.57 -179.708 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 11.8 t80 -74.8 -55.57 5.68 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.009 -179.798 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 1.9 t -68.53 -33.22 73.73 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.903 -0.319 . . . . 0.0 111.479 -179.282 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -71.6 -57.85 5.74 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 111.205 -0.758 . . . . 0.0 111.205 -179.612 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 29.2 tp60 -59.57 -43.85 93.49 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 11.1 tp -58.13 -38.57 76.8 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 179.241 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.816 ' O ' ' HB2' ' A' ' 94' ' ' ALA . . . -58.36 -64.48 0.9 Allowed 'General case' 0 C--N 1.319 -0.754 0 C-N-CA 120.062 -0.655 . . . . 0.0 110.435 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.476 ' N ' HD23 ' A' ' 91' ' ' LEU . 6.2 mt -58.69 -56.48 21.64 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 -178.688 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -66.43 -62.12 1.63 Allowed 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -177.755 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' TRP . . . . . 0.596 ' CD1' ' C ' ' A' ' 93' ' ' TRP . 0.0 OUTLIER -63.54 -16.89 62.05 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 -177.913 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.816 ' HB2' ' O ' ' A' ' 90' ' ' ALA . . . -54.63 82.19 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 120.286 -0.566 . . . . 0.0 109.868 179.155 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.688 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 19.8 p-90 -100.81 -15.71 0.18 Allowed Pre-proline 0 CA--C 1.533 0.307 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -179.488 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.688 ' CD ' ' N ' ' A' ' 95' ' ' TRP . 52.9 Cg_exo -61.08 -15.22 37.97 Favored 'Trans proline' 0 N--CA 1.497 1.7 0 C-N-CA 120.471 0.781 . . . . 0.0 113.403 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.614 ' CD ' ' N ' ' A' ' 96' ' ' PRO . 31.6 Cg_exo -87.08 -0.38 7.77 Favored 'Trans proline' 0 N--CA 1.5 1.867 0 C-N-CA 120.659 0.906 . . . . 0.0 112.928 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 1.3 pp -91.86 25.19 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 C-N-CA 120.73 -0.388 . . . . 0.0 110.833 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.528 ' CD1' ' O ' ' A' ' 96' ' ' PRO . 3.0 m-85 -46.8 -34.46 5.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.167 179.687 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -63.13 -27.39 69.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.786 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -95.73 -13.52 50.19 Favored Glycine 0 CA--C 1.526 0.743 0 N-CA-C 110.902 -0.879 . . . . 0.0 110.902 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -70.49 -6.73 38.2 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.613 0.244 . . . . 0.0 111.018 -179.701 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 15.5 ptt180 -97.97 -10.08 25.08 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.065 -179.756 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' GLN . . . . . 0.438 ' C ' ' N ' ' A' ' 106' ' ' GLY . 3.2 pt20 -125.49 168.94 12.93 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.832 0.348 . . . . 0.0 110.781 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 9.8 mmt -45.19 -20.2 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.679 -179.849 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.438 ' N ' ' C ' ' A' ' 104' ' ' GLN . . . -62.26 -15.69 51.94 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 111.102 -0.799 . . . . 0.0 111.102 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' TRP . . . . . 0.543 ' CZ3' ' NZ ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -50.2 -13.42 0.11 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.742 0.306 . . . . 0.0 110.702 -179.596 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.468 ' N ' ' CD1' ' A' ' 107' ' ' TRP . . . -64.73 -19.58 65.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.075 0.464 . . . . 0.0 110.105 179.638 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 8.2 mt -57.04 -26.04 59.64 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.531 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -59.4 -58.66 7.62 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.569 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.709 ' O ' HG23 ' A' ' 115' ' ' VAL . 1.3 p30 -62.07 -52.21 64.84 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.303 -179.617 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.524 ' N ' ' CG ' ' A' ' 111' ' ' ASP . 31.7 tp -54.95 -37.4 66.42 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.919 -0.313 . . . . 0.0 111.618 -179.099 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 49.4 mt -72.8 -61.57 1.76 Allowed 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -178.714 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.5 pp -59.66 -32.52 70.54 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 120.24 -0.584 . . . . 0.0 110.955 -179.047 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.709 HG23 ' O ' ' A' ' 111' ' ' ASP . 53.5 t -64.16 -60.14 3.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.405 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' SER . . . . . 0.485 ' O ' ' OG1' ' A' ' 120' ' ' THR . 50.3 m -68.41 -28.31 66.97 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.555 -178.84 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -63.08 -62.24 5.63 Favored Glycine 0 CA--C 1.526 0.759 0 C-N-CA 120.973 -0.632 . . . . 0.0 111.769 -179.348 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.571 ' O ' HG23 ' A' ' 122' ' ' THR . 9.3 p -70.94 -37.99 70.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 111.667 0.247 . . . . 0.0 111.667 -179.231 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.508 ' O ' ' OG1' ' A' ' 123' ' ' THR . . . -68.25 -60.8 2.19 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.446 -0.502 . . . . 0.0 111.002 -179.404 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.485 ' OG1' ' O ' ' A' ' 116' ' ' SER . 3.7 m -56.35 -55.87 28.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.44 -179.49 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -51.58 -43.92 62.61 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.404 -179.391 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.571 HG23 ' O ' ' A' ' 118' ' ' VAL . 41.4 p -71.91 -25.25 61.84 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.054 0.39 . . . . 0.0 112.054 -178.943 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.508 ' OG1' ' O ' ' A' ' 119' ' ' ALA . 0.2 OUTLIER -69.28 -49.99 51.0 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.631 -0.428 . . . . 0.0 110.516 -179.636 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.4 ' CD1' HD23 ' A' ' 84' ' ' LEU . 2.4 pp -79.34 -19.94 49.05 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.246 -179.475 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -89.77 -67.37 0.85 Allowed 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.734 0.642 . . . . 0.0 112.734 -178.718 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' TRP . . . . . 0.458 ' CD1' ' N ' ' A' ' 126' ' ' TRP . 34.1 m0 -84.82 -57.54 3.07 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 112.87 0.693 . . . . 0.0 112.87 -177.785 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' HIS . . . . . 0.657 ' CD2' ' HB2' ' A' ' 134' ' ' ALA . 9.6 m170 -53.98 -22.29 10.08 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.731 -0.388 . . . . 0.0 111.517 -178.703 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 29.2 ttt85 -73.76 -46.47 45.5 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.822 -0.351 . . . . 0.0 111.416 -179.474 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 39.1 t -81.36 -40.62 18.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.73 0.3 . . . . 0.0 111.313 -179.229 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 3.6 t -138.38 121.66 11.15 Favored Pre-proline 0 CA--C 1.536 0.428 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.541 -179.634 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' PRO . . . . . 0.612 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 83.4 Cg_exo -73.61 -48.35 0.25 Allowed 'Trans proline' 0 N--CA 1.493 1.488 0 C-N-CA 121.32 1.347 . . . . 0.0 113.212 179.529 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 132' ' ' PRO . . . . . 0.612 ' CD ' ' N ' ' A' ' 131' ' ' PRO . 31.2 Cg_exo -33.63 -55.97 0.41 Allowed 'Trans proline' 0 N--CA 1.497 1.73 0 C-N-CA 121.583 1.522 . . . . 0.0 112.177 -179.222 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -47.48 -46.69 27.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.862 0.363 . . . . 0.0 110.384 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' ALA . . . . . 0.657 ' HB2' ' CD2' ' A' ' 127' ' ' HIS . . . -55.21 -22.72 18.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.406 179.815 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 10.2 tpt180 -77.28 -29.63 53.88 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-O 120.937 0.399 . . . . 0.0 110.342 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 39.4 mt -75.92 -33.97 59.88 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 179.604 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.461 ' O ' ' CD1' ' A' ' 140' ' ' TYR . 4.3 mt -85.56 -23.31 27.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.341 179.778 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.551 ' CD1' ' C ' ' A' ' 138' ' ' TYR . 0.3 OUTLIER -36.65 -53.9 1.74 Allowed Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.323 -179.881 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.429 ' HD2' ' N ' ' A' ' 138' ' ' TYR . 8.2 Cg_endo -60.79 3.41 0.29 Allowed 'Trans proline' 0 N--CA 1.498 1.755 0 C-N-CA 121.481 1.454 . . . . 0.0 113.057 -179.415 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 140' ' ' TYR . . . . . 0.496 ' CE2' HD11 ' A' ' 144' ' ' LEU . 0.1 OUTLIER -82.79 -14.3 54.67 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.489 -0.484 . . . . 0.0 110.954 -179.96 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 86.8 mt -59.14 -25.25 63.72 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 178.825 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -64.13 -39.84 94.89 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.631 179.224 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' TRP . . . . . 0.714 ' CE2' HD12 ' A' ' 52' ' ' ILE . 11.6 t-105 -70.08 -40.78 74.81 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.723 179.441 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.531 HD13 HG13 ' A' ' 115' ' ' VAL . 10.3 mt -62.48 -42.02 99.2 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 120.403 -0.519 . . . . 0.0 109.712 179.739 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.68 ' O ' HG23 ' A' ' 149' ' ' VAL . . . -73.03 -21.91 60.73 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.776 179.268 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 32.2 t80 -64.85 -58.58 5.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.481 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -68.5 -44.15 75.34 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.567 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' THR . . . . . 0.638 ' O ' ' ND2' ' A' ' 151' ' ' ASN . 51.3 m -57.27 -37.3 72.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.411 179.851 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.68 HG23 ' O ' ' A' ' 145' ' ' ALA . 55.0 t -75.8 -30.2 21.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.416 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 2.3 tp -61.39 -57.49 12.04 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 179.694 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 151' ' ' ASN . . . . . 0.638 ' ND2' ' O ' ' A' ' 148' ' ' THR . 0.5 OUTLIER -63.81 -42.36 97.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.632 179.891 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 152' ' ' TYR . . . . . 0.507 ' N ' HD21 ' A' ' 151' ' ' ASN . 60.8 t80 -56.65 -45.86 81.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.552 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 9.5 t80 -63.18 -36.72 84.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.477 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 55.5 t -67.36 -34.0 66.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.632 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 155' ' ' TRP . . . . . . . . . . . . . 10.9 m0 -68.7 -41.12 79.57 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.791 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -72.63 -35.61 67.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.865 -179.659 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -75.18 -43.03 54.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.878 -179.571 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 158' ' ' ASN . . . . . 0.402 ' OD1' ' N ' ' A' ' 158' ' ' ASN . 1.5 m-20 . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.872 -179.711 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.724 ' O ' HG23 ' A' ' 9' ' ' VAL . 0.5 OUTLIER . . . . . 0 CA--C 1.53 0.192 0 CA-C-O 120.651 0.262 . . . . 0.0 110.301 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.619 ' N ' ' CD ' ' A' ' 7' ' ' PRO . 1.0 OUTLIER -63.68 -38.71 40.53 Favored Pre-proline 0 CA--C 1.533 0.289 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 179.927 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.619 ' CD ' ' N ' ' A' ' 6' ' ' VAL . 15.4 Cg_exo -66.9 -66.18 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 121.891 1.727 . . . . 0.0 111.735 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.721 ' O ' HG23 ' A' ' 12' ' ' THR . . . -47.65 -40.63 20.28 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.173 -179.76 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.724 HG23 ' O ' ' A' ' 5' ' ' TRP . 59.2 t -61.11 -61.86 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.238 -179.354 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -57.88 -51.75 56.34 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 111.495 -0.642 . . . . 0.0 111.495 -179.55 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 9.4 mp -57.78 -31.81 66.91 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.572 0.225 . . . . 0.0 110.96 -179.666 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.721 HG23 ' O ' ' A' ' 8' ' ' ALA . 16.8 p -77.33 -24.81 50.75 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.862 0.363 . . . . 0.0 110.121 179.639 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.427 ' O ' ' CB ' ' A' ' 16' ' ' SER . 6.2 mt -80.12 -27.32 39.17 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.363 179.811 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 4.5 t -48.55 -59.64 5.81 Favored Pre-proline 0 CA--C 1.535 0.38 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.718 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -54.98 -12.38 4.85 Favored 'Trans proline' 0 N--CA 1.498 1.746 0 C-N-CA 121.056 1.171 . . . . 0.0 111.96 179.767 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.427 ' CB ' ' O ' ' A' ' 13' ' ' LEU . 1.6 t -73.5 -30.49 63.16 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.66 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 59.5 mt -74.3 -56.73 4.54 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.664 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -64.83 -34.3 89.52 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 110.802 -0.919 . . . . 0.0 110.802 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -74.88 -28.51 62.59 Favored Glycine 0 CA--C 1.521 0.433 0 N-CA-C 110.614 -0.994 . . . . 0.0 110.614 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 48.8 t80 -74.99 -60.43 2.29 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 110.177 -0.305 . . . . 0.0 110.177 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 19.2 ttp -65.53 -25.1 67.29 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.397 179.749 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.471 ' C ' ' CZ2' ' A' ' 95' ' ' TRP . . . -68.2 -62.13 4.39 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 110.819 -0.912 . . . . 0.0 110.819 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.482 ' O ' HG22 ' A' ' 26' ' ' VAL . . . -70.62 -16.62 62.85 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.993 -0.283 . . . . 0.0 110.397 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 68.5 t80 -47.81 -24.49 0.99 Allowed 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 179.403 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.451 ' CD1' ' C ' ' A' ' 25' ' ' PHE . 22.8 t80 -67.99 -53.57 25.01 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.667 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.482 HG22 ' O ' ' A' ' 23' ' ' ALA . 34.1 m -71.43 -13.46 16.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.702 -179.736 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.424 HH21 ' HA3' ' A' ' 28' ' ' GLY . 1.3 ttp180 -63.31 -46.16 87.97 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.992 -179.758 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.424 ' HA3' HH21 ' A' ' 27' ' ' ARG . . . -105.42 -77.99 1.17 Allowed Glycine 0 CA--C 1.525 0.696 0 N-CA-C 111.197 -0.761 . . . . 0.0 111.197 -179.676 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 53.3 tt0 -44.42 -23.08 0.09 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.698 0.285 . . . . 0.0 110.808 -179.628 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -66.51 -58.49 8.48 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 110.989 -0.845 . . . . 0.0 110.989 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 11.1 mt -51.99 -21.74 3.36 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.836 0.35 . . . . 0.0 110.365 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 16.2 tpp180 -84.79 -54.03 4.95 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.524 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' TRP . . . . . 0.428 ' O ' ' N ' ' A' ' 36' ' ' GLY . 0.4 OUTLIER -44.95 -46.77 11.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.551 -179.756 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 46.5 t80 -47.23 -35.58 7.82 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.9 0.381 . . . . 0.0 110.373 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.61 -25.33 68.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.354 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.428 ' N ' ' O ' ' A' ' 33' ' ' TRP . . . -92.72 -68.74 1.12 Allowed Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.892 -0.883 . . . . 0.0 110.892 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.575 ' O ' HD12 ' A' ' 37' ' ' LEU . 0.3 OUTLIER -95.75 166.18 11.94 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.793 0.33 . . . . 0.0 110.583 179.712 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.624 ' CD ' ' H ' ' A' ' 38' ' ' GLN . 0.5 OUTLIER -86.63 113.0 22.15 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.861 -179.578 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.638 ' NZ ' ' CZ3' ' A' ' 107' ' ' TRP . 22.1 mtpt -129.13 156.71 77.79 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.197 179.812 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo . . . . . 0 C--N 1.307 -1.654 0 C-N-CA 121.814 1.676 . . . . 0.0 110.803 178.822 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.749 ' O ' HG23 ' A' ' 52' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.466 0.372 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.646 ' C ' ' H ' ' A' ' 52' ' ' ILE . . . -37.83 -31.0 0.15 Allowed Pre-proline 0 C--O 1.237 0.402 0 C-N-CA 121.113 -0.235 . . . . 0.0 111.218 -179.04 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.433 ' HD2' ' N ' ' A' ' 50' ' ' ALA . 32.9 Cg_exo -55.62 8.99 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.659 0 CA-C-N 118.425 0.473 . . . . 0.0 112.204 178.11 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.749 HG23 ' O ' ' A' ' 49' ' ' LEU . 12.1 pt -55.71 -27.36 21.73 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 178.939 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 3.2 m0 -64.62 -30.02 71.03 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.783 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -72.98 -46.93 26.72 Favored Glycine 0 CA--C 1.522 0.519 0 N-CA-C 111.027 -0.829 . . . . 0.0 111.027 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 91.2 m -61.53 -53.37 57.28 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.74 0.305 . . . . 0.0 110.59 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 57.5 mt -64.91 -28.68 69.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.506 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.528 ' CD1' ' C ' ' A' ' 57' ' ' TYR . 1.6 t80 -63.6 -41.62 98.32 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 179.455 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 26.1 t -68.02 -49.43 61.55 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.42 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.67 -46.07 88.02 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.758 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.498 ' HG2' HD21 ' A' ' 137' ' ' LEU . 21.3 mtm -65.45 -33.14 75.25 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.31 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -63.35 -49.68 68.49 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 111.324 -0.71 . . . . 0.0 111.324 -179.663 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -63.15 -60.06 3.93 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 121.07 -0.252 . . . . 0.0 110.739 -179.652 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.484 ' O ' HG23 ' A' ' 67' ' ' VAL . . . -52.58 -52.08 39.94 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 110.811 -0.916 . . . . 0.0 110.811 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.442 ' OG ' ' O ' ' A' ' 60' ' ' MET . 34.2 p -48.14 -56.64 7.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.087 0.47 . . . . 0.0 110.831 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 68.0 t80 -51.38 -37.4 48.0 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.196 -179.704 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 56.6 mt -71.44 -37.09 63.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.165 -179.548 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.484 HG23 ' O ' ' A' ' 63' ' ' GLY . 49.1 t -59.48 -52.09 65.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 C-N-CA 120.735 -0.386 . . . . 0.0 110.598 -179.694 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' TRP . . . . . 0.59 ' O ' ' N ' ' A' ' 73' ' ' GLY . 0.9 OUTLIER -64.7 -44.72 89.36 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.859 -179.878 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.25 -23.08 63.81 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.862 -0.335 . . . . 0.0 110.725 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -79.67 -62.81 1.57 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.667 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.73 ' C ' HD12 ' A' ' 71' ' ' LEU . 2.8 pp -65.67 -6.8 12.45 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.161 -179.661 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.684 ' N ' HD12 ' A' ' 71' ' ' LEU . . . 109.69 72.09 0.7 Allowed Glycine 0 CA--C 1.527 0.822 0 N-CA-C 111.511 -0.636 . . . . 0.0 111.511 179.7 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.59 ' N ' ' O ' ' A' ' 68' ' ' TRP . . . 46.58 -174.15 0.01 OUTLIER Glycine 0 CA--C 1.526 0.768 0 N-CA-C 111.761 -0.536 . . . . 0.0 111.761 179.532 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 41.2 t80 -77.28 111.99 13.52 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.884 0.373 . . . . 0.0 111.03 -179.584 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.547 ' OG1' ' N ' ' A' ' 76' ' ' GLU . 0.0 OUTLIER -142.54 -179.99 6.63 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.254 179.468 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.547 ' N ' ' OG1' ' A' ' 75' ' ' THR . 7.4 pt-20 -51.57 -23.53 4.29 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.401 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -72.9 -36.95 67.41 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.757 -179.878 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.44 ' O ' HD12 ' A' ' 82' ' ' LEU . . . -81.63 -22.1 37.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.975 0.417 . . . . 0.0 110.824 -179.813 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 73.0 mmm -61.56 -26.07 67.72 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.177 -179.468 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 14.8 t -68.09 -46.36 41.09 Favored Pre-proline 0 CA--C 1.534 0.338 0 C-N-CA 120.511 -0.476 . . . . 0.0 110.619 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_endo -74.66 -54.76 0.09 OUTLIER 'Trans proline' 0 N--CA 1.497 1.717 0 C-N-CA 120.953 1.102 . . . . 0.0 111.517 178.664 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.44 HD12 ' O ' ' A' ' 78' ' ' ALA . 3.2 mt -50.99 -55.25 18.26 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.534 179.685 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.455 ' O ' ' N ' ' A' ' 86' ' ' THR . . . -64.51 -63.87 3.98 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 111.488 -0.645 . . . . 0.0 111.488 -179.157 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.4 HD12 ' HA ' ' A' ' 84' ' ' LEU . 43.2 tp -43.91 -29.71 0.6 Allowed 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.664 -0.415 . . . . 0.0 109.92 -179.858 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 13.3 t80 -75.4 -42.83 52.87 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.843 179.518 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.455 ' N ' ' O ' ' A' ' 83' ' ' GLY . 1.4 m -66.86 -56.65 9.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.799 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -58.92 -55.36 31.33 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 111.401 -0.679 . . . . 0.0 111.401 -179.628 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.424 ' O ' ' CB ' ' A' ' 92' ' ' ASN . 9.6 tp-100 -55.47 -42.87 74.91 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 121.001 -0.28 . . . . 0.0 110.89 -179.572 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.42 ' O ' ' CD1' ' A' ' 93' ' ' TRP . 10.4 tp -66.04 -31.38 72.24 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.903 -0.319 . . . . 0.0 110.383 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.834 ' O ' ' HB2' ' A' ' 94' ' ' ALA . . . -65.87 -65.83 0.63 Allowed 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 120.314 -0.554 . . . . 0.0 111.182 -179.561 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.4 pp -66.0 -34.35 77.88 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.157 0.428 . . . . 0.0 112.157 -179.001 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.424 ' CB ' ' O ' ' A' ' 88' ' ' GLN . 47.5 t30 -78.39 -61.34 2.04 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.862 -0.335 . . . . 0.0 111.826 -178.811 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' TRP . . . . . 0.613 ' O ' ' N ' ' A' ' 95' ' ' TRP . 0.0 OUTLIER -68.96 -13.32 62.37 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.906 -0.318 . . . . 0.0 111.527 -178.543 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.834 ' HB2' ' O ' ' A' ' 90' ' ' ALA . . . -52.77 80.76 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 120.663 -0.415 . . . . 0.0 109.913 179.38 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.706 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 32.8 p-90 -98.18 -16.95 0.2 Allowed Pre-proline 0 CA--C 1.535 0.39 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -179.389 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.706 ' CD ' ' N ' ' A' ' 95' ' ' TRP . 51.4 Cg_exo -54.51 -40.86 81.69 Favored 'Trans proline' 0 N--CA 1.496 1.632 0 C-N-CA 120.537 0.825 . . . . 0.0 113.03 179.562 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.459 ' HD2' ' N ' ' A' ' 96' ' ' PRO . 41.9 Cg_exo -36.69 -31.31 0.1 Allowed 'Trans proline' 0 N--CA 1.492 1.41 0 CA-C-N 118.98 0.671 . . . . 0.0 112.777 -179.776 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.45 ' N ' ' O ' ' A' ' 96' ' ' PRO . 1.1 pp -83.63 22.19 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.427 179.797 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.581 ' N ' ' O ' ' A' ' 96' ' ' PRO . 22.3 t80 -44.71 -41.63 6.96 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.463 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 48.9 m-85 -83.89 -40.92 18.0 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.529 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -58.0 -14.1 16.24 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 111.006 -0.838 . . . . 0.0 111.006 -179.767 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -65.05 -7.26 11.22 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.801 0.334 . . . . 0.0 110.472 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 15.3 ptt180 -82.14 4.78 21.9 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.602 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 5.6 mt-30 -122.41 164.92 17.16 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.247 179.757 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -59.94 -17.06 34.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.328 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.608 ' O ' ' N ' ' A' ' 108' ' ' ALA . . . -66.62 -14.62 62.88 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 111.203 -0.759 . . . . 0.0 111.203 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' TRP . . . . . 0.638 ' CZ3' ' NZ ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -41.25 -15.37 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.716 0.294 . . . . 0.0 111.031 -179.366 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.608 ' N ' ' O ' ' A' ' 106' ' ' GLY . . . -58.77 -27.2 64.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.935 0.398 . . . . 0.0 110.435 179.72 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 9.3 mt -46.46 -29.01 1.55 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.444 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -60.22 -63.63 1.23 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.759 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.674 ' O ' HG23 ' A' ' 115' ' ' VAL . 1.4 p30 -55.07 -51.88 64.97 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.781 -179.269 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.613 HD13 ' O ' ' A' ' 112' ' ' LEU . 0.2 OUTLIER -58.52 -45.11 89.49 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.103 0.409 . . . . 0.0 112.103 -178.539 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 57.2 mt -64.74 -55.27 20.91 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -178.202 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.3 pp -68.06 -33.55 74.78 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 120.455 -0.498 . . . . 0.0 111.703 -178.746 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.674 HG23 ' O ' ' A' ' 111' ' ' ASP . 38.7 t -62.22 -54.37 35.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.736 0.303 . . . . 0.0 111.186 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' SER . . . . . 0.483 ' O ' ' OG1' ' A' ' 120' ' ' THR . 39.0 t -75.3 -23.93 57.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.093 -179.353 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -62.74 -62.46 5.51 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 111.186 -0.765 . . . . 0.0 111.186 -179.727 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.562 ' O ' HG23 ' A' ' 122' ' ' THR . 7.3 p -71.93 -37.92 62.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 111.57 0.211 . . . . 0.0 111.57 -179.547 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.518 ' O ' ' OG1' ' A' ' 123' ' ' THR . . . -68.41 -61.0 2.03 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.281 -0.568 . . . . 0.0 111.075 -179.234 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.483 ' OG1' ' O ' ' A' ' 116' ' ' SER . 2.7 m -56.7 -53.33 58.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.257 -179.541 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.41 ' O ' ' CB ' ' A' ' 125' ' ' ALA . . . -54.36 -40.84 68.47 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.455 -179.256 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.562 HG23 ' O ' ' A' ' 118' ' ' VAL . 37.6 p -74.88 -29.17 60.92 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 111.872 0.323 . . . . 0.0 111.872 -179.034 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.518 ' OG1' ' O ' ' A' ' 119' ' ' ALA . 0.1 OUTLIER -65.71 -47.59 74.85 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.594 -0.442 . . . . 0.0 110.683 -179.639 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.4 pp -83.98 -19.4 34.64 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.373 -179.15 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.41 ' CB ' ' O ' ' A' ' 121' ' ' ALA . . . -89.74 -67.55 0.84 Allowed 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.497 0.555 . . . . 0.0 112.497 -178.589 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 126' ' ' TRP . . . . . 0.433 ' CD1' ' N ' ' A' ' 126' ' ' TRP . 39.3 m0 -84.36 -57.66 3.07 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 112.662 0.616 . . . . 0.0 112.662 -177.942 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' HIS . . . . . 0.57 ' CG ' ' HB2' ' A' ' 134' ' ' ALA . 9.3 m170 -54.51 -22.48 13.06 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.865 -0.334 . . . . 0.0 111.115 -178.702 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 22.4 ttt180 -68.44 -38.97 81.65 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.755 0.312 . . . . 0.0 110.994 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 25.9 t -92.67 -47.89 13.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.31 -179.388 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -125.57 117.33 24.75 Favored Pre-proline 0 CA--C 1.535 0.374 0 CA-C-N 116.575 -0.284 . . . . 0.0 111.048 -179.385 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 131' ' ' PRO . . . . . 0.647 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 88.4 Cg_exo -75.03 -38.43 1.58 Allowed 'Trans proline' 0 N--CA 1.492 1.424 0 C-N-CA 121.454 1.436 . . . . 0.0 112.646 179.074 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 132' ' ' PRO . . . . . 0.647 ' CD ' ' N ' ' A' ' 131' ' ' PRO . 37.9 Cg_exo -46.98 -46.24 19.22 Favored 'Trans proline' 0 N--CA 1.497 1.688 0 C-N-CA 121.646 1.564 . . . . 0.0 111.983 -179.699 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -57.15 -38.22 73.21 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 179.568 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' ALA . . . . . 0.57 ' HB2' ' CG ' ' A' ' 127' ' ' HIS . . . -62.69 -23.07 66.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.196 179.763 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 9.3 tpp180 -78.5 -37.3 43.51 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.234 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 12.6 mt -69.61 -29.52 67.04 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.241 -0.436 . . . . 0.0 109.867 179.601 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.583 ' O ' ' N ' ' A' ' 140' ' ' TYR . 8.2 mt -84.14 -42.39 16.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.025 179.489 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.491 ' C ' ' O ' ' A' ' 137' ' ' LEU . 1.9 t80 -23.15 -41.39 0.04 OUTLIER Pre-proline 0 N--CA 1.464 0.252 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.753 -179.686 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.574 ' N ' ' O ' ' A' ' 137' ' ' LEU . 12.3 Cg_exo -64.37 7.29 0.24 Allowed 'Trans proline' 0 C--N 1.307 -1.643 0 C-N-CA 120.699 0.933 . . . . 0.0 112.0 179.45 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 140' ' ' TYR . . . . . 0.747 ' CE2' HD11 ' A' ' 144' ' ' LEU . 1.9 p90 -93.13 -13.67 28.19 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.903 -179.862 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.587 HD13 HD12 ' A' ' 144' ' ' LEU . 4.1 mm? -55.94 -26.63 48.74 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 178.299 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -64.28 -49.14 73.0 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.833 179.483 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' TRP . . . . . . . . . . . . . 10.7 t-105 -56.91 -45.84 82.39 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.103 -0.498 . . . . 0.0 109.659 179.375 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.747 HD11 ' CE2' ' A' ' 140' ' ' TYR . 11.5 mt -54.63 -51.15 66.29 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.199 -0.455 . . . . 0.0 109.962 179.504 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.646 ' O ' HG23 ' A' ' 149' ' ' VAL . . . -63.72 -22.16 66.77 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.413 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -67.25 -64.82 0.78 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.61 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -63.94 -41.9 97.48 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.615 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 59.9 m -57.16 -58.68 7.14 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.499 179.821 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.646 HG23 ' O ' ' A' ' 145' ' ' ALA . 89.5 t -55.61 -39.49 54.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.708 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.464 ' O ' HG23 ' A' ' 154' ' ' VAL . 1.6 tp -50.84 -57.49 8.31 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.696 -0.402 . . . . 0.0 110.069 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 151' ' ' ASN . . . . . 0.434 ' ND2' ' CB ' ' A' ' 108' ' ' ALA . 12.1 t30 -53.7 -57.02 12.32 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.706 179.73 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 152' ' ' TYR . . . . . 0.467 ' CZ ' ' NE ' ' A' ' 156' ' ' ARG . 46.5 t80 -48.53 -36.14 14.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.519 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 153' ' ' TYR . . . . . 0.49 ' CE2' ' OD2' ' A' ' 157' ' ' ASP . 8.8 t80 -65.96 -39.52 90.51 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.688 -179.799 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.493 HG22 ' HG2' ' A' ' 39' ' ' LYS . 15.7 t -66.21 -38.02 81.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.002 -179.791 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 155' ' ' TRP . . . . . . . . . . . . . 7.9 m0 -68.17 -39.15 82.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.964 -179.579 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 156' ' ' ARG . . . . . 0.467 ' NE ' ' CZ ' ' A' ' 152' ' ' TYR . 0.9 OUTLIER -77.15 -24.04 51.59 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.808 -0.357 . . . . 0.0 110.071 179.999 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 157' ' ' ASP . . . . . 0.49 ' OD2' ' CE2' ' A' ' 153' ' ' TYR . 98.2 m-20 -86.9 -51.08 6.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.661 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 158' ' ' ASN . . . . . 0.403 ' HA ' HE21 ' A' ' 38' ' ' GLN . 30.2 t-20 . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.831 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.595 ' CD1' ' CE2' ' A' ' 68' ' ' TRP . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.746 0.307 . . . . 0.0 110.238 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.62 ' N ' ' CD ' ' A' ' 7' ' ' PRO . 1.0 OUTLIER -64.2 -33.88 10.33 Favored Pre-proline 0 C--N 1.329 -0.309 0 N-CA-C 109.916 -0.402 . . . . 0.0 109.916 179.942 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.62 ' CD ' ' N ' ' A' ' 6' ' ' VAL . 21.3 Cg_exo -71.61 -67.51 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.626 0 C-N-CA 121.709 1.606 . . . . 0.0 111.899 179.63 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.666 ' O ' HG23 ' A' ' 12' ' ' THR . . . -48.31 -39.16 20.92 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.19 -179.513 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.582 HG23 ' O ' ' A' ' 5' ' ' TRP . 95.9 t -69.98 -62.48 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -179.049 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -55.32 -47.34 75.81 Favored Glycine 0 CA--C 1.526 0.764 0 C-N-CA 121.207 -0.52 . . . . 0.0 111.834 -179.108 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.411 ' N ' ' CD1' ' A' ' 11' ' ' LEU . 6.8 mp -62.5 -38.47 90.05 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.485 0.183 . . . . 0.0 110.805 -179.584 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.666 HG23 ' O ' ' A' ' 8' ' ' ALA . 22.3 p -73.34 -23.53 60.24 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.801 -0.36 . . . . 0.0 110.871 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.55 HD13 ' O ' ' A' ' 9' ' ' VAL . 7.0 mp -82.97 -24.88 32.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.297 -179.749 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.427 ' N ' ' HD2' ' A' ' 15' ' ' PRO . 2.7 t -50.02 -63.16 1.92 Allowed Pre-proline 0 CA--C 1.536 0.442 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.723 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.427 ' HD2' ' N ' ' A' ' 14' ' ' VAL . 24.5 Cg_endo -53.78 -40.08 81.48 Favored 'Trans proline' 0 N--CA 1.498 1.788 0 C-N-CA 120.876 1.05 . . . . 0.0 112.366 -179.462 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.1 t -46.19 -25.68 0.65 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.811 0.338 . . . . 0.0 110.664 -179.717 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 83.1 mt -70.03 -57.94 4.4 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.726 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -68.35 -20.71 73.67 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 111.163 -0.775 . . . . 0.0 111.163 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -72.92 -45.53 32.78 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 37.7 t80 -69.89 -57.63 4.82 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.79 0.329 . . . . 0.0 110.707 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -66.83 -21.55 66.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.07 -179.743 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -77.5 -63.5 2.22 Favored Glycine 0 CA--C 1.524 0.608 0 C-N-CA 120.842 -0.694 . . . . 0.0 111.572 -179.504 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.541 ' O ' HG22 ' A' ' 26' ' ' VAL . . . -64.15 -20.98 66.37 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.671 -0.412 . . . . 0.0 110.245 -179.618 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.461 ' CD1' ' C ' ' A' ' 24' ' ' TYR . 11.0 t80 -48.77 -23.7 1.15 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.278 -0.419 . . . . 0.0 109.912 179.357 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.493 ' CE2' ' HB1' ' A' ' 102' ' ' ALA . 83.3 t80 -70.78 -52.63 19.44 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.765 -179.884 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.541 HG22 ' O ' ' A' ' 23' ' ' ALA . 35.3 m -66.53 -17.21 22.16 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 C-N-CA 120.535 -0.466 . . . . 0.0 110.41 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.9 tmt_? -58.08 -43.41 87.0 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.854 0.359 . . . . 0.0 110.32 179.456 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -101.41 -46.9 1.61 Allowed Glycine 0 CA--C 1.526 0.738 0 N-CA-C 110.957 -0.857 . . . . 0.0 110.957 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -59.91 -38.59 82.75 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.759 0.314 . . . . 0.0 110.64 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -58.68 -44.93 95.4 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.857 -0.897 . . . . 0.0 110.857 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 81.0 mt -58.47 -31.95 68.3 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.944 -0.302 . . . . 0.0 110.392 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.443 ' O ' ' HB3' ' A' ' 35' ' ' ALA . 14.6 mmm180 -76.68 -50.03 14.69 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.464 179.793 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 13.0 m0 -44.84 -48.14 11.05 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.289 -0.414 . . . . 0.0 109.998 179.489 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.452 ' O ' ' CD1' ' A' ' 34' ' ' TYR . 26.3 t80 -50.62 -27.05 6.14 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.751 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.443 ' HB3' ' O ' ' A' ' 32' ' ' ARG . . . -65.95 -45.83 80.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.763 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -91.87 -69.67 1.16 Allowed Glycine 0 CA--C 1.524 0.601 0 N-CA-C 110.992 -0.843 . . . . 0.0 110.992 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.761 ' C ' HD12 ' A' ' 37' ' ' LEU . 3.9 pp -87.66 162.78 16.91 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.677 0.275 . . . . 0.0 110.359 179.722 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 29.5 mt-30 -97.32 123.23 41.07 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.71 -179.645 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 13.9 mtpp -90.41 163.23 31.8 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.21 179.787 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_exo . . . . . 0 C--N 1.307 -1.628 0 C-N-CA 122.153 1.902 . . . . 0.0 112.198 -179.709 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.759 ' O ' HG23 ' A' ' 52' ' ' ILE . 0.2 OUTLIER . . . . . 0 CA--C 1.535 0.388 0 N-CA-C 112.411 0.523 . . . . 0.0 112.411 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.62 ' C ' ' H ' ' A' ' 52' ' ' ILE . . . -39.91 -31.63 0.26 Allowed Pre-proline 0 CA--C 1.534 0.344 0 N-CA-C 111.952 0.353 . . . . 0.0 111.952 -179.085 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.418 ' HD2' ' N ' ' A' ' 50' ' ' ALA . 28.2 Cg_exo -52.87 6.37 0.03 OUTLIER 'Trans proline' 0 C--N 1.311 -1.417 0 CA-C-N 118.928 0.653 . . . . 0.0 112.984 178.915 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.759 HG23 ' O ' ' A' ' 49' ' ' LEU . 10.9 pt -55.59 -28.5 23.15 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.178 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 179.04 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.462 ' CH2' ' HB1' ' A' ' 50' ' ' ALA . 3.0 m0 -67.68 -28.53 67.77 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.484 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -69.41 -60.94 4.76 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 111.464 -0.654 . . . . 0.0 111.464 -179.566 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.618 HG23 ' N ' ' A' ' 56' ' ' LEU . 7.3 t -57.56 -53.37 58.93 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.897 -0.321 . . . . 0.0 111.125 -179.343 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.618 ' N ' HG23 ' A' ' 55' ' ' THR . 73.2 mt -58.24 -39.41 79.04 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.524 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.414 ' CB ' ' O ' ' A' ' 53' ' ' TRP . 6.1 t80 -54.79 -57.89 9.73 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 179.747 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 7.1 t -48.63 -50.39 33.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.552 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -57.18 -42.55 81.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.606 -179.866 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 14.6 mtt -63.0 -55.09 28.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.525 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -44.73 -47.44 9.15 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 111.16 -0.776 . . . . 0.0 111.16 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -61.17 -49.37 77.47 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.845 0.355 . . . . 0.0 110.279 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.471 ' O ' HG23 ' A' ' 67' ' ' VAL . . . -54.87 -45.06 81.59 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 110.187 -1.165 . . . . 0.0 110.187 179.575 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.592 ' O ' ' NE1' ' A' ' 68' ' ' TRP . 0.7 OUTLIER -60.52 -42.35 96.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.906 0.384 . . . . 0.0 110.221 179.642 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.426 ' OH ' ' NZ ' ' A' ' 69' ' ' LYS . 87.3 t80 -53.11 -43.47 66.88 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 179.361 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 79.4 mt -72.15 -25.81 24.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.024 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.552 HG22 ' OG ' ' A' ' 130' ' ' SER . 55.1 t -66.15 -60.05 3.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 C-N-CA 120.664 -0.414 . . . . 0.0 111.333 -179.522 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' TRP . . . . . 0.595 ' CE2' ' CD1' ' A' ' 5' ' ' TRP . 0.0 OUTLIER -70.37 -29.39 66.04 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 119.974 -0.69 . . . . 0.0 110.725 -179.601 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.426 ' NZ ' ' OH ' ' A' ' 65' ' ' TYR . 10.8 mmmt -72.79 -26.55 61.56 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.336 -0.546 . . . . 0.0 110.616 179.825 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -78.42 -60.98 2.16 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.85 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.7 pp -70.38 -19.17 63.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.087 -179.482 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.502 ' O ' ' O ' ' A' ' 73' ' ' GLY . . . 110.24 95.43 2.33 Favored Glycine 0 CA--C 1.53 0.985 0 C-N-CA 121.257 -0.496 . . . . 0.0 112.043 179.218 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.594 ' N ' ' O ' ' A' ' 68' ' ' TRP . . . 41.51 -174.33 0.01 OUTLIER Glycine 0 CA--C 1.525 0.691 0 N-CA-C 111.944 -0.462 . . . . 0.0 111.944 178.963 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 49.3 t80 -79.78 111.05 15.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.675 0.274 . . . . 0.0 110.408 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.427 ' OG1' ' N ' ' A' ' 76' ' ' GLU . 2.1 t -139.35 177.31 8.01 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 120.993 0.425 . . . . 0.0 110.949 -179.641 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.5 ' CD ' ' H ' ' A' ' 76' ' ' GLU . 2.3 mp0 -50.05 -40.84 46.41 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.795 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 27.7 m-20 -62.39 -22.03 65.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.505 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -93.64 -24.82 17.75 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.663 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 13.2 mtp -69.14 -29.57 67.63 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.535 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.406 ' O ' ' CB ' ' A' ' 84' ' ' LEU . 6.5 t -65.56 -45.74 68.11 Favored Pre-proline 0 CA--C 1.535 0.372 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.505 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -76.33 -63.87 0.03 OUTLIER 'Trans proline' 0 N--CA 1.498 1.749 0 C-N-CA 120.903 1.069 . . . . 0.0 111.563 178.789 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 4.2 mt -47.19 -46.73 24.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.439 179.7 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.499 ' O ' ' N ' ' A' ' 86' ' ' THR . . . -68.38 -64.13 3.25 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 111.015 -0.834 . . . . 0.0 111.015 -179.852 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.406 ' CB ' ' O ' ' A' ' 80' ' ' VAL . 65.3 tp -41.9 -28.18 0.15 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.03 0.443 . . . . 0.0 109.88 179.751 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.465 ' CD1' ' C ' ' A' ' 85' ' ' TYR . 0.6 OUTLIER -76.85 -43.6 35.54 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.029 179.663 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.499 ' N ' ' O ' ' A' ' 83' ' ' GLY . 0.3 OUTLIER -61.56 -43.95 97.92 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.164 -179.57 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -73.62 -58.17 4.65 Favored Glycine 0 CA--C 1.527 0.808 0 C-N-CA 120.9 -0.667 . . . . 0.0 111.466 -179.455 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -51.14 -48.61 61.77 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-O 121.052 0.453 . . . . 0.0 109.943 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.455 HD22 ' CZ ' ' A' ' 85' ' ' TYR . 23.3 tp -54.85 -63.39 1.17 Allowed 'General case' 0 C--O 1.211 -0.927 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.814 179.593 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.588 ' O ' ' HB2' ' A' ' 94' ' ' ALA . . . -37.86 -42.87 0.64 Allowed 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 120.568 -0.453 . . . . 0.0 111.522 -179.497 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 90.8 mt -63.38 -56.98 11.87 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -178.689 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -72.62 -53.85 10.73 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.346 0.593 . . . . 0.0 111.33 -178.83 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' TRP . . . . . 0.606 ' O ' ' N ' ' A' ' 95' ' ' TRP . 30.7 t-105 -51.86 -33.31 35.85 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.152 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.588 ' HB2' ' O ' ' A' ' 90' ' ' ALA . . . -60.01 72.11 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 120.611 -0.436 . . . . 0.0 109.89 179.228 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.694 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 22.2 p-90 -99.42 -15.91 0.19 Allowed Pre-proline 0 CA--C 1.538 0.505 0 N-CA-C 112.581 0.586 . . . . 0.0 112.581 -179.113 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.694 ' CD ' ' N ' ' A' ' 95' ' ' TRP . 49.3 Cg_exo -58.87 -31.14 94.79 Favored 'Trans proline' 0 N--CA 1.497 1.717 0 C-N-CA 120.645 0.897 . . . . 0.0 113.808 -179.731 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.494 ' CD ' ' N ' ' A' ' 96' ' ' PRO . 89.0 Cg_exo -56.99 -13.91 12.99 Favored 'Trans proline' 0 N--CA 1.499 1.825 0 C-N-CA 120.642 0.895 . . . . 0.0 113.654 -179.152 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 1.1 pp -90.05 29.96 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 C-N-CA 120.453 -0.499 . . . . 0.0 110.779 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.585 ' CD2' ' O ' ' A' ' 96' ' ' PRO . 42.6 m-85 -50.37 -40.09 48.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.213 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.598 ' CD1' ' N ' ' A' ' 100' ' ' PHE . 0.1 OUTLIER -70.05 -58.84 3.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.318 -179.311 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -55.56 -14.82 7.42 Favored Glycine 0 CA--C 1.522 0.489 0 N-CA-C 110.847 -0.901 . . . . 0.0 110.847 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.493 ' HB1' ' CE2' ' A' ' 25' ' ' PHE . . . -59.76 -12.14 6.63 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.587 0.232 . . . . 0.0 111.203 -179.662 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 -94.78 10.3 35.7 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 121.005 -0.278 . . . . 0.0 110.862 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 16.6 mt-30 -117.21 -175.35 2.78 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.732 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.495 ' CE ' ' CZ3' ' A' ' 155' ' ' TRP . 17.5 mmt -74.78 -18.31 60.49 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.094 0.473 . . . . 0.0 109.78 179.662 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.613 ' O ' ' N ' ' A' ' 108' ' ' ALA . . . -74.23 -14.77 80.39 Favored Glycine 0 CA--C 1.524 0.653 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.355 -179.702 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' TRP . . . . . 0.78 ' HE1' ' ND2' ' A' ' 151' ' ' ASN . 0.0 OUTLIER -41.6 -14.96 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.252 0 CA-C-O 120.749 0.309 . . . . 0.0 110.879 -179.468 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.892 ' HB2' ' ND2' ' A' ' 151' ' ' ASN . . . -62.49 -17.57 59.9 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.983 0.421 . . . . 0.0 110.172 179.53 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.52 HD13 ' O ' ' A' ' 106' ' ' GLY . 6.8 mp -47.5 -30.7 3.65 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.358 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.416 ' HB2' ' CZ3' ' A' ' 95' ' ' TRP . . . -57.81 -63.98 1.06 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.935 -179.72 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.691 ' O ' HG23 ' A' ' 115' ' ' VAL . 1.9 p30 -57.82 -54.34 48.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.764 -179.224 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.54 ' N ' ' CG ' ' A' ' 111' ' ' ASP . 38.1 tp -52.84 -41.49 64.31 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.506 -0.316 . . . . 0.0 111.727 -178.926 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.403 HD23 ' HA ' ' A' ' 113' ' ' LEU . 57.2 mt -70.33 -62.12 1.51 Allowed 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.616 0.599 . . . . 0.0 112.616 -178.333 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.0 pp -59.0 -29.84 67.53 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 120.431 -0.508 . . . . 0.0 111.066 -178.775 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.691 HG23 ' O ' ' A' ' 111' ' ' ASP . 38.8 t -65.12 -60.61 2.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.221 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' SER . . . . . 0.498 ' O ' ' OG1' ' A' ' 120' ' ' THR . 9.8 p -68.81 -22.29 64.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.954 -179.55 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' GLY . . . . . 0.405 ' O ' ' CB ' ' A' ' 121' ' ' ALA . . . -65.34 -62.66 4.69 Favored Glycine 0 CA--C 1.525 0.693 0 C-N-CA 120.903 -0.665 . . . . 0.0 111.496 -179.474 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.595 ' O ' HG23 ' A' ' 122' ' ' THR . 9.6 p -73.24 -37.5 52.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 C-N-CA 120.957 -0.297 . . . . 0.0 111.233 -179.531 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.524 ' O ' ' OG1' ' A' ' 123' ' ' THR . . . -67.02 -60.86 2.27 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.596 -0.442 . . . . 0.0 111.145 -179.393 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.498 ' OG1' ' O ' ' A' ' 116' ' ' SER . 1.6 m -60.36 -53.23 60.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.412 -179.455 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.405 ' CB ' ' O ' ' A' ' 117' ' ' GLY . . . -51.83 -42.38 62.5 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.916 -0.314 . . . . 0.0 111.044 -179.391 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.595 HG23 ' O ' ' A' ' 118' ' ' VAL . 35.6 p -71.55 -40.15 70.19 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.769 -179.09 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.524 ' OG1' ' O ' ' A' ' 119' ' ' ALA . 0.1 OUTLIER -54.77 -49.29 71.24 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 120.761 0.315 . . . . 0.0 110.897 -179.143 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.9 pp -84.11 -20.21 32.93 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.202 -0.454 . . . . 0.0 112.089 -178.741 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -90.17 -71.19 0.63 Allowed 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.821 0.675 . . . . 0.0 112.821 -178.331 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 41.6 m0 -80.46 -57.13 3.73 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 -177.738 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' HIS . . . . . 0.578 ' CG ' ' HB2' ' A' ' 134' ' ' ALA . 10.4 m170 -55.48 -23.57 26.53 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.826 -0.35 . . . . 0.0 111.54 -178.794 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.77 -39.56 87.89 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.756 -0.377 . . . . 0.0 110.666 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 98.7 t -90.6 -49.54 13.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.942 -179.574 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' SER . . . . . 0.552 ' OG ' HG22 ' A' ' 67' ' ' VAL . 1.9 p -114.06 109.34 49.63 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.468 -179.661 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 131' ' ' PRO . . . . . 0.629 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 71.4 Cg_exo -69.68 -35.91 12.01 Favored 'Trans proline' 0 C--N 1.311 -1.418 0 C-N-CA 121.38 1.386 . . . . 0.0 112.422 179.472 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 132' ' ' PRO . . . . . 0.629 ' CD ' ' N ' ' A' ' 131' ' ' PRO . 29.8 Cg_exo -56.28 -40.64 83.41 Favored 'Trans proline' 0 N--CA 1.495 1.58 0 C-N-CA 121.374 1.383 . . . . 0.0 111.679 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -51.89 -44.54 63.79 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.265 179.694 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' ALA . . . . . 0.578 ' HB2' ' CG ' ' A' ' 127' ' ' HIS . . . -58.65 -22.64 57.28 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.511 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 7.7 tpt85 -79.32 -29.42 42.35 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.535 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 12.8 mt -79.01 -28.96 43.42 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.389 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.477 ' O ' ' CD1' ' A' ' 140' ' ' TYR . 13.2 mt -93.74 -18.64 21.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.091 179.686 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.54 ' CD1' ' C ' ' A' ' 138' ' ' TYR . 0.3 OUTLIER -37.43 -52.19 2.46 Favored Pre-proline 0 CA--C 1.537 0.461 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.715 -179.764 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.404 ' HD2' ' N ' ' A' ' 138' ' ' TYR . 5.6 Cg_endo -62.65 1.54 1.01 Allowed 'Trans proline' 0 N--CA 1.499 1.797 0 C-N-CA 121.734 1.622 . . . . 0.0 113.38 -179.281 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 140' ' ' TYR . . . . . 0.477 ' CD1' ' O ' ' A' ' 137' ' ' LEU . 0.1 OUTLIER -80.0 -13.7 59.13 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-O 120.921 0.391 . . . . 0.0 111.53 -179.679 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.586 HD23 HD12 ' A' ' 144' ' ' LEU . 74.8 mt -57.64 -34.05 68.93 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.072 179.099 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -53.45 -47.2 69.91 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 179.469 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' TRP . . . . . 0.434 ' CE2' HD12 ' A' ' 52' ' ' ILE . 8.8 t-105 -63.37 -44.2 95.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.74 179.523 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.586 HD12 HD23 ' A' ' 141' ' ' LEU . 25.3 mt -55.19 -54.97 36.61 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.334 -0.547 . . . . 0.0 110.281 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.534 ' O ' HG23 ' A' ' 149' ' ' VAL . . . -64.68 -23.57 67.3 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.636 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 25.9 t80 -61.35 -59.16 5.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.771 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -64.33 -50.38 68.0 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.005 -179.604 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 10.9 m -52.62 -55.83 19.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.904 0.383 . . . . 0.0 110.769 -179.745 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.534 HG23 ' O ' ' A' ' 145' ' ' ALA . 80.9 t -58.25 -35.05 51.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.726 -179.772 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.432 ' O ' HG23 ' A' ' 154' ' ' VAL . 4.8 tp -54.7 -58.11 8.82 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.471 -179.865 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 151' ' ' ASN . . . . . 0.892 ' ND2' ' HB2' ' A' ' 108' ' ' ALA . 2.0 t-20 -56.4 -58.89 6.08 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-O 120.988 0.423 . . . . 0.0 110.783 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 50.5 t80 -47.42 -39.65 16.03 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.83 -179.383 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 31.5 t80 -72.12 -35.83 69.25 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.401 -179.53 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.432 HG23 ' O ' ' A' ' 150' ' ' LEU . 45.1 t -59.15 -47.04 91.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 C-N-CA 120.791 -0.364 . . . . 0.0 111.395 -179.291 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 155' ' ' TRP . . . . . 0.495 ' CZ3' ' CE ' ' A' ' 105' ' ' MET . 22.9 m95 -79.95 -28.68 39.63 Favored 'General case' 0 N--CA 1.464 0.225 0 C-N-CA 119.818 -0.753 . . . . 0.0 111.521 -179.279 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.41 -21.66 61.23 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.461 -0.495 . . . . 0.0 110.164 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -83.57 -40.06 19.58 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.918 -179.668 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 18.2 t30 . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.084 -179.587 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.559 ' O ' HG23 ' A' ' 9' ' ' VAL . 0.7 OUTLIER . . . . . 0 CA--C 1.528 0.127 0 CA-C-O 120.784 0.326 . . . . 0.0 110.275 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.585 ' N ' ' CD ' ' A' ' 7' ' ' PRO . 0.9 OUTLIER -60.84 -33.62 15.03 Favored Pre-proline 0 CA--C 1.533 0.306 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.144 -179.759 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.585 ' CD ' ' N ' ' A' ' 6' ' ' VAL . 24.2 Cg_exo -73.34 -62.64 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 121.613 1.542 . . . . 0.0 111.518 179.282 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.708 ' O ' HG23 ' A' ' 12' ' ' THR . . . -50.78 -36.51 37.29 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.849 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.559 HG23 ' O ' ' A' ' 5' ' ' TRP . 56.0 t -68.27 -62.17 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.511 -179.442 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -55.6 -47.73 75.42 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 111.484 -0.646 . . . . 0.0 111.484 -179.33 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.434 HD12 ' N ' ' A' ' 11' ' ' LEU . 8.5 mp -64.84 -30.86 71.88 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 121.177 -0.209 . . . . 0.0 110.968 -179.514 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.708 HG23 ' O ' ' A' ' 8' ' ' ALA . 6.1 p -74.47 -22.95 58.84 Favored 'General case' 0 C--N 1.333 -0.135 0 C-N-CA 120.569 -0.453 . . . . 0.0 110.016 179.439 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 52.5 mt -80.18 -34.77 37.24 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.213 179.644 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.415 ' N ' ' HD2' ' A' ' 15' ' ' PRO . 11.9 t -43.63 -55.21 9.05 Favored Pre-proline 0 CA--C 1.536 0.423 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.45 -179.722 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.415 ' HD2' ' N ' ' A' ' 14' ' ' VAL . 13.8 Cg_endo -58.92 -21.92 60.26 Favored 'Trans proline' 0 N--CA 1.498 1.754 0 C-N-CA 120.672 0.915 . . . . 0.0 112.303 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 5.7 t -62.08 -30.59 71.1 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.825 -179.749 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 71.5 mt -71.62 -57.1 4.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.817 0.342 . . . . 0.0 110.893 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -61.16 -36.97 93.18 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 111.287 -0.725 . . . . 0.0 111.287 -179.702 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -75.44 -25.94 66.9 Favored Glycine 0 CA--C 1.521 0.461 0 N-CA-C 110.694 -0.962 . . . . 0.0 110.694 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 62.0 t80 -75.54 -60.62 2.23 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.528 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 3.9 ttt -70.16 -22.29 62.99 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.17 179.74 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -69.47 -62.31 3.97 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.825 -0.91 . . . . 0.0 110.825 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.496 ' O ' HG22 ' A' ' 26' ' ' VAL . . . -68.55 -21.28 64.56 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.831 -0.348 . . . . 0.0 110.635 -179.857 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 40.2 t80 -47.45 -24.0 0.73 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.013 0.435 . . . . 0.0 109.984 179.608 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 25.6 t80 -69.72 -52.26 27.07 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.966 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.496 HG22 ' O ' ' A' ' 23' ' ' ALA . 36.0 m -72.14 -15.89 18.2 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.894 -179.736 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -59.82 -28.88 67.85 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.258 -179.388 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -123.39 -59.39 0.19 Allowed Glycine 0 CA--C 1.524 0.643 0 N-CA-C 111.199 -0.76 . . . . 0.0 111.199 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 27.7 tp10 -53.92 -28.99 40.18 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.745 0.307 . . . . 0.0 110.686 -179.711 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -73.78 -40.98 43.73 Favored Glycine 0 CA--C 1.526 0.754 0 N-CA-C 111.134 -0.786 . . . . 0.0 111.134 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 85.6 mt -62.98 -33.2 74.9 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.881 0.372 . . . . 0.0 110.482 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 18.6 mmm-85 -81.0 -40.01 24.98 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.35 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' TRP . . . . . 0.489 ' O ' ' N ' ' A' ' 36' ' ' GLY . 0.0 OUTLIER -56.11 -40.41 73.67 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.802 179.624 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 91.4 t80 -44.5 -42.11 6.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.518 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -60.27 -29.32 68.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.145 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.489 ' N ' ' O ' ' A' ' 33' ' ' TRP . . . -84.86 -76.72 1.19 Allowed Glycine 0 CA--C 1.524 0.602 0 N-CA-C 110.437 -1.065 . . . . 0.0 110.437 179.679 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.582 ' O ' HD12 ' A' ' 37' ' ' LEU . 0.3 OUTLIER -95.65 166.94 11.58 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.791 0.329 . . . . 0.0 110.221 179.277 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.415 ' N ' ' CD ' ' A' ' 38' ' ' GLN . 3.7 mp0 -81.54 113.02 19.29 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.483 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 8.9 mtpt -122.18 146.63 47.25 Favored Pre-proline 0 N--CA 1.464 0.265 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.05 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo . . . . . 0 C--N 1.309 -1.503 0 C-N-CA 121.28 1.32 . . . . 0.0 111.386 179.406 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.703 ' O ' HG23 ' A' ' 52' ' ' ILE . 0.1 OUTLIER . . . . . 0 CA--C 1.533 0.301 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.615 ' C ' ' H ' ' A' ' 52' ' ' ILE . . . -40.94 -28.92 0.23 Allowed Pre-proline 0 N--CA 1.465 0.281 0 N-CA-C 111.892 0.33 . . . . 0.0 111.892 -179.057 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.409 ' HD2' ' N ' ' A' ' 50' ' ' ALA . 17.6 Cg_exo -54.03 7.36 0.03 OUTLIER 'Trans proline' 0 C--N 1.312 -1.359 0 CA-C-N 119.126 0.724 . . . . 0.0 112.78 178.501 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.703 HG23 ' O ' ' A' ' 49' ' ' LEU . 8.1 pt -55.19 -31.35 26.05 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.133 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 178.881 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.403 ' O ' ' CB ' ' A' ' 57' ' ' TYR . 72.8 m95 -80.98 -22.21 39.7 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.124 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -69.92 -52.12 20.78 Favored Glycine 0 CA--C 1.527 0.828 0 N-CA-C 109.987 -1.245 . . . . 0.0 109.987 178.941 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.617 HG23 ' N ' ' A' ' 56' ' ' LEU . 9.3 t -67.23 -50.2 61.58 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 179.321 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.617 ' N ' HG23 ' A' ' 55' ' ' THR . 90.4 mt -58.4 -33.77 70.01 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 120.655 -0.418 . . . . 0.0 109.89 179.389 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.403 ' CB ' ' O ' ' A' ' 53' ' ' TRP . 3.6 t80 -59.16 -55.93 28.7 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 179.42 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 34.6 t -48.01 -50.33 27.95 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.347 -0.541 . . . . 0.0 109.88 179.339 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -55.63 -52.59 63.28 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.57 179.622 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.4 ' O ' ' CB ' ' A' ' 64' ' ' SER . 16.2 mtm -55.09 -37.68 67.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.036 -179.715 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -62.87 -41.2 99.92 Favored Glycine 0 CA--C 1.523 0.55 0 N-CA-C 111.216 -0.754 . . . . 0.0 111.216 -179.587 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -68.61 -60.25 2.55 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.695 0.283 . . . . 0.0 110.869 -179.487 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.475 ' O ' HG23 ' A' ' 67' ' ' VAL . . . -55.48 -56.58 22.83 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 110.749 -0.94 . . . . 0.0 110.749 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.477 ' O ' ' NE1' ' A' ' 68' ' ' TRP . 92.7 p -45.77 -49.53 14.87 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.004 0.43 . . . . 0.0 110.473 179.699 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 73.5 t80 -58.16 -34.4 70.26 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.835 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 96.2 mt -74.25 -39.13 49.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.882 -179.809 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.475 HG23 ' O ' ' A' ' 63' ' ' GLY . 37.4 t -56.98 -58.17 6.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.616 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' TRP . . . . . 0.578 ' O ' ' N ' ' A' ' 73' ' ' GLY . 1.0 OUTLIER -60.82 -45.04 96.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.692 -179.837 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 2.7 mmmt -56.65 -25.73 54.25 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.02 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 23.5 tp10 -82.41 -63.06 1.45 Allowed 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.827 -0.349 . . . . 0.0 111.317 -179.359 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.743 ' C ' HD12 ' A' ' 71' ' ' LEU . 3.3 pp -62.93 -7.12 4.58 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.777 -0.369 . . . . 0.0 111.023 -179.478 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.659 ' N ' HD12 ' A' ' 71' ' ' LEU . . . 108.45 71.69 0.73 Allowed Glycine 0 CA--C 1.527 0.791 0 N-CA-C 111.402 -0.679 . . . . 0.0 111.402 179.697 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.578 ' N ' ' O ' ' A' ' 68' ' ' TRP . . . 42.15 -174.03 0.01 OUTLIER Glycine 0 CA--C 1.525 0.698 0 N-CA-C 111.748 -0.541 . . . . 0.0 111.748 179.496 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 63.4 t80 -69.33 111.42 5.22 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.372 -0.414 . . . . 0.0 110.432 -179.795 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.477 ' OG1' ' N ' ' A' ' 76' ' ' GLU . 1.7 t -140.0 -178.6 5.52 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.538 -179.812 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.477 ' N ' ' OG1' ' A' ' 75' ' ' THR . 96.3 mt-10 -55.51 -23.24 25.09 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.632 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -79.97 -18.84 49.34 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.664 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -94.09 -24.42 17.59 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.927 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 13.1 mtp -62.19 -26.98 68.65 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.813 -0.355 . . . . 0.0 110.439 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 10.8 t -68.49 -52.99 18.4 Favored Pre-proline 0 CA--C 1.535 0.386 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.953 -179.602 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -66.42 -59.53 0.13 Allowed 'Trans proline' 0 N--CA 1.497 1.733 0 C-N-CA 120.97 1.113 . . . . 0.0 111.77 179.29 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.445 HD21 ' CZ2' ' A' ' 68' ' ' TRP . 1.2 mt -55.27 -51.49 66.47 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.492 179.714 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -57.82 -51.08 60.22 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 111.153 -0.779 . . . . 0.0 111.153 -179.722 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.427 ' O ' ' CB ' ' A' ' 88' ' ' GLN . 44.3 tp -60.15 -29.74 68.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.834 0.349 . . . . 0.0 110.61 -179.832 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 11.6 t80 -71.25 -43.51 67.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.627 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 1.5 m -67.29 -48.03 68.86 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.888 -179.625 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -68.75 -57.27 8.14 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 111.162 -0.775 . . . . 0.0 111.162 -179.743 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.427 ' CB ' ' O ' ' A' ' 84' ' ' LEU . 8.3 tp-100 -52.13 -46.01 65.19 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.826 0.346 . . . . 0.0 110.711 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 11.7 tp -66.12 -31.94 73.1 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.94 -179.542 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.79 ' O ' ' HB2' ' A' ' 94' ' ' ALA . . . -64.4 -65.64 0.65 Allowed 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 120.272 -0.571 . . . . 0.0 111.183 -179.547 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.431 HD12 ' N ' ' A' ' 92' ' ' ASN . 2.8 pp -67.65 -36.96 81.72 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 -178.88 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.431 ' N ' HD12 ' A' ' 91' ' ' LEU . 8.3 t-20 -75.03 -59.13 2.88 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 -178.768 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' TRP . . . . . 0.62 ' O ' ' N ' ' A' ' 95' ' ' TRP . 0.0 OUTLIER -69.95 -17.15 63.3 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 120.681 -0.408 . . . . 0.0 111.499 -178.576 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.79 ' HB2' ' O ' ' A' ' 90' ' ' ALA . . . -49.0 83.23 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 120.739 -0.385 . . . . 0.0 110.206 179.512 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.696 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 34.8 p-90 -101.42 -15.75 0.18 Allowed Pre-proline 0 CA--C 1.536 0.419 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 -179.278 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.696 ' CD ' ' N ' ' A' ' 95' ' ' TRP . 32.0 Cg_exo -60.24 -27.79 85.58 Favored 'Trans proline' 0 N--CA 1.495 1.564 0 C-N-CA 120.484 0.79 . . . . 0.0 113.126 179.654 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.52 ' CD ' ' N ' ' A' ' 96' ' ' PRO . 97.2 Cg_exo -58.96 -17.53 37.93 Favored 'Trans proline' 0 N--CA 1.496 1.671 0 C-N-CA 120.592 0.861 . . . . 0.0 113.127 -179.81 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.531 ' O ' ' N ' ' A' ' 101' ' ' GLY . 1.2 pp -82.24 17.26 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 121.105 0.479 . . . . 0.0 110.304 179.699 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -40.22 -31.7 0.14 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.789 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -80.85 -30.32 35.67 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.246 -179.36 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.531 ' N ' ' O ' ' A' ' 98' ' ' ILE . . . -83.66 -11.97 78.67 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 111.372 -0.691 . . . . 0.0 111.372 -179.742 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -63.55 -33.06 74.77 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.673 0.273 . . . . 0.0 111.033 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -75.91 9.65 2.29 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.98 -179.654 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' GLN . . . . . 0.416 ' C ' ' N ' ' A' ' 106' ' ' GLY . 5.3 mt-30 -126.09 158.83 34.45 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.748 0.308 . . . . 0.0 110.574 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 6.7 mmt -48.79 -18.91 0.31 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.097 0.475 . . . . 0.0 110.348 179.835 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.593 ' O ' ' N ' ' A' ' 108' ' ' ALA . . . -66.51 -14.59 62.59 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 111.351 -0.7 . . . . 0.0 111.351 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' TRP . . . . . 0.455 ' CD1' ' N ' ' A' ' 108' ' ' ALA . 0.0 OUTLIER -42.33 -14.52 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.287 0 CA-C-O 120.561 0.22 . . . . 0.0 111.137 -179.368 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.593 ' N ' ' O ' ' A' ' 106' ' ' GLY . . . -64.78 -24.1 67.45 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.092 0.472 . . . . 0.0 110.321 179.686 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 6.6 mt -49.98 -27.99 6.2 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.59 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.24 -58.51 7.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.733 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.708 ' O ' HG23 ' A' ' 115' ' ' VAL . 1.0 OUTLIER -59.2 -52.32 66.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.558 -179.422 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.538 ' N ' ' CG ' ' A' ' 111' ' ' ASP . 57.4 tp -55.07 -43.17 73.66 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.43 -179.137 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.402 HD23 ' HA ' ' A' ' 113' ' ' LEU . 51.6 mt -67.12 -61.55 1.87 Allowed 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 -178.487 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.0 pp -60.94 -34.04 74.12 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.337 -0.545 . . . . 0.0 111.413 -178.582 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.708 HG23 ' O ' ' A' ' 111' ' ' ASP . 40.7 t -59.87 -56.82 14.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.763 179.877 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' SER . . . . . 0.491 ' O ' ' OG1' ' A' ' 120' ' ' THR . 41.5 t -72.09 -22.54 61.34 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.54 -179.208 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -64.98 -62.74 4.7 Favored Glycine 0 CA--C 1.526 0.75 0 C-N-CA 120.938 -0.648 . . . . 0.0 111.674 -179.357 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.535 ' O ' HG23 ' A' ' 122' ' ' THR . 10.3 p -73.01 -37.62 53.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 C-N-CA 121.08 -0.248 . . . . 0.0 111.408 -179.476 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.527 ' O ' ' OG1' ' A' ' 123' ' ' THR . . . -65.53 -60.24 3.14 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.684 -0.406 . . . . 0.0 111.149 -179.344 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.491 ' OG1' ' O ' ' A' ' 116' ' ' SER . 1.9 m -60.43 -52.77 63.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.673 -179.237 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -54.6 -39.93 68.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.601 -0.272 . . . . 0.0 111.417 -179.166 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.535 HG23 ' O ' ' A' ' 118' ' ' VAL . 22.9 p -71.48 -39.11 71.09 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.994 -0.283 . . . . 0.0 111.728 -179.195 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.527 ' OG1' ' O ' ' A' ' 119' ' ' ALA . 0.1 OUTLIER -58.46 -49.44 77.33 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.782 -0.367 . . . . 0.0 111.08 -179.286 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.2 pp -79.97 -20.48 45.47 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.581 -179.057 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -87.42 -70.88 0.59 Allowed 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 112.515 0.561 . . . . 0.0 112.515 -178.77 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' TRP . . . . . 0.469 ' CD1' ' N ' ' A' ' 126' ' ' TRP . 32.0 m0 -83.57 -57.36 3.27 Favored 'General case' 0 N--CA 1.465 0.275 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -177.687 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 127' ' ' HIS . . . . . 0.496 ' CG ' ' HB2' ' A' ' 134' ' ' ALA . 7.0 m170 -54.52 -22.68 13.68 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.642 -0.423 . . . . 0.0 111.419 -178.672 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 17.1 ttt-85 -66.35 -39.62 89.28 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.877 -0.329 . . . . 0.0 111.137 -179.563 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 21.5 t -96.18 -49.77 11.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.149 -179.543 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' SER . . . . . 0.467 ' HB2' HG22 ' A' ' 67' ' ' VAL . 16.8 m -114.72 110.35 46.84 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.699 -179.661 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 131' ' ' PRO . . . . . 0.64 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 77.7 Cg_exo -75.19 -33.11 4.64 Favored 'Trans proline' 0 C--N 1.31 -1.479 0 C-N-CA 121.73 1.62 . . . . 0.0 112.871 179.544 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 132' ' ' PRO . . . . . 0.64 ' CD ' ' N ' ' A' ' 131' ' ' PRO . 53.1 Cg_exo -52.97 -49.91 15.92 Favored 'Trans proline' 0 N--CA 1.497 1.687 0 C-N-CA 121.587 1.525 . . . . 0.0 112.572 -179.536 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -53.27 -38.98 63.55 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.908 0.385 . . . . 0.0 110.666 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' ALA . . . . . 0.496 ' HB2' ' CG ' ' A' ' 127' ' ' HIS . . . -56.18 -28.06 56.79 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.596 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 11.4 tpp180 -75.98 -29.66 58.3 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.653 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 54.3 mt -72.43 -35.74 68.39 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.878 0.37 . . . . 0.0 110.118 179.627 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.589 ' O ' ' N ' ' A' ' 140' ' ' TYR . 6.2 mt -82.46 -36.81 26.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.211 179.571 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.519 ' C ' ' H ' ' A' ' 140' ' ' TYR . 0.8 OUTLIER -21.04 -45.48 0.04 OUTLIER Pre-proline 0 N--CA 1.467 0.399 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.811 -179.725 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.559 ' N ' ' O ' ' A' ' 137' ' ' LEU . 5.5 Cg_exo -66.08 14.33 0.11 Allowed 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 120.986 1.124 . . . . 0.0 112.001 179.593 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 140' ' ' TYR . . . . . 0.771 ' CE2' HD11 ' A' ' 144' ' ' LEU . 3.7 p90 -93.25 -14.64 26.78 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.197 0.522 . . . . 0.0 110.341 179.684 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.656 ' CD1' ' CE1' ' A' ' 140' ' ' TYR . 5.9 mp -58.79 -30.63 67.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.268 178.578 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -60.92 -45.37 94.91 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.983 179.562 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' TRP . . . . . 0.475 ' CE2' HD12 ' A' ' 52' ' ' ILE . 7.7 t-105 -60.33 -49.57 77.06 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 179.415 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.771 HD11 ' CE2' ' A' ' 140' ' ' TYR . 11.9 mt -51.37 -54.61 24.75 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.743 179.322 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.616 ' O ' HG23 ' A' ' 149' ' ' VAL . . . -59.72 -24.79 64.29 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.792 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 23.0 t80 -65.1 -59.16 4.42 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.741 -0.383 . . . . 0.0 110.711 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -67.18 -43.41 82.24 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.622 -0.431 . . . . 0.0 110.633 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 5.2 m -57.3 -55.13 38.79 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.579 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.616 HG23 ' O ' ' A' ' 145' ' ' ALA . 91.2 t -59.19 -31.66 46.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.59 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -58.33 -53.94 52.6 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.796 -0.362 . . . . 0.0 110.068 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 151' ' ' ASN . . . . . 0.621 ' ND2' ' OD2' ' A' ' 111' ' ' ASP . 43.9 m-20 -64.16 -53.37 50.49 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.939 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 31.5 t80 -51.4 -37.53 48.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.867 -179.682 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 90.8 t80 -67.93 -42.68 80.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.949 -179.692 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 86.7 t -63.61 -38.27 81.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 C-N-CA 120.945 -0.302 . . . . 0.0 110.79 -179.758 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 155' ' ' TRP . . . . . . . . . . . . . 4.8 m0 -64.06 -45.96 86.49 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.536 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 7.5 mpt_? -70.62 -34.31 71.97 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.954 -179.605 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -74.64 -37.79 62.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.111 -179.314 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 12.4 t-20 . . . . . 0 C--N 1.33 -0.256 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.918 -179.745 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.688 ' O ' HG23 ' A' ' 9' ' ' VAL . 0.7 OUTLIER . . . . . 0 CA--C 1.528 0.102 0 CA-C-O 120.786 0.327 . . . . 0.0 110.282 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.594 ' N ' ' CD ' ' A' ' 7' ' ' PRO . 0.9 OUTLIER -62.36 -35.76 22.72 Favored Pre-proline 0 CA--C 1.534 0.35 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.43 -179.715 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.594 ' CD ' ' N ' ' A' ' 6' ' ' VAL . 35.2 Cg_exo -65.99 -64.59 0.05 OUTLIER 'Trans proline' 0 C--N 1.306 -1.665 0 C-N-CA 121.668 1.579 . . . . 0.0 111.827 179.624 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.761 ' O ' HG22 ' A' ' 12' ' ' THR . . . -51.65 -32.76 30.63 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.973 -179.706 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.688 HG23 ' O ' ' A' ' 5' ' ' TRP . 58.5 t -69.87 -61.37 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.94 0.4 . . . . 0.0 111.304 -179.447 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -57.89 -43.36 94.85 Favored Glycine 0 CA--C 1.528 0.853 0 N-CA-C 111.215 -0.754 . . . . 0.0 111.215 -179.545 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 8.1 mp -65.92 -62.95 1.21 Allowed 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 111.544 0.202 . . . . 0.0 111.544 -179.166 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.761 HG22 ' O ' ' A' ' 8' ' ' ALA . 6.9 t -54.38 -20.55 7.57 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.449 -0.5 . . . . 0.0 110.572 -179.395 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.431 ' O ' ' C ' ' A' ' 14' ' ' VAL . 17.6 mt -78.79 -38.12 39.17 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.779 0.324 . . . . 0.0 110.371 179.611 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.432 ' N ' ' HD2' ' A' ' 15' ' ' PRO . 28.1 t -35.55 -56.72 1.01 Allowed Pre-proline 0 CA--C 1.534 0.342 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.63 -179.774 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.432 ' HD2' ' N ' ' A' ' 14' ' ' VAL . 15.4 Cg_endo -54.6 -32.59 75.46 Favored 'Trans proline' 0 N--CA 1.498 1.772 0 C-N-CA 120.475 0.783 . . . . 0.0 112.501 -179.488 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.421 ' N ' ' O ' ' A' ' 13' ' ' LEU . 2.3 t -45.05 -25.96 0.39 Allowed 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 120.396 -0.522 . . . . 0.0 110.341 -179.586 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 74.5 mt -72.85 -53.69 10.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.128 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -68.61 -34.48 78.69 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 111.594 -0.602 . . . . 0.0 111.594 -179.399 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -75.14 -29.61 60.21 Favored Glycine 0 CA--C 1.517 0.184 0 N-CA-C 110.651 -0.98 . . . . 0.0 110.651 -179.7 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 36.9 t80 -74.79 -60.71 2.16 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.506 -0.478 . . . . 0.0 110.64 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 9.4 ttt -69.7 -22.85 63.38 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.809 -179.829 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -73.59 -63.23 2.8 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 111.081 -0.808 . . . . 0.0 111.081 -179.781 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.482 ' O ' HG22 ' A' ' 26' ' ' VAL . . . -63.83 -23.49 67.38 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.424 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 76.2 t80 -47.83 -23.5 0.76 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.936 0.398 . . . . 0.0 109.95 179.235 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 46.8 t80 -69.49 -52.65 24.56 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.703 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.482 HG22 ' O ' ' A' ' 23' ' ' ALA . 31.1 m -71.14 -16.2 19.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.864 -179.685 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 2.4 tmt_? -58.04 -46.38 85.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.79 0.328 . . . . 0.0 110.568 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -100.73 -60.51 0.81 Allowed Glycine 0 CA--C 1.526 0.749 0 N-CA-C 110.916 -0.873 . . . . 0.0 110.916 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -49.84 -31.69 12.51 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.753 0.311 . . . . 0.0 110.546 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -68.7 -53.6 19.26 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 110.826 -0.91 . . . . 0.0 110.826 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 71.2 mt -51.24 -38.68 53.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.831 0.348 . . . . 0.0 110.51 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 20.1 mmm-85 -75.13 -46.85 31.7 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.035 -179.68 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 4.8 m95 -47.12 -39.35 13.17 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 120.853 -0.339 . . . . 0.0 110.269 -179.685 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 77.6 t80 -53.33 -26.11 17.63 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.312 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -75.89 -16.38 60.05 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.377 179.748 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -111.37 -76.47 0.83 Allowed Glycine 0 CA--C 1.523 0.568 0 N-CA-C 110.727 -0.949 . . . . 0.0 110.727 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.795 ' C ' HD12 ' A' ' 37' ' ' LEU . 3.6 pp -95.27 165.41 12.4 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 110.245 -0.28 . . . . 0.0 110.245 179.708 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.414 ' N ' HD12 ' A' ' 37' ' ' LEU . 77.0 mm-40 -75.55 113.08 12.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.93 0.395 . . . . 0.0 111.624 -179.121 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.416 ' HG3' HD11 ' A' ' 37' ' ' LEU . 0.7 OUTLIER -129.59 135.48 27.61 Favored Pre-proline 0 CA--C 1.536 0.424 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 179.313 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo . . . . . 0 N--CA 1.496 1.671 0 C-N-CA 120.386 0.724 . . . . 0.0 111.617 179.582 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.712 ' O ' HG23 ' A' ' 52' ' ' ILE . 0.1 OUTLIER . . . . . 0 CA--C 1.533 0.289 0 N-CA-C 111.867 0.321 . . . . 0.0 111.867 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.613 ' C ' ' H ' ' A' ' 52' ' ' ILE . . . -39.96 -29.57 0.21 Allowed Pre-proline 0 C--O 1.234 0.281 0 N-CA-C 111.88 0.326 . . . . 0.0 111.88 -178.922 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.404 ' HD2' ' N ' ' A' ' 50' ' ' ALA . 33.7 Cg_exo -53.19 4.5 0.03 OUTLIER 'Trans proline' 0 C--N 1.312 -1.379 0 CA-C-N 119.179 0.742 . . . . 0.0 112.439 178.158 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.712 HG23 ' O ' ' A' ' 49' ' ' LEU . 8.1 pt -52.49 -33.45 17.84 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.174 0 CA-C-O 121.101 0.477 . . . . 0.0 109.961 179.214 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.439 ' O ' ' CB ' ' A' ' 57' ' ' TYR . 72.6 m95 -79.72 -23.38 42.37 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.45 -179.002 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -71.76 -46.22 39.52 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 110.12 -1.192 . . . . 0.0 110.12 179.08 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 5.9 m -68.36 -52.22 35.66 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 179.321 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.413 HD23 ' HA ' ' A' ' 56' ' ' LEU . 96.0 mt -60.02 -28.72 67.97 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.887 179.438 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.512 ' CD1' ' C ' ' A' ' 57' ' ' TYR . 0.4 OUTLIER -63.76 -51.53 64.43 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 179.454 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 5.8 p -53.98 -50.73 65.91 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.152 179.467 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.71 -42.03 87.7 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.329 179.621 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.517 ' SD ' ' OG1' ' A' ' 12' ' ' THR . 11.3 mtm -59.27 -40.87 87.41 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.926 179.579 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -58.83 -45.09 95.47 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 110.526 -1.03 . . . . 0.0 110.526 179.591 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.481 ' CD1' ' N ' ' A' ' 62' ' ' TYR . 2.9 m-30 -62.15 -60.0 4.23 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 121.06 -0.256 . . . . 0.0 110.951 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.475 ' O ' HG23 ' A' ' 67' ' ' VAL . . . -54.04 -60.89 7.76 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 110.986 -0.845 . . . . 0.0 110.986 -179.593 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.521 ' O ' ' CD1' ' A' ' 68' ' ' TRP . 56.0 p -45.5 -48.27 14.09 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.012 0.434 . . . . 0.0 110.465 179.804 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 57.6 t80 -56.47 -41.05 75.91 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.945 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 79.4 mt -67.8 -43.44 86.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.952 -179.585 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.496 ' CG1' ' CZ3' ' A' ' 68' ' ' TRP . 21.5 t -52.54 -56.33 7.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.86 -179.774 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' TRP . . . . . 0.609 ' CE2' HD11 ' A' ' 82' ' ' LEU . 1.0 OUTLIER -66.29 -46.85 75.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.089 -179.391 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.07 -24.46 40.0 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.947 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -81.19 -62.1 1.76 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.348 -179.455 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.2 pp -69.3 -2.15 9.99 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.46 -179.101 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.491 ' O ' ' O ' ' A' ' 73' ' ' GLY . . . 108.4 71.13 0.71 Allowed Glycine 0 CA--C 1.527 0.817 0 N-CA-C 111.572 -0.611 . . . . 0.0 111.572 179.557 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.591 ' N ' ' O ' ' A' ' 68' ' ' TRP . . . 42.03 -173.53 0.01 OUTLIER Glycine 0 CA--C 1.525 0.701 0 N-CA-C 111.94 -0.464 . . . . 0.0 111.94 179.286 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 57.6 t80 -69.81 111.21 5.4 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.203 -0.498 . . . . 0.0 111.009 -179.523 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.516 ' OG1' ' N ' ' A' ' 76' ' ' GLU . 1.3 t -139.4 -175.44 4.18 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.226 179.664 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.516 ' N ' ' OG1' ' A' ' 75' ' ' THR . 73.4 mt-10 -52.92 -24.4 9.18 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.086 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -79.92 -17.71 52.39 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.001 -179.588 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.531 ' O ' HD12 ' A' ' 82' ' ' LEU . . . -96.78 -15.6 21.26 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.04 -179.495 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 7.0 mtp -70.05 -28.27 65.32 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.484 -0.326 . . . . 0.0 110.885 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 5.1 t -70.47 -54.99 8.02 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.758 -179.717 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -62.93 -54.61 1.08 Allowed 'Trans proline' 0 N--CA 1.498 1.764 0 C-N-CA 120.993 1.129 . . . . 0.0 111.802 179.324 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.609 HD11 ' CE2' ' A' ' 68' ' ' TRP . 1.5 mt -61.05 -55.91 27.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.533 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -53.33 -60.32 8.34 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 111.084 -0.807 . . . . 0.0 111.084 -179.696 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.6 tt -48.54 -40.82 28.34 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.781 0.324 . . . . 0.0 110.631 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.4 ' O ' ' CB ' ' A' ' 89' ' ' LEU . 11.0 t80 -63.02 -36.15 82.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.597 -179.747 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.74 -63.05 1.14 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.197 -179.556 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -60.11 -55.59 29.39 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 111.378 -0.689 . . . . 0.0 111.378 -179.547 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.423 ' O ' ' CB ' ' A' ' 92' ' ' ASN . 6.5 tp-100 -50.84 -47.25 60.28 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.652 0.263 . . . . 0.0 111.029 -179.669 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.4 ' CB ' ' O ' ' A' ' 85' ' ' TYR . 11.4 tp -65.3 -28.83 69.59 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.98 0.419 . . . . 0.0 110.313 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.789 ' O ' ' HB2' ' A' ' 94' ' ' ALA . . . -64.7 -65.57 0.66 Allowed 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 120.429 -0.509 . . . . 0.0 111.404 -179.811 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.3 pp -71.59 -26.11 62.46 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -178.727 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.423 ' CB ' ' O ' ' A' ' 88' ' ' GLN . 19.1 t-20 -83.53 -57.23 3.32 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.68 -0.408 . . . . 0.0 111.75 -178.847 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' TRP . . . . . 0.621 ' O ' ' N ' ' A' ' 95' ' ' TRP . 0.0 OUTLIER -72.08 -20.58 61.63 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.693 -0.403 . . . . 0.0 111.091 -178.851 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.789 ' HB2' ' O ' ' A' ' 90' ' ' ALA . . . -46.94 85.31 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.115 0 C-N-CA 120.703 -0.399 . . . . 0.0 110.207 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.707 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 34.4 p-90 -99.77 -16.9 0.2 Allowed Pre-proline 0 CA--C 1.537 0.445 0 CA-C-N 116.2 -0.455 . . . . 0.0 112.119 -179.653 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.707 ' CD ' ' N ' ' A' ' 95' ' ' TRP . 50.1 Cg_exo -55.15 -36.61 93.49 Favored 'Trans proline' 0 N--CA 1.496 1.639 0 C-N-CA 120.424 0.749 . . . . 0.0 113.106 179.483 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.469 ' HD2' ' N ' ' A' ' 96' ' ' PRO . 26.7 Cg_exo -39.74 -29.5 0.29 Allowed 'Trans proline' 0 N--CA 1.491 1.364 0 CA-C-N 118.979 0.671 . . . . 0.0 113.261 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 1.1 pt -83.87 26.45 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 121.109 0.48 . . . . 0.0 110.341 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.444 ' N ' ' O ' ' A' ' 96' ' ' PRO . 11.1 t80 -40.82 -43.52 2.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.794 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -81.53 -42.8 19.66 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.859 -179.699 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -61.09 -7.01 7.94 Favored Glycine 0 CA--C 1.527 0.791 0 N-CA-C 111.21 -0.756 . . . . 0.0 111.21 -179.746 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -76.01 -7.32 54.38 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 121.015 -0.274 . . . . 0.0 110.884 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 39.7 ptt85 -89.34 2.04 54.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.77 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 9.4 mt-30 -119.47 164.34 15.92 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.492 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.586 ' O ' ' NE1' ' A' ' 155' ' ' TRP . 0.0 OUTLIER -52.44 -17.46 1.22 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.296 179.78 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.577 ' O ' ' N ' ' A' ' 108' ' ' ALA . . . -68.11 -15.34 67.33 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 111.058 -0.817 . . . . 0.0 111.058 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' TRP . . . . . 0.416 ' CD1' ' C ' ' A' ' 107' ' ' TRP . 0.0 OUTLIER -44.87 -11.71 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.726 0.298 . . . . 0.0 110.802 -179.727 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.577 ' N ' ' O ' ' A' ' 106' ' ' GLY . . . -66.99 -23.28 65.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.998 0.428 . . . . 0.0 110.485 179.765 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 8.3 mp -52.44 -29.82 26.43 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.023 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -55.87 -64.02 0.99 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.396 179.784 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.748 ' O ' HG23 ' A' ' 115' ' ' VAL . 1.6 p30 -55.62 -52.46 63.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.917 -179.418 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.586 ' N ' ' OD1' ' A' ' 111' ' ' ASP . 8.1 tp -55.55 -40.88 72.47 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.884 -0.327 . . . . 0.0 111.714 -178.66 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 50.5 mt -68.68 -61.36 1.85 Allowed 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.678 -0.409 . . . . 0.0 111.912 -178.722 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.5 pp -57.95 -34.51 69.98 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 120.361 -0.536 . . . . 0.0 111.122 -178.995 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.748 HG23 ' O ' ' A' ' 111' ' ' ASP . 41.0 t -59.96 -54.52 33.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.912 179.745 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' SER . . . . . 0.443 ' O ' ' OG1' ' A' ' 120' ' ' THR . 58.7 m -71.68 -24.01 61.75 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.573 -179.286 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -65.22 -63.05 4.39 Favored Glycine 0 CA--C 1.527 0.821 0 C-N-CA 120.824 -0.703 . . . . 0.0 111.762 -179.32 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.566 ' O ' HG23 ' A' ' 122' ' ' THR . 8.0 p -71.78 -37.87 63.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 O-C-N 122.834 -0.215 . . . . 0.0 111.429 -179.404 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.491 ' O ' ' OG1' ' A' ' 123' ' ' THR . . . -66.22 -60.85 2.4 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.623 -0.431 . . . . 0.0 111.192 -179.171 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.443 ' OG1' ' O ' ' A' ' 116' ' ' SER . 3.0 m -59.1 -54.28 48.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.408 -179.241 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.411 ' O ' ' CB ' ' A' ' 125' ' ' ALA . . . -52.31 -40.35 61.74 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.414 -179.24 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.566 HG23 ' O ' ' A' ' 118' ' ' VAL . 33.4 p -73.71 -35.53 65.12 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 111.918 0.34 . . . . 0.0 111.918 -178.966 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.491 ' OG1' ' O ' ' A' ' 119' ' ' ALA . 0.1 OUTLIER -59.94 -48.51 81.41 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.821 -0.352 . . . . 0.0 110.947 -179.458 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.6 pp -83.79 -19.98 34.09 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.616 -179.011 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.411 ' CB ' ' O ' ' A' ' 121' ' ' ALA . . . -87.66 -68.03 0.78 Allowed 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -178.606 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' TRP . . . . . 0.44 ' CD1' ' N ' ' A' ' 126' ' ' TRP . 38.0 m0 -85.22 -57.44 3.08 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 112.762 0.653 . . . . 0.0 112.762 -177.816 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 127' ' ' HIS . . . . . 0.494 ' CD2' ' N ' ' A' ' 127' ' ' HIS . 8.5 m170 -54.37 -22.46 12.32 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.903 -0.319 . . . . 0.0 111.374 -178.58 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.409 ' C ' ' CD ' ' A' ' 128' ' ' ARG . 0.0 OUTLIER -70.84 -48.49 53.66 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.877 -0.329 . . . . 0.0 111.058 -179.665 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 44.2 t -80.82 -49.83 17.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.207 -179.471 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 5.7 t -129.85 115.6 17.94 Favored Pre-proline 0 CA--C 1.532 0.281 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.827 -179.487 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' PRO . . . . . 0.565 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 82.7 Cg_exo -72.12 -43.34 1.16 Allowed 'Trans proline' 0 N--CA 1.491 1.371 0 C-N-CA 121.294 1.329 . . . . 0.0 113.077 179.436 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 132' ' ' PRO . . . . . 0.565 ' CD ' ' N ' ' A' ' 131' ' ' PRO . 68.8 Cg_exo -36.91 -48.82 1.5 Allowed 'Trans proline' 0 N--CA 1.497 1.684 0 C-N-CA 121.038 1.159 . . . . 0.0 112.099 -179.392 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -54.94 -34.98 63.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.042 0.448 . . . . 0.0 110.028 179.568 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' ALA . . . . . 0.554 ' N ' ' O ' ' A' ' 131' ' ' PRO . . . -61.64 -22.36 65.2 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.316 179.609 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 12.1 tpp180 -77.69 -34.58 52.83 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.844 -179.707 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 29.9 mt -73.9 -33.52 64.04 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.63 -0.428 . . . . 0.0 109.922 179.631 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.586 ' O ' ' N ' ' A' ' 139' ' ' PRO . 10.1 mt -80.16 -40.37 27.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.276 -0.42 . . . . 0.0 109.973 179.315 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.493 ' CD1' ' O ' ' A' ' 138' ' ' TYR . 1.1 t80 -23.02 -40.61 0.03 OUTLIER Pre-proline 0 CA--C 1.534 0.335 0 CA-C-N 115.251 -0.886 . . . . 0.0 112.0 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.586 ' N ' ' O ' ' A' ' 137' ' ' LEU . 3.0 Cg_exo -70.59 13.51 0.35 Allowed 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 121.037 1.158 . . . . 0.0 112.237 179.698 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 140' ' ' TYR . . . . . 0.766 ' CE2' HD11 ' A' ' 144' ' ' LEU . 2.6 p90 -94.18 -14.81 25.21 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-O 121.27 0.557 . . . . 0.0 110.438 179.833 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.64 ' CD1' ' CE1' ' A' ' 140' ' ' TYR . 5.2 mp -56.41 -27.8 57.55 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.266 178.805 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -63.78 -46.43 85.28 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.002 179.451 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' TRP . . . . . 0.515 ' CE2' HD12 ' A' ' 52' ' ' ILE . 13.6 t-105 -59.61 -46.82 87.84 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 179.572 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.766 HD11 ' CE2' ' A' ' 140' ' ' TYR . 10.8 mt -52.48 -52.34 54.82 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.263 -0.575 . . . . 0.0 109.871 179.625 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.657 ' O ' HG23 ' A' ' 149' ' ' VAL . . . -64.14 -21.76 66.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.664 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 13.5 t80 -66.09 -63.0 1.18 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.828 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -68.9 -36.48 78.08 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.882 -179.713 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 148' ' ' THR . . . . . 0.498 ' O ' ' OD1' ' A' ' 151' ' ' ASN . 14.8 m -63.32 -50.01 71.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.735 0.302 . . . . 0.0 110.684 -179.828 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.657 HG23 ' O ' ' A' ' 145' ' ' ALA . 88.3 t -65.84 -30.69 50.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.567 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 1.4 tp -60.53 -52.9 63.22 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.9 -0.32 . . . . 0.0 110.209 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 151' ' ' ASN . . . . . 0.498 ' OD1' ' O ' ' A' ' 148' ' ' THR . 0.8 OUTLIER -64.53 -44.04 92.12 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.905 -179.959 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 152' ' ' TYR . . . . . 0.495 ' N ' ' ND2' ' A' ' 151' ' ' ASN . 26.0 t80 -56.64 -44.51 81.37 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.653 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 153' ' ' TYR . . . . . 0.428 ' CD2' ' OD2' ' A' ' 157' ' ' ASP . 20.5 t80 -59.08 -55.07 39.85 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.574 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 64.8 t -57.35 -46.09 85.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.75 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 155' ' ' TRP . . . . . 0.586 ' NE1' ' O ' ' A' ' 105' ' ' MET . 5.1 m0 -48.07 -52.06 21.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.818 0.342 . . . . 0.0 110.173 179.817 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 156' ' ' ARG . . . . . 0.435 ' HA ' ' HE ' ' A' ' 156' ' ' ARG . 0.0 OUTLIER -64.7 -52.2 58.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.685 -179.83 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 157' ' ' ASP . . . . . 0.428 ' OD2' ' CD2' ' A' ' 153' ' ' TYR . 80.0 m-20 -50.02 -48.14 52.76 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.854 -179.689 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 29.2 t-20 . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.777 -179.991 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.711 ' CE2' ' CE3' ' A' ' 68' ' ' TRP . 0.4 OUTLIER . . . . . 0 CA--C 1.528 0.13 0 CA-C-O 120.663 0.268 . . . . 0.0 110.595 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.638 ' N ' ' CD ' ' A' ' 7' ' ' PRO . 1.0 OUTLIER -64.26 -33.32 8.96 Favored Pre-proline 0 C--N 1.328 -0.329 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 179.662 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.638 ' CD ' ' N ' ' A' ' 6' ' ' VAL . 18.9 Cg_exo -72.78 -67.12 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 121.855 1.703 . . . . 0.0 111.867 179.613 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.711 ' O ' HG23 ' A' ' 12' ' ' THR . . . -47.74 -41.89 24.12 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.319 -179.537 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.468 ' O ' ' OG1' ' A' ' 12' ' ' THR . 74.7 t -67.94 -62.41 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -178.892 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -53.78 -47.53 64.74 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 111.567 -0.613 . . . . 0.0 111.567 -179.163 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.415 ' CD1' ' N ' ' A' ' 11' ' ' LEU . 7.6 mp -65.34 -30.53 71.37 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.533 0.206 . . . . 0.0 111.105 -179.519 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.711 HG23 ' O ' ' A' ' 8' ' ' ALA . 6.6 p -76.14 -25.18 55.08 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.749 -0.381 . . . . 0.0 110.786 -179.831 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.425 ' O ' ' C ' ' A' ' 14' ' ' VAL . 9.3 mt -81.72 -36.3 28.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.673 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.428 ' N ' ' HD2' ' A' ' 15' ' ' PRO . 4.9 t -37.08 -55.08 1.74 Allowed Pre-proline 0 CA--C 1.535 0.398 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.784 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.428 ' HD2' ' N ' ' A' ' 14' ' ' VAL . 19.3 Cg_endo -60.98 -47.82 11.84 Favored 'Trans proline' 0 N--CA 1.5 1.868 0 C-N-CA 120.678 0.919 . . . . 0.0 112.125 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.9 m -46.01 -22.14 0.19 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.662 -179.556 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 83.9 mt -71.02 -55.9 7.32 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.85 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -74.84 -21.57 78.33 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 111.157 -0.777 . . . . 0.0 111.157 -179.686 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -69.79 -52.69 18.71 Favored Glycine 0 CA--C 1.522 0.483 0 N-CA-C 110.573 -1.011 . . . . 0.0 110.573 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 68.9 t80 -71.14 -57.88 4.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.721 0.296 . . . . 0.0 110.595 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 8.1 tpp -59.95 -25.69 65.39 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.278 -179.555 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -82.55 -62.98 1.81 Allowed Glycine 0 CA--C 1.525 0.718 0 C-N-CA 120.839 -0.696 . . . . 0.0 111.485 -179.421 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.582 ' O ' HG22 ' A' ' 26' ' ' VAL . . . -59.6 -15.64 20.14 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.798 -0.361 . . . . 0.0 110.659 -179.371 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 61.6 t80 -46.7 -26.19 0.88 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.981 0.42 . . . . 0.0 110.389 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 70.5 t80 -67.73 -50.65 56.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.661 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.582 HG22 ' O ' ' A' ' 23' ' ' ALA . 31.3 m -72.57 -21.03 19.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.671 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -61.24 -41.09 96.28 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.381 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -110.17 -73.44 0.74 Allowed Glycine 0 CA--C 1.525 0.702 0 N-CA-C 111.034 -0.826 . . . . 0.0 111.034 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.422 ' CD ' ' O ' ' A' ' 29' ' ' GLU . 13.0 tm-20 -46.01 -26.51 0.74 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.753 0.311 . . . . 0.0 110.57 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -65.28 -53.25 33.96 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 111.185 -0.766 . . . . 0.0 111.185 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 24.7 mt -48.5 -28.93 3.66 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.916 0.389 . . . . 0.0 110.211 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 82.8 mtt180 -84.1 -53.75 5.32 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.567 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' TRP . . . . . 0.637 ' CZ3' HD21 ' A' ' 37' ' ' LEU . 0.0 OUTLIER -44.74 -35.92 2.92 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.19 -0.459 . . . . 0.0 109.96 179.949 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.443 ' O ' ' O ' ' A' ' 37' ' ' LEU . 2.8 t80 -64.42 -46.62 82.42 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.938 179.558 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -51.18 -22.88 2.86 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.124 179.677 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -90.59 -73.9 1.27 Allowed Glycine 0 CA--C 1.524 0.614 0 N-CA-C 110.569 -1.013 . . . . 0.0 110.569 179.729 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.637 HD21 ' CZ3' ' A' ' 33' ' ' TRP . 0.6 OUTLIER -96.2 167.23 11.32 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 120.791 0.329 . . . . 0.0 110.238 179.171 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -77.57 116.09 17.86 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.963 0.411 . . . . 0.0 111.55 -178.735 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 8.0 mtpt -128.93 149.12 71.54 Favored Pre-proline 0 CA--C 1.532 0.275 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.562 179.385 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo . . . . . 0 C--N 1.308 -1.564 0 C-N-CA 121.199 1.266 . . . . 0.0 111.022 179.304 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.666 ' O ' HG23 ' A' ' 52' ' ' ILE . 44.1 tp . . . . . 0 CA--C 1.531 0.235 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.626 ' C ' ' H ' ' A' ' 52' ' ' ILE . . . -41.74 -28.92 0.27 Allowed Pre-proline 0 N--CA 1.466 0.358 0 C-N-CA 120.22 -0.592 . . . . 0.0 111.46 -179.138 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.426 ' HD2' ' N ' ' A' ' 50' ' ' ALA . 23.2 Cg_exo -53.05 4.06 0.03 OUTLIER 'Trans proline' 0 C--N 1.312 -1.364 0 CA-C-N 118.847 0.624 . . . . 0.0 112.123 177.829 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.666 HG23 ' O ' ' A' ' 49' ' ' LEU . 7.1 pt -48.44 -29.61 2.55 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.177 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 179.054 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 6.5 m0 -58.97 -45.44 90.54 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.465 -0.788 . . . . 0.0 110.89 -179.607 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -68.84 -42.53 78.48 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 110.901 -0.879 . . . . 0.0 110.901 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.48 ' O ' ' OG ' ' A' ' 58' ' ' SER . 51.9 m -59.04 -56.31 23.93 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.798 0.332 . . . . 0.0 110.709 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 70.4 mt -67.32 -30.45 70.29 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.665 -179.722 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.493 ' CD1' ' C ' ' A' ' 57' ' ' TYR . 13.7 t80 -60.8 -36.31 78.7 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.132 179.572 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.48 ' OG ' ' O ' ' A' ' 55' ' ' THR . 7.7 p -74.07 -57.92 3.64 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.047 179.587 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -48.53 -52.29 23.29 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.022 179.645 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 70.6 mtm -55.09 -47.88 74.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.072 179.608 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -46.82 -59.56 5.44 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 110.717 -0.953 . . . . 0.0 110.717 179.804 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 3.4 m-30 -51.84 -52.18 51.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.924 0.392 . . . . 0.0 110.116 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.501 ' O ' HG23 ' A' ' 67' ' ' VAL . . . -47.83 -46.76 25.33 Favored Glycine 0 CA--C 1.522 0.53 0 N-CA-C 110.487 -1.045 . . . . 0.0 110.487 179.674 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.537 ' O ' ' NE1' ' A' ' 68' ' ' TRP . 1.1 t -60.53 -45.04 95.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.793 0.33 . . . . 0.0 110.577 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.416 ' HA ' ' CZ2' ' A' ' 68' ' ' TRP . 84.6 t80 -48.55 -45.85 38.19 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 179.58 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 37.9 mt -72.27 -26.06 24.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.136 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.501 HG23 ' O ' ' A' ' 63' ' ' GLY . 55.8 t -65.21 -59.94 3.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 C-N-CA 120.584 -0.446 . . . . 0.0 111.09 -179.673 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' TRP . . . . . 0.711 ' CE3' ' CE2' ' A' ' 5' ' ' TRP . 0.0 OUTLIER -67.51 -33.83 75.88 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 119.9 -0.72 . . . . 0.0 110.563 -179.753 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 5.8 mmmt -69.56 -23.41 63.56 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.517 -0.473 . . . . 0.0 111.035 -179.762 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 19.9 tp10 -80.95 -55.61 4.67 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.941 -0.304 . . . . 0.0 111.226 -179.471 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.6 pp -77.04 -11.77 59.85 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.93 -0.308 . . . . 0.0 111.184 -179.301 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.491 ' O ' ' O ' ' A' ' 73' ' ' GLY . . . 107.0 87.29 1.93 Allowed Glycine 0 CA--C 1.527 0.835 0 N-CA-C 111.604 -0.598 . . . . 0.0 111.604 179.398 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.596 ' N ' ' O ' ' A' ' 68' ' ' TRP . . . 41.56 -173.82 0.01 OUTLIER Glycine 0 CA--C 1.525 0.714 0 N-CA-C 111.797 -0.521 . . . . 0.0 111.797 179.207 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 82.7 t80 -79.94 113.39 18.07 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.841 0.353 . . . . 0.0 110.548 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.548 ' OG1' ' N ' ' A' ' 76' ' ' GLU . 0.0 OUTLIER -141.89 -178.85 5.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.626 -179.86 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.548 ' N ' ' OG1' ' A' ' 75' ' ' THR . 31.8 mt-10 -54.93 -20.12 8.23 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.623 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 76.0 m-20 -83.1 -18.57 39.1 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.921 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -93.32 -20.21 20.61 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.862 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 11.7 mtp -69.01 -27.22 65.49 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.846 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 5.9 t -67.56 -46.9 47.3 Favored Pre-proline 0 CA--C 1.536 0.432 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.534 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -75.18 -61.65 0.04 OUTLIER 'Trans proline' 0 N--CA 1.499 1.845 0 C-N-CA 121.106 1.204 . . . . 0.0 111.656 178.809 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 4.6 mt -52.33 -50.66 61.84 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.363 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.406 ' O ' ' N ' ' A' ' 86' ' ' THR . . . -61.93 -64.04 4.27 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 111.262 -0.735 . . . . 0.0 111.262 -179.705 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 40.3 tp -46.83 -29.61 2.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.823 0.344 . . . . 0.0 110.233 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.423 ' CD1' ' C ' ' A' ' 85' ' ' TYR . 1.1 t80 -75.27 -37.68 60.82 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.033 179.744 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.406 ' N ' ' O ' ' A' ' 83' ' ' GLY . 0.8 OUTLIER -67.91 -48.92 64.63 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.094 -179.648 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -69.15 -58.04 7.06 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 111.492 -0.643 . . . . 0.0 111.492 -179.507 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 34.0 tp60 -51.45 -49.23 62.14 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-O 120.991 0.424 . . . . 0.0 110.414 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.427 ' O ' ' C ' ' A' ' 90' ' ' ALA . 27.3 tp -54.65 -62.62 1.54 Allowed 'General case' 0 C--O 1.212 -0.869 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 179.525 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.696 ' O ' ' HB2' ' A' ' 94' ' ' ALA . . . -38.24 -42.81 0.72 Allowed 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 120.537 -0.465 . . . . 0.0 111.426 -179.683 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 92.1 mt -63.16 -56.81 13.57 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 -178.575 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 15.8 m-20 -72.24 -54.63 9.02 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 121.431 0.634 . . . . 0.0 111.058 -178.897 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' TRP . . . . . 0.61 ' O ' ' N ' ' A' ' 95' ' ' TRP . 16.6 t-105 -52.75 -30.0 30.23 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.049 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.696 ' HB2' ' O ' ' A' ' 90' ' ' ALA . . . -60.38 71.8 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 121.084 0.469 . . . . 0.0 109.753 179.376 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.71 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 23.8 p-90 -98.49 -17.18 0.2 Allowed Pre-proline 0 CA--C 1.537 0.478 0 CA-C-N 115.852 -0.613 . . . . 0.0 112.336 -179.255 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.71 ' CD ' ' N ' ' A' ' 95' ' ' TRP . 52.6 Cg_exo -53.4 -39.84 80.31 Favored 'Trans proline' 0 N--CA 1.497 1.684 0 C-N-CA 120.556 0.837 . . . . 0.0 113.341 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.457 ' HD2' ' N ' ' A' ' 96' ' ' PRO . 31.7 Cg_exo -36.52 -34.94 0.17 Allowed 'Trans proline' 0 N--CA 1.491 1.327 0 CA-C-N 119.143 0.73 . . . . 0.0 113.185 -179.727 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -79.58 24.27 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 121.024 0.44 . . . . 0.0 110.386 179.696 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.537 ' N ' ' O ' ' A' ' 96' ' ' PRO . 27.0 t80 -44.31 -34.93 2.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.666 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -86.19 -42.97 13.39 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.893 -179.762 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -61.42 -9.59 18.12 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 111.07 -0.812 . . . . 0.0 111.07 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -61.55 -13.27 20.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.748 0.309 . . . . 0.0 110.935 -179.762 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 25.3 ptt180 -90.68 4.56 51.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.809 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 12.1 mt-30 -115.28 154.2 29.53 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.435 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -52.71 -18.26 1.73 Allowed 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 179.559 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.583 ' O ' ' N ' ' A' ' 108' ' ' ALA . . . -69.43 -15.96 71.01 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' TRP . . . . . 0.452 ' CD1' ' N ' ' A' ' 108' ' ' ALA . 0.1 OUTLIER -45.36 -11.67 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.9 0.381 . . . . 0.0 110.54 -179.865 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.583 ' N ' ' O ' ' A' ' 106' ' ' GLY . . . -59.32 -23.15 62.24 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.193 179.657 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 13.9 mt -53.7 -28.66 35.05 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.383 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -56.71 -61.37 2.48 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.862 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.716 ' O ' HG23 ' A' ' 115' ' ' VAL . 1.4 p30 -61.53 -52.29 65.08 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.785 -179.293 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.531 ' N ' ' CG ' ' A' ' 111' ' ' ASP . 56.1 tp -55.42 -38.41 68.93 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.716 -178.876 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.42 HD23 ' HA ' ' A' ' 113' ' ' LEU . 51.7 mt -71.4 -61.81 1.64 Allowed 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.36 0.504 . . . . 0.0 112.36 -178.611 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.6 pp -59.75 -32.84 70.95 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.213 -0.595 . . . . 0.0 110.95 -178.947 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.716 HG23 ' O ' ' A' ' 111' ' ' ASP . 41.3 t -61.7 -59.47 4.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.752 179.767 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' SER . . . . . 0.49 ' O ' ' OG1' ' A' ' 120' ' ' THR . 49.4 m -68.84 -22.1 64.25 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.428 -179.261 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -66.51 -62.58 4.49 Favored Glycine 0 CA--C 1.527 0.823 0 C-N-CA 121.039 -0.601 . . . . 0.0 111.934 -179.124 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.6 ' O ' HG23 ' A' ' 122' ' ' THR . 7.0 p -72.43 -36.91 56.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 C-N-CA 120.915 -0.314 . . . . 0.0 111.411 -179.23 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.531 ' O ' ' OG1' ' A' ' 123' ' ' THR . . . -67.41 -61.01 2.11 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.593 -0.443 . . . . 0.0 110.953 -179.362 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.49 ' OG1' ' O ' ' A' ' 116' ' ' SER . 2.8 m -58.64 -55.33 36.53 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.234 -179.584 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.419 ' O ' ' CB ' ' A' ' 125' ' ' ALA . . . -50.53 -41.95 54.45 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.304 -179.352 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.6 HG23 ' O ' ' A' ' 118' ' ' VAL . 38.9 p -73.32 -39.72 65.04 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 111.844 0.313 . . . . 0.0 111.844 -179.095 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.531 ' OG1' ' O ' ' A' ' 119' ' ' ALA . 0.1 OUTLIER -54.09 -50.28 67.17 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.91 -179.268 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.6 pp -84.11 -20.32 32.76 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.198 -0.455 . . . . 0.0 112.077 -178.663 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.419 ' CB ' ' O ' ' A' ' 121' ' ' ALA . . . -88.68 -70.68 0.63 Allowed 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 -178.47 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' TRP . . . . . 0.55 ' CD1' ' N ' ' A' ' 126' ' ' TRP . 18.6 m0 -83.93 -58.0 2.97 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 112.84 0.681 . . . . 0.0 112.84 -177.862 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 18.9 m170 -49.77 -22.23 1.35 Allowed 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.458 -0.497 . . . . 0.0 110.932 -179.128 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 1.4 tmt_? -73.44 -29.47 62.57 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.023 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 14.6 t -99.76 -49.85 11.07 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 CA-C-O 120.942 0.401 . . . . 0.0 110.763 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -115.56 105.83 51.36 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.202 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 131' ' ' PRO . . . . . 0.64 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 76.9 Cg_exo -72.77 -24.34 18.22 Favored 'Trans proline' 0 C--N 1.311 -1.398 0 C-N-CA 121.59 1.526 . . . . 0.0 112.686 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 132' ' ' PRO . . . . . 0.64 ' CD ' ' N ' ' A' ' 131' ' ' PRO . 51.2 Cg_exo -66.21 -47.47 3.34 Favored 'Trans proline' 0 N--CA 1.496 1.627 0 C-N-CA 121.292 1.328 . . . . 0.0 112.084 179.624 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -50.41 -39.39 47.03 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.568 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -53.92 -23.48 13.02 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.404 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 11.0 tpp180 -78.25 -32.4 49.63 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.545 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 47.0 mt -72.77 -33.47 66.34 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.32 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.58 ' O ' ' N ' ' A' ' 140' ' ' TYR . 5.6 mt -84.09 -39.26 19.74 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.002 -0.545 . . . . 0.0 109.855 179.519 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.477 ' C ' ' O ' ' A' ' 137' ' ' LEU . 2.0 t80 -23.72 -43.67 0.05 OUTLIER Pre-proline 0 CA--C 1.534 0.338 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.82 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.516 ' N ' ' O ' ' A' ' 137' ' ' LEU . 3.4 Cg_exo -67.61 10.96 0.24 Allowed 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 120.984 1.123 . . . . 0.0 112.561 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 140' ' ' TYR . . . . . 0.871 ' CE2' HD11 ' A' ' 144' ' ' LEU . 1.5 p90 -93.83 -14.88 25.65 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 121.083 0.468 . . . . 0.0 110.483 179.819 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.618 ' CD1' ' CE1' ' A' ' 140' ' ' TYR . 4.1 mp -53.63 -32.45 51.36 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 179.004 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -60.33 -52.46 65.17 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.217 179.75 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' TRP . . . . . 0.545 ' CE2' HD12 ' A' ' 52' ' ' ILE . 7.7 t-105 -53.08 -49.66 65.95 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 179.577 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.871 HD11 ' CE2' ' A' ' 140' ' ' TYR . 10.5 mt -49.99 -59.6 3.72 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.015 179.51 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.614 ' O ' HG23 ' A' ' 149' ' ' VAL . . . -58.73 -20.71 51.49 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.056 -179.684 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -67.18 -57.6 6.43 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.805 -0.358 . . . . 0.0 110.402 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -66.08 -47.4 74.38 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.216 179.75 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 7.1 m -55.68 -51.35 67.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.709 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.614 HG23 ' O ' ' A' ' 145' ' ' ALA . 90.7 t -64.68 -26.53 40.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 C-N-CA 120.895 -0.322 . . . . 0.0 110.278 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -60.72 -55.0 38.38 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.313 -0.555 . . . . 0.0 109.794 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -65.85 -39.89 91.19 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.694 -0.403 . . . . 0.0 110.357 179.429 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 29.3 t80 -56.05 -46.19 78.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.569 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 153' ' ' TYR . . . . . 0.408 ' O ' ' OD1' ' A' ' 157' ' ' ASP . 5.5 t80 -63.56 -44.66 93.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.479 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 79.5 t -57.74 -45.15 86.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.653 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 155' ' ' TRP . . . . . . . . . . . . . 10.2 m0 -56.45 -56.98 14.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.518 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -49.16 -38.71 26.4 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.589 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 157' ' ' ASP . . . . . 0.408 ' OD1' ' O ' ' A' ' 153' ' ' TYR . 1.5 m-20 -75.41 -52.04 11.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.803 0.335 . . . . 0.0 110.675 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 158' ' ' ASN . . . . . 0.402 HD22 ' HB2' ' A' ' 37' ' ' LEU . 4.4 m-80 . . . . . 0 C--N 1.327 -0.409 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.648 -179.772 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.69 ' CE2' ' CE3' ' A' ' 68' ' ' TRP . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.094 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.609 ' N ' ' CD ' ' A' ' 7' ' ' PRO . 0.9 OUTLIER -61.66 -35.5 22.96 Favored Pre-proline 0 CA--C 1.532 0.277 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 -179.914 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.609 ' CD ' ' N ' ' A' ' 6' ' ' VAL . 18.6 Cg_exo -70.83 -67.53 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.509 0 C-N-CA 121.686 1.59 . . . . 0.0 111.835 179.541 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.656 ' O ' HG23 ' A' ' 12' ' ' THR . . . -46.79 -40.27 13.37 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.202 -179.652 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.572 HG23 ' O ' ' A' ' 5' ' ' TRP . 73.8 t -65.24 -61.97 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 112.062 0.393 . . . . 0.0 112.062 -178.938 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -58.38 -49.49 75.81 Favored Glycine 0 CA--C 1.527 0.837 0 N-CA-C 111.269 -0.732 . . . . 0.0 111.269 -179.158 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 9.3 mp -58.87 -30.54 67.81 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.538 0.209 . . . . 0.0 110.755 -179.852 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.656 HG23 ' O ' ' A' ' 8' ' ' ALA . 7.5 p -78.66 -31.18 46.64 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 120.801 -0.36 . . . . 0.0 110.191 179.548 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.416 ' HA ' HD23 ' A' ' 13' ' ' LEU . 81.2 mt -73.53 -22.17 60.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.117 179.656 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.498 ' O ' ' N ' ' A' ' 16' ' ' SER . 9.7 t -58.22 -66.6 1.26 Allowed Pre-proline 0 CA--C 1.536 0.434 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.312 -179.798 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -45.49 -14.87 0.11 Allowed 'Trans proline' 0 N--CA 1.499 1.799 0 C-N-CA 120.778 0.985 . . . . 0.0 112.074 -179.625 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.498 ' N ' ' O ' ' A' ' 14' ' ' VAL . 1.1 t -76.17 -35.99 58.9 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.866 0.365 . . . . 0.0 110.6 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 8.9 mt -69.75 -45.12 68.8 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.172 -179.736 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -73.6 -48.86 16.25 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 111.631 -0.588 . . . . 0.0 111.631 -179.545 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -63.24 -30.16 76.67 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 111.18 -0.768 . . . . 0.0 111.18 -179.576 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 64.4 t80 -75.95 -60.77 2.18 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.838 -0.345 . . . . 0.0 111.107 -179.528 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 28.0 ttp -61.59 -21.31 64.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.908 0.385 . . . . 0.0 110.324 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.515 ' C ' ' CZ2' ' A' ' 95' ' ' TRP . . . -73.45 -62.9 2.92 Favored Glycine 0 CA--C 1.524 0.615 0 N-CA-C 111.135 -0.786 . . . . 0.0 111.135 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.94 -16.49 63.92 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.54 -179.752 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 42.8 t80 -49.93 -24.15 2.37 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 179.264 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 9.7 t80 -72.11 -53.41 12.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.862 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 16.4 m -72.09 -14.58 17.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.81 -179.668 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.64 -42.69 75.35 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.255 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -121.45 -49.86 0.26 Allowed Glycine 0 CA--C 1.525 0.709 0 N-CA-C 110.693 -0.963 . . . . 0.0 110.693 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -56.01 -32.03 63.61 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.887 0.375 . . . . 0.0 110.417 179.838 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -75.46 -58.23 3.96 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.874 -0.89 . . . . 0.0 110.874 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 11.0 mp -53.49 -21.89 7.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.903 0.382 . . . . 0.0 110.06 179.676 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 38.9 mtp180 -84.86 -54.98 4.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.526 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -48.52 -30.57 5.36 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.182 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 52.1 t80 -50.3 -40.02 47.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.877 0.37 . . . . 0.0 110.31 179.723 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -58.91 -17.42 24.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.393 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -100.44 -72.15 0.99 Allowed Glycine 0 CA--C 1.527 0.796 0 N-CA-C 111.003 -0.839 . . . . 0.0 111.003 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.575 ' O ' HD12 ' A' ' 37' ' ' LEU . 0.3 OUTLIER -95.45 167.08 11.54 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.838 0.352 . . . . 0.0 110.828 179.861 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.441 ' CD ' ' H ' ' A' ' 38' ' ' GLN . 0.2 OUTLIER -81.62 113.38 19.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.126 -179.673 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 15.4 mtpt -129.05 160.19 64.91 Favored Pre-proline 0 CA--C 1.531 0.248 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.718 179.489 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo . . . . . 0 C--N 1.309 -1.538 0 C-N-CA 121.806 1.671 . . . . 0.0 111.381 179.356 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.823 ' O ' HG23 ' A' ' 52' ' ' ILE . 0.2 OUTLIER . . . . . 0 CA--C 1.533 0.297 0 N-CA-C 112.243 0.46 . . . . 0.0 112.243 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.587 ' C ' ' H ' ' A' ' 52' ' ' ILE . . . -38.3 -33.78 0.25 Allowed Pre-proline 0 C--O 1.235 0.337 0 C-N-CA 120.771 -0.372 . . . . 0.0 111.431 -179.03 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.43 ' HD2' ' N ' ' A' ' 50' ' ' ALA . 34.4 Cg_exo -53.69 4.93 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.613 0 C-N-CA 120.355 0.703 . . . . 0.0 112.773 178.816 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.823 HG23 ' O ' ' A' ' 49' ' ' LEU . 10.5 pt -54.08 -35.65 29.57 Favored 'Isoleucine or valine' 0 C--O 1.232 0.169 0 CA-C-O 121.248 0.547 . . . . 0.0 109.542 179.157 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.421 ' O ' ' CB ' ' A' ' 57' ' ' TYR . 62.3 m95 -73.17 -22.95 60.38 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.244 -0.889 . . . . 0.0 111.35 -179.285 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -70.49 -48.15 38.33 Favored Glycine 0 CA--C 1.527 0.812 0 N-CA-C 110.481 -1.048 . . . . 0.0 110.481 179.503 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 11.0 m -65.75 -55.28 18.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.969 0.414 . . . . 0.0 109.909 179.58 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.562 ' O ' ' SD ' ' A' ' 60' ' ' MET . 94.8 mt -56.71 -36.29 69.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.954 179.463 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.548 ' CD1' ' C ' ' A' ' 57' ' ' TYR . 0.4 OUTLIER -54.76 -52.03 63.84 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 179.109 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 3.1 m -52.23 -47.26 65.8 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 178.919 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -56.26 -46.24 79.74 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.343 179.781 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.562 ' SD ' ' O ' ' A' ' 56' ' ' LEU . 0.0 OUTLIER -61.87 -40.74 96.44 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.334 179.926 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -52.46 -52.89 34.69 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 110.641 -0.984 . . . . 0.0 110.641 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.46 ' CD1' ' N ' ' A' ' 62' ' ' TYR . 1.1 m-85 -65.78 -40.86 92.38 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.925 0.393 . . . . 0.0 110.376 179.762 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.46 ' O ' HG23 ' A' ' 67' ' ' VAL . . . -54.19 -52.55 43.13 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 110.342 -1.103 . . . . 0.0 110.342 179.644 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.587 ' O ' ' CD1' ' A' ' 68' ' ' TRP . 1.0 OUTLIER -56.47 -44.56 80.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.86 0.362 . . . . 0.0 110.42 179.684 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.45 ' HA ' ' CZ2' ' A' ' 68' ' ' TRP . 85.4 t80 -48.45 -47.35 38.27 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.674 -0.41 . . . . 0.0 110.083 179.651 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 53.3 mt -70.7 -25.95 27.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.041 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.46 HG23 ' O ' ' A' ' 63' ' ' GLY . 68.8 t -66.02 -58.79 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 C-N-CA 120.582 -0.447 . . . . 0.0 111.578 -179.41 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' TRP . . . . . 0.69 ' CE3' ' CE2' ' A' ' 5' ' ' TRP . 0.0 OUTLIER -71.79 -27.8 63.18 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 119.656 -0.818 . . . . 0.0 110.69 -179.643 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 9.4 mmmt -72.25 -24.2 61.33 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.468 -0.493 . . . . 0.0 110.352 179.658 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -82.31 -59.18 2.63 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.949 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.5 pp -71.67 -16.77 62.26 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.02 -179.548 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.5 ' O ' ' O ' ' A' ' 73' ' ' GLY . . . 108.39 94.53 2.34 Favored Glycine 0 CA--C 1.527 0.826 0 N-CA-C 111.703 -0.559 . . . . 0.0 111.703 179.459 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.585 ' N ' ' O ' ' A' ' 68' ' ' TRP . . . 42.02 -174.1 0.01 OUTLIER Glycine 0 CA--C 1.525 0.704 0 N-CA-C 111.799 -0.52 . . . . 0.0 111.799 179.198 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 32.4 t80 -87.22 113.21 22.75 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.547 -0.327 . . . . 0.0 110.595 -179.76 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.528 ' OG1' ' N ' ' A' ' 76' ' ' GLU . 0.8 OUTLIER -142.13 -177.41 5.22 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.686 -179.909 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.528 ' N ' ' OG1' ' A' ' 75' ' ' THR . 29.5 mt-10 -51.78 -23.14 4.27 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.796 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -79.72 -24.58 41.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.939 -179.76 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.446 ' O ' HD12 ' A' ' 82' ' ' LEU . . . -90.33 -20.59 22.7 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.003 -179.836 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 14.9 mtp -69.49 -28.66 66.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.806 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.416 ' O ' ' CB ' ' A' ' 84' ' ' LEU . 5.9 t -67.16 -50.77 39.01 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.507 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.4 ' HD2' ' N ' ' A' ' 80' ' ' VAL . 14.7 Cg_endo -69.52 -60.45 0.07 OUTLIER 'Trans proline' 0 N--CA 1.499 1.846 0 C-N-CA 121.065 1.177 . . . . 0.0 111.81 179.031 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.446 HD12 ' O ' ' A' ' 78' ' ' ALA . 1.3 mt -53.37 -51.95 60.84 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.614 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -62.84 -63.33 4.7 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 111.383 -0.687 . . . . 0.0 111.383 -179.485 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.416 ' CB ' ' O ' ' A' ' 80' ' ' VAL . 52.6 tp -45.87 -31.64 2.23 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.749 0.309 . . . . 0.0 110.647 -179.845 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 7.0 t80 -67.96 -58.51 4.42 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.274 -179.729 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 3.5 m -61.89 -60.35 3.77 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.841 -179.754 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -45.56 -57.11 6.04 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 111.112 -0.795 . . . . 0.0 111.112 -179.693 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 11.1 tp-100 -58.94 -32.85 69.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.759 0.314 . . . . 0.0 110.679 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.445 ' O ' ' CD1' ' A' ' 93' ' ' TRP . 11.8 tp -67.73 -36.59 80.85 Favored 'General case' 0 C--O 1.222 -0.379 0 C-N-CA 120.685 -0.406 . . . . 0.0 110.306 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.856 ' O ' ' HB2' ' A' ' 94' ' ' ALA . . . -65.81 -59.91 3.41 Favored 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 120.268 -0.573 . . . . 0.0 110.379 179.833 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.416 ' N ' HD23 ' A' ' 91' ' ' LEU . 7.9 mt -55.31 -53.89 50.44 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.786 -0.643 . . . . 0.0 112.21 -179.085 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -75.2 -60.83 2.12 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -177.769 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' TRP . . . . . 0.611 ' O ' ' N ' ' A' ' 95' ' ' TRP . 0.0 OUTLIER -63.78 -11.74 29.4 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.192 0.441 . . . . 0.0 112.192 -177.688 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.856 ' HB2' ' O ' ' A' ' 90' ' ' ALA . . . -54.12 80.5 0.0 OUTLIER 'General case' 0 CA--C 1.528 0.126 0 C-N-CA 120.399 -0.521 . . . . 0.0 109.76 179.224 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.689 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 14.6 p-90 -101.22 -15.23 0.18 Allowed Pre-proline 0 CA--C 1.534 0.338 0 CA-C-N 116.208 -0.451 . . . . 0.0 112.086 -179.312 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.689 ' CD ' ' N ' ' A' ' 95' ' ' TRP . 64.8 Cg_exo -64.12 -12.65 33.48 Favored 'Trans proline' 0 N--CA 1.498 1.768 0 C-N-CA 120.875 1.05 . . . . 0.0 113.558 179.634 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.621 ' CD ' ' N ' ' A' ' 96' ' ' PRO . 51.2 Cg_exo -85.33 -8.79 8.55 Favored 'Trans proline' 0 N--CA 1.502 1.978 0 C-N-CA 120.753 0.968 . . . . 0.0 113.519 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.416 ' O ' ' N ' ' A' ' 101' ' ' GLY . 1.5 pp -84.18 18.62 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 C-N-CA 120.608 -0.437 . . . . 0.0 110.932 -179.661 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.565 ' CD1' ' O ' ' A' ' 96' ' ' PRO . 2.7 m-30 -39.85 -34.12 0.25 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.211 179.673 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.457 ' O ' ' NE ' ' A' ' 103' ' ' ARG . 0.9 OUTLIER -76.36 -45.08 33.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.745 -179.902 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.416 ' N ' ' O ' ' A' ' 98' ' ' ILE . . . -65.98 -9.98 49.36 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 110.97 -0.852 . . . . 0.0 110.97 -179.921 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -78.35 -7.17 56.98 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.749 0.309 . . . . 0.0 110.724 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.457 ' NE ' ' O ' ' A' ' 100' ' ' PHE . 1.2 ptp180 -79.16 -14.8 58.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.867 -179.769 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' GLN . . . . . 0.407 ' C ' ' N ' ' A' ' 106' ' ' GLY . 1.4 pt20 -125.82 172.58 9.74 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.826 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.493 ' N ' ' SD ' ' A' ' 105' ' ' MET . 0.0 OUTLIER -49.37 -16.88 0.21 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.457 179.822 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.437 ' C ' ' N ' ' A' ' 108' ' ' ALA . . . -60.6 -15.79 41.84 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 111.1 -0.8 . . . . 0.0 111.1 -179.892 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' TRP . . . . . 0.481 ' CD1' ' N ' ' A' ' 108' ' ' ALA . 0.0 OUTLIER -50.48 -14.46 0.18 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.848 0.356 . . . . 0.0 110.432 -179.779 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.481 ' N ' ' CD1' ' A' ' 107' ' ' TRP . . . -61.11 -17.55 53.3 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.212 179.621 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 6.0 mp -56.67 -28.56 60.96 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.671 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -58.71 -62.63 1.72 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.845 0.355 . . . . 0.0 110.672 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.691 ' O ' HG23 ' A' ' 115' ' ' VAL . 4.4 p-10 -57.29 -53.67 55.53 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.358 -179.429 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 29.9 tp -54.45 -43.13 71.37 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.773 -179.034 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 53.7 mt -67.54 -61.3 1.96 Allowed 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.584 0.587 . . . . 0.0 112.584 -178.387 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.9 pp -61.09 -34.36 74.82 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 120.445 -0.502 . . . . 0.0 111.572 -178.555 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.691 HG23 ' O ' ' A' ' 111' ' ' ASP . 48.1 t -61.49 -58.0 9.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.383 -0.372 . . . . 0.0 111.385 -179.856 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 23.4 p -71.9 -23.59 61.51 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.603 -179.091 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -64.61 -62.14 5.31 Favored Glycine 0 CA--C 1.525 0.67 0 C-N-CA 120.842 -0.694 . . . . 0.0 111.472 -179.389 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.6 ' O ' HG23 ' A' ' 122' ' ' THR . 9.8 p -70.71 -37.18 68.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 111.874 0.324 . . . . 0.0 111.874 -179.336 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.512 ' O ' ' OG1' ' A' ' 123' ' ' THR . . . -67.96 -60.91 2.14 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.545 -0.462 . . . . 0.0 111.63 -179.087 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 6.4 m -59.47 -51.84 68.16 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.909 0.385 . . . . 0.0 111.464 -179.299 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -53.92 -43.37 69.71 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.272 -179.203 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.6 HG23 ' O ' ' A' ' 118' ' ' VAL . 38.0 p -71.13 -30.81 66.95 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 111.971 0.36 . . . . 0.0 111.971 -179.135 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.512 ' OG1' ' O ' ' A' ' 119' ' ' ALA . 0.1 OUTLIER -64.72 -48.79 73.32 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 120.851 -0.34 . . . . 0.0 111.074 -179.141 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.8 pp -82.79 -19.92 36.8 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.763 -0.375 . . . . 0.0 111.531 -179.021 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -88.93 -69.59 0.7 Allowed 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.594 0.591 . . . . 0.0 112.594 -178.689 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' TRP . . . . . 0.445 ' CD1' ' N ' ' A' ' 126' ' ' TRP . 36.9 m0 -83.14 -57.53 3.23 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 -177.751 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 127' ' ' HIS . . . . . 0.47 ' CD2' ' N ' ' A' ' 127' ' ' HIS . 10.0 m170 -52.12 -22.18 3.95 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.418 -0.513 . . . . 0.0 111.06 -178.661 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 2.8 tmt_? -71.07 -43.39 67.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.504 -0.317 . . . . 0.0 111.225 -179.833 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 14.9 t -86.92 -49.6 14.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 C-N-CA 120.922 -0.311 . . . . 0.0 111.054 -179.523 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 7.5 m -120.11 110.83 35.92 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.434 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' PRO . . . . . 0.627 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 73.6 Cg_exo -71.34 -33.78 10.68 Favored 'Trans proline' 0 N--CA 1.491 1.345 0 C-N-CA 121.373 1.382 . . . . 0.0 112.387 179.488 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 132' ' ' PRO . . . . . 0.627 ' CD ' ' N ' ' A' ' 131' ' ' PRO . 37.1 Cg_exo -55.36 -39.09 92.91 Favored 'Trans proline' 0 N--CA 1.495 1.595 0 C-N-CA 121.31 1.34 . . . . 0.0 111.75 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -55.91 -34.66 65.78 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.334 179.772 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' ALA . . . . . 0.403 ' HB2' ' CG ' ' A' ' 127' ' ' HIS . . . -64.83 -24.97 67.71 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.38 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 13.5 tpt180 -77.12 -29.12 54.59 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.362 179.801 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 18.4 mt -74.9 -41.05 60.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.379 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.574 ' O ' ' N ' ' A' ' 140' ' ' TYR . 5.0 mt -78.82 -35.49 44.06 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.152 179.624 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.481 ' C ' ' O ' ' A' ' 137' ' ' LEU . 2.0 t80 -23.4 -44.75 0.05 OUTLIER Pre-proline 0 CA--C 1.535 0.372 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.853 -179.865 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.515 ' N ' ' O ' ' A' ' 137' ' ' LEU . 1.7 Cg_endo -67.91 12.6 0.21 Allowed 'Trans proline' 0 C--N 1.309 -1.5 0 C-N-CA 121.188 1.259 . . . . 0.0 112.57 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 140' ' ' TYR . . . . . 0.865 ' CE2' HD11 ' A' ' 144' ' ' LEU . 1.7 p90 -93.41 -14.2 27.08 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-O 121.008 0.432 . . . . 0.0 110.633 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.492 HD22 ' CE1' ' A' ' 140' ' ' TYR . 4.1 mm? -53.37 -38.64 63.54 Favored 'General case' 0 C--N 1.333 -0.122 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 178.754 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -54.99 -46.58 75.14 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.549 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 143' ' ' TRP . . . . . 0.627 ' CE2' HD12 ' A' ' 52' ' ' ILE . 9.5 t-105 -59.21 -49.36 78.16 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.773 -0.455 . . . . 0.0 109.773 179.807 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.865 HD11 ' CE2' ' A' ' 140' ' ' TYR . 12.2 mt -51.89 -54.5 28.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.086 179.722 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.628 ' O ' HG23 ' A' ' 149' ' ' VAL . . . -60.5 -27.01 67.26 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.536 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -60.99 -64.56 0.91 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.533 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -63.83 -49.14 74.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.694 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 73.8 m -51.21 -47.22 62.33 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.911 -179.809 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.628 HG23 ' O ' ' A' ' 145' ' ' ALA . 53.3 t -65.24 -34.47 70.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.882 -179.738 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 1.7 tp -57.15 -55.56 33.22 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.837 0.351 . . . . 0.0 110.307 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -58.12 -57.12 14.22 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.413 179.697 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 18.5 t80 -46.76 -47.26 20.8 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.589 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 43.6 t80 -55.79 -42.98 76.38 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.611 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 89.1 t -66.53 -40.42 86.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.826 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 155' ' ' TRP . . . . . 0.515 ' C ' ' HE ' ' A' ' 156' ' ' ARG . 8.8 m0 -58.61 -39.74 81.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.801 -179.707 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 156' ' ' ARG . . . . . 0.515 ' HE ' ' C ' ' A' ' 155' ' ' TRP . 0.0 OUTLIER -79.29 -45.93 18.75 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.504 -179.885 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -64.19 -50.11 69.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.445 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.524 -179.945 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.663 ' CE2' ' CE3' ' A' ' 68' ' ' TRP . 0.4 OUTLIER . . . . . 0 N--CA 1.46 0.067 0 CA-C-O 120.781 0.324 . . . . 0.0 110.287 . . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.626 ' N ' ' CD ' ' A' ' 7' ' ' PRO . 0.9 OUTLIER -64.61 -32.79 7.52 Favored Pre-proline 0 CA--C 1.534 0.335 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 179.743 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.626 ' CD ' ' N ' ' A' ' 6' ' ' VAL . 23.8 Cg_exo -72.61 -67.02 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 121.888 1.726 . . . . 0.0 112.156 179.654 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.696 ' O ' HG23 ' A' ' 12' ' ' THR . . . -50.93 -38.24 49.09 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.541 -0.3 . . . . 0.0 111.278 -179.565 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.559 HG23 ' O ' ' A' ' 5' ' ' TRP . 75.5 t -67.63 -62.25 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.756 -179.14 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -56.74 -47.61 84.16 Favored Glycine 0 CA--C 1.527 0.79 0 N-CA-C 111.743 -0.543 . . . . 0.0 111.743 -179.192 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.414 ' N ' ' CD1' ' A' ' 11' ' ' LEU . 7.7 mp -64.02 -30.91 71.95 Favored 'General case' 0 C--N 1.326 -0.433 0 O-C-N 122.921 -0.164 . . . . 0.0 111.052 -179.498 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.696 HG23 ' O ' ' A' ' 8' ' ' ALA . 7.5 p -74.96 -25.15 58.66 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.621 -0.432 . . . . 0.0 110.129 179.549 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.454 ' O ' ' CB ' ' A' ' 16' ' ' SER . 9.4 mt -80.65 -32.26 36.21 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.133 179.563 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.42 ' N ' ' HD2' ' A' ' 15' ' ' PRO . 17.9 t -44.65 -53.29 15.5 Favored Pre-proline 0 CA--C 1.536 0.414 0 CA-C-N 115.894 -0.593 . . . . 0.0 111.237 -179.806 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.42 ' HD2' ' N ' ' A' ' 14' ' ' VAL . 18.6 Cg_endo -62.56 -7.53 10.97 Favored 'Trans proline' 0 N--CA 1.499 1.82 0 C-N-CA 120.591 0.861 . . . . 0.0 111.882 179.582 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.454 ' CB ' ' O ' ' A' ' 13' ' ' LEU . 3.7 t -77.69 -26.37 50.15 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.543 -179.866 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 15.9 mt -76.73 -49.66 15.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.85 -179.818 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -77.79 -29.27 55.21 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 111.329 -0.708 . . . . 0.0 111.329 -179.652 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -76.72 -37.49 34.3 Favored Glycine 0 CA--C 1.523 0.539 0 N-CA-C 110.877 -0.889 . . . . 0.0 110.877 -179.829 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 77.9 t80 -72.85 -55.81 6.12 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.875 0.369 . . . . 0.0 110.295 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 32.5 ttp -69.81 -22.09 63.34 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.464 179.768 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.462 ' C ' ' CZ2' ' A' ' 95' ' ' TRP . . . -69.99 -63.38 3.33 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 111.159 -0.776 . . . . 0.0 111.159 -179.804 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.496 ' O ' HG22 ' A' ' 26' ' ' VAL . . . -68.86 -20.77 64.29 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 120.999 -0.281 . . . . 0.0 110.793 -179.623 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 56.5 t80 -47.27 -25.15 0.88 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.872 0.367 . . . . 0.0 110.479 179.706 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.426 ' CZ ' ' HB3' ' A' ' 102' ' ' ALA . 24.8 t80 -67.55 -55.55 13.01 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.797 -179.871 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.496 HG22 ' O ' ' A' ' 23' ' ' ALA . 27.5 m -68.08 -16.79 21.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.867 -179.663 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 3.3 ttm180 -60.5 -41.13 93.68 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.037 -179.613 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -104.74 -74.32 0.96 Allowed Glycine 0 CA--C 1.525 0.686 0 N-CA-C 111.393 -0.683 . . . . 0.0 111.393 -179.57 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.412 ' OE1' ' CZ ' ' A' ' 25' ' ' PHE . 22.8 tt0 -44.38 -33.02 1.51 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.641 0.258 . . . . 0.0 110.965 -179.515 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -63.38 -51.61 53.27 Favored Glycine 0 CA--C 1.526 0.757 0 N-CA-C 111.222 -0.751 . . . . 0.0 111.222 -179.833 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 83.6 mt -49.43 -47.24 48.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.728 0.299 . . . . 0.0 110.851 -179.829 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 67.8 mtm180 -68.79 -49.38 59.1 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.86 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -45.13 -43.61 9.92 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.429 -179.717 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 75.9 t80 -46.11 -45.13 16.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.802 -179.656 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -57.42 -25.91 60.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.811 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -87.64 -73.8 1.28 Allowed Glycine 0 CA--C 1.526 0.74 0 N-CA-C 110.901 -0.88 . . . . 0.0 110.901 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.566 ' O ' HD12 ' A' ' 37' ' ' LEU . 0.3 OUTLIER -95.89 167.63 11.13 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.873 0.368 . . . . 0.0 110.673 179.838 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -81.74 114.76 20.61 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.778 -179.725 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 11.0 mtpt -128.77 148.78 70.04 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.076 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo . . . . . 0 C--N 1.308 -1.566 0 C-N-CA 121.445 1.43 . . . . 0.0 110.968 179.293 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.673 ' O ' HG23 ' A' ' 52' ' ' ILE . 27.6 tp . . . . . 0 CA--C 1.532 0.265 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.643 ' C ' ' H ' ' A' ' 52' ' ' ILE . . . -41.22 -28.46 0.24 Allowed Pre-proline 0 C--O 1.234 0.27 0 C-N-CA 120.141 -0.623 . . . . 0.0 111.516 -179.021 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.418 ' HD2' ' N ' ' A' ' 50' ' ' ALA . 22.3 Cg_exo -53.63 5.16 0.03 OUTLIER 'Trans proline' 0 C--N 1.313 -1.317 0 CA-C-N 118.955 0.663 . . . . 0.0 112.085 177.903 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.673 HG23 ' O ' ' A' ' 49' ' ' LEU . 7.2 pt -49.37 -29.27 3.73 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.144 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 178.841 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.605 ' O ' ' CD1' ' A' ' 57' ' ' TYR . 2.8 m0 -66.06 -45.91 79.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.799 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -59.34 -60.26 9.14 Favored Glycine 0 CA--C 1.527 0.82 0 N-CA-C 111.593 -0.603 . . . . 0.0 111.593 -179.609 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.734 HG23 ' H ' ' A' ' 56' ' ' LEU . 5.3 t -56.21 -60.71 3.11 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 121.033 -0.267 . . . . 0.0 111.329 -179.279 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.734 ' H ' HG23 ' A' ' 55' ' ' THR . 82.6 mt -50.82 -44.68 59.23 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 120.59 -0.444 . . . . 0.0 110.478 -179.744 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.605 ' CD1' ' O ' ' A' ' 53' ' ' TRP . 3.7 m-30 -50.93 -46.96 61.08 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 75.7 m -57.89 -42.15 84.05 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.187 -0.46 . . . . 0.0 109.911 179.584 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.78 -37.24 86.65 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.203 179.627 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 41.5 mtt -67.69 -49.18 64.07 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.462 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -52.09 -48.57 52.27 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 111.108 -0.797 . . . . 0.0 111.108 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -60.97 -56.69 18.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.868 0.366 . . . . 0.0 110.512 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.486 ' O ' HG23 ' A' ' 67' ' ' VAL . . . -49.55 -48.47 35.11 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.504 -1.038 . . . . 0.0 110.504 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.523 ' O ' ' NE1' ' A' ' 68' ' ' TRP . 1.2 t -57.7 -44.92 86.22 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.667 0.27 . . . . 0.0 110.707 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.451 ' HA ' ' CZ2' ' A' ' 68' ' ' TRP . 87.3 t80 -50.79 -44.52 58.9 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 179.301 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 69.9 mt -70.79 -25.16 25.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.787 179.598 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.486 HG23 ' O ' ' A' ' 63' ' ' GLY . 77.9 t -68.8 -59.04 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.155 0 C-N-CA 120.69 -0.404 . . . . 0.0 111.192 -179.67 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' TRP . . . . . 0.663 ' CE3' ' CE2' ' A' ' 5' ' ' TRP . 0.0 OUTLIER -67.65 -28.1 67.43 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 119.973 -0.691 . . . . 0.0 110.646 -179.666 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -73.22 -28.18 62.02 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.532 -0.467 . . . . 0.0 110.526 -179.885 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 32.0 tp10 -76.85 -59.99 2.54 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.79 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.447 HD11 ' O ' ' A' ' 73' ' ' GLY . 3.3 pp -69.11 -22.14 63.99 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.717 -179.744 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.497 ' O ' ' O ' ' A' ' 73' ' ' GLY . . . 110.68 97.58 2.43 Favored Glycine 0 CA--C 1.526 0.775 0 N-CA-C 111.585 -0.606 . . . . 0.0 111.585 179.586 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.557 ' N ' ' O ' ' A' ' 68' ' ' TRP . . . 41.88 -173.86 0.01 OUTLIER Glycine 0 CA--C 1.523 0.557 0 N-CA-C 111.667 -0.573 . . . . 0.0 111.667 179.389 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 51.5 t80 -87.54 111.64 21.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.819 0.342 . . . . 0.0 110.741 -179.606 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.576 ' OG1' ' N ' ' A' ' 76' ' ' GLU . 0.8 OUTLIER -141.73 -174.03 3.95 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.672 179.73 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.576 ' N ' ' OG1' ' A' ' 75' ' ' THR . 46.1 mt-10 -47.98 -44.29 30.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.174 -179.768 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -60.49 -24.4 65.26 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.502 -179.239 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -91.09 -25.34 19.68 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.82 -0.352 . . . . 0.0 111.234 -179.424 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 12.5 mtp -66.79 -27.78 67.86 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.814 -0.354 . . . . 0.0 111.354 -179.283 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.403 ' N ' ' HD2' ' A' ' 81' ' ' PRO . 4.7 t -68.72 -50.89 22.78 Favored Pre-proline 0 C--N 1.328 -0.335 0 C-N-CA 120.673 -0.411 . . . . 0.0 110.364 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.403 ' HD2' ' N ' ' A' ' 80' ' ' VAL . 15.5 Cg_endo -69.43 -62.38 0.05 OUTLIER 'Trans proline' 0 N--CA 1.498 1.764 0 C-N-CA 120.955 1.103 . . . . 0.0 111.616 179.007 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.0 mt -52.12 -52.45 51.45 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.271 179.592 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.504 ' O ' ' N ' ' A' ' 86' ' ' THR . . . -60.46 -63.88 4.61 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 111.367 -0.693 . . . . 0.0 111.367 -179.549 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 59.3 tp -43.15 -38.74 2.56 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.9 0.381 . . . . 0.0 110.114 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 6.3 t80 -68.22 -34.33 76.05 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.242 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.504 ' N ' ' O ' ' A' ' 83' ' ' GLY . 1.3 m -70.42 -57.97 4.23 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.917 -179.683 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -62.51 -49.23 75.64 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 111.463 -0.655 . . . . 0.0 111.463 -179.591 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.416 ' O ' ' CB ' ' A' ' 92' ' ' ASN . 51.6 tp60 -57.26 -45.54 83.91 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.739 0.304 . . . . 0.0 110.952 -179.583 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 11.6 tp -65.4 -29.12 69.79 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.475 -179.827 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.781 ' O ' ' HB2' ' A' ' 94' ' ' ALA . . . -67.04 -66.08 0.6 Allowed 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.393 -0.523 . . . . 0.0 111.176 -179.723 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.2 pp -67.64 -29.79 69.19 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 -178.842 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.416 ' CB ' ' O ' ' A' ' 88' ' ' GLN . 11.1 t-20 -84.12 -54.52 4.77 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 -178.441 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' TRP . . . . . 0.609 ' O ' ' N ' ' A' ' 95' ' ' TRP . 0.0 OUTLIER -76.57 -12.53 60.04 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.516 -0.474 . . . . 0.0 111.491 -178.478 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.781 ' HB2' ' O ' ' A' ' 90' ' ' ALA . . . -55.69 78.73 0.0 OUTLIER 'General case' 0 C--O 1.231 0.129 0 C-N-CA 120.448 -0.501 . . . . 0.0 109.852 179.174 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.708 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 44.1 p-90 -93.11 -16.87 0.21 Allowed Pre-proline 0 CA--C 1.533 0.302 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -179.444 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.708 ' CD ' ' N ' ' A' ' 95' ' ' TRP . 46.5 Cg_exo -55.66 -34.49 90.6 Favored 'Trans proline' 0 N--CA 1.495 1.576 0 C-N-CA 120.422 0.748 . . . . 0.0 113.021 179.502 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.555 ' C ' ' H ' ' A' ' 99' ' ' PHE . 33.6 Cg_exo -44.08 -30.84 3.58 Favored 'Trans proline' 0 N--CA 1.492 1.386 0 CA-C-N 118.969 0.668 . . . . 0.0 112.994 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.577 ' O ' ' N ' ' A' ' 101' ' ' GLY . 1.3 pp -72.61 20.22 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 121.076 0.465 . . . . 0.0 110.059 179.66 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.555 ' H ' ' C ' ' A' ' 97' ' ' PRO . 0.8 OUTLIER -39.72 -36.67 0.44 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.889 -179.968 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.401 ' O ' ' CG ' ' A' ' 103' ' ' ARG . 1.6 m-85 -85.98 -21.0 28.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.045 -179.518 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.577 ' N ' ' O ' ' A' ' 98' ' ' ILE . . . -89.16 -5.45 72.97 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 111.153 -0.779 . . . . 0.0 111.153 -179.718 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.426 ' HB3' ' CZ ' ' A' ' 25' ' ' PHE . . . -73.16 -11.26 60.47 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.778 0.323 . . . . 0.0 110.753 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.401 ' CG ' ' O ' ' A' ' 100' ' ' PHE . 5.4 ptp180 -94.94 11.61 31.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.586 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -123.97 162.62 23.02 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.63 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 21.2 mmm -57.18 -17.13 9.83 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.234 179.831 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.589 ' O ' ' N ' ' A' ' 108' ' ' ALA . . . -70.42 -15.01 72.48 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 111.214 -0.755 . . . . 0.0 111.214 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' TRP . . . . . 0.444 ' CD1' ' N ' ' A' ' 108' ' ' ALA . 0.1 OUTLIER -43.14 -12.51 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.521 0.2 . . . . 0.0 111.113 -179.468 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.589 ' N ' ' O ' ' A' ' 106' ' ' GLY . . . -63.01 -23.44 67.46 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-O 121.132 0.491 . . . . 0.0 110.075 179.417 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 54.6 mt -52.71 -29.45 26.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.107 179.726 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -56.19 -60.76 3.04 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.548 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.713 ' O ' HG23 ' A' ' 115' ' ' VAL . 1.2 p30 -57.46 -51.24 70.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.323 -179.673 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.601 HD13 ' O ' ' A' ' 112' ' ' LEU . 0.2 OUTLIER -55.29 -40.26 70.85 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.474 -178.944 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 11.3 mt -70.18 -61.51 1.75 Allowed 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 -178.655 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.4 pp -58.38 -30.55 66.88 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 120.292 -0.563 . . . . 0.0 110.866 -179.052 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.713 HG23 ' O ' ' A' ' 111' ' ' ASP . 38.7 t -65.49 -55.78 18.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.264 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 4.9 m -71.45 -24.57 62.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.4 -179.009 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' GLY . . . . . 0.411 ' O ' ' CB ' ' A' ' 121' ' ' ALA . . . -68.02 -62.49 4.2 Favored Glycine 0 CA--C 1.527 0.794 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.051 -179.218 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.559 ' O ' HG23 ' A' ' 122' ' ' THR . 8.5 p -70.62 -36.93 67.64 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 O-C-N 122.738 -0.272 . . . . 0.0 111.572 -179.14 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.526 ' O ' ' OG1' ' A' ' 123' ' ' THR . . . -66.67 -60.54 2.61 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.493 -0.483 . . . . 0.0 111.201 -179.288 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 1.9 m -61.56 -53.68 53.11 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.334 -179.446 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.411 ' CB ' ' O ' ' A' ' 117' ' ' GLY . . . -50.12 -42.41 50.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.411 -0.358 . . . . 0.0 111.152 -179.494 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.559 HG23 ' O ' ' A' ' 118' ' ' VAL . 27.7 p -70.65 -39.32 73.69 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.64 -179.28 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.526 ' OG1' ' O ' ' A' ' 119' ' ' ALA . 0.2 OUTLIER -55.29 -52.2 64.23 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.921 0.391 . . . . 0.0 111.197 -179.312 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.7 pp -80.49 -20.33 43.91 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.752 -178.827 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -86.06 -73.88 0.44 Allowed 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -178.179 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' TRP . . . . . 0.571 ' CD1' ' N ' ' A' ' 126' ' ' TRP . 15.7 m0 -84.88 -57.37 3.14 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 112.762 0.653 . . . . 0.0 112.762 -177.444 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 127' ' ' HIS . . . . . 0.492 ' CD2' ' N ' ' A' ' 127' ' ' HIS . 9.7 m170 -47.71 -22.12 0.48 Allowed 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.686 -0.405 . . . . 0.0 111.121 -179.027 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 19.2 ttt85 -72.59 -40.84 66.25 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.063 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 86.4 t -88.37 -50.01 13.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.788 0.328 . . . . 0.0 111.076 -179.514 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 6.0 m -115.69 105.28 51.98 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.502 -179.734 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' PRO . . . . . 0.631 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 73.5 Cg_exo -70.98 -36.43 7.58 Favored 'Trans proline' 0 C--N 1.312 -1.364 0 C-N-CA 121.557 1.505 . . . . 0.0 112.726 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 132' ' ' PRO . . . . . 0.631 ' CD ' ' N ' ' A' ' 131' ' ' PRO . 32.4 Cg_exo -55.8 -35.48 93.72 Favored 'Trans proline' 0 N--CA 1.496 1.675 0 C-N-CA 121.678 1.585 . . . . 0.0 111.946 -179.847 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -62.6 -43.2 99.41 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.66 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -50.47 -24.77 3.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.764 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 14.9 ttp180 -80.93 -28.39 35.78 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.786 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 26.7 mt -72.84 -39.18 66.75 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.779 -0.368 . . . . 0.0 110.068 179.807 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.583 ' O ' ' N ' ' A' ' 139' ' ' PRO . 4.8 mt -81.04 -35.78 31.38 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 179.126 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.473 ' C ' ' O ' ' A' ' 137' ' ' LEU . 14.3 t80 -24.23 -38.9 0.03 OUTLIER Pre-proline 0 CA--C 1.534 0.356 0 CA-C-N 115.368 -0.833 . . . . 0.0 112.118 -179.888 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.583 ' N ' ' O ' ' A' ' 137' ' ' LEU . 5.8 Cg_exo -66.62 5.54 0.73 Allowed 'Trans proline' 0 C--N 1.31 -1.479 0 C-N-CA 120.897 1.065 . . . . 0.0 112.771 179.508 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 140' ' ' TYR . . . . . 0.756 ' CE2' HD11 ' A' ' 144' ' ' LEU . 2.5 p90 -88.62 -14.55 37.22 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 120.54 -0.464 . . . . 0.0 111.074 -179.842 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.463 HD22 ' CE1' ' A' ' 140' ' ' TYR . 4.1 mm? -53.55 -33.45 54.72 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 178.568 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -60.63 -50.01 75.21 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.473 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 143' ' ' TRP . . . . . 0.462 ' CH2' ' HB2' ' A' ' 147' ' ' ALA . 8.8 t-105 -55.13 -46.1 75.62 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.226 -0.443 . . . . 0.0 109.844 179.74 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.756 HD11 ' CE2' ' A' ' 140' ' ' TYR . 9.3 mt -53.35 -55.96 20.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.267 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.605 ' O ' HG23 ' A' ' 149' ' ' VAL . . . -62.86 -18.85 63.5 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.94 -179.786 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -69.45 -63.34 1.09 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.682 -179.725 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 147' ' ' ALA . . . . . 0.462 ' HB2' ' CH2' ' A' ' 143' ' ' TRP . . . -60.37 -47.42 86.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.414 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 89.0 m -53.93 -49.67 68.14 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.495 179.854 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.605 HG23 ' O ' ' A' ' 145' ' ' ALA . 45.0 t -62.42 -28.54 44.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.594 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.447 ' O ' HG23 ' A' ' 154' ' ' VAL . 0.9 OUTLIER -63.53 -54.85 29.81 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.704 -0.398 . . . . 0.0 110.415 -179.598 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 151' ' ' ASN . . . . . 0.612 ' ND2' ' H ' ' A' ' 152' ' ' TYR . 1.4 p-10 -67.47 -54.65 18.37 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.96 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 152' ' ' TYR . . . . . 0.612 ' H ' ' ND2' ' A' ' 151' ' ' ASN . 15.6 t80 -50.5 -43.26 55.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.681 -179.69 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 153' ' ' TYR . . . . . 0.481 ' C ' ' CD1' ' A' ' 153' ' ' TYR . 17.5 t80 -61.86 -43.75 98.22 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.188 179.72 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.447 HG23 ' O ' ' A' ' 150' ' ' LEU . 49.4 t -60.27 -35.25 60.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.597 179.801 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 155' ' ' TRP . . . . . . . . . . . . . 8.1 m0 -62.99 -53.32 55.86 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.413 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 156' ' ' ARG . . . . . 0.436 ' CZ ' ' OH ' ' A' ' 152' ' ' TYR . 0.5 OUTLIER -64.73 -31.61 72.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.414 -179.899 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -71.33 -52.59 17.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.678 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 22.3 m-20 . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.646 -179.903 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.645 ' O ' HG23 ' A' ' 9' ' ' VAL . 2.2 t-105 . . . . . 0 CA--C 1.528 0.128 0 CA-C-O 121.001 0.429 . . . . 0.0 110.038 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.497 HG12 ' N ' ' A' ' 7' ' ' PRO . 3.0 t -56.69 -69.45 0.44 Allowed Pre-proline 0 CA--C 1.537 0.471 0 CA-C-N 115.717 -0.674 . . . . 0.0 112.285 -178.375 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.497 ' N ' HG12 ' A' ' 6' ' ' VAL . 18.1 Cg_endo -46.3 -53.49 5.87 Favored 'Trans proline' 0 N--CA 1.494 1.519 0 C-N-CA 120.349 0.699 . . . . 0.0 112.343 -178.618 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.579 ' HB2' ' OG ' ' A' ' 64' ' ' SER . . . -49.14 -43.92 42.16 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.595 -0.442 . . . . 0.0 111.195 -179.74 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.645 HG23 ' O ' ' A' ' 5' ' ' TRP . 63.3 t -60.85 -60.97 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.775 -179.04 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -58.05 -53.95 41.42 Favored Glycine 0 CA--C 1.527 0.808 0 N-CA-C 111.369 -0.692 . . . . 0.0 111.369 -179.398 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 9.0 mp -54.53 -31.36 56.2 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.605 0.241 . . . . 0.0 110.775 -179.771 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.576 HG23 ' O ' ' A' ' 8' ' ' ALA . 8.9 p -79.03 -24.39 43.66 Favored 'General case' 0 C--N 1.333 -0.145 0 C-N-CA 120.783 -0.367 . . . . 0.0 110.41 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.423 ' HA ' HD23 ' A' ' 13' ' ' LEU . 41.3 mt -76.84 -26.48 54.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.152 179.49 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.486 ' O ' ' N ' ' A' ' 16' ' ' SER . 13.7 t -52.05 -64.22 1.64 Allowed Pre-proline 0 CA--C 1.536 0.42 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.593 -179.519 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_endo -44.6 -16.29 0.11 Allowed 'Trans proline' 0 N--CA 1.497 1.726 0 C-N-CA 120.941 1.094 . . . . 0.0 112.137 -179.434 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.486 ' N ' ' O ' ' A' ' 14' ' ' VAL . 0.5 OUTLIER -75.49 -29.12 59.46 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.641 -179.915 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 81.7 mt -68.22 -56.17 9.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.002 -179.816 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -66.96 -38.55 92.89 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 111.558 -0.617 . . . . 0.0 111.558 -179.362 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -74.12 -26.2 69.2 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 111.378 -0.689 . . . . 0.0 111.378 -179.433 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.441 ' CB ' ' O ' ' A' ' 16' ' ' SER . 34.3 t80 -78.0 -60.7 2.26 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.78 -0.368 . . . . 0.0 110.998 -179.665 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 19.9 tpp -71.53 -21.26 61.93 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.34 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.422 ' C ' ' CZ2' ' A' ' 95' ' ' TRP . . . -75.51 -53.59 5.92 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 111.302 -0.719 . . . . 0.0 111.302 -179.802 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.625 ' O ' HG22 ' A' ' 26' ' ' VAL . . . -73.56 -20.81 60.53 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.963 0.411 . . . . 0.0 110.461 -179.702 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.43 ' CD1' ' O ' ' A' ' 24' ' ' TYR . 27.2 t80 -51.08 -23.9 3.49 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.862 179.298 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 52.1 t80 -71.27 -55.46 8.02 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.02 -179.779 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.625 HG22 ' O ' ' A' ' 23' ' ' ALA . 34.6 m -58.46 -26.06 29.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 C-N-CA 120.599 -0.441 . . . . 0.0 110.306 -179.796 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.519 ' O ' ' CD1' ' A' ' 31' ' ' LEU . 0.0 OUTLIER -87.95 -15.08 37.53 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.338 179.851 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -101.33 -71.66 0.94 Allowed Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.835 -0.906 . . . . 0.0 110.835 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.403 ' OE2' ' O ' ' A' ' 29' ' ' GLU . 3.3 tm-20 -76.88 -36.89 56.39 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.739 0.304 . . . . 0.0 110.567 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -51.3 -36.12 36.38 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 110.89 -0.884 . . . . 0.0 110.89 -179.79 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.519 ' CD1' ' O ' ' A' ' 27' ' ' ARG . 86.3 mt -55.35 -32.17 62.34 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.737 0.303 . . . . 0.0 110.348 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.434 ' O ' ' N ' ' A' ' 35' ' ' ALA . 37.6 ttm180 -81.28 -48.96 11.33 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.252 179.728 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' TRP . . . . . 0.565 ' CZ3' HD21 ' A' ' 37' ' ' LEU . 0.0 OUTLIER -44.76 -36.13 3.05 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 179.473 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 26.6 t80 -55.66 -40.52 72.36 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.287 179.452 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.434 ' N ' ' O ' ' A' ' 32' ' ' ARG . . . -53.29 -26.96 20.46 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.169 179.784 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -90.37 -72.32 1.25 Allowed Glycine 0 CA--C 1.524 0.615 0 N-CA-C 110.921 -0.872 . . . . 0.0 110.921 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.565 HD21 ' CZ3' ' A' ' 33' ' ' TRP . 0.3 OUTLIER -96.1 167.64 11.09 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 120.947 0.404 . . . . 0.0 110.88 179.614 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 43.8 mm-40 -84.79 122.93 29.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.241 -179.256 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 16.0 mtpt -129.28 153.34 80.47 Favored Pre-proline 0 N--CA 1.464 0.24 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.048 179.443 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo . . . . . 0 C--N 1.31 -1.47 0 C-N-CA 121.549 1.499 . . . . 0.0 111.372 179.417 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.751 ' O ' HG23 ' A' ' 52' ' ' ILE . 0.2 OUTLIER . . . . . 0 CA--C 1.537 0.455 0 N-CA-C 112.686 0.624 . . . . 0.0 112.686 . . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.591 ' C ' ' H ' ' A' ' 52' ' ' ILE . . . -40.34 -30.26 0.24 Allowed Pre-proline 0 N--CA 1.468 0.427 0 C-N-CA 120.857 -0.337 . . . . 0.0 111.818 -178.699 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.408 ' HD2' ' N ' ' A' ' 50' ' ' ALA . 33.6 Cg_exo -53.76 4.53 0.04 OUTLIER 'Trans proline' 0 C--N 1.312 -1.382 0 CA-C-N 119.163 0.737 . . . . 0.0 112.547 178.498 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.751 HG23 ' O ' ' A' ' 49' ' ' LEU . 44.0 pt -53.52 -32.42 20.51 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 C-N-CA 120.515 -0.474 . . . . 0.0 109.779 179.52 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.457 ' O ' ' CB ' ' A' ' 57' ' ' TYR . 60.9 m95 -78.94 -23.08 44.87 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.267 -179.145 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -68.54 -45.47 67.24 Favored Glycine 0 CA--C 1.527 0.793 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 178.773 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 16.5 m -69.27 -58.45 4.02 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-O 120.991 0.424 . . . . 0.0 110.0 179.408 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 96.6 mt -54.55 -28.62 46.99 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.033 179.511 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.521 ' CD1' ' C ' ' A' ' 57' ' ' TYR . 0.6 OUTLIER -63.51 -58.98 5.27 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 179.523 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 11.0 m -46.16 -49.29 17.01 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.406 -0.518 . . . . 0.0 109.909 179.515 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.55 -51.49 69.65 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.856 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 12.3 mtm -55.81 -35.59 66.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.78 -179.682 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -61.88 -49.31 77.05 Favored Glycine 0 CA--C 1.522 0.491 0 N-CA-C 110.59 -1.004 . . . . 0.0 110.59 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -56.83 -60.27 3.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.817 0.341 . . . . 0.0 110.501 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.539 ' O ' HG23 ' A' ' 67' ' ' VAL . . . -52.21 -49.74 49.15 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 110.66 -0.976 . . . . 0.0 110.66 179.892 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.58 ' O ' ' CE2' ' A' ' 68' ' ' TRP . 1.4 t -48.1 -54.24 13.87 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.108 0.48 . . . . 0.0 110.396 179.617 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 59.0 t80 -51.28 -41.48 60.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.51 179.834 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 84.9 mt -67.72 -45.58 84.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.329 -179.856 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.789 HG22 ' OG ' ' A' ' 130' ' ' SER . 39.0 t -50.72 -55.81 5.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 C-N-CA 121.043 -0.263 . . . . 0.0 111.277 -179.327 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' TRP . . . . . 0.585 ' O ' ' N ' ' A' ' 73' ' ' GLY . 0.7 OUTLIER -59.97 -52.56 64.89 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.686 -179.542 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 24.3 mmtt -53.64 -22.67 9.22 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.993 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 43.0 tp10 -79.6 -62.46 1.68 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.441 -179.312 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.0 pp -71.22 -1.17 11.72 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.2 -179.297 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 104.43 64.98 0.68 Allowed Glycine 0 CA--C 1.526 0.778 0 N-CA-C 111.43 -0.668 . . . . 0.0 111.43 179.51 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.585 ' N ' ' O ' ' A' ' 68' ' ' TRP . . . 51.75 -174.46 0.15 Allowed Glycine 0 CA--C 1.525 0.679 0 N-CA-C 111.325 -0.71 . . . . 0.0 111.325 179.661 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 89.8 t80 -76.62 110.72 11.42 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.86 0.362 . . . . 0.0 110.604 -179.784 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.591 ' OG1' ' N ' ' A' ' 76' ' ' GLU . 0.0 OUTLIER -139.17 -174.94 4.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.13 179.804 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.591 ' N ' ' OG1' ' A' ' 75' ' ' THR . 3.1 pt-20 -50.55 -21.62 1.61 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.839 -179.838 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -83.95 -18.47 37.16 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.105 -179.538 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -89.32 -18.25 27.32 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.874 -0.33 . . . . 0.0 110.838 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 15.4 mtp -69.32 -27.4 65.35 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.871 -0.332 . . . . 0.0 110.573 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 5.0 t -67.73 -47.94 43.26 Favored Pre-proline 0 CA--C 1.535 0.4 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.582 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -71.83 -58.12 0.08 OUTLIER 'Trans proline' 0 N--CA 1.498 1.786 0 C-N-CA 121.187 1.258 . . . . 0.0 112.087 179.277 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 13.0 mt -60.08 -53.4 58.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.985 0.421 . . . . 0.0 110.678 -179.851 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -55.86 -55.19 30.28 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 111.268 -0.733 . . . . 0.0 111.268 -179.537 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.404 ' O ' ' CB ' ' A' ' 88' ' ' GLN . 33.0 tp -61.01 -24.23 66.0 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.687 0.279 . . . . 0.0 110.936 -179.702 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -74.7 -56.49 4.74 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.884 -179.685 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.415 HG23 ' N ' ' A' ' 87' ' ' GLY . 14.2 t -66.13 -38.35 87.97 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.799 -0.361 . . . . 0.0 110.977 -179.64 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.415 ' N ' HG23 ' A' ' 86' ' ' THR . . . -68.77 -57.26 8.14 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.932 -0.867 . . . . 0.0 110.932 -179.843 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.45 ' O ' ' CB ' ' A' ' 92' ' ' ASN . 5.0 tp-100 -58.09 -40.5 81.28 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.859 0.362 . . . . 0.0 110.149 179.756 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 12.3 tp -67.37 -30.54 70.35 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.292 179.798 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.826 ' O ' ' HB2' ' A' ' 94' ' ' ALA . . . -66.95 -66.09 0.6 Allowed 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 120.13 -0.628 . . . . 0.0 110.944 -179.746 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.0 pp -66.51 -29.68 69.83 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.389 0.514 . . . . 0.0 112.389 -178.948 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.45 ' CB ' ' O ' ' A' ' 88' ' ' GLN . 35.3 t-20 -85.2 -62.2 1.59 Allowed 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.551 -0.46 . . . . 0.0 111.815 -178.827 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' TRP . . . . . 0.631 ' O ' ' N ' ' A' ' 95' ' ' TRP . 0.0 OUTLIER -64.57 -17.57 64.08 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.552 -0.459 . . . . 0.0 110.834 -179.007 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.826 ' HB2' ' O ' ' A' ' 90' ' ' ALA . . . -48.76 83.81 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 179.313 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.698 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 23.2 p-90 -100.95 -16.13 0.19 Allowed Pre-proline 0 CA--C 1.535 0.377 0 CA-C-N 116.107 -0.497 . . . . 0.0 112.334 -179.235 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.698 ' CD ' ' N ' ' A' ' 95' ' ' TRP . 37.2 Cg_exo -60.65 -31.52 92.21 Favored 'Trans proline' 0 N--CA 1.495 1.582 0 CA-C-N 119.067 0.703 . . . . 0.0 112.718 179.691 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.518 ' CD ' ' N ' ' A' ' 96' ' ' PRO . 83.8 Cg_exo -56.76 -16.92 21.23 Favored 'Trans proline' 0 N--CA 1.496 1.647 0 C-N-CA 120.803 1.002 . . . . 0.0 113.15 -179.775 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.423 ' O ' ' N ' ' A' ' 101' ' ' GLY . 1.1 pp -88.34 20.36 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 C-N-CA 120.713 -0.395 . . . . 0.0 110.732 -179.718 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.597 ' CD2' ' O ' ' A' ' 96' ' ' PRO . 29.7 m-85 -39.36 -36.96 0.4 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.326 179.649 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.557 ' CD1' ' N ' ' A' ' 100' ' ' PHE . 0.5 OUTLIER -76.71 -43.87 35.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.697 179.948 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.423 ' N ' ' O ' ' A' ' 98' ' ' ILE . . . -62.23 -11.28 32.29 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 111.083 -0.807 . . . . 0.0 111.083 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -62.17 -38.47 89.17 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.637 0.256 . . . . 0.0 111.198 -179.615 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.16 17.97 2.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.078 -179.607 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 11.5 mt-30 -124.4 160.15 28.81 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.888 0.375 . . . . 0.0 110.638 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.547 ' N ' ' SD ' ' A' ' 105' ' ' MET . 0.0 OUTLIER -51.12 -17.06 0.57 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.416 179.813 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.601 ' O ' ' N ' ' A' ' 108' ' ' ALA . . . -75.48 -14.13 82.27 Favored Glycine 0 CA--C 1.529 0.919 0 CA-C-N 115.938 -0.573 . . . . 0.0 111.722 -179.554 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' TRP . . . . . 0.617 ' CD1' ' CZ2' ' A' ' 155' ' ' TRP . 0.0 OUTLIER -36.62 -21.84 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.417 0 CA-C-O 120.529 0.204 . . . . 0.0 111.366 -179.165 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.601 ' N ' ' O ' ' A' ' 106' ' ' GLY . . . -63.35 -16.67 61.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.669 0.271 . . . . 0.0 111.168 -179.322 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 6.2 mp -54.5 -32.95 58.95 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.776 -179.632 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.442 ' O ' HD23 ' A' ' 114' ' ' LEU . . . -55.82 -62.33 1.76 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.858 0.361 . . . . 0.0 111.138 -179.628 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.689 ' O ' HG23 ' A' ' 115' ' ' VAL . 3.8 p-10 -58.92 -54.43 47.24 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.033 -0.53 . . . . 0.0 112.005 -179.155 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 34.3 tp -55.76 -44.36 77.59 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 -178.56 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 52.1 mt -64.24 -60.68 2.9 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.254 0.465 . . . . 0.0 112.254 -178.482 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.442 HD23 ' O ' ' A' ' 110' ' ' ALA . 2.3 pp -62.89 -35.32 79.64 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.494 -0.483 . . . . 0.0 111.68 -178.565 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.689 HG23 ' O ' ' A' ' 111' ' ' ASP . 27.2 t -57.91 -60.12 2.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.136 -179.687 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 116' ' ' SER . . . . . 0.488 ' O ' ' OG1' ' A' ' 120' ' ' THR . 4.5 m -74.18 -22.44 59.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.427 -0.352 . . . . 0.0 111.592 -178.934 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -62.93 -62.71 5.22 Favored Glycine 0 CA--C 1.526 0.721 0 C-N-CA 120.783 -0.723 . . . . 0.0 111.475 -179.418 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.593 ' O ' HG23 ' A' ' 122' ' ' THR . 8.6 p -75.58 -35.1 30.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 C-N-CA 121.035 -0.266 . . . . 0.0 111.046 -179.579 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.526 ' O ' ' OG1' ' A' ' 123' ' ' THR . . . -66.69 -60.4 2.73 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.635 -0.426 . . . . 0.0 110.56 -179.742 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.488 ' OG1' ' O ' ' A' ' 116' ' ' SER . 2.4 m -60.32 -54.57 44.15 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.408 -179.589 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.408 ' O ' ' CB ' ' A' ' 125' ' ' ALA . . . -51.25 -41.12 60.14 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.314 -179.153 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.593 HG23 ' O ' ' A' ' 118' ' ' VAL . 36.0 p -73.19 -29.95 63.2 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.625 -179.19 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.526 ' OG1' ' O ' ' A' ' 119' ' ' ALA . 0.2 OUTLIER -66.84 -49.89 64.3 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.714 -0.394 . . . . 0.0 110.864 -179.412 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.8 pp -81.44 -19.05 43.27 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.57 -179.04 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.408 ' CB ' ' O ' ' A' ' 121' ' ' ALA . . . -93.61 -65.28 1.0 Allowed 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.427 0.529 . . . . 0.0 112.427 -178.824 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 42.1 m0 -83.59 -56.98 3.42 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 113.056 0.762 . . . . 0.0 113.056 -177.802 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' HIS . . . . . 0.467 ' CG ' ' HB2' ' A' ' 134' ' ' ALA . 11.1 m170 -59.6 -25.62 64.77 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.586 -0.445 . . . . 0.0 111.569 -178.535 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 15.9 ttt180 -61.76 -41.17 97.34 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.31 -179.455 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 33.4 t -93.34 -48.88 13.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.517 -0.311 . . . . 0.0 110.964 -179.611 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' SER . . . . . 0.789 ' OG ' HG22 ' A' ' 67' ' ' VAL . 2.1 p -113.07 107.94 53.63 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.884 -179.301 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 131' ' ' PRO . . . . . 0.646 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 73.8 Cg_exo -74.69 -26.52 11.49 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 C-N-CA 121.702 1.601 . . . . 0.0 112.741 179.355 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 132' ' ' PRO . . . . . 0.646 ' CD ' ' N ' ' A' ' 131' ' ' PRO . 52.0 Cg_exo -62.09 -54.97 1.17 Allowed 'Trans proline' 0 N--CA 1.496 1.666 0 C-N-CA 121.357 1.372 . . . . 0.0 112.194 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.524 ' O ' ' N ' ' A' ' 136' ' ' LEU . . . -45.97 -46.07 16.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.879 0.371 . . . . 0.0 110.42 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 134' ' ' ALA . . . . . 0.467 ' HB2' ' CG ' ' A' ' 127' ' ' HIS . . . -45.12 -27.31 0.57 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.109 179.816 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 10.1 tpp180 -76.3 -30.7 57.85 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.299 179.865 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.524 ' N ' ' O ' ' A' ' 133' ' ' ALA . 36.6 mt -74.16 -24.9 59.47 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 179.303 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.573 ' O ' ' N ' ' A' ' 140' ' ' TYR . 3.7 mt -89.81 -33.26 16.58 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.075 179.511 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.519 ' CD1' ' C ' ' A' ' 138' ' ' TYR . 0.5 OUTLIER -27.68 -51.13 0.23 Allowed Pre-proline 0 CA--C 1.536 0.416 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.554 179.727 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.432 ' HD2' ' N ' ' A' ' 138' ' ' TYR . 2.2 Cg_endo -58.76 4.69 0.11 Allowed 'Trans proline' 0 N--CA 1.497 1.687 0 C-N-CA 121.374 1.383 . . . . 0.0 112.689 -179.823 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 140' ' ' TYR . . . . . 0.573 ' N ' ' O ' ' A' ' 137' ' ' LEU . 0.3 OUTLIER -90.66 -15.41 30.45 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.904 0.383 . . . . 0.0 110.724 179.764 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.467 HD23 HD12 ' A' ' 144' ' ' LEU . 97.6 mt -60.09 -36.5 77.55 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 178.872 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -56.61 -41.8 77.67 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.689 179.161 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 143' ' ' TRP . . . . . . . . . . . . . 7.5 t-105 -62.74 -43.66 98.22 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 115.771 -0.65 . . . . 0.0 109.472 179.227 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.467 HD12 HD23 ' A' ' 141' ' ' LEU . 22.0 mt -58.44 -37.59 75.73 Favored 'General case' 0 CA--C 1.521 -0.163 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.707 179.268 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.673 ' O ' HG23 ' A' ' 149' ' ' VAL . . . -73.28 -27.84 61.78 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.496 179.848 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 28.7 t80 -64.75 -62.32 1.64 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.781 -179.781 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 147' ' ' ALA . . . . . 0.489 ' O ' ' OD1' ' A' ' 151' ' ' ASN . . . -64.15 -43.84 93.95 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.432 -0.507 . . . . 0.0 110.45 -179.815 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 148' ' ' THR . . . . . 0.499 ' O ' ' OD1' ' A' ' 151' ' ' ASN . 52.4 m -57.89 -36.71 72.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.475 179.807 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.673 HG23 ' O ' ' A' ' 145' ' ' ALA . 39.3 t -74.65 -27.5 20.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.686 179.82 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.546 ' O ' HG23 ' A' ' 154' ' ' VAL . 0.7 OUTLIER -66.41 -52.64 44.45 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.426 -0.509 . . . . 0.0 110.209 -179.935 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 151' ' ' ASN . . . . . 0.499 ' OD1' ' O ' ' A' ' 148' ' ' THR . 8.1 p-10 -65.35 -43.42 90.93 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.25 -179.837 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 152' ' ' TYR . . . . . 0.455 ' C ' ' CD1' ' A' ' 152' ' ' TYR . 22.6 t80 -64.78 -42.44 95.09 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.988 -0.285 . . . . 0.0 111.006 -179.562 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 77.1 t80 -61.18 -41.16 96.29 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.181 -179.376 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.546 HG23 ' O ' ' A' ' 150' ' ' LEU . 42.9 t -75.44 -50.46 23.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.38 -179.348 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 155' ' ' TRP . . . . . 0.617 ' CZ2' ' CD1' ' A' ' 107' ' ' TRP . 0.1 OUTLIER -55.4 -29.4 58.45 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.826 -178.889 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 156' ' ' ARG . . . . . 0.418 ' HA ' HH11 ' A' ' 156' ' ' ARG . 0.1 OUTLIER -85.41 -45.93 11.4 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.952 -0.299 . . . . 0.0 110.625 -179.639 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -69.02 -44.02 73.58 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.897 -179.741 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 16.3 t30 . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.79 -179.971 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.694 ' CE2' ' CE3' ' A' ' 68' ' ' TRP . 1.0 OUTLIER . . . . . 0 CA--C 1.529 0.141 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 . . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.576 ' N ' ' CD ' ' A' ' 7' ' ' PRO . 0.9 OUTLIER -60.52 -33.01 12.86 Favored Pre-proline 0 CA--C 1.534 0.362 0 C-N-CA 120.858 -0.337 . . . . 0.0 110.274 -179.653 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.576 ' CD ' ' N ' ' A' ' 6' ' ' VAL . 24.6 Cg_exo -73.14 -66.23 0.03 OUTLIER 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 121.517 1.478 . . . . 0.0 112.069 179.577 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.4 ' O ' ' OG1' ' A' ' 12' ' ' THR . . . -50.11 -36.58 30.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.261 -179.485 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.594 HG23 ' O ' ' A' ' 5' ' ' TRP . 78.7 t -69.53 -61.96 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.552 -179.292 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -56.11 -34.71 62.71 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 111.51 -0.636 . . . . 0.0 111.51 -179.347 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 6.9 mp -74.44 -30.29 61.83 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.57 0.224 . . . . 0.0 110.737 -179.532 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.4 ' OG1' ' O ' ' A' ' 8' ' ' ALA . 3.1 p -81.21 -21.02 39.9 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.876 0.37 . . . . 0.0 110.578 179.83 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.423 ' O ' ' N ' ' A' ' 16' ' ' SER . 69.8 mt -82.9 -38.12 23.3 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.517 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.403 ' N ' ' HD2' ' A' ' 15' ' ' PRO . 5.1 t -43.07 -58.9 3.55 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.717 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.403 ' HD2' ' N ' ' A' ' 14' ' ' VAL . 11.7 Cg_endo -56.8 -13.96 12.57 Favored 'Trans proline' 0 N--CA 1.497 1.71 0 C-N-CA 121.02 1.147 . . . . 0.0 111.789 179.718 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.423 ' N ' ' O ' ' A' ' 13' ' ' LEU . 1.9 t -79.52 -24.73 42.01 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.506 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 55.0 mt -74.24 -58.16 3.48 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.323 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -75.72 -23.24 73.13 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 110.685 -0.966 . . . . 0.0 110.685 179.828 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -70.38 -52.49 16.86 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 111.259 -0.736 . . . . 0.0 111.259 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 86.9 t80 -74.07 -55.14 6.47 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.682 0.277 . . . . 0.0 111.184 -179.597 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 16.2 ttm -62.97 -30.12 71.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.26 -179.365 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -72.76 -59.54 4.34 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 111.277 -0.729 . . . . 0.0 111.277 -179.669 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.553 ' O ' HG22 ' A' ' 26' ' ' VAL . . . -64.22 -16.43 62.0 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.784 -0.366 . . . . 0.0 110.62 -179.434 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 63.4 t80 -48.14 -23.99 1.0 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.104 179.56 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 48.5 t80 -72.08 -53.54 12.54 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.953 -179.798 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.553 HG22 ' O ' ' A' ' 23' ' ' ALA . 33.3 m -65.52 -16.32 20.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 C-N-CA 120.835 -0.346 . . . . 0.0 110.672 -179.777 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.458 ' O ' ' CD1' ' A' ' 31' ' ' LEU . 0.0 OUTLIER -56.57 -47.51 79.34 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.741 -179.813 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -105.51 -62.98 0.63 Allowed Glycine 0 CA--C 1.525 0.7 0 N-CA-C 111.191 -0.764 . . . . 0.0 111.191 -179.827 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 6.1 tm-20 -45.09 -33.89 2.36 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.722 0.296 . . . . 0.0 110.626 -179.843 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -71.66 -51.11 17.05 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 111.023 -0.831 . . . . 0.0 111.023 -179.884 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.458 ' CD1' ' O ' ' A' ' 27' ' ' ARG . 86.6 mt -57.61 -35.04 69.93 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.752 0.31 . . . . 0.0 110.609 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 62.8 mtp180 -76.07 -42.72 46.56 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.36 179.796 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -51.71 -40.61 60.46 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.372 179.845 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.506 ' CD1' ' C ' ' A' ' 34' ' ' TYR . 9.8 t80 -48.23 -40.6 24.96 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.67 -179.797 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -57.73 -24.95 59.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.449 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -95.55 -75.18 1.26 Allowed Glycine 0 CA--C 1.525 0.663 0 N-CA-C 110.974 -0.85 . . . . 0.0 110.974 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.569 ' O ' HD12 ' A' ' 37' ' ' LEU . 0.4 OUTLIER -95.79 167.54 11.21 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.971 0.415 . . . . 0.0 110.739 179.823 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 47.2 mm-40 -79.91 113.21 17.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.888 -179.568 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 8.3 mtpt -128.86 150.72 75.86 Favored Pre-proline 0 CA--C 1.532 0.281 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.068 179.637 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo . . . . . 0 C--N 1.31 -1.492 0 C-N-CA 121.871 1.714 . . . . 0.0 111.636 179.526 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.778 ' O ' HG23 ' A' ' 52' ' ' ILE . 31.5 tp . . . . . 0 CA--C 1.531 0.249 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.634 ' C ' ' H ' ' A' ' 52' ' ' ILE . . . -40.43 -29.08 0.21 Allowed Pre-proline 0 N--CA 1.466 0.327 0 C-N-CA 120.069 -0.652 . . . . 0.0 111.569 -178.872 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.408 ' HD2' ' N ' ' A' ' 50' ' ' ALA . 25.2 Cg_exo -54.93 7.39 0.03 OUTLIER 'Trans proline' 0 C--N 1.312 -1.355 0 CA-C-N 119.058 0.699 . . . . 0.0 112.205 177.946 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.778 HG23 ' O ' ' A' ' 49' ' ' LEU . 11.6 pt -54.37 -35.19 29.98 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.203 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 178.983 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 63.0 m95 -81.79 -24.12 36.16 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.359 179.728 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -71.43 -47.07 37.23 Favored Glycine 0 CA--C 1.527 0.792 0 N-CA-C 110.36 -1.096 . . . . 0.0 110.36 179.275 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.612 HG23 ' N ' ' A' ' 56' ' ' LEU . 13.3 t -70.65 -48.15 56.38 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 179.408 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.612 ' N ' HG23 ' A' ' 55' ' ' THR . 93.5 mt -60.92 -27.9 68.54 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 178.992 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.46 ' CD1' ' C ' ' A' ' 57' ' ' TYR . 0.8 OUTLIER -65.94 -53.64 36.54 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 179.375 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -48.88 -47.56 42.89 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 178.928 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.11 -48.21 82.44 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.062 179.177 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 27.1 mtt -52.67 -50.55 63.02 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.876 179.652 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -48.37 -53.63 15.38 Favored Glycine 0 CA--C 1.522 0.526 0 N-CA-C 110.399 -1.081 . . . . 0.0 110.399 179.638 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.538 ' CD1' ' N ' ' A' ' 62' ' ' TYR . 1.4 m-30 -56.55 -50.31 72.25 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.8 0.333 . . . . 0.0 110.527 179.68 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -52.06 -54.13 27.42 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 110.475 -1.05 . . . . 0.0 110.475 179.722 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.617 ' CB ' ' HE1' ' A' ' 68' ' ' TRP . 1.4 t -54.88 -47.23 74.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.834 0.349 . . . . 0.0 110.281 179.672 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.449 ' O ' ' CG ' ' A' ' 69' ' ' LYS . 74.7 t80 -46.27 -45.17 17.04 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.647 -0.421 . . . . 0.0 109.899 179.69 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 59.0 mt -71.38 -27.1 27.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.902 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 73.6 t -67.34 -57.71 8.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 C-N-CA 120.732 -0.387 . . . . 0.0 111.6 -179.3 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' TRP . . . . . 0.694 ' CE3' ' CE2' ' A' ' 5' ' ' TRP . 0.0 OUTLIER -72.82 -24.61 60.93 Favored 'General case' 0 CA--C 1.528 0.11 0 C-N-CA 119.814 -0.754 . . . . 0.0 110.73 -179.654 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.449 ' CG ' ' O ' ' A' ' 65' ' ' TYR . 6.5 mmmt -76.73 -26.74 54.98 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.427 -0.509 . . . . 0.0 110.181 179.341 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 33.6 tp10 -79.96 -58.4 3.18 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.817 -179.842 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.462 HD21 ' HB2' ' A' ' 78' ' ' ALA . 2.2 pp -73.34 -21.72 60.48 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.878 -179.597 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.499 ' O ' ' O ' ' A' ' 73' ' ' GLY . . . 109.32 98.57 2.54 Favored Glycine 0 CA--C 1.528 0.844 0 C-N-CA 121.088 -0.577 . . . . 0.0 112.248 178.995 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.577 ' N ' ' O ' ' A' ' 68' ' ' TRP . . . 41.52 -173.99 0.01 OUTLIER Glycine 0 CA--C 1.525 0.691 0 N-CA-C 111.975 -0.45 . . . . 0.0 111.975 178.878 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 84.0 t80 -90.42 110.64 21.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.724 0.297 . . . . 0.0 110.483 -179.865 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.568 ' OG1' ' N ' ' A' ' 76' ' ' GLU . 0.8 OUTLIER -142.43 -173.6 3.9 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.909 0.385 . . . . 0.0 110.893 -179.839 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.568 ' N ' ' OG1' ' A' ' 75' ' ' THR . 26.0 mt-10 -53.27 -21.68 5.83 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.692 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 24.3 m-20 -79.67 -33.07 41.5 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.778 -179.796 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.462 ' HB2' HD21 ' A' ' 71' ' ' LEU . . . -87.02 -15.62 38.12 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.821 -179.785 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 8.1 mtp -70.99 -27.24 63.56 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.763 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.401 ' N ' ' HD2' ' A' ' 81' ' ' PRO . 8.4 t -66.85 -45.12 54.36 Favored Pre-proline 0 C--N 1.328 -0.331 0 C-N-CA 120.783 -0.367 . . . . 0.0 110.52 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.401 ' HD2' ' N ' ' A' ' 80' ' ' VAL . 12.4 Cg_endo -77.1 -61.7 0.03 OUTLIER 'Trans proline' 0 N--CA 1.499 1.816 0 C-N-CA 121.227 1.284 . . . . 0.0 111.799 178.814 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 12.7 mt -55.39 -44.41 76.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.759 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -65.92 -55.85 17.43 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.972 -0.851 . . . . 0.0 110.972 -179.792 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 60.3 tp -55.28 -21.87 16.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.812 0.339 . . . . 0.0 110.37 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 30.7 t80 -78.03 -51.89 9.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.063 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -61.84 -38.58 88.75 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.8 -0.36 . . . . 0.0 111.277 -179.059 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -73.67 -58.14 4.65 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 111.277 -0.729 . . . . 0.0 111.277 -179.571 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 5.0 tp-100 -53.45 -47.74 69.45 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-O 121.127 0.489 . . . . 0.0 109.778 179.714 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.445 ' O ' ' C ' ' A' ' 90' ' ' ALA . 19.5 tp -52.81 -66.02 0.46 Allowed 'General case' 0 C--O 1.211 -0.961 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.904 179.823 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.563 ' O ' ' HB2' ' A' ' 94' ' ' ALA . . . -38.17 -48.7 1.29 Allowed 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 120.267 -0.573 . . . . 0.0 111.771 -179.496 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 95.3 mt -55.22 -57.03 13.45 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 113.415 0.894 . . . . 0.0 113.415 -178.407 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.758 ' O ' HD22 ' A' ' 113' ' ' LEU . 4.8 m-20 -78.05 -53.42 7.43 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 121.284 0.564 . . . . 0.0 111.604 -178.223 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' TRP . . . . . 0.645 ' O ' ' N ' ' A' ' 95' ' ' TRP . 5.6 t-105 -52.13 -25.11 8.12 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.568 -179.679 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.563 ' HB2' ' O ' ' A' ' 90' ' ' ALA . . . -55.74 71.35 0.0 OUTLIER 'General case' 0 CA--C 1.528 0.133 0 CA-C-O 120.829 0.347 . . . . 0.0 110.675 -179.722 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.681 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 7.0 p-90 -101.62 -17.73 0.19 Allowed Pre-proline 0 CA--C 1.534 0.35 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.891 -179.784 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.681 ' CD ' ' N ' ' A' ' 95' ' ' TRP . 44.5 Cg_exo -61.16 -24.78 79.85 Favored 'Trans proline' 0 C--N 1.311 -1.396 0 C-N-CA 120.248 0.632 . . . . 0.0 112.412 179.034 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.529 ' CD ' ' N ' ' A' ' 96' ' ' PRO . 63.8 Cg_exo -59.82 -31.82 94.51 Favored 'Trans proline' 0 N--CA 1.493 1.474 0 C-N-CA 120.339 0.693 . . . . 0.0 112.803 179.547 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 1.4 pt -77.2 44.01 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 C-N-CA 120.342 -0.543 . . . . 0.0 110.259 179.793 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -61.57 -35.59 78.23 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.302 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -82.62 -20.01 37.2 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.399 179.859 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -87.28 -14.73 63.57 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.912 -0.875 . . . . 0.0 110.912 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -62.04 -34.18 75.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.783 0.325 . . . . 0.0 110.672 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 15.8 ptt180 -76.4 11.24 1.65 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.78 -179.843 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 14.8 mt-30 -121.89 154.56 36.93 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.564 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 6.0 mmt -51.49 -18.59 1.12 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.413 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.606 ' O ' ' N ' ' A' ' 108' ' ' ALA . . . -71.13 -14.98 74.19 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 111.18 -0.768 . . . . 0.0 111.18 179.874 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' TRP . . . . . 0.461 ' CD1' ' N ' ' A' ' 108' ' ' ALA . 0.1 OUTLIER -42.55 -14.12 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.683 0.278 . . . . 0.0 110.822 -179.498 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.606 ' N ' ' O ' ' A' ' 106' ' ' GLY . . . -58.49 -28.68 65.6 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 179.416 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 12.2 mt -47.02 -31.68 3.42 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.889 179.49 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -54.55 -60.47 3.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.39 179.76 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.715 ' O ' HG23 ' A' ' 115' ' ' VAL . 1.6 p30 -59.0 -53.68 55.72 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.76 -179.44 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.589 ' N ' ' OD1' ' A' ' 111' ' ' ASP . 40.5 tp -55.43 -39.81 70.72 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -178.414 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.758 HD22 ' O ' ' A' ' 92' ' ' ASN . 17.9 mt -70.47 -61.69 1.67 Allowed 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.124 0.416 . . . . 0.0 112.124 -178.506 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.9 pp -59.6 -34.02 72.21 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 120.339 -0.544 . . . . 0.0 111.064 -179.006 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.715 HG23 ' O ' ' A' ' 111' ' ' ASP . 42.3 t -61.68 -60.86 2.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.102 -179.863 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 13.0 m -68.0 -22.62 64.99 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.546 -178.981 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -66.35 -62.75 4.39 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 120.696 -0.764 . . . . 0.0 111.856 -179.252 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.602 ' O ' HG23 ' A' ' 122' ' ' THR . 9.1 p -72.46 -35.86 52.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 111.614 0.227 . . . . 0.0 111.614 -179.183 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.547 ' O ' ' OG1' ' A' ' 123' ' ' THR . . . -67.96 -61.31 1.92 Allowed 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.387 -0.525 . . . . 0.0 111.289 -179.326 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 8.1 m -59.64 -50.43 73.9 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.561 -0.291 . . . . 0.0 111.492 -179.184 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.447 ' O ' HD23 ' A' ' 124' ' ' LEU . . . -55.29 -40.49 71.13 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.79 0.329 . . . . 0.0 111.019 -179.461 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.602 HG23 ' O ' ' A' ' 118' ' ' VAL . 40.4 p -74.79 -33.44 62.24 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.803 -0.359 . . . . 0.0 111.713 -179.253 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.547 ' OG1' ' O ' ' A' ' 119' ' ' ALA . 0.2 OUTLIER -60.07 -56.48 21.15 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.559 -0.456 . . . . 0.0 110.784 -179.521 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.606 HD23 ' N ' ' A' ' 125' ' ' ALA . 0.6 OUTLIER -79.19 -20.16 49.07 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 -178.584 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.606 ' N ' HD23 ' A' ' 124' ' ' LEU . . . -91.17 -66.73 0.9 Allowed 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 112.789 0.663 . . . . 0.0 112.789 -178.818 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 43.4 m0 -83.0 -57.42 3.3 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -177.777 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' HIS . . . . . 0.57 ' CG ' ' HB2' ' A' ' 134' ' ' ALA . 11.5 m170 -55.69 -22.18 22.08 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.584 -0.446 . . . . 0.0 111.129 -179.004 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 19.2 ttt85 -69.66 -48.79 58.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.148 -179.624 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 10.3 t -81.39 -47.46 19.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.993 -179.453 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 61.0 p -116.28 104.98 51.39 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.51 -179.851 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' PRO . . . . . 0.639 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 57.2 Cg_exo -70.79 -29.43 18.99 Favored 'Trans proline' 0 C--N 1.31 -1.477 0 C-N-CA 121.537 1.491 . . . . 0.0 112.367 179.639 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 132' ' ' PRO . . . . . 0.639 ' CD ' ' N ' ' A' ' 131' ' ' PRO . 41.4 Cg_exo -62.58 -42.81 24.51 Favored 'Trans proline' 0 N--CA 1.496 1.663 0 C-N-CA 121.391 1.394 . . . . 0.0 111.787 179.7 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -54.44 -41.52 69.5 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.311 179.813 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' ALA . . . . . 0.57 ' HB2' ' CG ' ' A' ' 127' ' ' HIS . . . -57.18 -22.66 42.06 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.309 179.705 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 11.2 tpp180 -77.06 -31.7 56.32 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.61 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 82.8 mt -72.56 -43.54 63.3 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.857 0.361 . . . . 0.0 110.082 179.571 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.556 ' O ' ' N ' ' A' ' 140' ' ' TYR . 3.4 mt -75.31 -37.68 60.68 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.442 179.79 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.55 ' C ' ' H ' ' A' ' 140' ' ' TYR . 0.8 OUTLIER -19.4 -48.64 0.04 OUTLIER Pre-proline 0 N--CA 1.466 0.352 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.948 -179.608 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.527 ' N ' ' O ' ' A' ' 137' ' ' LEU . 1.6 Cg_endo -64.45 16.08 0.08 OUTLIER 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 120.968 1.112 . . . . 0.0 112.142 179.617 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 140' ' ' TYR . . . . . 0.76 ' CE2' HD11 ' A' ' 144' ' ' LEU . 5.3 p90 -93.35 -15.17 26.01 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-O 121.153 0.501 . . . . 0.0 110.22 179.634 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.653 ' CD1' ' CE1' ' A' ' 140' ' ' TYR . 5.8 mp -57.43 -26.74 61.62 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.273 178.773 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -66.49 -48.93 68.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.08 179.651 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 143' ' ' TRP . . . . . 0.563 ' CZ2' HD12 ' A' ' 52' ' ' ILE . 12.0 t-105 -55.81 -48.7 74.96 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 179.499 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.76 HD11 ' CE2' ' A' ' 140' ' ' TYR . 8.8 mt -50.37 -56.58 10.76 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 120.444 -0.502 . . . . 0.0 109.968 179.714 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.514 ' O ' HG23 ' A' ' 149' ' ' VAL . . . -61.41 -18.28 58.09 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.709 -179.815 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 6.5 t80 -70.93 -65.04 0.79 Allowed 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.843 -0.343 . . . . 0.0 110.829 -179.745 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 147' ' ' ALA . . . . . 0.494 ' O ' ' OD1' ' A' ' 151' ' ' ASN . . . -62.95 -40.23 97.03 Favored 'General case' 0 C--N 1.332 -0.154 0 C-N-CA 120.769 -0.372 . . . . 0.0 110.309 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 13.9 m -58.77 -49.83 76.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.46 179.805 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.514 HG23 ' O ' ' A' ' 145' ' ' ALA . 53.6 t -66.9 -29.38 46.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.334 179.831 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.445 ' O ' HG23 ' A' ' 154' ' ' VAL . 1.0 OUTLIER -58.33 -59.6 5.08 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.506 -0.478 . . . . 0.0 109.935 179.989 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 151' ' ' ASN . . . . . 0.494 ' OD1' ' O ' ' A' ' 147' ' ' ALA . 6.7 p-10 -60.6 -51.29 70.02 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.543 179.624 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 152' ' ' TYR . . . . . 0.665 ' CZ ' ' NE ' ' A' ' 156' ' ' ARG . 53.8 t80 -50.13 -34.74 23.18 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.283 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 153' ' ' TYR . . . . . 0.552 ' CE2' ' OD2' ' A' ' 157' ' ' ASP . 41.0 t80 -68.06 -46.07 72.09 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.529 179.826 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.445 HG23 ' O ' ' A' ' 150' ' ' LEU . 19.0 t -58.14 -36.8 58.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.305 179.797 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 155' ' ' TRP . . . . . . . . . . . . . 15.3 m0 -65.57 -46.02 81.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.624 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 156' ' ' ARG . . . . . 0.665 ' NE ' ' CZ ' ' A' ' 152' ' ' TYR . 7.2 mpt_? -68.4 -29.27 67.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.579 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 157' ' ' ASP . . . . . 0.552 ' OD2' ' CE2' ' A' ' 153' ' ' TYR . 17.0 m-20 -72.3 -51.71 19.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.819 -179.78 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 . . . . . 0 C--N 1.328 -0.341 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.602 -179.917 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.569 ' O ' HG23 ' A' ' 9' ' ' VAL . 0.6 OUTLIER . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.702 0.287 . . . . 0.0 110.354 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.589 ' N ' ' CD ' ' A' ' 7' ' ' PRO . 0.9 OUTLIER -62.28 -37.52 37.86 Favored Pre-proline 0 CA--C 1.534 0.352 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.114 -179.999 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.589 ' CD ' ' N ' ' A' ' 6' ' ' VAL . 33.5 Cg_exo -63.68 -64.21 0.07 OUTLIER 'Trans proline' 0 C--N 1.307 -1.621 0 C-N-CA 121.704 1.603 . . . . 0.0 111.525 179.638 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.7 ' O ' HG23 ' A' ' 12' ' ' THR . . . -52.77 -38.84 61.64 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.695 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.569 HG23 ' O ' ' A' ' 5' ' ' TRP . 24.8 t -59.3 -62.02 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.848 -179.691 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -59.86 -56.67 23.48 Favored Glycine 0 CA--C 1.527 0.81 0 N-CA-C 111.516 -0.634 . . . . 0.0 111.516 -179.628 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 10.1 mp -50.15 -37.77 36.19 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.563 0.22 . . . . 0.0 110.888 -179.643 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.7 HG23 ' O ' ' A' ' 8' ' ' ALA . 35.9 p -75.57 -25.18 56.85 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.858 -0.337 . . . . 0.0 110.625 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.55 HD13 ' O ' ' A' ' 9' ' ' VAL . 4.1 mp -75.81 -25.11 56.06 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.196 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.2 t -54.54 -61.87 4.94 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.428 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -55.8 -46.16 33.67 Favored 'Trans proline' 0 N--CA 1.496 1.672 0 C-N-CA 120.662 0.908 . . . . 0.0 111.808 179.855 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.2 t -46.13 -28.37 1.2 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.236 -179.474 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 92.7 mt -70.2 -56.02 7.86 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.645 -0.422 . . . . 0.0 110.742 -179.705 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -68.0 -23.2 74.42 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 111.316 -0.714 . . . . 0.0 111.316 -179.659 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -69.93 -54.66 11.13 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 110.881 -0.888 . . . . 0.0 110.881 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 52.3 t80 -65.94 -60.29 2.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.833 0.349 . . . . 0.0 110.675 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 17.3 tpp -59.09 -27.67 65.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.04 -179.726 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -74.71 -62.91 2.71 Favored Glycine 0 CA--C 1.523 0.536 0 N-CA-C 111.011 -0.836 . . . . 0.0 111.011 -179.78 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.593 ' O ' HG22 ' A' ' 26' ' ' VAL . . . -55.48 -19.54 9.9 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.947 0.403 . . . . 0.0 109.994 -179.917 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 9.5 t80 -47.83 -24.39 0.98 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.409 179.713 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.466 ' CE2' ' O ' ' A' ' 99' ' ' PHE . 50.0 t80 -69.34 -48.32 61.74 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.417 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.593 HG22 ' O ' ' A' ' 23' ' ' ALA . 35.6 m -75.23 -16.37 15.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.634 -179.893 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -56.31 -47.28 79.01 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.834 -179.77 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -107.14 -42.2 1.55 Allowed Glycine 0 CA--C 1.525 0.7 0 N-CA-C 111.055 -0.818 . . . . 0.0 111.055 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.44 ' OE2' ' CZ3' ' A' ' 33' ' ' TRP . 16.8 tp10 -71.45 -29.63 65.09 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.701 0.286 . . . . 0.0 110.693 -179.845 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -73.99 -57.36 4.87 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.913 -0.875 . . . . 0.0 110.913 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 10.0 mp -56.83 -25.42 56.02 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.973 -0.381 . . . . 0.0 109.973 179.781 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 55.4 ttt180 -81.2 -49.89 10.24 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.088 -0.506 . . . . 0.0 109.989 179.432 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' TRP . . . . . 0.44 ' CZ3' ' OE2' ' A' ' 29' ' ' GLU . 0.2 OUTLIER -45.83 -39.94 9.14 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.688 179.252 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 42.2 t80 -47.37 -38.67 13.55 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.774 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -55.97 -35.18 66.43 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.262 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -84.31 -72.27 1.29 Allowed Glycine 0 CA--C 1.524 0.634 0 N-CA-C 110.804 -0.918 . . . . 0.0 110.804 179.853 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.587 ' O ' HD12 ' A' ' 37' ' ' LEU . 0.4 OUTLIER -96.67 167.89 10.85 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.798 0.333 . . . . 0.0 110.611 179.622 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 10.7 mm100 -83.71 118.53 23.95 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.512 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 15.0 mtpt -127.47 150.15 71.97 Favored Pre-proline 0 N--CA 1.465 0.277 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.255 -179.804 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo . . . . . 0 C--N 1.309 -1.509 0 C-N-CA 121.747 1.632 . . . . 0.0 111.045 179.177 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.673 ' O ' HG23 ' A' ' 52' ' ' ILE . 15.5 tp . . . . . 0 CA--C 1.535 0.398 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.649 ' C ' ' H ' ' A' ' 52' ' ' ILE . . . -43.41 -27.84 0.33 Allowed Pre-proline 0 N--CA 1.468 0.431 0 N-CA-C 112.141 0.422 . . . . 0.0 112.141 -179.141 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.433 ' HD2' ' N ' ' A' ' 50' ' ' ALA . 26.6 Cg_exo -53.41 6.46 0.03 OUTLIER 'Trans proline' 0 C--N 1.313 -1.309 0 CA-C-N 119.003 0.68 . . . . 0.0 112.476 178.214 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.673 HG23 ' O ' ' A' ' 49' ' ' LEU . 7.0 pt -51.85 -36.81 19.84 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.19 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 178.827 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.403 ' CH2' ' CZ3' ' A' ' 93' ' ' TRP . 66.1 m95 -80.74 -25.0 38.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.143 -179.752 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -73.1 -50.75 11.64 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 110.326 -1.109 . . . . 0.0 110.326 179.326 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.593 HG23 ' N ' ' A' ' 56' ' ' LEU . 6.8 t -66.28 -49.16 68.04 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.983 -0.287 . . . . 0.0 110.287 179.713 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.593 ' N ' HG23 ' A' ' 55' ' ' THR . 77.7 mt -60.33 -36.53 78.17 Favored 'General case' 0 CA--C 1.521 -0.16 0 C-N-CA 120.403 -0.519 . . . . 0.0 109.608 179.317 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.485 ' CD1' ' C ' ' A' ' 57' ' ' TYR . 0.8 OUTLIER -56.46 -48.29 77.38 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.61 179.334 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.7 p -55.87 -48.06 76.23 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.022 179.5 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.0 -38.82 80.09 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.315 179.558 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 22.2 mtt -63.16 -37.91 89.1 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.479 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -63.38 -47.02 91.28 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 111.245 -0.742 . . . . 0.0 111.245 -179.703 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 3.3 m-30 -61.49 -59.13 5.71 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.574 -179.662 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.448 ' O ' HG23 ' A' ' 67' ' ' VAL . . . -53.94 -60.06 8.95 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 111.02 -0.832 . . . . 0.0 111.02 -179.884 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.534 ' OG ' ' CH2' ' A' ' 126' ' ' TRP . 44.7 m -45.51 -48.47 14.12 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.001 0.429 . . . . 0.0 110.726 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 62.6 t80 -56.51 -41.45 76.74 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.697 -179.828 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 74.7 mt -65.43 -37.56 80.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.923 -179.694 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.571 HG22 ' CB ' ' A' ' 130' ' ' SER . 21.3 t -59.85 -60.83 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.721 -179.801 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' TRP . . . . . 0.576 ' O ' ' N ' ' A' ' 73' ' ' GLY . 0.7 OUTLIER -57.3 -41.51 79.96 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.655 -0.418 . . . . 0.0 110.325 179.933 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 13.9 mmmt -61.44 -24.77 66.77 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.498 179.622 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 17.7 tp10 -82.34 -62.47 1.61 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.187 -179.473 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.743 ' C ' HD12 ' A' ' 71' ' ' LEU . 3.4 pp -65.25 -8.88 19.7 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.831 -0.348 . . . . 0.0 111.377 -179.152 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.676 ' N ' HD12 ' A' ' 71' ' ' LEU . . . 108.87 76.43 0.93 Allowed Glycine 0 CA--C 1.527 0.801 0 C-N-CA 120.939 -0.648 . . . . 0.0 111.592 179.561 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.576 ' N ' ' O ' ' A' ' 68' ' ' TRP . . . 42.84 -174.03 0.01 OUTLIER Glycine 0 CA--C 1.524 0.595 0 N-CA-C 111.947 -0.461 . . . . 0.0 111.947 179.219 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 43.8 t80 -76.33 110.71 11.07 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.262 -0.469 . . . . 0.0 110.837 -179.671 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.573 HG23 ' H ' ' A' ' 77' ' ' ASP . 7.4 t -142.37 -178.21 5.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.428 179.743 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -46.8 -26.57 0.98 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.179 -179.66 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.573 ' H ' HG23 ' A' ' 75' ' ' THR . 51.7 m-20 -79.05 -28.78 43.21 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.268 -179.422 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.485 ' O ' HD12 ' A' ' 82' ' ' LEU . . . -86.4 -18.34 32.05 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.955 -0.298 . . . . 0.0 110.937 -179.681 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 9.1 mtp -68.96 -27.38 65.68 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.604 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.404 ' N ' ' HD2' ' A' ' 81' ' ' PRO . 7.0 t -68.37 -47.77 36.5 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.9 -179.832 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.404 ' HD2' ' N ' ' A' ' 80' ' ' VAL . 11.4 Cg_endo -72.03 -58.56 0.07 OUTLIER 'Trans proline' 0 N--CA 1.498 1.792 0 C-N-CA 121.113 1.208 . . . . 0.0 111.843 179.253 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.519 HD11 ' CE2' ' A' ' 68' ' ' TRP . 1.6 mt -57.07 -43.71 82.34 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.48 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -66.84 -63.77 3.67 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 111.142 -0.783 . . . . 0.0 111.142 -179.475 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 57.7 tp -49.66 -23.07 1.55 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.924 0.393 . . . . 0.0 110.137 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.462 ' CZ ' HD22 ' A' ' 89' ' ' LEU . 12.9 t80 -76.61 -48.58 18.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.54 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.44 -42.45 95.99 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.8 -0.36 . . . . 0.0 111.056 -179.442 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -70.05 -57.97 6.55 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 111.149 -0.78 . . . . 0.0 111.149 -179.675 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 36.5 tp60 -54.71 -47.52 73.64 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-O 121.012 0.434 . . . . 0.0 110.104 179.731 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.462 HD22 ' CZ ' ' A' ' 85' ' ' TYR . 17.4 tp -56.55 -65.04 0.68 Allowed 'General case' 0 C--O 1.21 -0.991 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.936 179.581 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.592 ' O ' ' HB2' ' A' ' 94' ' ' ALA . . . -37.86 -44.33 0.75 Allowed 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 120.407 -0.517 . . . . 0.0 111.649 -179.407 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 78.2 mt -60.97 -56.89 15.81 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 113.102 0.778 . . . . 0.0 113.102 -178.664 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 41.7 m-20 -75.9 -53.11 8.93 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.392 0.615 . . . . 0.0 111.697 -178.369 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' TRP . . . . . 0.628 ' O ' ' N ' ' A' ' 95' ' ' TRP . 9.8 t-105 -52.05 -33.68 40.07 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.055 -0.975 . . . . 0.0 111.594 -179.938 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.592 ' HB2' ' O ' ' A' ' 90' ' ' ALA . . . -57.03 72.3 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.892 0.377 . . . . 0.0 110.076 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.705 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 22.1 p-90 -97.47 -17.0 0.2 Allowed Pre-proline 0 CA--C 1.532 0.264 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.966 -179.387 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.705 ' CD ' ' N ' ' A' ' 95' ' ' TRP . 52.8 Cg_exo -60.14 -32.23 94.32 Favored 'Trans proline' 0 N--CA 1.493 1.493 0 C-N-CA 120.357 0.705 . . . . 0.0 112.635 179.387 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.484 ' CD ' ' N ' ' A' ' 96' ' ' PRO . 70.1 Cg_exo -50.35 -23.31 9.98 Favored 'Trans proline' 0 N--CA 1.493 1.458 0 C-N-CA 120.254 0.636 . . . . 0.0 112.443 179.785 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.588 ' O ' ' N ' ' A' ' 101' ' ' GLY . 1.1 pp -84.5 19.77 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 121.087 0.47 . . . . 0.0 110.135 179.531 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.466 ' O ' ' CE2' ' A' ' 25' ' ' PHE . 4.4 t80 -39.13 -35.41 0.23 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.843 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 30.6 m-85 -86.59 -25.79 24.79 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.82 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.588 ' N ' ' O ' ' A' ' 98' ' ' ILE . . . -82.8 -4.4 90.07 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 111.195 -0.762 . . . . 0.0 111.195 -179.886 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -72.24 -9.63 58.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.637 0.256 . . . . 0.0 111.081 -179.704 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 3.7 ptm180 -105.25 4.3 30.95 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.755 0.312 . . . . 0.0 110.779 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' GLN . . . . . 0.406 ' C ' ' N ' ' A' ' 106' ' ' GLY . 14.9 mt-30 -113.69 167.54 10.53 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.475 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.486 ' N ' ' SD ' ' A' ' 105' ' ' MET . 0.0 OUTLIER -49.64 -17.38 0.32 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.532 179.979 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.578 ' O ' ' N ' ' A' ' 108' ' ' ALA . . . -72.77 -15.12 78.0 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 111.37 -0.692 . . . . 0.0 111.37 -179.751 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' TRP . . . . . 0.665 ' CD1' ' CZ2' ' A' ' 155' ' ' TRP . 0.0 OUTLIER -38.15 -21.32 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 120.548 0.213 . . . . 0.0 111.239 -179.473 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.578 ' N ' ' O ' ' A' ' 106' ' ' GLY . . . -66.81 -16.15 64.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.912 0.387 . . . . 0.0 111.291 -179.531 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 13.5 mt -60.31 -36.79 78.73 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.479 -179.246 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -53.66 -63.59 1.1 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.967 0.413 . . . . 0.0 110.721 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.742 ' O ' HG23 ' A' ' 115' ' ' VAL . 5.6 p-10 -56.76 -60.69 3.2 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.826 -179.297 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 51.9 tp -49.83 -41.9 46.06 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -178.477 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.418 HD23 ' HA ' ' A' ' 113' ' ' LEU . 71.4 mt -68.49 -61.72 1.7 Allowed 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 -178.144 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.3 pp -59.76 -33.29 71.48 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 120.581 -0.448 . . . . 0.0 111.281 -178.723 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.742 HG23 ' O ' ' A' ' 111' ' ' ASP . 53.3 t -62.04 -60.93 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.148 -179.838 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 116' ' ' SER . . . . . 0.493 ' O ' ' OG1' ' A' ' 120' ' ' THR . 11.4 t -68.57 -22.12 64.49 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.1 -179.373 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -64.8 -62.92 4.58 Favored Glycine 0 CA--C 1.526 0.764 0 C-N-CA 120.883 -0.675 . . . . 0.0 111.742 -179.284 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.585 ' O ' HG23 ' A' ' 122' ' ' THR . 9.9 p -73.38 -36.57 49.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 C-N-CA 120.948 -0.301 . . . . 0.0 111.286 -179.389 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.536 ' O ' ' OG1' ' A' ' 123' ' ' THR . . . -67.41 -61.21 2.02 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.529 -0.469 . . . . 0.0 111.019 -179.462 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.493 ' OG1' ' O ' ' A' ' 116' ' ' SER . 2.0 m -59.27 -54.59 45.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.351 -179.431 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.437 ' O ' ' CB ' ' A' ' 125' ' ' ALA . . . -49.5 -45.89 47.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.854 -179.513 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.585 HG23 ' O ' ' A' ' 118' ' ' VAL . 40.9 p -69.75 -35.29 74.84 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.996 -179.06 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.536 ' OG1' ' O ' ' A' ' 119' ' ' ALA . 0.2 OUTLIER -58.2 -52.07 67.1 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.633 -0.427 . . . . 0.0 111.139 -179.218 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.7 pp -83.96 -19.73 34.11 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.705 -0.398 . . . . 0.0 111.721 -178.852 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.437 ' CB ' ' O ' ' A' ' 121' ' ' ALA . . . -88.02 -70.11 0.65 Allowed 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.584 0.587 . . . . 0.0 112.584 -178.796 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 126' ' ' TRP . . . . . 0.534 ' CH2' ' OG ' ' A' ' 64' ' ' SER . 35.9 m0 -83.23 -57.82 3.1 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 -177.702 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 127' ' ' HIS . . . . . 0.449 ' CD2' ' N ' ' A' ' 127' ' ' HIS . 12.3 m170 -52.22 -21.82 3.76 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.663 -0.415 . . . . 0.0 111.295 -178.825 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 28.3 ttt180 -70.05 -47.01 63.75 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.667 -179.337 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 4.1 t -94.44 -9.58 9.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 111.861 0.319 . . . . 0.0 111.861 -178.674 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' SER . . . . . 0.571 ' CB ' HG22 ' A' ' 67' ' ' VAL . 0.8 OUTLIER -149.56 106.39 3.29 Favored Pre-proline 0 C--N 1.328 -0.368 0 C-N-CA 120.872 -0.331 . . . . 0.0 111.183 -179.364 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 131' ' ' PRO . . . . . 0.665 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 74.4 Cg_exo -76.05 -23.27 12.28 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 121.759 1.639 . . . . 0.0 112.656 179.058 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 132' ' ' PRO . . . . . 0.665 ' CD ' ' N ' ' A' ' 131' ' ' PRO . 52.4 Cg_exo -65.89 -56.85 0.28 Allowed 'Trans proline' 0 N--CA 1.496 1.652 0 C-N-CA 121.322 1.348 . . . . 0.0 112.347 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -46.76 -40.73 14.07 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.64 -179.793 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -52.35 -24.39 7.54 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.533 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 6.1 tpt180 -76.93 -36.71 56.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.432 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 41.3 mt -67.19 -37.06 83.05 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.353 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.568 ' O ' ' N ' ' A' ' 140' ' ' TYR . 5.8 mt -81.86 -39.63 23.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.487 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.513 ' C ' ' H ' ' A' ' 140' ' ' TYR . 4.2 t80 -22.58 -43.57 0.04 OUTLIER Pre-proline 0 CA--C 1.532 0.274 0 O-C-N 123.664 0.602 . . . . 0.0 111.819 -179.601 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.552 ' N ' ' O ' ' A' ' 137' ' ' LEU . 6.3 Cg_exo -65.36 12.66 0.12 Allowed 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 120.852 1.034 . . . . 0.0 111.975 179.291 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 140' ' ' TYR . . . . . 0.702 ' CE2' HD11 ' A' ' 144' ' ' LEU . 3.1 p90 -93.15 -14.42 27.21 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-O 120.892 0.377 . . . . 0.0 110.852 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.53 HD13 HD12 ' A' ' 144' ' ' LEU . 4.3 mm? -55.94 -33.48 64.77 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 178.536 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -56.21 -55.43 33.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.005 179.604 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 143' ' ' TRP . . . . . 0.655 ' CE2' HD12 ' A' ' 52' ' ' ILE . 10.8 t-105 -52.08 -50.49 61.46 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 179.643 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.702 HD11 ' CE2' ' A' ' 140' ' ' TYR . 13.3 mt -49.68 -54.92 15.83 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 120.348 -0.541 . . . . 0.0 109.91 179.599 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.643 ' O ' HG23 ' A' ' 149' ' ' VAL . . . -60.44 -21.35 62.19 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.852 -179.779 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 0.583 ' CE1' HD21 ' A' ' 49' ' ' LEU . 6.2 t80 -69.48 -63.18 1.12 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.837 -179.582 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 147' ' ' ALA . . . . . 0.429 ' HB2' ' CH2' ' A' ' 143' ' ' TRP . . . -64.91 -33.4 75.94 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.728 -0.389 . . . . 0.0 110.436 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 68.9 m -67.13 -35.35 79.53 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.2 179.673 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.643 HG23 ' O ' ' A' ' 145' ' ' ALA . 43.5 t -79.5 -26.87 12.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.179 179.79 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.526 ' O ' HG23 ' A' ' 154' ' ' VAL . 0.8 OUTLIER -66.55 -48.7 68.83 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.827 -0.435 . . . . 0.0 109.827 179.747 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 151' ' ' ASN . . . . . 0.55 ' CG ' ' HE1' ' A' ' 107' ' ' TRP . 0.9 OUTLIER -72.92 -51.23 19.34 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.627 179.81 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 152' ' ' TYR . . . . . 0.414 ' CD1' ' C ' ' A' ' 152' ' ' TYR . 27.8 t80 -56.16 -43.31 78.22 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.855 -179.77 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 153' ' ' TYR . . . . . 0.437 ' CB ' ' O ' ' A' ' 149' ' ' VAL . 63.9 t80 -62.46 -54.38 40.98 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.299 -179.548 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.526 HG23 ' O ' ' A' ' 150' ' ' LEU . 72.7 t -60.44 -54.81 29.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.151 -179.291 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 155' ' ' TRP . . . . . 0.665 ' CZ2' ' CD1' ' A' ' 107' ' ' TRP . 0.4 OUTLIER -48.92 -37.6 20.36 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.206 -0.452 . . . . 0.0 109.978 -179.564 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -77.51 -28.98 52.23 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.296 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 12.5 t0 -75.44 -52.82 9.82 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.826 -179.595 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 158' ' ' ASN . . . . . 0.484 ' OD1' ' O ' ' A' ' 158' ' ' ASN . 48.9 t-20 . . . . . 0 N--CA 1.452 -0.354 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.731 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.629 ' O ' HG23 ' A' ' 9' ' ' VAL . 0.3 OUTLIER . . . . . 0 CA--C 1.528 0.127 0 CA-C-O 120.719 0.295 . . . . 0.0 110.239 . . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.648 ' N ' ' CD ' ' A' ' 7' ' ' PRO . 1.0 OUTLIER -62.64 -33.73 12.4 Favored Pre-proline 0 C--N 1.328 -0.326 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 179.788 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.648 ' CD ' ' N ' ' A' ' 6' ' ' VAL . 21.6 Cg_exo -72.37 -66.97 0.03 OUTLIER 'Trans proline' 0 C--N 1.308 -1.557 0 C-N-CA 121.957 1.772 . . . . 0.0 111.895 179.516 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.647 ' O ' HG23 ' A' ' 12' ' ' THR . . . -49.65 -31.32 10.67 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.153 -179.683 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.629 HG23 ' O ' ' A' ' 5' ' ' TRP . 47.4 t -71.36 -62.2 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.425 -179.182 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -59.02 -43.82 96.67 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 111.262 -0.735 . . . . 0.0 111.262 -179.419 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 8.0 mp -61.87 -39.03 90.5 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.697 0.284 . . . . 0.0 110.637 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.647 HG23 ' O ' ' A' ' 8' ' ' ALA . 8.0 p -69.73 -28.48 65.84 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.786 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.427 ' O ' ' CB ' ' A' ' 16' ' ' SER . 10.7 mt -78.27 -33.38 49.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.669 -179.843 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.443 ' N ' ' HD2' ' A' ' 15' ' ' PRO . 20.3 t -42.0 -59.48 2.58 Favored Pre-proline 0 CA--C 1.535 0.38 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.561 -179.681 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.443 ' HD2' ' N ' ' A' ' 14' ' ' VAL . 17.1 Cg_endo -51.69 -9.46 0.4 Allowed 'Trans proline' 0 N--CA 1.5 1.869 0 C-N-CA 120.616 0.877 . . . . 0.0 112.317 -179.471 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.427 ' CB ' ' O ' ' A' ' 13' ' ' LEU . 3.1 t -79.35 -30.99 42.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.74 -179.865 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 16.6 mt -69.63 -54.44 13.95 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.998 -179.728 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -73.38 -38.55 52.75 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 111.632 -0.587 . . . . 0.0 111.632 -179.374 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -68.94 -29.84 72.42 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 111.066 -0.813 . . . . 0.0 111.066 -179.546 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.412 ' CB ' ' O ' ' A' ' 16' ' ' SER . 64.0 t80 -78.73 -60.32 2.42 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.815 -0.354 . . . . 0.0 110.934 -179.672 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 23.8 ttm -64.88 -21.1 66.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.66 -179.805 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -79.09 -63.02 2.12 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 111.309 -0.716 . . . . 0.0 111.309 -179.628 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.559 ' O ' HG22 ' A' ' 26' ' ' VAL . . . -62.93 -22.19 66.6 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.594 -179.667 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 64.4 t80 -50.9 -23.91 3.19 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.989 0.424 . . . . 0.0 109.892 179.31 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.446 ' CD1' ' C ' ' A' ' 25' ' ' PHE . 25.4 t80 -67.08 -55.01 16.14 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.964 -179.84 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.559 HG22 ' O ' ' A' ' 23' ' ' ALA . 27.2 m -65.87 -22.13 30.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.966 -179.509 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.7 tmt_? -75.56 -17.54 60.03 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.698 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -116.06 -67.3 0.41 Allowed Glycine 0 CA--C 1.525 0.7 0 N-CA-C 111.239 -0.744 . . . . 0.0 111.239 -179.846 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -67.97 -29.72 68.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.751 0.31 . . . . 0.0 110.94 -179.69 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -69.27 -45.91 59.33 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 111.31 -0.716 . . . . 0.0 111.31 -179.737 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.405 HD12 ' N ' ' A' ' 31' ' ' LEU . 11.1 mp -60.34 -28.53 68.24 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.692 0.282 . . . . 0.0 110.677 -179.789 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 76.7 mtm180 -80.38 -43.03 21.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.829 0.347 . . . . 0.0 110.36 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' TRP . . . . . 0.466 ' O ' ' N ' ' A' ' 36' ' ' GLY . 0.2 OUTLIER -59.91 -27.2 66.54 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 179.751 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.487 ' CD1' ' C ' ' A' ' 34' ' ' TYR . 10.3 t80 -49.02 -37.02 19.33 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.894 179.496 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -70.87 -21.66 62.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.902 179.447 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.466 ' N ' ' O ' ' A' ' 33' ' ' TRP . . . -87.95 -76.89 1.28 Allowed Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.442 -1.063 . . . . 0.0 110.442 179.591 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.596 ' O ' HD12 ' A' ' 37' ' ' LEU . 0.4 OUTLIER -96.04 163.7 13.01 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 109.889 -0.411 . . . . 0.0 109.889 179.011 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.506 ' CD ' ' H ' ' A' ' 38' ' ' GLN . 11.2 mp0 -81.79 122.64 27.95 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.932 0.396 . . . . 0.0 111.432 -179.066 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 20.3 mtpt -119.02 160.01 42.58 Favored Pre-proline 0 C--N 1.332 -0.176 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.575 179.182 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo . . . . . 0 C--N 1.305 -1.714 0 C-N-CA 122.023 1.815 . . . . 0.0 111.972 -179.936 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.853 ' O ' HG23 ' A' ' 52' ' ' ILE . 2.1 mm? . . . . . 0 CA--C 1.534 0.344 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.565 ' C ' ' H ' ' A' ' 52' ' ' ILE . . . -39.87 -29.12 0.19 Allowed Pre-proline 0 N--CA 1.466 0.346 0 C-N-CA 120.14 -0.624 . . . . 0.0 111.849 -178.266 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.423 ' HD2' ' N ' ' A' ' 50' ' ' ALA . 95.5 Cg_exo -57.01 5.85 0.06 OUTLIER 'Trans proline' 0 C--N 1.313 -1.323 0 CA-C-N 119.114 0.719 . . . . 0.0 112.273 178.125 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.853 HG23 ' O ' ' A' ' 49' ' ' LEU . 33.5 pt -55.29 -31.37 26.65 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.295 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 179.514 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.459 ' O ' ' CB ' ' A' ' 57' ' ' TYR . 72.7 m95 -78.73 -22.81 45.98 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.892 -179.497 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -69.22 -48.23 47.52 Favored Glycine 0 CA--C 1.526 0.772 0 N-CA-C 110.064 -1.214 . . . . 0.0 110.064 178.754 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 14.5 m -66.77 -55.63 14.12 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.783 0.325 . . . . 0.0 110.142 179.431 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 86.1 mt -58.62 -26.98 64.26 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.44 179.713 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.526 ' CD1' ' C ' ' A' ' 57' ' ' TYR . 0.5 OUTLIER -64.98 -54.1 35.79 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 179.509 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 37.2 t -51.19 -50.49 58.92 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 179.126 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -56.6 -45.18 81.58 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.319 179.435 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 12.3 mtt -57.72 -49.03 77.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.365 179.861 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -51.49 -43.98 52.98 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 110.994 -0.842 . . . . 0.0 110.994 -179.854 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 3.2 m-30 -65.26 -56.3 13.54 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.762 0.315 . . . . 0.0 110.943 -179.456 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -52.06 -48.53 52.21 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.37 -1.092 . . . . 0.0 110.37 179.785 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.488 ' O ' ' CD1' ' A' ' 68' ' ' TRP . 1.7 t -58.83 -41.9 87.98 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.652 -0.274 . . . . 0.0 110.571 179.889 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.406 ' O ' ' CG ' ' A' ' 69' ' ' LYS . 14.5 t80 -54.58 -37.97 66.14 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 109.138 -0.689 . . . . 0.0 109.138 179.038 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 97.3 mt -73.34 -27.29 23.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.096 179.223 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 61.2 t -69.52 -61.69 1.58 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.252 0 C-N-CA 120.746 -0.382 . . . . 0.0 110.763 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' TRP . . . . . 0.516 ' CD1' ' N ' ' A' ' 68' ' ' TRP . 0.0 OUTLIER -57.9 -38.07 75.17 Favored 'General case' 0 C--O 1.221 -0.402 0 C-N-CA 119.388 -0.925 . . . . 0.0 109.622 179.758 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.406 ' CG ' ' O ' ' A' ' 65' ' ' TYR . 0.2 OUTLIER -58.39 -40.52 82.56 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.889 0.376 . . . . 0.0 110.458 179.956 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 55.8 tt0 -64.35 -41.67 96.64 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.344 -179.555 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.6 mt -78.78 -17.64 55.45 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.955 0.407 . . . . 0.0 111.053 -179.347 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 97.84 43.16 2.93 Favored Glycine 0 CA--C 1.526 0.771 0 N-CA-C 110.345 -1.102 . . . . 0.0 110.345 -178.801 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 96.98 -175.09 30.76 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 111.03 -0.828 . . . . 0.0 111.03 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -71.8 112.44 7.91 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.844 0.354 . . . . 0.0 110.533 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.433 ' OG1' ' N ' ' A' ' 76' ' ' GLU . 3.0 t -139.4 179.51 6.5 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.855 -179.801 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.433 ' N ' ' OG1' ' A' ' 75' ' ' THR . 5.0 mm-40 -54.56 -50.06 68.85 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.595 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -55.0 -16.11 2.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.454 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -95.56 -30.7 13.68 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.392 179.769 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 3.5 mtp -64.9 -27.06 68.6 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.495 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.427 ' O ' ' CB ' ' A' ' 84' ' ' LEU . 9.1 t -68.9 -49.64 25.67 Favored Pre-proline 0 CA--C 1.534 0.345 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.643 -179.694 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -72.13 -61.48 0.05 OUTLIER 'Trans proline' 0 N--CA 1.497 1.728 0 C-N-CA 121.127 1.218 . . . . 0.0 111.523 178.891 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.7 mt -51.3 -46.32 62.5 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.384 179.809 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.452 ' O ' ' N ' ' A' ' 86' ' ' THR . . . -67.6 -63.56 3.65 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.672 -0.971 . . . . 0.0 110.672 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.427 ' CB ' ' O ' ' A' ' 80' ' ' VAL . 56.9 tp -43.73 -24.75 0.14 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.892 0.377 . . . . 0.0 110.014 179.727 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.424 ' N ' ' C ' ' A' ' 83' ' ' GLY . 7.2 t80 -80.62 -40.48 25.59 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.442 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.452 ' N ' ' O ' ' A' ' 83' ' ' GLY . 0.7 OUTLIER -71.63 -39.07 70.65 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 120.599 -0.44 . . . . 0.0 110.854 -179.787 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -74.7 -56.92 4.74 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 110.758 -0.937 . . . . 0.0 110.758 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.454 ' O ' ' CB ' ' A' ' 92' ' ' ASN . 9.4 tp-100 -52.7 -43.88 65.93 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.723 0.296 . . . . 0.0 110.236 179.747 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 11.1 tp -67.59 -34.9 77.95 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.605 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.74 ' O ' ' HB2' ' A' ' 94' ' ' ALA . . . -59.73 -65.75 0.63 Allowed 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 120.279 -0.568 . . . . 0.0 111.343 -179.633 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.0 pp -70.71 -39.01 73.67 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -178.479 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.454 ' CB ' ' O ' ' A' ' 88' ' ' GLN . 36.7 t-20 -72.42 -50.33 27.14 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 -178.6 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' TRP . . . . . 0.622 ' O ' ' N ' ' A' ' 95' ' ' TRP . 0.0 OUTLIER -79.63 -16.63 55.45 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.536 -0.466 . . . . 0.0 111.832 -178.374 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.74 ' HB2' ' O ' ' A' ' 90' ' ' ALA . . . -52.02 81.83 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 120.31 -0.556 . . . . 0.0 109.965 179.336 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.704 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 33.8 p-90 -98.97 -16.14 0.19 Allowed Pre-proline 0 CA--C 1.537 0.451 0 N-CA-C 112.564 0.579 . . . . 0.0 112.564 -179.103 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.704 ' CD ' ' N ' ' A' ' 95' ' ' TRP . 36.6 Cg_exo -57.31 -31.5 91.09 Favored 'Trans proline' 0 N--CA 1.495 1.609 0 C-N-CA 120.526 0.818 . . . . 0.0 113.125 179.777 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.455 ' CD ' ' N ' ' A' ' 96' ' ' PRO . 80.4 Cg_exo -53.14 -20.28 13.87 Favored 'Trans proline' 0 N--CA 1.495 1.601 0 C-N-CA 120.352 0.701 . . . . 0.0 113.271 -179.873 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.463 ' O ' ' N ' ' A' ' 101' ' ' GLY . 1.3 pp -82.61 19.21 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 C-N-CA 120.586 -0.446 . . . . 0.0 110.469 -179.897 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -40.76 -41.48 1.56 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.933 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 2.5 p90 -85.5 -23.75 27.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.914 -179.698 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.463 ' N ' ' O ' ' A' ' 98' ' ' ILE . . . -78.82 -7.7 88.15 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 111.194 -0.762 . . . . 0.0 111.194 -179.851 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -80.14 -7.11 58.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.774 0.321 . . . . 0.0 110.729 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -74.36 -12.18 60.45 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.846 -179.727 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' GLN . . . . . 0.429 ' C ' ' N ' ' A' ' 106' ' ' GLY . 2.8 pt20 -117.39 164.62 14.59 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.804 -179.862 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 8.6 mmt -47.92 -17.15 0.1 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.536 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.595 ' O ' ' N ' ' A' ' 108' ' ' ALA . . . -62.09 -15.56 50.58 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 107' ' ' TRP . . . . . 0.512 ' CD1' ' C ' ' A' ' 107' ' ' TRP . 0.0 OUTLIER -44.04 -12.62 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.758 0.313 . . . . 0.0 110.725 -179.687 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.595 ' N ' ' O ' ' A' ' 106' ' ' GLY . . . -65.27 -28.52 69.4 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.363 179.743 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.413 HD13 ' O ' ' A' ' 106' ' ' GLY . 9.1 mp -45.76 -26.43 0.65 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.231 179.842 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -60.82 -63.97 1.12 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.595 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.704 ' O ' HG23 ' A' ' 115' ' ' VAL . 4.1 p30 -57.66 -50.75 72.15 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.464 -179.614 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.438 ' N ' ' OD1' ' A' ' 111' ' ' ASP . 53.2 tp -55.14 -44.27 74.92 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.875 -0.33 . . . . 0.0 111.587 -178.968 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 54.2 mt -66.7 -61.39 1.99 Allowed 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -178.515 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.3 pp -61.51 -32.64 72.67 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 120.567 -0.453 . . . . 0.0 111.842 -178.391 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.704 HG23 ' O ' ' A' ' 111' ' ' ASP . 46.0 t -63.32 -54.44 32.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.24 -179.9 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 116' ' ' SER . . . . . 0.447 ' O ' ' OG1' ' A' ' 120' ' ' THR . 28.9 t -72.46 -24.12 61.15 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.316 -179.059 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -66.2 -62.66 4.49 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 120.944 -0.646 . . . . 0.0 111.749 -179.278 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.588 ' O ' HG23 ' A' ' 122' ' ' THR . 7.5 p -71.79 -38.48 65.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 C-N-CA 120.961 -0.296 . . . . 0.0 111.709 -179.246 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.527 ' O ' ' OG1' ' A' ' 123' ' ' THR . . . -64.54 -60.92 2.58 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.697 -0.401 . . . . 0.0 111.221 -179.286 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.447 ' OG1' ' O ' ' A' ' 116' ' ' SER . 2.1 m -60.28 -55.16 37.12 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.56 -179.275 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -51.11 -40.65 58.95 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.204 -179.268 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.588 HG23 ' O ' ' A' ' 118' ' ' VAL . 30.9 p -72.25 -35.54 68.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.3 -179.363 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.527 ' OG1' ' O ' ' A' ' 119' ' ' ALA . 0.2 OUTLIER -58.28 -50.66 72.81 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.812 0.339 . . . . 0.0 111.148 -179.221 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.6 pp -82.42 -20.19 37.54 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.669 -178.914 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -88.12 -72.72 0.52 Allowed 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 -178.511 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 43.7 m0 -81.83 -57.93 3.21 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 112.662 0.616 . . . . 0.0 112.662 -177.97 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' HIS . . . . . 0.533 ' CD2' ' N ' ' A' ' 127' ' ' HIS . 5.3 m170 -53.18 -22.23 6.28 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.63 -0.428 . . . . 0.0 111.14 -178.823 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 14.0 ttt180 -76.31 -30.49 57.74 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.146 -179.61 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 73.8 t -95.64 -49.9 12.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.769 0.319 . . . . 0.0 111.29 -179.422 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 67.7 p -117.6 109.23 41.99 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.511 -179.707 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' PRO . . . . . 0.657 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 50.5 Cg_exo -71.68 -18.13 29.04 Favored 'Trans proline' 0 N--CA 1.493 1.461 0 C-N-CA 121.458 1.439 . . . . 0.0 112.584 179.638 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 132' ' ' PRO . . . . . 0.657 ' CD ' ' N ' ' A' ' 131' ' ' PRO . 54.3 Cg_exo -74.43 -35.57 3.68 Favored 'Trans proline' 0 N--CA 1.496 1.653 0 C-N-CA 121.262 1.308 . . . . 0.0 112.0 179.365 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -63.49 -39.64 94.97 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.348 179.846 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -57.33 -26.56 61.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.2 179.85 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 15.9 tpt180 -77.66 -31.09 52.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.373 179.83 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 20.5 mt -75.5 -25.83 57.63 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.261 -0.427 . . . . 0.0 109.849 179.506 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.486 ' O ' ' N ' ' A' ' 140' ' ' TYR . 68.6 mt -92.47 -23.81 19.01 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.165 179.505 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.518 ' CD1' ' C ' ' A' ' 138' ' ' TYR . 0.3 OUTLIER -35.43 -50.19 1.33 Allowed Pre-proline 0 CA--C 1.535 0.395 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.977 179.715 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.439 ' HD2' ' N ' ' A' ' 138' ' ' TYR . 0.9 OUTLIER -61.28 4.89 0.2 Allowed 'Trans proline' 0 N--CA 1.496 1.667 0 C-N-CA 121.64 1.56 . . . . 0.0 112.958 -179.471 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 140' ' ' TYR . . . . . 0.486 ' N ' ' O ' ' A' ' 137' ' ' LEU . 0.1 OUTLIER -88.88 -14.32 37.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.0 0.429 . . . . 0.0 110.562 179.657 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.538 HD23 HD12 ' A' ' 144' ' ' LEU . 97.5 mt -60.02 -33.6 72.22 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.685 178.582 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -57.15 -41.39 79.06 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.584 179.304 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 143' ' ' TRP . . . . . 0.431 ' CE2' HD12 ' A' ' 52' ' ' ILE . 8.6 t-105 -66.11 -43.64 86.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.591 179.24 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.538 HD12 HD23 ' A' ' 141' ' ' LEU . 30.0 mt -59.08 -41.97 89.27 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.174 179.765 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.619 ' O ' HG23 ' A' ' 149' ' ' VAL . . . -72.65 -23.4 60.9 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.419 179.855 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 24.4 t80 -65.91 -57.11 8.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.804 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -68.08 -43.37 78.69 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 120.91 -0.316 . . . . 0.0 110.886 -179.727 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 63.6 m -58.99 -45.68 90.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.831 0.348 . . . . 0.0 110.754 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.619 HG23 ' O ' ' A' ' 145' ' ' ALA . 69.4 t -68.49 -29.43 43.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.632 -179.885 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.464 ' O ' HG23 ' A' ' 154' ' ' VAL . 1.6 tp -62.51 -47.09 85.44 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.293 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 151' ' ' ASN . . . . . 0.596 ' ND2' ' N ' ' A' ' 152' ' ' TYR . 0.3 OUTLIER -69.27 -37.2 77.77 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.568 179.934 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 152' ' ' TYR . . . . . 0.596 ' N ' ' ND2' ' A' ' 151' ' ' ASN . 26.0 t80 -64.15 -48.82 74.53 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.593 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 31.1 t80 -59.27 -43.51 92.49 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.872 -179.864 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.464 HG23 ' O ' ' A' ' 150' ' ' LEU . 75.8 t -61.7 -36.04 71.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.81 -179.757 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 155' ' ' TRP . . . . . . . . . . . . . 8.0 m0 -64.44 -59.19 4.63 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.74 -179.814 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 156' ' ' ARG . . . . . 0.411 ' NE ' ' CZ ' ' A' ' 152' ' ' TYR . 3.3 mpt_? -60.62 -51.29 70.05 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.829 -179.571 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 31.3 t0 -53.82 -43.79 69.7 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.791 -179.849 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 16.5 t-20 . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.55 -179.933 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.712 ' O ' HG23 ' A' ' 9' ' ' VAL . 1.3 t-105 . . . . . 0 CA--C 1.528 0.128 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.576 ' N ' ' CD ' ' A' ' 7' ' ' PRO . 0.9 OUTLIER -62.23 -40.43 66.78 Favored Pre-proline 0 CA--C 1.533 0.313 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.479 -179.479 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.576 ' CD ' ' N ' ' A' ' 6' ' ' VAL . 25.1 Cg_exo -61.24 -60.29 0.24 Allowed 'Trans proline' 0 C--N 1.306 -1.66 0 C-N-CA 121.627 1.551 . . . . 0.0 111.874 179.904 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.722 ' O ' HG23 ' A' ' 12' ' ' THR . . . -56.88 -32.94 66.37 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.42 -179.465 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.712 HG23 ' O ' ' A' ' 5' ' ' TRP . 55.3 t -67.22 -62.03 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 C-N-CA 120.897 -0.321 . . . . 0.0 111.397 -179.263 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -57.52 -41.23 93.33 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 111.354 -0.698 . . . . 0.0 111.354 -179.509 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 7.7 mp -69.64 -30.14 67.78 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 121.043 -0.263 . . . . 0.0 110.758 -179.641 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.722 HG23 ' O ' ' A' ' 8' ' ' ALA . 4.8 p -74.81 -25.24 58.89 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.842 -0.343 . . . . 0.0 110.406 179.802 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.441 ' O ' ' CB ' ' A' ' 16' ' ' SER . 6.4 mp -81.48 -33.79 31.74 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.023 179.688 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.416 ' N ' ' HD2' ' A' ' 15' ' ' PRO . 7.9 t -40.25 -60.66 1.4 Allowed Pre-proline 0 CA--C 1.535 0.366 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.061 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.416 ' HD2' ' N ' ' A' ' 14' ' ' VAL . 10.5 Cg_endo -51.49 -17.15 4.14 Favored 'Trans proline' 0 N--CA 1.499 1.8 0 C-N-CA 120.949 1.099 . . . . 0.0 112.091 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.441 ' CB ' ' O ' ' A' ' 13' ' ' LEU . 4.0 t -70.0 -33.3 71.86 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.886 0.374 . . . . 0.0 110.512 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 27.9 mt -72.11 -55.17 7.77 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.336 179.86 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -60.75 -46.36 94.63 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 110.857 -0.897 . . . . 0.0 110.857 179.784 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -65.35 -29.45 75.28 Favored Glycine 0 CA--C 1.526 0.756 0 N-CA-C 111.051 -0.82 . . . . 0.0 111.051 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 31.9 t80 -74.23 -59.98 2.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.696 0.284 . . . . 0.0 110.66 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 6.7 ttp -63.31 -22.47 66.9 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.621 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.479 ' C ' ' CZ2' ' A' ' 95' ' ' TRP . . . -77.2 -62.65 2.41 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 111.093 -0.803 . . . . 0.0 111.093 -179.874 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.41 ' O ' HG22 ' A' ' 26' ' ' VAL . . . -64.51 -17.54 63.99 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.006 0.431 . . . . 0.0 110.314 179.891 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 41.4 t80 -48.91 -24.73 1.58 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.143 179.634 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 33.9 t80 -67.64 -54.72 17.31 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.761 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.41 HG22 ' O ' ' A' ' 23' ' ' ALA . 22.2 m -71.64 -17.2 19.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.761 -179.724 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -62.17 -39.84 94.0 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.623 -179.885 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -114.65 -72.42 0.55 Allowed Glycine 0 CA--C 1.525 0.681 0 N-CA-C 110.824 -0.91 . . . . 0.0 110.824 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -45.92 -28.23 1.07 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.82 0.343 . . . . 0.0 110.431 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -68.26 -45.16 71.91 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 84.2 mt -54.95 -36.43 65.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.887 0.375 . . . . 0.0 110.274 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 56.2 mtp180 -77.69 -50.53 12.26 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.637 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' TRP . . . . . 0.422 ' O ' ' N ' ' A' ' 36' ' ' GLY . 0.6 OUTLIER -46.73 -30.68 2.52 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 116.3 -0.409 . . . . 0.0 109.909 -179.996 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 37.7 t80 -47.75 -33.62 7.33 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.424 179.723 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -74.9 -30.64 61.35 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.263 179.731 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.422 ' N ' ' O ' ' A' ' 33' ' ' TRP . . . -77.72 -77.39 0.83 Allowed Glycine 0 CA--C 1.524 0.64 0 N-CA-C 110.793 -0.923 . . . . 0.0 110.793 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.56 ' O ' HD12 ' A' ' 37' ' ' LEU . 0.4 OUTLIER -96.45 166.23 11.8 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 120.791 0.329 . . . . 0.0 110.739 179.712 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -83.17 113.41 20.63 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.767 -179.739 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 7.8 mtpt -97.24 157.28 35.16 Favored Pre-proline 0 CA--C 1.532 0.267 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo . . . . . 0 N--CA 1.495 1.568 0 C-N-CA 120.924 1.083 . . . . 0.0 112.104 -178.714 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.757 ' O ' HG23 ' A' ' 52' ' ' ILE . 0.2 OUTLIER . . . . . 0 CA--C 1.533 0.309 0 N-CA-C 112.808 0.669 . . . . 0.0 112.808 . . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.6 ' C ' ' H ' ' A' ' 52' ' ' ILE . . . -39.08 -30.98 0.21 Allowed Pre-proline 0 C--O 1.235 0.305 0 C-N-CA 120.614 -0.435 . . . . 0.0 111.73 -178.391 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.413 ' HD2' ' N ' ' A' ' 50' ' ' ALA . 39.7 Cg_exo -53.53 5.55 0.03 OUTLIER 'Trans proline' 0 C--N 1.311 -1.417 0 CA-C-N 118.99 0.675 . . . . 0.0 112.456 178.253 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.757 HG23 ' O ' ' A' ' 49' ' ' LEU . 9.9 pt -53.34 -34.86 23.3 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.201 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 179.114 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.454 ' O ' ' CB ' ' A' ' 57' ' ' TYR . 72.6 m95 -78.83 -23.24 45.19 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.151 -179.415 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -68.96 -45.12 64.33 Favored Glycine 0 CA--C 1.527 0.797 0 N-CA-C 109.909 -1.276 . . . . 0.0 109.909 179.047 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 6.2 m -68.8 -56.89 6.58 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 179.282 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 95.8 mt -57.32 -26.0 60.25 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.094 179.733 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.543 ' CD1' ' C ' ' A' ' 57' ' ' TYR . 0.5 OUTLIER -66.27 -54.65 22.37 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 179.482 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 61.5 m -51.13 -53.85 30.59 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.539 -0.464 . . . . 0.0 109.92 179.369 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -54.51 -41.07 69.2 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.485 179.772 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 10.1 mtt -62.45 -58.2 8.46 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.354 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -42.31 -41.99 4.17 Favored Glycine 0 CA--C 1.521 0.445 0 N-CA-C 110.641 -0.984 . . . . 0.0 110.641 179.823 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -63.55 -57.64 9.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.896 0.379 . . . . 0.0 110.412 179.848 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -52.1 -57.0 14.11 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 110.682 -0.967 . . . . 0.0 110.682 179.771 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.455 ' O ' ' CD1' ' A' ' 68' ' ' TRP . 0.3 OUTLIER -46.26 -51.64 14.09 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.927 0.394 . . . . 0.0 110.176 179.574 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 70.6 t80 -49.84 -41.07 44.24 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.447 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 40.9 mt -69.63 -44.68 79.3 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.023 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.465 ' CG1' ' CZ3' ' A' ' 68' ' ' TRP . 23.3 t -53.83 -58.61 3.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 120.962 0.411 . . . . 0.0 110.815 -179.722 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' TRP . . . . . 0.526 ' O ' ' N ' ' A' ' 73' ' ' GLY . 1.5 m95 -64.06 -39.48 94.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.196 -179.526 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 4.9 mmmt -63.0 -23.96 67.69 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.847 0.356 . . . . 0.0 110.543 179.804 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -83.0 -62.67 1.53 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.08 -179.47 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.743 ' C ' HD12 ' A' ' 71' ' ' LEU . 3.6 pp -64.92 -9.29 20.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.179 -179.487 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.646 ' N ' HD12 ' A' ' 71' ' ' LEU . . . 106.05 81.99 1.49 Allowed Glycine 0 CA--C 1.525 0.707 0 C-N-CA 121.071 -0.585 . . . . 0.0 111.783 179.335 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.526 ' N ' ' O ' ' A' ' 68' ' ' TRP . . . 42.03 -174.13 0.01 OUTLIER Glycine 0 CA--C 1.526 0.722 0 N-CA-C 111.933 -0.467 . . . . 0.0 111.933 179.097 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 69.8 t80 -76.98 110.8 11.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.871 0.367 . . . . 0.0 110.884 -179.718 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.539 ' OG1' ' N ' ' A' ' 76' ' ' GLU . 1.1 t -142.05 -173.66 3.88 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.326 179.781 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.539 ' N ' ' OG1' ' A' ' 75' ' ' THR . 9.1 mm-40 -49.25 -34.71 15.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.779 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -69.64 -24.29 63.61 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.027 -179.729 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.485 ' O ' HD12 ' A' ' 82' ' ' LEU . . . -91.53 -24.22 19.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.861 0.362 . . . . 0.0 110.642 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 9.2 mtp -63.05 -26.72 68.98 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.576 179.861 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 6.8 t -70.41 -53.9 9.54 Favored Pre-proline 0 CA--C 1.536 0.405 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.838 -179.617 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -64.34 -56.32 0.46 Allowed 'Trans proline' 0 N--CA 1.498 1.753 0 C-N-CA 121.053 1.169 . . . . 0.0 112.097 179.551 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.504 HD11 ' CE2' ' A' ' 68' ' ' TRP . 1.2 mt -61.41 -46.56 89.64 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.911 0.386 . . . . 0.0 110.569 -179.896 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -61.03 -53.96 40.7 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 111.241 -0.743 . . . . 0.0 111.241 -179.64 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 54.9 tp -62.69 -26.58 68.73 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.885 0.374 . . . . 0.0 110.603 -179.707 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 20.9 t80 -68.65 -50.88 47.67 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.783 -179.732 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 9.7 t -70.98 -33.82 70.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.268 -179.468 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -70.52 -57.2 6.8 Favored Glycine 0 CA--C 1.523 0.587 0 N-CA-C 110.947 -0.861 . . . . 0.0 110.947 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.428 ' O ' ' CB ' ' A' ' 92' ' ' ASN . 1.8 tp-100 -59.51 -40.54 87.42 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.818 0.342 . . . . 0.0 110.397 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.405 ' O ' ' CD1' ' A' ' 93' ' ' TRP . 11.4 tp -66.52 -34.91 78.98 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.41 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.766 ' O ' ' HB2' ' A' ' 94' ' ' ALA . . . -64.52 -65.73 0.64 Allowed 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 120.254 -0.578 . . . . 0.0 111.489 -179.398 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.6 pp -66.42 -34.48 78.04 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.714 0.635 . . . . 0.0 112.714 -178.493 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.428 ' CB ' ' O ' ' A' ' 88' ' ' GLN . 7.5 t-20 -82.04 -57.6 3.33 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 -178.461 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' TRP . . . . . 0.6 ' O ' ' N ' ' A' ' 95' ' ' TRP . 0.0 OUTLIER -69.94 -17.04 63.3 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 111.838 0.31 . . . . 0.0 111.838 -178.265 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.766 ' HB2' ' O ' ' A' ' 90' ' ' ALA . . . -52.51 82.95 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.14 0 C-N-CA 120.349 -0.54 . . . . 0.0 110.068 179.637 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.702 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 30.8 p-90 -99.32 -16.31 0.19 Allowed Pre-proline 0 CA--C 1.535 0.375 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 -179.449 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.702 ' CD ' ' N ' ' A' ' 95' ' ' TRP . 48.8 Cg_exo -58.91 -32.92 98.31 Favored 'Trans proline' 0 N--CA 1.495 1.579 0 C-N-CA 120.692 0.928 . . . . 0.0 112.977 179.393 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.466 ' CD ' ' N ' ' A' ' 96' ' ' PRO . 66.4 Cg_exo -49.41 -18.55 2.37 Favored 'Trans proline' 0 N--CA 1.495 1.559 0 C-N-CA 120.389 0.726 . . . . 0.0 112.971 -179.903 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.549 ' O ' ' N ' ' A' ' 101' ' ' GLY . 1.1 pp -92.06 20.97 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.934 0.397 . . . . 0.0 110.466 179.758 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 10.3 t80 -40.41 -48.42 2.73 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.488 179.808 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -77.5 -19.73 55.41 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.546 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.549 ' N ' ' O ' ' A' ' 98' ' ' ILE . . . -78.34 -15.17 81.35 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 110.892 -0.883 . . . . 0.0 110.892 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -67.73 -12.95 61.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.772 0.32 . . . . 0.0 110.468 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.413 ' HB2' HH11 ' A' ' 103' ' ' ARG . 0.0 OUTLIER -81.56 -8.44 59.72 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.467 179.998 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 104' ' ' GLN . . . . . 0.523 ' O ' ' N ' ' A' ' 106' ' ' GLY . 19.1 pt20 -123.87 173.8 7.95 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.838 179.852 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.55 ' N ' ' SD ' ' A' ' 105' ' ' MET . 0.0 OUTLIER -42.83 -17.02 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.125 -179.748 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.523 ' N ' ' O ' ' A' ' 104' ' ' GLN . . . -63.34 -16.84 58.74 Favored Glycine 0 CA--C 1.527 0.836 0 C-N-CA 121.324 -0.465 . . . . 0.0 111.979 -179.233 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 107' ' ' TRP . . . . . 0.686 ' CD1' ' CH2' ' A' ' 155' ' ' TRP . 0.0 OUTLIER -51.11 -15.87 0.4 Allowed 'General case' 0 C--N 1.329 -0.314 0 O-C-N 122.626 -0.338 . . . . 0.0 110.554 -179.581 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.492 ' O ' ' OD1' ' A' ' 111' ' ' ASP . . . -76.2 -25.05 54.78 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.855 0.359 . . . . 0.0 110.621 -179.825 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 84.2 mt -59.24 -29.72 67.73 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.923 -179.716 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.417 ' O ' HD23 ' A' ' 114' ' ' LEU . . . -54.1 -62.02 1.92 Allowed 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.728 -0.389 . . . . 0.0 110.502 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.68 ' O ' HG23 ' A' ' 115' ' ' VAL . 5.5 p-10 -62.02 -53.73 51.42 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.108 -0.496 . . . . 0.0 112.024 -179.432 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 31.8 tp -52.95 -45.13 67.57 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 -178.458 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.404 ' HA ' HD23 ' A' ' 113' ' ' LEU . 60.3 mt -67.67 -61.7 1.76 Allowed 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.624 0.601 . . . . 0.0 112.624 -178.322 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.417 HD23 ' O ' ' A' ' 110' ' ' ALA . 2.9 pp -58.62 -35.1 71.94 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 120.157 -0.617 . . . . 0.0 111.251 -178.736 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.68 HG23 ' O ' ' A' ' 111' ' ' ASP . 37.2 t -58.86 -59.27 3.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.963 179.801 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 116' ' ' SER . . . . . 0.494 ' O ' ' OG1' ' A' ' 120' ' ' THR . 5.6 t -70.45 -22.34 62.71 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.658 -179.009 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -64.93 -62.84 4.62 Favored Glycine 0 CA--C 1.526 0.778 0 C-N-CA 120.963 -0.637 . . . . 0.0 111.84 -179.058 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.529 ' O ' HG23 ' A' ' 122' ' ' THR . 8.9 p -72.16 -37.51 59.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 C-N-CA 120.975 -0.29 . . . . 0.0 111.39 -179.404 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.51 ' O ' ' OG1' ' A' ' 123' ' ' THR . . . -67.07 -60.21 2.81 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.338 -0.545 . . . . 0.0 111.038 -179.549 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.494 ' OG1' ' O ' ' A' ' 116' ' ' SER . 3.3 m -57.92 -56.46 21.75 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.754 0.311 . . . . 0.0 111.393 -179.638 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -50.68 -41.15 55.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.305 -179.302 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.529 HG23 ' O ' ' A' ' 118' ' ' VAL . 31.4 p -73.53 -30.16 62.92 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.855 -0.338 . . . . 0.0 111.817 -179.144 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.51 ' OG1' ' O ' ' A' ' 119' ' ' ALA . 0.2 OUTLIER -64.96 -49.04 71.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.942 0.401 . . . . 0.0 110.759 -179.559 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.0 pp -81.59 -20.18 40.38 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.488 -179.274 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -90.8 -67.04 0.88 Allowed 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 -178.552 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 34.8 m0 -83.73 -57.15 3.34 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 112.962 0.727 . . . . 0.0 112.962 -177.831 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' HIS . . . . . 0.492 ' CD2' ' N ' ' A' ' 127' ' ' HIS . 9.1 m170 -55.88 -22.21 24.24 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.715 -0.394 . . . . 0.0 111.707 -178.565 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 33.5 ttt-85 -72.91 -47.25 47.37 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.783 -0.367 . . . . 0.0 111.178 -179.592 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 64.3 t -79.47 -41.49 22.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.168 -179.449 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -130.2 118.22 18.23 Favored Pre-proline 0 CA--C 1.536 0.405 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.578 -179.543 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 131' ' ' PRO . . . . . 0.647 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 70.9 Cg_exo -75.26 -26.6 10.36 Favored 'Trans proline' 0 N--CA 1.493 1.476 0 C-N-CA 121.238 1.292 . . . . 0.0 112.857 179.276 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 132' ' ' PRO . . . . . 0.647 ' CD ' ' N ' ' A' ' 131' ' ' PRO . 53.8 Cg_exo -60.4 -55.22 1.6 Allowed 'Trans proline' 0 N--CA 1.497 1.73 0 C-N-CA 121.517 1.478 . . . . 0.0 112.492 -179.731 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -46.28 -37.36 7.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.857 0.361 . . . . 0.0 110.315 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 134' ' ' ALA . . . . . 0.427 ' HB2' ' CG ' ' A' ' 127' ' ' HIS . . . -57.57 -29.45 64.45 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.366 179.894 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 25.5 ttp180 -74.44 -30.47 61.91 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.319 179.788 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 48.5 mt -73.28 -28.91 62.38 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 179.405 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.519 ' O ' ' N ' ' A' ' 140' ' ' TYR . 5.7 mt -86.45 -31.01 21.61 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.413 179.614 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.462 ' C ' ' H ' ' A' ' 140' ' ' TYR . 1.5 t80 -31.52 -49.72 0.45 Allowed Pre-proline 0 CA--C 1.538 0.506 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.508 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.429 ' HD2' ' N ' ' A' ' 138' ' ' TYR . 4.1 Cg_endo -62.65 7.42 0.15 Allowed 'Trans proline' 0 N--CA 1.498 1.764 0 C-N-CA 121.526 1.484 . . . . 0.0 112.807 -179.689 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 140' ' ' TYR . . . . . 0.519 ' N ' ' O ' ' A' ' 137' ' ' LEU . 0.1 OUTLIER -93.08 -14.41 27.32 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 121.013 0.435 . . . . 0.0 111.096 179.806 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.581 HD23 HD12 ' A' ' 144' ' ' LEU . 97.7 mt -59.73 -26.53 65.72 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.16 -0.473 . . . . 0.0 109.942 178.949 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -64.38 -39.3 93.6 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 179.256 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 143' ' ' TRP . . . . . 0.509 ' CE2' HD12 ' A' ' 52' ' ' ILE . 10.5 t-105 -67.19 -42.45 84.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.521 179.115 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.581 HD12 HD23 ' A' ' 141' ' ' LEU . 17.9 mt -58.73 -45.66 89.13 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.226 179.8 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.603 ' O ' HG23 ' A' ' 149' ' ' VAL . . . -70.35 -23.29 62.78 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.27 179.715 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 33.8 t80 -64.83 -64.34 0.89 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.776 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -64.96 -43.82 91.4 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.977 -179.571 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 37.4 m -56.89 -49.86 74.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.804 -179.781 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.603 HG23 ' O ' ' A' ' 145' ' ' ALA . 90.5 t -68.57 -31.78 52.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.935 -179.56 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 1.9 tp -57.07 -46.46 82.48 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.983 0.42 . . . . 0.0 109.912 179.738 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 151' ' ' ASN . . . . . 0.601 ' OD1' ' NE1' ' A' ' 107' ' ' TRP . 7.3 t30 -70.08 -54.53 12.67 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.922 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 65.8 t80 -51.58 -39.09 57.25 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.4 -179.397 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 153' ' ' TYR . . . . . 0.578 ' CE1' ' OD2' ' A' ' 157' ' ' ASP . 53.2 t80 -68.22 -52.43 34.2 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.63 -179.08 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 86.6 t -65.16 -28.07 43.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.596 -178.967 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 155' ' ' TRP . . . . . 0.686 ' CH2' ' CD1' ' A' ' 107' ' ' TRP . 0.6 OUTLIER -78.32 -40.64 36.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.773 0.32 . . . . 0.0 110.445 -179.334 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 156' ' ' ARG . . . . . 0.402 ' HD2' ' N ' ' A' ' 156' ' ' ARG . 6.0 mpt_? -76.52 -23.22 53.67 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 110.051 -0.351 . . . . 0.0 110.051 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 157' ' ' ASP . . . . . 0.578 ' OD2' ' CE1' ' A' ' 153' ' ' TYR . 2.1 m-20 -79.53 -39.89 30.89 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.537 179.79 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 158' ' ' ASN . . . . . 0.5 ' OD1' ' O ' ' A' ' 155' ' ' TRP . 43.1 p30 . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.501 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.564 ' O ' HG23 ' A' ' 9' ' ' VAL . 0.9 OUTLIER . . . . . 0 CA--C 1.529 0.136 0 N-CA-C 110.148 -0.316 . . . . 0.0 110.148 . . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.538 ' N ' ' CD ' ' A' ' 7' ' ' PRO . 0.9 OUTLIER -57.94 -45.1 99.81 Favored Pre-proline 0 CA--C 1.534 0.346 0 C-N-CA 120.855 -0.338 . . . . 0.0 110.297 -179.577 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.538 ' CD ' ' N ' ' A' ' 6' ' ' VAL . 20.6 Cg_exo -58.02 -65.36 0.1 OUTLIER 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 121.416 1.411 . . . . 0.0 111.646 179.559 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.69 ' O ' HG23 ' A' ' 12' ' ' THR . . . -45.32 -36.32 4.06 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.366 -179.701 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.564 HG23 ' O ' ' A' ' 5' ' ' TRP . 69.0 t -70.04 -62.59 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 C-N-CA 120.866 -0.334 . . . . 0.0 111.775 -178.962 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -57.23 -43.59 93.53 Favored Glycine 0 CA--C 1.527 0.822 0 C-N-CA 121.275 -0.488 . . . . 0.0 112.0 -179.051 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.437 HD12 ' N ' ' A' ' 11' ' ' LEU . 8.5 mp -67.13 -35.53 79.94 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.569 0.223 . . . . 0.0 111.324 -179.166 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.69 HG23 ' O ' ' A' ' 8' ' ' ALA . 10.6 p -69.66 -29.83 67.38 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.733 -0.387 . . . . 0.0 110.635 -179.9 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.445 ' O ' ' C ' ' A' ' 14' ' ' VAL . 6.0 mp -78.58 -32.13 47.53 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.738 -179.758 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.445 ' C ' ' O ' ' A' ' 13' ' ' LEU . 6.0 t -35.97 -55.91 1.23 Allowed Pre-proline 0 CA--C 1.534 0.35 0 C-N-CA 120.891 -0.323 . . . . 0.0 110.867 -179.704 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.403 ' HD2' ' N ' ' A' ' 14' ' ' VAL . 13.2 Cg_endo -61.03 -41.27 45.25 Favored 'Trans proline' 0 N--CA 1.5 1.87 0 C-N-CA 120.936 1.091 . . . . 0.0 112.026 179.644 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 7.8 t -45.54 -28.34 0.92 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.665 -179.57 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 87.4 mt -66.0 -57.89 6.75 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.72 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -64.55 -24.92 69.83 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 111.291 -0.724 . . . . 0.0 111.291 -179.738 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -77.32 -27.82 59.01 Favored Glycine 0 CA--C 1.518 0.256 0 N-CA-C 110.432 -1.067 . . . . 0.0 110.432 -179.709 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 19.7 t80 -76.08 -60.75 2.19 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.785 0.326 . . . . 0.0 110.617 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 48.6 ttm -73.17 -21.08 60.76 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.216 -179.673 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -79.39 -57.04 3.24 Favored Glycine 0 CA--C 1.526 0.769 0 C-N-CA 120.956 -0.64 . . . . 0.0 111.664 -179.478 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.616 ' O ' HG22 ' A' ' 26' ' ' VAL . . . -69.65 -26.74 64.54 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 120.59 -0.444 . . . . 0.0 110.794 -179.466 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 45.1 t80 -46.92 -23.89 0.52 Allowed 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.516 -0.474 . . . . 0.0 109.848 179.443 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.566 ' CD1' ' CE1' ' A' ' 99' ' ' PHE . 56.6 t80 -72.71 -54.99 7.49 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.086 -179.769 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.616 HG22 ' O ' ' A' ' 23' ' ' ALA . 29.1 m -57.15 -25.83 23.91 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.107 0 C-N-CA 120.392 -0.523 . . . . 0.0 110.291 -179.528 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.75 -37.38 81.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.709 179.592 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -101.07 -56.03 0.9 Allowed Glycine 0 CA--C 1.525 0.693 0 N-CA-C 111.447 -0.661 . . . . 0.0 111.447 -179.596 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 6.0 tm-20 -65.63 -34.72 78.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.603 0.24 . . . . 0.0 111.107 -179.589 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -71.74 -55.02 7.72 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 111.076 -0.81 . . . . 0.0 111.076 -179.775 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 11.0 mp -59.32 -28.33 66.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.744 0.307 . . . . 0.0 110.508 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 40.3 ttm180 -79.02 -52.79 7.75 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.814 0.34 . . . . 0.0 110.466 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -50.51 -33.74 22.63 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 179.87 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.427 ' CD1' ' C ' ' A' ' 34' ' ' TYR . 25.8 t80 -45.51 -35.2 3.7 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.216 179.641 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -56.42 -36.94 69.52 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.58 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -85.67 -66.26 1.42 Allowed Glycine 0 CA--C 1.525 0.657 0 N-CA-C 111.033 -0.827 . . . . 0.0 111.033 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.785 HD22 HD21 ' A' ' 158' ' ' ASN . 0.4 OUTLIER -96.49 167.2 11.3 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.843 0.354 . . . . 0.0 110.532 179.564 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 -90.05 113.58 25.31 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.635 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.581 ' NZ ' ' CH2' ' A' ' 107' ' ' TRP . 17.9 mtpt -125.65 156.23 71.18 Favored Pre-proline 0 C--N 1.331 -0.211 0 CA-C-N 116.174 -0.466 . . . . 0.0 109.862 179.727 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo . . . . . 0 C--N 1.305 -1.712 0 C-N-CA 121.984 1.789 . . . . 0.0 111.497 179.672 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.695 ' O ' HG23 ' A' ' 52' ' ' ILE . 0.1 OUTLIER . . . . . 0 CA--C 1.533 0.303 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 . . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.633 ' C ' ' H ' ' A' ' 52' ' ' ILE . . . -39.19 -29.23 0.17 Allowed Pre-proline 0 C--O 1.237 0.407 0 C-N-CA 120.745 -0.382 . . . . 0.0 111.44 -178.618 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.426 ' HD2' ' N ' ' A' ' 50' ' ' ALA . 35.1 Cg_exo -52.92 3.71 0.04 OUTLIER 'Trans proline' 0 C--N 1.313 -1.32 0 CA-C-N 118.852 0.626 . . . . 0.0 111.877 177.516 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.695 HG23 ' O ' ' A' ' 49' ' ' LEU . 5.7 pt -51.12 -45.23 30.3 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.233 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 178.966 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.534 ' N ' ' CG1' ' A' ' 52' ' ' ILE . 87.6 m95 -57.66 -23.41 51.22 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.789 -179.094 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -68.48 -45.33 68.6 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 109.411 -1.476 . . . . 0.0 109.411 178.399 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 6.0 m -69.1 -57.6 5.2 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 179.133 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.509 HD13 ' CE3' ' A' ' 143' ' ' TRP . 34.6 mt -48.52 -49.58 35.45 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 179.112 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 6.9 t80 -46.37 -58.48 3.69 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.696 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.431 ' O ' ' CE1' ' A' ' 62' ' ' TYR . 0.2 OUTLIER -48.05 -58.88 3.87 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.881 0.372 . . . . 0.0 110.686 -179.556 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.534 ' HB1' ' O ' ' A' ' 136' ' ' LEU . . . -51.68 -61.46 2.24 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.852 -179.893 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.433 ' SD ' ' C ' ' A' ' 56' ' ' LEU . 0.2 OUTLIER -46.1 -38.93 8.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.396 -179.957 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -56.6 -54.29 37.37 Favored Glycine 0 CA--C 1.522 0.493 0 N-CA-C 110.905 -0.878 . . . . 0.0 110.905 -179.859 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.6 ' CD1' ' N ' ' A' ' 62' ' ' TYR . 0.6 OUTLIER -55.85 -59.81 4.36 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.876 -0.33 . . . . 0.0 110.847 -179.814 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -48.33 -56.14 9.69 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 110.75 -0.94 . . . . 0.0 110.75 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.563 ' OG ' ' NE1' ' A' ' 68' ' ' TRP . 0.6 OUTLIER -45.6 -56.07 5.59 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.963 0.411 . . . . 0.0 111.025 179.967 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 59.7 t80 -47.51 -47.11 27.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.023 -179.723 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 53.6 mt -59.62 -40.01 81.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.009 -179.588 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.447 ' CG1' ' CZ3' ' A' ' 68' ' ' TRP . 43.0 t -57.74 -52.12 61.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 C-N-CA 120.862 -0.335 . . . . 0.0 110.849 -179.612 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' TRP . . . . . 0.563 ' NE1' ' OG ' ' A' ' 64' ' ' SER . 0.6 OUTLIER -64.19 -28.94 70.09 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 120.643 -0.423 . . . . 0.0 110.778 -179.978 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.06 -22.46 59.52 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.816 0.341 . . . . 0.0 110.374 179.828 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -81.35 -61.36 1.96 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.053 -179.72 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.8 pp -74.43 -20.67 59.95 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.788 -0.365 . . . . 0.0 111.209 -179.294 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.509 ' O ' ' O ' ' A' ' 73' ' ' GLY . . . 109.44 99.11 2.56 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 121.135 -0.555 . . . . 0.0 112.268 178.976 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.509 ' O ' ' O ' ' A' ' 72' ' ' GLY . . . 40.64 -173.55 0.01 OUTLIER Glycine 0 CA--C 1.525 0.671 0 N-CA-C 112.195 -0.362 . . . . 0.0 112.195 178.684 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 25.4 t80 -90.2 110.88 21.9 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.538 -0.331 . . . . 0.0 110.53 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.587 ' OG1' ' N ' ' A' ' 76' ' ' GLU . 0.1 OUTLIER -142.2 -177.43 5.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.592 179.796 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.587 ' N ' ' OG1' ' A' ' 75' ' ' THR . 35.8 mt-10 -47.92 -29.6 3.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.636 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -70.04 -27.57 64.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.895 -179.76 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.416 ' O ' HD12 ' A' ' 82' ' ' LEU . . . -95.64 -17.74 21.09 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.917 -179.798 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 25.9 mtp -68.7 -28.63 67.01 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.836 -0.346 . . . . 0.0 110.786 -179.859 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 9.1 t -66.78 -49.29 49.77 Favored Pre-proline 0 CA--C 1.533 0.292 0 C-N-CA 120.782 -0.367 . . . . 0.0 110.536 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -69.52 -59.7 0.08 OUTLIER 'Trans proline' 0 N--CA 1.497 1.692 0 C-N-CA 121.051 1.167 . . . . 0.0 111.61 179.094 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.431 HD11 ' CH2' ' A' ' 68' ' ' TRP . 5.0 mt -52.47 -52.4 54.49 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.411 179.836 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -58.37 -57.67 18.64 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 110.484 -1.046 . . . . 0.0 110.484 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.425 ' O ' ' CB ' ' A' ' 88' ' ' GLN . 57.0 tp -48.22 -32.98 7.86 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 179.534 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -74.56 -47.53 32.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.827 -179.823 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -60.08 -48.74 80.44 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.742 -0.383 . . . . 0.0 110.919 -179.597 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -70.73 -58.33 5.88 Favored Glycine 0 CA--C 1.527 0.822 0 N-CA-C 111.477 -0.649 . . . . 0.0 111.477 -179.611 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.425 ' CB ' ' O ' ' A' ' 84' ' ' LEU . 12.4 tp-100 -50.45 -40.66 51.27 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.092 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.419 ' O ' ' C ' ' A' ' 90' ' ' ALA . 50.6 tp -58.51 -65.84 0.59 Allowed 'General case' 0 C--O 1.215 -0.719 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.927 179.717 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.699 ' O ' ' HB2' ' A' ' 94' ' ' ALA . . . -38.56 -46.13 1.15 Allowed 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 120.349 -0.54 . . . . 0.0 111.622 -179.448 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 83.8 mt -57.86 -56.43 22.11 Favored 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 112.815 0.672 . . . . 0.0 112.815 -178.694 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 6.7 m-20 -75.2 -57.07 4.12 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.185 0.517 . . . . 0.0 111.742 -178.396 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' TRP . . . . . 0.676 ' O ' ' N ' ' A' ' 95' ' ' TRP . 0.1 OUTLIER -53.92 -23.44 12.84 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.454 -0.793 . . . . 0.0 111.49 -179.468 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.699 ' HB2' ' O ' ' A' ' 90' ' ' ALA . . . -52.34 73.64 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.818 0.342 . . . . 0.0 110.757 -179.549 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.682 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 13.5 p-90 -101.96 -17.48 0.19 Allowed Pre-proline 0 CA--C 1.532 0.266 0 CA-C-N 116.279 -0.418 . . . . 0.0 112.127 -179.522 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.682 ' CD ' ' N ' ' A' ' 95' ' ' TRP . 39.5 Cg_exo -62.43 -24.81 75.76 Favored 'Trans proline' 0 N--CA 1.495 1.577 0 C-N-CA 120.404 0.736 . . . . 0.0 112.812 179.401 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.541 ' CD ' ' N ' ' A' ' 96' ' ' PRO . 92.5 Cg_exo -62.02 -26.94 78.93 Favored 'Trans proline' 0 N--CA 1.496 1.628 0 C-N-CA 120.496 0.798 . . . . 0.0 112.675 179.679 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 1.2 pp -72.79 17.49 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-O 121.086 0.47 . . . . 0.0 110.107 179.797 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.566 ' CE1' ' CD1' ' A' ' 25' ' ' PHE . 2.4 t80 -39.49 -31.65 0.1 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.191 -179.802 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.488 ' CE1' ' O ' ' A' ' 97' ' ' PRO . 3.4 p90 -84.69 -50.37 7.69 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.942 -0.303 . . . . 0.0 110.869 -179.633 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.417 ' N ' ' CD2' ' A' ' 100' ' ' PHE . . . -64.22 -4.58 12.48 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 111.171 -0.772 . . . . 0.0 111.171 -179.739 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -75.07 -14.17 60.56 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.643 0.258 . . . . 0.0 110.939 -179.792 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 4.3 ptm180 -86.68 5.35 36.49 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.915 -0.314 . . . . 0.0 110.677 -179.895 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -121.57 171.01 9.13 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.565 179.832 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 4.7 mmt -59.37 -17.68 32.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.419 179.737 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.588 ' O ' ' N ' ' A' ' 108' ' ' ALA . . . -69.46 -15.37 70.47 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 111.455 -0.658 . . . . 0.0 111.455 -179.571 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' TRP . . . . . 0.581 ' CH2' ' NZ ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -43.49 -13.86 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.749 0.309 . . . . 0.0 110.725 -179.604 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.588 ' N ' ' O ' ' A' ' 106' ' ' GLY . . . -57.96 -18.68 25.18 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.431 179.718 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 13.4 mt -54.45 -32.13 56.92 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.386 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.439 ' O ' ' CD2' ' A' ' 114' ' ' LEU . . . -52.85 -63.05 1.27 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.544 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.757 ' O ' HG23 ' A' ' 115' ' ' VAL . 0.9 OUTLIER -59.67 -57.79 11.38 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.495 -179.545 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.418 ' N ' ' OD1' ' A' ' 111' ' ' ASP . 50.8 tp -47.82 -41.72 24.43 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.115 -0.493 . . . . 0.0 112.025 -178.87 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.421 HD23 ' HA ' ' A' ' 113' ' ' LEU . 64.5 mt -71.84 -61.84 1.64 Allowed 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -178.14 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.439 ' CD2' ' O ' ' A' ' 110' ' ' ALA . 1.1 pp -57.22 -32.8 66.88 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 120.037 -0.665 . . . . 0.0 111.432 -178.178 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.757 HG23 ' O ' ' A' ' 111' ' ' ASP . 98.0 t -67.06 -51.36 54.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.84 0.353 . . . . 0.0 110.925 179.777 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 18.0 m -68.53 -27.72 66.35 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.393 -179.312 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -68.07 -59.96 6.0 Favored Glycine 0 CA--C 1.528 0.867 0 C-N-CA 121.045 -0.598 . . . . 0.0 111.899 -179.036 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.532 ' O ' HG23 ' A' ' 122' ' ' THR . 7.5 p -65.27 -38.51 82.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 -178.831 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.449 ' N ' HG13 ' A' ' 118' ' ' VAL . . . -71.12 -60.76 2.06 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.518 -0.473 . . . . 0.0 111.52 -178.687 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 43.7 m -52.23 -52.97 49.28 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.918 0.39 . . . . 0.0 110.975 -179.594 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -57.47 -50.91 71.51 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.115 -0.493 . . . . 0.0 112.226 -179.161 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.532 HG23 ' O ' ' A' ' 118' ' ' VAL . 40.0 p -64.75 -64.54 0.85 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.969 0.414 . . . . 0.0 111.745 -178.72 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.434 ' OG1' ' O ' ' A' ' 119' ' ' ALA . 0.2 OUTLIER -44.06 -41.31 5.41 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.892 -0.595 . . . . 0.0 112.295 -178.448 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.78 ' C ' HD12 ' A' ' 124' ' ' LEU . 1.5 pp -84.34 -19.93 32.87 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.393 -0.523 . . . . 0.0 111.643 -179.117 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -94.77 -71.3 0.67 Allowed 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 113.053 0.761 . . . . 0.0 113.053 -178.433 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' TRP . . . . . 0.467 ' CD1' ' N ' ' A' ' 126' ' ' TRP . 25.6 m0 -76.71 -57.09 4.06 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 -177.411 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 127' ' ' HIS . . . . . 0.502 ' CG ' ' HB2' ' A' ' 134' ' ' ALA . 18.1 m170 -48.79 -22.58 0.84 Allowed 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.558 -0.457 . . . . 0.0 111.332 -178.63 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 23.0 ttt180 -69.11 -48.1 63.41 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.838 -0.345 . . . . 0.0 111.06 -179.628 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 15.0 t -79.77 -49.33 19.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.962 -179.62 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' SER . . . . . 0.455 ' O ' ' OG ' ' A' ' 130' ' ' SER . 0.4 OUTLIER -118.71 108.92 40.47 Favored Pre-proline 0 CA--C 1.532 0.258 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.673 -179.701 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 131' ' ' PRO . . . . . 0.654 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 82.1 Cg_exo -74.38 -32.52 6.33 Favored 'Trans proline' 0 C--N 1.311 -1.447 0 C-N-CA 121.577 1.518 . . . . 0.0 112.794 179.451 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 132' ' ' PRO . . . . . 0.654 ' CD ' ' N ' ' A' ' 131' ' ' PRO . 27.5 Cg_exo -58.67 -44.43 36.66 Favored 'Trans proline' 0 N--CA 1.494 1.558 0 C-N-CA 121.706 1.604 . . . . 0.0 112.199 -179.82 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.413 ' O ' ' N ' ' A' ' 136' ' ' LEU . . . -50.24 -49.51 52.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.672 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 134' ' ' ALA . . . . . 0.502 ' HB2' ' CG ' ' A' ' 127' ' ' HIS . . . -44.19 -23.07 0.08 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.665 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 135' ' ' ARG . . . . . 0.401 ' N ' ' O ' ' A' ' 133' ' ' ALA . 14.1 tpp180 -76.66 -37.11 56.82 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.17 -179.528 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.534 ' O ' ' HB1' ' A' ' 59' ' ' ALA . 9.4 mt -76.26 -22.13 55.5 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 179.777 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.547 ' O ' ' N ' ' A' ' 140' ' ' TYR . 0.7 OUTLIER -85.44 -43.64 13.43 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 179.147 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.559 ' C ' ' H ' ' A' ' 140' ' ' TYR . 0.2 OUTLIER -21.32 -50.66 0.06 OUTLIER Pre-proline 0 N--CA 1.466 0.341 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.871 179.71 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.434 ' N ' ' O ' ' A' ' 137' ' ' LEU . 17.2 Cg_exo -51.21 -3.33 0.07 OUTLIER 'Trans proline' 0 C--N 1.308 -1.598 0 C-N-CA 121.247 1.298 . . . . 0.0 112.051 179.824 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 140' ' ' TYR . . . . . 0.674 ' CE2' HD11 ' A' ' 144' ' ' LEU . 1.9 p90 -83.45 -17.55 41.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.779 -179.836 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.402 HD12 ' CD1' ' A' ' 138' ' ' TYR . 93.4 mt -61.35 -36.59 80.61 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 179.154 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -56.95 -40.29 76.16 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 179.08 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 143' ' ' TRP . . . . . 0.55 ' CD1' ' C ' ' A' ' 143' ' ' TRP . 0.4 OUTLIER -63.54 -45.14 91.93 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.647 179.414 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.674 HD11 ' CE2' ' A' ' 140' ' ' TYR . 13.7 mt -60.81 -41.53 95.85 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 179.354 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.66 ' O ' HG23 ' A' ' 149' ' ' VAL . . . -70.42 -18.98 63.02 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.103 -0.499 . . . . 0.0 109.766 179.217 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -71.14 -63.09 1.17 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.823 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -68.64 -31.74 71.09 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 120.607 -0.437 . . . . 0.0 110.583 -179.804 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 85.0 m -67.7 -45.48 74.99 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.851 -0.34 . . . . 0.0 110.217 179.772 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.66 HG23 ' O ' ' A' ' 145' ' ' ALA . 45.7 t -64.64 -33.71 64.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.047 179.731 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.485 ' O ' HG23 ' A' ' 154' ' ' VAL . 0.9 OUTLIER -60.59 -58.9 6.53 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.033 179.859 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 151' ' ' ASN . . . . . 0.467 ' OD1' ' HB2' ' A' ' 108' ' ' ALA . 11.1 t30 -55.8 -54.43 44.54 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.56 179.823 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 16.6 t80 -52.42 -34.36 48.1 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.649 -179.852 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 153' ' ' TYR . . . . . 0.583 ' CE2' ' OD2' ' A' ' 157' ' ' ASP . 59.4 t80 -66.53 -47.1 73.98 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.821 -179.729 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.485 HG23 ' O ' ' A' ' 150' ' ' LEU . 13.0 t -55.9 -42.16 69.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.659 -179.825 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 155' ' ' TRP . . . . . . . . . . . . . 16.5 m0 -62.5 -59.45 4.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.151 -179.657 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.63 -25.93 63.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.047 -179.43 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 157' ' ' ASP . . . . . 0.583 ' OD2' ' CE2' ' A' ' 153' ' ' TYR . 0.8 OUTLIER -86.74 -42.67 13.15 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.885 -0.326 . . . . 0.0 111.333 -179.393 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 158' ' ' ASN . . . . . 0.785 HD21 HD22 ' A' ' 37' ' ' LEU . 2.4 m-20 . . . . . 0 C--N 1.328 -0.359 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.208 -179.43 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.668 ' CD2' ' CZ3' ' A' ' 68' ' ' TRP . 0.3 OUTLIER . . . . . 0 C--O 1.232 0.167 0 CA-C-O 120.697 0.284 . . . . 0.0 110.624 . . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.59 ' N ' ' CD ' ' A' ' 7' ' ' PRO . 0.9 OUTLIER -61.05 -32.66 11.44 Favored Pre-proline 0 C--N 1.329 -0.291 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 179.7 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.59 ' CD ' ' N ' ' A' ' 6' ' ' VAL . 22.7 Cg_exo -74.71 -67.81 0.02 OUTLIER 'Trans proline' 0 N--CA 1.492 1.423 0 C-N-CA 121.531 1.488 . . . . 0.0 111.953 179.168 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.656 ' O ' HG23 ' A' ' 12' ' ' THR . . . -48.13 -38.95 19.09 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.965 -0.294 . . . . 0.0 111.178 -179.569 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.512 HG23 ' O ' ' A' ' 5' ' ' TRP . 89.2 t -69.96 -62.21 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.802 -179.255 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -53.9 -50.94 52.65 Favored Glycine 0 CA--C 1.526 0.773 0 N-CA-C 111.486 -0.646 . . . . 0.0 111.486 -179.307 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 8.8 mp -58.47 -40.9 83.94 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.615 0.245 . . . . 0.0 111.134 -179.603 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.656 HG23 ' O ' ' A' ' 8' ' ' ALA . 18.2 p -69.39 -28.71 66.42 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.843 -0.343 . . . . 0.0 110.998 -179.643 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.418 HD13 ' O ' ' A' ' 9' ' ' VAL . 7.1 mp -80.2 -26.31 39.25 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.737 -179.737 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.402 ' N ' ' HD2' ' A' ' 15' ' ' PRO . 14.2 t -44.58 -60.15 3.26 Favored Pre-proline 0 CA--C 1.534 0.342 0 C-N-CA 120.89 -0.324 . . . . 0.0 110.934 -179.64 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.402 ' HD2' ' N ' ' A' ' 14' ' ' VAL . 9.7 Cg_endo -52.7 -20.65 13.01 Favored 'Trans proline' 0 N--CA 1.498 1.761 0 C-N-CA 121.025 1.15 . . . . 0.0 111.749 179.746 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.587 ' OG ' ' CE3' ' A' ' 53' ' ' TRP . 1.6 t -73.79 -27.39 61.11 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.857 -179.744 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 87.7 mt -73.77 -58.16 3.49 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.477 -179.859 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -68.95 -22.06 75.59 Favored Glycine 0 CA--C 1.523 0.539 0 N-CA-C 110.449 -1.06 . . . . 0.0 110.449 179.694 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -74.12 -39.1 45.96 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 110.517 -1.033 . . . . 0.0 110.517 179.836 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 67.4 t80 -70.82 -60.09 2.44 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.676 0.274 . . . . 0.0 110.668 179.797 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 16.2 ttm -67.27 -21.21 65.72 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.951 -179.703 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -81.42 -62.68 1.93 Allowed Glycine 0 CA--C 1.525 0.672 0 N-CA-C 111.43 -0.668 . . . . 0.0 111.43 -179.671 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.652 ' O ' HG22 ' A' ' 26' ' ' VAL . . . -64.88 -24.96 67.69 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.77 0.319 . . . . 0.0 111.129 -179.386 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 27.8 t80 -47.36 -23.2 0.54 Allowed 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 179.558 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.4 ' CE2' ' HB3' ' A' ' 102' ' ' ALA . 21.3 t80 -72.72 -51.21 20.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.916 -0.583 . . . . 0.0 111.25 -179.769 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.652 HG22 ' O ' ' A' ' 23' ' ' ALA . 34.9 m -62.79 -26.88 41.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 C-N-CA 120.541 -0.464 . . . . 0.0 110.522 -179.745 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -66.72 -24.9 66.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.223 179.799 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -106.03 -35.36 2.98 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 110.377 -1.089 . . . . 0.0 110.377 179.531 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.419 ' O ' ' N ' ' A' ' 32' ' ' ARG . 18.8 tt0 -84.95 -47.42 10.29 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.753 0.311 . . . . 0.0 110.227 179.644 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.459 ' N ' ' O ' ' A' ' 26' ' ' VAL . . . -48.39 -46.5 28.87 Favored Glycine 0 CA--C 1.523 0.567 0 N-CA-C 110.567 -1.013 . . . . 0.0 110.567 179.787 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.407 ' N ' HD12 ' A' ' 31' ' ' LEU . 10.5 mp -60.0 -25.12 65.02 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 179.612 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.452 ' O ' ' HB3' ' A' ' 35' ' ' ALA . 56.6 ttt180 -78.33 -50.96 10.84 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.131 179.344 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 11.9 m0 -47.26 -45.24 23.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.231 179.745 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 88.3 t80 -52.52 -23.99 7.29 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.438 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.452 ' HB3' ' O ' ' A' ' 32' ' ' ARG . . . -67.73 -42.16 82.31 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.696 -179.868 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -97.1 -68.83 0.97 Allowed Glycine 0 CA--C 1.525 0.683 0 N-CA-C 111.076 -0.809 . . . . 0.0 111.076 -179.896 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.777 ' C ' HD12 ' A' ' 37' ' ' LEU . 3.6 pp -90.52 166.2 13.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.875 0.369 . . . . 0.0 110.592 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 48.5 mm-40 -85.46 129.8 34.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.608 -179.16 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.409 ' HG3' HD11 ' A' ' 37' ' ' LEU . 14.2 mtpt -118.63 165.02 17.78 Favored Pre-proline 0 CA--C 1.532 0.25 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 179.013 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo . . . . . 0 C--N 1.307 -1.612 0 C-N-CA 122.164 1.909 . . . . 0.0 111.75 179.917 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.675 ' O ' HG23 ' A' ' 52' ' ' ILE . 0.1 OUTLIER . . . . . 0 CA--C 1.535 0.403 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 . . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.639 ' C ' ' H ' ' A' ' 52' ' ' ILE . . . -40.8 -28.34 0.21 Allowed Pre-proline 0 N--CA 1.465 0.287 0 N-CA-C 111.934 0.346 . . . . 0.0 111.934 -179.107 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.417 ' HD2' ' N ' ' A' ' 50' ' ' ALA . 12.4 Cg_exo -54.48 8.28 0.03 OUTLIER 'Trans proline' 0 C--N 1.311 -1.401 0 CA-C-N 119.005 0.68 . . . . 0.0 112.533 178.352 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.675 HG23 ' O ' ' A' ' 49' ' ' LEU . 9.2 pt -55.62 -35.56 39.12 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 178.673 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.587 ' CE3' ' OG ' ' A' ' 16' ' ' SER . 3.5 m0 -55.11 -25.01 28.79 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.433 179.615 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -69.89 -61.51 4.3 Favored Glycine 0 CA--C 1.528 0.845 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.906 -179.371 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.49 ' CG2' ' N ' ' A' ' 56' ' ' LEU . 1.9 t -56.39 -46.69 79.99 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 120.729 -0.389 . . . . 0.0 110.706 -179.351 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.49 ' N ' ' CG2' ' A' ' 55' ' ' THR . 57.9 mt -62.31 -41.57 98.65 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.365 -0.534 . . . . 0.0 109.639 179.313 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.532 ' CD1' ' C ' ' A' ' 57' ' ' TYR . 4.2 t80 -56.69 -40.27 75.29 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.678 -179.707 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.431 ' OG ' ' N ' ' A' ' 59' ' ' ALA . 1.3 p -62.85 -53.63 51.26 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 179.62 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.669 ' HB1' ' O ' ' A' ' 136' ' ' LEU . . . -55.78 -62.3 1.79 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.503 179.713 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 36.5 mtm -51.72 -32.35 29.99 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.447 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -57.93 -56.06 27.22 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 111.19 -0.764 . . . . 0.0 111.19 -179.774 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.459 ' HB3' HD13 ' A' ' 136' ' ' LEU . 3.4 m-30 -65.46 -42.67 92.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.05 0.452 . . . . 0.0 110.301 -179.834 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -53.35 -56.27 20.4 Favored Glycine 0 CA--C 1.524 0.615 0 N-CA-C 110.44 -1.064 . . . . 0.0 110.44 179.68 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.582 ' O ' ' CD1' ' A' ' 68' ' ' TRP . 0.9 OUTLIER -54.97 -45.12 74.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.774 0.321 . . . . 0.0 110.539 179.815 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.438 ' HA ' ' CZ2' ' A' ' 68' ' ' TRP . 74.7 t80 -47.01 -47.21 22.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.019 0.438 . . . . 0.0 110.01 179.668 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 62.4 mt -70.56 -28.14 33.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.058 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 59.3 t -63.42 -59.22 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 C-N-CA 120.617 -0.433 . . . . 0.0 111.647 -179.399 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' TRP . . . . . 0.668 ' CZ3' ' CD2' ' A' ' 5' ' ' TRP . 0.0 OUTLIER -70.78 -29.56 65.8 Favored 'General case' 0 N--CA 1.462 0.152 0 C-N-CA 119.84 -0.744 . . . . 0.0 110.822 -179.327 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -70.89 -22.38 62.28 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.517 -0.473 . . . . 0.0 110.207 179.524 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -82.22 -60.75 2.1 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.924 -179.677 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.8 pp -72.92 -11.19 60.49 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.99 -179.395 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.515 ' O ' ' O ' ' A' ' 73' ' ' GLY . . . 104.86 92.57 2.27 Favored Glycine 0 CA--C 1.527 0.814 0 C-N-CA 121.163 -0.541 . . . . 0.0 112.149 179.101 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.586 ' N ' ' O ' ' A' ' 68' ' ' TRP . . . 40.94 -173.52 0.01 OUTLIER Glycine 0 CA--C 1.524 0.652 0 N-CA-C 111.973 -0.451 . . . . 0.0 111.973 179.009 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 42.9 t80 -86.98 110.18 19.87 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.85 0.357 . . . . 0.0 110.341 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.576 ' OG1' ' N ' ' A' ' 76' ' ' GLU . 0.1 OUTLIER -142.57 -174.12 4.05 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.788 -179.822 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.576 ' N ' ' OG1' ' A' ' 75' ' ' THR . 92.2 mt-10 -49.89 -24.43 2.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.884 179.881 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -78.63 -31.68 47.03 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.893 -179.804 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -85.8 -20.57 29.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.831 0.348 . . . . 0.0 110.716 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 8.3 mtp -65.43 -27.1 68.29 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.658 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.409 ' O ' ' CB ' ' A' ' 84' ' ' LEU . 6.9 t -69.4 -48.74 24.75 Favored Pre-proline 0 C--N 1.328 -0.33 0 C-N-CA 120.839 -0.345 . . . . 0.0 110.728 -179.768 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -71.23 -60.85 0.05 OUTLIER 'Trans proline' 0 N--CA 1.497 1.715 0 C-N-CA 120.961 1.107 . . . . 0.0 111.829 179.179 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 5.0 mt -57.6 -48.73 78.61 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.618 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -61.2 -61.45 6.91 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 110.938 -0.865 . . . . 0.0 110.938 -179.756 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.409 ' CB ' ' O ' ' A' ' 80' ' ' VAL . 33.2 tp -53.54 -24.05 12.37 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.902 0.382 . . . . 0.0 110.494 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 13.5 t80 -77.33 -47.99 18.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.433 179.85 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -66.71 -37.0 83.81 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.603 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -71.21 -57.44 6.18 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 110.612 -0.995 . . . . 0.0 110.612 179.823 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 49.3 tp60 -53.38 -45.29 69.2 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 179.61 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.424 ' O ' ' C ' ' A' ' 90' ' ' ALA . 24.3 tp -53.35 -66.14 0.44 Allowed 'General case' 0 C--O 1.21 -0.994 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.63 179.603 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.613 ' O ' ' HB2' ' A' ' 94' ' ' ALA . . . -38.65 -48.64 1.48 Allowed 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 120.637 -0.425 . . . . 0.0 111.85 -179.575 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 94.6 mt -55.04 -57.28 12.33 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 112.9 0.704 . . . . 0.0 112.9 -178.277 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -74.84 -55.88 5.35 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 121.316 0.579 . . . . 0.0 111.419 -178.717 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' TRP . . . . . 0.642 ' O ' ' N ' ' A' ' 95' ' ' TRP . 4.9 t-105 -53.19 -19.45 3.06 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.124 -0.943 . . . . 0.0 111.209 -179.781 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.613 ' HB2' ' O ' ' A' ' 90' ' ' ALA . . . -59.19 69.37 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.161 0 CA-C-O 120.992 0.425 . . . . 0.0 109.86 179.629 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.688 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 11.9 p-90 -101.95 -17.04 0.19 Allowed Pre-proline 0 CA--C 1.536 0.418 0 CA-C-N 115.729 -0.668 . . . . 0.0 112.142 -179.106 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.688 ' CD ' ' N ' ' A' ' 95' ' ' TRP . 31.9 Cg_exo -60.89 -30.57 90.28 Favored 'Trans proline' 0 N--CA 1.495 1.573 0 C-N-CA 120.383 0.722 . . . . 0.0 112.618 179.638 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.514 ' CD ' ' N ' ' A' ' 96' ' ' PRO . 91.8 Cg_exo -55.24 -27.55 57.42 Favored 'Trans proline' 0 N--CA 1.494 1.526 0 C-N-CA 120.495 0.796 . . . . 0.0 112.607 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 1.1 pp -76.79 22.73 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.152 0 CA-C-O 121.335 0.588 . . . . 0.0 109.933 179.537 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.504 ' H ' ' C ' ' A' ' 97' ' ' PRO . 2.4 t80 -39.53 -45.74 1.62 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.043 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.434 ' C ' ' H ' ' A' ' 102' ' ' ALA . 4.7 m-85 -83.11 -49.65 9.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.195 -179.361 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -54.81 -7.75 1.12 Allowed Glycine 0 CA--C 1.526 0.726 0 N-CA-C 111.372 -0.691 . . . . 0.0 111.372 -179.506 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.434 ' H ' ' C ' ' A' ' 100' ' ' PHE . . . -75.06 -13.43 60.49 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 121.079 -0.248 . . . . 0.0 110.964 -179.707 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -75.77 6.98 4.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.768 0.318 . . . . 0.0 110.82 -179.848 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -125.63 165.95 17.62 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.326 179.839 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 8.4 mmt -56.07 -17.12 6.15 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.924 0.392 . . . . 0.0 110.183 179.602 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.514 ' O ' ' N ' ' A' ' 108' ' ' ALA . . . -63.36 -15.85 57.44 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 110.611 -0.996 . . . . 0.0 110.611 179.718 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 107' ' ' TRP . . . . . 0.483 ' CD1' ' C ' ' A' ' 107' ' ' TRP . 0.0 OUTLIER -47.47 -11.8 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.762 0.315 . . . . 0.0 110.525 -179.776 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.514 ' N ' ' O ' ' A' ' 106' ' ' GLY . . . -63.58 -20.7 65.86 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-O 121.118 0.485 . . . . 0.0 109.816 179.432 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 7.1 mt -55.36 -30.76 60.95 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.717 179.491 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.433 ' O ' HD23 ' A' ' 114' ' ' LEU . . . -53.86 -61.87 2.02 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.548 179.718 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.722 ' O ' HG23 ' A' ' 115' ' ' VAL . 1.4 p30 -60.69 -57.97 10.46 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.769 -179.351 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.526 ' N ' ' OD1' ' A' ' 111' ' ' ASP . 9.1 tp -50.46 -38.12 41.96 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 -178.733 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.406 HD23 ' HA ' ' A' ' 113' ' ' LEU . 62.6 mt -72.7 -62.24 1.52 Allowed 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -178.409 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.433 HD23 ' O ' ' A' ' 110' ' ' ALA . 1.3 pp -58.29 -35.45 71.82 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 120.063 -0.655 . . . . 0.0 110.912 -178.724 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.722 HG23 ' O ' ' A' ' 111' ' ' ASP . 87.7 t -63.46 -52.66 55.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.746 -179.708 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 39.0 t -69.81 -32.31 70.69 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.428 -178.704 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -61.22 -59.96 9.13 Favored Glycine 0 CA--C 1.526 0.753 0 C-N-CA 121.05 -0.595 . . . . 0.0 111.924 -179.262 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.564 ' O ' HG23 ' A' ' 122' ' ' THR . 4.4 p -68.78 -38.05 78.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -178.789 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.503 ' O ' ' OG1' ' A' ' 123' ' ' THR . . . -65.99 -60.19 3.08 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.625 -0.43 . . . . 0.0 111.339 -178.746 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 28.1 m -59.73 -57.26 13.67 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.366 -179.285 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -49.07 -43.93 41.45 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.42 -179.29 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.564 HG23 ' O ' ' A' ' 118' ' ' VAL . 27.9 p -68.32 -38.06 81.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.511 -179.197 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.503 ' OG1' ' O ' ' A' ' 119' ' ' ALA . 0.1 OUTLIER -56.77 -49.81 74.18 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.845 0.355 . . . . 0.0 111.134 -179.191 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.6 pp -83.76 -19.82 34.45 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.886 -178.745 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -86.48 -71.32 0.55 Allowed 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -178.433 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' TRP . . . . . 0.456 ' CD1' ' N ' ' A' ' 126' ' ' TRP . 37.0 m0 -85.01 -57.23 3.18 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 112.767 0.654 . . . . 0.0 112.767 -177.881 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 127' ' ' HIS . . . . . 0.514 ' CD2' ' N ' ' A' ' 127' ' ' HIS . 8.7 m170 -50.4 -23.97 2.74 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.874 -0.33 . . . . 0.0 111.549 -178.7 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 40.4 ttt-85 -76.34 -37.08 57.82 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.918 -0.313 . . . . 0.0 110.99 -179.721 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 60.2 t -83.94 -48.88 16.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.783 0.325 . . . . 0.0 110.88 -179.575 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -128.2 112.82 19.9 Favored Pre-proline 0 CA--C 1.532 0.274 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.573 -179.624 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 131' ' ' PRO . . . . . 0.625 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 67.1 Cg_exo -70.71 -34.28 11.67 Favored 'Trans proline' 0 N--CA 1.492 1.423 0 C-N-CA 121.092 1.195 . . . . 0.0 112.307 179.473 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 132' ' ' PRO . . . . . 0.625 ' CD ' ' N ' ' A' ' 131' ' ' PRO . 32.3 Cg_exo -56.34 -35.0 95.56 Favored 'Trans proline' 0 N--CA 1.495 1.607 0 C-N-CA 121.52 1.48 . . . . 0.0 111.877 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -63.66 -38.68 92.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.321 179.865 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -54.51 -25.39 25.36 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.194 -0.457 . . . . 0.0 109.994 179.697 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 9.5 tpt85 -77.37 -29.82 53.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.002 179.63 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.669 ' O ' ' HB1' ' A' ' 59' ' ' ALA . 79.1 mt -80.02 -31.34 39.64 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.829 179.362 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.579 ' O ' ' N ' ' A' ' 140' ' ' TYR . 0.7 OUTLIER -79.39 -44.61 21.13 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 179.344 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.548 ' C ' ' H ' ' A' ' 140' ' ' TYR . 0.4 OUTLIER -19.97 -51.24 0.05 OUTLIER Pre-proline 0 N--CA 1.466 0.327 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.913 179.916 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.457 ' N ' ' O ' ' A' ' 137' ' ' LEU . 16.9 Cg_exo -53.08 -1.69 0.09 OUTLIER 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 121.11 1.207 . . . . 0.0 112.015 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 140' ' ' TYR . . . . . 0.657 ' CE2' HD11 ' A' ' 144' ' ' LEU . 2.2 p90 -84.24 -19.5 33.82 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 120.919 0.39 . . . . 0.0 110.638 -179.781 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 95.6 mt -59.98 -49.92 75.79 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.63 -0.428 . . . . 0.0 109.986 179.253 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -45.55 -44.92 13.15 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 179.37 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 143' ' ' TRP . . . . . 0.575 ' CD1' ' C ' ' A' ' 143' ' ' TRP . 0.3 OUTLIER -58.34 -48.74 79.59 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.423 179.37 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.657 HD11 ' CE2' ' A' ' 140' ' ' TYR . 16.1 mt -55.46 -46.7 76.78 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.32 -0.552 . . . . 0.0 109.59 179.567 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.563 ' O ' HG23 ' A' ' 149' ' ' VAL . . . -63.44 -20.91 65.97 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.902 179.3 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -68.99 -62.91 1.18 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.504 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -67.8 -45.61 74.28 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 120.57 -0.452 . . . . 0.0 110.414 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 19.2 m -52.28 -60.29 3.39 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.756 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.563 HG23 ' O ' ' A' ' 145' ' ' ALA . 93.2 t -54.16 -41.64 52.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 C-N-CA 120.878 -0.329 . . . . 0.0 110.798 -179.725 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 3.5 tp -50.39 -56.05 13.1 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.819 0.342 . . . . 0.0 110.548 -179.679 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 151' ' ' ASN . . . . . 0.414 ' ND2' ' CB ' ' A' ' 108' ' ' ALA . 9.8 t30 -61.7 -54.76 38.24 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.672 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 152' ' ' TYR . . . . . 0.443 ' CZ ' ' NE ' ' A' ' 156' ' ' ARG . 40.5 t80 -46.36 -38.09 8.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.616 -179.702 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 32.0 t80 -65.9 -53.39 40.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.699 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 62.8 t -49.22 -48.13 18.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 C-N-CA 120.614 -0.435 . . . . 0.0 110.365 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 155' ' ' TRP . . . . . . . . . . . . . 13.5 m0 -53.67 -55.56 24.99 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.363 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 156' ' ' ARG . . . . . 0.443 ' NE ' ' CZ ' ' A' ' 152' ' ' TYR . 0.7 OUTLIER -54.79 -52.14 63.55 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.362 179.949 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -49.19 -46.89 46.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.743 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.73 -179.949 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.436 ' CE2' ' CD2' ' A' ' 68' ' ' TRP . 0.5 OUTLIER . . . . . 0 CA--C 1.527 0.094 0 CA-C-O 120.761 0.315 . . . . 0.0 110.234 . . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.633 ' N ' ' CD ' ' A' ' 7' ' ' PRO . 1.0 OUTLIER -63.8 -36.56 22.04 Favored Pre-proline 0 C--N 1.328 -0.328 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 179.875 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.633 ' CD ' ' N ' ' A' ' 6' ' ' VAL . 15.0 Cg_exo -70.09 -68.23 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 121.987 1.792 . . . . 0.0 112.251 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.655 ' HB2' ' OG ' ' A' ' 64' ' ' SER . . . -47.41 -42.8 22.88 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.538 -179.35 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.462 ' O ' ' OG1' ' A' ' 12' ' ' THR . 60.6 t -65.1 -62.51 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 111.852 0.316 . . . . 0.0 111.852 -179.126 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -53.92 -40.03 64.14 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 111.462 -0.655 . . . . 0.0 111.462 -179.355 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.673 ' HG ' HG22 ' A' ' 86' ' ' THR . 6.7 mp -68.61 -28.7 67.15 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.646 0.26 . . . . 0.0 110.862 -179.575 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.462 ' OG1' ' O ' ' A' ' 9' ' ' VAL . 2.2 p -81.25 -24.0 37.63 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.844 -0.342 . . . . 0.0 110.901 -179.933 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 84.6 mt -81.4 -33.39 32.28 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.517 -0.31 . . . . 0.0 110.695 -179.845 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.421 ' N ' ' HD2' ' A' ' 15' ' ' PRO . 3.9 t -47.11 -57.89 8.35 Favored Pre-proline 0 CA--C 1.535 0.373 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.907 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.421 ' HD2' ' N ' ' A' ' 14' ' ' VAL . 11.6 Cg_endo -56.66 -30.9 85.58 Favored 'Trans proline' 0 N--CA 1.498 1.754 0 C-N-CA 121.169 1.246 . . . . 0.0 112.3 -179.857 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.1 t -67.84 -27.16 66.46 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.694 -179.828 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 96.2 mt -69.54 -58.16 4.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.861 -179.687 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -68.92 -20.27 74.36 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 110.816 -0.913 . . . . 0.0 110.816 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -71.02 -46.07 46.57 Favored Glycine 0 CA--C 1.522 0.502 0 N-CA-C 110.909 -0.876 . . . . 0.0 110.909 -179.881 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -74.44 -59.64 2.64 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.737 0.303 . . . . 0.0 110.796 -179.822 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 1.1 tpt -60.9 -26.78 67.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.108 -179.509 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -79.26 -59.84 2.64 Favored Glycine 0 CA--C 1.527 0.8 0 N-CA-C 111.602 -0.599 . . . . 0.0 111.602 -179.462 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.617 ' O ' HG22 ' A' ' 26' ' ' VAL . . . -61.35 -17.13 52.4 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.812 0.339 . . . . 0.0 110.843 -179.264 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 28.7 t80 -50.01 -24.0 2.37 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.935 0.398 . . . . 0.0 110.223 179.69 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.582 ' CE2' ' HB3' ' A' ' 102' ' ' ALA . 53.9 t80 -69.38 -48.6 60.67 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.904 -179.775 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.617 HG22 ' O ' ' A' ' 23' ' ' ALA . 27.6 m -72.12 -19.52 19.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.805 -179.624 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.55 -44.38 86.97 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.764 -179.751 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -102.37 -43.9 1.94 Allowed Glycine 0 CA--C 1.525 0.711 0 N-CA-C 111.503 -0.639 . . . . 0.0 111.503 -179.472 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -73.78 -24.62 59.87 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.95 -0.3 . . . . 0.0 111.019 -179.605 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -81.33 -58.77 2.52 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 111.24 -0.744 . . . . 0.0 111.24 -179.659 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 10.3 mp -51.69 -29.05 16.73 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.853 -0.339 . . . . 0.0 110.122 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 33.3 ttt180 -82.55 -47.84 11.69 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.217 179.52 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -49.09 -27.67 3.57 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.294 -0.412 . . . . 0.0 109.921 179.748 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.52 ' CD1' ' C ' ' A' ' 34' ' ' TYR . 9.0 t80 -46.83 -43.31 18.42 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.241 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -54.37 -24.4 19.42 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.489 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -96.09 -72.6 1.13 Allowed Glycine 0 CA--C 1.525 0.706 0 N-CA-C 110.986 -0.845 . . . . 0.0 110.986 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.585 ' O ' HD12 ' A' ' 37' ' ' LEU . 0.4 OUTLIER -95.95 166.87 11.57 Favored 'General case' 0 N--CA 1.462 0.173 0 C-N-CA 120.863 -0.335 . . . . 0.0 110.431 179.546 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 31.2 tp60 -85.92 118.67 25.55 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.947 -179.471 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 7.6 mtpt -105.13 162.28 20.23 Favored Pre-proline 0 CA--C 1.535 0.392 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.73 179.7 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo . . . . . 0 N--CA 1.494 1.503 0 C-N-CA 121.369 1.379 . . . . 0.0 112.408 -179.353 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.913 ' O ' HG23 ' A' ' 52' ' ' ILE . 0.3 OUTLIER . . . . . 0 CA--C 1.534 0.327 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 . . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.587 ' C ' ' H ' ' A' ' 52' ' ' ILE . . . -40.37 -32.17 0.3 Allowed Pre-proline 0 CA--C 1.534 0.348 0 C-N-CA 120.425 -0.51 . . . . 0.0 111.835 -178.922 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.407 ' HD2' ' N ' ' A' ' 50' ' ' ALA . 81.6 Cg_exo -54.24 4.26 0.04 OUTLIER 'Trans proline' 0 C--N 1.316 -1.182 0 CA-C-N 119.052 0.697 . . . . 0.0 112.342 178.23 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.913 HG23 ' O ' ' A' ' 49' ' ' LEU . 46.9 pt -54.24 -30.75 21.11 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.113 0 CA-C-O 121.167 0.508 . . . . 0.0 110.066 179.662 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.428 ' CE2' HD11 ' A' ' 52' ' ' ILE . 52.9 m95 -80.1 -23.41 41.27 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.898 -179.44 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -70.85 -45.0 54.66 Favored Glycine 0 CA--C 1.523 0.585 0 N-CA-C 109.916 -1.274 . . . . 0.0 109.916 178.972 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 5.3 m -68.52 -51.8 39.07 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 179.294 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 94.5 mt -60.8 -26.53 67.36 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.044 179.586 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.543 ' CD1' ' C ' ' A' ' 57' ' ' TYR . 0.4 OUTLIER -65.61 -56.72 10.69 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 179.615 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 40.3 t -52.2 -44.01 64.5 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.775 -0.37 . . . . 0.0 110.288 179.784 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.76 -47.15 82.14 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.789 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 30.3 mtm -60.47 -35.65 76.38 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.563 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -64.53 -43.15 97.0 Favored Glycine 0 CA--C 1.523 0.538 0 N-CA-C 110.815 -0.914 . . . . 0.0 110.815 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -63.18 -53.41 53.63 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.466 ' O ' HG23 ' A' ' 67' ' ' VAL . . . -57.32 -37.08 79.31 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 179.032 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.655 ' OG ' ' HB2' ' A' ' 8' ' ' ALA . 23.3 t -62.33 -44.62 96.08 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 179.278 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.4 ' HA ' ' CE3' ' A' ' 68' ' ' TRP . 21.1 t80 -54.16 -44.06 71.12 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 179.155 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 65.7 mt -65.05 -30.52 50.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.603 179.625 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.466 HG23 ' O ' ' A' ' 63' ' ' GLY . 73.1 t -65.49 -58.8 5.46 Favored 'Isoleucine or valine' 0 C--O 1.233 0.186 0 C-N-CA 120.501 -0.479 . . . . 0.0 111.125 -179.711 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' TRP . . . . . 0.631 ' CD1' ' N ' ' A' ' 68' ' ' TRP . 0.0 OUTLIER -56.17 -37.17 69.21 Favored 'General case' 0 CA--C 1.528 0.104 0 C-N-CA 119.96 -0.696 . . . . 0.0 110.119 -179.78 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 16.5 mmmt -73.17 -21.62 60.66 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.416 -0.514 . . . . 0.0 110.917 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 15.8 tp10 -76.83 -40.64 47.14 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 -178.966 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.612 HD12 ' N ' ' A' ' 72' ' ' GLY . 0.5 OUTLIER -105.03 -0.11 27.1 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 120.32 -0.552 . . . . 0.0 111.44 -179.506 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.612 ' N ' HD12 ' A' ' 71' ' ' LEU . . . 96.3 84.62 1.71 Allowed Glycine 0 CA--C 1.525 0.662 0 C-N-CA 120.992 -0.623 . . . . 0.0 111.628 179.222 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.578 ' N ' ' O ' ' A' ' 68' ' ' TRP . . . 44.81 -173.88 0.01 OUTLIER Glycine 0 CA--C 1.525 0.691 0 N-CA-C 111.652 -0.579 . . . . 0.0 111.652 179.31 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 77.7 t80 -81.71 110.46 17.06 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.875 0.369 . . . . 0.0 110.651 -179.663 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.503 ' OG1' ' N ' ' A' ' 76' ' ' GLU . 2.6 t -142.65 -173.77 3.97 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.646 179.849 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.503 ' N ' ' OG1' ' A' ' 75' ' ' THR . 22.0 mt-10 -51.97 -24.56 6.68 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.649 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.451 ' H ' HG23 ' A' ' 75' ' ' THR . 30.9 m-20 -79.29 -24.69 42.72 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.901 -179.752 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -93.28 -16.83 24.3 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.838 0.352 . . . . 0.0 111.031 -179.663 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 14.1 mtp -69.54 -30.46 68.28 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.871 -179.782 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.42 ' N ' ' HD2' ' A' ' 81' ' ' PRO . 6.3 t -68.16 -46.57 40.29 Favored Pre-proline 0 CA--C 1.533 0.291 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.749 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.42 ' HD2' ' N ' ' A' ' 80' ' ' VAL . 13.4 Cg_endo -71.76 -61.18 0.05 OUTLIER 'Trans proline' 0 N--CA 1.498 1.786 0 C-N-CA 120.841 1.027 . . . . 0.0 111.916 179.397 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.715 ' O ' HG23 ' A' ' 86' ' ' THR . 8.4 mt -56.22 -51.9 66.4 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 121.014 0.435 . . . . 0.0 109.906 179.54 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -52.03 -53.96 28.09 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 111.167 -0.773 . . . . 0.0 111.167 -179.79 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.494 HD21 HD11 ' A' ' 124' ' ' LEU . 29.6 tp -58.42 -33.09 69.28 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.554 0.216 . . . . 0.0 110.954 -179.512 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 31.1 t80 -68.42 -37.08 79.97 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.801 -0.36 . . . . 0.0 110.86 -179.645 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.715 HG23 ' O ' ' A' ' 82' ' ' LEU . 5.1 p -68.44 -58.73 3.89 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.742 -0.383 . . . . 0.0 110.747 -179.46 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.428 ' N ' ' OG1' ' A' ' 86' ' ' THR . . . -58.69 -57.46 19.76 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 111.268 -0.733 . . . . 0.0 111.268 -179.799 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 54.1 tp60 -50.6 -55.36 16.66 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-O 120.88 0.371 . . . . 0.0 110.922 -179.758 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.424 ' O ' ' C ' ' A' ' 90' ' ' ALA . 26.3 tp -47.88 -66.27 0.43 Allowed 'General case' 0 C--O 1.209 -1.051 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.06 -179.731 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.476 ' O ' ' HB2' ' A' ' 94' ' ' ALA . . . -38.37 -50.51 1.5 Allowed 'General case' 0 C--N 1.319 -0.759 0 C-N-CA 120.633 -0.427 . . . . 0.0 112.026 -179.309 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 95.2 mt -53.64 -56.75 14.54 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 -178.312 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.411 ' O ' HD22 ' A' ' 113' ' ' LEU . 3.0 m120 -76.97 -53.7 7.51 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.275 0.559 . . . . 0.0 111.615 -178.312 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' TRP . . . . . 0.64 ' O ' ' N ' ' A' ' 95' ' ' TRP . 3.9 t-105 -53.11 -20.76 4.04 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.364 -0.835 . . . . 0.0 111.63 -179.595 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.476 ' HB2' ' O ' ' A' ' 90' ' ' ALA . . . -57.01 70.48 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 120.793 0.33 . . . . 0.0 110.608 -179.807 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.68 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 5.6 p-90 -102.38 -17.32 0.19 Allowed Pre-proline 0 CA--C 1.537 0.472 0 CA-C-N 116.051 -0.522 . . . . 0.0 112.036 -179.543 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.68 ' CD ' ' N ' ' A' ' 95' ' ' TRP . 32.5 Cg_exo -63.28 -24.2 72.06 Favored 'Trans proline' 0 N--CA 1.495 1.614 0 C-N-CA 120.629 0.886 . . . . 0.0 112.831 179.466 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.558 ' CD ' ' N ' ' A' ' 96' ' ' PRO . 97.3 Cg_exo -62.93 -24.87 74.14 Favored 'Trans proline' 0 N--CA 1.495 1.563 0 C-N-CA 120.833 1.022 . . . . 0.0 112.832 179.856 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 1.1 pp -78.58 22.53 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 121.015 0.436 . . . . 0.0 110.1 179.751 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.445 ' H ' ' C ' ' A' ' 97' ' ' PRO . 2.5 t80 -40.21 -42.78 1.55 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.531 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -86.23 -33.1 20.83 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.724 -179.875 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -68.46 -5.12 41.8 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 111.231 -0.748 . . . . 0.0 111.231 -179.716 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.582 ' HB3' ' CE2' ' A' ' 25' ' ' PHE . . . -74.63 -9.45 58.58 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.74 0.305 . . . . 0.0 110.908 -179.76 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.488 ' C ' ' CD ' ' A' ' 103' ' ' ARG . 0.0 OUTLIER -88.56 -11.73 44.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.828 -179.792 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -109.7 -178.92 3.67 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.914 0.387 . . . . 0.0 110.801 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.66 ' N ' ' SD ' ' A' ' 105' ' ' MET . 0.0 OUTLIER -55.45 -23.0 22.99 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.123 -179.826 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -62.22 -15.42 51.0 Favored Glycine 0 CA--C 1.528 0.847 0 CA-C-N 116.193 -0.458 . . . . 0.0 112.08 -179.287 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' TRP . . . . . 0.688 ' CD1' ' CZ2' ' A' ' 155' ' ' TRP . 0.0 OUTLIER -48.75 -18.98 0.31 Allowed 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 116.812 0.306 . . . . 0.0 110.972 -179.329 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -70.8 -23.76 62.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.991 0.424 . . . . 0.0 110.647 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 7.5 mt -54.21 -28.68 42.46 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.635 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -53.29 -63.01 1.29 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.087 0.47 . . . . 0.0 110.334 179.819 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.699 ' O ' HG23 ' A' ' 115' ' ' VAL . 2.1 p30 -62.26 -53.38 56.06 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.838 -0.619 . . . . 0.0 112.039 -179.376 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.611 HD13 ' O ' ' A' ' 112' ' ' LEU . 0.2 OUTLIER -53.49 -40.46 65.36 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.268 0.47 . . . . 0.0 112.268 -178.194 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.45 HD23 ' HA ' ' A' ' 113' ' ' LEU . 61.4 mt -71.4 -61.69 1.68 Allowed 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.281 0.475 . . . . 0.0 112.281 -178.479 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.5 pp -58.3 -33.67 69.71 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 120.15 -0.62 . . . . 0.0 110.9 -178.759 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.699 HG23 ' O ' ' A' ' 111' ' ' ASP . 41.2 t -62.16 -60.91 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.462 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 57.3 p -68.87 -22.24 64.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.474 -178.864 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -66.17 -62.22 4.85 Favored Glycine 0 CA--C 1.526 0.723 0 C-N-CA 120.952 -0.642 . . . . 0.0 111.549 -179.27 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.588 ' O ' HG23 ' A' ' 122' ' ' THR . 10.0 p -71.12 -37.54 67.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 C-N-CA 120.872 -0.331 . . . . 0.0 111.694 -179.258 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.508 ' O ' ' OG1' ' A' ' 123' ' ' THR . . . -68.39 -60.64 2.29 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.564 -0.454 . . . . 0.0 111.522 -179.204 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 3.7 m -58.7 -51.73 68.7 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.892 0.377 . . . . 0.0 111.372 -179.34 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.442 ' O ' HD23 ' A' ' 124' ' ' LEU . . . -55.58 -39.7 71.04 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.381 -179.384 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.588 HG23 ' O ' ' A' ' 118' ' ' VAL . 36.2 p -75.01 -28.94 60.7 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.638 -0.425 . . . . 0.0 111.601 -179.279 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.508 ' OG1' ' O ' ' A' ' 119' ' ' ALA . 0.1 OUTLIER -65.11 -54.55 28.23 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.631 -0.428 . . . . 0.0 110.717 -179.669 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.56 HD23 ' N ' ' A' ' 125' ' ' ALA . 0.6 OUTLIER -79.45 -19.73 49.16 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.576 -0.449 . . . . 0.0 111.73 -179.043 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.56 ' N ' HD23 ' A' ' 124' ' ' LEU . . . -88.33 -68.28 0.77 Allowed 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 -179.083 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 126' ' ' TRP . . . . . 0.4 ' N ' ' CD1' ' A' ' 126' ' ' TRP . 41.8 m0 -84.17 -57.23 3.26 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -177.87 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 127' ' ' HIS . . . . . 0.505 ' CD2' ' N ' ' A' ' 127' ' ' HIS . 7.1 m170 -54.69 -22.11 12.83 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.581 -0.448 . . . . 0.0 111.289 -178.718 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 26.8 ttt180 -68.34 -42.98 78.49 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.863 -0.335 . . . . 0.0 110.821 -179.694 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 23.2 t -87.51 -49.64 14.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.807 -179.796 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 26.6 p -116.23 108.32 46.03 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.523 -179.793 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' PRO . . . . . 0.642 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 79.5 Cg_exo -74.22 -25.71 13.3 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 121.554 1.503 . . . . 0.0 112.663 179.471 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 132' ' ' PRO . . . . . 0.642 ' CD ' ' N ' ' A' ' 131' ' ' PRO . 51.4 Cg_exo -63.16 -43.31 19.28 Favored 'Trans proline' 0 N--CA 1.495 1.609 0 C-N-CA 121.371 1.38 . . . . 0.0 111.961 179.797 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -54.83 -38.75 67.78 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.251 179.771 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 134' ' ' ALA . . . . . 0.426 ' HB2' ' CG ' ' A' ' 127' ' ' HIS . . . -55.06 -26.28 36.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.256 179.813 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 13.4 tpp180 -76.07 -32.23 59.16 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.248 179.658 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.401 HD23 ' HA ' ' A' ' 136' ' ' LEU . 95.9 mt -72.53 -26.78 61.88 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 179.314 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.512 ' O ' ' N ' ' A' ' 140' ' ' TYR . 2.6 mt -88.69 -29.25 20.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.376 179.757 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.516 ' CD1' ' C ' ' A' ' 138' ' ' TYR . 0.4 OUTLIER -33.59 -49.3 0.75 Allowed Pre-proline 0 CA--C 1.537 0.458 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.381 -179.819 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.416 ' HD2' ' N ' ' A' ' 138' ' ' TYR . 3.9 Cg_exo -60.96 4.96 0.17 Allowed 'Trans proline' 0 N--CA 1.494 1.535 0 C-N-CA 121.402 1.401 . . . . 0.0 112.591 -179.688 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 140' ' ' TYR . . . . . 0.512 ' N ' ' O ' ' A' ' 137' ' ' LEU . 0.1 OUTLIER -90.07 -16.65 29.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.709 0.29 . . . . 0.0 111.125 179.88 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.55 HD23 HD12 ' A' ' 144' ' ' LEU . 94.8 mt -58.42 -26.19 63.0 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 178.831 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -63.41 -42.3 98.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.628 179.266 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 143' ' ' TRP . . . . . 0.444 ' CE2' HD12 ' A' ' 52' ' ' ILE . 12.3 t-105 -66.72 -38.72 87.27 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.7 179.387 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.55 HD12 HD23 ' A' ' 141' ' ' LEU . 18.0 mt -62.55 -37.64 86.93 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 120.539 -0.465 . . . . 0.0 110.035 179.616 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.598 ' O ' HG23 ' A' ' 149' ' ' VAL . . . -76.91 -25.92 53.52 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.389 179.746 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 26.4 t80 -64.28 -57.96 7.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.744 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -70.4 -49.38 49.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.794 -179.74 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 99.2 m -51.38 -47.46 62.86 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.906 -179.667 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.598 HG23 ' O ' ' A' ' 145' ' ' ALA . 94.2 t -69.54 -34.06 59.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.176 -179.502 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -56.18 -52.9 62.71 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.917 0.389 . . . . 0.0 110.383 -179.683 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 151' ' ' ASN . . . . . 0.494 ' OD1' ' NE1' ' A' ' 107' ' ' TRP . 3.4 t30 -63.88 -51.25 65.41 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.843 -179.841 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 58.9 t80 -56.27 -29.8 61.6 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.454 -179.282 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 153' ' ' TYR . . . . . 0.436 ' O ' ' CG ' ' A' ' 157' ' ' ASP . 55.8 t80 -73.02 -52.58 13.84 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.827 -0.349 . . . . 0.0 111.296 -179.464 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.486 ' O ' ' OD1' ' A' ' 157' ' ' ASP . 54.3 t -65.1 -32.44 58.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.593 -179.353 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 155' ' ' TRP . . . . . 0.688 ' CZ2' ' CD1' ' A' ' 107' ' ' TRP . 0.2 OUTLIER -73.4 -42.14 62.46 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.177 -178.559 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 156' ' ' ARG . . . . . 0.437 ' HE ' ' C ' ' A' ' 155' ' ' TRP . 0.0 OUTLIER -77.61 -57.04 4.03 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.855 -0.338 . . . . 0.0 110.751 -179.753 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 157' ' ' ASP . . . . . 0.579 ' OD1' ' N ' ' A' ' 158' ' ' ASN . 39.7 p-10 -48.24 -36.31 13.66 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.962 -0.295 . . . . 0.0 110.76 -179.688 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 158' ' ' ASN . . . . . 0.579 ' N ' ' OD1' ' A' ' 157' ' ' ASP . 8.7 t-20 . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.773 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.4 mtp . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.96 0.409 . . . . 0.0 110.541 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -40.73 140.93 0.97 Allowed 'Trans proline' 0 C--N 1.305 -1.727 0 C-N-CA 122.69 2.26 . . . . 0.0 112.28 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 82.6 mt-10 -73.78 -33.54 64.29 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.441 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 23.3 p -74.25 172.53 11.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.93 -179.703 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.624 ' O ' HG23 ' A' ' 9' ' ' VAL . 1.2 t-105 -63.56 112.07 2.64 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.167 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.566 ' N ' ' CD ' ' A' ' 7' ' ' PRO . 0.9 OUTLIER -62.02 -44.97 91.34 Favored Pre-proline 0 CA--C 1.533 0.319 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.316 -179.796 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.566 ' CD ' ' N ' ' A' ' 6' ' ' VAL . 21.3 Cg_exo -57.14 -65.42 0.1 Allowed 'Trans proline' 0 C--N 1.307 -1.655 0 C-N-CA 121.671 1.58 . . . . 0.0 111.585 179.673 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.727 ' O ' HG23 ' A' ' 12' ' ' THR . . . -49.23 -41.44 37.38 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.226 -179.632 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.624 HG23 ' O ' ' A' ' 5' ' ' TRP . 49.7 t -60.53 -62.75 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 120.824 0.345 . . . . 0.0 111.533 -179.07 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -57.78 -52.33 52.74 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 111.456 -0.658 . . . . 0.0 111.456 -179.406 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 9.5 mp -57.99 -30.38 66.02 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.474 0.178 . . . . 0.0 110.961 -179.535 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.727 HG23 ' O ' ' A' ' 8' ' ' ALA . 20.8 p -79.93 -20.74 44.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.087 0.47 . . . . 0.0 109.766 179.295 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.7 mt -82.0 -22.86 36.32 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.499 179.404 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.405 ' N ' ' HD2' ' A' ' 15' ' ' PRO . 5.4 t -54.35 -54.63 45.99 Favored Pre-proline 0 CA--C 1.535 0.398 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.655 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.405 ' HD2' ' N ' ' A' ' 14' ' ' VAL . 6.4 Cg_endo -57.55 -8.59 4.2 Favored 'Trans proline' 0 N--CA 1.495 1.572 0 C-N-CA 120.935 1.09 . . . . 0.0 111.642 179.657 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.4 t -75.08 -27.62 60.0 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.124 179.766 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 63.8 mt -79.45 -43.67 22.84 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.767 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -77.63 -31.74 48.9 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 111.012 -0.835 . . . . 0.0 111.012 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -78.36 -34.76 35.36 Favored Glycine 0 CA--C 1.52 0.379 0 N-CA-C 110.305 -1.118 . . . . 0.0 110.305 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 41.4 t80 -72.01 -58.99 2.98 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 179.459 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 48.8 tpp -64.61 -28.02 69.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.625 179.587 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.541 ' C ' ' CZ2' ' A' ' 95' ' ' TRP . . . -65.66 -63.12 4.27 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 111.674 -0.571 . . . . 0.0 111.674 -179.462 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.496 ' O ' HG22 ' A' ' 26' ' ' VAL . . . -69.34 -18.2 63.78 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.891 -0.324 . . . . 0.0 111.03 -179.388 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 80.7 t80 -50.6 -24.64 3.41 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.959 0.409 . . . . 0.0 110.045 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.461 ' CE2' ' HB1' ' A' ' 102' ' ' ALA . 63.5 t80 -69.2 -48.26 62.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.979 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.496 HG22 ' O ' ' A' ' 23' ' ' ALA . 32.9 m -75.55 -14.24 15.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 C-N-CA 120.73 -0.388 . . . . 0.0 110.768 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.542 ' O ' ' CD1' ' A' ' 31' ' ' LEU . 0.0 OUTLIER -57.79 -44.03 85.98 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.626 179.879 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -112.16 -54.56 0.48 Allowed Glycine 0 CA--C 1.525 0.667 0 N-CA-C 110.978 -0.849 . . . . 0.0 110.978 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -58.99 -27.61 65.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.836 0.351 . . . . 0.0 110.495 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -78.52 -49.05 6.89 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 111.062 -0.815 . . . . 0.0 111.062 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.542 ' CD1' ' O ' ' A' ' 27' ' ' ARG . 95.0 mt -56.7 -34.51 67.5 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.769 0.319 . . . . 0.0 110.541 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 49.4 mtp180 -77.06 -54.21 6.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.669 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -44.96 -41.65 7.48 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.298 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 56.2 t80 -49.44 -31.43 9.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.879 -179.697 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -66.28 -25.24 66.77 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.678 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -92.67 -67.36 1.1 Allowed Glycine 0 CA--C 1.523 0.573 0 N-CA-C 111.049 -0.82 . . . . 0.0 111.049 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.571 ' O ' HD12 ' A' ' 37' ' ' LEU . 0.3 OUTLIER -95.2 166.96 11.65 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.827 0.346 . . . . 0.0 110.561 179.666 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -87.1 112.82 22.29 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.704 -179.681 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.688 ' NZ ' ' CH2' ' A' ' 107' ' ' TRP . 17.3 mtpt -129.42 153.31 80.57 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.193 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.605 ' C ' ' H ' ' A' ' 42' ' ' TRP . 71.8 Cg_endo -72.82 18.85 0.35 Allowed 'Trans proline' 0 C--N 1.305 -1.725 0 C-N-CA 121.438 1.425 . . . . 0.0 110.668 178.843 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.508 ' H ' ' C ' ' A' ' 39' ' ' LYS . 39.0 t -49.09 -2.53 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.186 -0.915 . . . . 0.0 111.46 -179.784 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' TRP . . . . . 0.696 ' CZ2' ' CE1' ' A' ' 43' ' ' HIS . 47.7 p-90 -76.35 -15.03 60.06 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.46 -0.496 . . . . 0.0 110.448 -179.587 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.696 ' CE1' ' CZ2' ' A' ' 42' ' ' TRP . 37.4 m80 -61.32 143.91 92.33 Favored Pre-proline 0 C--N 1.332 -0.171 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 178.869 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.455 ' C ' ' O ' ' A' ' 43' ' ' HIS . 47.1 Cg_exo -34.65 130.09 0.2 Allowed 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 121.237 1.291 . . . . 0.0 111.273 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.567 ' O ' ' N ' ' A' ' 47' ' ' TRP . 16.0 Cg_exo -52.86 155.89 10.22 Favored 'Trans proline' 0 C--N 1.311 -1.398 0 C-N-CA 120.599 0.866 . . . . 0.0 111.929 -179.481 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.45 ' O ' ' CB ' ' A' ' 50' ' ' ALA . 2.1 ppt_? -41.75 -17.24 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.834 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.626 ' CD1' ' N ' ' A' ' 48' ' ' THR . 0.7 OUTLIER -61.14 -50.18 74.24 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 120.658 -0.417 . . . . 0.0 110.94 -179.391 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.626 ' N ' ' CD1' ' A' ' 47' ' ' TRP . 1.0 OUTLIER -90.56 -27.0 19.42 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.632 -179.146 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.74 ' O ' HG23 ' A' ' 52' ' ' ILE . 0.1 OUTLIER -83.01 -51.35 7.64 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 120.46 -0.496 . . . . 0.0 111.804 -178.677 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.602 ' C ' ' H ' ' A' ' 52' ' ' ILE . . . -40.13 -29.17 0.2 Allowed Pre-proline 0 N--CA 1.466 0.339 0 N-CA-C 112.129 0.418 . . . . 0.0 112.129 -178.898 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.407 ' HD2' ' N ' ' A' ' 50' ' ' ALA . 26.3 Cg_exo -52.82 3.0 0.04 OUTLIER 'Trans proline' 0 C--N 1.312 -1.363 0 CA-C-N 119.336 0.799 . . . . 0.0 112.441 178.287 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.74 HG23 ' O ' ' A' ' 49' ' ' LEU . 7.9 pt -52.51 -40.36 32.77 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.238 0 CA-C-O 121.22 0.534 . . . . 0.0 109.842 179.258 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.456 ' N ' ' CG1' ' A' ' 52' ' ' ILE . 69.7 m95 -73.4 -22.41 60.25 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.157 -179.328 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -67.43 -49.28 52.51 Favored Glycine 0 CA--C 1.527 0.833 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 179.015 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 3.3 m -65.54 -56.95 9.54 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.909 0.385 . . . . 0.0 110.209 179.464 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 83.3 mt -57.18 -26.52 60.76 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.503 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.509 ' CD1' ' C ' ' A' ' 57' ' ' TYR . 2.3 t80 -67.17 -47.63 70.41 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 179.464 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 15.1 m -56.43 -53.62 55.22 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.957 179.331 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -57.98 -41.06 82.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.34 179.524 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 8.3 mtm -56.71 -58.28 8.78 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.092 179.765 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -46.95 -44.07 17.92 Favored Glycine 0 CA--C 1.523 0.573 0 N-CA-C 110.696 -0.961 . . . . 0.0 110.696 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -61.72 -59.22 5.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.708 0.29 . . . . 0.0 110.468 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.539 ' O ' HG23 ' A' ' 67' ' ' VAL . . . -49.79 -57.34 9.81 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.88 -0.888 . . . . 0.0 110.88 179.792 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.592 ' O ' ' CD1' ' A' ' 68' ' ' TRP . 0.3 OUTLIER -45.68 -55.51 6.34 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.958 0.408 . . . . 0.0 110.526 179.803 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.415 ' N ' ' OG ' ' A' ' 64' ' ' SER . 50.0 t80 -48.54 -42.23 32.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.965 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 93.4 mt -66.73 -49.25 76.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.176 -179.577 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.539 HG23 ' O ' ' A' ' 63' ' ' GLY . 9.1 t -51.43 -54.54 11.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.907 0.384 . . . . 0.0 111.162 -179.47 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' TRP . . . . . 0.592 ' CD1' ' O ' ' A' ' 64' ' ' SER . 1.7 m95 -65.81 -35.01 79.5 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.097 -179.458 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 7.1 mmmt -65.63 -22.93 66.7 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.653 -0.419 . . . . 0.0 110.349 179.369 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -81.95 -62.68 1.57 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.542 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.729 ' C ' HD12 ' A' ' 71' ' ' LEU . 3.1 pp -65.68 -8.96 23.5 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.643 -0.423 . . . . 0.0 110.839 -179.814 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.687 ' N ' HD12 ' A' ' 71' ' ' LEU . . . 104.6 84.38 1.76 Allowed Glycine 0 CA--C 1.526 0.767 0 C-N-CA 120.994 -0.622 . . . . 0.0 111.77 179.19 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.554 ' N ' ' O ' ' A' ' 68' ' ' TRP . . . 41.91 -174.16 0.01 OUTLIER Glycine 0 CA--C 1.526 0.75 0 N-CA-C 111.795 -0.522 . . . . 0.0 111.795 179.212 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 46.6 t80 -78.7 114.21 17.43 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.866 0.365 . . . . 0.0 110.563 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.58 ' OG1' ' N ' ' A' ' 76' ' ' GLU . 0.0 OUTLIER -142.04 -175.48 4.43 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.423 -179.966 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.58 ' N ' ' OG1' ' A' ' 75' ' ' THR . 4.7 pt-20 -51.3 -25.8 6.42 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.601 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 64.3 t0 -76.12 -31.35 58.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.081 -179.696 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.41 ' O ' HD12 ' A' ' 82' ' ' LEU . . . -83.71 -19.11 35.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.937 -179.764 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 24.6 mtp -68.24 -27.38 66.31 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.847 -179.823 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 6.4 t -67.07 -49.39 46.3 Favored Pre-proline 0 CA--C 1.534 0.352 0 CA-C-N 116.438 -0.347 . . . . 0.0 110.729 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_endo -71.77 -58.85 0.07 OUTLIER 'Trans proline' 0 N--CA 1.498 1.74 0 C-N-CA 120.985 1.123 . . . . 0.0 111.721 179.166 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.414 HD11 ' CE2' ' A' ' 68' ' ' TRP . 2.8 mt -51.74 -47.59 63.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.781 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -67.88 -64.16 3.3 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 111.204 -0.758 . . . . 0.0 111.204 -179.471 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 31.4 tp -46.04 -26.71 0.78 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.988 0.423 . . . . 0.0 110.169 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 12.2 t80 -77.23 -41.98 39.12 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.245 179.767 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 1.3 m -69.52 -43.44 73.04 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.842 -179.824 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -69.84 -56.79 7.78 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 110.986 -0.846 . . . . 0.0 110.986 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.433 ' O ' ' CB ' ' A' ' 92' ' ' ASN . 3.5 tp60 -53.84 -45.2 70.83 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.9 0.381 . . . . 0.0 110.514 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 11.4 tp -66.19 -33.16 75.14 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.834 -179.722 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.761 ' O ' ' HB2' ' A' ' 94' ' ' ALA . . . -64.11 -65.68 0.65 Allowed 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 120.256 -0.578 . . . . 0.0 111.291 -179.324 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.9 pp -68.04 -33.37 74.46 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 -178.611 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.433 ' CB ' ' O ' ' A' ' 88' ' ' GLN . 32.2 t-20 -81.13 -55.11 4.97 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.249 0.463 . . . . 0.0 112.249 -178.444 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' TRP . . . . . 0.614 ' O ' ' N ' ' A' ' 95' ' ' TRP . 0.0 OUTLIER -73.54 -17.43 61.21 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.699 -0.4 . . . . 0.0 111.773 -178.371 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.761 ' HB2' ' O ' ' A' ' 90' ' ' ALA . . . -52.82 82.04 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 120.473 -0.491 . . . . 0.0 109.911 179.505 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.704 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 38.4 p-90 -97.08 -15.47 0.2 Allowed Pre-proline 0 CA--C 1.536 0.437 0 N-CA-C 112.635 0.605 . . . . 0.0 112.635 -179.16 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.704 ' CD ' ' N ' ' A' ' 95' ' ' TRP . 47.4 Cg_exo -60.39 -18.76 55.09 Favored 'Trans proline' 0 N--CA 1.498 1.744 0 C-N-CA 120.675 0.917 . . . . 0.0 113.663 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.562 ' CD ' ' N ' ' A' ' 96' ' ' PRO . 71.5 Cg_exo -76.76 0.69 9.34 Favored 'Trans proline' 0 N--CA 1.498 1.788 0 C-N-CA 120.534 0.822 . . . . 0.0 113.183 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.486 ' O ' ' N ' ' A' ' 101' ' ' GLY . 1.9 pp -91.76 9.37 3.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 C-N-CA 120.739 -0.385 . . . . 0.0 110.632 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.535 ' CD1' ' O ' ' A' ' 96' ' ' PRO . 2.8 m-30 -40.44 -36.32 0.54 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.678 179.716 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.547 ' CD1' ' N ' ' A' ' 100' ' ' PHE . 0.1 OUTLIER -66.9 -35.41 79.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.203 -179.334 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.486 ' N ' ' O ' ' A' ' 98' ' ' ILE . . . -92.89 -4.27 65.28 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 111.402 -0.679 . . . . 0.0 111.402 -179.538 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.461 ' HB1' ' CE2' ' A' ' 25' ' ' PHE . . . -65.85 -13.96 60.56 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.683 0.278 . . . . 0.0 110.925 -179.764 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 16.2 ptt180 -89.26 3.35 52.34 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.832 0.348 . . . . 0.0 110.81 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 8.5 mt-30 -120.61 158.74 26.72 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.362 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.409 ' N ' ' SD ' ' A' ' 105' ' ' MET . 0.0 OUTLIER -49.31 -18.37 0.36 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.232 179.907 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.566 ' O ' ' N ' ' A' ' 108' ' ' ALA . . . -64.48 -15.68 59.66 Favored Glycine 0 CA--C 1.526 0.764 0 N-CA-C 111.022 -0.831 . . . . 0.0 111.022 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' TRP . . . . . 0.688 ' CH2' ' NZ ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -41.8 -16.59 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 120.619 0.247 . . . . 0.0 111.241 -179.533 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.566 ' N ' ' O ' ' A' ' 106' ' ' GLY . . . -64.0 -17.3 63.18 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.96 0.409 . . . . 0.0 110.514 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 9.9 mt -51.64 -29.99 19.83 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.591 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.436 ' HB2' ' CE3' ' A' ' 95' ' ' TRP . . . -58.96 -62.78 1.62 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.644 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.71 ' O ' HG23 ' A' ' 115' ' ' VAL . 1.4 p30 -54.72 -53.86 49.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.453 -179.456 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.573 ' N ' ' OD1' ' A' ' 111' ' ' ASP . 31.3 tp -55.94 -40.78 73.66 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.918 -0.313 . . . . 0.0 111.662 -179.112 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 24.9 mt -68.35 -61.3 1.9 Allowed 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.363 0.505 . . . . 0.0 112.363 -178.598 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.0 pp -61.89 -32.86 73.26 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 120.435 -0.506 . . . . 0.0 111.41 -178.606 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.71 HG23 ' O ' ' A' ' 111' ' ' ASP . 41.8 t -61.86 -55.98 20.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.15 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.499 ' O ' ' OG1' ' A' ' 120' ' ' THR . 14.8 m -74.56 -22.9 58.76 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.447 -179.222 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -65.2 -62.48 4.87 Favored Glycine 0 CA--C 1.526 0.72 0 C-N-CA 120.809 -0.71 . . . . 0.0 111.419 -179.326 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.557 ' O ' HG23 ' A' ' 122' ' ' THR . 5.4 p -73.64 -35.5 44.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 C-N-CA 121.134 -0.226 . . . . 0.0 111.418 -179.507 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.508 ' O ' ' OG1' ' A' ' 123' ' ' THR . . . -69.76 -60.32 2.39 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.484 -0.487 . . . . 0.0 111.045 -179.457 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.499 ' OG1' ' O ' ' A' ' 116' ' ' SER . 1.9 m -59.28 -50.36 74.28 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.775 0.322 . . . . 0.0 111.34 -179.478 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -56.56 -41.75 77.39 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.464 -179.284 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.557 HG23 ' O ' ' A' ' 118' ' ' VAL . 33.9 p -72.44 -25.53 61.49 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.849 -0.34 . . . . 0.0 111.658 -179.238 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.508 ' OG1' ' O ' ' A' ' 119' ' ' ALA . 0.1 OUTLIER -69.55 -47.39 63.82 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.645 -0.422 . . . . 0.0 110.456 -179.747 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.8 pp -83.26 -18.32 39.56 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.18 -179.47 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -91.91 -65.01 1.04 Allowed 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -178.644 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 40.3 m0 -85.77 -57.63 2.97 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 113.032 0.753 . . . . 0.0 113.032 -177.791 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' HIS . . . . . 0.514 ' CD2' ' HB2' ' A' ' 134' ' ' ALA . 15.2 m170 -56.6 -22.6 35.04 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 111.762 0.282 . . . . 0.0 111.762 -178.324 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.51 -37.32 87.14 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 120.897 -0.321 . . . . 0.0 110.798 -179.574 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 47.9 t -101.16 -48.48 11.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.51 -179.466 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' SER . . . . . 0.523 ' HB3' HG22 ' A' ' 67' ' ' VAL . 6.2 t -113.15 108.13 53.25 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.585 -178.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' PRO . . . . . 0.663 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 73.1 Cg_exo -76.41 -26.6 8.59 Favored 'Trans proline' 0 C--N 1.31 -1.47 0 C-N-CA 121.788 1.659 . . . . 0.0 112.393 178.592 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.663 ' CD ' ' N ' ' A' ' 131' ' ' PRO . 51.0 Cg_exo -61.15 -44.87 21.62 Favored 'Trans proline' 0 N--CA 1.497 1.682 0 C-N-CA 121.485 1.457 . . . . 0.0 112.248 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.405 ' O ' ' N ' ' A' ' 136' ' ' LEU . . . -59.05 -43.25 91.68 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.02 0.438 . . . . 0.0 110.321 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.514 ' HB2' ' CD2' ' A' ' 127' ' ' HIS . . . -49.61 -27.28 4.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.039 179.713 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 7.0 tpt180 -77.96 -29.53 49.84 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.345 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.405 ' N ' ' O ' ' A' ' 133' ' ' ALA . 39.0 mt -74.16 -21.74 59.71 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 178.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.49 ' O ' ' N ' ' A' ' 140' ' ' TYR . 3.3 mt -93.7 -28.29 16.04 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.278 -0.873 . . . . 0.0 110.232 179.455 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.513 ' CD1' ' C ' ' A' ' 138' ' ' TYR . 0.6 OUTLIER -32.3 -50.41 0.55 Allowed Pre-proline 0 CA--C 1.537 0.462 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.586 -179.929 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.42 ' HD2' ' N ' ' A' ' 138' ' ' TYR . 2.7 Cg_endo -61.91 5.94 0.19 Allowed 'Trans proline' 0 N--CA 1.498 1.773 0 C-N-CA 121.476 1.451 . . . . 0.0 112.972 -179.5 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' TYR . . . . . 0.49 ' N ' ' O ' ' A' ' 137' ' ' LEU . 0.1 OUTLIER -90.41 -15.18 31.45 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.904 0.383 . . . . 0.0 110.891 179.866 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.511 HD23 HD12 ' A' ' 144' ' ' LEU . 98.7 mt -59.38 -35.89 74.76 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.216 -0.447 . . . . 0.0 109.922 178.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -56.06 -41.48 75.15 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.768 179.286 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' TRP . . . . . 0.502 ' CE2' HD12 ' A' ' 52' ' ' ILE . 8.4 t-105 -64.65 -44.49 90.26 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.606 179.266 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.511 HD12 HD23 ' A' ' 141' ' ' LEU . 19.2 mt -57.33 -43.3 83.27 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.802 179.573 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.5 ' O ' HG23 ' A' ' 149' ' ' VAL . . . -70.26 -26.69 63.94 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.007 179.644 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 11.1 t80 -60.65 -61.73 2.37 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.647 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.491 ' O ' ' OD1' ' A' ' 151' ' ' ASN . . . -66.55 -50.34 63.47 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 120.696 -0.401 . . . . 0.0 110.615 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 148' ' ' THR . . . . . 0.576 ' O ' ' ND2' ' A' ' 151' ' ' ASN . 17.0 m -48.99 -55.43 11.96 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.626 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.5 HG23 ' O ' ' A' ' 145' ' ' ALA . 73.1 t -59.46 -35.86 61.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.613 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.42 ' O ' HG23 ' A' ' 154' ' ' VAL . 0.8 OUTLIER -51.73 -61.23 2.38 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.628 -0.429 . . . . 0.0 110.083 -179.873 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 151' ' ' ASN . . . . . 0.576 ' ND2' ' O ' ' A' ' 148' ' ' THR . 1.3 p-10 -54.34 -47.15 72.87 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.766 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 38.1 t80 -53.23 -40.73 64.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.766 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 37.1 t80 -63.92 -45.92 87.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.912 -179.696 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.42 HG23 ' O ' ' A' ' 150' ' ' LEU . 14.6 t -56.6 -51.69 62.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.926 0.393 . . . . 0.0 110.806 -179.792 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 155' ' ' TRP . . . . . . . . . . . . . 15.9 m0 -52.28 -55.33 22.06 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.225 -179.642 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -66.65 -19.73 65.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.28 -179.066 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 37.8 t0 -71.1 -52.7 17.84 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.73 0.3 . . . . 0.0 111.164 -179.456 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 19.6 p30 -83.1 -25.3 32.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.861 -179.483 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 2.6 p -144.41 100.36 3.52 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.599 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' GLY . . . . . 0.44 ' O ' ' C ' ' A' ' 161' ' ' ARG . . . -152.73 168.62 31.72 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 111.147 -0.781 . . . . 0.0 111.147 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 161' ' ' ARG . . . . . 0.44 ' C ' ' O ' ' A' ' 160' ' ' GLY . 87.7 mtt180 36.63 74.25 0.08 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.841 0.353 . . . . 0.0 110.682 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 66.9 mtm180 -104.28 141.37 36.41 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.484 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 147.98 76.85 0.02 OUTLIER Glycine 0 CA--C 1.524 0.635 0 N-CA-C 110.948 -0.861 . . . . 0.0 110.948 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -135.86 -167.18 11.2 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 110.817 -0.913 . . . . 0.0 110.817 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 17.5 m -86.02 179.32 7.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.868 0.366 . . . . 0.0 110.597 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' ARG . . . . . 0.456 ' C ' HD12 ' A' ' 167' ' ' LEU . 90.4 mtt180 -107.07 -102.88 0.35 Allowed 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.403 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.456 HD12 ' C ' ' A' ' 166' ' ' ARG . 11.1 mp -106.83 -66.79 0.99 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.466 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.451 ' O ' ' O ' ' A' ' 167' ' ' LEU . . . 53.83 108.33 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.276 -179.772 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 48.3 mm-40 . . . . . 0 C--O 1.221 -0.422 0 CA-C-O 117.941 -1.028 . . . . 0.0 110.584 -179.865 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 201' ' ' PKA . . . . . 0.539 ' C15' 'CL ' ' A' ' 201' ' ' PKA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.508 ' SD ' ' O ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.148 0 CA-C-O 120.878 0.371 . . . . 0.0 110.439 . . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -60.14 -165.46 0.03 OUTLIER 'Trans proline' 0 C--N 1.304 -1.796 0 C-N-CA 122.436 2.091 . . . . 0.0 112.033 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -151.02 -19.59 0.21 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.558 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 23.2 t -83.84 130.64 34.92 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.401 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.761 ' O ' HG23 ' A' ' 9' ' ' VAL . 0.5 OUTLIER -90.88 117.11 29.23 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.23 -179.953 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.571 ' N ' ' CD ' ' A' ' 7' ' ' PRO . 0.9 OUTLIER -61.43 -42.86 86.99 Favored Pre-proline 0 CA--C 1.532 0.266 0 C-N-CA 120.938 -0.305 . . . . 0.0 110.26 -179.819 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.571 ' CD ' ' N ' ' A' ' 6' ' ' VAL . 24.1 Cg_exo -58.88 -65.1 0.09 OUTLIER 'Trans proline' 0 C--N 1.307 -1.623 0 C-N-CA 121.472 1.448 . . . . 0.0 111.52 179.585 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.732 ' O ' HG23 ' A' ' 12' ' ' THR . . . -50.42 -37.74 39.54 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.201 -179.765 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.761 HG23 ' O ' ' A' ' 5' ' ' TRP . 46.1 t -59.9 -62.45 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.831 0.348 . . . . 0.0 111.376 -179.28 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -61.67 -48.28 85.29 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 111.316 -0.714 . . . . 0.0 111.316 -179.431 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 9.0 mp -60.26 -24.96 65.33 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.49 0.186 . . . . 0.0 111.153 -179.609 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.732 HG23 ' O ' ' A' ' 8' ' ' ALA . 14.4 p -83.92 -29.11 27.39 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.77 -0.372 . . . . 0.0 110.539 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.422 ' O ' ' CB ' ' A' ' 16' ' ' SER . 6.4 mp -78.47 -20.87 49.98 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 179.661 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.421 ' C ' ' H ' ' A' ' 16' ' ' SER . 3.5 t -49.73 -57.63 11.67 Favored Pre-proline 0 CA--C 1.534 0.349 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.739 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.418 ' HD2' ' N ' ' A' ' 14' ' ' VAL . 11.3 Cg_endo -56.5 -4.19 0.75 Allowed 'Trans proline' 0 N--CA 1.497 1.725 0 C-N-CA 120.81 1.007 . . . . 0.0 111.974 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.422 ' CB ' ' O ' ' A' ' 13' ' ' LEU . 1.6 t -81.46 -27.81 34.44 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.832 0.348 . . . . 0.0 110.464 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 13.4 mt -71.56 -54.93 8.86 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.671 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -74.02 -35.8 53.08 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 111.035 -0.826 . . . . 0.0 111.035 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -67.27 -33.69 83.34 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 111.011 -0.836 . . . . 0.0 111.011 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -78.14 -60.09 2.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.74 0.305 . . . . 0.0 111.002 -179.739 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 3.3 ttt -61.95 -23.19 66.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.777 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.405 ' C ' ' CZ2' ' A' ' 95' ' ' TRP . . . -77.94 -60.43 2.75 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 111.681 -0.567 . . . . 0.0 111.681 -179.565 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.646 ' O ' HG22 ' A' ' 26' ' ' VAL . . . -66.79 -22.42 66.03 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.857 -179.146 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 88.5 t80 -49.86 -24.15 2.3 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.192 179.741 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 65.3 t80 -70.56 -52.09 24.05 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.007 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.646 HG22 ' O ' ' A' ' 23' ' ' ALA . 31.9 m -64.57 -22.59 31.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 C-N-CA 120.826 -0.35 . . . . 0.0 110.697 -179.725 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.448 ' NH2' ' HE ' ' A' ' 46' ' ' ARG . 16.3 ttt180 -67.66 -31.77 71.98 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.518 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -106.17 -61.41 0.6 Allowed Glycine 0 CA--C 1.525 0.706 0 N-CA-C 111.522 -0.631 . . . . 0.0 111.522 -179.503 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.45 ' C ' ' OE1' ' A' ' 29' ' ' GLU . 4.2 tm-20 -66.52 -34.48 78.01 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 121.032 -0.267 . . . . 0.0 111.304 -179.471 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -64.73 -58.23 10.56 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 110.932 -0.867 . . . . 0.0 110.932 -179.757 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 10.9 mp -51.67 -30.11 20.61 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.665 0.269 . . . . 0.0 110.511 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 16.1 tpp180 -78.61 -49.93 12.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.888 -179.746 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -51.4 -29.96 17.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.357 -179.652 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 39.1 t80 -46.28 -35.94 5.76 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.232 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -61.4 -29.03 69.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.486 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -89.13 -70.64 1.26 Allowed Glycine 0 CA--C 1.525 0.668 0 N-CA-C 110.851 -0.9 . . . . 0.0 110.851 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.572 ' O ' HD12 ' A' ' 37' ' ' LEU . 0.3 OUTLIER -95.21 167.15 11.53 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.912 0.387 . . . . 0.0 110.687 179.606 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 20.1 mt-30 -92.77 114.04 26.48 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.062 -179.542 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 18.8 mtpt -107.27 160.03 27.95 Favored Pre-proline 0 C--N 1.331 -0.2 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.907 179.493 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.564 ' O ' ' CD2' ' A' ' 43' ' ' HIS . 10.9 Cg_endo -65.12 96.33 0.27 Allowed 'Trans proline' 0 C--N 1.307 -1.641 0 C-N-CA 122.147 1.898 . . . . 0.0 111.535 179.595 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 4.1 t -60.97 -1.45 0.43 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.474 -0.785 . . . . 0.0 111.54 -179.515 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' TRP . . . . . 0.592 ' CD2' ' N ' ' A' ' 42' ' ' TRP . 0.0 OUTLIER -78.17 -15.06 59.18 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.421 -0.512 . . . . 0.0 110.123 -179.405 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.632 ' O ' ' CD2' ' A' ' 43' ' ' HIS . 0.3 OUTLIER -79.48 118.88 74.82 Favored Pre-proline 0 CA--C 1.535 0.391 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.38 -179.753 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.446 ' O ' ' C ' ' A' ' 45' ' ' PRO . 71.8 Cg_endo -87.02 150.71 8.29 Favored 'Trans proline' 0 C--N 1.312 -1.381 0 C-N-CA 120.787 0.991 . . . . 0.0 111.084 179.123 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.512 ' O ' ' N ' ' A' ' 47' ' ' TRP . 35.8 Cg_exo -37.4 137.1 0.36 Allowed 'Trans proline' 0 C--N 1.309 -1.534 0 C-N-CA 120.68 0.92 . . . . 0.0 111.435 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.448 ' HE ' ' NH2' ' A' ' 27' ' ' ARG . 1.3 ppt_? -42.31 -17.45 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.545 -179.347 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.563 ' CD1' ' N ' ' A' ' 48' ' ' THR . 0.1 OUTLIER -49.24 -51.58 32.41 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 120.623 -0.431 . . . . 0.0 111.809 -178.841 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.563 ' N ' ' CD1' ' A' ' 47' ' ' TRP . 15.0 t -91.25 -27.26 18.56 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 112.918 0.71 . . . . 0.0 112.918 -179.246 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.774 ' O ' HG23 ' A' ' 52' ' ' ILE . 0.2 OUTLIER -80.94 -53.74 6.19 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.447 -0.501 . . . . 0.0 112.133 -177.895 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.62 ' C ' ' H ' ' A' ' 52' ' ' ILE . . . -39.37 -30.09 0.2 Allowed Pre-proline 0 C--N 1.33 -0.263 0 C-N-CA 120.961 -0.296 . . . . 0.0 111.436 -179.171 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.423 ' HD2' ' N ' ' A' ' 50' ' ' ALA . 28.6 Cg_exo -54.79 7.67 0.03 OUTLIER 'Trans proline' 0 C--N 1.311 -1.44 0 CA-C-N 118.916 0.649 . . . . 0.0 112.57 178.388 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.774 HG23 ' O ' ' A' ' 49' ' ' LEU . 9.8 pt -56.35 -31.23 32.45 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.242 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 178.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.429 ' CH2' ' HB1' ' A' ' 50' ' ' ALA . 3.6 m0 -64.58 -24.15 67.5 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.616 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -71.62 -46.59 38.58 Favored Glycine 0 CA--C 1.523 0.551 0 N-CA-C 110.629 -0.988 . . . . 0.0 110.629 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 87.0 m -62.09 -50.21 72.85 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.875 0.369 . . . . 0.0 110.447 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 36.9 mt -69.08 -24.9 64.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.692 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.42 ' CD1' ' C ' ' A' ' 57' ' ' TYR . 1.6 t80 -65.34 -48.43 73.03 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 179.769 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -64.91 -46.13 82.98 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.32 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.61 -48.15 82.81 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.695 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 55.1 mtm -63.22 -36.45 83.7 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.713 -179.781 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -59.21 -47.29 91.55 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 111.423 -0.671 . . . . 0.0 111.423 -179.474 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 3.3 m-30 -66.84 -59.85 3.18 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.991 -0.284 . . . . 0.0 110.77 -179.496 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.517 ' O ' HG23 ' A' ' 67' ' ' VAL . . . -50.84 -59.12 8.35 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 110.972 -0.851 . . . . 0.0 110.972 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.511 ' O ' ' CD1' ' A' ' 68' ' ' TRP . 34.5 t -45.11 -52.04 9.61 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-O 120.986 0.422 . . . . 0.0 110.783 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 70.6 t80 -56.16 -36.64 68.53 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.116 -179.794 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 70.5 mt -70.83 -48.44 57.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.775 0.321 . . . . 0.0 110.798 -179.716 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.517 HG23 ' O ' ' A' ' 63' ' ' GLY . 18.3 t -48.9 -54.69 4.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.0 -179.711 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' TRP . . . . . 0.586 ' O ' ' N ' ' A' ' 73' ' ' GLY . 0.9 OUTLIER -64.15 -45.22 89.46 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.76 -0.376 . . . . 0.0 111.047 -179.587 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 14.6 mmmt -57.22 -23.28 46.91 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.888 -0.325 . . . . 0.0 110.913 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 24.1 tp10 -82.34 -63.33 1.4 Allowed 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.799 -0.361 . . . . 0.0 110.848 -179.636 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.742 ' C ' HD12 ' A' ' 71' ' ' LEU . 3.0 pp -64.82 -4.36 4.32 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.965 -179.652 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.618 ' N ' HD12 ' A' ' 71' ' ' LEU . . . 110.95 71.68 0.65 Allowed Glycine 0 CA--C 1.526 0.777 0 C-N-CA 121.177 -0.535 . . . . 0.0 111.817 179.454 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.586 ' N ' ' O ' ' A' ' 68' ' ' TRP . . . 40.93 -173.83 0.01 OUTLIER Glycine 0 CA--C 1.525 0.667 0 CA-C-O 121.365 0.425 . . . . 0.0 112.281 179.077 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 39.4 t80 -70.45 109.84 5.02 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.316 -0.442 . . . . 0.0 110.7 -179.691 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.532 ' OG1' ' N ' ' A' ' 76' ' ' GLU . 1.5 t -142.89 -173.56 3.93 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.231 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.532 ' N ' ' OG1' ' A' ' 75' ' ' THR . 16.6 mp0 -56.73 -23.17 40.63 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.301 179.625 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -78.48 -29.01 46.5 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.785 -179.748 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.437 ' O ' HD12 ' A' ' 82' ' ' LEU . . . -86.85 -30.67 21.28 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.546 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 66.8 mmm -60.46 -27.11 67.27 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.905 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 17.6 t -65.97 -48.11 61.96 Favored Pre-proline 0 CA--C 1.534 0.33 0 C-N-CA 120.711 -0.396 . . . . 0.0 110.817 -179.688 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_endo -73.22 -52.87 0.14 Allowed 'Trans proline' 0 N--CA 1.495 1.615 0 C-N-CA 120.727 0.951 . . . . 0.0 111.355 178.551 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.437 HD12 ' O ' ' A' ' 78' ' ' ALA . 3.6 mt -51.49 -52.8 43.58 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.333 179.769 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.5 ' O ' ' N ' ' A' ' 86' ' ' THR . . . -66.65 -64.54 3.26 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 111.332 -0.707 . . . . 0.0 111.332 -179.237 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 34.3 tp -42.01 -28.08 0.16 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.065 0.46 . . . . 0.0 109.994 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.414 ' N ' ' O ' ' A' ' 83' ' ' GLY . 4.3 t80 -77.29 -43.11 34.41 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.061 179.543 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.5 ' N ' ' O ' ' A' ' 83' ' ' GLY . 3.0 m -68.02 -52.78 31.58 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.744 179.883 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -60.56 -55.9 27.36 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 111.163 -0.775 . . . . 0.0 111.163 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.427 ' O ' ' CB ' ' A' ' 92' ' ' ASN . 8.1 tp-100 -55.99 -42.87 77.03 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.799 0.333 . . . . 0.0 110.471 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 10.5 tp -66.01 -28.61 69.0 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.879 0.371 . . . . 0.0 110.125 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.783 ' O ' ' HB2' ' A' ' 94' ' ' ALA . . . -69.35 -65.82 0.66 Allowed 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.095 -0.642 . . . . 0.0 111.225 -179.814 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.7 pp -66.19 -29.16 69.38 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.149 0.426 . . . . 0.0 112.149 -179.01 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.427 ' CB ' ' O ' ' A' ' 88' ' ' GLN . 36.3 t-20 -85.22 -60.91 1.9 Allowed 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 -178.848 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' TRP . . . . . 0.609 ' O ' ' N ' ' A' ' 95' ' ' TRP . 0.0 OUTLIER -68.25 -14.78 63.24 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.69 -0.404 . . . . 0.0 111.403 -178.486 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.783 ' HB2' ' O ' ' A' ' 90' ' ' ALA . . . -54.04 80.25 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.137 0 C-N-CA 120.439 -0.505 . . . . 0.0 109.995 179.498 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.711 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 33.8 p-90 -94.44 -16.42 0.21 Allowed Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.24 -0.437 . . . . 0.0 112.061 -179.633 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.711 ' CD ' ' N ' ' A' ' 95' ' ' TRP . 46.9 Cg_exo -56.96 -31.99 91.46 Favored 'Trans proline' 0 N--CA 1.494 1.504 0 CA-C-N 118.921 0.65 . . . . 0.0 112.789 179.366 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.524 ' C ' ' H ' ' A' ' 99' ' ' PHE . 59.6 Cg_exo -50.33 -30.55 26.97 Favored 'Trans proline' 0 N--CA 1.493 1.479 0 CA-C-N 118.969 0.668 . . . . 0.0 112.838 179.736 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.492 ' O ' ' N ' ' A' ' 101' ' ' GLY . 1.2 pp -74.01 20.87 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.022 0.439 . . . . 0.0 110.187 179.662 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.524 ' H ' ' C ' ' A' ' 97' ' ' PRO . 0.9 OUTLIER -39.29 -58.18 1.25 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.038 -179.666 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 4.2 p90 -66.89 -18.04 65.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.143 -179.595 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.492 ' N ' ' O ' ' A' ' 98' ' ' ILE . . . -86.99 -10.7 71.45 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 111.17 -0.772 . . . . 0.0 111.17 -179.815 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -70.74 -9.4 57.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.56 0.219 . . . . 0.0 111.093 -179.673 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 10.6 ptm180 -91.97 -5.39 53.16 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.8 0.333 . . . . 0.0 110.734 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 10.0 mt-30 -109.11 160.45 16.05 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.554 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -53.76 -19.25 3.99 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.049 0.452 . . . . 0.0 110.237 179.883 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.605 ' O ' ' N ' ' A' ' 108' ' ' ALA . . . -65.4 -14.93 60.59 Favored Glycine 0 CA--C 1.523 0.592 0 N-CA-C 111.073 -0.811 . . . . 0.0 111.073 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' TRP . . . . . 0.505 ' NE1' ' OD1' ' A' ' 151' ' ' ASN . 0.0 OUTLIER -42.41 -15.12 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.791 0.329 . . . . 0.0 110.517 -179.663 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.605 ' N ' ' O ' ' A' ' 106' ' ' GLY . . . -58.76 -16.83 18.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.136 0.493 . . . . 0.0 109.85 179.427 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 12.1 mt -58.74 -33.92 70.79 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.569 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -53.8 -61.04 2.56 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.936 0.398 . . . . 0.0 110.898 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.571 ' O ' HG23 ' A' ' 115' ' ' VAL . 2.3 p-10 -58.83 -54.89 41.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.733 -179.392 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 43.5 tp -52.82 -43.52 66.01 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.351 -0.386 . . . . 0.0 112.01 -178.83 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 8.6 mt -66.96 -61.37 1.97 Allowed 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -178.17 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.3 pp -61.23 -35.18 76.52 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.304 -0.558 . . . . 0.0 111.499 -178.496 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.571 HG23 ' O ' ' A' ' 111' ' ' ASP . 41.5 t -60.07 -56.64 16.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.596 -0.274 . . . . 0.0 111.116 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.489 ' O ' ' OG1' ' A' ' 120' ' ' THR . 58.1 m -72.92 -24.1 60.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.615 -0.266 . . . . 0.0 111.58 -178.939 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.406 ' O ' ' CB ' ' A' ' 121' ' ' ALA . . . -63.69 -62.73 5.02 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 111.537 -0.625 . . . . 0.0 111.537 -179.285 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.585 ' O ' HG23 ' A' ' 122' ' ' THR . 8.7 p -74.03 -34.59 39.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 C-N-CA 120.883 -0.327 . . . . 0.0 111.231 -179.481 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.524 ' O ' ' OG1' ' A' ' 123' ' ' THR . . . -68.95 -60.57 2.27 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.781 -0.367 . . . . 0.0 111.201 -179.429 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.489 ' OG1' ' O ' ' A' ' 116' ' ' SER . 1.4 m -61.47 -48.66 80.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.397 -179.252 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.407 ' O ' ' CB ' ' A' ' 125' ' ' ALA . . . -56.68 -42.01 78.31 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.173 -179.4 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.585 HG23 ' O ' ' A' ' 118' ' ' VAL . 35.3 p -71.7 -29.22 64.32 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.948 -0.301 . . . . 0.0 111.567 -179.317 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.524 ' OG1' ' O ' ' A' ' 119' ' ' ALA . 0.1 OUTLIER -67.41 -50.7 58.37 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.584 -0.446 . . . . 0.0 110.577 -179.749 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.0 pp -79.71 -20.39 46.61 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.625 -179.085 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.407 ' CB ' ' O ' ' A' ' 121' ' ' ALA . . . -91.47 -64.72 1.08 Allowed 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.678 0.621 . . . . 0.0 112.678 -178.351 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' TRP . . . . . 0.433 ' CD1' ' N ' ' A' ' 126' ' ' TRP . 40.2 m0 -85.69 -57.08 3.19 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 -177.587 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' HIS . . . . . 0.532 ' CG ' ' HB2' ' A' ' 134' ' ' ALA . 11.3 m170 -57.2 -31.58 65.59 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.795 -0.362 . . . . 0.0 111.919 -178.577 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 18.6 ttt180 -56.98 -38.51 73.11 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.709 -0.396 . . . . 0.0 111.367 -179.237 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 48.5 t -97.22 -49.56 11.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.793 0.33 . . . . 0.0 111.403 -179.244 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' SER . . . . . 0.509 ' HB3' HG22 ' A' ' 67' ' ' VAL . 15.0 t -113.91 108.31 51.25 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.748 -179.546 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' PRO . . . . . 0.635 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 82.3 Cg_exo -75.26 -28.07 9.07 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 C-N-CA 121.755 1.637 . . . . 0.0 112.72 179.338 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.635 ' CD ' ' N ' ' A' ' 131' ' ' PRO . 53.5 Cg_exo -57.77 -55.45 2.36 Favored 'Trans proline' 0 N--CA 1.497 1.68 0 C-N-CA 121.142 1.228 . . . . 0.0 111.968 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -49.26 -38.48 27.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.463 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.532 ' HB2' ' CG ' ' A' ' 127' ' ' HIS . . . -57.08 -29.04 63.14 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.337 179.786 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 9.7 tpp85 -76.36 -24.5 54.2 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.335 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 84.6 mt -76.04 -39.73 54.95 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 179.42 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.608 ' O ' ' N ' ' A' ' 140' ' ' TYR . 9.7 mt -77.0 -37.42 55.15 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.791 -0.641 . . . . 0.0 109.823 179.166 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.493 ' C ' ' O ' ' A' ' 137' ' ' LEU . 2.9 t80 -21.0 -44.41 0.04 OUTLIER Pre-proline 0 N--CA 1.467 0.375 0 O-C-N 123.918 0.761 . . . . 0.0 111.828 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.564 ' N ' ' O ' ' A' ' 137' ' ' LEU . 2.0 Cg_endo -67.75 11.55 0.23 Allowed 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 121.026 1.151 . . . . 0.0 112.296 179.554 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 140' ' ' TYR . . . . . 0.756 ' CE2' HD11 ' A' ' 144' ' ' LEU . 2.4 p90 -93.14 -14.15 27.56 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 121.188 0.518 . . . . 0.0 110.118 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.605 ' CD1' ' CE1' ' A' ' 140' ' ' TYR . 5.2 mp -57.05 -25.91 59.45 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 178.522 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -66.66 -44.51 81.68 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.826 179.495 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' TRP . . . . . 0.453 ' CZ2' HD12 ' A' ' 52' ' ' ILE . 7.9 t-105 -59.77 -48.08 83.13 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 179.358 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.756 HD11 ' CE2' ' A' ' 140' ' ' TYR . 9.1 mt -53.22 -50.96 63.64 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 179.09 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.645 ' O ' HG23 ' A' ' 149' ' ' VAL . . . -61.33 -26.58 67.9 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.667 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 25.4 t80 -65.01 -62.43 1.55 Allowed 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.812 -0.355 . . . . 0.0 110.775 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.416 ' HB1' ' C20' ' A' ' 201' ' ' PKA . . . -66.25 -43.38 86.68 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.612 -0.435 . . . . 0.0 110.492 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 16.2 m -57.06 -57.62 11.78 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.765 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.645 HG23 ' O ' ' A' ' 145' ' ' ALA . 85.4 t -56.95 -32.77 40.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 C-N-CA 120.836 -0.346 . . . . 0.0 110.731 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.541 ' O ' HG23 ' A' ' 154' ' ' VAL . 1.8 tp -58.39 -48.62 80.03 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.523 -0.471 . . . . 0.0 109.813 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 151' ' ' ASN . . . . . 0.505 ' OD1' ' NE1' ' A' ' 107' ' ' TRP . 21.1 t30 -69.62 -55.68 9.4 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.528 179.701 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 84.8 t80 -47.49 -39.53 16.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.818 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 25.8 t80 -67.82 -46.59 71.45 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.765 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.541 HG23 ' O ' ' A' ' 150' ' ' LEU . 93.7 t -61.88 -33.06 56.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.742 -179.853 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 155' ' ' TRP . . . . . . . . . . . . . 6.3 m0 -67.02 -58.48 4.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.511 179.778 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -62.94 -19.43 64.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.553 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -80.09 -51.66 8.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.169 -179.547 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -87.15 -40.47 14.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.084 -179.449 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -79.22 110.34 14.39 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.543 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 120.85 -152.72 16.77 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 111.011 -0.836 . . . . 0.0 111.011 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 19.0 ttt85 48.45 51.73 14.8 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.835 0.35 . . . . 0.0 110.535 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 42.0 mtm180 -81.03 138.87 36.01 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.591 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 163' ' ' GLY . . . . . 0.485 ' O ' ' O ' ' A' ' 164' ' ' GLY . . . 171.52 -176.17 44.81 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 111.014 -0.834 . . . . 0.0 111.014 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 164' ' ' GLY . . . . . 0.485 ' O ' ' O ' ' A' ' 163' ' ' GLY . . . 51.6 108.96 0.01 OUTLIER Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.944 -0.862 . . . . 0.0 110.944 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 165' ' ' SER . . . . . 0.406 ' C ' ' OE2' ' A' ' 169' ' ' GLU . 46.3 t -93.25 18.16 9.97 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.91 0.386 . . . . 0.0 110.462 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 166' ' ' ARG . . . . . 0.462 ' O ' ' N ' ' A' ' 168' ' ' ALA . 94.0 mtt180 -52.72 -176.96 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.575 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.531 HD12 ' N ' ' A' ' 167' ' ' LEU . 9.4 mp 59.28 -80.45 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.713 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.462 ' N ' ' O ' ' A' ' 166' ' ' ARG . . . -40.22 -33.61 0.25 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.761 -179.814 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 169' ' ' GLU . . . . . 0.406 ' OE2' ' C ' ' A' ' 165' ' ' SER . 11.2 mt-10 . . . . . 0 C--O 1.22 -0.455 0 CA-C-O 118.026 -0.987 . . . . 0.0 110.549 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 201' ' ' PKA . . . . . 0.513 ' C15' 'CL ' ' A' ' 201' ' ' PKA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.65 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 CA--C 1.527 0.089 0 CA-C-O 120.901 0.381 . . . . 0.0 110.64 . . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.467 ' O ' ' CB ' ' A' ' 3' ' ' GLU . 37.3 Cg_endo -98.83 -73.7 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.609 0 C-N-CA 122.343 2.029 . . . . 0.0 112.146 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.467 ' CB ' ' O ' ' A' ' 2' ' ' PRO . 13.0 tt0 80.88 -19.41 0.44 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.416 -179.764 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 30.2 p 53.29 99.0 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.504 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.605 ' O ' HG23 ' A' ' 9' ' ' VAL . 0.5 OUTLIER -45.44 116.97 1.27 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.308 179.952 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.589 ' N ' ' CD ' ' A' ' 7' ' ' PRO . 0.9 OUTLIER -61.0 -40.77 77.17 Favored Pre-proline 0 C--N 1.33 -0.269 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 -179.919 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.589 ' CD ' ' N ' ' A' ' 6' ' ' VAL . 23.4 Cg_exo -62.82 -64.59 0.07 OUTLIER 'Trans proline' 0 C--N 1.307 -1.649 0 C-N-CA 121.683 1.589 . . . . 0.0 111.388 179.526 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.681 ' O ' HG23 ' A' ' 12' ' ' THR . . . -48.9 -30.09 5.47 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.84 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.605 HG23 ' O ' ' A' ' 5' ' ' TRP . 43.5 t -74.18 -62.8 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.709 0.29 . . . . 0.0 111.658 -179.258 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -58.13 -35.21 76.23 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 111.598 -0.601 . . . . 0.0 111.598 -179.268 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.528 ' HG ' HG22 ' A' ' 86' ' ' THR . 6.9 mp -73.52 -38.17 65.39 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.621 0.248 . . . . 0.0 110.567 -179.663 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.681 HG23 ' O ' ' A' ' 8' ' ' ALA . 12.3 p -70.16 -20.59 63.13 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.017 0.436 . . . . 0.0 109.86 179.456 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.418 ' O ' ' C ' ' A' ' 14' ' ' VAL . 7.8 mt -80.95 -42.76 20.76 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.695 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.439 HG12 ' N ' ' A' ' 15' ' ' PRO . 3.1 t -35.71 -66.08 0.27 Allowed Pre-proline 0 CA--C 1.534 0.35 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.997 -179.766 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.439 ' N ' HG12 ' A' ' 14' ' ' VAL . 27.7 Cg_endo -51.23 -48.04 23.04 Favored 'Trans proline' 0 N--CA 1.498 1.754 0 C-N-CA 120.712 0.941 . . . . 0.0 112.126 -179.515 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 7.5 t -45.06 -21.32 0.06 Allowed 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.793 -0.363 . . . . 0.0 110.726 -179.468 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.421 ' N ' ' O ' ' A' ' 15' ' ' PRO . 73.2 mt -74.22 -53.37 9.94 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.395 179.77 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -72.01 -23.82 77.42 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 111.11 -0.796 . . . . 0.0 111.11 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -72.1 -49.2 22.64 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 110.952 -0.859 . . . . 0.0 110.952 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 11.2 t80 -67.94 -59.02 3.6 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.831 0.348 . . . . 0.0 110.566 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 8.0 tpp -62.88 -26.95 69.03 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.156 -179.634 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -77.68 -62.55 2.37 Favored Glycine 0 CA--C 1.526 0.753 0 C-N-CA 120.963 -0.637 . . . . 0.0 111.913 -179.316 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.626 ' O ' HG22 ' A' ' 26' ' ' VAL . . . -57.57 -24.79 58.15 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.834 -0.347 . . . . 0.0 110.666 -179.085 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 54.2 t80 -47.82 -24.5 1.0 Allowed 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.769 -0.372 . . . . 0.0 110.11 179.546 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.4 ' CE2' ' HB3' ' A' ' 102' ' ' ALA . 21.7 t80 -69.45 -55.78 9.28 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.777 -179.801 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.626 HG22 ' O ' ' A' ' 23' ' ' ALA . 33.7 m -60.44 -23.99 29.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 C-N-CA 120.699 -0.4 . . . . 0.0 110.344 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 2.9 tmt_? -66.09 -20.86 66.29 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.631 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -116.29 -75.22 0.57 Allowed Glycine 0 CA--C 1.523 0.569 0 N-CA-C 111.021 -0.832 . . . . 0.0 111.021 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -50.36 -31.68 15.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.654 0.264 . . . . 0.0 110.774 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -72.82 -53.39 8.21 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.81 -0.916 . . . . 0.0 110.81 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 11.0 mp -57.58 -29.94 64.86 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.84 0.352 . . . . 0.0 110.317 179.83 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 45.0 mtp180 -79.94 -48.92 12.63 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.549 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -52.15 -29.97 24.52 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.013 -0.539 . . . . 0.0 109.923 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 51.1 t80 -48.54 -40.03 25.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.61 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -58.9 -22.52 59.67 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.461 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -94.95 -73.5 1.2 Allowed Glycine 0 CA--C 1.524 0.638 0 N-CA-C 110.721 -0.951 . . . . 0.0 110.721 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.568 ' O ' HD12 ' A' ' 37' ' ' LEU . 0.3 OUTLIER -95.52 167.14 11.49 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.711 0.291 . . . . 0.0 110.424 179.494 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 33.3 mt-30 -85.02 115.72 23.0 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.887 0.375 . . . . 0.0 111.168 -179.421 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 12.0 mtpt -122.78 164.66 25.51 Favored Pre-proline 0 N--CA 1.462 0.168 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 179.276 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.611 ' C ' ' H ' ' A' ' 42' ' ' TRP . 20.4 Cg_endo -80.5 43.53 1.55 Allowed 'Trans proline' 0 C--N 1.306 -1.678 0 C-N-CA 121.743 1.628 . . . . 0.0 111.159 179.358 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -50.89 0.73 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.106 -0.952 . . . . 0.0 111.695 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' TRP . . . . . 0.611 ' H ' ' C ' ' A' ' 40' ' ' PRO . 39.9 p-90 -76.22 -15.26 60.07 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.479 -0.488 . . . . 0.0 110.923 -178.641 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.595 ' CD2' ' O ' ' A' ' 40' ' ' PRO . 2.9 p80 -77.3 137.09 64.5 Favored Pre-proline 0 C--N 1.326 -0.415 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 179.26 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.419 ' HG2' HD23 ' A' ' 49' ' ' LEU . 55.0 Cg_endo -55.58 160.51 9.16 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 121.398 1.398 . . . . 0.0 111.793 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -52.01 162.8 1.71 Allowed 'Trans proline' 0 C--N 1.306 -1.69 0 C-N-CA 121.986 1.791 . . . . 0.0 111.79 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.495 ' O ' ' HB2' ' A' ' 50' ' ' ALA . 0.1 OUTLIER -57.82 -25.37 60.54 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.768 -179.171 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.484 ' CD1' ' N ' ' A' ' 48' ' ' THR . 0.0 OUTLIER -66.41 -13.4 60.66 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.348 -0.541 . . . . 0.0 110.77 -179.192 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.484 ' N ' ' CD1' ' A' ' 47' ' ' TRP . 29.5 m -91.79 -57.75 2.64 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.046 -0.525 . . . . 0.0 112.204 -179.236 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.957 ' O ' HG23 ' A' ' 52' ' ' ILE . 1.5 mm? -81.18 -28.68 34.88 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 -177.96 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.543 ' C ' ' H ' ' A' ' 52' ' ' ILE . . . -40.42 -34.97 0.48 Allowed Pre-proline 0 C--N 1.326 -0.416 0 C-N-CA 120.427 -0.509 . . . . 0.0 111.42 -179.143 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.43 ' HD2' ' N ' ' A' ' 50' ' ' ALA . 69.6 Cg_exo -54.26 3.0 0.05 OUTLIER 'Trans proline' 0 C--N 1.314 -1.283 0 C-N-CA 120.644 0.896 . . . . 0.0 112.954 179.257 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.957 HG23 ' O ' ' A' ' 49' ' ' LEU . 42.1 pt -55.55 -30.27 26.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 121.133 0.492 . . . . 0.0 110.032 179.624 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.484 ' CE2' HD11 ' A' ' 52' ' ' ILE . 45.7 m95 -81.51 -22.51 37.9 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.413 -179.606 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -72.01 -47.51 31.04 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 109.709 -1.356 . . . . 0.0 109.709 178.792 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 5.0 m -67.12 -54.98 16.25 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 178.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.41 HD23 ' HA ' ' A' ' 56' ' ' LEU . 92.8 mt -53.76 -39.63 65.52 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.848 -0.614 . . . . 0.0 109.5 179.119 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.42 ' CD1' ' C ' ' A' ' 57' ' ' TYR . 1.3 t80 -54.6 -50.75 67.28 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 179.394 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 5.7 m -52.22 -50.22 62.42 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.223 179.608 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.55 -47.95 82.51 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.574 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 15.4 mtt -56.07 -44.14 78.66 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.461 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -54.59 -55.91 24.82 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 111.155 -0.778 . . . . 0.0 111.155 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -53.65 -54.66 34.59 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.727 0.299 . . . . 0.0 110.448 -179.724 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.487 ' O ' HG23 ' A' ' 67' ' ' VAL . . . -52.53 -56.97 15.18 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 110.824 -0.91 . . . . 0.0 110.824 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.592 ' O ' ' CD1' ' A' ' 68' ' ' TRP . 0.0 OUTLIER -49.19 -50.13 39.48 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.897 0.379 . . . . 0.0 110.324 179.957 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.487 ' O ' ' CG ' ' A' ' 69' ' ' LYS . 83.9 t80 -51.43 -38.33 53.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.709 -179.758 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 51.9 mt -71.59 -48.67 51.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.166 -179.693 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.487 HG23 ' O ' ' A' ' 63' ' ' GLY . 15.9 t -51.51 -61.35 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.867 0.365 . . . . 0.0 111.334 -179.46 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' TRP . . . . . 0.592 ' CD1' ' O ' ' A' ' 64' ' ' SER . 1.5 m95 -60.72 -40.67 93.18 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.339 -179.179 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.487 ' CG ' ' O ' ' A' ' 65' ' ' TYR . 10.6 mmmt -64.2 -22.68 67.03 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.847 0.356 . . . . 0.0 110.706 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -82.89 -62.36 1.62 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.671 -179.785 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.74 ' C ' HD12 ' A' ' 71' ' ' LEU . 3.6 pp -65.22 -9.73 25.95 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.962 -179.775 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.668 ' N ' HD12 ' A' ' 71' ' ' LEU . . . 106.09 85.69 1.83 Allowed Glycine 0 CA--C 1.527 0.788 0 C-N-CA 121.221 -0.514 . . . . 0.0 111.939 179.234 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.493 ' O ' HD11 ' A' ' 71' ' ' LEU . . . 42.06 -173.72 0.01 OUTLIER Glycine 0 CA--C 1.526 0.719 0 N-CA-C 111.838 -0.505 . . . . 0.0 111.838 179.078 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -85.02 110.93 19.28 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.527 -0.336 . . . . 0.0 110.773 -179.758 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.524 ' OG1' ' N ' ' A' ' 76' ' ' GLU . 1.7 t -142.53 -173.81 3.97 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.665 179.751 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.524 ' N ' ' OG1' ' A' ' 75' ' ' THR . 6.9 pt-20 -45.45 -34.9 3.4 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.889 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -67.91 -32.65 73.28 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.071 -179.584 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -83.98 -22.69 31.32 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.844 0.354 . . . . 0.0 110.816 -179.747 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 4.8 mtp -62.99 -26.63 68.94 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.775 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.2 t -68.67 -52.92 17.4 Favored Pre-proline 0 CA--C 1.534 0.35 0 C-N-CA 120.608 -0.437 . . . . 0.0 110.749 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -65.86 -60.78 0.11 Allowed 'Trans proline' 0 N--CA 1.497 1.678 0 C-N-CA 121.07 1.18 . . . . 0.0 111.703 179.137 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.624 ' O ' HG23 ' A' ' 86' ' ' THR . 2.7 mt -56.77 -56.43 21.55 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.391 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -47.82 -51.37 18.37 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 111.168 -0.773 . . . . 0.0 111.168 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 16.0 tp -62.58 -30.13 71.1 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 121.019 -0.273 . . . . 0.0 110.753 -179.698 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.597 ' CZ ' HD22 ' A' ' 89' ' ' LEU . 23.0 t80 -71.51 -39.11 71.01 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.963 -0.295 . . . . 0.0 110.468 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.624 HG23 ' O ' ' A' ' 82' ' ' LEU . 8.8 p -64.49 -53.54 46.49 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.802 -0.359 . . . . 0.0 110.656 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -68.04 -58.09 7.85 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 111.527 -0.629 . . . . 0.0 111.527 -179.266 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 52.4 tp60 -49.47 -54.61 16.84 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-O 121.039 0.447 . . . . 0.0 110.551 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.597 HD22 ' CZ ' ' A' ' 85' ' ' TYR . 27.1 tp -51.03 -64.4 0.82 Allowed 'General case' 0 C--O 1.209 -1.027 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.906 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.622 ' O ' ' HB2' ' A' ' 94' ' ' ALA . . . -38.05 -48.85 1.25 Allowed 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 120.434 -0.506 . . . . 0.0 111.916 -179.561 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 94.1 mt -56.6 -57.17 13.54 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 -178.438 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.798 ' O ' HD22 ' A' ' 113' ' ' LEU . 2.8 m120 -74.21 -55.11 6.43 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 121.415 0.626 . . . . 0.0 111.301 -178.621 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' TRP . . . . . 0.623 ' O ' ' N ' ' A' ' 95' ' ' TRP . 7.4 t-105 -52.84 -21.92 4.8 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.114 -0.948 . . . . 0.0 111.273 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.622 ' HB2' ' O ' ' A' ' 90' ' ' ALA . . . -60.05 69.27 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.929 0.395 . . . . 0.0 109.948 179.623 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.685 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 9.9 p-90 -99.94 -17.39 0.2 Allowed Pre-proline 0 CA--C 1.536 0.439 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.73 -179.363 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.685 ' CD ' ' N ' ' A' ' 95' ' ' TRP . 31.8 Cg_exo -62.86 -26.24 74.57 Favored 'Trans proline' 0 N--CA 1.494 1.522 0 C-N-CA 120.442 0.762 . . . . 0.0 112.659 179.193 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.544 ' CD ' ' N ' ' A' ' 96' ' ' PRO . 84.2 Cg_exo -60.1 -25.69 80.49 Favored 'Trans proline' 0 N--CA 1.496 1.638 0 C-N-CA 120.744 0.963 . . . . 0.0 112.781 179.83 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -80.74 33.03 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 121.003 0.43 . . . . 0.0 110.427 179.82 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.402 ' H ' ' C ' ' A' ' 97' ' ' PRO . 1.6 t80 -44.7 -52.92 7.82 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.488 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -73.63 -40.33 63.86 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.673 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -57.14 -15.47 14.69 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 111.135 -0.786 . . . . 0.0 111.135 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.4 ' HB3' ' CE2' ' A' ' 25' ' ' PHE . . . -74.64 -7.88 54.62 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.69 0.281 . . . . 0.0 110.837 -179.831 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.41 -17.12 52.75 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.657 -179.857 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' GLN . . . . . 0.536 ' O ' ' N ' ' A' ' 106' ' ' GLY . 2.2 pt20 -110.95 158.06 19.19 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.599 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 6.0 mmt -43.26 -17.32 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.669 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.536 ' N ' ' O ' ' A' ' 104' ' ' GLN . . . -62.78 -15.82 55.32 Favored Glycine 0 CA--C 1.526 0.77 0 N-CA-C 111.122 -0.791 . . . . 0.0 111.122 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' TRP . . . . . 0.481 ' CD1' ' C ' ' A' ' 107' ' ' TRP . 0.0 OUTLIER -47.68 -12.09 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.887 0.375 . . . . 0.0 110.664 -179.881 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.498 ' H ' ' C ' ' A' ' 106' ' ' GLY . . . -62.7 -22.51 66.56 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.082 179.754 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 8.2 mt -53.39 -29.68 35.96 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.297 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -54.91 -64.4 0.85 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.957 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.707 ' O ' HG23 ' A' ' 115' ' ' VAL . 1.4 p30 -58.82 -51.1 71.45 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.457 -179.477 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.549 ' N ' ' OD1' ' A' ' 111' ' ' ASP . 39.6 tp -52.48 -47.79 66.31 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.813 -178.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.798 HD22 ' O ' ' A' ' 92' ' ' ASN . 17.3 mt -65.81 -62.07 1.71 Allowed 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 -178.002 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.1 pp -58.36 -35.32 71.77 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 120.369 -0.533 . . . . 0.0 111.48 -178.478 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.707 HG23 ' O ' ' A' ' 111' ' ' ASP . 40.2 t -59.56 -61.27 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.132 -179.675 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.49 ' O ' ' OG1' ' A' ' 120' ' ' THR . 9.0 p -69.22 -22.24 63.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.291 -179.082 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -63.3 -63.02 4.85 Favored Glycine 0 CA--C 1.527 0.841 0 C-N-CA 120.838 -0.696 . . . . 0.0 111.597 -179.284 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.614 ' O ' HG23 ' A' ' 122' ' ' THR . 9.9 p -73.07 -37.04 52.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 C-N-CA 120.88 -0.328 . . . . 0.0 111.239 -179.415 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.515 ' O ' ' OG1' ' A' ' 123' ' ' THR . . . -67.58 -60.75 2.31 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.692 -0.403 . . . . 0.0 111.212 -179.563 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.49 ' OG1' ' O ' ' A' ' 116' ' ' SER . 2.3 m -58.42 -53.52 57.36 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.432 -179.339 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.439 ' O ' HD23 ' A' ' 124' ' ' LEU . . . -53.76 -41.36 67.06 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.253 -179.345 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.614 HG23 ' O ' ' A' ' 118' ' ' VAL . 42.1 p -73.73 -34.05 64.6 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 120.783 -0.367 . . . . 0.0 111.889 -179.12 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.515 ' OG1' ' O ' ' A' ' 119' ' ' ALA . 0.0 OUTLIER -60.27 -56.04 26.38 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 120.555 -0.458 . . . . 0.0 110.938 -179.453 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.579 HD23 ' N ' ' A' ' 125' ' ' ALA . 0.6 OUTLIER -79.06 -20.28 49.24 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.323 0.49 . . . . 0.0 112.323 -178.653 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.579 ' N ' HD23 ' A' ' 124' ' ' LEU . . . -87.91 -67.83 0.8 Allowed 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 -178.716 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' TRP . . . . . 0.522 ' CD1' ' N ' ' A' ' 126' ' ' TRP . 22.9 m0 -84.61 -57.27 3.2 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 -177.789 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' HIS . . . . . 0.551 ' CD2' ' N ' ' A' ' 127' ' ' HIS . 5.2 m170 -56.09 -22.3 27.16 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.916 -0.314 . . . . 0.0 111.569 -178.755 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.42 -37.21 84.7 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.856 0.36 . . . . 0.0 110.69 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 74.1 t -96.33 -49.47 12.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.209 -179.45 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 6.0 t -111.88 108.41 55.7 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.958 -179.432 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' PRO . . . . . 0.67 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 73.0 Cg_exo -75.27 -22.11 14.68 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 121.611 1.541 . . . . 0.0 112.379 178.946 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.67 ' CD ' ' N ' ' A' ' 131' ' ' PRO . 58.8 Cg_exo -67.12 -45.01 4.29 Favored 'Trans proline' 0 N--CA 1.496 1.632 0 C-N-CA 121.42 1.414 . . . . 0.0 112.184 179.782 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -56.3 -37.01 69.31 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.884 0.373 . . . . 0.0 110.459 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -59.72 -24.84 64.33 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.711 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 15.5 ttp-105 -79.32 -30.61 42.9 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.664 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 86.3 mt -71.49 -36.09 71.02 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 179.556 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.58 ' O ' ' N ' ' A' ' 139' ' ' PRO . 6.4 mt -81.47 -39.93 24.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.312 179.548 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.574 ' C ' ' H ' ' A' ' 140' ' ' TYR . 0.7 OUTLIER -17.45 -48.7 0.04 OUTLIER Pre-proline 0 N--CA 1.468 0.47 0 O-C-N 123.921 0.763 . . . . 0.0 111.882 -179.65 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.58 ' N ' ' O ' ' A' ' 137' ' ' LEU . 2.1 Cg_endo -63.74 14.93 0.07 OUTLIER 'Trans proline' 0 C--N 1.308 -1.564 0 C-N-CA 120.91 1.073 . . . . 0.0 111.809 179.518 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' TYR . . . . . 0.698 ' CE2' HD11 ' A' ' 144' ' ' LEU . 7.0 p90 -92.77 -14.34 28.02 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 121.208 0.528 . . . . 0.0 110.26 179.702 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.637 ' CD1' ' CE1' ' A' ' 140' ' ' TYR . 6.7 mp -59.96 -36.76 77.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.301 178.629 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -55.5 -45.42 77.04 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.091 179.634 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' TRP . . . . . 0.442 ' CE2' HD12 ' A' ' 52' ' ' ILE . 9.1 t-105 -60.63 -51.57 68.84 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 179.537 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.698 HD11 ' CE2' ' A' ' 140' ' ' TYR . 11.4 mt -50.27 -53.58 27.45 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 120.23 -0.588 . . . . 0.0 109.594 179.366 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.681 ' O ' HG23 ' A' ' 149' ' ' VAL . . . -59.22 -23.01 61.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.269 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 5.1 t80 -67.07 -63.44 1.06 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.693 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.421 ' HB1' ' C20' ' A' ' 201' ' ' PKA . . . -66.51 -35.6 80.64 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.65 -179.698 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 9.7 m -65.58 -39.58 91.78 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.868 -0.333 . . . . 0.0 110.371 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.681 HG23 ' O ' ' A' ' 145' ' ' ALA . 37.7 t -69.17 -36.55 73.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.198 179.733 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 2.1 tp -58.62 -54.26 49.11 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.044 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' ASN . . . . . 0.441 ' OD1' ' NE1' ' A' ' 107' ' ' TRP . 14.3 t30 -58.58 -55.21 37.99 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.62 179.688 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 69.6 t80 -50.38 -47.27 56.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.214 -179.714 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 14.4 t80 -56.08 -43.49 78.07 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.953 -179.576 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 84.4 t -68.35 -41.28 83.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.486 -0.324 . . . . 0.0 111.141 -179.715 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' TRP . . . . . . . . . . . . . 5.3 m0 -58.55 -38.17 77.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.617 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' ARG . . . . . 0.433 ' HA ' ' HE ' ' A' ' 156' ' ' ARG . 0.0 OUTLIER -81.07 -54.91 5.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.931 -179.51 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 33.2 t0 -51.58 -43.91 62.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.191 -179.489 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' ASN . . . . . 0.533 ' ND2' ' O ' ' A' ' 158' ' ' ASN . 0.4 OUTLIER -80.7 -10.85 59.7 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.163 -179.444 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 159' ' ' SER . . . . . 0.42 ' C ' ' O ' ' A' ' 158' ' ' ASN . 7.2 m 40.05 85.25 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.792 0.329 . . . . 0.0 110.253 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -77.96 95.23 1.26 Allowed Glycine 0 CA--C 1.525 0.701 0 N-CA-C 111.299 -0.72 . . . . 0.0 111.299 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 77.0 ttt180 -68.01 119.86 13.32 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.77 0.319 . . . . 0.0 110.188 179.668 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 39.7 ttt180 -91.63 126.69 36.8 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.781 -179.672 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -171.63 -172.63 37.85 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 110.905 -0.878 . . . . 0.0 110.905 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 151.64 -40.04 0.78 Allowed Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.875 -0.89 . . . . 0.0 110.875 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 16.5 t -178.16 121.54 0.1 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.825 0.345 . . . . 0.0 110.531 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' ARG . . . . . 0.558 ' C ' HD13 ' A' ' 167' ' ' LEU . 78.8 mtt-85 -83.98 173.07 11.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.684 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.851 ' N ' HD13 ' A' ' 167' ' ' LEU . 0.0 OUTLIER -150.69 22.98 0.79 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.624 179.597 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -102.7 106.48 17.13 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.536 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 . . . . . 0 C--O 1.22 -0.495 0 CA-C-O 118.085 -0.96 . . . . 0.0 110.63 179.934 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 201' ' ' PKA . . . . . 0.54 ' C15' 'CL ' ' A' ' 201' ' ' PKA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.5 ttm . . . . . 0 C--O 1.232 0.145 0 CA-C-O 120.863 0.364 . . . . 0.0 110.644 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -60.19 -150.07 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 122.488 2.125 . . . . 0.0 112.027 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -158.53 -51.62 0.06 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.918 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 80.1 p -75.94 135.21 40.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.128 -179.494 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.574 ' O ' HG23 ' A' ' 9' ' ' VAL . 0.5 OUTLIER -54.21 119.07 4.63 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.165 179.717 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.575 ' N ' ' CD ' ' A' ' 7' ' ' PRO . 0.9 OUTLIER -61.1 -41.81 82.97 Favored Pre-proline 0 CA--C 1.533 0.304 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 179.932 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.575 ' CD ' ' N ' ' A' ' 6' ' ' VAL . 17.3 Cg_exo -62.62 -66.41 0.05 OUTLIER 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 121.579 1.519 . . . . 0.0 111.733 179.478 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.675 ' O ' HG23 ' A' ' 12' ' ' THR . . . -48.5 -33.56 9.68 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.339 -179.422 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.574 HG23 ' O ' ' A' ' 5' ' ' TRP . 39.5 t -69.51 -63.24 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 111.76 0.281 . . . . 0.0 111.76 -178.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -60.53 -45.97 95.28 Favored Glycine 0 CA--C 1.526 0.73 0 C-N-CA 121.195 -0.526 . . . . 0.0 111.84 -179.101 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.445 HD12 ' N ' ' A' ' 11' ' ' LEU . 9.3 mp -62.25 -38.31 88.75 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 122.873 -0.193 . . . . 0.0 111.09 -179.264 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.675 HG23 ' O ' ' A' ' 8' ' ' ALA . 36.1 p -73.42 -22.55 60.19 Favored 'General case' 0 C--N 1.332 -0.166 0 C-N-CA 120.298 -0.561 . . . . 0.0 109.924 179.268 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 5.6 mt -76.5 -30.97 57.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.228 179.671 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.9 t -43.53 -55.09 9.04 Favored Pre-proline 0 CA--C 1.534 0.363 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.788 -179.829 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -66.19 -17.06 54.03 Favored 'Trans proline' 0 N--CA 1.499 1.796 0 C-N-CA 120.925 1.083 . . . . 0.0 111.825 179.554 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.6 t -75.07 -28.74 60.46 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.551 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 56.5 mt -72.36 -57.82 3.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.433 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -69.78 -21.17 76.46 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 110.865 -0.894 . . . . 0.0 110.865 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -70.59 -54.07 11.08 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 111.008 -0.837 . . . . 0.0 111.008 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 37.7 t80 -70.17 -58.24 4.02 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.787 0.327 . . . . 0.0 110.518 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 20.5 ttp -57.21 -35.99 70.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.762 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -69.78 -62.23 3.94 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 111.121 -0.792 . . . . 0.0 111.121 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.555 ' O ' HG22 ' A' ' 26' ' ' VAL . . . -55.55 -17.14 4.83 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.906 0.384 . . . . 0.0 110.31 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 47.4 t80 -51.26 -25.47 5.72 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.277 179.72 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 71.8 t80 -67.17 -47.29 71.41 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.507 179.797 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.555 HG22 ' O ' ' A' ' 23' ' ' ALA . 32.6 m -77.52 -13.94 14.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.379 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.4 tmt_? -67.43 -30.57 70.35 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.743 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -119.45 -69.9 0.32 Allowed Glycine 0 CA--C 1.525 0.691 0 N-CA-C 110.996 -0.841 . . . . 0.0 110.996 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -47.57 -22.63 0.51 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.744 0.307 . . . . 0.0 110.659 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -76.29 -52.15 6.32 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 111.119 -0.792 . . . . 0.0 111.119 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 72.6 mt -53.45 -36.28 61.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.758 0.313 . . . . 0.0 110.625 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 11.3 mmt180 -78.0 -49.89 13.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.809 -179.736 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -47.53 -31.54 4.45 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 110.101 -0.333 . . . . 0.0 110.101 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.445 ' CD1' ' C ' ' A' ' 34' ' ' TYR . 23.8 t80 -52.82 -39.03 62.09 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.486 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -56.94 -20.77 25.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.28 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -98.01 -73.34 1.11 Allowed Glycine 0 CA--C 1.526 0.749 0 N-CA-C 110.858 -0.897 . . . . 0.0 110.858 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.572 ' O ' HD12 ' A' ' 37' ' ' LEU . 0.3 OUTLIER -96.05 166.9 11.54 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 120.938 0.399 . . . . 0.0 110.898 179.806 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 6.6 mp0 -84.1 117.08 23.22 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.636 -179.713 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.5 ' C ' ' H ' ' A' ' 41' ' ' SER . 6.7 mtpt -126.1 149.57 66.97 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.797 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.608 ' C ' ' H ' ' A' ' 42' ' ' TRP . 59.4 Cg_endo -73.23 23.69 0.31 Allowed 'Trans proline' 0 C--N 1.307 -1.62 0 C-N-CA 121.328 1.352 . . . . 0.0 111.387 179.296 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.5 ' H ' ' C ' ' A' ' 39' ' ' LYS . 1.2 t -51.23 -1.69 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.959 179.816 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' TRP . . . . . 0.608 ' H ' ' C ' ' A' ' 40' ' ' PRO . 41.5 p-90 -77.54 -15.99 58.94 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.564 -0.454 . . . . 0.0 111.093 -179.014 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.494 ' O ' ' ND1' ' A' ' 43' ' ' HIS . 0.0 OUTLIER -80.41 147.86 65.08 Favored Pre-proline 0 C--N 1.328 -0.346 0 C-N-CA 120.209 -0.596 . . . . 0.0 109.475 179.419 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.468 ' C ' ' O ' ' A' ' 43' ' ' HIS . 12.6 Cg_exo -32.95 131.04 0.11 Allowed 'Trans proline' 0 C--N 1.311 -1.396 0 C-N-CA 121.423 1.416 . . . . 0.0 111.877 -179.018 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.48 ' O ' ' N ' ' A' ' 47' ' ' TRP . 72.9 Cg_exo -64.98 163.67 27.63 Favored 'Trans proline' 0 C--N 1.312 -1.347 0 C-N-CA 120.888 1.058 . . . . 0.0 112.681 179.722 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 2.7 ppt_? -44.25 -16.18 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.433 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.55 ' CG ' ' N ' ' A' ' 48' ' ' THR . 3.3 p-90 -52.69 -54.08 38.51 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.166 -0.614 . . . . 0.0 111.609 -177.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.55 ' N ' ' CG ' ' A' ' 47' ' ' TRP . 15.0 t -93.86 -21.49 19.23 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 120.25 -0.58 . . . . 0.0 112.076 179.44 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.898 ' O ' HG23 ' A' ' 52' ' ' ILE . 1.0 OUTLIER -81.14 -47.12 13.91 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 112.505 0.557 . . . . 0.0 112.505 -177.89 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.584 ' C ' ' H ' ' A' ' 52' ' ' ILE . . . -39.85 -33.46 0.33 Allowed Pre-proline 0 C--N 1.327 -0.394 0 C-N-CA 120.675 -0.41 . . . . 0.0 111.539 -179.033 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.421 ' HD2' ' N ' ' A' ' 50' ' ' ALA . 56.9 Cg_exo -54.23 4.1 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.522 0 CA-C-N 118.615 0.541 . . . . 0.0 112.587 178.82 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.898 HG23 ' O ' ' A' ' 49' ' ' LEU . 45.6 pt -53.52 -31.74 19.65 Favored 'Isoleucine or valine' 0 C--O 1.232 0.151 0 CA-C-O 121.211 0.529 . . . . 0.0 109.766 179.423 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.518 ' CE2' HD11 ' A' ' 52' ' ' ILE . 48.2 m95 -81.35 -25.6 36.23 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.814 -179.361 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -69.44 -43.52 69.07 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 178.876 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 17.3 m -69.15 -59.05 3.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.87 0.367 . . . . 0.0 110.115 179.298 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.422 ' HA ' HD23 ' A' ' 56' ' ' LEU . 96.9 mt -54.19 -33.84 59.11 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.208 -0.451 . . . . 0.0 109.99 179.661 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.442 ' CB ' ' O ' ' A' ' 53' ' ' TRP . 1.7 t80 -59.2 -55.32 36.38 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.751 179.528 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 4.9 t -49.53 -49.66 45.09 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.097 179.632 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -57.21 -48.38 78.92 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.335 179.728 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.407 ' O ' ' OG ' ' A' ' 64' ' ' SER . 23.5 mtm -58.17 -33.61 69.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.513 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.501 ' O ' ' OG ' ' A' ' 64' ' ' SER . . . -65.21 -43.23 95.71 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 111.197 -0.761 . . . . 0.0 111.197 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -66.41 -59.99 3.16 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.676 -0.409 . . . . 0.0 110.282 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.439 ' O ' HG23 ' A' ' 67' ' ' VAL . . . -52.48 -50.08 49.43 Favored Glycine 0 CA--C 1.522 0.507 0 N-CA-C 110.32 -1.112 . . . . 0.0 110.32 179.541 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.577 ' O ' ' CE2' ' A' ' 68' ' ' TRP . 6.2 p -45.96 -50.6 14.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.099 0.476 . . . . 0.0 110.321 179.575 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 67.2 t80 -56.48 -40.24 74.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.507 179.745 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 91.5 mt -65.45 -41.87 92.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.926 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.48 HG22 ' OG ' ' A' ' 130' ' ' SER . 23.4 t -56.56 -53.67 38.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.047 -179.621 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' TRP . . . . . 0.585 ' O ' ' N ' ' A' ' 73' ' ' GLY . 0.6 OUTLIER -65.27 -35.98 82.71 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 120.577 -0.449 . . . . 0.0 110.839 -179.702 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 13.4 mmmt -63.73 -25.85 68.38 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.798 -0.361 . . . . 0.0 110.677 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 23.1 tp10 -82.65 -62.34 1.63 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.471 -179.369 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.752 ' C ' HD12 ' A' ' 71' ' ' LEU . 3.8 pp -68.59 -8.55 42.85 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.834 -0.347 . . . . 0.0 111.489 -179.222 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.605 ' N ' HD12 ' A' ' 71' ' ' LEU . . . 102.1 83.61 1.74 Allowed Glycine 0 CA--C 1.528 0.891 0 C-N-CA 121.208 -0.52 . . . . 0.0 111.873 179.32 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.585 ' N ' ' O ' ' A' ' 68' ' ' TRP . . . 42.37 -174.08 0.01 OUTLIER Glycine 0 CA--C 1.525 0.683 0 N-CA-C 111.782 -0.527 . . . . 0.0 111.782 179.46 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 38.4 t80 -80.87 110.59 16.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.867 0.365 . . . . 0.0 110.663 -179.676 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.482 ' OG1' ' N ' ' A' ' 76' ' ' GLU . 2.8 t -142.29 -173.86 3.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.488 179.797 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.482 ' N ' ' OG1' ' A' ' 75' ' ' THR . 2.8 mp0 -47.42 -32.15 4.77 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.679 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 12.8 t0 -71.0 -28.35 64.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.977 -179.679 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -88.51 -22.92 23.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.8 0.333 . . . . 0.0 110.886 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -66.34 -27.72 68.1 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.723 -179.807 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 8.8 t -68.34 -47.23 37.95 Favored Pre-proline 0 CA--C 1.534 0.338 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.864 -179.759 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -73.95 -57.03 0.07 OUTLIER 'Trans proline' 0 N--CA 1.499 1.797 0 C-N-CA 121.165 1.243 . . . . 0.0 111.738 179.021 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.491 HD21 ' CZ2' ' A' ' 68' ' ' TRP . 7.7 mt -56.02 -51.43 67.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.543 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -60.95 -61.66 6.75 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 110.805 -0.918 . . . . 0.0 110.805 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 58.7 tp -46.96 -33.51 4.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.929 0.395 . . . . 0.0 110.269 179.733 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.454 ' C ' ' CD1' ' A' ' 85' ' ' TYR . 2.0 t80 -73.89 -47.27 39.23 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.703 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 1.3 m -60.82 -49.0 79.23 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.91 -0.316 . . . . 0.0 111.146 -179.49 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -69.84 -58.33 6.39 Favored Glycine 0 CA--C 1.527 0.798 0 C-N-CA 120.95 -0.643 . . . . 0.0 111.615 -179.421 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 37.7 tp60 -51.99 -46.28 64.83 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 120.728 -0.389 . . . . 0.0 110.374 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.415 ' O ' ' C ' ' A' ' 90' ' ' ALA . 25.4 tp -53.71 -65.32 0.59 Allowed 'General case' 0 C--O 1.214 -0.803 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 179.566 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.663 ' O ' ' HB2' ' A' ' 94' ' ' ALA . . . -38.58 -44.32 0.96 Allowed 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 120.533 -0.467 . . . . 0.0 111.637 -179.64 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 80.3 mt -59.57 -56.86 16.6 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 -178.529 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 8.7 m-20 -75.89 -54.37 7.01 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 121.286 0.565 . . . . 0.0 111.428 -178.588 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' TRP . . . . . 0.677 ' O ' ' N ' ' A' ' 95' ' ' TRP . 3.6 t-105 -52.5 -28.98 22.7 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.265 -0.879 . . . . 0.0 111.583 -179.665 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.663 ' HB2' ' O ' ' A' ' 90' ' ' ALA . . . -52.06 73.38 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.846 0.355 . . . . 0.0 110.727 -179.494 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.683 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 13.9 p-90 -102.32 -18.7 0.19 Allowed Pre-proline 0 CA--C 1.534 0.332 0 CA-C-N 115.991 -0.55 . . . . 0.0 112.049 -179.621 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.683 ' CD ' ' N ' ' A' ' 95' ' ' TRP . 31.6 Cg_exo -59.79 -31.08 93.47 Favored 'Trans proline' 0 N--CA 1.494 1.502 0 C-N-CA 120.353 0.702 . . . . 0.0 112.819 179.785 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.491 ' C ' ' H ' ' A' ' 99' ' ' PHE . 75.5 Cg_exo -53.36 -28.11 42.2 Favored 'Trans proline' 0 N--CA 1.492 1.436 0 C-N-CA 120.431 0.754 . . . . 0.0 112.583 179.671 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 1.2 pp -75.42 18.79 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 121.167 0.508 . . . . 0.0 110.173 179.735 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.491 ' H ' ' C ' ' A' ' 97' ' ' PRO . 4.5 t80 -38.98 -41.74 0.79 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.814 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -84.59 -44.49 13.46 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.829 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -59.8 -5.37 3.98 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 111.368 -0.693 . . . . 0.0 111.368 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -75.95 -13.46 60.25 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 121.016 -0.274 . . . . 0.0 110.971 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 24.2 ptt180 -80.25 3.31 21.27 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.775 0.321 . . . . 0.0 110.639 -179.747 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 5.2 mt-30 -120.92 160.29 23.79 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.321 179.72 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -49.4 -19.82 0.59 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.822 0.344 . . . . 0.0 110.205 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.538 ' O ' ' N ' ' A' ' 108' ' ' ALA . . . -65.38 -15.6 61.54 Favored Glycine 0 CA--C 1.527 0.788 0 N-CA-C 111.305 -0.718 . . . . 0.0 111.305 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' TRP . . . . . 0.49 ' CD1' ' N ' ' A' ' 108' ' ' ALA . 0.0 OUTLIER -45.29 -13.6 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.789 0.328 . . . . 0.0 110.844 -179.665 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.538 ' N ' ' O ' ' A' ' 106' ' ' GLY . . . -64.64 -21.84 66.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.511 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 12.1 mt -52.18 -27.16 13.46 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.405 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.417 ' HB3' ' C22' ' A' ' 201' ' ' PKA . . . -55.84 -63.82 1.05 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.345 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.683 ' O ' HG23 ' A' ' 115' ' ' VAL . 2.0 p30 -60.37 -51.65 68.6 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.598 -179.609 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.581 ' N ' ' OD1' ' A' ' 111' ' ' ASP . 43.3 tp -52.51 -42.35 64.24 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.552 -178.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 81.5 mt -71.66 -61.93 1.6 Allowed 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.701 0.63 . . . . 0.0 112.701 -178.269 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.403 ' HB2' ' CZ3' ' A' ' 93' ' ' TRP . 1.8 pp -57.39 -35.18 69.67 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 120.117 -0.633 . . . . 0.0 111.116 -178.811 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.683 HG23 ' O ' ' A' ' 111' ' ' ASP . 54.6 t -62.13 -58.47 7.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.262 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 3.5 t -68.73 -22.37 64.33 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.79 -178.852 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -68.56 -62.71 3.93 Favored Glycine 0 CA--C 1.526 0.746 0 C-N-CA 121.011 -0.614 . . . . 0.0 111.745 -179.03 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.563 ' O ' HG23 ' A' ' 122' ' ' THR . 7.4 p -70.47 -37.73 71.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 C-N-CA 120.967 -0.293 . . . . 0.0 111.354 -179.421 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.515 ' O ' ' OG1' ' A' ' 123' ' ' THR . . . -66.47 -60.78 2.43 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 120.54 -0.464 . . . . 0.0 111.533 -179.21 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 5.0 m -58.38 -55.01 40.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.696 -179.202 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -52.48 -41.69 63.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.349 -179.248 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.563 HG23 ' O ' ' A' ' 118' ' ' VAL . 36.5 p -72.19 -32.59 66.94 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.823 -0.351 . . . . 0.0 111.615 -179.156 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.515 ' OG1' ' O ' ' A' ' 119' ' ' ALA . 0.2 OUTLIER -61.55 -50.16 73.79 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.908 0.385 . . . . 0.0 110.868 -179.489 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.6 pp -82.56 -20.0 37.44 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.701 -179.014 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -86.49 -70.69 0.59 Allowed 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 112.659 0.614 . . . . 0.0 112.659 -178.567 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' TRP . . . . . 0.403 ' N ' ' CD1' ' A' ' 126' ' ' TRP . 41.8 m0 -85.18 -58.8 2.54 Favored 'General case' 0 N--CA 1.465 0.325 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 -177.866 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' HIS . . . . . 0.433 ' CD2' ' N ' ' A' ' 127' ' ' HIS . 20.2 m170 -47.99 -21.52 0.46 Allowed 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 120.719 -0.392 . . . . 0.0 111.522 -178.546 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 29.6 ttt85 -73.1 -42.48 62.91 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.974 -0.29 . . . . 0.0 111.456 -179.589 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 6.3 t -92.07 -47.88 13.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.717 0.294 . . . . 0.0 111.332 -179.309 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' SER . . . . . 0.48 ' OG ' HG22 ' A' ' 67' ' ' VAL . 46.2 p -109.59 102.77 51.11 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.817 -179.764 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' PRO . . . . . 0.657 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 75.7 Cg_exo -71.05 -26.26 21.77 Favored 'Trans proline' 0 C--N 1.311 -1.444 0 C-N-CA 121.733 1.622 . . . . 0.0 112.465 179.43 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.657 ' CD ' ' N ' ' A' ' 131' ' ' PRO . 38.2 Cg_exo -68.62 -49.43 0.81 Allowed 'Trans proline' 0 N--CA 1.494 1.523 0 C-N-CA 121.496 1.464 . . . . 0.0 111.877 179.796 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.406 ' C ' ' N ' ' A' ' 135' ' ' ARG . . . -46.67 -49.02 19.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.191 179.774 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.428 ' HB2' ' CD2' ' A' ' 127' ' ' HIS . . . -46.7 -22.35 0.29 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.031 179.628 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' ARG . . . . . 0.406 ' N ' ' C ' ' A' ' 133' ' ' ALA . 5.7 tpp85 -78.41 -39.2 39.63 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.541 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 93.1 mt -68.87 -25.94 64.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.259 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.571 ' O ' ' N ' ' A' ' 140' ' ' TYR . 3.2 mt -89.11 -41.8 12.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.935 179.477 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.516 ' C ' ' H ' ' A' ' 140' ' ' TYR . 0.7 OUTLIER -22.11 -47.68 0.06 OUTLIER Pre-proline 0 N--CA 1.464 0.261 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.782 -179.776 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.483 ' N ' ' O ' ' A' ' 137' ' ' LEU . 3.1 Cg_exo -59.66 5.57 0.12 Allowed 'Trans proline' 0 C--N 1.307 -1.621 0 C-N-CA 121.071 1.18 . . . . 0.0 112.256 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 140' ' ' TYR . . . . . 0.817 ' CE2' HD11 ' A' ' 144' ' ' LEU . 1.9 p90 -90.78 -15.33 30.31 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 120.705 -0.398 . . . . 0.0 110.644 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.637 HD22 ' CE1' ' A' ' 140' ' ' TYR . 2.9 mm? -54.17 -36.0 62.91 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 179.216 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -57.47 -53.98 52.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.378 179.67 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' TRP . . . . . 0.44 ' CE2' HD12 ' A' ' 52' ' ' ILE . 11.7 t-105 -51.06 -48.9 61.46 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 116.318 -0.401 . . . . 0.0 109.939 179.793 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.817 HD11 ' CE2' ' A' ' 140' ' ' TYR . 11.4 mt -50.09 -48.29 53.35 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 120.533 -0.467 . . . . 0.0 109.832 179.558 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.619 ' O ' HG23 ' A' ' 149' ' ' VAL . . . -65.12 -30.52 71.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.699 -179.838 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 21.0 t80 -58.93 -62.19 2.07 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.73 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.49 ' O ' ' OD1' ' A' ' 151' ' ' ASN . . . -67.74 -50.4 57.51 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.6 -0.44 . . . . 0.0 110.648 -179.708 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 148' ' ' THR . . . . . 0.401 ' OG1' ' O ' ' A' ' 144' ' ' LEU . 27.0 m -48.91 -44.61 40.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.842 -179.854 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.619 HG23 ' O ' ' A' ' 145' ' ' ALA . 68.7 t -69.08 -36.11 71.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.127 -179.683 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.482 HD11 ' CD2' ' A' ' 43' ' ' HIS . 0.8 OUTLIER -56.24 -51.5 67.9 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.535 -0.466 . . . . 0.0 110.696 -179.334 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 151' ' ' ASN . . . . . 0.49 ' OD1' ' O ' ' A' ' 147' ' ' ALA . 4.6 p-10 -65.3 -48.83 71.73 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.945 -0.302 . . . . 0.0 111.055 -179.741 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 82.7 t80 -53.86 -49.17 69.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.931 -179.649 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' TYR . . . . . 0.56 ' CE2' ' OD2' ' A' ' 157' ' ' ASP . 79.5 t80 -57.35 -45.56 84.22 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.644 -179.719 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.471 HG23 ' O ' ' A' ' 150' ' ' LEU . 94.4 t -63.7 -33.68 63.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.096 -179.699 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 155' ' ' TRP . . . . . 0.551 ' C ' ' HE ' ' A' ' 156' ' ' ARG . 9.5 m0 -62.3 -49.69 74.64 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.647 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 156' ' ' ARG . . . . . 0.601 ' HE ' ' N ' ' A' ' 156' ' ' ARG . 0.0 OUTLIER -71.02 -32.63 69.44 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.871 -179.639 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 157' ' ' ASP . . . . . 0.56 ' OD2' ' CE2' ' A' ' 153' ' ' TYR . 2.6 m-20 -74.85 -47.85 28.12 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.823 -179.785 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -70.17 -39.29 75.37 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.61 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 96.6 p -70.89 96.5 1.28 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.471 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -71.15 68.7 0.85 Allowed Glycine 0 CA--C 1.525 0.715 0 N-CA-C 111.199 -0.76 . . . . 0.0 111.199 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 7.3 tpm_? -56.87 -36.58 70.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.867 0.365 . . . . 0.0 110.418 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.2 123.62 12.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.302 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -175.75 176.46 47.49 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 111.02 -0.832 . . . . 0.0 111.02 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 164' ' ' GLY . . . . . 0.545 ' O ' ' N ' ' A' ' 166' ' ' ARG . . . 57.06 111.5 0.01 OUTLIER Glycine 0 CA--C 1.526 0.779 0 N-CA-C 111.022 -0.831 . . . . 0.0 111.022 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 13.1 t -61.48 70.83 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.766 0.317 . . . . 0.0 110.551 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 166' ' ' ARG . . . . . 0.549 ' C ' HD13 ' A' ' 167' ' ' LEU . 68.8 mtp180 58.02 170.0 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.545 -179.895 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.837 ' N ' HD13 ' A' ' 167' ' ' LEU . 0.0 OUTLIER -150.06 17.99 0.87 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.804 179.621 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.467 ' O ' ' C ' ' A' ' 169' ' ' GLU . . . -97.34 88.04 4.31 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.421 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 169' ' ' GLU . . . . . 0.467 ' C ' ' O ' ' A' ' 168' ' ' ALA . 4.4 pt-20 . . . . . 0 C--O 1.22 -0.459 0 CA-C-O 117.956 -1.021 . . . . 0.0 110.912 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 201' ' ' PKA . . . . . 0.569 ' C15' 'CL ' ' A' ' 201' ' ' PKA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 35.1 mtt . . . . . 0 CA--C 1.529 0.14 0 CA-C-O 120.751 0.31 . . . . 0.0 110.446 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -78.4 80.84 2.91 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.05 1.833 . . . . 0.0 112.005 179.675 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -130.12 -23.86 2.68 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.55 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 20.1 p -143.56 121.59 12.1 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.677 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.644 ' O ' HG23 ' A' ' 9' ' ' VAL . 1.3 t-105 -61.53 118.18 6.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.861 179.676 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.465 ' N ' ' CD ' ' A' ' 7' ' ' PRO . 1.0 OUTLIER -59.38 -42.08 90.59 Favored Pre-proline 0 CA--C 1.537 0.464 0 C-N-CA 120.564 -0.454 . . . . 0.0 110.492 -179.439 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.465 ' CD ' ' N ' ' A' ' 6' ' ' VAL . 23.0 Cg_exo -64.9 -65.91 0.05 OUTLIER 'Trans proline' 0 N--CA 1.493 1.498 0 C-N-CA 120.909 1.072 . . . . 0.0 111.611 179.498 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.728 ' O ' HG23 ' A' ' 12' ' ' THR . . . -47.46 -37.74 12.29 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.208 -179.581 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.644 HG23 ' O ' ' A' ' 5' ' ' TRP . 42.4 t -63.12 -62.08 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 C-N-CA 121.048 -0.261 . . . . 0.0 111.404 -179.337 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -58.25 -49.85 72.0 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 110.858 -0.897 . . . . 0.0 110.858 -179.667 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 10.8 mp -59.08 -27.8 65.88 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.596 0.236 . . . . 0.0 110.65 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.728 HG23 ' O ' ' A' ' 8' ' ' ALA . 13.5 p -83.0 -20.73 34.54 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.783 -0.367 . . . . 0.0 110.238 179.566 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 9.3 mt -80.35 -26.42 38.7 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 179.343 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 18.9 t -54.95 -57.38 19.77 Favored Pre-proline 0 CA--C 1.533 0.305 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.033 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -55.84 -10.46 4.04 Favored 'Trans proline' 0 N--CA 1.497 1.711 0 C-N-CA 120.754 0.969 . . . . 0.0 111.651 179.503 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.488 ' N ' ' OH ' ' A' ' 57' ' ' TYR . 1.8 t -74.61 -33.63 62.63 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.19 179.708 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 32.1 mt -73.58 -39.42 64.67 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.63 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -77.04 -49.91 7.23 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 111.263 -0.735 . . . . 0.0 111.263 -179.685 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -62.58 -34.69 90.28 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 111.306 -0.717 . . . . 0.0 111.306 -179.774 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 81.8 t80 -73.36 -60.1 2.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.742 0.306 . . . . 0.0 111.102 -179.462 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 32.4 tpp -61.6 -20.9 63.84 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.74 -179.768 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.525 ' C ' ' CZ2' ' A' ' 95' ' ' TRP . . . -75.13 -63.76 2.45 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 111.656 -0.577 . . . . 0.0 111.656 -179.533 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.44 ' O ' HG22 ' A' ' 26' ' ' VAL . . . -66.3 -16.43 64.03 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.706 -0.397 . . . . 0.0 110.817 -179.474 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 54.2 t80 -48.67 -24.41 1.36 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.111 0.481 . . . . 0.0 110.004 179.472 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 55.2 t80 -70.1 -50.73 37.91 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.947 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.44 HG22 ' O ' ' A' ' 23' ' ' ALA . 22.8 m -74.6 -13.29 15.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.877 -179.664 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.65 ' NE ' ' HE ' ' A' ' 46' ' ' ARG . 8.9 ttt85 -55.7 -41.45 73.78 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.893 -179.795 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -122.51 -57.99 0.2 Allowed Glycine 0 CA--C 1.526 0.746 0 N-CA-C 111.444 -0.663 . . . . 0.0 111.444 -179.585 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 20.8 tp10 -56.35 -23.0 34.62 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.709 0.29 . . . . 0.0 110.796 -179.664 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -76.62 -53.69 5.34 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 111.072 -0.811 . . . . 0.0 111.072 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.414 HD12 ' N ' ' A' ' 31' ' ' LEU . 9.9 mp -56.39 -24.94 48.01 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.774 0.321 . . . . 0.0 110.424 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 71.1 ttt180 -81.55 -52.57 7.07 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.352 179.704 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -46.59 -36.06 6.51 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.962 179.709 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 27.1 t80 -47.81 -38.82 16.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.599 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -63.51 -24.61 67.89 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.797 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -89.32 -72.08 1.26 Allowed Glycine 0 CA--C 1.526 0.728 0 N-CA-C 110.981 -0.848 . . . . 0.0 110.981 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.573 ' O ' HD12 ' A' ' 37' ' ' LEU . 0.3 OUTLIER -95.69 167.17 11.44 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.761 0.315 . . . . 0.0 110.672 179.602 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 47.2 mm-40 -80.91 112.65 18.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.0 -179.502 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.543 ' NZ ' ' CZ3' ' A' ' 107' ' ' TRP . 12.0 mtpt -129.79 156.54 78.76 Favored Pre-proline 0 N--CA 1.463 0.213 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.214 179.535 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.626 ' C ' ' H ' ' A' ' 42' ' ' TRP . 73.9 Cg_endo -81.43 23.45 0.75 Allowed 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 121.578 1.518 . . . . 0.0 111.189 179.072 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 30.4 m -49.96 -1.27 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.193 179.808 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' TRP . . . . . 0.626 ' H ' ' C ' ' A' ' 40' ' ' PRO . 2.7 p90 -76.19 -15.4 60.06 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.558 -0.457 . . . . 0.0 111.171 -178.787 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.469 ' O ' ' O ' ' A' ' 44' ' ' PRO . 22.5 m-70 -62.95 144.04 97.19 Favored Pre-proline 0 C--N 1.33 -0.262 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 178.836 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.469 ' O ' ' O ' ' A' ' 43' ' ' HIS . 50.7 Cg_exo -32.2 153.74 0.02 OUTLIER 'Trans proline' 0 N--CA 1.492 1.419 0 C-N-CA 121.444 1.429 . . . . 0.0 111.708 -179.199 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -60.68 153.16 64.04 Favored 'Trans proline' 0 C--N 1.308 -1.565 0 C-N-CA 120.644 0.896 . . . . 0.0 111.344 179.816 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.65 ' HE ' ' NE ' ' A' ' 27' ' ' ARG . 0.0 OUTLIER -50.01 -15.84 0.24 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.307 -179.727 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.556 ' CD1' ' N ' ' A' ' 48' ' ' THR . 0.7 OUTLIER -54.34 -47.87 72.05 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.664 -0.414 . . . . 0.0 111.793 -178.309 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.556 ' N ' ' CD1' ' A' ' 47' ' ' TRP . 8.9 t -91.2 -25.96 19.27 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -179.472 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.81 ' O ' HG23 ' A' ' 52' ' ' ILE . 0.2 OUTLIER -80.53 -58.84 2.93 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.623 -0.431 . . . . 0.0 111.884 -178.412 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.609 ' C ' ' H ' ' A' ' 52' ' ' ILE . . . -38.74 -31.04 0.19 Allowed Pre-proline 0 C--O 1.234 0.257 0 C-N-CA 120.751 -0.38 . . . . 0.0 111.311 -179.133 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.439 ' HD2' ' N ' ' A' ' 50' ' ' ALA . 46.6 Cg_exo -54.19 5.18 0.04 OUTLIER 'Trans proline' 0 C--N 1.31 -1.471 0 CA-C-N 118.691 0.568 . . . . 0.0 112.422 178.2 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.81 HG23 ' O ' ' A' ' 49' ' ' LEU . 10.4 pt -54.29 -39.2 42.49 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.258 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 179.344 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.621 ' O ' ' CD1' ' A' ' 57' ' ' TYR . 65.7 m95 -69.32 -24.45 63.92 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.746 -179.583 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -67.83 -53.2 24.65 Favored Glycine 0 CA--C 1.527 0.836 0 N-CA-C 110.013 -1.235 . . . . 0.0 110.013 179.002 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 18.6 m -60.02 -54.73 42.56 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.623 0.249 . . . . 0.0 110.581 179.611 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.408 ' O ' ' SD ' ' A' ' 60' ' ' MET . 88.5 mt -55.82 -47.96 76.27 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.254 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.621 ' CD1' ' O ' ' A' ' 53' ' ' TRP . 3.6 m-30 -46.19 -47.13 17.79 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 179.31 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 7.0 t -56.77 -57.28 13.14 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.215 179.479 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -48.7 -50.06 35.1 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.183 179.682 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.408 ' SD ' ' O ' ' A' ' 56' ' ' LEU . 0.0 OUTLIER -52.05 -50.56 61.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.368 179.828 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -49.13 -48.96 31.46 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 111.338 -0.705 . . . . 0.0 111.338 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -62.17 -59.93 4.32 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.849 0.357 . . . . 0.0 110.85 -179.631 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.452 ' O ' HG23 ' A' ' 67' ' ' VAL . . . -47.47 -56.02 8.67 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 110.93 -0.868 . . . . 0.0 110.93 -179.841 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.588 ' O ' ' CD1' ' A' ' 68' ' ' TRP . 0.0 OUTLIER -45.64 -55.28 6.57 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.898 0.38 . . . . 0.0 110.664 -179.929 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.501 ' OH ' ' NZ ' ' A' ' 69' ' ' LYS . 69.1 t80 -49.73 -40.0 39.27 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.804 -179.674 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 77.4 mt -69.3 -54.84 17.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.257 -179.473 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.509 ' CG1' ' CZ3' ' A' ' 68' ' ' TRP . 18.8 t -46.16 -61.23 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.857 0.36 . . . . 0.0 111.257 -179.39 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' TRP . . . . . 0.588 ' CD1' ' O ' ' A' ' 64' ' ' SER . 0.9 OUTLIER -60.68 -42.31 96.84 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.485 -179.124 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.501 ' NZ ' ' OH ' ' A' ' 65' ' ' TYR . 5.8 mmmt -59.13 -31.92 69.39 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.979 -0.288 . . . . 0.0 111.052 -179.697 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 24.2 tp10 -74.81 -62.28 1.59 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.037 -179.366 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.739 ' C ' HD12 ' A' ' 71' ' ' LEU . 3.4 pp -64.33 -8.58 13.54 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.239 -179.344 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.655 ' N ' HD12 ' A' ' 71' ' ' LEU . . . 110.35 77.51 0.93 Allowed Glycine 0 CA--C 1.527 0.826 0 C-N-CA 121.014 -0.612 . . . . 0.0 111.98 179.359 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.511 ' N ' ' O ' ' A' ' 68' ' ' TRP . . . 41.56 -173.57 0.01 OUTLIER Glycine 0 CA--C 1.526 0.749 0 C-N-CA 121.504 -0.379 . . . . 0.0 112.165 178.842 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 36.0 t80 -74.48 113.05 11.27 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.382 -0.409 . . . . 0.0 110.715 -179.679 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.569 ' OG1' ' N ' ' A' ' 76' ' ' GLU . 0.4 OUTLIER -142.38 -175.02 4.29 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.256 179.713 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.569 ' N ' ' OG1' ' A' ' 75' ' ' THR . 2.7 mp0 -55.08 -34.22 63.45 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.916 0.389 . . . . 0.0 110.4 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -66.29 -33.06 74.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.67 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.494 ' O ' HD12 ' A' ' 82' ' ' LEU . . . -83.91 -19.09 35.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.046 0.45 . . . . 0.0 110.748 -179.82 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 65.0 mmm -68.93 -27.07 65.43 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.22 -179.344 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.4 ' N ' ' HD2' ' A' ' 81' ' ' PRO . 6.0 t -67.45 -43.51 42.48 Favored Pre-proline 0 C--N 1.329 -0.322 0 C-N-CA 120.673 -0.411 . . . . 0.0 110.413 179.781 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.4 ' HD2' ' N ' ' A' ' 80' ' ' VAL . 9.3 Cg_endo -76.31 -52.18 0.09 OUTLIER 'Trans proline' 0 N--CA 1.496 1.673 0 C-N-CA 121.047 1.165 . . . . 0.0 111.508 178.643 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.494 HD12 ' O ' ' A' ' 78' ' ' ALA . 5.5 mt -56.03 -47.14 78.39 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.277 179.71 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -68.28 -63.83 3.4 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 111.318 -0.713 . . . . 0.0 111.318 -179.517 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.4 HD23 ' CD1' ' A' ' 124' ' ' LEU . 38.5 tp -47.91 -23.79 0.86 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.941 0.4 . . . . 0.0 110.57 -179.708 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 11.8 t80 -74.8 -55.57 5.68 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.009 -179.798 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 1.9 t -68.53 -33.22 73.73 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.903 -0.319 . . . . 0.0 111.479 -179.282 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -71.6 -57.85 5.74 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 111.205 -0.758 . . . . 0.0 111.205 -179.612 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 29.2 tp60 -59.57 -43.85 93.49 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 11.1 tp -58.13 -38.57 76.8 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 179.241 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.816 ' O ' ' HB2' ' A' ' 94' ' ' ALA . . . -58.36 -64.48 0.9 Allowed 'General case' 0 C--N 1.319 -0.754 0 C-N-CA 120.062 -0.655 . . . . 0.0 110.435 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.476 ' N ' HD23 ' A' ' 91' ' ' LEU . 6.2 mt -58.69 -56.48 21.64 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 -178.688 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -66.43 -62.12 1.63 Allowed 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -177.755 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' TRP . . . . . 0.596 ' CD1' ' C ' ' A' ' 93' ' ' TRP . 0.0 OUTLIER -63.54 -16.89 62.05 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 -177.913 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.816 ' HB2' ' O ' ' A' ' 90' ' ' ALA . . . -54.63 82.19 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 120.286 -0.566 . . . . 0.0 109.868 179.155 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.688 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 19.8 p-90 -100.81 -15.71 0.18 Allowed Pre-proline 0 CA--C 1.533 0.307 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -179.488 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.688 ' CD ' ' N ' ' A' ' 95' ' ' TRP . 52.9 Cg_exo -61.08 -15.22 37.97 Favored 'Trans proline' 0 N--CA 1.497 1.7 0 C-N-CA 120.471 0.781 . . . . 0.0 113.403 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.614 ' CD ' ' N ' ' A' ' 96' ' ' PRO . 31.6 Cg_exo -87.08 -0.38 7.77 Favored 'Trans proline' 0 N--CA 1.5 1.867 0 C-N-CA 120.659 0.906 . . . . 0.0 112.928 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 1.3 pp -91.86 25.19 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 C-N-CA 120.73 -0.388 . . . . 0.0 110.833 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.528 ' CD1' ' O ' ' A' ' 96' ' ' PRO . 3.0 m-85 -46.8 -34.46 5.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.167 179.687 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -63.13 -27.39 69.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.786 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -95.73 -13.52 50.19 Favored Glycine 0 CA--C 1.526 0.743 0 N-CA-C 110.902 -0.879 . . . . 0.0 110.902 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -70.49 -6.73 38.2 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.613 0.244 . . . . 0.0 111.018 -179.701 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 15.5 ptt180 -97.97 -10.08 25.08 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.065 -179.756 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' GLN . . . . . 0.438 ' C ' ' N ' ' A' ' 106' ' ' GLY . 3.2 pt20 -125.49 168.94 12.93 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.832 0.348 . . . . 0.0 110.781 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 9.8 mmt -45.19 -20.2 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.679 -179.849 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.438 ' N ' ' C ' ' A' ' 104' ' ' GLN . . . -62.26 -15.69 51.94 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 111.102 -0.799 . . . . 0.0 111.102 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' TRP . . . . . 0.543 ' CZ3' ' NZ ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -50.2 -13.42 0.11 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.742 0.306 . . . . 0.0 110.702 -179.596 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.468 ' N ' ' CD1' ' A' ' 107' ' ' TRP . . . -64.73 -19.58 65.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.075 0.464 . . . . 0.0 110.105 179.638 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 8.2 mt -57.04 -26.04 59.64 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.531 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -59.4 -58.66 7.62 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.569 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.709 ' O ' HG23 ' A' ' 115' ' ' VAL . 1.3 p30 -62.07 -52.21 64.84 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.303 -179.617 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.524 ' N ' ' CG ' ' A' ' 111' ' ' ASP . 31.7 tp -54.95 -37.4 66.42 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.919 -0.313 . . . . 0.0 111.618 -179.099 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 49.4 mt -72.8 -61.57 1.76 Allowed 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -178.714 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.5 pp -59.66 -32.52 70.54 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 120.24 -0.584 . . . . 0.0 110.955 -179.047 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.709 HG23 ' O ' ' A' ' 111' ' ' ASP . 53.5 t -64.16 -60.14 3.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.405 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.485 ' O ' ' OG1' ' A' ' 120' ' ' THR . 50.3 m -68.41 -28.31 66.97 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.555 -178.84 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -63.08 -62.24 5.63 Favored Glycine 0 CA--C 1.526 0.759 0 C-N-CA 120.973 -0.632 . . . . 0.0 111.769 -179.348 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.571 ' O ' HG23 ' A' ' 122' ' ' THR . 9.3 p -70.94 -37.99 70.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 111.667 0.247 . . . . 0.0 111.667 -179.231 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.508 ' O ' ' OG1' ' A' ' 123' ' ' THR . . . -68.25 -60.8 2.19 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.446 -0.502 . . . . 0.0 111.002 -179.404 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.485 ' OG1' ' O ' ' A' ' 116' ' ' SER . 3.7 m -56.35 -55.87 28.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.44 -179.49 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -51.58 -43.92 62.61 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.404 -179.391 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.571 HG23 ' O ' ' A' ' 118' ' ' VAL . 41.4 p -71.91 -25.25 61.84 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.054 0.39 . . . . 0.0 112.054 -178.943 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.508 ' OG1' ' O ' ' A' ' 119' ' ' ALA . 0.2 OUTLIER -69.28 -49.99 51.0 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.631 -0.428 . . . . 0.0 110.516 -179.636 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.4 ' CD1' HD23 ' A' ' 84' ' ' LEU . 2.4 pp -79.34 -19.94 49.05 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.246 -179.475 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -89.77 -67.37 0.85 Allowed 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.734 0.642 . . . . 0.0 112.734 -178.718 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' TRP . . . . . 0.458 ' CD1' ' N ' ' A' ' 126' ' ' TRP . 34.1 m0 -84.82 -57.54 3.07 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 112.87 0.693 . . . . 0.0 112.87 -177.785 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' HIS . . . . . 0.657 ' CD2' ' HB2' ' A' ' 134' ' ' ALA . 9.6 m170 -53.98 -22.29 10.08 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.731 -0.388 . . . . 0.0 111.517 -178.703 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 29.2 ttt85 -73.76 -46.47 45.5 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.822 -0.351 . . . . 0.0 111.416 -179.474 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 39.1 t -81.36 -40.62 18.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.73 0.3 . . . . 0.0 111.313 -179.229 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 3.6 t -138.38 121.66 11.15 Favored Pre-proline 0 CA--C 1.536 0.428 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.541 -179.634 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' PRO . . . . . 0.612 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 83.4 Cg_exo -73.61 -48.35 0.25 Allowed 'Trans proline' 0 N--CA 1.493 1.488 0 C-N-CA 121.32 1.347 . . . . 0.0 113.212 179.529 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.612 ' CD ' ' N ' ' A' ' 131' ' ' PRO . 31.2 Cg_exo -33.63 -55.97 0.41 Allowed 'Trans proline' 0 N--CA 1.497 1.73 0 C-N-CA 121.583 1.522 . . . . 0.0 112.177 -179.222 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -47.48 -46.69 27.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.862 0.363 . . . . 0.0 110.384 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.657 ' HB2' ' CD2' ' A' ' 127' ' ' HIS . . . -55.21 -22.72 18.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.406 179.815 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 10.2 tpt180 -77.28 -29.63 53.88 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-O 120.937 0.399 . . . . 0.0 110.342 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 39.4 mt -75.92 -33.97 59.88 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 179.604 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.461 ' O ' ' CD1' ' A' ' 140' ' ' TYR . 4.3 mt -85.56 -23.31 27.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.341 179.778 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.551 ' CD1' ' C ' ' A' ' 138' ' ' TYR . 0.3 OUTLIER -36.65 -53.9 1.74 Allowed Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.323 -179.881 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.429 ' HD2' ' N ' ' A' ' 138' ' ' TYR . 8.2 Cg_endo -60.79 3.41 0.29 Allowed 'Trans proline' 0 N--CA 1.498 1.755 0 C-N-CA 121.481 1.454 . . . . 0.0 113.057 -179.415 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 140' ' ' TYR . . . . . 0.496 ' CE2' HD11 ' A' ' 144' ' ' LEU . 0.1 OUTLIER -82.79 -14.3 54.67 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.489 -0.484 . . . . 0.0 110.954 -179.96 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 86.8 mt -59.14 -25.25 63.72 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 178.825 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -64.13 -39.84 94.89 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.631 179.224 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' TRP . . . . . 0.714 ' CE2' HD12 ' A' ' 52' ' ' ILE . 11.6 t-105 -70.08 -40.78 74.81 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.723 179.441 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.531 HD13 HG13 ' A' ' 115' ' ' VAL . 10.3 mt -62.48 -42.02 99.2 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 120.403 -0.519 . . . . 0.0 109.712 179.739 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.68 ' O ' HG23 ' A' ' 149' ' ' VAL . . . -73.03 -21.91 60.73 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.776 179.268 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 32.2 t80 -64.85 -58.58 5.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.481 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -68.5 -44.15 75.34 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.567 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' THR . . . . . 0.638 ' O ' ' ND2' ' A' ' 151' ' ' ASN . 51.3 m -57.27 -37.3 72.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.411 179.851 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.68 HG23 ' O ' ' A' ' 145' ' ' ALA . 55.0 t -75.8 -30.2 21.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.416 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 2.3 tp -61.39 -57.49 12.04 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 179.694 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' ASN . . . . . 0.638 ' ND2' ' O ' ' A' ' 148' ' ' THR . 0.5 OUTLIER -63.81 -42.36 97.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.632 179.891 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 152' ' ' TYR . . . . . 0.507 ' N ' HD21 ' A' ' 151' ' ' ASN . 60.8 t80 -56.65 -45.86 81.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.552 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 9.5 t80 -63.18 -36.72 84.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.477 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 55.5 t -67.36 -34.0 66.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.632 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' TRP . . . . . . . . . . . . . 10.9 m0 -68.7 -41.12 79.57 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.791 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' ARG . . . . . 0.487 ' O ' ' O ' ' A' ' 159' ' ' SER . 0.3 OUTLIER -72.63 -35.61 67.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.865 -179.659 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -75.18 -43.03 54.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.878 -179.571 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' ASN . . . . . 0.402 ' OD1' ' N ' ' A' ' 158' ' ' ASN . 1.5 m-20 -79.07 -4.02 48.18 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.872 -179.711 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 159' ' ' SER . . . . . 0.487 ' O ' ' O ' ' A' ' 156' ' ' ARG . 6.6 t -149.49 -161.5 1.36 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.534 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 81.35 47.18 6.56 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 110.98 -0.848 . . . . 0.0 110.98 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 24.5 ttt-85 -42.67 122.82 2.44 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.795 0.331 . . . . 0.0 110.612 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 15.6 mtm180 -99.08 145.55 27.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.508 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -79.44 145.52 27.95 Favored Glycine 0 CA--C 1.524 0.602 0 N-CA-C 111.025 -0.83 . . . . 0.0 111.025 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 75.95 -176.8 50.87 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 111.123 -0.791 . . . . 0.0 111.123 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 25.7 t -147.13 113.54 5.95 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.808 0.337 . . . . 0.0 110.429 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 166' ' ' ARG . . . . . 0.523 ' O ' ' N ' ' A' ' 168' ' ' ALA . 3.5 tpt180 -49.98 167.05 0.06 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.548 -179.795 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.418 HD12 ' N ' ' A' ' 167' ' ' LEU . 10.8 mp 58.48 -77.72 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.657 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.523 ' N ' ' O ' ' A' ' 166' ' ' ARG . . . -55.65 -15.17 2.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.667 -179.82 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 . . . . . 0 C--O 1.219 -0.526 0 CA-C-O 118.007 -0.997 . . . . 0.0 110.595 179.965 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 201' ' ' PKA . . . . . 0.478 ' C15' 'CL ' ' A' ' 201' ' ' PKA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.641 ' N ' ' CD ' ' A' ' 2' ' ' PRO . 0.4 OUTLIER . . . . . 0 CA--C 1.53 0.206 0 CA-C-O 120.63 0.252 . . . . 0.0 110.783 . . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.641 ' CD ' ' N ' ' A' ' 1' ' ' MET . 43.3 Cg_exo -70.11 123.51 10.05 Favored 'Trans proline' 0 N--CA 1.495 1.56 0 C-N-CA 121.969 1.779 . . . . 0.0 112.385 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 65.8 mt-10 -87.73 -26.29 23.01 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.143 179.603 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 44.4 m -150.03 -175.78 5.19 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.612 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.724 ' O ' HG23 ' A' ' 9' ' ' VAL . 0.5 OUTLIER -49.39 117.98 2.49 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.301 -179.975 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.619 ' N ' ' CD ' ' A' ' 7' ' ' PRO . 1.0 OUTLIER -63.68 -38.71 40.53 Favored Pre-proline 0 CA--C 1.533 0.289 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 179.927 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.619 ' CD ' ' N ' ' A' ' 6' ' ' VAL . 15.4 Cg_exo -66.9 -66.18 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 121.891 1.727 . . . . 0.0 111.735 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.721 ' O ' HG23 ' A' ' 12' ' ' THR . . . -47.65 -40.63 20.28 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.173 -179.76 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.724 HG23 ' O ' ' A' ' 5' ' ' TRP . 59.2 t -61.11 -61.86 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.238 -179.354 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -57.88 -51.75 56.34 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 111.495 -0.642 . . . . 0.0 111.495 -179.55 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 9.4 mp -57.78 -31.81 66.91 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.572 0.225 . . . . 0.0 110.96 -179.666 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.721 HG23 ' O ' ' A' ' 8' ' ' ALA . 16.8 p -77.33 -24.81 50.75 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.862 0.363 . . . . 0.0 110.121 179.639 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.427 ' O ' ' CB ' ' A' ' 16' ' ' SER . 6.2 mt -80.12 -27.32 39.17 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.363 179.811 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 4.5 t -48.55 -59.64 5.81 Favored Pre-proline 0 CA--C 1.535 0.38 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.718 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -54.98 -12.38 4.85 Favored 'Trans proline' 0 N--CA 1.498 1.746 0 C-N-CA 121.056 1.171 . . . . 0.0 111.96 179.767 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.427 ' CB ' ' O ' ' A' ' 13' ' ' LEU . 1.6 t -73.5 -30.49 63.16 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.66 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 59.5 mt -74.3 -56.73 4.54 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.664 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -64.83 -34.3 89.52 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 110.802 -0.919 . . . . 0.0 110.802 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -74.88 -28.51 62.59 Favored Glycine 0 CA--C 1.521 0.433 0 N-CA-C 110.614 -0.994 . . . . 0.0 110.614 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 48.8 t80 -74.99 -60.43 2.29 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 110.177 -0.305 . . . . 0.0 110.177 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 19.2 ttp -65.53 -25.1 67.29 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.397 179.749 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.471 ' C ' ' CZ2' ' A' ' 95' ' ' TRP . . . -68.2 -62.13 4.39 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 110.819 -0.912 . . . . 0.0 110.819 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.482 ' O ' HG22 ' A' ' 26' ' ' VAL . . . -70.62 -16.62 62.85 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.993 -0.283 . . . . 0.0 110.397 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 68.5 t80 -47.81 -24.49 0.99 Allowed 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 179.403 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.451 ' CD1' ' C ' ' A' ' 25' ' ' PHE . 22.8 t80 -67.99 -53.57 25.01 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.667 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.482 HG22 ' O ' ' A' ' 23' ' ' ALA . 34.1 m -71.43 -13.46 16.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.702 -179.736 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.424 HH21 ' HA3' ' A' ' 28' ' ' GLY . 1.3 ttp180 -63.31 -46.16 87.97 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.992 -179.758 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.424 ' HA3' HH21 ' A' ' 27' ' ' ARG . . . -105.42 -77.99 1.17 Allowed Glycine 0 CA--C 1.525 0.696 0 N-CA-C 111.197 -0.761 . . . . 0.0 111.197 -179.676 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 53.3 tt0 -44.42 -23.08 0.09 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.698 0.285 . . . . 0.0 110.808 -179.628 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -66.51 -58.49 8.48 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 110.989 -0.845 . . . . 0.0 110.989 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 11.1 mt -51.99 -21.74 3.36 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.836 0.35 . . . . 0.0 110.365 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 16.2 tpp180 -84.79 -54.03 4.95 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.524 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' TRP . . . . . 0.428 ' O ' ' N ' ' A' ' 36' ' ' GLY . 0.4 OUTLIER -44.95 -46.77 11.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.551 -179.756 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 46.5 t80 -47.23 -35.58 7.82 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.9 0.381 . . . . 0.0 110.373 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.61 -25.33 68.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.354 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.428 ' N ' ' O ' ' A' ' 33' ' ' TRP . . . -92.72 -68.74 1.12 Allowed Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.892 -0.883 . . . . 0.0 110.892 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.575 ' O ' HD12 ' A' ' 37' ' ' LEU . 0.3 OUTLIER -95.75 166.18 11.94 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.793 0.33 . . . . 0.0 110.583 179.712 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.624 ' CD ' ' H ' ' A' ' 38' ' ' GLN . 0.5 OUTLIER -86.63 113.0 22.15 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.861 -179.578 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.638 ' NZ ' ' CZ3' ' A' ' 107' ' ' TRP . 22.1 mtpt -129.13 156.71 77.79 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.197 179.812 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.624 ' C ' ' H ' ' A' ' 42' ' ' TRP . 89.6 Cg_endo -73.46 18.13 0.42 Allowed 'Trans proline' 0 C--N 1.307 -1.654 0 C-N-CA 121.814 1.676 . . . . 0.0 110.803 178.822 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.495 ' H ' ' C ' ' A' ' 39' ' ' LYS . 21.7 t -48.52 -1.12 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.246 -0.888 . . . . 0.0 111.442 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' TRP . . . . . 0.643 ' CH2' ' NE2' ' A' ' 43' ' ' HIS . 44.6 p-90 -75.24 -15.12 60.56 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.341 -0.543 . . . . 0.0 110.318 -179.297 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.643 ' NE2' ' CH2' ' A' ' 42' ' ' TRP . 6.6 m-70 -61.49 140.69 94.85 Favored Pre-proline 0 C--N 1.331 -0.206 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 178.218 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.468 ' C ' ' O ' ' A' ' 43' ' ' HIS . 11.0 Cg_endo -32.51 149.01 0.02 OUTLIER 'Trans proline' 0 N--CA 1.496 1.635 0 C-N-CA 121.405 1.403 . . . . 0.0 111.683 -179.227 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -59.39 155.61 40.23 Favored 'Trans proline' 0 C--N 1.312 -1.344 0 C-N-CA 121.12 1.213 . . . . 0.0 112.088 -179.583 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -53.14 -18.37 2.16 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.675 -179.296 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.566 ' CD1' ' N ' ' A' ' 48' ' ' THR . 1.0 OUTLIER -49.46 -47.5 48.32 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.092 -0.643 . . . . 0.0 110.897 -178.898 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.566 ' N ' ' CD1' ' A' ' 47' ' ' TRP . 13.2 t -91.95 -24.82 19.14 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.052 0.39 . . . . 0.0 112.052 -179.732 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.749 ' O ' HG23 ' A' ' 52' ' ' ILE . 0.1 OUTLIER -80.23 -62.35 1.7 Allowed 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -178.215 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.646 ' C ' ' H ' ' A' ' 52' ' ' ILE . . . -37.83 -31.0 0.15 Allowed Pre-proline 0 C--O 1.237 0.402 0 C-N-CA 121.113 -0.235 . . . . 0.0 111.218 -179.04 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.433 ' HD2' ' N ' ' A' ' 50' ' ' ALA . 32.9 Cg_exo -55.62 8.99 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.659 0 CA-C-N 118.425 0.473 . . . . 0.0 112.204 178.11 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.749 HG23 ' O ' ' A' ' 49' ' ' LEU . 12.1 pt -55.71 -27.36 21.73 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 178.939 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 3.2 m0 -64.62 -30.02 71.03 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.783 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -72.98 -46.93 26.72 Favored Glycine 0 CA--C 1.522 0.519 0 N-CA-C 111.027 -0.829 . . . . 0.0 111.027 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 91.2 m -61.53 -53.37 57.28 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.74 0.305 . . . . 0.0 110.59 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 57.5 mt -64.91 -28.68 69.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.506 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.528 ' CD1' ' C ' ' A' ' 57' ' ' TYR . 1.6 t80 -63.6 -41.62 98.32 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 179.455 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 26.1 t -68.02 -49.43 61.55 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.42 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.67 -46.07 88.02 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.758 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.498 ' HG2' HD21 ' A' ' 137' ' ' LEU . 21.3 mtm -65.45 -33.14 75.25 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.31 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -63.35 -49.68 68.49 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 111.324 -0.71 . . . . 0.0 111.324 -179.663 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -63.15 -60.06 3.93 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 121.07 -0.252 . . . . 0.0 110.739 -179.652 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.484 ' O ' HG23 ' A' ' 67' ' ' VAL . . . -52.58 -52.08 39.94 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 110.811 -0.916 . . . . 0.0 110.811 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.442 ' OG ' ' O ' ' A' ' 60' ' ' MET . 34.2 p -48.14 -56.64 7.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.087 0.47 . . . . 0.0 110.831 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 68.0 t80 -51.38 -37.4 48.0 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.196 -179.704 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 56.6 mt -71.44 -37.09 63.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.165 -179.548 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.484 HG23 ' O ' ' A' ' 63' ' ' GLY . 49.1 t -59.48 -52.09 65.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 C-N-CA 120.735 -0.386 . . . . 0.0 110.598 -179.694 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' TRP . . . . . 0.59 ' O ' ' N ' ' A' ' 73' ' ' GLY . 0.9 OUTLIER -64.7 -44.72 89.36 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.859 -179.878 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.25 -23.08 63.81 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.862 -0.335 . . . . 0.0 110.725 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -79.67 -62.81 1.57 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.667 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.73 ' C ' HD12 ' A' ' 71' ' ' LEU . 2.8 pp -65.67 -6.8 12.45 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.161 -179.661 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.684 ' N ' HD12 ' A' ' 71' ' ' LEU . . . 109.69 72.09 0.7 Allowed Glycine 0 CA--C 1.527 0.822 0 N-CA-C 111.511 -0.636 . . . . 0.0 111.511 179.7 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.59 ' N ' ' O ' ' A' ' 68' ' ' TRP . . . 46.58 -174.15 0.01 OUTLIER Glycine 0 CA--C 1.526 0.768 0 N-CA-C 111.761 -0.536 . . . . 0.0 111.761 179.532 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 41.2 t80 -77.28 111.99 13.52 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.884 0.373 . . . . 0.0 111.03 -179.584 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.547 ' OG1' ' N ' ' A' ' 76' ' ' GLU . 0.0 OUTLIER -142.54 -179.99 6.63 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.254 179.468 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.547 ' N ' ' OG1' ' A' ' 75' ' ' THR . 7.4 pt-20 -51.57 -23.53 4.29 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.401 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -72.9 -36.95 67.41 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.757 -179.878 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.44 ' O ' HD12 ' A' ' 82' ' ' LEU . . . -81.63 -22.1 37.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.975 0.417 . . . . 0.0 110.824 -179.813 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 73.0 mmm -61.56 -26.07 67.72 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.177 -179.468 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 14.8 t -68.09 -46.36 41.09 Favored Pre-proline 0 CA--C 1.534 0.338 0 C-N-CA 120.511 -0.476 . . . . 0.0 110.619 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_endo -74.66 -54.76 0.09 OUTLIER 'Trans proline' 0 N--CA 1.497 1.717 0 C-N-CA 120.953 1.102 . . . . 0.0 111.517 178.664 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.44 HD12 ' O ' ' A' ' 78' ' ' ALA . 3.2 mt -50.99 -55.25 18.26 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.534 179.685 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.455 ' O ' ' N ' ' A' ' 86' ' ' THR . . . -64.51 -63.87 3.98 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 111.488 -0.645 . . . . 0.0 111.488 -179.157 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.4 HD12 ' HA ' ' A' ' 84' ' ' LEU . 43.2 tp -43.91 -29.71 0.6 Allowed 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.664 -0.415 . . . . 0.0 109.92 -179.858 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 13.3 t80 -75.4 -42.83 52.87 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.843 179.518 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.455 ' N ' ' O ' ' A' ' 83' ' ' GLY . 1.4 m -66.86 -56.65 9.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.799 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -58.92 -55.36 31.33 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 111.401 -0.679 . . . . 0.0 111.401 -179.628 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.424 ' O ' ' CB ' ' A' ' 92' ' ' ASN . 9.6 tp-100 -55.47 -42.87 74.91 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 121.001 -0.28 . . . . 0.0 110.89 -179.572 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.42 ' O ' ' CD1' ' A' ' 93' ' ' TRP . 10.4 tp -66.04 -31.38 72.24 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.903 -0.319 . . . . 0.0 110.383 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.834 ' O ' ' HB2' ' A' ' 94' ' ' ALA . . . -65.87 -65.83 0.63 Allowed 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 120.314 -0.554 . . . . 0.0 111.182 -179.561 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.4 pp -66.0 -34.35 77.88 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.157 0.428 . . . . 0.0 112.157 -179.001 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.424 ' CB ' ' O ' ' A' ' 88' ' ' GLN . 47.5 t30 -78.39 -61.34 2.04 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.862 -0.335 . . . . 0.0 111.826 -178.811 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' TRP . . . . . 0.613 ' O ' ' N ' ' A' ' 95' ' ' TRP . 0.0 OUTLIER -68.96 -13.32 62.37 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.906 -0.318 . . . . 0.0 111.527 -178.543 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.834 ' HB2' ' O ' ' A' ' 90' ' ' ALA . . . -52.77 80.76 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 120.663 -0.415 . . . . 0.0 109.913 179.38 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.706 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 32.8 p-90 -98.18 -16.95 0.2 Allowed Pre-proline 0 CA--C 1.535 0.39 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -179.389 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.706 ' CD ' ' N ' ' A' ' 95' ' ' TRP . 51.4 Cg_exo -54.51 -40.86 81.69 Favored 'Trans proline' 0 N--CA 1.496 1.632 0 C-N-CA 120.537 0.825 . . . . 0.0 113.03 179.562 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.459 ' HD2' ' N ' ' A' ' 96' ' ' PRO . 41.9 Cg_exo -36.69 -31.31 0.1 Allowed 'Trans proline' 0 N--CA 1.492 1.41 0 CA-C-N 118.98 0.671 . . . . 0.0 112.777 -179.776 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.45 ' N ' ' O ' ' A' ' 96' ' ' PRO . 1.1 pp -83.63 22.19 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.427 179.797 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.581 ' N ' ' O ' ' A' ' 96' ' ' PRO . 22.3 t80 -44.71 -41.63 6.96 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.463 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 48.9 m-85 -83.89 -40.92 18.0 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.529 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -58.0 -14.1 16.24 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 111.006 -0.838 . . . . 0.0 111.006 -179.767 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -65.05 -7.26 11.22 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.801 0.334 . . . . 0.0 110.472 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 15.3 ptt180 -82.14 4.78 21.9 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.602 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 5.6 mt-30 -122.41 164.92 17.16 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.247 179.757 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -59.94 -17.06 34.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.328 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.608 ' O ' ' N ' ' A' ' 108' ' ' ALA . . . -66.62 -14.62 62.88 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 111.203 -0.759 . . . . 0.0 111.203 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' TRP . . . . . 0.638 ' CZ3' ' NZ ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -41.25 -15.37 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.716 0.294 . . . . 0.0 111.031 -179.366 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.608 ' N ' ' O ' ' A' ' 106' ' ' GLY . . . -58.77 -27.2 64.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.935 0.398 . . . . 0.0 110.435 179.72 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 9.3 mt -46.46 -29.01 1.55 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.444 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -60.22 -63.63 1.23 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.759 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.674 ' O ' HG23 ' A' ' 115' ' ' VAL . 1.4 p30 -55.07 -51.88 64.97 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.781 -179.269 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.613 HD13 ' O ' ' A' ' 112' ' ' LEU . 0.2 OUTLIER -58.52 -45.11 89.49 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.103 0.409 . . . . 0.0 112.103 -178.539 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 57.2 mt -64.74 -55.27 20.91 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -178.202 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.3 pp -68.06 -33.55 74.78 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 120.455 -0.498 . . . . 0.0 111.703 -178.746 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.674 HG23 ' O ' ' A' ' 111' ' ' ASP . 38.7 t -62.22 -54.37 35.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.736 0.303 . . . . 0.0 111.186 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.483 ' O ' ' OG1' ' A' ' 120' ' ' THR . 39.0 t -75.3 -23.93 57.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.093 -179.353 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -62.74 -62.46 5.51 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 111.186 -0.765 . . . . 0.0 111.186 -179.727 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.562 ' O ' HG23 ' A' ' 122' ' ' THR . 7.3 p -71.93 -37.92 62.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 111.57 0.211 . . . . 0.0 111.57 -179.547 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.518 ' O ' ' OG1' ' A' ' 123' ' ' THR . . . -68.41 -61.0 2.03 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.281 -0.568 . . . . 0.0 111.075 -179.234 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.483 ' OG1' ' O ' ' A' ' 116' ' ' SER . 2.7 m -56.7 -53.33 58.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.257 -179.541 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.41 ' O ' ' CB ' ' A' ' 125' ' ' ALA . . . -54.36 -40.84 68.47 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.455 -179.256 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.562 HG23 ' O ' ' A' ' 118' ' ' VAL . 37.6 p -74.88 -29.17 60.92 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 111.872 0.323 . . . . 0.0 111.872 -179.034 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.518 ' OG1' ' O ' ' A' ' 119' ' ' ALA . 0.1 OUTLIER -65.71 -47.59 74.85 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.594 -0.442 . . . . 0.0 110.683 -179.639 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.4 pp -83.98 -19.4 34.64 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.373 -179.15 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.41 ' CB ' ' O ' ' A' ' 121' ' ' ALA . . . -89.74 -67.55 0.84 Allowed 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.497 0.555 . . . . 0.0 112.497 -178.589 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' TRP . . . . . 0.433 ' CD1' ' N ' ' A' ' 126' ' ' TRP . 39.3 m0 -84.36 -57.66 3.07 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 112.662 0.616 . . . . 0.0 112.662 -177.942 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' HIS . . . . . 0.57 ' CG ' ' HB2' ' A' ' 134' ' ' ALA . 9.3 m170 -54.51 -22.48 13.06 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.865 -0.334 . . . . 0.0 111.115 -178.702 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 22.4 ttt180 -68.44 -38.97 81.65 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.755 0.312 . . . . 0.0 110.994 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 25.9 t -92.67 -47.89 13.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.31 -179.388 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -125.57 117.33 24.75 Favored Pre-proline 0 CA--C 1.535 0.374 0 CA-C-N 116.575 -0.284 . . . . 0.0 111.048 -179.385 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' PRO . . . . . 0.647 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 88.4 Cg_exo -75.03 -38.43 1.58 Allowed 'Trans proline' 0 N--CA 1.492 1.424 0 C-N-CA 121.454 1.436 . . . . 0.0 112.646 179.074 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.647 ' CD ' ' N ' ' A' ' 131' ' ' PRO . 37.9 Cg_exo -46.98 -46.24 19.22 Favored 'Trans proline' 0 N--CA 1.497 1.688 0 C-N-CA 121.646 1.564 . . . . 0.0 111.983 -179.699 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -57.15 -38.22 73.21 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 179.568 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.57 ' HB2' ' CG ' ' A' ' 127' ' ' HIS . . . -62.69 -23.07 66.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.196 179.763 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 9.3 tpp180 -78.5 -37.3 43.51 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.234 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 12.6 mt -69.61 -29.52 67.04 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.241 -0.436 . . . . 0.0 109.867 179.601 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.583 ' O ' ' N ' ' A' ' 140' ' ' TYR . 8.2 mt -84.14 -42.39 16.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.025 179.489 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.491 ' C ' ' O ' ' A' ' 137' ' ' LEU . 1.9 t80 -23.15 -41.39 0.04 OUTLIER Pre-proline 0 N--CA 1.464 0.252 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.753 -179.686 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.574 ' N ' ' O ' ' A' ' 137' ' ' LEU . 12.3 Cg_exo -64.37 7.29 0.24 Allowed 'Trans proline' 0 C--N 1.307 -1.643 0 C-N-CA 120.699 0.933 . . . . 0.0 112.0 179.45 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 140' ' ' TYR . . . . . 0.747 ' CE2' HD11 ' A' ' 144' ' ' LEU . 1.9 p90 -93.13 -13.67 28.19 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.903 -179.862 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.587 HD13 HD12 ' A' ' 144' ' ' LEU . 4.1 mm? -55.94 -26.63 48.74 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 178.299 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -64.28 -49.14 73.0 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.833 179.483 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' TRP . . . . . . . . . . . . . 10.7 t-105 -56.91 -45.84 82.39 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.103 -0.498 . . . . 0.0 109.659 179.375 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.747 HD11 ' CE2' ' A' ' 140' ' ' TYR . 11.5 mt -54.63 -51.15 66.29 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.199 -0.455 . . . . 0.0 109.962 179.504 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.646 ' O ' HG23 ' A' ' 149' ' ' VAL . . . -63.72 -22.16 66.77 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.413 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -67.25 -64.82 0.78 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.61 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -63.94 -41.9 97.48 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.615 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 59.9 m -57.16 -58.68 7.14 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.499 179.821 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.646 HG23 ' O ' ' A' ' 145' ' ' ALA . 89.5 t -55.61 -39.49 54.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.708 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.464 ' O ' HG23 ' A' ' 154' ' ' VAL . 1.6 tp -50.84 -57.49 8.31 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.696 -0.402 . . . . 0.0 110.069 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 151' ' ' ASN . . . . . 0.434 ' ND2' ' CB ' ' A' ' 108' ' ' ALA . 12.1 t30 -53.7 -57.02 12.32 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.706 179.73 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 152' ' ' TYR . . . . . 0.467 ' CZ ' ' NE ' ' A' ' 156' ' ' ARG . 46.5 t80 -48.53 -36.14 14.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.519 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 153' ' ' TYR . . . . . 0.49 ' CE2' ' OD2' ' A' ' 157' ' ' ASP . 8.8 t80 -65.96 -39.52 90.51 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.688 -179.799 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.493 HG22 ' HG2' ' A' ' 39' ' ' LYS . 15.7 t -66.21 -38.02 81.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.002 -179.791 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 155' ' ' TRP . . . . . . . . . . . . . 7.9 m0 -68.17 -39.15 82.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.964 -179.579 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' ARG . . . . . 0.467 ' NE ' ' CZ ' ' A' ' 152' ' ' TYR . 0.9 OUTLIER -77.15 -24.04 51.59 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.808 -0.357 . . . . 0.0 110.071 179.999 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 157' ' ' ASP . . . . . 0.49 ' OD2' ' CE2' ' A' ' 153' ' ' TYR . 98.2 m-20 -86.9 -51.08 6.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.661 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 158' ' ' ASN . . . . . 0.505 ' C ' HD22 ' A' ' 158' ' ' ASN . 0.2 OUTLIER -77.47 -29.08 52.53 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.831 -179.809 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 9.8 t 46.89 -166.63 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.438 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 157.31 19.79 0.03 OUTLIER Glycine 0 CA--C 1.525 0.69 0 N-CA-C 110.997 -0.841 . . . . 0.0 110.997 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 6.2 mtm180 -56.59 -175.0 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.744 0.307 . . . . 0.0 110.576 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 43.1 ttm-85 -91.53 149.93 21.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.673 -179.776 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 102.11 53.71 0.94 Allowed Glycine 0 CA--C 1.525 0.669 0 N-CA-C 111.084 -0.806 . . . . 0.0 111.084 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -65.38 -39.17 95.67 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 110.769 -0.932 . . . . 0.0 110.769 179.773 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 3.3 m -155.37 144.76 21.06 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.742 0.306 . . . . 0.0 110.388 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? -90.82 -65.92 0.97 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.547 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -94.15 173.48 7.63 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 179.446 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -163.72 131.18 3.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.612 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 15.3 mm-40 . . . . . 0 C--O 1.22 -0.457 0 CA-C-O 117.998 -1.001 . . . . 0.0 110.529 -179.98 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 201' ' ' PKA . . . . . 0.517 ' C15' 'CL ' ' A' ' 201' ' ' PKA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.479 ' H2 ' ' HD3' ' A' ' 2' ' ' PRO . 44.6 mmm . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.959 0.409 . . . . 0.0 110.52 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.479 ' HD3' ' H2 ' ' A' ' 1' ' ' MET . 73.8 Cg_exo -70.12 144.0 50.8 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 C-N-CA 122.562 2.175 . . . . 0.0 112.183 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 59.0 mt-10 -47.32 -25.77 1.08 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.921 -179.717 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 28.7 m -164.04 160.71 22.03 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.734 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.595 ' CD1' ' CE2' ' A' ' 68' ' ' TRP . 0.2 OUTLIER -76.22 120.24 21.22 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.238 -179.922 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.62 ' N ' ' CD ' ' A' ' 7' ' ' PRO . 1.0 OUTLIER -64.2 -33.88 10.33 Favored Pre-proline 0 C--N 1.329 -0.309 0 N-CA-C 109.916 -0.402 . . . . 0.0 109.916 179.942 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.62 ' CD ' ' N ' ' A' ' 6' ' ' VAL . 21.3 Cg_exo -71.61 -67.51 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.626 0 C-N-CA 121.709 1.606 . . . . 0.0 111.899 179.63 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.666 ' O ' HG23 ' A' ' 12' ' ' THR . . . -48.31 -39.16 20.92 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.19 -179.513 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.582 HG23 ' O ' ' A' ' 5' ' ' TRP . 95.9 t -69.98 -62.48 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -179.049 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -55.32 -47.34 75.81 Favored Glycine 0 CA--C 1.526 0.764 0 C-N-CA 121.207 -0.52 . . . . 0.0 111.834 -179.108 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.411 ' N ' ' CD1' ' A' ' 11' ' ' LEU . 6.8 mp -62.5 -38.47 90.05 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.485 0.183 . . . . 0.0 110.805 -179.584 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.666 HG23 ' O ' ' A' ' 8' ' ' ALA . 22.3 p -73.34 -23.53 60.24 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.801 -0.36 . . . . 0.0 110.871 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.55 HD13 ' O ' ' A' ' 9' ' ' VAL . 7.0 mp -82.97 -24.88 32.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.297 -179.749 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.427 ' N ' ' HD2' ' A' ' 15' ' ' PRO . 2.7 t -50.02 -63.16 1.92 Allowed Pre-proline 0 CA--C 1.536 0.442 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.723 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.427 ' HD2' ' N ' ' A' ' 14' ' ' VAL . 24.5 Cg_endo -53.78 -40.08 81.48 Favored 'Trans proline' 0 N--CA 1.498 1.788 0 C-N-CA 120.876 1.05 . . . . 0.0 112.366 -179.462 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.1 t -46.19 -25.68 0.65 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.811 0.338 . . . . 0.0 110.664 -179.717 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 83.1 mt -70.03 -57.94 4.4 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.726 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -68.35 -20.71 73.67 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 111.163 -0.775 . . . . 0.0 111.163 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -72.92 -45.53 32.78 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 37.7 t80 -69.89 -57.63 4.82 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.79 0.329 . . . . 0.0 110.707 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -66.83 -21.55 66.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.07 -179.743 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -77.5 -63.5 2.22 Favored Glycine 0 CA--C 1.524 0.608 0 C-N-CA 120.842 -0.694 . . . . 0.0 111.572 -179.504 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.541 ' O ' HG22 ' A' ' 26' ' ' VAL . . . -64.15 -20.98 66.37 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.671 -0.412 . . . . 0.0 110.245 -179.618 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.461 ' CD1' ' C ' ' A' ' 24' ' ' TYR . 11.0 t80 -48.77 -23.7 1.15 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.278 -0.419 . . . . 0.0 109.912 179.357 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.493 ' CE2' ' HB1' ' A' ' 102' ' ' ALA . 83.3 t80 -70.78 -52.63 19.44 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.765 -179.884 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.541 HG22 ' O ' ' A' ' 23' ' ' ALA . 35.3 m -66.53 -17.21 22.16 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 C-N-CA 120.535 -0.466 . . . . 0.0 110.41 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.9 tmt_? -58.08 -43.41 87.0 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.854 0.359 . . . . 0.0 110.32 179.456 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -101.41 -46.9 1.61 Allowed Glycine 0 CA--C 1.526 0.738 0 N-CA-C 110.957 -0.857 . . . . 0.0 110.957 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -59.91 -38.59 82.75 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.759 0.314 . . . . 0.0 110.64 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -58.68 -44.93 95.4 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.857 -0.897 . . . . 0.0 110.857 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 81.0 mt -58.47 -31.95 68.3 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.944 -0.302 . . . . 0.0 110.392 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.443 ' O ' ' HB3' ' A' ' 35' ' ' ALA . 14.6 mmm180 -76.68 -50.03 14.69 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.464 179.793 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 13.0 m0 -44.84 -48.14 11.05 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.289 -0.414 . . . . 0.0 109.998 179.489 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.452 ' O ' ' CD1' ' A' ' 34' ' ' TYR . 26.3 t80 -50.62 -27.05 6.14 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.751 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.443 ' HB3' ' O ' ' A' ' 32' ' ' ARG . . . -65.95 -45.83 80.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.763 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -91.87 -69.67 1.16 Allowed Glycine 0 CA--C 1.524 0.601 0 N-CA-C 110.992 -0.843 . . . . 0.0 110.992 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.761 ' C ' HD12 ' A' ' 37' ' ' LEU . 3.9 pp -87.66 162.78 16.91 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.677 0.275 . . . . 0.0 110.359 179.722 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 29.5 mt-30 -97.32 123.23 41.07 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.71 -179.645 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 13.9 mtpp -90.41 163.23 31.8 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.21 179.787 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.592 ' O ' ' ND1' ' A' ' 43' ' ' HIS . 15.7 Cg_exo -45.93 146.54 4.04 Favored 'Trans proline' 0 C--N 1.307 -1.628 0 C-N-CA 122.153 1.902 . . . . 0.0 112.198 -179.709 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 11.6 t -81.84 -2.16 50.05 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.653 -179.683 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 13.5 p90 -117.87 9.91 13.03 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 120.484 -0.486 . . . . 0.0 111.623 -178.912 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.599 ' CG ' ' O ' ' A' ' 43' ' ' HIS . 3.5 p-80 -88.96 117.6 68.42 Favored Pre-proline 0 CA--C 1.535 0.374 0 C-N-CA 121.078 -0.249 . . . . 0.0 111.028 179.757 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.567 ' CG ' HD23 ' A' ' 49' ' ' LEU . 65.9 Cg_endo -101.29 148.54 0.32 Allowed 'Trans proline' 0 C--N 1.313 -1.334 0 C-N-CA 120.427 0.751 . . . . 0.0 111.112 178.646 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.421 ' C ' ' O ' ' A' ' 44' ' ' PRO . 5.7 Cg_endo -40.62 137.4 1.67 Allowed 'Trans proline' 0 C--N 1.3 -1.98 0 C-N-CA 120.543 0.829 . . . . 0.0 110.419 179.631 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 4.8 ppt_? -48.09 -17.01 0.1 Allowed 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 113.125 0.787 . . . . 0.0 113.125 -178.109 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.562 ' CD1' ' N ' ' A' ' 48' ' ' THR . 0.7 OUTLIER -56.48 -44.63 80.83 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.267 -0.573 . . . . 0.0 112.239 -178.201 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.562 ' N ' ' CD1' ' A' ' 47' ' ' TRP . 13.3 t -91.5 -30.74 16.27 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 -178.889 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.759 ' O ' HG23 ' A' ' 52' ' ' ILE . 0.2 OUTLIER -82.42 -45.4 14.86 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 112.411 0.523 . . . . 0.0 112.411 -177.921 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.62 ' C ' ' H ' ' A' ' 52' ' ' ILE . . . -39.91 -31.63 0.26 Allowed Pre-proline 0 CA--C 1.534 0.344 0 N-CA-C 111.952 0.353 . . . . 0.0 111.952 -179.085 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.418 ' HD2' ' N ' ' A' ' 50' ' ' ALA . 28.2 Cg_exo -52.87 6.37 0.03 OUTLIER 'Trans proline' 0 C--N 1.311 -1.417 0 CA-C-N 118.928 0.653 . . . . 0.0 112.984 178.915 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.759 HG23 ' O ' ' A' ' 49' ' ' LEU . 10.9 pt -55.59 -28.5 23.15 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.178 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 179.04 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.462 ' CH2' ' HB1' ' A' ' 50' ' ' ALA . 3.0 m0 -67.68 -28.53 67.77 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.484 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -69.41 -60.94 4.76 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 111.464 -0.654 . . . . 0.0 111.464 -179.566 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.618 HG23 ' N ' ' A' ' 56' ' ' LEU . 7.3 t -57.56 -53.37 58.93 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.897 -0.321 . . . . 0.0 111.125 -179.343 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.618 ' N ' HG23 ' A' ' 55' ' ' THR . 73.2 mt -58.24 -39.41 79.04 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.524 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.414 ' CB ' ' O ' ' A' ' 53' ' ' TRP . 6.1 t80 -54.79 -57.89 9.73 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 179.747 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 7.1 t -48.63 -50.39 33.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.552 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -57.18 -42.55 81.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.606 -179.866 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 14.6 mtt -63.0 -55.09 28.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.525 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -44.73 -47.44 9.15 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 111.16 -0.776 . . . . 0.0 111.16 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -61.17 -49.37 77.47 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.845 0.355 . . . . 0.0 110.279 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.471 ' O ' HG23 ' A' ' 67' ' ' VAL . . . -54.87 -45.06 81.59 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 110.187 -1.165 . . . . 0.0 110.187 179.575 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.592 ' O ' ' NE1' ' A' ' 68' ' ' TRP . 0.7 OUTLIER -60.52 -42.35 96.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.906 0.384 . . . . 0.0 110.221 179.642 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.426 ' OH ' ' NZ ' ' A' ' 69' ' ' LYS . 87.3 t80 -53.11 -43.47 66.88 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 179.361 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 79.4 mt -72.15 -25.81 24.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.024 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.552 HG22 ' OG ' ' A' ' 130' ' ' SER . 55.1 t -66.15 -60.05 3.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 C-N-CA 120.664 -0.414 . . . . 0.0 111.333 -179.522 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' TRP . . . . . 0.595 ' CE2' ' CD1' ' A' ' 5' ' ' TRP . 0.0 OUTLIER -70.37 -29.39 66.04 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 119.974 -0.69 . . . . 0.0 110.725 -179.601 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.426 ' NZ ' ' OH ' ' A' ' 65' ' ' TYR . 10.8 mmmt -72.79 -26.55 61.56 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.336 -0.546 . . . . 0.0 110.616 179.825 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -78.42 -60.98 2.16 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.85 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.7 pp -70.38 -19.17 63.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.087 -179.482 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.502 ' O ' ' O ' ' A' ' 73' ' ' GLY . . . 110.24 95.43 2.33 Favored Glycine 0 CA--C 1.53 0.985 0 C-N-CA 121.257 -0.496 . . . . 0.0 112.043 179.218 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.594 ' N ' ' O ' ' A' ' 68' ' ' TRP . . . 41.51 -174.33 0.01 OUTLIER Glycine 0 CA--C 1.525 0.691 0 N-CA-C 111.944 -0.462 . . . . 0.0 111.944 178.963 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 49.3 t80 -79.78 111.05 15.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.675 0.274 . . . . 0.0 110.408 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.427 ' OG1' ' N ' ' A' ' 76' ' ' GLU . 2.1 t -139.35 177.31 8.01 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 120.993 0.425 . . . . 0.0 110.949 -179.641 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.5 ' CD ' ' H ' ' A' ' 76' ' ' GLU . 2.3 mp0 -50.05 -40.84 46.41 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.795 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 27.7 m-20 -62.39 -22.03 65.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.505 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -93.64 -24.82 17.75 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.663 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 13.2 mtp -69.14 -29.57 67.63 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.535 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.406 ' O ' ' CB ' ' A' ' 84' ' ' LEU . 6.5 t -65.56 -45.74 68.11 Favored Pre-proline 0 CA--C 1.535 0.372 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.505 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -76.33 -63.87 0.03 OUTLIER 'Trans proline' 0 N--CA 1.498 1.749 0 C-N-CA 120.903 1.069 . . . . 0.0 111.563 178.789 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 4.2 mt -47.19 -46.73 24.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.439 179.7 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.499 ' O ' ' N ' ' A' ' 86' ' ' THR . . . -68.38 -64.13 3.25 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 111.015 -0.834 . . . . 0.0 111.015 -179.852 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.406 ' CB ' ' O ' ' A' ' 80' ' ' VAL . 65.3 tp -41.9 -28.18 0.15 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.03 0.443 . . . . 0.0 109.88 179.751 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.465 ' CD1' ' C ' ' A' ' 85' ' ' TYR . 0.6 OUTLIER -76.85 -43.6 35.54 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.029 179.663 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.499 ' N ' ' O ' ' A' ' 83' ' ' GLY . 0.3 OUTLIER -61.56 -43.95 97.92 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.164 -179.57 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -73.62 -58.17 4.65 Favored Glycine 0 CA--C 1.527 0.808 0 C-N-CA 120.9 -0.667 . . . . 0.0 111.466 -179.455 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -51.14 -48.61 61.77 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-O 121.052 0.453 . . . . 0.0 109.943 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.455 HD22 ' CZ ' ' A' ' 85' ' ' TYR . 23.3 tp -54.85 -63.39 1.17 Allowed 'General case' 0 C--O 1.211 -0.927 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.814 179.593 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.588 ' O ' ' HB2' ' A' ' 94' ' ' ALA . . . -37.86 -42.87 0.64 Allowed 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 120.568 -0.453 . . . . 0.0 111.522 -179.497 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 90.8 mt -63.38 -56.98 11.87 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -178.689 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -72.62 -53.85 10.73 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.346 0.593 . . . . 0.0 111.33 -178.83 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' TRP . . . . . 0.606 ' O ' ' N ' ' A' ' 95' ' ' TRP . 30.7 t-105 -51.86 -33.31 35.85 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.152 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.588 ' HB2' ' O ' ' A' ' 90' ' ' ALA . . . -60.01 72.11 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 120.611 -0.436 . . . . 0.0 109.89 179.228 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.694 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 22.2 p-90 -99.42 -15.91 0.19 Allowed Pre-proline 0 CA--C 1.538 0.505 0 N-CA-C 112.581 0.586 . . . . 0.0 112.581 -179.113 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.694 ' CD ' ' N ' ' A' ' 95' ' ' TRP . 49.3 Cg_exo -58.87 -31.14 94.79 Favored 'Trans proline' 0 N--CA 1.497 1.717 0 C-N-CA 120.645 0.897 . . . . 0.0 113.808 -179.731 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.494 ' CD ' ' N ' ' A' ' 96' ' ' PRO . 89.0 Cg_exo -56.99 -13.91 12.99 Favored 'Trans proline' 0 N--CA 1.499 1.825 0 C-N-CA 120.642 0.895 . . . . 0.0 113.654 -179.152 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 1.1 pp -90.05 29.96 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 C-N-CA 120.453 -0.499 . . . . 0.0 110.779 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.585 ' CD2' ' O ' ' A' ' 96' ' ' PRO . 42.6 m-85 -50.37 -40.09 48.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.213 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.598 ' CD1' ' N ' ' A' ' 100' ' ' PHE . 0.1 OUTLIER -70.05 -58.84 3.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.318 -179.311 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -55.56 -14.82 7.42 Favored Glycine 0 CA--C 1.522 0.489 0 N-CA-C 110.847 -0.901 . . . . 0.0 110.847 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.493 ' HB1' ' CE2' ' A' ' 25' ' ' PHE . . . -59.76 -12.14 6.63 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.587 0.232 . . . . 0.0 111.203 -179.662 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 -94.78 10.3 35.7 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 121.005 -0.278 . . . . 0.0 110.862 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 16.6 mt-30 -117.21 -175.35 2.78 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.732 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.495 ' CE ' ' CZ3' ' A' ' 155' ' ' TRP . 17.5 mmt -74.78 -18.31 60.49 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.094 0.473 . . . . 0.0 109.78 179.662 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.613 ' O ' ' N ' ' A' ' 108' ' ' ALA . . . -74.23 -14.77 80.39 Favored Glycine 0 CA--C 1.524 0.653 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.355 -179.702 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' TRP . . . . . 0.78 ' HE1' ' ND2' ' A' ' 151' ' ' ASN . 0.0 OUTLIER -41.6 -14.96 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.252 0 CA-C-O 120.749 0.309 . . . . 0.0 110.879 -179.468 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.892 ' HB2' ' ND2' ' A' ' 151' ' ' ASN . . . -62.49 -17.57 59.9 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.983 0.421 . . . . 0.0 110.172 179.53 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.52 HD13 ' O ' ' A' ' 106' ' ' GLY . 6.8 mp -47.5 -30.7 3.65 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.358 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.416 ' HB2' ' CZ3' ' A' ' 95' ' ' TRP . . . -57.81 -63.98 1.06 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.935 -179.72 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.691 ' O ' HG23 ' A' ' 115' ' ' VAL . 1.9 p30 -57.82 -54.34 48.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.764 -179.224 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.54 ' N ' ' CG ' ' A' ' 111' ' ' ASP . 38.1 tp -52.84 -41.49 64.31 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.506 -0.316 . . . . 0.0 111.727 -178.926 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.403 HD23 ' HA ' ' A' ' 113' ' ' LEU . 57.2 mt -70.33 -62.12 1.51 Allowed 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.616 0.599 . . . . 0.0 112.616 -178.333 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.0 pp -59.0 -29.84 67.53 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 120.431 -0.508 . . . . 0.0 111.066 -178.775 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.691 HG23 ' O ' ' A' ' 111' ' ' ASP . 38.8 t -65.12 -60.61 2.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.221 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.498 ' O ' ' OG1' ' A' ' 120' ' ' THR . 9.8 p -68.81 -22.29 64.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.954 -179.55 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.405 ' O ' ' CB ' ' A' ' 121' ' ' ALA . . . -65.34 -62.66 4.69 Favored Glycine 0 CA--C 1.525 0.693 0 C-N-CA 120.903 -0.665 . . . . 0.0 111.496 -179.474 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.595 ' O ' HG23 ' A' ' 122' ' ' THR . 9.6 p -73.24 -37.5 52.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 C-N-CA 120.957 -0.297 . . . . 0.0 111.233 -179.531 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.524 ' O ' ' OG1' ' A' ' 123' ' ' THR . . . -67.02 -60.86 2.27 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.596 -0.442 . . . . 0.0 111.145 -179.393 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.498 ' OG1' ' O ' ' A' ' 116' ' ' SER . 1.6 m -60.36 -53.23 60.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.412 -179.455 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.405 ' CB ' ' O ' ' A' ' 117' ' ' GLY . . . -51.83 -42.38 62.5 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.916 -0.314 . . . . 0.0 111.044 -179.391 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.595 HG23 ' O ' ' A' ' 118' ' ' VAL . 35.6 p -71.55 -40.15 70.19 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.769 -179.09 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.524 ' OG1' ' O ' ' A' ' 119' ' ' ALA . 0.1 OUTLIER -54.77 -49.29 71.24 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 120.761 0.315 . . . . 0.0 110.897 -179.143 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.9 pp -84.11 -20.21 32.93 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.202 -0.454 . . . . 0.0 112.089 -178.741 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -90.17 -71.19 0.63 Allowed 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.821 0.675 . . . . 0.0 112.821 -178.331 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 41.6 m0 -80.46 -57.13 3.73 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 -177.738 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' HIS . . . . . 0.578 ' CG ' ' HB2' ' A' ' 134' ' ' ALA . 10.4 m170 -55.48 -23.57 26.53 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.826 -0.35 . . . . 0.0 111.54 -178.794 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.77 -39.56 87.89 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.756 -0.377 . . . . 0.0 110.666 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 98.7 t -90.6 -49.54 13.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.942 -179.574 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' SER . . . . . 0.552 ' OG ' HG22 ' A' ' 67' ' ' VAL . 1.9 p -114.06 109.34 49.63 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.468 -179.661 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' PRO . . . . . 0.629 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 71.4 Cg_exo -69.68 -35.91 12.01 Favored 'Trans proline' 0 C--N 1.311 -1.418 0 C-N-CA 121.38 1.386 . . . . 0.0 112.422 179.472 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.629 ' CD ' ' N ' ' A' ' 131' ' ' PRO . 29.8 Cg_exo -56.28 -40.64 83.41 Favored 'Trans proline' 0 N--CA 1.495 1.58 0 C-N-CA 121.374 1.383 . . . . 0.0 111.679 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -51.89 -44.54 63.79 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.265 179.694 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.578 ' HB2' ' CG ' ' A' ' 127' ' ' HIS . . . -58.65 -22.64 57.28 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.511 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 7.7 tpt85 -79.32 -29.42 42.35 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.535 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 12.8 mt -79.01 -28.96 43.42 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.389 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.477 ' O ' ' CD1' ' A' ' 140' ' ' TYR . 13.2 mt -93.74 -18.64 21.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.091 179.686 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.54 ' CD1' ' C ' ' A' ' 138' ' ' TYR . 0.3 OUTLIER -37.43 -52.19 2.46 Favored Pre-proline 0 CA--C 1.537 0.461 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.715 -179.764 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.404 ' HD2' ' N ' ' A' ' 138' ' ' TYR . 5.6 Cg_endo -62.65 1.54 1.01 Allowed 'Trans proline' 0 N--CA 1.499 1.797 0 C-N-CA 121.734 1.622 . . . . 0.0 113.38 -179.281 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' TYR . . . . . 0.477 ' CD1' ' O ' ' A' ' 137' ' ' LEU . 0.1 OUTLIER -80.0 -13.7 59.13 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-O 120.921 0.391 . . . . 0.0 111.53 -179.679 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.586 HD23 HD12 ' A' ' 144' ' ' LEU . 74.8 mt -57.64 -34.05 68.93 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.072 179.099 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -53.45 -47.2 69.91 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 179.469 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' TRP . . . . . 0.434 ' CE2' HD12 ' A' ' 52' ' ' ILE . 8.8 t-105 -63.37 -44.2 95.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.74 179.523 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.586 HD12 HD23 ' A' ' 141' ' ' LEU . 25.3 mt -55.19 -54.97 36.61 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.334 -0.547 . . . . 0.0 110.281 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.534 ' O ' HG23 ' A' ' 149' ' ' VAL . . . -64.68 -23.57 67.3 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.636 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 25.9 t80 -61.35 -59.16 5.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.771 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -64.33 -50.38 68.0 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.005 -179.604 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 10.9 m -52.62 -55.83 19.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.904 0.383 . . . . 0.0 110.769 -179.745 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.534 HG23 ' O ' ' A' ' 145' ' ' ALA . 80.9 t -58.25 -35.05 51.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.726 -179.772 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.432 ' O ' HG23 ' A' ' 154' ' ' VAL . 4.8 tp -54.7 -58.11 8.82 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.471 -179.865 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 151' ' ' ASN . . . . . 0.892 ' ND2' ' HB2' ' A' ' 108' ' ' ALA . 2.0 t-20 -56.4 -58.89 6.08 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-O 120.988 0.423 . . . . 0.0 110.783 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 50.5 t80 -47.42 -39.65 16.03 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.83 -179.383 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 31.5 t80 -72.12 -35.83 69.25 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.401 -179.53 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.432 HG23 ' O ' ' A' ' 150' ' ' LEU . 45.1 t -59.15 -47.04 91.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 C-N-CA 120.791 -0.364 . . . . 0.0 111.395 -179.291 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 155' ' ' TRP . . . . . 0.495 ' CZ3' ' CE ' ' A' ' 105' ' ' MET . 22.9 m95 -79.95 -28.68 39.63 Favored 'General case' 0 N--CA 1.464 0.225 0 C-N-CA 119.818 -0.753 . . . . 0.0 111.521 -179.279 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.41 -21.66 61.23 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.461 -0.495 . . . . 0.0 110.164 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -83.57 -40.06 19.58 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.918 -179.668 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 18.2 t30 -90.53 -24.24 20.69 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.084 -179.587 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 63.69 148.33 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.34 -179.754 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -95.13 -170.08 36.46 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 111.31 -0.716 . . . . 0.0 111.31 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 69.1 mtt180 -80.6 39.17 0.46 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.69 0.281 . . . . 0.0 110.771 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 32.8 mtt180 -63.92 153.63 36.38 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.66 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -72.7 177.21 41.49 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 110.97 -0.852 . . . . 0.0 110.97 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -96.58 -3.35 59.7 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 111.035 -0.826 . . . . 0.0 111.035 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -160.69 170.9 19.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.784 0.326 . . . . 0.0 110.641 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 89.6 mtt180 -101.7 -132.29 0.27 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.305 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.608 HD12 ' N ' ' A' ' 167' ' ' LEU . 8.8 mp -89.28 -171.9 3.42 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.884 0.373 . . . . 0.0 110.63 -179.849 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -163.49 125.59 2.5 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.329 179.8 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 . . . . . 0 C--O 1.22 -0.455 0 CA-C-O 117.943 -1.027 . . . . 0.0 110.572 -179.959 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 201' ' ' PKA . . . . . 0.517 ' C15' 'CL ' ' A' ' 201' ' ' PKA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.537 ' SD ' ' N ' ' A' ' 1' ' ' MET . 9.3 mmm . . . . . 0 CA--C 1.529 0.148 0 N-CA-C 110.451 -0.203 . . . . 0.0 110.451 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -75.51 39.36 0.62 Allowed 'Trans proline' 0 N--CA 1.493 1.488 0 C-N-CA 121.778 1.652 . . . . 0.0 112.034 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -56.98 -42.48 80.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.715 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.8 t 53.61 179.31 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.463 -179.811 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.559 ' O ' HG23 ' A' ' 9' ' ' VAL . 0.7 OUTLIER -79.58 116.84 20.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.275 -179.826 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.585 ' N ' ' CD ' ' A' ' 7' ' ' PRO . 0.9 OUTLIER -60.84 -33.62 15.03 Favored Pre-proline 0 CA--C 1.533 0.306 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.144 -179.759 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.585 ' CD ' ' N ' ' A' ' 6' ' ' VAL . 24.2 Cg_exo -73.34 -62.64 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 121.613 1.542 . . . . 0.0 111.518 179.282 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.708 ' O ' HG23 ' A' ' 12' ' ' THR . . . -50.78 -36.51 37.29 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.849 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.559 HG23 ' O ' ' A' ' 5' ' ' TRP . 56.0 t -68.27 -62.17 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.511 -179.442 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -55.6 -47.73 75.42 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 111.484 -0.646 . . . . 0.0 111.484 -179.33 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.434 HD12 ' N ' ' A' ' 11' ' ' LEU . 8.5 mp -64.84 -30.86 71.88 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 121.177 -0.209 . . . . 0.0 110.968 -179.514 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.708 HG23 ' O ' ' A' ' 8' ' ' ALA . 6.1 p -74.47 -22.95 58.84 Favored 'General case' 0 C--N 1.333 -0.135 0 C-N-CA 120.569 -0.453 . . . . 0.0 110.016 179.439 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 52.5 mt -80.18 -34.77 37.24 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.213 179.644 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.415 ' N ' ' HD2' ' A' ' 15' ' ' PRO . 11.9 t -43.63 -55.21 9.05 Favored Pre-proline 0 CA--C 1.536 0.423 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.45 -179.722 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.415 ' HD2' ' N ' ' A' ' 14' ' ' VAL . 13.8 Cg_endo -58.92 -21.92 60.26 Favored 'Trans proline' 0 N--CA 1.498 1.754 0 C-N-CA 120.672 0.915 . . . . 0.0 112.303 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 5.7 t -62.08 -30.59 71.1 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.825 -179.749 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 71.5 mt -71.62 -57.1 4.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.817 0.342 . . . . 0.0 110.893 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -61.16 -36.97 93.18 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 111.287 -0.725 . . . . 0.0 111.287 -179.702 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -75.44 -25.94 66.9 Favored Glycine 0 CA--C 1.521 0.461 0 N-CA-C 110.694 -0.962 . . . . 0.0 110.694 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 62.0 t80 -75.54 -60.62 2.23 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.528 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 3.9 ttt -70.16 -22.29 62.99 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.17 179.74 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -69.47 -62.31 3.97 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.825 -0.91 . . . . 0.0 110.825 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.496 ' O ' HG22 ' A' ' 26' ' ' VAL . . . -68.55 -21.28 64.56 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.831 -0.348 . . . . 0.0 110.635 -179.857 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 40.2 t80 -47.45 -24.0 0.73 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.013 0.435 . . . . 0.0 109.984 179.608 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 25.6 t80 -69.72 -52.26 27.07 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.966 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.496 HG22 ' O ' ' A' ' 23' ' ' ALA . 36.0 m -72.14 -15.89 18.2 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.894 -179.736 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -59.82 -28.88 67.85 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.258 -179.388 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -123.39 -59.39 0.19 Allowed Glycine 0 CA--C 1.524 0.643 0 N-CA-C 111.199 -0.76 . . . . 0.0 111.199 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 27.7 tp10 -53.92 -28.99 40.18 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.745 0.307 . . . . 0.0 110.686 -179.711 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -73.78 -40.98 43.73 Favored Glycine 0 CA--C 1.526 0.754 0 N-CA-C 111.134 -0.786 . . . . 0.0 111.134 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 85.6 mt -62.98 -33.2 74.9 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.881 0.372 . . . . 0.0 110.482 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 18.6 mmm-85 -81.0 -40.01 24.98 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.35 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' TRP . . . . . 0.489 ' O ' ' N ' ' A' ' 36' ' ' GLY . 0.0 OUTLIER -56.11 -40.41 73.67 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.802 179.624 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 91.4 t80 -44.5 -42.11 6.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.518 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -60.27 -29.32 68.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.145 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.489 ' N ' ' O ' ' A' ' 33' ' ' TRP . . . -84.86 -76.72 1.19 Allowed Glycine 0 CA--C 1.524 0.602 0 N-CA-C 110.437 -1.065 . . . . 0.0 110.437 179.679 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.582 ' O ' HD12 ' A' ' 37' ' ' LEU . 0.3 OUTLIER -95.65 166.94 11.58 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.791 0.329 . . . . 0.0 110.221 179.277 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.415 ' N ' ' CD ' ' A' ' 38' ' ' GLN . 3.7 mp0 -81.54 113.02 19.29 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.483 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.49 ' C ' ' H ' ' A' ' 41' ' ' SER . 8.9 mtpt -122.18 146.63 47.25 Favored Pre-proline 0 N--CA 1.464 0.265 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.05 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.623 ' C ' ' H ' ' A' ' 42' ' ' TRP . 85.5 Cg_endo -74.13 30.19 0.33 Allowed 'Trans proline' 0 C--N 1.309 -1.503 0 C-N-CA 121.28 1.32 . . . . 0.0 111.386 179.406 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.49 ' H ' ' C ' ' A' ' 39' ' ' LYS . 53.7 p -52.37 -0.1 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.94 179.565 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' TRP . . . . . 0.623 ' H ' ' C ' ' A' ' 40' ' ' PRO . 1.2 p90 -75.72 -14.0 60.32 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.398 -0.521 . . . . 0.0 110.758 -178.884 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.481 ' O ' ' C ' ' A' ' 44' ' ' PRO . 30.5 m-70 -74.59 140.32 75.13 Favored Pre-proline 0 C--N 1.328 -0.359 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 178.759 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.481 ' C ' ' O ' ' A' ' 43' ' ' HIS . 51.9 Cg_exo -32.55 131.54 0.1 OUTLIER 'Trans proline' 0 N--CA 1.492 1.439 0 C-N-CA 121.204 1.27 . . . . 0.0 111.346 -179.343 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.431 ' O ' ' N ' ' A' ' 47' ' ' TRP . 5.8 Cg_exo -54.82 162.94 4.45 Favored 'Trans proline' 0 C--N 1.311 -1.402 0 CA-C-N 118.791 0.604 . . . . 0.0 111.676 -179.191 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.462 ' O ' ' CB ' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -45.47 -17.73 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.202 -179.482 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.599 ' CD1' ' N ' ' A' ' 48' ' ' THR . 1.6 p-90 -63.74 -48.6 76.35 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.851 -0.34 . . . . 0.0 111.587 -179.03 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.599 ' N ' ' CD1' ' A' ' 47' ' ' TRP . 1.1 m -90.16 -27.45 19.57 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.555 -178.854 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.703 ' O ' HG23 ' A' ' 52' ' ' ILE . 0.1 OUTLIER -83.39 -45.92 13.15 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.473 -0.491 . . . . 0.0 112.029 -178.733 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.615 ' C ' ' H ' ' A' ' 52' ' ' ILE . . . -40.94 -28.92 0.23 Allowed Pre-proline 0 N--CA 1.465 0.281 0 N-CA-C 111.892 0.33 . . . . 0.0 111.892 -179.057 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.409 ' HD2' ' N ' ' A' ' 50' ' ' ALA . 17.6 Cg_exo -54.03 7.36 0.03 OUTLIER 'Trans proline' 0 C--N 1.312 -1.359 0 CA-C-N 119.126 0.724 . . . . 0.0 112.78 178.501 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.703 HG23 ' O ' ' A' ' 49' ' ' LEU . 8.1 pt -55.19 -31.35 26.05 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.133 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 178.881 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.403 ' O ' ' CB ' ' A' ' 57' ' ' TYR . 72.8 m95 -80.98 -22.21 39.7 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.124 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -69.92 -52.12 20.78 Favored Glycine 0 CA--C 1.527 0.828 0 N-CA-C 109.987 -1.245 . . . . 0.0 109.987 178.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.617 HG23 ' N ' ' A' ' 56' ' ' LEU . 9.3 t -67.23 -50.2 61.58 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 179.321 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.617 ' N ' HG23 ' A' ' 55' ' ' THR . 90.4 mt -58.4 -33.77 70.01 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 120.655 -0.418 . . . . 0.0 109.89 179.389 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.403 ' CB ' ' O ' ' A' ' 53' ' ' TRP . 3.6 t80 -59.16 -55.93 28.7 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 179.42 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 34.6 t -48.01 -50.33 27.95 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.347 -0.541 . . . . 0.0 109.88 179.339 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -55.63 -52.59 63.28 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.57 179.622 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.4 ' O ' ' CB ' ' A' ' 64' ' ' SER . 16.2 mtm -55.09 -37.68 67.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.036 -179.715 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -62.87 -41.2 99.92 Favored Glycine 0 CA--C 1.523 0.55 0 N-CA-C 111.216 -0.754 . . . . 0.0 111.216 -179.587 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -68.61 -60.25 2.55 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.695 0.283 . . . . 0.0 110.869 -179.487 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.475 ' O ' HG23 ' A' ' 67' ' ' VAL . . . -55.48 -56.58 22.83 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 110.749 -0.94 . . . . 0.0 110.749 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.477 ' O ' ' NE1' ' A' ' 68' ' ' TRP . 92.7 p -45.77 -49.53 14.87 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.004 0.43 . . . . 0.0 110.473 179.699 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 73.5 t80 -58.16 -34.4 70.26 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.835 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 96.2 mt -74.25 -39.13 49.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.882 -179.809 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.475 HG23 ' O ' ' A' ' 63' ' ' GLY . 37.4 t -56.98 -58.17 6.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.616 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' TRP . . . . . 0.578 ' O ' ' N ' ' A' ' 73' ' ' GLY . 1.0 OUTLIER -60.82 -45.04 96.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.692 -179.837 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 2.7 mmmt -56.65 -25.73 54.25 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.02 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 23.5 tp10 -82.41 -63.06 1.45 Allowed 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.827 -0.349 . . . . 0.0 111.317 -179.359 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.743 ' C ' HD12 ' A' ' 71' ' ' LEU . 3.3 pp -62.93 -7.12 4.58 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.777 -0.369 . . . . 0.0 111.023 -179.478 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.659 ' N ' HD12 ' A' ' 71' ' ' LEU . . . 108.45 71.69 0.73 Allowed Glycine 0 CA--C 1.527 0.791 0 N-CA-C 111.402 -0.679 . . . . 0.0 111.402 179.697 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.578 ' N ' ' O ' ' A' ' 68' ' ' TRP . . . 42.15 -174.03 0.01 OUTLIER Glycine 0 CA--C 1.525 0.698 0 N-CA-C 111.748 -0.541 . . . . 0.0 111.748 179.496 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 63.4 t80 -69.33 111.42 5.22 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.372 -0.414 . . . . 0.0 110.432 -179.795 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.477 ' OG1' ' N ' ' A' ' 76' ' ' GLU . 1.7 t -140.0 -178.6 5.52 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.538 -179.812 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.477 ' N ' ' OG1' ' A' ' 75' ' ' THR . 96.3 mt-10 -55.51 -23.24 25.09 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.632 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -79.97 -18.84 49.34 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.664 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -94.09 -24.42 17.59 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.927 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 13.1 mtp -62.19 -26.98 68.65 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.813 -0.355 . . . . 0.0 110.439 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 10.8 t -68.49 -52.99 18.4 Favored Pre-proline 0 CA--C 1.535 0.386 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.953 -179.602 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -66.42 -59.53 0.13 Allowed 'Trans proline' 0 N--CA 1.497 1.733 0 C-N-CA 120.97 1.113 . . . . 0.0 111.77 179.29 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.445 HD21 ' CZ2' ' A' ' 68' ' ' TRP . 1.2 mt -55.27 -51.49 66.47 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.492 179.714 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -57.82 -51.08 60.22 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 111.153 -0.779 . . . . 0.0 111.153 -179.722 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.427 ' O ' ' CB ' ' A' ' 88' ' ' GLN . 44.3 tp -60.15 -29.74 68.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.834 0.349 . . . . 0.0 110.61 -179.832 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 11.6 t80 -71.25 -43.51 67.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.627 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 1.5 m -67.29 -48.03 68.86 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.888 -179.625 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -68.75 -57.27 8.14 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 111.162 -0.775 . . . . 0.0 111.162 -179.743 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.427 ' CB ' ' O ' ' A' ' 84' ' ' LEU . 8.3 tp-100 -52.13 -46.01 65.19 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.826 0.346 . . . . 0.0 110.711 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 11.7 tp -66.12 -31.94 73.1 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.94 -179.542 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.79 ' O ' ' HB2' ' A' ' 94' ' ' ALA . . . -64.4 -65.64 0.65 Allowed 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 120.272 -0.571 . . . . 0.0 111.183 -179.547 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.431 HD12 ' N ' ' A' ' 92' ' ' ASN . 2.8 pp -67.65 -36.96 81.72 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 -178.88 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.431 ' N ' HD12 ' A' ' 91' ' ' LEU . 8.3 t-20 -75.03 -59.13 2.88 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 -178.768 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' TRP . . . . . 0.62 ' O ' ' N ' ' A' ' 95' ' ' TRP . 0.0 OUTLIER -69.95 -17.15 63.3 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 120.681 -0.408 . . . . 0.0 111.499 -178.576 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.79 ' HB2' ' O ' ' A' ' 90' ' ' ALA . . . -49.0 83.23 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 120.739 -0.385 . . . . 0.0 110.206 179.512 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.696 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 34.8 p-90 -101.42 -15.75 0.18 Allowed Pre-proline 0 CA--C 1.536 0.419 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 -179.278 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.696 ' CD ' ' N ' ' A' ' 95' ' ' TRP . 32.0 Cg_exo -60.24 -27.79 85.58 Favored 'Trans proline' 0 N--CA 1.495 1.564 0 C-N-CA 120.484 0.79 . . . . 0.0 113.126 179.654 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.52 ' CD ' ' N ' ' A' ' 96' ' ' PRO . 97.2 Cg_exo -58.96 -17.53 37.93 Favored 'Trans proline' 0 N--CA 1.496 1.671 0 C-N-CA 120.592 0.861 . . . . 0.0 113.127 -179.81 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.531 ' O ' ' N ' ' A' ' 101' ' ' GLY . 1.2 pp -82.24 17.26 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 121.105 0.479 . . . . 0.0 110.304 179.699 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -40.22 -31.7 0.14 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.789 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -80.85 -30.32 35.67 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.246 -179.36 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.531 ' N ' ' O ' ' A' ' 98' ' ' ILE . . . -83.66 -11.97 78.67 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 111.372 -0.691 . . . . 0.0 111.372 -179.742 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -63.55 -33.06 74.77 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.673 0.273 . . . . 0.0 111.033 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -75.91 9.65 2.29 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.98 -179.654 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' GLN . . . . . 0.416 ' C ' ' N ' ' A' ' 106' ' ' GLY . 5.3 mt-30 -126.09 158.83 34.45 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.748 0.308 . . . . 0.0 110.574 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 6.7 mmt -48.79 -18.91 0.31 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.097 0.475 . . . . 0.0 110.348 179.835 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.593 ' O ' ' N ' ' A' ' 108' ' ' ALA . . . -66.51 -14.59 62.59 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 111.351 -0.7 . . . . 0.0 111.351 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' TRP . . . . . 0.455 ' CD1' ' N ' ' A' ' 108' ' ' ALA . 0.0 OUTLIER -42.33 -14.52 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.287 0 CA-C-O 120.561 0.22 . . . . 0.0 111.137 -179.368 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.593 ' N ' ' O ' ' A' ' 106' ' ' GLY . . . -64.78 -24.1 67.45 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.092 0.472 . . . . 0.0 110.321 179.686 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 6.6 mt -49.98 -27.99 6.2 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.59 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.24 -58.51 7.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.733 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.708 ' O ' HG23 ' A' ' 115' ' ' VAL . 1.0 OUTLIER -59.2 -52.32 66.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.558 -179.422 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.538 ' N ' ' CG ' ' A' ' 111' ' ' ASP . 57.4 tp -55.07 -43.17 73.66 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.43 -179.137 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.402 HD23 ' HA ' ' A' ' 113' ' ' LEU . 51.6 mt -67.12 -61.55 1.87 Allowed 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 -178.487 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.0 pp -60.94 -34.04 74.12 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.337 -0.545 . . . . 0.0 111.413 -178.582 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.708 HG23 ' O ' ' A' ' 111' ' ' ASP . 40.7 t -59.87 -56.82 14.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.763 179.877 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.491 ' O ' ' OG1' ' A' ' 120' ' ' THR . 41.5 t -72.09 -22.54 61.34 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.54 -179.208 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -64.98 -62.74 4.7 Favored Glycine 0 CA--C 1.526 0.75 0 C-N-CA 120.938 -0.648 . . . . 0.0 111.674 -179.357 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.535 ' O ' HG23 ' A' ' 122' ' ' THR . 10.3 p -73.01 -37.62 53.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 C-N-CA 121.08 -0.248 . . . . 0.0 111.408 -179.476 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.527 ' O ' ' OG1' ' A' ' 123' ' ' THR . . . -65.53 -60.24 3.14 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.684 -0.406 . . . . 0.0 111.149 -179.344 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.491 ' OG1' ' O ' ' A' ' 116' ' ' SER . 1.9 m -60.43 -52.77 63.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.673 -179.237 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -54.6 -39.93 68.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.601 -0.272 . . . . 0.0 111.417 -179.166 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.535 HG23 ' O ' ' A' ' 118' ' ' VAL . 22.9 p -71.48 -39.11 71.09 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.994 -0.283 . . . . 0.0 111.728 -179.195 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.527 ' OG1' ' O ' ' A' ' 119' ' ' ALA . 0.1 OUTLIER -58.46 -49.44 77.33 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.782 -0.367 . . . . 0.0 111.08 -179.286 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.2 pp -79.97 -20.48 45.47 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.581 -179.057 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -87.42 -70.88 0.59 Allowed 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 112.515 0.561 . . . . 0.0 112.515 -178.77 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' TRP . . . . . 0.469 ' CD1' ' N ' ' A' ' 126' ' ' TRP . 32.0 m0 -83.57 -57.36 3.27 Favored 'General case' 0 N--CA 1.465 0.275 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -177.687 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' HIS . . . . . 0.496 ' CG ' ' HB2' ' A' ' 134' ' ' ALA . 7.0 m170 -54.52 -22.68 13.68 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.642 -0.423 . . . . 0.0 111.419 -178.672 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 17.1 ttt-85 -66.35 -39.62 89.28 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.877 -0.329 . . . . 0.0 111.137 -179.563 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 21.5 t -96.18 -49.77 11.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.149 -179.543 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' SER . . . . . 0.467 ' HB2' HG22 ' A' ' 67' ' ' VAL . 16.8 m -114.72 110.35 46.84 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.699 -179.661 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' PRO . . . . . 0.64 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 77.7 Cg_exo -75.19 -33.11 4.64 Favored 'Trans proline' 0 C--N 1.31 -1.479 0 C-N-CA 121.73 1.62 . . . . 0.0 112.871 179.544 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.64 ' CD ' ' N ' ' A' ' 131' ' ' PRO . 53.1 Cg_exo -52.97 -49.91 15.92 Favored 'Trans proline' 0 N--CA 1.497 1.687 0 C-N-CA 121.587 1.525 . . . . 0.0 112.572 -179.536 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -53.27 -38.98 63.55 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.908 0.385 . . . . 0.0 110.666 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.496 ' HB2' ' CG ' ' A' ' 127' ' ' HIS . . . -56.18 -28.06 56.79 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.596 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 11.4 tpp180 -75.98 -29.66 58.3 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.653 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 54.3 mt -72.43 -35.74 68.39 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.878 0.37 . . . . 0.0 110.118 179.627 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.589 ' O ' ' N ' ' A' ' 140' ' ' TYR . 6.2 mt -82.46 -36.81 26.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.211 179.571 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.519 ' C ' ' H ' ' A' ' 140' ' ' TYR . 0.8 OUTLIER -21.04 -45.48 0.04 OUTLIER Pre-proline 0 N--CA 1.467 0.399 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.811 -179.725 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.559 ' N ' ' O ' ' A' ' 137' ' ' LEU . 5.5 Cg_exo -66.08 14.33 0.11 Allowed 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 120.986 1.124 . . . . 0.0 112.001 179.593 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' TYR . . . . . 0.771 ' CE2' HD11 ' A' ' 144' ' ' LEU . 3.7 p90 -93.25 -14.64 26.78 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.197 0.522 . . . . 0.0 110.341 179.684 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.656 ' CD1' ' CE1' ' A' ' 140' ' ' TYR . 5.9 mp -58.79 -30.63 67.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.268 178.578 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -60.92 -45.37 94.91 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.983 179.562 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' TRP . . . . . 0.475 ' CE2' HD12 ' A' ' 52' ' ' ILE . 7.7 t-105 -60.33 -49.57 77.06 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 179.415 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.771 HD11 ' CE2' ' A' ' 140' ' ' TYR . 11.9 mt -51.37 -54.61 24.75 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.743 179.322 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.616 ' O ' HG23 ' A' ' 149' ' ' VAL . . . -59.72 -24.79 64.29 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.792 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 23.0 t80 -65.1 -59.16 4.42 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.741 -0.383 . . . . 0.0 110.711 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -67.18 -43.41 82.24 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.622 -0.431 . . . . 0.0 110.633 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 5.2 m -57.3 -55.13 38.79 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.579 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.616 HG23 ' O ' ' A' ' 145' ' ' ALA . 91.2 t -59.19 -31.66 46.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.59 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -58.33 -53.94 52.6 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.796 -0.362 . . . . 0.0 110.068 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 151' ' ' ASN . . . . . 0.621 ' ND2' ' OD2' ' A' ' 111' ' ' ASP . 43.9 m-20 -64.16 -53.37 50.49 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.939 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 31.5 t80 -51.4 -37.53 48.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.867 -179.682 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 90.8 t80 -67.93 -42.68 80.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.949 -179.692 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 86.7 t -63.61 -38.27 81.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 C-N-CA 120.945 -0.302 . . . . 0.0 110.79 -179.758 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' TRP . . . . . . . . . . . . . 4.8 m0 -64.06 -45.96 86.49 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.536 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 7.5 mpt_? -70.62 -34.31 71.97 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.954 -179.605 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -74.64 -37.79 62.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.111 -179.314 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' ASN . . . . . 0.476 ' ND2' ' O ' ' A' ' 158' ' ' ASN . 0.6 OUTLIER -84.45 -23.42 29.95 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.918 -179.745 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 9.4 p 52.33 -160.1 0.11 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.342 -179.782 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 165.56 80.19 0.04 OUTLIER Glycine 0 CA--C 1.525 0.694 0 N-CA-C 111.102 -0.799 . . . . 0.0 111.102 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 24.4 ttm180 -98.44 -56.58 2.42 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.771 0.32 . . . . 0.0 110.552 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 67.1 mtt85 -76.96 147.04 37.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.611 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 169.94 165.52 27.44 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 111.064 -0.815 . . . . 0.0 111.064 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -90.88 48.26 3.0 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.904 -0.878 . . . . 0.0 110.904 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 5.7 t -92.77 123.3 35.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.783 0.325 . . . . 0.0 110.61 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 8.4 mtp180 -141.57 -141.67 0.14 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.165 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.794 HD22 ' C ' ' A' ' 167' ' ' LEU . 0.0 OUTLIER -173.76 -10.08 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.834 -0.347 . . . . 0.0 111.217 179.781 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.504 ' N ' HD22 ' A' ' 167' ' ' LEU . . . -43.71 117.13 1.09 Allowed 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.912 -0.315 . . . . 0.0 110.416 179.859 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 . . . . . 0 C--O 1.22 -0.464 0 CA-C-O 117.985 -1.007 . . . . 0.0 110.64 -179.938 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 201' ' ' PKA . . . . . 0.519 ' C15' 'CL ' ' A' ' 201' ' ' PKA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 56.3 mmm . . . . . 0 CA--C 1.528 0.129 0 CA-C-O 120.546 0.212 . . . . 0.0 110.442 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_exo -39.86 125.85 1.66 Allowed 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 121.819 1.679 . . . . 0.0 112.123 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.546 ' CD ' ' H ' ' A' ' 3' ' ' GLU . 10.3 mp0 -49.71 -52.12 33.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.806 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.407 ' C ' ' O ' ' A' ' 3' ' ' GLU . 34.8 t -38.99 116.78 0.61 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.544 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.688 ' O ' HG23 ' A' ' 9' ' ' VAL . 0.7 OUTLIER -63.97 116.93 6.33 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.282 -179.816 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.594 ' N ' ' CD ' ' A' ' 7' ' ' PRO . 0.9 OUTLIER -62.36 -35.76 22.72 Favored Pre-proline 0 CA--C 1.534 0.35 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.43 -179.715 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.594 ' CD ' ' N ' ' A' ' 6' ' ' VAL . 35.2 Cg_exo -65.99 -64.59 0.05 OUTLIER 'Trans proline' 0 C--N 1.306 -1.665 0 C-N-CA 121.668 1.579 . . . . 0.0 111.827 179.624 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.761 ' O ' HG22 ' A' ' 12' ' ' THR . . . -51.65 -32.76 30.63 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.973 -179.706 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.688 HG23 ' O ' ' A' ' 5' ' ' TRP . 58.5 t -69.87 -61.37 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.94 0.4 . . . . 0.0 111.304 -179.447 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -57.89 -43.36 94.85 Favored Glycine 0 CA--C 1.528 0.853 0 N-CA-C 111.215 -0.754 . . . . 0.0 111.215 -179.545 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 8.1 mp -65.92 -62.95 1.21 Allowed 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 111.544 0.202 . . . . 0.0 111.544 -179.166 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.761 HG22 ' O ' ' A' ' 8' ' ' ALA . 6.9 t -54.38 -20.55 7.57 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.449 -0.5 . . . . 0.0 110.572 -179.395 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.431 ' O ' ' C ' ' A' ' 14' ' ' VAL . 17.6 mt -78.79 -38.12 39.17 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.779 0.324 . . . . 0.0 110.371 179.611 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.432 ' N ' ' HD2' ' A' ' 15' ' ' PRO . 28.1 t -35.55 -56.72 1.01 Allowed Pre-proline 0 CA--C 1.534 0.342 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.63 -179.774 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.432 ' HD2' ' N ' ' A' ' 14' ' ' VAL . 15.4 Cg_endo -54.6 -32.59 75.46 Favored 'Trans proline' 0 N--CA 1.498 1.772 0 C-N-CA 120.475 0.783 . . . . 0.0 112.501 -179.488 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.421 ' N ' ' O ' ' A' ' 13' ' ' LEU . 2.3 t -45.05 -25.96 0.39 Allowed 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 120.396 -0.522 . . . . 0.0 110.341 -179.586 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 74.5 mt -72.85 -53.69 10.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.128 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -68.61 -34.48 78.69 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 111.594 -0.602 . . . . 0.0 111.594 -179.399 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -75.14 -29.61 60.21 Favored Glycine 0 CA--C 1.517 0.184 0 N-CA-C 110.651 -0.98 . . . . 0.0 110.651 -179.7 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 36.9 t80 -74.79 -60.71 2.16 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.506 -0.478 . . . . 0.0 110.64 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 9.4 ttt -69.7 -22.85 63.38 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.809 -179.829 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -73.59 -63.23 2.8 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 111.081 -0.808 . . . . 0.0 111.081 -179.781 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.482 ' O ' HG22 ' A' ' 26' ' ' VAL . . . -63.83 -23.49 67.38 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.424 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 76.2 t80 -47.83 -23.5 0.76 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.936 0.398 . . . . 0.0 109.95 179.235 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 46.8 t80 -69.49 -52.65 24.56 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.703 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.482 HG22 ' O ' ' A' ' 23' ' ' ALA . 31.1 m -71.14 -16.2 19.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.864 -179.685 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 2.4 tmt_? -58.04 -46.38 85.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.79 0.328 . . . . 0.0 110.568 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -100.73 -60.51 0.81 Allowed Glycine 0 CA--C 1.526 0.749 0 N-CA-C 110.916 -0.873 . . . . 0.0 110.916 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -49.84 -31.69 12.51 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.753 0.311 . . . . 0.0 110.546 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -68.7 -53.6 19.26 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 110.826 -0.91 . . . . 0.0 110.826 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 71.2 mt -51.24 -38.68 53.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.831 0.348 . . . . 0.0 110.51 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 20.1 mmm-85 -75.13 -46.85 31.7 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.035 -179.68 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 4.8 m95 -47.12 -39.35 13.17 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 120.853 -0.339 . . . . 0.0 110.269 -179.685 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 77.6 t80 -53.33 -26.11 17.63 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.312 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -75.89 -16.38 60.05 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.377 179.748 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -111.37 -76.47 0.83 Allowed Glycine 0 CA--C 1.523 0.568 0 N-CA-C 110.727 -0.949 . . . . 0.0 110.727 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.795 ' C ' HD12 ' A' ' 37' ' ' LEU . 3.6 pp -95.27 165.41 12.4 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 110.245 -0.28 . . . . 0.0 110.245 179.708 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.414 ' N ' HD12 ' A' ' 37' ' ' LEU . 77.0 mm-40 -75.55 113.08 12.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.93 0.395 . . . . 0.0 111.624 -179.121 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.538 ' C ' ' H ' ' A' ' 41' ' ' SER . 0.7 OUTLIER -129.59 135.48 27.61 Favored Pre-proline 0 CA--C 1.536 0.424 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 179.313 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.536 ' C ' ' H ' ' A' ' 42' ' ' TRP . 43.1 Cg_endo -70.39 25.54 0.19 Allowed 'Trans proline' 0 N--CA 1.496 1.671 0 C-N-CA 120.386 0.724 . . . . 0.0 111.617 179.582 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.538 ' H ' ' C ' ' A' ' 39' ' ' LYS . 2.9 t -53.54 -2.28 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.154 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' TRP . . . . . 0.692 ' CH2' ' NE2' ' A' ' 43' ' ' HIS . 48.4 p-90 -77.49 -16.12 58.91 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.365 -0.534 . . . . 0.0 110.708 -179.367 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.692 ' NE2' ' CH2' ' A' ' 42' ' ' TRP . 6.9 m-70 -65.6 147.16 98.84 Favored Pre-proline 0 C--N 1.33 -0.267 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 178.857 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.474 ' C ' ' O ' ' A' ' 43' ' ' HIS . 53.0 Cg_exo -31.45 114.39 0.05 OUTLIER 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 121.762 1.642 . . . . 0.0 111.441 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.598 ' O ' ' N ' ' A' ' 47' ' ' TRP . 33.1 Cg_exo -41.89 154.24 0.11 Allowed 'Trans proline' 0 C--N 1.308 -1.555 0 CA-C-N 118.796 0.606 . . . . 0.0 111.844 -179.356 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.443 ' O ' ' CB ' ' A' ' 50' ' ' ALA . 3.0 ppt_? -40.19 -16.77 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.034 -179.83 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.622 ' CD1' ' N ' ' A' ' 48' ' ' THR . 0.7 OUTLIER -60.81 -50.41 73.56 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.77 -0.372 . . . . 0.0 111.005 -179.175 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.622 ' N ' ' CD1' ' A' ' 47' ' ' TRP . 0.9 OUTLIER -90.34 -27.24 19.51 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.621 -178.922 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.712 ' O ' HG23 ' A' ' 52' ' ' ILE . 0.1 OUTLIER -83.13 -51.97 7.03 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.524 -0.47 . . . . 0.0 111.867 -178.659 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.613 ' C ' ' H ' ' A' ' 52' ' ' ILE . . . -39.96 -29.57 0.21 Allowed Pre-proline 0 C--O 1.234 0.281 0 N-CA-C 111.88 0.326 . . . . 0.0 111.88 -178.922 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.404 ' HD2' ' N ' ' A' ' 50' ' ' ALA . 33.7 Cg_exo -53.19 4.5 0.03 OUTLIER 'Trans proline' 0 C--N 1.312 -1.379 0 CA-C-N 119.179 0.742 . . . . 0.0 112.439 178.158 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.712 HG23 ' O ' ' A' ' 49' ' ' LEU . 8.1 pt -52.49 -33.45 17.84 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.174 0 CA-C-O 121.101 0.477 . . . . 0.0 109.961 179.214 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.439 ' O ' ' CB ' ' A' ' 57' ' ' TYR . 72.6 m95 -79.72 -23.38 42.37 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.45 -179.002 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -71.76 -46.22 39.52 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 110.12 -1.192 . . . . 0.0 110.12 179.08 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 5.9 m -68.36 -52.22 35.66 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 179.321 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.413 HD23 ' HA ' ' A' ' 56' ' ' LEU . 96.0 mt -60.02 -28.72 67.97 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.887 179.438 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.512 ' CD1' ' C ' ' A' ' 57' ' ' TYR . 0.4 OUTLIER -63.76 -51.53 64.43 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 179.454 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 5.8 p -53.98 -50.73 65.91 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.152 179.467 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.71 -42.03 87.7 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.329 179.621 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.517 ' SD ' ' OG1' ' A' ' 12' ' ' THR . 11.3 mtm -59.27 -40.87 87.41 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.926 179.579 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -58.83 -45.09 95.47 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 110.526 -1.03 . . . . 0.0 110.526 179.591 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.481 ' CD1' ' N ' ' A' ' 62' ' ' TYR . 2.9 m-30 -62.15 -60.0 4.23 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 121.06 -0.256 . . . . 0.0 110.951 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.475 ' O ' HG23 ' A' ' 67' ' ' VAL . . . -54.04 -60.89 7.76 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 110.986 -0.845 . . . . 0.0 110.986 -179.593 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.521 ' O ' ' CD1' ' A' ' 68' ' ' TRP . 56.0 p -45.5 -48.27 14.09 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.012 0.434 . . . . 0.0 110.465 179.804 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 57.6 t80 -56.47 -41.05 75.91 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.945 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 79.4 mt -67.8 -43.44 86.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.952 -179.585 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.496 ' CG1' ' CZ3' ' A' ' 68' ' ' TRP . 21.5 t -52.54 -56.33 7.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.86 -179.774 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' TRP . . . . . 0.609 ' CE2' HD11 ' A' ' 82' ' ' LEU . 1.0 OUTLIER -66.29 -46.85 75.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.089 -179.391 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.07 -24.46 40.0 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.947 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -81.19 -62.1 1.76 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.348 -179.455 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.2 pp -69.3 -2.15 9.99 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.46 -179.101 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.491 ' O ' ' O ' ' A' ' 73' ' ' GLY . . . 108.4 71.13 0.71 Allowed Glycine 0 CA--C 1.527 0.817 0 N-CA-C 111.572 -0.611 . . . . 0.0 111.572 179.557 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.591 ' N ' ' O ' ' A' ' 68' ' ' TRP . . . 42.03 -173.53 0.01 OUTLIER Glycine 0 CA--C 1.525 0.701 0 N-CA-C 111.94 -0.464 . . . . 0.0 111.94 179.286 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 57.6 t80 -69.81 111.21 5.4 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.203 -0.498 . . . . 0.0 111.009 -179.523 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.516 ' OG1' ' N ' ' A' ' 76' ' ' GLU . 1.3 t -139.4 -175.44 4.18 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.226 179.664 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.516 ' N ' ' OG1' ' A' ' 75' ' ' THR . 73.4 mt-10 -52.92 -24.4 9.18 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.086 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -79.92 -17.71 52.39 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.001 -179.588 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.531 ' O ' HD12 ' A' ' 82' ' ' LEU . . . -96.78 -15.6 21.26 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.04 -179.495 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 7.0 mtp -70.05 -28.27 65.32 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.484 -0.326 . . . . 0.0 110.885 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 5.1 t -70.47 -54.99 8.02 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.758 -179.717 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -62.93 -54.61 1.08 Allowed 'Trans proline' 0 N--CA 1.498 1.764 0 C-N-CA 120.993 1.129 . . . . 0.0 111.802 179.324 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.609 HD11 ' CE2' ' A' ' 68' ' ' TRP . 1.5 mt -61.05 -55.91 27.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.533 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -53.33 -60.32 8.34 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 111.084 -0.807 . . . . 0.0 111.084 -179.696 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.6 tt -48.54 -40.82 28.34 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.781 0.324 . . . . 0.0 110.631 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.4 ' O ' ' CB ' ' A' ' 89' ' ' LEU . 11.0 t80 -63.02 -36.15 82.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.597 -179.747 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.74 -63.05 1.14 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.197 -179.556 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -60.11 -55.59 29.39 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 111.378 -0.689 . . . . 0.0 111.378 -179.547 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.423 ' O ' ' CB ' ' A' ' 92' ' ' ASN . 6.5 tp-100 -50.84 -47.25 60.28 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.652 0.263 . . . . 0.0 111.029 -179.669 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.4 ' CB ' ' O ' ' A' ' 85' ' ' TYR . 11.4 tp -65.3 -28.83 69.59 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.98 0.419 . . . . 0.0 110.313 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.789 ' O ' ' HB2' ' A' ' 94' ' ' ALA . . . -64.7 -65.57 0.66 Allowed 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 120.429 -0.509 . . . . 0.0 111.404 -179.811 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.3 pp -71.59 -26.11 62.46 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -178.727 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.423 ' CB ' ' O ' ' A' ' 88' ' ' GLN . 19.1 t-20 -83.53 -57.23 3.32 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.68 -0.408 . . . . 0.0 111.75 -178.847 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' TRP . . . . . 0.621 ' O ' ' N ' ' A' ' 95' ' ' TRP . 0.0 OUTLIER -72.08 -20.58 61.63 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.693 -0.403 . . . . 0.0 111.091 -178.851 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.789 ' HB2' ' O ' ' A' ' 90' ' ' ALA . . . -46.94 85.31 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.115 0 C-N-CA 120.703 -0.399 . . . . 0.0 110.207 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.707 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 34.4 p-90 -99.77 -16.9 0.2 Allowed Pre-proline 0 CA--C 1.537 0.445 0 CA-C-N 116.2 -0.455 . . . . 0.0 112.119 -179.653 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.707 ' CD ' ' N ' ' A' ' 95' ' ' TRP . 50.1 Cg_exo -55.15 -36.61 93.49 Favored 'Trans proline' 0 N--CA 1.496 1.639 0 C-N-CA 120.424 0.749 . . . . 0.0 113.106 179.483 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.469 ' HD2' ' N ' ' A' ' 96' ' ' PRO . 26.7 Cg_exo -39.74 -29.5 0.29 Allowed 'Trans proline' 0 N--CA 1.491 1.364 0 CA-C-N 118.979 0.671 . . . . 0.0 113.261 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 1.1 pt -83.87 26.45 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 121.109 0.48 . . . . 0.0 110.341 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.444 ' N ' ' O ' ' A' ' 96' ' ' PRO . 11.1 t80 -40.82 -43.52 2.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.794 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -81.53 -42.8 19.66 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.859 -179.699 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -61.09 -7.01 7.94 Favored Glycine 0 CA--C 1.527 0.791 0 N-CA-C 111.21 -0.756 . . . . 0.0 111.21 -179.746 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -76.01 -7.32 54.38 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 121.015 -0.274 . . . . 0.0 110.884 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 39.7 ptt85 -89.34 2.04 54.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.77 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 9.4 mt-30 -119.47 164.34 15.92 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.492 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.586 ' O ' ' NE1' ' A' ' 155' ' ' TRP . 0.0 OUTLIER -52.44 -17.46 1.22 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.296 179.78 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.577 ' O ' ' N ' ' A' ' 108' ' ' ALA . . . -68.11 -15.34 67.33 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 111.058 -0.817 . . . . 0.0 111.058 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' TRP . . . . . 0.416 ' CD1' ' C ' ' A' ' 107' ' ' TRP . 0.0 OUTLIER -44.87 -11.71 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.726 0.298 . . . . 0.0 110.802 -179.727 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.577 ' N ' ' O ' ' A' ' 106' ' ' GLY . . . -66.99 -23.28 65.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.998 0.428 . . . . 0.0 110.485 179.765 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 8.3 mp -52.44 -29.82 26.43 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.023 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -55.87 -64.02 0.99 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.396 179.784 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.748 ' O ' HG23 ' A' ' 115' ' ' VAL . 1.6 p30 -55.62 -52.46 63.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.917 -179.418 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.586 ' N ' ' OD1' ' A' ' 111' ' ' ASP . 8.1 tp -55.55 -40.88 72.47 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.884 -0.327 . . . . 0.0 111.714 -178.66 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 50.5 mt -68.68 -61.36 1.85 Allowed 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.678 -0.409 . . . . 0.0 111.912 -178.722 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.5 pp -57.95 -34.51 69.98 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 120.361 -0.536 . . . . 0.0 111.122 -178.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.748 HG23 ' O ' ' A' ' 111' ' ' ASP . 41.0 t -59.96 -54.52 33.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.912 179.745 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.443 ' O ' ' OG1' ' A' ' 120' ' ' THR . 58.7 m -71.68 -24.01 61.75 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.573 -179.286 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -65.22 -63.05 4.39 Favored Glycine 0 CA--C 1.527 0.821 0 C-N-CA 120.824 -0.703 . . . . 0.0 111.762 -179.32 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.566 ' O ' HG23 ' A' ' 122' ' ' THR . 8.0 p -71.78 -37.87 63.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 O-C-N 122.834 -0.215 . . . . 0.0 111.429 -179.404 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.491 ' O ' ' OG1' ' A' ' 123' ' ' THR . . . -66.22 -60.85 2.4 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.623 -0.431 . . . . 0.0 111.192 -179.171 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.443 ' OG1' ' O ' ' A' ' 116' ' ' SER . 3.0 m -59.1 -54.28 48.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.408 -179.241 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.411 ' O ' ' CB ' ' A' ' 125' ' ' ALA . . . -52.31 -40.35 61.74 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.414 -179.24 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.566 HG23 ' O ' ' A' ' 118' ' ' VAL . 33.4 p -73.71 -35.53 65.12 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 111.918 0.34 . . . . 0.0 111.918 -178.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.491 ' OG1' ' O ' ' A' ' 119' ' ' ALA . 0.1 OUTLIER -59.94 -48.51 81.41 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.821 -0.352 . . . . 0.0 110.947 -179.458 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.6 pp -83.79 -19.98 34.09 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.616 -179.011 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.411 ' CB ' ' O ' ' A' ' 121' ' ' ALA . . . -87.66 -68.03 0.78 Allowed 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -178.606 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' TRP . . . . . 0.44 ' CD1' ' N ' ' A' ' 126' ' ' TRP . 38.0 m0 -85.22 -57.44 3.08 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 112.762 0.653 . . . . 0.0 112.762 -177.816 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' HIS . . . . . 0.494 ' CD2' ' N ' ' A' ' 127' ' ' HIS . 8.5 m170 -54.37 -22.46 12.32 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.903 -0.319 . . . . 0.0 111.374 -178.58 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.409 ' C ' ' CD ' ' A' ' 128' ' ' ARG . 0.0 OUTLIER -70.84 -48.49 53.66 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.877 -0.329 . . . . 0.0 111.058 -179.665 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 44.2 t -80.82 -49.83 17.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.207 -179.471 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 5.7 t -129.85 115.6 17.94 Favored Pre-proline 0 CA--C 1.532 0.281 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.827 -179.487 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' PRO . . . . . 0.565 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 82.7 Cg_exo -72.12 -43.34 1.16 Allowed 'Trans proline' 0 N--CA 1.491 1.371 0 C-N-CA 121.294 1.329 . . . . 0.0 113.077 179.436 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.565 ' CD ' ' N ' ' A' ' 131' ' ' PRO . 68.8 Cg_exo -36.91 -48.82 1.5 Allowed 'Trans proline' 0 N--CA 1.497 1.684 0 C-N-CA 121.038 1.159 . . . . 0.0 112.099 -179.392 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -54.94 -34.98 63.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.042 0.448 . . . . 0.0 110.028 179.568 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.554 ' N ' ' O ' ' A' ' 131' ' ' PRO . . . -61.64 -22.36 65.2 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.316 179.609 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 12.1 tpp180 -77.69 -34.58 52.83 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.844 -179.707 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 29.9 mt -73.9 -33.52 64.04 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.63 -0.428 . . . . 0.0 109.922 179.631 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.586 ' O ' ' N ' ' A' ' 139' ' ' PRO . 10.1 mt -80.16 -40.37 27.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.276 -0.42 . . . . 0.0 109.973 179.315 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.493 ' CD1' ' O ' ' A' ' 138' ' ' TYR . 1.1 t80 -23.02 -40.61 0.03 OUTLIER Pre-proline 0 CA--C 1.534 0.335 0 CA-C-N 115.251 -0.886 . . . . 0.0 112.0 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.586 ' N ' ' O ' ' A' ' 137' ' ' LEU . 3.0 Cg_exo -70.59 13.51 0.35 Allowed 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 121.037 1.158 . . . . 0.0 112.237 179.698 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' TYR . . . . . 0.766 ' CE2' HD11 ' A' ' 144' ' ' LEU . 2.6 p90 -94.18 -14.81 25.21 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-O 121.27 0.557 . . . . 0.0 110.438 179.833 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.64 ' CD1' ' CE1' ' A' ' 140' ' ' TYR . 5.2 mp -56.41 -27.8 57.55 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.266 178.805 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -63.78 -46.43 85.28 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.002 179.451 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' TRP . . . . . 0.515 ' CE2' HD12 ' A' ' 52' ' ' ILE . 13.6 t-105 -59.61 -46.82 87.84 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 179.572 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.766 HD11 ' CE2' ' A' ' 140' ' ' TYR . 10.8 mt -52.48 -52.34 54.82 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.263 -0.575 . . . . 0.0 109.871 179.625 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.657 ' O ' HG23 ' A' ' 149' ' ' VAL . . . -64.14 -21.76 66.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.664 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 13.5 t80 -66.09 -63.0 1.18 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.828 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -68.9 -36.48 78.08 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.882 -179.713 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' THR . . . . . 0.498 ' O ' ' OD1' ' A' ' 151' ' ' ASN . 14.8 m -63.32 -50.01 71.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.735 0.302 . . . . 0.0 110.684 -179.828 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.657 HG23 ' O ' ' A' ' 145' ' ' ALA . 88.3 t -65.84 -30.69 50.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.567 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 1.4 tp -60.53 -52.9 63.22 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.9 -0.32 . . . . 0.0 110.209 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' ASN . . . . . 0.498 ' OD1' ' O ' ' A' ' 148' ' ' THR . 0.8 OUTLIER -64.53 -44.04 92.12 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.905 -179.959 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 152' ' ' TYR . . . . . 0.495 ' N ' ' ND2' ' A' ' 151' ' ' ASN . 26.0 t80 -56.64 -44.51 81.37 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.653 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 153' ' ' TYR . . . . . 0.428 ' CD2' ' OD2' ' A' ' 157' ' ' ASP . 20.5 t80 -59.08 -55.07 39.85 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.574 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 64.8 t -57.35 -46.09 85.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.75 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' TRP . . . . . 0.586 ' NE1' ' O ' ' A' ' 105' ' ' MET . 5.1 m0 -48.07 -52.06 21.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.818 0.342 . . . . 0.0 110.173 179.817 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 156' ' ' ARG . . . . . 0.435 ' HA ' ' HE ' ' A' ' 156' ' ' ARG . 0.0 OUTLIER -64.7 -52.2 58.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.685 -179.83 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 157' ' ' ASP . . . . . 0.428 ' OD2' ' CD2' ' A' ' 153' ' ' TYR . 80.0 m-20 -50.02 -48.14 52.76 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.854 -179.689 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 29.2 t-20 -67.83 -30.88 70.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.777 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 31.4 t -73.67 157.69 36.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.699 -179.811 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -162.36 -169.42 25.71 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 111.013 -0.835 . . . . 0.0 111.013 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 39.4 mtm105 -141.61 -107.08 0.14 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.745 0.307 . . . . 0.0 110.47 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 85.8 mtt180 -92.86 149.58 21.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.589 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -166.11 -70.04 0.03 OUTLIER Glycine 0 CA--C 1.526 0.746 0 N-CA-C 110.941 -0.864 . . . . 0.0 110.941 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 68.04 95.98 0.04 OUTLIER Glycine 0 CA--C 1.525 0.678 0 N-CA-C 111.183 -0.767 . . . . 0.0 111.183 179.798 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 2.3 p -97.27 115.25 27.28 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.753 0.311 . . . . 0.0 110.538 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 38.5 ttm-85 -86.83 42.23 1.01 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.703 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.501 ' C ' ' H ' ' A' ' 169' ' ' GLU . 2.2 mp -139.37 179.32 6.61 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.93 0.395 . . . . 0.0 110.743 -179.684 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.49 ' HB3' ' O ' ' A' ' 167' ' ' LEU . . . 69.41 -38.86 0.41 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.884 179.725 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 169' ' ' GLU . . . . . 0.501 ' H ' ' C ' ' A' ' 167' ' ' LEU . 42.6 mm-40 . . . . . 0 C--O 1.219 -0.505 0 CA-C-O 117.963 -1.018 . . . . 0.0 110.655 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 201' ' ' PKA . . . . . 0.534 ' C15' 'CL ' ' A' ' 201' ' ' PKA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.425 ' O ' ' N ' ' A' ' 3' ' ' GLU . 5.1 mmt . . . . . 0 CA--C 1.528 0.115 0 N-CA-C 110.406 -0.22 . . . . 0.0 110.406 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_exo -48.81 89.99 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 121.687 1.591 . . . . 0.0 112.147 179.7 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.425 ' N ' ' O ' ' A' ' 1' ' ' MET . 20.8 mt-10 -66.55 -16.75 64.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.457 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.1 t 62.65 -162.55 0.28 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.919 179.683 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.711 ' CE2' ' CE3' ' A' ' 68' ' ' TRP . 0.4 OUTLIER -55.38 117.87 3.93 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.595 -179.738 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.638 ' N ' ' CD ' ' A' ' 7' ' ' PRO . 1.0 OUTLIER -64.26 -33.32 8.96 Favored Pre-proline 0 C--N 1.328 -0.329 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 179.662 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.638 ' CD ' ' N ' ' A' ' 6' ' ' VAL . 18.9 Cg_exo -72.78 -67.12 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 121.855 1.703 . . . . 0.0 111.867 179.613 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.711 ' O ' HG23 ' A' ' 12' ' ' THR . . . -47.74 -41.89 24.12 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.319 -179.537 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.468 ' O ' ' OG1' ' A' ' 12' ' ' THR . 74.7 t -67.94 -62.41 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -178.892 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -53.78 -47.53 64.74 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 111.567 -0.613 . . . . 0.0 111.567 -179.163 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.415 ' CD1' ' N ' ' A' ' 11' ' ' LEU . 7.6 mp -65.34 -30.53 71.37 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.533 0.206 . . . . 0.0 111.105 -179.519 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.711 HG23 ' O ' ' A' ' 8' ' ' ALA . 6.6 p -76.14 -25.18 55.08 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.749 -0.381 . . . . 0.0 110.786 -179.831 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.425 ' O ' ' C ' ' A' ' 14' ' ' VAL . 9.3 mt -81.72 -36.3 28.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.673 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.428 ' N ' ' HD2' ' A' ' 15' ' ' PRO . 4.9 t -37.08 -55.08 1.74 Allowed Pre-proline 0 CA--C 1.535 0.398 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.784 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.428 ' HD2' ' N ' ' A' ' 14' ' ' VAL . 19.3 Cg_endo -60.98 -47.82 11.84 Favored 'Trans proline' 0 N--CA 1.5 1.868 0 C-N-CA 120.678 0.919 . . . . 0.0 112.125 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.9 m -46.01 -22.14 0.19 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.662 -179.556 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 83.9 mt -71.02 -55.9 7.32 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.85 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -74.84 -21.57 78.33 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 111.157 -0.777 . . . . 0.0 111.157 -179.686 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -69.79 -52.69 18.71 Favored Glycine 0 CA--C 1.522 0.483 0 N-CA-C 110.573 -1.011 . . . . 0.0 110.573 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 68.9 t80 -71.14 -57.88 4.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.721 0.296 . . . . 0.0 110.595 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 8.1 tpp -59.95 -25.69 65.39 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.278 -179.555 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -82.55 -62.98 1.81 Allowed Glycine 0 CA--C 1.525 0.718 0 C-N-CA 120.839 -0.696 . . . . 0.0 111.485 -179.421 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.582 ' O ' HG22 ' A' ' 26' ' ' VAL . . . -59.6 -15.64 20.14 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.798 -0.361 . . . . 0.0 110.659 -179.371 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 61.6 t80 -46.7 -26.19 0.88 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.981 0.42 . . . . 0.0 110.389 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 70.5 t80 -67.73 -50.65 56.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.661 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.603 HG21 'CL ' ' A' ' 201' ' ' PKA . 31.3 m -72.57 -21.03 19.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.671 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -61.24 -41.09 96.28 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.381 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -110.17 -73.44 0.74 Allowed Glycine 0 CA--C 1.525 0.702 0 N-CA-C 111.034 -0.826 . . . . 0.0 111.034 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.422 ' CD ' ' O ' ' A' ' 29' ' ' GLU . 13.0 tm-20 -46.01 -26.51 0.74 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.753 0.311 . . . . 0.0 110.57 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -65.28 -53.25 33.96 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 111.185 -0.766 . . . . 0.0 111.185 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 24.7 mt -48.5 -28.93 3.66 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.916 0.389 . . . . 0.0 110.211 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 82.8 mtt180 -84.1 -53.75 5.32 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.567 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' TRP . . . . . 0.637 ' CZ3' HD21 ' A' ' 37' ' ' LEU . 0.0 OUTLIER -44.74 -35.92 2.92 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.19 -0.459 . . . . 0.0 109.96 179.949 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.443 ' O ' ' O ' ' A' ' 37' ' ' LEU . 2.8 t80 -64.42 -46.62 82.42 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.938 179.558 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -51.18 -22.88 2.86 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.124 179.677 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -90.59 -73.9 1.27 Allowed Glycine 0 CA--C 1.524 0.614 0 N-CA-C 110.569 -1.013 . . . . 0.0 110.569 179.729 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.637 HD21 ' CZ3' ' A' ' 33' ' ' TRP . 0.6 OUTLIER -96.2 167.23 11.32 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 120.791 0.329 . . . . 0.0 110.238 179.171 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -77.57 116.09 17.86 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.963 0.411 . . . . 0.0 111.55 -178.735 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.496 ' C ' ' H ' ' A' ' 41' ' ' SER . 8.0 mtpt -128.93 149.12 71.54 Favored Pre-proline 0 CA--C 1.532 0.275 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.562 179.385 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.656 ' C ' ' H ' ' A' ' 42' ' ' TRP . 93.5 Cg_endo -74.05 20.2 0.41 Allowed 'Trans proline' 0 C--N 1.308 -1.564 0 C-N-CA 121.199 1.266 . . . . 0.0 111.022 179.304 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.496 ' H ' ' C ' ' A' ' 39' ' ' LYS . 11.9 p -49.28 -0.67 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.212 179.743 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' TRP . . . . . 0.656 ' H ' ' C ' ' A' ' 40' ' ' PRO . 1.8 p90 -75.56 -15.53 60.36 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.568 -0.453 . . . . 0.0 110.662 -179.076 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.455 ' O ' ' C ' ' A' ' 44' ' ' PRO . 3.6 m-70 -62.7 147.28 93.38 Favored Pre-proline 0 C--N 1.329 -0.3 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 179.095 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.474 ' O ' ' O ' ' A' ' 45' ' ' PRO . 6.7 Cg_endo -32.76 120.42 0.1 OUTLIER 'Trans proline' 0 N--CA 1.493 1.46 0 C-N-CA 121.483 1.455 . . . . 0.0 110.837 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.474 ' O ' ' O ' ' A' ' 44' ' ' PRO . 1.5 Cg_endo -37.89 160.99 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.398 0 C-N-CA 120.342 0.694 . . . . 0.0 111.997 -178.411 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.632 ' O ' ' HB3' ' A' ' 50' ' ' ALA . 7.1 ppt_? -49.37 -22.83 1.23 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.277 -0.874 . . . . 0.0 112.134 -178.889 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.585 ' CD1' ' N ' ' A' ' 48' ' ' THR . 1.2 p-90 -58.94 -41.5 87.55 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.93 0.715 . . . . 0.0 112.93 -178.487 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.585 ' N ' ' CD1' ' A' ' 47' ' ' TRP . 0.9 OUTLIER -88.86 -43.44 11.21 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.477 0.547 . . . . 0.0 112.477 -177.6 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.666 ' O ' HG23 ' A' ' 52' ' ' ILE . 44.1 tp -82.81 -51.59 7.52 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.134 -0.626 . . . . 0.0 112.471 -178.051 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.632 ' HB3' ' O ' ' A' ' 46' ' ' ARG . . . -41.74 -28.92 0.27 Allowed Pre-proline 0 N--CA 1.466 0.358 0 C-N-CA 120.22 -0.592 . . . . 0.0 111.46 -179.138 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.426 ' HD2' ' N ' ' A' ' 50' ' ' ALA . 23.2 Cg_exo -53.05 4.06 0.03 OUTLIER 'Trans proline' 0 C--N 1.312 -1.364 0 CA-C-N 118.847 0.624 . . . . 0.0 112.123 177.829 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.666 HG23 ' O ' ' A' ' 49' ' ' LEU . 7.1 pt -48.44 -29.61 2.55 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.177 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 179.054 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 6.5 m0 -58.97 -45.44 90.54 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.465 -0.788 . . . . 0.0 110.89 -179.607 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -68.84 -42.53 78.48 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 110.901 -0.879 . . . . 0.0 110.901 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.48 ' O ' ' OG ' ' A' ' 58' ' ' SER . 51.9 m -59.04 -56.31 23.93 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.798 0.332 . . . . 0.0 110.709 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 70.4 mt -67.32 -30.45 70.29 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.665 -179.722 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.493 ' CD1' ' C ' ' A' ' 57' ' ' TYR . 13.7 t80 -60.8 -36.31 78.7 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.132 179.572 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.48 ' OG ' ' O ' ' A' ' 55' ' ' THR . 7.7 p -74.07 -57.92 3.64 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.047 179.587 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -48.53 -52.29 23.29 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.022 179.645 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 70.6 mtm -55.09 -47.88 74.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.072 179.608 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -46.82 -59.56 5.44 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 110.717 -0.953 . . . . 0.0 110.717 179.804 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 3.4 m-30 -51.84 -52.18 51.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.924 0.392 . . . . 0.0 110.116 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.501 ' O ' HG23 ' A' ' 67' ' ' VAL . . . -47.83 -46.76 25.33 Favored Glycine 0 CA--C 1.522 0.53 0 N-CA-C 110.487 -1.045 . . . . 0.0 110.487 179.674 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.537 ' O ' ' NE1' ' A' ' 68' ' ' TRP . 1.1 t -60.53 -45.04 95.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.793 0.33 . . . . 0.0 110.577 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.416 ' HA ' ' CZ2' ' A' ' 68' ' ' TRP . 84.6 t80 -48.55 -45.85 38.19 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 179.58 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 37.9 mt -72.27 -26.06 24.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.136 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.501 HG23 ' O ' ' A' ' 63' ' ' GLY . 55.8 t -65.21 -59.94 3.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 C-N-CA 120.584 -0.446 . . . . 0.0 111.09 -179.673 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' TRP . . . . . 0.711 ' CE3' ' CE2' ' A' ' 5' ' ' TRP . 0.0 OUTLIER -67.51 -33.83 75.88 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 119.9 -0.72 . . . . 0.0 110.563 -179.753 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 5.8 mmmt -69.56 -23.41 63.56 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.517 -0.473 . . . . 0.0 111.035 -179.762 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 19.9 tp10 -80.95 -55.61 4.67 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.941 -0.304 . . . . 0.0 111.226 -179.471 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.6 pp -77.04 -11.77 59.85 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.93 -0.308 . . . . 0.0 111.184 -179.301 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.491 ' O ' ' O ' ' A' ' 73' ' ' GLY . . . 107.0 87.29 1.93 Allowed Glycine 0 CA--C 1.527 0.835 0 N-CA-C 111.604 -0.598 . . . . 0.0 111.604 179.398 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.596 ' N ' ' O ' ' A' ' 68' ' ' TRP . . . 41.56 -173.82 0.01 OUTLIER Glycine 0 CA--C 1.525 0.714 0 N-CA-C 111.797 -0.521 . . . . 0.0 111.797 179.207 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 82.7 t80 -79.94 113.39 18.07 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.841 0.353 . . . . 0.0 110.548 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.548 ' OG1' ' N ' ' A' ' 76' ' ' GLU . 0.0 OUTLIER -141.89 -178.85 5.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.626 -179.86 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.548 ' N ' ' OG1' ' A' ' 75' ' ' THR . 31.8 mt-10 -54.93 -20.12 8.23 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.623 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 76.0 m-20 -83.1 -18.57 39.1 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.921 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -93.32 -20.21 20.61 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.862 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 11.7 mtp -69.01 -27.22 65.49 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.846 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 5.9 t -67.56 -46.9 47.3 Favored Pre-proline 0 CA--C 1.536 0.432 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.534 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -75.18 -61.65 0.04 OUTLIER 'Trans proline' 0 N--CA 1.499 1.845 0 C-N-CA 121.106 1.204 . . . . 0.0 111.656 178.809 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 4.6 mt -52.33 -50.66 61.84 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.363 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.406 ' O ' ' N ' ' A' ' 86' ' ' THR . . . -61.93 -64.04 4.27 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 111.262 -0.735 . . . . 0.0 111.262 -179.705 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 40.3 tp -46.83 -29.61 2.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.823 0.344 . . . . 0.0 110.233 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.423 ' CD1' ' C ' ' A' ' 85' ' ' TYR . 1.1 t80 -75.27 -37.68 60.82 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.033 179.744 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.406 ' N ' ' O ' ' A' ' 83' ' ' GLY . 0.8 OUTLIER -67.91 -48.92 64.63 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.094 -179.648 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -69.15 -58.04 7.06 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 111.492 -0.643 . . . . 0.0 111.492 -179.507 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 34.0 tp60 -51.45 -49.23 62.14 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-O 120.991 0.424 . . . . 0.0 110.414 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.427 ' O ' ' C ' ' A' ' 90' ' ' ALA . 27.3 tp -54.65 -62.62 1.54 Allowed 'General case' 0 C--O 1.212 -0.869 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 179.525 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.696 ' O ' ' HB2' ' A' ' 94' ' ' ALA . . . -38.24 -42.81 0.72 Allowed 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 120.537 -0.465 . . . . 0.0 111.426 -179.683 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 92.1 mt -63.16 -56.81 13.57 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 -178.575 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 15.8 m-20 -72.24 -54.63 9.02 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 121.431 0.634 . . . . 0.0 111.058 -178.897 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' TRP . . . . . 0.61 ' O ' ' N ' ' A' ' 95' ' ' TRP . 16.6 t-105 -52.75 -30.0 30.23 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.049 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.696 ' HB2' ' O ' ' A' ' 90' ' ' ALA . . . -60.38 71.8 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 121.084 0.469 . . . . 0.0 109.753 179.376 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.71 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 23.8 p-90 -98.49 -17.18 0.2 Allowed Pre-proline 0 CA--C 1.537 0.478 0 CA-C-N 115.852 -0.613 . . . . 0.0 112.336 -179.255 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.71 ' CD ' ' N ' ' A' ' 95' ' ' TRP . 52.6 Cg_exo -53.4 -39.84 80.31 Favored 'Trans proline' 0 N--CA 1.497 1.684 0 C-N-CA 120.556 0.837 . . . . 0.0 113.341 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.457 ' HD2' ' N ' ' A' ' 96' ' ' PRO . 31.7 Cg_exo -36.52 -34.94 0.17 Allowed 'Trans proline' 0 N--CA 1.491 1.327 0 CA-C-N 119.143 0.73 . . . . 0.0 113.185 -179.727 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -79.58 24.27 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 121.024 0.44 . . . . 0.0 110.386 179.696 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.537 ' N ' ' O ' ' A' ' 96' ' ' PRO . 27.0 t80 -44.31 -34.93 2.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.666 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -86.19 -42.97 13.39 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.893 -179.762 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -61.42 -9.59 18.12 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 111.07 -0.812 . . . . 0.0 111.07 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -61.55 -13.27 20.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.748 0.309 . . . . 0.0 110.935 -179.762 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 25.3 ptt180 -90.68 4.56 51.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.809 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 12.1 mt-30 -115.28 154.2 29.53 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.435 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -52.71 -18.26 1.73 Allowed 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 179.559 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.583 ' O ' ' N ' ' A' ' 108' ' ' ALA . . . -69.43 -15.96 71.01 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' TRP . . . . . 0.452 ' CD1' ' N ' ' A' ' 108' ' ' ALA . 0.1 OUTLIER -45.36 -11.67 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.9 0.381 . . . . 0.0 110.54 -179.865 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.583 ' N ' ' O ' ' A' ' 106' ' ' GLY . . . -59.32 -23.15 62.24 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.193 179.657 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 13.9 mt -53.7 -28.66 35.05 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.383 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -56.71 -61.37 2.48 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.862 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.716 ' O ' HG23 ' A' ' 115' ' ' VAL . 1.4 p30 -61.53 -52.29 65.08 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.785 -179.293 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.531 ' N ' ' CG ' ' A' ' 111' ' ' ASP . 56.1 tp -55.42 -38.41 68.93 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.716 -178.876 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.42 HD23 ' HA ' ' A' ' 113' ' ' LEU . 51.7 mt -71.4 -61.81 1.64 Allowed 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.36 0.504 . . . . 0.0 112.36 -178.611 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.6 pp -59.75 -32.84 70.95 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.213 -0.595 . . . . 0.0 110.95 -178.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.716 HG23 ' O ' ' A' ' 111' ' ' ASP . 41.3 t -61.7 -59.47 4.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.752 179.767 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.49 ' O ' ' OG1' ' A' ' 120' ' ' THR . 49.4 m -68.84 -22.1 64.25 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.428 -179.261 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -66.51 -62.58 4.49 Favored Glycine 0 CA--C 1.527 0.823 0 C-N-CA 121.039 -0.601 . . . . 0.0 111.934 -179.124 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.6 ' O ' HG23 ' A' ' 122' ' ' THR . 7.0 p -72.43 -36.91 56.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 C-N-CA 120.915 -0.314 . . . . 0.0 111.411 -179.23 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.531 ' O ' ' OG1' ' A' ' 123' ' ' THR . . . -67.41 -61.01 2.11 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.593 -0.443 . . . . 0.0 110.953 -179.362 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.49 ' OG1' ' O ' ' A' ' 116' ' ' SER . 2.8 m -58.64 -55.33 36.53 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.234 -179.584 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.419 ' O ' ' CB ' ' A' ' 125' ' ' ALA . . . -50.53 -41.95 54.45 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.304 -179.352 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.6 HG23 ' O ' ' A' ' 118' ' ' VAL . 38.9 p -73.32 -39.72 65.04 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 111.844 0.313 . . . . 0.0 111.844 -179.095 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.531 ' OG1' ' O ' ' A' ' 119' ' ' ALA . 0.1 OUTLIER -54.09 -50.28 67.17 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.91 -179.268 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.6 pp -84.11 -20.32 32.76 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.198 -0.455 . . . . 0.0 112.077 -178.663 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.419 ' CB ' ' O ' ' A' ' 121' ' ' ALA . . . -88.68 -70.68 0.63 Allowed 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 -178.47 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' TRP . . . . . 0.55 ' CD1' ' N ' ' A' ' 126' ' ' TRP . 18.6 m0 -83.93 -58.0 2.97 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 112.84 0.681 . . . . 0.0 112.84 -177.862 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 18.9 m170 -49.77 -22.23 1.35 Allowed 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.458 -0.497 . . . . 0.0 110.932 -179.128 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 1.4 tmt_? -73.44 -29.47 62.57 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.023 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 14.6 t -99.76 -49.85 11.07 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 CA-C-O 120.942 0.401 . . . . 0.0 110.763 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -115.56 105.83 51.36 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.202 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' PRO . . . . . 0.64 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 76.9 Cg_exo -72.77 -24.34 18.22 Favored 'Trans proline' 0 C--N 1.311 -1.398 0 C-N-CA 121.59 1.526 . . . . 0.0 112.686 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.64 ' CD ' ' N ' ' A' ' 131' ' ' PRO . 51.2 Cg_exo -66.21 -47.47 3.34 Favored 'Trans proline' 0 N--CA 1.496 1.627 0 C-N-CA 121.292 1.328 . . . . 0.0 112.084 179.624 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -50.41 -39.39 47.03 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.568 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -53.92 -23.48 13.02 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.404 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 11.0 tpp180 -78.25 -32.4 49.63 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.545 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 47.0 mt -72.77 -33.47 66.34 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.32 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.58 ' O ' ' N ' ' A' ' 140' ' ' TYR . 5.6 mt -84.09 -39.26 19.74 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.002 -0.545 . . . . 0.0 109.855 179.519 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.477 ' C ' ' O ' ' A' ' 137' ' ' LEU . 2.0 t80 -23.72 -43.67 0.05 OUTLIER Pre-proline 0 CA--C 1.534 0.338 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.82 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.516 ' N ' ' O ' ' A' ' 137' ' ' LEU . 3.4 Cg_exo -67.61 10.96 0.24 Allowed 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 120.984 1.123 . . . . 0.0 112.561 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 140' ' ' TYR . . . . . 0.871 ' CE2' HD11 ' A' ' 144' ' ' LEU . 1.5 p90 -93.83 -14.88 25.65 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 121.083 0.468 . . . . 0.0 110.483 179.819 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.618 ' CD1' ' CE1' ' A' ' 140' ' ' TYR . 4.1 mp -53.63 -32.45 51.36 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 179.004 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -60.33 -52.46 65.17 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.217 179.75 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' TRP . . . . . 0.545 ' CE2' HD12 ' A' ' 52' ' ' ILE . 7.7 t-105 -53.08 -49.66 65.95 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 179.577 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.871 HD11 ' CE2' ' A' ' 140' ' ' TYR . 10.5 mt -49.99 -59.6 3.72 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.015 179.51 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.614 ' O ' HG23 ' A' ' 149' ' ' VAL . . . -58.73 -20.71 51.49 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.056 -179.684 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -67.18 -57.6 6.43 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.805 -0.358 . . . . 0.0 110.402 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -66.08 -47.4 74.38 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.216 179.75 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 7.1 m -55.68 -51.35 67.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.709 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.614 HG23 ' O ' ' A' ' 145' ' ' ALA . 90.7 t -64.68 -26.53 40.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 C-N-CA 120.895 -0.322 . . . . 0.0 110.278 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -60.72 -55.0 38.38 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.313 -0.555 . . . . 0.0 109.794 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 151' ' ' ASN . . . . . 0.495 ' ND2' ' OD2' ' A' ' 111' ' ' ASP . 1.9 m-80 -65.85 -39.89 91.19 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.694 -0.403 . . . . 0.0 110.357 179.429 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 29.3 t80 -56.05 -46.19 78.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.569 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' TYR . . . . . 0.408 ' O ' ' OD1' ' A' ' 157' ' ' ASP . 5.5 t80 -63.56 -44.66 93.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.479 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 79.5 t -57.74 -45.15 86.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.653 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' TRP . . . . . 0.588 ' O ' ' N ' ' A' ' 159' ' ' SER . 10.2 m0 -56.45 -56.98 14.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.518 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 156' ' ' ARG . . . . . 0.455 ' O ' ' O ' ' A' ' 159' ' ' SER . 0.9 OUTLIER -49.16 -38.71 26.4 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.589 -179.962 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 157' ' ' ASP . . . . . 0.408 ' OD1' ' O ' ' A' ' 153' ' ' TYR . 1.5 m-20 -75.41 -52.04 11.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.803 0.335 . . . . 0.0 110.675 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 158' ' ' ASN . . . . . 0.402 HD22 ' HB2' ' A' ' 37' ' ' LEU . 4.4 m-80 -74.79 -6.12 47.2 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.648 -179.772 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 159' ' ' SER . . . . . 0.588 ' N ' ' O ' ' A' ' 155' ' ' TRP . 7.6 t -149.03 131.52 15.75 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.808 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -175.32 71.51 0.09 OUTLIER Glycine 0 CA--C 1.526 0.759 0 N-CA-C 111.176 -0.77 . . . . 0.0 111.176 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 10.5 mtm-85 -95.17 90.38 5.87 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.752 0.31 . . . . 0.0 110.505 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 54.9 mtm180 -87.67 124.64 33.77 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.681 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 90.48 -165.5 31.2 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 111.128 -0.789 . . . . 0.0 111.128 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 164' ' ' GLY . . . . . 0.428 ' H ' ' H ' ' A' ' 165' ' ' SER . . . 176.48 11.76 0.02 OUTLIER Glycine 0 CA--C 1.525 0.707 0 N-CA-C 111.017 -0.833 . . . . 0.0 111.017 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 165' ' ' SER . . . . . 0.428 ' H ' ' H ' ' A' ' 164' ' ' GLY . 3.5 t 63.27 -172.26 0.17 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.837 0.351 . . . . 0.0 110.569 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 83.4 mtt180 -89.23 173.41 8.42 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.656 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.78 HD22 ' N ' ' A' ' 167' ' ' LEU . 1.5 mm? -108.13 62.12 0.61 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.113 179.608 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -74.23 -0.84 18.17 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.676 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 . . . . . 0 C--O 1.219 -0.503 0 CA-C-O 118.008 -0.996 . . . . 0.0 110.473 179.852 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 201' ' ' PKA . . . . . 0.603 'CL ' HG21 ' A' ' 26' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.529 0.151 0 CA-C-O 120.74 0.305 . . . . 0.0 110.463 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -73.9 150.14 43.42 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 C-N-CA 122.095 1.863 . . . . 0.0 112.118 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -133.93 -30.94 1.18 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.291 179.868 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.6 p 73.36 133.8 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.694 179.827 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.69 ' CE2' ' CE3' ' A' ' 68' ' ' TRP . 0.3 OUTLIER -61.43 118.41 6.94 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.001 179.806 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.609 ' N ' ' CD ' ' A' ' 7' ' ' PRO . 0.9 OUTLIER -61.66 -35.5 22.96 Favored Pre-proline 0 CA--C 1.532 0.277 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 -179.914 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.609 ' CD ' ' N ' ' A' ' 6' ' ' VAL . 18.6 Cg_exo -70.83 -67.53 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.509 0 C-N-CA 121.686 1.59 . . . . 0.0 111.835 179.541 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.656 ' O ' HG23 ' A' ' 12' ' ' THR . . . -46.79 -40.27 13.37 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.202 -179.652 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.572 HG23 ' O ' ' A' ' 5' ' ' TRP . 73.8 t -65.24 -61.97 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 112.062 0.393 . . . . 0.0 112.062 -178.938 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -58.38 -49.49 75.81 Favored Glycine 0 CA--C 1.527 0.837 0 N-CA-C 111.269 -0.732 . . . . 0.0 111.269 -179.158 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 9.3 mp -58.87 -30.54 67.81 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.538 0.209 . . . . 0.0 110.755 -179.852 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.656 HG23 ' O ' ' A' ' 8' ' ' ALA . 7.5 p -78.66 -31.18 46.64 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 120.801 -0.36 . . . . 0.0 110.191 179.548 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.416 ' HA ' HD23 ' A' ' 13' ' ' LEU . 81.2 mt -73.53 -22.17 60.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.117 179.656 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.498 ' O ' ' N ' ' A' ' 16' ' ' SER . 9.7 t -58.22 -66.6 1.26 Allowed Pre-proline 0 CA--C 1.536 0.434 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.312 -179.798 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -45.49 -14.87 0.11 Allowed 'Trans proline' 0 N--CA 1.499 1.799 0 C-N-CA 120.778 0.985 . . . . 0.0 112.074 -179.625 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.498 ' N ' ' O ' ' A' ' 14' ' ' VAL . 1.1 t -76.17 -35.99 58.9 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.866 0.365 . . . . 0.0 110.6 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 8.9 mt -69.75 -45.12 68.8 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.172 -179.736 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -73.6 -48.86 16.25 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 111.631 -0.588 . . . . 0.0 111.631 -179.545 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -63.24 -30.16 76.67 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 111.18 -0.768 . . . . 0.0 111.18 -179.576 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 64.4 t80 -75.95 -60.77 2.18 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.838 -0.345 . . . . 0.0 111.107 -179.528 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 28.0 ttp -61.59 -21.31 64.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.908 0.385 . . . . 0.0 110.324 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.515 ' C ' ' CZ2' ' A' ' 95' ' ' TRP . . . -73.45 -62.9 2.92 Favored Glycine 0 CA--C 1.524 0.615 0 N-CA-C 111.135 -0.786 . . . . 0.0 111.135 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.94 -16.49 63.92 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.54 -179.752 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 42.8 t80 -49.93 -24.15 2.37 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 179.264 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 9.7 t80 -72.11 -53.41 12.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.862 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 16.4 m -72.09 -14.58 17.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.81 -179.668 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.64 -42.69 75.35 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.255 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -121.45 -49.86 0.26 Allowed Glycine 0 CA--C 1.525 0.709 0 N-CA-C 110.693 -0.963 . . . . 0.0 110.693 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -56.01 -32.03 63.61 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.887 0.375 . . . . 0.0 110.417 179.838 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -75.46 -58.23 3.96 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.874 -0.89 . . . . 0.0 110.874 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 11.0 mp -53.49 -21.89 7.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.903 0.382 . . . . 0.0 110.06 179.676 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 38.9 mtp180 -84.86 -54.98 4.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.526 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -48.52 -30.57 5.36 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.182 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 52.1 t80 -50.3 -40.02 47.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.877 0.37 . . . . 0.0 110.31 179.723 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -58.91 -17.42 24.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.393 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -100.44 -72.15 0.99 Allowed Glycine 0 CA--C 1.527 0.796 0 N-CA-C 111.003 -0.839 . . . . 0.0 111.003 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.575 ' O ' HD12 ' A' ' 37' ' ' LEU . 0.3 OUTLIER -95.45 167.08 11.54 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.838 0.352 . . . . 0.0 110.828 179.861 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.441 ' CD ' ' H ' ' A' ' 38' ' ' GLN . 0.2 OUTLIER -81.62 113.38 19.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.126 -179.673 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 15.4 mtpt -129.05 160.19 64.91 Favored Pre-proline 0 CA--C 1.531 0.248 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.718 179.489 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.595 ' C ' ' H ' ' A' ' 42' ' ' TRP . 56.3 Cg_endo -82.55 30.48 0.53 Allowed 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 121.806 1.671 . . . . 0.0 111.381 179.356 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -51.12 -1.29 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.486 -179.896 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' TRP . . . . . 0.673 ' CH2' ' NE2' ' A' ' 43' ' ' HIS . 43.6 p-90 -76.38 -11.3 59.87 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.331 -0.548 . . . . 0.0 110.326 -179.247 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.673 ' NE2' ' CH2' ' A' ' 42' ' ' TRP . 5.6 m80 -63.71 133.16 95.44 Favored Pre-proline 0 C--N 1.328 -0.354 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 178.352 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.538 ' HG2' HD23 ' A' ' 49' ' ' LEU . 30.2 Cg_endo -34.94 149.82 0.03 OUTLIER 'Trans proline' 0 N--CA 1.496 1.622 0 C-N-CA 121.034 1.156 . . . . 0.0 111.464 -179.158 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -53.68 151.1 26.3 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 120.896 1.064 . . . . 0.0 111.823 -179.48 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.58 ' C ' ' HE ' ' A' ' 46' ' ' ARG . 0.0 OUTLIER -52.4 -17.71 1.31 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.997 -179.812 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.56 ' CD1' ' N ' ' A' ' 48' ' ' THR . 0.8 OUTLIER -49.71 -48.68 49.67 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.876 -0.33 . . . . 0.0 111.608 -179.105 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.56 ' N ' ' CD1' ' A' ' 47' ' ' TRP . 12.9 t -91.79 -27.47 17.98 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 -179.496 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.823 ' O ' HG23 ' A' ' 52' ' ' ILE . 0.2 OUTLIER -77.73 -56.77 4.24 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 112.243 0.46 . . . . 0.0 112.243 -178.05 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.587 ' C ' ' H ' ' A' ' 52' ' ' ILE . . . -38.3 -33.78 0.25 Allowed Pre-proline 0 C--O 1.235 0.337 0 C-N-CA 120.771 -0.372 . . . . 0.0 111.431 -179.03 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.43 ' HD2' ' N ' ' A' ' 50' ' ' ALA . 34.4 Cg_exo -53.69 4.93 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.613 0 C-N-CA 120.355 0.703 . . . . 0.0 112.773 178.816 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.823 HG23 ' O ' ' A' ' 49' ' ' LEU . 10.5 pt -54.08 -35.65 29.57 Favored 'Isoleucine or valine' 0 C--O 1.232 0.169 0 CA-C-O 121.248 0.547 . . . . 0.0 109.542 179.157 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.421 ' O ' ' CB ' ' A' ' 57' ' ' TYR . 62.3 m95 -73.17 -22.95 60.38 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.244 -0.889 . . . . 0.0 111.35 -179.285 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -70.49 -48.15 38.33 Favored Glycine 0 CA--C 1.527 0.812 0 N-CA-C 110.481 -1.048 . . . . 0.0 110.481 179.503 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 11.0 m -65.75 -55.28 18.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.969 0.414 . . . . 0.0 109.909 179.58 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.562 ' O ' ' SD ' ' A' ' 60' ' ' MET . 94.8 mt -56.71 -36.29 69.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.954 179.463 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.548 ' CD1' ' C ' ' A' ' 57' ' ' TYR . 0.4 OUTLIER -54.76 -52.03 63.84 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 179.109 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 3.1 m -52.23 -47.26 65.8 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 178.919 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -56.26 -46.24 79.74 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.343 179.781 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.562 ' SD ' ' O ' ' A' ' 56' ' ' LEU . 0.0 OUTLIER -61.87 -40.74 96.44 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.334 179.926 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -52.46 -52.89 34.69 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 110.641 -0.984 . . . . 0.0 110.641 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.46 ' CD1' ' N ' ' A' ' 62' ' ' TYR . 1.1 m-85 -65.78 -40.86 92.38 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.925 0.393 . . . . 0.0 110.376 179.762 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.46 ' O ' HG23 ' A' ' 67' ' ' VAL . . . -54.19 -52.55 43.13 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 110.342 -1.103 . . . . 0.0 110.342 179.644 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.587 ' O ' ' CD1' ' A' ' 68' ' ' TRP . 1.0 OUTLIER -56.47 -44.56 80.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.86 0.362 . . . . 0.0 110.42 179.684 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.45 ' HA ' ' CZ2' ' A' ' 68' ' ' TRP . 85.4 t80 -48.45 -47.35 38.27 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.674 -0.41 . . . . 0.0 110.083 179.651 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 53.3 mt -70.7 -25.95 27.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.041 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.46 HG23 ' O ' ' A' ' 63' ' ' GLY . 68.8 t -66.02 -58.79 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 C-N-CA 120.582 -0.447 . . . . 0.0 111.578 -179.41 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' TRP . . . . . 0.69 ' CE3' ' CE2' ' A' ' 5' ' ' TRP . 0.0 OUTLIER -71.79 -27.8 63.18 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 119.656 -0.818 . . . . 0.0 110.69 -179.643 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 9.4 mmmt -72.25 -24.2 61.33 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.468 -0.493 . . . . 0.0 110.352 179.658 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -82.31 -59.18 2.63 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.949 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.5 pp -71.67 -16.77 62.26 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.02 -179.548 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.5 ' O ' ' O ' ' A' ' 73' ' ' GLY . . . 108.39 94.53 2.34 Favored Glycine 0 CA--C 1.527 0.826 0 N-CA-C 111.703 -0.559 . . . . 0.0 111.703 179.459 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.585 ' N ' ' O ' ' A' ' 68' ' ' TRP . . . 42.02 -174.1 0.01 OUTLIER Glycine 0 CA--C 1.525 0.704 0 N-CA-C 111.799 -0.52 . . . . 0.0 111.799 179.198 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 32.4 t80 -87.22 113.21 22.75 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.547 -0.327 . . . . 0.0 110.595 -179.76 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.528 ' OG1' ' N ' ' A' ' 76' ' ' GLU . 0.8 OUTLIER -142.13 -177.41 5.22 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.686 -179.909 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.528 ' N ' ' OG1' ' A' ' 75' ' ' THR . 29.5 mt-10 -51.78 -23.14 4.27 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.796 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -79.72 -24.58 41.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.939 -179.76 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.446 ' O ' HD12 ' A' ' 82' ' ' LEU . . . -90.33 -20.59 22.7 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.003 -179.836 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 14.9 mtp -69.49 -28.66 66.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.806 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.416 ' O ' ' CB ' ' A' ' 84' ' ' LEU . 5.9 t -67.16 -50.77 39.01 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.507 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.4 ' HD2' ' N ' ' A' ' 80' ' ' VAL . 14.7 Cg_endo -69.52 -60.45 0.07 OUTLIER 'Trans proline' 0 N--CA 1.499 1.846 0 C-N-CA 121.065 1.177 . . . . 0.0 111.81 179.031 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.446 HD12 ' O ' ' A' ' 78' ' ' ALA . 1.3 mt -53.37 -51.95 60.84 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.614 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -62.84 -63.33 4.7 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 111.383 -0.687 . . . . 0.0 111.383 -179.485 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.416 ' CB ' ' O ' ' A' ' 80' ' ' VAL . 52.6 tp -45.87 -31.64 2.23 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.749 0.309 . . . . 0.0 110.647 -179.845 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 7.0 t80 -67.96 -58.51 4.42 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.274 -179.729 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 3.5 m -61.89 -60.35 3.77 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.841 -179.754 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -45.56 -57.11 6.04 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 111.112 -0.795 . . . . 0.0 111.112 -179.693 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 11.1 tp-100 -58.94 -32.85 69.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.759 0.314 . . . . 0.0 110.679 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.445 ' O ' ' CD1' ' A' ' 93' ' ' TRP . 11.8 tp -67.73 -36.59 80.85 Favored 'General case' 0 C--O 1.222 -0.379 0 C-N-CA 120.685 -0.406 . . . . 0.0 110.306 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.856 ' O ' ' HB2' ' A' ' 94' ' ' ALA . . . -65.81 -59.91 3.41 Favored 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 120.268 -0.573 . . . . 0.0 110.379 179.833 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.416 ' N ' HD23 ' A' ' 91' ' ' LEU . 7.9 mt -55.31 -53.89 50.44 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.786 -0.643 . . . . 0.0 112.21 -179.085 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -75.2 -60.83 2.12 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -177.769 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' TRP . . . . . 0.611 ' O ' ' N ' ' A' ' 95' ' ' TRP . 0.0 OUTLIER -63.78 -11.74 29.4 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.192 0.441 . . . . 0.0 112.192 -177.688 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.856 ' HB2' ' O ' ' A' ' 90' ' ' ALA . . . -54.12 80.5 0.0 OUTLIER 'General case' 0 CA--C 1.528 0.126 0 C-N-CA 120.399 -0.521 . . . . 0.0 109.76 179.224 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.689 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 14.6 p-90 -101.22 -15.23 0.18 Allowed Pre-proline 0 CA--C 1.534 0.338 0 CA-C-N 116.208 -0.451 . . . . 0.0 112.086 -179.312 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.689 ' CD ' ' N ' ' A' ' 95' ' ' TRP . 64.8 Cg_exo -64.12 -12.65 33.48 Favored 'Trans proline' 0 N--CA 1.498 1.768 0 C-N-CA 120.875 1.05 . . . . 0.0 113.558 179.634 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.621 ' CD ' ' N ' ' A' ' 96' ' ' PRO . 51.2 Cg_exo -85.33 -8.79 8.55 Favored 'Trans proline' 0 N--CA 1.502 1.978 0 C-N-CA 120.753 0.968 . . . . 0.0 113.519 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.416 ' O ' ' N ' ' A' ' 101' ' ' GLY . 1.5 pp -84.18 18.62 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 C-N-CA 120.608 -0.437 . . . . 0.0 110.932 -179.661 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.565 ' CD1' ' O ' ' A' ' 96' ' ' PRO . 2.7 m-30 -39.85 -34.12 0.25 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.211 179.673 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.457 ' O ' ' NE ' ' A' ' 103' ' ' ARG . 0.9 OUTLIER -76.36 -45.08 33.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.745 -179.902 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.416 ' N ' ' O ' ' A' ' 98' ' ' ILE . . . -65.98 -9.98 49.36 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 110.97 -0.852 . . . . 0.0 110.97 -179.921 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -78.35 -7.17 56.98 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.749 0.309 . . . . 0.0 110.724 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.457 ' NE ' ' O ' ' A' ' 100' ' ' PHE . 1.2 ptp180 -79.16 -14.8 58.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.867 -179.769 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' GLN . . . . . 0.407 ' C ' ' N ' ' A' ' 106' ' ' GLY . 1.4 pt20 -125.82 172.58 9.74 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.826 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.493 ' N ' ' SD ' ' A' ' 105' ' ' MET . 0.0 OUTLIER -49.37 -16.88 0.21 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.457 179.822 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.437 ' C ' ' N ' ' A' ' 108' ' ' ALA . . . -60.6 -15.79 41.84 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 111.1 -0.8 . . . . 0.0 111.1 -179.892 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' TRP . . . . . 0.481 ' CD1' ' N ' ' A' ' 108' ' ' ALA . 0.0 OUTLIER -50.48 -14.46 0.18 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.848 0.356 . . . . 0.0 110.432 -179.779 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.481 ' N ' ' CD1' ' A' ' 107' ' ' TRP . . . -61.11 -17.55 53.3 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.212 179.621 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 6.0 mp -56.67 -28.56 60.96 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.671 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -58.71 -62.63 1.72 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.845 0.355 . . . . 0.0 110.672 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.691 ' O ' HG23 ' A' ' 115' ' ' VAL . 4.4 p-10 -57.29 -53.67 55.53 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.358 -179.429 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 29.9 tp -54.45 -43.13 71.37 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.773 -179.034 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 53.7 mt -67.54 -61.3 1.96 Allowed 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.584 0.587 . . . . 0.0 112.584 -178.387 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.9 pp -61.09 -34.36 74.82 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 120.445 -0.502 . . . . 0.0 111.572 -178.555 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.691 HG23 ' O ' ' A' ' 111' ' ' ASP . 48.1 t -61.49 -58.0 9.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.383 -0.372 . . . . 0.0 111.385 -179.856 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 23.4 p -71.9 -23.59 61.51 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.603 -179.091 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -64.61 -62.14 5.31 Favored Glycine 0 CA--C 1.525 0.67 0 C-N-CA 120.842 -0.694 . . . . 0.0 111.472 -179.389 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.6 ' O ' HG23 ' A' ' 122' ' ' THR . 9.8 p -70.71 -37.18 68.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 111.874 0.324 . . . . 0.0 111.874 -179.336 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.512 ' O ' ' OG1' ' A' ' 123' ' ' THR . . . -67.96 -60.91 2.14 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.545 -0.462 . . . . 0.0 111.63 -179.087 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 6.4 m -59.47 -51.84 68.16 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.909 0.385 . . . . 0.0 111.464 -179.299 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -53.92 -43.37 69.71 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.272 -179.203 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.6 HG23 ' O ' ' A' ' 118' ' ' VAL . 38.0 p -71.13 -30.81 66.95 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 111.971 0.36 . . . . 0.0 111.971 -179.135 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.512 ' OG1' ' O ' ' A' ' 119' ' ' ALA . 0.1 OUTLIER -64.72 -48.79 73.32 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 120.851 -0.34 . . . . 0.0 111.074 -179.141 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.8 pp -82.79 -19.92 36.8 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.763 -0.375 . . . . 0.0 111.531 -179.021 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -88.93 -69.59 0.7 Allowed 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.594 0.591 . . . . 0.0 112.594 -178.689 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' TRP . . . . . 0.445 ' CD1' ' N ' ' A' ' 126' ' ' TRP . 36.9 m0 -83.14 -57.53 3.23 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 -177.751 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 127' ' ' HIS . . . . . 0.47 ' CD2' ' N ' ' A' ' 127' ' ' HIS . 10.0 m170 -52.12 -22.18 3.95 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.418 -0.513 . . . . 0.0 111.06 -178.661 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 2.8 tmt_? -71.07 -43.39 67.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.504 -0.317 . . . . 0.0 111.225 -179.833 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 14.9 t -86.92 -49.6 14.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 C-N-CA 120.922 -0.311 . . . . 0.0 111.054 -179.523 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 7.5 m -120.11 110.83 35.92 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.434 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' PRO . . . . . 0.627 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 73.6 Cg_exo -71.34 -33.78 10.68 Favored 'Trans proline' 0 N--CA 1.491 1.345 0 C-N-CA 121.373 1.382 . . . . 0.0 112.387 179.488 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.627 ' CD ' ' N ' ' A' ' 131' ' ' PRO . 37.1 Cg_exo -55.36 -39.09 92.91 Favored 'Trans proline' 0 N--CA 1.495 1.595 0 C-N-CA 121.31 1.34 . . . . 0.0 111.75 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -55.91 -34.66 65.78 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.334 179.772 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.403 ' HB2' ' CG ' ' A' ' 127' ' ' HIS . . . -64.83 -24.97 67.71 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.38 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 13.5 tpt180 -77.12 -29.12 54.59 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.362 179.801 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 18.4 mt -74.9 -41.05 60.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.379 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.574 ' O ' ' N ' ' A' ' 140' ' ' TYR . 5.0 mt -78.82 -35.49 44.06 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.152 179.624 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.481 ' C ' ' O ' ' A' ' 137' ' ' LEU . 2.0 t80 -23.4 -44.75 0.05 OUTLIER Pre-proline 0 CA--C 1.535 0.372 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.853 -179.865 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.515 ' N ' ' O ' ' A' ' 137' ' ' LEU . 1.7 Cg_endo -67.91 12.6 0.21 Allowed 'Trans proline' 0 C--N 1.309 -1.5 0 C-N-CA 121.188 1.259 . . . . 0.0 112.57 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 140' ' ' TYR . . . . . 0.865 ' CE2' HD11 ' A' ' 144' ' ' LEU . 1.7 p90 -93.41 -14.2 27.08 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-O 121.008 0.432 . . . . 0.0 110.633 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.492 HD22 ' CE1' ' A' ' 140' ' ' TYR . 4.1 mm? -53.37 -38.64 63.54 Favored 'General case' 0 C--N 1.333 -0.122 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 178.754 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -54.99 -46.58 75.14 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.549 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' TRP . . . . . 0.627 ' CE2' HD12 ' A' ' 52' ' ' ILE . 9.5 t-105 -59.21 -49.36 78.16 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.773 -0.455 . . . . 0.0 109.773 179.807 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.865 HD11 ' CE2' ' A' ' 140' ' ' TYR . 12.2 mt -51.89 -54.5 28.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.086 179.722 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.628 ' O ' HG23 ' A' ' 149' ' ' VAL . . . -60.5 -27.01 67.26 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.536 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -60.99 -64.56 0.91 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.533 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.4 ' HB1' ' C20' ' A' ' 201' ' ' PKA . . . -63.83 -49.14 74.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.694 -179.914 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 73.8 m -51.21 -47.22 62.33 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.911 -179.809 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.628 HG23 ' O ' ' A' ' 145' ' ' ALA . 53.3 t -65.24 -34.47 70.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.882 -179.738 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 1.7 tp -57.15 -55.56 33.22 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.837 0.351 . . . . 0.0 110.307 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -58.12 -57.12 14.22 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.413 179.697 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 18.5 t80 -46.76 -47.26 20.8 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.589 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 43.6 t80 -55.79 -42.98 76.38 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.611 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 89.1 t -66.53 -40.42 86.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.826 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 155' ' ' TRP . . . . . 0.515 ' C ' ' HE ' ' A' ' 156' ' ' ARG . 8.8 m0 -58.61 -39.74 81.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.801 -179.707 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 156' ' ' ARG . . . . . 0.515 ' HE ' ' C ' ' A' ' 155' ' ' TRP . 0.0 OUTLIER -79.29 -45.93 18.75 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.504 -179.885 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -64.19 -50.11 69.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.445 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -79.72 -12.39 59.8 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.524 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 92.6 p 49.19 98.36 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.597 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -71.13 -89.01 0.11 Allowed Glycine 0 CA--C 1.524 0.619 0 N-CA-C 110.804 -0.918 . . . . 0.0 110.804 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 13.8 mtm180 -70.39 80.5 0.55 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.828 0.347 . . . . 0.0 110.346 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 43.8 ttt180 -67.9 139.36 56.47 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.594 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 103.22 -72.51 0.28 Allowed Glycine 0 CA--C 1.526 0.738 0 N-CA-C 111.111 -0.795 . . . . 0.0 111.111 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 66.79 -109.52 2.95 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 110.809 -0.917 . . . . 0.0 110.809 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 48.0 t -67.04 153.06 44.59 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.875 0.369 . . . . 0.0 110.566 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 166' ' ' ARG . . . . . 0.462 ' O ' ' O ' ' A' ' 167' ' ' LEU . 93.0 mtt180 -44.27 159.28 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.675 -179.88 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.462 ' O ' ' O ' ' A' ' 166' ' ' ARG . 2.2 mp 54.02 161.58 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.779 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -158.01 -46.28 0.06 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.674 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 15.1 tt0 . . . . . 0 C--O 1.219 -0.522 0 CA-C-O 118.006 -0.997 . . . . 0.0 110.373 -179.797 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 201' ' ' PKA . . . . . 0.523 ' C15' 'CL ' ' A' ' 201' ' ' PKA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.547 ' SD ' ' O ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.888 0.375 . . . . 0.0 110.552 . . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.43 ' CD ' ' N ' ' A' ' 1' ' ' MET . 41.0 Cg_endo -76.66 155.94 35.53 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 C-N-CA 122.299 1.999 . . . . 0.0 112.01 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 -74.61 -47.51 31.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.64 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.1 p -176.59 132.64 0.21 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.494 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.663 ' CE2' ' CE3' ' A' ' 68' ' ' TRP . 0.4 OUTLIER -67.14 118.0 9.95 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.287 -179.86 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.626 ' N ' ' CD ' ' A' ' 7' ' ' PRO . 0.9 OUTLIER -64.61 -32.79 7.52 Favored Pre-proline 0 CA--C 1.534 0.335 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 179.743 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.626 ' CD ' ' N ' ' A' ' 6' ' ' VAL . 23.8 Cg_exo -72.61 -67.02 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 121.888 1.726 . . . . 0.0 112.156 179.654 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.696 ' O ' HG23 ' A' ' 12' ' ' THR . . . -50.93 -38.24 49.09 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.541 -0.3 . . . . 0.0 111.278 -179.565 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.559 HG23 ' O ' ' A' ' 5' ' ' TRP . 75.5 t -67.63 -62.25 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.756 -179.14 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -56.74 -47.61 84.16 Favored Glycine 0 CA--C 1.527 0.79 0 N-CA-C 111.743 -0.543 . . . . 0.0 111.743 -179.192 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.414 ' N ' ' CD1' ' A' ' 11' ' ' LEU . 7.7 mp -64.02 -30.91 71.95 Favored 'General case' 0 C--N 1.326 -0.433 0 O-C-N 122.921 -0.164 . . . . 0.0 111.052 -179.498 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.696 HG23 ' O ' ' A' ' 8' ' ' ALA . 7.5 p -74.96 -25.15 58.66 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.621 -0.432 . . . . 0.0 110.129 179.549 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.454 ' O ' ' CB ' ' A' ' 16' ' ' SER . 9.4 mt -80.65 -32.26 36.21 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.133 179.563 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.42 ' N ' ' HD2' ' A' ' 15' ' ' PRO . 17.9 t -44.65 -53.29 15.5 Favored Pre-proline 0 CA--C 1.536 0.414 0 CA-C-N 115.894 -0.593 . . . . 0.0 111.237 -179.806 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.42 ' HD2' ' N ' ' A' ' 14' ' ' VAL . 18.6 Cg_endo -62.56 -7.53 10.97 Favored 'Trans proline' 0 N--CA 1.499 1.82 0 C-N-CA 120.591 0.861 . . . . 0.0 111.882 179.582 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.454 ' CB ' ' O ' ' A' ' 13' ' ' LEU . 3.7 t -77.69 -26.37 50.15 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.543 -179.866 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 15.9 mt -76.73 -49.66 15.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.85 -179.818 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -77.79 -29.27 55.21 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 111.329 -0.708 . . . . 0.0 111.329 -179.652 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -76.72 -37.49 34.3 Favored Glycine 0 CA--C 1.523 0.539 0 N-CA-C 110.877 -0.889 . . . . 0.0 110.877 -179.829 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 77.9 t80 -72.85 -55.81 6.12 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.875 0.369 . . . . 0.0 110.295 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 32.5 ttp -69.81 -22.09 63.34 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.464 179.768 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.462 ' C ' ' CZ2' ' A' ' 95' ' ' TRP . . . -69.99 -63.38 3.33 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 111.159 -0.776 . . . . 0.0 111.159 -179.804 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.496 ' O ' HG22 ' A' ' 26' ' ' VAL . . . -68.86 -20.77 64.29 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 120.999 -0.281 . . . . 0.0 110.793 -179.623 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 56.5 t80 -47.27 -25.15 0.88 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.872 0.367 . . . . 0.0 110.479 179.706 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.426 ' CZ ' ' HB3' ' A' ' 102' ' ' ALA . 24.8 t80 -67.55 -55.55 13.01 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.797 -179.871 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.496 HG22 ' O ' ' A' ' 23' ' ' ALA . 27.5 m -68.08 -16.79 21.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.867 -179.663 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 3.3 ttm180 -60.5 -41.13 93.68 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.037 -179.613 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -104.74 -74.32 0.96 Allowed Glycine 0 CA--C 1.525 0.686 0 N-CA-C 111.393 -0.683 . . . . 0.0 111.393 -179.57 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.412 ' OE1' ' CZ ' ' A' ' 25' ' ' PHE . 22.8 tt0 -44.38 -33.02 1.51 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.641 0.258 . . . . 0.0 110.965 -179.515 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -63.38 -51.61 53.27 Favored Glycine 0 CA--C 1.526 0.757 0 N-CA-C 111.222 -0.751 . . . . 0.0 111.222 -179.833 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.638 HD21 ' NH2' ' A' ' 46' ' ' ARG . 83.6 mt -49.43 -47.24 48.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.728 0.299 . . . . 0.0 110.851 -179.829 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 67.8 mtm180 -68.79 -49.38 59.1 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.86 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -45.13 -43.61 9.92 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.429 -179.717 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 75.9 t80 -46.11 -45.13 16.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.802 -179.656 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -57.42 -25.91 60.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.811 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -87.64 -73.8 1.28 Allowed Glycine 0 CA--C 1.526 0.74 0 N-CA-C 110.901 -0.88 . . . . 0.0 110.901 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.566 ' O ' HD12 ' A' ' 37' ' ' LEU . 0.3 OUTLIER -95.89 167.63 11.13 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.873 0.368 . . . . 0.0 110.673 179.838 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -81.74 114.76 20.61 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.778 -179.725 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.509 ' C ' ' H ' ' A' ' 41' ' ' SER . 11.0 mtpt -128.77 148.78 70.04 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.076 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.631 ' C ' ' H ' ' A' ' 42' ' ' TRP . 93.2 Cg_endo -72.71 19.49 0.33 Allowed 'Trans proline' 0 C--N 1.308 -1.566 0 C-N-CA 121.445 1.43 . . . . 0.0 110.968 179.293 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.509 ' H ' ' C ' ' A' ' 39' ' ' LYS . 15.7 t -49.63 -1.7 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.386 -0.824 . . . . 0.0 110.972 179.781 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' TRP . . . . . 0.631 ' H ' ' C ' ' A' ' 40' ' ' PRO . 2.3 p90 -76.53 -15.21 59.93 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.744 -0.382 . . . . 0.0 110.369 -179.472 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.489 ' O ' ' C ' ' A' ' 44' ' ' PRO . 23.0 m80 -65.05 143.55 98.9 Favored Pre-proline 0 C--N 1.328 -0.353 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 179.071 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.489 ' C ' ' O ' ' A' ' 43' ' ' HIS . 68.6 Cg_exo -31.26 125.45 0.08 OUTLIER 'Trans proline' 0 N--CA 1.492 1.422 0 C-N-CA 121.441 1.427 . . . . 0.0 111.319 -179.461 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.6 ' O ' ' N ' ' A' ' 47' ' ' TRP . 11.4 Cg_endo -45.92 151.35 1.44 Allowed 'Trans proline' 0 C--N 1.31 -1.488 0 C-N-CA 120.22 0.614 . . . . 0.0 111.883 -178.906 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.735 ' H ' ' NE ' ' A' ' 46' ' ' ARG . 0.0 OUTLIER -38.66 -18.16 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.595 -179.008 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.6 ' N ' ' O ' ' A' ' 45' ' ' PRO . 0.0 OUTLIER -60.58 -37.54 81.68 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.705 0.288 . . . . 0.0 111.696 -179.05 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.585 ' N ' ' CD1' ' A' ' 47' ' ' TRP . 1.0 OUTLIER -91.01 -44.88 9.04 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 -178.399 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.68 HD23 ' O8 ' ' A' ' 201' ' ' PKA . 27.6 tp -83.02 -50.74 8.22 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -177.61 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.643 ' C ' ' H ' ' A' ' 52' ' ' ILE . . . -41.22 -28.46 0.24 Allowed Pre-proline 0 C--O 1.234 0.27 0 C-N-CA 120.141 -0.623 . . . . 0.0 111.516 -179.021 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.418 ' HD2' ' N ' ' A' ' 50' ' ' ALA . 22.3 Cg_exo -53.63 5.16 0.03 OUTLIER 'Trans proline' 0 C--N 1.313 -1.317 0 CA-C-N 118.955 0.663 . . . . 0.0 112.085 177.903 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.673 HG23 ' O ' ' A' ' 49' ' ' LEU . 7.2 pt -49.37 -29.27 3.73 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.144 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 178.841 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.605 ' O ' ' CD1' ' A' ' 57' ' ' TYR . 2.8 m0 -66.06 -45.91 79.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.799 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -59.34 -60.26 9.14 Favored Glycine 0 CA--C 1.527 0.82 0 N-CA-C 111.593 -0.603 . . . . 0.0 111.593 -179.609 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.734 HG23 ' H ' ' A' ' 56' ' ' LEU . 5.3 t -56.21 -60.71 3.11 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 121.033 -0.267 . . . . 0.0 111.329 -179.279 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.734 ' H ' HG23 ' A' ' 55' ' ' THR . 82.6 mt -50.82 -44.68 59.23 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 120.59 -0.444 . . . . 0.0 110.478 -179.744 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.605 ' CD1' ' O ' ' A' ' 53' ' ' TRP . 3.7 m-30 -50.93 -46.96 61.08 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 75.7 m -57.89 -42.15 84.05 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.187 -0.46 . . . . 0.0 109.911 179.584 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.78 -37.24 86.65 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.203 179.627 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 41.5 mtt -67.69 -49.18 64.07 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.462 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -52.09 -48.57 52.27 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 111.108 -0.797 . . . . 0.0 111.108 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -60.97 -56.69 18.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.868 0.366 . . . . 0.0 110.512 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.486 ' O ' HG23 ' A' ' 67' ' ' VAL . . . -49.55 -48.47 35.11 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.504 -1.038 . . . . 0.0 110.504 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.523 ' O ' ' NE1' ' A' ' 68' ' ' TRP . 1.2 t -57.7 -44.92 86.22 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.667 0.27 . . . . 0.0 110.707 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.451 ' HA ' ' CZ2' ' A' ' 68' ' ' TRP . 87.3 t80 -50.79 -44.52 58.9 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 179.301 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 69.9 mt -70.79 -25.16 25.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.787 179.598 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.486 HG23 ' O ' ' A' ' 63' ' ' GLY . 77.9 t -68.8 -59.04 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.155 0 C-N-CA 120.69 -0.404 . . . . 0.0 111.192 -179.67 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' TRP . . . . . 0.663 ' CE3' ' CE2' ' A' ' 5' ' ' TRP . 0.0 OUTLIER -67.65 -28.1 67.43 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 119.973 -0.691 . . . . 0.0 110.646 -179.666 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -73.22 -28.18 62.02 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.532 -0.467 . . . . 0.0 110.526 -179.885 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 32.0 tp10 -76.85 -59.99 2.54 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.79 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.447 HD11 ' O ' ' A' ' 73' ' ' GLY . 3.3 pp -69.11 -22.14 63.99 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.717 -179.744 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.497 ' O ' ' O ' ' A' ' 73' ' ' GLY . . . 110.68 97.58 2.43 Favored Glycine 0 CA--C 1.526 0.775 0 N-CA-C 111.585 -0.606 . . . . 0.0 111.585 179.586 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.557 ' N ' ' O ' ' A' ' 68' ' ' TRP . . . 41.88 -173.86 0.01 OUTLIER Glycine 0 CA--C 1.523 0.557 0 N-CA-C 111.667 -0.573 . . . . 0.0 111.667 179.389 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 51.5 t80 -87.54 111.64 21.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.819 0.342 . . . . 0.0 110.741 -179.606 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.576 ' OG1' ' N ' ' A' ' 76' ' ' GLU . 0.8 OUTLIER -141.73 -174.03 3.95 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.672 179.73 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.576 ' N ' ' OG1' ' A' ' 75' ' ' THR . 46.1 mt-10 -47.98 -44.29 30.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.174 -179.768 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -60.49 -24.4 65.26 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.502 -179.239 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -91.09 -25.34 19.68 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.82 -0.352 . . . . 0.0 111.234 -179.424 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 12.5 mtp -66.79 -27.78 67.86 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.814 -0.354 . . . . 0.0 111.354 -179.283 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.403 ' N ' ' HD2' ' A' ' 81' ' ' PRO . 4.7 t -68.72 -50.89 22.78 Favored Pre-proline 0 C--N 1.328 -0.335 0 C-N-CA 120.673 -0.411 . . . . 0.0 110.364 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.403 ' HD2' ' N ' ' A' ' 80' ' ' VAL . 15.5 Cg_endo -69.43 -62.38 0.05 OUTLIER 'Trans proline' 0 N--CA 1.498 1.764 0 C-N-CA 120.955 1.103 . . . . 0.0 111.616 179.007 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.0 mt -52.12 -52.45 51.45 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.271 179.592 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.504 ' O ' ' N ' ' A' ' 86' ' ' THR . . . -60.46 -63.88 4.61 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 111.367 -0.693 . . . . 0.0 111.367 -179.549 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 59.3 tp -43.15 -38.74 2.56 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.9 0.381 . . . . 0.0 110.114 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 6.3 t80 -68.22 -34.33 76.05 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.242 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.504 ' N ' ' O ' ' A' ' 83' ' ' GLY . 1.3 m -70.42 -57.97 4.23 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.917 -179.683 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -62.51 -49.23 75.64 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 111.463 -0.655 . . . . 0.0 111.463 -179.591 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.416 ' O ' ' CB ' ' A' ' 92' ' ' ASN . 51.6 tp60 -57.26 -45.54 83.91 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.739 0.304 . . . . 0.0 110.952 -179.583 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 11.6 tp -65.4 -29.12 69.79 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.475 -179.827 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.781 ' O ' ' HB2' ' A' ' 94' ' ' ALA . . . -67.04 -66.08 0.6 Allowed 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.393 -0.523 . . . . 0.0 111.176 -179.723 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.2 pp -67.64 -29.79 69.19 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 -178.842 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.416 ' CB ' ' O ' ' A' ' 88' ' ' GLN . 11.1 t-20 -84.12 -54.52 4.77 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 -178.441 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' TRP . . . . . 0.609 ' O ' ' N ' ' A' ' 95' ' ' TRP . 0.0 OUTLIER -76.57 -12.53 60.04 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.516 -0.474 . . . . 0.0 111.491 -178.478 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.781 ' HB2' ' O ' ' A' ' 90' ' ' ALA . . . -55.69 78.73 0.0 OUTLIER 'General case' 0 C--O 1.231 0.129 0 C-N-CA 120.448 -0.501 . . . . 0.0 109.852 179.174 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.708 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 44.1 p-90 -93.11 -16.87 0.21 Allowed Pre-proline 0 CA--C 1.533 0.302 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -179.444 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.708 ' CD ' ' N ' ' A' ' 95' ' ' TRP . 46.5 Cg_exo -55.66 -34.49 90.6 Favored 'Trans proline' 0 N--CA 1.495 1.576 0 C-N-CA 120.422 0.748 . . . . 0.0 113.021 179.502 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.555 ' C ' ' H ' ' A' ' 99' ' ' PHE . 33.6 Cg_exo -44.08 -30.84 3.58 Favored 'Trans proline' 0 N--CA 1.492 1.386 0 CA-C-N 118.969 0.668 . . . . 0.0 112.994 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.577 ' O ' ' N ' ' A' ' 101' ' ' GLY . 1.3 pp -72.61 20.22 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 121.076 0.465 . . . . 0.0 110.059 179.66 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.555 ' H ' ' C ' ' A' ' 97' ' ' PRO . 0.8 OUTLIER -39.72 -36.67 0.44 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.889 -179.968 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.401 ' O ' ' CG ' ' A' ' 103' ' ' ARG . 1.6 m-85 -85.98 -21.0 28.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.045 -179.518 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.577 ' N ' ' O ' ' A' ' 98' ' ' ILE . . . -89.16 -5.45 72.97 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 111.153 -0.779 . . . . 0.0 111.153 -179.718 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.426 ' HB3' ' CZ ' ' A' ' 25' ' ' PHE . . . -73.16 -11.26 60.47 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.778 0.323 . . . . 0.0 110.753 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.401 ' CG ' ' O ' ' A' ' 100' ' ' PHE . 5.4 ptp180 -94.94 11.61 31.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.586 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -123.97 162.62 23.02 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.63 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 21.2 mmm -57.18 -17.13 9.83 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.234 179.831 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.589 ' O ' ' N ' ' A' ' 108' ' ' ALA . . . -70.42 -15.01 72.48 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 111.214 -0.755 . . . . 0.0 111.214 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' TRP . . . . . 0.444 ' CD1' ' N ' ' A' ' 108' ' ' ALA . 0.1 OUTLIER -43.14 -12.51 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.521 0.2 . . . . 0.0 111.113 -179.468 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.589 ' N ' ' O ' ' A' ' 106' ' ' GLY . . . -63.01 -23.44 67.46 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-O 121.132 0.491 . . . . 0.0 110.075 179.417 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 54.6 mt -52.71 -29.45 26.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.107 179.726 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -56.19 -60.76 3.04 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.548 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.713 ' O ' HG23 ' A' ' 115' ' ' VAL . 1.2 p30 -57.46 -51.24 70.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.323 -179.673 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.601 HD13 ' O ' ' A' ' 112' ' ' LEU . 0.2 OUTLIER -55.29 -40.26 70.85 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.474 -178.944 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 11.3 mt -70.18 -61.51 1.75 Allowed 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 -178.655 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.4 pp -58.38 -30.55 66.88 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 120.292 -0.563 . . . . 0.0 110.866 -179.052 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.713 HG23 ' O ' ' A' ' 111' ' ' ASP . 38.7 t -65.49 -55.78 18.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.264 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 4.9 m -71.45 -24.57 62.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.4 -179.009 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.411 ' O ' ' CB ' ' A' ' 121' ' ' ALA . . . -68.02 -62.49 4.2 Favored Glycine 0 CA--C 1.527 0.794 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.051 -179.218 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.559 ' O ' HG23 ' A' ' 122' ' ' THR . 8.5 p -70.62 -36.93 67.64 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 O-C-N 122.738 -0.272 . . . . 0.0 111.572 -179.14 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.526 ' O ' ' OG1' ' A' ' 123' ' ' THR . . . -66.67 -60.54 2.61 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.493 -0.483 . . . . 0.0 111.201 -179.288 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 1.9 m -61.56 -53.68 53.11 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.334 -179.446 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.411 ' CB ' ' O ' ' A' ' 117' ' ' GLY . . . -50.12 -42.41 50.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.411 -0.358 . . . . 0.0 111.152 -179.494 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.559 HG23 ' O ' ' A' ' 118' ' ' VAL . 27.7 p -70.65 -39.32 73.69 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.64 -179.28 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.526 ' OG1' ' O ' ' A' ' 119' ' ' ALA . 0.2 OUTLIER -55.29 -52.2 64.23 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.921 0.391 . . . . 0.0 111.197 -179.312 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.7 pp -80.49 -20.33 43.91 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.752 -178.827 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -86.06 -73.88 0.44 Allowed 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -178.179 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' TRP . . . . . 0.571 ' CD1' ' N ' ' A' ' 126' ' ' TRP . 15.7 m0 -84.88 -57.37 3.14 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 112.762 0.653 . . . . 0.0 112.762 -177.444 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' HIS . . . . . 0.492 ' CD2' ' N ' ' A' ' 127' ' ' HIS . 9.7 m170 -47.71 -22.12 0.48 Allowed 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.686 -0.405 . . . . 0.0 111.121 -179.027 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 19.2 ttt85 -72.59 -40.84 66.25 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.063 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 86.4 t -88.37 -50.01 13.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.788 0.328 . . . . 0.0 111.076 -179.514 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 6.0 m -115.69 105.28 51.98 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.502 -179.734 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' PRO . . . . . 0.631 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 73.5 Cg_exo -70.98 -36.43 7.58 Favored 'Trans proline' 0 C--N 1.312 -1.364 0 C-N-CA 121.557 1.505 . . . . 0.0 112.726 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.631 ' CD ' ' N ' ' A' ' 131' ' ' PRO . 32.4 Cg_exo -55.8 -35.48 93.72 Favored 'Trans proline' 0 N--CA 1.496 1.675 0 C-N-CA 121.678 1.585 . . . . 0.0 111.946 -179.847 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -62.6 -43.2 99.41 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.66 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -50.47 -24.77 3.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.764 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 14.9 ttp180 -80.93 -28.39 35.78 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.786 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 26.7 mt -72.84 -39.18 66.75 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.779 -0.368 . . . . 0.0 110.068 179.807 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.583 ' O ' ' N ' ' A' ' 139' ' ' PRO . 4.8 mt -81.04 -35.78 31.38 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 179.126 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.473 ' C ' ' O ' ' A' ' 137' ' ' LEU . 14.3 t80 -24.23 -38.9 0.03 OUTLIER Pre-proline 0 CA--C 1.534 0.356 0 CA-C-N 115.368 -0.833 . . . . 0.0 112.118 -179.888 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.583 ' N ' ' O ' ' A' ' 137' ' ' LEU . 5.8 Cg_exo -66.62 5.54 0.73 Allowed 'Trans proline' 0 C--N 1.31 -1.479 0 C-N-CA 120.897 1.065 . . . . 0.0 112.771 179.508 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 140' ' ' TYR . . . . . 0.756 ' CE2' HD11 ' A' ' 144' ' ' LEU . 2.5 p90 -88.62 -14.55 37.22 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 120.54 -0.464 . . . . 0.0 111.074 -179.842 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.463 HD22 ' CE1' ' A' ' 140' ' ' TYR . 4.1 mm? -53.55 -33.45 54.72 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 178.568 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -60.63 -50.01 75.21 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.473 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' TRP . . . . . 0.462 ' CH2' ' HB2' ' A' ' 147' ' ' ALA . 8.8 t-105 -55.13 -46.1 75.62 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.226 -0.443 . . . . 0.0 109.844 179.74 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.756 HD11 ' CE2' ' A' ' 140' ' ' TYR . 9.3 mt -53.35 -55.96 20.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.267 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.605 ' O ' HG23 ' A' ' 149' ' ' VAL . . . -62.86 -18.85 63.5 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.94 -179.786 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -69.45 -63.34 1.09 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.682 -179.725 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.462 ' HB2' ' CH2' ' A' ' 143' ' ' TRP . . . -60.37 -47.42 86.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.414 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 89.0 m -53.93 -49.67 68.14 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.495 179.854 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.605 HG23 ' O ' ' A' ' 145' ' ' ALA . 45.0 t -62.42 -28.54 44.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.594 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.447 ' O ' HG23 ' A' ' 154' ' ' VAL . 0.9 OUTLIER -63.53 -54.85 29.81 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.704 -0.398 . . . . 0.0 110.415 -179.598 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 151' ' ' ASN . . . . . 0.612 ' ND2' ' H ' ' A' ' 152' ' ' TYR . 1.4 p-10 -67.47 -54.65 18.37 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.96 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 152' ' ' TYR . . . . . 0.612 ' H ' ' ND2' ' A' ' 151' ' ' ASN . 15.6 t80 -50.5 -43.26 55.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.681 -179.69 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 153' ' ' TYR . . . . . 0.481 ' C ' ' CD1' ' A' ' 153' ' ' TYR . 17.5 t80 -61.86 -43.75 98.22 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.188 179.72 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.447 HG23 ' O ' ' A' ' 150' ' ' LEU . 49.4 t -60.27 -35.25 60.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.597 179.801 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 155' ' ' TRP . . . . . 0.519 ' O ' ' N ' ' A' ' 159' ' ' SER . 8.1 m0 -62.99 -53.32 55.86 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.413 179.895 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 156' ' ' ARG . . . . . 0.436 ' CZ ' ' OH ' ' A' ' 152' ' ' TYR . 0.5 OUTLIER -64.73 -31.61 72.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.414 -179.899 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -71.33 -52.59 17.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.678 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 22.3 m-20 -83.92 -12.27 55.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.646 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 159' ' ' SER . . . . . 0.519 ' N ' ' O ' ' A' ' 155' ' ' TRP . 10.9 m 53.44 24.78 4.18 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.447 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 85.22 -105.62 2.91 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.784 -0.926 . . . . 0.0 110.784 -179.854 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 73.9 mtt85 -94.19 -111.78 0.12 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.757 0.313 . . . . 0.0 110.441 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.403 ' O ' ' CG ' ' A' ' 162' ' ' ARG . 25.1 ptt-85 -82.37 128.45 34.24 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 120.869 -0.333 . . . . 0.0 110.443 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -91.02 79.74 1.35 Allowed Glycine 0 CA--C 1.524 0.613 0 N-CA-C 110.946 -0.862 . . . . 0.0 110.946 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -147.15 34.28 1.31 Allowed Glycine 0 CA--C 1.526 0.719 0 N-CA-C 111.202 -0.759 . . . . 0.0 111.202 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 24.0 p -89.06 169.85 11.15 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.784 0.326 . . . . 0.0 110.634 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 166' ' ' ARG . . . . . 0.554 ' C ' HD13 ' A' ' 167' ' ' LEU . 11.0 mmp_? -107.16 178.81 4.44 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.536 179.805 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.853 ' N ' HD13 ' A' ' 167' ' ' LEU . 0.0 OUTLIER -150.8 -179.92 7.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.619 179.656 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -167.77 47.83 0.05 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.378 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 33.8 mm-40 . . . . . 0 C--O 1.221 -0.425 0 CA-C-O 118.011 -0.995 . . . . 0.0 110.573 179.946 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 201' ' ' PKA . . . . . 0.68 ' O8 ' HD23 ' A' ' 49' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.484 ' C ' ' SD ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.183 0 CA-C-O 120.888 0.375 . . . . 0.0 110.518 . . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -70.82 120.87 7.4 Favored 'Trans proline' 0 C--N 1.303 -1.823 0 C-N-CA 122.528 2.152 . . . . 0.0 112.228 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -55.98 -25.22 43.08 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.451 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.0 m 65.39 175.09 0.21 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.501 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.645 ' O ' HG23 ' A' ' 9' ' ' VAL . 2.2 t-105 -57.25 119.84 7.09 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.001 0.429 . . . . 0.0 110.038 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.497 HG12 ' N ' ' A' ' 7' ' ' PRO . 3.0 t -56.69 -69.45 0.44 Allowed Pre-proline 0 CA--C 1.537 0.471 0 CA-C-N 115.717 -0.674 . . . . 0.0 112.285 -178.375 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.497 ' N ' HG12 ' A' ' 6' ' ' VAL . 18.1 Cg_endo -46.3 -53.49 5.87 Favored 'Trans proline' 0 N--CA 1.494 1.519 0 C-N-CA 120.349 0.699 . . . . 0.0 112.343 -178.618 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.579 ' HB2' ' OG ' ' A' ' 64' ' ' SER . . . -49.14 -43.92 42.16 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.595 -0.442 . . . . 0.0 111.195 -179.74 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.645 HG23 ' O ' ' A' ' 5' ' ' TRP . 63.3 t -60.85 -60.97 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.775 -179.04 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -58.05 -53.95 41.42 Favored Glycine 0 CA--C 1.527 0.808 0 N-CA-C 111.369 -0.692 . . . . 0.0 111.369 -179.398 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 9.0 mp -54.53 -31.36 56.2 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.605 0.241 . . . . 0.0 110.775 -179.771 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.576 HG23 ' O ' ' A' ' 8' ' ' ALA . 8.9 p -79.03 -24.39 43.66 Favored 'General case' 0 C--N 1.333 -0.145 0 C-N-CA 120.783 -0.367 . . . . 0.0 110.41 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.423 ' HA ' HD23 ' A' ' 13' ' ' LEU . 41.3 mt -76.84 -26.48 54.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.152 179.49 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.486 ' O ' ' N ' ' A' ' 16' ' ' SER . 13.7 t -52.05 -64.22 1.64 Allowed Pre-proline 0 CA--C 1.536 0.42 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.593 -179.519 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_endo -44.6 -16.29 0.11 Allowed 'Trans proline' 0 N--CA 1.497 1.726 0 C-N-CA 120.941 1.094 . . . . 0.0 112.137 -179.434 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.486 ' N ' ' O ' ' A' ' 14' ' ' VAL . 0.5 OUTLIER -75.49 -29.12 59.46 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.641 -179.915 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 81.7 mt -68.22 -56.17 9.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.002 -179.816 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -66.96 -38.55 92.89 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 111.558 -0.617 . . . . 0.0 111.558 -179.362 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -74.12 -26.2 69.2 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 111.378 -0.689 . . . . 0.0 111.378 -179.433 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.441 ' CB ' ' O ' ' A' ' 16' ' ' SER . 34.3 t80 -78.0 -60.7 2.26 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.78 -0.368 . . . . 0.0 110.998 -179.665 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 19.9 tpp -71.53 -21.26 61.93 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.34 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.422 ' C ' ' CZ2' ' A' ' 95' ' ' TRP . . . -75.51 -53.59 5.92 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 111.302 -0.719 . . . . 0.0 111.302 -179.802 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.625 ' O ' HG22 ' A' ' 26' ' ' VAL . . . -73.56 -20.81 60.53 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.963 0.411 . . . . 0.0 110.461 -179.702 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.43 ' CD1' ' O ' ' A' ' 24' ' ' TYR . 27.2 t80 -51.08 -23.9 3.49 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.862 179.298 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 52.1 t80 -71.27 -55.46 8.02 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.02 -179.779 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.625 HG22 ' O ' ' A' ' 23' ' ' ALA . 34.6 m -58.46 -26.06 29.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 C-N-CA 120.599 -0.441 . . . . 0.0 110.306 -179.796 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.519 ' O ' ' CD1' ' A' ' 31' ' ' LEU . 0.0 OUTLIER -87.95 -15.08 37.53 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.338 179.851 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -101.33 -71.66 0.94 Allowed Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.835 -0.906 . . . . 0.0 110.835 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.403 ' OE2' ' O ' ' A' ' 29' ' ' GLU . 3.3 tm-20 -76.88 -36.89 56.39 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.739 0.304 . . . . 0.0 110.567 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -51.3 -36.12 36.38 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 110.89 -0.884 . . . . 0.0 110.89 -179.79 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.519 ' CD1' ' O ' ' A' ' 27' ' ' ARG . 86.3 mt -55.35 -32.17 62.34 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.737 0.303 . . . . 0.0 110.348 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.434 ' O ' ' N ' ' A' ' 35' ' ' ALA . 37.6 ttm180 -81.28 -48.96 11.33 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.252 179.728 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' TRP . . . . . 0.565 ' CZ3' HD21 ' A' ' 37' ' ' LEU . 0.0 OUTLIER -44.76 -36.13 3.05 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 179.473 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 26.6 t80 -55.66 -40.52 72.36 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.287 179.452 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.434 ' N ' ' O ' ' A' ' 32' ' ' ARG . . . -53.29 -26.96 20.46 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.169 179.784 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -90.37 -72.32 1.25 Allowed Glycine 0 CA--C 1.524 0.615 0 N-CA-C 110.921 -0.872 . . . . 0.0 110.921 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.565 HD21 ' CZ3' ' A' ' 33' ' ' TRP . 0.3 OUTLIER -96.1 167.64 11.09 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 120.947 0.404 . . . . 0.0 110.88 179.614 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 43.8 mm-40 -84.79 122.93 29.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.241 -179.256 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.508 ' C ' ' H ' ' A' ' 41' ' ' SER . 16.0 mtpt -129.28 153.34 80.47 Favored Pre-proline 0 N--CA 1.464 0.24 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.048 179.443 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.637 ' C ' ' H ' ' A' ' 42' ' ' TRP . 56.8 Cg_endo -73.17 26.23 0.3 Allowed 'Trans proline' 0 C--N 1.31 -1.47 0 C-N-CA 121.549 1.499 . . . . 0.0 111.372 179.417 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.508 ' H ' ' C ' ' A' ' 39' ' ' LYS . 1.5 t -50.13 -0.65 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.105 179.689 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' TRP . . . . . 0.637 ' H ' ' C ' ' A' ' 40' ' ' PRO . 44.6 p-90 -76.27 -15.07 60.08 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.517 -0.473 . . . . 0.0 111.144 -178.875 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.454 ' O ' ' C ' ' A' ' 44' ' ' PRO . 0.3 OUTLIER -82.07 143.13 48.75 Favored Pre-proline 0 C--N 1.329 -0.292 0 C-N-CA 120.157 -0.617 . . . . 0.0 109.419 178.622 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.454 ' C ' ' O ' ' A' ' 43' ' ' HIS . 52.2 Cg_exo -33.88 143.04 0.06 OUTLIER 'Trans proline' 0 C--N 1.311 -1.41 0 C-N-CA 121.399 1.4 . . . . 0.0 111.717 -179.463 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -69.49 169.91 17.47 Favored 'Trans proline' 0 C--N 1.313 -1.29 0 C-N-CA 120.595 0.864 . . . . 0.0 111.322 179.748 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.471 HH11 ' N ' ' A' ' 47' ' ' TRP . 0.0 OUTLIER -47.7 -17.9 0.12 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.771 -179.149 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.599 ' CD1' ' N ' ' A' ' 48' ' ' THR . 1.4 p-90 -61.81 -45.05 95.5 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 120.151 -0.62 . . . . 0.0 111.159 -179.188 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.599 ' N ' ' CD1' ' A' ' 47' ' ' TRP . 1.2 m -91.43 -33.79 15.1 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.983 -178.973 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.751 ' O ' HG23 ' A' ' 52' ' ' ILE . 0.2 OUTLIER -83.28 -43.86 15.58 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 112.686 0.624 . . . . 0.0 112.686 -177.936 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.591 ' C ' ' H ' ' A' ' 52' ' ' ILE . . . -40.34 -30.26 0.24 Allowed Pre-proline 0 N--CA 1.468 0.427 0 C-N-CA 120.857 -0.337 . . . . 0.0 111.818 -178.699 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.408 ' HD2' ' N ' ' A' ' 50' ' ' ALA . 33.6 Cg_exo -53.76 4.53 0.04 OUTLIER 'Trans proline' 0 C--N 1.312 -1.382 0 CA-C-N 119.163 0.737 . . . . 0.0 112.547 178.498 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.751 HG23 ' O ' ' A' ' 49' ' ' LEU . 44.0 pt -53.52 -32.42 20.51 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 C-N-CA 120.515 -0.474 . . . . 0.0 109.779 179.52 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.457 ' O ' ' CB ' ' A' ' 57' ' ' TYR . 60.9 m95 -78.94 -23.08 44.87 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.267 -179.145 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -68.54 -45.47 67.24 Favored Glycine 0 CA--C 1.527 0.793 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 178.773 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 16.5 m -69.27 -58.45 4.02 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-O 120.991 0.424 . . . . 0.0 110.0 179.408 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 96.6 mt -54.55 -28.62 46.99 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.033 179.511 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.521 ' CD1' ' C ' ' A' ' 57' ' ' TYR . 0.6 OUTLIER -63.51 -58.98 5.27 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 179.523 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 11.0 m -46.16 -49.29 17.01 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.406 -0.518 . . . . 0.0 109.909 179.515 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.55 -51.49 69.65 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.856 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 12.3 mtm -55.81 -35.59 66.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.78 -179.682 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -61.88 -49.31 77.05 Favored Glycine 0 CA--C 1.522 0.491 0 N-CA-C 110.59 -1.004 . . . . 0.0 110.59 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -56.83 -60.27 3.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.817 0.341 . . . . 0.0 110.501 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.539 ' O ' HG23 ' A' ' 67' ' ' VAL . . . -52.21 -49.74 49.15 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 110.66 -0.976 . . . . 0.0 110.66 179.892 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.58 ' O ' ' CE2' ' A' ' 68' ' ' TRP . 1.4 t -48.1 -54.24 13.87 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.108 0.48 . . . . 0.0 110.396 179.617 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 59.0 t80 -51.28 -41.48 60.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.51 179.834 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 84.9 mt -67.72 -45.58 84.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.329 -179.856 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.789 HG22 ' OG ' ' A' ' 130' ' ' SER . 39.0 t -50.72 -55.81 5.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 C-N-CA 121.043 -0.263 . . . . 0.0 111.277 -179.327 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' TRP . . . . . 0.585 ' O ' ' N ' ' A' ' 73' ' ' GLY . 0.7 OUTLIER -59.97 -52.56 64.89 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.686 -179.542 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 24.3 mmtt -53.64 -22.67 9.22 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.993 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 43.0 tp10 -79.6 -62.46 1.68 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.441 -179.312 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.0 pp -71.22 -1.17 11.72 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.2 -179.297 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 104.43 64.98 0.68 Allowed Glycine 0 CA--C 1.526 0.778 0 N-CA-C 111.43 -0.668 . . . . 0.0 111.43 179.51 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.585 ' N ' ' O ' ' A' ' 68' ' ' TRP . . . 51.75 -174.46 0.15 Allowed Glycine 0 CA--C 1.525 0.679 0 N-CA-C 111.325 -0.71 . . . . 0.0 111.325 179.661 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 89.8 t80 -76.62 110.72 11.42 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.86 0.362 . . . . 0.0 110.604 -179.784 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.591 ' OG1' ' N ' ' A' ' 76' ' ' GLU . 0.0 OUTLIER -139.17 -174.94 4.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.13 179.804 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.591 ' N ' ' OG1' ' A' ' 75' ' ' THR . 3.1 pt-20 -50.55 -21.62 1.61 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.839 -179.838 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -83.95 -18.47 37.16 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.105 -179.538 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -89.32 -18.25 27.32 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.874 -0.33 . . . . 0.0 110.838 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 15.4 mtp -69.32 -27.4 65.35 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.871 -0.332 . . . . 0.0 110.573 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 5.0 t -67.73 -47.94 43.26 Favored Pre-proline 0 CA--C 1.535 0.4 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.582 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -71.83 -58.12 0.08 OUTLIER 'Trans proline' 0 N--CA 1.498 1.786 0 C-N-CA 121.187 1.258 . . . . 0.0 112.087 179.277 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 13.0 mt -60.08 -53.4 58.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.985 0.421 . . . . 0.0 110.678 -179.851 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -55.86 -55.19 30.28 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 111.268 -0.733 . . . . 0.0 111.268 -179.537 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.404 ' O ' ' CB ' ' A' ' 88' ' ' GLN . 33.0 tp -61.01 -24.23 66.0 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.687 0.279 . . . . 0.0 110.936 -179.702 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -74.7 -56.49 4.74 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.884 -179.685 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.415 HG23 ' N ' ' A' ' 87' ' ' GLY . 14.2 t -66.13 -38.35 87.97 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.799 -0.361 . . . . 0.0 110.977 -179.64 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.415 ' N ' HG23 ' A' ' 86' ' ' THR . . . -68.77 -57.26 8.14 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.932 -0.867 . . . . 0.0 110.932 -179.843 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.45 ' O ' ' CB ' ' A' ' 92' ' ' ASN . 5.0 tp-100 -58.09 -40.5 81.28 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.859 0.362 . . . . 0.0 110.149 179.756 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 12.3 tp -67.37 -30.54 70.35 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.292 179.798 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.826 ' O ' ' HB2' ' A' ' 94' ' ' ALA . . . -66.95 -66.09 0.6 Allowed 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 120.13 -0.628 . . . . 0.0 110.944 -179.746 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.0 pp -66.51 -29.68 69.83 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.389 0.514 . . . . 0.0 112.389 -178.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.45 ' CB ' ' O ' ' A' ' 88' ' ' GLN . 35.3 t-20 -85.2 -62.2 1.59 Allowed 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.551 -0.46 . . . . 0.0 111.815 -178.827 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' TRP . . . . . 0.631 ' O ' ' N ' ' A' ' 95' ' ' TRP . 0.0 OUTLIER -64.57 -17.57 64.08 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.552 -0.459 . . . . 0.0 110.834 -179.007 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.826 ' HB2' ' O ' ' A' ' 90' ' ' ALA . . . -48.76 83.81 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 179.313 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.698 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 23.2 p-90 -100.95 -16.13 0.19 Allowed Pre-proline 0 CA--C 1.535 0.377 0 CA-C-N 116.107 -0.497 . . . . 0.0 112.334 -179.235 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.698 ' CD ' ' N ' ' A' ' 95' ' ' TRP . 37.2 Cg_exo -60.65 -31.52 92.21 Favored 'Trans proline' 0 N--CA 1.495 1.582 0 CA-C-N 119.067 0.703 . . . . 0.0 112.718 179.691 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.518 ' CD ' ' N ' ' A' ' 96' ' ' PRO . 83.8 Cg_exo -56.76 -16.92 21.23 Favored 'Trans proline' 0 N--CA 1.496 1.647 0 C-N-CA 120.803 1.002 . . . . 0.0 113.15 -179.775 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.423 ' O ' ' N ' ' A' ' 101' ' ' GLY . 1.1 pp -88.34 20.36 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 C-N-CA 120.713 -0.395 . . . . 0.0 110.732 -179.718 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.597 ' CD2' ' O ' ' A' ' 96' ' ' PRO . 29.7 m-85 -39.36 -36.96 0.4 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.326 179.649 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.557 ' CD1' ' N ' ' A' ' 100' ' ' PHE . 0.5 OUTLIER -76.71 -43.87 35.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.697 179.948 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.423 ' N ' ' O ' ' A' ' 98' ' ' ILE . . . -62.23 -11.28 32.29 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 111.083 -0.807 . . . . 0.0 111.083 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -62.17 -38.47 89.17 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.637 0.256 . . . . 0.0 111.198 -179.615 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.16 17.97 2.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.078 -179.607 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 11.5 mt-30 -124.4 160.15 28.81 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.888 0.375 . . . . 0.0 110.638 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.547 ' N ' ' SD ' ' A' ' 105' ' ' MET . 0.0 OUTLIER -51.12 -17.06 0.57 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.416 179.813 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.601 ' O ' ' N ' ' A' ' 108' ' ' ALA . . . -75.48 -14.13 82.27 Favored Glycine 0 CA--C 1.529 0.919 0 CA-C-N 115.938 -0.573 . . . . 0.0 111.722 -179.554 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' TRP . . . . . 0.617 ' CD1' ' CZ2' ' A' ' 155' ' ' TRP . 0.0 OUTLIER -36.62 -21.84 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.417 0 CA-C-O 120.529 0.204 . . . . 0.0 111.366 -179.165 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.601 ' N ' ' O ' ' A' ' 106' ' ' GLY . . . -63.35 -16.67 61.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.669 0.271 . . . . 0.0 111.168 -179.322 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 6.2 mp -54.5 -32.95 58.95 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.776 -179.632 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.442 ' O ' HD23 ' A' ' 114' ' ' LEU . . . -55.82 -62.33 1.76 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.858 0.361 . . . . 0.0 111.138 -179.628 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.689 ' O ' HG23 ' A' ' 115' ' ' VAL . 3.8 p-10 -58.92 -54.43 47.24 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.033 -0.53 . . . . 0.0 112.005 -179.155 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 34.3 tp -55.76 -44.36 77.59 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 -178.56 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 52.1 mt -64.24 -60.68 2.9 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.254 0.465 . . . . 0.0 112.254 -178.482 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.442 HD23 ' O ' ' A' ' 110' ' ' ALA . 2.3 pp -62.89 -35.32 79.64 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.494 -0.483 . . . . 0.0 111.68 -178.565 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.689 HG23 ' O ' ' A' ' 111' ' ' ASP . 27.2 t -57.91 -60.12 2.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.136 -179.687 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.488 ' O ' ' OG1' ' A' ' 120' ' ' THR . 4.5 m -74.18 -22.44 59.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.427 -0.352 . . . . 0.0 111.592 -178.934 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -62.93 -62.71 5.22 Favored Glycine 0 CA--C 1.526 0.721 0 C-N-CA 120.783 -0.723 . . . . 0.0 111.475 -179.418 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.593 ' O ' HG23 ' A' ' 122' ' ' THR . 8.6 p -75.58 -35.1 30.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 C-N-CA 121.035 -0.266 . . . . 0.0 111.046 -179.579 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.526 ' O ' ' OG1' ' A' ' 123' ' ' THR . . . -66.69 -60.4 2.73 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.635 -0.426 . . . . 0.0 110.56 -179.742 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.488 ' OG1' ' O ' ' A' ' 116' ' ' SER . 2.4 m -60.32 -54.57 44.15 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.408 -179.589 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.408 ' O ' ' CB ' ' A' ' 125' ' ' ALA . . . -51.25 -41.12 60.14 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.314 -179.153 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.593 HG23 ' O ' ' A' ' 118' ' ' VAL . 36.0 p -73.19 -29.95 63.2 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.625 -179.19 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.526 ' OG1' ' O ' ' A' ' 119' ' ' ALA . 0.2 OUTLIER -66.84 -49.89 64.3 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.714 -0.394 . . . . 0.0 110.864 -179.412 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.8 pp -81.44 -19.05 43.27 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.57 -179.04 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.408 ' CB ' ' O ' ' A' ' 121' ' ' ALA . . . -93.61 -65.28 1.0 Allowed 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.427 0.529 . . . . 0.0 112.427 -178.824 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 42.1 m0 -83.59 -56.98 3.42 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 113.056 0.762 . . . . 0.0 113.056 -177.802 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' HIS . . . . . 0.467 ' CG ' ' HB2' ' A' ' 134' ' ' ALA . 11.1 m170 -59.6 -25.62 64.77 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.586 -0.445 . . . . 0.0 111.569 -178.535 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 15.9 ttt180 -61.76 -41.17 97.34 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.31 -179.455 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 33.4 t -93.34 -48.88 13.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.517 -0.311 . . . . 0.0 110.964 -179.611 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' SER . . . . . 0.789 ' OG ' HG22 ' A' ' 67' ' ' VAL . 2.1 p -113.07 107.94 53.63 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.884 -179.301 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 131' ' ' PRO . . . . . 0.646 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 73.8 Cg_exo -74.69 -26.52 11.49 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 C-N-CA 121.702 1.601 . . . . 0.0 112.741 179.355 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.646 ' CD ' ' N ' ' A' ' 131' ' ' PRO . 52.0 Cg_exo -62.09 -54.97 1.17 Allowed 'Trans proline' 0 N--CA 1.496 1.666 0 C-N-CA 121.357 1.372 . . . . 0.0 112.194 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.524 ' O ' ' N ' ' A' ' 136' ' ' LEU . . . -45.97 -46.07 16.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.879 0.371 . . . . 0.0 110.42 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.467 ' HB2' ' CG ' ' A' ' 127' ' ' HIS . . . -45.12 -27.31 0.57 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.109 179.816 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 10.1 tpp180 -76.3 -30.7 57.85 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.299 179.865 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.524 ' N ' ' O ' ' A' ' 133' ' ' ALA . 36.6 mt -74.16 -24.9 59.47 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 179.303 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.573 ' O ' ' N ' ' A' ' 140' ' ' TYR . 3.7 mt -89.81 -33.26 16.58 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.075 179.511 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.519 ' CD1' ' C ' ' A' ' 138' ' ' TYR . 0.5 OUTLIER -27.68 -51.13 0.23 Allowed Pre-proline 0 CA--C 1.536 0.416 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.554 179.727 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.432 ' HD2' ' N ' ' A' ' 138' ' ' TYR . 2.2 Cg_endo -58.76 4.69 0.11 Allowed 'Trans proline' 0 N--CA 1.497 1.687 0 C-N-CA 121.374 1.383 . . . . 0.0 112.689 -179.823 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 140' ' ' TYR . . . . . 0.573 ' N ' ' O ' ' A' ' 137' ' ' LEU . 0.3 OUTLIER -90.66 -15.41 30.45 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.904 0.383 . . . . 0.0 110.724 179.764 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.467 HD23 HD12 ' A' ' 144' ' ' LEU . 97.6 mt -60.09 -36.5 77.55 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 178.872 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -56.61 -41.8 77.67 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.689 179.161 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' TRP . . . . . . . . . . . . . 7.5 t-105 -62.74 -43.66 98.22 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 115.771 -0.65 . . . . 0.0 109.472 179.227 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.467 HD12 HD23 ' A' ' 141' ' ' LEU . 22.0 mt -58.44 -37.59 75.73 Favored 'General case' 0 CA--C 1.521 -0.163 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.707 179.268 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.673 ' O ' HG23 ' A' ' 149' ' ' VAL . . . -73.28 -27.84 61.78 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.496 179.848 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 28.7 t80 -64.75 -62.32 1.64 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.781 -179.781 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.489 ' O ' ' OD1' ' A' ' 151' ' ' ASN . . . -64.15 -43.84 93.95 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.432 -0.507 . . . . 0.0 110.45 -179.815 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 148' ' ' THR . . . . . 0.499 ' O ' ' OD1' ' A' ' 151' ' ' ASN . 52.4 m -57.89 -36.71 72.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.475 179.807 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.673 HG23 ' O ' ' A' ' 145' ' ' ALA . 39.3 t -74.65 -27.5 20.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.686 179.82 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.546 ' O ' HG23 ' A' ' 154' ' ' VAL . 0.7 OUTLIER -66.41 -52.64 44.45 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.426 -0.509 . . . . 0.0 110.209 -179.935 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 151' ' ' ASN . . . . . 0.499 ' OD1' ' O ' ' A' ' 148' ' ' THR . 8.1 p-10 -65.35 -43.42 90.93 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.25 -179.837 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 152' ' ' TYR . . . . . 0.455 ' C ' ' CD1' ' A' ' 152' ' ' TYR . 22.6 t80 -64.78 -42.44 95.09 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.988 -0.285 . . . . 0.0 111.006 -179.562 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 77.1 t80 -61.18 -41.16 96.29 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.181 -179.376 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.546 HG23 ' O ' ' A' ' 150' ' ' LEU . 42.9 t -75.44 -50.46 23.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.38 -179.348 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 155' ' ' TRP . . . . . 0.617 ' CZ2' ' CD1' ' A' ' 107' ' ' TRP . 0.1 OUTLIER -55.4 -29.4 58.45 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.826 -178.889 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 156' ' ' ARG . . . . . 0.418 ' HA ' HH11 ' A' ' 156' ' ' ARG . 0.1 OUTLIER -85.41 -45.93 11.4 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.952 -0.299 . . . . 0.0 110.625 -179.639 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -69.02 -44.02 73.58 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.897 -179.741 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 16.3 t30 -69.74 -10.22 57.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.79 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 27.0 t -62.22 -28.51 69.74 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.71 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 83.0 -162.01 40.32 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 110.842 -0.903 . . . . 0.0 110.842 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 83.0 mtt-85 -139.06 167.93 20.95 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.828 0.347 . . . . 0.0 110.526 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 89.3 mtt180 -89.05 141.83 28.16 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.7 -179.796 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 82.09 118.66 0.52 Allowed Glycine 0 CA--C 1.524 0.62 0 N-CA-C 111.106 -0.798 . . . . 0.0 111.106 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 160.15 -106.31 0.28 Allowed Glycine 0 CA--C 1.524 0.624 0 N-CA-C 111.223 -0.751 . . . . 0.0 111.223 179.824 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 9.5 p -56.43 159.14 3.84 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.891 0.377 . . . . 0.0 110.846 -179.744 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 43.9 ttp85 -139.74 128.03 22.62 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.453 179.853 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.756 HD22 ' N ' ' A' ' 167' ' ' LEU . 1.3 mm? -108.38 172.19 6.98 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.044 179.785 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -139.64 139.81 36.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.598 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 . . . . . 0 C--O 1.219 -0.511 0 CA-C-O 117.999 -1.001 . . . . 0.0 110.453 179.929 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 201' ' ' PKA . . . . . 0.521 ' C15' 'CL ' ' A' ' 201' ' ' PKA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.492 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.903 0.382 . . . . 0.0 110.636 . . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_exo -62.09 -45.25 16.54 Favored 'Trans proline' 0 C--N 1.304 -1.765 0 C-N-CA 122.515 2.143 . . . . 0.0 112.266 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -166.53 -21.86 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.57 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 67.5 p -54.14 124.66 16.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.734 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.694 ' CE2' ' CE3' ' A' ' 68' ' ' TRP . 1.0 OUTLIER -76.57 117.81 18.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.898 179.748 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.576 ' N ' ' CD ' ' A' ' 7' ' ' PRO . 0.9 OUTLIER -60.52 -33.01 12.86 Favored Pre-proline 0 CA--C 1.534 0.362 0 C-N-CA 120.858 -0.337 . . . . 0.0 110.274 -179.653 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.576 ' CD ' ' N ' ' A' ' 6' ' ' VAL . 24.6 Cg_exo -73.14 -66.23 0.03 OUTLIER 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 121.517 1.478 . . . . 0.0 112.069 179.577 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.4 ' O ' ' OG1' ' A' ' 12' ' ' THR . . . -50.11 -36.58 30.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.261 -179.485 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.594 HG23 ' O ' ' A' ' 5' ' ' TRP . 78.7 t -69.53 -61.96 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.552 -179.292 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -56.11 -34.71 62.71 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 111.51 -0.636 . . . . 0.0 111.51 -179.347 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 6.9 mp -74.44 -30.29 61.83 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.57 0.224 . . . . 0.0 110.737 -179.532 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.4 ' OG1' ' O ' ' A' ' 8' ' ' ALA . 3.1 p -81.21 -21.02 39.9 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.876 0.37 . . . . 0.0 110.578 179.83 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.423 ' O ' ' N ' ' A' ' 16' ' ' SER . 69.8 mt -82.9 -38.12 23.3 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.517 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.403 ' N ' ' HD2' ' A' ' 15' ' ' PRO . 5.1 t -43.07 -58.9 3.55 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.717 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.403 ' HD2' ' N ' ' A' ' 14' ' ' VAL . 11.7 Cg_endo -56.8 -13.96 12.57 Favored 'Trans proline' 0 N--CA 1.497 1.71 0 C-N-CA 121.02 1.147 . . . . 0.0 111.789 179.718 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.423 ' N ' ' O ' ' A' ' 13' ' ' LEU . 1.9 t -79.52 -24.73 42.01 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.506 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 55.0 mt -74.24 -58.16 3.48 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.323 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -75.72 -23.24 73.13 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 110.685 -0.966 . . . . 0.0 110.685 179.828 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -70.38 -52.49 16.86 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 111.259 -0.736 . . . . 0.0 111.259 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 86.9 t80 -74.07 -55.14 6.47 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.682 0.277 . . . . 0.0 111.184 -179.597 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 16.2 ttm -62.97 -30.12 71.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.26 -179.365 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -72.76 -59.54 4.34 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 111.277 -0.729 . . . . 0.0 111.277 -179.669 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.553 ' O ' HG22 ' A' ' 26' ' ' VAL . . . -64.22 -16.43 62.0 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.784 -0.366 . . . . 0.0 110.62 -179.434 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 63.4 t80 -48.14 -23.99 1.0 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.104 179.56 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 48.5 t80 -72.08 -53.54 12.54 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.953 -179.798 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.553 HG22 ' O ' ' A' ' 23' ' ' ALA . 33.3 m -65.52 -16.32 20.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 C-N-CA 120.835 -0.346 . . . . 0.0 110.672 -179.777 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.458 ' O ' ' CD1' ' A' ' 31' ' ' LEU . 0.0 OUTLIER -56.57 -47.51 79.34 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.741 -179.813 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -105.51 -62.98 0.63 Allowed Glycine 0 CA--C 1.525 0.7 0 N-CA-C 111.191 -0.764 . . . . 0.0 111.191 -179.827 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 6.1 tm-20 -45.09 -33.89 2.36 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.722 0.296 . . . . 0.0 110.626 -179.843 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -71.66 -51.11 17.05 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 111.023 -0.831 . . . . 0.0 111.023 -179.884 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.458 ' CD1' ' O ' ' A' ' 27' ' ' ARG . 86.6 mt -57.61 -35.04 69.93 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.752 0.31 . . . . 0.0 110.609 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 62.8 mtp180 -76.07 -42.72 46.56 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.36 179.796 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -51.71 -40.61 60.46 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.372 179.845 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.506 ' CD1' ' C ' ' A' ' 34' ' ' TYR . 9.8 t80 -48.23 -40.6 24.96 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.67 -179.797 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -57.73 -24.95 59.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.449 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -95.55 -75.18 1.26 Allowed Glycine 0 CA--C 1.525 0.663 0 N-CA-C 110.974 -0.85 . . . . 0.0 110.974 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.569 ' O ' HD12 ' A' ' 37' ' ' LEU . 0.4 OUTLIER -95.79 167.54 11.21 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.971 0.415 . . . . 0.0 110.739 179.823 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 47.2 mm-40 -79.91 113.21 17.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.888 -179.568 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.419 ' C ' ' H ' ' A' ' 41' ' ' SER . 8.3 mtpt -128.86 150.72 75.86 Favored Pre-proline 0 CA--C 1.532 0.281 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.068 179.637 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.595 ' C ' ' H ' ' A' ' 42' ' ' TRP . 72.4 Cg_endo -75.7 23.8 0.43 Allowed 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 121.871 1.714 . . . . 0.0 111.636 179.526 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.494 ' HG ' ' HD2' ' A' ' 34' ' ' TYR . 98.1 p -51.66 -1.72 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.264 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' TRP . . . . . 0.695 ' CH2' ' NE2' ' A' ' 43' ' ' HIS . 55.7 p-90 -76.81 -14.2 59.93 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.397 -0.521 . . . . 0.0 110.558 -179.308 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.695 ' NE2' ' CH2' ' A' ' 42' ' ' TRP . 19.0 m80 -64.45 139.14 97.65 Favored Pre-proline 0 C--N 1.33 -0.267 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 178.438 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.48 ' C ' ' O ' ' A' ' 43' ' ' HIS . 71.2 Cg_exo -31.37 116.12 0.06 OUTLIER 'Trans proline' 0 N--CA 1.494 1.537 0 C-N-CA 121.215 1.276 . . . . 0.0 111.349 -179.771 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.596 ' O ' ' N ' ' A' ' 47' ' ' TRP . 38.5 Cg_exo -39.65 152.82 0.06 OUTLIER 'Trans proline' 0 C--N 1.308 -1.588 0 CA-C-N 118.776 0.599 . . . . 0.0 111.774 -179.194 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.467 ' O ' ' CB ' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -40.57 -17.74 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.726 -179.812 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.602 ' CD1' ' N ' ' A' ' 48' ' ' THR . 0.2 OUTLIER -60.12 -45.78 91.84 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.899 -0.32 . . . . 0.0 111.685 -179.247 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.602 ' N ' ' CD1' ' A' ' 47' ' ' TRP . 1.0 OUTLIER -91.21 -39.78 11.91 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 112.824 0.675 . . . . 0.0 112.824 -178.268 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.808 HD23 ' O8 ' ' A' ' 201' ' ' PKA . 31.5 tp -83.0 -39.67 20.98 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -177.097 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.634 ' C ' ' H ' ' A' ' 52' ' ' ILE . . . -40.43 -29.08 0.21 Allowed Pre-proline 0 N--CA 1.466 0.327 0 C-N-CA 120.069 -0.652 . . . . 0.0 111.569 -178.872 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.408 ' HD2' ' N ' ' A' ' 50' ' ' ALA . 25.2 Cg_exo -54.93 7.39 0.03 OUTLIER 'Trans proline' 0 C--N 1.312 -1.355 0 CA-C-N 119.058 0.699 . . . . 0.0 112.205 177.946 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.778 HG23 ' O ' ' A' ' 49' ' ' LEU . 11.6 pt -54.37 -35.19 29.98 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.203 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 178.983 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 63.0 m95 -81.79 -24.12 36.16 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.359 179.728 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -71.43 -47.07 37.23 Favored Glycine 0 CA--C 1.527 0.792 0 N-CA-C 110.36 -1.096 . . . . 0.0 110.36 179.275 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.612 HG23 ' N ' ' A' ' 56' ' ' LEU . 13.3 t -70.65 -48.15 56.38 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 179.408 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.612 ' N ' HG23 ' A' ' 55' ' ' THR . 93.5 mt -60.92 -27.9 68.54 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 178.992 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.46 ' CD1' ' C ' ' A' ' 57' ' ' TYR . 0.8 OUTLIER -65.94 -53.64 36.54 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 179.375 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -48.88 -47.56 42.89 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 178.928 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.11 -48.21 82.44 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.062 179.177 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 27.1 mtt -52.67 -50.55 63.02 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.876 179.652 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -48.37 -53.63 15.38 Favored Glycine 0 CA--C 1.522 0.526 0 N-CA-C 110.399 -1.081 . . . . 0.0 110.399 179.638 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.538 ' CD1' ' N ' ' A' ' 62' ' ' TYR . 1.4 m-30 -56.55 -50.31 72.25 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.8 0.333 . . . . 0.0 110.527 179.68 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -52.06 -54.13 27.42 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 110.475 -1.05 . . . . 0.0 110.475 179.722 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.617 ' CB ' ' HE1' ' A' ' 68' ' ' TRP . 1.4 t -54.88 -47.23 74.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.834 0.349 . . . . 0.0 110.281 179.672 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.449 ' O ' ' CG ' ' A' ' 69' ' ' LYS . 74.7 t80 -46.27 -45.17 17.04 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.647 -0.421 . . . . 0.0 109.899 179.69 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 59.0 mt -71.38 -27.1 27.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.902 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 73.6 t -67.34 -57.71 8.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 C-N-CA 120.732 -0.387 . . . . 0.0 111.6 -179.3 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' TRP . . . . . 0.694 ' CE3' ' CE2' ' A' ' 5' ' ' TRP . 0.0 OUTLIER -72.82 -24.61 60.93 Favored 'General case' 0 CA--C 1.528 0.11 0 C-N-CA 119.814 -0.754 . . . . 0.0 110.73 -179.654 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.449 ' CG ' ' O ' ' A' ' 65' ' ' TYR . 6.5 mmmt -76.73 -26.74 54.98 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.427 -0.509 . . . . 0.0 110.181 179.341 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 33.6 tp10 -79.96 -58.4 3.18 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.817 -179.842 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.462 HD21 ' HB2' ' A' ' 78' ' ' ALA . 2.2 pp -73.34 -21.72 60.48 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.878 -179.597 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.499 ' O ' ' O ' ' A' ' 73' ' ' GLY . . . 109.32 98.57 2.54 Favored Glycine 0 CA--C 1.528 0.844 0 C-N-CA 121.088 -0.577 . . . . 0.0 112.248 178.995 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.577 ' N ' ' O ' ' A' ' 68' ' ' TRP . . . 41.52 -173.99 0.01 OUTLIER Glycine 0 CA--C 1.525 0.691 0 N-CA-C 111.975 -0.45 . . . . 0.0 111.975 178.878 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 84.0 t80 -90.42 110.64 21.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.724 0.297 . . . . 0.0 110.483 -179.865 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.568 ' OG1' ' N ' ' A' ' 76' ' ' GLU . 0.8 OUTLIER -142.43 -173.6 3.9 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.909 0.385 . . . . 0.0 110.893 -179.839 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.568 ' N ' ' OG1' ' A' ' 75' ' ' THR . 26.0 mt-10 -53.27 -21.68 5.83 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.692 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 24.3 m-20 -79.67 -33.07 41.5 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.778 -179.796 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.462 ' HB2' HD21 ' A' ' 71' ' ' LEU . . . -87.02 -15.62 38.12 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.821 -179.785 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 8.1 mtp -70.99 -27.24 63.56 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.763 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.401 ' N ' ' HD2' ' A' ' 81' ' ' PRO . 8.4 t -66.85 -45.12 54.36 Favored Pre-proline 0 C--N 1.328 -0.331 0 C-N-CA 120.783 -0.367 . . . . 0.0 110.52 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.401 ' HD2' ' N ' ' A' ' 80' ' ' VAL . 12.4 Cg_endo -77.1 -61.7 0.03 OUTLIER 'Trans proline' 0 N--CA 1.499 1.816 0 C-N-CA 121.227 1.284 . . . . 0.0 111.799 178.814 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 12.7 mt -55.39 -44.41 76.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.759 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -65.92 -55.85 17.43 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.972 -0.851 . . . . 0.0 110.972 -179.792 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 60.3 tp -55.28 -21.87 16.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.812 0.339 . . . . 0.0 110.37 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 30.7 t80 -78.03 -51.89 9.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.063 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -61.84 -38.58 88.75 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.8 -0.36 . . . . 0.0 111.277 -179.059 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -73.67 -58.14 4.65 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 111.277 -0.729 . . . . 0.0 111.277 -179.571 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 5.0 tp-100 -53.45 -47.74 69.45 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-O 121.127 0.489 . . . . 0.0 109.778 179.714 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.445 ' O ' ' C ' ' A' ' 90' ' ' ALA . 19.5 tp -52.81 -66.02 0.46 Allowed 'General case' 0 C--O 1.211 -0.961 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.904 179.823 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.563 ' O ' ' HB2' ' A' ' 94' ' ' ALA . . . -38.17 -48.7 1.29 Allowed 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 120.267 -0.573 . . . . 0.0 111.771 -179.496 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 95.3 mt -55.22 -57.03 13.45 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 113.415 0.894 . . . . 0.0 113.415 -178.407 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.758 ' O ' HD22 ' A' ' 113' ' ' LEU . 4.8 m-20 -78.05 -53.42 7.43 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 121.284 0.564 . . . . 0.0 111.604 -178.223 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' TRP . . . . . 0.645 ' O ' ' N ' ' A' ' 95' ' ' TRP . 5.6 t-105 -52.13 -25.11 8.12 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.568 -179.679 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.563 ' HB2' ' O ' ' A' ' 90' ' ' ALA . . . -55.74 71.35 0.0 OUTLIER 'General case' 0 CA--C 1.528 0.133 0 CA-C-O 120.829 0.347 . . . . 0.0 110.675 -179.722 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.681 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 7.0 p-90 -101.62 -17.73 0.19 Allowed Pre-proline 0 CA--C 1.534 0.35 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.891 -179.784 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.681 ' CD ' ' N ' ' A' ' 95' ' ' TRP . 44.5 Cg_exo -61.16 -24.78 79.85 Favored 'Trans proline' 0 C--N 1.311 -1.396 0 C-N-CA 120.248 0.632 . . . . 0.0 112.412 179.034 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.529 ' CD ' ' N ' ' A' ' 96' ' ' PRO . 63.8 Cg_exo -59.82 -31.82 94.51 Favored 'Trans proline' 0 N--CA 1.493 1.474 0 C-N-CA 120.339 0.693 . . . . 0.0 112.803 179.547 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 1.4 pt -77.2 44.01 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 C-N-CA 120.342 -0.543 . . . . 0.0 110.259 179.793 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -61.57 -35.59 78.23 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.302 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -82.62 -20.01 37.2 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.399 179.859 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -87.28 -14.73 63.57 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.912 -0.875 . . . . 0.0 110.912 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -62.04 -34.18 75.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.783 0.325 . . . . 0.0 110.672 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 15.8 ptt180 -76.4 11.24 1.65 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.78 -179.843 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 14.8 mt-30 -121.89 154.56 36.93 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.564 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 6.0 mmt -51.49 -18.59 1.12 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.413 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.606 ' O ' ' N ' ' A' ' 108' ' ' ALA . . . -71.13 -14.98 74.19 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 111.18 -0.768 . . . . 0.0 111.18 179.874 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' TRP . . . . . 0.461 ' CD1' ' N ' ' A' ' 108' ' ' ALA . 0.1 OUTLIER -42.55 -14.12 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.683 0.278 . . . . 0.0 110.822 -179.498 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.606 ' N ' ' O ' ' A' ' 106' ' ' GLY . . . -58.49 -28.68 65.6 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 179.416 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 12.2 mt -47.02 -31.68 3.42 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.889 179.49 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -54.55 -60.47 3.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.39 179.76 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.715 ' O ' HG23 ' A' ' 115' ' ' VAL . 1.6 p30 -59.0 -53.68 55.72 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.76 -179.44 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.589 ' N ' ' OD1' ' A' ' 111' ' ' ASP . 40.5 tp -55.43 -39.81 70.72 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -178.414 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.758 HD22 ' O ' ' A' ' 92' ' ' ASN . 17.9 mt -70.47 -61.69 1.67 Allowed 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.124 0.416 . . . . 0.0 112.124 -178.506 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.9 pp -59.6 -34.02 72.21 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 120.339 -0.544 . . . . 0.0 111.064 -179.006 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.715 HG23 ' O ' ' A' ' 111' ' ' ASP . 42.3 t -61.68 -60.86 2.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.102 -179.863 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 13.0 m -68.0 -22.62 64.99 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.546 -178.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -66.35 -62.75 4.39 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 120.696 -0.764 . . . . 0.0 111.856 -179.252 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.602 ' O ' HG23 ' A' ' 122' ' ' THR . 9.1 p -72.46 -35.86 52.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 111.614 0.227 . . . . 0.0 111.614 -179.183 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.547 ' O ' ' OG1' ' A' ' 123' ' ' THR . . . -67.96 -61.31 1.92 Allowed 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.387 -0.525 . . . . 0.0 111.289 -179.326 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 8.1 m -59.64 -50.43 73.9 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.561 -0.291 . . . . 0.0 111.492 -179.184 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.447 ' O ' HD23 ' A' ' 124' ' ' LEU . . . -55.29 -40.49 71.13 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.79 0.329 . . . . 0.0 111.019 -179.461 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.602 HG23 ' O ' ' A' ' 118' ' ' VAL . 40.4 p -74.79 -33.44 62.24 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.803 -0.359 . . . . 0.0 111.713 -179.253 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.547 ' OG1' ' O ' ' A' ' 119' ' ' ALA . 0.2 OUTLIER -60.07 -56.48 21.15 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.559 -0.456 . . . . 0.0 110.784 -179.521 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.606 HD23 ' N ' ' A' ' 125' ' ' ALA . 0.6 OUTLIER -79.19 -20.16 49.07 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 -178.584 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.606 ' N ' HD23 ' A' ' 124' ' ' LEU . . . -91.17 -66.73 0.9 Allowed 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 112.789 0.663 . . . . 0.0 112.789 -178.818 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 43.4 m0 -83.0 -57.42 3.3 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -177.777 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' HIS . . . . . 0.57 ' CG ' ' HB2' ' A' ' 134' ' ' ALA . 11.5 m170 -55.69 -22.18 22.08 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.584 -0.446 . . . . 0.0 111.129 -179.004 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 19.2 ttt85 -69.66 -48.79 58.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.148 -179.624 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 10.3 t -81.39 -47.46 19.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.993 -179.453 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 61.0 p -116.28 104.98 51.39 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.51 -179.851 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' PRO . . . . . 0.639 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 57.2 Cg_exo -70.79 -29.43 18.99 Favored 'Trans proline' 0 C--N 1.31 -1.477 0 C-N-CA 121.537 1.491 . . . . 0.0 112.367 179.639 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.639 ' CD ' ' N ' ' A' ' 131' ' ' PRO . 41.4 Cg_exo -62.58 -42.81 24.51 Favored 'Trans proline' 0 N--CA 1.496 1.663 0 C-N-CA 121.391 1.394 . . . . 0.0 111.787 179.7 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -54.44 -41.52 69.5 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.311 179.813 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.57 ' HB2' ' CG ' ' A' ' 127' ' ' HIS . . . -57.18 -22.66 42.06 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.309 179.705 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 11.2 tpp180 -77.06 -31.7 56.32 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.61 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 82.8 mt -72.56 -43.54 63.3 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.857 0.361 . . . . 0.0 110.082 179.571 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.556 ' O ' ' N ' ' A' ' 140' ' ' TYR . 3.4 mt -75.31 -37.68 60.68 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.442 179.79 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.55 ' C ' ' H ' ' A' ' 140' ' ' TYR . 0.8 OUTLIER -19.4 -48.64 0.04 OUTLIER Pre-proline 0 N--CA 1.466 0.352 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.948 -179.608 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.527 ' N ' ' O ' ' A' ' 137' ' ' LEU . 1.6 Cg_endo -64.45 16.08 0.08 OUTLIER 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 120.968 1.112 . . . . 0.0 112.142 179.617 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 140' ' ' TYR . . . . . 0.76 ' CE2' HD11 ' A' ' 144' ' ' LEU . 5.3 p90 -93.35 -15.17 26.01 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-O 121.153 0.501 . . . . 0.0 110.22 179.634 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.653 ' CD1' ' CE1' ' A' ' 140' ' ' TYR . 5.8 mp -57.43 -26.74 61.62 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.273 178.773 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -66.49 -48.93 68.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.08 179.651 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' TRP . . . . . 0.563 ' CZ2' HD12 ' A' ' 52' ' ' ILE . 12.0 t-105 -55.81 -48.7 74.96 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 179.499 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.76 HD11 ' CE2' ' A' ' 140' ' ' TYR . 8.8 mt -50.37 -56.58 10.76 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 120.444 -0.502 . . . . 0.0 109.968 179.714 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.514 ' O ' HG23 ' A' ' 149' ' ' VAL . . . -61.41 -18.28 58.09 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.709 -179.815 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 6.5 t80 -70.93 -65.04 0.79 Allowed 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.843 -0.343 . . . . 0.0 110.829 -179.745 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.494 ' O ' ' OD1' ' A' ' 151' ' ' ASN . . . -62.95 -40.23 97.03 Favored 'General case' 0 C--N 1.332 -0.154 0 C-N-CA 120.769 -0.372 . . . . 0.0 110.309 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 13.9 m -58.77 -49.83 76.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.46 179.805 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.514 HG23 ' O ' ' A' ' 145' ' ' ALA . 53.6 t -66.9 -29.38 46.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.334 179.831 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.445 ' O ' HG23 ' A' ' 154' ' ' VAL . 1.0 OUTLIER -58.33 -59.6 5.08 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.506 -0.478 . . . . 0.0 109.935 179.989 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 151' ' ' ASN . . . . . 0.494 ' OD1' ' O ' ' A' ' 147' ' ' ALA . 6.7 p-10 -60.6 -51.29 70.02 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.543 179.624 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 152' ' ' TYR . . . . . 0.665 ' CZ ' ' NE ' ' A' ' 156' ' ' ARG . 53.8 t80 -50.13 -34.74 23.18 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.283 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 153' ' ' TYR . . . . . 0.552 ' CE2' ' OD2' ' A' ' 157' ' ' ASP . 41.0 t80 -68.06 -46.07 72.09 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.529 179.826 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.445 HG23 ' O ' ' A' ' 150' ' ' LEU . 19.0 t -58.14 -36.8 58.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.305 179.797 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 155' ' ' TRP . . . . . 0.575 ' O ' ' N ' ' A' ' 159' ' ' SER . 15.3 m0 -65.57 -46.02 81.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.624 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 156' ' ' ARG . . . . . 0.665 ' NE ' ' CZ ' ' A' ' 152' ' ' TYR . 7.2 mpt_? -68.4 -29.27 67.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.579 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 157' ' ' ASP . . . . . 0.552 ' OD2' ' CE2' ' A' ' 153' ' ' TYR . 17.0 m-20 -72.3 -51.71 19.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.819 -179.78 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 -89.2 -40.02 13.15 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.602 -179.917 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 159' ' ' SER . . . . . 0.575 ' N ' ' O ' ' A' ' 155' ' ' TRP . 23.0 t -115.78 -170.12 1.72 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.632 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 84.81 25.53 41.28 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 110.974 -0.851 . . . . 0.0 110.974 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 69.6 mtt180 -48.77 -24.92 1.58 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.766 0.317 . . . . 0.0 110.721 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 11.9 ttt85 -61.92 153.7 28.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.968 0.413 . . . . 0.0 110.616 -179.788 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -153.87 179.32 30.22 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 110.713 -0.955 . . . . 0.0 110.713 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -176.7 -90.98 0.08 OUTLIER Glycine 0 CA--C 1.525 0.709 0 N-CA-C 111.1 -0.8 . . . . 0.0 111.1 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 165' ' ' SER . . . . . 0.561 ' OG ' ' N ' ' A' ' 166' ' ' ARG . 5.6 t -76.91 -174.32 3.04 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.705 0.288 . . . . 0.0 110.759 -179.853 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 166' ' ' ARG . . . . . 0.561 ' N ' ' OG ' ' A' ' 165' ' ' SER . 22.0 ttp180 83.52 137.09 0.06 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.319 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.772 HD22 ' N ' ' A' ' 167' ' ' LEU . 1.4 mm? -111.19 54.16 0.69 Allowed 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.401 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.522 ' HB2' ' HE ' ' A' ' 166' ' ' ARG . . . -50.47 -39.13 47.19 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.617 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 . . . . . 0 C--O 1.221 -0.431 0 CA-C-O 118.011 -0.995 . . . . 0.0 110.444 179.855 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 201' ' ' PKA . . . . . 0.808 ' O8 ' HD23 ' A' ' 49' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 37.9 mtt . . . . . 0 C--O 1.231 0.08 0 CA-C-O 120.689 0.28 . . . . 0.0 110.41 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -81.72 -15.15 9.76 Favored 'Trans proline' 0 N--CA 1.494 1.538 0 C-N-CA 121.84 1.693 . . . . 0.0 111.944 179.68 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -62.75 -26.56 68.76 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.481 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 4.3 m -177.99 145.22 0.37 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.522 179.854 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.569 ' O ' HG23 ' A' ' 9' ' ' VAL . 0.6 OUTLIER -65.68 117.03 7.53 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.354 -179.872 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.589 ' N ' ' CD ' ' A' ' 7' ' ' PRO . 0.9 OUTLIER -62.28 -37.52 37.86 Favored Pre-proline 0 CA--C 1.534 0.352 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.114 -179.999 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.589 ' CD ' ' N ' ' A' ' 6' ' ' VAL . 33.5 Cg_exo -63.68 -64.21 0.07 OUTLIER 'Trans proline' 0 C--N 1.307 -1.621 0 C-N-CA 121.704 1.603 . . . . 0.0 111.525 179.638 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.7 ' O ' HG23 ' A' ' 12' ' ' THR . . . -52.77 -38.84 61.64 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.695 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.569 HG23 ' O ' ' A' ' 5' ' ' TRP . 24.8 t -59.3 -62.02 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.848 -179.691 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -59.86 -56.67 23.48 Favored Glycine 0 CA--C 1.527 0.81 0 N-CA-C 111.516 -0.634 . . . . 0.0 111.516 -179.628 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 10.1 mp -50.15 -37.77 36.19 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.563 0.22 . . . . 0.0 110.888 -179.643 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.7 HG23 ' O ' ' A' ' 8' ' ' ALA . 35.9 p -75.57 -25.18 56.85 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.858 -0.337 . . . . 0.0 110.625 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.55 HD13 ' O ' ' A' ' 9' ' ' VAL . 4.1 mp -75.81 -25.11 56.06 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.196 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.2 t -54.54 -61.87 4.94 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.428 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -55.8 -46.16 33.67 Favored 'Trans proline' 0 N--CA 1.496 1.672 0 C-N-CA 120.662 0.908 . . . . 0.0 111.808 179.855 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.2 t -46.13 -28.37 1.2 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.236 -179.474 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 92.7 mt -70.2 -56.02 7.86 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.645 -0.422 . . . . 0.0 110.742 -179.705 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -68.0 -23.2 74.42 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 111.316 -0.714 . . . . 0.0 111.316 -179.659 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -69.93 -54.66 11.13 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 110.881 -0.888 . . . . 0.0 110.881 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 52.3 t80 -65.94 -60.29 2.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.833 0.349 . . . . 0.0 110.675 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 17.3 tpp -59.09 -27.67 65.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.04 -179.726 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -74.71 -62.91 2.71 Favored Glycine 0 CA--C 1.523 0.536 0 N-CA-C 111.011 -0.836 . . . . 0.0 111.011 -179.78 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.593 ' O ' HG22 ' A' ' 26' ' ' VAL . . . -55.48 -19.54 9.9 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.947 0.403 . . . . 0.0 109.994 -179.917 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 9.5 t80 -47.83 -24.39 0.98 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.409 179.713 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.466 ' CE2' ' O ' ' A' ' 99' ' ' PHE . 50.0 t80 -69.34 -48.32 61.74 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.417 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.593 HG22 ' O ' ' A' ' 23' ' ' ALA . 35.6 m -75.23 -16.37 15.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.634 -179.893 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -56.31 -47.28 79.01 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.834 -179.77 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -107.14 -42.2 1.55 Allowed Glycine 0 CA--C 1.525 0.7 0 N-CA-C 111.055 -0.818 . . . . 0.0 111.055 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.44 ' OE2' ' CZ3' ' A' ' 33' ' ' TRP . 16.8 tp10 -71.45 -29.63 65.09 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.701 0.286 . . . . 0.0 110.693 -179.845 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -73.99 -57.36 4.87 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.913 -0.875 . . . . 0.0 110.913 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 10.0 mp -56.83 -25.42 56.02 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.973 -0.381 . . . . 0.0 109.973 179.781 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 55.4 ttt180 -81.2 -49.89 10.24 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.088 -0.506 . . . . 0.0 109.989 179.432 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' TRP . . . . . 0.44 ' CZ3' ' OE2' ' A' ' 29' ' ' GLU . 0.2 OUTLIER -45.83 -39.94 9.14 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.688 179.252 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 42.2 t80 -47.37 -38.67 13.55 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.774 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -55.97 -35.18 66.43 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.262 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -84.31 -72.27 1.29 Allowed Glycine 0 CA--C 1.524 0.634 0 N-CA-C 110.804 -0.918 . . . . 0.0 110.804 179.853 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.587 ' O ' HD12 ' A' ' 37' ' ' LEU . 0.4 OUTLIER -96.67 167.89 10.85 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.798 0.333 . . . . 0.0 110.611 179.622 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 10.7 mm100 -83.71 118.53 23.95 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.512 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.474 ' C ' ' H ' ' A' ' 41' ' ' SER . 15.0 mtpt -127.47 150.15 71.97 Favored Pre-proline 0 N--CA 1.465 0.277 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.255 -179.804 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.607 ' C ' ' H ' ' A' ' 42' ' ' TRP . 99.0 Cg_endo -72.61 17.23 0.37 Allowed 'Trans proline' 0 C--N 1.309 -1.509 0 C-N-CA 121.747 1.632 . . . . 0.0 111.045 179.177 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.474 ' H ' ' C ' ' A' ' 39' ' ' LYS . 95.1 p -49.28 -2.04 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.397 -0.82 . . . . 0.0 111.447 -179.861 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' TRP . . . . . 0.607 ' H ' ' C ' ' A' ' 40' ' ' PRO . 48.7 p-90 -77.19 -15.14 59.63 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.448 -0.501 . . . . 0.0 110.557 -179.381 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.587 ' CE1' ' CH2' ' A' ' 42' ' ' TRP . 6.9 m-70 -60.71 146.07 86.84 Favored Pre-proline 0 C--N 1.33 -0.265 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 178.587 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.455 ' C ' ' O ' ' A' ' 43' ' ' HIS . 9.7 Cg_endo -34.18 139.79 0.08 OUTLIER 'Trans proline' 0 C--N 1.309 -1.515 0 C-N-CA 121.377 1.385 . . . . 0.0 111.145 -179.645 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -59.94 163.18 14.4 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 C-N-CA 120.148 0.565 . . . . 0.0 112.003 -179.347 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.64 ' O ' ' HB3' ' A' ' 50' ' ' ALA . 1.6 ptm180 -46.19 -26.88 0.85 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.832 -179.066 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.597 ' CD1' ' N ' ' A' ' 48' ' ' THR . 1.4 p-90 -55.42 -46.23 76.68 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 120.805 -0.358 . . . . 0.0 111.872 -178.678 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.597 ' N ' ' CD1' ' A' ' 47' ' ' TRP . 1.1 m -91.41 -40.92 11.16 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -178.499 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.673 ' O ' HG23 ' A' ' 52' ' ' ILE . 15.5 tp -83.19 -47.43 11.59 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -177.188 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.649 ' C ' ' H ' ' A' ' 52' ' ' ILE . . . -43.41 -27.84 0.33 Allowed Pre-proline 0 N--CA 1.468 0.431 0 N-CA-C 112.141 0.422 . . . . 0.0 112.141 -179.141 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.433 ' HD2' ' N ' ' A' ' 50' ' ' ALA . 26.6 Cg_exo -53.41 6.46 0.03 OUTLIER 'Trans proline' 0 C--N 1.313 -1.309 0 CA-C-N 119.003 0.68 . . . . 0.0 112.476 178.214 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.673 HG23 ' O ' ' A' ' 49' ' ' LEU . 7.0 pt -51.85 -36.81 19.84 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.19 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 178.827 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.423 ' HE1' ' C13' ' A' ' 201' ' ' PKA . 66.1 m95 -80.74 -25.0 38.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.143 -179.752 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -73.1 -50.75 11.64 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 110.326 -1.109 . . . . 0.0 110.326 179.326 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.593 HG23 ' N ' ' A' ' 56' ' ' LEU . 6.8 t -66.28 -49.16 68.04 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.983 -0.287 . . . . 0.0 110.287 179.713 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.593 ' N ' HG23 ' A' ' 55' ' ' THR . 77.7 mt -60.33 -36.53 78.17 Favored 'General case' 0 CA--C 1.521 -0.16 0 C-N-CA 120.403 -0.519 . . . . 0.0 109.608 179.317 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.485 ' CD1' ' C ' ' A' ' 57' ' ' TYR . 0.8 OUTLIER -56.46 -48.29 77.38 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.61 179.334 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.7 p -55.87 -48.06 76.23 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.022 179.5 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.0 -38.82 80.09 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.315 179.558 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 22.2 mtt -63.16 -37.91 89.1 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.479 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -63.38 -47.02 91.28 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 111.245 -0.742 . . . . 0.0 111.245 -179.703 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 3.3 m-30 -61.49 -59.13 5.71 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.574 -179.662 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.448 ' O ' HG23 ' A' ' 67' ' ' VAL . . . -53.94 -60.06 8.95 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 111.02 -0.832 . . . . 0.0 111.02 -179.884 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.534 ' OG ' ' CH2' ' A' ' 126' ' ' TRP . 44.7 m -45.51 -48.47 14.12 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.001 0.429 . . . . 0.0 110.726 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 62.6 t80 -56.51 -41.45 76.74 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.697 -179.828 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 74.7 mt -65.43 -37.56 80.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.923 -179.694 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.571 HG22 ' CB ' ' A' ' 130' ' ' SER . 21.3 t -59.85 -60.83 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.721 -179.801 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' TRP . . . . . 0.576 ' O ' ' N ' ' A' ' 73' ' ' GLY . 0.7 OUTLIER -57.3 -41.51 79.96 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.655 -0.418 . . . . 0.0 110.325 179.933 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 13.9 mmmt -61.44 -24.77 66.77 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.498 179.622 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 17.7 tp10 -82.34 -62.47 1.61 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.187 -179.473 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.743 ' C ' HD12 ' A' ' 71' ' ' LEU . 3.4 pp -65.25 -8.88 19.7 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.831 -0.348 . . . . 0.0 111.377 -179.152 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.676 ' N ' HD12 ' A' ' 71' ' ' LEU . . . 108.87 76.43 0.93 Allowed Glycine 0 CA--C 1.527 0.801 0 C-N-CA 120.939 -0.648 . . . . 0.0 111.592 179.561 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.576 ' N ' ' O ' ' A' ' 68' ' ' TRP . . . 42.84 -174.03 0.01 OUTLIER Glycine 0 CA--C 1.524 0.595 0 N-CA-C 111.947 -0.461 . . . . 0.0 111.947 179.219 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 43.8 t80 -76.33 110.71 11.07 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.262 -0.469 . . . . 0.0 110.837 -179.671 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.573 HG23 ' H ' ' A' ' 77' ' ' ASP . 7.4 t -142.37 -178.21 5.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.428 179.743 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -46.8 -26.57 0.98 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.179 -179.66 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.573 ' H ' HG23 ' A' ' 75' ' ' THR . 51.7 m-20 -79.05 -28.78 43.21 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.268 -179.422 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.485 ' O ' HD12 ' A' ' 82' ' ' LEU . . . -86.4 -18.34 32.05 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.955 -0.298 . . . . 0.0 110.937 -179.681 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 9.1 mtp -68.96 -27.38 65.68 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.604 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.404 ' N ' ' HD2' ' A' ' 81' ' ' PRO . 7.0 t -68.37 -47.77 36.5 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.9 -179.832 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.404 ' HD2' ' N ' ' A' ' 80' ' ' VAL . 11.4 Cg_endo -72.03 -58.56 0.07 OUTLIER 'Trans proline' 0 N--CA 1.498 1.792 0 C-N-CA 121.113 1.208 . . . . 0.0 111.843 179.253 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.519 HD11 ' CE2' ' A' ' 68' ' ' TRP . 1.6 mt -57.07 -43.71 82.34 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.48 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -66.84 -63.77 3.67 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 111.142 -0.783 . . . . 0.0 111.142 -179.475 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 57.7 tp -49.66 -23.07 1.55 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.924 0.393 . . . . 0.0 110.137 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.462 ' CZ ' HD22 ' A' ' 89' ' ' LEU . 12.9 t80 -76.61 -48.58 18.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.54 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.44 -42.45 95.99 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.8 -0.36 . . . . 0.0 111.056 -179.442 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -70.05 -57.97 6.55 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 111.149 -0.78 . . . . 0.0 111.149 -179.675 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 36.5 tp60 -54.71 -47.52 73.64 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-O 121.012 0.434 . . . . 0.0 110.104 179.731 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.462 HD22 ' CZ ' ' A' ' 85' ' ' TYR . 17.4 tp -56.55 -65.04 0.68 Allowed 'General case' 0 C--O 1.21 -0.991 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.936 179.581 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.592 ' O ' ' HB2' ' A' ' 94' ' ' ALA . . . -37.86 -44.33 0.75 Allowed 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 120.407 -0.517 . . . . 0.0 111.649 -179.407 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 78.2 mt -60.97 -56.89 15.81 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 113.102 0.778 . . . . 0.0 113.102 -178.664 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 41.7 m-20 -75.9 -53.11 8.93 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.392 0.615 . . . . 0.0 111.697 -178.369 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' TRP . . . . . 0.628 ' O ' ' N ' ' A' ' 95' ' ' TRP . 9.8 t-105 -52.05 -33.68 40.07 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.055 -0.975 . . . . 0.0 111.594 -179.938 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.592 ' HB2' ' O ' ' A' ' 90' ' ' ALA . . . -57.03 72.3 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.892 0.377 . . . . 0.0 110.076 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.705 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 22.1 p-90 -97.47 -17.0 0.2 Allowed Pre-proline 0 CA--C 1.532 0.264 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.966 -179.387 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.705 ' CD ' ' N ' ' A' ' 95' ' ' TRP . 52.8 Cg_exo -60.14 -32.23 94.32 Favored 'Trans proline' 0 N--CA 1.493 1.493 0 C-N-CA 120.357 0.705 . . . . 0.0 112.635 179.387 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.484 ' CD ' ' N ' ' A' ' 96' ' ' PRO . 70.1 Cg_exo -50.35 -23.31 9.98 Favored 'Trans proline' 0 N--CA 1.493 1.458 0 C-N-CA 120.254 0.636 . . . . 0.0 112.443 179.785 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.588 ' O ' ' N ' ' A' ' 101' ' ' GLY . 1.1 pp -84.5 19.77 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 121.087 0.47 . . . . 0.0 110.135 179.531 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.466 ' O ' ' CE2' ' A' ' 25' ' ' PHE . 4.4 t80 -39.13 -35.41 0.23 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.843 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 30.6 m-85 -86.59 -25.79 24.79 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.82 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.588 ' N ' ' O ' ' A' ' 98' ' ' ILE . . . -82.8 -4.4 90.07 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 111.195 -0.762 . . . . 0.0 111.195 -179.886 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -72.24 -9.63 58.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.637 0.256 . . . . 0.0 111.081 -179.704 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 3.7 ptm180 -105.25 4.3 30.95 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.755 0.312 . . . . 0.0 110.779 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' GLN . . . . . 0.406 ' C ' ' N ' ' A' ' 106' ' ' GLY . 14.9 mt-30 -113.69 167.54 10.53 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.475 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.486 ' N ' ' SD ' ' A' ' 105' ' ' MET . 0.0 OUTLIER -49.64 -17.38 0.32 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.532 179.979 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.578 ' O ' ' N ' ' A' ' 108' ' ' ALA . . . -72.77 -15.12 78.0 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 111.37 -0.692 . . . . 0.0 111.37 -179.751 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' TRP . . . . . 0.665 ' CD1' ' CZ2' ' A' ' 155' ' ' TRP . 0.0 OUTLIER -38.15 -21.32 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 120.548 0.213 . . . . 0.0 111.239 -179.473 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.578 ' N ' ' O ' ' A' ' 106' ' ' GLY . . . -66.81 -16.15 64.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.912 0.387 . . . . 0.0 111.291 -179.531 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 13.5 mt -60.31 -36.79 78.73 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.479 -179.246 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -53.66 -63.59 1.1 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.967 0.413 . . . . 0.0 110.721 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.742 ' O ' HG23 ' A' ' 115' ' ' VAL . 5.6 p-10 -56.76 -60.69 3.2 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.826 -179.297 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 51.9 tp -49.83 -41.9 46.06 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -178.477 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.418 HD23 ' HA ' ' A' ' 113' ' ' LEU . 71.4 mt -68.49 -61.72 1.7 Allowed 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 -178.144 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.3 pp -59.76 -33.29 71.48 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 120.581 -0.448 . . . . 0.0 111.281 -178.723 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.742 HG23 ' O ' ' A' ' 111' ' ' ASP . 53.3 t -62.04 -60.93 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.148 -179.838 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.493 ' O ' ' OG1' ' A' ' 120' ' ' THR . 11.4 t -68.57 -22.12 64.49 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.1 -179.373 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -64.8 -62.92 4.58 Favored Glycine 0 CA--C 1.526 0.764 0 C-N-CA 120.883 -0.675 . . . . 0.0 111.742 -179.284 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.585 ' O ' HG23 ' A' ' 122' ' ' THR . 9.9 p -73.38 -36.57 49.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 C-N-CA 120.948 -0.301 . . . . 0.0 111.286 -179.389 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.536 ' O ' ' OG1' ' A' ' 123' ' ' THR . . . -67.41 -61.21 2.02 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.529 -0.469 . . . . 0.0 111.019 -179.462 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.493 ' OG1' ' O ' ' A' ' 116' ' ' SER . 2.0 m -59.27 -54.59 45.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.351 -179.431 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.437 ' O ' ' CB ' ' A' ' 125' ' ' ALA . . . -49.5 -45.89 47.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.854 -179.513 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.585 HG23 ' O ' ' A' ' 118' ' ' VAL . 40.9 p -69.75 -35.29 74.84 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.996 -179.06 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.536 ' OG1' ' O ' ' A' ' 119' ' ' ALA . 0.2 OUTLIER -58.2 -52.07 67.1 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.633 -0.427 . . . . 0.0 111.139 -179.218 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.7 pp -83.96 -19.73 34.11 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.705 -0.398 . . . . 0.0 111.721 -178.852 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.437 ' CB ' ' O ' ' A' ' 121' ' ' ALA . . . -88.02 -70.11 0.65 Allowed 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.584 0.587 . . . . 0.0 112.584 -178.796 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 126' ' ' TRP . . . . . 0.534 ' CH2' ' OG ' ' A' ' 64' ' ' SER . 35.9 m0 -83.23 -57.82 3.1 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 -177.702 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 127' ' ' HIS . . . . . 0.449 ' CD2' ' N ' ' A' ' 127' ' ' HIS . 12.3 m170 -52.22 -21.82 3.76 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.663 -0.415 . . . . 0.0 111.295 -178.825 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 28.3 ttt180 -70.05 -47.01 63.75 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.667 -179.337 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 4.1 t -94.44 -9.58 9.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 111.861 0.319 . . . . 0.0 111.861 -178.674 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' SER . . . . . 0.571 ' CB ' HG22 ' A' ' 67' ' ' VAL . 0.8 OUTLIER -149.56 106.39 3.29 Favored Pre-proline 0 C--N 1.328 -0.368 0 C-N-CA 120.872 -0.331 . . . . 0.0 111.183 -179.364 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 131' ' ' PRO . . . . . 0.665 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 74.4 Cg_exo -76.05 -23.27 12.28 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 121.759 1.639 . . . . 0.0 112.656 179.058 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.665 ' CD ' ' N ' ' A' ' 131' ' ' PRO . 52.4 Cg_exo -65.89 -56.85 0.28 Allowed 'Trans proline' 0 N--CA 1.496 1.652 0 C-N-CA 121.322 1.348 . . . . 0.0 112.347 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -46.76 -40.73 14.07 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.64 -179.793 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -52.35 -24.39 7.54 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.533 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 6.1 tpt180 -76.93 -36.71 56.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.432 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 41.3 mt -67.19 -37.06 83.05 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.353 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.568 ' O ' ' N ' ' A' ' 140' ' ' TYR . 5.8 mt -81.86 -39.63 23.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.487 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.513 ' C ' ' H ' ' A' ' 140' ' ' TYR . 4.2 t80 -22.58 -43.57 0.04 OUTLIER Pre-proline 0 CA--C 1.532 0.274 0 O-C-N 123.664 0.602 . . . . 0.0 111.819 -179.601 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.552 ' N ' ' O ' ' A' ' 137' ' ' LEU . 6.3 Cg_exo -65.36 12.66 0.12 Allowed 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 120.852 1.034 . . . . 0.0 111.975 179.291 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 140' ' ' TYR . . . . . 0.702 ' CE2' HD11 ' A' ' 144' ' ' LEU . 3.1 p90 -93.15 -14.42 27.21 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-O 120.892 0.377 . . . . 0.0 110.852 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.53 HD13 HD12 ' A' ' 144' ' ' LEU . 4.3 mm? -55.94 -33.48 64.77 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 178.536 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -56.21 -55.43 33.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.005 179.604 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' TRP . . . . . 0.655 ' CE2' HD12 ' A' ' 52' ' ' ILE . 10.8 t-105 -52.08 -50.49 61.46 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 179.643 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.702 HD11 ' CE2' ' A' ' 140' ' ' TYR . 13.3 mt -49.68 -54.92 15.83 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 120.348 -0.541 . . . . 0.0 109.91 179.599 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.643 ' O ' HG23 ' A' ' 149' ' ' VAL . . . -60.44 -21.35 62.19 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.852 -179.779 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.583 ' CE1' HD21 ' A' ' 49' ' ' LEU . 6.2 t80 -69.48 -63.18 1.12 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.837 -179.582 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.429 ' HB2' ' CH2' ' A' ' 143' ' ' TRP . . . -64.91 -33.4 75.94 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.728 -0.389 . . . . 0.0 110.436 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 68.9 m -67.13 -35.35 79.53 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.2 179.673 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.643 HG23 ' O ' ' A' ' 145' ' ' ALA . 43.5 t -79.5 -26.87 12.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.179 179.79 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.526 ' O ' HG23 ' A' ' 154' ' ' VAL . 0.8 OUTLIER -66.55 -48.7 68.83 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.827 -0.435 . . . . 0.0 109.827 179.747 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 151' ' ' ASN . . . . . 0.55 ' CG ' ' HE1' ' A' ' 107' ' ' TRP . 0.9 OUTLIER -72.92 -51.23 19.34 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.627 179.81 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 152' ' ' TYR . . . . . 0.414 ' CD1' ' C ' ' A' ' 152' ' ' TYR . 27.8 t80 -56.16 -43.31 78.22 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.855 -179.77 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 153' ' ' TYR . . . . . 0.437 ' CB ' ' O ' ' A' ' 149' ' ' VAL . 63.9 t80 -62.46 -54.38 40.98 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.299 -179.548 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.526 HG23 ' O ' ' A' ' 150' ' ' LEU . 72.7 t -60.44 -54.81 29.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.151 -179.291 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 155' ' ' TRP . . . . . 0.665 ' CZ2' ' CD1' ' A' ' 107' ' ' TRP . 0.4 OUTLIER -48.92 -37.6 20.36 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.206 -0.452 . . . . 0.0 109.978 -179.564 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -77.51 -28.98 52.23 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.296 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 12.5 t0 -75.44 -52.82 9.82 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.826 -179.595 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 158' ' ' ASN . . . . . 0.484 ' OD1' ' O ' ' A' ' 158' ' ' ASN . 48.9 t-20 -68.03 -31.28 70.85 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.731 -179.861 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 3.8 m -54.46 174.46 0.06 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.636 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 175.88 177.09 44.65 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 111.217 -0.753 . . . . 0.0 111.217 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 15.3 tpt85 -100.68 146.27 27.4 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.82 0.343 . . . . 0.0 110.253 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 66.9 ttp85 -75.15 125.2 28.45 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.664 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -147.93 35.04 1.2 Allowed Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.76 -0.936 . . . . 0.0 110.76 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 60.19 151.26 0.01 OUTLIER Glycine 0 CA--C 1.523 0.569 0 N-CA-C 110.774 -0.93 . . . . 0.0 110.774 -179.876 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -64.37 -12.45 42.79 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.825 0.345 . . . . 0.0 110.42 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -137.95 -122.67 0.13 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.026 179.834 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.583 HD12 ' N ' ' A' ' 167' ' ' LEU . 8.4 mp -92.87 -79.43 0.4 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.803 0.335 . . . . 0.0 110.205 179.77 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.414 ' HB3' ' O ' ' A' ' 167' ' ' LEU . . . 64.52 118.89 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.718 179.722 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 . . . . . 0 C--O 1.221 -0.426 0 CA-C-O 117.988 -1.006 . . . . 0.0 110.303 179.822 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 201' ' ' PKA . . . . . 0.495 ' C15' 'CL ' ' A' ' 201' ' ' PKA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.563 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.085 0 CA-C-O 121.009 0.433 . . . . 0.0 110.472 . . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -66.4 -12.71 36.82 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 C-N-CA 122.679 2.252 . . . . 0.0 112.213 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.435 ' O ' ' C ' ' A' ' 4' ' ' SER . 47.4 mm-40 -43.22 -29.86 0.43 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.648 -179.887 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.435 ' C ' ' O ' ' A' ' 3' ' ' GLU . 32.5 p 36.59 87.98 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.539 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.629 ' O ' HG23 ' A' ' 9' ' ' VAL . 0.3 OUTLIER -66.97 117.51 9.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.239 -179.938 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.648 ' N ' ' CD ' ' A' ' 7' ' ' PRO . 1.0 OUTLIER -62.64 -33.73 12.4 Favored Pre-proline 0 C--N 1.328 -0.326 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 179.788 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.648 ' CD ' ' N ' ' A' ' 6' ' ' VAL . 21.6 Cg_exo -72.37 -66.97 0.03 OUTLIER 'Trans proline' 0 C--N 1.308 -1.557 0 C-N-CA 121.957 1.772 . . . . 0.0 111.895 179.516 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.647 ' O ' HG23 ' A' ' 12' ' ' THR . . . -49.65 -31.32 10.67 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.153 -179.683 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.629 HG23 ' O ' ' A' ' 5' ' ' TRP . 47.4 t -71.36 -62.2 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.425 -179.182 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -59.02 -43.82 96.67 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 111.262 -0.735 . . . . 0.0 111.262 -179.419 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 8.0 mp -61.87 -39.03 90.5 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.697 0.284 . . . . 0.0 110.637 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.647 HG23 ' O ' ' A' ' 8' ' ' ALA . 8.0 p -69.73 -28.48 65.84 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.786 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.427 ' O ' ' CB ' ' A' ' 16' ' ' SER . 10.7 mt -78.27 -33.38 49.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.669 -179.843 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.443 ' N ' ' HD2' ' A' ' 15' ' ' PRO . 20.3 t -42.0 -59.48 2.58 Favored Pre-proline 0 CA--C 1.535 0.38 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.561 -179.681 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.443 ' HD2' ' N ' ' A' ' 14' ' ' VAL . 17.1 Cg_endo -51.69 -9.46 0.4 Allowed 'Trans proline' 0 N--CA 1.5 1.869 0 C-N-CA 120.616 0.877 . . . . 0.0 112.317 -179.471 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.427 ' CB ' ' O ' ' A' ' 13' ' ' LEU . 3.1 t -79.35 -30.99 42.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.74 -179.865 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 16.6 mt -69.63 -54.44 13.95 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.998 -179.728 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -73.38 -38.55 52.75 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 111.632 -0.587 . . . . 0.0 111.632 -179.374 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -68.94 -29.84 72.42 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 111.066 -0.813 . . . . 0.0 111.066 -179.546 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.412 ' CB ' ' O ' ' A' ' 16' ' ' SER . 64.0 t80 -78.73 -60.32 2.42 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.815 -0.354 . . . . 0.0 110.934 -179.672 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 23.8 ttm -64.88 -21.1 66.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.66 -179.805 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -79.09 -63.02 2.12 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 111.309 -0.716 . . . . 0.0 111.309 -179.628 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.559 ' O ' HG22 ' A' ' 26' ' ' VAL . . . -62.93 -22.19 66.6 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.594 -179.667 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 64.4 t80 -50.9 -23.91 3.19 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.989 0.424 . . . . 0.0 109.892 179.31 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.446 ' CD1' ' C ' ' A' ' 25' ' ' PHE . 25.4 t80 -67.08 -55.01 16.14 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.964 -179.84 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.559 HG22 ' O ' ' A' ' 23' ' ' ALA . 27.2 m -65.87 -22.13 30.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.966 -179.509 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.7 tmt_? -75.56 -17.54 60.03 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.698 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -116.06 -67.3 0.41 Allowed Glycine 0 CA--C 1.525 0.7 0 N-CA-C 111.239 -0.744 . . . . 0.0 111.239 -179.846 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -67.97 -29.72 68.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.751 0.31 . . . . 0.0 110.94 -179.69 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -69.27 -45.91 59.33 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 111.31 -0.716 . . . . 0.0 111.31 -179.737 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.405 HD12 ' N ' ' A' ' 31' ' ' LEU . 11.1 mp -60.34 -28.53 68.24 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.692 0.282 . . . . 0.0 110.677 -179.789 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 76.7 mtm180 -80.38 -43.03 21.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.829 0.347 . . . . 0.0 110.36 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' TRP . . . . . 0.466 ' O ' ' N ' ' A' ' 36' ' ' GLY . 0.2 OUTLIER -59.91 -27.2 66.54 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 179.751 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.487 ' CD1' ' C ' ' A' ' 34' ' ' TYR . 10.3 t80 -49.02 -37.02 19.33 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.894 179.496 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -70.87 -21.66 62.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.902 179.447 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.466 ' N ' ' O ' ' A' ' 33' ' ' TRP . . . -87.95 -76.89 1.28 Allowed Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.442 -1.063 . . . . 0.0 110.442 179.591 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.596 ' O ' HD12 ' A' ' 37' ' ' LEU . 0.4 OUTLIER -96.04 163.7 13.01 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 109.889 -0.411 . . . . 0.0 109.889 179.011 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.506 ' CD ' ' H ' ' A' ' 38' ' ' GLN . 11.2 mp0 -81.79 122.64 27.95 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.932 0.396 . . . . 0.0 111.432 -179.066 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 20.3 mtpt -119.02 160.01 42.58 Favored Pre-proline 0 C--N 1.332 -0.176 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.575 179.182 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -41.97 131.79 4.37 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 C-N-CA 122.023 1.815 . . . . 0.0 111.972 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.6 t -80.57 -2.53 46.67 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.021 -179.631 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 6.1 p90 -111.42 22.85 14.66 Favored 'General case' 0 N--CA 1.463 0.187 0 C-N-CA 120.959 -0.297 . . . . 0.0 110.845 -179.364 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.567 ' CG ' ' O ' ' A' ' 43' ' ' HIS . 8.0 p-80 -90.27 122.92 66.92 Favored Pre-proline 0 CA--C 1.538 0.519 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.821 -179.891 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -105.44 -175.83 0.07 OUTLIER 'Trans proline' 0 N--CA 1.496 1.662 0 C-N-CA 120.933 1.089 . . . . 0.0 111.13 177.713 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -77.45 155.8 32.25 Favored 'Trans proline' 0 C--N 1.303 -1.839 0 C-N-CA 121.359 1.372 . . . . 0.0 110.698 178.659 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.504 ' O ' ' HB3' ' A' ' 50' ' ' ALA . 40.7 ptt85 -48.14 -32.28 6.73 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 112.2 0.444 . . . . 0.0 112.2 -178.693 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.499 ' CD1' ' N ' ' A' ' 48' ' ' THR . 0.0 OUTLIER -61.86 -17.0 54.85 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 120.618 -0.433 . . . . 0.0 111.551 -178.596 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.499 ' N ' ' CD1' ' A' ' 47' ' ' TRP . 8.9 m -92.39 -63.5 1.22 Allowed 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 -178.666 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.853 ' O ' HG23 ' A' ' 52' ' ' ILE . 2.1 mm? -85.02 -35.49 21.88 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 -177.657 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.565 ' C ' ' H ' ' A' ' 52' ' ' ILE . . . -39.87 -29.12 0.19 Allowed Pre-proline 0 N--CA 1.466 0.346 0 C-N-CA 120.14 -0.624 . . . . 0.0 111.849 -178.266 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.423 ' HD2' ' N ' ' A' ' 50' ' ' ALA . 95.5 Cg_exo -57.01 5.85 0.06 OUTLIER 'Trans proline' 0 C--N 1.313 -1.323 0 CA-C-N 119.114 0.719 . . . . 0.0 112.273 178.125 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.853 HG23 ' O ' ' A' ' 49' ' ' LEU . 33.5 pt -55.29 -31.37 26.65 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.295 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 179.514 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.459 ' O ' ' CB ' ' A' ' 57' ' ' TYR . 72.7 m95 -78.73 -22.81 45.98 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.892 -179.497 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -69.22 -48.23 47.52 Favored Glycine 0 CA--C 1.526 0.772 0 N-CA-C 110.064 -1.214 . . . . 0.0 110.064 178.754 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 14.5 m -66.77 -55.63 14.12 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.783 0.325 . . . . 0.0 110.142 179.431 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 86.1 mt -58.62 -26.98 64.26 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.44 179.713 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.526 ' CD1' ' C ' ' A' ' 57' ' ' TYR . 0.5 OUTLIER -64.98 -54.1 35.79 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 179.509 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 37.2 t -51.19 -50.49 58.92 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 179.126 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -56.6 -45.18 81.58 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.319 179.435 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 12.3 mtt -57.72 -49.03 77.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.365 179.861 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -51.49 -43.98 52.98 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 110.994 -0.842 . . . . 0.0 110.994 -179.854 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 3.2 m-30 -65.26 -56.3 13.54 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.762 0.315 . . . . 0.0 110.943 -179.456 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -52.06 -48.53 52.21 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.37 -1.092 . . . . 0.0 110.37 179.785 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.488 ' O ' ' CD1' ' A' ' 68' ' ' TRP . 1.7 t -58.83 -41.9 87.98 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.652 -0.274 . . . . 0.0 110.571 179.889 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.406 ' O ' ' CG ' ' A' ' 69' ' ' LYS . 14.5 t80 -54.58 -37.97 66.14 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 109.138 -0.689 . . . . 0.0 109.138 179.038 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 97.3 mt -73.34 -27.29 23.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.096 179.223 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 61.2 t -69.52 -61.69 1.58 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.252 0 C-N-CA 120.746 -0.382 . . . . 0.0 110.763 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' TRP . . . . . 0.516 ' CD1' ' N ' ' A' ' 68' ' ' TRP . 0.0 OUTLIER -57.9 -38.07 75.17 Favored 'General case' 0 C--O 1.221 -0.402 0 C-N-CA 119.388 -0.925 . . . . 0.0 109.622 179.758 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.406 ' CG ' ' O ' ' A' ' 65' ' ' TYR . 0.2 OUTLIER -58.39 -40.52 82.56 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.889 0.376 . . . . 0.0 110.458 179.956 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 55.8 tt0 -64.35 -41.67 96.64 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.344 -179.555 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.6 mt -78.78 -17.64 55.45 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.955 0.407 . . . . 0.0 111.053 -179.347 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 97.84 43.16 2.93 Favored Glycine 0 CA--C 1.526 0.771 0 N-CA-C 110.345 -1.102 . . . . 0.0 110.345 -178.801 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 96.98 -175.09 30.76 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 111.03 -0.828 . . . . 0.0 111.03 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -71.8 112.44 7.91 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.844 0.354 . . . . 0.0 110.533 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.433 ' OG1' ' N ' ' A' ' 76' ' ' GLU . 3.0 t -139.4 179.51 6.5 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.855 -179.801 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.433 ' N ' ' OG1' ' A' ' 75' ' ' THR . 5.0 mm-40 -54.56 -50.06 68.85 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.595 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -55.0 -16.11 2.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.454 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -95.56 -30.7 13.68 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.392 179.769 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 3.5 mtp -64.9 -27.06 68.6 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.495 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.427 ' O ' ' CB ' ' A' ' 84' ' ' LEU . 9.1 t -68.9 -49.64 25.67 Favored Pre-proline 0 CA--C 1.534 0.345 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.643 -179.694 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -72.13 -61.48 0.05 OUTLIER 'Trans proline' 0 N--CA 1.497 1.728 0 C-N-CA 121.127 1.218 . . . . 0.0 111.523 178.891 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.7 mt -51.3 -46.32 62.5 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.384 179.809 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.452 ' O ' ' N ' ' A' ' 86' ' ' THR . . . -67.6 -63.56 3.65 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.672 -0.971 . . . . 0.0 110.672 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.427 ' CB ' ' O ' ' A' ' 80' ' ' VAL . 56.9 tp -43.73 -24.75 0.14 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.892 0.377 . . . . 0.0 110.014 179.727 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.424 ' N ' ' C ' ' A' ' 83' ' ' GLY . 7.2 t80 -80.62 -40.48 25.59 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.442 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.452 ' N ' ' O ' ' A' ' 83' ' ' GLY . 0.7 OUTLIER -71.63 -39.07 70.65 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 120.599 -0.44 . . . . 0.0 110.854 -179.787 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -74.7 -56.92 4.74 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 110.758 -0.937 . . . . 0.0 110.758 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.454 ' O ' ' CB ' ' A' ' 92' ' ' ASN . 9.4 tp-100 -52.7 -43.88 65.93 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.723 0.296 . . . . 0.0 110.236 179.747 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 11.1 tp -67.59 -34.9 77.95 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.605 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.74 ' O ' ' HB2' ' A' ' 94' ' ' ALA . . . -59.73 -65.75 0.63 Allowed 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 120.279 -0.568 . . . . 0.0 111.343 -179.633 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.0 pp -70.71 -39.01 73.67 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -178.479 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.454 ' CB ' ' O ' ' A' ' 88' ' ' GLN . 36.7 t-20 -72.42 -50.33 27.14 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 -178.6 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' TRP . . . . . 0.622 ' O ' ' N ' ' A' ' 95' ' ' TRP . 0.0 OUTLIER -79.63 -16.63 55.45 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.536 -0.466 . . . . 0.0 111.832 -178.374 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.74 ' HB2' ' O ' ' A' ' 90' ' ' ALA . . . -52.02 81.83 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 120.31 -0.556 . . . . 0.0 109.965 179.336 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.704 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 33.8 p-90 -98.97 -16.14 0.19 Allowed Pre-proline 0 CA--C 1.537 0.451 0 N-CA-C 112.564 0.579 . . . . 0.0 112.564 -179.103 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.704 ' CD ' ' N ' ' A' ' 95' ' ' TRP . 36.6 Cg_exo -57.31 -31.5 91.09 Favored 'Trans proline' 0 N--CA 1.495 1.609 0 C-N-CA 120.526 0.818 . . . . 0.0 113.125 179.777 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.455 ' CD ' ' N ' ' A' ' 96' ' ' PRO . 80.4 Cg_exo -53.14 -20.28 13.87 Favored 'Trans proline' 0 N--CA 1.495 1.601 0 C-N-CA 120.352 0.701 . . . . 0.0 113.271 -179.873 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.463 ' O ' ' N ' ' A' ' 101' ' ' GLY . 1.3 pp -82.61 19.21 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 C-N-CA 120.586 -0.446 . . . . 0.0 110.469 -179.897 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -40.76 -41.48 1.56 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.933 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 2.5 p90 -85.5 -23.75 27.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.914 -179.698 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.463 ' N ' ' O ' ' A' ' 98' ' ' ILE . . . -78.82 -7.7 88.15 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 111.194 -0.762 . . . . 0.0 111.194 -179.851 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -80.14 -7.11 58.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.774 0.321 . . . . 0.0 110.729 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -74.36 -12.18 60.45 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.846 -179.727 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' GLN . . . . . 0.429 ' C ' ' N ' ' A' ' 106' ' ' GLY . 2.8 pt20 -117.39 164.62 14.59 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.804 -179.862 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 8.6 mmt -47.92 -17.15 0.1 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.536 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.595 ' O ' ' N ' ' A' ' 108' ' ' ALA . . . -62.09 -15.56 50.58 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' TRP . . . . . 0.512 ' CD1' ' C ' ' A' ' 107' ' ' TRP . 0.0 OUTLIER -44.04 -12.62 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.758 0.313 . . . . 0.0 110.725 -179.687 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.595 ' N ' ' O ' ' A' ' 106' ' ' GLY . . . -65.27 -28.52 69.4 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.363 179.743 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.413 HD13 ' O ' ' A' ' 106' ' ' GLY . 9.1 mp -45.76 -26.43 0.65 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.231 179.842 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -60.82 -63.97 1.12 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.595 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.704 ' O ' HG23 ' A' ' 115' ' ' VAL . 4.1 p30 -57.66 -50.75 72.15 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.464 -179.614 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.438 ' N ' ' OD1' ' A' ' 111' ' ' ASP . 53.2 tp -55.14 -44.27 74.92 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.875 -0.33 . . . . 0.0 111.587 -178.968 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 54.2 mt -66.7 -61.39 1.99 Allowed 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -178.515 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.3 pp -61.51 -32.64 72.67 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 120.567 -0.453 . . . . 0.0 111.842 -178.391 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.704 HG23 ' O ' ' A' ' 111' ' ' ASP . 46.0 t -63.32 -54.44 32.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.24 -179.9 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.447 ' O ' ' OG1' ' A' ' 120' ' ' THR . 28.9 t -72.46 -24.12 61.15 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.316 -179.059 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -66.2 -62.66 4.49 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 120.944 -0.646 . . . . 0.0 111.749 -179.278 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.588 ' O ' HG23 ' A' ' 122' ' ' THR . 7.5 p -71.79 -38.48 65.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 C-N-CA 120.961 -0.296 . . . . 0.0 111.709 -179.246 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.527 ' O ' ' OG1' ' A' ' 123' ' ' THR . . . -64.54 -60.92 2.58 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.697 -0.401 . . . . 0.0 111.221 -179.286 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.447 ' OG1' ' O ' ' A' ' 116' ' ' SER . 2.1 m -60.28 -55.16 37.12 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.56 -179.275 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -51.11 -40.65 58.95 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.204 -179.268 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.588 HG23 ' O ' ' A' ' 118' ' ' VAL . 30.9 p -72.25 -35.54 68.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.3 -179.363 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.527 ' OG1' ' O ' ' A' ' 119' ' ' ALA . 0.2 OUTLIER -58.28 -50.66 72.81 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.812 0.339 . . . . 0.0 111.148 -179.221 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.6 pp -82.42 -20.19 37.54 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.669 -178.914 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -88.12 -72.72 0.52 Allowed 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 -178.511 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 43.7 m0 -81.83 -57.93 3.21 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 112.662 0.616 . . . . 0.0 112.662 -177.97 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' HIS . . . . . 0.533 ' CD2' ' N ' ' A' ' 127' ' ' HIS . 5.3 m170 -53.18 -22.23 6.28 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.63 -0.428 . . . . 0.0 111.14 -178.823 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 14.0 ttt180 -76.31 -30.49 57.74 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.146 -179.61 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 73.8 t -95.64 -49.9 12.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.769 0.319 . . . . 0.0 111.29 -179.422 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 67.7 p -117.6 109.23 41.99 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.511 -179.707 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' PRO . . . . . 0.657 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 50.5 Cg_exo -71.68 -18.13 29.04 Favored 'Trans proline' 0 N--CA 1.493 1.461 0 C-N-CA 121.458 1.439 . . . . 0.0 112.584 179.638 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.657 ' CD ' ' N ' ' A' ' 131' ' ' PRO . 54.3 Cg_exo -74.43 -35.57 3.68 Favored 'Trans proline' 0 N--CA 1.496 1.653 0 C-N-CA 121.262 1.308 . . . . 0.0 112.0 179.365 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -63.49 -39.64 94.97 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.348 179.846 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -57.33 -26.56 61.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.2 179.85 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 15.9 tpt180 -77.66 -31.09 52.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.373 179.83 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 20.5 mt -75.5 -25.83 57.63 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.261 -0.427 . . . . 0.0 109.849 179.506 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.486 ' O ' ' N ' ' A' ' 140' ' ' TYR . 68.6 mt -92.47 -23.81 19.01 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.165 179.505 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.518 ' CD1' ' C ' ' A' ' 138' ' ' TYR . 0.3 OUTLIER -35.43 -50.19 1.33 Allowed Pre-proline 0 CA--C 1.535 0.395 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.977 179.715 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.439 ' HD2' ' N ' ' A' ' 138' ' ' TYR . 0.9 OUTLIER -61.28 4.89 0.2 Allowed 'Trans proline' 0 N--CA 1.496 1.667 0 C-N-CA 121.64 1.56 . . . . 0.0 112.958 -179.471 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 140' ' ' TYR . . . . . 0.486 ' N ' ' O ' ' A' ' 137' ' ' LEU . 0.1 OUTLIER -88.88 -14.32 37.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.0 0.429 . . . . 0.0 110.562 179.657 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.538 HD23 HD12 ' A' ' 144' ' ' LEU . 97.5 mt -60.02 -33.6 72.22 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.685 178.582 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -57.15 -41.39 79.06 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.584 179.304 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' TRP . . . . . 0.431 ' CE2' HD12 ' A' ' 52' ' ' ILE . 8.6 t-105 -66.11 -43.64 86.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.591 179.24 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.538 HD12 HD23 ' A' ' 141' ' ' LEU . 30.0 mt -59.08 -41.97 89.27 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.174 179.765 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.619 ' O ' HG23 ' A' ' 149' ' ' VAL . . . -72.65 -23.4 60.9 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.419 179.855 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 24.4 t80 -65.91 -57.11 8.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.804 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.4 ' HB1' ' C20' ' A' ' 201' ' ' PKA . . . -68.08 -43.37 78.69 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 120.91 -0.316 . . . . 0.0 110.886 -179.727 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 63.6 m -58.99 -45.68 90.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.831 0.348 . . . . 0.0 110.754 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.619 HG23 ' O ' ' A' ' 145' ' ' ALA . 69.4 t -68.49 -29.43 43.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.632 -179.885 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.464 ' O ' HG23 ' A' ' 154' ' ' VAL . 1.6 tp -62.51 -47.09 85.44 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.293 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 151' ' ' ASN . . . . . 0.596 ' ND2' ' N ' ' A' ' 152' ' ' TYR . 0.3 OUTLIER -69.27 -37.2 77.77 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.568 179.934 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 152' ' ' TYR . . . . . 0.596 ' N ' ' ND2' ' A' ' 151' ' ' ASN . 26.0 t80 -64.15 -48.82 74.53 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.593 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 31.1 t80 -59.27 -43.51 92.49 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.872 -179.864 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.464 HG23 ' O ' ' A' ' 150' ' ' LEU . 75.8 t -61.7 -36.04 71.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.81 -179.757 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 155' ' ' TRP . . . . . . . . . . . . . 8.0 m0 -64.44 -59.19 4.63 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.74 -179.814 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 156' ' ' ARG . . . . . 0.411 ' NE ' ' CZ ' ' A' ' 152' ' ' TYR . 3.3 mpt_? -60.62 -51.29 70.05 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.829 -179.571 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 31.3 t0 -53.82 -43.79 69.7 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.791 -179.849 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 16.5 t-20 -76.18 -31.41 58.48 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.55 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 86.2 p -128.65 116.44 19.58 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.439 179.671 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 160' ' ' GLY . . . . . 0.476 ' O ' ' O ' ' A' ' 161' ' ' ARG . . . -93.09 130.41 10.32 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 110.999 -0.841 . . . . 0.0 110.999 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 161' ' ' ARG . . . . . 0.476 ' O ' ' O ' ' A' ' 160' ' ' GLY . 46.9 mtt180 45.67 -177.22 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.826 0.346 . . . . 0.0 110.742 179.872 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 34.9 ttp180 -94.66 129.8 41.39 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.504 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -79.67 -169.17 37.96 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 110.827 -0.909 . . . . 0.0 110.827 179.805 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 71.3 -123.82 10.63 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.809 -0.916 . . . . 0.0 110.809 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 6.0 t 63.4 158.34 0.08 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.759 0.314 . . . . 0.0 110.512 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 166' ' ' ARG . . . . . 0.407 HH11 ' HB3' ' A' ' 166' ' ' ARG . 4.1 ttm105 -80.35 -70.63 0.51 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.336 -0.393 . . . . 0.0 109.977 179.882 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 3.8 mp -141.73 -113.94 0.12 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.351 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -91.59 107.09 18.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.578 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 . . . . . 0 C--O 1.219 -0.525 0 CA-C-O 117.974 -1.013 . . . . 0.0 110.525 -179.98 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 201' ' ' PKA . . . . . 0.535 ' C15' 'CL ' ' A' ' 201' ' ' PKA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.644 ' N ' ' CD ' ' A' ' 2' ' ' PRO . 1.6 mmt . . . . . 0 CA--C 1.53 0.179 0 CA-C-O 120.511 0.196 . . . . 0.0 110.99 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.644 ' CD ' ' N ' ' A' ' 1' ' ' MET . 52.5 Cg_exo -60.42 139.12 84.88 Favored 'Trans proline' 0 N--CA 1.495 1.602 0 C-N-CA 121.602 1.535 . . . . 0.0 112.13 -179.823 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.4 ' O ' ' CB ' ' A' ' 4' ' ' SER . 92.1 mt-10 -145.54 -25.63 0.47 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.459 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.4 ' CB ' ' O ' ' A' ' 3' ' ' GLU . 1.3 p 73.98 137.56 0.06 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.379 -179.814 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.712 ' O ' HG23 ' A' ' 9' ' ' VAL . 1.3 t-105 -60.2 109.12 0.9 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.096 -179.881 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.576 ' N ' ' CD ' ' A' ' 7' ' ' PRO . 0.9 OUTLIER -62.23 -40.43 66.78 Favored Pre-proline 0 CA--C 1.533 0.313 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.479 -179.479 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.576 ' CD ' ' N ' ' A' ' 6' ' ' VAL . 25.1 Cg_exo -61.24 -60.29 0.24 Allowed 'Trans proline' 0 C--N 1.306 -1.66 0 C-N-CA 121.627 1.551 . . . . 0.0 111.874 179.904 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.722 ' O ' HG23 ' A' ' 12' ' ' THR . . . -56.88 -32.94 66.37 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.42 -179.465 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.712 HG23 ' O ' ' A' ' 5' ' ' TRP . 55.3 t -67.22 -62.03 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 C-N-CA 120.897 -0.321 . . . . 0.0 111.397 -179.263 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -57.52 -41.23 93.33 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 111.354 -0.698 . . . . 0.0 111.354 -179.509 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 7.7 mp -69.64 -30.14 67.78 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 121.043 -0.263 . . . . 0.0 110.758 -179.641 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.722 HG23 ' O ' ' A' ' 8' ' ' ALA . 4.8 p -74.81 -25.24 58.89 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.842 -0.343 . . . . 0.0 110.406 179.802 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.441 ' O ' ' CB ' ' A' ' 16' ' ' SER . 6.4 mp -81.48 -33.79 31.74 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.023 179.688 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.416 ' N ' ' HD2' ' A' ' 15' ' ' PRO . 7.9 t -40.25 -60.66 1.4 Allowed Pre-proline 0 CA--C 1.535 0.366 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.061 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.416 ' HD2' ' N ' ' A' ' 14' ' ' VAL . 10.5 Cg_endo -51.49 -17.15 4.14 Favored 'Trans proline' 0 N--CA 1.499 1.8 0 C-N-CA 120.949 1.099 . . . . 0.0 112.091 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.441 ' CB ' ' O ' ' A' ' 13' ' ' LEU . 4.0 t -70.0 -33.3 71.86 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.886 0.374 . . . . 0.0 110.512 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 27.9 mt -72.11 -55.17 7.77 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.336 179.86 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -60.75 -46.36 94.63 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 110.857 -0.897 . . . . 0.0 110.857 179.784 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -65.35 -29.45 75.28 Favored Glycine 0 CA--C 1.526 0.756 0 N-CA-C 111.051 -0.82 . . . . 0.0 111.051 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 31.9 t80 -74.23 -59.98 2.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.696 0.284 . . . . 0.0 110.66 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 6.7 ttp -63.31 -22.47 66.9 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.621 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.479 ' C ' ' CZ2' ' A' ' 95' ' ' TRP . . . -77.2 -62.65 2.41 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 111.093 -0.803 . . . . 0.0 111.093 -179.874 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.41 ' O ' HG22 ' A' ' 26' ' ' VAL . . . -64.51 -17.54 63.99 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.006 0.431 . . . . 0.0 110.314 179.891 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 41.4 t80 -48.91 -24.73 1.58 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.143 179.634 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 33.9 t80 -67.64 -54.72 17.31 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.761 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.41 HG22 ' O ' ' A' ' 23' ' ' ALA . 22.2 m -71.64 -17.2 19.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.761 -179.724 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -62.17 -39.84 94.0 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.623 -179.885 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -114.65 -72.42 0.55 Allowed Glycine 0 CA--C 1.525 0.681 0 N-CA-C 110.824 -0.91 . . . . 0.0 110.824 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -45.92 -28.23 1.07 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.82 0.343 . . . . 0.0 110.431 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -68.26 -45.16 71.91 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 84.2 mt -54.95 -36.43 65.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.887 0.375 . . . . 0.0 110.274 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 56.2 mtp180 -77.69 -50.53 12.26 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.637 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' TRP . . . . . 0.422 ' O ' ' N ' ' A' ' 36' ' ' GLY . 0.6 OUTLIER -46.73 -30.68 2.52 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 116.3 -0.409 . . . . 0.0 109.909 -179.996 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 37.7 t80 -47.75 -33.62 7.33 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.424 179.723 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -74.9 -30.64 61.35 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.263 179.731 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.422 ' N ' ' O ' ' A' ' 33' ' ' TRP . . . -77.72 -77.39 0.83 Allowed Glycine 0 CA--C 1.524 0.64 0 N-CA-C 110.793 -0.923 . . . . 0.0 110.793 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.56 ' O ' HD12 ' A' ' 37' ' ' LEU . 0.4 OUTLIER -96.45 166.23 11.8 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 120.791 0.329 . . . . 0.0 110.739 179.712 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -83.17 113.41 20.63 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.767 -179.739 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 7.8 mtpt -97.24 157.28 35.16 Favored Pre-proline 0 CA--C 1.532 0.267 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -49.79 139.85 31.35 Favored 'Trans proline' 0 N--CA 1.495 1.568 0 C-N-CA 120.924 1.083 . . . . 0.0 112.104 -178.714 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 6.0 t -80.86 -2.83 49.02 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.841 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 4.5 p90 -114.27 15.96 18.01 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.256 -179.257 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.567 ' CG ' ' O ' ' A' ' 43' ' ' HIS . 3.8 p-80 -88.68 119.67 70.06 Favored Pre-proline 0 CA--C 1.537 0.459 0 CA-C-N 116.742 -0.208 . . . . 0.0 111.484 -179.684 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.462 ' CG ' HD23 ' A' ' 49' ' ' LEU . 65.4 Cg_endo -102.77 152.42 0.26 Allowed 'Trans proline' 0 N--CA 1.491 1.367 0 C-N-CA 120.763 0.975 . . . . 0.0 111.049 178.47 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.481 ' O ' ' N ' ' A' ' 47' ' ' TRP . 2.0 Cg_endo -47.85 135.47 22.94 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 C-N-CA 120.615 0.877 . . . . 0.0 111.088 179.877 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.486 ' C ' ' HE ' ' A' ' 46' ' ' ARG . 0.0 OUTLIER -41.87 -18.43 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.904 -0.589 . . . . 0.0 112.258 -178.879 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.564 ' CD1' ' N ' ' A' ' 48' ' ' THR . 0.2 OUTLIER -53.91 -47.44 71.15 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 112.508 0.559 . . . . 0.0 112.508 -178.412 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.564 ' N ' ' CD1' ' A' ' 47' ' ' TRP . 4.7 t -90.43 -32.65 16.32 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 113.256 0.836 . . . . 0.0 113.256 -178.124 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.757 ' O ' HG23 ' A' ' 52' ' ' ILE . 0.2 OUTLIER -83.63 -46.32 12.48 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.808 0.669 . . . . 0.0 112.808 -177.658 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.6 ' C ' ' H ' ' A' ' 52' ' ' ILE . . . -39.08 -30.98 0.21 Allowed Pre-proline 0 C--O 1.235 0.305 0 C-N-CA 120.614 -0.435 . . . . 0.0 111.73 -178.391 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.413 ' HD2' ' N ' ' A' ' 50' ' ' ALA . 39.7 Cg_exo -53.53 5.55 0.03 OUTLIER 'Trans proline' 0 C--N 1.311 -1.417 0 CA-C-N 118.99 0.675 . . . . 0.0 112.456 178.253 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.757 HG23 ' O ' ' A' ' 49' ' ' LEU . 9.9 pt -53.34 -34.86 23.3 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.201 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 179.114 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.454 ' O ' ' CB ' ' A' ' 57' ' ' TYR . 72.6 m95 -78.83 -23.24 45.19 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.151 -179.415 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -68.96 -45.12 64.33 Favored Glycine 0 CA--C 1.527 0.797 0 N-CA-C 109.909 -1.276 . . . . 0.0 109.909 179.047 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 6.2 m -68.8 -56.89 6.58 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 179.282 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 95.8 mt -57.32 -26.0 60.25 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.094 179.733 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.543 ' CD1' ' C ' ' A' ' 57' ' ' TYR . 0.5 OUTLIER -66.27 -54.65 22.37 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 179.482 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 61.5 m -51.13 -53.85 30.59 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.539 -0.464 . . . . 0.0 109.92 179.369 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -54.51 -41.07 69.2 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.485 179.772 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 10.1 mtt -62.45 -58.2 8.46 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.354 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -42.31 -41.99 4.17 Favored Glycine 0 CA--C 1.521 0.445 0 N-CA-C 110.641 -0.984 . . . . 0.0 110.641 179.823 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -63.55 -57.64 9.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.896 0.379 . . . . 0.0 110.412 179.848 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -52.1 -57.0 14.11 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 110.682 -0.967 . . . . 0.0 110.682 179.771 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.455 ' O ' ' CD1' ' A' ' 68' ' ' TRP . 0.3 OUTLIER -46.26 -51.64 14.09 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.927 0.394 . . . . 0.0 110.176 179.574 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 70.6 t80 -49.84 -41.07 44.24 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.447 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 40.9 mt -69.63 -44.68 79.3 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.023 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.465 ' CG1' ' CZ3' ' A' ' 68' ' ' TRP . 23.3 t -53.83 -58.61 3.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 120.962 0.411 . . . . 0.0 110.815 -179.722 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' TRP . . . . . 0.526 ' O ' ' N ' ' A' ' 73' ' ' GLY . 1.5 m95 -64.06 -39.48 94.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.196 -179.526 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 4.9 mmmt -63.0 -23.96 67.69 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.847 0.356 . . . . 0.0 110.543 179.804 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -83.0 -62.67 1.53 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.08 -179.47 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.743 ' C ' HD12 ' A' ' 71' ' ' LEU . 3.6 pp -64.92 -9.29 20.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.179 -179.487 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.646 ' N ' HD12 ' A' ' 71' ' ' LEU . . . 106.05 81.99 1.49 Allowed Glycine 0 CA--C 1.525 0.707 0 C-N-CA 121.071 -0.585 . . . . 0.0 111.783 179.335 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.526 ' N ' ' O ' ' A' ' 68' ' ' TRP . . . 42.03 -174.13 0.01 OUTLIER Glycine 0 CA--C 1.526 0.722 0 N-CA-C 111.933 -0.467 . . . . 0.0 111.933 179.097 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 69.8 t80 -76.98 110.8 11.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.871 0.367 . . . . 0.0 110.884 -179.718 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.539 ' OG1' ' N ' ' A' ' 76' ' ' GLU . 1.1 t -142.05 -173.66 3.88 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.326 179.781 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.539 ' N ' ' OG1' ' A' ' 75' ' ' THR . 9.1 mm-40 -49.25 -34.71 15.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.779 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -69.64 -24.29 63.61 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.027 -179.729 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.485 ' O ' HD12 ' A' ' 82' ' ' LEU . . . -91.53 -24.22 19.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.861 0.362 . . . . 0.0 110.642 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 9.2 mtp -63.05 -26.72 68.98 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.576 179.861 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 6.8 t -70.41 -53.9 9.54 Favored Pre-proline 0 CA--C 1.536 0.405 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.838 -179.617 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -64.34 -56.32 0.46 Allowed 'Trans proline' 0 N--CA 1.498 1.753 0 C-N-CA 121.053 1.169 . . . . 0.0 112.097 179.551 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.504 HD11 ' CE2' ' A' ' 68' ' ' TRP . 1.2 mt -61.41 -46.56 89.64 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.911 0.386 . . . . 0.0 110.569 -179.896 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -61.03 -53.96 40.7 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 111.241 -0.743 . . . . 0.0 111.241 -179.64 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 54.9 tp -62.69 -26.58 68.73 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.885 0.374 . . . . 0.0 110.603 -179.707 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 20.9 t80 -68.65 -50.88 47.67 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.783 -179.732 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 9.7 t -70.98 -33.82 70.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.268 -179.468 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -70.52 -57.2 6.8 Favored Glycine 0 CA--C 1.523 0.587 0 N-CA-C 110.947 -0.861 . . . . 0.0 110.947 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.428 ' O ' ' CB ' ' A' ' 92' ' ' ASN . 1.8 tp-100 -59.51 -40.54 87.42 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.818 0.342 . . . . 0.0 110.397 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.405 ' O ' ' CD1' ' A' ' 93' ' ' TRP . 11.4 tp -66.52 -34.91 78.98 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.41 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.766 ' O ' ' HB2' ' A' ' 94' ' ' ALA . . . -64.52 -65.73 0.64 Allowed 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 120.254 -0.578 . . . . 0.0 111.489 -179.398 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.6 pp -66.42 -34.48 78.04 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.714 0.635 . . . . 0.0 112.714 -178.493 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.428 ' CB ' ' O ' ' A' ' 88' ' ' GLN . 7.5 t-20 -82.04 -57.6 3.33 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 -178.461 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' TRP . . . . . 0.6 ' O ' ' N ' ' A' ' 95' ' ' TRP . 0.0 OUTLIER -69.94 -17.04 63.3 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 111.838 0.31 . . . . 0.0 111.838 -178.265 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.766 ' HB2' ' O ' ' A' ' 90' ' ' ALA . . . -52.51 82.95 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.14 0 C-N-CA 120.349 -0.54 . . . . 0.0 110.068 179.637 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.702 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 30.8 p-90 -99.32 -16.31 0.19 Allowed Pre-proline 0 CA--C 1.535 0.375 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 -179.449 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.702 ' CD ' ' N ' ' A' ' 95' ' ' TRP . 48.8 Cg_exo -58.91 -32.92 98.31 Favored 'Trans proline' 0 N--CA 1.495 1.579 0 C-N-CA 120.692 0.928 . . . . 0.0 112.977 179.393 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.466 ' CD ' ' N ' ' A' ' 96' ' ' PRO . 66.4 Cg_exo -49.41 -18.55 2.37 Favored 'Trans proline' 0 N--CA 1.495 1.559 0 C-N-CA 120.389 0.726 . . . . 0.0 112.971 -179.903 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.549 ' O ' ' N ' ' A' ' 101' ' ' GLY . 1.1 pp -92.06 20.97 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.934 0.397 . . . . 0.0 110.466 179.758 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 10.3 t80 -40.41 -48.42 2.73 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.488 179.808 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -77.5 -19.73 55.41 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.546 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.549 ' N ' ' O ' ' A' ' 98' ' ' ILE . . . -78.34 -15.17 81.35 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 110.892 -0.883 . . . . 0.0 110.892 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -67.73 -12.95 61.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.772 0.32 . . . . 0.0 110.468 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.413 ' HB2' HH11 ' A' ' 103' ' ' ARG . 0.0 OUTLIER -81.56 -8.44 59.72 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.467 179.998 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 104' ' ' GLN . . . . . 0.523 ' O ' ' N ' ' A' ' 106' ' ' GLY . 19.1 pt20 -123.87 173.8 7.95 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.838 179.852 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.55 ' N ' ' SD ' ' A' ' 105' ' ' MET . 0.0 OUTLIER -42.83 -17.02 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.125 -179.748 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.523 ' N ' ' O ' ' A' ' 104' ' ' GLN . . . -63.34 -16.84 58.74 Favored Glycine 0 CA--C 1.527 0.836 0 C-N-CA 121.324 -0.465 . . . . 0.0 111.979 -179.233 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' TRP . . . . . 0.686 ' CD1' ' CH2' ' A' ' 155' ' ' TRP . 0.0 OUTLIER -51.11 -15.87 0.4 Allowed 'General case' 0 C--N 1.329 -0.314 0 O-C-N 122.626 -0.338 . . . . 0.0 110.554 -179.581 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.492 ' O ' ' OD1' ' A' ' 111' ' ' ASP . . . -76.2 -25.05 54.78 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.855 0.359 . . . . 0.0 110.621 -179.825 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 84.2 mt -59.24 -29.72 67.73 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.923 -179.716 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.417 ' O ' HD23 ' A' ' 114' ' ' LEU . . . -54.1 -62.02 1.92 Allowed 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.728 -0.389 . . . . 0.0 110.502 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.68 ' O ' HG23 ' A' ' 115' ' ' VAL . 5.5 p-10 -62.02 -53.73 51.42 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.108 -0.496 . . . . 0.0 112.024 -179.432 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 31.8 tp -52.95 -45.13 67.57 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 -178.458 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.404 ' HA ' HD23 ' A' ' 113' ' ' LEU . 60.3 mt -67.67 -61.7 1.76 Allowed 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.624 0.601 . . . . 0.0 112.624 -178.322 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.417 HD23 ' O ' ' A' ' 110' ' ' ALA . 2.9 pp -58.62 -35.1 71.94 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 120.157 -0.617 . . . . 0.0 111.251 -178.736 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.68 HG23 ' O ' ' A' ' 111' ' ' ASP . 37.2 t -58.86 -59.27 3.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.963 179.801 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.494 ' O ' ' OG1' ' A' ' 120' ' ' THR . 5.6 t -70.45 -22.34 62.71 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.658 -179.009 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -64.93 -62.84 4.62 Favored Glycine 0 CA--C 1.526 0.778 0 C-N-CA 120.963 -0.637 . . . . 0.0 111.84 -179.058 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.529 ' O ' HG23 ' A' ' 122' ' ' THR . 8.9 p -72.16 -37.51 59.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 C-N-CA 120.975 -0.29 . . . . 0.0 111.39 -179.404 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.51 ' O ' ' OG1' ' A' ' 123' ' ' THR . . . -67.07 -60.21 2.81 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.338 -0.545 . . . . 0.0 111.038 -179.549 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.494 ' OG1' ' O ' ' A' ' 116' ' ' SER . 3.3 m -57.92 -56.46 21.75 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.754 0.311 . . . . 0.0 111.393 -179.638 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -50.68 -41.15 55.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.305 -179.302 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.529 HG23 ' O ' ' A' ' 118' ' ' VAL . 31.4 p -73.53 -30.16 62.92 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.855 -0.338 . . . . 0.0 111.817 -179.144 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.51 ' OG1' ' O ' ' A' ' 119' ' ' ALA . 0.2 OUTLIER -64.96 -49.04 71.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.942 0.401 . . . . 0.0 110.759 -179.559 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.0 pp -81.59 -20.18 40.38 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.488 -179.274 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -90.8 -67.04 0.88 Allowed 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 -178.552 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 34.8 m0 -83.73 -57.15 3.34 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 112.962 0.727 . . . . 0.0 112.962 -177.831 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' HIS . . . . . 0.492 ' CD2' ' N ' ' A' ' 127' ' ' HIS . 9.1 m170 -55.88 -22.21 24.24 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.715 -0.394 . . . . 0.0 111.707 -178.565 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 33.5 ttt-85 -72.91 -47.25 47.37 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.783 -0.367 . . . . 0.0 111.178 -179.592 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 64.3 t -79.47 -41.49 22.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.168 -179.449 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -130.2 118.22 18.23 Favored Pre-proline 0 CA--C 1.536 0.405 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.578 -179.543 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 131' ' ' PRO . . . . . 0.647 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 70.9 Cg_exo -75.26 -26.6 10.36 Favored 'Trans proline' 0 N--CA 1.493 1.476 0 C-N-CA 121.238 1.292 . . . . 0.0 112.857 179.276 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.647 ' CD ' ' N ' ' A' ' 131' ' ' PRO . 53.8 Cg_exo -60.4 -55.22 1.6 Allowed 'Trans proline' 0 N--CA 1.497 1.73 0 C-N-CA 121.517 1.478 . . . . 0.0 112.492 -179.731 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -46.28 -37.36 7.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.857 0.361 . . . . 0.0 110.315 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.427 ' HB2' ' CG ' ' A' ' 127' ' ' HIS . . . -57.57 -29.45 64.45 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.366 179.894 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 25.5 ttp180 -74.44 -30.47 61.91 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.319 179.788 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 48.5 mt -73.28 -28.91 62.38 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 179.405 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.519 ' O ' ' N ' ' A' ' 140' ' ' TYR . 5.7 mt -86.45 -31.01 21.61 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.413 179.614 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.462 ' C ' ' H ' ' A' ' 140' ' ' TYR . 1.5 t80 -31.52 -49.72 0.45 Allowed Pre-proline 0 CA--C 1.538 0.506 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.508 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.429 ' HD2' ' N ' ' A' ' 138' ' ' TYR . 4.1 Cg_endo -62.65 7.42 0.15 Allowed 'Trans proline' 0 N--CA 1.498 1.764 0 C-N-CA 121.526 1.484 . . . . 0.0 112.807 -179.689 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 140' ' ' TYR . . . . . 0.519 ' N ' ' O ' ' A' ' 137' ' ' LEU . 0.1 OUTLIER -93.08 -14.41 27.32 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 121.013 0.435 . . . . 0.0 111.096 179.806 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.581 HD23 HD12 ' A' ' 144' ' ' LEU . 97.7 mt -59.73 -26.53 65.72 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.16 -0.473 . . . . 0.0 109.942 178.949 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -64.38 -39.3 93.6 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 179.256 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' TRP . . . . . 0.509 ' CE2' HD12 ' A' ' 52' ' ' ILE . 10.5 t-105 -67.19 -42.45 84.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.521 179.115 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.581 HD12 HD23 ' A' ' 141' ' ' LEU . 17.9 mt -58.73 -45.66 89.13 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.226 179.8 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.603 ' O ' HG23 ' A' ' 149' ' ' VAL . . . -70.35 -23.29 62.78 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.27 179.715 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 33.8 t80 -64.83 -64.34 0.89 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.776 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -64.96 -43.82 91.4 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.977 -179.571 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 37.4 m -56.89 -49.86 74.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.804 -179.781 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.603 HG23 ' O ' ' A' ' 145' ' ' ALA . 90.5 t -68.57 -31.78 52.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.935 -179.56 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 1.9 tp -57.07 -46.46 82.48 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.983 0.42 . . . . 0.0 109.912 179.738 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 151' ' ' ASN . . . . . 0.601 ' OD1' ' NE1' ' A' ' 107' ' ' TRP . 7.3 t30 -70.08 -54.53 12.67 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.922 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 65.8 t80 -51.58 -39.09 57.25 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.4 -179.397 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 153' ' ' TYR . . . . . 0.578 ' CE1' ' OD2' ' A' ' 157' ' ' ASP . 53.2 t80 -68.22 -52.43 34.2 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.63 -179.08 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 86.6 t -65.16 -28.07 43.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.596 -178.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 155' ' ' TRP . . . . . 0.686 ' CH2' ' CD1' ' A' ' 107' ' ' TRP . 0.6 OUTLIER -78.32 -40.64 36.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.773 0.32 . . . . 0.0 110.445 -179.334 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 156' ' ' ARG . . . . . 0.402 ' HD2' ' N ' ' A' ' 156' ' ' ARG . 6.0 mpt_? -76.52 -23.22 53.67 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 110.051 -0.351 . . . . 0.0 110.051 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 157' ' ' ASP . . . . . 0.578 ' OD2' ' CE1' ' A' ' 153' ' ' TYR . 2.1 m-20 -79.53 -39.89 30.89 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.537 179.79 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 158' ' ' ASN . . . . . 0.583 ' OD1' ' N ' ' A' ' 159' ' ' SER . 43.1 p30 -86.82 -18.42 31.04 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.501 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 159' ' ' SER . . . . . 0.583 ' N ' ' OD1' ' A' ' 158' ' ' ASN . 19.0 p 54.17 -157.39 0.19 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.734 179.837 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -172.68 -73.11 0.05 OUTLIER Glycine 0 CA--C 1.526 0.733 0 N-CA-C 110.864 -0.895 . . . . 0.0 110.864 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 41.4 ttm180 -160.79 90.92 0.87 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.8 0.334 . . . . 0.0 110.514 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 27.1 ttm180 -65.88 143.01 57.71 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.451 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -82.97 -171.52 47.46 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 111.061 -0.816 . . . . 0.0 111.061 -179.805 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -159.11 -167.76 20.24 Favored Glycine 0 CA--C 1.526 0.733 0 N-CA-C 110.869 -0.893 . . . . 0.0 110.869 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 3.1 t -79.74 -74.12 0.31 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.749 0.309 . . . . 0.0 110.596 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 75.3 mtm180 57.2 179.86 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.647 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.62 HD12 ' N ' ' A' ' 167' ' ' LEU . 8.9 mp 57.27 -102.93 0.16 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.488 -179.92 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -56.41 90.94 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.531 179.827 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.22 -0.496 0 CA-C-O 118.021 -0.99 . . . . 0.0 110.509 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 201' ' ' PKA . . . . . 0.524 ' C15' 'CL ' ' A' ' 201' ' ' PKA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 81.4 mmm . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.971 0.415 . . . . 0.0 110.571 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -59.3 -69.81 0.04 OUTLIER 'Trans proline' 0 C--N 1.306 -1.677 0 C-N-CA 122.565 2.176 . . . . 0.0 112.275 179.841 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 19.6 pt-20 -167.71 -32.03 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.793 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 12.9 m -154.17 -178.43 7.1 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.89 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.564 ' O ' HG23 ' A' ' 9' ' ' VAL . 0.9 OUTLIER -88.87 116.8 27.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.148 -179.983 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.538 ' N ' ' CD ' ' A' ' 7' ' ' PRO . 0.9 OUTLIER -57.94 -45.1 99.81 Favored Pre-proline 0 CA--C 1.534 0.346 0 C-N-CA 120.855 -0.338 . . . . 0.0 110.297 -179.577 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.538 ' CD ' ' N ' ' A' ' 6' ' ' VAL . 20.6 Cg_exo -58.02 -65.36 0.1 OUTLIER 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 121.416 1.411 . . . . 0.0 111.646 179.559 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.69 ' O ' HG23 ' A' ' 12' ' ' THR . . . -45.32 -36.32 4.06 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.366 -179.701 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.564 HG23 ' O ' ' A' ' 5' ' ' TRP . 69.0 t -70.04 -62.59 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 C-N-CA 120.866 -0.334 . . . . 0.0 111.775 -178.962 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -57.23 -43.59 93.53 Favored Glycine 0 CA--C 1.527 0.822 0 C-N-CA 121.275 -0.488 . . . . 0.0 112.0 -179.051 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.437 HD12 ' N ' ' A' ' 11' ' ' LEU . 8.5 mp -67.13 -35.53 79.94 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.569 0.223 . . . . 0.0 111.324 -179.166 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.69 HG23 ' O ' ' A' ' 8' ' ' ALA . 10.6 p -69.66 -29.83 67.38 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.733 -0.387 . . . . 0.0 110.635 -179.9 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.445 ' O ' ' C ' ' A' ' 14' ' ' VAL . 6.0 mp -78.58 -32.13 47.53 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.738 -179.758 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.445 ' C ' ' O ' ' A' ' 13' ' ' LEU . 6.0 t -35.97 -55.91 1.23 Allowed Pre-proline 0 CA--C 1.534 0.35 0 C-N-CA 120.891 -0.323 . . . . 0.0 110.867 -179.704 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.403 ' HD2' ' N ' ' A' ' 14' ' ' VAL . 13.2 Cg_endo -61.03 -41.27 45.25 Favored 'Trans proline' 0 N--CA 1.5 1.87 0 C-N-CA 120.936 1.091 . . . . 0.0 112.026 179.644 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 7.8 t -45.54 -28.34 0.92 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.665 -179.57 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 87.4 mt -66.0 -57.89 6.75 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.72 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -64.55 -24.92 69.83 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 111.291 -0.724 . . . . 0.0 111.291 -179.738 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -77.32 -27.82 59.01 Favored Glycine 0 CA--C 1.518 0.256 0 N-CA-C 110.432 -1.067 . . . . 0.0 110.432 -179.709 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 19.7 t80 -76.08 -60.75 2.19 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.785 0.326 . . . . 0.0 110.617 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 48.6 ttm -73.17 -21.08 60.76 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.216 -179.673 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -79.39 -57.04 3.24 Favored Glycine 0 CA--C 1.526 0.769 0 C-N-CA 120.956 -0.64 . . . . 0.0 111.664 -179.478 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.616 ' O ' HG22 ' A' ' 26' ' ' VAL . . . -69.65 -26.74 64.54 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 120.59 -0.444 . . . . 0.0 110.794 -179.466 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 45.1 t80 -46.92 -23.89 0.52 Allowed 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.516 -0.474 . . . . 0.0 109.848 179.443 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.566 ' CD1' ' CE1' ' A' ' 99' ' ' PHE . 56.6 t80 -72.71 -54.99 7.49 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.086 -179.769 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.616 HG22 ' O ' ' A' ' 23' ' ' ALA . 29.1 m -57.15 -25.83 23.91 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.107 0 C-N-CA 120.392 -0.523 . . . . 0.0 110.291 -179.528 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.75 -37.38 81.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.709 179.592 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -101.07 -56.03 0.9 Allowed Glycine 0 CA--C 1.525 0.693 0 N-CA-C 111.447 -0.661 . . . . 0.0 111.447 -179.596 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 6.0 tm-20 -65.63 -34.72 78.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.603 0.24 . . . . 0.0 111.107 -179.589 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -71.74 -55.02 7.72 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 111.076 -0.81 . . . . 0.0 111.076 -179.775 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 11.0 mp -59.32 -28.33 66.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.744 0.307 . . . . 0.0 110.508 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 40.3 ttm180 -79.02 -52.79 7.75 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.814 0.34 . . . . 0.0 110.466 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -50.51 -33.74 22.63 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 179.87 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.427 ' CD1' ' C ' ' A' ' 34' ' ' TYR . 25.8 t80 -45.51 -35.2 3.7 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.216 179.641 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -56.42 -36.94 69.52 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.58 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -85.67 -66.26 1.42 Allowed Glycine 0 CA--C 1.525 0.657 0 N-CA-C 111.033 -0.827 . . . . 0.0 111.033 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.785 HD22 HD21 ' A' ' 158' ' ' ASN . 0.4 OUTLIER -96.49 167.2 11.3 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.843 0.354 . . . . 0.0 110.532 179.564 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 -90.05 113.58 25.31 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.635 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.581 ' NZ ' ' CH2' ' A' ' 107' ' ' TRP . 17.9 mtpt -125.65 156.23 71.18 Favored Pre-proline 0 C--N 1.331 -0.211 0 CA-C-N 116.174 -0.466 . . . . 0.0 109.862 179.727 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.574 ' C ' ' H ' ' A' ' 42' ' ' TRP . 62.8 Cg_endo -74.72 29.06 0.35 Allowed 'Trans proline' 0 C--N 1.305 -1.712 0 C-N-CA 121.984 1.789 . . . . 0.0 111.497 179.672 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.463 ' H ' ' C ' ' A' ' 39' ' ' LYS . 87.4 p -52.41 -1.85 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.139 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' TRP . . . . . 0.574 ' H ' ' C ' ' A' ' 40' ' ' PRO . 3.5 p90 -76.9 -11.8 59.87 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.798 -0.361 . . . . 0.0 110.928 -179.259 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.457 ' O ' ' C ' ' A' ' 44' ' ' PRO . 24.2 m80 -68.52 135.56 90.68 Favored Pre-proline 0 C--N 1.329 -0.295 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 179.097 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.457 ' C ' ' O ' ' A' ' 43' ' ' HIS . 74.6 Cg_exo -33.79 148.52 0.03 OUTLIER 'Trans proline' 0 N--CA 1.495 1.566 0 C-N-CA 121.312 1.341 . . . . 0.0 111.683 -179.69 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.469 ' O ' ' N ' ' A' ' 47' ' ' TRP . 5.0 Cg_exo -64.13 157.83 51.37 Favored 'Trans proline' 0 C--N 1.311 -1.432 0 C-N-CA 120.627 0.885 . . . . 0.0 111.475 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.562 ' O ' ' HB3' ' A' ' 50' ' ' ALA . 3.1 ptm180 -43.51 -18.51 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.59 -179.188 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.588 ' CD1' ' N ' ' A' ' 48' ' ' THR . 1.0 OUTLIER -64.7 -42.41 95.31 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.658 -0.417 . . . . 0.0 111.012 -179.469 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.588 ' N ' ' CD1' ' A' ' 47' ' ' TRP . 1.7 m -90.58 -34.34 15.53 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.438 -179.257 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.695 ' O ' HG23 ' A' ' 52' ' ' ILE . 0.1 OUTLIER -83.3 -56.31 3.84 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 120.454 -0.498 . . . . 0.0 112.05 -178.635 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.633 ' C ' ' H ' ' A' ' 52' ' ' ILE . . . -39.19 -29.23 0.17 Allowed Pre-proline 0 C--O 1.237 0.407 0 C-N-CA 120.745 -0.382 . . . . 0.0 111.44 -178.618 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.426 ' HD2' ' N ' ' A' ' 50' ' ' ALA . 35.1 Cg_exo -52.92 3.71 0.04 OUTLIER 'Trans proline' 0 C--N 1.313 -1.32 0 CA-C-N 118.852 0.626 . . . . 0.0 111.877 177.516 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.695 HG23 ' O ' ' A' ' 49' ' ' LEU . 5.7 pt -51.12 -45.23 30.3 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.233 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 178.966 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.534 ' N ' ' CG1' ' A' ' 52' ' ' ILE . 87.6 m95 -57.66 -23.41 51.22 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.789 -179.094 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -68.48 -45.33 68.6 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 109.411 -1.476 . . . . 0.0 109.411 178.399 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 6.0 m -69.1 -57.6 5.2 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 179.133 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.509 HD13 ' CE3' ' A' ' 143' ' ' TRP . 34.6 mt -48.52 -49.58 35.45 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 179.112 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 6.9 t80 -46.37 -58.48 3.69 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.696 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.431 ' O ' ' CE1' ' A' ' 62' ' ' TYR . 0.2 OUTLIER -48.05 -58.88 3.87 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.881 0.372 . . . . 0.0 110.686 -179.556 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.534 ' HB1' ' O ' ' A' ' 136' ' ' LEU . . . -51.68 -61.46 2.24 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.852 -179.893 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.433 ' SD ' ' C ' ' A' ' 56' ' ' LEU . 0.2 OUTLIER -46.1 -38.93 8.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.396 -179.957 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -56.6 -54.29 37.37 Favored Glycine 0 CA--C 1.522 0.493 0 N-CA-C 110.905 -0.878 . . . . 0.0 110.905 -179.859 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.6 ' CD1' ' N ' ' A' ' 62' ' ' TYR . 0.6 OUTLIER -55.85 -59.81 4.36 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.876 -0.33 . . . . 0.0 110.847 -179.814 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -48.33 -56.14 9.69 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 110.75 -0.94 . . . . 0.0 110.75 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.563 ' OG ' ' NE1' ' A' ' 68' ' ' TRP . 0.6 OUTLIER -45.6 -56.07 5.59 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.963 0.411 . . . . 0.0 111.025 179.967 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 59.7 t80 -47.51 -47.11 27.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.023 -179.723 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 53.6 mt -59.62 -40.01 81.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.009 -179.588 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.447 ' CG1' ' CZ3' ' A' ' 68' ' ' TRP . 43.0 t -57.74 -52.12 61.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 C-N-CA 120.862 -0.335 . . . . 0.0 110.849 -179.612 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' TRP . . . . . 0.563 ' NE1' ' OG ' ' A' ' 64' ' ' SER . 0.6 OUTLIER -64.19 -28.94 70.09 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 120.643 -0.423 . . . . 0.0 110.778 -179.978 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.06 -22.46 59.52 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.816 0.341 . . . . 0.0 110.374 179.828 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -81.35 -61.36 1.96 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.053 -179.72 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.8 pp -74.43 -20.67 59.95 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.788 -0.365 . . . . 0.0 111.209 -179.294 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.509 ' O ' ' O ' ' A' ' 73' ' ' GLY . . . 109.44 99.11 2.56 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 121.135 -0.555 . . . . 0.0 112.268 178.976 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.509 ' O ' ' O ' ' A' ' 72' ' ' GLY . . . 40.64 -173.55 0.01 OUTLIER Glycine 0 CA--C 1.525 0.671 0 N-CA-C 112.195 -0.362 . . . . 0.0 112.195 178.684 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 25.4 t80 -90.2 110.88 21.9 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.538 -0.331 . . . . 0.0 110.53 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.587 ' OG1' ' N ' ' A' ' 76' ' ' GLU . 0.1 OUTLIER -142.2 -177.43 5.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.592 179.796 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.587 ' N ' ' OG1' ' A' ' 75' ' ' THR . 35.8 mt-10 -47.92 -29.6 3.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.636 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -70.04 -27.57 64.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.895 -179.76 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.416 ' O ' HD12 ' A' ' 82' ' ' LEU . . . -95.64 -17.74 21.09 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.917 -179.798 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 25.9 mtp -68.7 -28.63 67.01 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.836 -0.346 . . . . 0.0 110.786 -179.859 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 9.1 t -66.78 -49.29 49.77 Favored Pre-proline 0 CA--C 1.533 0.292 0 C-N-CA 120.782 -0.367 . . . . 0.0 110.536 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -69.52 -59.7 0.08 OUTLIER 'Trans proline' 0 N--CA 1.497 1.692 0 C-N-CA 121.051 1.167 . . . . 0.0 111.61 179.094 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.431 HD11 ' CH2' ' A' ' 68' ' ' TRP . 5.0 mt -52.47 -52.4 54.49 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.411 179.836 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -58.37 -57.67 18.64 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 110.484 -1.046 . . . . 0.0 110.484 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.425 ' O ' ' CB ' ' A' ' 88' ' ' GLN . 57.0 tp -48.22 -32.98 7.86 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 179.534 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -74.56 -47.53 32.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.827 -179.823 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -60.08 -48.74 80.44 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.742 -0.383 . . . . 0.0 110.919 -179.597 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -70.73 -58.33 5.88 Favored Glycine 0 CA--C 1.527 0.822 0 N-CA-C 111.477 -0.649 . . . . 0.0 111.477 -179.611 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.425 ' CB ' ' O ' ' A' ' 84' ' ' LEU . 12.4 tp-100 -50.45 -40.66 51.27 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.092 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.419 ' O ' ' C ' ' A' ' 90' ' ' ALA . 50.6 tp -58.51 -65.84 0.59 Allowed 'General case' 0 C--O 1.215 -0.719 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.927 179.717 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.699 ' O ' ' HB2' ' A' ' 94' ' ' ALA . . . -38.56 -46.13 1.15 Allowed 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 120.349 -0.54 . . . . 0.0 111.622 -179.448 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 83.8 mt -57.86 -56.43 22.11 Favored 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 112.815 0.672 . . . . 0.0 112.815 -178.694 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 6.7 m-20 -75.2 -57.07 4.12 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.185 0.517 . . . . 0.0 111.742 -178.396 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' TRP . . . . . 0.676 ' O ' ' N ' ' A' ' 95' ' ' TRP . 0.1 OUTLIER -53.92 -23.44 12.84 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.454 -0.793 . . . . 0.0 111.49 -179.468 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.699 ' HB2' ' O ' ' A' ' 90' ' ' ALA . . . -52.34 73.64 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.818 0.342 . . . . 0.0 110.757 -179.549 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.682 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 13.5 p-90 -101.96 -17.48 0.19 Allowed Pre-proline 0 CA--C 1.532 0.266 0 CA-C-N 116.279 -0.418 . . . . 0.0 112.127 -179.522 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.682 ' CD ' ' N ' ' A' ' 95' ' ' TRP . 39.5 Cg_exo -62.43 -24.81 75.76 Favored 'Trans proline' 0 N--CA 1.495 1.577 0 C-N-CA 120.404 0.736 . . . . 0.0 112.812 179.401 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.541 ' CD ' ' N ' ' A' ' 96' ' ' PRO . 92.5 Cg_exo -62.02 -26.94 78.93 Favored 'Trans proline' 0 N--CA 1.496 1.628 0 C-N-CA 120.496 0.798 . . . . 0.0 112.675 179.679 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 1.2 pp -72.79 17.49 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-O 121.086 0.47 . . . . 0.0 110.107 179.797 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.566 ' CE1' ' CD1' ' A' ' 25' ' ' PHE . 2.4 t80 -39.49 -31.65 0.1 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.191 -179.802 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.488 ' CE1' ' O ' ' A' ' 97' ' ' PRO . 3.4 p90 -84.69 -50.37 7.69 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.942 -0.303 . . . . 0.0 110.869 -179.633 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.417 ' N ' ' CD2' ' A' ' 100' ' ' PHE . . . -64.22 -4.58 12.48 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 111.171 -0.772 . . . . 0.0 111.171 -179.739 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -75.07 -14.17 60.56 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.643 0.258 . . . . 0.0 110.939 -179.792 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 4.3 ptm180 -86.68 5.35 36.49 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.915 -0.314 . . . . 0.0 110.677 -179.895 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -121.57 171.01 9.13 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.565 179.832 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 4.7 mmt -59.37 -17.68 32.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.419 179.737 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.588 ' O ' ' N ' ' A' ' 108' ' ' ALA . . . -69.46 -15.37 70.47 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 111.455 -0.658 . . . . 0.0 111.455 -179.571 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' TRP . . . . . 0.581 ' CH2' ' NZ ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -43.49 -13.86 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.749 0.309 . . . . 0.0 110.725 -179.604 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.588 ' N ' ' O ' ' A' ' 106' ' ' GLY . . . -57.96 -18.68 25.18 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.431 179.718 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 13.4 mt -54.45 -32.13 56.92 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.386 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.558 ' HB3' ' C22' ' A' ' 201' ' ' PKA . . . -52.85 -63.05 1.27 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.544 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.757 ' O ' HG23 ' A' ' 115' ' ' VAL . 0.9 OUTLIER -59.67 -57.79 11.38 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.495 -179.545 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.418 ' N ' ' OD1' ' A' ' 111' ' ' ASP . 50.8 tp -47.82 -41.72 24.43 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.115 -0.493 . . . . 0.0 112.025 -178.87 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.421 HD23 ' HA ' ' A' ' 113' ' ' LEU . 64.5 mt -71.84 -61.84 1.64 Allowed 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -178.14 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.439 ' CD2' ' O ' ' A' ' 110' ' ' ALA . 1.1 pp -57.22 -32.8 66.88 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 120.037 -0.665 . . . . 0.0 111.432 -178.178 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.757 HG23 ' O ' ' A' ' 111' ' ' ASP . 98.0 t -67.06 -51.36 54.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.84 0.353 . . . . 0.0 110.925 179.777 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 18.0 m -68.53 -27.72 66.35 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.393 -179.312 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -68.07 -59.96 6.0 Favored Glycine 0 CA--C 1.528 0.867 0 C-N-CA 121.045 -0.598 . . . . 0.0 111.899 -179.036 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.532 ' O ' HG23 ' A' ' 122' ' ' THR . 7.5 p -65.27 -38.51 82.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 -178.831 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.449 ' N ' HG13 ' A' ' 118' ' ' VAL . . . -71.12 -60.76 2.06 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.518 -0.473 . . . . 0.0 111.52 -178.687 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 43.7 m -52.23 -52.97 49.28 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.918 0.39 . . . . 0.0 110.975 -179.594 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -57.47 -50.91 71.51 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.115 -0.493 . . . . 0.0 112.226 -179.161 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.532 HG23 ' O ' ' A' ' 118' ' ' VAL . 40.0 p -64.75 -64.54 0.85 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.969 0.414 . . . . 0.0 111.745 -178.72 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.434 ' OG1' ' O ' ' A' ' 119' ' ' ALA . 0.2 OUTLIER -44.06 -41.31 5.41 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.892 -0.595 . . . . 0.0 112.295 -178.448 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.78 ' C ' HD12 ' A' ' 124' ' ' LEU . 1.5 pp -84.34 -19.93 32.87 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.393 -0.523 . . . . 0.0 111.643 -179.117 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -94.77 -71.3 0.67 Allowed 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 113.053 0.761 . . . . 0.0 113.053 -178.433 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' TRP . . . . . 0.467 ' CD1' ' N ' ' A' ' 126' ' ' TRP . 25.6 m0 -76.71 -57.09 4.06 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 -177.411 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 127' ' ' HIS . . . . . 0.502 ' CG ' ' HB2' ' A' ' 134' ' ' ALA . 18.1 m170 -48.79 -22.58 0.84 Allowed 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.558 -0.457 . . . . 0.0 111.332 -178.63 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 23.0 ttt180 -69.11 -48.1 63.41 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.838 -0.345 . . . . 0.0 111.06 -179.628 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 15.0 t -79.77 -49.33 19.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.962 -179.62 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' SER . . . . . 0.455 ' O ' ' OG ' ' A' ' 130' ' ' SER . 0.4 OUTLIER -118.71 108.92 40.47 Favored Pre-proline 0 CA--C 1.532 0.258 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.673 -179.701 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 131' ' ' PRO . . . . . 0.654 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 82.1 Cg_exo -74.38 -32.52 6.33 Favored 'Trans proline' 0 C--N 1.311 -1.447 0 C-N-CA 121.577 1.518 . . . . 0.0 112.794 179.451 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.654 ' CD ' ' N ' ' A' ' 131' ' ' PRO . 27.5 Cg_exo -58.67 -44.43 36.66 Favored 'Trans proline' 0 N--CA 1.494 1.558 0 C-N-CA 121.706 1.604 . . . . 0.0 112.199 -179.82 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.413 ' O ' ' N ' ' A' ' 136' ' ' LEU . . . -50.24 -49.51 52.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.672 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.502 ' HB2' ' CG ' ' A' ' 127' ' ' HIS . . . -44.19 -23.07 0.08 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.665 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 135' ' ' ARG . . . . . 0.401 ' N ' ' O ' ' A' ' 133' ' ' ALA . 14.1 tpp180 -76.66 -37.11 56.82 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.17 -179.528 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.534 ' O ' ' HB1' ' A' ' 59' ' ' ALA . 9.4 mt -76.26 -22.13 55.5 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 179.777 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.547 ' O ' ' N ' ' A' ' 140' ' ' TYR . 0.7 OUTLIER -85.44 -43.64 13.43 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 179.147 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.559 ' C ' ' H ' ' A' ' 140' ' ' TYR . 0.2 OUTLIER -21.32 -50.66 0.06 OUTLIER Pre-proline 0 N--CA 1.466 0.341 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.871 179.71 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.434 ' N ' ' O ' ' A' ' 137' ' ' LEU . 17.2 Cg_exo -51.21 -3.33 0.07 OUTLIER 'Trans proline' 0 C--N 1.308 -1.598 0 C-N-CA 121.247 1.298 . . . . 0.0 112.051 179.824 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 140' ' ' TYR . . . . . 0.674 ' CE2' HD11 ' A' ' 144' ' ' LEU . 1.9 p90 -83.45 -17.55 41.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.779 -179.836 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.402 HD12 ' CD1' ' A' ' 138' ' ' TYR . 93.4 mt -61.35 -36.59 80.61 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 179.154 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -56.95 -40.29 76.16 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 179.08 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' TRP . . . . . 0.55 ' CD1' ' C ' ' A' ' 143' ' ' TRP . 0.4 OUTLIER -63.54 -45.14 91.93 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.647 179.414 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.674 HD11 ' CE2' ' A' ' 140' ' ' TYR . 13.7 mt -60.81 -41.53 95.85 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 179.354 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.66 ' O ' HG23 ' A' ' 149' ' ' VAL . . . -70.42 -18.98 63.02 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.103 -0.499 . . . . 0.0 109.766 179.217 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -71.14 -63.09 1.17 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.823 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.415 ' HB1' ' C20' ' A' ' 201' ' ' PKA . . . -68.64 -31.74 71.09 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 120.607 -0.437 . . . . 0.0 110.583 -179.804 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 85.0 m -67.7 -45.48 74.99 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.851 -0.34 . . . . 0.0 110.217 179.772 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.66 HG23 ' O ' ' A' ' 145' ' ' ALA . 45.7 t -64.64 -33.71 64.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.047 179.731 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.485 ' O ' HG23 ' A' ' 154' ' ' VAL . 0.9 OUTLIER -60.59 -58.9 6.53 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.033 179.859 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 151' ' ' ASN . . . . . 0.467 ' OD1' ' HB2' ' A' ' 108' ' ' ALA . 11.1 t30 -55.8 -54.43 44.54 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.56 179.823 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 16.6 t80 -52.42 -34.36 48.1 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.649 -179.852 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 153' ' ' TYR . . . . . 0.583 ' CE2' ' OD2' ' A' ' 157' ' ' ASP . 59.4 t80 -66.53 -47.1 73.98 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.821 -179.729 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.485 HG23 ' O ' ' A' ' 150' ' ' LEU . 13.0 t -55.9 -42.16 69.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.659 -179.825 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 155' ' ' TRP . . . . . . . . . . . . . 16.5 m0 -62.5 -59.45 4.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.151 -179.657 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.63 -25.93 63.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.047 -179.43 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 157' ' ' ASP . . . . . 0.583 ' OD2' ' CE2' ' A' ' 153' ' ' TYR . 0.8 OUTLIER -86.74 -42.67 13.15 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.885 -0.326 . . . . 0.0 111.333 -179.393 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 158' ' ' ASN . . . . . 0.785 HD21 HD22 ' A' ' 37' ' ' LEU . 2.4 m-20 -78.02 -40.78 37.85 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.208 -179.43 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 159' ' ' SER . . . . . 0.473 ' O ' ' OG ' ' A' ' 159' ' ' SER . 22.8 p -67.57 90.5 0.26 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.476 -179.893 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 161.92 58.42 0.02 OUTLIER Glycine 0 CA--C 1.526 0.719 0 N-CA-C 111.176 -0.769 . . . . 0.0 111.176 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 27.8 mmt180 -89.19 -49.48 6.71 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.849 0.357 . . . . 0.0 110.586 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 36.7 ttt180 -52.34 143.96 13.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.632 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -139.44 -95.65 0.31 Allowed Glycine 0 CA--C 1.525 0.66 0 N-CA-C 111.024 -0.83 . . . . 0.0 111.024 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -159.73 45.81 0.43 Allowed Glycine 0 CA--C 1.524 0.629 0 N-CA-C 110.845 -0.902 . . . . 0.0 110.845 179.895 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 165' ' ' SER . . . . . 0.426 ' O ' ' O ' ' A' ' 166' ' ' ARG . 1.1 t 56.97 18.74 4.11 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.803 0.335 . . . . 0.0 110.502 -179.816 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 166' ' ' ARG . . . . . 0.433 ' C ' HD22 ' A' ' 167' ' ' LEU . 0.3 OUTLIER 48.88 -178.97 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.439 179.89 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.791 HD22 ' N ' ' A' ' 167' ' ' LEU . 2.0 mm? -107.49 31.35 5.49 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.795 179.661 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -48.73 -37.87 20.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.869 -179.771 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 66.9 mm-40 . . . . . 0 C--O 1.22 -0.497 0 CA-C-O 117.98 -1.01 . . . . 0.0 110.511 179.882 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 201' ' ' PKA . . . . . 0.558 ' C22' ' HB3' ' A' ' 110' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 42.0 mtt . . . . . 0 CA--C 1.529 0.145 0 CA-C-O 120.593 0.235 . . . . 0.0 110.495 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_exo -45.01 148.58 1.53 Allowed 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 121.997 1.798 . . . . 0.0 112.182 179.759 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.408 ' CD ' ' N ' ' A' ' 3' ' ' GLU . 4.5 mp0 -109.42 -20.26 12.97 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.416 179.853 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 22.7 t -79.84 65.67 5.07 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.485 179.822 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.668 ' CD2' ' CZ3' ' A' ' 68' ' ' TRP . 0.3 OUTLIER -49.31 119.75 3.56 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.624 -179.858 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.59 ' N ' ' CD ' ' A' ' 7' ' ' PRO . 0.9 OUTLIER -61.05 -32.66 11.44 Favored Pre-proline 0 C--N 1.329 -0.291 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 179.7 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.59 ' CD ' ' N ' ' A' ' 6' ' ' VAL . 22.7 Cg_exo -74.71 -67.81 0.02 OUTLIER 'Trans proline' 0 N--CA 1.492 1.423 0 C-N-CA 121.531 1.488 . . . . 0.0 111.953 179.168 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.656 ' O ' HG23 ' A' ' 12' ' ' THR . . . -48.13 -38.95 19.09 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.965 -0.294 . . . . 0.0 111.178 -179.569 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.512 HG23 ' O ' ' A' ' 5' ' ' TRP . 89.2 t -69.96 -62.21 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.802 -179.255 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -53.9 -50.94 52.65 Favored Glycine 0 CA--C 1.526 0.773 0 N-CA-C 111.486 -0.646 . . . . 0.0 111.486 -179.307 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 8.8 mp -58.47 -40.9 83.94 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.615 0.245 . . . . 0.0 111.134 -179.603 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.656 HG23 ' O ' ' A' ' 8' ' ' ALA . 18.2 p -69.39 -28.71 66.42 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.843 -0.343 . . . . 0.0 110.998 -179.643 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.418 HD13 ' O ' ' A' ' 9' ' ' VAL . 7.1 mp -80.2 -26.31 39.25 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.737 -179.737 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.402 ' N ' ' HD2' ' A' ' 15' ' ' PRO . 14.2 t -44.58 -60.15 3.26 Favored Pre-proline 0 CA--C 1.534 0.342 0 C-N-CA 120.89 -0.324 . . . . 0.0 110.934 -179.64 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.402 ' HD2' ' N ' ' A' ' 14' ' ' VAL . 9.7 Cg_endo -52.7 -20.65 13.01 Favored 'Trans proline' 0 N--CA 1.498 1.761 0 C-N-CA 121.025 1.15 . . . . 0.0 111.749 179.746 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.587 ' OG ' ' CE3' ' A' ' 53' ' ' TRP . 1.6 t -73.79 -27.39 61.11 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.857 -179.744 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 87.7 mt -73.77 -58.16 3.49 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.477 -179.859 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -68.95 -22.06 75.59 Favored Glycine 0 CA--C 1.523 0.539 0 N-CA-C 110.449 -1.06 . . . . 0.0 110.449 179.694 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -74.12 -39.1 45.96 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 110.517 -1.033 . . . . 0.0 110.517 179.836 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 67.4 t80 -70.82 -60.09 2.44 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.676 0.274 . . . . 0.0 110.668 179.797 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 16.2 ttm -67.27 -21.21 65.72 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.951 -179.703 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -81.42 -62.68 1.93 Allowed Glycine 0 CA--C 1.525 0.672 0 N-CA-C 111.43 -0.668 . . . . 0.0 111.43 -179.671 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.652 ' O ' HG22 ' A' ' 26' ' ' VAL . . . -64.88 -24.96 67.69 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.77 0.319 . . . . 0.0 111.129 -179.386 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 27.8 t80 -47.36 -23.2 0.54 Allowed 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 179.558 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.4 ' CE2' ' HB3' ' A' ' 102' ' ' ALA . 21.3 t80 -72.72 -51.21 20.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.916 -0.583 . . . . 0.0 111.25 -179.769 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.652 HG22 ' O ' ' A' ' 23' ' ' ALA . 34.9 m -62.79 -26.88 41.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 C-N-CA 120.541 -0.464 . . . . 0.0 110.522 -179.745 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -66.72 -24.9 66.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.223 179.799 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -106.03 -35.36 2.98 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 110.377 -1.089 . . . . 0.0 110.377 179.531 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.419 ' O ' ' N ' ' A' ' 32' ' ' ARG . 18.8 tt0 -84.95 -47.42 10.29 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.753 0.311 . . . . 0.0 110.227 179.644 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.459 ' N ' ' O ' ' A' ' 26' ' ' VAL . . . -48.39 -46.5 28.87 Favored Glycine 0 CA--C 1.523 0.567 0 N-CA-C 110.567 -1.013 . . . . 0.0 110.567 179.787 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.407 ' N ' HD12 ' A' ' 31' ' ' LEU . 10.5 mp -60.0 -25.12 65.02 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 179.612 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.452 ' O ' ' HB3' ' A' ' 35' ' ' ALA . 56.6 ttt180 -78.33 -50.96 10.84 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.131 179.344 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 11.9 m0 -47.26 -45.24 23.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.231 179.745 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 88.3 t80 -52.52 -23.99 7.29 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.438 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.452 ' HB3' ' O ' ' A' ' 32' ' ' ARG . . . -67.73 -42.16 82.31 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.696 -179.868 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -97.1 -68.83 0.97 Allowed Glycine 0 CA--C 1.525 0.683 0 N-CA-C 111.076 -0.809 . . . . 0.0 111.076 -179.896 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.777 ' C ' HD12 ' A' ' 37' ' ' LEU . 3.6 pp -90.52 166.2 13.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.875 0.369 . . . . 0.0 110.592 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 48.5 mm-40 -85.46 129.8 34.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.608 -179.16 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.409 ' HG3' HD11 ' A' ' 37' ' ' LEU . 14.2 mtpt -118.63 165.02 17.78 Favored Pre-proline 0 CA--C 1.532 0.25 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 179.013 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.498 ' C ' ' H ' ' A' ' 42' ' ' TRP . 2.8 Cg_endo -63.77 92.36 0.17 Allowed 'Trans proline' 0 C--N 1.307 -1.612 0 C-N-CA 122.164 1.909 . . . . 0.0 111.75 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.2 m -56.02 -1.68 0.05 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.324 -179.792 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' TRP . . . . . 0.501 ' CD1' ' C ' ' A' ' 42' ' ' TRP . 2.8 p90 -95.07 -9.24 34.29 Favored 'General case' 0 C--O 1.231 0.113 0 C-N-CA 120.295 -0.562 . . . . 0.0 110.772 -179.386 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.583 ' O ' ' ND1' ' A' ' 43' ' ' HIS . 0.9 OUTLIER -87.86 121.2 70.91 Favored Pre-proline 0 CA--C 1.537 0.471 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.813 -179.985 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -95.11 156.98 1.72 Allowed 'Trans proline' 0 N--CA 1.492 1.429 0 C-N-CA 120.844 1.029 . . . . 0.0 111.562 179.13 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.425 ' C ' ' N ' ' A' ' 47' ' ' TRP . 2.9 Cg_endo -43.01 140.3 3.22 Favored 'Trans proline' 0 C--N 1.306 -1.694 0 C-N-CA 121.511 1.474 . . . . 0.0 111.59 -179.764 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -45.82 -16.96 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.231 -179.528 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.593 ' CD1' ' N ' ' A' ' 48' ' ' THR . 0.3 OUTLIER -53.06 -49.66 65.92 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 120.407 -0.517 . . . . 0.0 111.818 -178.653 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.593 ' N ' ' CD1' ' A' ' 47' ' ' TRP . 6.6 t -91.29 -30.09 16.79 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 113.341 0.867 . . . . 0.0 113.341 -178.606 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.675 ' O ' HG23 ' A' ' 52' ' ' ILE . 0.1 OUTLIER -83.14 -43.01 16.69 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -177.999 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.639 ' C ' ' H ' ' A' ' 52' ' ' ILE . . . -40.8 -28.34 0.21 Allowed Pre-proline 0 N--CA 1.465 0.287 0 N-CA-C 111.934 0.346 . . . . 0.0 111.934 -179.107 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.417 ' HD2' ' N ' ' A' ' 50' ' ' ALA . 12.4 Cg_exo -54.48 8.28 0.03 OUTLIER 'Trans proline' 0 C--N 1.311 -1.401 0 CA-C-N 119.005 0.68 . . . . 0.0 112.533 178.352 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.675 HG23 ' O ' ' A' ' 49' ' ' LEU . 9.2 pt -55.62 -35.56 39.12 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 178.673 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.587 ' CE3' ' OG ' ' A' ' 16' ' ' SER . 3.5 m0 -55.11 -25.01 28.79 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.433 179.615 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -69.89 -61.51 4.3 Favored Glycine 0 CA--C 1.528 0.845 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.906 -179.371 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.49 ' CG2' ' N ' ' A' ' 56' ' ' LEU . 1.9 t -56.39 -46.69 79.99 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 120.729 -0.389 . . . . 0.0 110.706 -179.351 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.49 ' N ' ' CG2' ' A' ' 55' ' ' THR . 57.9 mt -62.31 -41.57 98.65 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.365 -0.534 . . . . 0.0 109.639 179.313 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.532 ' CD1' ' C ' ' A' ' 57' ' ' TYR . 4.2 t80 -56.69 -40.27 75.29 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.678 -179.707 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.431 ' OG ' ' N ' ' A' ' 59' ' ' ALA . 1.3 p -62.85 -53.63 51.26 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 179.62 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.669 ' HB1' ' O ' ' A' ' 136' ' ' LEU . . . -55.78 -62.3 1.79 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.503 179.713 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 36.5 mtm -51.72 -32.35 29.99 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.447 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -57.93 -56.06 27.22 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 111.19 -0.764 . . . . 0.0 111.19 -179.774 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.459 ' HB3' HD13 ' A' ' 136' ' ' LEU . 3.4 m-30 -65.46 -42.67 92.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.05 0.452 . . . . 0.0 110.301 -179.834 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -53.35 -56.27 20.4 Favored Glycine 0 CA--C 1.524 0.615 0 N-CA-C 110.44 -1.064 . . . . 0.0 110.44 179.68 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.582 ' O ' ' CD1' ' A' ' 68' ' ' TRP . 0.9 OUTLIER -54.97 -45.12 74.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.774 0.321 . . . . 0.0 110.539 179.815 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.438 ' HA ' ' CZ2' ' A' ' 68' ' ' TRP . 74.7 t80 -47.01 -47.21 22.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.019 0.438 . . . . 0.0 110.01 179.668 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 62.4 mt -70.56 -28.14 33.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.058 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 59.3 t -63.42 -59.22 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 C-N-CA 120.617 -0.433 . . . . 0.0 111.647 -179.399 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' TRP . . . . . 0.668 ' CZ3' ' CD2' ' A' ' 5' ' ' TRP . 0.0 OUTLIER -70.78 -29.56 65.8 Favored 'General case' 0 N--CA 1.462 0.152 0 C-N-CA 119.84 -0.744 . . . . 0.0 110.822 -179.327 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -70.89 -22.38 62.28 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.517 -0.473 . . . . 0.0 110.207 179.524 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -82.22 -60.75 2.1 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.924 -179.677 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.8 pp -72.92 -11.19 60.49 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.99 -179.395 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.515 ' O ' ' O ' ' A' ' 73' ' ' GLY . . . 104.86 92.57 2.27 Favored Glycine 0 CA--C 1.527 0.814 0 C-N-CA 121.163 -0.541 . . . . 0.0 112.149 179.101 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.586 ' N ' ' O ' ' A' ' 68' ' ' TRP . . . 40.94 -173.52 0.01 OUTLIER Glycine 0 CA--C 1.524 0.652 0 N-CA-C 111.973 -0.451 . . . . 0.0 111.973 179.009 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 42.9 t80 -86.98 110.18 19.87 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.85 0.357 . . . . 0.0 110.341 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.576 ' OG1' ' N ' ' A' ' 76' ' ' GLU . 0.1 OUTLIER -142.57 -174.12 4.05 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.788 -179.822 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.576 ' N ' ' OG1' ' A' ' 75' ' ' THR . 92.2 mt-10 -49.89 -24.43 2.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.884 179.881 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -78.63 -31.68 47.03 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.893 -179.804 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -85.8 -20.57 29.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.831 0.348 . . . . 0.0 110.716 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 8.3 mtp -65.43 -27.1 68.29 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.658 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.409 ' O ' ' CB ' ' A' ' 84' ' ' LEU . 6.9 t -69.4 -48.74 24.75 Favored Pre-proline 0 C--N 1.328 -0.33 0 C-N-CA 120.839 -0.345 . . . . 0.0 110.728 -179.768 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -71.23 -60.85 0.05 OUTLIER 'Trans proline' 0 N--CA 1.497 1.715 0 C-N-CA 120.961 1.107 . . . . 0.0 111.829 179.179 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 5.0 mt -57.6 -48.73 78.61 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.618 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -61.2 -61.45 6.91 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 110.938 -0.865 . . . . 0.0 110.938 -179.756 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.409 ' CB ' ' O ' ' A' ' 80' ' ' VAL . 33.2 tp -53.54 -24.05 12.37 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.902 0.382 . . . . 0.0 110.494 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 13.5 t80 -77.33 -47.99 18.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.433 179.85 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -66.71 -37.0 83.81 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.603 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -71.21 -57.44 6.18 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 110.612 -0.995 . . . . 0.0 110.612 179.823 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 49.3 tp60 -53.38 -45.29 69.2 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 179.61 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.424 ' O ' ' C ' ' A' ' 90' ' ' ALA . 24.3 tp -53.35 -66.14 0.44 Allowed 'General case' 0 C--O 1.21 -0.994 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.63 179.603 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.613 ' O ' ' HB2' ' A' ' 94' ' ' ALA . . . -38.65 -48.64 1.48 Allowed 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 120.637 -0.425 . . . . 0.0 111.85 -179.575 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 94.6 mt -55.04 -57.28 12.33 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 112.9 0.704 . . . . 0.0 112.9 -178.277 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -74.84 -55.88 5.35 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 121.316 0.579 . . . . 0.0 111.419 -178.717 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' TRP . . . . . 0.642 ' O ' ' N ' ' A' ' 95' ' ' TRP . 4.9 t-105 -53.19 -19.45 3.06 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.124 -0.943 . . . . 0.0 111.209 -179.781 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.613 ' HB2' ' O ' ' A' ' 90' ' ' ALA . . . -59.19 69.37 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.161 0 CA-C-O 120.992 0.425 . . . . 0.0 109.86 179.629 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.688 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 11.9 p-90 -101.95 -17.04 0.19 Allowed Pre-proline 0 CA--C 1.536 0.418 0 CA-C-N 115.729 -0.668 . . . . 0.0 112.142 -179.106 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.688 ' CD ' ' N ' ' A' ' 95' ' ' TRP . 31.9 Cg_exo -60.89 -30.57 90.28 Favored 'Trans proline' 0 N--CA 1.495 1.573 0 C-N-CA 120.383 0.722 . . . . 0.0 112.618 179.638 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.514 ' CD ' ' N ' ' A' ' 96' ' ' PRO . 91.8 Cg_exo -55.24 -27.55 57.42 Favored 'Trans proline' 0 N--CA 1.494 1.526 0 C-N-CA 120.495 0.796 . . . . 0.0 112.607 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 1.1 pp -76.79 22.73 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.152 0 CA-C-O 121.335 0.588 . . . . 0.0 109.933 179.537 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.504 ' H ' ' C ' ' A' ' 97' ' ' PRO . 2.4 t80 -39.53 -45.74 1.62 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.043 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.434 ' C ' ' H ' ' A' ' 102' ' ' ALA . 4.7 m-85 -83.11 -49.65 9.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.195 -179.361 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -54.81 -7.75 1.12 Allowed Glycine 0 CA--C 1.526 0.726 0 N-CA-C 111.372 -0.691 . . . . 0.0 111.372 -179.506 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.434 ' H ' ' C ' ' A' ' 100' ' ' PHE . . . -75.06 -13.43 60.49 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 121.079 -0.248 . . . . 0.0 110.964 -179.707 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -75.77 6.98 4.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.768 0.318 . . . . 0.0 110.82 -179.848 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -125.63 165.95 17.62 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.326 179.839 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 8.4 mmt -56.07 -17.12 6.15 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.924 0.392 . . . . 0.0 110.183 179.602 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.514 ' O ' ' N ' ' A' ' 108' ' ' ALA . . . -63.36 -15.85 57.44 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 110.611 -0.996 . . . . 0.0 110.611 179.718 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' TRP . . . . . 0.483 ' CD1' ' C ' ' A' ' 107' ' ' TRP . 0.0 OUTLIER -47.47 -11.8 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.762 0.315 . . . . 0.0 110.525 -179.776 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.514 ' N ' ' O ' ' A' ' 106' ' ' GLY . . . -63.58 -20.7 65.86 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-O 121.118 0.485 . . . . 0.0 109.816 179.432 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 7.1 mt -55.36 -30.76 60.95 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.717 179.491 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.433 ' O ' HD23 ' A' ' 114' ' ' LEU . . . -53.86 -61.87 2.02 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.548 179.718 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.722 ' O ' HG23 ' A' ' 115' ' ' VAL . 1.4 p30 -60.69 -57.97 10.46 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.769 -179.351 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.526 ' N ' ' OD1' ' A' ' 111' ' ' ASP . 9.1 tp -50.46 -38.12 41.96 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 -178.733 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.406 HD23 ' HA ' ' A' ' 113' ' ' LEU . 62.6 mt -72.7 -62.24 1.52 Allowed 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -178.409 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.433 HD23 ' O ' ' A' ' 110' ' ' ALA . 1.3 pp -58.29 -35.45 71.82 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 120.063 -0.655 . . . . 0.0 110.912 -178.724 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.722 HG23 ' O ' ' A' ' 111' ' ' ASP . 87.7 t -63.46 -52.66 55.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.746 -179.708 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 39.0 t -69.81 -32.31 70.69 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.428 -178.704 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -61.22 -59.96 9.13 Favored Glycine 0 CA--C 1.526 0.753 0 C-N-CA 121.05 -0.595 . . . . 0.0 111.924 -179.262 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.564 ' O ' HG23 ' A' ' 122' ' ' THR . 4.4 p -68.78 -38.05 78.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -178.789 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.503 ' O ' ' OG1' ' A' ' 123' ' ' THR . . . -65.99 -60.19 3.08 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.625 -0.43 . . . . 0.0 111.339 -178.746 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 28.1 m -59.73 -57.26 13.67 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.366 -179.285 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -49.07 -43.93 41.45 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.42 -179.29 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.564 HG23 ' O ' ' A' ' 118' ' ' VAL . 27.9 p -68.32 -38.06 81.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.511 -179.197 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.503 ' OG1' ' O ' ' A' ' 119' ' ' ALA . 0.1 OUTLIER -56.77 -49.81 74.18 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.845 0.355 . . . . 0.0 111.134 -179.191 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.6 pp -83.76 -19.82 34.45 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.886 -178.745 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -86.48 -71.32 0.55 Allowed 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -178.433 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' TRP . . . . . 0.456 ' CD1' ' N ' ' A' ' 126' ' ' TRP . 37.0 m0 -85.01 -57.23 3.18 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 112.767 0.654 . . . . 0.0 112.767 -177.881 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 127' ' ' HIS . . . . . 0.514 ' CD2' ' N ' ' A' ' 127' ' ' HIS . 8.7 m170 -50.4 -23.97 2.74 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.874 -0.33 . . . . 0.0 111.549 -178.7 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 40.4 ttt-85 -76.34 -37.08 57.82 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.918 -0.313 . . . . 0.0 110.99 -179.721 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 60.2 t -83.94 -48.88 16.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.783 0.325 . . . . 0.0 110.88 -179.575 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -128.2 112.82 19.9 Favored Pre-proline 0 CA--C 1.532 0.274 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.573 -179.624 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 131' ' ' PRO . . . . . 0.625 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 67.1 Cg_exo -70.71 -34.28 11.67 Favored 'Trans proline' 0 N--CA 1.492 1.423 0 C-N-CA 121.092 1.195 . . . . 0.0 112.307 179.473 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.625 ' CD ' ' N ' ' A' ' 131' ' ' PRO . 32.3 Cg_exo -56.34 -35.0 95.56 Favored 'Trans proline' 0 N--CA 1.495 1.607 0 C-N-CA 121.52 1.48 . . . . 0.0 111.877 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -63.66 -38.68 92.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.321 179.865 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -54.51 -25.39 25.36 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.194 -0.457 . . . . 0.0 109.994 179.697 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 9.5 tpt85 -77.37 -29.82 53.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.002 179.63 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.669 ' O ' ' HB1' ' A' ' 59' ' ' ALA . 79.1 mt -80.02 -31.34 39.64 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.829 179.362 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.579 ' O ' ' N ' ' A' ' 140' ' ' TYR . 0.7 OUTLIER -79.39 -44.61 21.13 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 179.344 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.548 ' C ' ' H ' ' A' ' 140' ' ' TYR . 0.4 OUTLIER -19.97 -51.24 0.05 OUTLIER Pre-proline 0 N--CA 1.466 0.327 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.913 179.916 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.457 ' N ' ' O ' ' A' ' 137' ' ' LEU . 16.9 Cg_exo -53.08 -1.69 0.09 OUTLIER 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 121.11 1.207 . . . . 0.0 112.015 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 140' ' ' TYR . . . . . 0.657 ' CE2' HD11 ' A' ' 144' ' ' LEU . 2.2 p90 -84.24 -19.5 33.82 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 120.919 0.39 . . . . 0.0 110.638 -179.781 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 95.6 mt -59.98 -49.92 75.79 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.63 -0.428 . . . . 0.0 109.986 179.253 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -45.55 -44.92 13.15 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 179.37 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' TRP . . . . . 0.575 ' CD1' ' C ' ' A' ' 143' ' ' TRP . 0.3 OUTLIER -58.34 -48.74 79.59 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.423 179.37 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.657 HD11 ' CE2' ' A' ' 140' ' ' TYR . 16.1 mt -55.46 -46.7 76.78 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.32 -0.552 . . . . 0.0 109.59 179.567 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.563 ' O ' HG23 ' A' ' 149' ' ' VAL . . . -63.44 -20.91 65.97 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.902 179.3 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -68.99 -62.91 1.18 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.504 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.452 ' HB1' ' C20' ' A' ' 201' ' ' PKA . . . -67.8 -45.61 74.28 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 120.57 -0.452 . . . . 0.0 110.414 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 19.2 m -52.28 -60.29 3.39 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.756 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.563 HG23 ' O ' ' A' ' 145' ' ' ALA . 93.2 t -54.16 -41.64 52.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 C-N-CA 120.878 -0.329 . . . . 0.0 110.798 -179.725 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 3.5 tp -50.39 -56.05 13.1 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.819 0.342 . . . . 0.0 110.548 -179.679 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 151' ' ' ASN . . . . . 0.414 ' ND2' ' CB ' ' A' ' 108' ' ' ALA . 9.8 t30 -61.7 -54.76 38.24 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.672 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 152' ' ' TYR . . . . . 0.443 ' CZ ' ' NE ' ' A' ' 156' ' ' ARG . 40.5 t80 -46.36 -38.09 8.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.616 -179.702 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 32.0 t80 -65.9 -53.39 40.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.699 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 62.8 t -49.22 -48.13 18.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 C-N-CA 120.614 -0.435 . . . . 0.0 110.365 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 155' ' ' TRP . . . . . . . . . . . . . 13.5 m0 -53.67 -55.56 24.99 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.363 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 156' ' ' ARG . . . . . 0.443 ' NE ' ' CZ ' ' A' ' 152' ' ' TYR . 0.7 OUTLIER -54.79 -52.14 63.55 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.362 179.949 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -49.19 -46.89 46.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.743 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 -79.2 -12.92 59.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.73 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 159' ' ' SER . . . . . 0.532 ' OG ' ' N ' ' A' ' 160' ' ' GLY . 1.6 t 57.73 -95.4 0.05 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.603 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 160' ' ' GLY . . . . . 0.532 ' N ' ' OG ' ' A' ' 159' ' ' SER . . . 85.43 16.33 64.51 Favored Glycine 0 CA--C 1.525 0.705 0 N-CA-C 111.102 -0.799 . . . . 0.0 111.102 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 15.5 mmt180 -56.74 -55.07 38.92 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.772 0.32 . . . . 0.0 110.66 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.54 ' CD ' ' H ' ' A' ' 162' ' ' ARG . 0.0 OUTLIER -91.17 125.13 35.86 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.618 -179.958 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 95.22 -95.8 1.91 Allowed Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.896 -0.882 . . . . 0.0 110.896 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -170.67 -106.92 0.19 Allowed Glycine 0 CA--C 1.523 0.552 0 N-CA-C 110.873 -0.891 . . . . 0.0 110.873 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 40.0 m -73.03 -24.5 60.73 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.866 0.365 . . . . 0.0 110.426 179.818 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 19.5 ttp180 63.36 140.41 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.552 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.776 HD22 ' N ' ' A' ' 167' ' ' LEU . 1.6 mm? -108.72 63.64 0.61 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.108 179.739 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -43.97 93.58 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.728 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 169' ' ' GLU . . . . . 0.461 ' N ' ' O ' ' A' ' 167' ' ' LEU . 27.8 mm-40 . . . . . 0 C--O 1.22 -0.479 0 CA-C-O 117.943 -1.027 . . . . 0.0 110.689 179.822 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 201' ' ' PKA . . . . . 0.5 ' C15' 'CL ' ' A' ' 201' ' ' PKA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 29.3 mtt . . . . . 0 CA--C 1.529 0.156 0 N-CA-C 110.404 -0.221 . . . . 0.0 110.404 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_exo -41.33 124.95 2.45 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 121.593 1.529 . . . . 0.0 112.129 179.758 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 52.3 tt0 -80.96 -63.4 1.41 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.354 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 79.9 p -102.14 154.44 19.0 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.439 179.707 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.436 ' CE2' ' CD2' ' A' ' 68' ' ' TRP . 0.5 OUTLIER -60.1 116.2 4.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.234 -179.931 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.633 ' N ' ' CD ' ' A' ' 7' ' ' PRO . 1.0 OUTLIER -63.8 -36.56 22.04 Favored Pre-proline 0 C--N 1.328 -0.328 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 179.875 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.633 ' CD ' ' N ' ' A' ' 6' ' ' VAL . 15.0 Cg_exo -70.09 -68.23 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 121.987 1.792 . . . . 0.0 112.251 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.655 ' HB2' ' OG ' ' A' ' 64' ' ' SER . . . -47.41 -42.8 22.88 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.538 -179.35 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.462 ' O ' ' OG1' ' A' ' 12' ' ' THR . 60.6 t -65.1 -62.51 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 111.852 0.316 . . . . 0.0 111.852 -179.126 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -53.92 -40.03 64.14 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 111.462 -0.655 . . . . 0.0 111.462 -179.355 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.673 ' HG ' HG22 ' A' ' 86' ' ' THR . 6.7 mp -68.61 -28.7 67.15 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.646 0.26 . . . . 0.0 110.862 -179.575 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.462 ' OG1' ' O ' ' A' ' 9' ' ' VAL . 2.2 p -81.25 -24.0 37.63 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.844 -0.342 . . . . 0.0 110.901 -179.933 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 84.6 mt -81.4 -33.39 32.28 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.517 -0.31 . . . . 0.0 110.695 -179.845 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.421 ' N ' ' HD2' ' A' ' 15' ' ' PRO . 3.9 t -47.11 -57.89 8.35 Favored Pre-proline 0 CA--C 1.535 0.373 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.907 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.421 ' HD2' ' N ' ' A' ' 14' ' ' VAL . 11.6 Cg_endo -56.66 -30.9 85.58 Favored 'Trans proline' 0 N--CA 1.498 1.754 0 C-N-CA 121.169 1.246 . . . . 0.0 112.3 -179.857 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.1 t -67.84 -27.16 66.46 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.694 -179.828 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 96.2 mt -69.54 -58.16 4.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.861 -179.687 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -68.92 -20.27 74.36 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 110.816 -0.913 . . . . 0.0 110.816 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -71.02 -46.07 46.57 Favored Glycine 0 CA--C 1.522 0.502 0 N-CA-C 110.909 -0.876 . . . . 0.0 110.909 -179.881 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -74.44 -59.64 2.64 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.737 0.303 . . . . 0.0 110.796 -179.822 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 1.1 tpt -60.9 -26.78 67.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.108 -179.509 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -79.26 -59.84 2.64 Favored Glycine 0 CA--C 1.527 0.8 0 N-CA-C 111.602 -0.599 . . . . 0.0 111.602 -179.462 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.617 ' O ' HG22 ' A' ' 26' ' ' VAL . . . -61.35 -17.13 52.4 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.812 0.339 . . . . 0.0 110.843 -179.264 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 28.7 t80 -50.01 -24.0 2.37 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.935 0.398 . . . . 0.0 110.223 179.69 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.582 ' CE2' ' HB3' ' A' ' 102' ' ' ALA . 53.9 t80 -69.38 -48.6 60.67 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.904 -179.775 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.624 HG21 'CL ' ' A' ' 201' ' ' PKA . 27.6 m -72.12 -19.52 19.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.805 -179.624 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.55 -44.38 86.97 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.764 -179.751 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -102.37 -43.9 1.94 Allowed Glycine 0 CA--C 1.525 0.711 0 N-CA-C 111.503 -0.639 . . . . 0.0 111.503 -179.472 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -73.78 -24.62 59.87 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.95 -0.3 . . . . 0.0 111.019 -179.605 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -81.33 -58.77 2.52 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 111.24 -0.744 . . . . 0.0 111.24 -179.659 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 10.3 mp -51.69 -29.05 16.73 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.853 -0.339 . . . . 0.0 110.122 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 33.3 ttt180 -82.55 -47.84 11.69 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.217 179.52 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -49.09 -27.67 3.57 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.294 -0.412 . . . . 0.0 109.921 179.748 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.52 ' CD1' ' C ' ' A' ' 34' ' ' TYR . 9.0 t80 -46.83 -43.31 18.42 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.241 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -54.37 -24.4 19.42 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.489 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -96.09 -72.6 1.13 Allowed Glycine 0 CA--C 1.525 0.706 0 N-CA-C 110.986 -0.845 . . . . 0.0 110.986 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.585 ' O ' HD12 ' A' ' 37' ' ' LEU . 0.4 OUTLIER -95.95 166.87 11.57 Favored 'General case' 0 N--CA 1.462 0.173 0 C-N-CA 120.863 -0.335 . . . . 0.0 110.431 179.546 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 31.2 tp60 -85.92 118.67 25.55 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.947 -179.471 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 7.6 mtpt -105.13 162.28 20.23 Favored Pre-proline 0 CA--C 1.535 0.392 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.73 179.7 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.426 ' O ' ' ND1' ' A' ' 43' ' ' HIS . 8.2 Cg_exo -53.05 139.5 61.47 Favored 'Trans proline' 0 N--CA 1.494 1.503 0 C-N-CA 121.369 1.379 . . . . 0.0 112.408 -179.353 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 35.9 t -81.71 -2.81 51.87 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.69 179.632 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 2.6 p90 -112.41 20.25 16.86 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.656 -0.247 . . . . 0.0 110.98 -179.213 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.536 ' CG ' ' O ' ' A' ' 43' ' ' HIS . 2.0 p-80 -88.65 117.2 68.08 Favored Pre-proline 0 CA--C 1.535 0.375 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.369 -179.66 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.48 ' CG ' HD23 ' A' ' 49' ' ' LEU . 85.6 Cg_endo -99.35 -175.19 0.16 Allowed 'Trans proline' 0 N--CA 1.489 1.248 0 C-N-CA 120.836 1.024 . . . . 0.0 111.13 178.457 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.479 ' O ' ' N ' ' A' ' 47' ' ' TRP . 3.0 Cg_endo -80.3 140.97 14.07 Favored 'Trans proline' 0 C--N 1.302 -1.893 0 C-N-CA 121.573 1.515 . . . . 0.0 111.62 179.665 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.442 ' O ' ' HB3' ' A' ' 50' ' ' ALA . 23.6 ptt180 -41.2 -18.57 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.725 -0.671 . . . . 0.0 112.557 -178.758 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.586 ' CD1' ' N ' ' A' ' 48' ' ' THR . 0.4 OUTLIER -58.7 -48.58 80.64 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 112.48 0.548 . . . . 0.0 112.48 -178.335 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.586 ' N ' ' CD1' ' A' ' 47' ' ' TRP . 5.1 t -89.72 -34.3 16.27 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 113.196 0.813 . . . . 0.0 113.196 -178.019 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.913 ' O ' HG23 ' A' ' 52' ' ' ILE . 0.3 OUTLIER -82.71 -49.33 9.89 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.212 -0.595 . . . . 0.0 112.263 -178.016 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.587 ' C ' ' H ' ' A' ' 52' ' ' ILE . . . -40.37 -32.17 0.3 Allowed Pre-proline 0 CA--C 1.534 0.348 0 C-N-CA 120.425 -0.51 . . . . 0.0 111.835 -178.922 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.407 ' HD2' ' N ' ' A' ' 50' ' ' ALA . 81.6 Cg_exo -54.24 4.26 0.04 OUTLIER 'Trans proline' 0 C--N 1.316 -1.182 0 CA-C-N 119.052 0.697 . . . . 0.0 112.342 178.23 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.913 HG23 ' O ' ' A' ' 49' ' ' LEU . 46.9 pt -54.24 -30.75 21.11 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.113 0 CA-C-O 121.167 0.508 . . . . 0.0 110.066 179.662 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.428 ' CE2' HD11 ' A' ' 52' ' ' ILE . 52.9 m95 -80.1 -23.41 41.27 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.898 -179.44 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -70.85 -45.0 54.66 Favored Glycine 0 CA--C 1.523 0.585 0 N-CA-C 109.916 -1.274 . . . . 0.0 109.916 178.972 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 5.3 m -68.52 -51.8 39.07 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 179.294 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 94.5 mt -60.8 -26.53 67.36 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.044 179.586 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.543 ' CD1' ' C ' ' A' ' 57' ' ' TYR . 0.4 OUTLIER -65.61 -56.72 10.69 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 179.615 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 40.3 t -52.2 -44.01 64.5 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.775 -0.37 . . . . 0.0 110.288 179.784 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.76 -47.15 82.14 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.789 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 30.3 mtm -60.47 -35.65 76.38 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.563 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -64.53 -43.15 97.0 Favored Glycine 0 CA--C 1.523 0.538 0 N-CA-C 110.815 -0.914 . . . . 0.0 110.815 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -63.18 -53.41 53.63 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.466 ' O ' HG23 ' A' ' 67' ' ' VAL . . . -57.32 -37.08 79.31 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 179.032 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.655 ' OG ' ' HB2' ' A' ' 8' ' ' ALA . 23.3 t -62.33 -44.62 96.08 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 179.278 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.4 ' HA ' ' CE3' ' A' ' 68' ' ' TRP . 21.1 t80 -54.16 -44.06 71.12 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 179.155 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 65.7 mt -65.05 -30.52 50.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.603 179.625 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.466 HG23 ' O ' ' A' ' 63' ' ' GLY . 73.1 t -65.49 -58.8 5.46 Favored 'Isoleucine or valine' 0 C--O 1.233 0.186 0 C-N-CA 120.501 -0.479 . . . . 0.0 111.125 -179.711 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' TRP . . . . . 0.631 ' CD1' ' N ' ' A' ' 68' ' ' TRP . 0.0 OUTLIER -56.17 -37.17 69.21 Favored 'General case' 0 CA--C 1.528 0.104 0 C-N-CA 119.96 -0.696 . . . . 0.0 110.119 -179.78 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 16.5 mmmt -73.17 -21.62 60.66 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.416 -0.514 . . . . 0.0 110.917 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 15.8 tp10 -76.83 -40.64 47.14 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 -178.966 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.612 HD12 ' N ' ' A' ' 72' ' ' GLY . 0.5 OUTLIER -105.03 -0.11 27.1 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 120.32 -0.552 . . . . 0.0 111.44 -179.506 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.612 ' N ' HD12 ' A' ' 71' ' ' LEU . . . 96.3 84.62 1.71 Allowed Glycine 0 CA--C 1.525 0.662 0 C-N-CA 120.992 -0.623 . . . . 0.0 111.628 179.222 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.578 ' N ' ' O ' ' A' ' 68' ' ' TRP . . . 44.81 -173.88 0.01 OUTLIER Glycine 0 CA--C 1.525 0.691 0 N-CA-C 111.652 -0.579 . . . . 0.0 111.652 179.31 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 77.7 t80 -81.71 110.46 17.06 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.875 0.369 . . . . 0.0 110.651 -179.663 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.503 ' OG1' ' N ' ' A' ' 76' ' ' GLU . 2.6 t -142.65 -173.77 3.97 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.646 179.849 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.503 ' N ' ' OG1' ' A' ' 75' ' ' THR . 22.0 mt-10 -51.97 -24.56 6.68 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.649 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.451 ' H ' HG23 ' A' ' 75' ' ' THR . 30.9 m-20 -79.29 -24.69 42.72 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.901 -179.752 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -93.28 -16.83 24.3 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.838 0.352 . . . . 0.0 111.031 -179.663 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 14.1 mtp -69.54 -30.46 68.28 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.871 -179.782 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.42 ' N ' ' HD2' ' A' ' 81' ' ' PRO . 6.3 t -68.16 -46.57 40.29 Favored Pre-proline 0 CA--C 1.533 0.291 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.749 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.42 ' HD2' ' N ' ' A' ' 80' ' ' VAL . 13.4 Cg_endo -71.76 -61.18 0.05 OUTLIER 'Trans proline' 0 N--CA 1.498 1.786 0 C-N-CA 120.841 1.027 . . . . 0.0 111.916 179.397 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.715 ' O ' HG23 ' A' ' 86' ' ' THR . 8.4 mt -56.22 -51.9 66.4 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 121.014 0.435 . . . . 0.0 109.906 179.54 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -52.03 -53.96 28.09 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 111.167 -0.773 . . . . 0.0 111.167 -179.79 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.494 HD21 HD11 ' A' ' 124' ' ' LEU . 29.6 tp -58.42 -33.09 69.28 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.554 0.216 . . . . 0.0 110.954 -179.512 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 31.1 t80 -68.42 -37.08 79.97 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.801 -0.36 . . . . 0.0 110.86 -179.645 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.715 HG23 ' O ' ' A' ' 82' ' ' LEU . 5.1 p -68.44 -58.73 3.89 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.742 -0.383 . . . . 0.0 110.747 -179.46 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.428 ' N ' ' OG1' ' A' ' 86' ' ' THR . . . -58.69 -57.46 19.76 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 111.268 -0.733 . . . . 0.0 111.268 -179.799 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 54.1 tp60 -50.6 -55.36 16.66 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-O 120.88 0.371 . . . . 0.0 110.922 -179.758 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.424 ' O ' ' C ' ' A' ' 90' ' ' ALA . 26.3 tp -47.88 -66.27 0.43 Allowed 'General case' 0 C--O 1.209 -1.051 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.06 -179.731 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.476 ' O ' ' HB2' ' A' ' 94' ' ' ALA . . . -38.37 -50.51 1.5 Allowed 'General case' 0 C--N 1.319 -0.759 0 C-N-CA 120.633 -0.427 . . . . 0.0 112.026 -179.309 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 95.2 mt -53.64 -56.75 14.54 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 -178.312 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.411 ' O ' HD22 ' A' ' 113' ' ' LEU . 3.0 m120 -76.97 -53.7 7.51 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.275 0.559 . . . . 0.0 111.615 -178.312 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' TRP . . . . . 0.64 ' O ' ' N ' ' A' ' 95' ' ' TRP . 3.9 t-105 -53.11 -20.76 4.04 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.364 -0.835 . . . . 0.0 111.63 -179.595 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.476 ' HB2' ' O ' ' A' ' 90' ' ' ALA . . . -57.01 70.48 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 120.793 0.33 . . . . 0.0 110.608 -179.807 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.68 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 5.6 p-90 -102.38 -17.32 0.19 Allowed Pre-proline 0 CA--C 1.537 0.472 0 CA-C-N 116.051 -0.522 . . . . 0.0 112.036 -179.543 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.68 ' CD ' ' N ' ' A' ' 95' ' ' TRP . 32.5 Cg_exo -63.28 -24.2 72.06 Favored 'Trans proline' 0 N--CA 1.495 1.614 0 C-N-CA 120.629 0.886 . . . . 0.0 112.831 179.466 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.558 ' CD ' ' N ' ' A' ' 96' ' ' PRO . 97.3 Cg_exo -62.93 -24.87 74.14 Favored 'Trans proline' 0 N--CA 1.495 1.563 0 C-N-CA 120.833 1.022 . . . . 0.0 112.832 179.856 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 1.1 pp -78.58 22.53 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 121.015 0.436 . . . . 0.0 110.1 179.751 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.445 ' H ' ' C ' ' A' ' 97' ' ' PRO . 2.5 t80 -40.21 -42.78 1.55 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.531 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -86.23 -33.1 20.83 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.724 -179.875 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -68.46 -5.12 41.8 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 111.231 -0.748 . . . . 0.0 111.231 -179.716 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.582 ' HB3' ' CE2' ' A' ' 25' ' ' PHE . . . -74.63 -9.45 58.58 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.74 0.305 . . . . 0.0 110.908 -179.76 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.488 ' C ' ' CD ' ' A' ' 103' ' ' ARG . 0.0 OUTLIER -88.56 -11.73 44.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.828 -179.792 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -109.7 -178.92 3.67 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.914 0.387 . . . . 0.0 110.801 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.66 ' N ' ' SD ' ' A' ' 105' ' ' MET . 0.0 OUTLIER -55.45 -23.0 22.99 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.123 -179.826 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -62.22 -15.42 51.0 Favored Glycine 0 CA--C 1.528 0.847 0 CA-C-N 116.193 -0.458 . . . . 0.0 112.08 -179.287 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' TRP . . . . . 0.688 ' CD1' ' CZ2' ' A' ' 155' ' ' TRP . 0.0 OUTLIER -48.75 -18.98 0.31 Allowed 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 116.812 0.306 . . . . 0.0 110.972 -179.329 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -70.8 -23.76 62.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.991 0.424 . . . . 0.0 110.647 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 7.5 mt -54.21 -28.68 42.46 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.635 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -53.29 -63.01 1.29 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.087 0.47 . . . . 0.0 110.334 179.819 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.699 ' O ' HG23 ' A' ' 115' ' ' VAL . 2.1 p30 -62.26 -53.38 56.06 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.838 -0.619 . . . . 0.0 112.039 -179.376 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.611 HD13 ' O ' ' A' ' 112' ' ' LEU . 0.2 OUTLIER -53.49 -40.46 65.36 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.268 0.47 . . . . 0.0 112.268 -178.194 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.45 HD23 ' HA ' ' A' ' 113' ' ' LEU . 61.4 mt -71.4 -61.69 1.68 Allowed 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.281 0.475 . . . . 0.0 112.281 -178.479 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.5 pp -58.3 -33.67 69.71 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 120.15 -0.62 . . . . 0.0 110.9 -178.759 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.699 HG23 ' O ' ' A' ' 111' ' ' ASP . 41.2 t -62.16 -60.91 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.462 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 57.3 p -68.87 -22.24 64.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.474 -178.864 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -66.17 -62.22 4.85 Favored Glycine 0 CA--C 1.526 0.723 0 C-N-CA 120.952 -0.642 . . . . 0.0 111.549 -179.27 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.588 ' O ' HG23 ' A' ' 122' ' ' THR . 10.0 p -71.12 -37.54 67.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 C-N-CA 120.872 -0.331 . . . . 0.0 111.694 -179.258 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.508 ' O ' ' OG1' ' A' ' 123' ' ' THR . . . -68.39 -60.64 2.29 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.564 -0.454 . . . . 0.0 111.522 -179.204 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 3.7 m -58.7 -51.73 68.7 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.892 0.377 . . . . 0.0 111.372 -179.34 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.442 ' O ' HD23 ' A' ' 124' ' ' LEU . . . -55.58 -39.7 71.04 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.381 -179.384 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.588 HG23 ' O ' ' A' ' 118' ' ' VAL . 36.2 p -75.01 -28.94 60.7 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.638 -0.425 . . . . 0.0 111.601 -179.279 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.508 ' OG1' ' O ' ' A' ' 119' ' ' ALA . 0.1 OUTLIER -65.11 -54.55 28.23 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.631 -0.428 . . . . 0.0 110.717 -179.669 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.56 HD23 ' N ' ' A' ' 125' ' ' ALA . 0.6 OUTLIER -79.45 -19.73 49.16 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.576 -0.449 . . . . 0.0 111.73 -179.043 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.56 ' N ' HD23 ' A' ' 124' ' ' LEU . . . -88.33 -68.28 0.77 Allowed 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 -179.083 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 126' ' ' TRP . . . . . 0.4 ' N ' ' CD1' ' A' ' 126' ' ' TRP . 41.8 m0 -84.17 -57.23 3.26 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -177.87 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 127' ' ' HIS . . . . . 0.505 ' CD2' ' N ' ' A' ' 127' ' ' HIS . 7.1 m170 -54.69 -22.11 12.83 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.581 -0.448 . . . . 0.0 111.289 -178.718 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 26.8 ttt180 -68.34 -42.98 78.49 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.863 -0.335 . . . . 0.0 110.821 -179.694 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 23.2 t -87.51 -49.64 14.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.807 -179.796 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 26.6 p -116.23 108.32 46.03 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.523 -179.793 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' PRO . . . . . 0.642 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 79.5 Cg_exo -74.22 -25.71 13.3 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 121.554 1.503 . . . . 0.0 112.663 179.471 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.642 ' CD ' ' N ' ' A' ' 131' ' ' PRO . 51.4 Cg_exo -63.16 -43.31 19.28 Favored 'Trans proline' 0 N--CA 1.495 1.609 0 C-N-CA 121.371 1.38 . . . . 0.0 111.961 179.797 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -54.83 -38.75 67.78 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.251 179.771 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.426 ' HB2' ' CG ' ' A' ' 127' ' ' HIS . . . -55.06 -26.28 36.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.256 179.813 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 13.4 tpp180 -76.07 -32.23 59.16 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.248 179.658 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.401 HD23 ' HA ' ' A' ' 136' ' ' LEU . 95.9 mt -72.53 -26.78 61.88 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 179.314 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.512 ' O ' ' N ' ' A' ' 140' ' ' TYR . 2.6 mt -88.69 -29.25 20.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.376 179.757 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.516 ' CD1' ' C ' ' A' ' 138' ' ' TYR . 0.4 OUTLIER -33.59 -49.3 0.75 Allowed Pre-proline 0 CA--C 1.537 0.458 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.381 -179.819 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.416 ' HD2' ' N ' ' A' ' 138' ' ' TYR . 3.9 Cg_exo -60.96 4.96 0.17 Allowed 'Trans proline' 0 N--CA 1.494 1.535 0 C-N-CA 121.402 1.401 . . . . 0.0 112.591 -179.688 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 140' ' ' TYR . . . . . 0.512 ' N ' ' O ' ' A' ' 137' ' ' LEU . 0.1 OUTLIER -90.07 -16.65 29.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.709 0.29 . . . . 0.0 111.125 179.88 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.55 HD23 HD12 ' A' ' 144' ' ' LEU . 94.8 mt -58.42 -26.19 63.0 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 178.831 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -63.41 -42.3 98.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.628 179.266 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 143' ' ' TRP . . . . . 0.444 ' CE2' HD12 ' A' ' 52' ' ' ILE . 12.3 t-105 -66.72 -38.72 87.27 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.7 179.387 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.55 HD12 HD23 ' A' ' 141' ' ' LEU . 18.0 mt -62.55 -37.64 86.93 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 120.539 -0.465 . . . . 0.0 110.035 179.616 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.598 ' O ' HG23 ' A' ' 149' ' ' VAL . . . -76.91 -25.92 53.52 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.389 179.746 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 26.4 t80 -64.28 -57.96 7.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.744 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -70.4 -49.38 49.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.794 -179.74 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 99.2 m -51.38 -47.46 62.86 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.906 -179.667 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.598 HG23 ' O ' ' A' ' 145' ' ' ALA . 94.2 t -69.54 -34.06 59.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.176 -179.502 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -56.18 -52.9 62.71 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.917 0.389 . . . . 0.0 110.383 -179.683 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 151' ' ' ASN . . . . . 0.494 ' OD1' ' NE1' ' A' ' 107' ' ' TRP . 3.4 t30 -63.88 -51.25 65.41 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.843 -179.841 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 58.9 t80 -56.27 -29.8 61.6 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.454 -179.282 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 153' ' ' TYR . . . . . 0.436 ' O ' ' CG ' ' A' ' 157' ' ' ASP . 55.8 t80 -73.02 -52.58 13.84 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.827 -0.349 . . . . 0.0 111.296 -179.464 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.486 ' O ' ' OD1' ' A' ' 157' ' ' ASP . 54.3 t -65.1 -32.44 58.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.593 -179.353 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 155' ' ' TRP . . . . . 0.688 ' CZ2' ' CD1' ' A' ' 107' ' ' TRP . 0.2 OUTLIER -73.4 -42.14 62.46 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.177 -178.559 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 156' ' ' ARG . . . . . 0.437 ' HE ' ' C ' ' A' ' 155' ' ' TRP . 0.0 OUTLIER -77.61 -57.04 4.03 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.855 -0.338 . . . . 0.0 110.751 -179.753 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 157' ' ' ASP . . . . . 0.579 ' OD1' ' N ' ' A' ' 158' ' ' ASN . 39.7 p-10 -48.24 -36.31 13.66 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.962 -0.295 . . . . 0.0 110.76 -179.688 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 158' ' ' ASN . . . . . 0.579 ' N ' ' OD1' ' A' ' 157' ' ' ASP . 8.7 t-20 -89.03 -22.34 23.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.773 -179.715 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 159' ' ' SER . . . . . 0.446 ' O ' ' O ' ' A' ' 158' ' ' ASN . 8.7 t 53.83 165.51 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.726 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 160.16 98.53 0.14 Allowed Glycine 0 CA--C 1.524 0.656 0 N-CA-C 110.731 -0.948 . . . . 0.0 110.731 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 26.7 ttt85 -166.9 -33.12 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.833 0.349 . . . . 0.0 110.728 -179.642 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 62.2 mtt85 -74.98 140.5 43.69 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.757 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -74.39 2.61 45.05 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 111.208 -0.757 . . . . 0.0 111.208 -179.687 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 105.97 -149.96 16.8 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 111.077 -0.809 . . . . 0.0 111.077 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 4.9 t -78.17 -159.57 0.17 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.844 0.354 . . . . 0.0 110.686 -179.907 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 166' ' ' ARG . . . . . 0.48 ' C ' HD12 ' A' ' 167' ' ' LEU . 16.4 mmt85 -66.62 -95.28 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.366 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.48 HD12 ' C ' ' A' ' 166' ' ' ARG . 7.6 mp -113.12 -75.73 0.6 Allowed 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.294 179.89 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . 59.04 111.08 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.554 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.22 -0.481 0 CA-C-O 117.97 -1.014 . . . . 0.0 110.564 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 201' ' ' PKA . . . . . 0.624 'CL ' HG21 ' A' ' 26' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.624 ' O ' HG23 ' A' ' 9' ' ' VAL . 1.2 t-105 . . . . . 0 CA--C 1.531 0.219 0 N-CA-C 110.167 -0.308 . . . . 0.0 110.167 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.566 ' N ' ' CD ' ' A' ' 7' ' ' PRO . 0.9 OUTLIER -62.02 -44.97 91.34 Favored Pre-proline 0 CA--C 1.533 0.319 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.316 -179.796 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.566 ' CD ' ' N ' ' A' ' 6' ' ' VAL . 21.3 Cg_exo -57.14 -65.42 0.1 Allowed 'Trans proline' 0 C--N 1.307 -1.655 0 C-N-CA 121.671 1.58 . . . . 0.0 111.585 179.673 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.727 ' O ' HG23 ' A' ' 12' ' ' THR . . . -49.23 -41.44 37.38 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.226 -179.632 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.624 HG23 ' O ' ' A' ' 5' ' ' TRP . 49.7 t -60.53 -62.75 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 120.824 0.345 . . . . 0.0 111.533 -179.07 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -57.78 -52.33 52.74 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 111.456 -0.658 . . . . 0.0 111.456 -179.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 9.5 mp -57.99 -30.38 66.02 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.474 0.178 . . . . 0.0 110.961 -179.535 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.727 HG23 ' O ' ' A' ' 8' ' ' ALA . 20.8 p -79.93 -20.74 44.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.087 0.47 . . . . 0.0 109.766 179.295 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.7 mt -82.0 -22.86 36.32 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.499 179.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.405 ' N ' ' HD2' ' A' ' 15' ' ' PRO . 5.4 t -54.35 -54.63 45.99 Favored Pre-proline 0 CA--C 1.535 0.398 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.655 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.405 ' HD2' ' N ' ' A' ' 14' ' ' VAL . 6.4 Cg_endo -57.55 -8.59 4.2 Favored 'Trans proline' 0 N--CA 1.495 1.572 0 C-N-CA 120.935 1.09 . . . . 0.0 111.642 179.657 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.4 t -75.08 -27.62 60.0 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.124 179.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 63.8 mt -79.45 -43.67 22.84 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.767 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -77.63 -31.74 48.9 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 111.012 -0.835 . . . . 0.0 111.012 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -78.36 -34.76 35.36 Favored Glycine 0 CA--C 1.52 0.379 0 N-CA-C 110.305 -1.118 . . . . 0.0 110.305 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 41.4 t80 -72.01 -58.99 2.98 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 179.459 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 48.8 tpp -64.61 -28.02 69.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.625 179.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.541 ' C ' ' CZ2' ' A' ' 95' ' ' TRP . . . -65.66 -63.12 4.27 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 111.674 -0.571 . . . . 0.0 111.674 -179.462 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.496 ' O ' HG22 ' A' ' 26' ' ' VAL . . . -69.34 -18.2 63.78 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.891 -0.324 . . . . 0.0 111.03 -179.388 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 80.7 t80 -50.6 -24.64 3.41 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.959 0.409 . . . . 0.0 110.045 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.461 ' CE2' ' HB1' ' A' ' 102' ' ' ALA . 63.5 t80 -69.2 -48.26 62.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.979 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.496 HG22 ' O ' ' A' ' 23' ' ' ALA . 32.9 m -75.55 -14.24 15.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 C-N-CA 120.73 -0.388 . . . . 0.0 110.768 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.542 ' O ' ' CD1' ' A' ' 31' ' ' LEU . 0.0 OUTLIER -57.79 -44.03 85.98 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.626 179.879 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -112.16 -54.56 0.48 Allowed Glycine 0 CA--C 1.525 0.667 0 N-CA-C 110.978 -0.849 . . . . 0.0 110.978 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -58.99 -27.61 65.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.836 0.351 . . . . 0.0 110.495 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -78.52 -49.05 6.89 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 111.062 -0.815 . . . . 0.0 111.062 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.542 ' CD1' ' O ' ' A' ' 27' ' ' ARG . 95.0 mt -56.7 -34.51 67.5 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.769 0.319 . . . . 0.0 110.541 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 49.4 mtp180 -77.06 -54.21 6.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.669 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -44.96 -41.65 7.48 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.298 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 56.2 t80 -49.44 -31.43 9.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.879 -179.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -66.28 -25.24 66.77 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.678 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -92.67 -67.36 1.1 Allowed Glycine 0 CA--C 1.523 0.573 0 N-CA-C 111.049 -0.82 . . . . 0.0 111.049 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.571 ' O ' HD12 ' A' ' 37' ' ' LEU . 0.3 OUTLIER -95.2 166.96 11.65 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.827 0.346 . . . . 0.0 110.561 179.666 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -87.1 112.82 22.29 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.704 -179.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.688 ' NZ ' ' CH2' ' A' ' 107' ' ' TRP . 17.3 mtpt -129.42 153.31 80.57 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.193 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo . . . . . 0 C--N 1.305 -1.725 0 C-N-CA 121.438 1.425 . . . . 0.0 110.668 178.843 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.74 ' O ' HG23 ' A' ' 52' ' ' ILE . 0.1 OUTLIER . . . . . 0 CA--C 1.534 0.359 0 N-CA-C 111.804 0.298 . . . . 0.0 111.804 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.602 ' C ' ' H ' ' A' ' 52' ' ' ILE . . . -40.13 -29.17 0.2 Allowed Pre-proline 0 N--CA 1.466 0.339 0 N-CA-C 112.129 0.418 . . . . 0.0 112.129 -178.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.407 ' HD2' ' N ' ' A' ' 50' ' ' ALA . 26.3 Cg_exo -52.82 3.0 0.04 OUTLIER 'Trans proline' 0 C--N 1.312 -1.363 0 CA-C-N 119.336 0.799 . . . . 0.0 112.441 178.287 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.74 HG23 ' O ' ' A' ' 49' ' ' LEU . 7.9 pt -52.51 -40.36 32.77 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.238 0 CA-C-O 121.22 0.534 . . . . 0.0 109.842 179.258 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.456 ' N ' ' CG1' ' A' ' 52' ' ' ILE . 69.7 m95 -73.4 -22.41 60.25 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.157 -179.328 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -67.43 -49.28 52.51 Favored Glycine 0 CA--C 1.527 0.833 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 179.015 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 3.3 m -65.54 -56.95 9.54 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.909 0.385 . . . . 0.0 110.209 179.464 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 83.3 mt -57.18 -26.52 60.76 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.503 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.509 ' C ' ' CD1' ' A' ' 57' ' ' TYR . 2.3 t80 -67.17 -47.63 70.41 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 179.464 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 15.1 m -56.43 -53.62 55.22 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.957 179.331 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -57.98 -41.06 82.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.34 179.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 8.3 mtm -56.71 -58.28 8.78 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.092 179.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -46.95 -44.07 17.92 Favored Glycine 0 CA--C 1.523 0.573 0 N-CA-C 110.696 -0.961 . . . . 0.0 110.696 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -61.72 -59.22 5.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.708 0.29 . . . . 0.0 110.468 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.539 ' O ' HG23 ' A' ' 67' ' ' VAL . . . -49.79 -57.34 9.81 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.88 -0.888 . . . . 0.0 110.88 179.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.592 ' O ' ' CD1' ' A' ' 68' ' ' TRP . 0.3 OUTLIER -45.68 -55.51 6.34 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.958 0.408 . . . . 0.0 110.526 179.803 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.415 ' N ' ' OG ' ' A' ' 64' ' ' SER . 50.0 t80 -48.54 -42.23 32.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.965 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 93.4 mt -66.73 -49.25 76.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.176 -179.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.539 HG23 ' O ' ' A' ' 63' ' ' GLY . 9.1 t -51.43 -54.54 11.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.907 0.384 . . . . 0.0 111.162 -179.47 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' TRP . . . . . 0.592 ' CD1' ' O ' ' A' ' 64' ' ' SER . 1.7 m95 -65.81 -35.01 79.5 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.097 -179.458 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 7.1 mmmt -65.63 -22.93 66.7 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.653 -0.419 . . . . 0.0 110.349 179.369 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -81.95 -62.68 1.57 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.542 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.729 ' C ' HD12 ' A' ' 71' ' ' LEU . 3.1 pp -65.68 -8.96 23.5 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.643 -0.423 . . . . 0.0 110.839 -179.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.687 ' N ' HD12 ' A' ' 71' ' ' LEU . . . 104.6 84.38 1.76 Allowed Glycine 0 CA--C 1.526 0.767 0 C-N-CA 120.994 -0.622 . . . . 0.0 111.77 179.19 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.554 ' N ' ' O ' ' A' ' 68' ' ' TRP . . . 41.91 -174.16 0.01 OUTLIER Glycine 0 CA--C 1.526 0.75 0 N-CA-C 111.795 -0.522 . . . . 0.0 111.795 179.212 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 46.6 t80 -78.7 114.21 17.43 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.866 0.365 . . . . 0.0 110.563 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.58 ' OG1' ' N ' ' A' ' 76' ' ' GLU . 0.0 OUTLIER -142.04 -175.48 4.43 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.423 -179.966 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.58 ' N ' ' OG1' ' A' ' 75' ' ' THR . 4.7 pt-20 -51.3 -25.8 6.42 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.601 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 64.3 t0 -76.12 -31.35 58.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.081 -179.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.41 ' O ' HD12 ' A' ' 82' ' ' LEU . . . -83.71 -19.11 35.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.937 -179.764 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 24.6 mtp -68.24 -27.38 66.31 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.847 -179.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 6.4 t -67.07 -49.39 46.3 Favored Pre-proline 0 CA--C 1.534 0.352 0 CA-C-N 116.438 -0.347 . . . . 0.0 110.729 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_endo -71.77 -58.85 0.07 OUTLIER 'Trans proline' 0 N--CA 1.498 1.74 0 C-N-CA 120.985 1.123 . . . . 0.0 111.721 179.166 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.414 HD11 ' CE2' ' A' ' 68' ' ' TRP . 2.8 mt -51.74 -47.59 63.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.781 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -67.88 -64.16 3.3 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 111.204 -0.758 . . . . 0.0 111.204 -179.471 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 31.4 tp -46.04 -26.71 0.78 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.988 0.423 . . . . 0.0 110.169 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 12.2 t80 -77.23 -41.98 39.12 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.245 179.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 1.3 m -69.52 -43.44 73.04 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.842 -179.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -69.84 -56.79 7.78 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 110.986 -0.846 . . . . 0.0 110.986 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.433 ' O ' ' CB ' ' A' ' 92' ' ' ASN . 3.5 tp60 -53.84 -45.2 70.83 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.9 0.381 . . . . 0.0 110.514 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 11.4 tp -66.19 -33.16 75.14 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.834 -179.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.761 ' O ' ' HB2' ' A' ' 94' ' ' ALA . . . -64.11 -65.68 0.65 Allowed 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 120.256 -0.578 . . . . 0.0 111.291 -179.324 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.9 pp -68.04 -33.37 74.46 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 -178.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.433 ' CB ' ' O ' ' A' ' 88' ' ' GLN . 32.2 t-20 -81.13 -55.11 4.97 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.249 0.463 . . . . 0.0 112.249 -178.444 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . 0.614 ' O ' ' N ' ' A' ' 95' ' ' TRP . 0.0 OUTLIER -73.54 -17.43 61.21 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.699 -0.4 . . . . 0.0 111.773 -178.371 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.761 ' HB2' ' O ' ' A' ' 90' ' ' ALA . . . -52.82 82.04 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 120.473 -0.491 . . . . 0.0 109.911 179.505 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.704 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 38.4 p-90 -97.08 -15.47 0.2 Allowed Pre-proline 0 CA--C 1.536 0.437 0 N-CA-C 112.635 0.605 . . . . 0.0 112.635 -179.16 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.704 ' CD ' ' N ' ' A' ' 95' ' ' TRP . 47.4 Cg_exo -60.39 -18.76 55.09 Favored 'Trans proline' 0 N--CA 1.498 1.744 0 C-N-CA 120.675 0.917 . . . . 0.0 113.663 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.562 ' CD ' ' N ' ' A' ' 96' ' ' PRO . 71.5 Cg_exo -76.76 0.69 9.34 Favored 'Trans proline' 0 N--CA 1.498 1.788 0 C-N-CA 120.534 0.822 . . . . 0.0 113.183 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.486 ' O ' ' N ' ' A' ' 101' ' ' GLY . 1.9 pp -91.76 9.37 3.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 C-N-CA 120.739 -0.385 . . . . 0.0 110.632 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.535 ' CD1' ' O ' ' A' ' 96' ' ' PRO . 2.8 m-30 -40.44 -36.32 0.54 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.678 179.716 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.547 ' CD1' ' N ' ' A' ' 100' ' ' PHE . 0.1 OUTLIER -66.9 -35.41 79.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.203 -179.334 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.486 ' N ' ' O ' ' A' ' 98' ' ' ILE . . . -92.89 -4.27 65.28 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 111.402 -0.679 . . . . 0.0 111.402 -179.538 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.461 ' HB1' ' CE2' ' A' ' 25' ' ' PHE . . . -65.85 -13.96 60.56 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.683 0.278 . . . . 0.0 110.925 -179.764 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 16.2 ptt180 -89.26 3.35 52.34 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.832 0.348 . . . . 0.0 110.81 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 9.4 mt-30 -120.61 158.74 26.72 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.362 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.409 ' N ' ' SD ' ' A' ' 105' ' ' MET . 0.0 OUTLIER -49.31 -18.37 0.36 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.232 179.907 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.566 ' O ' ' N ' ' A' ' 108' ' ' ALA . . . -64.48 -15.68 59.66 Favored Glycine 0 CA--C 1.526 0.764 0 N-CA-C 111.022 -0.831 . . . . 0.0 111.022 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' TRP . . . . . 0.688 ' CH2' ' NZ ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -41.8 -16.59 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 120.619 0.247 . . . . 0.0 111.241 -179.533 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.566 ' N ' ' O ' ' A' ' 106' ' ' GLY . . . -64.0 -17.3 63.18 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.96 0.409 . . . . 0.0 110.514 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 9.9 mt -51.64 -29.99 19.83 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.591 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.436 ' HB2' ' CE3' ' A' ' 95' ' ' TRP . . . -58.96 -62.78 1.62 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.644 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.71 ' O ' HG23 ' A' ' 115' ' ' VAL . 1.4 p30 -54.72 -53.86 49.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.453 -179.456 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.573 ' N ' ' OD1' ' A' ' 111' ' ' ASP . 31.3 tp -55.94 -40.78 73.66 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.918 -0.313 . . . . 0.0 111.662 -179.112 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 24.9 mt -68.35 -61.3 1.9 Allowed 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.363 0.505 . . . . 0.0 112.363 -178.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.0 pp -61.89 -32.86 73.26 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 120.435 -0.506 . . . . 0.0 111.41 -178.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.71 HG23 ' O ' ' A' ' 111' ' ' ASP . 41.8 t -61.86 -55.98 20.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.15 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . 0.499 ' O ' ' OG1' ' A' ' 120' ' ' THR . 14.8 m -74.56 -22.9 58.76 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.447 -179.222 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -65.2 -62.48 4.87 Favored Glycine 0 CA--C 1.526 0.72 0 C-N-CA 120.809 -0.71 . . . . 0.0 111.419 -179.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.557 ' O ' HG23 ' A' ' 122' ' ' THR . 5.4 p -73.64 -35.5 44.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 C-N-CA 121.134 -0.226 . . . . 0.0 111.418 -179.507 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.508 ' O ' ' OG1' ' A' ' 123' ' ' THR . . . -69.76 -60.32 2.39 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.484 -0.487 . . . . 0.0 111.045 -179.457 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.499 ' OG1' ' O ' ' A' ' 116' ' ' SER . 1.9 m -59.28 -50.36 74.28 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.775 0.322 . . . . 0.0 111.34 -179.478 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -56.56 -41.75 77.39 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.464 -179.284 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.557 HG23 ' O ' ' A' ' 118' ' ' VAL . 33.9 p -72.44 -25.53 61.49 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.849 -0.34 . . . . 0.0 111.658 -179.238 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.508 ' OG1' ' O ' ' A' ' 119' ' ' ALA . 0.1 OUTLIER -69.55 -47.39 63.82 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.645 -0.422 . . . . 0.0 110.456 -179.747 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.8 pp -83.26 -18.32 39.56 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.18 -179.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -91.91 -65.01 1.04 Allowed 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -178.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 40.3 m0 -85.77 -57.63 2.97 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 113.032 0.753 . . . . 0.0 113.032 -177.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . 0.514 ' CD2' ' HB2' ' A' ' 134' ' ' ALA . 15.2 m170 -56.6 -22.6 35.04 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 111.762 0.282 . . . . 0.0 111.762 -178.324 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.51 -37.32 87.14 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 120.897 -0.321 . . . . 0.0 110.798 -179.574 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 47.9 t -101.16 -48.48 11.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.51 -179.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . 0.523 ' HB3' HG22 ' A' ' 67' ' ' VAL . 6.2 t -113.15 108.13 53.25 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.585 -178.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . 0.663 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 73.1 Cg_exo -76.41 -26.6 8.59 Favored 'Trans proline' 0 C--N 1.31 -1.47 0 C-N-CA 121.788 1.659 . . . . 0.0 112.393 178.592 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . 0.663 ' CD ' ' N ' ' A' ' 131' ' ' PRO . 51.0 Cg_exo -61.15 -44.87 21.62 Favored 'Trans proline' 0 N--CA 1.497 1.682 0 C-N-CA 121.485 1.457 . . . . 0.0 112.248 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.405 ' O ' ' N ' ' A' ' 136' ' ' LEU . . . -59.05 -43.25 91.68 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.02 0.438 . . . . 0.0 110.321 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . 0.514 ' HB2' ' CD2' ' A' ' 127' ' ' HIS . . . -49.61 -27.28 4.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.039 179.713 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 7.0 tpt180 -77.96 -29.53 49.84 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.345 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.405 ' N ' ' O ' ' A' ' 133' ' ' ALA . 39.0 mt -74.16 -21.74 59.71 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 178.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.49 ' O ' ' N ' ' A' ' 140' ' ' TYR . 3.3 mt -93.7 -28.29 16.04 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.278 -0.873 . . . . 0.0 110.232 179.455 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.513 ' C ' ' CD1' ' A' ' 138' ' ' TYR . 0.6 OUTLIER -32.3 -50.41 0.55 Allowed Pre-proline 0 CA--C 1.537 0.462 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.586 -179.929 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.42 ' HD2' ' N ' ' A' ' 138' ' ' TYR . 2.7 Cg_endo -61.91 5.94 0.19 Allowed 'Trans proline' 0 N--CA 1.498 1.773 0 C-N-CA 121.476 1.451 . . . . 0.0 112.972 -179.5 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . 0.49 ' N ' ' O ' ' A' ' 137' ' ' LEU . 0.1 OUTLIER -90.41 -15.18 31.45 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.904 0.383 . . . . 0.0 110.891 179.866 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.511 HD23 HD12 ' A' ' 144' ' ' LEU . 98.7 mt -59.38 -35.89 74.76 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.216 -0.447 . . . . 0.0 109.922 178.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -56.06 -41.48 75.15 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.768 179.286 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' TRP . . . . . 0.502 ' CE2' HD12 ' A' ' 52' ' ' ILE . 8.4 t-105 -64.65 -44.49 90.26 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.606 179.266 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.511 HD12 HD23 ' A' ' 141' ' ' LEU . 19.2 mt -57.33 -43.3 83.27 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.802 179.573 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.5 ' O ' HG23 ' A' ' 149' ' ' VAL . . . -70.26 -26.69 63.94 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.007 179.644 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 11.1 t80 -60.65 -61.73 2.37 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.647 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . 0.491 ' O ' ' OD1' ' A' ' 151' ' ' ASN . . . -66.55 -50.34 63.47 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 120.696 -0.401 . . . . 0.0 110.615 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . 0.576 ' O ' ' ND2' ' A' ' 151' ' ' ASN . 17.0 m -48.99 -55.43 11.96 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.626 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.5 HG23 ' O ' ' A' ' 145' ' ' ALA . 73.1 t -59.46 -35.86 61.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.613 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.42 ' O ' HG23 ' A' ' 154' ' ' VAL . 0.8 OUTLIER -51.73 -61.23 2.38 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.628 -0.429 . . . . 0.0 110.083 -179.873 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . 0.576 ' ND2' ' O ' ' A' ' 148' ' ' THR . 1.3 p-10 -54.34 -47.15 72.87 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.766 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 38.1 t80 -53.23 -40.73 64.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.766 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 37.1 t80 -63.92 -45.92 87.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.912 -179.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.42 HG23 ' O ' ' A' ' 150' ' ' LEU . 14.6 t -56.6 -51.69 62.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.926 0.393 . . . . 0.0 110.806 -179.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' TRP . . . . . . . . . . . . . 15.9 m0 -52.28 -55.33 22.06 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.225 -179.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -66.65 -19.73 65.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.28 -179.066 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 37.8 t0 -71.1 -52.7 17.84 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.73 0.3 . . . . 0.0 111.164 -179.456 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 19.6 p30 . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.861 -179.483 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.761 ' O ' HG23 ' A' ' 9' ' ' VAL . 0.5 OUTLIER . . . . . 0 CA--C 1.528 0.125 0 N-CA-C 110.23 -0.285 . . . . 0.0 110.23 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.571 ' N ' ' CD ' ' A' ' 7' ' ' PRO . 0.9 OUTLIER -61.43 -42.86 86.99 Favored Pre-proline 0 CA--C 1.532 0.266 0 C-N-CA 120.938 -0.305 . . . . 0.0 110.26 -179.819 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.571 ' CD ' ' N ' ' A' ' 6' ' ' VAL . 24.1 Cg_exo -58.88 -65.1 0.09 OUTLIER 'Trans proline' 0 C--N 1.307 -1.623 0 C-N-CA 121.472 1.448 . . . . 0.0 111.52 179.585 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.732 ' O ' HG23 ' A' ' 12' ' ' THR . . . -50.42 -37.74 39.54 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.201 -179.765 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.761 HG23 ' O ' ' A' ' 5' ' ' TRP . 46.1 t -59.9 -62.45 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.831 0.348 . . . . 0.0 111.376 -179.28 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -61.67 -48.28 85.29 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 111.316 -0.714 . . . . 0.0 111.316 -179.431 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 9.0 mp -60.26 -24.96 65.33 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.49 0.186 . . . . 0.0 111.153 -179.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.732 HG23 ' O ' ' A' ' 8' ' ' ALA . 14.4 p -83.92 -29.11 27.39 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.77 -0.372 . . . . 0.0 110.539 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.422 ' O ' ' CB ' ' A' ' 16' ' ' SER . 6.4 mp -78.47 -20.87 49.98 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 179.661 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.421 ' C ' ' H ' ' A' ' 16' ' ' SER . 3.5 t -49.73 -57.63 11.67 Favored Pre-proline 0 CA--C 1.534 0.349 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.739 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.418 ' HD2' ' N ' ' A' ' 14' ' ' VAL . 11.3 Cg_endo -56.5 -4.19 0.75 Allowed 'Trans proline' 0 N--CA 1.497 1.725 0 C-N-CA 120.81 1.007 . . . . 0.0 111.974 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.422 ' CB ' ' O ' ' A' ' 13' ' ' LEU . 1.6 t -81.46 -27.81 34.44 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.832 0.348 . . . . 0.0 110.464 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 13.4 mt -71.56 -54.93 8.86 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.671 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -74.02 -35.8 53.08 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 111.035 -0.826 . . . . 0.0 111.035 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -67.27 -33.69 83.34 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 111.011 -0.836 . . . . 0.0 111.011 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -78.14 -60.09 2.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.74 0.305 . . . . 0.0 111.002 -179.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 3.3 ttt -61.95 -23.19 66.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.777 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.405 ' C ' ' CZ2' ' A' ' 95' ' ' TRP . . . -77.94 -60.43 2.75 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 111.681 -0.567 . . . . 0.0 111.681 -179.565 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.646 ' O ' HG22 ' A' ' 26' ' ' VAL . . . -66.79 -22.42 66.03 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.857 -179.146 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 88.5 t80 -49.86 -24.15 2.3 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.192 179.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 65.3 t80 -70.56 -52.09 24.05 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.007 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.646 HG22 ' O ' ' A' ' 23' ' ' ALA . 31.9 m -64.57 -22.59 31.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 C-N-CA 120.826 -0.35 . . . . 0.0 110.697 -179.725 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 16.3 ttt180 -67.66 -31.77 71.98 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.518 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -106.17 -61.41 0.6 Allowed Glycine 0 CA--C 1.525 0.706 0 N-CA-C 111.522 -0.631 . . . . 0.0 111.522 -179.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.45 ' C ' ' OE1' ' A' ' 29' ' ' GLU . 4.2 tm-20 -66.52 -34.48 78.01 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 121.032 -0.267 . . . . 0.0 111.304 -179.471 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -64.73 -58.23 10.56 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 110.932 -0.867 . . . . 0.0 110.932 -179.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 10.9 mp -51.67 -30.11 20.61 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.665 0.269 . . . . 0.0 110.511 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 16.1 tpp180 -78.61 -49.93 12.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.888 -179.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -51.4 -29.96 17.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.357 -179.652 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 39.1 t80 -46.28 -35.94 5.76 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.232 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -61.4 -29.03 69.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.486 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -89.13 -70.64 1.26 Allowed Glycine 0 CA--C 1.525 0.668 0 N-CA-C 110.851 -0.9 . . . . 0.0 110.851 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.572 ' O ' HD12 ' A' ' 37' ' ' LEU . 0.3 OUTLIER -95.21 167.15 11.53 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.912 0.387 . . . . 0.0 110.687 179.606 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 20.1 mt-30 -92.77 114.04 26.48 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.062 -179.542 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 18.8 mtpt -107.27 160.03 27.95 Favored Pre-proline 0 C--N 1.331 -0.2 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.907 179.493 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo . . . . . 0 C--N 1.307 -1.641 0 C-N-CA 122.147 1.898 . . . . 0.0 111.535 179.595 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.774 ' O ' HG23 ' A' ' 52' ' ' ILE . 0.2 OUTLIER . . . . . 0 CA--C 1.533 0.326 0 N-CA-C 112.133 0.419 . . . . 0.0 112.133 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.62 ' C ' ' H ' ' A' ' 52' ' ' ILE . . . -39.37 -30.09 0.2 Allowed Pre-proline 0 C--N 1.33 -0.263 0 C-N-CA 120.961 -0.296 . . . . 0.0 111.436 -179.171 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.423 ' HD2' ' N ' ' A' ' 50' ' ' ALA . 28.6 Cg_exo -54.79 7.67 0.03 OUTLIER 'Trans proline' 0 C--N 1.311 -1.44 0 CA-C-N 118.916 0.649 . . . . 0.0 112.57 178.388 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.774 HG23 ' O ' ' A' ' 49' ' ' LEU . 9.8 pt -56.35 -31.23 32.45 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.242 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 178.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.429 ' CH2' ' HB1' ' A' ' 50' ' ' ALA . 3.6 m0 -64.58 -24.15 67.5 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.616 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -71.62 -46.59 38.58 Favored Glycine 0 CA--C 1.523 0.551 0 N-CA-C 110.629 -0.988 . . . . 0.0 110.629 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 87.0 m -62.09 -50.21 72.85 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.875 0.369 . . . . 0.0 110.447 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 36.9 mt -69.08 -24.9 64.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.692 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.42 ' C ' ' CD1' ' A' ' 57' ' ' TYR . 1.6 t80 -65.34 -48.43 73.03 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 179.769 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -64.91 -46.13 82.98 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.32 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.61 -48.15 82.81 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.695 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 55.1 mtm -63.22 -36.45 83.7 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.713 -179.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -59.21 -47.29 91.55 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 111.423 -0.671 . . . . 0.0 111.423 -179.474 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 3.3 m-30 -66.84 -59.85 3.18 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.991 -0.284 . . . . 0.0 110.77 -179.496 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.517 ' O ' HG23 ' A' ' 67' ' ' VAL . . . -50.84 -59.12 8.35 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 110.972 -0.851 . . . . 0.0 110.972 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.511 ' O ' ' CD1' ' A' ' 68' ' ' TRP . 34.5 t -45.11 -52.04 9.61 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-O 120.986 0.422 . . . . 0.0 110.783 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 70.6 t80 -56.16 -36.64 68.53 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.116 -179.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 70.5 mt -70.83 -48.44 57.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.775 0.321 . . . . 0.0 110.798 -179.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.517 HG23 ' O ' ' A' ' 63' ' ' GLY . 18.3 t -48.9 -54.69 4.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.0 -179.711 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' TRP . . . . . 0.586 ' O ' ' N ' ' A' ' 73' ' ' GLY . 0.9 OUTLIER -64.15 -45.22 89.46 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.76 -0.376 . . . . 0.0 111.047 -179.587 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 14.6 mmmt -57.22 -23.28 46.91 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.888 -0.325 . . . . 0.0 110.913 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 24.1 tp10 -82.34 -63.33 1.4 Allowed 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.799 -0.361 . . . . 0.0 110.848 -179.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.742 ' C ' HD12 ' A' ' 71' ' ' LEU . 3.0 pp -64.82 -4.36 4.32 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.965 -179.652 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.618 ' N ' HD12 ' A' ' 71' ' ' LEU . . . 110.95 71.68 0.65 Allowed Glycine 0 CA--C 1.526 0.777 0 C-N-CA 121.177 -0.535 . . . . 0.0 111.817 179.454 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.586 ' N ' ' O ' ' A' ' 68' ' ' TRP . . . 40.93 -173.83 0.01 OUTLIER Glycine 0 CA--C 1.525 0.667 0 CA-C-O 121.365 0.425 . . . . 0.0 112.281 179.077 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 39.4 t80 -70.45 109.84 5.02 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.316 -0.442 . . . . 0.0 110.7 -179.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.532 ' OG1' ' N ' ' A' ' 76' ' ' GLU . 1.5 t -142.89 -173.56 3.93 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.231 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.532 ' N ' ' OG1' ' A' ' 75' ' ' THR . 16.6 mp0 -56.73 -23.17 40.63 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.301 179.625 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -78.48 -29.01 46.5 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.785 -179.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.437 ' O ' HD12 ' A' ' 82' ' ' LEU . . . -86.85 -30.67 21.28 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.546 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 66.8 mmm -60.46 -27.11 67.27 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.905 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 17.6 t -65.97 -48.11 61.96 Favored Pre-proline 0 CA--C 1.534 0.33 0 C-N-CA 120.711 -0.396 . . . . 0.0 110.817 -179.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_endo -73.22 -52.87 0.14 Allowed 'Trans proline' 0 N--CA 1.495 1.615 0 C-N-CA 120.727 0.951 . . . . 0.0 111.355 178.551 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.437 HD12 ' O ' ' A' ' 78' ' ' ALA . 3.6 mt -51.49 -52.8 43.58 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.333 179.769 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.5 ' O ' ' N ' ' A' ' 86' ' ' THR . . . -66.65 -64.54 3.26 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 111.332 -0.707 . . . . 0.0 111.332 -179.237 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 34.3 tp -42.01 -28.08 0.16 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.065 0.46 . . . . 0.0 109.994 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.414 ' N ' ' O ' ' A' ' 83' ' ' GLY . 4.3 t80 -77.29 -43.11 34.41 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.061 179.543 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.5 ' N ' ' O ' ' A' ' 83' ' ' GLY . 3.0 m -68.02 -52.78 31.58 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.744 179.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -60.56 -55.9 27.36 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 111.163 -0.775 . . . . 0.0 111.163 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.427 ' O ' ' CB ' ' A' ' 92' ' ' ASN . 52.2 tp60 -55.99 -42.87 77.03 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.799 0.333 . . . . 0.0 110.471 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 10.5 tp -66.01 -28.61 69.0 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.879 0.371 . . . . 0.0 110.125 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.783 ' O ' ' HB2' ' A' ' 94' ' ' ALA . . . -69.35 -65.82 0.66 Allowed 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.095 -0.642 . . . . 0.0 111.225 -179.814 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.7 pp -66.19 -29.16 69.38 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.149 0.426 . . . . 0.0 112.149 -179.01 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.427 ' CB ' ' O ' ' A' ' 88' ' ' GLN . 36.3 t-20 -85.22 -60.91 1.9 Allowed 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 -178.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . 0.609 ' O ' ' N ' ' A' ' 95' ' ' TRP . 0.0 OUTLIER -68.25 -14.78 63.24 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.69 -0.404 . . . . 0.0 111.403 -178.486 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.783 ' HB2' ' O ' ' A' ' 90' ' ' ALA . . . -54.04 80.25 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.137 0 C-N-CA 120.439 -0.505 . . . . 0.0 109.995 179.498 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.711 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 33.8 p-90 -94.44 -16.42 0.21 Allowed Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.24 -0.437 . . . . 0.0 112.061 -179.633 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.711 ' CD ' ' N ' ' A' ' 95' ' ' TRP . 46.9 Cg_exo -56.96 -31.99 91.46 Favored 'Trans proline' 0 N--CA 1.494 1.504 0 CA-C-N 118.921 0.65 . . . . 0.0 112.789 179.366 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.524 ' C ' ' H ' ' A' ' 99' ' ' PHE . 59.6 Cg_exo -50.33 -30.55 26.97 Favored 'Trans proline' 0 N--CA 1.493 1.479 0 CA-C-N 118.969 0.668 . . . . 0.0 112.838 179.736 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.492 ' O ' ' N ' ' A' ' 101' ' ' GLY . 1.2 pp -74.01 20.87 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.022 0.439 . . . . 0.0 110.187 179.662 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.524 ' H ' ' C ' ' A' ' 97' ' ' PRO . 0.9 OUTLIER -39.29 -58.18 1.25 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.038 -179.666 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 4.2 p90 -66.89 -18.04 65.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.143 -179.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.492 ' N ' ' O ' ' A' ' 98' ' ' ILE . . . -86.99 -10.7 71.45 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 111.17 -0.772 . . . . 0.0 111.17 -179.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -70.74 -9.4 57.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.56 0.219 . . . . 0.0 111.093 -179.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 10.6 ptm180 -91.97 -5.39 53.16 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.8 0.333 . . . . 0.0 110.734 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 10.0 mt-30 -109.11 160.45 16.05 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.554 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -53.76 -19.25 3.99 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.049 0.452 . . . . 0.0 110.237 179.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.605 ' O ' ' N ' ' A' ' 108' ' ' ALA . . . -65.4 -14.93 60.59 Favored Glycine 0 CA--C 1.523 0.592 0 N-CA-C 111.073 -0.811 . . . . 0.0 111.073 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' TRP . . . . . 0.505 ' NE1' ' OD1' ' A' ' 151' ' ' ASN . 0.0 OUTLIER -42.41 -15.12 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.791 0.329 . . . . 0.0 110.517 -179.663 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.605 ' N ' ' O ' ' A' ' 106' ' ' GLY . . . -58.76 -16.83 18.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.136 0.493 . . . . 0.0 109.85 179.427 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 12.1 mt -58.74 -33.92 70.79 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.569 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -53.8 -61.04 2.56 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.936 0.398 . . . . 0.0 110.898 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.571 ' O ' HG23 ' A' ' 115' ' ' VAL . 2.3 p-10 -58.83 -54.89 41.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.733 -179.392 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 43.5 tp -52.82 -43.52 66.01 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.351 -0.386 . . . . 0.0 112.01 -178.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 8.6 mt -66.96 -61.37 1.97 Allowed 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -178.17 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.3 pp -61.23 -35.18 76.52 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.304 -0.558 . . . . 0.0 111.499 -178.496 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.571 HG23 ' O ' ' A' ' 111' ' ' ASP . 41.5 t -60.07 -56.64 16.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.596 -0.274 . . . . 0.0 111.116 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . 0.489 ' O ' ' OG1' ' A' ' 120' ' ' THR . 58.1 m -72.92 -24.1 60.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.615 -0.266 . . . . 0.0 111.58 -178.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . 0.406 ' O ' ' CB ' ' A' ' 121' ' ' ALA . . . -63.69 -62.73 5.02 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 111.537 -0.625 . . . . 0.0 111.537 -179.285 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.585 ' O ' HG23 ' A' ' 122' ' ' THR . 8.7 p -74.03 -34.59 39.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 C-N-CA 120.883 -0.327 . . . . 0.0 111.231 -179.481 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.524 ' O ' ' OG1' ' A' ' 123' ' ' THR . . . -68.95 -60.57 2.27 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.781 -0.367 . . . . 0.0 111.201 -179.429 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.489 ' OG1' ' O ' ' A' ' 116' ' ' SER . 1.4 m -61.47 -48.66 80.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.397 -179.252 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.407 ' O ' ' CB ' ' A' ' 125' ' ' ALA . . . -56.68 -42.01 78.31 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.173 -179.4 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.585 HG23 ' O ' ' A' ' 118' ' ' VAL . 35.3 p -71.7 -29.22 64.32 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.948 -0.301 . . . . 0.0 111.567 -179.317 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.524 ' OG1' ' O ' ' A' ' 119' ' ' ALA . 0.1 OUTLIER -67.41 -50.7 58.37 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.584 -0.446 . . . . 0.0 110.577 -179.749 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.0 pp -79.71 -20.39 46.61 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.625 -179.085 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.407 ' CB ' ' O ' ' A' ' 121' ' ' ALA . . . -91.47 -64.72 1.08 Allowed 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.678 0.621 . . . . 0.0 112.678 -178.351 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' TRP . . . . . 0.433 ' N ' ' CD1' ' A' ' 126' ' ' TRP . 40.2 m0 -85.69 -57.08 3.19 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 -177.587 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . 0.532 ' CG ' ' HB2' ' A' ' 134' ' ' ALA . 11.3 m170 -57.2 -31.58 65.59 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.795 -0.362 . . . . 0.0 111.919 -178.577 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 18.6 ttt180 -56.98 -38.51 73.11 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.709 -0.396 . . . . 0.0 111.367 -179.237 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 48.5 t -97.22 -49.56 11.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.793 0.33 . . . . 0.0 111.403 -179.244 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . 0.509 ' HB3' HG22 ' A' ' 67' ' ' VAL . 15.0 t -113.91 108.31 51.25 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.748 -179.546 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . 0.635 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 82.3 Cg_exo -75.26 -28.07 9.07 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 C-N-CA 121.755 1.637 . . . . 0.0 112.72 179.338 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . 0.635 ' CD ' ' N ' ' A' ' 131' ' ' PRO . 53.5 Cg_exo -57.77 -55.45 2.36 Favored 'Trans proline' 0 N--CA 1.497 1.68 0 C-N-CA 121.142 1.228 . . . . 0.0 111.968 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -49.26 -38.48 27.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.463 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . 0.532 ' HB2' ' CG ' ' A' ' 127' ' ' HIS . . . -57.08 -29.04 63.14 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.337 179.786 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 9.7 tpp85 -76.36 -24.5 54.2 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.335 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 84.6 mt -76.04 -39.73 54.95 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 179.42 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.608 ' O ' ' N ' ' A' ' 140' ' ' TYR . 9.7 mt -77.0 -37.42 55.15 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.791 -0.641 . . . . 0.0 109.823 179.166 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.493 ' C ' ' O ' ' A' ' 137' ' ' LEU . 2.9 t80 -21.0 -44.41 0.04 OUTLIER Pre-proline 0 N--CA 1.467 0.375 0 O-C-N 123.918 0.761 . . . . 0.0 111.828 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.564 ' N ' ' O ' ' A' ' 137' ' ' LEU . 2.0 Cg_endo -67.75 11.55 0.23 Allowed 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 121.026 1.151 . . . . 0.0 112.296 179.554 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . 0.756 ' CE2' HD11 ' A' ' 144' ' ' LEU . 2.4 p90 -93.14 -14.15 27.56 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 121.188 0.518 . . . . 0.0 110.118 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.605 ' CD1' ' CE1' ' A' ' 140' ' ' TYR . 5.2 mp -57.05 -25.91 59.45 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 178.522 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -66.66 -44.51 81.68 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.826 179.495 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' TRP . . . . . 0.453 ' CZ2' HD12 ' A' ' 52' ' ' ILE . 7.9 t-105 -59.77 -48.08 83.13 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 179.358 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.756 HD11 ' CE2' ' A' ' 140' ' ' TYR . 9.1 mt -53.22 -50.96 63.64 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 179.09 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.645 ' O ' HG23 ' A' ' 149' ' ' VAL . . . -61.33 -26.58 67.9 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.667 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 25.4 t80 -65.01 -62.43 1.55 Allowed 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.812 -0.355 . . . . 0.0 110.775 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -66.25 -43.38 86.68 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.612 -0.435 . . . . 0.0 110.492 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 16.2 m -57.06 -57.62 11.78 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.765 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.645 HG23 ' O ' ' A' ' 145' ' ' ALA . 85.4 t -56.95 -32.77 40.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 C-N-CA 120.836 -0.346 . . . . 0.0 110.731 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.541 ' O ' HG23 ' A' ' 154' ' ' VAL . 1.8 tp -58.39 -48.62 80.03 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.523 -0.471 . . . . 0.0 109.813 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . 0.505 ' OD1' ' NE1' ' A' ' 107' ' ' TRP . 21.1 t30 -69.62 -55.68 9.4 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.528 179.701 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 84.8 t80 -47.49 -39.53 16.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.818 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 25.8 t80 -67.82 -46.59 71.45 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.765 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.541 HG23 ' O ' ' A' ' 150' ' ' LEU . 93.7 t -61.88 -33.06 56.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.742 -179.853 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' TRP . . . . . . . . . . . . . 6.3 m0 -67.02 -58.48 4.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.511 179.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -62.94 -19.43 64.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.553 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -80.09 -51.66 8.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.169 -179.547 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 33.5 m-20 . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.084 -179.449 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.605 ' O ' HG23 ' A' ' 9' ' ' VAL . 0.5 OUTLIER . . . . . 0 C--O 1.233 0.207 0 CA-C-O 120.732 0.301 . . . . 0.0 110.308 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.589 ' N ' ' CD ' ' A' ' 7' ' ' PRO . 0.9 OUTLIER -61.0 -40.77 77.17 Favored Pre-proline 0 C--N 1.33 -0.269 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 -179.919 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.589 ' CD ' ' N ' ' A' ' 6' ' ' VAL . 23.4 Cg_exo -62.82 -64.59 0.07 OUTLIER 'Trans proline' 0 C--N 1.307 -1.649 0 C-N-CA 121.683 1.589 . . . . 0.0 111.388 179.526 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.681 ' O ' HG23 ' A' ' 12' ' ' THR . . . -48.9 -30.09 5.47 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.84 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.605 HG23 ' O ' ' A' ' 5' ' ' TRP . 43.5 t -74.18 -62.8 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.709 0.29 . . . . 0.0 111.658 -179.258 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -58.13 -35.21 76.23 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 111.598 -0.601 . . . . 0.0 111.598 -179.268 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.528 ' HG ' HG22 ' A' ' 86' ' ' THR . 6.9 mp -73.52 -38.17 65.39 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.621 0.248 . . . . 0.0 110.567 -179.663 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.681 HG23 ' O ' ' A' ' 8' ' ' ALA . 12.3 p -70.16 -20.59 63.13 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.017 0.436 . . . . 0.0 109.86 179.456 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.418 ' O ' ' C ' ' A' ' 14' ' ' VAL . 7.8 mt -80.95 -42.76 20.76 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.695 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.439 HG12 ' N ' ' A' ' 15' ' ' PRO . 3.1 t -35.71 -66.08 0.27 Allowed Pre-proline 0 CA--C 1.534 0.35 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.997 -179.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.439 ' N ' HG12 ' A' ' 14' ' ' VAL . 27.7 Cg_endo -51.23 -48.04 23.04 Favored 'Trans proline' 0 N--CA 1.498 1.754 0 C-N-CA 120.712 0.941 . . . . 0.0 112.126 -179.515 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 7.5 t -45.06 -21.32 0.06 Allowed 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.793 -0.363 . . . . 0.0 110.726 -179.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.421 ' N ' ' O ' ' A' ' 15' ' ' PRO . 73.2 mt -74.22 -53.37 9.94 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.395 179.77 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -72.01 -23.82 77.42 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 111.11 -0.796 . . . . 0.0 111.11 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -72.1 -49.2 22.64 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 110.952 -0.859 . . . . 0.0 110.952 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 11.2 t80 -67.94 -59.02 3.6 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.831 0.348 . . . . 0.0 110.566 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 8.0 tpp -62.88 -26.95 69.03 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.156 -179.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -77.68 -62.55 2.37 Favored Glycine 0 CA--C 1.526 0.753 0 C-N-CA 120.963 -0.637 . . . . 0.0 111.913 -179.316 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.626 ' O ' HG22 ' A' ' 26' ' ' VAL . . . -57.57 -24.79 58.15 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.834 -0.347 . . . . 0.0 110.666 -179.085 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 54.2 t80 -47.82 -24.5 1.0 Allowed 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.769 -0.372 . . . . 0.0 110.11 179.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.4 ' CE2' ' HB3' ' A' ' 102' ' ' ALA . 21.7 t80 -69.45 -55.78 9.28 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.777 -179.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.626 HG22 ' O ' ' A' ' 23' ' ' ALA . 33.7 m -60.44 -23.99 29.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 C-N-CA 120.699 -0.4 . . . . 0.0 110.344 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 2.9 tmt_? -66.09 -20.86 66.29 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.631 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -116.29 -75.22 0.57 Allowed Glycine 0 CA--C 1.523 0.569 0 N-CA-C 111.021 -0.832 . . . . 0.0 111.021 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -50.36 -31.68 15.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.654 0.264 . . . . 0.0 110.774 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -72.82 -53.39 8.21 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.81 -0.916 . . . . 0.0 110.81 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 11.0 mp -57.58 -29.94 64.86 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.84 0.352 . . . . 0.0 110.317 179.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 45.0 mtp180 -79.94 -48.92 12.63 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.549 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -52.15 -29.97 24.52 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.013 -0.539 . . . . 0.0 109.923 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 51.1 t80 -48.54 -40.03 25.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.61 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -58.9 -22.52 59.67 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.461 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -94.95 -73.5 1.2 Allowed Glycine 0 CA--C 1.524 0.638 0 N-CA-C 110.721 -0.951 . . . . 0.0 110.721 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.568 ' O ' HD12 ' A' ' 37' ' ' LEU . 0.3 OUTLIER -95.52 167.14 11.49 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.711 0.291 . . . . 0.0 110.424 179.494 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 33.3 mt-30 -85.02 115.72 23.0 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.887 0.375 . . . . 0.0 111.168 -179.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 12.0 mtpt -122.78 164.66 25.51 Favored Pre-proline 0 N--CA 1.462 0.168 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 179.276 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo . . . . . 0 C--N 1.306 -1.678 0 C-N-CA 121.743 1.628 . . . . 0.0 111.159 179.358 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.957 ' O ' HG23 ' A' ' 52' ' ' ILE . 1.5 mm? . . . . . 0 CA--C 1.531 0.249 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.543 ' C ' ' H ' ' A' ' 52' ' ' ILE . . . -40.42 -34.97 0.48 Allowed Pre-proline 0 C--N 1.326 -0.416 0 C-N-CA 120.427 -0.509 . . . . 0.0 111.42 -179.143 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.43 ' HD2' ' N ' ' A' ' 50' ' ' ALA . 69.6 Cg_exo -54.26 3.0 0.05 OUTLIER 'Trans proline' 0 C--N 1.314 -1.283 0 C-N-CA 120.644 0.896 . . . . 0.0 112.954 179.257 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.957 HG23 ' O ' ' A' ' 49' ' ' LEU . 42.1 pt -55.55 -30.27 26.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 121.133 0.492 . . . . 0.0 110.032 179.624 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.484 ' CE2' HD11 ' A' ' 52' ' ' ILE . 45.7 m95 -81.51 -22.51 37.9 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.413 -179.606 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -72.01 -47.51 31.04 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 109.709 -1.356 . . . . 0.0 109.709 178.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 5.0 m -67.12 -54.98 16.25 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 178.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.41 HD23 ' HA ' ' A' ' 56' ' ' LEU . 92.8 mt -53.76 -39.63 65.52 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.848 -0.614 . . . . 0.0 109.5 179.119 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.42 ' CD1' ' C ' ' A' ' 57' ' ' TYR . 1.3 t80 -54.6 -50.75 67.28 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 179.394 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 5.7 m -52.22 -50.22 62.42 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.223 179.608 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.55 -47.95 82.51 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.574 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 15.4 mtt -56.07 -44.14 78.66 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.461 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -54.59 -55.91 24.82 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 111.155 -0.778 . . . . 0.0 111.155 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -53.65 -54.66 34.59 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.727 0.299 . . . . 0.0 110.448 -179.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.487 ' O ' HG23 ' A' ' 67' ' ' VAL . . . -52.53 -56.97 15.18 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 110.824 -0.91 . . . . 0.0 110.824 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.592 ' O ' ' CD1' ' A' ' 68' ' ' TRP . 0.0 OUTLIER -49.19 -50.13 39.48 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.897 0.379 . . . . 0.0 110.324 179.957 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.487 ' O ' ' CG ' ' A' ' 69' ' ' LYS . 83.9 t80 -51.43 -38.33 53.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.709 -179.758 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 51.9 mt -71.59 -48.67 51.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.166 -179.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.487 HG23 ' O ' ' A' ' 63' ' ' GLY . 15.9 t -51.51 -61.35 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.867 0.365 . . . . 0.0 111.334 -179.46 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' TRP . . . . . 0.592 ' CD1' ' O ' ' A' ' 64' ' ' SER . 1.5 m95 -60.72 -40.67 93.18 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.339 -179.179 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.487 ' CG ' ' O ' ' A' ' 65' ' ' TYR . 10.6 mmmt -64.2 -22.68 67.03 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.847 0.356 . . . . 0.0 110.706 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -82.89 -62.36 1.62 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.671 -179.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.74 ' C ' HD12 ' A' ' 71' ' ' LEU . 3.6 pp -65.22 -9.73 25.95 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.962 -179.775 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.668 ' N ' HD12 ' A' ' 71' ' ' LEU . . . 106.09 85.69 1.83 Allowed Glycine 0 CA--C 1.527 0.788 0 C-N-CA 121.221 -0.514 . . . . 0.0 111.939 179.234 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.493 ' O ' HD11 ' A' ' 71' ' ' LEU . . . 42.06 -173.72 0.01 OUTLIER Glycine 0 CA--C 1.526 0.719 0 N-CA-C 111.838 -0.505 . . . . 0.0 111.838 179.078 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -85.02 110.93 19.28 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.527 -0.336 . . . . 0.0 110.773 -179.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.524 ' OG1' ' N ' ' A' ' 76' ' ' GLU . 1.7 t -142.53 -173.81 3.97 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.665 179.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.524 ' N ' ' OG1' ' A' ' 75' ' ' THR . 6.9 pt-20 -45.45 -34.9 3.4 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.889 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -67.91 -32.65 73.28 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.071 -179.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -83.98 -22.69 31.32 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.844 0.354 . . . . 0.0 110.816 -179.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 4.8 mtp -62.99 -26.63 68.94 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.775 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.2 t -68.67 -52.92 17.4 Favored Pre-proline 0 CA--C 1.534 0.35 0 C-N-CA 120.608 -0.437 . . . . 0.0 110.749 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -65.86 -60.78 0.11 Allowed 'Trans proline' 0 N--CA 1.497 1.678 0 C-N-CA 121.07 1.18 . . . . 0.0 111.703 179.137 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.624 ' O ' HG23 ' A' ' 86' ' ' THR . 2.7 mt -56.77 -56.43 21.55 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.391 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -47.82 -51.37 18.37 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 111.168 -0.773 . . . . 0.0 111.168 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 16.0 tp -62.58 -30.13 71.1 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 121.019 -0.273 . . . . 0.0 110.753 -179.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.597 ' CZ ' HD22 ' A' ' 89' ' ' LEU . 23.0 t80 -71.51 -39.11 71.01 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.963 -0.295 . . . . 0.0 110.468 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.624 HG23 ' O ' ' A' ' 82' ' ' LEU . 8.8 p -64.49 -53.54 46.49 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.802 -0.359 . . . . 0.0 110.656 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -68.04 -58.09 7.85 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 111.527 -0.629 . . . . 0.0 111.527 -179.266 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 52.4 tp60 -49.47 -54.61 16.84 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-O 121.039 0.447 . . . . 0.0 110.551 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.597 HD22 ' CZ ' ' A' ' 85' ' ' TYR . 27.1 tp -51.03 -64.4 0.82 Allowed 'General case' 0 C--O 1.209 -1.027 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.906 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.622 ' O ' ' HB2' ' A' ' 94' ' ' ALA . . . -38.05 -48.85 1.25 Allowed 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 120.434 -0.506 . . . . 0.0 111.916 -179.561 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 94.1 mt -56.6 -57.17 13.54 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 -178.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.798 ' O ' HD22 ' A' ' 113' ' ' LEU . 2.8 m120 -74.21 -55.11 6.43 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 121.415 0.626 . . . . 0.0 111.301 -178.621 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . 0.623 ' O ' ' N ' ' A' ' 95' ' ' TRP . 7.4 t-105 -52.84 -21.92 4.8 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.114 -0.948 . . . . 0.0 111.273 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.622 ' HB2' ' O ' ' A' ' 90' ' ' ALA . . . -60.05 69.27 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.929 0.395 . . . . 0.0 109.948 179.623 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.685 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 9.9 p-90 -99.94 -17.39 0.2 Allowed Pre-proline 0 CA--C 1.536 0.439 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.73 -179.363 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.685 ' CD ' ' N ' ' A' ' 95' ' ' TRP . 31.8 Cg_exo -62.86 -26.24 74.57 Favored 'Trans proline' 0 N--CA 1.494 1.522 0 C-N-CA 120.442 0.762 . . . . 0.0 112.659 179.193 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.544 ' CD ' ' N ' ' A' ' 96' ' ' PRO . 84.2 Cg_exo -60.1 -25.69 80.49 Favored 'Trans proline' 0 N--CA 1.496 1.638 0 C-N-CA 120.744 0.963 . . . . 0.0 112.781 179.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -80.74 33.03 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 121.003 0.43 . . . . 0.0 110.427 179.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.402 ' H ' ' C ' ' A' ' 97' ' ' PRO . 1.6 t80 -44.7 -52.92 7.82 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.488 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -73.63 -40.33 63.86 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.673 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -57.14 -15.47 14.69 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 111.135 -0.786 . . . . 0.0 111.135 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.4 ' HB3' ' CE2' ' A' ' 25' ' ' PHE . . . -74.64 -7.88 54.62 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.69 0.281 . . . . 0.0 110.837 -179.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.41 -17.12 52.75 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.657 -179.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . 0.536 ' O ' ' N ' ' A' ' 106' ' ' GLY . 5.4 pt20 -110.95 158.06 19.19 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.599 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 6.0 mmt -43.26 -17.32 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.669 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.536 ' N ' ' O ' ' A' ' 104' ' ' GLN . . . -62.78 -15.82 55.32 Favored Glycine 0 CA--C 1.526 0.77 0 N-CA-C 111.122 -0.791 . . . . 0.0 111.122 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' TRP . . . . . 0.481 ' C ' ' CD1' ' A' ' 107' ' ' TRP . 0.0 OUTLIER -47.68 -12.09 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.887 0.375 . . . . 0.0 110.664 -179.881 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.498 ' H ' ' C ' ' A' ' 106' ' ' GLY . . . -62.7 -22.51 66.56 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.082 179.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 8.2 mt -53.39 -29.68 35.96 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.297 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -54.91 -64.4 0.85 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.957 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.707 ' O ' HG23 ' A' ' 115' ' ' VAL . 1.4 p30 -58.82 -51.1 71.45 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.457 -179.477 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.549 ' N ' ' OD1' ' A' ' 111' ' ' ASP . 39.6 tp -52.48 -47.79 66.31 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.813 -178.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.798 HD22 ' O ' ' A' ' 92' ' ' ASN . 17.3 mt -65.81 -62.07 1.71 Allowed 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 -178.002 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.1 pp -58.36 -35.32 71.77 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 120.369 -0.533 . . . . 0.0 111.48 -178.478 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.707 HG23 ' O ' ' A' ' 111' ' ' ASP . 40.2 t -59.56 -61.27 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.132 -179.675 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . 0.49 ' O ' ' OG1' ' A' ' 120' ' ' THR . 9.0 p -69.22 -22.24 63.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.291 -179.082 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -63.3 -63.02 4.85 Favored Glycine 0 CA--C 1.527 0.841 0 C-N-CA 120.838 -0.696 . . . . 0.0 111.597 -179.284 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.614 ' O ' HG23 ' A' ' 122' ' ' THR . 9.9 p -73.07 -37.04 52.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 C-N-CA 120.88 -0.328 . . . . 0.0 111.239 -179.415 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.515 ' O ' ' OG1' ' A' ' 123' ' ' THR . . . -67.58 -60.75 2.31 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.692 -0.403 . . . . 0.0 111.212 -179.563 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.49 ' OG1' ' O ' ' A' ' 116' ' ' SER . 2.3 m -58.42 -53.52 57.36 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.432 -179.339 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.439 ' O ' HD23 ' A' ' 124' ' ' LEU . . . -53.76 -41.36 67.06 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.253 -179.345 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.614 HG23 ' O ' ' A' ' 118' ' ' VAL . 42.1 p -73.73 -34.05 64.6 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 120.783 -0.367 . . . . 0.0 111.889 -179.12 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.515 ' OG1' ' O ' ' A' ' 119' ' ' ALA . 0.0 OUTLIER -60.27 -56.04 26.38 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 120.555 -0.458 . . . . 0.0 110.938 -179.453 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.579 HD23 ' N ' ' A' ' 125' ' ' ALA . 0.6 OUTLIER -79.06 -20.28 49.24 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.323 0.49 . . . . 0.0 112.323 -178.653 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.579 ' N ' HD23 ' A' ' 124' ' ' LEU . . . -87.91 -67.83 0.8 Allowed 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 -178.716 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' TRP . . . . . 0.522 ' N ' ' CD1' ' A' ' 126' ' ' TRP . 22.9 m0 -84.61 -57.27 3.2 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 -177.789 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . 0.551 ' CD2' ' N ' ' A' ' 127' ' ' HIS . 5.2 m170 -56.09 -22.3 27.16 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.916 -0.314 . . . . 0.0 111.569 -178.755 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.42 -37.21 84.7 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.856 0.36 . . . . 0.0 110.69 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 74.1 t -96.33 -49.47 12.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.209 -179.45 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 6.0 t -111.88 108.41 55.7 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.958 -179.432 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . 0.67 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 73.0 Cg_exo -75.27 -22.11 14.68 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 121.611 1.541 . . . . 0.0 112.379 178.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . 0.67 ' CD ' ' N ' ' A' ' 131' ' ' PRO . 58.8 Cg_exo -67.12 -45.01 4.29 Favored 'Trans proline' 0 N--CA 1.496 1.632 0 C-N-CA 121.42 1.414 . . . . 0.0 112.184 179.782 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -56.3 -37.01 69.31 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.884 0.373 . . . . 0.0 110.459 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -59.72 -24.84 64.33 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.711 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 15.5 ttp-105 -79.32 -30.61 42.9 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.664 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 86.3 mt -71.49 -36.09 71.02 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 179.556 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.58 ' O ' ' N ' ' A' ' 139' ' ' PRO . 6.4 mt -81.47 -39.93 24.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.312 179.548 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.574 ' C ' ' H ' ' A' ' 140' ' ' TYR . 0.7 OUTLIER -17.45 -48.7 0.04 OUTLIER Pre-proline 0 N--CA 1.468 0.47 0 O-C-N 123.921 0.763 . . . . 0.0 111.882 -179.65 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.58 ' N ' ' O ' ' A' ' 137' ' ' LEU . 2.1 Cg_endo -63.74 14.93 0.07 OUTLIER 'Trans proline' 0 C--N 1.308 -1.564 0 C-N-CA 120.91 1.073 . . . . 0.0 111.809 179.518 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . 0.698 ' CE2' HD11 ' A' ' 144' ' ' LEU . 7.0 p90 -92.77 -14.34 28.02 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 121.208 0.528 . . . . 0.0 110.26 179.702 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.637 ' CD1' ' CE1' ' A' ' 140' ' ' TYR . 6.7 mp -59.96 -36.76 77.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.301 178.629 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -55.5 -45.42 77.04 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.091 179.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' TRP . . . . . 0.442 ' CE2' HD12 ' A' ' 52' ' ' ILE . 9.1 t-105 -60.63 -51.57 68.84 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 179.537 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.698 HD11 ' CE2' ' A' ' 140' ' ' TYR . 11.4 mt -50.27 -53.58 27.45 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 120.23 -0.588 . . . . 0.0 109.594 179.366 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.681 ' O ' HG23 ' A' ' 149' ' ' VAL . . . -59.22 -23.01 61.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.269 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 5.1 t80 -67.07 -63.44 1.06 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.693 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -66.51 -35.6 80.64 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.65 -179.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 9.7 m -65.58 -39.58 91.78 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.868 -0.333 . . . . 0.0 110.371 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.681 HG23 ' O ' ' A' ' 145' ' ' ALA . 37.7 t -69.17 -36.55 73.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.198 179.733 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 2.1 tp -58.62 -54.26 49.11 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.044 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . 0.441 ' OD1' ' NE1' ' A' ' 107' ' ' TRP . 14.3 t30 -58.58 -55.21 37.99 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.62 179.688 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 69.6 t80 -50.38 -47.27 56.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.214 -179.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 14.4 t80 -56.08 -43.49 78.07 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.953 -179.576 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 84.4 t -68.35 -41.28 83.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.486 -0.324 . . . . 0.0 111.141 -179.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' TRP . . . . . . . . . . . . . 5.3 m0 -58.55 -38.17 77.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.617 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . 0.433 ' HA ' ' HE ' ' A' ' 156' ' ' ARG . 0.0 OUTLIER -81.07 -54.91 5.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.931 -179.51 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 33.2 t0 -51.58 -43.91 62.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.191 -179.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' ASN . . . . . 0.533 ' O ' ' ND2' ' A' ' 158' ' ' ASN . 0.4 OUTLIER . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.163 -179.444 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.574 ' O ' HG23 ' A' ' 9' ' ' VAL . 0.5 OUTLIER . . . . . 0 C--O 1.232 0.153 0 N-CA-C 110.165 -0.309 . . . . 0.0 110.165 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.575 ' N ' ' CD ' ' A' ' 7' ' ' PRO . 0.9 OUTLIER -61.1 -41.81 82.97 Favored Pre-proline 0 CA--C 1.533 0.304 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 179.932 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.575 ' CD ' ' N ' ' A' ' 6' ' ' VAL . 17.3 Cg_exo -62.62 -66.41 0.05 OUTLIER 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 121.579 1.519 . . . . 0.0 111.733 179.478 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.675 ' O ' HG23 ' A' ' 12' ' ' THR . . . -48.5 -33.56 9.68 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.339 -179.422 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.574 HG23 ' O ' ' A' ' 5' ' ' TRP . 39.5 t -69.51 -63.24 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 111.76 0.281 . . . . 0.0 111.76 -178.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -60.53 -45.97 95.28 Favored Glycine 0 CA--C 1.526 0.73 0 C-N-CA 121.195 -0.526 . . . . 0.0 111.84 -179.101 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.445 ' N ' HD12 ' A' ' 11' ' ' LEU . 9.3 mp -62.25 -38.31 88.75 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 122.873 -0.193 . . . . 0.0 111.09 -179.264 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.675 HG23 ' O ' ' A' ' 8' ' ' ALA . 36.1 p -73.42 -22.55 60.19 Favored 'General case' 0 C--N 1.332 -0.166 0 C-N-CA 120.298 -0.561 . . . . 0.0 109.924 179.268 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 5.6 mt -76.5 -30.97 57.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.228 179.671 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.9 t -43.53 -55.09 9.04 Favored Pre-proline 0 CA--C 1.534 0.363 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.788 -179.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -66.19 -17.06 54.03 Favored 'Trans proline' 0 N--CA 1.499 1.796 0 C-N-CA 120.925 1.083 . . . . 0.0 111.825 179.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.6 t -75.07 -28.74 60.46 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.551 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 56.5 mt -72.36 -57.82 3.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.433 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -69.78 -21.17 76.46 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 110.865 -0.894 . . . . 0.0 110.865 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -70.59 -54.07 11.08 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 111.008 -0.837 . . . . 0.0 111.008 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 37.7 t80 -70.17 -58.24 4.02 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.787 0.327 . . . . 0.0 110.518 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 20.5 ttp -57.21 -35.99 70.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.762 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -69.78 -62.23 3.94 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 111.121 -0.792 . . . . 0.0 111.121 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.555 ' O ' HG22 ' A' ' 26' ' ' VAL . . . -55.55 -17.14 4.83 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.906 0.384 . . . . 0.0 110.31 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 47.4 t80 -51.26 -25.47 5.72 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.277 179.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 71.8 t80 -67.17 -47.29 71.41 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.507 179.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.555 HG22 ' O ' ' A' ' 23' ' ' ALA . 32.6 m -77.52 -13.94 14.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.379 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.4 tmt_? -67.43 -30.57 70.35 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.743 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -119.45 -69.9 0.32 Allowed Glycine 0 CA--C 1.525 0.691 0 N-CA-C 110.996 -0.841 . . . . 0.0 110.996 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -47.57 -22.63 0.51 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.744 0.307 . . . . 0.0 110.659 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -76.29 -52.15 6.32 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 111.119 -0.792 . . . . 0.0 111.119 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 72.6 mt -53.45 -36.28 61.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.758 0.313 . . . . 0.0 110.625 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 11.3 mmt180 -78.0 -49.89 13.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.809 -179.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -47.53 -31.54 4.45 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 110.101 -0.333 . . . . 0.0 110.101 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.445 ' CD1' ' C ' ' A' ' 34' ' ' TYR . 23.8 t80 -52.82 -39.03 62.09 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.486 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -56.94 -20.77 25.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.28 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -98.01 -73.34 1.11 Allowed Glycine 0 CA--C 1.526 0.749 0 N-CA-C 110.858 -0.897 . . . . 0.0 110.858 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.572 ' O ' HD12 ' A' ' 37' ' ' LEU . 0.3 OUTLIER -96.05 166.9 11.54 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 120.938 0.399 . . . . 0.0 110.898 179.806 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 6.6 mp0 -84.1 117.08 23.22 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.636 -179.713 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 6.7 mtpt -126.1 149.57 66.97 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.797 179.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo . . . . . 0 C--N 1.307 -1.62 0 C-N-CA 121.328 1.352 . . . . 0.0 111.387 179.296 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.898 ' O ' HG23 ' A' ' 52' ' ' ILE . 1.0 OUTLIER . . . . . 0 N--CA 1.466 0.354 0 N-CA-C 112.505 0.557 . . . . 0.0 112.505 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.584 ' C ' ' H ' ' A' ' 52' ' ' ILE . . . -39.85 -33.46 0.33 Allowed Pre-proline 0 C--N 1.327 -0.394 0 C-N-CA 120.675 -0.41 . . . . 0.0 111.539 -179.033 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.421 ' HD2' ' N ' ' A' ' 50' ' ' ALA . 56.9 Cg_exo -54.23 4.1 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.522 0 CA-C-N 118.615 0.541 . . . . 0.0 112.587 178.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.898 HG23 ' O ' ' A' ' 49' ' ' LEU . 45.6 pt -53.52 -31.74 19.65 Favored 'Isoleucine or valine' 0 C--O 1.232 0.151 0 CA-C-O 121.211 0.529 . . . . 0.0 109.766 179.423 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.518 ' CE2' HD11 ' A' ' 52' ' ' ILE . 48.2 m95 -81.35 -25.6 36.23 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.814 -179.361 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -69.44 -43.52 69.07 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 178.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 17.3 m -69.15 -59.05 3.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.87 0.367 . . . . 0.0 110.115 179.298 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.422 HD23 ' HA ' ' A' ' 56' ' ' LEU . 96.9 mt -54.19 -33.84 59.11 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.208 -0.451 . . . . 0.0 109.99 179.661 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.442 ' CB ' ' O ' ' A' ' 53' ' ' TRP . 1.7 t80 -59.2 -55.32 36.38 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.751 179.528 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 4.9 t -49.53 -49.66 45.09 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.097 179.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -57.21 -48.38 78.92 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.335 179.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.407 ' O ' ' OG ' ' A' ' 64' ' ' SER . 23.5 mtm -58.17 -33.61 69.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.513 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.501 ' O ' ' OG ' ' A' ' 64' ' ' SER . . . -65.21 -43.23 95.71 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 111.197 -0.761 . . . . 0.0 111.197 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -66.41 -59.99 3.16 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.676 -0.409 . . . . 0.0 110.282 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.439 ' O ' HG23 ' A' ' 67' ' ' VAL . . . -52.48 -50.08 49.43 Favored Glycine 0 CA--C 1.522 0.507 0 N-CA-C 110.32 -1.112 . . . . 0.0 110.32 179.541 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.577 ' O ' ' CE2' ' A' ' 68' ' ' TRP . 6.2 p -45.96 -50.6 14.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.099 0.476 . . . . 0.0 110.321 179.575 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 67.2 t80 -56.48 -40.24 74.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.507 179.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 91.5 mt -65.45 -41.87 92.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.926 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.48 HG22 ' OG ' ' A' ' 130' ' ' SER . 23.4 t -56.56 -53.67 38.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.047 -179.621 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' TRP . . . . . 0.585 ' O ' ' N ' ' A' ' 73' ' ' GLY . 0.6 OUTLIER -65.27 -35.98 82.71 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 120.577 -0.449 . . . . 0.0 110.839 -179.702 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 13.4 mmmt -63.73 -25.85 68.38 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.798 -0.361 . . . . 0.0 110.677 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 23.1 tp10 -82.65 -62.34 1.63 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.471 -179.369 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.752 ' C ' HD12 ' A' ' 71' ' ' LEU . 3.8 pp -68.59 -8.55 42.85 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.834 -0.347 . . . . 0.0 111.489 -179.222 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.605 ' N ' HD12 ' A' ' 71' ' ' LEU . . . 102.1 83.61 1.74 Allowed Glycine 0 CA--C 1.528 0.891 0 C-N-CA 121.208 -0.52 . . . . 0.0 111.873 179.32 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.585 ' N ' ' O ' ' A' ' 68' ' ' TRP . . . 42.37 -174.08 0.01 OUTLIER Glycine 0 CA--C 1.525 0.683 0 N-CA-C 111.782 -0.527 . . . . 0.0 111.782 179.46 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 38.4 t80 -80.87 110.59 16.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.867 0.365 . . . . 0.0 110.663 -179.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.482 ' OG1' ' N ' ' A' ' 76' ' ' GLU . 2.8 t -142.29 -173.86 3.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.488 179.797 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.482 ' N ' ' OG1' ' A' ' 75' ' ' THR . 2.8 mp0 -47.42 -32.15 4.77 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.679 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 12.8 t0 -71.0 -28.35 64.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.977 -179.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -88.51 -22.92 23.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.8 0.333 . . . . 0.0 110.886 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -66.34 -27.72 68.1 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.723 -179.807 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 8.8 t -68.34 -47.23 37.95 Favored Pre-proline 0 CA--C 1.534 0.338 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.864 -179.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -73.95 -57.03 0.07 OUTLIER 'Trans proline' 0 N--CA 1.499 1.797 0 C-N-CA 121.165 1.243 . . . . 0.0 111.738 179.021 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.491 HD21 ' CZ2' ' A' ' 68' ' ' TRP . 7.7 mt -56.02 -51.43 67.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.543 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -60.95 -61.66 6.75 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 110.805 -0.918 . . . . 0.0 110.805 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 58.7 tp -46.96 -33.51 4.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.929 0.395 . . . . 0.0 110.269 179.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.454 ' C ' ' CD1' ' A' ' 85' ' ' TYR . 2.0 t80 -73.89 -47.27 39.23 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.703 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 1.3 m -60.82 -49.0 79.23 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.91 -0.316 . . . . 0.0 111.146 -179.49 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -69.84 -58.33 6.39 Favored Glycine 0 CA--C 1.527 0.798 0 C-N-CA 120.95 -0.643 . . . . 0.0 111.615 -179.421 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 37.7 tp60 -51.99 -46.28 64.83 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 120.728 -0.389 . . . . 0.0 110.374 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.415 ' O ' ' C ' ' A' ' 90' ' ' ALA . 25.4 tp -53.71 -65.32 0.59 Allowed 'General case' 0 C--O 1.214 -0.803 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 179.566 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.663 ' O ' ' HB2' ' A' ' 94' ' ' ALA . . . -38.58 -44.32 0.96 Allowed 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 120.533 -0.467 . . . . 0.0 111.637 -179.64 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 80.3 mt -59.57 -56.86 16.6 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 -178.529 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 8.7 m-20 -75.89 -54.37 7.01 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 121.286 0.565 . . . . 0.0 111.428 -178.588 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . 0.677 ' O ' ' N ' ' A' ' 95' ' ' TRP . 3.6 t-105 -52.5 -28.98 22.7 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.265 -0.879 . . . . 0.0 111.583 -179.665 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.663 ' HB2' ' O ' ' A' ' 90' ' ' ALA . . . -52.06 73.38 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.846 0.355 . . . . 0.0 110.727 -179.494 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.683 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 13.9 p-90 -102.32 -18.7 0.19 Allowed Pre-proline 0 CA--C 1.534 0.332 0 CA-C-N 115.991 -0.55 . . . . 0.0 112.049 -179.621 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.683 ' CD ' ' N ' ' A' ' 95' ' ' TRP . 31.6 Cg_exo -59.79 -31.08 93.47 Favored 'Trans proline' 0 N--CA 1.494 1.502 0 C-N-CA 120.353 0.702 . . . . 0.0 112.819 179.785 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.491 ' C ' ' H ' ' A' ' 99' ' ' PHE . 75.5 Cg_exo -53.36 -28.11 42.2 Favored 'Trans proline' 0 N--CA 1.492 1.436 0 C-N-CA 120.431 0.754 . . . . 0.0 112.583 179.671 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 1.2 pp -75.42 18.79 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 121.167 0.508 . . . . 0.0 110.173 179.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.491 ' H ' ' C ' ' A' ' 97' ' ' PRO . 4.5 t80 -38.98 -41.74 0.79 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.814 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -84.59 -44.49 13.46 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.829 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -59.8 -5.37 3.98 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 111.368 -0.693 . . . . 0.0 111.368 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -75.95 -13.46 60.25 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 121.016 -0.274 . . . . 0.0 110.971 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 24.2 ptt180 -80.25 3.31 21.27 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.775 0.321 . . . . 0.0 110.639 -179.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 5.2 mt-30 -120.92 160.29 23.79 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.321 179.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -49.4 -19.82 0.59 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.822 0.344 . . . . 0.0 110.205 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.538 ' O ' ' N ' ' A' ' 108' ' ' ALA . . . -65.38 -15.6 61.54 Favored Glycine 0 CA--C 1.527 0.788 0 N-CA-C 111.305 -0.718 . . . . 0.0 111.305 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' TRP . . . . . 0.49 ' CD1' ' N ' ' A' ' 108' ' ' ALA . 0.0 OUTLIER -45.29 -13.6 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.789 0.328 . . . . 0.0 110.844 -179.665 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.538 ' N ' ' O ' ' A' ' 106' ' ' GLY . . . -64.64 -21.84 66.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.511 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 12.1 mt -52.18 -27.16 13.46 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.405 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -55.84 -63.82 1.05 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.345 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.683 ' O ' HG23 ' A' ' 115' ' ' VAL . 2.0 p30 -60.37 -51.65 68.6 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.598 -179.609 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.581 ' N ' ' OD1' ' A' ' 111' ' ' ASP . 43.3 tp -52.51 -42.35 64.24 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.552 -178.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 81.5 mt -71.66 -61.93 1.6 Allowed 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.701 0.63 . . . . 0.0 112.701 -178.269 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.403 ' HB2' ' CZ3' ' A' ' 93' ' ' TRP . 1.8 pp -57.39 -35.18 69.67 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 120.117 -0.633 . . . . 0.0 111.116 -178.811 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.683 HG23 ' O ' ' A' ' 111' ' ' ASP . 54.6 t -62.13 -58.47 7.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.262 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 3.5 t -68.73 -22.37 64.33 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.79 -178.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -68.56 -62.71 3.93 Favored Glycine 0 CA--C 1.526 0.746 0 C-N-CA 121.011 -0.614 . . . . 0.0 111.745 -179.03 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.563 ' O ' HG23 ' A' ' 122' ' ' THR . 7.4 p -70.47 -37.73 71.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 C-N-CA 120.967 -0.293 . . . . 0.0 111.354 -179.421 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.515 ' O ' ' OG1' ' A' ' 123' ' ' THR . . . -66.47 -60.78 2.43 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 120.54 -0.464 . . . . 0.0 111.533 -179.21 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 5.0 m -58.38 -55.01 40.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.696 -179.202 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -52.48 -41.69 63.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.349 -179.248 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.563 HG23 ' O ' ' A' ' 118' ' ' VAL . 36.5 p -72.19 -32.59 66.94 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.823 -0.351 . . . . 0.0 111.615 -179.156 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.515 ' OG1' ' O ' ' A' ' 119' ' ' ALA . 0.2 OUTLIER -61.55 -50.16 73.79 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.908 0.385 . . . . 0.0 110.868 -179.489 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.6 pp -82.56 -20.0 37.44 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.701 -179.014 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -86.49 -70.69 0.59 Allowed 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 112.659 0.614 . . . . 0.0 112.659 -178.567 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' TRP . . . . . 0.403 ' N ' ' CD1' ' A' ' 126' ' ' TRP . 41.8 m0 -85.18 -58.8 2.54 Favored 'General case' 0 N--CA 1.465 0.325 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 -177.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . 0.433 ' CD2' ' N ' ' A' ' 127' ' ' HIS . 20.2 m170 -47.99 -21.52 0.46 Allowed 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 120.719 -0.392 . . . . 0.0 111.522 -178.546 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 29.6 ttt85 -73.1 -42.48 62.91 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.974 -0.29 . . . . 0.0 111.456 -179.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 6.3 t -92.07 -47.88 13.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.717 0.294 . . . . 0.0 111.332 -179.309 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . 0.48 ' OG ' HG22 ' A' ' 67' ' ' VAL . 46.2 p -109.59 102.77 51.11 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.817 -179.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . 0.657 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 75.7 Cg_exo -71.05 -26.26 21.77 Favored 'Trans proline' 0 C--N 1.311 -1.444 0 C-N-CA 121.733 1.622 . . . . 0.0 112.465 179.43 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . 0.657 ' CD ' ' N ' ' A' ' 131' ' ' PRO . 38.2 Cg_exo -68.62 -49.43 0.81 Allowed 'Trans proline' 0 N--CA 1.494 1.523 0 C-N-CA 121.496 1.464 . . . . 0.0 111.877 179.796 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.406 ' C ' ' N ' ' A' ' 135' ' ' ARG . . . -46.67 -49.02 19.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.191 179.774 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . 0.428 ' HB2' ' CD2' ' A' ' 127' ' ' HIS . . . -46.7 -22.35 0.29 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.031 179.628 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . 0.406 ' N ' ' C ' ' A' ' 133' ' ' ALA . 5.7 tpp85 -78.41 -39.2 39.63 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.541 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 93.1 mt -68.87 -25.94 64.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.259 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.571 ' O ' ' N ' ' A' ' 140' ' ' TYR . 3.2 mt -89.11 -41.8 12.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.935 179.477 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.516 ' C ' ' H ' ' A' ' 140' ' ' TYR . 0.7 OUTLIER -22.11 -47.68 0.06 OUTLIER Pre-proline 0 N--CA 1.464 0.261 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.782 -179.776 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.483 ' N ' ' O ' ' A' ' 137' ' ' LEU . 3.1 Cg_exo -59.66 5.57 0.12 Allowed 'Trans proline' 0 C--N 1.307 -1.621 0 C-N-CA 121.071 1.18 . . . . 0.0 112.256 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . 0.817 ' CE2' HD11 ' A' ' 144' ' ' LEU . 1.9 p90 -90.78 -15.33 30.31 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 120.705 -0.398 . . . . 0.0 110.644 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.637 HD22 ' CE1' ' A' ' 140' ' ' TYR . 2.9 mm? -54.17 -36.0 62.91 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 179.216 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -57.47 -53.98 52.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.378 179.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' TRP . . . . . 0.44 ' CE2' HD12 ' A' ' 52' ' ' ILE . 11.7 t-105 -51.06 -48.9 61.46 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 116.318 -0.401 . . . . 0.0 109.939 179.793 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.817 HD11 ' CE2' ' A' ' 140' ' ' TYR . 11.4 mt -50.09 -48.29 53.35 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 120.533 -0.467 . . . . 0.0 109.832 179.558 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.619 ' O ' HG23 ' A' ' 149' ' ' VAL . . . -65.12 -30.52 71.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.699 -179.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 21.0 t80 -58.93 -62.19 2.07 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.73 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . 0.49 ' O ' ' OD1' ' A' ' 151' ' ' ASN . . . -67.74 -50.4 57.51 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.6 -0.44 . . . . 0.0 110.648 -179.708 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . 0.401 ' OG1' ' O ' ' A' ' 144' ' ' LEU . 27.0 m -48.91 -44.61 40.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.842 -179.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.619 HG23 ' O ' ' A' ' 145' ' ' ALA . 68.7 t -69.08 -36.11 71.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.127 -179.683 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.471 ' O ' HG23 ' A' ' 154' ' ' VAL . 0.8 OUTLIER -56.24 -51.5 67.9 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.535 -0.466 . . . . 0.0 110.696 -179.334 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . 0.49 ' OD1' ' O ' ' A' ' 147' ' ' ALA . 4.6 p-10 -65.3 -48.83 71.73 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.945 -0.302 . . . . 0.0 111.055 -179.741 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 82.7 t80 -53.86 -49.17 69.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.931 -179.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . 0.56 ' CE2' ' OD2' ' A' ' 157' ' ' ASP . 79.5 t80 -57.35 -45.56 84.22 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.644 -179.719 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.471 HG23 ' O ' ' A' ' 150' ' ' LEU . 94.4 t -63.7 -33.68 63.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.096 -179.699 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' TRP . . . . . 0.551 ' C ' ' HE ' ' A' ' 156' ' ' ARG . 9.5 m0 -62.3 -49.69 74.64 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.647 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . 0.601 ' HE ' ' N ' ' A' ' 156' ' ' ARG . 0.0 OUTLIER -71.02 -32.63 69.44 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.871 -179.639 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . 0.56 ' OD2' ' CE2' ' A' ' 153' ' ' TYR . 2.6 m-20 -74.85 -47.85 28.12 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.823 -179.785 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 1.5 t30 . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.61 -179.947 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.644 ' O ' HG23 ' A' ' 9' ' ' VAL . 1.3 t-105 . . . . . 0 CA--C 1.528 0.101 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.465 ' N ' ' CD ' ' A' ' 7' ' ' PRO . 1.0 OUTLIER -59.38 -42.08 90.59 Favored Pre-proline 0 CA--C 1.537 0.464 0 C-N-CA 120.564 -0.454 . . . . 0.0 110.492 -179.439 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.465 ' CD ' ' N ' ' A' ' 6' ' ' VAL . 23.0 Cg_exo -64.9 -65.91 0.05 OUTLIER 'Trans proline' 0 N--CA 1.493 1.498 0 C-N-CA 120.909 1.072 . . . . 0.0 111.611 179.498 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.728 ' O ' HG23 ' A' ' 12' ' ' THR . . . -47.46 -37.74 12.29 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.208 -179.581 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.644 HG23 ' O ' ' A' ' 5' ' ' TRP . 42.4 t -63.12 -62.08 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 C-N-CA 121.048 -0.261 . . . . 0.0 111.404 -179.337 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -58.25 -49.85 72.0 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 110.858 -0.897 . . . . 0.0 110.858 -179.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 10.8 mp -59.08 -27.8 65.88 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.596 0.236 . . . . 0.0 110.65 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.728 HG23 ' O ' ' A' ' 8' ' ' ALA . 13.5 p -83.0 -20.73 34.54 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.783 -0.367 . . . . 0.0 110.238 179.566 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 9.3 mt -80.35 -26.42 38.7 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 179.343 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 18.9 t -54.95 -57.38 19.77 Favored Pre-proline 0 CA--C 1.533 0.305 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.033 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -55.84 -10.46 4.04 Favored 'Trans proline' 0 N--CA 1.497 1.711 0 C-N-CA 120.754 0.969 . . . . 0.0 111.651 179.503 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.488 ' N ' ' OH ' ' A' ' 57' ' ' TYR . 1.8 t -74.61 -33.63 62.63 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.19 179.708 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 32.1 mt -73.58 -39.42 64.67 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.63 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -77.04 -49.91 7.23 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 111.263 -0.735 . . . . 0.0 111.263 -179.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -62.58 -34.69 90.28 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 111.306 -0.717 . . . . 0.0 111.306 -179.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 81.8 t80 -73.36 -60.1 2.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.742 0.306 . . . . 0.0 111.102 -179.462 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 32.4 tpp -61.6 -20.9 63.84 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.74 -179.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.525 ' C ' ' CZ2' ' A' ' 95' ' ' TRP . . . -75.13 -63.76 2.45 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 111.656 -0.577 . . . . 0.0 111.656 -179.533 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.44 ' O ' HG22 ' A' ' 26' ' ' VAL . . . -66.3 -16.43 64.03 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.706 -0.397 . . . . 0.0 110.817 -179.474 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 54.2 t80 -48.67 -24.41 1.36 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.111 0.481 . . . . 0.0 110.004 179.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 55.2 t80 -70.1 -50.73 37.91 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.947 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.44 HG22 ' O ' ' A' ' 23' ' ' ALA . 22.8 m -74.6 -13.29 15.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.877 -179.664 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 8.9 ttt85 -55.7 -41.45 73.78 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.893 -179.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -122.51 -57.99 0.2 Allowed Glycine 0 CA--C 1.526 0.746 0 N-CA-C 111.444 -0.663 . . . . 0.0 111.444 -179.585 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 20.8 tp10 -56.35 -23.0 34.62 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.709 0.29 . . . . 0.0 110.796 -179.664 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -76.62 -53.69 5.34 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 111.072 -0.811 . . . . 0.0 111.072 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.414 ' N ' HD12 ' A' ' 31' ' ' LEU . 9.9 mp -56.39 -24.94 48.01 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.774 0.321 . . . . 0.0 110.424 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 71.1 ttt180 -81.55 -52.57 7.07 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.352 179.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -46.59 -36.06 6.51 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.962 179.709 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 27.1 t80 -47.81 -38.82 16.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.599 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -63.51 -24.61 67.89 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.797 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -89.32 -72.08 1.26 Allowed Glycine 0 CA--C 1.526 0.728 0 N-CA-C 110.981 -0.848 . . . . 0.0 110.981 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.573 ' O ' HD12 ' A' ' 37' ' ' LEU . 0.3 OUTLIER -95.69 167.17 11.44 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.761 0.315 . . . . 0.0 110.672 179.602 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 47.2 mm-40 -80.91 112.65 18.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.0 -179.502 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.543 ' NZ ' ' CZ3' ' A' ' 107' ' ' TRP . 12.0 mtpt -129.79 156.54 78.76 Favored Pre-proline 0 N--CA 1.463 0.213 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.214 179.535 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo . . . . . 0 C--N 1.309 -1.531 0 C-N-CA 121.578 1.518 . . . . 0.0 111.189 179.072 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.81 ' O ' HG23 ' A' ' 52' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--O 1.224 -0.241 0 N-CA-C 111.884 0.327 . . . . 0.0 111.884 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.609 ' C ' ' H ' ' A' ' 52' ' ' ILE . . . -38.74 -31.04 0.19 Allowed Pre-proline 0 C--O 1.234 0.257 0 C-N-CA 120.751 -0.38 . . . . 0.0 111.311 -179.133 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.439 ' HD2' ' N ' ' A' ' 50' ' ' ALA . 46.6 Cg_exo -54.19 5.18 0.04 OUTLIER 'Trans proline' 0 C--N 1.31 -1.471 0 CA-C-N 118.691 0.568 . . . . 0.0 112.422 178.2 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.81 HG23 ' O ' ' A' ' 49' ' ' LEU . 10.4 pt -54.29 -39.2 42.49 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.258 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 179.344 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.621 ' O ' ' CD1' ' A' ' 57' ' ' TYR . 65.7 m95 -69.32 -24.45 63.92 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.746 -179.583 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -67.83 -53.2 24.65 Favored Glycine 0 CA--C 1.527 0.836 0 N-CA-C 110.013 -1.235 . . . . 0.0 110.013 179.002 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 18.6 m -60.02 -54.73 42.56 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.623 0.249 . . . . 0.0 110.581 179.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.408 ' O ' ' SD ' ' A' ' 60' ' ' MET . 88.5 mt -55.82 -47.96 76.27 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.254 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.621 ' CD1' ' O ' ' A' ' 53' ' ' TRP . 3.6 m-30 -46.19 -47.13 17.79 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 179.31 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 7.0 t -56.77 -57.28 13.14 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.215 179.479 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -48.7 -50.06 35.1 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.183 179.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.408 ' SD ' ' O ' ' A' ' 56' ' ' LEU . 0.0 OUTLIER -52.05 -50.56 61.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.368 179.828 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -49.13 -48.96 31.46 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 111.338 -0.705 . . . . 0.0 111.338 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -62.17 -59.93 4.32 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.849 0.357 . . . . 0.0 110.85 -179.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.452 ' O ' HG23 ' A' ' 67' ' ' VAL . . . -47.47 -56.02 8.67 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 110.93 -0.868 . . . . 0.0 110.93 -179.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.588 ' O ' ' CD1' ' A' ' 68' ' ' TRP . 0.0 OUTLIER -45.64 -55.28 6.57 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.898 0.38 . . . . 0.0 110.664 -179.929 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.501 ' OH ' ' NZ ' ' A' ' 69' ' ' LYS . 69.1 t80 -49.73 -40.0 39.27 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.804 -179.674 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 77.4 mt -69.3 -54.84 17.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.257 -179.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.509 ' CG1' ' CZ3' ' A' ' 68' ' ' TRP . 18.8 t -46.16 -61.23 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.857 0.36 . . . . 0.0 111.257 -179.39 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' TRP . . . . . 0.588 ' CD1' ' O ' ' A' ' 64' ' ' SER . 0.9 OUTLIER -60.68 -42.31 96.84 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.485 -179.124 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.501 ' NZ ' ' OH ' ' A' ' 65' ' ' TYR . 5.8 mmmt -59.13 -31.92 69.39 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.979 -0.288 . . . . 0.0 111.052 -179.697 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 24.2 tp10 -74.81 -62.28 1.59 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.037 -179.366 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.739 ' C ' HD12 ' A' ' 71' ' ' LEU . 3.4 pp -64.33 -8.58 13.54 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.239 -179.344 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.655 ' N ' HD12 ' A' ' 71' ' ' LEU . . . 110.35 77.51 0.93 Allowed Glycine 0 CA--C 1.527 0.826 0 C-N-CA 121.014 -0.612 . . . . 0.0 111.98 179.359 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.511 ' N ' ' O ' ' A' ' 68' ' ' TRP . . . 41.56 -173.57 0.01 OUTLIER Glycine 0 CA--C 1.526 0.749 0 C-N-CA 121.504 -0.379 . . . . 0.0 112.165 178.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 36.0 t80 -74.48 113.05 11.27 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.382 -0.409 . . . . 0.0 110.715 -179.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.569 ' OG1' ' N ' ' A' ' 76' ' ' GLU . 0.4 OUTLIER -142.38 -175.02 4.29 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.256 179.713 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.569 ' N ' ' OG1' ' A' ' 75' ' ' THR . 2.7 mp0 -55.08 -34.22 63.45 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.916 0.389 . . . . 0.0 110.4 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -66.29 -33.06 74.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.67 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.494 ' O ' HD12 ' A' ' 82' ' ' LEU . . . -83.91 -19.09 35.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.046 0.45 . . . . 0.0 110.748 -179.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 65.0 mmm -68.93 -27.07 65.43 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.22 -179.344 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.4 ' N ' ' HD2' ' A' ' 81' ' ' PRO . 6.0 t -67.45 -43.51 42.48 Favored Pre-proline 0 C--N 1.329 -0.322 0 C-N-CA 120.673 -0.411 . . . . 0.0 110.413 179.781 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.4 ' HD2' ' N ' ' A' ' 80' ' ' VAL . 9.3 Cg_endo -76.31 -52.18 0.09 OUTLIER 'Trans proline' 0 N--CA 1.496 1.673 0 C-N-CA 121.047 1.165 . . . . 0.0 111.508 178.643 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.494 HD12 ' O ' ' A' ' 78' ' ' ALA . 5.5 mt -56.03 -47.14 78.39 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.277 179.71 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -68.28 -63.83 3.4 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 111.318 -0.713 . . . . 0.0 111.318 -179.517 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.4 HD23 ' CD1' ' A' ' 124' ' ' LEU . 38.5 tp -47.91 -23.79 0.86 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.941 0.4 . . . . 0.0 110.57 -179.708 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 11.8 t80 -74.8 -55.57 5.68 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.009 -179.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 1.9 t -68.53 -33.22 73.73 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.903 -0.319 . . . . 0.0 111.479 -179.282 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -71.6 -57.85 5.74 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 111.205 -0.758 . . . . 0.0 111.205 -179.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 29.2 tp60 -59.57 -43.85 93.49 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 11.1 tp -58.13 -38.57 76.8 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 179.241 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.816 ' O ' ' HB2' ' A' ' 94' ' ' ALA . . . -58.36 -64.48 0.9 Allowed 'General case' 0 C--N 1.319 -0.754 0 C-N-CA 120.062 -0.655 . . . . 0.0 110.435 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.476 HD23 ' N ' ' A' ' 91' ' ' LEU . 6.2 mt -58.69 -56.48 21.64 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 -178.688 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -66.43 -62.12 1.63 Allowed 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -177.755 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . 0.596 ' C ' ' CD1' ' A' ' 93' ' ' TRP . 0.0 OUTLIER -63.54 -16.89 62.05 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 -177.913 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.816 ' HB2' ' O ' ' A' ' 90' ' ' ALA . . . -54.63 82.19 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 120.286 -0.566 . . . . 0.0 109.868 179.155 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.688 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 19.8 p-90 -100.81 -15.71 0.18 Allowed Pre-proline 0 CA--C 1.533 0.307 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -179.488 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.688 ' CD ' ' N ' ' A' ' 95' ' ' TRP . 52.9 Cg_exo -61.08 -15.22 37.97 Favored 'Trans proline' 0 N--CA 1.497 1.7 0 C-N-CA 120.471 0.781 . . . . 0.0 113.403 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.614 ' CD ' ' N ' ' A' ' 96' ' ' PRO . 31.6 Cg_exo -87.08 -0.38 7.77 Favored 'Trans proline' 0 N--CA 1.5 1.867 0 C-N-CA 120.659 0.906 . . . . 0.0 112.928 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 1.3 pp -91.86 25.19 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 C-N-CA 120.73 -0.388 . . . . 0.0 110.833 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.528 ' CD1' ' O ' ' A' ' 96' ' ' PRO . 3.0 m-85 -46.8 -34.46 5.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.167 179.687 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -63.13 -27.39 69.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.786 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -95.73 -13.52 50.19 Favored Glycine 0 CA--C 1.526 0.743 0 N-CA-C 110.902 -0.879 . . . . 0.0 110.902 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -70.49 -6.73 38.2 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.613 0.244 . . . . 0.0 111.018 -179.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 15.5 ptt180 -97.97 -10.08 25.08 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.065 -179.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . 0.438 ' C ' ' N ' ' A' ' 106' ' ' GLY . 3.2 pt20 -125.49 168.94 12.93 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.832 0.348 . . . . 0.0 110.781 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 9.8 mmt -45.19 -20.2 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.679 -179.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.438 ' N ' ' C ' ' A' ' 104' ' ' GLN . . . -62.26 -15.69 51.94 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 111.102 -0.799 . . . . 0.0 111.102 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' TRP . . . . . 0.543 ' CZ3' ' NZ ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -50.2 -13.42 0.11 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.742 0.306 . . . . 0.0 110.702 -179.596 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.468 ' N ' ' CD1' ' A' ' 107' ' ' TRP . . . -64.73 -19.58 65.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.075 0.464 . . . . 0.0 110.105 179.638 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 8.2 mt -57.04 -26.04 59.64 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.531 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -59.4 -58.66 7.62 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.569 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.709 ' O ' HG23 ' A' ' 115' ' ' VAL . 1.3 p30 -62.07 -52.21 64.84 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.303 -179.617 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.524 ' N ' ' CG ' ' A' ' 111' ' ' ASP . 31.7 tp -54.95 -37.4 66.42 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.919 -0.313 . . . . 0.0 111.618 -179.099 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 49.4 mt -72.8 -61.57 1.76 Allowed 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -178.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.5 pp -59.66 -32.52 70.54 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 120.24 -0.584 . . . . 0.0 110.955 -179.047 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.709 HG23 ' O ' ' A' ' 111' ' ' ASP . 53.5 t -64.16 -60.14 3.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.405 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . 0.485 ' O ' ' OG1' ' A' ' 120' ' ' THR . 50.3 m -68.41 -28.31 66.97 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.555 -178.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -63.08 -62.24 5.63 Favored Glycine 0 CA--C 1.526 0.759 0 C-N-CA 120.973 -0.632 . . . . 0.0 111.769 -179.348 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.571 ' O ' HG23 ' A' ' 122' ' ' THR . 9.3 p -70.94 -37.99 70.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 111.667 0.247 . . . . 0.0 111.667 -179.231 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.508 ' O ' ' OG1' ' A' ' 123' ' ' THR . . . -68.25 -60.8 2.19 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.446 -0.502 . . . . 0.0 111.002 -179.404 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.485 ' OG1' ' O ' ' A' ' 116' ' ' SER . 3.7 m -56.35 -55.87 28.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.44 -179.49 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -51.58 -43.92 62.61 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.404 -179.391 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.571 HG23 ' O ' ' A' ' 118' ' ' VAL . 41.4 p -71.91 -25.25 61.84 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.054 0.39 . . . . 0.0 112.054 -178.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.508 ' OG1' ' O ' ' A' ' 119' ' ' ALA . 0.2 OUTLIER -69.28 -49.99 51.0 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.631 -0.428 . . . . 0.0 110.516 -179.636 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.4 ' CD1' HD23 ' A' ' 84' ' ' LEU . 2.4 pp -79.34 -19.94 49.05 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.246 -179.475 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -89.77 -67.37 0.85 Allowed 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.734 0.642 . . . . 0.0 112.734 -178.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' TRP . . . . . 0.458 ' N ' ' CD1' ' A' ' 126' ' ' TRP . 34.1 m0 -84.82 -57.54 3.07 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 112.87 0.693 . . . . 0.0 112.87 -177.785 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . 0.657 ' CD2' ' HB2' ' A' ' 134' ' ' ALA . 9.6 m170 -53.98 -22.29 10.08 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.731 -0.388 . . . . 0.0 111.517 -178.703 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 29.2 ttt85 -73.76 -46.47 45.5 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.822 -0.351 . . . . 0.0 111.416 -179.474 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 39.1 t -81.36 -40.62 18.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.73 0.3 . . . . 0.0 111.313 -179.229 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 3.6 t -138.38 121.66 11.15 Favored Pre-proline 0 CA--C 1.536 0.428 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.541 -179.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . 0.612 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 83.4 Cg_exo -73.61 -48.35 0.25 Allowed 'Trans proline' 0 N--CA 1.493 1.488 0 C-N-CA 121.32 1.347 . . . . 0.0 113.212 179.529 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . 0.612 ' CD ' ' N ' ' A' ' 131' ' ' PRO . 31.2 Cg_exo -33.63 -55.97 0.41 Allowed 'Trans proline' 0 N--CA 1.497 1.73 0 C-N-CA 121.583 1.522 . . . . 0.0 112.177 -179.222 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -47.48 -46.69 27.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.862 0.363 . . . . 0.0 110.384 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . 0.657 ' HB2' ' CD2' ' A' ' 127' ' ' HIS . . . -55.21 -22.72 18.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.406 179.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 10.2 tpt180 -77.28 -29.63 53.88 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-O 120.937 0.399 . . . . 0.0 110.342 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 39.4 mt -75.92 -33.97 59.88 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 179.604 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.461 ' O ' ' CD1' ' A' ' 140' ' ' TYR . 4.3 mt -85.56 -23.31 27.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.341 179.778 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.551 ' C ' ' CD1' ' A' ' 138' ' ' TYR . 0.3 OUTLIER -36.65 -53.9 1.74 Allowed Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.323 -179.881 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.429 ' HD2' ' N ' ' A' ' 138' ' ' TYR . 8.2 Cg_endo -60.79 3.41 0.29 Allowed 'Trans proline' 0 N--CA 1.498 1.755 0 C-N-CA 121.481 1.454 . . . . 0.0 113.057 -179.415 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . 0.496 ' CE2' HD11 ' A' ' 144' ' ' LEU . 0.1 OUTLIER -82.79 -14.3 54.67 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.489 -0.484 . . . . 0.0 110.954 -179.96 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 86.8 mt -59.14 -25.25 63.72 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 178.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -64.13 -39.84 94.89 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.631 179.224 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' TRP . . . . . 0.714 ' CE2' HD12 ' A' ' 52' ' ' ILE . 11.6 t-105 -70.08 -40.78 74.81 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.723 179.441 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.531 HD13 HG13 ' A' ' 115' ' ' VAL . 10.3 mt -62.48 -42.02 99.2 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 120.403 -0.519 . . . . 0.0 109.712 179.739 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.68 ' O ' HG23 ' A' ' 149' ' ' VAL . . . -73.03 -21.91 60.73 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.776 179.268 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 32.2 t80 -64.85 -58.58 5.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.481 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . 0.558 ' O ' ' ND2' ' A' ' 151' ' ' ASN . . . -68.5 -44.15 75.34 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.567 179.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . 0.478 ' O ' ' OD1' ' A' ' 151' ' ' ASN . 51.3 m -57.27 -37.3 72.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.411 179.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.68 HG23 ' O ' ' A' ' 145' ' ' ALA . 55.0 t -75.8 -30.2 21.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.416 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 2.3 tp -61.39 -57.49 12.04 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 179.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . 0.558 ' ND2' ' O ' ' A' ' 147' ' ' ALA . 1.8 p30 -63.81 -42.36 97.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.632 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 60.8 t80 -56.65 -45.86 81.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.552 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 9.5 t80 -63.18 -36.72 84.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.477 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 55.5 t -67.36 -34.0 66.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.632 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' TRP . . . . . . . . . . . . . 10.9 m0 -68.7 -41.12 79.57 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.791 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -72.63 -35.61 67.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.865 -179.659 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -75.18 -43.03 54.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.878 -179.571 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' ASN . . . . . 0.402 ' OD1' ' N ' ' A' ' 158' ' ' ASN . 1.5 m-20 . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.872 -179.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.724 ' O ' HG23 ' A' ' 9' ' ' VAL . 0.5 OUTLIER . . . . . 0 CA--C 1.53 0.192 0 CA-C-O 120.651 0.262 . . . . 0.0 110.301 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.619 ' N ' ' CD ' ' A' ' 7' ' ' PRO . 1.0 OUTLIER -63.68 -38.71 40.53 Favored Pre-proline 0 CA--C 1.533 0.289 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 179.927 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.619 ' CD ' ' N ' ' A' ' 6' ' ' VAL . 15.4 Cg_exo -66.9 -66.18 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 121.891 1.727 . . . . 0.0 111.735 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.721 ' O ' HG23 ' A' ' 12' ' ' THR . . . -47.65 -40.63 20.28 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.173 -179.76 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.724 HG23 ' O ' ' A' ' 5' ' ' TRP . 59.2 t -61.11 -61.86 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.238 -179.354 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -57.88 -51.75 56.34 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 111.495 -0.642 . . . . 0.0 111.495 -179.55 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 9.4 mp -57.78 -31.81 66.91 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.572 0.225 . . . . 0.0 110.96 -179.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.721 HG23 ' O ' ' A' ' 8' ' ' ALA . 16.8 p -77.33 -24.81 50.75 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.862 0.363 . . . . 0.0 110.121 179.639 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.427 ' O ' ' CB ' ' A' ' 16' ' ' SER . 6.2 mt -80.12 -27.32 39.17 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.363 179.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 4.5 t -48.55 -59.64 5.81 Favored Pre-proline 0 CA--C 1.535 0.38 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.718 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -54.98 -12.38 4.85 Favored 'Trans proline' 0 N--CA 1.498 1.746 0 C-N-CA 121.056 1.171 . . . . 0.0 111.96 179.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.427 ' CB ' ' O ' ' A' ' 13' ' ' LEU . 1.6 t -73.5 -30.49 63.16 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.66 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 59.5 mt -74.3 -56.73 4.54 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.664 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -64.83 -34.3 89.52 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 110.802 -0.919 . . . . 0.0 110.802 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -74.88 -28.51 62.59 Favored Glycine 0 CA--C 1.521 0.433 0 N-CA-C 110.614 -0.994 . . . . 0.0 110.614 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 48.8 t80 -74.99 -60.43 2.29 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 110.177 -0.305 . . . . 0.0 110.177 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 19.2 ttp -65.53 -25.1 67.29 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.397 179.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.471 ' C ' ' CZ2' ' A' ' 95' ' ' TRP . . . -68.2 -62.13 4.39 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 110.819 -0.912 . . . . 0.0 110.819 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.482 ' O ' HG22 ' A' ' 26' ' ' VAL . . . -70.62 -16.62 62.85 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.993 -0.283 . . . . 0.0 110.397 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 68.5 t80 -47.81 -24.49 0.99 Allowed 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 179.403 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.451 ' CD1' ' C ' ' A' ' 25' ' ' PHE . 22.8 t80 -67.99 -53.57 25.01 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.667 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.482 HG22 ' O ' ' A' ' 23' ' ' ALA . 34.1 m -71.43 -13.46 16.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.702 -179.736 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.424 HH21 ' HA3' ' A' ' 28' ' ' GLY . 1.3 ttp180 -63.31 -46.16 87.97 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.992 -179.758 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.424 ' HA3' HH21 ' A' ' 27' ' ' ARG . . . -105.42 -77.99 1.17 Allowed Glycine 0 CA--C 1.525 0.696 0 N-CA-C 111.197 -0.761 . . . . 0.0 111.197 -179.676 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 53.3 tt0 -44.42 -23.08 0.09 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.698 0.285 . . . . 0.0 110.808 -179.628 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -66.51 -58.49 8.48 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 110.989 -0.845 . . . . 0.0 110.989 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 11.1 mt -51.99 -21.74 3.36 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.836 0.35 . . . . 0.0 110.365 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 16.2 tpp180 -84.79 -54.03 4.95 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.524 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . 0.428 ' O ' ' N ' ' A' ' 36' ' ' GLY . 0.4 OUTLIER -44.95 -46.77 11.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.551 -179.756 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 46.5 t80 -47.23 -35.58 7.82 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.9 0.381 . . . . 0.0 110.373 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.61 -25.33 68.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.354 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.428 ' N ' ' O ' ' A' ' 33' ' ' TRP . . . -92.72 -68.74 1.12 Allowed Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.892 -0.883 . . . . 0.0 110.892 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.575 ' O ' HD12 ' A' ' 37' ' ' LEU . 0.3 OUTLIER -95.75 166.18 11.94 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.793 0.33 . . . . 0.0 110.583 179.712 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.624 ' H ' ' CD ' ' A' ' 38' ' ' GLN . 0.5 OUTLIER -86.63 113.0 22.15 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.861 -179.578 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.638 ' NZ ' ' CZ3' ' A' ' 107' ' ' TRP . 22.1 mtpt -129.13 156.71 77.79 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.197 179.812 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo . . . . . 0 C--N 1.307 -1.654 0 C-N-CA 121.814 1.676 . . . . 0.0 110.803 178.822 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.749 ' O ' HG23 ' A' ' 52' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.466 0.372 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.646 ' C ' ' H ' ' A' ' 52' ' ' ILE . . . -37.83 -31.0 0.15 Allowed Pre-proline 0 C--O 1.237 0.402 0 C-N-CA 121.113 -0.235 . . . . 0.0 111.218 -179.04 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.433 ' HD2' ' N ' ' A' ' 50' ' ' ALA . 32.9 Cg_exo -55.62 8.99 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.659 0 CA-C-N 118.425 0.473 . . . . 0.0 112.204 178.11 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.749 HG23 ' O ' ' A' ' 49' ' ' LEU . 12.1 pt -55.71 -27.36 21.73 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 178.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 3.2 m0 -64.62 -30.02 71.03 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.783 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -72.98 -46.93 26.72 Favored Glycine 0 CA--C 1.522 0.519 0 N-CA-C 111.027 -0.829 . . . . 0.0 111.027 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 91.2 m -61.53 -53.37 57.28 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.74 0.305 . . . . 0.0 110.59 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 57.5 mt -64.91 -28.68 69.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.506 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.528 ' C ' ' CD1' ' A' ' 57' ' ' TYR . 1.6 t80 -63.6 -41.62 98.32 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 179.455 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 26.1 t -68.02 -49.43 61.55 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.42 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.67 -46.07 88.02 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.758 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.498 ' HG2' HD21 ' A' ' 137' ' ' LEU . 21.3 mtm -65.45 -33.14 75.25 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.31 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -63.35 -49.68 68.49 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 111.324 -0.71 . . . . 0.0 111.324 -179.663 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -63.15 -60.06 3.93 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 121.07 -0.252 . . . . 0.0 110.739 -179.652 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.484 ' O ' HG23 ' A' ' 67' ' ' VAL . . . -52.58 -52.08 39.94 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 110.811 -0.916 . . . . 0.0 110.811 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.442 ' OG ' ' O ' ' A' ' 60' ' ' MET . 34.2 p -48.14 -56.64 7.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.087 0.47 . . . . 0.0 110.831 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 68.0 t80 -51.38 -37.4 48.0 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.196 -179.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 56.6 mt -71.44 -37.09 63.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.165 -179.548 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.484 HG23 ' O ' ' A' ' 63' ' ' GLY . 49.1 t -59.48 -52.09 65.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 C-N-CA 120.735 -0.386 . . . . 0.0 110.598 -179.694 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' TRP . . . . . 0.59 ' O ' ' N ' ' A' ' 73' ' ' GLY . 0.9 OUTLIER -64.7 -44.72 89.36 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.859 -179.878 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.25 -23.08 63.81 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.862 -0.335 . . . . 0.0 110.725 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -79.67 -62.81 1.57 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.667 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.73 ' C ' HD12 ' A' ' 71' ' ' LEU . 2.8 pp -65.67 -6.8 12.45 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.161 -179.661 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.684 ' N ' HD12 ' A' ' 71' ' ' LEU . . . 109.69 72.09 0.7 Allowed Glycine 0 CA--C 1.527 0.822 0 N-CA-C 111.511 -0.636 . . . . 0.0 111.511 179.7 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.59 ' N ' ' O ' ' A' ' 68' ' ' TRP . . . 46.58 -174.15 0.01 OUTLIER Glycine 0 CA--C 1.526 0.768 0 N-CA-C 111.761 -0.536 . . . . 0.0 111.761 179.532 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 41.2 t80 -77.28 111.99 13.52 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.884 0.373 . . . . 0.0 111.03 -179.584 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.547 ' OG1' ' N ' ' A' ' 76' ' ' GLU . 0.0 OUTLIER -142.54 -179.99 6.63 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.254 179.468 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.547 ' N ' ' OG1' ' A' ' 75' ' ' THR . 7.4 pt-20 -51.57 -23.53 4.29 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.401 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -72.9 -36.95 67.41 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.757 -179.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.44 ' O ' HD12 ' A' ' 82' ' ' LEU . . . -81.63 -22.1 37.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.975 0.417 . . . . 0.0 110.824 -179.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 73.0 mmm -61.56 -26.07 67.72 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.177 -179.468 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 14.8 t -68.09 -46.36 41.09 Favored Pre-proline 0 CA--C 1.534 0.338 0 C-N-CA 120.511 -0.476 . . . . 0.0 110.619 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_endo -74.66 -54.76 0.09 OUTLIER 'Trans proline' 0 N--CA 1.497 1.717 0 C-N-CA 120.953 1.102 . . . . 0.0 111.517 178.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.44 HD12 ' O ' ' A' ' 78' ' ' ALA . 3.2 mt -50.99 -55.25 18.26 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.534 179.685 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.455 ' O ' ' N ' ' A' ' 86' ' ' THR . . . -64.51 -63.87 3.98 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 111.488 -0.645 . . . . 0.0 111.488 -179.157 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.4 HD12 ' HA ' ' A' ' 84' ' ' LEU . 43.2 tp -43.91 -29.71 0.6 Allowed 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.664 -0.415 . . . . 0.0 109.92 -179.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 13.3 t80 -75.4 -42.83 52.87 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.843 179.518 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.455 ' N ' ' O ' ' A' ' 83' ' ' GLY . 1.4 m -66.86 -56.65 9.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.799 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -58.92 -55.36 31.33 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 111.401 -0.679 . . . . 0.0 111.401 -179.628 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.424 ' O ' ' CB ' ' A' ' 92' ' ' ASN . 9.6 tp-100 -55.47 -42.87 74.91 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 121.001 -0.28 . . . . 0.0 110.89 -179.572 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.42 ' O ' ' CD1' ' A' ' 93' ' ' TRP . 10.4 tp -66.04 -31.38 72.24 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.903 -0.319 . . . . 0.0 110.383 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.834 ' O ' ' HB2' ' A' ' 94' ' ' ALA . . . -65.87 -65.83 0.63 Allowed 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 120.314 -0.554 . . . . 0.0 111.182 -179.561 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.4 pp -66.0 -34.35 77.88 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.157 0.428 . . . . 0.0 112.157 -179.001 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.424 ' CB ' ' O ' ' A' ' 88' ' ' GLN . 47.5 t30 -78.39 -61.34 2.04 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.862 -0.335 . . . . 0.0 111.826 -178.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . 0.613 ' O ' ' N ' ' A' ' 95' ' ' TRP . 0.0 OUTLIER -68.96 -13.32 62.37 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.906 -0.318 . . . . 0.0 111.527 -178.543 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.834 ' HB2' ' O ' ' A' ' 90' ' ' ALA . . . -52.77 80.76 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 120.663 -0.415 . . . . 0.0 109.913 179.38 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.706 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 32.8 p-90 -98.18 -16.95 0.2 Allowed Pre-proline 0 CA--C 1.535 0.39 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -179.389 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.706 ' CD ' ' N ' ' A' ' 95' ' ' TRP . 51.4 Cg_exo -54.51 -40.86 81.69 Favored 'Trans proline' 0 N--CA 1.496 1.632 0 C-N-CA 120.537 0.825 . . . . 0.0 113.03 179.562 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.459 ' HD2' ' N ' ' A' ' 96' ' ' PRO . 41.9 Cg_exo -36.69 -31.31 0.1 Allowed 'Trans proline' 0 N--CA 1.492 1.41 0 CA-C-N 118.98 0.671 . . . . 0.0 112.777 -179.776 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.45 ' N ' ' O ' ' A' ' 96' ' ' PRO . 1.1 pp -83.63 22.19 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.427 179.797 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.581 ' N ' ' O ' ' A' ' 96' ' ' PRO . 22.3 t80 -44.71 -41.63 6.96 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.463 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 48.9 m-85 -83.89 -40.92 18.0 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.529 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -58.0 -14.1 16.24 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 111.006 -0.838 . . . . 0.0 111.006 -179.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -65.05 -7.26 11.22 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.801 0.334 . . . . 0.0 110.472 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 15.3 ptt180 -82.14 4.78 21.9 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.602 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 5.6 mt-30 -122.41 164.92 17.16 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.247 179.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -59.94 -17.06 34.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.328 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.608 ' O ' ' N ' ' A' ' 108' ' ' ALA . . . -66.62 -14.62 62.88 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 111.203 -0.759 . . . . 0.0 111.203 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' TRP . . . . . 0.638 ' CZ3' ' NZ ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -41.25 -15.37 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.716 0.294 . . . . 0.0 111.031 -179.366 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.608 ' N ' ' O ' ' A' ' 106' ' ' GLY . . . -58.77 -27.2 64.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.935 0.398 . . . . 0.0 110.435 179.72 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 9.3 mt -46.46 -29.01 1.55 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.444 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -60.22 -63.63 1.23 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.759 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.674 ' O ' HG23 ' A' ' 115' ' ' VAL . 1.4 p30 -55.07 -51.88 64.97 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.781 -179.269 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.613 HD13 ' O ' ' A' ' 112' ' ' LEU . 0.2 OUTLIER -58.52 -45.11 89.49 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.103 0.409 . . . . 0.0 112.103 -178.539 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 57.2 mt -64.74 -55.27 20.91 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -178.202 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.3 pp -68.06 -33.55 74.78 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 120.455 -0.498 . . . . 0.0 111.703 -178.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.674 HG23 ' O ' ' A' ' 111' ' ' ASP . 38.7 t -62.22 -54.37 35.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.736 0.303 . . . . 0.0 111.186 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . 0.483 ' O ' ' OG1' ' A' ' 120' ' ' THR . 39.0 t -75.3 -23.93 57.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.093 -179.353 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -62.74 -62.46 5.51 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 111.186 -0.765 . . . . 0.0 111.186 -179.727 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.562 ' O ' HG23 ' A' ' 122' ' ' THR . 7.3 p -71.93 -37.92 62.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 111.57 0.211 . . . . 0.0 111.57 -179.547 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.518 ' O ' ' OG1' ' A' ' 123' ' ' THR . . . -68.41 -61.0 2.03 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.281 -0.568 . . . . 0.0 111.075 -179.234 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.483 ' OG1' ' O ' ' A' ' 116' ' ' SER . 2.7 m -56.7 -53.33 58.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.257 -179.541 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.41 ' O ' ' CB ' ' A' ' 125' ' ' ALA . . . -54.36 -40.84 68.47 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.455 -179.256 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.562 HG23 ' O ' ' A' ' 118' ' ' VAL . 37.6 p -74.88 -29.17 60.92 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 111.872 0.323 . . . . 0.0 111.872 -179.034 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.518 ' OG1' ' O ' ' A' ' 119' ' ' ALA . 0.1 OUTLIER -65.71 -47.59 74.85 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.594 -0.442 . . . . 0.0 110.683 -179.639 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.4 pp -83.98 -19.4 34.64 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.373 -179.15 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.41 ' CB ' ' O ' ' A' ' 121' ' ' ALA . . . -89.74 -67.55 0.84 Allowed 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.497 0.555 . . . . 0.0 112.497 -178.589 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' TRP . . . . . 0.433 ' N ' ' CD1' ' A' ' 126' ' ' TRP . 39.3 m0 -84.36 -57.66 3.07 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 112.662 0.616 . . . . 0.0 112.662 -177.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . 0.57 ' CG ' ' HB2' ' A' ' 134' ' ' ALA . 9.3 m170 -54.51 -22.48 13.06 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.865 -0.334 . . . . 0.0 111.115 -178.702 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 22.4 ttt180 -68.44 -38.97 81.65 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.755 0.312 . . . . 0.0 110.994 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 25.9 t -92.67 -47.89 13.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.31 -179.388 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -125.57 117.33 24.75 Favored Pre-proline 0 CA--C 1.535 0.374 0 CA-C-N 116.575 -0.284 . . . . 0.0 111.048 -179.385 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . 0.647 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 88.4 Cg_exo -75.03 -38.43 1.58 Allowed 'Trans proline' 0 N--CA 1.492 1.424 0 C-N-CA 121.454 1.436 . . . . 0.0 112.646 179.074 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . 0.647 ' CD ' ' N ' ' A' ' 131' ' ' PRO . 37.9 Cg_exo -46.98 -46.24 19.22 Favored 'Trans proline' 0 N--CA 1.497 1.688 0 C-N-CA 121.646 1.564 . . . . 0.0 111.983 -179.699 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -57.15 -38.22 73.21 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 179.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . 0.57 ' HB2' ' CG ' ' A' ' 127' ' ' HIS . . . -62.69 -23.07 66.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.196 179.763 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 9.3 tpp180 -78.5 -37.3 43.51 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.234 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 12.6 mt -69.61 -29.52 67.04 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.241 -0.436 . . . . 0.0 109.867 179.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.583 ' O ' ' N ' ' A' ' 140' ' ' TYR . 8.2 mt -84.14 -42.39 16.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.025 179.489 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.491 ' C ' ' O ' ' A' ' 137' ' ' LEU . 1.9 t80 -23.15 -41.39 0.04 OUTLIER Pre-proline 0 N--CA 1.464 0.252 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.753 -179.686 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.574 ' N ' ' O ' ' A' ' 137' ' ' LEU . 12.3 Cg_exo -64.37 7.29 0.24 Allowed 'Trans proline' 0 C--N 1.307 -1.643 0 C-N-CA 120.699 0.933 . . . . 0.0 112.0 179.45 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . 0.747 ' CE2' HD11 ' A' ' 144' ' ' LEU . 1.9 p90 -93.13 -13.67 28.19 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.903 -179.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.587 HD13 HD12 ' A' ' 144' ' ' LEU . 4.1 mm? -55.94 -26.63 48.74 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 178.299 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -64.28 -49.14 73.0 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.833 179.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' TRP . . . . . . . . . . . . . 10.7 t-105 -56.91 -45.84 82.39 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.103 -0.498 . . . . 0.0 109.659 179.375 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.747 HD11 ' CE2' ' A' ' 140' ' ' TYR . 11.5 mt -54.63 -51.15 66.29 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.199 -0.455 . . . . 0.0 109.962 179.504 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.646 ' O ' HG23 ' A' ' 149' ' ' VAL . . . -63.72 -22.16 66.77 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.413 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -67.25 -64.82 0.78 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.61 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -63.94 -41.9 97.48 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.615 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 59.9 m -57.16 -58.68 7.14 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.499 179.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.646 HG23 ' O ' ' A' ' 145' ' ' ALA . 89.5 t -55.61 -39.49 54.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.708 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.464 ' O ' HG23 ' A' ' 154' ' ' VAL . 1.6 tp -50.84 -57.49 8.31 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.696 -0.402 . . . . 0.0 110.069 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . 0.586 HD22 ' HE1' ' A' ' 107' ' ' TRP . 2.9 t-20 -53.7 -57.02 12.32 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.706 179.73 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . 0.467 ' CZ ' ' NE ' ' A' ' 156' ' ' ARG . 46.5 t80 -48.53 -36.14 14.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.519 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . 0.49 ' CE2' ' OD2' ' A' ' 157' ' ' ASP . 8.8 t80 -65.96 -39.52 90.51 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.688 -179.799 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.493 HG22 ' HG2' ' A' ' 39' ' ' LYS . 15.7 t -66.21 -38.02 81.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.002 -179.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' TRP . . . . . . . . . . . . . 7.9 m0 -68.17 -39.15 82.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.964 -179.579 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . 0.467 ' NE ' ' CZ ' ' A' ' 152' ' ' TYR . 0.9 OUTLIER -77.15 -24.04 51.59 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.808 -0.357 . . . . 0.0 110.071 179.999 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . 0.49 ' OD2' ' CE2' ' A' ' 153' ' ' TYR . 98.2 m-20 -86.9 -51.08 6.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.661 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' ASN . . . . . 0.505 ' C ' HD22 ' A' ' 158' ' ' ASN . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.831 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.595 ' CD1' ' CE2' ' A' ' 68' ' ' TRP . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.746 0.307 . . . . 0.0 110.238 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.62 ' N ' ' CD ' ' A' ' 7' ' ' PRO . 1.0 OUTLIER -64.2 -33.88 10.33 Favored Pre-proline 0 C--N 1.329 -0.309 0 N-CA-C 109.916 -0.402 . . . . 0.0 109.916 179.942 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.62 ' CD ' ' N ' ' A' ' 6' ' ' VAL . 21.3 Cg_exo -71.61 -67.51 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.626 0 C-N-CA 121.709 1.606 . . . . 0.0 111.899 179.63 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.666 ' O ' HG23 ' A' ' 12' ' ' THR . . . -48.31 -39.16 20.92 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.19 -179.513 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.582 HG23 ' O ' ' A' ' 5' ' ' TRP . 95.9 t -69.98 -62.48 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -179.049 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -55.32 -47.34 75.81 Favored Glycine 0 CA--C 1.526 0.764 0 C-N-CA 121.207 -0.52 . . . . 0.0 111.834 -179.108 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.411 ' N ' ' CD1' ' A' ' 11' ' ' LEU . 6.8 mp -62.5 -38.47 90.05 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.485 0.183 . . . . 0.0 110.805 -179.584 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.666 HG23 ' O ' ' A' ' 8' ' ' ALA . 22.3 p -73.34 -23.53 60.24 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.801 -0.36 . . . . 0.0 110.871 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.55 HD13 ' O ' ' A' ' 9' ' ' VAL . 7.0 mp -82.97 -24.88 32.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.297 -179.749 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.427 ' N ' ' HD2' ' A' ' 15' ' ' PRO . 2.7 t -50.02 -63.16 1.92 Allowed Pre-proline 0 CA--C 1.536 0.442 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.723 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.427 ' HD2' ' N ' ' A' ' 14' ' ' VAL . 24.5 Cg_endo -53.78 -40.08 81.48 Favored 'Trans proline' 0 N--CA 1.498 1.788 0 C-N-CA 120.876 1.05 . . . . 0.0 112.366 -179.462 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.1 t -46.19 -25.68 0.65 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.811 0.338 . . . . 0.0 110.664 -179.717 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 83.1 mt -70.03 -57.94 4.4 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.726 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -68.35 -20.71 73.67 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 111.163 -0.775 . . . . 0.0 111.163 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -72.92 -45.53 32.78 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 37.7 t80 -69.89 -57.63 4.82 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.79 0.329 . . . . 0.0 110.707 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -66.83 -21.55 66.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.07 -179.743 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -77.5 -63.5 2.22 Favored Glycine 0 CA--C 1.524 0.608 0 C-N-CA 120.842 -0.694 . . . . 0.0 111.572 -179.504 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.541 ' O ' HG22 ' A' ' 26' ' ' VAL . . . -64.15 -20.98 66.37 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.671 -0.412 . . . . 0.0 110.245 -179.618 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.461 ' CD1' ' C ' ' A' ' 24' ' ' TYR . 11.0 t80 -48.77 -23.7 1.15 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.278 -0.419 . . . . 0.0 109.912 179.357 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.493 ' CE2' ' HB1' ' A' ' 102' ' ' ALA . 83.3 t80 -70.78 -52.63 19.44 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.765 -179.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.541 HG22 ' O ' ' A' ' 23' ' ' ALA . 35.3 m -66.53 -17.21 22.16 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 C-N-CA 120.535 -0.466 . . . . 0.0 110.41 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.9 tmt_? -58.08 -43.41 87.0 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.854 0.359 . . . . 0.0 110.32 179.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -101.41 -46.9 1.61 Allowed Glycine 0 CA--C 1.526 0.738 0 N-CA-C 110.957 -0.857 . . . . 0.0 110.957 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -59.91 -38.59 82.75 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.759 0.314 . . . . 0.0 110.64 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -58.68 -44.93 95.4 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.857 -0.897 . . . . 0.0 110.857 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 81.0 mt -58.47 -31.95 68.3 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.944 -0.302 . . . . 0.0 110.392 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.443 ' O ' ' HB3' ' A' ' 35' ' ' ALA . 14.6 mmm180 -76.68 -50.03 14.69 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.464 179.793 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 13.0 m0 -44.84 -48.14 11.05 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.289 -0.414 . . . . 0.0 109.998 179.489 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.452 ' O ' ' CD1' ' A' ' 34' ' ' TYR . 26.3 t80 -50.62 -27.05 6.14 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.751 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.443 ' HB3' ' O ' ' A' ' 32' ' ' ARG . . . -65.95 -45.83 80.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.763 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -91.87 -69.67 1.16 Allowed Glycine 0 CA--C 1.524 0.601 0 N-CA-C 110.992 -0.843 . . . . 0.0 110.992 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.761 ' C ' HD12 ' A' ' 37' ' ' LEU . 3.9 pp -87.66 162.78 16.91 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.677 0.275 . . . . 0.0 110.359 179.722 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 29.5 mt-30 -97.32 123.23 41.07 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.71 -179.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 13.9 mtpp -90.41 163.23 31.8 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.21 179.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_exo . . . . . 0 C--N 1.307 -1.628 0 C-N-CA 122.153 1.902 . . . . 0.0 112.198 -179.709 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.759 ' O ' HG23 ' A' ' 52' ' ' ILE . 0.2 OUTLIER . . . . . 0 CA--C 1.535 0.388 0 N-CA-C 112.411 0.523 . . . . 0.0 112.411 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.62 ' C ' ' H ' ' A' ' 52' ' ' ILE . . . -39.91 -31.63 0.26 Allowed Pre-proline 0 CA--C 1.534 0.344 0 N-CA-C 111.952 0.353 . . . . 0.0 111.952 -179.085 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.418 ' HD2' ' N ' ' A' ' 50' ' ' ALA . 28.2 Cg_exo -52.87 6.37 0.03 OUTLIER 'Trans proline' 0 C--N 1.311 -1.417 0 CA-C-N 118.928 0.653 . . . . 0.0 112.984 178.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.759 HG23 ' O ' ' A' ' 49' ' ' LEU . 10.9 pt -55.59 -28.5 23.15 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.178 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 179.04 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.462 ' CH2' ' HB1' ' A' ' 50' ' ' ALA . 3.0 m0 -67.68 -28.53 67.77 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.484 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -69.41 -60.94 4.76 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 111.464 -0.654 . . . . 0.0 111.464 -179.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.618 HG23 ' N ' ' A' ' 56' ' ' LEU . 7.3 t -57.56 -53.37 58.93 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.897 -0.321 . . . . 0.0 111.125 -179.343 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.618 ' N ' HG23 ' A' ' 55' ' ' THR . 73.2 mt -58.24 -39.41 79.04 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.524 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.414 ' CB ' ' O ' ' A' ' 53' ' ' TRP . 6.1 t80 -54.79 -57.89 9.73 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 179.747 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 7.1 t -48.63 -50.39 33.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.552 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -57.18 -42.55 81.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.606 -179.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 14.6 mtt -63.0 -55.09 28.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.525 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -44.73 -47.44 9.15 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 111.16 -0.776 . . . . 0.0 111.16 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -61.17 -49.37 77.47 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.845 0.355 . . . . 0.0 110.279 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.471 ' O ' HG23 ' A' ' 67' ' ' VAL . . . -54.87 -45.06 81.59 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 110.187 -1.165 . . . . 0.0 110.187 179.575 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.592 ' O ' ' NE1' ' A' ' 68' ' ' TRP . 0.7 OUTLIER -60.52 -42.35 96.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.906 0.384 . . . . 0.0 110.221 179.642 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.426 ' OH ' ' NZ ' ' A' ' 69' ' ' LYS . 87.3 t80 -53.11 -43.47 66.88 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 179.361 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 79.4 mt -72.15 -25.81 24.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.024 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.552 HG22 ' OG ' ' A' ' 130' ' ' SER . 55.1 t -66.15 -60.05 3.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 C-N-CA 120.664 -0.414 . . . . 0.0 111.333 -179.522 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' TRP . . . . . 0.595 ' CE2' ' CD1' ' A' ' 5' ' ' TRP . 0.0 OUTLIER -70.37 -29.39 66.04 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 119.974 -0.69 . . . . 0.0 110.725 -179.601 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.426 ' NZ ' ' OH ' ' A' ' 65' ' ' TYR . 10.8 mmmt -72.79 -26.55 61.56 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.336 -0.546 . . . . 0.0 110.616 179.825 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -78.42 -60.98 2.16 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.85 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.7 pp -70.38 -19.17 63.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.087 -179.482 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.502 ' O ' ' O ' ' A' ' 73' ' ' GLY . . . 110.24 95.43 2.33 Favored Glycine 0 CA--C 1.53 0.985 0 C-N-CA 121.257 -0.496 . . . . 0.0 112.043 179.218 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.594 ' N ' ' O ' ' A' ' 68' ' ' TRP . . . 41.51 -174.33 0.01 OUTLIER Glycine 0 CA--C 1.525 0.691 0 N-CA-C 111.944 -0.462 . . . . 0.0 111.944 178.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 49.3 t80 -79.78 111.05 15.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.675 0.274 . . . . 0.0 110.408 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.427 ' OG1' ' N ' ' A' ' 76' ' ' GLU . 2.1 t -139.35 177.31 8.01 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 120.993 0.425 . . . . 0.0 110.949 -179.641 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.5 ' H ' ' CD ' ' A' ' 76' ' ' GLU . 2.3 mp0 -50.05 -40.84 46.41 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.795 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 27.7 m-20 -62.39 -22.03 65.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.505 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -93.64 -24.82 17.75 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.663 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 13.2 mtp -69.14 -29.57 67.63 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.535 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.406 ' O ' ' CB ' ' A' ' 84' ' ' LEU . 6.5 t -65.56 -45.74 68.11 Favored Pre-proline 0 CA--C 1.535 0.372 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.505 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -76.33 -63.87 0.03 OUTLIER 'Trans proline' 0 N--CA 1.498 1.749 0 C-N-CA 120.903 1.069 . . . . 0.0 111.563 178.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 4.2 mt -47.19 -46.73 24.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.439 179.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.499 ' O ' ' N ' ' A' ' 86' ' ' THR . . . -68.38 -64.13 3.25 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 111.015 -0.834 . . . . 0.0 111.015 -179.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.406 ' CB ' ' O ' ' A' ' 80' ' ' VAL . 65.3 tp -41.9 -28.18 0.15 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.03 0.443 . . . . 0.0 109.88 179.751 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.465 ' CD1' ' C ' ' A' ' 85' ' ' TYR . 0.6 OUTLIER -76.85 -43.6 35.54 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.029 179.663 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.499 ' N ' ' O ' ' A' ' 83' ' ' GLY . 0.3 OUTLIER -61.56 -43.95 97.92 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.164 -179.57 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -73.62 -58.17 4.65 Favored Glycine 0 CA--C 1.527 0.808 0 C-N-CA 120.9 -0.667 . . . . 0.0 111.466 -179.455 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -51.14 -48.61 61.77 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-O 121.052 0.453 . . . . 0.0 109.943 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.455 HD22 ' CZ ' ' A' ' 85' ' ' TYR . 23.3 tp -54.85 -63.39 1.17 Allowed 'General case' 0 C--O 1.211 -0.927 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.814 179.593 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.588 ' O ' ' HB2' ' A' ' 94' ' ' ALA . . . -37.86 -42.87 0.64 Allowed 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 120.568 -0.453 . . . . 0.0 111.522 -179.497 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 90.8 mt -63.38 -56.98 11.87 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -178.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -72.62 -53.85 10.73 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.346 0.593 . . . . 0.0 111.33 -178.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . 0.606 ' O ' ' N ' ' A' ' 95' ' ' TRP . 30.7 t-105 -51.86 -33.31 35.85 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.152 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.588 ' HB2' ' O ' ' A' ' 90' ' ' ALA . . . -60.01 72.11 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 120.611 -0.436 . . . . 0.0 109.89 179.228 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.694 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 22.2 p-90 -99.42 -15.91 0.19 Allowed Pre-proline 0 CA--C 1.538 0.505 0 N-CA-C 112.581 0.586 . . . . 0.0 112.581 -179.113 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.694 ' CD ' ' N ' ' A' ' 95' ' ' TRP . 49.3 Cg_exo -58.87 -31.14 94.79 Favored 'Trans proline' 0 N--CA 1.497 1.717 0 C-N-CA 120.645 0.897 . . . . 0.0 113.808 -179.731 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.494 ' CD ' ' N ' ' A' ' 96' ' ' PRO . 89.0 Cg_exo -56.99 -13.91 12.99 Favored 'Trans proline' 0 N--CA 1.499 1.825 0 C-N-CA 120.642 0.895 . . . . 0.0 113.654 -179.152 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 1.1 pp -90.05 29.96 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 C-N-CA 120.453 -0.499 . . . . 0.0 110.779 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.585 ' CD2' ' O ' ' A' ' 96' ' ' PRO . 42.6 m-85 -50.37 -40.09 48.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.213 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.598 ' CD1' ' N ' ' A' ' 100' ' ' PHE . 0.1 OUTLIER -70.05 -58.84 3.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.318 -179.311 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -55.56 -14.82 7.42 Favored Glycine 0 CA--C 1.522 0.489 0 N-CA-C 110.847 -0.901 . . . . 0.0 110.847 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.493 ' HB1' ' CE2' ' A' ' 25' ' ' PHE . . . -59.76 -12.14 6.63 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.587 0.232 . . . . 0.0 111.203 -179.662 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 -94.78 10.3 35.7 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 121.005 -0.278 . . . . 0.0 110.862 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 16.6 mt-30 -117.21 -175.35 2.78 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.732 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.495 ' CE ' ' CZ3' ' A' ' 155' ' ' TRP . 17.5 mmt -74.78 -18.31 60.49 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.094 0.473 . . . . 0.0 109.78 179.662 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.613 ' O ' ' N ' ' A' ' 108' ' ' ALA . . . -74.23 -14.77 80.39 Favored Glycine 0 CA--C 1.524 0.653 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.355 -179.702 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' TRP . . . . . 0.606 ' NE1' ' OD1' ' A' ' 151' ' ' ASN . 0.0 OUTLIER -41.6 -14.96 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.252 0 CA-C-O 120.749 0.309 . . . . 0.0 110.879 -179.468 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.752 ' HB2' ' OD1' ' A' ' 151' ' ' ASN . . . -62.49 -17.57 59.9 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.983 0.421 . . . . 0.0 110.172 179.53 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.52 HD13 ' O ' ' A' ' 106' ' ' GLY . 6.8 mp -47.5 -30.7 3.65 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.358 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.416 ' HB2' ' CZ3' ' A' ' 95' ' ' TRP . . . -57.81 -63.98 1.06 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.935 -179.72 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.691 ' O ' HG23 ' A' ' 115' ' ' VAL . 1.9 p30 -57.82 -54.34 48.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.764 -179.224 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.54 ' N ' ' CG ' ' A' ' 111' ' ' ASP . 38.1 tp -52.84 -41.49 64.31 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.506 -0.316 . . . . 0.0 111.727 -178.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.403 HD23 ' HA ' ' A' ' 113' ' ' LEU . 57.2 mt -70.33 -62.12 1.51 Allowed 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.616 0.599 . . . . 0.0 112.616 -178.333 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.0 pp -59.0 -29.84 67.53 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 120.431 -0.508 . . . . 0.0 111.066 -178.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.691 HG23 ' O ' ' A' ' 111' ' ' ASP . 38.8 t -65.12 -60.61 2.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.221 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . 0.498 ' O ' ' OG1' ' A' ' 120' ' ' THR . 9.8 p -68.81 -22.29 64.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.954 -179.55 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . 0.405 ' O ' ' CB ' ' A' ' 121' ' ' ALA . . . -65.34 -62.66 4.69 Favored Glycine 0 CA--C 1.525 0.693 0 C-N-CA 120.903 -0.665 . . . . 0.0 111.496 -179.474 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.595 ' O ' HG23 ' A' ' 122' ' ' THR . 9.6 p -73.24 -37.5 52.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 C-N-CA 120.957 -0.297 . . . . 0.0 111.233 -179.531 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.524 ' O ' ' OG1' ' A' ' 123' ' ' THR . . . -67.02 -60.86 2.27 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.596 -0.442 . . . . 0.0 111.145 -179.393 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.498 ' OG1' ' O ' ' A' ' 116' ' ' SER . 1.6 m -60.36 -53.23 60.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.412 -179.455 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.405 ' CB ' ' O ' ' A' ' 117' ' ' GLY . . . -51.83 -42.38 62.5 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.916 -0.314 . . . . 0.0 111.044 -179.391 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.595 HG23 ' O ' ' A' ' 118' ' ' VAL . 35.6 p -71.55 -40.15 70.19 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.769 -179.09 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.524 ' OG1' ' O ' ' A' ' 119' ' ' ALA . 0.1 OUTLIER -54.77 -49.29 71.24 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 120.761 0.315 . . . . 0.0 110.897 -179.143 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.9 pp -84.11 -20.21 32.93 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.202 -0.454 . . . . 0.0 112.089 -178.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -90.17 -71.19 0.63 Allowed 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.821 0.675 . . . . 0.0 112.821 -178.331 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 41.6 m0 -80.46 -57.13 3.73 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 -177.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . 0.578 ' CG ' ' HB2' ' A' ' 134' ' ' ALA . 10.4 m170 -55.48 -23.57 26.53 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.826 -0.35 . . . . 0.0 111.54 -178.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.77 -39.56 87.89 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.756 -0.377 . . . . 0.0 110.666 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 98.7 t -90.6 -49.54 13.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.942 -179.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . 0.552 ' OG ' HG22 ' A' ' 67' ' ' VAL . 1.9 p -114.06 109.34 49.63 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.468 -179.661 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . 0.629 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 71.4 Cg_exo -69.68 -35.91 12.01 Favored 'Trans proline' 0 C--N 1.311 -1.418 0 C-N-CA 121.38 1.386 . . . . 0.0 112.422 179.472 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . 0.629 ' CD ' ' N ' ' A' ' 131' ' ' PRO . 29.8 Cg_exo -56.28 -40.64 83.41 Favored 'Trans proline' 0 N--CA 1.495 1.58 0 C-N-CA 121.374 1.383 . . . . 0.0 111.679 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -51.89 -44.54 63.79 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.265 179.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . 0.578 ' HB2' ' CG ' ' A' ' 127' ' ' HIS . . . -58.65 -22.64 57.28 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.511 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 7.7 tpt85 -79.32 -29.42 42.35 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.535 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 12.8 mt -79.01 -28.96 43.42 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.389 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.477 ' O ' ' CD1' ' A' ' 140' ' ' TYR . 13.2 mt -93.74 -18.64 21.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.091 179.686 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.54 ' C ' ' CD1' ' A' ' 138' ' ' TYR . 0.3 OUTLIER -37.43 -52.19 2.46 Favored Pre-proline 0 CA--C 1.537 0.461 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.715 -179.764 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.404 ' HD2' ' N ' ' A' ' 138' ' ' TYR . 5.6 Cg_endo -62.65 1.54 1.01 Allowed 'Trans proline' 0 N--CA 1.499 1.797 0 C-N-CA 121.734 1.622 . . . . 0.0 113.38 -179.281 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . 0.477 ' CD1' ' O ' ' A' ' 137' ' ' LEU . 0.1 OUTLIER -80.0 -13.7 59.13 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-O 120.921 0.391 . . . . 0.0 111.53 -179.679 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.586 HD23 HD12 ' A' ' 144' ' ' LEU . 74.8 mt -57.64 -34.05 68.93 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.072 179.099 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -53.45 -47.2 69.91 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 179.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' TRP . . . . . 0.434 ' CE2' HD12 ' A' ' 52' ' ' ILE . 8.8 t-105 -63.37 -44.2 95.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.74 179.523 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.586 HD12 HD23 ' A' ' 141' ' ' LEU . 25.3 mt -55.19 -54.97 36.61 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.334 -0.547 . . . . 0.0 110.281 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.534 ' O ' HG23 ' A' ' 149' ' ' VAL . . . -64.68 -23.57 67.3 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.636 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 25.9 t80 -61.35 -59.16 5.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.771 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -64.33 -50.38 68.0 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.005 -179.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 10.9 m -52.62 -55.83 19.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.904 0.383 . . . . 0.0 110.769 -179.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.534 HG23 ' O ' ' A' ' 145' ' ' ALA . 80.9 t -58.25 -35.05 51.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.726 -179.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.432 ' O ' HG23 ' A' ' 154' ' ' VAL . 4.8 tp -54.7 -58.11 8.82 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.471 -179.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . 0.763 HD22 ' N ' ' A' ' 152' ' ' TYR . 0.2 OUTLIER -56.4 -58.89 6.08 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-O 120.988 0.423 . . . . 0.0 110.783 179.94 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . 0.763 ' N ' HD22 ' A' ' 151' ' ' ASN . 50.5 t80 -47.42 -39.65 16.03 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.83 -179.383 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 31.5 t80 -72.12 -35.83 69.25 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.401 -179.53 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.432 HG23 ' O ' ' A' ' 150' ' ' LEU . 45.1 t -59.15 -47.04 91.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 C-N-CA 120.791 -0.364 . . . . 0.0 111.395 -179.291 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' TRP . . . . . 0.495 ' CZ3' ' CE ' ' A' ' 105' ' ' MET . 22.9 m95 -79.95 -28.68 39.63 Favored 'General case' 0 N--CA 1.464 0.225 0 C-N-CA 119.818 -0.753 . . . . 0.0 111.521 -179.279 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.41 -21.66 61.23 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.461 -0.495 . . . . 0.0 110.164 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -83.57 -40.06 19.58 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.918 -179.668 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 18.2 t30 . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.084 -179.587 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.559 ' O ' HG23 ' A' ' 9' ' ' VAL . 0.7 OUTLIER . . . . . 0 CA--C 1.528 0.127 0 CA-C-O 120.784 0.326 . . . . 0.0 110.275 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.585 ' N ' ' CD ' ' A' ' 7' ' ' PRO . 0.9 OUTLIER -60.84 -33.62 15.03 Favored Pre-proline 0 CA--C 1.533 0.306 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.144 -179.759 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.585 ' CD ' ' N ' ' A' ' 6' ' ' VAL . 24.2 Cg_exo -73.34 -62.64 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 121.613 1.542 . . . . 0.0 111.518 179.282 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.708 ' O ' HG23 ' A' ' 12' ' ' THR . . . -50.78 -36.51 37.29 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.849 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.559 HG23 ' O ' ' A' ' 5' ' ' TRP . 56.0 t -68.27 -62.17 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.511 -179.442 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -55.6 -47.73 75.42 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 111.484 -0.646 . . . . 0.0 111.484 -179.33 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.434 ' N ' HD12 ' A' ' 11' ' ' LEU . 8.5 mp -64.84 -30.86 71.88 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 121.177 -0.209 . . . . 0.0 110.968 -179.514 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.708 HG23 ' O ' ' A' ' 8' ' ' ALA . 6.1 p -74.47 -22.95 58.84 Favored 'General case' 0 C--N 1.333 -0.135 0 C-N-CA 120.569 -0.453 . . . . 0.0 110.016 179.439 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 52.5 mt -80.18 -34.77 37.24 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.213 179.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.415 ' N ' ' HD2' ' A' ' 15' ' ' PRO . 11.9 t -43.63 -55.21 9.05 Favored Pre-proline 0 CA--C 1.536 0.423 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.45 -179.722 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.415 ' HD2' ' N ' ' A' ' 14' ' ' VAL . 13.8 Cg_endo -58.92 -21.92 60.26 Favored 'Trans proline' 0 N--CA 1.498 1.754 0 C-N-CA 120.672 0.915 . . . . 0.0 112.303 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 5.7 t -62.08 -30.59 71.1 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.825 -179.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 71.5 mt -71.62 -57.1 4.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.817 0.342 . . . . 0.0 110.893 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -61.16 -36.97 93.18 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 111.287 -0.725 . . . . 0.0 111.287 -179.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -75.44 -25.94 66.9 Favored Glycine 0 CA--C 1.521 0.461 0 N-CA-C 110.694 -0.962 . . . . 0.0 110.694 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 62.0 t80 -75.54 -60.62 2.23 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.528 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 3.9 ttt -70.16 -22.29 62.99 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.17 179.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -69.47 -62.31 3.97 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.825 -0.91 . . . . 0.0 110.825 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.496 ' O ' HG22 ' A' ' 26' ' ' VAL . . . -68.55 -21.28 64.56 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.831 -0.348 . . . . 0.0 110.635 -179.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 40.2 t80 -47.45 -24.0 0.73 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.013 0.435 . . . . 0.0 109.984 179.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 25.6 t80 -69.72 -52.26 27.07 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.966 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.496 HG22 ' O ' ' A' ' 23' ' ' ALA . 36.0 m -72.14 -15.89 18.2 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.894 -179.736 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -59.82 -28.88 67.85 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.258 -179.388 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -123.39 -59.39 0.19 Allowed Glycine 0 CA--C 1.524 0.643 0 N-CA-C 111.199 -0.76 . . . . 0.0 111.199 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 27.7 tp10 -53.92 -28.99 40.18 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.745 0.307 . . . . 0.0 110.686 -179.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -73.78 -40.98 43.73 Favored Glycine 0 CA--C 1.526 0.754 0 N-CA-C 111.134 -0.786 . . . . 0.0 111.134 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 85.6 mt -62.98 -33.2 74.9 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.881 0.372 . . . . 0.0 110.482 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 18.6 mmm-85 -81.0 -40.01 24.98 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.35 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . 0.489 ' O ' ' N ' ' A' ' 36' ' ' GLY . 0.0 OUTLIER -56.11 -40.41 73.67 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.802 179.624 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 91.4 t80 -44.5 -42.11 6.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.518 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -60.27 -29.32 68.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.145 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.489 ' N ' ' O ' ' A' ' 33' ' ' TRP . . . -84.86 -76.72 1.19 Allowed Glycine 0 CA--C 1.524 0.602 0 N-CA-C 110.437 -1.065 . . . . 0.0 110.437 179.679 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.582 ' O ' HD12 ' A' ' 37' ' ' LEU . 0.3 OUTLIER -95.65 166.94 11.58 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.791 0.329 . . . . 0.0 110.221 179.277 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.415 ' N ' ' CD ' ' A' ' 38' ' ' GLN . 3.7 mp0 -81.54 113.02 19.29 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.483 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 8.9 mtpt -122.18 146.63 47.25 Favored Pre-proline 0 N--CA 1.464 0.265 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.05 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo . . . . . 0 C--N 1.309 -1.503 0 C-N-CA 121.28 1.32 . . . . 0.0 111.386 179.406 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.703 ' O ' HG23 ' A' ' 52' ' ' ILE . 0.1 OUTLIER . . . . . 0 CA--C 1.533 0.301 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.615 ' C ' ' H ' ' A' ' 52' ' ' ILE . . . -40.94 -28.92 0.23 Allowed Pre-proline 0 N--CA 1.465 0.281 0 N-CA-C 111.892 0.33 . . . . 0.0 111.892 -179.057 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.409 ' HD2' ' N ' ' A' ' 50' ' ' ALA . 17.6 Cg_exo -54.03 7.36 0.03 OUTLIER 'Trans proline' 0 C--N 1.312 -1.359 0 CA-C-N 119.126 0.724 . . . . 0.0 112.78 178.501 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.703 HG23 ' O ' ' A' ' 49' ' ' LEU . 8.1 pt -55.19 -31.35 26.05 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.133 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 178.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.403 ' O ' ' CB ' ' A' ' 57' ' ' TYR . 72.8 m95 -80.98 -22.21 39.7 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.124 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -69.92 -52.12 20.78 Favored Glycine 0 CA--C 1.527 0.828 0 N-CA-C 109.987 -1.245 . . . . 0.0 109.987 178.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.617 HG23 ' N ' ' A' ' 56' ' ' LEU . 9.3 t -67.23 -50.2 61.58 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 179.321 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.617 ' N ' HG23 ' A' ' 55' ' ' THR . 90.4 mt -58.4 -33.77 70.01 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 120.655 -0.418 . . . . 0.0 109.89 179.389 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.403 ' CB ' ' O ' ' A' ' 53' ' ' TRP . 3.6 t80 -59.16 -55.93 28.7 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 179.42 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 34.6 t -48.01 -50.33 27.95 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.347 -0.541 . . . . 0.0 109.88 179.339 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -55.63 -52.59 63.28 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.57 179.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.4 ' O ' ' CB ' ' A' ' 64' ' ' SER . 16.2 mtm -55.09 -37.68 67.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.036 -179.715 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -62.87 -41.2 99.92 Favored Glycine 0 CA--C 1.523 0.55 0 N-CA-C 111.216 -0.754 . . . . 0.0 111.216 -179.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -68.61 -60.25 2.55 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.695 0.283 . . . . 0.0 110.869 -179.487 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.475 ' O ' HG23 ' A' ' 67' ' ' VAL . . . -55.48 -56.58 22.83 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 110.749 -0.94 . . . . 0.0 110.749 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.477 ' O ' ' NE1' ' A' ' 68' ' ' TRP . 92.7 p -45.77 -49.53 14.87 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.004 0.43 . . . . 0.0 110.473 179.699 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 73.5 t80 -58.16 -34.4 70.26 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.835 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 96.2 mt -74.25 -39.13 49.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.882 -179.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.475 HG23 ' O ' ' A' ' 63' ' ' GLY . 37.4 t -56.98 -58.17 6.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.616 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' TRP . . . . . 0.578 ' O ' ' N ' ' A' ' 73' ' ' GLY . 1.0 OUTLIER -60.82 -45.04 96.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.692 -179.837 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 2.7 mmmt -56.65 -25.73 54.25 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.02 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 23.5 tp10 -82.41 -63.06 1.45 Allowed 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.827 -0.349 . . . . 0.0 111.317 -179.359 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.743 ' C ' HD12 ' A' ' 71' ' ' LEU . 3.3 pp -62.93 -7.12 4.58 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.777 -0.369 . . . . 0.0 111.023 -179.478 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.659 ' N ' HD12 ' A' ' 71' ' ' LEU . . . 108.45 71.69 0.73 Allowed Glycine 0 CA--C 1.527 0.791 0 N-CA-C 111.402 -0.679 . . . . 0.0 111.402 179.697 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.578 ' N ' ' O ' ' A' ' 68' ' ' TRP . . . 42.15 -174.03 0.01 OUTLIER Glycine 0 CA--C 1.525 0.698 0 N-CA-C 111.748 -0.541 . . . . 0.0 111.748 179.496 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 63.4 t80 -69.33 111.42 5.22 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.372 -0.414 . . . . 0.0 110.432 -179.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.477 ' OG1' ' N ' ' A' ' 76' ' ' GLU . 1.7 t -140.0 -178.6 5.52 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.538 -179.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.477 ' N ' ' OG1' ' A' ' 75' ' ' THR . 96.3 mt-10 -55.51 -23.24 25.09 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.632 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -79.97 -18.84 49.34 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.664 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -94.09 -24.42 17.59 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.927 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 13.1 mtp -62.19 -26.98 68.65 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.813 -0.355 . . . . 0.0 110.439 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 10.8 t -68.49 -52.99 18.4 Favored Pre-proline 0 CA--C 1.535 0.386 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.953 -179.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -66.42 -59.53 0.13 Allowed 'Trans proline' 0 N--CA 1.497 1.733 0 C-N-CA 120.97 1.113 . . . . 0.0 111.77 179.29 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.445 HD21 ' CZ2' ' A' ' 68' ' ' TRP . 1.2 mt -55.27 -51.49 66.47 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.492 179.714 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -57.82 -51.08 60.22 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 111.153 -0.779 . . . . 0.0 111.153 -179.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.427 ' O ' ' CB ' ' A' ' 88' ' ' GLN . 44.3 tp -60.15 -29.74 68.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.834 0.349 . . . . 0.0 110.61 -179.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 11.6 t80 -71.25 -43.51 67.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.627 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 1.5 m -67.29 -48.03 68.86 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.888 -179.625 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -68.75 -57.27 8.14 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 111.162 -0.775 . . . . 0.0 111.162 -179.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.443 HE21 ' HB2' ' A' ' 92' ' ' ASN . 53.1 tp60 -52.13 -46.01 65.19 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.826 0.346 . . . . 0.0 110.711 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 11.7 tp -66.12 -31.94 73.1 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.94 -179.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.79 ' O ' ' HB2' ' A' ' 94' ' ' ALA . . . -64.4 -65.64 0.65 Allowed 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 120.272 -0.571 . . . . 0.0 111.183 -179.547 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.431 HD12 ' N ' ' A' ' 92' ' ' ASN . 2.8 pp -67.65 -36.96 81.72 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 -178.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.454 HD22 ' HA2' ' A' ' 117' ' ' GLY . 34.7 t30 -75.03 -59.13 2.88 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 -178.768 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . 0.62 ' O ' ' N ' ' A' ' 95' ' ' TRP . 0.0 OUTLIER -69.95 -17.15 63.3 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 120.681 -0.408 . . . . 0.0 111.499 -178.576 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.79 ' HB2' ' O ' ' A' ' 90' ' ' ALA . . . -49.0 83.23 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 120.739 -0.385 . . . . 0.0 110.206 179.512 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.696 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 34.8 p-90 -101.42 -15.75 0.18 Allowed Pre-proline 0 CA--C 1.536 0.419 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 -179.278 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.696 ' CD ' ' N ' ' A' ' 95' ' ' TRP . 32.0 Cg_exo -60.24 -27.79 85.58 Favored 'Trans proline' 0 N--CA 1.495 1.564 0 C-N-CA 120.484 0.79 . . . . 0.0 113.126 179.654 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.52 ' CD ' ' N ' ' A' ' 96' ' ' PRO . 97.2 Cg_exo -58.96 -17.53 37.93 Favored 'Trans proline' 0 N--CA 1.496 1.671 0 C-N-CA 120.592 0.861 . . . . 0.0 113.127 -179.81 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.531 ' O ' ' N ' ' A' ' 101' ' ' GLY . 1.2 pp -82.24 17.26 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 121.105 0.479 . . . . 0.0 110.304 179.699 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -40.22 -31.7 0.14 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.789 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -80.85 -30.32 35.67 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.246 -179.36 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.531 ' N ' ' O ' ' A' ' 98' ' ' ILE . . . -83.66 -11.97 78.67 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 111.372 -0.691 . . . . 0.0 111.372 -179.742 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -63.55 -33.06 74.77 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.673 0.273 . . . . 0.0 111.033 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -75.91 9.65 2.29 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.98 -179.654 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . 0.416 ' C ' ' N ' ' A' ' 106' ' ' GLY . 5.3 mt-30 -126.09 158.83 34.45 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.748 0.308 . . . . 0.0 110.574 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 6.7 mmt -48.79 -18.91 0.31 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.097 0.475 . . . . 0.0 110.348 179.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.593 ' O ' ' N ' ' A' ' 108' ' ' ALA . . . -66.51 -14.59 62.59 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 111.351 -0.7 . . . . 0.0 111.351 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' TRP . . . . . 0.526 ' CZ2' ' ND2' ' A' ' 151' ' ' ASN . 0.0 OUTLIER -42.33 -14.52 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.287 0 CA-C-O 120.561 0.22 . . . . 0.0 111.137 -179.368 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.593 ' N ' ' O ' ' A' ' 106' ' ' GLY . . . -64.78 -24.1 67.45 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.092 0.472 . . . . 0.0 110.321 179.686 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 6.6 mt -49.98 -27.99 6.2 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.59 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.24 -58.51 7.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.733 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.708 ' O ' HG23 ' A' ' 115' ' ' VAL . 1.0 OUTLIER -59.2 -52.32 66.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.558 -179.422 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.538 ' N ' ' CG ' ' A' ' 111' ' ' ASP . 57.4 tp -55.07 -43.17 73.66 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.43 -179.137 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.402 HD23 ' HA ' ' A' ' 113' ' ' LEU . 51.6 mt -67.12 -61.55 1.87 Allowed 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 -178.487 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.0 pp -60.94 -34.04 74.12 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.337 -0.545 . . . . 0.0 111.413 -178.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.708 HG23 ' O ' ' A' ' 111' ' ' ASP . 40.7 t -59.87 -56.82 14.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.763 179.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . 0.491 ' O ' ' OG1' ' A' ' 120' ' ' THR . 41.5 t -72.09 -22.54 61.34 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.54 -179.208 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . 0.454 ' HA2' HD22 ' A' ' 92' ' ' ASN . . . -64.98 -62.74 4.7 Favored Glycine 0 CA--C 1.526 0.75 0 C-N-CA 120.938 -0.648 . . . . 0.0 111.674 -179.357 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.535 ' O ' HG23 ' A' ' 122' ' ' THR . 10.3 p -73.01 -37.62 53.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 C-N-CA 121.08 -0.248 . . . . 0.0 111.408 -179.476 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.527 ' O ' ' OG1' ' A' ' 123' ' ' THR . . . -65.53 -60.24 3.14 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.684 -0.406 . . . . 0.0 111.149 -179.344 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.491 ' OG1' ' O ' ' A' ' 116' ' ' SER . 1.9 m -60.43 -52.77 63.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.673 -179.237 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -54.6 -39.93 68.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.601 -0.272 . . . . 0.0 111.417 -179.166 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.535 HG23 ' O ' ' A' ' 118' ' ' VAL . 22.9 p -71.48 -39.11 71.09 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.994 -0.283 . . . . 0.0 111.728 -179.195 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.527 ' OG1' ' O ' ' A' ' 119' ' ' ALA . 0.1 OUTLIER -58.46 -49.44 77.33 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.782 -0.367 . . . . 0.0 111.08 -179.286 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.2 pp -79.97 -20.48 45.47 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.581 -179.057 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -87.42 -70.88 0.59 Allowed 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 112.515 0.561 . . . . 0.0 112.515 -178.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' TRP . . . . . 0.469 ' N ' ' CD1' ' A' ' 126' ' ' TRP . 32.0 m0 -83.57 -57.36 3.27 Favored 'General case' 0 N--CA 1.465 0.275 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -177.687 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . 0.496 ' CG ' ' HB2' ' A' ' 134' ' ' ALA . 7.0 m170 -54.52 -22.68 13.68 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.642 -0.423 . . . . 0.0 111.419 -178.672 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 17.1 ttt-85 -66.35 -39.62 89.28 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.877 -0.329 . . . . 0.0 111.137 -179.563 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 21.5 t -96.18 -49.77 11.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.149 -179.543 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . 0.467 ' HB2' HG22 ' A' ' 67' ' ' VAL . 16.8 m -114.72 110.35 46.84 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.699 -179.661 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . 0.64 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 77.7 Cg_exo -75.19 -33.11 4.64 Favored 'Trans proline' 0 C--N 1.31 -1.479 0 C-N-CA 121.73 1.62 . . . . 0.0 112.871 179.544 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . 0.64 ' CD ' ' N ' ' A' ' 131' ' ' PRO . 53.1 Cg_exo -52.97 -49.91 15.92 Favored 'Trans proline' 0 N--CA 1.497 1.687 0 C-N-CA 121.587 1.525 . . . . 0.0 112.572 -179.536 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -53.27 -38.98 63.55 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.908 0.385 . . . . 0.0 110.666 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . 0.496 ' HB2' ' CG ' ' A' ' 127' ' ' HIS . . . -56.18 -28.06 56.79 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.596 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 11.4 tpp180 -75.98 -29.66 58.3 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.653 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 54.3 mt -72.43 -35.74 68.39 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.878 0.37 . . . . 0.0 110.118 179.627 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.589 ' O ' ' N ' ' A' ' 140' ' ' TYR . 6.2 mt -82.46 -36.81 26.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.211 179.571 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.519 ' C ' ' H ' ' A' ' 140' ' ' TYR . 0.8 OUTLIER -21.04 -45.48 0.04 OUTLIER Pre-proline 0 N--CA 1.467 0.399 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.811 -179.725 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.559 ' N ' ' O ' ' A' ' 137' ' ' LEU . 5.5 Cg_exo -66.08 14.33 0.11 Allowed 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 120.986 1.124 . . . . 0.0 112.001 179.593 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . 0.771 ' CE2' HD11 ' A' ' 144' ' ' LEU . 3.7 p90 -93.25 -14.64 26.78 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.197 0.522 . . . . 0.0 110.341 179.684 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.656 ' CD1' ' CE1' ' A' ' 140' ' ' TYR . 5.9 mp -58.79 -30.63 67.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.268 178.578 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -60.92 -45.37 94.91 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.983 179.562 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' TRP . . . . . 0.475 ' CE2' HD12 ' A' ' 52' ' ' ILE . 7.7 t-105 -60.33 -49.57 77.06 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 179.415 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.771 HD11 ' CE2' ' A' ' 140' ' ' TYR . 11.9 mt -51.37 -54.61 24.75 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.743 179.322 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.616 ' O ' HG23 ' A' ' 149' ' ' VAL . . . -59.72 -24.79 64.29 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.792 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 23.0 t80 -65.1 -59.16 4.42 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.741 -0.383 . . . . 0.0 110.711 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -67.18 -43.41 82.24 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.622 -0.431 . . . . 0.0 110.633 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 5.2 m -57.3 -55.13 38.79 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.579 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.616 HG23 ' O ' ' A' ' 145' ' ' ALA . 91.2 t -59.19 -31.66 46.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.59 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -58.33 -53.94 52.6 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.796 -0.362 . . . . 0.0 110.068 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . 0.526 ' ND2' ' CZ2' ' A' ' 107' ' ' TRP . 8.3 m120 -64.16 -53.37 50.49 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.939 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 31.5 t80 -51.4 -37.53 48.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.867 -179.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 90.8 t80 -67.93 -42.68 80.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.949 -179.692 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 86.7 t -63.61 -38.27 81.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 C-N-CA 120.945 -0.302 . . . . 0.0 110.79 -179.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' TRP . . . . . . . . . . . . . 4.8 m0 -64.06 -45.96 86.49 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.536 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 7.5 mpt_? -70.62 -34.31 71.97 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.954 -179.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -74.64 -37.79 62.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.111 -179.314 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' ASN . . . . . 0.476 ' O ' ' ND2' ' A' ' 158' ' ' ASN . 0.6 OUTLIER . . . . . 0 C--N 1.33 -0.256 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.918 -179.745 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.688 ' O ' HG23 ' A' ' 9' ' ' VAL . 0.7 OUTLIER . . . . . 0 CA--C 1.528 0.102 0 CA-C-O 120.786 0.327 . . . . 0.0 110.282 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.594 ' N ' ' CD ' ' A' ' 7' ' ' PRO . 0.9 OUTLIER -62.36 -35.76 22.72 Favored Pre-proline 0 CA--C 1.534 0.35 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.43 -179.715 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.594 ' CD ' ' N ' ' A' ' 6' ' ' VAL . 35.2 Cg_exo -65.99 -64.59 0.05 OUTLIER 'Trans proline' 0 C--N 1.306 -1.665 0 C-N-CA 121.668 1.579 . . . . 0.0 111.827 179.624 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.761 ' O ' HG22 ' A' ' 12' ' ' THR . . . -51.65 -32.76 30.63 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.973 -179.706 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.688 HG23 ' O ' ' A' ' 5' ' ' TRP . 58.5 t -69.87 -61.37 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.94 0.4 . . . . 0.0 111.304 -179.447 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -57.89 -43.36 94.85 Favored Glycine 0 CA--C 1.528 0.853 0 N-CA-C 111.215 -0.754 . . . . 0.0 111.215 -179.545 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 8.1 mp -65.92 -62.95 1.21 Allowed 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 111.544 0.202 . . . . 0.0 111.544 -179.166 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.761 HG22 ' O ' ' A' ' 8' ' ' ALA . 6.9 t -54.38 -20.55 7.57 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.449 -0.5 . . . . 0.0 110.572 -179.395 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.431 ' O ' ' C ' ' A' ' 14' ' ' VAL . 17.6 mt -78.79 -38.12 39.17 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.779 0.324 . . . . 0.0 110.371 179.611 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.432 ' N ' ' HD2' ' A' ' 15' ' ' PRO . 28.1 t -35.55 -56.72 1.01 Allowed Pre-proline 0 CA--C 1.534 0.342 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.63 -179.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.432 ' HD2' ' N ' ' A' ' 14' ' ' VAL . 15.4 Cg_endo -54.6 -32.59 75.46 Favored 'Trans proline' 0 N--CA 1.498 1.772 0 C-N-CA 120.475 0.783 . . . . 0.0 112.501 -179.488 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.421 ' N ' ' O ' ' A' ' 13' ' ' LEU . 2.3 t -45.05 -25.96 0.39 Allowed 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 120.396 -0.522 . . . . 0.0 110.341 -179.586 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 74.5 mt -72.85 -53.69 10.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.128 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -68.61 -34.48 78.69 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 111.594 -0.602 . . . . 0.0 111.594 -179.399 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -75.14 -29.61 60.21 Favored Glycine 0 CA--C 1.517 0.184 0 N-CA-C 110.651 -0.98 . . . . 0.0 110.651 -179.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 36.9 t80 -74.79 -60.71 2.16 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.506 -0.478 . . . . 0.0 110.64 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 9.4 ttt -69.7 -22.85 63.38 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.809 -179.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -73.59 -63.23 2.8 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 111.081 -0.808 . . . . 0.0 111.081 -179.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.482 ' O ' HG22 ' A' ' 26' ' ' VAL . . . -63.83 -23.49 67.38 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.424 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 76.2 t80 -47.83 -23.5 0.76 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.936 0.398 . . . . 0.0 109.95 179.235 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 46.8 t80 -69.49 -52.65 24.56 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.703 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.482 HG22 ' O ' ' A' ' 23' ' ' ALA . 31.1 m -71.14 -16.2 19.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.864 -179.685 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 2.4 tmt_? -58.04 -46.38 85.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.79 0.328 . . . . 0.0 110.568 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -100.73 -60.51 0.81 Allowed Glycine 0 CA--C 1.526 0.749 0 N-CA-C 110.916 -0.873 . . . . 0.0 110.916 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -49.84 -31.69 12.51 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.753 0.311 . . . . 0.0 110.546 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -68.7 -53.6 19.26 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 110.826 -0.91 . . . . 0.0 110.826 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 71.2 mt -51.24 -38.68 53.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.831 0.348 . . . . 0.0 110.51 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 20.1 mmm-85 -75.13 -46.85 31.7 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.035 -179.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 4.8 m95 -47.12 -39.35 13.17 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 120.853 -0.339 . . . . 0.0 110.269 -179.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 77.6 t80 -53.33 -26.11 17.63 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.312 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -75.89 -16.38 60.05 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.377 179.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -111.37 -76.47 0.83 Allowed Glycine 0 CA--C 1.523 0.568 0 N-CA-C 110.727 -0.949 . . . . 0.0 110.727 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.795 ' C ' HD12 ' A' ' 37' ' ' LEU . 3.6 pp -95.27 165.41 12.4 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 110.245 -0.28 . . . . 0.0 110.245 179.708 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.414 ' N ' HD12 ' A' ' 37' ' ' LEU . 77.0 mm-40 -75.55 113.08 12.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.93 0.395 . . . . 0.0 111.624 -179.121 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.416 ' HG3' HD11 ' A' ' 37' ' ' LEU . 0.7 OUTLIER -129.59 135.48 27.61 Favored Pre-proline 0 CA--C 1.536 0.424 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 179.313 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo . . . . . 0 N--CA 1.496 1.671 0 C-N-CA 120.386 0.724 . . . . 0.0 111.617 179.582 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.712 ' O ' HG23 ' A' ' 52' ' ' ILE . 0.1 OUTLIER . . . . . 0 CA--C 1.533 0.289 0 N-CA-C 111.867 0.321 . . . . 0.0 111.867 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.613 ' C ' ' H ' ' A' ' 52' ' ' ILE . . . -39.96 -29.57 0.21 Allowed Pre-proline 0 C--O 1.234 0.281 0 N-CA-C 111.88 0.326 . . . . 0.0 111.88 -178.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.404 ' HD2' ' N ' ' A' ' 50' ' ' ALA . 33.7 Cg_exo -53.19 4.5 0.03 OUTLIER 'Trans proline' 0 C--N 1.312 -1.379 0 CA-C-N 119.179 0.742 . . . . 0.0 112.439 178.158 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.712 HG23 ' O ' ' A' ' 49' ' ' LEU . 8.1 pt -52.49 -33.45 17.84 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.174 0 CA-C-O 121.101 0.477 . . . . 0.0 109.961 179.214 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.439 ' O ' ' CB ' ' A' ' 57' ' ' TYR . 72.6 m95 -79.72 -23.38 42.37 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.45 -179.002 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -71.76 -46.22 39.52 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 110.12 -1.192 . . . . 0.0 110.12 179.08 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 5.9 m -68.36 -52.22 35.66 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 179.321 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.413 HD23 ' HA ' ' A' ' 56' ' ' LEU . 96.0 mt -60.02 -28.72 67.97 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.887 179.438 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.512 ' C ' ' CD1' ' A' ' 57' ' ' TYR . 0.4 OUTLIER -63.76 -51.53 64.43 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 179.454 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 5.8 p -53.98 -50.73 65.91 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.152 179.467 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.71 -42.03 87.7 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.329 179.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.517 ' SD ' ' OG1' ' A' ' 12' ' ' THR . 11.3 mtm -59.27 -40.87 87.41 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.926 179.579 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -58.83 -45.09 95.47 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 110.526 -1.03 . . . . 0.0 110.526 179.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.481 ' N ' ' CD1' ' A' ' 62' ' ' TYR . 2.9 m-30 -62.15 -60.0 4.23 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 121.06 -0.256 . . . . 0.0 110.951 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.475 ' O ' HG23 ' A' ' 67' ' ' VAL . . . -54.04 -60.89 7.76 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 110.986 -0.845 . . . . 0.0 110.986 -179.593 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.521 ' O ' ' CD1' ' A' ' 68' ' ' TRP . 56.0 p -45.5 -48.27 14.09 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.012 0.434 . . . . 0.0 110.465 179.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 57.6 t80 -56.47 -41.05 75.91 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.945 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 79.4 mt -67.8 -43.44 86.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.952 -179.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.496 ' CG1' ' CZ3' ' A' ' 68' ' ' TRP . 21.5 t -52.54 -56.33 7.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.86 -179.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' TRP . . . . . 0.609 ' CE2' HD11 ' A' ' 82' ' ' LEU . 1.0 OUTLIER -66.29 -46.85 75.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.089 -179.391 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.07 -24.46 40.0 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.947 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -81.19 -62.1 1.76 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.348 -179.455 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.2 pp -69.3 -2.15 9.99 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.46 -179.101 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.491 ' O ' ' O ' ' A' ' 73' ' ' GLY . . . 108.4 71.13 0.71 Allowed Glycine 0 CA--C 1.527 0.817 0 N-CA-C 111.572 -0.611 . . . . 0.0 111.572 179.557 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.591 ' N ' ' O ' ' A' ' 68' ' ' TRP . . . 42.03 -173.53 0.01 OUTLIER Glycine 0 CA--C 1.525 0.701 0 N-CA-C 111.94 -0.464 . . . . 0.0 111.94 179.286 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 57.6 t80 -69.81 111.21 5.4 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.203 -0.498 . . . . 0.0 111.009 -179.523 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.516 ' OG1' ' N ' ' A' ' 76' ' ' GLU . 1.3 t -139.4 -175.44 4.18 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.226 179.664 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.516 ' N ' ' OG1' ' A' ' 75' ' ' THR . 73.4 mt-10 -52.92 -24.4 9.18 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.086 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -79.92 -17.71 52.39 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.001 -179.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.531 ' O ' HD12 ' A' ' 82' ' ' LEU . . . -96.78 -15.6 21.26 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.04 -179.495 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 7.0 mtp -70.05 -28.27 65.32 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.484 -0.326 . . . . 0.0 110.885 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 5.1 t -70.47 -54.99 8.02 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.758 -179.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -62.93 -54.61 1.08 Allowed 'Trans proline' 0 N--CA 1.498 1.764 0 C-N-CA 120.993 1.129 . . . . 0.0 111.802 179.324 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.609 HD11 ' CE2' ' A' ' 68' ' ' TRP . 1.5 mt -61.05 -55.91 27.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.533 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -53.33 -60.32 8.34 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 111.084 -0.807 . . . . 0.0 111.084 -179.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.6 tt -48.54 -40.82 28.34 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.781 0.324 . . . . 0.0 110.631 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.4 ' O ' ' CB ' ' A' ' 89' ' ' LEU . 11.0 t80 -63.02 -36.15 82.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.597 -179.747 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.74 -63.05 1.14 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.197 -179.556 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -60.11 -55.59 29.39 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 111.378 -0.689 . . . . 0.0 111.378 -179.547 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.423 ' O ' ' CB ' ' A' ' 92' ' ' ASN . 6.5 tp-100 -50.84 -47.25 60.28 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.652 0.263 . . . . 0.0 111.029 -179.669 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.4 ' CB ' ' O ' ' A' ' 85' ' ' TYR . 11.4 tp -65.3 -28.83 69.59 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.98 0.419 . . . . 0.0 110.313 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.789 ' O ' ' HB2' ' A' ' 94' ' ' ALA . . . -64.7 -65.57 0.66 Allowed 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 120.429 -0.509 . . . . 0.0 111.404 -179.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.3 pp -71.59 -26.11 62.46 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -178.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.423 ' CB ' ' O ' ' A' ' 88' ' ' GLN . 19.1 t-20 -83.53 -57.23 3.32 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.68 -0.408 . . . . 0.0 111.75 -178.847 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . 0.621 ' O ' ' N ' ' A' ' 95' ' ' TRP . 0.0 OUTLIER -72.08 -20.58 61.63 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.693 -0.403 . . . . 0.0 111.091 -178.851 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.789 ' HB2' ' O ' ' A' ' 90' ' ' ALA . . . -46.94 85.31 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.115 0 C-N-CA 120.703 -0.399 . . . . 0.0 110.207 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.707 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 34.4 p-90 -99.77 -16.9 0.2 Allowed Pre-proline 0 CA--C 1.537 0.445 0 CA-C-N 116.2 -0.455 . . . . 0.0 112.119 -179.653 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.707 ' CD ' ' N ' ' A' ' 95' ' ' TRP . 50.1 Cg_exo -55.15 -36.61 93.49 Favored 'Trans proline' 0 N--CA 1.496 1.639 0 C-N-CA 120.424 0.749 . . . . 0.0 113.106 179.483 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.469 ' HD2' ' N ' ' A' ' 96' ' ' PRO . 26.7 Cg_exo -39.74 -29.5 0.29 Allowed 'Trans proline' 0 N--CA 1.491 1.364 0 CA-C-N 118.979 0.671 . . . . 0.0 113.261 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 1.1 pt -83.87 26.45 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 121.109 0.48 . . . . 0.0 110.341 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.444 ' N ' ' O ' ' A' ' 96' ' ' PRO . 11.1 t80 -40.82 -43.52 2.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.794 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -81.53 -42.8 19.66 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.859 -179.699 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -61.09 -7.01 7.94 Favored Glycine 0 CA--C 1.527 0.791 0 N-CA-C 111.21 -0.756 . . . . 0.0 111.21 -179.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -76.01 -7.32 54.38 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 121.015 -0.274 . . . . 0.0 110.884 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 39.7 ptt85 -89.34 2.04 54.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.77 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 9.4 mt-30 -119.47 164.34 15.92 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.492 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.586 ' O ' ' NE1' ' A' ' 155' ' ' TRP . 0.0 OUTLIER -52.44 -17.46 1.22 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.296 179.78 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.577 ' O ' ' N ' ' A' ' 108' ' ' ALA . . . -68.11 -15.34 67.33 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 111.058 -0.817 . . . . 0.0 111.058 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' TRP . . . . . 0.416 ' CD1' ' C ' ' A' ' 107' ' ' TRP . 0.0 OUTLIER -44.87 -11.71 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.726 0.298 . . . . 0.0 110.802 -179.727 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.577 ' N ' ' O ' ' A' ' 106' ' ' GLY . . . -66.99 -23.28 65.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.998 0.428 . . . . 0.0 110.485 179.765 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 8.3 mp -52.44 -29.82 26.43 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.023 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -55.87 -64.02 0.99 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.396 179.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.748 ' O ' HG23 ' A' ' 115' ' ' VAL . 1.6 p30 -55.62 -52.46 63.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.917 -179.418 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.586 ' N ' ' OD1' ' A' ' 111' ' ' ASP . 8.1 tp -55.55 -40.88 72.47 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.884 -0.327 . . . . 0.0 111.714 -178.66 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 50.5 mt -68.68 -61.36 1.85 Allowed 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.678 -0.409 . . . . 0.0 111.912 -178.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.5 pp -57.95 -34.51 69.98 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 120.361 -0.536 . . . . 0.0 111.122 -178.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.748 HG23 ' O ' ' A' ' 111' ' ' ASP . 41.0 t -59.96 -54.52 33.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.912 179.745 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . 0.443 ' O ' ' OG1' ' A' ' 120' ' ' THR . 58.7 m -71.68 -24.01 61.75 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.573 -179.286 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -65.22 -63.05 4.39 Favored Glycine 0 CA--C 1.527 0.821 0 C-N-CA 120.824 -0.703 . . . . 0.0 111.762 -179.32 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.566 ' O ' HG23 ' A' ' 122' ' ' THR . 8.0 p -71.78 -37.87 63.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 O-C-N 122.834 -0.215 . . . . 0.0 111.429 -179.404 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.491 ' O ' ' OG1' ' A' ' 123' ' ' THR . . . -66.22 -60.85 2.4 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.623 -0.431 . . . . 0.0 111.192 -179.171 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.443 ' OG1' ' O ' ' A' ' 116' ' ' SER . 3.0 m -59.1 -54.28 48.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.408 -179.241 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.411 ' O ' ' CB ' ' A' ' 125' ' ' ALA . . . -52.31 -40.35 61.74 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.414 -179.24 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.566 HG23 ' O ' ' A' ' 118' ' ' VAL . 33.4 p -73.71 -35.53 65.12 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 111.918 0.34 . . . . 0.0 111.918 -178.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.491 ' OG1' ' O ' ' A' ' 119' ' ' ALA . 0.1 OUTLIER -59.94 -48.51 81.41 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.821 -0.352 . . . . 0.0 110.947 -179.458 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.6 pp -83.79 -19.98 34.09 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.616 -179.011 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.411 ' CB ' ' O ' ' A' ' 121' ' ' ALA . . . -87.66 -68.03 0.78 Allowed 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -178.606 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' TRP . . . . . 0.44 ' N ' ' CD1' ' A' ' 126' ' ' TRP . 38.0 m0 -85.22 -57.44 3.08 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 112.762 0.653 . . . . 0.0 112.762 -177.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . 0.494 ' CD2' ' N ' ' A' ' 127' ' ' HIS . 8.5 m170 -54.37 -22.46 12.32 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.903 -0.319 . . . . 0.0 111.374 -178.58 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.409 ' C ' ' CD ' ' A' ' 128' ' ' ARG . 0.0 OUTLIER -70.84 -48.49 53.66 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.877 -0.329 . . . . 0.0 111.058 -179.665 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 44.2 t -80.82 -49.83 17.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.207 -179.471 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 5.7 t -129.85 115.6 17.94 Favored Pre-proline 0 CA--C 1.532 0.281 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.827 -179.487 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . 0.565 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 82.7 Cg_exo -72.12 -43.34 1.16 Allowed 'Trans proline' 0 N--CA 1.491 1.371 0 C-N-CA 121.294 1.329 . . . . 0.0 113.077 179.436 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . 0.565 ' CD ' ' N ' ' A' ' 131' ' ' PRO . 68.8 Cg_exo -36.91 -48.82 1.5 Allowed 'Trans proline' 0 N--CA 1.497 1.684 0 C-N-CA 121.038 1.159 . . . . 0.0 112.099 -179.392 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -54.94 -34.98 63.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.042 0.448 . . . . 0.0 110.028 179.568 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . 0.554 ' N ' ' O ' ' A' ' 131' ' ' PRO . . . -61.64 -22.36 65.2 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.316 179.609 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 12.1 tpp180 -77.69 -34.58 52.83 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.844 -179.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 29.9 mt -73.9 -33.52 64.04 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.63 -0.428 . . . . 0.0 109.922 179.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.586 ' O ' ' N ' ' A' ' 139' ' ' PRO . 10.1 mt -80.16 -40.37 27.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.276 -0.42 . . . . 0.0 109.973 179.315 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.493 ' O ' ' CD1' ' A' ' 138' ' ' TYR . 1.1 t80 -23.02 -40.61 0.03 OUTLIER Pre-proline 0 CA--C 1.534 0.335 0 CA-C-N 115.251 -0.886 . . . . 0.0 112.0 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.586 ' N ' ' O ' ' A' ' 137' ' ' LEU . 3.0 Cg_exo -70.59 13.51 0.35 Allowed 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 121.037 1.158 . . . . 0.0 112.237 179.698 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . 0.766 ' CE2' HD11 ' A' ' 144' ' ' LEU . 2.6 p90 -94.18 -14.81 25.21 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-O 121.27 0.557 . . . . 0.0 110.438 179.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.64 ' CD1' ' CE1' ' A' ' 140' ' ' TYR . 5.2 mp -56.41 -27.8 57.55 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.266 178.805 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -63.78 -46.43 85.28 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.002 179.451 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' TRP . . . . . 0.515 ' CE2' HD12 ' A' ' 52' ' ' ILE . 13.6 t-105 -59.61 -46.82 87.84 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 179.572 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.766 HD11 ' CE2' ' A' ' 140' ' ' TYR . 10.8 mt -52.48 -52.34 54.82 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.263 -0.575 . . . . 0.0 109.871 179.625 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.657 ' O ' HG23 ' A' ' 149' ' ' VAL . . . -64.14 -21.76 66.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.664 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 13.5 t80 -66.09 -63.0 1.18 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.828 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -68.9 -36.48 78.08 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.882 -179.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . 0.498 ' O ' ' OD1' ' A' ' 151' ' ' ASN . 14.8 m -63.32 -50.01 71.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.735 0.302 . . . . 0.0 110.684 -179.828 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.657 HG23 ' O ' ' A' ' 145' ' ' ALA . 88.3 t -65.84 -30.69 50.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.567 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 1.4 tp -60.53 -52.9 63.22 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.9 -0.32 . . . . 0.0 110.209 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . 0.498 ' OD1' ' O ' ' A' ' 148' ' ' THR . 0.8 OUTLIER -64.53 -44.04 92.12 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.905 -179.959 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . 0.495 ' N ' ' ND2' ' A' ' 151' ' ' ASN . 26.0 t80 -56.64 -44.51 81.37 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.653 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . 0.428 ' CD2' ' OD2' ' A' ' 157' ' ' ASP . 20.5 t80 -59.08 -55.07 39.85 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.574 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 64.8 t -57.35 -46.09 85.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.75 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' TRP . . . . . 0.586 ' NE1' ' O ' ' A' ' 105' ' ' MET . 5.1 m0 -48.07 -52.06 21.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.818 0.342 . . . . 0.0 110.173 179.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . 0.435 ' HA ' ' HE ' ' A' ' 156' ' ' ARG . 0.0 OUTLIER -64.7 -52.2 58.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.685 -179.83 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . 0.428 ' OD2' ' CD2' ' A' ' 153' ' ' TYR . 80.0 m-20 -50.02 -48.14 52.76 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.854 -179.689 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 29.2 t-20 . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.777 -179.991 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.711 ' CE2' ' CE3' ' A' ' 68' ' ' TRP . 0.4 OUTLIER . . . . . 0 CA--C 1.528 0.13 0 CA-C-O 120.663 0.268 . . . . 0.0 110.595 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.638 ' N ' ' CD ' ' A' ' 7' ' ' PRO . 1.0 OUTLIER -64.26 -33.32 8.96 Favored Pre-proline 0 C--N 1.328 -0.329 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 179.662 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.638 ' CD ' ' N ' ' A' ' 6' ' ' VAL . 18.9 Cg_exo -72.78 -67.12 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 121.855 1.703 . . . . 0.0 111.867 179.613 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.711 ' O ' HG23 ' A' ' 12' ' ' THR . . . -47.74 -41.89 24.12 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.319 -179.537 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.468 ' O ' ' OG1' ' A' ' 12' ' ' THR . 74.7 t -67.94 -62.41 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -178.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -53.78 -47.53 64.74 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 111.567 -0.613 . . . . 0.0 111.567 -179.163 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.415 ' N ' ' CD1' ' A' ' 11' ' ' LEU . 7.6 mp -65.34 -30.53 71.37 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.533 0.206 . . . . 0.0 111.105 -179.519 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.711 HG23 ' O ' ' A' ' 8' ' ' ALA . 6.6 p -76.14 -25.18 55.08 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.749 -0.381 . . . . 0.0 110.786 -179.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.425 ' O ' ' C ' ' A' ' 14' ' ' VAL . 9.3 mt -81.72 -36.3 28.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.673 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.428 ' N ' ' HD2' ' A' ' 15' ' ' PRO . 4.9 t -37.08 -55.08 1.74 Allowed Pre-proline 0 CA--C 1.535 0.398 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.784 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.428 ' HD2' ' N ' ' A' ' 14' ' ' VAL . 19.3 Cg_endo -60.98 -47.82 11.84 Favored 'Trans proline' 0 N--CA 1.5 1.868 0 C-N-CA 120.678 0.919 . . . . 0.0 112.125 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.9 m -46.01 -22.14 0.19 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.662 -179.556 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 83.9 mt -71.02 -55.9 7.32 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.85 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -74.84 -21.57 78.33 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 111.157 -0.777 . . . . 0.0 111.157 -179.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -69.79 -52.69 18.71 Favored Glycine 0 CA--C 1.522 0.483 0 N-CA-C 110.573 -1.011 . . . . 0.0 110.573 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 68.9 t80 -71.14 -57.88 4.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.721 0.296 . . . . 0.0 110.595 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 8.1 tpp -59.95 -25.69 65.39 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.278 -179.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -82.55 -62.98 1.81 Allowed Glycine 0 CA--C 1.525 0.718 0 C-N-CA 120.839 -0.696 . . . . 0.0 111.485 -179.421 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.582 ' O ' HG22 ' A' ' 26' ' ' VAL . . . -59.6 -15.64 20.14 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.798 -0.361 . . . . 0.0 110.659 -179.371 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 61.6 t80 -46.7 -26.19 0.88 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.981 0.42 . . . . 0.0 110.389 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 70.5 t80 -67.73 -50.65 56.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.661 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.582 HG22 ' O ' ' A' ' 23' ' ' ALA . 31.3 m -72.57 -21.03 19.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.671 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -61.24 -41.09 96.28 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.381 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -110.17 -73.44 0.74 Allowed Glycine 0 CA--C 1.525 0.702 0 N-CA-C 111.034 -0.826 . . . . 0.0 111.034 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.422 ' O ' ' CD ' ' A' ' 29' ' ' GLU . 13.0 tm-20 -46.01 -26.51 0.74 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.753 0.311 . . . . 0.0 110.57 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -65.28 -53.25 33.96 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 111.185 -0.766 . . . . 0.0 111.185 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 24.7 mt -48.5 -28.93 3.66 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.916 0.389 . . . . 0.0 110.211 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 82.8 mtt180 -84.1 -53.75 5.32 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.567 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . 0.637 ' CZ3' HD21 ' A' ' 37' ' ' LEU . 0.0 OUTLIER -44.74 -35.92 2.92 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.19 -0.459 . . . . 0.0 109.96 179.949 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.443 ' O ' ' O ' ' A' ' 37' ' ' LEU . 2.8 t80 -64.42 -46.62 82.42 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.938 179.558 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -51.18 -22.88 2.86 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.124 179.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -90.59 -73.9 1.27 Allowed Glycine 0 CA--C 1.524 0.614 0 N-CA-C 110.569 -1.013 . . . . 0.0 110.569 179.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.637 HD21 ' CZ3' ' A' ' 33' ' ' TRP . 0.6 OUTLIER -96.2 167.23 11.32 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 120.791 0.329 . . . . 0.0 110.238 179.171 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -77.57 116.09 17.86 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.963 0.411 . . . . 0.0 111.55 -178.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 8.0 mtpt -128.93 149.12 71.54 Favored Pre-proline 0 CA--C 1.532 0.275 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.562 179.385 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo . . . . . 0 C--N 1.308 -1.564 0 C-N-CA 121.199 1.266 . . . . 0.0 111.022 179.304 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.666 ' O ' HG23 ' A' ' 52' ' ' ILE . 44.1 tp . . . . . 0 CA--C 1.531 0.235 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.626 ' C ' ' H ' ' A' ' 52' ' ' ILE . . . -41.74 -28.92 0.27 Allowed Pre-proline 0 N--CA 1.466 0.358 0 C-N-CA 120.22 -0.592 . . . . 0.0 111.46 -179.138 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.426 ' HD2' ' N ' ' A' ' 50' ' ' ALA . 23.2 Cg_exo -53.05 4.06 0.03 OUTLIER 'Trans proline' 0 C--N 1.312 -1.364 0 CA-C-N 118.847 0.624 . . . . 0.0 112.123 177.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.666 HG23 ' O ' ' A' ' 49' ' ' LEU . 7.1 pt -48.44 -29.61 2.55 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.177 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 179.054 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 6.5 m0 -58.97 -45.44 90.54 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.465 -0.788 . . . . 0.0 110.89 -179.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -68.84 -42.53 78.48 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 110.901 -0.879 . . . . 0.0 110.901 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.48 ' O ' ' OG ' ' A' ' 58' ' ' SER . 51.9 m -59.04 -56.31 23.93 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.798 0.332 . . . . 0.0 110.709 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 70.4 mt -67.32 -30.45 70.29 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.665 -179.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.493 ' C ' ' CD1' ' A' ' 57' ' ' TYR . 13.7 t80 -60.8 -36.31 78.7 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.132 179.572 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.48 ' OG ' ' O ' ' A' ' 55' ' ' THR . 7.7 p -74.07 -57.92 3.64 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.047 179.587 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -48.53 -52.29 23.29 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.022 179.645 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 70.6 mtm -55.09 -47.88 74.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.072 179.608 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -46.82 -59.56 5.44 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 110.717 -0.953 . . . . 0.0 110.717 179.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 3.4 m-30 -51.84 -52.18 51.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.924 0.392 . . . . 0.0 110.116 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.501 ' O ' HG23 ' A' ' 67' ' ' VAL . . . -47.83 -46.76 25.33 Favored Glycine 0 CA--C 1.522 0.53 0 N-CA-C 110.487 -1.045 . . . . 0.0 110.487 179.674 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.537 ' O ' ' NE1' ' A' ' 68' ' ' TRP . 1.1 t -60.53 -45.04 95.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.793 0.33 . . . . 0.0 110.577 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.416 ' HA ' ' CZ2' ' A' ' 68' ' ' TRP . 84.6 t80 -48.55 -45.85 38.19 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 179.58 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 37.9 mt -72.27 -26.06 24.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.136 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.501 HG23 ' O ' ' A' ' 63' ' ' GLY . 55.8 t -65.21 -59.94 3.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 C-N-CA 120.584 -0.446 . . . . 0.0 111.09 -179.673 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' TRP . . . . . 0.711 ' CE3' ' CE2' ' A' ' 5' ' ' TRP . 0.0 OUTLIER -67.51 -33.83 75.88 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 119.9 -0.72 . . . . 0.0 110.563 -179.753 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 5.8 mmmt -69.56 -23.41 63.56 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.517 -0.473 . . . . 0.0 111.035 -179.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 19.9 tp10 -80.95 -55.61 4.67 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.941 -0.304 . . . . 0.0 111.226 -179.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.6 pp -77.04 -11.77 59.85 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.93 -0.308 . . . . 0.0 111.184 -179.301 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.491 ' O ' ' O ' ' A' ' 73' ' ' GLY . . . 107.0 87.29 1.93 Allowed Glycine 0 CA--C 1.527 0.835 0 N-CA-C 111.604 -0.598 . . . . 0.0 111.604 179.398 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.596 ' N ' ' O ' ' A' ' 68' ' ' TRP . . . 41.56 -173.82 0.01 OUTLIER Glycine 0 CA--C 1.525 0.714 0 N-CA-C 111.797 -0.521 . . . . 0.0 111.797 179.207 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 82.7 t80 -79.94 113.39 18.07 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.841 0.353 . . . . 0.0 110.548 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.548 ' OG1' ' N ' ' A' ' 76' ' ' GLU . 0.0 OUTLIER -141.89 -178.85 5.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.626 -179.86 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.548 ' N ' ' OG1' ' A' ' 75' ' ' THR . 31.8 mt-10 -54.93 -20.12 8.23 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.623 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 76.0 m-20 -83.1 -18.57 39.1 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.921 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -93.32 -20.21 20.61 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.862 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 11.7 mtp -69.01 -27.22 65.49 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.846 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 5.9 t -67.56 -46.9 47.3 Favored Pre-proline 0 CA--C 1.536 0.432 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.534 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -75.18 -61.65 0.04 OUTLIER 'Trans proline' 0 N--CA 1.499 1.845 0 C-N-CA 121.106 1.204 . . . . 0.0 111.656 178.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 4.6 mt -52.33 -50.66 61.84 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.363 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.406 ' O ' ' N ' ' A' ' 86' ' ' THR . . . -61.93 -64.04 4.27 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 111.262 -0.735 . . . . 0.0 111.262 -179.705 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 40.3 tp -46.83 -29.61 2.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.823 0.344 . . . . 0.0 110.233 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.423 ' CD1' ' C ' ' A' ' 85' ' ' TYR . 1.1 t80 -75.27 -37.68 60.82 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.033 179.744 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.406 ' N ' ' O ' ' A' ' 83' ' ' GLY . 0.8 OUTLIER -67.91 -48.92 64.63 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.094 -179.648 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -69.15 -58.04 7.06 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 111.492 -0.643 . . . . 0.0 111.492 -179.507 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 34.0 tp60 -51.45 -49.23 62.14 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-O 120.991 0.424 . . . . 0.0 110.414 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.427 ' O ' ' C ' ' A' ' 90' ' ' ALA . 27.3 tp -54.65 -62.62 1.54 Allowed 'General case' 0 C--O 1.212 -0.869 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 179.525 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.696 ' O ' ' HB2' ' A' ' 94' ' ' ALA . . . -38.24 -42.81 0.72 Allowed 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 120.537 -0.465 . . . . 0.0 111.426 -179.683 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 92.1 mt -63.16 -56.81 13.57 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 -178.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 15.8 m-20 -72.24 -54.63 9.02 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 121.431 0.634 . . . . 0.0 111.058 -178.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . 0.61 ' O ' ' N ' ' A' ' 95' ' ' TRP . 16.6 t-105 -52.75 -30.0 30.23 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.049 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.696 ' HB2' ' O ' ' A' ' 90' ' ' ALA . . . -60.38 71.8 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 121.084 0.469 . . . . 0.0 109.753 179.376 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.71 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 23.8 p-90 -98.49 -17.18 0.2 Allowed Pre-proline 0 CA--C 1.537 0.478 0 CA-C-N 115.852 -0.613 . . . . 0.0 112.336 -179.255 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.71 ' CD ' ' N ' ' A' ' 95' ' ' TRP . 52.6 Cg_exo -53.4 -39.84 80.31 Favored 'Trans proline' 0 N--CA 1.497 1.684 0 C-N-CA 120.556 0.837 . . . . 0.0 113.341 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.457 ' HD2' ' N ' ' A' ' 96' ' ' PRO . 31.7 Cg_exo -36.52 -34.94 0.17 Allowed 'Trans proline' 0 N--CA 1.491 1.327 0 CA-C-N 119.143 0.73 . . . . 0.0 113.185 -179.727 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -79.58 24.27 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 121.024 0.44 . . . . 0.0 110.386 179.696 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.537 ' N ' ' O ' ' A' ' 96' ' ' PRO . 27.0 t80 -44.31 -34.93 2.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.666 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -86.19 -42.97 13.39 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.893 -179.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -61.42 -9.59 18.12 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 111.07 -0.812 . . . . 0.0 111.07 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -61.55 -13.27 20.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.748 0.309 . . . . 0.0 110.935 -179.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 25.3 ptt180 -90.68 4.56 51.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.809 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 12.1 mt-30 -115.28 154.2 29.53 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.435 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -52.71 -18.26 1.73 Allowed 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 179.559 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.583 ' O ' ' N ' ' A' ' 108' ' ' ALA . . . -69.43 -15.96 71.01 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' TRP . . . . . 0.452 ' CD1' ' N ' ' A' ' 108' ' ' ALA . 0.1 OUTLIER -45.36 -11.67 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.9 0.381 . . . . 0.0 110.54 -179.865 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.583 ' N ' ' O ' ' A' ' 106' ' ' GLY . . . -59.32 -23.15 62.24 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.193 179.657 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 13.9 mt -53.7 -28.66 35.05 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.383 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -56.71 -61.37 2.48 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.862 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.716 ' O ' HG23 ' A' ' 115' ' ' VAL . 1.4 p30 -61.53 -52.29 65.08 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.785 -179.293 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.531 ' N ' ' CG ' ' A' ' 111' ' ' ASP . 56.1 tp -55.42 -38.41 68.93 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.716 -178.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.42 HD23 ' HA ' ' A' ' 113' ' ' LEU . 51.7 mt -71.4 -61.81 1.64 Allowed 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.36 0.504 . . . . 0.0 112.36 -178.611 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.6 pp -59.75 -32.84 70.95 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.213 -0.595 . . . . 0.0 110.95 -178.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.716 HG23 ' O ' ' A' ' 111' ' ' ASP . 41.3 t -61.7 -59.47 4.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.752 179.767 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . 0.49 ' O ' ' OG1' ' A' ' 120' ' ' THR . 49.4 m -68.84 -22.1 64.25 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.428 -179.261 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -66.51 -62.58 4.49 Favored Glycine 0 CA--C 1.527 0.823 0 C-N-CA 121.039 -0.601 . . . . 0.0 111.934 -179.124 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.6 ' O ' HG23 ' A' ' 122' ' ' THR . 7.0 p -72.43 -36.91 56.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 C-N-CA 120.915 -0.314 . . . . 0.0 111.411 -179.23 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.531 ' O ' ' OG1' ' A' ' 123' ' ' THR . . . -67.41 -61.01 2.11 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.593 -0.443 . . . . 0.0 110.953 -179.362 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.49 ' OG1' ' O ' ' A' ' 116' ' ' SER . 2.8 m -58.64 -55.33 36.53 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.234 -179.584 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.419 ' O ' ' CB ' ' A' ' 125' ' ' ALA . . . -50.53 -41.95 54.45 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.304 -179.352 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.6 HG23 ' O ' ' A' ' 118' ' ' VAL . 38.9 p -73.32 -39.72 65.04 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 111.844 0.313 . . . . 0.0 111.844 -179.095 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.531 ' OG1' ' O ' ' A' ' 119' ' ' ALA . 0.1 OUTLIER -54.09 -50.28 67.17 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.91 -179.268 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.6 pp -84.11 -20.32 32.76 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.198 -0.455 . . . . 0.0 112.077 -178.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.419 ' CB ' ' O ' ' A' ' 121' ' ' ALA . . . -88.68 -70.68 0.63 Allowed 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 -178.47 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' TRP . . . . . 0.55 ' N ' ' CD1' ' A' ' 126' ' ' TRP . 18.6 m0 -83.93 -58.0 2.97 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 112.84 0.681 . . . . 0.0 112.84 -177.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 18.9 m170 -49.77 -22.23 1.35 Allowed 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.458 -0.497 . . . . 0.0 110.932 -179.128 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 1.4 tmt_? -73.44 -29.47 62.57 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.023 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 14.6 t -99.76 -49.85 11.07 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 CA-C-O 120.942 0.401 . . . . 0.0 110.763 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -115.56 105.83 51.36 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.202 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . 0.64 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 76.9 Cg_exo -72.77 -24.34 18.22 Favored 'Trans proline' 0 C--N 1.311 -1.398 0 C-N-CA 121.59 1.526 . . . . 0.0 112.686 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . 0.64 ' CD ' ' N ' ' A' ' 131' ' ' PRO . 51.2 Cg_exo -66.21 -47.47 3.34 Favored 'Trans proline' 0 N--CA 1.496 1.627 0 C-N-CA 121.292 1.328 . . . . 0.0 112.084 179.624 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -50.41 -39.39 47.03 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.568 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -53.92 -23.48 13.02 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.404 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 11.0 tpp180 -78.25 -32.4 49.63 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.545 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 47.0 mt -72.77 -33.47 66.34 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.32 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.58 ' O ' ' N ' ' A' ' 140' ' ' TYR . 5.6 mt -84.09 -39.26 19.74 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.002 -0.545 . . . . 0.0 109.855 179.519 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.477 ' C ' ' O ' ' A' ' 137' ' ' LEU . 2.0 t80 -23.72 -43.67 0.05 OUTLIER Pre-proline 0 CA--C 1.534 0.338 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.82 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.516 ' N ' ' O ' ' A' ' 137' ' ' LEU . 3.4 Cg_exo -67.61 10.96 0.24 Allowed 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 120.984 1.123 . . . . 0.0 112.561 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . 0.871 ' CE2' HD11 ' A' ' 144' ' ' LEU . 1.5 p90 -93.83 -14.88 25.65 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 121.083 0.468 . . . . 0.0 110.483 179.819 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.618 ' CD1' ' CE1' ' A' ' 140' ' ' TYR . 4.1 mp -53.63 -32.45 51.36 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 179.004 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -60.33 -52.46 65.17 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.217 179.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' TRP . . . . . 0.545 ' CE2' HD12 ' A' ' 52' ' ' ILE . 7.7 t-105 -53.08 -49.66 65.95 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 179.577 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.871 HD11 ' CE2' ' A' ' 140' ' ' TYR . 10.5 mt -49.99 -59.6 3.72 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.015 179.51 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.614 ' O ' HG23 ' A' ' 149' ' ' VAL . . . -58.73 -20.71 51.49 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.056 -179.684 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -67.18 -57.6 6.43 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.805 -0.358 . . . . 0.0 110.402 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -66.08 -47.4 74.38 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.216 179.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 7.1 m -55.68 -51.35 67.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.709 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.614 HG23 ' O ' ' A' ' 145' ' ' ALA . 90.7 t -64.68 -26.53 40.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 C-N-CA 120.895 -0.322 . . . . 0.0 110.278 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -60.72 -55.0 38.38 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.313 -0.555 . . . . 0.0 109.794 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . 0.495 ' ND2' ' OD2' ' A' ' 111' ' ' ASP . 1.9 m-80 -65.85 -39.89 91.19 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.694 -0.403 . . . . 0.0 110.357 179.429 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 29.3 t80 -56.05 -46.19 78.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.569 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . 0.408 ' O ' ' OD1' ' A' ' 157' ' ' ASP . 5.5 t80 -63.56 -44.66 93.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.479 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 79.5 t -57.74 -45.15 86.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.653 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' TRP . . . . . . . . . . . . . 10.2 m0 -56.45 -56.98 14.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.518 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -49.16 -38.71 26.4 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.589 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . 0.408 ' OD1' ' O ' ' A' ' 153' ' ' TYR . 1.5 m-20 -75.41 -52.04 11.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.803 0.335 . . . . 0.0 110.675 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' ASN . . . . . 0.532 HD21 ' CB ' ' A' ' 37' ' ' LEU . 4.7 m120 . . . . . 0 C--N 1.327 -0.409 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.648 -179.772 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.69 ' CE2' ' CE3' ' A' ' 68' ' ' TRP . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.094 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.609 ' N ' ' CD ' ' A' ' 7' ' ' PRO . 0.9 OUTLIER -61.66 -35.5 22.96 Favored Pre-proline 0 CA--C 1.532 0.277 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 -179.914 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.609 ' CD ' ' N ' ' A' ' 6' ' ' VAL . 18.6 Cg_exo -70.83 -67.53 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.509 0 C-N-CA 121.686 1.59 . . . . 0.0 111.835 179.541 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.656 ' O ' HG23 ' A' ' 12' ' ' THR . . . -46.79 -40.27 13.37 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.202 -179.652 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.572 HG23 ' O ' ' A' ' 5' ' ' TRP . 73.8 t -65.24 -61.97 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 112.062 0.393 . . . . 0.0 112.062 -178.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -58.38 -49.49 75.81 Favored Glycine 0 CA--C 1.527 0.837 0 N-CA-C 111.269 -0.732 . . . . 0.0 111.269 -179.158 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 9.3 mp -58.87 -30.54 67.81 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.538 0.209 . . . . 0.0 110.755 -179.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.656 HG23 ' O ' ' A' ' 8' ' ' ALA . 7.5 p -78.66 -31.18 46.64 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 120.801 -0.36 . . . . 0.0 110.191 179.548 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.416 ' HA ' HD23 ' A' ' 13' ' ' LEU . 81.2 mt -73.53 -22.17 60.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.117 179.656 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.498 ' O ' ' N ' ' A' ' 16' ' ' SER . 9.7 t -58.22 -66.6 1.26 Allowed Pre-proline 0 CA--C 1.536 0.434 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.312 -179.798 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -45.49 -14.87 0.11 Allowed 'Trans proline' 0 N--CA 1.499 1.799 0 C-N-CA 120.778 0.985 . . . . 0.0 112.074 -179.625 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.498 ' N ' ' O ' ' A' ' 14' ' ' VAL . 1.1 t -76.17 -35.99 58.9 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.866 0.365 . . . . 0.0 110.6 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 8.9 mt -69.75 -45.12 68.8 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.172 -179.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -73.6 -48.86 16.25 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 111.631 -0.588 . . . . 0.0 111.631 -179.545 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -63.24 -30.16 76.67 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 111.18 -0.768 . . . . 0.0 111.18 -179.576 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 64.4 t80 -75.95 -60.77 2.18 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.838 -0.345 . . . . 0.0 111.107 -179.528 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 28.0 ttp -61.59 -21.31 64.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.908 0.385 . . . . 0.0 110.324 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.515 ' C ' ' CZ2' ' A' ' 95' ' ' TRP . . . -73.45 -62.9 2.92 Favored Glycine 0 CA--C 1.524 0.615 0 N-CA-C 111.135 -0.786 . . . . 0.0 111.135 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.94 -16.49 63.92 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.54 -179.752 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 42.8 t80 -49.93 -24.15 2.37 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 179.264 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 9.7 t80 -72.11 -53.41 12.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.862 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 16.4 m -72.09 -14.58 17.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.81 -179.668 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.64 -42.69 75.35 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.255 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -121.45 -49.86 0.26 Allowed Glycine 0 CA--C 1.525 0.709 0 N-CA-C 110.693 -0.963 . . . . 0.0 110.693 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -56.01 -32.03 63.61 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.887 0.375 . . . . 0.0 110.417 179.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -75.46 -58.23 3.96 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.874 -0.89 . . . . 0.0 110.874 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 11.0 mp -53.49 -21.89 7.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.903 0.382 . . . . 0.0 110.06 179.676 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 38.9 mtp180 -84.86 -54.98 4.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.526 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -48.52 -30.57 5.36 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.182 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 52.1 t80 -50.3 -40.02 47.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.877 0.37 . . . . 0.0 110.31 179.723 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -58.91 -17.42 24.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.393 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -100.44 -72.15 0.99 Allowed Glycine 0 CA--C 1.527 0.796 0 N-CA-C 111.003 -0.839 . . . . 0.0 111.003 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.575 ' O ' HD12 ' A' ' 37' ' ' LEU . 0.3 OUTLIER -95.45 167.08 11.54 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.838 0.352 . . . . 0.0 110.828 179.861 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.51 ' NE2' ' H ' ' A' ' 38' ' ' GLN . 2.4 mp0 -81.62 113.38 19.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.126 -179.673 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 15.4 mtpt -129.05 160.19 64.91 Favored Pre-proline 0 CA--C 1.531 0.248 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.718 179.489 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo . . . . . 0 C--N 1.309 -1.538 0 C-N-CA 121.806 1.671 . . . . 0.0 111.381 179.356 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.823 ' O ' HG23 ' A' ' 52' ' ' ILE . 0.2 OUTLIER . . . . . 0 CA--C 1.533 0.297 0 N-CA-C 112.243 0.46 . . . . 0.0 112.243 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.587 ' C ' ' H ' ' A' ' 52' ' ' ILE . . . -38.3 -33.78 0.25 Allowed Pre-proline 0 C--O 1.235 0.337 0 C-N-CA 120.771 -0.372 . . . . 0.0 111.431 -179.03 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.43 ' HD2' ' N ' ' A' ' 50' ' ' ALA . 34.4 Cg_exo -53.69 4.93 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.613 0 C-N-CA 120.355 0.703 . . . . 0.0 112.773 178.816 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.823 HG23 ' O ' ' A' ' 49' ' ' LEU . 10.5 pt -54.08 -35.65 29.57 Favored 'Isoleucine or valine' 0 C--O 1.232 0.169 0 CA-C-O 121.248 0.547 . . . . 0.0 109.542 179.157 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.421 ' O ' ' CB ' ' A' ' 57' ' ' TYR . 62.3 m95 -73.17 -22.95 60.38 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.244 -0.889 . . . . 0.0 111.35 -179.285 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -70.49 -48.15 38.33 Favored Glycine 0 CA--C 1.527 0.812 0 N-CA-C 110.481 -1.048 . . . . 0.0 110.481 179.503 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 11.0 m -65.75 -55.28 18.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.969 0.414 . . . . 0.0 109.909 179.58 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.562 ' O ' ' SD ' ' A' ' 60' ' ' MET . 94.8 mt -56.71 -36.29 69.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.954 179.463 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.548 ' C ' ' CD1' ' A' ' 57' ' ' TYR . 0.4 OUTLIER -54.76 -52.03 63.84 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 179.109 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 3.1 m -52.23 -47.26 65.8 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 178.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -56.26 -46.24 79.74 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.343 179.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.562 ' SD ' ' O ' ' A' ' 56' ' ' LEU . 0.0 OUTLIER -61.87 -40.74 96.44 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.334 179.926 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -52.46 -52.89 34.69 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 110.641 -0.984 . . . . 0.0 110.641 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.46 ' CD1' ' N ' ' A' ' 62' ' ' TYR . 1.1 m-85 -65.78 -40.86 92.38 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.925 0.393 . . . . 0.0 110.376 179.762 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.46 ' O ' HG23 ' A' ' 67' ' ' VAL . . . -54.19 -52.55 43.13 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 110.342 -1.103 . . . . 0.0 110.342 179.644 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.587 ' O ' ' CD1' ' A' ' 68' ' ' TRP . 1.0 OUTLIER -56.47 -44.56 80.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.86 0.362 . . . . 0.0 110.42 179.684 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.45 ' HA ' ' CZ2' ' A' ' 68' ' ' TRP . 85.4 t80 -48.45 -47.35 38.27 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.674 -0.41 . . . . 0.0 110.083 179.651 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 53.3 mt -70.7 -25.95 27.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.041 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.46 HG23 ' O ' ' A' ' 63' ' ' GLY . 68.8 t -66.02 -58.79 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 C-N-CA 120.582 -0.447 . . . . 0.0 111.578 -179.41 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' TRP . . . . . 0.69 ' CE3' ' CE2' ' A' ' 5' ' ' TRP . 0.0 OUTLIER -71.79 -27.8 63.18 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 119.656 -0.818 . . . . 0.0 110.69 -179.643 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 9.4 mmmt -72.25 -24.2 61.33 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.468 -0.493 . . . . 0.0 110.352 179.658 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -82.31 -59.18 2.63 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.949 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.5 pp -71.67 -16.77 62.26 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.02 -179.548 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.5 ' O ' ' O ' ' A' ' 73' ' ' GLY . . . 108.39 94.53 2.34 Favored Glycine 0 CA--C 1.527 0.826 0 N-CA-C 111.703 -0.559 . . . . 0.0 111.703 179.459 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.585 ' N ' ' O ' ' A' ' 68' ' ' TRP . . . 42.02 -174.1 0.01 OUTLIER Glycine 0 CA--C 1.525 0.704 0 N-CA-C 111.799 -0.52 . . . . 0.0 111.799 179.198 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 32.4 t80 -87.22 113.21 22.75 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.547 -0.327 . . . . 0.0 110.595 -179.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.528 ' OG1' ' N ' ' A' ' 76' ' ' GLU . 0.8 OUTLIER -142.13 -177.41 5.22 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.686 -179.909 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.528 ' N ' ' OG1' ' A' ' 75' ' ' THR . 29.5 mt-10 -51.78 -23.14 4.27 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.796 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -79.72 -24.58 41.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.939 -179.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.446 ' O ' HD12 ' A' ' 82' ' ' LEU . . . -90.33 -20.59 22.7 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.003 -179.836 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 14.9 mtp -69.49 -28.66 66.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.806 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.416 ' O ' ' CB ' ' A' ' 84' ' ' LEU . 5.9 t -67.16 -50.77 39.01 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.507 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.4 ' HD2' ' N ' ' A' ' 80' ' ' VAL . 14.7 Cg_endo -69.52 -60.45 0.07 OUTLIER 'Trans proline' 0 N--CA 1.499 1.846 0 C-N-CA 121.065 1.177 . . . . 0.0 111.81 179.031 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.446 HD12 ' O ' ' A' ' 78' ' ' ALA . 1.3 mt -53.37 -51.95 60.84 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.614 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -62.84 -63.33 4.7 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 111.383 -0.687 . . . . 0.0 111.383 -179.485 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.416 ' CB ' ' O ' ' A' ' 80' ' ' VAL . 52.6 tp -45.87 -31.64 2.23 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.749 0.309 . . . . 0.0 110.647 -179.845 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 7.0 t80 -67.96 -58.51 4.42 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.274 -179.729 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 3.5 m -61.89 -60.35 3.77 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.841 -179.754 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -45.56 -57.11 6.04 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 111.112 -0.795 . . . . 0.0 111.112 -179.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 11.1 tp-100 -58.94 -32.85 69.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.759 0.314 . . . . 0.0 110.679 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.445 ' O ' ' CD1' ' A' ' 93' ' ' TRP . 11.8 tp -67.73 -36.59 80.85 Favored 'General case' 0 C--O 1.222 -0.379 0 C-N-CA 120.685 -0.406 . . . . 0.0 110.306 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.856 ' O ' ' HB2' ' A' ' 94' ' ' ALA . . . -65.81 -59.91 3.41 Favored 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 120.268 -0.573 . . . . 0.0 110.379 179.833 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.416 ' N ' HD23 ' A' ' 91' ' ' LEU . 7.9 mt -55.31 -53.89 50.44 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.786 -0.643 . . . . 0.0 112.21 -179.085 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -75.2 -60.83 2.12 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -177.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . 0.611 ' O ' ' N ' ' A' ' 95' ' ' TRP . 0.0 OUTLIER -63.78 -11.74 29.4 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.192 0.441 . . . . 0.0 112.192 -177.688 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.856 ' HB2' ' O ' ' A' ' 90' ' ' ALA . . . -54.12 80.5 0.0 OUTLIER 'General case' 0 CA--C 1.528 0.126 0 C-N-CA 120.399 -0.521 . . . . 0.0 109.76 179.224 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.689 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 14.6 p-90 -101.22 -15.23 0.18 Allowed Pre-proline 0 CA--C 1.534 0.338 0 CA-C-N 116.208 -0.451 . . . . 0.0 112.086 -179.312 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.689 ' CD ' ' N ' ' A' ' 95' ' ' TRP . 64.8 Cg_exo -64.12 -12.65 33.48 Favored 'Trans proline' 0 N--CA 1.498 1.768 0 C-N-CA 120.875 1.05 . . . . 0.0 113.558 179.634 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.621 ' CD ' ' N ' ' A' ' 96' ' ' PRO . 51.2 Cg_exo -85.33 -8.79 8.55 Favored 'Trans proline' 0 N--CA 1.502 1.978 0 C-N-CA 120.753 0.968 . . . . 0.0 113.519 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.416 ' O ' ' N ' ' A' ' 101' ' ' GLY . 1.5 pp -84.18 18.62 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 C-N-CA 120.608 -0.437 . . . . 0.0 110.932 -179.661 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.565 ' CD1' ' O ' ' A' ' 96' ' ' PRO . 2.7 m-30 -39.85 -34.12 0.25 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.211 179.673 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.457 ' O ' ' NE ' ' A' ' 103' ' ' ARG . 0.9 OUTLIER -76.36 -45.08 33.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.745 -179.902 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.416 ' N ' ' O ' ' A' ' 98' ' ' ILE . . . -65.98 -9.98 49.36 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 110.97 -0.852 . . . . 0.0 110.97 -179.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -78.35 -7.17 56.98 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.749 0.309 . . . . 0.0 110.724 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.457 ' NE ' ' O ' ' A' ' 100' ' ' PHE . 1.2 ptp180 -79.16 -14.8 58.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.867 -179.769 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . 0.407 ' C ' ' N ' ' A' ' 106' ' ' GLY . 1.4 pt20 -125.82 172.58 9.74 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.826 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.493 ' N ' ' SD ' ' A' ' 105' ' ' MET . 0.0 OUTLIER -49.37 -16.88 0.21 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.457 179.822 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.437 ' C ' ' N ' ' A' ' 108' ' ' ALA . . . -60.6 -15.79 41.84 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 111.1 -0.8 . . . . 0.0 111.1 -179.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' TRP . . . . . 0.481 ' CD1' ' N ' ' A' ' 108' ' ' ALA . 0.0 OUTLIER -50.48 -14.46 0.18 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.848 0.356 . . . . 0.0 110.432 -179.779 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.481 ' N ' ' CD1' ' A' ' 107' ' ' TRP . . . -61.11 -17.55 53.3 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.212 179.621 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 6.0 mp -56.67 -28.56 60.96 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.671 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -58.71 -62.63 1.72 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.845 0.355 . . . . 0.0 110.672 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.691 ' O ' HG23 ' A' ' 115' ' ' VAL . 4.4 p-10 -57.29 -53.67 55.53 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.358 -179.429 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 29.9 tp -54.45 -43.13 71.37 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.773 -179.034 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 53.7 mt -67.54 -61.3 1.96 Allowed 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.584 0.587 . . . . 0.0 112.584 -178.387 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.9 pp -61.09 -34.36 74.82 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 120.445 -0.502 . . . . 0.0 111.572 -178.555 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.691 HG23 ' O ' ' A' ' 111' ' ' ASP . 48.1 t -61.49 -58.0 9.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.383 -0.372 . . . . 0.0 111.385 -179.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 23.4 p -71.9 -23.59 61.51 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.603 -179.091 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -64.61 -62.14 5.31 Favored Glycine 0 CA--C 1.525 0.67 0 C-N-CA 120.842 -0.694 . . . . 0.0 111.472 -179.389 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.6 ' O ' HG23 ' A' ' 122' ' ' THR . 9.8 p -70.71 -37.18 68.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 111.874 0.324 . . . . 0.0 111.874 -179.336 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.512 ' O ' ' OG1' ' A' ' 123' ' ' THR . . . -67.96 -60.91 2.14 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.545 -0.462 . . . . 0.0 111.63 -179.087 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 6.4 m -59.47 -51.84 68.16 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.909 0.385 . . . . 0.0 111.464 -179.299 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -53.92 -43.37 69.71 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.272 -179.203 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.6 HG23 ' O ' ' A' ' 118' ' ' VAL . 38.0 p -71.13 -30.81 66.95 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 111.971 0.36 . . . . 0.0 111.971 -179.135 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.512 ' OG1' ' O ' ' A' ' 119' ' ' ALA . 0.1 OUTLIER -64.72 -48.79 73.32 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 120.851 -0.34 . . . . 0.0 111.074 -179.141 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.8 pp -82.79 -19.92 36.8 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.763 -0.375 . . . . 0.0 111.531 -179.021 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -88.93 -69.59 0.7 Allowed 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.594 0.591 . . . . 0.0 112.594 -178.689 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' TRP . . . . . 0.445 ' N ' ' CD1' ' A' ' 126' ' ' TRP . 36.9 m0 -83.14 -57.53 3.23 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 -177.751 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . 0.47 ' CD2' ' N ' ' A' ' 127' ' ' HIS . 10.0 m170 -52.12 -22.18 3.95 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.418 -0.513 . . . . 0.0 111.06 -178.661 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 2.8 tmt_? -71.07 -43.39 67.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.504 -0.317 . . . . 0.0 111.225 -179.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 14.9 t -86.92 -49.6 14.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 C-N-CA 120.922 -0.311 . . . . 0.0 111.054 -179.523 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 7.5 m -120.11 110.83 35.92 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.434 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . 0.627 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 73.6 Cg_exo -71.34 -33.78 10.68 Favored 'Trans proline' 0 N--CA 1.491 1.345 0 C-N-CA 121.373 1.382 . . . . 0.0 112.387 179.488 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . 0.627 ' CD ' ' N ' ' A' ' 131' ' ' PRO . 37.1 Cg_exo -55.36 -39.09 92.91 Favored 'Trans proline' 0 N--CA 1.495 1.595 0 C-N-CA 121.31 1.34 . . . . 0.0 111.75 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -55.91 -34.66 65.78 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.334 179.772 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . 0.403 ' HB2' ' CG ' ' A' ' 127' ' ' HIS . . . -64.83 -24.97 67.71 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.38 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 13.5 tpt180 -77.12 -29.12 54.59 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.362 179.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 18.4 mt -74.9 -41.05 60.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.379 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.574 ' O ' ' N ' ' A' ' 140' ' ' TYR . 5.0 mt -78.82 -35.49 44.06 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.152 179.624 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.481 ' C ' ' O ' ' A' ' 137' ' ' LEU . 2.0 t80 -23.4 -44.75 0.05 OUTLIER Pre-proline 0 CA--C 1.535 0.372 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.853 -179.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.515 ' N ' ' O ' ' A' ' 137' ' ' LEU . 1.7 Cg_endo -67.91 12.6 0.21 Allowed 'Trans proline' 0 C--N 1.309 -1.5 0 C-N-CA 121.188 1.259 . . . . 0.0 112.57 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . 0.865 ' CE2' HD11 ' A' ' 144' ' ' LEU . 1.7 p90 -93.41 -14.2 27.08 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-O 121.008 0.432 . . . . 0.0 110.633 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.492 HD22 ' CE1' ' A' ' 140' ' ' TYR . 4.1 mm? -53.37 -38.64 63.54 Favored 'General case' 0 C--N 1.333 -0.122 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 178.754 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -54.99 -46.58 75.14 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.549 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' TRP . . . . . 0.627 ' CE2' HD12 ' A' ' 52' ' ' ILE . 9.5 t-105 -59.21 -49.36 78.16 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.773 -0.455 . . . . 0.0 109.773 179.807 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.865 HD11 ' CE2' ' A' ' 140' ' ' TYR . 12.2 mt -51.89 -54.5 28.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.086 179.722 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.628 ' O ' HG23 ' A' ' 149' ' ' VAL . . . -60.5 -27.01 67.26 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.536 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -60.99 -64.56 0.91 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.533 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -63.83 -49.14 74.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.694 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 73.8 m -51.21 -47.22 62.33 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.911 -179.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.628 HG23 ' O ' ' A' ' 145' ' ' ALA . 53.3 t -65.24 -34.47 70.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.882 -179.738 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 1.7 tp -57.15 -55.56 33.22 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.837 0.351 . . . . 0.0 110.307 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -58.12 -57.12 14.22 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.413 179.697 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 18.5 t80 -46.76 -47.26 20.8 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.589 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 43.6 t80 -55.79 -42.98 76.38 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.611 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 89.1 t -66.53 -40.42 86.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.826 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' TRP . . . . . 0.515 ' C ' ' HE ' ' A' ' 156' ' ' ARG . 8.8 m0 -58.61 -39.74 81.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.801 -179.707 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . 0.515 ' HE ' ' C ' ' A' ' 155' ' ' TRP . 0.0 OUTLIER -79.29 -45.93 18.75 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.504 -179.885 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -64.19 -50.11 69.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.445 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.524 -179.945 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.663 ' CE2' ' CE3' ' A' ' 68' ' ' TRP . 0.4 OUTLIER . . . . . 0 N--CA 1.46 0.067 0 CA-C-O 120.781 0.324 . . . . 0.0 110.287 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.626 ' N ' ' CD ' ' A' ' 7' ' ' PRO . 0.9 OUTLIER -64.61 -32.79 7.52 Favored Pre-proline 0 CA--C 1.534 0.335 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 179.743 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.626 ' CD ' ' N ' ' A' ' 6' ' ' VAL . 23.8 Cg_exo -72.61 -67.02 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 121.888 1.726 . . . . 0.0 112.156 179.654 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.696 ' O ' HG23 ' A' ' 12' ' ' THR . . . -50.93 -38.24 49.09 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.541 -0.3 . . . . 0.0 111.278 -179.565 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.559 HG23 ' O ' ' A' ' 5' ' ' TRP . 75.5 t -67.63 -62.25 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.756 -179.14 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -56.74 -47.61 84.16 Favored Glycine 0 CA--C 1.527 0.79 0 N-CA-C 111.743 -0.543 . . . . 0.0 111.743 -179.192 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.414 ' N ' ' CD1' ' A' ' 11' ' ' LEU . 7.7 mp -64.02 -30.91 71.95 Favored 'General case' 0 C--N 1.326 -0.433 0 O-C-N 122.921 -0.164 . . . . 0.0 111.052 -179.498 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.696 HG23 ' O ' ' A' ' 8' ' ' ALA . 7.5 p -74.96 -25.15 58.66 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.621 -0.432 . . . . 0.0 110.129 179.549 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.454 ' O ' ' CB ' ' A' ' 16' ' ' SER . 9.4 mt -80.65 -32.26 36.21 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.133 179.563 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.42 ' N ' ' HD2' ' A' ' 15' ' ' PRO . 17.9 t -44.65 -53.29 15.5 Favored Pre-proline 0 CA--C 1.536 0.414 0 CA-C-N 115.894 -0.593 . . . . 0.0 111.237 -179.806 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.42 ' HD2' ' N ' ' A' ' 14' ' ' VAL . 18.6 Cg_endo -62.56 -7.53 10.97 Favored 'Trans proline' 0 N--CA 1.499 1.82 0 C-N-CA 120.591 0.861 . . . . 0.0 111.882 179.582 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.454 ' CB ' ' O ' ' A' ' 13' ' ' LEU . 3.7 t -77.69 -26.37 50.15 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.543 -179.866 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 15.9 mt -76.73 -49.66 15.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.85 -179.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -77.79 -29.27 55.21 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 111.329 -0.708 . . . . 0.0 111.329 -179.652 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -76.72 -37.49 34.3 Favored Glycine 0 CA--C 1.523 0.539 0 N-CA-C 110.877 -0.889 . . . . 0.0 110.877 -179.829 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 77.9 t80 -72.85 -55.81 6.12 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.875 0.369 . . . . 0.0 110.295 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 32.5 ttp -69.81 -22.09 63.34 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.464 179.768 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.462 ' C ' ' CZ2' ' A' ' 95' ' ' TRP . . . -69.99 -63.38 3.33 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 111.159 -0.776 . . . . 0.0 111.159 -179.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.496 ' O ' HG22 ' A' ' 26' ' ' VAL . . . -68.86 -20.77 64.29 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 120.999 -0.281 . . . . 0.0 110.793 -179.623 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 56.5 t80 -47.27 -25.15 0.88 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.872 0.367 . . . . 0.0 110.479 179.706 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.426 ' CZ ' ' HB3' ' A' ' 102' ' ' ALA . 24.8 t80 -67.55 -55.55 13.01 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.797 -179.871 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.496 HG22 ' O ' ' A' ' 23' ' ' ALA . 27.5 m -68.08 -16.79 21.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.867 -179.663 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 3.3 ttm180 -60.5 -41.13 93.68 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.037 -179.613 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -104.74 -74.32 0.96 Allowed Glycine 0 CA--C 1.525 0.686 0 N-CA-C 111.393 -0.683 . . . . 0.0 111.393 -179.57 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.412 ' OE1' ' CZ ' ' A' ' 25' ' ' PHE . 22.8 tt0 -44.38 -33.02 1.51 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.641 0.258 . . . . 0.0 110.965 -179.515 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -63.38 -51.61 53.27 Favored Glycine 0 CA--C 1.526 0.757 0 N-CA-C 111.222 -0.751 . . . . 0.0 111.222 -179.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 83.6 mt -49.43 -47.24 48.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.728 0.299 . . . . 0.0 110.851 -179.829 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 67.8 mtm180 -68.79 -49.38 59.1 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.86 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -45.13 -43.61 9.92 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.429 -179.717 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 75.9 t80 -46.11 -45.13 16.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.802 -179.656 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -57.42 -25.91 60.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.811 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -87.64 -73.8 1.28 Allowed Glycine 0 CA--C 1.526 0.74 0 N-CA-C 110.901 -0.88 . . . . 0.0 110.901 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.566 ' O ' HD12 ' A' ' 37' ' ' LEU . 0.3 OUTLIER -95.89 167.63 11.13 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.873 0.368 . . . . 0.0 110.673 179.838 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.524 ' NE2' ' C ' ' A' ' 38' ' ' GLN . 0.0 OUTLIER -81.74 114.76 20.61 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.778 -179.725 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 11.0 mtpt -128.77 148.78 70.04 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.076 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo . . . . . 0 C--N 1.308 -1.566 0 C-N-CA 121.445 1.43 . . . . 0.0 110.968 179.293 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.673 ' O ' HG23 ' A' ' 52' ' ' ILE . 27.6 tp . . . . . 0 CA--C 1.532 0.265 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.643 ' C ' ' H ' ' A' ' 52' ' ' ILE . . . -41.22 -28.46 0.24 Allowed Pre-proline 0 C--O 1.234 0.27 0 C-N-CA 120.141 -0.623 . . . . 0.0 111.516 -179.021 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.418 ' HD2' ' N ' ' A' ' 50' ' ' ALA . 22.3 Cg_exo -53.63 5.16 0.03 OUTLIER 'Trans proline' 0 C--N 1.313 -1.317 0 CA-C-N 118.955 0.663 . . . . 0.0 112.085 177.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.673 HG23 ' O ' ' A' ' 49' ' ' LEU . 7.2 pt -49.37 -29.27 3.73 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.144 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 178.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.605 ' O ' ' CD1' ' A' ' 57' ' ' TYR . 2.8 m0 -66.06 -45.91 79.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.799 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -59.34 -60.26 9.14 Favored Glycine 0 CA--C 1.527 0.82 0 N-CA-C 111.593 -0.603 . . . . 0.0 111.593 -179.609 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.734 HG23 ' H ' ' A' ' 56' ' ' LEU . 5.3 t -56.21 -60.71 3.11 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 121.033 -0.267 . . . . 0.0 111.329 -179.279 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.734 ' H ' HG23 ' A' ' 55' ' ' THR . 82.6 mt -50.82 -44.68 59.23 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 120.59 -0.444 . . . . 0.0 110.478 -179.744 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.605 ' CD1' ' O ' ' A' ' 53' ' ' TRP . 3.7 m-30 -50.93 -46.96 61.08 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 75.7 m -57.89 -42.15 84.05 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.187 -0.46 . . . . 0.0 109.911 179.584 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.78 -37.24 86.65 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.203 179.627 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 41.5 mtt -67.69 -49.18 64.07 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.462 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -52.09 -48.57 52.27 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 111.108 -0.797 . . . . 0.0 111.108 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -60.97 -56.69 18.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.868 0.366 . . . . 0.0 110.512 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.486 ' O ' HG23 ' A' ' 67' ' ' VAL . . . -49.55 -48.47 35.11 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.504 -1.038 . . . . 0.0 110.504 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.523 ' O ' ' NE1' ' A' ' 68' ' ' TRP . 1.2 t -57.7 -44.92 86.22 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.667 0.27 . . . . 0.0 110.707 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.451 ' HA ' ' CZ2' ' A' ' 68' ' ' TRP . 87.3 t80 -50.79 -44.52 58.9 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 179.301 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 69.9 mt -70.79 -25.16 25.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.787 179.598 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.486 HG23 ' O ' ' A' ' 63' ' ' GLY . 77.9 t -68.8 -59.04 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.155 0 C-N-CA 120.69 -0.404 . . . . 0.0 111.192 -179.67 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' TRP . . . . . 0.663 ' CE3' ' CE2' ' A' ' 5' ' ' TRP . 0.0 OUTLIER -67.65 -28.1 67.43 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 119.973 -0.691 . . . . 0.0 110.646 -179.666 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -73.22 -28.18 62.02 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.532 -0.467 . . . . 0.0 110.526 -179.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 32.0 tp10 -76.85 -59.99 2.54 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.79 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.447 HD11 ' O ' ' A' ' 73' ' ' GLY . 3.3 pp -69.11 -22.14 63.99 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.717 -179.744 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.497 ' O ' ' O ' ' A' ' 73' ' ' GLY . . . 110.68 97.58 2.43 Favored Glycine 0 CA--C 1.526 0.775 0 N-CA-C 111.585 -0.606 . . . . 0.0 111.585 179.586 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.557 ' N ' ' O ' ' A' ' 68' ' ' TRP . . . 41.88 -173.86 0.01 OUTLIER Glycine 0 CA--C 1.523 0.557 0 N-CA-C 111.667 -0.573 . . . . 0.0 111.667 179.389 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 51.5 t80 -87.54 111.64 21.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.819 0.342 . . . . 0.0 110.741 -179.606 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.576 ' OG1' ' N ' ' A' ' 76' ' ' GLU . 0.8 OUTLIER -141.73 -174.03 3.95 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.672 179.73 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.576 ' N ' ' OG1' ' A' ' 75' ' ' THR . 46.1 mt-10 -47.98 -44.29 30.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.174 -179.768 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -60.49 -24.4 65.26 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.502 -179.239 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -91.09 -25.34 19.68 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.82 -0.352 . . . . 0.0 111.234 -179.424 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 12.5 mtp -66.79 -27.78 67.86 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.814 -0.354 . . . . 0.0 111.354 -179.283 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.403 ' N ' ' HD2' ' A' ' 81' ' ' PRO . 4.7 t -68.72 -50.89 22.78 Favored Pre-proline 0 C--N 1.328 -0.335 0 C-N-CA 120.673 -0.411 . . . . 0.0 110.364 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.403 ' HD2' ' N ' ' A' ' 80' ' ' VAL . 15.5 Cg_endo -69.43 -62.38 0.05 OUTLIER 'Trans proline' 0 N--CA 1.498 1.764 0 C-N-CA 120.955 1.103 . . . . 0.0 111.616 179.007 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.0 mt -52.12 -52.45 51.45 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.271 179.592 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.504 ' O ' ' N ' ' A' ' 86' ' ' THR . . . -60.46 -63.88 4.61 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 111.367 -0.693 . . . . 0.0 111.367 -179.549 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 59.3 tp -43.15 -38.74 2.56 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.9 0.381 . . . . 0.0 110.114 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 6.3 t80 -68.22 -34.33 76.05 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.242 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.504 ' N ' ' O ' ' A' ' 83' ' ' GLY . 1.3 m -70.42 -57.97 4.23 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.917 -179.683 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -62.51 -49.23 75.64 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 111.463 -0.655 . . . . 0.0 111.463 -179.591 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.416 ' O ' ' CB ' ' A' ' 92' ' ' ASN . 51.6 tp60 -57.26 -45.54 83.91 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.739 0.304 . . . . 0.0 110.952 -179.583 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 11.6 tp -65.4 -29.12 69.79 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.475 -179.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.781 ' O ' ' HB2' ' A' ' 94' ' ' ALA . . . -67.04 -66.08 0.6 Allowed 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.393 -0.523 . . . . 0.0 111.176 -179.723 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.2 pp -67.64 -29.79 69.19 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 -178.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.416 ' CB ' ' O ' ' A' ' 88' ' ' GLN . 11.1 t-20 -84.12 -54.52 4.77 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 -178.441 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . 0.609 ' O ' ' N ' ' A' ' 95' ' ' TRP . 0.0 OUTLIER -76.57 -12.53 60.04 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.516 -0.474 . . . . 0.0 111.491 -178.478 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.781 ' HB2' ' O ' ' A' ' 90' ' ' ALA . . . -55.69 78.73 0.0 OUTLIER 'General case' 0 C--O 1.231 0.129 0 C-N-CA 120.448 -0.501 . . . . 0.0 109.852 179.174 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.708 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 44.1 p-90 -93.11 -16.87 0.21 Allowed Pre-proline 0 CA--C 1.533 0.302 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -179.444 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.708 ' CD ' ' N ' ' A' ' 95' ' ' TRP . 46.5 Cg_exo -55.66 -34.49 90.6 Favored 'Trans proline' 0 N--CA 1.495 1.576 0 C-N-CA 120.422 0.748 . . . . 0.0 113.021 179.502 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.555 ' C ' ' H ' ' A' ' 99' ' ' PHE . 33.6 Cg_exo -44.08 -30.84 3.58 Favored 'Trans proline' 0 N--CA 1.492 1.386 0 CA-C-N 118.969 0.668 . . . . 0.0 112.994 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.577 ' O ' ' N ' ' A' ' 101' ' ' GLY . 1.3 pp -72.61 20.22 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 121.076 0.465 . . . . 0.0 110.059 179.66 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.555 ' H ' ' C ' ' A' ' 97' ' ' PRO . 0.8 OUTLIER -39.72 -36.67 0.44 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.889 -179.968 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.401 ' O ' ' CG ' ' A' ' 103' ' ' ARG . 1.6 m-85 -85.98 -21.0 28.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.045 -179.518 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.577 ' N ' ' O ' ' A' ' 98' ' ' ILE . . . -89.16 -5.45 72.97 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 111.153 -0.779 . . . . 0.0 111.153 -179.718 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.426 ' HB3' ' CZ ' ' A' ' 25' ' ' PHE . . . -73.16 -11.26 60.47 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.778 0.323 . . . . 0.0 110.753 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.401 ' CG ' ' O ' ' A' ' 100' ' ' PHE . 5.4 ptp180 -94.94 11.61 31.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.586 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -123.97 162.62 23.02 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.63 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 21.2 mmm -57.18 -17.13 9.83 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.234 179.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.589 ' O ' ' N ' ' A' ' 108' ' ' ALA . . . -70.42 -15.01 72.48 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 111.214 -0.755 . . . . 0.0 111.214 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' TRP . . . . . 0.444 ' CD1' ' N ' ' A' ' 108' ' ' ALA . 0.1 OUTLIER -43.14 -12.51 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.521 0.2 . . . . 0.0 111.113 -179.468 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.589 ' N ' ' O ' ' A' ' 106' ' ' GLY . . . -63.01 -23.44 67.46 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-O 121.132 0.491 . . . . 0.0 110.075 179.417 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 54.6 mt -52.71 -29.45 26.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.107 179.726 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -56.19 -60.76 3.04 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.548 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.713 ' O ' HG23 ' A' ' 115' ' ' VAL . 1.2 p30 -57.46 -51.24 70.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.323 -179.673 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.601 HD13 ' O ' ' A' ' 112' ' ' LEU . 0.2 OUTLIER -55.29 -40.26 70.85 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.474 -178.944 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 11.3 mt -70.18 -61.51 1.75 Allowed 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 -178.655 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.4 pp -58.38 -30.55 66.88 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 120.292 -0.563 . . . . 0.0 110.866 -179.052 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.713 HG23 ' O ' ' A' ' 111' ' ' ASP . 38.7 t -65.49 -55.78 18.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.264 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 4.9 m -71.45 -24.57 62.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.4 -179.009 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . 0.411 ' O ' ' CB ' ' A' ' 121' ' ' ALA . . . -68.02 -62.49 4.2 Favored Glycine 0 CA--C 1.527 0.794 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.051 -179.218 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.559 ' O ' HG23 ' A' ' 122' ' ' THR . 8.5 p -70.62 -36.93 67.64 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 O-C-N 122.738 -0.272 . . . . 0.0 111.572 -179.14 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.526 ' O ' ' OG1' ' A' ' 123' ' ' THR . . . -66.67 -60.54 2.61 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.493 -0.483 . . . . 0.0 111.201 -179.288 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 1.9 m -61.56 -53.68 53.11 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.334 -179.446 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.411 ' CB ' ' O ' ' A' ' 117' ' ' GLY . . . -50.12 -42.41 50.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.411 -0.358 . . . . 0.0 111.152 -179.494 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.559 HG23 ' O ' ' A' ' 118' ' ' VAL . 27.7 p -70.65 -39.32 73.69 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.64 -179.28 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.526 ' OG1' ' O ' ' A' ' 119' ' ' ALA . 0.2 OUTLIER -55.29 -52.2 64.23 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.921 0.391 . . . . 0.0 111.197 -179.312 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.7 pp -80.49 -20.33 43.91 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.752 -178.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -86.06 -73.88 0.44 Allowed 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -178.179 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' TRP . . . . . 0.571 ' N ' ' CD1' ' A' ' 126' ' ' TRP . 15.7 m0 -84.88 -57.37 3.14 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 112.762 0.653 . . . . 0.0 112.762 -177.444 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . 0.492 ' CD2' ' N ' ' A' ' 127' ' ' HIS . 9.7 m170 -47.71 -22.12 0.48 Allowed 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.686 -0.405 . . . . 0.0 111.121 -179.027 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 19.2 ttt85 -72.59 -40.84 66.25 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.063 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 86.4 t -88.37 -50.01 13.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.788 0.328 . . . . 0.0 111.076 -179.514 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 6.0 m -115.69 105.28 51.98 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.502 -179.734 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . 0.631 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 73.5 Cg_exo -70.98 -36.43 7.58 Favored 'Trans proline' 0 C--N 1.312 -1.364 0 C-N-CA 121.557 1.505 . . . . 0.0 112.726 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . 0.631 ' CD ' ' N ' ' A' ' 131' ' ' PRO . 32.4 Cg_exo -55.8 -35.48 93.72 Favored 'Trans proline' 0 N--CA 1.496 1.675 0 C-N-CA 121.678 1.585 . . . . 0.0 111.946 -179.847 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -62.6 -43.2 99.41 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.66 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -50.47 -24.77 3.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.764 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 14.9 ttp180 -80.93 -28.39 35.78 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.786 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 26.7 mt -72.84 -39.18 66.75 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.779 -0.368 . . . . 0.0 110.068 179.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.583 ' O ' ' N ' ' A' ' 139' ' ' PRO . 4.8 mt -81.04 -35.78 31.38 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 179.126 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.473 ' C ' ' O ' ' A' ' 137' ' ' LEU . 14.3 t80 -24.23 -38.9 0.03 OUTLIER Pre-proline 0 CA--C 1.534 0.356 0 CA-C-N 115.368 -0.833 . . . . 0.0 112.118 -179.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.583 ' N ' ' O ' ' A' ' 137' ' ' LEU . 5.8 Cg_exo -66.62 5.54 0.73 Allowed 'Trans proline' 0 C--N 1.31 -1.479 0 C-N-CA 120.897 1.065 . . . . 0.0 112.771 179.508 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . 0.756 ' CE2' HD11 ' A' ' 144' ' ' LEU . 2.5 p90 -88.62 -14.55 37.22 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 120.54 -0.464 . . . . 0.0 111.074 -179.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.463 HD22 ' CE1' ' A' ' 140' ' ' TYR . 4.1 mm? -53.55 -33.45 54.72 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 178.568 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -60.63 -50.01 75.21 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.473 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' TRP . . . . . 0.462 ' CH2' ' HB2' ' A' ' 147' ' ' ALA . 8.8 t-105 -55.13 -46.1 75.62 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.226 -0.443 . . . . 0.0 109.844 179.74 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.756 HD11 ' CE2' ' A' ' 140' ' ' TYR . 9.3 mt -53.35 -55.96 20.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.267 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.605 ' O ' HG23 ' A' ' 149' ' ' VAL . . . -62.86 -18.85 63.5 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.94 -179.786 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -69.45 -63.34 1.09 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.682 -179.725 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . 0.462 ' HB2' ' CH2' ' A' ' 143' ' ' TRP . . . -60.37 -47.42 86.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.414 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 89.0 m -53.93 -49.67 68.14 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.495 179.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.605 HG23 ' O ' ' A' ' 145' ' ' ALA . 45.0 t -62.42 -28.54 44.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.594 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.447 ' O ' HG23 ' A' ' 154' ' ' VAL . 0.9 OUTLIER -63.53 -54.85 29.81 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.704 -0.398 . . . . 0.0 110.415 -179.598 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . 0.612 ' ND2' ' H ' ' A' ' 152' ' ' TYR . 1.4 p-10 -67.47 -54.65 18.37 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.96 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . 0.612 ' H ' ' ND2' ' A' ' 151' ' ' ASN . 15.6 t80 -50.5 -43.26 55.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.681 -179.69 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . 0.481 ' C ' ' CD1' ' A' ' 153' ' ' TYR . 17.5 t80 -61.86 -43.75 98.22 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.188 179.72 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.447 HG23 ' O ' ' A' ' 150' ' ' LEU . 49.4 t -60.27 -35.25 60.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.597 179.801 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' TRP . . . . . . . . . . . . . 8.1 m0 -62.99 -53.32 55.86 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.413 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . 0.436 ' CZ ' ' OH ' ' A' ' 152' ' ' TYR . 0.5 OUTLIER -64.73 -31.61 72.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.414 -179.899 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -71.33 -52.59 17.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.678 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 22.3 m-20 . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.646 -179.903 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.645 ' O ' HG23 ' A' ' 9' ' ' VAL . 2.2 t-105 . . . . . 0 CA--C 1.528 0.128 0 CA-C-O 121.001 0.429 . . . . 0.0 110.038 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.497 HG12 ' N ' ' A' ' 7' ' ' PRO . 3.0 t -56.69 -69.45 0.44 Allowed Pre-proline 0 CA--C 1.537 0.471 0 CA-C-N 115.717 -0.674 . . . . 0.0 112.285 -178.375 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.497 ' N ' HG12 ' A' ' 6' ' ' VAL . 18.1 Cg_endo -46.3 -53.49 5.87 Favored 'Trans proline' 0 N--CA 1.494 1.519 0 C-N-CA 120.349 0.699 . . . . 0.0 112.343 -178.618 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.579 ' HB2' ' OG ' ' A' ' 64' ' ' SER . . . -49.14 -43.92 42.16 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.595 -0.442 . . . . 0.0 111.195 -179.74 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.645 HG23 ' O ' ' A' ' 5' ' ' TRP . 63.3 t -60.85 -60.97 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.775 -179.04 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -58.05 -53.95 41.42 Favored Glycine 0 CA--C 1.527 0.808 0 N-CA-C 111.369 -0.692 . . . . 0.0 111.369 -179.398 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 9.0 mp -54.53 -31.36 56.2 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.605 0.241 . . . . 0.0 110.775 -179.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.576 HG23 ' O ' ' A' ' 8' ' ' ALA . 8.9 p -79.03 -24.39 43.66 Favored 'General case' 0 C--N 1.333 -0.145 0 C-N-CA 120.783 -0.367 . . . . 0.0 110.41 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.423 ' HA ' HD23 ' A' ' 13' ' ' LEU . 41.3 mt -76.84 -26.48 54.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.152 179.49 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.486 ' O ' ' N ' ' A' ' 16' ' ' SER . 13.7 t -52.05 -64.22 1.64 Allowed Pre-proline 0 CA--C 1.536 0.42 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.593 -179.519 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_endo -44.6 -16.29 0.11 Allowed 'Trans proline' 0 N--CA 1.497 1.726 0 C-N-CA 120.941 1.094 . . . . 0.0 112.137 -179.434 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.486 ' N ' ' O ' ' A' ' 14' ' ' VAL . 0.5 OUTLIER -75.49 -29.12 59.46 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.641 -179.915 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 81.7 mt -68.22 -56.17 9.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.002 -179.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -66.96 -38.55 92.89 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 111.558 -0.617 . . . . 0.0 111.558 -179.362 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -74.12 -26.2 69.2 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 111.378 -0.689 . . . . 0.0 111.378 -179.433 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.441 ' CB ' ' O ' ' A' ' 16' ' ' SER . 34.3 t80 -78.0 -60.7 2.26 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.78 -0.368 . . . . 0.0 110.998 -179.665 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 19.9 tpp -71.53 -21.26 61.93 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.34 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.422 ' C ' ' CZ2' ' A' ' 95' ' ' TRP . . . -75.51 -53.59 5.92 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 111.302 -0.719 . . . . 0.0 111.302 -179.802 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.625 ' O ' HG22 ' A' ' 26' ' ' VAL . . . -73.56 -20.81 60.53 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.963 0.411 . . . . 0.0 110.461 -179.702 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.43 ' O ' ' CD1' ' A' ' 24' ' ' TYR . 27.2 t80 -51.08 -23.9 3.49 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.862 179.298 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 52.1 t80 -71.27 -55.46 8.02 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.02 -179.779 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.625 HG22 ' O ' ' A' ' 23' ' ' ALA . 34.6 m -58.46 -26.06 29.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 C-N-CA 120.599 -0.441 . . . . 0.0 110.306 -179.796 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.519 ' O ' ' CD1' ' A' ' 31' ' ' LEU . 0.0 OUTLIER -87.95 -15.08 37.53 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.338 179.851 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -101.33 -71.66 0.94 Allowed Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.835 -0.906 . . . . 0.0 110.835 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.403 ' OE2' ' O ' ' A' ' 29' ' ' GLU . 3.3 tm-20 -76.88 -36.89 56.39 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.739 0.304 . . . . 0.0 110.567 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -51.3 -36.12 36.38 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 110.89 -0.884 . . . . 0.0 110.89 -179.79 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.519 ' CD1' ' O ' ' A' ' 27' ' ' ARG . 86.3 mt -55.35 -32.17 62.34 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.737 0.303 . . . . 0.0 110.348 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.434 ' O ' ' N ' ' A' ' 35' ' ' ALA . 37.6 ttm180 -81.28 -48.96 11.33 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.252 179.728 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . 0.565 ' CZ3' HD21 ' A' ' 37' ' ' LEU . 0.0 OUTLIER -44.76 -36.13 3.05 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 179.473 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 26.6 t80 -55.66 -40.52 72.36 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.287 179.452 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.434 ' N ' ' O ' ' A' ' 32' ' ' ARG . . . -53.29 -26.96 20.46 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.169 179.784 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -90.37 -72.32 1.25 Allowed Glycine 0 CA--C 1.524 0.615 0 N-CA-C 110.921 -0.872 . . . . 0.0 110.921 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.565 HD21 ' CZ3' ' A' ' 33' ' ' TRP . 0.3 OUTLIER -96.1 167.64 11.09 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 120.947 0.404 . . . . 0.0 110.88 179.614 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 43.8 mm-40 -84.79 122.93 29.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.241 -179.256 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 16.0 mtpt -129.28 153.34 80.47 Favored Pre-proline 0 N--CA 1.464 0.24 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.048 179.443 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo . . . . . 0 C--N 1.31 -1.47 0 C-N-CA 121.549 1.499 . . . . 0.0 111.372 179.417 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.751 ' O ' HG23 ' A' ' 52' ' ' ILE . 0.2 OUTLIER . . . . . 0 CA--C 1.537 0.455 0 N-CA-C 112.686 0.624 . . . . 0.0 112.686 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.591 ' C ' ' H ' ' A' ' 52' ' ' ILE . . . -40.34 -30.26 0.24 Allowed Pre-proline 0 N--CA 1.468 0.427 0 C-N-CA 120.857 -0.337 . . . . 0.0 111.818 -178.699 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.408 ' HD2' ' N ' ' A' ' 50' ' ' ALA . 33.6 Cg_exo -53.76 4.53 0.04 OUTLIER 'Trans proline' 0 C--N 1.312 -1.382 0 CA-C-N 119.163 0.737 . . . . 0.0 112.547 178.498 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.751 HG23 ' O ' ' A' ' 49' ' ' LEU . 44.0 pt -53.52 -32.42 20.51 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 C-N-CA 120.515 -0.474 . . . . 0.0 109.779 179.52 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.457 ' O ' ' CB ' ' A' ' 57' ' ' TYR . 60.9 m95 -78.94 -23.08 44.87 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.267 -179.145 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -68.54 -45.47 67.24 Favored Glycine 0 CA--C 1.527 0.793 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 178.773 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 16.5 m -69.27 -58.45 4.02 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-O 120.991 0.424 . . . . 0.0 110.0 179.408 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 96.6 mt -54.55 -28.62 46.99 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.033 179.511 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.521 ' C ' ' CD1' ' A' ' 57' ' ' TYR . 0.6 OUTLIER -63.51 -58.98 5.27 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 179.523 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 11.0 m -46.16 -49.29 17.01 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.406 -0.518 . . . . 0.0 109.909 179.515 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.55 -51.49 69.65 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.856 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 12.3 mtm -55.81 -35.59 66.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.78 -179.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -61.88 -49.31 77.05 Favored Glycine 0 CA--C 1.522 0.491 0 N-CA-C 110.59 -1.004 . . . . 0.0 110.59 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -56.83 -60.27 3.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.817 0.341 . . . . 0.0 110.501 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.539 ' O ' HG23 ' A' ' 67' ' ' VAL . . . -52.21 -49.74 49.15 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 110.66 -0.976 . . . . 0.0 110.66 179.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.58 ' O ' ' CE2' ' A' ' 68' ' ' TRP . 1.4 t -48.1 -54.24 13.87 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.108 0.48 . . . . 0.0 110.396 179.617 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 59.0 t80 -51.28 -41.48 60.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.51 179.834 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 84.9 mt -67.72 -45.58 84.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.329 -179.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.789 HG22 ' OG ' ' A' ' 130' ' ' SER . 39.0 t -50.72 -55.81 5.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 C-N-CA 121.043 -0.263 . . . . 0.0 111.277 -179.327 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' TRP . . . . . 0.585 ' O ' ' N ' ' A' ' 73' ' ' GLY . 0.7 OUTLIER -59.97 -52.56 64.89 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.686 -179.542 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 24.3 mmtt -53.64 -22.67 9.22 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.993 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 43.0 tp10 -79.6 -62.46 1.68 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.441 -179.312 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.0 pp -71.22 -1.17 11.72 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.2 -179.297 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 104.43 64.98 0.68 Allowed Glycine 0 CA--C 1.526 0.778 0 N-CA-C 111.43 -0.668 . . . . 0.0 111.43 179.51 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.585 ' N ' ' O ' ' A' ' 68' ' ' TRP . . . 51.75 -174.46 0.15 Allowed Glycine 0 CA--C 1.525 0.679 0 N-CA-C 111.325 -0.71 . . . . 0.0 111.325 179.661 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 89.8 t80 -76.62 110.72 11.42 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.86 0.362 . . . . 0.0 110.604 -179.784 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.591 ' OG1' ' N ' ' A' ' 76' ' ' GLU . 0.0 OUTLIER -139.17 -174.94 4.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.13 179.804 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.591 ' N ' ' OG1' ' A' ' 75' ' ' THR . 3.1 pt-20 -50.55 -21.62 1.61 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.839 -179.838 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -83.95 -18.47 37.16 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.105 -179.538 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -89.32 -18.25 27.32 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.874 -0.33 . . . . 0.0 110.838 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 15.4 mtp -69.32 -27.4 65.35 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.871 -0.332 . . . . 0.0 110.573 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 5.0 t -67.73 -47.94 43.26 Favored Pre-proline 0 CA--C 1.535 0.4 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.582 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -71.83 -58.12 0.08 OUTLIER 'Trans proline' 0 N--CA 1.498 1.786 0 C-N-CA 121.187 1.258 . . . . 0.0 112.087 179.277 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 13.0 mt -60.08 -53.4 58.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.985 0.421 . . . . 0.0 110.678 -179.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -55.86 -55.19 30.28 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 111.268 -0.733 . . . . 0.0 111.268 -179.537 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.404 ' O ' ' CB ' ' A' ' 88' ' ' GLN . 33.0 tp -61.01 -24.23 66.0 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.687 0.279 . . . . 0.0 110.936 -179.702 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -74.7 -56.49 4.74 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.884 -179.685 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.415 HG23 ' N ' ' A' ' 87' ' ' GLY . 14.2 t -66.13 -38.35 87.97 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.799 -0.361 . . . . 0.0 110.977 -179.64 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.415 ' N ' HG23 ' A' ' 86' ' ' THR . . . -68.77 -57.26 8.14 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.932 -0.867 . . . . 0.0 110.932 -179.843 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.45 ' O ' ' CB ' ' A' ' 92' ' ' ASN . 36.3 tp60 -58.09 -40.5 81.28 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.859 0.362 . . . . 0.0 110.149 179.756 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 12.3 tp -67.37 -30.54 70.35 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.292 179.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.826 ' O ' ' HB2' ' A' ' 94' ' ' ALA . . . -66.95 -66.09 0.6 Allowed 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 120.13 -0.628 . . . . 0.0 110.944 -179.746 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.0 pp -66.51 -29.68 69.83 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.389 0.514 . . . . 0.0 112.389 -178.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.582 ' C ' HD22 ' A' ' 92' ' ' ASN . 0.2 OUTLIER -85.2 -62.2 1.59 Allowed 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.551 -0.46 . . . . 0.0 111.815 -178.827 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . 0.631 ' O ' ' N ' ' A' ' 95' ' ' TRP . 0.0 OUTLIER -64.57 -17.57 64.08 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.552 -0.459 . . . . 0.0 110.834 -179.007 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.826 ' HB2' ' O ' ' A' ' 90' ' ' ALA . . . -48.76 83.81 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 179.313 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.698 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 23.2 p-90 -100.95 -16.13 0.19 Allowed Pre-proline 0 CA--C 1.535 0.377 0 CA-C-N 116.107 -0.497 . . . . 0.0 112.334 -179.235 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.698 ' CD ' ' N ' ' A' ' 95' ' ' TRP . 37.2 Cg_exo -60.65 -31.52 92.21 Favored 'Trans proline' 0 N--CA 1.495 1.582 0 CA-C-N 119.067 0.703 . . . . 0.0 112.718 179.691 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.518 ' CD ' ' N ' ' A' ' 96' ' ' PRO . 83.8 Cg_exo -56.76 -16.92 21.23 Favored 'Trans proline' 0 N--CA 1.496 1.647 0 C-N-CA 120.803 1.002 . . . . 0.0 113.15 -179.775 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.423 ' O ' ' N ' ' A' ' 101' ' ' GLY . 1.1 pp -88.34 20.36 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 C-N-CA 120.713 -0.395 . . . . 0.0 110.732 -179.718 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.597 ' CD2' ' O ' ' A' ' 96' ' ' PRO . 29.7 m-85 -39.36 -36.96 0.4 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.326 179.649 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.557 ' CD1' ' N ' ' A' ' 100' ' ' PHE . 0.5 OUTLIER -76.71 -43.87 35.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.697 179.948 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.423 ' N ' ' O ' ' A' ' 98' ' ' ILE . . . -62.23 -11.28 32.29 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 111.083 -0.807 . . . . 0.0 111.083 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -62.17 -38.47 89.17 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.637 0.256 . . . . 0.0 111.198 -179.615 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.16 17.97 2.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.078 -179.607 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 11.5 mt-30 -124.4 160.15 28.81 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.888 0.375 . . . . 0.0 110.638 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.547 ' N ' ' SD ' ' A' ' 105' ' ' MET . 0.0 OUTLIER -51.12 -17.06 0.57 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.416 179.813 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.601 ' O ' ' N ' ' A' ' 108' ' ' ALA . . . -75.48 -14.13 82.27 Favored Glycine 0 CA--C 1.529 0.919 0 CA-C-N 115.938 -0.573 . . . . 0.0 111.722 -179.554 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' TRP . . . . . 0.617 ' CD1' ' CZ2' ' A' ' 155' ' ' TRP . 0.0 OUTLIER -36.62 -21.84 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.417 0 CA-C-O 120.529 0.204 . . . . 0.0 111.366 -179.165 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.601 ' N ' ' O ' ' A' ' 106' ' ' GLY . . . -63.35 -16.67 61.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.669 0.271 . . . . 0.0 111.168 -179.322 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 6.2 mp -54.5 -32.95 58.95 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.776 -179.632 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.442 ' O ' HD23 ' A' ' 114' ' ' LEU . . . -55.82 -62.33 1.76 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.858 0.361 . . . . 0.0 111.138 -179.628 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.689 ' O ' HG23 ' A' ' 115' ' ' VAL . 3.8 p-10 -58.92 -54.43 47.24 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.033 -0.53 . . . . 0.0 112.005 -179.155 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 34.3 tp -55.76 -44.36 77.59 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 -178.56 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 52.1 mt -64.24 -60.68 2.9 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.254 0.465 . . . . 0.0 112.254 -178.482 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.442 HD23 ' O ' ' A' ' 110' ' ' ALA . 2.3 pp -62.89 -35.32 79.64 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.494 -0.483 . . . . 0.0 111.68 -178.565 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.689 HG23 ' O ' ' A' ' 111' ' ' ASP . 27.2 t -57.91 -60.12 2.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.136 -179.687 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . 0.488 ' O ' ' OG1' ' A' ' 120' ' ' THR . 4.5 m -74.18 -22.44 59.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.427 -0.352 . . . . 0.0 111.592 -178.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -62.93 -62.71 5.22 Favored Glycine 0 CA--C 1.526 0.721 0 C-N-CA 120.783 -0.723 . . . . 0.0 111.475 -179.418 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.593 ' O ' HG23 ' A' ' 122' ' ' THR . 8.6 p -75.58 -35.1 30.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 C-N-CA 121.035 -0.266 . . . . 0.0 111.046 -179.579 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.526 ' O ' ' OG1' ' A' ' 123' ' ' THR . . . -66.69 -60.4 2.73 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.635 -0.426 . . . . 0.0 110.56 -179.742 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.488 ' OG1' ' O ' ' A' ' 116' ' ' SER . 2.4 m -60.32 -54.57 44.15 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.408 -179.589 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.408 ' O ' ' CB ' ' A' ' 125' ' ' ALA . . . -51.25 -41.12 60.14 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.314 -179.153 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.593 HG23 ' O ' ' A' ' 118' ' ' VAL . 36.0 p -73.19 -29.95 63.2 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.625 -179.19 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.526 ' OG1' ' O ' ' A' ' 119' ' ' ALA . 0.2 OUTLIER -66.84 -49.89 64.3 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.714 -0.394 . . . . 0.0 110.864 -179.412 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.8 pp -81.44 -19.05 43.27 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.57 -179.04 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.408 ' CB ' ' O ' ' A' ' 121' ' ' ALA . . . -93.61 -65.28 1.0 Allowed 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.427 0.529 . . . . 0.0 112.427 -178.824 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 42.1 m0 -83.59 -56.98 3.42 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 113.056 0.762 . . . . 0.0 113.056 -177.802 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . 0.467 ' CG ' ' HB2' ' A' ' 134' ' ' ALA . 11.1 m170 -59.6 -25.62 64.77 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.586 -0.445 . . . . 0.0 111.569 -178.535 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 15.9 ttt180 -61.76 -41.17 97.34 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.31 -179.455 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 33.4 t -93.34 -48.88 13.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.517 -0.311 . . . . 0.0 110.964 -179.611 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . 0.789 ' OG ' HG22 ' A' ' 67' ' ' VAL . 2.1 p -113.07 107.94 53.63 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.884 -179.301 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . 0.646 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 73.8 Cg_exo -74.69 -26.52 11.49 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 C-N-CA 121.702 1.601 . . . . 0.0 112.741 179.355 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . 0.646 ' CD ' ' N ' ' A' ' 131' ' ' PRO . 52.0 Cg_exo -62.09 -54.97 1.17 Allowed 'Trans proline' 0 N--CA 1.496 1.666 0 C-N-CA 121.357 1.372 . . . . 0.0 112.194 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.524 ' O ' ' N ' ' A' ' 136' ' ' LEU . . . -45.97 -46.07 16.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.879 0.371 . . . . 0.0 110.42 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . 0.467 ' HB2' ' CG ' ' A' ' 127' ' ' HIS . . . -45.12 -27.31 0.57 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.109 179.816 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 10.1 tpp180 -76.3 -30.7 57.85 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.299 179.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.524 ' N ' ' O ' ' A' ' 133' ' ' ALA . 36.6 mt -74.16 -24.9 59.47 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 179.303 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.573 ' O ' ' N ' ' A' ' 140' ' ' TYR . 3.7 mt -89.81 -33.26 16.58 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.075 179.511 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.519 ' C ' ' CD1' ' A' ' 138' ' ' TYR . 0.5 OUTLIER -27.68 -51.13 0.23 Allowed Pre-proline 0 CA--C 1.536 0.416 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.554 179.727 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.432 ' HD2' ' N ' ' A' ' 138' ' ' TYR . 2.2 Cg_endo -58.76 4.69 0.11 Allowed 'Trans proline' 0 N--CA 1.497 1.687 0 C-N-CA 121.374 1.383 . . . . 0.0 112.689 -179.823 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . 0.573 ' N ' ' O ' ' A' ' 137' ' ' LEU . 0.3 OUTLIER -90.66 -15.41 30.45 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.904 0.383 . . . . 0.0 110.724 179.764 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.467 HD23 HD12 ' A' ' 144' ' ' LEU . 97.6 mt -60.09 -36.5 77.55 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 178.872 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -56.61 -41.8 77.67 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.689 179.161 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' TRP . . . . . . . . . . . . . 7.5 t-105 -62.74 -43.66 98.22 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 115.771 -0.65 . . . . 0.0 109.472 179.227 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.467 HD12 HD23 ' A' ' 141' ' ' LEU . 22.0 mt -58.44 -37.59 75.73 Favored 'General case' 0 CA--C 1.521 -0.163 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.707 179.268 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.673 ' O ' HG23 ' A' ' 149' ' ' VAL . . . -73.28 -27.84 61.78 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.496 179.848 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 28.7 t80 -64.75 -62.32 1.64 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.781 -179.781 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . 0.489 ' O ' ' OD1' ' A' ' 151' ' ' ASN . . . -64.15 -43.84 93.95 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.432 -0.507 . . . . 0.0 110.45 -179.815 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . 0.499 ' O ' ' OD1' ' A' ' 151' ' ' ASN . 52.4 m -57.89 -36.71 72.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.475 179.807 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.673 HG23 ' O ' ' A' ' 145' ' ' ALA . 39.3 t -74.65 -27.5 20.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.686 179.82 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.546 ' O ' HG23 ' A' ' 154' ' ' VAL . 0.7 OUTLIER -66.41 -52.64 44.45 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.426 -0.509 . . . . 0.0 110.209 -179.935 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . 0.499 ' OD1' ' O ' ' A' ' 148' ' ' THR . 8.1 p-10 -65.35 -43.42 90.93 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.25 -179.837 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . 0.455 ' C ' ' CD1' ' A' ' 152' ' ' TYR . 22.6 t80 -64.78 -42.44 95.09 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.988 -0.285 . . . . 0.0 111.006 -179.562 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 77.1 t80 -61.18 -41.16 96.29 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.181 -179.376 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.546 HG23 ' O ' ' A' ' 150' ' ' LEU . 42.9 t -75.44 -50.46 23.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.38 -179.348 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' TRP . . . . . 0.617 ' CZ2' ' CD1' ' A' ' 107' ' ' TRP . 0.1 OUTLIER -55.4 -29.4 58.45 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.826 -178.889 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . 0.418 ' HA ' HH11 ' A' ' 156' ' ' ARG . 0.1 OUTLIER -85.41 -45.93 11.4 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.952 -0.299 . . . . 0.0 110.625 -179.639 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -69.02 -44.02 73.58 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.897 -179.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 16.3 t30 . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.79 -179.971 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.694 ' CE2' ' CE3' ' A' ' 68' ' ' TRP . 1.0 OUTLIER . . . . . 0 CA--C 1.529 0.141 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.576 ' N ' ' CD ' ' A' ' 7' ' ' PRO . 0.9 OUTLIER -60.52 -33.01 12.86 Favored Pre-proline 0 CA--C 1.534 0.362 0 C-N-CA 120.858 -0.337 . . . . 0.0 110.274 -179.653 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.576 ' CD ' ' N ' ' A' ' 6' ' ' VAL . 24.6 Cg_exo -73.14 -66.23 0.03 OUTLIER 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 121.517 1.478 . . . . 0.0 112.069 179.577 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.4 ' O ' ' OG1' ' A' ' 12' ' ' THR . . . -50.11 -36.58 30.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.261 -179.485 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.594 HG23 ' O ' ' A' ' 5' ' ' TRP . 78.7 t -69.53 -61.96 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.552 -179.292 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -56.11 -34.71 62.71 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 111.51 -0.636 . . . . 0.0 111.51 -179.347 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 6.9 mp -74.44 -30.29 61.83 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.57 0.224 . . . . 0.0 110.737 -179.532 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.4 ' OG1' ' O ' ' A' ' 8' ' ' ALA . 3.1 p -81.21 -21.02 39.9 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.876 0.37 . . . . 0.0 110.578 179.83 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.423 ' O ' ' N ' ' A' ' 16' ' ' SER . 69.8 mt -82.9 -38.12 23.3 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.517 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.403 ' N ' ' HD2' ' A' ' 15' ' ' PRO . 5.1 t -43.07 -58.9 3.55 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.717 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.403 ' HD2' ' N ' ' A' ' 14' ' ' VAL . 11.7 Cg_endo -56.8 -13.96 12.57 Favored 'Trans proline' 0 N--CA 1.497 1.71 0 C-N-CA 121.02 1.147 . . . . 0.0 111.789 179.718 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.423 ' N ' ' O ' ' A' ' 13' ' ' LEU . 1.9 t -79.52 -24.73 42.01 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.506 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 55.0 mt -74.24 -58.16 3.48 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.323 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -75.72 -23.24 73.13 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 110.685 -0.966 . . . . 0.0 110.685 179.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -70.38 -52.49 16.86 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 111.259 -0.736 . . . . 0.0 111.259 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 86.9 t80 -74.07 -55.14 6.47 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.682 0.277 . . . . 0.0 111.184 -179.597 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 16.2 ttm -62.97 -30.12 71.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.26 -179.365 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -72.76 -59.54 4.34 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 111.277 -0.729 . . . . 0.0 111.277 -179.669 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.553 ' O ' HG22 ' A' ' 26' ' ' VAL . . . -64.22 -16.43 62.0 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.784 -0.366 . . . . 0.0 110.62 -179.434 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 63.4 t80 -48.14 -23.99 1.0 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.104 179.56 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 48.5 t80 -72.08 -53.54 12.54 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.953 -179.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.553 HG22 ' O ' ' A' ' 23' ' ' ALA . 33.3 m -65.52 -16.32 20.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 C-N-CA 120.835 -0.346 . . . . 0.0 110.672 -179.777 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.458 ' O ' ' CD1' ' A' ' 31' ' ' LEU . 0.0 OUTLIER -56.57 -47.51 79.34 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.741 -179.813 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -105.51 -62.98 0.63 Allowed Glycine 0 CA--C 1.525 0.7 0 N-CA-C 111.191 -0.764 . . . . 0.0 111.191 -179.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 6.1 tm-20 -45.09 -33.89 2.36 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.722 0.296 . . . . 0.0 110.626 -179.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -71.66 -51.11 17.05 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 111.023 -0.831 . . . . 0.0 111.023 -179.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.458 ' CD1' ' O ' ' A' ' 27' ' ' ARG . 86.6 mt -57.61 -35.04 69.93 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.752 0.31 . . . . 0.0 110.609 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 62.8 mtp180 -76.07 -42.72 46.56 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.36 179.796 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -51.71 -40.61 60.46 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.372 179.845 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.506 ' C ' ' CD1' ' A' ' 34' ' ' TYR . 9.8 t80 -48.23 -40.6 24.96 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.67 -179.797 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -57.73 -24.95 59.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.449 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -95.55 -75.18 1.26 Allowed Glycine 0 CA--C 1.525 0.663 0 N-CA-C 110.974 -0.85 . . . . 0.0 110.974 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.569 ' O ' HD12 ' A' ' 37' ' ' LEU . 0.4 OUTLIER -95.79 167.54 11.21 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.971 0.415 . . . . 0.0 110.739 179.823 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 47.2 mm-40 -79.91 113.21 17.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.888 -179.568 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 8.3 mtpt -128.86 150.72 75.86 Favored Pre-proline 0 CA--C 1.532 0.281 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.068 179.637 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo . . . . . 0 C--N 1.31 -1.492 0 C-N-CA 121.871 1.714 . . . . 0.0 111.636 179.526 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.778 ' O ' HG23 ' A' ' 52' ' ' ILE . 31.5 tp . . . . . 0 CA--C 1.531 0.249 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.634 ' C ' ' H ' ' A' ' 52' ' ' ILE . . . -40.43 -29.08 0.21 Allowed Pre-proline 0 N--CA 1.466 0.327 0 C-N-CA 120.069 -0.652 . . . . 0.0 111.569 -178.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.408 ' HD2' ' N ' ' A' ' 50' ' ' ALA . 25.2 Cg_exo -54.93 7.39 0.03 OUTLIER 'Trans proline' 0 C--N 1.312 -1.355 0 CA-C-N 119.058 0.699 . . . . 0.0 112.205 177.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.778 HG23 ' O ' ' A' ' 49' ' ' LEU . 11.6 pt -54.37 -35.19 29.98 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.203 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 178.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 63.0 m95 -81.79 -24.12 36.16 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.359 179.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -71.43 -47.07 37.23 Favored Glycine 0 CA--C 1.527 0.792 0 N-CA-C 110.36 -1.096 . . . . 0.0 110.36 179.275 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.612 HG23 ' N ' ' A' ' 56' ' ' LEU . 13.3 t -70.65 -48.15 56.38 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 179.408 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.612 ' N ' HG23 ' A' ' 55' ' ' THR . 93.5 mt -60.92 -27.9 68.54 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 178.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.46 ' C ' ' CD1' ' A' ' 57' ' ' TYR . 0.8 OUTLIER -65.94 -53.64 36.54 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 179.375 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -48.88 -47.56 42.89 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 178.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.11 -48.21 82.44 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.062 179.177 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 27.1 mtt -52.67 -50.55 63.02 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.876 179.652 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -48.37 -53.63 15.38 Favored Glycine 0 CA--C 1.522 0.526 0 N-CA-C 110.399 -1.081 . . . . 0.0 110.399 179.638 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.538 ' N ' ' CD1' ' A' ' 62' ' ' TYR . 1.4 m-30 -56.55 -50.31 72.25 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.8 0.333 . . . . 0.0 110.527 179.68 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -52.06 -54.13 27.42 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 110.475 -1.05 . . . . 0.0 110.475 179.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.617 ' CB ' ' HE1' ' A' ' 68' ' ' TRP . 1.4 t -54.88 -47.23 74.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.834 0.349 . . . . 0.0 110.281 179.672 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.449 ' O ' ' CG ' ' A' ' 69' ' ' LYS . 74.7 t80 -46.27 -45.17 17.04 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.647 -0.421 . . . . 0.0 109.899 179.69 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 59.0 mt -71.38 -27.1 27.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.902 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 73.6 t -67.34 -57.71 8.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 C-N-CA 120.732 -0.387 . . . . 0.0 111.6 -179.3 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' TRP . . . . . 0.694 ' CE3' ' CE2' ' A' ' 5' ' ' TRP . 0.0 OUTLIER -72.82 -24.61 60.93 Favored 'General case' 0 CA--C 1.528 0.11 0 C-N-CA 119.814 -0.754 . . . . 0.0 110.73 -179.654 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.449 ' CG ' ' O ' ' A' ' 65' ' ' TYR . 6.5 mmmt -76.73 -26.74 54.98 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.427 -0.509 . . . . 0.0 110.181 179.341 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 33.6 tp10 -79.96 -58.4 3.18 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.817 -179.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.462 HD21 ' HB2' ' A' ' 78' ' ' ALA . 2.2 pp -73.34 -21.72 60.48 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.878 -179.597 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.499 ' O ' ' O ' ' A' ' 73' ' ' GLY . . . 109.32 98.57 2.54 Favored Glycine 0 CA--C 1.528 0.844 0 C-N-CA 121.088 -0.577 . . . . 0.0 112.248 178.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.577 ' N ' ' O ' ' A' ' 68' ' ' TRP . . . 41.52 -173.99 0.01 OUTLIER Glycine 0 CA--C 1.525 0.691 0 N-CA-C 111.975 -0.45 . . . . 0.0 111.975 178.878 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 84.0 t80 -90.42 110.64 21.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.724 0.297 . . . . 0.0 110.483 -179.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.568 ' OG1' ' N ' ' A' ' 76' ' ' GLU . 0.8 OUTLIER -142.43 -173.6 3.9 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.909 0.385 . . . . 0.0 110.893 -179.839 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.568 ' N ' ' OG1' ' A' ' 75' ' ' THR . 26.0 mt-10 -53.27 -21.68 5.83 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.692 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 24.3 m-20 -79.67 -33.07 41.5 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.778 -179.796 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.462 ' HB2' HD21 ' A' ' 71' ' ' LEU . . . -87.02 -15.62 38.12 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.821 -179.785 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 8.1 mtp -70.99 -27.24 63.56 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.763 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.401 ' N ' ' HD2' ' A' ' 81' ' ' PRO . 8.4 t -66.85 -45.12 54.36 Favored Pre-proline 0 C--N 1.328 -0.331 0 C-N-CA 120.783 -0.367 . . . . 0.0 110.52 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.401 ' HD2' ' N ' ' A' ' 80' ' ' VAL . 12.4 Cg_endo -77.1 -61.7 0.03 OUTLIER 'Trans proline' 0 N--CA 1.499 1.816 0 C-N-CA 121.227 1.284 . . . . 0.0 111.799 178.814 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 12.7 mt -55.39 -44.41 76.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.759 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -65.92 -55.85 17.43 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.972 -0.851 . . . . 0.0 110.972 -179.792 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 60.3 tp -55.28 -21.87 16.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.812 0.339 . . . . 0.0 110.37 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 30.7 t80 -78.03 -51.89 9.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.063 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -61.84 -38.58 88.75 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.8 -0.36 . . . . 0.0 111.277 -179.059 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -73.67 -58.14 4.65 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 111.277 -0.729 . . . . 0.0 111.277 -179.571 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 5.0 tp-100 -53.45 -47.74 69.45 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-O 121.127 0.489 . . . . 0.0 109.778 179.714 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.445 ' O ' ' C ' ' A' ' 90' ' ' ALA . 19.5 tp -52.81 -66.02 0.46 Allowed 'General case' 0 C--O 1.211 -0.961 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.904 179.823 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.563 ' O ' ' HB2' ' A' ' 94' ' ' ALA . . . -38.17 -48.7 1.29 Allowed 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 120.267 -0.573 . . . . 0.0 111.771 -179.496 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 95.3 mt -55.22 -57.03 13.45 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 113.415 0.894 . . . . 0.0 113.415 -178.407 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.758 ' O ' HD22 ' A' ' 113' ' ' LEU . 4.8 m-20 -78.05 -53.42 7.43 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 121.284 0.564 . . . . 0.0 111.604 -178.223 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . 0.645 ' O ' ' N ' ' A' ' 95' ' ' TRP . 5.6 t-105 -52.13 -25.11 8.12 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.568 -179.679 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.563 ' HB2' ' O ' ' A' ' 90' ' ' ALA . . . -55.74 71.35 0.0 OUTLIER 'General case' 0 CA--C 1.528 0.133 0 CA-C-O 120.829 0.347 . . . . 0.0 110.675 -179.722 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.681 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 7.0 p-90 -101.62 -17.73 0.19 Allowed Pre-proline 0 CA--C 1.534 0.35 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.891 -179.784 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.681 ' CD ' ' N ' ' A' ' 95' ' ' TRP . 44.5 Cg_exo -61.16 -24.78 79.85 Favored 'Trans proline' 0 C--N 1.311 -1.396 0 C-N-CA 120.248 0.632 . . . . 0.0 112.412 179.034 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.529 ' CD ' ' N ' ' A' ' 96' ' ' PRO . 63.8 Cg_exo -59.82 -31.82 94.51 Favored 'Trans proline' 0 N--CA 1.493 1.474 0 C-N-CA 120.339 0.693 . . . . 0.0 112.803 179.547 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 1.4 pt -77.2 44.01 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 C-N-CA 120.342 -0.543 . . . . 0.0 110.259 179.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -61.57 -35.59 78.23 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.302 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -82.62 -20.01 37.2 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.399 179.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -87.28 -14.73 63.57 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.912 -0.875 . . . . 0.0 110.912 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -62.04 -34.18 75.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.783 0.325 . . . . 0.0 110.672 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 15.8 ptt180 -76.4 11.24 1.65 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.78 -179.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 14.8 mt-30 -121.89 154.56 36.93 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.564 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 6.0 mmt -51.49 -18.59 1.12 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.413 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.606 ' O ' ' N ' ' A' ' 108' ' ' ALA . . . -71.13 -14.98 74.19 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 111.18 -0.768 . . . . 0.0 111.18 179.874 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' TRP . . . . . 0.461 ' CD1' ' N ' ' A' ' 108' ' ' ALA . 0.1 OUTLIER -42.55 -14.12 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.683 0.278 . . . . 0.0 110.822 -179.498 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.606 ' N ' ' O ' ' A' ' 106' ' ' GLY . . . -58.49 -28.68 65.6 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 179.416 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 12.2 mt -47.02 -31.68 3.42 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.889 179.49 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -54.55 -60.47 3.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.39 179.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.715 ' O ' HG23 ' A' ' 115' ' ' VAL . 1.6 p30 -59.0 -53.68 55.72 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.76 -179.44 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.589 ' N ' ' OD1' ' A' ' 111' ' ' ASP . 40.5 tp -55.43 -39.81 70.72 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -178.414 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.758 HD22 ' O ' ' A' ' 92' ' ' ASN . 17.9 mt -70.47 -61.69 1.67 Allowed 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.124 0.416 . . . . 0.0 112.124 -178.506 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.9 pp -59.6 -34.02 72.21 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 120.339 -0.544 . . . . 0.0 111.064 -179.006 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.715 HG23 ' O ' ' A' ' 111' ' ' ASP . 42.3 t -61.68 -60.86 2.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.102 -179.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 13.0 m -68.0 -22.62 64.99 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.546 -178.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -66.35 -62.75 4.39 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 120.696 -0.764 . . . . 0.0 111.856 -179.252 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.602 ' O ' HG23 ' A' ' 122' ' ' THR . 9.1 p -72.46 -35.86 52.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 111.614 0.227 . . . . 0.0 111.614 -179.183 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.547 ' O ' ' OG1' ' A' ' 123' ' ' THR . . . -67.96 -61.31 1.92 Allowed 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.387 -0.525 . . . . 0.0 111.289 -179.326 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 8.1 m -59.64 -50.43 73.9 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.561 -0.291 . . . . 0.0 111.492 -179.184 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.447 ' O ' HD23 ' A' ' 124' ' ' LEU . . . -55.29 -40.49 71.13 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.79 0.329 . . . . 0.0 111.019 -179.461 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.602 HG23 ' O ' ' A' ' 118' ' ' VAL . 40.4 p -74.79 -33.44 62.24 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.803 -0.359 . . . . 0.0 111.713 -179.253 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.547 ' OG1' ' O ' ' A' ' 119' ' ' ALA . 0.2 OUTLIER -60.07 -56.48 21.15 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.559 -0.456 . . . . 0.0 110.784 -179.521 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.606 HD23 ' N ' ' A' ' 125' ' ' ALA . 0.6 OUTLIER -79.19 -20.16 49.07 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 -178.584 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.606 ' N ' HD23 ' A' ' 124' ' ' LEU . . . -91.17 -66.73 0.9 Allowed 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 112.789 0.663 . . . . 0.0 112.789 -178.818 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 43.4 m0 -83.0 -57.42 3.3 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -177.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . 0.57 ' CG ' ' HB2' ' A' ' 134' ' ' ALA . 11.5 m170 -55.69 -22.18 22.08 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.584 -0.446 . . . . 0.0 111.129 -179.004 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 19.2 ttt85 -69.66 -48.79 58.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.148 -179.624 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 10.3 t -81.39 -47.46 19.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.993 -179.453 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 61.0 p -116.28 104.98 51.39 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.51 -179.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . 0.639 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 57.2 Cg_exo -70.79 -29.43 18.99 Favored 'Trans proline' 0 C--N 1.31 -1.477 0 C-N-CA 121.537 1.491 . . . . 0.0 112.367 179.639 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . 0.639 ' CD ' ' N ' ' A' ' 131' ' ' PRO . 41.4 Cg_exo -62.58 -42.81 24.51 Favored 'Trans proline' 0 N--CA 1.496 1.663 0 C-N-CA 121.391 1.394 . . . . 0.0 111.787 179.7 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -54.44 -41.52 69.5 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.311 179.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . 0.57 ' HB2' ' CG ' ' A' ' 127' ' ' HIS . . . -57.18 -22.66 42.06 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.309 179.705 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 11.2 tpp180 -77.06 -31.7 56.32 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.61 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 82.8 mt -72.56 -43.54 63.3 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.857 0.361 . . . . 0.0 110.082 179.571 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.556 ' O ' ' N ' ' A' ' 140' ' ' TYR . 3.4 mt -75.31 -37.68 60.68 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.442 179.79 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.55 ' C ' ' H ' ' A' ' 140' ' ' TYR . 0.8 OUTLIER -19.4 -48.64 0.04 OUTLIER Pre-proline 0 N--CA 1.466 0.352 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.948 -179.608 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.527 ' N ' ' O ' ' A' ' 137' ' ' LEU . 1.6 Cg_endo -64.45 16.08 0.08 OUTLIER 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 120.968 1.112 . . . . 0.0 112.142 179.617 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . 0.76 ' CE2' HD11 ' A' ' 144' ' ' LEU . 5.3 p90 -93.35 -15.17 26.01 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-O 121.153 0.501 . . . . 0.0 110.22 179.634 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.653 ' CD1' ' CE1' ' A' ' 140' ' ' TYR . 5.8 mp -57.43 -26.74 61.62 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.273 178.773 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -66.49 -48.93 68.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.08 179.651 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' TRP . . . . . 0.563 ' CZ2' HD12 ' A' ' 52' ' ' ILE . 12.0 t-105 -55.81 -48.7 74.96 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 179.499 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.76 HD11 ' CE2' ' A' ' 140' ' ' TYR . 8.8 mt -50.37 -56.58 10.76 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 120.444 -0.502 . . . . 0.0 109.968 179.714 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.514 ' O ' HG23 ' A' ' 149' ' ' VAL . . . -61.41 -18.28 58.09 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.709 -179.815 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 6.5 t80 -70.93 -65.04 0.79 Allowed 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.843 -0.343 . . . . 0.0 110.829 -179.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . 0.494 ' O ' ' OD1' ' A' ' 151' ' ' ASN . . . -62.95 -40.23 97.03 Favored 'General case' 0 C--N 1.332 -0.154 0 C-N-CA 120.769 -0.372 . . . . 0.0 110.309 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 13.9 m -58.77 -49.83 76.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.46 179.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.514 HG23 ' O ' ' A' ' 145' ' ' ALA . 53.6 t -66.9 -29.38 46.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.334 179.831 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.445 ' O ' HG23 ' A' ' 154' ' ' VAL . 1.0 OUTLIER -58.33 -59.6 5.08 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.506 -0.478 . . . . 0.0 109.935 179.989 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . 0.494 ' OD1' ' O ' ' A' ' 147' ' ' ALA . 6.7 p-10 -60.6 -51.29 70.02 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.543 179.624 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . 0.665 ' CZ ' ' NE ' ' A' ' 156' ' ' ARG . 53.8 t80 -50.13 -34.74 23.18 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.283 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . 0.552 ' CE2' ' OD2' ' A' ' 157' ' ' ASP . 41.0 t80 -68.06 -46.07 72.09 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.529 179.826 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.445 HG23 ' O ' ' A' ' 150' ' ' LEU . 19.0 t -58.14 -36.8 58.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.305 179.797 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' TRP . . . . . . . . . . . . . 15.3 m0 -65.57 -46.02 81.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.624 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . 0.665 ' NE ' ' CZ ' ' A' ' 152' ' ' TYR . 7.2 mpt_? -68.4 -29.27 67.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.579 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . 0.552 ' OD2' ' CE2' ' A' ' 153' ' ' TYR . 17.0 m-20 -72.3 -51.71 19.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.819 -179.78 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 . . . . . 0 C--N 1.328 -0.341 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.602 -179.917 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.569 ' O ' HG23 ' A' ' 9' ' ' VAL . 0.6 OUTLIER . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.702 0.287 . . . . 0.0 110.354 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.589 ' N ' ' CD ' ' A' ' 7' ' ' PRO . 0.9 OUTLIER -62.28 -37.52 37.86 Favored Pre-proline 0 CA--C 1.534 0.352 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.114 -179.999 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.589 ' CD ' ' N ' ' A' ' 6' ' ' VAL . 33.5 Cg_exo -63.68 -64.21 0.07 OUTLIER 'Trans proline' 0 C--N 1.307 -1.621 0 C-N-CA 121.704 1.603 . . . . 0.0 111.525 179.638 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.7 ' O ' HG23 ' A' ' 12' ' ' THR . . . -52.77 -38.84 61.64 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.695 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.569 HG23 ' O ' ' A' ' 5' ' ' TRP . 24.8 t -59.3 -62.02 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.848 -179.691 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -59.86 -56.67 23.48 Favored Glycine 0 CA--C 1.527 0.81 0 N-CA-C 111.516 -0.634 . . . . 0.0 111.516 -179.628 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 10.1 mp -50.15 -37.77 36.19 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.563 0.22 . . . . 0.0 110.888 -179.643 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.7 HG23 ' O ' ' A' ' 8' ' ' ALA . 35.9 p -75.57 -25.18 56.85 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.858 -0.337 . . . . 0.0 110.625 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.55 HD13 ' O ' ' A' ' 9' ' ' VAL . 4.1 mp -75.81 -25.11 56.06 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.196 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.2 t -54.54 -61.87 4.94 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.428 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -55.8 -46.16 33.67 Favored 'Trans proline' 0 N--CA 1.496 1.672 0 C-N-CA 120.662 0.908 . . . . 0.0 111.808 179.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.2 t -46.13 -28.37 1.2 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.236 -179.474 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 92.7 mt -70.2 -56.02 7.86 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.645 -0.422 . . . . 0.0 110.742 -179.705 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -68.0 -23.2 74.42 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 111.316 -0.714 . . . . 0.0 111.316 -179.659 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -69.93 -54.66 11.13 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 110.881 -0.888 . . . . 0.0 110.881 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 52.3 t80 -65.94 -60.29 2.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.833 0.349 . . . . 0.0 110.675 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 17.3 tpp -59.09 -27.67 65.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.04 -179.726 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -74.71 -62.91 2.71 Favored Glycine 0 CA--C 1.523 0.536 0 N-CA-C 111.011 -0.836 . . . . 0.0 111.011 -179.78 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.593 ' O ' HG22 ' A' ' 26' ' ' VAL . . . -55.48 -19.54 9.9 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.947 0.403 . . . . 0.0 109.994 -179.917 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 9.5 t80 -47.83 -24.39 0.98 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.409 179.713 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.466 ' CE2' ' O ' ' A' ' 99' ' ' PHE . 50.0 t80 -69.34 -48.32 61.74 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.417 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.593 HG22 ' O ' ' A' ' 23' ' ' ALA . 35.6 m -75.23 -16.37 15.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.634 -179.893 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -56.31 -47.28 79.01 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.834 -179.77 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -107.14 -42.2 1.55 Allowed Glycine 0 CA--C 1.525 0.7 0 N-CA-C 111.055 -0.818 . . . . 0.0 111.055 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.44 ' OE2' ' CZ3' ' A' ' 33' ' ' TRP . 16.8 tp10 -71.45 -29.63 65.09 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.701 0.286 . . . . 0.0 110.693 -179.845 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -73.99 -57.36 4.87 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.913 -0.875 . . . . 0.0 110.913 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 10.0 mp -56.83 -25.42 56.02 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.973 -0.381 . . . . 0.0 109.973 179.781 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 55.4 ttt180 -81.2 -49.89 10.24 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.088 -0.506 . . . . 0.0 109.989 179.432 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . 0.44 ' CZ3' ' OE2' ' A' ' 29' ' ' GLU . 0.2 OUTLIER -45.83 -39.94 9.14 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.688 179.252 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 42.2 t80 -47.37 -38.67 13.55 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.774 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -55.97 -35.18 66.43 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.262 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -84.31 -72.27 1.29 Allowed Glycine 0 CA--C 1.524 0.634 0 N-CA-C 110.804 -0.918 . . . . 0.0 110.804 179.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.587 ' O ' HD12 ' A' ' 37' ' ' LEU . 0.4 OUTLIER -96.67 167.89 10.85 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.798 0.333 . . . . 0.0 110.611 179.622 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 42.3 mm-40 -83.71 118.53 23.95 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.512 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 15.0 mtpt -127.47 150.15 71.97 Favored Pre-proline 0 N--CA 1.465 0.277 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.255 -179.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo . . . . . 0 C--N 1.309 -1.509 0 C-N-CA 121.747 1.632 . . . . 0.0 111.045 179.177 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.673 ' O ' HG23 ' A' ' 52' ' ' ILE . 15.5 tp . . . . . 0 CA--C 1.535 0.398 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.649 ' C ' ' H ' ' A' ' 52' ' ' ILE . . . -43.41 -27.84 0.33 Allowed Pre-proline 0 N--CA 1.468 0.431 0 N-CA-C 112.141 0.422 . . . . 0.0 112.141 -179.141 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.433 ' HD2' ' N ' ' A' ' 50' ' ' ALA . 26.6 Cg_exo -53.41 6.46 0.03 OUTLIER 'Trans proline' 0 C--N 1.313 -1.309 0 CA-C-N 119.003 0.68 . . . . 0.0 112.476 178.214 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.673 HG23 ' O ' ' A' ' 49' ' ' LEU . 7.0 pt -51.85 -36.81 19.84 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.19 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 178.827 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.403 ' CH2' ' CZ3' ' A' ' 93' ' ' TRP . 66.1 m95 -80.74 -25.0 38.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.143 -179.752 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -73.1 -50.75 11.64 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 110.326 -1.109 . . . . 0.0 110.326 179.326 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.593 HG23 ' N ' ' A' ' 56' ' ' LEU . 6.8 t -66.28 -49.16 68.04 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.983 -0.287 . . . . 0.0 110.287 179.713 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.593 ' N ' HG23 ' A' ' 55' ' ' THR . 77.7 mt -60.33 -36.53 78.17 Favored 'General case' 0 CA--C 1.521 -0.16 0 C-N-CA 120.403 -0.519 . . . . 0.0 109.608 179.317 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.485 ' C ' ' CD1' ' A' ' 57' ' ' TYR . 0.8 OUTLIER -56.46 -48.29 77.38 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.61 179.334 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.7 p -55.87 -48.06 76.23 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.022 179.5 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.0 -38.82 80.09 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.315 179.558 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 22.2 mtt -63.16 -37.91 89.1 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.479 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -63.38 -47.02 91.28 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 111.245 -0.742 . . . . 0.0 111.245 -179.703 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 3.3 m-30 -61.49 -59.13 5.71 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.574 -179.662 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.448 ' O ' HG23 ' A' ' 67' ' ' VAL . . . -53.94 -60.06 8.95 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 111.02 -0.832 . . . . 0.0 111.02 -179.884 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.534 ' OG ' ' CH2' ' A' ' 126' ' ' TRP . 44.7 m -45.51 -48.47 14.12 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.001 0.429 . . . . 0.0 110.726 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 62.6 t80 -56.51 -41.45 76.74 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.697 -179.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 74.7 mt -65.43 -37.56 80.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.923 -179.694 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.571 HG22 ' CB ' ' A' ' 130' ' ' SER . 21.3 t -59.85 -60.83 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.721 -179.801 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' TRP . . . . . 0.576 ' O ' ' N ' ' A' ' 73' ' ' GLY . 0.7 OUTLIER -57.3 -41.51 79.96 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.655 -0.418 . . . . 0.0 110.325 179.933 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 13.9 mmmt -61.44 -24.77 66.77 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.498 179.622 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 17.7 tp10 -82.34 -62.47 1.61 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.187 -179.473 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.743 ' C ' HD12 ' A' ' 71' ' ' LEU . 3.4 pp -65.25 -8.88 19.7 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.831 -0.348 . . . . 0.0 111.377 -179.152 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.676 ' N ' HD12 ' A' ' 71' ' ' LEU . . . 108.87 76.43 0.93 Allowed Glycine 0 CA--C 1.527 0.801 0 C-N-CA 120.939 -0.648 . . . . 0.0 111.592 179.561 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.576 ' N ' ' O ' ' A' ' 68' ' ' TRP . . . 42.84 -174.03 0.01 OUTLIER Glycine 0 CA--C 1.524 0.595 0 N-CA-C 111.947 -0.461 . . . . 0.0 111.947 179.219 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 43.8 t80 -76.33 110.71 11.07 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.262 -0.469 . . . . 0.0 110.837 -179.671 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.573 HG23 ' H ' ' A' ' 77' ' ' ASP . 7.4 t -142.37 -178.21 5.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.428 179.743 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -46.8 -26.57 0.98 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.179 -179.66 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.573 ' H ' HG23 ' A' ' 75' ' ' THR . 51.7 m-20 -79.05 -28.78 43.21 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.268 -179.422 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.485 ' O ' HD12 ' A' ' 82' ' ' LEU . . . -86.4 -18.34 32.05 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.955 -0.298 . . . . 0.0 110.937 -179.681 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 9.1 mtp -68.96 -27.38 65.68 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.604 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.404 ' N ' ' HD2' ' A' ' 81' ' ' PRO . 7.0 t -68.37 -47.77 36.5 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.9 -179.832 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.404 ' HD2' ' N ' ' A' ' 80' ' ' VAL . 11.4 Cg_endo -72.03 -58.56 0.07 OUTLIER 'Trans proline' 0 N--CA 1.498 1.792 0 C-N-CA 121.113 1.208 . . . . 0.0 111.843 179.253 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.519 HD11 ' CE2' ' A' ' 68' ' ' TRP . 1.6 mt -57.07 -43.71 82.34 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.48 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -66.84 -63.77 3.67 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 111.142 -0.783 . . . . 0.0 111.142 -179.475 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 57.7 tp -49.66 -23.07 1.55 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.924 0.393 . . . . 0.0 110.137 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.462 ' CZ ' HD22 ' A' ' 89' ' ' LEU . 12.9 t80 -76.61 -48.58 18.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.54 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.44 -42.45 95.99 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.8 -0.36 . . . . 0.0 111.056 -179.442 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -70.05 -57.97 6.55 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 111.149 -0.78 . . . . 0.0 111.149 -179.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 36.5 tp60 -54.71 -47.52 73.64 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-O 121.012 0.434 . . . . 0.0 110.104 179.731 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.462 HD22 ' CZ ' ' A' ' 85' ' ' TYR . 17.4 tp -56.55 -65.04 0.68 Allowed 'General case' 0 C--O 1.21 -0.991 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.936 179.581 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.592 ' O ' ' HB2' ' A' ' 94' ' ' ALA . . . -37.86 -44.33 0.75 Allowed 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 120.407 -0.517 . . . . 0.0 111.649 -179.407 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 78.2 mt -60.97 -56.89 15.81 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 113.102 0.778 . . . . 0.0 113.102 -178.664 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 41.7 m-20 -75.9 -53.11 8.93 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.392 0.615 . . . . 0.0 111.697 -178.369 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . 0.628 ' O ' ' N ' ' A' ' 95' ' ' TRP . 9.8 t-105 -52.05 -33.68 40.07 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.055 -0.975 . . . . 0.0 111.594 -179.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.592 ' HB2' ' O ' ' A' ' 90' ' ' ALA . . . -57.03 72.3 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.892 0.377 . . . . 0.0 110.076 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.705 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 22.1 p-90 -97.47 -17.0 0.2 Allowed Pre-proline 0 CA--C 1.532 0.264 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.966 -179.387 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.705 ' CD ' ' N ' ' A' ' 95' ' ' TRP . 52.8 Cg_exo -60.14 -32.23 94.32 Favored 'Trans proline' 0 N--CA 1.493 1.493 0 C-N-CA 120.357 0.705 . . . . 0.0 112.635 179.387 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.484 ' CD ' ' N ' ' A' ' 96' ' ' PRO . 70.1 Cg_exo -50.35 -23.31 9.98 Favored 'Trans proline' 0 N--CA 1.493 1.458 0 C-N-CA 120.254 0.636 . . . . 0.0 112.443 179.785 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.588 ' O ' ' N ' ' A' ' 101' ' ' GLY . 1.1 pp -84.5 19.77 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 121.087 0.47 . . . . 0.0 110.135 179.531 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.466 ' O ' ' CE2' ' A' ' 25' ' ' PHE . 4.4 t80 -39.13 -35.41 0.23 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.843 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 30.6 m-85 -86.59 -25.79 24.79 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.82 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.588 ' N ' ' O ' ' A' ' 98' ' ' ILE . . . -82.8 -4.4 90.07 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 111.195 -0.762 . . . . 0.0 111.195 -179.886 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -72.24 -9.63 58.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.637 0.256 . . . . 0.0 111.081 -179.704 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 3.7 ptm180 -105.25 4.3 30.95 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.755 0.312 . . . . 0.0 110.779 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . 0.406 ' C ' ' N ' ' A' ' 106' ' ' GLY . 9.6 mt-30 -113.69 167.54 10.53 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.475 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.486 ' N ' ' SD ' ' A' ' 105' ' ' MET . 0.0 OUTLIER -49.64 -17.38 0.32 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.532 179.979 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.578 ' O ' ' N ' ' A' ' 108' ' ' ALA . . . -72.77 -15.12 78.0 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 111.37 -0.692 . . . . 0.0 111.37 -179.751 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' TRP . . . . . 0.665 ' CD1' ' CZ2' ' A' ' 155' ' ' TRP . 0.0 OUTLIER -38.15 -21.32 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 120.548 0.213 . . . . 0.0 111.239 -179.473 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.578 ' N ' ' O ' ' A' ' 106' ' ' GLY . . . -66.81 -16.15 64.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.912 0.387 . . . . 0.0 111.291 -179.531 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 13.5 mt -60.31 -36.79 78.73 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.479 -179.246 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -53.66 -63.59 1.1 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.967 0.413 . . . . 0.0 110.721 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.742 ' O ' HG23 ' A' ' 115' ' ' VAL . 5.6 p-10 -56.76 -60.69 3.2 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.826 -179.297 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 51.9 tp -49.83 -41.9 46.06 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -178.477 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.418 HD23 ' HA ' ' A' ' 113' ' ' LEU . 71.4 mt -68.49 -61.72 1.7 Allowed 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 -178.144 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.3 pp -59.76 -33.29 71.48 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 120.581 -0.448 . . . . 0.0 111.281 -178.723 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.742 HG23 ' O ' ' A' ' 111' ' ' ASP . 53.3 t -62.04 -60.93 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.148 -179.838 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . 0.493 ' O ' ' OG1' ' A' ' 120' ' ' THR . 11.4 t -68.57 -22.12 64.49 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.1 -179.373 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -64.8 -62.92 4.58 Favored Glycine 0 CA--C 1.526 0.764 0 C-N-CA 120.883 -0.675 . . . . 0.0 111.742 -179.284 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.585 ' O ' HG23 ' A' ' 122' ' ' THR . 9.9 p -73.38 -36.57 49.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 C-N-CA 120.948 -0.301 . . . . 0.0 111.286 -179.389 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.536 ' O ' ' OG1' ' A' ' 123' ' ' THR . . . -67.41 -61.21 2.02 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.529 -0.469 . . . . 0.0 111.019 -179.462 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.493 ' OG1' ' O ' ' A' ' 116' ' ' SER . 2.0 m -59.27 -54.59 45.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.351 -179.431 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.437 ' O ' ' CB ' ' A' ' 125' ' ' ALA . . . -49.5 -45.89 47.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.854 -179.513 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.585 HG23 ' O ' ' A' ' 118' ' ' VAL . 40.9 p -69.75 -35.29 74.84 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.996 -179.06 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.536 ' OG1' ' O ' ' A' ' 119' ' ' ALA . 0.2 OUTLIER -58.2 -52.07 67.1 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.633 -0.427 . . . . 0.0 111.139 -179.218 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.7 pp -83.96 -19.73 34.11 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.705 -0.398 . . . . 0.0 111.721 -178.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.437 ' CB ' ' O ' ' A' ' 121' ' ' ALA . . . -88.02 -70.11 0.65 Allowed 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.584 0.587 . . . . 0.0 112.584 -178.796 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' TRP . . . . . 0.534 ' CH2' ' OG ' ' A' ' 64' ' ' SER . 35.9 m0 -83.23 -57.82 3.1 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 -177.702 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . 0.449 ' CD2' ' N ' ' A' ' 127' ' ' HIS . 12.3 m170 -52.22 -21.82 3.76 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.663 -0.415 . . . . 0.0 111.295 -178.825 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 28.3 ttt180 -70.05 -47.01 63.75 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.667 -179.337 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 4.1 t -94.44 -9.58 9.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 111.861 0.319 . . . . 0.0 111.861 -178.674 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . 0.571 ' CB ' HG22 ' A' ' 67' ' ' VAL . 0.8 OUTLIER -149.56 106.39 3.29 Favored Pre-proline 0 C--N 1.328 -0.368 0 C-N-CA 120.872 -0.331 . . . . 0.0 111.183 -179.364 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . 0.665 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 74.4 Cg_exo -76.05 -23.27 12.28 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 121.759 1.639 . . . . 0.0 112.656 179.058 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . 0.665 ' CD ' ' N ' ' A' ' 131' ' ' PRO . 52.4 Cg_exo -65.89 -56.85 0.28 Allowed 'Trans proline' 0 N--CA 1.496 1.652 0 C-N-CA 121.322 1.348 . . . . 0.0 112.347 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -46.76 -40.73 14.07 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.64 -179.793 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -52.35 -24.39 7.54 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.533 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 6.1 tpt180 -76.93 -36.71 56.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.432 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 41.3 mt -67.19 -37.06 83.05 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.353 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.568 ' O ' ' N ' ' A' ' 140' ' ' TYR . 5.8 mt -81.86 -39.63 23.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.487 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.513 ' C ' ' H ' ' A' ' 140' ' ' TYR . 4.2 t80 -22.58 -43.57 0.04 OUTLIER Pre-proline 0 CA--C 1.532 0.274 0 O-C-N 123.664 0.602 . . . . 0.0 111.819 -179.601 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.552 ' N ' ' O ' ' A' ' 137' ' ' LEU . 6.3 Cg_exo -65.36 12.66 0.12 Allowed 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 120.852 1.034 . . . . 0.0 111.975 179.291 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . 0.702 ' CE2' HD11 ' A' ' 144' ' ' LEU . 3.1 p90 -93.15 -14.42 27.21 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-O 120.892 0.377 . . . . 0.0 110.852 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.53 HD13 HD12 ' A' ' 144' ' ' LEU . 4.3 mm? -55.94 -33.48 64.77 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 178.536 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -56.21 -55.43 33.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.005 179.604 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' TRP . . . . . 0.655 ' CE2' HD12 ' A' ' 52' ' ' ILE . 10.8 t-105 -52.08 -50.49 61.46 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 179.643 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.702 HD11 ' CE2' ' A' ' 140' ' ' TYR . 13.3 mt -49.68 -54.92 15.83 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 120.348 -0.541 . . . . 0.0 109.91 179.599 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.643 ' O ' HG23 ' A' ' 149' ' ' VAL . . . -60.44 -21.35 62.19 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.852 -179.779 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 0.583 ' CE1' HD21 ' A' ' 49' ' ' LEU . 6.2 t80 -69.48 -63.18 1.12 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.837 -179.582 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . 0.429 ' HB2' ' CH2' ' A' ' 143' ' ' TRP . . . -64.91 -33.4 75.94 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.728 -0.389 . . . . 0.0 110.436 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 68.9 m -67.13 -35.35 79.53 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.2 179.673 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.643 HG23 ' O ' ' A' ' 145' ' ' ALA . 43.5 t -79.5 -26.87 12.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.179 179.79 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.526 ' O ' HG23 ' A' ' 154' ' ' VAL . 0.8 OUTLIER -66.55 -48.7 68.83 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.827 -0.435 . . . . 0.0 109.827 179.747 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . 0.55 ' CG ' ' HE1' ' A' ' 107' ' ' TRP . 0.9 OUTLIER -72.92 -51.23 19.34 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.627 179.81 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . 0.414 ' CD1' ' C ' ' A' ' 152' ' ' TYR . 27.8 t80 -56.16 -43.31 78.22 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.855 -179.77 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . 0.437 ' CB ' ' O ' ' A' ' 149' ' ' VAL . 63.9 t80 -62.46 -54.38 40.98 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.299 -179.548 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.526 HG23 ' O ' ' A' ' 150' ' ' LEU . 72.7 t -60.44 -54.81 29.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.151 -179.291 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' TRP . . . . . 0.665 ' CZ2' ' CD1' ' A' ' 107' ' ' TRP . 0.4 OUTLIER -48.92 -37.6 20.36 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.206 -0.452 . . . . 0.0 109.978 -179.564 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -77.51 -28.98 52.23 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.296 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 12.5 t0 -75.44 -52.82 9.82 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.826 -179.595 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' ASN . . . . . 0.484 ' OD1' ' O ' ' A' ' 158' ' ' ASN . 48.9 t-20 . . . . . 0 N--CA 1.452 -0.354 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.731 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.629 ' O ' HG23 ' A' ' 9' ' ' VAL . 0.3 OUTLIER . . . . . 0 CA--C 1.528 0.127 0 CA-C-O 120.719 0.295 . . . . 0.0 110.239 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.648 ' N ' ' CD ' ' A' ' 7' ' ' PRO . 1.0 OUTLIER -62.64 -33.73 12.4 Favored Pre-proline 0 C--N 1.328 -0.326 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 179.788 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.648 ' CD ' ' N ' ' A' ' 6' ' ' VAL . 21.6 Cg_exo -72.37 -66.97 0.03 OUTLIER 'Trans proline' 0 C--N 1.308 -1.557 0 C-N-CA 121.957 1.772 . . . . 0.0 111.895 179.516 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.647 ' O ' HG23 ' A' ' 12' ' ' THR . . . -49.65 -31.32 10.67 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.153 -179.683 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.629 HG23 ' O ' ' A' ' 5' ' ' TRP . 47.4 t -71.36 -62.2 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.425 -179.182 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -59.02 -43.82 96.67 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 111.262 -0.735 . . . . 0.0 111.262 -179.419 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 8.0 mp -61.87 -39.03 90.5 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.697 0.284 . . . . 0.0 110.637 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.647 HG23 ' O ' ' A' ' 8' ' ' ALA . 8.0 p -69.73 -28.48 65.84 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.786 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.427 ' O ' ' CB ' ' A' ' 16' ' ' SER . 10.7 mt -78.27 -33.38 49.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.669 -179.843 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.443 ' N ' ' HD2' ' A' ' 15' ' ' PRO . 20.3 t -42.0 -59.48 2.58 Favored Pre-proline 0 CA--C 1.535 0.38 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.561 -179.681 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.443 ' HD2' ' N ' ' A' ' 14' ' ' VAL . 17.1 Cg_endo -51.69 -9.46 0.4 Allowed 'Trans proline' 0 N--CA 1.5 1.869 0 C-N-CA 120.616 0.877 . . . . 0.0 112.317 -179.471 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.427 ' CB ' ' O ' ' A' ' 13' ' ' LEU . 3.1 t -79.35 -30.99 42.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.74 -179.865 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 16.6 mt -69.63 -54.44 13.95 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.998 -179.728 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -73.38 -38.55 52.75 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 111.632 -0.587 . . . . 0.0 111.632 -179.374 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -68.94 -29.84 72.42 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 111.066 -0.813 . . . . 0.0 111.066 -179.546 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.412 ' CB ' ' O ' ' A' ' 16' ' ' SER . 64.0 t80 -78.73 -60.32 2.42 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.815 -0.354 . . . . 0.0 110.934 -179.672 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 23.8 ttm -64.88 -21.1 66.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.66 -179.805 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -79.09 -63.02 2.12 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 111.309 -0.716 . . . . 0.0 111.309 -179.628 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.559 ' O ' HG22 ' A' ' 26' ' ' VAL . . . -62.93 -22.19 66.6 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.594 -179.667 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 64.4 t80 -50.9 -23.91 3.19 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.989 0.424 . . . . 0.0 109.892 179.31 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.446 ' CD1' ' C ' ' A' ' 25' ' ' PHE . 25.4 t80 -67.08 -55.01 16.14 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.964 -179.84 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.559 HG22 ' O ' ' A' ' 23' ' ' ALA . 27.2 m -65.87 -22.13 30.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.966 -179.509 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.7 tmt_? -75.56 -17.54 60.03 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.698 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -116.06 -67.3 0.41 Allowed Glycine 0 CA--C 1.525 0.7 0 N-CA-C 111.239 -0.744 . . . . 0.0 111.239 -179.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -67.97 -29.72 68.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.751 0.31 . . . . 0.0 110.94 -179.69 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -69.27 -45.91 59.33 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 111.31 -0.716 . . . . 0.0 111.31 -179.737 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.405 ' N ' HD12 ' A' ' 31' ' ' LEU . 11.1 mp -60.34 -28.53 68.24 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.692 0.282 . . . . 0.0 110.677 -179.789 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 76.7 mtm180 -80.38 -43.03 21.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.829 0.347 . . . . 0.0 110.36 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . 0.466 ' O ' ' N ' ' A' ' 36' ' ' GLY . 0.2 OUTLIER -59.91 -27.2 66.54 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 179.751 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.487 ' C ' ' CD1' ' A' ' 34' ' ' TYR . 10.3 t80 -49.02 -37.02 19.33 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.894 179.496 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -70.87 -21.66 62.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.902 179.447 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.466 ' N ' ' O ' ' A' ' 33' ' ' TRP . . . -87.95 -76.89 1.28 Allowed Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.442 -1.063 . . . . 0.0 110.442 179.591 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.596 ' O ' HD12 ' A' ' 37' ' ' LEU . 0.4 OUTLIER -96.04 163.7 13.01 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 109.889 -0.411 . . . . 0.0 109.889 179.011 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.506 ' H ' ' CD ' ' A' ' 38' ' ' GLN . 11.2 mp0 -81.79 122.64 27.95 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.932 0.396 . . . . 0.0 111.432 -179.066 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 20.3 mtpt -119.02 160.01 42.58 Favored Pre-proline 0 C--N 1.332 -0.176 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.575 179.182 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo . . . . . 0 C--N 1.305 -1.714 0 C-N-CA 122.023 1.815 . . . . 0.0 111.972 -179.936 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.853 ' O ' HG23 ' A' ' 52' ' ' ILE . 2.1 mm? . . . . . 0 CA--C 1.534 0.344 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.565 ' C ' ' H ' ' A' ' 52' ' ' ILE . . . -39.87 -29.12 0.19 Allowed Pre-proline 0 N--CA 1.466 0.346 0 C-N-CA 120.14 -0.624 . . . . 0.0 111.849 -178.266 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.423 ' HD2' ' N ' ' A' ' 50' ' ' ALA . 95.5 Cg_exo -57.01 5.85 0.06 OUTLIER 'Trans proline' 0 C--N 1.313 -1.323 0 CA-C-N 119.114 0.719 . . . . 0.0 112.273 178.125 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.853 HG23 ' O ' ' A' ' 49' ' ' LEU . 33.5 pt -55.29 -31.37 26.65 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.295 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 179.514 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.459 ' O ' ' CB ' ' A' ' 57' ' ' TYR . 72.7 m95 -78.73 -22.81 45.98 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.892 -179.497 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -69.22 -48.23 47.52 Favored Glycine 0 CA--C 1.526 0.772 0 N-CA-C 110.064 -1.214 . . . . 0.0 110.064 178.754 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 14.5 m -66.77 -55.63 14.12 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.783 0.325 . . . . 0.0 110.142 179.431 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 86.1 mt -58.62 -26.98 64.26 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.44 179.713 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.526 ' C ' ' CD1' ' A' ' 57' ' ' TYR . 0.5 OUTLIER -64.98 -54.1 35.79 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 179.509 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 37.2 t -51.19 -50.49 58.92 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 179.126 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -56.6 -45.18 81.58 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.319 179.435 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 12.3 mtt -57.72 -49.03 77.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.365 179.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -51.49 -43.98 52.98 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 110.994 -0.842 . . . . 0.0 110.994 -179.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 3.2 m-30 -65.26 -56.3 13.54 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.762 0.315 . . . . 0.0 110.943 -179.456 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -52.06 -48.53 52.21 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.37 -1.092 . . . . 0.0 110.37 179.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.488 ' O ' ' CD1' ' A' ' 68' ' ' TRP . 1.7 t -58.83 -41.9 87.98 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.652 -0.274 . . . . 0.0 110.571 179.889 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.406 ' O ' ' CG ' ' A' ' 69' ' ' LYS . 14.5 t80 -54.58 -37.97 66.14 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 109.138 -0.689 . . . . 0.0 109.138 179.038 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 97.3 mt -73.34 -27.29 23.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.096 179.223 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 61.2 t -69.52 -61.69 1.58 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.252 0 C-N-CA 120.746 -0.382 . . . . 0.0 110.763 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' TRP . . . . . 0.516 ' CD1' ' N ' ' A' ' 68' ' ' TRP . 0.0 OUTLIER -57.9 -38.07 75.17 Favored 'General case' 0 C--O 1.221 -0.402 0 C-N-CA 119.388 -0.925 . . . . 0.0 109.622 179.758 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.406 ' CG ' ' O ' ' A' ' 65' ' ' TYR . 0.2 OUTLIER -58.39 -40.52 82.56 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.889 0.376 . . . . 0.0 110.458 179.956 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 55.8 tt0 -64.35 -41.67 96.64 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.344 -179.555 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.6 mt -78.78 -17.64 55.45 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.955 0.407 . . . . 0.0 111.053 -179.347 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 97.84 43.16 2.93 Favored Glycine 0 CA--C 1.526 0.771 0 N-CA-C 110.345 -1.102 . . . . 0.0 110.345 -178.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 96.98 -175.09 30.76 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 111.03 -0.828 . . . . 0.0 111.03 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -71.8 112.44 7.91 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.844 0.354 . . . . 0.0 110.533 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.433 ' OG1' ' N ' ' A' ' 76' ' ' GLU . 3.0 t -139.4 179.51 6.5 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.855 -179.801 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.433 ' N ' ' OG1' ' A' ' 75' ' ' THR . 5.0 mm-40 -54.56 -50.06 68.85 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.595 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -55.0 -16.11 2.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.454 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -95.56 -30.7 13.68 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.392 179.769 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 3.5 mtp -64.9 -27.06 68.6 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.495 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.427 ' O ' ' CB ' ' A' ' 84' ' ' LEU . 9.1 t -68.9 -49.64 25.67 Favored Pre-proline 0 CA--C 1.534 0.345 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.643 -179.694 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -72.13 -61.48 0.05 OUTLIER 'Trans proline' 0 N--CA 1.497 1.728 0 C-N-CA 121.127 1.218 . . . . 0.0 111.523 178.891 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.7 mt -51.3 -46.32 62.5 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.384 179.809 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.452 ' O ' ' N ' ' A' ' 86' ' ' THR . . . -67.6 -63.56 3.65 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.672 -0.971 . . . . 0.0 110.672 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.427 ' CB ' ' O ' ' A' ' 80' ' ' VAL . 56.9 tp -43.73 -24.75 0.14 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.892 0.377 . . . . 0.0 110.014 179.727 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.424 ' N ' ' C ' ' A' ' 83' ' ' GLY . 7.2 t80 -80.62 -40.48 25.59 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.442 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.452 ' N ' ' O ' ' A' ' 83' ' ' GLY . 0.7 OUTLIER -71.63 -39.07 70.65 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 120.599 -0.44 . . . . 0.0 110.854 -179.787 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -74.7 -56.92 4.74 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 110.758 -0.937 . . . . 0.0 110.758 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.454 ' O ' ' CB ' ' A' ' 92' ' ' ASN . 9.4 tp-100 -52.7 -43.88 65.93 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.723 0.296 . . . . 0.0 110.236 179.747 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 11.1 tp -67.59 -34.9 77.95 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.605 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.74 ' O ' ' HB2' ' A' ' 94' ' ' ALA . . . -59.73 -65.75 0.63 Allowed 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 120.279 -0.568 . . . . 0.0 111.343 -179.633 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.0 pp -70.71 -39.01 73.67 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -178.479 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.454 ' CB ' ' O ' ' A' ' 88' ' ' GLN . 36.7 t-20 -72.42 -50.33 27.14 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 -178.6 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . 0.622 ' O ' ' N ' ' A' ' 95' ' ' TRP . 0.0 OUTLIER -79.63 -16.63 55.45 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.536 -0.466 . . . . 0.0 111.832 -178.374 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.74 ' HB2' ' O ' ' A' ' 90' ' ' ALA . . . -52.02 81.83 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 120.31 -0.556 . . . . 0.0 109.965 179.336 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.704 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 33.8 p-90 -98.97 -16.14 0.19 Allowed Pre-proline 0 CA--C 1.537 0.451 0 N-CA-C 112.564 0.579 . . . . 0.0 112.564 -179.103 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.704 ' CD ' ' N ' ' A' ' 95' ' ' TRP . 36.6 Cg_exo -57.31 -31.5 91.09 Favored 'Trans proline' 0 N--CA 1.495 1.609 0 C-N-CA 120.526 0.818 . . . . 0.0 113.125 179.777 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.455 ' CD ' ' N ' ' A' ' 96' ' ' PRO . 80.4 Cg_exo -53.14 -20.28 13.87 Favored 'Trans proline' 0 N--CA 1.495 1.601 0 C-N-CA 120.352 0.701 . . . . 0.0 113.271 -179.873 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.463 ' O ' ' N ' ' A' ' 101' ' ' GLY . 1.3 pp -82.61 19.21 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 C-N-CA 120.586 -0.446 . . . . 0.0 110.469 -179.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -40.76 -41.48 1.56 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.933 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 2.5 p90 -85.5 -23.75 27.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.914 -179.698 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.463 ' N ' ' O ' ' A' ' 98' ' ' ILE . . . -78.82 -7.7 88.15 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 111.194 -0.762 . . . . 0.0 111.194 -179.851 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -80.14 -7.11 58.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.774 0.321 . . . . 0.0 110.729 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -74.36 -12.18 60.45 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.846 -179.727 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . 0.429 ' C ' ' N ' ' A' ' 106' ' ' GLY . 6.7 pt20 -117.39 164.62 14.59 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.804 -179.862 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 8.6 mmt -47.92 -17.15 0.1 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.536 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.595 ' O ' ' N ' ' A' ' 108' ' ' ALA . . . -62.09 -15.56 50.58 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' TRP . . . . . 0.512 ' C ' ' CD1' ' A' ' 107' ' ' TRP . 0.0 OUTLIER -44.04 -12.62 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.758 0.313 . . . . 0.0 110.725 -179.687 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.595 ' N ' ' O ' ' A' ' 106' ' ' GLY . . . -65.27 -28.52 69.4 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.363 179.743 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.413 HD13 ' O ' ' A' ' 106' ' ' GLY . 9.1 mp -45.76 -26.43 0.65 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.231 179.842 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -60.82 -63.97 1.12 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.595 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.704 ' O ' HG23 ' A' ' 115' ' ' VAL . 4.1 p30 -57.66 -50.75 72.15 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.464 -179.614 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.438 ' N ' ' OD1' ' A' ' 111' ' ' ASP . 53.2 tp -55.14 -44.27 74.92 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.875 -0.33 . . . . 0.0 111.587 -178.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 54.2 mt -66.7 -61.39 1.99 Allowed 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -178.515 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.3 pp -61.51 -32.64 72.67 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 120.567 -0.453 . . . . 0.0 111.842 -178.391 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.704 HG23 ' O ' ' A' ' 111' ' ' ASP . 46.0 t -63.32 -54.44 32.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.24 -179.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . 0.447 ' O ' ' OG1' ' A' ' 120' ' ' THR . 28.9 t -72.46 -24.12 61.15 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.316 -179.059 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -66.2 -62.66 4.49 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 120.944 -0.646 . . . . 0.0 111.749 -179.278 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.588 ' O ' HG23 ' A' ' 122' ' ' THR . 7.5 p -71.79 -38.48 65.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 C-N-CA 120.961 -0.296 . . . . 0.0 111.709 -179.246 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.527 ' O ' ' OG1' ' A' ' 123' ' ' THR . . . -64.54 -60.92 2.58 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.697 -0.401 . . . . 0.0 111.221 -179.286 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.447 ' OG1' ' O ' ' A' ' 116' ' ' SER . 2.1 m -60.28 -55.16 37.12 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.56 -179.275 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -51.11 -40.65 58.95 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.204 -179.268 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.588 HG23 ' O ' ' A' ' 118' ' ' VAL . 30.9 p -72.25 -35.54 68.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.3 -179.363 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.527 ' OG1' ' O ' ' A' ' 119' ' ' ALA . 0.2 OUTLIER -58.28 -50.66 72.81 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.812 0.339 . . . . 0.0 111.148 -179.221 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.6 pp -82.42 -20.19 37.54 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.669 -178.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -88.12 -72.72 0.52 Allowed 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 -178.511 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 43.7 m0 -81.83 -57.93 3.21 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 112.662 0.616 . . . . 0.0 112.662 -177.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . 0.533 ' CD2' ' N ' ' A' ' 127' ' ' HIS . 5.3 m170 -53.18 -22.23 6.28 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.63 -0.428 . . . . 0.0 111.14 -178.823 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 14.0 ttt180 -76.31 -30.49 57.74 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.146 -179.61 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 73.8 t -95.64 -49.9 12.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.769 0.319 . . . . 0.0 111.29 -179.422 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 67.7 p -117.6 109.23 41.99 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.511 -179.707 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . 0.657 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 50.5 Cg_exo -71.68 -18.13 29.04 Favored 'Trans proline' 0 N--CA 1.493 1.461 0 C-N-CA 121.458 1.439 . . . . 0.0 112.584 179.638 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . 0.657 ' CD ' ' N ' ' A' ' 131' ' ' PRO . 54.3 Cg_exo -74.43 -35.57 3.68 Favored 'Trans proline' 0 N--CA 1.496 1.653 0 C-N-CA 121.262 1.308 . . . . 0.0 112.0 179.365 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -63.49 -39.64 94.97 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.348 179.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -57.33 -26.56 61.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.2 179.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 15.9 tpt180 -77.66 -31.09 52.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.373 179.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 20.5 mt -75.5 -25.83 57.63 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.261 -0.427 . . . . 0.0 109.849 179.506 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.486 ' O ' ' N ' ' A' ' 140' ' ' TYR . 68.6 mt -92.47 -23.81 19.01 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.165 179.505 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.518 ' C ' ' CD1' ' A' ' 138' ' ' TYR . 0.3 OUTLIER -35.43 -50.19 1.33 Allowed Pre-proline 0 CA--C 1.535 0.395 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.977 179.715 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.439 ' HD2' ' N ' ' A' ' 138' ' ' TYR . 0.9 OUTLIER -61.28 4.89 0.2 Allowed 'Trans proline' 0 N--CA 1.496 1.667 0 C-N-CA 121.64 1.56 . . . . 0.0 112.958 -179.471 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . 0.486 ' N ' ' O ' ' A' ' 137' ' ' LEU . 0.1 OUTLIER -88.88 -14.32 37.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.0 0.429 . . . . 0.0 110.562 179.657 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.538 HD23 HD12 ' A' ' 144' ' ' LEU . 97.5 mt -60.02 -33.6 72.22 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.685 178.582 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -57.15 -41.39 79.06 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.584 179.304 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' TRP . . . . . 0.431 ' CE2' HD12 ' A' ' 52' ' ' ILE . 8.6 t-105 -66.11 -43.64 86.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.591 179.24 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.538 HD12 HD23 ' A' ' 141' ' ' LEU . 30.0 mt -59.08 -41.97 89.27 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.174 179.765 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.619 ' O ' HG23 ' A' ' 149' ' ' VAL . . . -72.65 -23.4 60.9 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.419 179.855 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 24.4 t80 -65.91 -57.11 8.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.804 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -68.08 -43.37 78.69 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 120.91 -0.316 . . . . 0.0 110.886 -179.727 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 63.6 m -58.99 -45.68 90.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.831 0.348 . . . . 0.0 110.754 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.619 HG23 ' O ' ' A' ' 145' ' ' ALA . 69.4 t -68.49 -29.43 43.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.632 -179.885 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.464 ' O ' HG23 ' A' ' 154' ' ' VAL . 1.6 tp -62.51 -47.09 85.44 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.293 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . 0.596 ' ND2' ' N ' ' A' ' 152' ' ' TYR . 0.3 OUTLIER -69.27 -37.2 77.77 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.568 179.934 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . 0.596 ' N ' ' ND2' ' A' ' 151' ' ' ASN . 26.0 t80 -64.15 -48.82 74.53 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.593 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 31.1 t80 -59.27 -43.51 92.49 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.872 -179.864 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.464 HG23 ' O ' ' A' ' 150' ' ' LEU . 75.8 t -61.7 -36.04 71.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.81 -179.757 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' TRP . . . . . . . . . . . . . 8.0 m0 -64.44 -59.19 4.63 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.74 -179.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . 0.411 ' NE ' ' CZ ' ' A' ' 152' ' ' TYR . 3.3 mpt_? -60.62 -51.29 70.05 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.829 -179.571 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 31.3 t0 -53.82 -43.79 69.7 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.791 -179.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 16.5 t-20 . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.55 -179.933 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.712 ' O ' HG23 ' A' ' 9' ' ' VAL . 1.3 t-105 . . . . . 0 CA--C 1.528 0.128 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.576 ' N ' ' CD ' ' A' ' 7' ' ' PRO . 0.9 OUTLIER -62.23 -40.43 66.78 Favored Pre-proline 0 CA--C 1.533 0.313 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.479 -179.479 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.576 ' CD ' ' N ' ' A' ' 6' ' ' VAL . 25.1 Cg_exo -61.24 -60.29 0.24 Allowed 'Trans proline' 0 C--N 1.306 -1.66 0 C-N-CA 121.627 1.551 . . . . 0.0 111.874 179.904 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.722 ' O ' HG23 ' A' ' 12' ' ' THR . . . -56.88 -32.94 66.37 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.42 -179.465 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.712 HG23 ' O ' ' A' ' 5' ' ' TRP . 55.3 t -67.22 -62.03 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 C-N-CA 120.897 -0.321 . . . . 0.0 111.397 -179.263 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -57.52 -41.23 93.33 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 111.354 -0.698 . . . . 0.0 111.354 -179.509 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 7.7 mp -69.64 -30.14 67.78 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 121.043 -0.263 . . . . 0.0 110.758 -179.641 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.722 HG23 ' O ' ' A' ' 8' ' ' ALA . 4.8 p -74.81 -25.24 58.89 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.842 -0.343 . . . . 0.0 110.406 179.802 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.441 ' O ' ' CB ' ' A' ' 16' ' ' SER . 6.4 mp -81.48 -33.79 31.74 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.023 179.688 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.416 ' N ' ' HD2' ' A' ' 15' ' ' PRO . 7.9 t -40.25 -60.66 1.4 Allowed Pre-proline 0 CA--C 1.535 0.366 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.061 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.416 ' HD2' ' N ' ' A' ' 14' ' ' VAL . 10.5 Cg_endo -51.49 -17.15 4.14 Favored 'Trans proline' 0 N--CA 1.499 1.8 0 C-N-CA 120.949 1.099 . . . . 0.0 112.091 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.441 ' CB ' ' O ' ' A' ' 13' ' ' LEU . 4.0 t -70.0 -33.3 71.86 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.886 0.374 . . . . 0.0 110.512 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 27.9 mt -72.11 -55.17 7.77 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.336 179.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -60.75 -46.36 94.63 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 110.857 -0.897 . . . . 0.0 110.857 179.784 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -65.35 -29.45 75.28 Favored Glycine 0 CA--C 1.526 0.756 0 N-CA-C 111.051 -0.82 . . . . 0.0 111.051 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 31.9 t80 -74.23 -59.98 2.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.696 0.284 . . . . 0.0 110.66 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 6.7 ttp -63.31 -22.47 66.9 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.621 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.479 ' C ' ' CZ2' ' A' ' 95' ' ' TRP . . . -77.2 -62.65 2.41 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 111.093 -0.803 . . . . 0.0 111.093 -179.874 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.41 ' O ' HG22 ' A' ' 26' ' ' VAL . . . -64.51 -17.54 63.99 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.006 0.431 . . . . 0.0 110.314 179.891 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 41.4 t80 -48.91 -24.73 1.58 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.143 179.634 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 33.9 t80 -67.64 -54.72 17.31 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.761 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.41 HG22 ' O ' ' A' ' 23' ' ' ALA . 22.2 m -71.64 -17.2 19.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.761 -179.724 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -62.17 -39.84 94.0 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.623 -179.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -114.65 -72.42 0.55 Allowed Glycine 0 CA--C 1.525 0.681 0 N-CA-C 110.824 -0.91 . . . . 0.0 110.824 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -45.92 -28.23 1.07 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.82 0.343 . . . . 0.0 110.431 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -68.26 -45.16 71.91 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 84.2 mt -54.95 -36.43 65.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.887 0.375 . . . . 0.0 110.274 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 56.2 mtp180 -77.69 -50.53 12.26 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.637 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . 0.422 ' O ' ' N ' ' A' ' 36' ' ' GLY . 0.6 OUTLIER -46.73 -30.68 2.52 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 116.3 -0.409 . . . . 0.0 109.909 -179.996 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 37.7 t80 -47.75 -33.62 7.33 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.424 179.723 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -74.9 -30.64 61.35 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.263 179.731 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.422 ' N ' ' O ' ' A' ' 33' ' ' TRP . . . -77.72 -77.39 0.83 Allowed Glycine 0 CA--C 1.524 0.64 0 N-CA-C 110.793 -0.923 . . . . 0.0 110.793 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.56 ' O ' HD12 ' A' ' 37' ' ' LEU . 0.4 OUTLIER -96.45 166.23 11.8 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 120.791 0.329 . . . . 0.0 110.739 179.712 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.597 HE21 ' C ' ' A' ' 39' ' ' LYS . 2.3 tm0? -83.17 113.41 20.63 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.767 -179.739 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.597 ' C ' HE21 ' A' ' 38' ' ' GLN . 7.8 mtpt -97.24 157.28 35.16 Favored Pre-proline 0 CA--C 1.532 0.267 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 179.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo . . . . . 0 N--CA 1.495 1.568 0 C-N-CA 120.924 1.083 . . . . 0.0 112.104 -178.714 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.757 ' O ' HG23 ' A' ' 52' ' ' ILE . 0.2 OUTLIER . . . . . 0 CA--C 1.533 0.309 0 N-CA-C 112.808 0.669 . . . . 0.0 112.808 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.6 ' C ' ' H ' ' A' ' 52' ' ' ILE . . . -39.08 -30.98 0.21 Allowed Pre-proline 0 C--O 1.235 0.305 0 C-N-CA 120.614 -0.435 . . . . 0.0 111.73 -178.391 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.413 ' HD2' ' N ' ' A' ' 50' ' ' ALA . 39.7 Cg_exo -53.53 5.55 0.03 OUTLIER 'Trans proline' 0 C--N 1.311 -1.417 0 CA-C-N 118.99 0.675 . . . . 0.0 112.456 178.253 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.757 HG23 ' O ' ' A' ' 49' ' ' LEU . 9.9 pt -53.34 -34.86 23.3 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.201 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 179.114 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.454 ' O ' ' CB ' ' A' ' 57' ' ' TYR . 72.6 m95 -78.83 -23.24 45.19 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.151 -179.415 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -68.96 -45.12 64.33 Favored Glycine 0 CA--C 1.527 0.797 0 N-CA-C 109.909 -1.276 . . . . 0.0 109.909 179.047 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 6.2 m -68.8 -56.89 6.58 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 179.282 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 95.8 mt -57.32 -26.0 60.25 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.094 179.733 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.543 ' C ' ' CD1' ' A' ' 57' ' ' TYR . 0.5 OUTLIER -66.27 -54.65 22.37 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 179.482 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 61.5 m -51.13 -53.85 30.59 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.539 -0.464 . . . . 0.0 109.92 179.369 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -54.51 -41.07 69.2 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.485 179.772 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 10.1 mtt -62.45 -58.2 8.46 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.354 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -42.31 -41.99 4.17 Favored Glycine 0 CA--C 1.521 0.445 0 N-CA-C 110.641 -0.984 . . . . 0.0 110.641 179.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -63.55 -57.64 9.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.896 0.379 . . . . 0.0 110.412 179.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -52.1 -57.0 14.11 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 110.682 -0.967 . . . . 0.0 110.682 179.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.455 ' O ' ' CD1' ' A' ' 68' ' ' TRP . 0.3 OUTLIER -46.26 -51.64 14.09 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.927 0.394 . . . . 0.0 110.176 179.574 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 70.6 t80 -49.84 -41.07 44.24 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.447 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 40.9 mt -69.63 -44.68 79.3 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.023 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.465 ' CG1' ' CZ3' ' A' ' 68' ' ' TRP . 23.3 t -53.83 -58.61 3.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 120.962 0.411 . . . . 0.0 110.815 -179.722 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' TRP . . . . . 0.526 ' O ' ' N ' ' A' ' 73' ' ' GLY . 1.5 m95 -64.06 -39.48 94.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.196 -179.526 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 4.9 mmmt -63.0 -23.96 67.69 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.847 0.356 . . . . 0.0 110.543 179.804 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -83.0 -62.67 1.53 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.08 -179.47 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.743 ' C ' HD12 ' A' ' 71' ' ' LEU . 3.6 pp -64.92 -9.29 20.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.179 -179.487 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.646 ' N ' HD12 ' A' ' 71' ' ' LEU . . . 106.05 81.99 1.49 Allowed Glycine 0 CA--C 1.525 0.707 0 C-N-CA 121.071 -0.585 . . . . 0.0 111.783 179.335 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.526 ' N ' ' O ' ' A' ' 68' ' ' TRP . . . 42.03 -174.13 0.01 OUTLIER Glycine 0 CA--C 1.526 0.722 0 N-CA-C 111.933 -0.467 . . . . 0.0 111.933 179.097 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 69.8 t80 -76.98 110.8 11.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.871 0.367 . . . . 0.0 110.884 -179.718 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.539 ' OG1' ' N ' ' A' ' 76' ' ' GLU . 1.1 t -142.05 -173.66 3.88 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.326 179.781 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.539 ' N ' ' OG1' ' A' ' 75' ' ' THR . 9.1 mm-40 -49.25 -34.71 15.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.779 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -69.64 -24.29 63.61 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.027 -179.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.485 ' O ' HD12 ' A' ' 82' ' ' LEU . . . -91.53 -24.22 19.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.861 0.362 . . . . 0.0 110.642 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 9.2 mtp -63.05 -26.72 68.98 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.576 179.861 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 6.8 t -70.41 -53.9 9.54 Favored Pre-proline 0 CA--C 1.536 0.405 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.838 -179.617 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -64.34 -56.32 0.46 Allowed 'Trans proline' 0 N--CA 1.498 1.753 0 C-N-CA 121.053 1.169 . . . . 0.0 112.097 179.551 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.504 HD11 ' CZ2' ' A' ' 68' ' ' TRP . 1.2 mt -61.41 -46.56 89.64 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.911 0.386 . . . . 0.0 110.569 -179.896 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -61.03 -53.96 40.7 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 111.241 -0.743 . . . . 0.0 111.241 -179.64 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 54.9 tp -62.69 -26.58 68.73 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.885 0.374 . . . . 0.0 110.603 -179.707 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 20.9 t80 -68.65 -50.88 47.67 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.783 -179.732 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 9.7 t -70.98 -33.82 70.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.268 -179.468 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -70.52 -57.2 6.8 Favored Glycine 0 CA--C 1.523 0.587 0 N-CA-C 110.947 -0.861 . . . . 0.0 110.947 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.428 ' O ' ' CB ' ' A' ' 92' ' ' ASN . 1.8 tp-100 -59.51 -40.54 87.42 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.818 0.342 . . . . 0.0 110.397 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.405 ' O ' ' CD1' ' A' ' 93' ' ' TRP . 11.4 tp -66.52 -34.91 78.98 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.41 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.766 ' O ' ' HB2' ' A' ' 94' ' ' ALA . . . -64.52 -65.73 0.64 Allowed 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 120.254 -0.578 . . . . 0.0 111.489 -179.398 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.6 pp -66.42 -34.48 78.04 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.714 0.635 . . . . 0.0 112.714 -178.493 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.428 ' CB ' ' O ' ' A' ' 88' ' ' GLN . 7.5 t-20 -82.04 -57.6 3.33 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 -178.461 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . 0.6 ' O ' ' N ' ' A' ' 95' ' ' TRP . 0.0 OUTLIER -69.94 -17.04 63.3 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 111.838 0.31 . . . . 0.0 111.838 -178.265 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.766 ' HB2' ' O ' ' A' ' 90' ' ' ALA . . . -52.51 82.95 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.14 0 C-N-CA 120.349 -0.54 . . . . 0.0 110.068 179.637 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.702 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 30.8 p-90 -99.32 -16.31 0.19 Allowed Pre-proline 0 CA--C 1.535 0.375 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 -179.449 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.702 ' CD ' ' N ' ' A' ' 95' ' ' TRP . 48.8 Cg_exo -58.91 -32.92 98.31 Favored 'Trans proline' 0 N--CA 1.495 1.579 0 C-N-CA 120.692 0.928 . . . . 0.0 112.977 179.393 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.466 ' CD ' ' N ' ' A' ' 96' ' ' PRO . 66.4 Cg_exo -49.41 -18.55 2.37 Favored 'Trans proline' 0 N--CA 1.495 1.559 0 C-N-CA 120.389 0.726 . . . . 0.0 112.971 -179.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.549 ' O ' ' N ' ' A' ' 101' ' ' GLY . 1.1 pp -92.06 20.97 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.934 0.397 . . . . 0.0 110.466 179.758 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 10.3 t80 -40.41 -48.42 2.73 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.488 179.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -77.5 -19.73 55.41 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.546 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.549 ' N ' ' O ' ' A' ' 98' ' ' ILE . . . -78.34 -15.17 81.35 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 110.892 -0.883 . . . . 0.0 110.892 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -67.73 -12.95 61.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.772 0.32 . . . . 0.0 110.468 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.413 HH11 ' HB2' ' A' ' 103' ' ' ARG . 0.0 OUTLIER -81.56 -8.44 59.72 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.467 179.998 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . 0.523 ' O ' ' N ' ' A' ' 106' ' ' GLY . 19.1 pt20 -123.87 173.8 7.95 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.838 179.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.55 ' N ' ' SD ' ' A' ' 105' ' ' MET . 0.0 OUTLIER -42.83 -17.02 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.125 -179.748 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.523 ' N ' ' O ' ' A' ' 104' ' ' GLN . . . -63.34 -16.84 58.74 Favored Glycine 0 CA--C 1.527 0.836 0 C-N-CA 121.324 -0.465 . . . . 0.0 111.979 -179.233 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' TRP . . . . . 0.686 ' CD1' ' CH2' ' A' ' 155' ' ' TRP . 0.0 OUTLIER -51.11 -15.87 0.4 Allowed 'General case' 0 C--N 1.329 -0.314 0 O-C-N 122.626 -0.338 . . . . 0.0 110.554 -179.581 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.492 ' O ' ' OD1' ' A' ' 111' ' ' ASP . . . -76.2 -25.05 54.78 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.855 0.359 . . . . 0.0 110.621 -179.825 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 84.2 mt -59.24 -29.72 67.73 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.923 -179.716 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.417 ' O ' HD23 ' A' ' 114' ' ' LEU . . . -54.1 -62.02 1.92 Allowed 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.728 -0.389 . . . . 0.0 110.502 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.68 ' O ' HG23 ' A' ' 115' ' ' VAL . 5.5 p-10 -62.02 -53.73 51.42 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.108 -0.496 . . . . 0.0 112.024 -179.432 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 31.8 tp -52.95 -45.13 67.57 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 -178.458 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.404 ' HA ' HD23 ' A' ' 113' ' ' LEU . 60.3 mt -67.67 -61.7 1.76 Allowed 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.624 0.601 . . . . 0.0 112.624 -178.322 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.417 HD23 ' O ' ' A' ' 110' ' ' ALA . 2.9 pp -58.62 -35.1 71.94 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 120.157 -0.617 . . . . 0.0 111.251 -178.736 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.68 HG23 ' O ' ' A' ' 111' ' ' ASP . 37.2 t -58.86 -59.27 3.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.963 179.801 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . 0.494 ' O ' ' OG1' ' A' ' 120' ' ' THR . 5.6 t -70.45 -22.34 62.71 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.658 -179.009 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -64.93 -62.84 4.62 Favored Glycine 0 CA--C 1.526 0.778 0 C-N-CA 120.963 -0.637 . . . . 0.0 111.84 -179.058 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.529 ' O ' HG23 ' A' ' 122' ' ' THR . 8.9 p -72.16 -37.51 59.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 C-N-CA 120.975 -0.29 . . . . 0.0 111.39 -179.404 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.51 ' O ' ' OG1' ' A' ' 123' ' ' THR . . . -67.07 -60.21 2.81 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.338 -0.545 . . . . 0.0 111.038 -179.549 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.494 ' OG1' ' O ' ' A' ' 116' ' ' SER . 3.3 m -57.92 -56.46 21.75 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.754 0.311 . . . . 0.0 111.393 -179.638 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -50.68 -41.15 55.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.305 -179.302 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.529 HG23 ' O ' ' A' ' 118' ' ' VAL . 31.4 p -73.53 -30.16 62.92 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.855 -0.338 . . . . 0.0 111.817 -179.144 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.51 ' OG1' ' O ' ' A' ' 119' ' ' ALA . 0.2 OUTLIER -64.96 -49.04 71.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.942 0.401 . . . . 0.0 110.759 -179.559 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.0 pp -81.59 -20.18 40.38 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.488 -179.274 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -90.8 -67.04 0.88 Allowed 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 -178.552 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 34.8 m0 -83.73 -57.15 3.34 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 112.962 0.727 . . . . 0.0 112.962 -177.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . 0.492 ' CD2' ' N ' ' A' ' 127' ' ' HIS . 9.1 m170 -55.88 -22.21 24.24 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.715 -0.394 . . . . 0.0 111.707 -178.565 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 33.5 ttt-85 -72.91 -47.25 47.37 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.783 -0.367 . . . . 0.0 111.178 -179.592 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 64.3 t -79.47 -41.49 22.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.168 -179.449 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -130.2 118.22 18.23 Favored Pre-proline 0 CA--C 1.536 0.405 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.578 -179.543 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . 0.647 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 70.9 Cg_exo -75.26 -26.6 10.36 Favored 'Trans proline' 0 N--CA 1.493 1.476 0 C-N-CA 121.238 1.292 . . . . 0.0 112.857 179.276 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . 0.647 ' CD ' ' N ' ' A' ' 131' ' ' PRO . 53.8 Cg_exo -60.4 -55.22 1.6 Allowed 'Trans proline' 0 N--CA 1.497 1.73 0 C-N-CA 121.517 1.478 . . . . 0.0 112.492 -179.731 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -46.28 -37.36 7.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.857 0.361 . . . . 0.0 110.315 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . 0.427 ' HB2' ' CG ' ' A' ' 127' ' ' HIS . . . -57.57 -29.45 64.45 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.366 179.894 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 25.5 ttp180 -74.44 -30.47 61.91 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.319 179.788 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 48.5 mt -73.28 -28.91 62.38 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 179.405 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.519 ' O ' ' N ' ' A' ' 140' ' ' TYR . 5.7 mt -86.45 -31.01 21.61 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.413 179.614 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.462 ' C ' ' H ' ' A' ' 140' ' ' TYR . 1.5 t80 -31.52 -49.72 0.45 Allowed Pre-proline 0 CA--C 1.538 0.506 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.508 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.429 ' HD2' ' N ' ' A' ' 138' ' ' TYR . 4.1 Cg_endo -62.65 7.42 0.15 Allowed 'Trans proline' 0 N--CA 1.498 1.764 0 C-N-CA 121.526 1.484 . . . . 0.0 112.807 -179.689 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . 0.519 ' N ' ' O ' ' A' ' 137' ' ' LEU . 0.1 OUTLIER -93.08 -14.41 27.32 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 121.013 0.435 . . . . 0.0 111.096 179.806 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.581 HD23 HD12 ' A' ' 144' ' ' LEU . 97.7 mt -59.73 -26.53 65.72 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.16 -0.473 . . . . 0.0 109.942 178.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -64.38 -39.3 93.6 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 179.256 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' TRP . . . . . 0.509 ' CE2' HD12 ' A' ' 52' ' ' ILE . 10.5 t-105 -67.19 -42.45 84.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.521 179.115 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.581 HD12 HD23 ' A' ' 141' ' ' LEU . 17.9 mt -58.73 -45.66 89.13 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.226 179.8 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.603 ' O ' HG23 ' A' ' 149' ' ' VAL . . . -70.35 -23.29 62.78 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.27 179.715 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 33.8 t80 -64.83 -64.34 0.89 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.776 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -64.96 -43.82 91.4 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.977 -179.571 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 37.4 m -56.89 -49.86 74.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.804 -179.781 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.603 HG23 ' O ' ' A' ' 145' ' ' ALA . 90.5 t -68.57 -31.78 52.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.935 -179.56 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 1.9 tp -57.07 -46.46 82.48 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.983 0.42 . . . . 0.0 109.912 179.738 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . 0.601 ' OD1' ' NE1' ' A' ' 107' ' ' TRP . 7.3 t30 -70.08 -54.53 12.67 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.922 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 65.8 t80 -51.58 -39.09 57.25 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.4 -179.397 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . 0.578 ' CE1' ' OD2' ' A' ' 157' ' ' ASP . 53.2 t80 -68.22 -52.43 34.2 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.63 -179.08 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 86.6 t -65.16 -28.07 43.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.596 -178.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' TRP . . . . . 0.686 ' CH2' ' CD1' ' A' ' 107' ' ' TRP . 0.6 OUTLIER -78.32 -40.64 36.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.773 0.32 . . . . 0.0 110.445 -179.334 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . 0.402 ' HD2' ' N ' ' A' ' 156' ' ' ARG . 6.0 mpt_? -76.52 -23.22 53.67 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 110.051 -0.351 . . . . 0.0 110.051 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . 0.578 ' OD2' ' CE1' ' A' ' 153' ' ' TYR . 2.1 m-20 -79.53 -39.89 30.89 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.537 179.79 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' ASN . . . . . 0.5 ' OD1' ' O ' ' A' ' 155' ' ' TRP . 43.1 p30 . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.501 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.564 ' O ' HG23 ' A' ' 9' ' ' VAL . 0.9 OUTLIER . . . . . 0 CA--C 1.529 0.136 0 N-CA-C 110.148 -0.316 . . . . 0.0 110.148 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.538 ' N ' ' CD ' ' A' ' 7' ' ' PRO . 0.9 OUTLIER -57.94 -45.1 99.81 Favored Pre-proline 0 CA--C 1.534 0.346 0 C-N-CA 120.855 -0.338 . . . . 0.0 110.297 -179.577 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.538 ' CD ' ' N ' ' A' ' 6' ' ' VAL . 20.6 Cg_exo -58.02 -65.36 0.1 OUTLIER 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 121.416 1.411 . . . . 0.0 111.646 179.559 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.69 ' O ' HG23 ' A' ' 12' ' ' THR . . . -45.32 -36.32 4.06 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.366 -179.701 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.564 HG23 ' O ' ' A' ' 5' ' ' TRP . 69.0 t -70.04 -62.59 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 C-N-CA 120.866 -0.334 . . . . 0.0 111.775 -178.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -57.23 -43.59 93.53 Favored Glycine 0 CA--C 1.527 0.822 0 C-N-CA 121.275 -0.488 . . . . 0.0 112.0 -179.051 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.437 ' N ' HD12 ' A' ' 11' ' ' LEU . 8.5 mp -67.13 -35.53 79.94 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.569 0.223 . . . . 0.0 111.324 -179.166 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.69 HG23 ' O ' ' A' ' 8' ' ' ALA . 10.6 p -69.66 -29.83 67.38 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.733 -0.387 . . . . 0.0 110.635 -179.9 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.445 ' O ' ' C ' ' A' ' 14' ' ' VAL . 6.0 mp -78.58 -32.13 47.53 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.738 -179.758 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.445 ' C ' ' O ' ' A' ' 13' ' ' LEU . 6.0 t -35.97 -55.91 1.23 Allowed Pre-proline 0 CA--C 1.534 0.35 0 C-N-CA 120.891 -0.323 . . . . 0.0 110.867 -179.704 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.403 ' HD2' ' N ' ' A' ' 14' ' ' VAL . 13.2 Cg_endo -61.03 -41.27 45.25 Favored 'Trans proline' 0 N--CA 1.5 1.87 0 C-N-CA 120.936 1.091 . . . . 0.0 112.026 179.644 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 7.8 t -45.54 -28.34 0.92 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.665 -179.57 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 87.4 mt -66.0 -57.89 6.75 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.72 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -64.55 -24.92 69.83 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 111.291 -0.724 . . . . 0.0 111.291 -179.738 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -77.32 -27.82 59.01 Favored Glycine 0 CA--C 1.518 0.256 0 N-CA-C 110.432 -1.067 . . . . 0.0 110.432 -179.709 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 19.7 t80 -76.08 -60.75 2.19 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.785 0.326 . . . . 0.0 110.617 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 48.6 ttm -73.17 -21.08 60.76 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.216 -179.673 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -79.39 -57.04 3.24 Favored Glycine 0 CA--C 1.526 0.769 0 C-N-CA 120.956 -0.64 . . . . 0.0 111.664 -179.478 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.616 ' O ' HG22 ' A' ' 26' ' ' VAL . . . -69.65 -26.74 64.54 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 120.59 -0.444 . . . . 0.0 110.794 -179.466 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 45.1 t80 -46.92 -23.89 0.52 Allowed 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.516 -0.474 . . . . 0.0 109.848 179.443 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.566 ' CD1' ' CE1' ' A' ' 99' ' ' PHE . 56.6 t80 -72.71 -54.99 7.49 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.086 -179.769 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.616 HG22 ' O ' ' A' ' 23' ' ' ALA . 29.1 m -57.15 -25.83 23.91 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.107 0 C-N-CA 120.392 -0.523 . . . . 0.0 110.291 -179.528 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.75 -37.38 81.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.709 179.592 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -101.07 -56.03 0.9 Allowed Glycine 0 CA--C 1.525 0.693 0 N-CA-C 111.447 -0.661 . . . . 0.0 111.447 -179.596 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 6.0 tm-20 -65.63 -34.72 78.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.603 0.24 . . . . 0.0 111.107 -179.589 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -71.74 -55.02 7.72 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 111.076 -0.81 . . . . 0.0 111.076 -179.775 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 11.0 mp -59.32 -28.33 66.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.744 0.307 . . . . 0.0 110.508 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 40.3 ttm180 -79.02 -52.79 7.75 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.814 0.34 . . . . 0.0 110.466 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -50.51 -33.74 22.63 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 179.87 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.427 ' CD1' ' C ' ' A' ' 34' ' ' TYR . 25.8 t80 -45.51 -35.2 3.7 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.216 179.641 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -56.42 -36.94 69.52 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.58 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -85.67 -66.26 1.42 Allowed Glycine 0 CA--C 1.525 0.657 0 N-CA-C 111.033 -0.827 . . . . 0.0 111.033 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.785 HD22 HD21 ' A' ' 158' ' ' ASN . 0.4 OUTLIER -96.49 167.2 11.3 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.843 0.354 . . . . 0.0 110.532 179.564 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 6.3 tt0 -90.05 113.58 25.31 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.635 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.581 ' NZ ' ' CH2' ' A' ' 107' ' ' TRP . 17.9 mtpt -125.65 156.23 71.18 Favored Pre-proline 0 C--N 1.331 -0.211 0 CA-C-N 116.174 -0.466 . . . . 0.0 109.862 179.727 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo . . . . . 0 C--N 1.305 -1.712 0 C-N-CA 121.984 1.789 . . . . 0.0 111.497 179.672 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.695 ' O ' HG23 ' A' ' 52' ' ' ILE . 0.1 OUTLIER . . . . . 0 CA--C 1.533 0.303 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.633 ' C ' ' H ' ' A' ' 52' ' ' ILE . . . -39.19 -29.23 0.17 Allowed Pre-proline 0 C--O 1.237 0.407 0 C-N-CA 120.745 -0.382 . . . . 0.0 111.44 -178.618 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.426 ' HD2' ' N ' ' A' ' 50' ' ' ALA . 35.1 Cg_exo -52.92 3.71 0.04 OUTLIER 'Trans proline' 0 C--N 1.313 -1.32 0 CA-C-N 118.852 0.626 . . . . 0.0 111.877 177.516 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.695 HG23 ' O ' ' A' ' 49' ' ' LEU . 5.7 pt -51.12 -45.23 30.3 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.233 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 178.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.534 ' N ' ' CG1' ' A' ' 52' ' ' ILE . 87.6 m95 -57.66 -23.41 51.22 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.789 -179.094 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -68.48 -45.33 68.6 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 109.411 -1.476 . . . . 0.0 109.411 178.399 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 6.0 m -69.1 -57.6 5.2 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 179.133 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.509 HD13 ' CE3' ' A' ' 143' ' ' TRP . 34.6 mt -48.52 -49.58 35.45 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 179.112 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 6.9 t80 -46.37 -58.48 3.69 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.696 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.431 ' O ' ' CE1' ' A' ' 62' ' ' TYR . 0.2 OUTLIER -48.05 -58.88 3.87 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.881 0.372 . . . . 0.0 110.686 -179.556 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.534 ' HB1' ' O ' ' A' ' 136' ' ' LEU . . . -51.68 -61.46 2.24 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.852 -179.893 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.433 ' SD ' ' C ' ' A' ' 56' ' ' LEU . 0.2 OUTLIER -46.1 -38.93 8.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.396 -179.957 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -56.6 -54.29 37.37 Favored Glycine 0 CA--C 1.522 0.493 0 N-CA-C 110.905 -0.878 . . . . 0.0 110.905 -179.859 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.6 ' N ' ' CD1' ' A' ' 62' ' ' TYR . 0.6 OUTLIER -55.85 -59.81 4.36 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.876 -0.33 . . . . 0.0 110.847 -179.814 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -48.33 -56.14 9.69 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 110.75 -0.94 . . . . 0.0 110.75 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.563 ' OG ' ' NE1' ' A' ' 68' ' ' TRP . 0.6 OUTLIER -45.6 -56.07 5.59 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.963 0.411 . . . . 0.0 111.025 179.967 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 59.7 t80 -47.51 -47.11 27.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.023 -179.723 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 53.6 mt -59.62 -40.01 81.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.009 -179.588 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.447 ' CG1' ' CZ3' ' A' ' 68' ' ' TRP . 43.0 t -57.74 -52.12 61.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 C-N-CA 120.862 -0.335 . . . . 0.0 110.849 -179.612 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' TRP . . . . . 0.563 ' NE1' ' OG ' ' A' ' 64' ' ' SER . 0.6 OUTLIER -64.19 -28.94 70.09 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 120.643 -0.423 . . . . 0.0 110.778 -179.978 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.06 -22.46 59.52 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.816 0.341 . . . . 0.0 110.374 179.828 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -81.35 -61.36 1.96 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.053 -179.72 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.8 pp -74.43 -20.67 59.95 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.788 -0.365 . . . . 0.0 111.209 -179.294 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.509 ' O ' ' O ' ' A' ' 73' ' ' GLY . . . 109.44 99.11 2.56 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 121.135 -0.555 . . . . 0.0 112.268 178.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.509 ' O ' ' O ' ' A' ' 72' ' ' GLY . . . 40.64 -173.55 0.01 OUTLIER Glycine 0 CA--C 1.525 0.671 0 N-CA-C 112.195 -0.362 . . . . 0.0 112.195 178.684 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 25.4 t80 -90.2 110.88 21.9 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.538 -0.331 . . . . 0.0 110.53 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.587 ' OG1' ' N ' ' A' ' 76' ' ' GLU . 0.1 OUTLIER -142.2 -177.43 5.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.592 179.796 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.587 ' N ' ' OG1' ' A' ' 75' ' ' THR . 35.8 mt-10 -47.92 -29.6 3.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.636 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -70.04 -27.57 64.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.895 -179.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.416 ' O ' HD12 ' A' ' 82' ' ' LEU . . . -95.64 -17.74 21.09 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.917 -179.798 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 25.9 mtp -68.7 -28.63 67.01 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.836 -0.346 . . . . 0.0 110.786 -179.859 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 9.1 t -66.78 -49.29 49.77 Favored Pre-proline 0 CA--C 1.533 0.292 0 C-N-CA 120.782 -0.367 . . . . 0.0 110.536 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -69.52 -59.7 0.08 OUTLIER 'Trans proline' 0 N--CA 1.497 1.692 0 C-N-CA 121.051 1.167 . . . . 0.0 111.61 179.094 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.431 HD11 ' CH2' ' A' ' 68' ' ' TRP . 5.0 mt -52.47 -52.4 54.49 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.411 179.836 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -58.37 -57.67 18.64 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 110.484 -1.046 . . . . 0.0 110.484 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.425 ' O ' ' CB ' ' A' ' 88' ' ' GLN . 57.0 tp -48.22 -32.98 7.86 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 179.534 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -74.56 -47.53 32.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.827 -179.823 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -60.08 -48.74 80.44 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.742 -0.383 . . . . 0.0 110.919 -179.597 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -70.73 -58.33 5.88 Favored Glycine 0 CA--C 1.527 0.822 0 N-CA-C 111.477 -0.649 . . . . 0.0 111.477 -179.611 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.425 ' CB ' ' O ' ' A' ' 84' ' ' LEU . 12.4 tp-100 -50.45 -40.66 51.27 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.092 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.419 ' O ' ' C ' ' A' ' 90' ' ' ALA . 50.6 tp -58.51 -65.84 0.59 Allowed 'General case' 0 C--O 1.215 -0.719 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.927 179.717 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.699 ' O ' ' HB2' ' A' ' 94' ' ' ALA . . . -38.56 -46.13 1.15 Allowed 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 120.349 -0.54 . . . . 0.0 111.622 -179.448 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 83.8 mt -57.86 -56.43 22.11 Favored 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 112.815 0.672 . . . . 0.0 112.815 -178.694 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -75.2 -57.07 4.12 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.185 0.517 . . . . 0.0 111.742 -178.396 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . 0.676 ' O ' ' N ' ' A' ' 95' ' ' TRP . 0.1 OUTLIER -53.92 -23.44 12.84 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.454 -0.793 . . . . 0.0 111.49 -179.468 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.699 ' HB2' ' O ' ' A' ' 90' ' ' ALA . . . -52.34 73.64 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.818 0.342 . . . . 0.0 110.757 -179.549 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.682 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 13.5 p-90 -101.96 -17.48 0.19 Allowed Pre-proline 0 CA--C 1.532 0.266 0 CA-C-N 116.279 -0.418 . . . . 0.0 112.127 -179.522 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.682 ' CD ' ' N ' ' A' ' 95' ' ' TRP . 39.5 Cg_exo -62.43 -24.81 75.76 Favored 'Trans proline' 0 N--CA 1.495 1.577 0 C-N-CA 120.404 0.736 . . . . 0.0 112.812 179.401 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.541 ' CD ' ' N ' ' A' ' 96' ' ' PRO . 92.5 Cg_exo -62.02 -26.94 78.93 Favored 'Trans proline' 0 N--CA 1.496 1.628 0 C-N-CA 120.496 0.798 . . . . 0.0 112.675 179.679 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 1.2 pp -72.79 17.49 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-O 121.086 0.47 . . . . 0.0 110.107 179.797 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.566 ' CE1' ' CD1' ' A' ' 25' ' ' PHE . 2.4 t80 -39.49 -31.65 0.1 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.191 -179.802 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.488 ' CE1' ' O ' ' A' ' 97' ' ' PRO . 3.4 p90 -84.69 -50.37 7.69 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.942 -0.303 . . . . 0.0 110.869 -179.633 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.417 ' N ' ' CD2' ' A' ' 100' ' ' PHE . . . -64.22 -4.58 12.48 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 111.171 -0.772 . . . . 0.0 111.171 -179.739 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -75.07 -14.17 60.56 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.643 0.258 . . . . 0.0 110.939 -179.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 4.3 ptm180 -86.68 5.35 36.49 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.915 -0.314 . . . . 0.0 110.677 -179.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -121.57 171.01 9.13 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.565 179.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 4.7 mmt -59.37 -17.68 32.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.419 179.737 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.588 ' O ' ' N ' ' A' ' 108' ' ' ALA . . . -69.46 -15.37 70.47 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 111.455 -0.658 . . . . 0.0 111.455 -179.571 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' TRP . . . . . 0.581 ' CH2' ' NZ ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -43.49 -13.86 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.749 0.309 . . . . 0.0 110.725 -179.604 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.588 ' N ' ' O ' ' A' ' 106' ' ' GLY . . . -57.96 -18.68 25.18 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.431 179.718 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 13.4 mt -54.45 -32.13 56.92 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.386 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.439 ' O ' ' CD2' ' A' ' 114' ' ' LEU . . . -52.85 -63.05 1.27 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.544 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.757 ' O ' HG23 ' A' ' 115' ' ' VAL . 0.9 OUTLIER -59.67 -57.79 11.38 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.495 -179.545 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.418 ' N ' ' OD1' ' A' ' 111' ' ' ASP . 50.8 tp -47.82 -41.72 24.43 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.115 -0.493 . . . . 0.0 112.025 -178.87 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.421 HD23 ' HA ' ' A' ' 113' ' ' LEU . 64.5 mt -71.84 -61.84 1.64 Allowed 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -178.14 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.439 ' CD2' ' O ' ' A' ' 110' ' ' ALA . 1.1 pp -57.22 -32.8 66.88 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 120.037 -0.665 . . . . 0.0 111.432 -178.178 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.757 HG23 ' O ' ' A' ' 111' ' ' ASP . 98.0 t -67.06 -51.36 54.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.84 0.353 . . . . 0.0 110.925 179.777 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 18.0 m -68.53 -27.72 66.35 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.393 -179.312 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -68.07 -59.96 6.0 Favored Glycine 0 CA--C 1.528 0.867 0 C-N-CA 121.045 -0.598 . . . . 0.0 111.899 -179.036 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.532 ' O ' HG23 ' A' ' 122' ' ' THR . 7.5 p -65.27 -38.51 82.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 -178.831 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.449 ' N ' HG13 ' A' ' 118' ' ' VAL . . . -71.12 -60.76 2.06 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.518 -0.473 . . . . 0.0 111.52 -178.687 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 43.7 m -52.23 -52.97 49.28 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.918 0.39 . . . . 0.0 110.975 -179.594 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -57.47 -50.91 71.51 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.115 -0.493 . . . . 0.0 112.226 -179.161 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.532 HG23 ' O ' ' A' ' 118' ' ' VAL . 40.0 p -64.75 -64.54 0.85 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.969 0.414 . . . . 0.0 111.745 -178.72 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.434 ' OG1' ' O ' ' A' ' 119' ' ' ALA . 0.2 OUTLIER -44.06 -41.31 5.41 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.892 -0.595 . . . . 0.0 112.295 -178.448 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.78 ' C ' HD12 ' A' ' 124' ' ' LEU . 1.5 pp -84.34 -19.93 32.87 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.393 -0.523 . . . . 0.0 111.643 -179.117 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -94.77 -71.3 0.67 Allowed 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 113.053 0.761 . . . . 0.0 113.053 -178.433 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' TRP . . . . . 0.467 ' N ' ' CD1' ' A' ' 126' ' ' TRP . 25.6 m0 -76.71 -57.09 4.06 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 -177.411 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . 0.502 ' CG ' ' HB2' ' A' ' 134' ' ' ALA . 18.1 m170 -48.79 -22.58 0.84 Allowed 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.558 -0.457 . . . . 0.0 111.332 -178.63 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 23.0 ttt180 -69.11 -48.1 63.41 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.838 -0.345 . . . . 0.0 111.06 -179.628 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 15.0 t -79.77 -49.33 19.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.962 -179.62 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . 0.455 ' O ' ' OG ' ' A' ' 130' ' ' SER . 0.4 OUTLIER -118.71 108.92 40.47 Favored Pre-proline 0 CA--C 1.532 0.258 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.673 -179.701 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . 0.654 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 82.1 Cg_exo -74.38 -32.52 6.33 Favored 'Trans proline' 0 C--N 1.311 -1.447 0 C-N-CA 121.577 1.518 . . . . 0.0 112.794 179.451 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . 0.654 ' CD ' ' N ' ' A' ' 131' ' ' PRO . 27.5 Cg_exo -58.67 -44.43 36.66 Favored 'Trans proline' 0 N--CA 1.494 1.558 0 C-N-CA 121.706 1.604 . . . . 0.0 112.199 -179.82 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.413 ' O ' ' N ' ' A' ' 136' ' ' LEU . . . -50.24 -49.51 52.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.672 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . 0.502 ' HB2' ' CG ' ' A' ' 127' ' ' HIS . . . -44.19 -23.07 0.08 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.665 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . 0.401 ' N ' ' O ' ' A' ' 133' ' ' ALA . 14.1 tpp180 -76.66 -37.11 56.82 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.17 -179.528 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.534 ' O ' ' HB1' ' A' ' 59' ' ' ALA . 9.4 mt -76.26 -22.13 55.5 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 179.777 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.547 ' O ' ' N ' ' A' ' 140' ' ' TYR . 0.7 OUTLIER -85.44 -43.64 13.43 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 179.147 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.559 ' C ' ' H ' ' A' ' 140' ' ' TYR . 0.2 OUTLIER -21.32 -50.66 0.06 OUTLIER Pre-proline 0 N--CA 1.466 0.341 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.871 179.71 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.434 ' N ' ' O ' ' A' ' 137' ' ' LEU . 17.2 Cg_exo -51.21 -3.33 0.07 OUTLIER 'Trans proline' 0 C--N 1.308 -1.598 0 C-N-CA 121.247 1.298 . . . . 0.0 112.051 179.824 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . 0.674 ' CE2' HD11 ' A' ' 144' ' ' LEU . 1.9 p90 -83.45 -17.55 41.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.779 -179.836 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.402 HD12 ' CD1' ' A' ' 138' ' ' TYR . 93.4 mt -61.35 -36.59 80.61 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 179.154 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -56.95 -40.29 76.16 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 179.08 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' TRP . . . . . 0.55 ' CD1' ' C ' ' A' ' 143' ' ' TRP . 0.4 OUTLIER -63.54 -45.14 91.93 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.647 179.414 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.674 HD11 ' CE2' ' A' ' 140' ' ' TYR . 13.7 mt -60.81 -41.53 95.85 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 179.354 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.66 ' O ' HG23 ' A' ' 149' ' ' VAL . . . -70.42 -18.98 63.02 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.103 -0.499 . . . . 0.0 109.766 179.217 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -71.14 -63.09 1.17 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.823 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -68.64 -31.74 71.09 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 120.607 -0.437 . . . . 0.0 110.583 -179.804 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 85.0 m -67.7 -45.48 74.99 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.851 -0.34 . . . . 0.0 110.217 179.772 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.66 HG23 ' O ' ' A' ' 145' ' ' ALA . 45.7 t -64.64 -33.71 64.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.047 179.731 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.485 ' O ' HG23 ' A' ' 154' ' ' VAL . 0.9 OUTLIER -60.59 -58.9 6.53 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.033 179.859 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . 0.467 ' OD1' ' HB2' ' A' ' 108' ' ' ALA . 11.1 t30 -55.8 -54.43 44.54 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.56 179.823 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 16.6 t80 -52.42 -34.36 48.1 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.649 -179.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . 0.583 ' CE2' ' OD2' ' A' ' 157' ' ' ASP . 59.4 t80 -66.53 -47.1 73.98 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.821 -179.729 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.485 HG23 ' O ' ' A' ' 150' ' ' LEU . 13.0 t -55.9 -42.16 69.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.659 -179.825 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' TRP . . . . . . . . . . . . . 16.5 m0 -62.5 -59.45 4.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.151 -179.657 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.63 -25.93 63.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.047 -179.43 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . 0.583 ' OD2' ' CE2' ' A' ' 153' ' ' TYR . 0.8 OUTLIER -86.74 -42.67 13.15 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.885 -0.326 . . . . 0.0 111.333 -179.393 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' ASN . . . . . 0.785 HD21 HD22 ' A' ' 37' ' ' LEU . 2.4 m-20 . . . . . 0 C--N 1.328 -0.359 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.208 -179.43 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.668 ' CD2' ' CZ3' ' A' ' 68' ' ' TRP . 0.3 OUTLIER . . . . . 0 C--O 1.232 0.167 0 CA-C-O 120.697 0.284 . . . . 0.0 110.624 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.59 ' N ' ' CD ' ' A' ' 7' ' ' PRO . 0.9 OUTLIER -61.05 -32.66 11.44 Favored Pre-proline 0 C--N 1.329 -0.291 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 179.7 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.59 ' CD ' ' N ' ' A' ' 6' ' ' VAL . 22.7 Cg_exo -74.71 -67.81 0.02 OUTLIER 'Trans proline' 0 N--CA 1.492 1.423 0 C-N-CA 121.531 1.488 . . . . 0.0 111.953 179.168 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.656 ' O ' HG23 ' A' ' 12' ' ' THR . . . -48.13 -38.95 19.09 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.965 -0.294 . . . . 0.0 111.178 -179.569 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.512 HG23 ' O ' ' A' ' 5' ' ' TRP . 89.2 t -69.96 -62.21 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.802 -179.255 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -53.9 -50.94 52.65 Favored Glycine 0 CA--C 1.526 0.773 0 N-CA-C 111.486 -0.646 . . . . 0.0 111.486 -179.307 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 8.8 mp -58.47 -40.9 83.94 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.615 0.245 . . . . 0.0 111.134 -179.603 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.656 HG23 ' O ' ' A' ' 8' ' ' ALA . 18.2 p -69.39 -28.71 66.42 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.843 -0.343 . . . . 0.0 110.998 -179.643 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.418 HD13 ' O ' ' A' ' 9' ' ' VAL . 7.1 mp -80.2 -26.31 39.25 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.737 -179.737 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.402 ' N ' ' HD2' ' A' ' 15' ' ' PRO . 14.2 t -44.58 -60.15 3.26 Favored Pre-proline 0 CA--C 1.534 0.342 0 C-N-CA 120.89 -0.324 . . . . 0.0 110.934 -179.64 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.402 ' HD2' ' N ' ' A' ' 14' ' ' VAL . 9.7 Cg_endo -52.7 -20.65 13.01 Favored 'Trans proline' 0 N--CA 1.498 1.761 0 C-N-CA 121.025 1.15 . . . . 0.0 111.749 179.746 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.587 ' OG ' ' CE3' ' A' ' 53' ' ' TRP . 1.6 t -73.79 -27.39 61.11 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.857 -179.744 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 87.7 mt -73.77 -58.16 3.49 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.477 -179.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -68.95 -22.06 75.59 Favored Glycine 0 CA--C 1.523 0.539 0 N-CA-C 110.449 -1.06 . . . . 0.0 110.449 179.694 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -74.12 -39.1 45.96 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 110.517 -1.033 . . . . 0.0 110.517 179.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 67.4 t80 -70.82 -60.09 2.44 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.676 0.274 . . . . 0.0 110.668 179.797 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 16.2 ttm -67.27 -21.21 65.72 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.951 -179.703 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -81.42 -62.68 1.93 Allowed Glycine 0 CA--C 1.525 0.672 0 N-CA-C 111.43 -0.668 . . . . 0.0 111.43 -179.671 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.652 ' O ' HG22 ' A' ' 26' ' ' VAL . . . -64.88 -24.96 67.69 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.77 0.319 . . . . 0.0 111.129 -179.386 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 27.8 t80 -47.36 -23.2 0.54 Allowed 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 179.558 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.4 ' CE2' ' HB3' ' A' ' 102' ' ' ALA . 21.3 t80 -72.72 -51.21 20.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.916 -0.583 . . . . 0.0 111.25 -179.769 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.652 HG22 ' O ' ' A' ' 23' ' ' ALA . 34.9 m -62.79 -26.88 41.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 C-N-CA 120.541 -0.464 . . . . 0.0 110.522 -179.745 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -66.72 -24.9 66.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.223 179.799 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -106.03 -35.36 2.98 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 110.377 -1.089 . . . . 0.0 110.377 179.531 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.419 ' O ' ' N ' ' A' ' 32' ' ' ARG . 18.8 tt0 -84.95 -47.42 10.29 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.753 0.311 . . . . 0.0 110.227 179.644 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.459 ' N ' ' O ' ' A' ' 26' ' ' VAL . . . -48.39 -46.5 28.87 Favored Glycine 0 CA--C 1.523 0.567 0 N-CA-C 110.567 -1.013 . . . . 0.0 110.567 179.787 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.407 ' N ' HD12 ' A' ' 31' ' ' LEU . 10.5 mp -60.0 -25.12 65.02 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 179.612 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.452 ' O ' ' HB3' ' A' ' 35' ' ' ALA . 56.6 ttt180 -78.33 -50.96 10.84 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.131 179.344 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 11.9 m0 -47.26 -45.24 23.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.231 179.745 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 88.3 t80 -52.52 -23.99 7.29 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.438 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.452 ' HB3' ' O ' ' A' ' 32' ' ' ARG . . . -67.73 -42.16 82.31 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.696 -179.868 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -97.1 -68.83 0.97 Allowed Glycine 0 CA--C 1.525 0.683 0 N-CA-C 111.076 -0.809 . . . . 0.0 111.076 -179.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.777 ' C ' HD12 ' A' ' 37' ' ' LEU . 3.6 pp -90.52 166.2 13.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.875 0.369 . . . . 0.0 110.592 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 48.5 mm-40 -85.46 129.8 34.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.608 -179.16 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.409 ' HG3' HD11 ' A' ' 37' ' ' LEU . 14.2 mtpt -118.63 165.02 17.78 Favored Pre-proline 0 CA--C 1.532 0.25 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 179.013 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo . . . . . 0 C--N 1.307 -1.612 0 C-N-CA 122.164 1.909 . . . . 0.0 111.75 179.917 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.675 ' O ' HG23 ' A' ' 52' ' ' ILE . 0.1 OUTLIER . . . . . 0 CA--C 1.535 0.403 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.639 ' C ' ' H ' ' A' ' 52' ' ' ILE . . . -40.8 -28.34 0.21 Allowed Pre-proline 0 N--CA 1.465 0.287 0 N-CA-C 111.934 0.346 . . . . 0.0 111.934 -179.107 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.417 ' HD2' ' N ' ' A' ' 50' ' ' ALA . 12.4 Cg_exo -54.48 8.28 0.03 OUTLIER 'Trans proline' 0 C--N 1.311 -1.401 0 CA-C-N 119.005 0.68 . . . . 0.0 112.533 178.352 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.675 HG23 ' O ' ' A' ' 49' ' ' LEU . 9.2 pt -55.62 -35.56 39.12 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 178.673 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.587 ' CE3' ' OG ' ' A' ' 16' ' ' SER . 3.5 m0 -55.11 -25.01 28.79 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.433 179.615 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -69.89 -61.51 4.3 Favored Glycine 0 CA--C 1.528 0.845 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.906 -179.371 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.49 ' CG2' ' N ' ' A' ' 56' ' ' LEU . 1.9 t -56.39 -46.69 79.99 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 120.729 -0.389 . . . . 0.0 110.706 -179.351 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.49 ' N ' ' CG2' ' A' ' 55' ' ' THR . 57.9 mt -62.31 -41.57 98.65 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.365 -0.534 . . . . 0.0 109.639 179.313 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.532 ' C ' ' CD1' ' A' ' 57' ' ' TYR . 4.2 t80 -56.69 -40.27 75.29 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.678 -179.707 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.431 ' OG ' ' N ' ' A' ' 59' ' ' ALA . 1.3 p -62.85 -53.63 51.26 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 179.62 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.669 ' HB1' ' O ' ' A' ' 136' ' ' LEU . . . -55.78 -62.3 1.79 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.503 179.713 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 36.5 mtm -51.72 -32.35 29.99 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.447 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -57.93 -56.06 27.22 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 111.19 -0.764 . . . . 0.0 111.19 -179.774 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.459 ' HB3' HD13 ' A' ' 136' ' ' LEU . 3.4 m-30 -65.46 -42.67 92.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.05 0.452 . . . . 0.0 110.301 -179.834 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -53.35 -56.27 20.4 Favored Glycine 0 CA--C 1.524 0.615 0 N-CA-C 110.44 -1.064 . . . . 0.0 110.44 179.68 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.582 ' O ' ' CD1' ' A' ' 68' ' ' TRP . 0.9 OUTLIER -54.97 -45.12 74.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.774 0.321 . . . . 0.0 110.539 179.815 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.438 ' HA ' ' CZ2' ' A' ' 68' ' ' TRP . 74.7 t80 -47.01 -47.21 22.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.019 0.438 . . . . 0.0 110.01 179.668 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 62.4 mt -70.56 -28.14 33.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.058 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 59.3 t -63.42 -59.22 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 C-N-CA 120.617 -0.433 . . . . 0.0 111.647 -179.399 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' TRP . . . . . 0.668 ' CZ3' ' CD2' ' A' ' 5' ' ' TRP . 0.0 OUTLIER -70.78 -29.56 65.8 Favored 'General case' 0 N--CA 1.462 0.152 0 C-N-CA 119.84 -0.744 . . . . 0.0 110.822 -179.327 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -70.89 -22.38 62.28 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.517 -0.473 . . . . 0.0 110.207 179.524 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -82.22 -60.75 2.1 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.924 -179.677 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.8 pp -72.92 -11.19 60.49 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.99 -179.395 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.515 ' O ' ' O ' ' A' ' 73' ' ' GLY . . . 104.86 92.57 2.27 Favored Glycine 0 CA--C 1.527 0.814 0 C-N-CA 121.163 -0.541 . . . . 0.0 112.149 179.101 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.586 ' N ' ' O ' ' A' ' 68' ' ' TRP . . . 40.94 -173.52 0.01 OUTLIER Glycine 0 CA--C 1.524 0.652 0 N-CA-C 111.973 -0.451 . . . . 0.0 111.973 179.009 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 42.9 t80 -86.98 110.18 19.87 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.85 0.357 . . . . 0.0 110.341 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.576 ' OG1' ' N ' ' A' ' 76' ' ' GLU . 0.1 OUTLIER -142.57 -174.12 4.05 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.788 -179.822 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.576 ' N ' ' OG1' ' A' ' 75' ' ' THR . 92.2 mt-10 -49.89 -24.43 2.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.884 179.881 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -78.63 -31.68 47.03 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.893 -179.804 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -85.8 -20.57 29.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.831 0.348 . . . . 0.0 110.716 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 8.3 mtp -65.43 -27.1 68.29 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.658 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.409 ' O ' ' CB ' ' A' ' 84' ' ' LEU . 6.9 t -69.4 -48.74 24.75 Favored Pre-proline 0 C--N 1.328 -0.33 0 C-N-CA 120.839 -0.345 . . . . 0.0 110.728 -179.768 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -71.23 -60.85 0.05 OUTLIER 'Trans proline' 0 N--CA 1.497 1.715 0 C-N-CA 120.961 1.107 . . . . 0.0 111.829 179.179 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 5.0 mt -57.6 -48.73 78.61 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.618 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -61.2 -61.45 6.91 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 110.938 -0.865 . . . . 0.0 110.938 -179.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.409 ' CB ' ' O ' ' A' ' 80' ' ' VAL . 33.2 tp -53.54 -24.05 12.37 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.902 0.382 . . . . 0.0 110.494 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 13.5 t80 -77.33 -47.99 18.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.433 179.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -66.71 -37.0 83.81 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.603 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -71.21 -57.44 6.18 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 110.612 -0.995 . . . . 0.0 110.612 179.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 49.3 tp60 -53.38 -45.29 69.2 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 179.61 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.424 ' O ' ' C ' ' A' ' 90' ' ' ALA . 24.3 tp -53.35 -66.14 0.44 Allowed 'General case' 0 C--O 1.21 -0.994 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.63 179.603 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.613 ' O ' ' HB2' ' A' ' 94' ' ' ALA . . . -38.65 -48.64 1.48 Allowed 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 120.637 -0.425 . . . . 0.0 111.85 -179.575 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 94.6 mt -55.04 -57.28 12.33 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 112.9 0.704 . . . . 0.0 112.9 -178.277 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -74.84 -55.88 5.35 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 121.316 0.579 . . . . 0.0 111.419 -178.717 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . 0.642 ' O ' ' N ' ' A' ' 95' ' ' TRP . 4.9 t-105 -53.19 -19.45 3.06 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.124 -0.943 . . . . 0.0 111.209 -179.781 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.613 ' HB2' ' O ' ' A' ' 90' ' ' ALA . . . -59.19 69.37 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.161 0 CA-C-O 120.992 0.425 . . . . 0.0 109.86 179.629 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.688 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 11.9 p-90 -101.95 -17.04 0.19 Allowed Pre-proline 0 CA--C 1.536 0.418 0 CA-C-N 115.729 -0.668 . . . . 0.0 112.142 -179.106 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.688 ' CD ' ' N ' ' A' ' 95' ' ' TRP . 31.9 Cg_exo -60.89 -30.57 90.28 Favored 'Trans proline' 0 N--CA 1.495 1.573 0 C-N-CA 120.383 0.722 . . . . 0.0 112.618 179.638 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.514 ' CD ' ' N ' ' A' ' 96' ' ' PRO . 91.8 Cg_exo -55.24 -27.55 57.42 Favored 'Trans proline' 0 N--CA 1.494 1.526 0 C-N-CA 120.495 0.796 . . . . 0.0 112.607 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 1.1 pp -76.79 22.73 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.152 0 CA-C-O 121.335 0.588 . . . . 0.0 109.933 179.537 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.504 ' H ' ' C ' ' A' ' 97' ' ' PRO . 2.4 t80 -39.53 -45.74 1.62 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.043 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.434 ' C ' ' H ' ' A' ' 102' ' ' ALA . 4.7 m-85 -83.11 -49.65 9.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.195 -179.361 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -54.81 -7.75 1.12 Allowed Glycine 0 CA--C 1.526 0.726 0 N-CA-C 111.372 -0.691 . . . . 0.0 111.372 -179.506 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.434 ' H ' ' C ' ' A' ' 100' ' ' PHE . . . -75.06 -13.43 60.49 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 121.079 -0.248 . . . . 0.0 110.964 -179.707 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -75.77 6.98 4.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.768 0.318 . . . . 0.0 110.82 -179.848 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -125.63 165.95 17.62 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.326 179.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 8.4 mmt -56.07 -17.12 6.15 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.924 0.392 . . . . 0.0 110.183 179.602 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.514 ' O ' ' N ' ' A' ' 108' ' ' ALA . . . -63.36 -15.85 57.44 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 110.611 -0.996 . . . . 0.0 110.611 179.718 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' TRP . . . . . 0.483 ' C ' ' CD1' ' A' ' 107' ' ' TRP . 0.0 OUTLIER -47.47 -11.8 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.762 0.315 . . . . 0.0 110.525 -179.776 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.514 ' N ' ' O ' ' A' ' 106' ' ' GLY . . . -63.58 -20.7 65.86 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-O 121.118 0.485 . . . . 0.0 109.816 179.432 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 7.1 mt -55.36 -30.76 60.95 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.717 179.491 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.433 ' O ' HD23 ' A' ' 114' ' ' LEU . . . -53.86 -61.87 2.02 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.548 179.718 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.722 ' O ' HG23 ' A' ' 115' ' ' VAL . 1.4 p30 -60.69 -57.97 10.46 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.769 -179.351 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.526 ' N ' ' OD1' ' A' ' 111' ' ' ASP . 9.1 tp -50.46 -38.12 41.96 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 -178.733 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.406 HD23 ' HA ' ' A' ' 113' ' ' LEU . 62.6 mt -72.7 -62.24 1.52 Allowed 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -178.409 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.433 HD23 ' O ' ' A' ' 110' ' ' ALA . 1.3 pp -58.29 -35.45 71.82 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 120.063 -0.655 . . . . 0.0 110.912 -178.724 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.722 HG23 ' O ' ' A' ' 111' ' ' ASP . 87.7 t -63.46 -52.66 55.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.746 -179.708 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 39.0 t -69.81 -32.31 70.69 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.428 -178.704 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -61.22 -59.96 9.13 Favored Glycine 0 CA--C 1.526 0.753 0 C-N-CA 121.05 -0.595 . . . . 0.0 111.924 -179.262 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.564 ' O ' HG23 ' A' ' 122' ' ' THR . 4.4 p -68.78 -38.05 78.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -178.789 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.503 ' O ' ' OG1' ' A' ' 123' ' ' THR . . . -65.99 -60.19 3.08 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.625 -0.43 . . . . 0.0 111.339 -178.746 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 28.1 m -59.73 -57.26 13.67 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.366 -179.285 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -49.07 -43.93 41.45 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.42 -179.29 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.564 HG23 ' O ' ' A' ' 118' ' ' VAL . 27.9 p -68.32 -38.06 81.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.511 -179.197 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.503 ' OG1' ' O ' ' A' ' 119' ' ' ALA . 0.1 OUTLIER -56.77 -49.81 74.18 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.845 0.355 . . . . 0.0 111.134 -179.191 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.6 pp -83.76 -19.82 34.45 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.886 -178.745 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -86.48 -71.32 0.55 Allowed 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -178.433 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' TRP . . . . . 0.456 ' N ' ' CD1' ' A' ' 126' ' ' TRP . 37.0 m0 -85.01 -57.23 3.18 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 112.767 0.654 . . . . 0.0 112.767 -177.881 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . 0.514 ' CD2' ' N ' ' A' ' 127' ' ' HIS . 8.7 m170 -50.4 -23.97 2.74 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.874 -0.33 . . . . 0.0 111.549 -178.7 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 40.4 ttt-85 -76.34 -37.08 57.82 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.918 -0.313 . . . . 0.0 110.99 -179.721 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 60.2 t -83.94 -48.88 16.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.783 0.325 . . . . 0.0 110.88 -179.575 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -128.2 112.82 19.9 Favored Pre-proline 0 CA--C 1.532 0.274 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.573 -179.624 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . 0.625 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 67.1 Cg_exo -70.71 -34.28 11.67 Favored 'Trans proline' 0 N--CA 1.492 1.423 0 C-N-CA 121.092 1.195 . . . . 0.0 112.307 179.473 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . 0.625 ' CD ' ' N ' ' A' ' 131' ' ' PRO . 32.3 Cg_exo -56.34 -35.0 95.56 Favored 'Trans proline' 0 N--CA 1.495 1.607 0 C-N-CA 121.52 1.48 . . . . 0.0 111.877 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -63.66 -38.68 92.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.321 179.865 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -54.51 -25.39 25.36 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.194 -0.457 . . . . 0.0 109.994 179.697 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 9.5 tpt85 -77.37 -29.82 53.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.002 179.63 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.669 ' O ' ' HB1' ' A' ' 59' ' ' ALA . 79.1 mt -80.02 -31.34 39.64 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.829 179.362 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.579 ' O ' ' N ' ' A' ' 140' ' ' TYR . 0.7 OUTLIER -79.39 -44.61 21.13 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 179.344 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.548 ' C ' ' H ' ' A' ' 140' ' ' TYR . 0.4 OUTLIER -19.97 -51.24 0.05 OUTLIER Pre-proline 0 N--CA 1.466 0.327 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.913 179.916 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.457 ' N ' ' O ' ' A' ' 137' ' ' LEU . 16.9 Cg_exo -53.08 -1.69 0.09 OUTLIER 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 121.11 1.207 . . . . 0.0 112.015 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . 0.657 ' CE2' HD11 ' A' ' 144' ' ' LEU . 2.2 p90 -84.24 -19.5 33.82 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 120.919 0.39 . . . . 0.0 110.638 -179.781 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 95.6 mt -59.98 -49.92 75.79 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.63 -0.428 . . . . 0.0 109.986 179.253 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -45.55 -44.92 13.15 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 179.37 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' TRP . . . . . 0.575 ' C ' ' CD1' ' A' ' 143' ' ' TRP . 0.3 OUTLIER -58.34 -48.74 79.59 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.423 179.37 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.657 HD11 ' CE2' ' A' ' 140' ' ' TYR . 16.1 mt -55.46 -46.7 76.78 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.32 -0.552 . . . . 0.0 109.59 179.567 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.563 ' O ' HG23 ' A' ' 149' ' ' VAL . . . -63.44 -20.91 65.97 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.902 179.3 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -68.99 -62.91 1.18 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.504 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -67.8 -45.61 74.28 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 120.57 -0.452 . . . . 0.0 110.414 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 19.2 m -52.28 -60.29 3.39 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.756 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.563 HG23 ' O ' ' A' ' 145' ' ' ALA . 93.2 t -54.16 -41.64 52.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 C-N-CA 120.878 -0.329 . . . . 0.0 110.798 -179.725 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 3.5 tp -50.39 -56.05 13.1 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.819 0.342 . . . . 0.0 110.548 -179.679 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . 0.414 ' ND2' ' CB ' ' A' ' 108' ' ' ALA . 9.8 t30 -61.7 -54.76 38.24 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.672 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . 0.443 ' CZ ' ' NE ' ' A' ' 156' ' ' ARG . 40.5 t80 -46.36 -38.09 8.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.616 -179.702 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 32.0 t80 -65.9 -53.39 40.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.699 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 62.8 t -49.22 -48.13 18.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 C-N-CA 120.614 -0.435 . . . . 0.0 110.365 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' TRP . . . . . . . . . . . . . 13.5 m0 -53.67 -55.56 24.99 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.363 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . 0.443 ' NE ' ' CZ ' ' A' ' 152' ' ' TYR . 0.7 OUTLIER -54.79 -52.14 63.55 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.362 179.949 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -49.19 -46.89 46.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.743 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' ASN . . . . . 0.478 ' O ' ' ND2' ' A' ' 158' ' ' ASN . 1.7 t30 . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.73 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.436 ' CE2' ' CD2' ' A' ' 68' ' ' TRP . 0.5 OUTLIER . . . . . 0 CA--C 1.527 0.094 0 CA-C-O 120.761 0.315 . . . . 0.0 110.234 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.633 ' N ' ' CD ' ' A' ' 7' ' ' PRO . 1.0 OUTLIER -63.8 -36.56 22.04 Favored Pre-proline 0 C--N 1.328 -0.328 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 179.875 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.633 ' CD ' ' N ' ' A' ' 6' ' ' VAL . 15.0 Cg_exo -70.09 -68.23 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 121.987 1.792 . . . . 0.0 112.251 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.655 ' HB2' ' OG ' ' A' ' 64' ' ' SER . . . -47.41 -42.8 22.88 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.538 -179.35 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.462 ' O ' ' OG1' ' A' ' 12' ' ' THR . 60.6 t -65.1 -62.51 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 111.852 0.316 . . . . 0.0 111.852 -179.126 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -53.92 -40.03 64.14 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 111.462 -0.655 . . . . 0.0 111.462 -179.355 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.673 ' HG ' HG22 ' A' ' 86' ' ' THR . 6.7 mp -68.61 -28.7 67.15 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.646 0.26 . . . . 0.0 110.862 -179.575 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.462 ' OG1' ' O ' ' A' ' 9' ' ' VAL . 2.2 p -81.25 -24.0 37.63 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.844 -0.342 . . . . 0.0 110.901 -179.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 84.6 mt -81.4 -33.39 32.28 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.517 -0.31 . . . . 0.0 110.695 -179.845 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.421 ' N ' ' HD2' ' A' ' 15' ' ' PRO . 3.9 t -47.11 -57.89 8.35 Favored Pre-proline 0 CA--C 1.535 0.373 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.907 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.421 ' HD2' ' N ' ' A' ' 14' ' ' VAL . 11.6 Cg_endo -56.66 -30.9 85.58 Favored 'Trans proline' 0 N--CA 1.498 1.754 0 C-N-CA 121.169 1.246 . . . . 0.0 112.3 -179.857 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.1 t -67.84 -27.16 66.46 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.694 -179.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 96.2 mt -69.54 -58.16 4.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.861 -179.687 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -68.92 -20.27 74.36 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 110.816 -0.913 . . . . 0.0 110.816 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -71.02 -46.07 46.57 Favored Glycine 0 CA--C 1.522 0.502 0 N-CA-C 110.909 -0.876 . . . . 0.0 110.909 -179.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -74.44 -59.64 2.64 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.737 0.303 . . . . 0.0 110.796 -179.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 1.1 tpt -60.9 -26.78 67.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.108 -179.509 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -79.26 -59.84 2.64 Favored Glycine 0 CA--C 1.527 0.8 0 N-CA-C 111.602 -0.599 . . . . 0.0 111.602 -179.462 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.617 ' O ' HG22 ' A' ' 26' ' ' VAL . . . -61.35 -17.13 52.4 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.812 0.339 . . . . 0.0 110.843 -179.264 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 28.7 t80 -50.01 -24.0 2.37 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.935 0.398 . . . . 0.0 110.223 179.69 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.582 ' CE2' ' HB3' ' A' ' 102' ' ' ALA . 53.9 t80 -69.38 -48.6 60.67 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.904 -179.775 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.617 HG22 ' O ' ' A' ' 23' ' ' ALA . 27.6 m -72.12 -19.52 19.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.805 -179.624 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.55 -44.38 86.97 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.764 -179.751 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -102.37 -43.9 1.94 Allowed Glycine 0 CA--C 1.525 0.711 0 N-CA-C 111.503 -0.639 . . . . 0.0 111.503 -179.472 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -73.78 -24.62 59.87 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.95 -0.3 . . . . 0.0 111.019 -179.605 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -81.33 -58.77 2.52 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 111.24 -0.744 . . . . 0.0 111.24 -179.659 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 10.3 mp -51.69 -29.05 16.73 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.853 -0.339 . . . . 0.0 110.122 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 33.3 ttt180 -82.55 -47.84 11.69 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.217 179.52 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -49.09 -27.67 3.57 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.294 -0.412 . . . . 0.0 109.921 179.748 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.52 ' C ' ' CD1' ' A' ' 34' ' ' TYR . 9.0 t80 -46.83 -43.31 18.42 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.241 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -54.37 -24.4 19.42 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.489 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -96.09 -72.6 1.13 Allowed Glycine 0 CA--C 1.525 0.706 0 N-CA-C 110.986 -0.845 . . . . 0.0 110.986 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.585 ' O ' HD12 ' A' ' 37' ' ' LEU . 0.4 OUTLIER -95.95 166.87 11.57 Favored 'General case' 0 N--CA 1.462 0.173 0 C-N-CA 120.863 -0.335 . . . . 0.0 110.431 179.546 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 31.2 tp60 -85.92 118.67 25.55 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.947 -179.471 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 7.6 mtpt -105.13 162.28 20.23 Favored Pre-proline 0 CA--C 1.535 0.392 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.73 179.7 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo . . . . . 0 N--CA 1.494 1.503 0 C-N-CA 121.369 1.379 . . . . 0.0 112.408 -179.353 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.913 ' O ' HG23 ' A' ' 52' ' ' ILE . 0.3 OUTLIER . . . . . 0 CA--C 1.534 0.327 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.587 ' C ' ' H ' ' A' ' 52' ' ' ILE . . . -40.37 -32.17 0.3 Allowed Pre-proline 0 CA--C 1.534 0.348 0 C-N-CA 120.425 -0.51 . . . . 0.0 111.835 -178.922 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.407 ' HD2' ' N ' ' A' ' 50' ' ' ALA . 81.6 Cg_exo -54.24 4.26 0.04 OUTLIER 'Trans proline' 0 C--N 1.316 -1.182 0 CA-C-N 119.052 0.697 . . . . 0.0 112.342 178.23 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.913 HG23 ' O ' ' A' ' 49' ' ' LEU . 46.9 pt -54.24 -30.75 21.11 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.113 0 CA-C-O 121.167 0.508 . . . . 0.0 110.066 179.662 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.428 ' CE2' HD11 ' A' ' 52' ' ' ILE . 52.9 m95 -80.1 -23.41 41.27 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.898 -179.44 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -70.85 -45.0 54.66 Favored Glycine 0 CA--C 1.523 0.585 0 N-CA-C 109.916 -1.274 . . . . 0.0 109.916 178.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 5.3 m -68.52 -51.8 39.07 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 179.294 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 94.5 mt -60.8 -26.53 67.36 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.044 179.586 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.543 ' C ' ' CD1' ' A' ' 57' ' ' TYR . 0.4 OUTLIER -65.61 -56.72 10.69 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 179.615 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 40.3 t -52.2 -44.01 64.5 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.775 -0.37 . . . . 0.0 110.288 179.784 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.76 -47.15 82.14 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.789 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 30.3 mtm -60.47 -35.65 76.38 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.563 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -64.53 -43.15 97.0 Favored Glycine 0 CA--C 1.523 0.538 0 N-CA-C 110.815 -0.914 . . . . 0.0 110.815 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -63.18 -53.41 53.63 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.466 ' O ' HG23 ' A' ' 67' ' ' VAL . . . -57.32 -37.08 79.31 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 179.032 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.655 ' OG ' ' HB2' ' A' ' 8' ' ' ALA . 23.3 t -62.33 -44.62 96.08 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 179.278 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.4 ' HA ' ' CE3' ' A' ' 68' ' ' TRP . 21.1 t80 -54.16 -44.06 71.12 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 179.155 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 65.7 mt -65.05 -30.52 50.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.603 179.625 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.466 HG23 ' O ' ' A' ' 63' ' ' GLY . 73.1 t -65.49 -58.8 5.46 Favored 'Isoleucine or valine' 0 C--O 1.233 0.186 0 C-N-CA 120.501 -0.479 . . . . 0.0 111.125 -179.711 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' TRP . . . . . 0.631 ' N ' ' CD1' ' A' ' 68' ' ' TRP . 0.0 OUTLIER -56.17 -37.17 69.21 Favored 'General case' 0 CA--C 1.528 0.104 0 C-N-CA 119.96 -0.696 . . . . 0.0 110.119 -179.78 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 16.5 mmmt -73.17 -21.62 60.66 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.416 -0.514 . . . . 0.0 110.917 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 15.8 tp10 -76.83 -40.64 47.14 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 -178.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.612 HD12 ' N ' ' A' ' 72' ' ' GLY . 0.5 OUTLIER -105.03 -0.11 27.1 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 120.32 -0.552 . . . . 0.0 111.44 -179.506 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.612 ' N ' HD12 ' A' ' 71' ' ' LEU . . . 96.3 84.62 1.71 Allowed Glycine 0 CA--C 1.525 0.662 0 C-N-CA 120.992 -0.623 . . . . 0.0 111.628 179.222 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.578 ' N ' ' O ' ' A' ' 68' ' ' TRP . . . 44.81 -173.88 0.01 OUTLIER Glycine 0 CA--C 1.525 0.691 0 N-CA-C 111.652 -0.579 . . . . 0.0 111.652 179.31 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 77.7 t80 -81.71 110.46 17.06 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.875 0.369 . . . . 0.0 110.651 -179.663 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.503 ' OG1' ' N ' ' A' ' 76' ' ' GLU . 2.6 t -142.65 -173.77 3.97 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.646 179.849 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.503 ' N ' ' OG1' ' A' ' 75' ' ' THR . 22.0 mt-10 -51.97 -24.56 6.68 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.649 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.451 ' H ' HG23 ' A' ' 75' ' ' THR . 30.9 m-20 -79.29 -24.69 42.72 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.901 -179.752 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -93.28 -16.83 24.3 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.838 0.352 . . . . 0.0 111.031 -179.663 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 14.1 mtp -69.54 -30.46 68.28 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.871 -179.782 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.42 ' N ' ' HD2' ' A' ' 81' ' ' PRO . 6.3 t -68.16 -46.57 40.29 Favored Pre-proline 0 CA--C 1.533 0.291 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.749 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.42 ' HD2' ' N ' ' A' ' 80' ' ' VAL . 13.4 Cg_endo -71.76 -61.18 0.05 OUTLIER 'Trans proline' 0 N--CA 1.498 1.786 0 C-N-CA 120.841 1.027 . . . . 0.0 111.916 179.397 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.715 ' O ' HG23 ' A' ' 86' ' ' THR . 8.4 mt -56.22 -51.9 66.4 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 121.014 0.435 . . . . 0.0 109.906 179.54 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -52.03 -53.96 28.09 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 111.167 -0.773 . . . . 0.0 111.167 -179.79 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.494 HD21 HD11 ' A' ' 124' ' ' LEU . 29.6 tp -58.42 -33.09 69.28 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.554 0.216 . . . . 0.0 110.954 -179.512 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 31.1 t80 -68.42 -37.08 79.97 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.801 -0.36 . . . . 0.0 110.86 -179.645 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.715 HG23 ' O ' ' A' ' 82' ' ' LEU . 5.1 p -68.44 -58.73 3.89 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.742 -0.383 . . . . 0.0 110.747 -179.46 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.428 ' N ' ' OG1' ' A' ' 86' ' ' THR . . . -58.69 -57.46 19.76 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 111.268 -0.733 . . . . 0.0 111.268 -179.799 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 54.1 tp60 -50.6 -55.36 16.66 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-O 120.88 0.371 . . . . 0.0 110.922 -179.758 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.424 ' O ' ' C ' ' A' ' 90' ' ' ALA . 26.3 tp -47.88 -66.27 0.43 Allowed 'General case' 0 C--O 1.209 -1.051 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.06 -179.731 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.476 ' O ' ' HB2' ' A' ' 94' ' ' ALA . . . -38.37 -50.51 1.5 Allowed 'General case' 0 C--N 1.319 -0.759 0 C-N-CA 120.633 -0.427 . . . . 0.0 112.026 -179.309 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 95.2 mt -53.64 -56.75 14.54 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 -178.312 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.411 ' O ' HD22 ' A' ' 113' ' ' LEU . 3.0 m120 -76.97 -53.7 7.51 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.275 0.559 . . . . 0.0 111.615 -178.312 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . 0.64 ' O ' ' N ' ' A' ' 95' ' ' TRP . 3.9 t-105 -53.11 -20.76 4.04 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.364 -0.835 . . . . 0.0 111.63 -179.595 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.476 ' HB2' ' O ' ' A' ' 90' ' ' ALA . . . -57.01 70.48 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 120.793 0.33 . . . . 0.0 110.608 -179.807 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.68 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 5.6 p-90 -102.38 -17.32 0.19 Allowed Pre-proline 0 CA--C 1.537 0.472 0 CA-C-N 116.051 -0.522 . . . . 0.0 112.036 -179.543 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.68 ' CD ' ' N ' ' A' ' 95' ' ' TRP . 32.5 Cg_exo -63.28 -24.2 72.06 Favored 'Trans proline' 0 N--CA 1.495 1.614 0 C-N-CA 120.629 0.886 . . . . 0.0 112.831 179.466 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.558 ' CD ' ' N ' ' A' ' 96' ' ' PRO . 97.3 Cg_exo -62.93 -24.87 74.14 Favored 'Trans proline' 0 N--CA 1.495 1.563 0 C-N-CA 120.833 1.022 . . . . 0.0 112.832 179.856 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 1.1 pp -78.58 22.53 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 121.015 0.436 . . . . 0.0 110.1 179.751 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.445 ' H ' ' C ' ' A' ' 97' ' ' PRO . 2.5 t80 -40.21 -42.78 1.55 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.531 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -86.23 -33.1 20.83 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.724 -179.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -68.46 -5.12 41.8 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 111.231 -0.748 . . . . 0.0 111.231 -179.716 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.582 ' HB3' ' CE2' ' A' ' 25' ' ' PHE . . . -74.63 -9.45 58.58 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.74 0.305 . . . . 0.0 110.908 -179.76 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.488 ' C ' ' CD ' ' A' ' 103' ' ' ARG . 0.0 OUTLIER -88.56 -11.73 44.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.828 -179.792 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -109.7 -178.92 3.67 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.914 0.387 . . . . 0.0 110.801 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.66 ' N ' ' SD ' ' A' ' 105' ' ' MET . 0.0 OUTLIER -55.45 -23.0 22.99 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.123 -179.826 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -62.22 -15.42 51.0 Favored Glycine 0 CA--C 1.528 0.847 0 CA-C-N 116.193 -0.458 . . . . 0.0 112.08 -179.287 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' TRP . . . . . 0.688 ' CD1' ' CZ2' ' A' ' 155' ' ' TRP . 0.0 OUTLIER -48.75 -18.98 0.31 Allowed 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 116.812 0.306 . . . . 0.0 110.972 -179.329 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -70.8 -23.76 62.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.991 0.424 . . . . 0.0 110.647 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 7.5 mt -54.21 -28.68 42.46 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.635 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -53.29 -63.01 1.29 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.087 0.47 . . . . 0.0 110.334 179.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.699 ' O ' HG23 ' A' ' 115' ' ' VAL . 2.1 p30 -62.26 -53.38 56.06 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.838 -0.619 . . . . 0.0 112.039 -179.376 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.611 HD13 ' O ' ' A' ' 112' ' ' LEU . 0.2 OUTLIER -53.49 -40.46 65.36 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.268 0.47 . . . . 0.0 112.268 -178.194 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.45 HD23 ' HA ' ' A' ' 113' ' ' LEU . 61.4 mt -71.4 -61.69 1.68 Allowed 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.281 0.475 . . . . 0.0 112.281 -178.479 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.5 pp -58.3 -33.67 69.71 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 120.15 -0.62 . . . . 0.0 110.9 -178.759 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.699 HG23 ' O ' ' A' ' 111' ' ' ASP . 41.2 t -62.16 -60.91 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.462 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 57.3 p -68.87 -22.24 64.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.474 -178.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -66.17 -62.22 4.85 Favored Glycine 0 CA--C 1.526 0.723 0 C-N-CA 120.952 -0.642 . . . . 0.0 111.549 -179.27 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.588 ' O ' HG23 ' A' ' 122' ' ' THR . 10.0 p -71.12 -37.54 67.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 C-N-CA 120.872 -0.331 . . . . 0.0 111.694 -179.258 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.508 ' O ' ' OG1' ' A' ' 123' ' ' THR . . . -68.39 -60.64 2.29 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.564 -0.454 . . . . 0.0 111.522 -179.204 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 3.7 m -58.7 -51.73 68.7 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.892 0.377 . . . . 0.0 111.372 -179.34 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.442 ' O ' HD23 ' A' ' 124' ' ' LEU . . . -55.58 -39.7 71.04 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.381 -179.384 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.588 HG23 ' O ' ' A' ' 118' ' ' VAL . 36.2 p -75.01 -28.94 60.7 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.638 -0.425 . . . . 0.0 111.601 -179.279 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.508 ' OG1' ' O ' ' A' ' 119' ' ' ALA . 0.1 OUTLIER -65.11 -54.55 28.23 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.631 -0.428 . . . . 0.0 110.717 -179.669 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.56 HD23 ' N ' ' A' ' 125' ' ' ALA . 0.6 OUTLIER -79.45 -19.73 49.16 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.576 -0.449 . . . . 0.0 111.73 -179.043 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.56 ' N ' HD23 ' A' ' 124' ' ' LEU . . . -88.33 -68.28 0.77 Allowed 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 -179.083 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' TRP . . . . . 0.4 ' N ' ' CD1' ' A' ' 126' ' ' TRP . 41.8 m0 -84.17 -57.23 3.26 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -177.87 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . 0.505 ' CD2' ' N ' ' A' ' 127' ' ' HIS . 7.1 m170 -54.69 -22.11 12.83 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.581 -0.448 . . . . 0.0 111.289 -178.718 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 26.8 ttt180 -68.34 -42.98 78.49 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.863 -0.335 . . . . 0.0 110.821 -179.694 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 23.2 t -87.51 -49.64 14.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.807 -179.796 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 26.6 p -116.23 108.32 46.03 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.523 -179.793 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . 0.642 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 79.5 Cg_exo -74.22 -25.71 13.3 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 121.554 1.503 . . . . 0.0 112.663 179.471 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . 0.642 ' CD ' ' N ' ' A' ' 131' ' ' PRO . 51.4 Cg_exo -63.16 -43.31 19.28 Favored 'Trans proline' 0 N--CA 1.495 1.609 0 C-N-CA 121.371 1.38 . . . . 0.0 111.961 179.797 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -54.83 -38.75 67.78 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.251 179.771 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . 0.426 ' HB2' ' CG ' ' A' ' 127' ' ' HIS . . . -55.06 -26.28 36.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.256 179.813 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 13.4 tpp180 -76.07 -32.23 59.16 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.248 179.658 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.401 HD23 ' HA ' ' A' ' 136' ' ' LEU . 95.9 mt -72.53 -26.78 61.88 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 179.314 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.512 ' O ' ' N ' ' A' ' 140' ' ' TYR . 2.6 mt -88.69 -29.25 20.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.376 179.757 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.516 ' C ' ' CD1' ' A' ' 138' ' ' TYR . 0.4 OUTLIER -33.59 -49.3 0.75 Allowed Pre-proline 0 CA--C 1.537 0.458 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.381 -179.819 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.416 ' HD2' ' N ' ' A' ' 138' ' ' TYR . 3.9 Cg_exo -60.96 4.96 0.17 Allowed 'Trans proline' 0 N--CA 1.494 1.535 0 C-N-CA 121.402 1.401 . . . . 0.0 112.591 -179.688 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . 0.512 ' N ' ' O ' ' A' ' 137' ' ' LEU . 0.1 OUTLIER -90.07 -16.65 29.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.709 0.29 . . . . 0.0 111.125 179.88 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.55 HD23 HD12 ' A' ' 144' ' ' LEU . 94.8 mt -58.42 -26.19 63.0 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 178.831 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -63.41 -42.3 98.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.628 179.266 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' TRP . . . . . 0.444 ' CE2' HD12 ' A' ' 52' ' ' ILE . 12.3 t-105 -66.72 -38.72 87.27 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.7 179.387 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.55 HD12 HD23 ' A' ' 141' ' ' LEU . 18.0 mt -62.55 -37.64 86.93 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 120.539 -0.465 . . . . 0.0 110.035 179.616 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.598 ' O ' HG23 ' A' ' 149' ' ' VAL . . . -76.91 -25.92 53.52 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.389 179.746 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 26.4 t80 -64.28 -57.96 7.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.744 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -70.4 -49.38 49.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.794 -179.74 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 99.2 m -51.38 -47.46 62.86 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.906 -179.667 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.598 HG23 ' O ' ' A' ' 145' ' ' ALA . 94.2 t -69.54 -34.06 59.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.176 -179.502 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -56.18 -52.9 62.71 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.917 0.389 . . . . 0.0 110.383 -179.683 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . 0.494 ' OD1' ' NE1' ' A' ' 107' ' ' TRP . 3.4 t30 -63.88 -51.25 65.41 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.843 -179.841 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 58.9 t80 -56.27 -29.8 61.6 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.454 -179.282 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . 0.436 ' O ' ' CG ' ' A' ' 157' ' ' ASP . 55.8 t80 -73.02 -52.58 13.84 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.827 -0.349 . . . . 0.0 111.296 -179.464 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.486 ' O ' ' OD1' ' A' ' 157' ' ' ASP . 54.3 t -65.1 -32.44 58.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.593 -179.353 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' TRP . . . . . 0.688 ' CZ2' ' CD1' ' A' ' 107' ' ' TRP . 0.2 OUTLIER -73.4 -42.14 62.46 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.177 -178.559 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . 0.437 ' HE ' ' C ' ' A' ' 155' ' ' TRP . 0.0 OUTLIER -77.61 -57.04 4.03 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.855 -0.338 . . . . 0.0 110.751 -179.753 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . 0.579 ' OD1' ' N ' ' A' ' 158' ' ' ASN . 39.7 p-10 -48.24 -36.31 13.66 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.962 -0.295 . . . . 0.0 110.76 -179.688 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' ASN . . . . . 0.579 ' N ' ' OD1' ' A' ' 157' ' ' ASP . 8.7 t-20 . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.773 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.4 mtp . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.96 0.409 . . . . 0.0 110.541 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -40.73 140.93 0.97 Allowed 'Trans proline' 0 C--N 1.305 -1.727 0 C-N-CA 122.69 2.26 . . . . 0.0 112.28 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 82.6 mt-10 -73.78 -33.54 64.29 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.441 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 23.3 p -74.25 172.53 11.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.93 -179.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.624 ' O ' HG23 ' A' ' 9' ' ' VAL . 1.2 t-105 -63.56 112.07 2.64 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.167 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.566 ' N ' ' CD ' ' A' ' 7' ' ' PRO . 0.9 OUTLIER -62.02 -44.97 91.34 Favored Pre-proline 0 CA--C 1.533 0.319 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.316 -179.796 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.566 ' CD ' ' N ' ' A' ' 6' ' ' VAL . 21.3 Cg_exo -57.14 -65.42 0.1 Allowed 'Trans proline' 0 C--N 1.307 -1.655 0 C-N-CA 121.671 1.58 . . . . 0.0 111.585 179.673 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.727 ' O ' HG23 ' A' ' 12' ' ' THR . . . -49.23 -41.44 37.38 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.226 -179.632 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.624 HG23 ' O ' ' A' ' 5' ' ' TRP . 49.7 t -60.53 -62.75 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 120.824 0.345 . . . . 0.0 111.533 -179.07 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -57.78 -52.33 52.74 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 111.456 -0.658 . . . . 0.0 111.456 -179.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 9.5 mp -57.99 -30.38 66.02 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.474 0.178 . . . . 0.0 110.961 -179.535 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.727 HG23 ' O ' ' A' ' 8' ' ' ALA . 20.8 p -79.93 -20.74 44.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.087 0.47 . . . . 0.0 109.766 179.295 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.7 mt -82.0 -22.86 36.32 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.499 179.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.405 ' N ' ' HD2' ' A' ' 15' ' ' PRO . 5.4 t -54.35 -54.63 45.99 Favored Pre-proline 0 CA--C 1.535 0.398 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.655 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.405 ' HD2' ' N ' ' A' ' 14' ' ' VAL . 6.4 Cg_endo -57.55 -8.59 4.2 Favored 'Trans proline' 0 N--CA 1.495 1.572 0 C-N-CA 120.935 1.09 . . . . 0.0 111.642 179.657 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.4 t -75.08 -27.62 60.0 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.124 179.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 63.8 mt -79.45 -43.67 22.84 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.767 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -77.63 -31.74 48.9 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 111.012 -0.835 . . . . 0.0 111.012 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -78.36 -34.76 35.36 Favored Glycine 0 CA--C 1.52 0.379 0 N-CA-C 110.305 -1.118 . . . . 0.0 110.305 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 41.4 t80 -72.01 -58.99 2.98 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 179.459 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 48.8 tpp -64.61 -28.02 69.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.625 179.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.541 ' C ' ' CZ2' ' A' ' 95' ' ' TRP . . . -65.66 -63.12 4.27 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 111.674 -0.571 . . . . 0.0 111.674 -179.462 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.496 ' O ' HG22 ' A' ' 26' ' ' VAL . . . -69.34 -18.2 63.78 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.891 -0.324 . . . . 0.0 111.03 -179.388 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 80.7 t80 -50.6 -24.64 3.41 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.959 0.409 . . . . 0.0 110.045 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.461 ' CE2' ' HB1' ' A' ' 102' ' ' ALA . 63.5 t80 -69.2 -48.26 62.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.979 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.496 HG22 ' O ' ' A' ' 23' ' ' ALA . 32.9 m -75.55 -14.24 15.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 C-N-CA 120.73 -0.388 . . . . 0.0 110.768 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.542 ' O ' ' CD1' ' A' ' 31' ' ' LEU . 0.0 OUTLIER -57.79 -44.03 85.98 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.626 179.879 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -112.16 -54.56 0.48 Allowed Glycine 0 CA--C 1.525 0.667 0 N-CA-C 110.978 -0.849 . . . . 0.0 110.978 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -58.99 -27.61 65.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.836 0.351 . . . . 0.0 110.495 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -78.52 -49.05 6.89 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 111.062 -0.815 . . . . 0.0 111.062 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.542 ' CD1' ' O ' ' A' ' 27' ' ' ARG . 95.0 mt -56.7 -34.51 67.5 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.769 0.319 . . . . 0.0 110.541 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 49.4 mtp180 -77.06 -54.21 6.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.669 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -44.96 -41.65 7.48 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.298 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 56.2 t80 -49.44 -31.43 9.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.879 -179.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -66.28 -25.24 66.77 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.678 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -92.67 -67.36 1.1 Allowed Glycine 0 CA--C 1.523 0.573 0 N-CA-C 111.049 -0.82 . . . . 0.0 111.049 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.571 ' O ' HD12 ' A' ' 37' ' ' LEU . 0.3 OUTLIER -95.2 166.96 11.65 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.827 0.346 . . . . 0.0 110.561 179.666 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -87.1 112.82 22.29 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.704 -179.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.688 ' NZ ' ' CH2' ' A' ' 107' ' ' TRP . 17.3 mtpt -129.42 153.31 80.57 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.193 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.605 ' C ' ' H ' ' A' ' 42' ' ' TRP . 71.8 Cg_endo -72.82 18.85 0.35 Allowed 'Trans proline' 0 C--N 1.305 -1.725 0 C-N-CA 121.438 1.425 . . . . 0.0 110.668 178.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.508 ' H ' ' C ' ' A' ' 39' ' ' LYS . 39.0 t -49.09 -2.53 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.186 -0.915 . . . . 0.0 111.46 -179.784 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . 0.696 ' CZ2' ' CE1' ' A' ' 43' ' ' HIS . 47.7 p-90 -76.35 -15.03 60.06 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.46 -0.496 . . . . 0.0 110.448 -179.587 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.696 ' CE1' ' CZ2' ' A' ' 42' ' ' TRP . 37.4 m80 -61.32 143.91 92.33 Favored Pre-proline 0 C--N 1.332 -0.171 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 178.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.455 ' C ' ' O ' ' A' ' 43' ' ' HIS . 47.1 Cg_exo -34.65 130.09 0.2 Allowed 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 121.237 1.291 . . . . 0.0 111.273 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.567 ' O ' ' N ' ' A' ' 47' ' ' TRP . 16.0 Cg_exo -52.86 155.89 10.22 Favored 'Trans proline' 0 C--N 1.311 -1.398 0 C-N-CA 120.599 0.866 . . . . 0.0 111.929 -179.481 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.45 ' O ' ' CB ' ' A' ' 50' ' ' ALA . 2.1 ppt_? -41.75 -17.24 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.834 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.626 ' CD1' ' N ' ' A' ' 48' ' ' THR . 0.7 OUTLIER -61.14 -50.18 74.24 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 120.658 -0.417 . . . . 0.0 110.94 -179.391 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.626 ' N ' ' CD1' ' A' ' 47' ' ' TRP . 1.0 OUTLIER -90.56 -27.0 19.42 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.632 -179.146 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.74 ' O ' HG23 ' A' ' 52' ' ' ILE . 0.1 OUTLIER -83.01 -51.35 7.64 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 120.46 -0.496 . . . . 0.0 111.804 -178.677 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.602 ' C ' ' H ' ' A' ' 52' ' ' ILE . . . -40.13 -29.17 0.2 Allowed Pre-proline 0 N--CA 1.466 0.339 0 N-CA-C 112.129 0.418 . . . . 0.0 112.129 -178.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.407 ' HD2' ' N ' ' A' ' 50' ' ' ALA . 26.3 Cg_exo -52.82 3.0 0.04 OUTLIER 'Trans proline' 0 C--N 1.312 -1.363 0 CA-C-N 119.336 0.799 . . . . 0.0 112.441 178.287 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.74 HG23 ' O ' ' A' ' 49' ' ' LEU . 7.9 pt -52.51 -40.36 32.77 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.238 0 CA-C-O 121.22 0.534 . . . . 0.0 109.842 179.258 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.456 ' N ' ' CG1' ' A' ' 52' ' ' ILE . 69.7 m95 -73.4 -22.41 60.25 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.157 -179.328 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -67.43 -49.28 52.51 Favored Glycine 0 CA--C 1.527 0.833 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 179.015 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 3.3 m -65.54 -56.95 9.54 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.909 0.385 . . . . 0.0 110.209 179.464 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 83.3 mt -57.18 -26.52 60.76 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.503 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.509 ' C ' ' CD1' ' A' ' 57' ' ' TYR . 2.3 t80 -67.17 -47.63 70.41 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 179.464 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 15.1 m -56.43 -53.62 55.22 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.957 179.331 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -57.98 -41.06 82.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.34 179.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 8.3 mtm -56.71 -58.28 8.78 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.092 179.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -46.95 -44.07 17.92 Favored Glycine 0 CA--C 1.523 0.573 0 N-CA-C 110.696 -0.961 . . . . 0.0 110.696 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -61.72 -59.22 5.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.708 0.29 . . . . 0.0 110.468 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.539 ' O ' HG23 ' A' ' 67' ' ' VAL . . . -49.79 -57.34 9.81 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.88 -0.888 . . . . 0.0 110.88 179.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.592 ' O ' ' CD1' ' A' ' 68' ' ' TRP . 0.3 OUTLIER -45.68 -55.51 6.34 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.958 0.408 . . . . 0.0 110.526 179.803 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.415 ' N ' ' OG ' ' A' ' 64' ' ' SER . 50.0 t80 -48.54 -42.23 32.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.965 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 93.4 mt -66.73 -49.25 76.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.176 -179.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.539 HG23 ' O ' ' A' ' 63' ' ' GLY . 9.1 t -51.43 -54.54 11.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.907 0.384 . . . . 0.0 111.162 -179.47 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . 0.592 ' CD1' ' O ' ' A' ' 64' ' ' SER . 1.7 m95 -65.81 -35.01 79.5 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.097 -179.458 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 7.1 mmmt -65.63 -22.93 66.7 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.653 -0.419 . . . . 0.0 110.349 179.369 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -81.95 -62.68 1.57 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.542 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.729 ' C ' HD12 ' A' ' 71' ' ' LEU . 3.1 pp -65.68 -8.96 23.5 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.643 -0.423 . . . . 0.0 110.839 -179.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.687 ' N ' HD12 ' A' ' 71' ' ' LEU . . . 104.6 84.38 1.76 Allowed Glycine 0 CA--C 1.526 0.767 0 C-N-CA 120.994 -0.622 . . . . 0.0 111.77 179.19 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.554 ' N ' ' O ' ' A' ' 68' ' ' TRP . . . 41.91 -174.16 0.01 OUTLIER Glycine 0 CA--C 1.526 0.75 0 N-CA-C 111.795 -0.522 . . . . 0.0 111.795 179.212 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 46.6 t80 -78.7 114.21 17.43 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.866 0.365 . . . . 0.0 110.563 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.58 ' OG1' ' N ' ' A' ' 76' ' ' GLU . 0.0 OUTLIER -142.04 -175.48 4.43 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.423 -179.966 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.58 ' N ' ' OG1' ' A' ' 75' ' ' THR . 4.7 pt-20 -51.3 -25.8 6.42 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.601 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 64.3 t0 -76.12 -31.35 58.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.081 -179.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.41 ' O ' HD12 ' A' ' 82' ' ' LEU . . . -83.71 -19.11 35.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.937 -179.764 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 24.6 mtp -68.24 -27.38 66.31 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.847 -179.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 6.4 t -67.07 -49.39 46.3 Favored Pre-proline 0 CA--C 1.534 0.352 0 CA-C-N 116.438 -0.347 . . . . 0.0 110.729 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_endo -71.77 -58.85 0.07 OUTLIER 'Trans proline' 0 N--CA 1.498 1.74 0 C-N-CA 120.985 1.123 . . . . 0.0 111.721 179.166 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.414 HD11 ' CE2' ' A' ' 68' ' ' TRP . 2.8 mt -51.74 -47.59 63.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.781 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -67.88 -64.16 3.3 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 111.204 -0.758 . . . . 0.0 111.204 -179.471 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 31.4 tp -46.04 -26.71 0.78 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.988 0.423 . . . . 0.0 110.169 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 12.2 t80 -77.23 -41.98 39.12 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.245 179.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 1.3 m -69.52 -43.44 73.04 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.842 -179.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -69.84 -56.79 7.78 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 110.986 -0.846 . . . . 0.0 110.986 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.433 ' O ' ' CB ' ' A' ' 92' ' ' ASN . 3.5 tp60 -53.84 -45.2 70.83 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.9 0.381 . . . . 0.0 110.514 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 11.4 tp -66.19 -33.16 75.14 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.834 -179.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.761 ' O ' ' HB2' ' A' ' 94' ' ' ALA . . . -64.11 -65.68 0.65 Allowed 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 120.256 -0.578 . . . . 0.0 111.291 -179.324 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.9 pp -68.04 -33.37 74.46 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 -178.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.433 ' CB ' ' O ' ' A' ' 88' ' ' GLN . 32.2 t-20 -81.13 -55.11 4.97 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.249 0.463 . . . . 0.0 112.249 -178.444 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . 0.614 ' O ' ' N ' ' A' ' 95' ' ' TRP . 0.0 OUTLIER -73.54 -17.43 61.21 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.699 -0.4 . . . . 0.0 111.773 -178.371 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.761 ' HB2' ' O ' ' A' ' 90' ' ' ALA . . . -52.82 82.04 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 120.473 -0.491 . . . . 0.0 109.911 179.505 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.704 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 38.4 p-90 -97.08 -15.47 0.2 Allowed Pre-proline 0 CA--C 1.536 0.437 0 N-CA-C 112.635 0.605 . . . . 0.0 112.635 -179.16 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.704 ' CD ' ' N ' ' A' ' 95' ' ' TRP . 47.4 Cg_exo -60.39 -18.76 55.09 Favored 'Trans proline' 0 N--CA 1.498 1.744 0 C-N-CA 120.675 0.917 . . . . 0.0 113.663 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.562 ' CD ' ' N ' ' A' ' 96' ' ' PRO . 71.5 Cg_exo -76.76 0.69 9.34 Favored 'Trans proline' 0 N--CA 1.498 1.788 0 C-N-CA 120.534 0.822 . . . . 0.0 113.183 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.486 ' O ' ' N ' ' A' ' 101' ' ' GLY . 1.9 pp -91.76 9.37 3.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 C-N-CA 120.739 -0.385 . . . . 0.0 110.632 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.535 ' CD1' ' O ' ' A' ' 96' ' ' PRO . 2.8 m-30 -40.44 -36.32 0.54 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.678 179.716 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.547 ' CD1' ' N ' ' A' ' 100' ' ' PHE . 0.1 OUTLIER -66.9 -35.41 79.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.203 -179.334 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.486 ' N ' ' O ' ' A' ' 98' ' ' ILE . . . -92.89 -4.27 65.28 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 111.402 -0.679 . . . . 0.0 111.402 -179.538 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.461 ' HB1' ' CE2' ' A' ' 25' ' ' PHE . . . -65.85 -13.96 60.56 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.683 0.278 . . . . 0.0 110.925 -179.764 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 16.2 ptt180 -89.26 3.35 52.34 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.832 0.348 . . . . 0.0 110.81 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 9.4 mt-30 -120.61 158.74 26.72 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.362 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.409 ' N ' ' SD ' ' A' ' 105' ' ' MET . 0.0 OUTLIER -49.31 -18.37 0.36 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.232 179.907 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.566 ' O ' ' N ' ' A' ' 108' ' ' ALA . . . -64.48 -15.68 59.66 Favored Glycine 0 CA--C 1.526 0.764 0 N-CA-C 111.022 -0.831 . . . . 0.0 111.022 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' TRP . . . . . 0.688 ' CH2' ' NZ ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -41.8 -16.59 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 120.619 0.247 . . . . 0.0 111.241 -179.533 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.566 ' N ' ' O ' ' A' ' 106' ' ' GLY . . . -64.0 -17.3 63.18 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.96 0.409 . . . . 0.0 110.514 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 9.9 mt -51.64 -29.99 19.83 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.591 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.436 ' HB2' ' CE3' ' A' ' 95' ' ' TRP . . . -58.96 -62.78 1.62 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.644 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.71 ' O ' HG23 ' A' ' 115' ' ' VAL . 1.4 p30 -54.72 -53.86 49.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.453 -179.456 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.573 ' N ' ' OD1' ' A' ' 111' ' ' ASP . 31.3 tp -55.94 -40.78 73.66 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.918 -0.313 . . . . 0.0 111.662 -179.112 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 24.9 mt -68.35 -61.3 1.9 Allowed 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.363 0.505 . . . . 0.0 112.363 -178.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.0 pp -61.89 -32.86 73.26 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 120.435 -0.506 . . . . 0.0 111.41 -178.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.71 HG23 ' O ' ' A' ' 111' ' ' ASP . 41.8 t -61.86 -55.98 20.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.15 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.499 ' O ' ' OG1' ' A' ' 120' ' ' THR . 14.8 m -74.56 -22.9 58.76 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.447 -179.222 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -65.2 -62.48 4.87 Favored Glycine 0 CA--C 1.526 0.72 0 C-N-CA 120.809 -0.71 . . . . 0.0 111.419 -179.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.557 ' O ' HG23 ' A' ' 122' ' ' THR . 5.4 p -73.64 -35.5 44.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 C-N-CA 121.134 -0.226 . . . . 0.0 111.418 -179.507 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.508 ' O ' ' OG1' ' A' ' 123' ' ' THR . . . -69.76 -60.32 2.39 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.484 -0.487 . . . . 0.0 111.045 -179.457 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.499 ' OG1' ' O ' ' A' ' 116' ' ' SER . 1.9 m -59.28 -50.36 74.28 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.775 0.322 . . . . 0.0 111.34 -179.478 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -56.56 -41.75 77.39 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.464 -179.284 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.557 HG23 ' O ' ' A' ' 118' ' ' VAL . 33.9 p -72.44 -25.53 61.49 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.849 -0.34 . . . . 0.0 111.658 -179.238 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.508 ' OG1' ' O ' ' A' ' 119' ' ' ALA . 0.1 OUTLIER -69.55 -47.39 63.82 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.645 -0.422 . . . . 0.0 110.456 -179.747 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.8 pp -83.26 -18.32 39.56 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.18 -179.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -91.91 -65.01 1.04 Allowed 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -178.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 40.3 m0 -85.77 -57.63 2.97 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 113.032 0.753 . . . . 0.0 113.032 -177.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . 0.514 ' CD2' ' HB2' ' A' ' 134' ' ' ALA . 15.2 m170 -56.6 -22.6 35.04 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 111.762 0.282 . . . . 0.0 111.762 -178.324 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.51 -37.32 87.14 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 120.897 -0.321 . . . . 0.0 110.798 -179.574 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 47.9 t -101.16 -48.48 11.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.51 -179.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . 0.523 ' HB3' HG22 ' A' ' 67' ' ' VAL . 6.2 t -113.15 108.13 53.25 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.585 -178.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . 0.663 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 73.1 Cg_exo -76.41 -26.6 8.59 Favored 'Trans proline' 0 C--N 1.31 -1.47 0 C-N-CA 121.788 1.659 . . . . 0.0 112.393 178.592 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.663 ' CD ' ' N ' ' A' ' 131' ' ' PRO . 51.0 Cg_exo -61.15 -44.87 21.62 Favored 'Trans proline' 0 N--CA 1.497 1.682 0 C-N-CA 121.485 1.457 . . . . 0.0 112.248 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.405 ' O ' ' N ' ' A' ' 136' ' ' LEU . . . -59.05 -43.25 91.68 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.02 0.438 . . . . 0.0 110.321 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.514 ' HB2' ' CD2' ' A' ' 127' ' ' HIS . . . -49.61 -27.28 4.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.039 179.713 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 7.0 tpt180 -77.96 -29.53 49.84 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.345 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.405 ' N ' ' O ' ' A' ' 133' ' ' ALA . 39.0 mt -74.16 -21.74 59.71 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 178.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.49 ' O ' ' N ' ' A' ' 140' ' ' TYR . 3.3 mt -93.7 -28.29 16.04 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.278 -0.873 . . . . 0.0 110.232 179.455 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.513 ' C ' ' CD1' ' A' ' 138' ' ' TYR . 0.6 OUTLIER -32.3 -50.41 0.55 Allowed Pre-proline 0 CA--C 1.537 0.462 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.586 -179.929 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.42 ' HD2' ' N ' ' A' ' 138' ' ' TYR . 2.7 Cg_endo -61.91 5.94 0.19 Allowed 'Trans proline' 0 N--CA 1.498 1.773 0 C-N-CA 121.476 1.451 . . . . 0.0 112.972 -179.5 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.49 ' N ' ' O ' ' A' ' 137' ' ' LEU . 0.1 OUTLIER -90.41 -15.18 31.45 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.904 0.383 . . . . 0.0 110.891 179.866 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.511 HD23 HD12 ' A' ' 144' ' ' LEU . 98.7 mt -59.38 -35.89 74.76 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.216 -0.447 . . . . 0.0 109.922 178.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -56.06 -41.48 75.15 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.768 179.286 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' TRP . . . . . 0.502 ' CE2' HD12 ' A' ' 52' ' ' ILE . 8.4 t-105 -64.65 -44.49 90.26 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.606 179.266 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.511 HD12 HD23 ' A' ' 141' ' ' LEU . 19.2 mt -57.33 -43.3 83.27 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.802 179.573 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.5 ' O ' HG23 ' A' ' 149' ' ' VAL . . . -70.26 -26.69 63.94 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.007 179.644 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 11.1 t80 -60.65 -61.73 2.37 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.647 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.491 ' O ' ' OD1' ' A' ' 151' ' ' ASN . . . -66.55 -50.34 63.47 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 120.696 -0.401 . . . . 0.0 110.615 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . 0.576 ' O ' ' ND2' ' A' ' 151' ' ' ASN . 17.0 m -48.99 -55.43 11.96 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.626 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.5 HG23 ' O ' ' A' ' 145' ' ' ALA . 73.1 t -59.46 -35.86 61.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.613 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.42 ' O ' HG23 ' A' ' 154' ' ' VAL . 0.8 OUTLIER -51.73 -61.23 2.38 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.628 -0.429 . . . . 0.0 110.083 -179.873 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . 0.576 ' ND2' ' O ' ' A' ' 148' ' ' THR . 1.3 p-10 -54.34 -47.15 72.87 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.766 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 38.1 t80 -53.23 -40.73 64.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.766 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 37.1 t80 -63.92 -45.92 87.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.912 -179.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.42 HG23 ' O ' ' A' ' 150' ' ' LEU . 14.6 t -56.6 -51.69 62.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.926 0.393 . . . . 0.0 110.806 -179.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' TRP . . . . . . . . . . . . . 15.9 m0 -52.28 -55.33 22.06 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.225 -179.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -66.65 -19.73 65.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.28 -179.066 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 37.8 t0 -71.1 -52.7 17.84 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.73 0.3 . . . . 0.0 111.164 -179.456 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 19.6 p30 -83.1 -25.3 32.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.861 -179.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 2.6 p -144.41 100.36 3.52 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.599 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . 0.44 ' O ' ' C ' ' A' ' 161' ' ' ARG . . . -152.73 168.62 31.72 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 111.147 -0.781 . . . . 0.0 111.147 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . 0.44 ' C ' ' O ' ' A' ' 160' ' ' GLY . 87.7 mtt180 36.63 74.25 0.08 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.841 0.353 . . . . 0.0 110.682 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 66.9 mtm180 -104.28 141.37 36.41 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.484 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 147.98 76.85 0.02 OUTLIER Glycine 0 CA--C 1.524 0.635 0 N-CA-C 110.948 -0.861 . . . . 0.0 110.948 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -135.86 -167.18 11.2 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 110.817 -0.913 . . . . 0.0 110.817 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 17.5 m -86.02 179.32 7.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.868 0.366 . . . . 0.0 110.597 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . 0.456 ' C ' HD12 ' A' ' 167' ' ' LEU . 90.4 mtt180 -107.07 -102.88 0.35 Allowed 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.403 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.456 HD12 ' C ' ' A' ' 166' ' ' ARG . 11.1 mp -106.83 -66.79 0.99 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.466 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.451 ' O ' ' O ' ' A' ' 167' ' ' LEU . . . 53.83 108.33 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.276 -179.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 48.3 mm-40 . . . . . 0 C--O 1.221 -0.422 0 CA-C-O 117.941 -1.028 . . . . 0.0 110.584 -179.865 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' PKA . . . . . 0.539 'CL ' ' C15' ' A' ' 201' ' ' PKA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.508 ' O ' ' SD ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.148 0 CA-C-O 120.878 0.371 . . . . 0.0 110.439 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -60.14 -165.46 0.03 OUTLIER 'Trans proline' 0 C--N 1.304 -1.796 0 C-N-CA 122.436 2.091 . . . . 0.0 112.033 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -151.02 -19.59 0.21 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.558 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 23.2 t -83.84 130.64 34.92 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.401 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.761 ' O ' HG23 ' A' ' 9' ' ' VAL . 0.5 OUTLIER -90.88 117.11 29.23 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.23 -179.953 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.571 ' N ' ' CD ' ' A' ' 7' ' ' PRO . 0.9 OUTLIER -61.43 -42.86 86.99 Favored Pre-proline 0 CA--C 1.532 0.266 0 C-N-CA 120.938 -0.305 . . . . 0.0 110.26 -179.819 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.571 ' CD ' ' N ' ' A' ' 6' ' ' VAL . 24.1 Cg_exo -58.88 -65.1 0.09 OUTLIER 'Trans proline' 0 C--N 1.307 -1.623 0 C-N-CA 121.472 1.448 . . . . 0.0 111.52 179.585 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.732 ' O ' HG23 ' A' ' 12' ' ' THR . . . -50.42 -37.74 39.54 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.201 -179.765 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.761 HG23 ' O ' ' A' ' 5' ' ' TRP . 46.1 t -59.9 -62.45 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.831 0.348 . . . . 0.0 111.376 -179.28 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -61.67 -48.28 85.29 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 111.316 -0.714 . . . . 0.0 111.316 -179.431 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 9.0 mp -60.26 -24.96 65.33 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.49 0.186 . . . . 0.0 111.153 -179.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.732 HG23 ' O ' ' A' ' 8' ' ' ALA . 14.4 p -83.92 -29.11 27.39 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.77 -0.372 . . . . 0.0 110.539 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.422 ' O ' ' CB ' ' A' ' 16' ' ' SER . 6.4 mp -78.47 -20.87 49.98 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 179.661 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.421 ' C ' ' H ' ' A' ' 16' ' ' SER . 3.5 t -49.73 -57.63 11.67 Favored Pre-proline 0 CA--C 1.534 0.349 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.739 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.418 ' HD2' ' N ' ' A' ' 14' ' ' VAL . 11.3 Cg_endo -56.5 -4.19 0.75 Allowed 'Trans proline' 0 N--CA 1.497 1.725 0 C-N-CA 120.81 1.007 . . . . 0.0 111.974 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.422 ' CB ' ' O ' ' A' ' 13' ' ' LEU . 1.6 t -81.46 -27.81 34.44 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.832 0.348 . . . . 0.0 110.464 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 13.4 mt -71.56 -54.93 8.86 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.671 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -74.02 -35.8 53.08 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 111.035 -0.826 . . . . 0.0 111.035 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -67.27 -33.69 83.34 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 111.011 -0.836 . . . . 0.0 111.011 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -78.14 -60.09 2.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.74 0.305 . . . . 0.0 111.002 -179.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 3.3 ttt -61.95 -23.19 66.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.777 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.405 ' C ' ' CZ2' ' A' ' 95' ' ' TRP . . . -77.94 -60.43 2.75 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 111.681 -0.567 . . . . 0.0 111.681 -179.565 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.646 ' O ' HG22 ' A' ' 26' ' ' VAL . . . -66.79 -22.42 66.03 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.857 -179.146 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 88.5 t80 -49.86 -24.15 2.3 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.192 179.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 65.3 t80 -70.56 -52.09 24.05 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.007 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.646 HG22 ' O ' ' A' ' 23' ' ' ALA . 31.9 m -64.57 -22.59 31.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 C-N-CA 120.826 -0.35 . . . . 0.0 110.697 -179.725 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.448 ' NH2' ' HE ' ' A' ' 46' ' ' ARG . 16.3 ttt180 -67.66 -31.77 71.98 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.518 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -106.17 -61.41 0.6 Allowed Glycine 0 CA--C 1.525 0.706 0 N-CA-C 111.522 -0.631 . . . . 0.0 111.522 -179.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.45 ' C ' ' OE1' ' A' ' 29' ' ' GLU . 4.2 tm-20 -66.52 -34.48 78.01 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 121.032 -0.267 . . . . 0.0 111.304 -179.471 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -64.73 -58.23 10.56 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 110.932 -0.867 . . . . 0.0 110.932 -179.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 10.9 mp -51.67 -30.11 20.61 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.665 0.269 . . . . 0.0 110.511 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 16.1 tpp180 -78.61 -49.93 12.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.888 -179.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -51.4 -29.96 17.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.357 -179.652 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 39.1 t80 -46.28 -35.94 5.76 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.232 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -61.4 -29.03 69.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.486 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -89.13 -70.64 1.26 Allowed Glycine 0 CA--C 1.525 0.668 0 N-CA-C 110.851 -0.9 . . . . 0.0 110.851 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.572 ' O ' HD12 ' A' ' 37' ' ' LEU . 0.3 OUTLIER -95.21 167.15 11.53 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.912 0.387 . . . . 0.0 110.687 179.606 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 20.1 mt-30 -92.77 114.04 26.48 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.062 -179.542 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 18.8 mtpt -107.27 160.03 27.95 Favored Pre-proline 0 C--N 1.331 -0.2 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.907 179.493 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.564 ' O ' ' CD2' ' A' ' 43' ' ' HIS . 10.9 Cg_endo -65.12 96.33 0.27 Allowed 'Trans proline' 0 C--N 1.307 -1.641 0 C-N-CA 122.147 1.898 . . . . 0.0 111.535 179.595 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 4.1 t -60.97 -1.45 0.43 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.474 -0.785 . . . . 0.0 111.54 -179.515 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . 0.592 ' CD2' ' N ' ' A' ' 42' ' ' TRP . 0.0 OUTLIER -78.17 -15.06 59.18 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.421 -0.512 . . . . 0.0 110.123 -179.405 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.632 ' CD2' ' O ' ' A' ' 43' ' ' HIS . 0.3 OUTLIER -79.48 118.88 74.82 Favored Pre-proline 0 CA--C 1.535 0.391 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.38 -179.753 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.446 ' O ' ' C ' ' A' ' 45' ' ' PRO . 71.8 Cg_endo -87.02 150.71 8.29 Favored 'Trans proline' 0 C--N 1.312 -1.381 0 C-N-CA 120.787 0.991 . . . . 0.0 111.084 179.123 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.512 ' O ' ' N ' ' A' ' 47' ' ' TRP . 35.8 Cg_exo -37.4 137.1 0.36 Allowed 'Trans proline' 0 C--N 1.309 -1.534 0 C-N-CA 120.68 0.92 . . . . 0.0 111.435 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.448 ' HE ' ' NH2' ' A' ' 27' ' ' ARG . 1.3 ppt_? -42.31 -17.45 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.545 -179.347 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.563 ' CD1' ' N ' ' A' ' 48' ' ' THR . 0.1 OUTLIER -49.24 -51.58 32.41 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 120.623 -0.431 . . . . 0.0 111.809 -178.841 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.563 ' N ' ' CD1' ' A' ' 47' ' ' TRP . 15.0 t -91.25 -27.26 18.56 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 112.918 0.71 . . . . 0.0 112.918 -179.246 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.774 ' O ' HG23 ' A' ' 52' ' ' ILE . 0.2 OUTLIER -80.94 -53.74 6.19 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.447 -0.501 . . . . 0.0 112.133 -177.895 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.62 ' C ' ' H ' ' A' ' 52' ' ' ILE . . . -39.37 -30.09 0.2 Allowed Pre-proline 0 C--N 1.33 -0.263 0 C-N-CA 120.961 -0.296 . . . . 0.0 111.436 -179.171 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.423 ' HD2' ' N ' ' A' ' 50' ' ' ALA . 28.6 Cg_exo -54.79 7.67 0.03 OUTLIER 'Trans proline' 0 C--N 1.311 -1.44 0 CA-C-N 118.916 0.649 . . . . 0.0 112.57 178.388 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.774 HG23 ' O ' ' A' ' 49' ' ' LEU . 9.8 pt -56.35 -31.23 32.45 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.242 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 178.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.429 ' CH2' ' HB1' ' A' ' 50' ' ' ALA . 3.6 m0 -64.58 -24.15 67.5 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.616 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -71.62 -46.59 38.58 Favored Glycine 0 CA--C 1.523 0.551 0 N-CA-C 110.629 -0.988 . . . . 0.0 110.629 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 87.0 m -62.09 -50.21 72.85 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.875 0.369 . . . . 0.0 110.447 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 36.9 mt -69.08 -24.9 64.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.692 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.42 ' C ' ' CD1' ' A' ' 57' ' ' TYR . 1.6 t80 -65.34 -48.43 73.03 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 179.769 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -64.91 -46.13 82.98 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.32 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.61 -48.15 82.81 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.695 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 55.1 mtm -63.22 -36.45 83.7 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.713 -179.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -59.21 -47.29 91.55 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 111.423 -0.671 . . . . 0.0 111.423 -179.474 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 3.3 m-30 -66.84 -59.85 3.18 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.991 -0.284 . . . . 0.0 110.77 -179.496 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.517 ' O ' HG23 ' A' ' 67' ' ' VAL . . . -50.84 -59.12 8.35 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 110.972 -0.851 . . . . 0.0 110.972 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.511 ' O ' ' CD1' ' A' ' 68' ' ' TRP . 34.5 t -45.11 -52.04 9.61 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-O 120.986 0.422 . . . . 0.0 110.783 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 70.6 t80 -56.16 -36.64 68.53 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.116 -179.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 70.5 mt -70.83 -48.44 57.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.775 0.321 . . . . 0.0 110.798 -179.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.517 HG23 ' O ' ' A' ' 63' ' ' GLY . 18.3 t -48.9 -54.69 4.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.0 -179.711 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . 0.586 ' O ' ' N ' ' A' ' 73' ' ' GLY . 0.9 OUTLIER -64.15 -45.22 89.46 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.76 -0.376 . . . . 0.0 111.047 -179.587 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 14.6 mmmt -57.22 -23.28 46.91 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.888 -0.325 . . . . 0.0 110.913 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 24.1 tp10 -82.34 -63.33 1.4 Allowed 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.799 -0.361 . . . . 0.0 110.848 -179.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.742 ' C ' HD12 ' A' ' 71' ' ' LEU . 3.0 pp -64.82 -4.36 4.32 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.965 -179.652 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.618 ' N ' HD12 ' A' ' 71' ' ' LEU . . . 110.95 71.68 0.65 Allowed Glycine 0 CA--C 1.526 0.777 0 C-N-CA 121.177 -0.535 . . . . 0.0 111.817 179.454 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.586 ' N ' ' O ' ' A' ' 68' ' ' TRP . . . 40.93 -173.83 0.01 OUTLIER Glycine 0 CA--C 1.525 0.667 0 CA-C-O 121.365 0.425 . . . . 0.0 112.281 179.077 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 39.4 t80 -70.45 109.84 5.02 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.316 -0.442 . . . . 0.0 110.7 -179.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.532 ' OG1' ' N ' ' A' ' 76' ' ' GLU . 1.5 t -142.89 -173.56 3.93 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.231 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.532 ' N ' ' OG1' ' A' ' 75' ' ' THR . 16.6 mp0 -56.73 -23.17 40.63 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.301 179.625 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -78.48 -29.01 46.5 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.785 -179.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.437 ' O ' HD12 ' A' ' 82' ' ' LEU . . . -86.85 -30.67 21.28 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.546 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 66.8 mmm -60.46 -27.11 67.27 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.905 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 17.6 t -65.97 -48.11 61.96 Favored Pre-proline 0 CA--C 1.534 0.33 0 C-N-CA 120.711 -0.396 . . . . 0.0 110.817 -179.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_endo -73.22 -52.87 0.14 Allowed 'Trans proline' 0 N--CA 1.495 1.615 0 C-N-CA 120.727 0.951 . . . . 0.0 111.355 178.551 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.437 HD12 ' O ' ' A' ' 78' ' ' ALA . 3.6 mt -51.49 -52.8 43.58 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.333 179.769 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.5 ' O ' ' N ' ' A' ' 86' ' ' THR . . . -66.65 -64.54 3.26 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 111.332 -0.707 . . . . 0.0 111.332 -179.237 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 34.3 tp -42.01 -28.08 0.16 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.065 0.46 . . . . 0.0 109.994 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.414 ' N ' ' O ' ' A' ' 83' ' ' GLY . 4.3 t80 -77.29 -43.11 34.41 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.061 179.543 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.5 ' N ' ' O ' ' A' ' 83' ' ' GLY . 3.0 m -68.02 -52.78 31.58 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.744 179.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -60.56 -55.9 27.36 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 111.163 -0.775 . . . . 0.0 111.163 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.427 ' O ' ' CB ' ' A' ' 92' ' ' ASN . 52.2 tp60 -55.99 -42.87 77.03 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.799 0.333 . . . . 0.0 110.471 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 10.5 tp -66.01 -28.61 69.0 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.879 0.371 . . . . 0.0 110.125 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.783 ' O ' ' HB2' ' A' ' 94' ' ' ALA . . . -69.35 -65.82 0.66 Allowed 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.095 -0.642 . . . . 0.0 111.225 -179.814 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.7 pp -66.19 -29.16 69.38 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.149 0.426 . . . . 0.0 112.149 -179.01 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.427 ' CB ' ' O ' ' A' ' 88' ' ' GLN . 36.3 t-20 -85.22 -60.91 1.9 Allowed 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 -178.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . 0.609 ' O ' ' N ' ' A' ' 95' ' ' TRP . 0.0 OUTLIER -68.25 -14.78 63.24 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.69 -0.404 . . . . 0.0 111.403 -178.486 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.783 ' HB2' ' O ' ' A' ' 90' ' ' ALA . . . -54.04 80.25 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.137 0 C-N-CA 120.439 -0.505 . . . . 0.0 109.995 179.498 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.711 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 33.8 p-90 -94.44 -16.42 0.21 Allowed Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.24 -0.437 . . . . 0.0 112.061 -179.633 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.711 ' CD ' ' N ' ' A' ' 95' ' ' TRP . 46.9 Cg_exo -56.96 -31.99 91.46 Favored 'Trans proline' 0 N--CA 1.494 1.504 0 CA-C-N 118.921 0.65 . . . . 0.0 112.789 179.366 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.524 ' C ' ' H ' ' A' ' 99' ' ' PHE . 59.6 Cg_exo -50.33 -30.55 26.97 Favored 'Trans proline' 0 N--CA 1.493 1.479 0 CA-C-N 118.969 0.668 . . . . 0.0 112.838 179.736 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.492 ' O ' ' N ' ' A' ' 101' ' ' GLY . 1.2 pp -74.01 20.87 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.022 0.439 . . . . 0.0 110.187 179.662 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.524 ' H ' ' C ' ' A' ' 97' ' ' PRO . 0.9 OUTLIER -39.29 -58.18 1.25 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.038 -179.666 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 4.2 p90 -66.89 -18.04 65.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.143 -179.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.492 ' N ' ' O ' ' A' ' 98' ' ' ILE . . . -86.99 -10.7 71.45 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 111.17 -0.772 . . . . 0.0 111.17 -179.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -70.74 -9.4 57.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.56 0.219 . . . . 0.0 111.093 -179.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 10.6 ptm180 -91.97 -5.39 53.16 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.8 0.333 . . . . 0.0 110.734 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 10.0 mt-30 -109.11 160.45 16.05 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.554 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -53.76 -19.25 3.99 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.049 0.452 . . . . 0.0 110.237 179.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.605 ' O ' ' N ' ' A' ' 108' ' ' ALA . . . -65.4 -14.93 60.59 Favored Glycine 0 CA--C 1.523 0.592 0 N-CA-C 111.073 -0.811 . . . . 0.0 111.073 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' TRP . . . . . 0.505 ' NE1' ' OD1' ' A' ' 151' ' ' ASN . 0.0 OUTLIER -42.41 -15.12 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.791 0.329 . . . . 0.0 110.517 -179.663 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.605 ' N ' ' O ' ' A' ' 106' ' ' GLY . . . -58.76 -16.83 18.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.136 0.493 . . . . 0.0 109.85 179.427 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 12.1 mt -58.74 -33.92 70.79 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.569 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -53.8 -61.04 2.56 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.936 0.398 . . . . 0.0 110.898 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.571 ' O ' HG23 ' A' ' 115' ' ' VAL . 2.3 p-10 -58.83 -54.89 41.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.733 -179.392 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 43.5 tp -52.82 -43.52 66.01 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.351 -0.386 . . . . 0.0 112.01 -178.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 8.6 mt -66.96 -61.37 1.97 Allowed 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -178.17 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.3 pp -61.23 -35.18 76.52 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.304 -0.558 . . . . 0.0 111.499 -178.496 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.571 HG23 ' O ' ' A' ' 111' ' ' ASP . 41.5 t -60.07 -56.64 16.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.596 -0.274 . . . . 0.0 111.116 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.489 ' O ' ' OG1' ' A' ' 120' ' ' THR . 58.1 m -72.92 -24.1 60.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.615 -0.266 . . . . 0.0 111.58 -178.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.406 ' O ' ' CB ' ' A' ' 121' ' ' ALA . . . -63.69 -62.73 5.02 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 111.537 -0.625 . . . . 0.0 111.537 -179.285 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.585 ' O ' HG23 ' A' ' 122' ' ' THR . 8.7 p -74.03 -34.59 39.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 C-N-CA 120.883 -0.327 . . . . 0.0 111.231 -179.481 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.524 ' O ' ' OG1' ' A' ' 123' ' ' THR . . . -68.95 -60.57 2.27 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.781 -0.367 . . . . 0.0 111.201 -179.429 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.489 ' OG1' ' O ' ' A' ' 116' ' ' SER . 1.4 m -61.47 -48.66 80.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.397 -179.252 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.407 ' O ' ' CB ' ' A' ' 125' ' ' ALA . . . -56.68 -42.01 78.31 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.173 -179.4 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.585 HG23 ' O ' ' A' ' 118' ' ' VAL . 35.3 p -71.7 -29.22 64.32 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.948 -0.301 . . . . 0.0 111.567 -179.317 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.524 ' OG1' ' O ' ' A' ' 119' ' ' ALA . 0.1 OUTLIER -67.41 -50.7 58.37 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.584 -0.446 . . . . 0.0 110.577 -179.749 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.0 pp -79.71 -20.39 46.61 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.625 -179.085 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.407 ' CB ' ' O ' ' A' ' 121' ' ' ALA . . . -91.47 -64.72 1.08 Allowed 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.678 0.621 . . . . 0.0 112.678 -178.351 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' TRP . . . . . 0.433 ' N ' ' CD1' ' A' ' 126' ' ' TRP . 40.2 m0 -85.69 -57.08 3.19 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 -177.587 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . 0.532 ' CG ' ' HB2' ' A' ' 134' ' ' ALA . 11.3 m170 -57.2 -31.58 65.59 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.795 -0.362 . . . . 0.0 111.919 -178.577 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 18.6 ttt180 -56.98 -38.51 73.11 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.709 -0.396 . . . . 0.0 111.367 -179.237 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 48.5 t -97.22 -49.56 11.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.793 0.33 . . . . 0.0 111.403 -179.244 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . 0.509 ' HB3' HG22 ' A' ' 67' ' ' VAL . 15.0 t -113.91 108.31 51.25 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.748 -179.546 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . 0.635 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 82.3 Cg_exo -75.26 -28.07 9.07 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 C-N-CA 121.755 1.637 . . . . 0.0 112.72 179.338 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.635 ' CD ' ' N ' ' A' ' 131' ' ' PRO . 53.5 Cg_exo -57.77 -55.45 2.36 Favored 'Trans proline' 0 N--CA 1.497 1.68 0 C-N-CA 121.142 1.228 . . . . 0.0 111.968 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -49.26 -38.48 27.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.463 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.532 ' HB2' ' CG ' ' A' ' 127' ' ' HIS . . . -57.08 -29.04 63.14 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.337 179.786 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 9.7 tpp85 -76.36 -24.5 54.2 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.335 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 84.6 mt -76.04 -39.73 54.95 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 179.42 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.608 ' O ' ' N ' ' A' ' 140' ' ' TYR . 9.7 mt -77.0 -37.42 55.15 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.791 -0.641 . . . . 0.0 109.823 179.166 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.493 ' C ' ' O ' ' A' ' 137' ' ' LEU . 2.9 t80 -21.0 -44.41 0.04 OUTLIER Pre-proline 0 N--CA 1.467 0.375 0 O-C-N 123.918 0.761 . . . . 0.0 111.828 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.564 ' N ' ' O ' ' A' ' 137' ' ' LEU . 2.0 Cg_endo -67.75 11.55 0.23 Allowed 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 121.026 1.151 . . . . 0.0 112.296 179.554 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.756 ' CE2' HD11 ' A' ' 144' ' ' LEU . 2.4 p90 -93.14 -14.15 27.56 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 121.188 0.518 . . . . 0.0 110.118 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.605 ' CD1' ' CE1' ' A' ' 140' ' ' TYR . 5.2 mp -57.05 -25.91 59.45 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 178.522 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -66.66 -44.51 81.68 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.826 179.495 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' TRP . . . . . 0.453 ' CZ2' HD12 ' A' ' 52' ' ' ILE . 7.9 t-105 -59.77 -48.08 83.13 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 179.358 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.756 HD11 ' CE2' ' A' ' 140' ' ' TYR . 9.1 mt -53.22 -50.96 63.64 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 179.09 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.645 ' O ' HG23 ' A' ' 149' ' ' VAL . . . -61.33 -26.58 67.9 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.667 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 25.4 t80 -65.01 -62.43 1.55 Allowed 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.812 -0.355 . . . . 0.0 110.775 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.416 ' HB1' ' C20' ' A' ' 201' ' ' PKA . . . -66.25 -43.38 86.68 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.612 -0.435 . . . . 0.0 110.492 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 16.2 m -57.06 -57.62 11.78 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.765 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.645 HG23 ' O ' ' A' ' 145' ' ' ALA . 85.4 t -56.95 -32.77 40.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 C-N-CA 120.836 -0.346 . . . . 0.0 110.731 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.541 ' O ' HG23 ' A' ' 154' ' ' VAL . 1.8 tp -58.39 -48.62 80.03 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.523 -0.471 . . . . 0.0 109.813 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . 0.505 ' OD1' ' NE1' ' A' ' 107' ' ' TRP . 21.1 t30 -69.62 -55.68 9.4 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.528 179.701 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 84.8 t80 -47.49 -39.53 16.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.818 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 25.8 t80 -67.82 -46.59 71.45 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.765 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.541 HG23 ' O ' ' A' ' 150' ' ' LEU . 93.7 t -61.88 -33.06 56.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.742 -179.853 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' TRP . . . . . . . . . . . . . 6.3 m0 -67.02 -58.48 4.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.511 179.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -62.94 -19.43 64.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.553 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -80.09 -51.66 8.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.169 -179.547 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 33.5 m-20 -87.15 -40.47 14.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.084 -179.449 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -79.22 110.34 14.39 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.543 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 120.85 -152.72 16.77 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 111.011 -0.836 . . . . 0.0 111.011 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 19.0 ttt85 48.45 51.73 14.8 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.835 0.35 . . . . 0.0 110.535 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 42.0 mtm180 -81.03 138.87 36.01 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.591 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . 0.485 ' O ' ' O ' ' A' ' 164' ' ' GLY . . . 171.52 -176.17 44.81 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 111.014 -0.834 . . . . 0.0 111.014 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . 0.485 ' O ' ' O ' ' A' ' 163' ' ' GLY . . . 51.6 108.96 0.01 OUTLIER Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.944 -0.862 . . . . 0.0 110.944 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . 0.406 ' C ' ' OE2' ' A' ' 169' ' ' GLU . 46.3 t -93.25 18.16 9.97 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.91 0.386 . . . . 0.0 110.462 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . 0.462 ' O ' ' N ' ' A' ' 168' ' ' ALA . 94.0 mtt180 -52.72 -176.96 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.575 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.531 ' N ' HD12 ' A' ' 167' ' ' LEU . 9.4 mp 59.28 -80.45 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.713 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.462 ' N ' ' O ' ' A' ' 166' ' ' ARG . . . -40.22 -33.61 0.25 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.761 -179.814 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . 0.406 ' OE2' ' C ' ' A' ' 165' ' ' SER . 11.2 mt-10 . . . . . 0 C--O 1.22 -0.455 0 CA-C-O 118.026 -0.987 . . . . 0.0 110.549 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' PKA . . . . . 0.513 'CL ' ' C15' ' A' ' 201' ' ' PKA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.65 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 CA--C 1.527 0.089 0 CA-C-O 120.901 0.381 . . . . 0.0 110.64 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.467 ' O ' ' CB ' ' A' ' 3' ' ' GLU . 37.3 Cg_endo -98.83 -73.7 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.609 0 C-N-CA 122.343 2.029 . . . . 0.0 112.146 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.467 ' CB ' ' O ' ' A' ' 2' ' ' PRO . 13.0 tt0 80.88 -19.41 0.44 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.416 -179.764 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 30.2 p 53.29 99.0 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.504 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.605 ' O ' HG23 ' A' ' 9' ' ' VAL . 0.5 OUTLIER -45.44 116.97 1.27 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.308 179.952 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.589 ' N ' ' CD ' ' A' ' 7' ' ' PRO . 0.9 OUTLIER -61.0 -40.77 77.17 Favored Pre-proline 0 C--N 1.33 -0.269 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 -179.919 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.589 ' CD ' ' N ' ' A' ' 6' ' ' VAL . 23.4 Cg_exo -62.82 -64.59 0.07 OUTLIER 'Trans proline' 0 C--N 1.307 -1.649 0 C-N-CA 121.683 1.589 . . . . 0.0 111.388 179.526 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.681 ' O ' HG23 ' A' ' 12' ' ' THR . . . -48.9 -30.09 5.47 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.84 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.605 HG23 ' O ' ' A' ' 5' ' ' TRP . 43.5 t -74.18 -62.8 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.709 0.29 . . . . 0.0 111.658 -179.258 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -58.13 -35.21 76.23 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 111.598 -0.601 . . . . 0.0 111.598 -179.268 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.528 ' HG ' HG22 ' A' ' 86' ' ' THR . 6.9 mp -73.52 -38.17 65.39 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.621 0.248 . . . . 0.0 110.567 -179.663 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.681 HG23 ' O ' ' A' ' 8' ' ' ALA . 12.3 p -70.16 -20.59 63.13 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.017 0.436 . . . . 0.0 109.86 179.456 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.418 ' O ' ' C ' ' A' ' 14' ' ' VAL . 7.8 mt -80.95 -42.76 20.76 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.695 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.439 HG12 ' N ' ' A' ' 15' ' ' PRO . 3.1 t -35.71 -66.08 0.27 Allowed Pre-proline 0 CA--C 1.534 0.35 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.997 -179.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.439 ' N ' HG12 ' A' ' 14' ' ' VAL . 27.7 Cg_endo -51.23 -48.04 23.04 Favored 'Trans proline' 0 N--CA 1.498 1.754 0 C-N-CA 120.712 0.941 . . . . 0.0 112.126 -179.515 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 7.5 t -45.06 -21.32 0.06 Allowed 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.793 -0.363 . . . . 0.0 110.726 -179.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.421 ' N ' ' O ' ' A' ' 15' ' ' PRO . 73.2 mt -74.22 -53.37 9.94 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.395 179.77 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -72.01 -23.82 77.42 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 111.11 -0.796 . . . . 0.0 111.11 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -72.1 -49.2 22.64 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 110.952 -0.859 . . . . 0.0 110.952 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 11.2 t80 -67.94 -59.02 3.6 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.831 0.348 . . . . 0.0 110.566 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 8.0 tpp -62.88 -26.95 69.03 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.156 -179.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -77.68 -62.55 2.37 Favored Glycine 0 CA--C 1.526 0.753 0 C-N-CA 120.963 -0.637 . . . . 0.0 111.913 -179.316 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.626 ' O ' HG22 ' A' ' 26' ' ' VAL . . . -57.57 -24.79 58.15 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.834 -0.347 . . . . 0.0 110.666 -179.085 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 54.2 t80 -47.82 -24.5 1.0 Allowed 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.769 -0.372 . . . . 0.0 110.11 179.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.4 ' CE2' ' HB3' ' A' ' 102' ' ' ALA . 21.7 t80 -69.45 -55.78 9.28 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.777 -179.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.626 HG22 ' O ' ' A' ' 23' ' ' ALA . 33.7 m -60.44 -23.99 29.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 C-N-CA 120.699 -0.4 . . . . 0.0 110.344 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 2.9 tmt_? -66.09 -20.86 66.29 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.631 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -116.29 -75.22 0.57 Allowed Glycine 0 CA--C 1.523 0.569 0 N-CA-C 111.021 -0.832 . . . . 0.0 111.021 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -50.36 -31.68 15.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.654 0.264 . . . . 0.0 110.774 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -72.82 -53.39 8.21 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.81 -0.916 . . . . 0.0 110.81 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 11.0 mp -57.58 -29.94 64.86 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.84 0.352 . . . . 0.0 110.317 179.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 45.0 mtp180 -79.94 -48.92 12.63 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.549 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -52.15 -29.97 24.52 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.013 -0.539 . . . . 0.0 109.923 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 51.1 t80 -48.54 -40.03 25.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.61 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -58.9 -22.52 59.67 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.461 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -94.95 -73.5 1.2 Allowed Glycine 0 CA--C 1.524 0.638 0 N-CA-C 110.721 -0.951 . . . . 0.0 110.721 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.568 ' O ' HD12 ' A' ' 37' ' ' LEU . 0.3 OUTLIER -95.52 167.14 11.49 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.711 0.291 . . . . 0.0 110.424 179.494 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 33.3 mt-30 -85.02 115.72 23.0 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.887 0.375 . . . . 0.0 111.168 -179.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 12.0 mtpt -122.78 164.66 25.51 Favored Pre-proline 0 N--CA 1.462 0.168 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 179.276 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.611 ' C ' ' H ' ' A' ' 42' ' ' TRP . 20.4 Cg_endo -80.5 43.53 1.55 Allowed 'Trans proline' 0 C--N 1.306 -1.678 0 C-N-CA 121.743 1.628 . . . . 0.0 111.159 179.358 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -50.89 0.73 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.106 -0.952 . . . . 0.0 111.695 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . 0.611 ' H ' ' C ' ' A' ' 40' ' ' PRO . 39.9 p-90 -76.22 -15.26 60.07 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.479 -0.488 . . . . 0.0 110.923 -178.641 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.595 ' CD2' ' O ' ' A' ' 40' ' ' PRO . 2.9 p80 -77.3 137.09 64.5 Favored Pre-proline 0 C--N 1.326 -0.415 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 179.26 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.419 ' HG2' HD23 ' A' ' 49' ' ' LEU . 55.0 Cg_endo -55.58 160.51 9.16 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 121.398 1.398 . . . . 0.0 111.793 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -52.01 162.8 1.71 Allowed 'Trans proline' 0 C--N 1.306 -1.69 0 C-N-CA 121.986 1.791 . . . . 0.0 111.79 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.495 ' O ' ' HB2' ' A' ' 50' ' ' ALA . 0.1 OUTLIER -57.82 -25.37 60.54 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.768 -179.171 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.484 ' CD1' ' N ' ' A' ' 48' ' ' THR . 0.0 OUTLIER -66.41 -13.4 60.66 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.348 -0.541 . . . . 0.0 110.77 -179.192 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.484 ' N ' ' CD1' ' A' ' 47' ' ' TRP . 29.5 m -91.79 -57.75 2.64 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.046 -0.525 . . . . 0.0 112.204 -179.236 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.957 ' O ' HG23 ' A' ' 52' ' ' ILE . 1.5 mm? -81.18 -28.68 34.88 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 -177.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.543 ' C ' ' H ' ' A' ' 52' ' ' ILE . . . -40.42 -34.97 0.48 Allowed Pre-proline 0 C--N 1.326 -0.416 0 C-N-CA 120.427 -0.509 . . . . 0.0 111.42 -179.143 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.43 ' HD2' ' N ' ' A' ' 50' ' ' ALA . 69.6 Cg_exo -54.26 3.0 0.05 OUTLIER 'Trans proline' 0 C--N 1.314 -1.283 0 C-N-CA 120.644 0.896 . . . . 0.0 112.954 179.257 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.957 HG23 ' O ' ' A' ' 49' ' ' LEU . 42.1 pt -55.55 -30.27 26.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 121.133 0.492 . . . . 0.0 110.032 179.624 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.484 ' CE2' HD11 ' A' ' 52' ' ' ILE . 45.7 m95 -81.51 -22.51 37.9 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.413 -179.606 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -72.01 -47.51 31.04 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 109.709 -1.356 . . . . 0.0 109.709 178.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 5.0 m -67.12 -54.98 16.25 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 178.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.41 HD23 ' HA ' ' A' ' 56' ' ' LEU . 92.8 mt -53.76 -39.63 65.52 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.848 -0.614 . . . . 0.0 109.5 179.119 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.42 ' CD1' ' C ' ' A' ' 57' ' ' TYR . 1.3 t80 -54.6 -50.75 67.28 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 179.394 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 5.7 m -52.22 -50.22 62.42 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.223 179.608 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.55 -47.95 82.51 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.574 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 15.4 mtt -56.07 -44.14 78.66 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.461 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -54.59 -55.91 24.82 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 111.155 -0.778 . . . . 0.0 111.155 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -53.65 -54.66 34.59 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.727 0.299 . . . . 0.0 110.448 -179.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.487 ' O ' HG23 ' A' ' 67' ' ' VAL . . . -52.53 -56.97 15.18 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 110.824 -0.91 . . . . 0.0 110.824 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.592 ' O ' ' CD1' ' A' ' 68' ' ' TRP . 0.0 OUTLIER -49.19 -50.13 39.48 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.897 0.379 . . . . 0.0 110.324 179.957 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.487 ' O ' ' CG ' ' A' ' 69' ' ' LYS . 83.9 t80 -51.43 -38.33 53.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.709 -179.758 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 51.9 mt -71.59 -48.67 51.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.166 -179.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.487 HG23 ' O ' ' A' ' 63' ' ' GLY . 15.9 t -51.51 -61.35 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.867 0.365 . . . . 0.0 111.334 -179.46 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . 0.592 ' CD1' ' O ' ' A' ' 64' ' ' SER . 1.5 m95 -60.72 -40.67 93.18 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.339 -179.179 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.487 ' CG ' ' O ' ' A' ' 65' ' ' TYR . 10.6 mmmt -64.2 -22.68 67.03 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.847 0.356 . . . . 0.0 110.706 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -82.89 -62.36 1.62 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.671 -179.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.74 ' C ' HD12 ' A' ' 71' ' ' LEU . 3.6 pp -65.22 -9.73 25.95 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.962 -179.775 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.668 ' N ' HD12 ' A' ' 71' ' ' LEU . . . 106.09 85.69 1.83 Allowed Glycine 0 CA--C 1.527 0.788 0 C-N-CA 121.221 -0.514 . . . . 0.0 111.939 179.234 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.493 ' O ' HD11 ' A' ' 71' ' ' LEU . . . 42.06 -173.72 0.01 OUTLIER Glycine 0 CA--C 1.526 0.719 0 N-CA-C 111.838 -0.505 . . . . 0.0 111.838 179.078 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -85.02 110.93 19.28 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.527 -0.336 . . . . 0.0 110.773 -179.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.524 ' OG1' ' N ' ' A' ' 76' ' ' GLU . 1.7 t -142.53 -173.81 3.97 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.665 179.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.524 ' N ' ' OG1' ' A' ' 75' ' ' THR . 6.9 pt-20 -45.45 -34.9 3.4 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.889 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -67.91 -32.65 73.28 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.071 -179.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -83.98 -22.69 31.32 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.844 0.354 . . . . 0.0 110.816 -179.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 4.8 mtp -62.99 -26.63 68.94 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.775 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.2 t -68.67 -52.92 17.4 Favored Pre-proline 0 CA--C 1.534 0.35 0 C-N-CA 120.608 -0.437 . . . . 0.0 110.749 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -65.86 -60.78 0.11 Allowed 'Trans proline' 0 N--CA 1.497 1.678 0 C-N-CA 121.07 1.18 . . . . 0.0 111.703 179.137 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.624 ' O ' HG23 ' A' ' 86' ' ' THR . 2.7 mt -56.77 -56.43 21.55 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.391 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -47.82 -51.37 18.37 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 111.168 -0.773 . . . . 0.0 111.168 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 16.0 tp -62.58 -30.13 71.1 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 121.019 -0.273 . . . . 0.0 110.753 -179.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.597 ' CZ ' HD22 ' A' ' 89' ' ' LEU . 23.0 t80 -71.51 -39.11 71.01 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.963 -0.295 . . . . 0.0 110.468 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.624 HG23 ' O ' ' A' ' 82' ' ' LEU . 8.8 p -64.49 -53.54 46.49 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.802 -0.359 . . . . 0.0 110.656 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -68.04 -58.09 7.85 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 111.527 -0.629 . . . . 0.0 111.527 -179.266 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 52.4 tp60 -49.47 -54.61 16.84 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-O 121.039 0.447 . . . . 0.0 110.551 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.597 HD22 ' CZ ' ' A' ' 85' ' ' TYR . 27.1 tp -51.03 -64.4 0.82 Allowed 'General case' 0 C--O 1.209 -1.027 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.906 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.622 ' O ' ' HB2' ' A' ' 94' ' ' ALA . . . -38.05 -48.85 1.25 Allowed 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 120.434 -0.506 . . . . 0.0 111.916 -179.561 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 94.1 mt -56.6 -57.17 13.54 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 -178.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.798 ' O ' HD22 ' A' ' 113' ' ' LEU . 2.8 m120 -74.21 -55.11 6.43 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 121.415 0.626 . . . . 0.0 111.301 -178.621 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . 0.623 ' O ' ' N ' ' A' ' 95' ' ' TRP . 7.4 t-105 -52.84 -21.92 4.8 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.114 -0.948 . . . . 0.0 111.273 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.622 ' HB2' ' O ' ' A' ' 90' ' ' ALA . . . -60.05 69.27 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.929 0.395 . . . . 0.0 109.948 179.623 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.685 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 9.9 p-90 -99.94 -17.39 0.2 Allowed Pre-proline 0 CA--C 1.536 0.439 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.73 -179.363 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.685 ' CD ' ' N ' ' A' ' 95' ' ' TRP . 31.8 Cg_exo -62.86 -26.24 74.57 Favored 'Trans proline' 0 N--CA 1.494 1.522 0 C-N-CA 120.442 0.762 . . . . 0.0 112.659 179.193 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.544 ' CD ' ' N ' ' A' ' 96' ' ' PRO . 84.2 Cg_exo -60.1 -25.69 80.49 Favored 'Trans proline' 0 N--CA 1.496 1.638 0 C-N-CA 120.744 0.963 . . . . 0.0 112.781 179.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -80.74 33.03 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 121.003 0.43 . . . . 0.0 110.427 179.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.402 ' H ' ' C ' ' A' ' 97' ' ' PRO . 1.6 t80 -44.7 -52.92 7.82 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.488 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -73.63 -40.33 63.86 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.673 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -57.14 -15.47 14.69 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 111.135 -0.786 . . . . 0.0 111.135 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.4 ' HB3' ' CE2' ' A' ' 25' ' ' PHE . . . -74.64 -7.88 54.62 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.69 0.281 . . . . 0.0 110.837 -179.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.41 -17.12 52.75 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.657 -179.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . 0.536 ' O ' ' N ' ' A' ' 106' ' ' GLY . 5.4 pt20 -110.95 158.06 19.19 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.599 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 6.0 mmt -43.26 -17.32 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.669 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.536 ' N ' ' O ' ' A' ' 104' ' ' GLN . . . -62.78 -15.82 55.32 Favored Glycine 0 CA--C 1.526 0.77 0 N-CA-C 111.122 -0.791 . . . . 0.0 111.122 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' TRP . . . . . 0.481 ' C ' ' CD1' ' A' ' 107' ' ' TRP . 0.0 OUTLIER -47.68 -12.09 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.887 0.375 . . . . 0.0 110.664 -179.881 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.498 ' H ' ' C ' ' A' ' 106' ' ' GLY . . . -62.7 -22.51 66.56 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.082 179.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 8.2 mt -53.39 -29.68 35.96 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.297 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -54.91 -64.4 0.85 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.957 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.707 ' O ' HG23 ' A' ' 115' ' ' VAL . 1.4 p30 -58.82 -51.1 71.45 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.457 -179.477 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.549 ' N ' ' OD1' ' A' ' 111' ' ' ASP . 39.6 tp -52.48 -47.79 66.31 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.813 -178.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.798 HD22 ' O ' ' A' ' 92' ' ' ASN . 17.3 mt -65.81 -62.07 1.71 Allowed 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 -178.002 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.1 pp -58.36 -35.32 71.77 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 120.369 -0.533 . . . . 0.0 111.48 -178.478 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.707 HG23 ' O ' ' A' ' 111' ' ' ASP . 40.2 t -59.56 -61.27 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.132 -179.675 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.49 ' O ' ' OG1' ' A' ' 120' ' ' THR . 9.0 p -69.22 -22.24 63.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.291 -179.082 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -63.3 -63.02 4.85 Favored Glycine 0 CA--C 1.527 0.841 0 C-N-CA 120.838 -0.696 . . . . 0.0 111.597 -179.284 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.614 ' O ' HG23 ' A' ' 122' ' ' THR . 9.9 p -73.07 -37.04 52.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 C-N-CA 120.88 -0.328 . . . . 0.0 111.239 -179.415 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.515 ' O ' ' OG1' ' A' ' 123' ' ' THR . . . -67.58 -60.75 2.31 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.692 -0.403 . . . . 0.0 111.212 -179.563 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.49 ' OG1' ' O ' ' A' ' 116' ' ' SER . 2.3 m -58.42 -53.52 57.36 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.432 -179.339 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.439 ' O ' HD23 ' A' ' 124' ' ' LEU . . . -53.76 -41.36 67.06 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.253 -179.345 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.614 HG23 ' O ' ' A' ' 118' ' ' VAL . 42.1 p -73.73 -34.05 64.6 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 120.783 -0.367 . . . . 0.0 111.889 -179.12 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.515 ' OG1' ' O ' ' A' ' 119' ' ' ALA . 0.0 OUTLIER -60.27 -56.04 26.38 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 120.555 -0.458 . . . . 0.0 110.938 -179.453 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.579 HD23 ' N ' ' A' ' 125' ' ' ALA . 0.6 OUTLIER -79.06 -20.28 49.24 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.323 0.49 . . . . 0.0 112.323 -178.653 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.579 ' N ' HD23 ' A' ' 124' ' ' LEU . . . -87.91 -67.83 0.8 Allowed 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 -178.716 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' TRP . . . . . 0.522 ' N ' ' CD1' ' A' ' 126' ' ' TRP . 22.9 m0 -84.61 -57.27 3.2 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 -177.789 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . 0.551 ' CD2' ' N ' ' A' ' 127' ' ' HIS . 5.2 m170 -56.09 -22.3 27.16 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.916 -0.314 . . . . 0.0 111.569 -178.755 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.42 -37.21 84.7 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.856 0.36 . . . . 0.0 110.69 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 74.1 t -96.33 -49.47 12.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.209 -179.45 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 6.0 t -111.88 108.41 55.7 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.958 -179.432 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . 0.67 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 73.0 Cg_exo -75.27 -22.11 14.68 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 121.611 1.541 . . . . 0.0 112.379 178.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.67 ' CD ' ' N ' ' A' ' 131' ' ' PRO . 58.8 Cg_exo -67.12 -45.01 4.29 Favored 'Trans proline' 0 N--CA 1.496 1.632 0 C-N-CA 121.42 1.414 . . . . 0.0 112.184 179.782 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -56.3 -37.01 69.31 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.884 0.373 . . . . 0.0 110.459 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -59.72 -24.84 64.33 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.711 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 15.5 ttp-105 -79.32 -30.61 42.9 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.664 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 86.3 mt -71.49 -36.09 71.02 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 179.556 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.58 ' O ' ' N ' ' A' ' 139' ' ' PRO . 6.4 mt -81.47 -39.93 24.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.312 179.548 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.574 ' C ' ' H ' ' A' ' 140' ' ' TYR . 0.7 OUTLIER -17.45 -48.7 0.04 OUTLIER Pre-proline 0 N--CA 1.468 0.47 0 O-C-N 123.921 0.763 . . . . 0.0 111.882 -179.65 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.58 ' N ' ' O ' ' A' ' 137' ' ' LEU . 2.1 Cg_endo -63.74 14.93 0.07 OUTLIER 'Trans proline' 0 C--N 1.308 -1.564 0 C-N-CA 120.91 1.073 . . . . 0.0 111.809 179.518 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.698 ' CE2' HD11 ' A' ' 144' ' ' LEU . 7.0 p90 -92.77 -14.34 28.02 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 121.208 0.528 . . . . 0.0 110.26 179.702 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.637 ' CD1' ' CE1' ' A' ' 140' ' ' TYR . 6.7 mp -59.96 -36.76 77.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.301 178.629 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -55.5 -45.42 77.04 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.091 179.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' TRP . . . . . 0.442 ' CE2' HD12 ' A' ' 52' ' ' ILE . 9.1 t-105 -60.63 -51.57 68.84 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 179.537 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.698 HD11 ' CE2' ' A' ' 140' ' ' TYR . 11.4 mt -50.27 -53.58 27.45 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 120.23 -0.588 . . . . 0.0 109.594 179.366 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.681 ' O ' HG23 ' A' ' 149' ' ' VAL . . . -59.22 -23.01 61.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.269 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 5.1 t80 -67.07 -63.44 1.06 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.693 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.421 ' HB1' ' C20' ' A' ' 201' ' ' PKA . . . -66.51 -35.6 80.64 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.65 -179.698 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 9.7 m -65.58 -39.58 91.78 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.868 -0.333 . . . . 0.0 110.371 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.681 HG23 ' O ' ' A' ' 145' ' ' ALA . 37.7 t -69.17 -36.55 73.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.198 179.733 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 2.1 tp -58.62 -54.26 49.11 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.044 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . 0.441 ' OD1' ' NE1' ' A' ' 107' ' ' TRP . 14.3 t30 -58.58 -55.21 37.99 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.62 179.688 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 69.6 t80 -50.38 -47.27 56.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.214 -179.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 14.4 t80 -56.08 -43.49 78.07 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.953 -179.576 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 84.4 t -68.35 -41.28 83.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.486 -0.324 . . . . 0.0 111.141 -179.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' TRP . . . . . . . . . . . . . 5.3 m0 -58.55 -38.17 77.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.617 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . 0.433 ' HA ' ' HE ' ' A' ' 156' ' ' ARG . 0.0 OUTLIER -81.07 -54.91 5.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.931 -179.51 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 33.2 t0 -51.58 -43.91 62.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.191 -179.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . 0.533 ' O ' ' ND2' ' A' ' 158' ' ' ASN . 0.4 OUTLIER -80.7 -10.85 59.7 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.163 -179.444 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . 0.42 ' C ' ' O ' ' A' ' 158' ' ' ASN . 7.2 m 40.05 85.25 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.792 0.329 . . . . 0.0 110.253 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -77.96 95.23 1.26 Allowed Glycine 0 CA--C 1.525 0.701 0 N-CA-C 111.299 -0.72 . . . . 0.0 111.299 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 77.0 ttt180 -68.01 119.86 13.32 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.77 0.319 . . . . 0.0 110.188 179.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 39.7 ttt180 -91.63 126.69 36.8 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.781 -179.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -171.63 -172.63 37.85 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 110.905 -0.878 . . . . 0.0 110.905 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 151.64 -40.04 0.78 Allowed Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.875 -0.89 . . . . 0.0 110.875 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 16.5 t -178.16 121.54 0.1 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.825 0.345 . . . . 0.0 110.531 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . 0.558 ' C ' HD13 ' A' ' 167' ' ' LEU . 78.8 mtt-85 -83.98 173.07 11.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.684 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.851 HD13 ' N ' ' A' ' 167' ' ' LEU . 0.0 OUTLIER -150.69 22.98 0.79 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.624 179.597 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -102.7 106.48 17.13 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.536 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 . . . . . 0 C--O 1.22 -0.495 0 CA-C-O 118.085 -0.96 . . . . 0.0 110.63 179.934 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' PKA . . . . . 0.54 'CL ' ' C15' ' A' ' 201' ' ' PKA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.5 ttm . . . . . 0 C--O 1.232 0.145 0 CA-C-O 120.863 0.364 . . . . 0.0 110.644 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -60.19 -150.07 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 122.488 2.125 . . . . 0.0 112.027 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -158.53 -51.62 0.06 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.918 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 80.1 p -75.94 135.21 40.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.128 -179.494 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.574 ' O ' HG23 ' A' ' 9' ' ' VAL . 0.5 OUTLIER -54.21 119.07 4.63 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.165 179.717 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.575 ' N ' ' CD ' ' A' ' 7' ' ' PRO . 0.9 OUTLIER -61.1 -41.81 82.97 Favored Pre-proline 0 CA--C 1.533 0.304 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 179.932 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.575 ' CD ' ' N ' ' A' ' 6' ' ' VAL . 17.3 Cg_exo -62.62 -66.41 0.05 OUTLIER 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 121.579 1.519 . . . . 0.0 111.733 179.478 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.675 ' O ' HG23 ' A' ' 12' ' ' THR . . . -48.5 -33.56 9.68 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.339 -179.422 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.574 HG23 ' O ' ' A' ' 5' ' ' TRP . 39.5 t -69.51 -63.24 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 111.76 0.281 . . . . 0.0 111.76 -178.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -60.53 -45.97 95.28 Favored Glycine 0 CA--C 1.526 0.73 0 C-N-CA 121.195 -0.526 . . . . 0.0 111.84 -179.101 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.445 ' N ' HD12 ' A' ' 11' ' ' LEU . 9.3 mp -62.25 -38.31 88.75 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 122.873 -0.193 . . . . 0.0 111.09 -179.264 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.675 HG23 ' O ' ' A' ' 8' ' ' ALA . 36.1 p -73.42 -22.55 60.19 Favored 'General case' 0 C--N 1.332 -0.166 0 C-N-CA 120.298 -0.561 . . . . 0.0 109.924 179.268 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 5.6 mt -76.5 -30.97 57.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.228 179.671 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.9 t -43.53 -55.09 9.04 Favored Pre-proline 0 CA--C 1.534 0.363 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.788 -179.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -66.19 -17.06 54.03 Favored 'Trans proline' 0 N--CA 1.499 1.796 0 C-N-CA 120.925 1.083 . . . . 0.0 111.825 179.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.6 t -75.07 -28.74 60.46 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.551 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 56.5 mt -72.36 -57.82 3.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.433 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -69.78 -21.17 76.46 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 110.865 -0.894 . . . . 0.0 110.865 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -70.59 -54.07 11.08 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 111.008 -0.837 . . . . 0.0 111.008 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 37.7 t80 -70.17 -58.24 4.02 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.787 0.327 . . . . 0.0 110.518 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 20.5 ttp -57.21 -35.99 70.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.762 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -69.78 -62.23 3.94 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 111.121 -0.792 . . . . 0.0 111.121 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.555 ' O ' HG22 ' A' ' 26' ' ' VAL . . . -55.55 -17.14 4.83 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.906 0.384 . . . . 0.0 110.31 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 47.4 t80 -51.26 -25.47 5.72 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.277 179.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 71.8 t80 -67.17 -47.29 71.41 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.507 179.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.555 HG22 ' O ' ' A' ' 23' ' ' ALA . 32.6 m -77.52 -13.94 14.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.379 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.4 tmt_? -67.43 -30.57 70.35 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.743 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -119.45 -69.9 0.32 Allowed Glycine 0 CA--C 1.525 0.691 0 N-CA-C 110.996 -0.841 . . . . 0.0 110.996 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -47.57 -22.63 0.51 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.744 0.307 . . . . 0.0 110.659 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -76.29 -52.15 6.32 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 111.119 -0.792 . . . . 0.0 111.119 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 72.6 mt -53.45 -36.28 61.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.758 0.313 . . . . 0.0 110.625 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 11.3 mmt180 -78.0 -49.89 13.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.809 -179.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -47.53 -31.54 4.45 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 110.101 -0.333 . . . . 0.0 110.101 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.445 ' CD1' ' C ' ' A' ' 34' ' ' TYR . 23.8 t80 -52.82 -39.03 62.09 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.486 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -56.94 -20.77 25.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.28 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -98.01 -73.34 1.11 Allowed Glycine 0 CA--C 1.526 0.749 0 N-CA-C 110.858 -0.897 . . . . 0.0 110.858 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.572 ' O ' HD12 ' A' ' 37' ' ' LEU . 0.3 OUTLIER -96.05 166.9 11.54 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 120.938 0.399 . . . . 0.0 110.898 179.806 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 6.6 mp0 -84.1 117.08 23.22 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.636 -179.713 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.5 ' C ' ' H ' ' A' ' 41' ' ' SER . 6.7 mtpt -126.1 149.57 66.97 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.797 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.608 ' C ' ' H ' ' A' ' 42' ' ' TRP . 59.4 Cg_endo -73.23 23.69 0.31 Allowed 'Trans proline' 0 C--N 1.307 -1.62 0 C-N-CA 121.328 1.352 . . . . 0.0 111.387 179.296 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.5 ' H ' ' C ' ' A' ' 39' ' ' LYS . 1.2 t -51.23 -1.69 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.959 179.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . 0.608 ' H ' ' C ' ' A' ' 40' ' ' PRO . 41.5 p-90 -77.54 -15.99 58.94 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.564 -0.454 . . . . 0.0 111.093 -179.014 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.494 ' O ' ' ND1' ' A' ' 43' ' ' HIS . 0.0 OUTLIER -80.41 147.86 65.08 Favored Pre-proline 0 C--N 1.328 -0.346 0 C-N-CA 120.209 -0.596 . . . . 0.0 109.475 179.419 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.468 ' C ' ' O ' ' A' ' 43' ' ' HIS . 12.6 Cg_exo -32.95 131.04 0.11 Allowed 'Trans proline' 0 C--N 1.311 -1.396 0 C-N-CA 121.423 1.416 . . . . 0.0 111.877 -179.018 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.48 ' O ' ' N ' ' A' ' 47' ' ' TRP . 72.9 Cg_exo -64.98 163.67 27.63 Favored 'Trans proline' 0 C--N 1.312 -1.347 0 C-N-CA 120.888 1.058 . . . . 0.0 112.681 179.722 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 2.7 ppt_? -44.25 -16.18 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.433 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.55 ' CG ' ' N ' ' A' ' 48' ' ' THR . 3.3 p-90 -52.69 -54.08 38.51 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.166 -0.614 . . . . 0.0 111.609 -177.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.55 ' N ' ' CG ' ' A' ' 47' ' ' TRP . 15.0 t -93.86 -21.49 19.23 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 120.25 -0.58 . . . . 0.0 112.076 179.44 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.898 ' O ' HG23 ' A' ' 52' ' ' ILE . 1.0 OUTLIER -81.14 -47.12 13.91 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 112.505 0.557 . . . . 0.0 112.505 -177.89 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.584 ' C ' ' H ' ' A' ' 52' ' ' ILE . . . -39.85 -33.46 0.33 Allowed Pre-proline 0 C--N 1.327 -0.394 0 C-N-CA 120.675 -0.41 . . . . 0.0 111.539 -179.033 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.421 ' HD2' ' N ' ' A' ' 50' ' ' ALA . 56.9 Cg_exo -54.23 4.1 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.522 0 CA-C-N 118.615 0.541 . . . . 0.0 112.587 178.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.898 HG23 ' O ' ' A' ' 49' ' ' LEU . 45.6 pt -53.52 -31.74 19.65 Favored 'Isoleucine or valine' 0 C--O 1.232 0.151 0 CA-C-O 121.211 0.529 . . . . 0.0 109.766 179.423 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.518 ' CE2' HD11 ' A' ' 52' ' ' ILE . 48.2 m95 -81.35 -25.6 36.23 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.814 -179.361 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -69.44 -43.52 69.07 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 178.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 17.3 m -69.15 -59.05 3.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.87 0.367 . . . . 0.0 110.115 179.298 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.422 HD23 ' HA ' ' A' ' 56' ' ' LEU . 96.9 mt -54.19 -33.84 59.11 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.208 -0.451 . . . . 0.0 109.99 179.661 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.442 ' CB ' ' O ' ' A' ' 53' ' ' TRP . 1.7 t80 -59.2 -55.32 36.38 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.751 179.528 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 4.9 t -49.53 -49.66 45.09 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.097 179.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -57.21 -48.38 78.92 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.335 179.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.407 ' O ' ' OG ' ' A' ' 64' ' ' SER . 23.5 mtm -58.17 -33.61 69.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.513 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.501 ' O ' ' OG ' ' A' ' 64' ' ' SER . . . -65.21 -43.23 95.71 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 111.197 -0.761 . . . . 0.0 111.197 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -66.41 -59.99 3.16 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.676 -0.409 . . . . 0.0 110.282 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.439 ' O ' HG23 ' A' ' 67' ' ' VAL . . . -52.48 -50.08 49.43 Favored Glycine 0 CA--C 1.522 0.507 0 N-CA-C 110.32 -1.112 . . . . 0.0 110.32 179.541 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.577 ' O ' ' CE2' ' A' ' 68' ' ' TRP . 6.2 p -45.96 -50.6 14.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.099 0.476 . . . . 0.0 110.321 179.575 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 67.2 t80 -56.48 -40.24 74.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.507 179.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 91.5 mt -65.45 -41.87 92.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.926 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.48 HG22 ' OG ' ' A' ' 130' ' ' SER . 23.4 t -56.56 -53.67 38.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.047 -179.621 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . 0.585 ' O ' ' N ' ' A' ' 73' ' ' GLY . 0.6 OUTLIER -65.27 -35.98 82.71 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 120.577 -0.449 . . . . 0.0 110.839 -179.702 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 13.4 mmmt -63.73 -25.85 68.38 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.798 -0.361 . . . . 0.0 110.677 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 23.1 tp10 -82.65 -62.34 1.63 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.471 -179.369 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.752 ' C ' HD12 ' A' ' 71' ' ' LEU . 3.8 pp -68.59 -8.55 42.85 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.834 -0.347 . . . . 0.0 111.489 -179.222 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.605 ' N ' HD12 ' A' ' 71' ' ' LEU . . . 102.1 83.61 1.74 Allowed Glycine 0 CA--C 1.528 0.891 0 C-N-CA 121.208 -0.52 . . . . 0.0 111.873 179.32 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.585 ' N ' ' O ' ' A' ' 68' ' ' TRP . . . 42.37 -174.08 0.01 OUTLIER Glycine 0 CA--C 1.525 0.683 0 N-CA-C 111.782 -0.527 . . . . 0.0 111.782 179.46 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 38.4 t80 -80.87 110.59 16.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.867 0.365 . . . . 0.0 110.663 -179.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.482 ' OG1' ' N ' ' A' ' 76' ' ' GLU . 2.8 t -142.29 -173.86 3.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.488 179.797 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.482 ' N ' ' OG1' ' A' ' 75' ' ' THR . 2.8 mp0 -47.42 -32.15 4.77 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.679 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 12.8 t0 -71.0 -28.35 64.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.977 -179.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -88.51 -22.92 23.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.8 0.333 . . . . 0.0 110.886 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -66.34 -27.72 68.1 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.723 -179.807 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 8.8 t -68.34 -47.23 37.95 Favored Pre-proline 0 CA--C 1.534 0.338 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.864 -179.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -73.95 -57.03 0.07 OUTLIER 'Trans proline' 0 N--CA 1.499 1.797 0 C-N-CA 121.165 1.243 . . . . 0.0 111.738 179.021 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.491 HD21 ' CZ2' ' A' ' 68' ' ' TRP . 7.7 mt -56.02 -51.43 67.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.543 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -60.95 -61.66 6.75 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 110.805 -0.918 . . . . 0.0 110.805 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 58.7 tp -46.96 -33.51 4.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.929 0.395 . . . . 0.0 110.269 179.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.454 ' C ' ' CD1' ' A' ' 85' ' ' TYR . 2.0 t80 -73.89 -47.27 39.23 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.703 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 1.3 m -60.82 -49.0 79.23 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.91 -0.316 . . . . 0.0 111.146 -179.49 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -69.84 -58.33 6.39 Favored Glycine 0 CA--C 1.527 0.798 0 C-N-CA 120.95 -0.643 . . . . 0.0 111.615 -179.421 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 37.7 tp60 -51.99 -46.28 64.83 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 120.728 -0.389 . . . . 0.0 110.374 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.415 ' O ' ' C ' ' A' ' 90' ' ' ALA . 25.4 tp -53.71 -65.32 0.59 Allowed 'General case' 0 C--O 1.214 -0.803 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 179.566 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.663 ' O ' ' HB2' ' A' ' 94' ' ' ALA . . . -38.58 -44.32 0.96 Allowed 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 120.533 -0.467 . . . . 0.0 111.637 -179.64 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 80.3 mt -59.57 -56.86 16.6 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 -178.529 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 8.7 m-20 -75.89 -54.37 7.01 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 121.286 0.565 . . . . 0.0 111.428 -178.588 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . 0.677 ' O ' ' N ' ' A' ' 95' ' ' TRP . 3.6 t-105 -52.5 -28.98 22.7 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.265 -0.879 . . . . 0.0 111.583 -179.665 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.663 ' HB2' ' O ' ' A' ' 90' ' ' ALA . . . -52.06 73.38 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.846 0.355 . . . . 0.0 110.727 -179.494 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.683 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 13.9 p-90 -102.32 -18.7 0.19 Allowed Pre-proline 0 CA--C 1.534 0.332 0 CA-C-N 115.991 -0.55 . . . . 0.0 112.049 -179.621 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.683 ' CD ' ' N ' ' A' ' 95' ' ' TRP . 31.6 Cg_exo -59.79 -31.08 93.47 Favored 'Trans proline' 0 N--CA 1.494 1.502 0 C-N-CA 120.353 0.702 . . . . 0.0 112.819 179.785 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.491 ' C ' ' H ' ' A' ' 99' ' ' PHE . 75.5 Cg_exo -53.36 -28.11 42.2 Favored 'Trans proline' 0 N--CA 1.492 1.436 0 C-N-CA 120.431 0.754 . . . . 0.0 112.583 179.671 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 1.2 pp -75.42 18.79 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 121.167 0.508 . . . . 0.0 110.173 179.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.491 ' H ' ' C ' ' A' ' 97' ' ' PRO . 4.5 t80 -38.98 -41.74 0.79 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.814 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -84.59 -44.49 13.46 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.829 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -59.8 -5.37 3.98 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 111.368 -0.693 . . . . 0.0 111.368 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -75.95 -13.46 60.25 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 121.016 -0.274 . . . . 0.0 110.971 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 24.2 ptt180 -80.25 3.31 21.27 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.775 0.321 . . . . 0.0 110.639 -179.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 5.2 mt-30 -120.92 160.29 23.79 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.321 179.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -49.4 -19.82 0.59 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.822 0.344 . . . . 0.0 110.205 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.538 ' O ' ' N ' ' A' ' 108' ' ' ALA . . . -65.38 -15.6 61.54 Favored Glycine 0 CA--C 1.527 0.788 0 N-CA-C 111.305 -0.718 . . . . 0.0 111.305 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' TRP . . . . . 0.49 ' CD1' ' N ' ' A' ' 108' ' ' ALA . 0.0 OUTLIER -45.29 -13.6 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.789 0.328 . . . . 0.0 110.844 -179.665 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.538 ' N ' ' O ' ' A' ' 106' ' ' GLY . . . -64.64 -21.84 66.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.511 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 12.1 mt -52.18 -27.16 13.46 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.405 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.417 ' HB3' ' C22' ' A' ' 201' ' ' PKA . . . -55.84 -63.82 1.05 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.345 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.683 ' O ' HG23 ' A' ' 115' ' ' VAL . 2.0 p30 -60.37 -51.65 68.6 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.598 -179.609 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.581 ' N ' ' OD1' ' A' ' 111' ' ' ASP . 43.3 tp -52.51 -42.35 64.24 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.552 -178.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 81.5 mt -71.66 -61.93 1.6 Allowed 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.701 0.63 . . . . 0.0 112.701 -178.269 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.403 ' HB2' ' CZ3' ' A' ' 93' ' ' TRP . 1.8 pp -57.39 -35.18 69.67 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 120.117 -0.633 . . . . 0.0 111.116 -178.811 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.683 HG23 ' O ' ' A' ' 111' ' ' ASP . 54.6 t -62.13 -58.47 7.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.262 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 3.5 t -68.73 -22.37 64.33 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.79 -178.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -68.56 -62.71 3.93 Favored Glycine 0 CA--C 1.526 0.746 0 C-N-CA 121.011 -0.614 . . . . 0.0 111.745 -179.03 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.563 ' O ' HG23 ' A' ' 122' ' ' THR . 7.4 p -70.47 -37.73 71.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 C-N-CA 120.967 -0.293 . . . . 0.0 111.354 -179.421 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.515 ' O ' ' OG1' ' A' ' 123' ' ' THR . . . -66.47 -60.78 2.43 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 120.54 -0.464 . . . . 0.0 111.533 -179.21 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 5.0 m -58.38 -55.01 40.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.696 -179.202 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -52.48 -41.69 63.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.349 -179.248 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.563 HG23 ' O ' ' A' ' 118' ' ' VAL . 36.5 p -72.19 -32.59 66.94 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.823 -0.351 . . . . 0.0 111.615 -179.156 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.515 ' OG1' ' O ' ' A' ' 119' ' ' ALA . 0.2 OUTLIER -61.55 -50.16 73.79 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.908 0.385 . . . . 0.0 110.868 -179.489 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.6 pp -82.56 -20.0 37.44 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.701 -179.014 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -86.49 -70.69 0.59 Allowed 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 112.659 0.614 . . . . 0.0 112.659 -178.567 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' TRP . . . . . 0.403 ' N ' ' CD1' ' A' ' 126' ' ' TRP . 41.8 m0 -85.18 -58.8 2.54 Favored 'General case' 0 N--CA 1.465 0.325 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 -177.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . 0.433 ' CD2' ' N ' ' A' ' 127' ' ' HIS . 20.2 m170 -47.99 -21.52 0.46 Allowed 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 120.719 -0.392 . . . . 0.0 111.522 -178.546 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 29.6 ttt85 -73.1 -42.48 62.91 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.974 -0.29 . . . . 0.0 111.456 -179.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 6.3 t -92.07 -47.88 13.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.717 0.294 . . . . 0.0 111.332 -179.309 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . 0.48 ' OG ' HG22 ' A' ' 67' ' ' VAL . 46.2 p -109.59 102.77 51.11 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.817 -179.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . 0.657 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 75.7 Cg_exo -71.05 -26.26 21.77 Favored 'Trans proline' 0 C--N 1.311 -1.444 0 C-N-CA 121.733 1.622 . . . . 0.0 112.465 179.43 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.657 ' CD ' ' N ' ' A' ' 131' ' ' PRO . 38.2 Cg_exo -68.62 -49.43 0.81 Allowed 'Trans proline' 0 N--CA 1.494 1.523 0 C-N-CA 121.496 1.464 . . . . 0.0 111.877 179.796 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.406 ' C ' ' N ' ' A' ' 135' ' ' ARG . . . -46.67 -49.02 19.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.191 179.774 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.428 ' HB2' ' CD2' ' A' ' 127' ' ' HIS . . . -46.7 -22.35 0.29 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.031 179.628 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . 0.406 ' N ' ' C ' ' A' ' 133' ' ' ALA . 5.7 tpp85 -78.41 -39.2 39.63 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.541 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 93.1 mt -68.87 -25.94 64.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.259 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.571 ' O ' ' N ' ' A' ' 140' ' ' TYR . 3.2 mt -89.11 -41.8 12.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.935 179.477 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.516 ' C ' ' H ' ' A' ' 140' ' ' TYR . 0.7 OUTLIER -22.11 -47.68 0.06 OUTLIER Pre-proline 0 N--CA 1.464 0.261 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.782 -179.776 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.483 ' N ' ' O ' ' A' ' 137' ' ' LEU . 3.1 Cg_exo -59.66 5.57 0.12 Allowed 'Trans proline' 0 C--N 1.307 -1.621 0 C-N-CA 121.071 1.18 . . . . 0.0 112.256 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.817 ' CE2' HD11 ' A' ' 144' ' ' LEU . 1.9 p90 -90.78 -15.33 30.31 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 120.705 -0.398 . . . . 0.0 110.644 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.637 HD22 ' CE1' ' A' ' 140' ' ' TYR . 2.9 mm? -54.17 -36.0 62.91 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 179.216 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -57.47 -53.98 52.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.378 179.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' TRP . . . . . 0.44 ' CE2' HD12 ' A' ' 52' ' ' ILE . 11.7 t-105 -51.06 -48.9 61.46 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 116.318 -0.401 . . . . 0.0 109.939 179.793 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.817 HD11 ' CE2' ' A' ' 140' ' ' TYR . 11.4 mt -50.09 -48.29 53.35 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 120.533 -0.467 . . . . 0.0 109.832 179.558 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.619 ' O ' HG23 ' A' ' 149' ' ' VAL . . . -65.12 -30.52 71.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.699 -179.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 21.0 t80 -58.93 -62.19 2.07 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.73 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.49 ' O ' ' OD1' ' A' ' 151' ' ' ASN . . . -67.74 -50.4 57.51 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.6 -0.44 . . . . 0.0 110.648 -179.708 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . 0.401 ' OG1' ' O ' ' A' ' 144' ' ' LEU . 27.0 m -48.91 -44.61 40.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.842 -179.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.619 HG23 ' O ' ' A' ' 145' ' ' ALA . 68.7 t -69.08 -36.11 71.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.127 -179.683 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.482 HD11 ' CD2' ' A' ' 43' ' ' HIS . 0.8 OUTLIER -56.24 -51.5 67.9 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.535 -0.466 . . . . 0.0 110.696 -179.334 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . 0.49 ' OD1' ' O ' ' A' ' 147' ' ' ALA . 4.6 p-10 -65.3 -48.83 71.73 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.945 -0.302 . . . . 0.0 111.055 -179.741 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 82.7 t80 -53.86 -49.17 69.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.931 -179.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . 0.56 ' CE2' ' OD2' ' A' ' 157' ' ' ASP . 79.5 t80 -57.35 -45.56 84.22 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.644 -179.719 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.471 HG23 ' O ' ' A' ' 150' ' ' LEU . 94.4 t -63.7 -33.68 63.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.096 -179.699 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' TRP . . . . . 0.551 ' C ' ' HE ' ' A' ' 156' ' ' ARG . 9.5 m0 -62.3 -49.69 74.64 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.647 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . 0.601 ' HE ' ' N ' ' A' ' 156' ' ' ARG . 0.0 OUTLIER -71.02 -32.63 69.44 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.871 -179.639 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . 0.56 ' OD2' ' CE2' ' A' ' 153' ' ' TYR . 2.6 m-20 -74.85 -47.85 28.12 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.823 -179.785 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -70.17 -39.29 75.37 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.61 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 96.6 p -70.89 96.5 1.28 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.471 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -71.15 68.7 0.85 Allowed Glycine 0 CA--C 1.525 0.715 0 N-CA-C 111.199 -0.76 . . . . 0.0 111.199 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 7.3 tpm_? -56.87 -36.58 70.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.867 0.365 . . . . 0.0 110.418 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.2 123.62 12.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.302 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -175.75 176.46 47.49 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 111.02 -0.832 . . . . 0.0 111.02 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . 0.545 ' O ' ' N ' ' A' ' 166' ' ' ARG . . . 57.06 111.5 0.01 OUTLIER Glycine 0 CA--C 1.526 0.779 0 N-CA-C 111.022 -0.831 . . . . 0.0 111.022 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 13.1 t -61.48 70.83 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.766 0.317 . . . . 0.0 110.551 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . 0.549 ' C ' HD13 ' A' ' 167' ' ' LEU . 68.8 mtp180 58.02 170.0 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.545 -179.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.837 HD13 ' N ' ' A' ' 167' ' ' LEU . 0.0 OUTLIER -150.06 17.99 0.87 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.804 179.621 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.467 ' O ' ' C ' ' A' ' 169' ' ' GLU . . . -97.34 88.04 4.31 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.421 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . 0.467 ' C ' ' O ' ' A' ' 168' ' ' ALA . 4.4 pt-20 . . . . . 0 C--O 1.22 -0.459 0 CA-C-O 117.956 -1.021 . . . . 0.0 110.912 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' PKA . . . . . 0.569 'CL ' ' C15' ' A' ' 201' ' ' PKA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 35.1 mtt . . . . . 0 CA--C 1.529 0.14 0 CA-C-O 120.751 0.31 . . . . 0.0 110.446 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -78.4 80.84 2.91 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.05 1.833 . . . . 0.0 112.005 179.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -130.12 -23.86 2.68 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.55 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 20.1 p -143.56 121.59 12.1 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.677 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.644 ' O ' HG23 ' A' ' 9' ' ' VAL . 1.3 t-105 -61.53 118.18 6.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.861 179.676 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.465 ' N ' ' CD ' ' A' ' 7' ' ' PRO . 1.0 OUTLIER -59.38 -42.08 90.59 Favored Pre-proline 0 CA--C 1.537 0.464 0 C-N-CA 120.564 -0.454 . . . . 0.0 110.492 -179.439 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.465 ' CD ' ' N ' ' A' ' 6' ' ' VAL . 23.0 Cg_exo -64.9 -65.91 0.05 OUTLIER 'Trans proline' 0 N--CA 1.493 1.498 0 C-N-CA 120.909 1.072 . . . . 0.0 111.611 179.498 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.728 ' O ' HG23 ' A' ' 12' ' ' THR . . . -47.46 -37.74 12.29 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.208 -179.581 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.644 HG23 ' O ' ' A' ' 5' ' ' TRP . 42.4 t -63.12 -62.08 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 C-N-CA 121.048 -0.261 . . . . 0.0 111.404 -179.337 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -58.25 -49.85 72.0 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 110.858 -0.897 . . . . 0.0 110.858 -179.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 10.8 mp -59.08 -27.8 65.88 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.596 0.236 . . . . 0.0 110.65 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.728 HG23 ' O ' ' A' ' 8' ' ' ALA . 13.5 p -83.0 -20.73 34.54 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.783 -0.367 . . . . 0.0 110.238 179.566 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 9.3 mt -80.35 -26.42 38.7 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 179.343 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 18.9 t -54.95 -57.38 19.77 Favored Pre-proline 0 CA--C 1.533 0.305 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.033 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -55.84 -10.46 4.04 Favored 'Trans proline' 0 N--CA 1.497 1.711 0 C-N-CA 120.754 0.969 . . . . 0.0 111.651 179.503 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.488 ' N ' ' OH ' ' A' ' 57' ' ' TYR . 1.8 t -74.61 -33.63 62.63 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.19 179.708 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 32.1 mt -73.58 -39.42 64.67 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.63 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -77.04 -49.91 7.23 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 111.263 -0.735 . . . . 0.0 111.263 -179.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -62.58 -34.69 90.28 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 111.306 -0.717 . . . . 0.0 111.306 -179.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 81.8 t80 -73.36 -60.1 2.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.742 0.306 . . . . 0.0 111.102 -179.462 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 32.4 tpp -61.6 -20.9 63.84 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.74 -179.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.525 ' C ' ' CZ2' ' A' ' 95' ' ' TRP . . . -75.13 -63.76 2.45 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 111.656 -0.577 . . . . 0.0 111.656 -179.533 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.44 ' O ' HG22 ' A' ' 26' ' ' VAL . . . -66.3 -16.43 64.03 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.706 -0.397 . . . . 0.0 110.817 -179.474 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 54.2 t80 -48.67 -24.41 1.36 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.111 0.481 . . . . 0.0 110.004 179.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 55.2 t80 -70.1 -50.73 37.91 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.947 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.44 HG22 ' O ' ' A' ' 23' ' ' ALA . 22.8 m -74.6 -13.29 15.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.877 -179.664 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.65 ' NE ' ' HE ' ' A' ' 46' ' ' ARG . 8.9 ttt85 -55.7 -41.45 73.78 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.893 -179.795 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -122.51 -57.99 0.2 Allowed Glycine 0 CA--C 1.526 0.746 0 N-CA-C 111.444 -0.663 . . . . 0.0 111.444 -179.585 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 20.8 tp10 -56.35 -23.0 34.62 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.709 0.29 . . . . 0.0 110.796 -179.664 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -76.62 -53.69 5.34 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 111.072 -0.811 . . . . 0.0 111.072 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.414 ' N ' HD12 ' A' ' 31' ' ' LEU . 9.9 mp -56.39 -24.94 48.01 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.774 0.321 . . . . 0.0 110.424 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 71.1 ttt180 -81.55 -52.57 7.07 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.352 179.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -46.59 -36.06 6.51 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.962 179.709 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 27.1 t80 -47.81 -38.82 16.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.599 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -63.51 -24.61 67.89 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.797 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -89.32 -72.08 1.26 Allowed Glycine 0 CA--C 1.526 0.728 0 N-CA-C 110.981 -0.848 . . . . 0.0 110.981 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.573 ' O ' HD12 ' A' ' 37' ' ' LEU . 0.3 OUTLIER -95.69 167.17 11.44 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.761 0.315 . . . . 0.0 110.672 179.602 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 47.2 mm-40 -80.91 112.65 18.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.0 -179.502 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.543 ' NZ ' ' CZ3' ' A' ' 107' ' ' TRP . 12.0 mtpt -129.79 156.54 78.76 Favored Pre-proline 0 N--CA 1.463 0.213 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.214 179.535 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.626 ' C ' ' H ' ' A' ' 42' ' ' TRP . 73.9 Cg_endo -81.43 23.45 0.75 Allowed 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 121.578 1.518 . . . . 0.0 111.189 179.072 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 30.4 m -49.96 -1.27 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.193 179.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . 0.626 ' H ' ' C ' ' A' ' 40' ' ' PRO . 2.7 p90 -76.19 -15.4 60.06 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.558 -0.457 . . . . 0.0 111.171 -178.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.469 ' O ' ' O ' ' A' ' 44' ' ' PRO . 22.5 m-70 -62.95 144.04 97.19 Favored Pre-proline 0 C--N 1.33 -0.262 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 178.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.469 ' O ' ' O ' ' A' ' 43' ' ' HIS . 50.7 Cg_exo -32.2 153.74 0.02 OUTLIER 'Trans proline' 0 N--CA 1.492 1.419 0 C-N-CA 121.444 1.429 . . . . 0.0 111.708 -179.199 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -60.68 153.16 64.04 Favored 'Trans proline' 0 C--N 1.308 -1.565 0 C-N-CA 120.644 0.896 . . . . 0.0 111.344 179.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.65 ' HE ' ' NE ' ' A' ' 27' ' ' ARG . 0.0 OUTLIER -50.01 -15.84 0.24 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.307 -179.727 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.556 ' CD1' ' N ' ' A' ' 48' ' ' THR . 0.7 OUTLIER -54.34 -47.87 72.05 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.664 -0.414 . . . . 0.0 111.793 -178.309 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.556 ' N ' ' CD1' ' A' ' 47' ' ' TRP . 8.9 t -91.2 -25.96 19.27 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -179.472 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.81 ' O ' HG23 ' A' ' 52' ' ' ILE . 0.2 OUTLIER -80.53 -58.84 2.93 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.623 -0.431 . . . . 0.0 111.884 -178.412 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.609 ' C ' ' H ' ' A' ' 52' ' ' ILE . . . -38.74 -31.04 0.19 Allowed Pre-proline 0 C--O 1.234 0.257 0 C-N-CA 120.751 -0.38 . . . . 0.0 111.311 -179.133 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.439 ' HD2' ' N ' ' A' ' 50' ' ' ALA . 46.6 Cg_exo -54.19 5.18 0.04 OUTLIER 'Trans proline' 0 C--N 1.31 -1.471 0 CA-C-N 118.691 0.568 . . . . 0.0 112.422 178.2 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.81 HG23 ' O ' ' A' ' 49' ' ' LEU . 10.4 pt -54.29 -39.2 42.49 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.258 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 179.344 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.621 ' O ' ' CD1' ' A' ' 57' ' ' TYR . 65.7 m95 -69.32 -24.45 63.92 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.746 -179.583 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -67.83 -53.2 24.65 Favored Glycine 0 CA--C 1.527 0.836 0 N-CA-C 110.013 -1.235 . . . . 0.0 110.013 179.002 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 18.6 m -60.02 -54.73 42.56 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.623 0.249 . . . . 0.0 110.581 179.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.408 ' O ' ' SD ' ' A' ' 60' ' ' MET . 88.5 mt -55.82 -47.96 76.27 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.254 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.621 ' CD1' ' O ' ' A' ' 53' ' ' TRP . 3.6 m-30 -46.19 -47.13 17.79 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 179.31 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 7.0 t -56.77 -57.28 13.14 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.215 179.479 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -48.7 -50.06 35.1 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.183 179.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.408 ' SD ' ' O ' ' A' ' 56' ' ' LEU . 0.0 OUTLIER -52.05 -50.56 61.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.368 179.828 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -49.13 -48.96 31.46 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 111.338 -0.705 . . . . 0.0 111.338 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -62.17 -59.93 4.32 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.849 0.357 . . . . 0.0 110.85 -179.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.452 ' O ' HG23 ' A' ' 67' ' ' VAL . . . -47.47 -56.02 8.67 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 110.93 -0.868 . . . . 0.0 110.93 -179.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.588 ' O ' ' CD1' ' A' ' 68' ' ' TRP . 0.0 OUTLIER -45.64 -55.28 6.57 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.898 0.38 . . . . 0.0 110.664 -179.929 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.501 ' OH ' ' NZ ' ' A' ' 69' ' ' LYS . 69.1 t80 -49.73 -40.0 39.27 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.804 -179.674 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 77.4 mt -69.3 -54.84 17.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.257 -179.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.509 ' CG1' ' CZ3' ' A' ' 68' ' ' TRP . 18.8 t -46.16 -61.23 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.857 0.36 . . . . 0.0 111.257 -179.39 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . 0.588 ' CD1' ' O ' ' A' ' 64' ' ' SER . 0.9 OUTLIER -60.68 -42.31 96.84 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.485 -179.124 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.501 ' NZ ' ' OH ' ' A' ' 65' ' ' TYR . 5.8 mmmt -59.13 -31.92 69.39 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.979 -0.288 . . . . 0.0 111.052 -179.697 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 24.2 tp10 -74.81 -62.28 1.59 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.037 -179.366 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.739 ' C ' HD12 ' A' ' 71' ' ' LEU . 3.4 pp -64.33 -8.58 13.54 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.239 -179.344 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.655 ' N ' HD12 ' A' ' 71' ' ' LEU . . . 110.35 77.51 0.93 Allowed Glycine 0 CA--C 1.527 0.826 0 C-N-CA 121.014 -0.612 . . . . 0.0 111.98 179.359 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.511 ' N ' ' O ' ' A' ' 68' ' ' TRP . . . 41.56 -173.57 0.01 OUTLIER Glycine 0 CA--C 1.526 0.749 0 C-N-CA 121.504 -0.379 . . . . 0.0 112.165 178.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 36.0 t80 -74.48 113.05 11.27 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.382 -0.409 . . . . 0.0 110.715 -179.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.569 ' OG1' ' N ' ' A' ' 76' ' ' GLU . 0.4 OUTLIER -142.38 -175.02 4.29 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.256 179.713 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.569 ' N ' ' OG1' ' A' ' 75' ' ' THR . 2.7 mp0 -55.08 -34.22 63.45 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.916 0.389 . . . . 0.0 110.4 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -66.29 -33.06 74.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.67 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.494 ' O ' HD12 ' A' ' 82' ' ' LEU . . . -83.91 -19.09 35.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.046 0.45 . . . . 0.0 110.748 -179.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 65.0 mmm -68.93 -27.07 65.43 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.22 -179.344 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.4 ' N ' ' HD2' ' A' ' 81' ' ' PRO . 6.0 t -67.45 -43.51 42.48 Favored Pre-proline 0 C--N 1.329 -0.322 0 C-N-CA 120.673 -0.411 . . . . 0.0 110.413 179.781 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.4 ' HD2' ' N ' ' A' ' 80' ' ' VAL . 9.3 Cg_endo -76.31 -52.18 0.09 OUTLIER 'Trans proline' 0 N--CA 1.496 1.673 0 C-N-CA 121.047 1.165 . . . . 0.0 111.508 178.643 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.494 HD12 ' O ' ' A' ' 78' ' ' ALA . 5.5 mt -56.03 -47.14 78.39 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.277 179.71 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -68.28 -63.83 3.4 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 111.318 -0.713 . . . . 0.0 111.318 -179.517 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.4 HD23 ' CD1' ' A' ' 124' ' ' LEU . 38.5 tp -47.91 -23.79 0.86 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.941 0.4 . . . . 0.0 110.57 -179.708 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 11.8 t80 -74.8 -55.57 5.68 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.009 -179.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 1.9 t -68.53 -33.22 73.73 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.903 -0.319 . . . . 0.0 111.479 -179.282 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -71.6 -57.85 5.74 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 111.205 -0.758 . . . . 0.0 111.205 -179.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 29.2 tp60 -59.57 -43.85 93.49 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 11.1 tp -58.13 -38.57 76.8 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 179.241 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.816 ' O ' ' HB2' ' A' ' 94' ' ' ALA . . . -58.36 -64.48 0.9 Allowed 'General case' 0 C--N 1.319 -0.754 0 C-N-CA 120.062 -0.655 . . . . 0.0 110.435 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.476 HD23 ' N ' ' A' ' 91' ' ' LEU . 6.2 mt -58.69 -56.48 21.64 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 -178.688 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -66.43 -62.12 1.63 Allowed 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -177.755 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . 0.596 ' C ' ' CD1' ' A' ' 93' ' ' TRP . 0.0 OUTLIER -63.54 -16.89 62.05 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 -177.913 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.816 ' HB2' ' O ' ' A' ' 90' ' ' ALA . . . -54.63 82.19 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 120.286 -0.566 . . . . 0.0 109.868 179.155 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.688 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 19.8 p-90 -100.81 -15.71 0.18 Allowed Pre-proline 0 CA--C 1.533 0.307 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -179.488 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.688 ' CD ' ' N ' ' A' ' 95' ' ' TRP . 52.9 Cg_exo -61.08 -15.22 37.97 Favored 'Trans proline' 0 N--CA 1.497 1.7 0 C-N-CA 120.471 0.781 . . . . 0.0 113.403 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.614 ' CD ' ' N ' ' A' ' 96' ' ' PRO . 31.6 Cg_exo -87.08 -0.38 7.77 Favored 'Trans proline' 0 N--CA 1.5 1.867 0 C-N-CA 120.659 0.906 . . . . 0.0 112.928 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 1.3 pp -91.86 25.19 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 C-N-CA 120.73 -0.388 . . . . 0.0 110.833 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.528 ' CD1' ' O ' ' A' ' 96' ' ' PRO . 3.0 m-85 -46.8 -34.46 5.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.167 179.687 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -63.13 -27.39 69.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.786 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -95.73 -13.52 50.19 Favored Glycine 0 CA--C 1.526 0.743 0 N-CA-C 110.902 -0.879 . . . . 0.0 110.902 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -70.49 -6.73 38.2 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.613 0.244 . . . . 0.0 111.018 -179.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 15.5 ptt180 -97.97 -10.08 25.08 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.065 -179.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . 0.438 ' C ' ' N ' ' A' ' 106' ' ' GLY . 3.2 pt20 -125.49 168.94 12.93 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.832 0.348 . . . . 0.0 110.781 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 9.8 mmt -45.19 -20.2 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.679 -179.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.438 ' N ' ' C ' ' A' ' 104' ' ' GLN . . . -62.26 -15.69 51.94 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 111.102 -0.799 . . . . 0.0 111.102 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' TRP . . . . . 0.543 ' CZ3' ' NZ ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -50.2 -13.42 0.11 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.742 0.306 . . . . 0.0 110.702 -179.596 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.468 ' N ' ' CD1' ' A' ' 107' ' ' TRP . . . -64.73 -19.58 65.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.075 0.464 . . . . 0.0 110.105 179.638 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 8.2 mt -57.04 -26.04 59.64 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.531 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -59.4 -58.66 7.62 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.569 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.709 ' O ' HG23 ' A' ' 115' ' ' VAL . 1.3 p30 -62.07 -52.21 64.84 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.303 -179.617 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.524 ' N ' ' CG ' ' A' ' 111' ' ' ASP . 31.7 tp -54.95 -37.4 66.42 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.919 -0.313 . . . . 0.0 111.618 -179.099 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 49.4 mt -72.8 -61.57 1.76 Allowed 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -178.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.5 pp -59.66 -32.52 70.54 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 120.24 -0.584 . . . . 0.0 110.955 -179.047 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.709 HG23 ' O ' ' A' ' 111' ' ' ASP . 53.5 t -64.16 -60.14 3.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.405 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.485 ' O ' ' OG1' ' A' ' 120' ' ' THR . 50.3 m -68.41 -28.31 66.97 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.555 -178.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -63.08 -62.24 5.63 Favored Glycine 0 CA--C 1.526 0.759 0 C-N-CA 120.973 -0.632 . . . . 0.0 111.769 -179.348 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.571 ' O ' HG23 ' A' ' 122' ' ' THR . 9.3 p -70.94 -37.99 70.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 111.667 0.247 . . . . 0.0 111.667 -179.231 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.508 ' O ' ' OG1' ' A' ' 123' ' ' THR . . . -68.25 -60.8 2.19 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.446 -0.502 . . . . 0.0 111.002 -179.404 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.485 ' OG1' ' O ' ' A' ' 116' ' ' SER . 3.7 m -56.35 -55.87 28.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.44 -179.49 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -51.58 -43.92 62.61 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.404 -179.391 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.571 HG23 ' O ' ' A' ' 118' ' ' VAL . 41.4 p -71.91 -25.25 61.84 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.054 0.39 . . . . 0.0 112.054 -178.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.508 ' OG1' ' O ' ' A' ' 119' ' ' ALA . 0.2 OUTLIER -69.28 -49.99 51.0 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.631 -0.428 . . . . 0.0 110.516 -179.636 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.4 ' CD1' HD23 ' A' ' 84' ' ' LEU . 2.4 pp -79.34 -19.94 49.05 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.246 -179.475 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -89.77 -67.37 0.85 Allowed 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.734 0.642 . . . . 0.0 112.734 -178.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' TRP . . . . . 0.458 ' N ' ' CD1' ' A' ' 126' ' ' TRP . 34.1 m0 -84.82 -57.54 3.07 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 112.87 0.693 . . . . 0.0 112.87 -177.785 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . 0.657 ' CD2' ' HB2' ' A' ' 134' ' ' ALA . 9.6 m170 -53.98 -22.29 10.08 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.731 -0.388 . . . . 0.0 111.517 -178.703 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 29.2 ttt85 -73.76 -46.47 45.5 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.822 -0.351 . . . . 0.0 111.416 -179.474 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 39.1 t -81.36 -40.62 18.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.73 0.3 . . . . 0.0 111.313 -179.229 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 3.6 t -138.38 121.66 11.15 Favored Pre-proline 0 CA--C 1.536 0.428 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.541 -179.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . 0.612 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 83.4 Cg_exo -73.61 -48.35 0.25 Allowed 'Trans proline' 0 N--CA 1.493 1.488 0 C-N-CA 121.32 1.347 . . . . 0.0 113.212 179.529 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.612 ' CD ' ' N ' ' A' ' 131' ' ' PRO . 31.2 Cg_exo -33.63 -55.97 0.41 Allowed 'Trans proline' 0 N--CA 1.497 1.73 0 C-N-CA 121.583 1.522 . . . . 0.0 112.177 -179.222 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -47.48 -46.69 27.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.862 0.363 . . . . 0.0 110.384 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.657 ' HB2' ' CD2' ' A' ' 127' ' ' HIS . . . -55.21 -22.72 18.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.406 179.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 10.2 tpt180 -77.28 -29.63 53.88 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-O 120.937 0.399 . . . . 0.0 110.342 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 39.4 mt -75.92 -33.97 59.88 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 179.604 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.461 ' O ' ' CD1' ' A' ' 140' ' ' TYR . 4.3 mt -85.56 -23.31 27.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.341 179.778 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.551 ' C ' ' CD1' ' A' ' 138' ' ' TYR . 0.3 OUTLIER -36.65 -53.9 1.74 Allowed Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.323 -179.881 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.429 ' HD2' ' N ' ' A' ' 138' ' ' TYR . 8.2 Cg_endo -60.79 3.41 0.29 Allowed 'Trans proline' 0 N--CA 1.498 1.755 0 C-N-CA 121.481 1.454 . . . . 0.0 113.057 -179.415 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.496 ' CE2' HD11 ' A' ' 144' ' ' LEU . 0.1 OUTLIER -82.79 -14.3 54.67 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.489 -0.484 . . . . 0.0 110.954 -179.96 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 86.8 mt -59.14 -25.25 63.72 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 178.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -64.13 -39.84 94.89 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.631 179.224 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' TRP . . . . . 0.714 ' CE2' HD12 ' A' ' 52' ' ' ILE . 11.6 t-105 -70.08 -40.78 74.81 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.723 179.441 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.531 HD13 HG13 ' A' ' 115' ' ' VAL . 10.3 mt -62.48 -42.02 99.2 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 120.403 -0.519 . . . . 0.0 109.712 179.739 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.68 ' O ' HG23 ' A' ' 149' ' ' VAL . . . -73.03 -21.91 60.73 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.776 179.268 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 32.2 t80 -64.85 -58.58 5.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.481 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.558 ' O ' ' ND2' ' A' ' 151' ' ' ASN . . . -68.5 -44.15 75.34 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.567 179.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . 0.478 ' O ' ' OD1' ' A' ' 151' ' ' ASN . 51.3 m -57.27 -37.3 72.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.411 179.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.68 HG23 ' O ' ' A' ' 145' ' ' ALA . 55.0 t -75.8 -30.2 21.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.416 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 2.3 tp -61.39 -57.49 12.04 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 179.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . 0.558 ' ND2' ' O ' ' A' ' 147' ' ' ALA . 1.8 p30 -63.81 -42.36 97.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.632 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 60.8 t80 -56.65 -45.86 81.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.552 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 9.5 t80 -63.18 -36.72 84.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.477 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 55.5 t -67.36 -34.0 66.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.632 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' TRP . . . . . . . . . . . . . 10.9 m0 -68.7 -41.12 79.57 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.791 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . 0.487 ' O ' ' O ' ' A' ' 159' ' ' SER . 0.3 OUTLIER -72.63 -35.61 67.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.865 -179.659 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -75.18 -43.03 54.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.878 -179.571 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . 0.402 ' OD1' ' N ' ' A' ' 158' ' ' ASN . 1.5 m-20 -79.07 -4.02 48.18 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.872 -179.711 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . 0.487 ' O ' ' O ' ' A' ' 156' ' ' ARG . 6.6 t -149.49 -161.5 1.36 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.534 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 81.35 47.18 6.56 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 110.98 -0.848 . . . . 0.0 110.98 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 24.5 ttt-85 -42.67 122.82 2.44 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.795 0.331 . . . . 0.0 110.612 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 15.6 mtm180 -99.08 145.55 27.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.508 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -79.44 145.52 27.95 Favored Glycine 0 CA--C 1.524 0.602 0 N-CA-C 111.025 -0.83 . . . . 0.0 111.025 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 75.95 -176.8 50.87 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 111.123 -0.791 . . . . 0.0 111.123 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 25.7 t -147.13 113.54 5.95 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.808 0.337 . . . . 0.0 110.429 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . 0.523 ' O ' ' N ' ' A' ' 168' ' ' ALA . 3.5 tpt180 -49.98 167.05 0.06 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.548 -179.795 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.418 ' N ' HD12 ' A' ' 167' ' ' LEU . 10.8 mp 58.48 -77.72 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.657 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.523 ' N ' ' O ' ' A' ' 166' ' ' ARG . . . -55.65 -15.17 2.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.667 -179.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 . . . . . 0 C--O 1.219 -0.526 0 CA-C-O 118.007 -0.997 . . . . 0.0 110.595 179.965 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' PKA . . . . . 0.478 'CL ' ' C15' ' A' ' 201' ' ' PKA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.641 ' N ' ' CD ' ' A' ' 2' ' ' PRO . 0.4 OUTLIER . . . . . 0 CA--C 1.53 0.206 0 CA-C-O 120.63 0.252 . . . . 0.0 110.783 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.641 ' CD ' ' N ' ' A' ' 1' ' ' MET . 43.3 Cg_exo -70.11 123.51 10.05 Favored 'Trans proline' 0 N--CA 1.495 1.56 0 C-N-CA 121.969 1.779 . . . . 0.0 112.385 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 65.8 mt-10 -87.73 -26.29 23.01 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.143 179.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 44.4 m -150.03 -175.78 5.19 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.612 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.724 ' O ' HG23 ' A' ' 9' ' ' VAL . 0.5 OUTLIER -49.39 117.98 2.49 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.301 -179.975 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.619 ' N ' ' CD ' ' A' ' 7' ' ' PRO . 1.0 OUTLIER -63.68 -38.71 40.53 Favored Pre-proline 0 CA--C 1.533 0.289 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 179.927 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.619 ' CD ' ' N ' ' A' ' 6' ' ' VAL . 15.4 Cg_exo -66.9 -66.18 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 121.891 1.727 . . . . 0.0 111.735 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.721 ' O ' HG23 ' A' ' 12' ' ' THR . . . -47.65 -40.63 20.28 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.173 -179.76 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.724 HG23 ' O ' ' A' ' 5' ' ' TRP . 59.2 t -61.11 -61.86 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.238 -179.354 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -57.88 -51.75 56.34 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 111.495 -0.642 . . . . 0.0 111.495 -179.55 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 9.4 mp -57.78 -31.81 66.91 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.572 0.225 . . . . 0.0 110.96 -179.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.721 HG23 ' O ' ' A' ' 8' ' ' ALA . 16.8 p -77.33 -24.81 50.75 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.862 0.363 . . . . 0.0 110.121 179.639 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.427 ' O ' ' CB ' ' A' ' 16' ' ' SER . 6.2 mt -80.12 -27.32 39.17 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.363 179.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 4.5 t -48.55 -59.64 5.81 Favored Pre-proline 0 CA--C 1.535 0.38 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.718 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -54.98 -12.38 4.85 Favored 'Trans proline' 0 N--CA 1.498 1.746 0 C-N-CA 121.056 1.171 . . . . 0.0 111.96 179.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.427 ' CB ' ' O ' ' A' ' 13' ' ' LEU . 1.6 t -73.5 -30.49 63.16 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.66 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 59.5 mt -74.3 -56.73 4.54 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.664 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -64.83 -34.3 89.52 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 110.802 -0.919 . . . . 0.0 110.802 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -74.88 -28.51 62.59 Favored Glycine 0 CA--C 1.521 0.433 0 N-CA-C 110.614 -0.994 . . . . 0.0 110.614 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 48.8 t80 -74.99 -60.43 2.29 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 110.177 -0.305 . . . . 0.0 110.177 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 19.2 ttp -65.53 -25.1 67.29 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.397 179.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.471 ' C ' ' CZ2' ' A' ' 95' ' ' TRP . . . -68.2 -62.13 4.39 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 110.819 -0.912 . . . . 0.0 110.819 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.482 ' O ' HG22 ' A' ' 26' ' ' VAL . . . -70.62 -16.62 62.85 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.993 -0.283 . . . . 0.0 110.397 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 68.5 t80 -47.81 -24.49 0.99 Allowed 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 179.403 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.451 ' CD1' ' C ' ' A' ' 25' ' ' PHE . 22.8 t80 -67.99 -53.57 25.01 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.667 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.482 HG22 ' O ' ' A' ' 23' ' ' ALA . 34.1 m -71.43 -13.46 16.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.702 -179.736 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.424 HH21 ' HA3' ' A' ' 28' ' ' GLY . 1.3 ttp180 -63.31 -46.16 87.97 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.992 -179.758 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.424 ' HA3' HH21 ' A' ' 27' ' ' ARG . . . -105.42 -77.99 1.17 Allowed Glycine 0 CA--C 1.525 0.696 0 N-CA-C 111.197 -0.761 . . . . 0.0 111.197 -179.676 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 53.3 tt0 -44.42 -23.08 0.09 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.698 0.285 . . . . 0.0 110.808 -179.628 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -66.51 -58.49 8.48 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 110.989 -0.845 . . . . 0.0 110.989 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 11.1 mt -51.99 -21.74 3.36 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.836 0.35 . . . . 0.0 110.365 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 16.2 tpp180 -84.79 -54.03 4.95 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.524 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . 0.428 ' O ' ' N ' ' A' ' 36' ' ' GLY . 0.4 OUTLIER -44.95 -46.77 11.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.551 -179.756 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 46.5 t80 -47.23 -35.58 7.82 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.9 0.381 . . . . 0.0 110.373 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.61 -25.33 68.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.354 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.428 ' N ' ' O ' ' A' ' 33' ' ' TRP . . . -92.72 -68.74 1.12 Allowed Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.892 -0.883 . . . . 0.0 110.892 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.575 ' O ' HD12 ' A' ' 37' ' ' LEU . 0.3 OUTLIER -95.75 166.18 11.94 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.793 0.33 . . . . 0.0 110.583 179.712 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.624 ' H ' ' CD ' ' A' ' 38' ' ' GLN . 0.5 OUTLIER -86.63 113.0 22.15 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.861 -179.578 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.638 ' NZ ' ' CZ3' ' A' ' 107' ' ' TRP . 22.1 mtpt -129.13 156.71 77.79 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.197 179.812 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.624 ' C ' ' H ' ' A' ' 42' ' ' TRP . 89.6 Cg_endo -73.46 18.13 0.42 Allowed 'Trans proline' 0 C--N 1.307 -1.654 0 C-N-CA 121.814 1.676 . . . . 0.0 110.803 178.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.495 ' H ' ' C ' ' A' ' 39' ' ' LYS . 21.7 t -48.52 -1.12 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.246 -0.888 . . . . 0.0 111.442 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . 0.643 ' CH2' ' NE2' ' A' ' 43' ' ' HIS . 44.6 p-90 -75.24 -15.12 60.56 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.341 -0.543 . . . . 0.0 110.318 -179.297 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.643 ' NE2' ' CH2' ' A' ' 42' ' ' TRP . 6.6 m-70 -61.49 140.69 94.85 Favored Pre-proline 0 C--N 1.331 -0.206 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 178.218 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.468 ' C ' ' O ' ' A' ' 43' ' ' HIS . 11.0 Cg_endo -32.51 149.01 0.02 OUTLIER 'Trans proline' 0 N--CA 1.496 1.635 0 C-N-CA 121.405 1.403 . . . . 0.0 111.683 -179.227 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -59.39 155.61 40.23 Favored 'Trans proline' 0 C--N 1.312 -1.344 0 C-N-CA 121.12 1.213 . . . . 0.0 112.088 -179.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -53.14 -18.37 2.16 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.675 -179.296 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.566 ' CD1' ' N ' ' A' ' 48' ' ' THR . 1.0 OUTLIER -49.46 -47.5 48.32 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.092 -0.643 . . . . 0.0 110.897 -178.898 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.566 ' N ' ' CD1' ' A' ' 47' ' ' TRP . 13.2 t -91.95 -24.82 19.14 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.052 0.39 . . . . 0.0 112.052 -179.732 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.749 ' O ' HG23 ' A' ' 52' ' ' ILE . 0.1 OUTLIER -80.23 -62.35 1.7 Allowed 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -178.215 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.646 ' C ' ' H ' ' A' ' 52' ' ' ILE . . . -37.83 -31.0 0.15 Allowed Pre-proline 0 C--O 1.237 0.402 0 C-N-CA 121.113 -0.235 . . . . 0.0 111.218 -179.04 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.433 ' HD2' ' N ' ' A' ' 50' ' ' ALA . 32.9 Cg_exo -55.62 8.99 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.659 0 CA-C-N 118.425 0.473 . . . . 0.0 112.204 178.11 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.749 HG23 ' O ' ' A' ' 49' ' ' LEU . 12.1 pt -55.71 -27.36 21.73 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 178.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 3.2 m0 -64.62 -30.02 71.03 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.783 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -72.98 -46.93 26.72 Favored Glycine 0 CA--C 1.522 0.519 0 N-CA-C 111.027 -0.829 . . . . 0.0 111.027 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 91.2 m -61.53 -53.37 57.28 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.74 0.305 . . . . 0.0 110.59 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 57.5 mt -64.91 -28.68 69.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.506 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.528 ' C ' ' CD1' ' A' ' 57' ' ' TYR . 1.6 t80 -63.6 -41.62 98.32 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 179.455 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 26.1 t -68.02 -49.43 61.55 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.42 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.67 -46.07 88.02 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.758 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.498 ' HG2' HD21 ' A' ' 137' ' ' LEU . 21.3 mtm -65.45 -33.14 75.25 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.31 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -63.35 -49.68 68.49 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 111.324 -0.71 . . . . 0.0 111.324 -179.663 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -63.15 -60.06 3.93 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 121.07 -0.252 . . . . 0.0 110.739 -179.652 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.484 ' O ' HG23 ' A' ' 67' ' ' VAL . . . -52.58 -52.08 39.94 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 110.811 -0.916 . . . . 0.0 110.811 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.442 ' OG ' ' O ' ' A' ' 60' ' ' MET . 34.2 p -48.14 -56.64 7.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.087 0.47 . . . . 0.0 110.831 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 68.0 t80 -51.38 -37.4 48.0 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.196 -179.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 56.6 mt -71.44 -37.09 63.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.165 -179.548 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.484 HG23 ' O ' ' A' ' 63' ' ' GLY . 49.1 t -59.48 -52.09 65.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 C-N-CA 120.735 -0.386 . . . . 0.0 110.598 -179.694 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . 0.59 ' O ' ' N ' ' A' ' 73' ' ' GLY . 0.9 OUTLIER -64.7 -44.72 89.36 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.859 -179.878 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.25 -23.08 63.81 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.862 -0.335 . . . . 0.0 110.725 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -79.67 -62.81 1.57 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.667 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.73 ' C ' HD12 ' A' ' 71' ' ' LEU . 2.8 pp -65.67 -6.8 12.45 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.161 -179.661 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.684 ' N ' HD12 ' A' ' 71' ' ' LEU . . . 109.69 72.09 0.7 Allowed Glycine 0 CA--C 1.527 0.822 0 N-CA-C 111.511 -0.636 . . . . 0.0 111.511 179.7 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.59 ' N ' ' O ' ' A' ' 68' ' ' TRP . . . 46.58 -174.15 0.01 OUTLIER Glycine 0 CA--C 1.526 0.768 0 N-CA-C 111.761 -0.536 . . . . 0.0 111.761 179.532 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 41.2 t80 -77.28 111.99 13.52 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.884 0.373 . . . . 0.0 111.03 -179.584 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.547 ' OG1' ' N ' ' A' ' 76' ' ' GLU . 0.0 OUTLIER -142.54 -179.99 6.63 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.254 179.468 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.547 ' N ' ' OG1' ' A' ' 75' ' ' THR . 7.4 pt-20 -51.57 -23.53 4.29 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.401 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -72.9 -36.95 67.41 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.757 -179.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.44 ' O ' HD12 ' A' ' 82' ' ' LEU . . . -81.63 -22.1 37.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.975 0.417 . . . . 0.0 110.824 -179.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 73.0 mmm -61.56 -26.07 67.72 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.177 -179.468 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 14.8 t -68.09 -46.36 41.09 Favored Pre-proline 0 CA--C 1.534 0.338 0 C-N-CA 120.511 -0.476 . . . . 0.0 110.619 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_endo -74.66 -54.76 0.09 OUTLIER 'Trans proline' 0 N--CA 1.497 1.717 0 C-N-CA 120.953 1.102 . . . . 0.0 111.517 178.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.44 HD12 ' O ' ' A' ' 78' ' ' ALA . 3.2 mt -50.99 -55.25 18.26 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.534 179.685 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.455 ' O ' ' N ' ' A' ' 86' ' ' THR . . . -64.51 -63.87 3.98 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 111.488 -0.645 . . . . 0.0 111.488 -179.157 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.4 HD12 ' HA ' ' A' ' 84' ' ' LEU . 43.2 tp -43.91 -29.71 0.6 Allowed 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.664 -0.415 . . . . 0.0 109.92 -179.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 13.3 t80 -75.4 -42.83 52.87 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.843 179.518 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.455 ' N ' ' O ' ' A' ' 83' ' ' GLY . 1.4 m -66.86 -56.65 9.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.799 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -58.92 -55.36 31.33 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 111.401 -0.679 . . . . 0.0 111.401 -179.628 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.424 ' O ' ' CB ' ' A' ' 92' ' ' ASN . 9.6 tp-100 -55.47 -42.87 74.91 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 121.001 -0.28 . . . . 0.0 110.89 -179.572 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.42 ' O ' ' CD1' ' A' ' 93' ' ' TRP . 10.4 tp -66.04 -31.38 72.24 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.903 -0.319 . . . . 0.0 110.383 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.834 ' O ' ' HB2' ' A' ' 94' ' ' ALA . . . -65.87 -65.83 0.63 Allowed 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 120.314 -0.554 . . . . 0.0 111.182 -179.561 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.4 pp -66.0 -34.35 77.88 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.157 0.428 . . . . 0.0 112.157 -179.001 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.424 ' CB ' ' O ' ' A' ' 88' ' ' GLN . 47.5 t30 -78.39 -61.34 2.04 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.862 -0.335 . . . . 0.0 111.826 -178.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . 0.613 ' O ' ' N ' ' A' ' 95' ' ' TRP . 0.0 OUTLIER -68.96 -13.32 62.37 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.906 -0.318 . . . . 0.0 111.527 -178.543 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.834 ' HB2' ' O ' ' A' ' 90' ' ' ALA . . . -52.77 80.76 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 120.663 -0.415 . . . . 0.0 109.913 179.38 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.706 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 32.8 p-90 -98.18 -16.95 0.2 Allowed Pre-proline 0 CA--C 1.535 0.39 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -179.389 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.706 ' CD ' ' N ' ' A' ' 95' ' ' TRP . 51.4 Cg_exo -54.51 -40.86 81.69 Favored 'Trans proline' 0 N--CA 1.496 1.632 0 C-N-CA 120.537 0.825 . . . . 0.0 113.03 179.562 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.459 ' HD2' ' N ' ' A' ' 96' ' ' PRO . 41.9 Cg_exo -36.69 -31.31 0.1 Allowed 'Trans proline' 0 N--CA 1.492 1.41 0 CA-C-N 118.98 0.671 . . . . 0.0 112.777 -179.776 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.45 ' N ' ' O ' ' A' ' 96' ' ' PRO . 1.1 pp -83.63 22.19 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.427 179.797 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.581 ' N ' ' O ' ' A' ' 96' ' ' PRO . 22.3 t80 -44.71 -41.63 6.96 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.463 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 48.9 m-85 -83.89 -40.92 18.0 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.529 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -58.0 -14.1 16.24 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 111.006 -0.838 . . . . 0.0 111.006 -179.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -65.05 -7.26 11.22 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.801 0.334 . . . . 0.0 110.472 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 15.3 ptt180 -82.14 4.78 21.9 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.602 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 5.6 mt-30 -122.41 164.92 17.16 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.247 179.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -59.94 -17.06 34.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.328 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.608 ' O ' ' N ' ' A' ' 108' ' ' ALA . . . -66.62 -14.62 62.88 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 111.203 -0.759 . . . . 0.0 111.203 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' TRP . . . . . 0.638 ' CZ3' ' NZ ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -41.25 -15.37 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.716 0.294 . . . . 0.0 111.031 -179.366 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.608 ' N ' ' O ' ' A' ' 106' ' ' GLY . . . -58.77 -27.2 64.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.935 0.398 . . . . 0.0 110.435 179.72 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 9.3 mt -46.46 -29.01 1.55 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.444 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -60.22 -63.63 1.23 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.759 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.674 ' O ' HG23 ' A' ' 115' ' ' VAL . 1.4 p30 -55.07 -51.88 64.97 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.781 -179.269 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.613 HD13 ' O ' ' A' ' 112' ' ' LEU . 0.2 OUTLIER -58.52 -45.11 89.49 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.103 0.409 . . . . 0.0 112.103 -178.539 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 57.2 mt -64.74 -55.27 20.91 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -178.202 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.3 pp -68.06 -33.55 74.78 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 120.455 -0.498 . . . . 0.0 111.703 -178.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.674 HG23 ' O ' ' A' ' 111' ' ' ASP . 38.7 t -62.22 -54.37 35.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.736 0.303 . . . . 0.0 111.186 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.483 ' O ' ' OG1' ' A' ' 120' ' ' THR . 39.0 t -75.3 -23.93 57.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.093 -179.353 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -62.74 -62.46 5.51 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 111.186 -0.765 . . . . 0.0 111.186 -179.727 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.562 ' O ' HG23 ' A' ' 122' ' ' THR . 7.3 p -71.93 -37.92 62.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 111.57 0.211 . . . . 0.0 111.57 -179.547 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.518 ' O ' ' OG1' ' A' ' 123' ' ' THR . . . -68.41 -61.0 2.03 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.281 -0.568 . . . . 0.0 111.075 -179.234 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.483 ' OG1' ' O ' ' A' ' 116' ' ' SER . 2.7 m -56.7 -53.33 58.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.257 -179.541 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.41 ' O ' ' CB ' ' A' ' 125' ' ' ALA . . . -54.36 -40.84 68.47 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.455 -179.256 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.562 HG23 ' O ' ' A' ' 118' ' ' VAL . 37.6 p -74.88 -29.17 60.92 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 111.872 0.323 . . . . 0.0 111.872 -179.034 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.518 ' OG1' ' O ' ' A' ' 119' ' ' ALA . 0.1 OUTLIER -65.71 -47.59 74.85 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.594 -0.442 . . . . 0.0 110.683 -179.639 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.4 pp -83.98 -19.4 34.64 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.373 -179.15 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.41 ' CB ' ' O ' ' A' ' 121' ' ' ALA . . . -89.74 -67.55 0.84 Allowed 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.497 0.555 . . . . 0.0 112.497 -178.589 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' TRP . . . . . 0.433 ' N ' ' CD1' ' A' ' 126' ' ' TRP . 39.3 m0 -84.36 -57.66 3.07 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 112.662 0.616 . . . . 0.0 112.662 -177.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . 0.57 ' CG ' ' HB2' ' A' ' 134' ' ' ALA . 9.3 m170 -54.51 -22.48 13.06 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.865 -0.334 . . . . 0.0 111.115 -178.702 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 22.4 ttt180 -68.44 -38.97 81.65 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.755 0.312 . . . . 0.0 110.994 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 25.9 t -92.67 -47.89 13.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.31 -179.388 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -125.57 117.33 24.75 Favored Pre-proline 0 CA--C 1.535 0.374 0 CA-C-N 116.575 -0.284 . . . . 0.0 111.048 -179.385 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . 0.647 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 88.4 Cg_exo -75.03 -38.43 1.58 Allowed 'Trans proline' 0 N--CA 1.492 1.424 0 C-N-CA 121.454 1.436 . . . . 0.0 112.646 179.074 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.647 ' CD ' ' N ' ' A' ' 131' ' ' PRO . 37.9 Cg_exo -46.98 -46.24 19.22 Favored 'Trans proline' 0 N--CA 1.497 1.688 0 C-N-CA 121.646 1.564 . . . . 0.0 111.983 -179.699 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -57.15 -38.22 73.21 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 179.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.57 ' HB2' ' CG ' ' A' ' 127' ' ' HIS . . . -62.69 -23.07 66.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.196 179.763 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 9.3 tpp180 -78.5 -37.3 43.51 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.234 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 12.6 mt -69.61 -29.52 67.04 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.241 -0.436 . . . . 0.0 109.867 179.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.583 ' O ' ' N ' ' A' ' 140' ' ' TYR . 8.2 mt -84.14 -42.39 16.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.025 179.489 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.491 ' C ' ' O ' ' A' ' 137' ' ' LEU . 1.9 t80 -23.15 -41.39 0.04 OUTLIER Pre-proline 0 N--CA 1.464 0.252 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.753 -179.686 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.574 ' N ' ' O ' ' A' ' 137' ' ' LEU . 12.3 Cg_exo -64.37 7.29 0.24 Allowed 'Trans proline' 0 C--N 1.307 -1.643 0 C-N-CA 120.699 0.933 . . . . 0.0 112.0 179.45 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.747 ' CE2' HD11 ' A' ' 144' ' ' LEU . 1.9 p90 -93.13 -13.67 28.19 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.903 -179.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.587 HD13 HD12 ' A' ' 144' ' ' LEU . 4.1 mm? -55.94 -26.63 48.74 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 178.299 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -64.28 -49.14 73.0 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.833 179.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' TRP . . . . . . . . . . . . . 10.7 t-105 -56.91 -45.84 82.39 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.103 -0.498 . . . . 0.0 109.659 179.375 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.747 HD11 ' CE2' ' A' ' 140' ' ' TYR . 11.5 mt -54.63 -51.15 66.29 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.199 -0.455 . . . . 0.0 109.962 179.504 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.646 ' O ' HG23 ' A' ' 149' ' ' VAL . . . -63.72 -22.16 66.77 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.413 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -67.25 -64.82 0.78 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.61 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -63.94 -41.9 97.48 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.615 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 59.9 m -57.16 -58.68 7.14 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.499 179.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.646 HG23 ' O ' ' A' ' 145' ' ' ALA . 89.5 t -55.61 -39.49 54.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.708 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.464 ' O ' HG23 ' A' ' 154' ' ' VAL . 1.6 tp -50.84 -57.49 8.31 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.696 -0.402 . . . . 0.0 110.069 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . 0.586 HD22 ' HE1' ' A' ' 107' ' ' TRP . 2.9 t-20 -53.7 -57.02 12.32 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.706 179.73 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . 0.467 ' CZ ' ' NE ' ' A' ' 156' ' ' ARG . 46.5 t80 -48.53 -36.14 14.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.519 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . 0.49 ' CE2' ' OD2' ' A' ' 157' ' ' ASP . 8.8 t80 -65.96 -39.52 90.51 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.688 -179.799 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.493 HG22 ' HG2' ' A' ' 39' ' ' LYS . 15.7 t -66.21 -38.02 81.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.002 -179.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' TRP . . . . . . . . . . . . . 7.9 m0 -68.17 -39.15 82.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.964 -179.579 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . 0.467 ' NE ' ' CZ ' ' A' ' 152' ' ' TYR . 0.9 OUTLIER -77.15 -24.04 51.59 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.808 -0.357 . . . . 0.0 110.071 179.999 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . 0.49 ' OD2' ' CE2' ' A' ' 153' ' ' TYR . 98.2 m-20 -86.9 -51.08 6.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.661 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . 0.505 ' C ' HD22 ' A' ' 158' ' ' ASN . 0.2 OUTLIER -77.47 -29.08 52.53 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.831 -179.809 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 9.8 t 46.89 -166.63 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.438 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 157.31 19.79 0.03 OUTLIER Glycine 0 CA--C 1.525 0.69 0 N-CA-C 110.997 -0.841 . . . . 0.0 110.997 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 6.2 mtm180 -56.59 -175.0 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.744 0.307 . . . . 0.0 110.576 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 43.1 ttm-85 -91.53 149.93 21.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.673 -179.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 102.11 53.71 0.94 Allowed Glycine 0 CA--C 1.525 0.669 0 N-CA-C 111.084 -0.806 . . . . 0.0 111.084 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -65.38 -39.17 95.67 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 110.769 -0.932 . . . . 0.0 110.769 179.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 3.3 m -155.37 144.76 21.06 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.742 0.306 . . . . 0.0 110.388 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? -90.82 -65.92 0.97 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.547 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -94.15 173.48 7.63 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 179.446 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -163.72 131.18 3.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.612 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 15.3 mm-40 . . . . . 0 C--O 1.22 -0.457 0 CA-C-O 117.998 -1.001 . . . . 0.0 110.529 -179.98 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' PKA . . . . . 0.517 'CL ' ' C15' ' A' ' 201' ' ' PKA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.479 ' H2 ' ' HD3' ' A' ' 2' ' ' PRO . 44.6 mmm . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.959 0.409 . . . . 0.0 110.52 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.479 ' HD3' ' H2 ' ' A' ' 1' ' ' MET . 73.8 Cg_exo -70.12 144.0 50.8 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 C-N-CA 122.562 2.175 . . . . 0.0 112.183 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 59.0 mt-10 -47.32 -25.77 1.08 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.921 -179.717 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 28.7 m -164.04 160.71 22.03 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.734 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.595 ' CD1' ' CE2' ' A' ' 68' ' ' TRP . 0.2 OUTLIER -76.22 120.24 21.22 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.238 -179.922 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.62 ' N ' ' CD ' ' A' ' 7' ' ' PRO . 1.0 OUTLIER -64.2 -33.88 10.33 Favored Pre-proline 0 C--N 1.329 -0.309 0 N-CA-C 109.916 -0.402 . . . . 0.0 109.916 179.942 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.62 ' CD ' ' N ' ' A' ' 6' ' ' VAL . 21.3 Cg_exo -71.61 -67.51 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.626 0 C-N-CA 121.709 1.606 . . . . 0.0 111.899 179.63 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.666 ' O ' HG23 ' A' ' 12' ' ' THR . . . -48.31 -39.16 20.92 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.19 -179.513 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.582 HG23 ' O ' ' A' ' 5' ' ' TRP . 95.9 t -69.98 -62.48 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -179.049 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -55.32 -47.34 75.81 Favored Glycine 0 CA--C 1.526 0.764 0 C-N-CA 121.207 -0.52 . . . . 0.0 111.834 -179.108 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.411 ' N ' ' CD1' ' A' ' 11' ' ' LEU . 6.8 mp -62.5 -38.47 90.05 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.485 0.183 . . . . 0.0 110.805 -179.584 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.666 HG23 ' O ' ' A' ' 8' ' ' ALA . 22.3 p -73.34 -23.53 60.24 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.801 -0.36 . . . . 0.0 110.871 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.55 HD13 ' O ' ' A' ' 9' ' ' VAL . 7.0 mp -82.97 -24.88 32.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.297 -179.749 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.427 ' N ' ' HD2' ' A' ' 15' ' ' PRO . 2.7 t -50.02 -63.16 1.92 Allowed Pre-proline 0 CA--C 1.536 0.442 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.723 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.427 ' HD2' ' N ' ' A' ' 14' ' ' VAL . 24.5 Cg_endo -53.78 -40.08 81.48 Favored 'Trans proline' 0 N--CA 1.498 1.788 0 C-N-CA 120.876 1.05 . . . . 0.0 112.366 -179.462 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.1 t -46.19 -25.68 0.65 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.811 0.338 . . . . 0.0 110.664 -179.717 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 83.1 mt -70.03 -57.94 4.4 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.726 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -68.35 -20.71 73.67 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 111.163 -0.775 . . . . 0.0 111.163 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -72.92 -45.53 32.78 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 37.7 t80 -69.89 -57.63 4.82 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.79 0.329 . . . . 0.0 110.707 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -66.83 -21.55 66.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.07 -179.743 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -77.5 -63.5 2.22 Favored Glycine 0 CA--C 1.524 0.608 0 C-N-CA 120.842 -0.694 . . . . 0.0 111.572 -179.504 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.541 ' O ' HG22 ' A' ' 26' ' ' VAL . . . -64.15 -20.98 66.37 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.671 -0.412 . . . . 0.0 110.245 -179.618 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.461 ' CD1' ' C ' ' A' ' 24' ' ' TYR . 11.0 t80 -48.77 -23.7 1.15 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.278 -0.419 . . . . 0.0 109.912 179.357 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.493 ' CE2' ' HB1' ' A' ' 102' ' ' ALA . 83.3 t80 -70.78 -52.63 19.44 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.765 -179.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.541 HG22 ' O ' ' A' ' 23' ' ' ALA . 35.3 m -66.53 -17.21 22.16 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 C-N-CA 120.535 -0.466 . . . . 0.0 110.41 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.9 tmt_? -58.08 -43.41 87.0 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.854 0.359 . . . . 0.0 110.32 179.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -101.41 -46.9 1.61 Allowed Glycine 0 CA--C 1.526 0.738 0 N-CA-C 110.957 -0.857 . . . . 0.0 110.957 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -59.91 -38.59 82.75 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.759 0.314 . . . . 0.0 110.64 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -58.68 -44.93 95.4 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.857 -0.897 . . . . 0.0 110.857 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 81.0 mt -58.47 -31.95 68.3 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.944 -0.302 . . . . 0.0 110.392 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.443 ' O ' ' HB3' ' A' ' 35' ' ' ALA . 14.6 mmm180 -76.68 -50.03 14.69 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.464 179.793 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 13.0 m0 -44.84 -48.14 11.05 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.289 -0.414 . . . . 0.0 109.998 179.489 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.452 ' O ' ' CD1' ' A' ' 34' ' ' TYR . 26.3 t80 -50.62 -27.05 6.14 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.751 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.443 ' HB3' ' O ' ' A' ' 32' ' ' ARG . . . -65.95 -45.83 80.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.763 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -91.87 -69.67 1.16 Allowed Glycine 0 CA--C 1.524 0.601 0 N-CA-C 110.992 -0.843 . . . . 0.0 110.992 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.761 ' C ' HD12 ' A' ' 37' ' ' LEU . 3.9 pp -87.66 162.78 16.91 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.677 0.275 . . . . 0.0 110.359 179.722 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 29.5 mt-30 -97.32 123.23 41.07 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.71 -179.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 13.9 mtpp -90.41 163.23 31.8 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.21 179.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.592 ' O ' ' ND1' ' A' ' 43' ' ' HIS . 15.7 Cg_exo -45.93 146.54 4.04 Favored 'Trans proline' 0 C--N 1.307 -1.628 0 C-N-CA 122.153 1.902 . . . . 0.0 112.198 -179.709 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 11.6 t -81.84 -2.16 50.05 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.653 -179.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 13.5 p90 -117.87 9.91 13.03 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 120.484 -0.486 . . . . 0.0 111.623 -178.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.599 ' O ' ' CG ' ' A' ' 43' ' ' HIS . 3.5 p-80 -88.96 117.6 68.42 Favored Pre-proline 0 CA--C 1.535 0.374 0 C-N-CA 121.078 -0.249 . . . . 0.0 111.028 179.757 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.567 ' CG ' HD23 ' A' ' 49' ' ' LEU . 65.9 Cg_endo -101.29 148.54 0.32 Allowed 'Trans proline' 0 C--N 1.313 -1.334 0 C-N-CA 120.427 0.751 . . . . 0.0 111.112 178.646 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.421 ' C ' ' O ' ' A' ' 44' ' ' PRO . 5.7 Cg_endo -40.62 137.4 1.67 Allowed 'Trans proline' 0 C--N 1.3 -1.98 0 C-N-CA 120.543 0.829 . . . . 0.0 110.419 179.631 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 4.8 ppt_? -48.09 -17.01 0.1 Allowed 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 113.125 0.787 . . . . 0.0 113.125 -178.109 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.562 ' CD1' ' N ' ' A' ' 48' ' ' THR . 0.7 OUTLIER -56.48 -44.63 80.83 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.267 -0.573 . . . . 0.0 112.239 -178.201 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.562 ' N ' ' CD1' ' A' ' 47' ' ' TRP . 13.3 t -91.5 -30.74 16.27 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 -178.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.759 ' O ' HG23 ' A' ' 52' ' ' ILE . 0.2 OUTLIER -82.42 -45.4 14.86 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 112.411 0.523 . . . . 0.0 112.411 -177.921 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.62 ' C ' ' H ' ' A' ' 52' ' ' ILE . . . -39.91 -31.63 0.26 Allowed Pre-proline 0 CA--C 1.534 0.344 0 N-CA-C 111.952 0.353 . . . . 0.0 111.952 -179.085 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.418 ' HD2' ' N ' ' A' ' 50' ' ' ALA . 28.2 Cg_exo -52.87 6.37 0.03 OUTLIER 'Trans proline' 0 C--N 1.311 -1.417 0 CA-C-N 118.928 0.653 . . . . 0.0 112.984 178.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.759 HG23 ' O ' ' A' ' 49' ' ' LEU . 10.9 pt -55.59 -28.5 23.15 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.178 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 179.04 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.462 ' CH2' ' HB1' ' A' ' 50' ' ' ALA . 3.0 m0 -67.68 -28.53 67.77 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.484 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -69.41 -60.94 4.76 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 111.464 -0.654 . . . . 0.0 111.464 -179.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.618 HG23 ' N ' ' A' ' 56' ' ' LEU . 7.3 t -57.56 -53.37 58.93 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.897 -0.321 . . . . 0.0 111.125 -179.343 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.618 ' N ' HG23 ' A' ' 55' ' ' THR . 73.2 mt -58.24 -39.41 79.04 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.524 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.414 ' CB ' ' O ' ' A' ' 53' ' ' TRP . 6.1 t80 -54.79 -57.89 9.73 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 179.747 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 7.1 t -48.63 -50.39 33.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.552 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -57.18 -42.55 81.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.606 -179.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 14.6 mtt -63.0 -55.09 28.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.525 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -44.73 -47.44 9.15 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 111.16 -0.776 . . . . 0.0 111.16 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -61.17 -49.37 77.47 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.845 0.355 . . . . 0.0 110.279 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.471 ' O ' HG23 ' A' ' 67' ' ' VAL . . . -54.87 -45.06 81.59 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 110.187 -1.165 . . . . 0.0 110.187 179.575 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.592 ' O ' ' NE1' ' A' ' 68' ' ' TRP . 0.7 OUTLIER -60.52 -42.35 96.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.906 0.384 . . . . 0.0 110.221 179.642 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.426 ' OH ' ' NZ ' ' A' ' 69' ' ' LYS . 87.3 t80 -53.11 -43.47 66.88 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 179.361 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 79.4 mt -72.15 -25.81 24.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.024 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.552 HG22 ' OG ' ' A' ' 130' ' ' SER . 55.1 t -66.15 -60.05 3.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 C-N-CA 120.664 -0.414 . . . . 0.0 111.333 -179.522 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . 0.595 ' CE2' ' CD1' ' A' ' 5' ' ' TRP . 0.0 OUTLIER -70.37 -29.39 66.04 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 119.974 -0.69 . . . . 0.0 110.725 -179.601 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.426 ' NZ ' ' OH ' ' A' ' 65' ' ' TYR . 10.8 mmmt -72.79 -26.55 61.56 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.336 -0.546 . . . . 0.0 110.616 179.825 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -78.42 -60.98 2.16 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.85 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.7 pp -70.38 -19.17 63.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.087 -179.482 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.502 ' O ' ' O ' ' A' ' 73' ' ' GLY . . . 110.24 95.43 2.33 Favored Glycine 0 CA--C 1.53 0.985 0 C-N-CA 121.257 -0.496 . . . . 0.0 112.043 179.218 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.594 ' N ' ' O ' ' A' ' 68' ' ' TRP . . . 41.51 -174.33 0.01 OUTLIER Glycine 0 CA--C 1.525 0.691 0 N-CA-C 111.944 -0.462 . . . . 0.0 111.944 178.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 49.3 t80 -79.78 111.05 15.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.675 0.274 . . . . 0.0 110.408 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.427 ' OG1' ' N ' ' A' ' 76' ' ' GLU . 2.1 t -139.35 177.31 8.01 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 120.993 0.425 . . . . 0.0 110.949 -179.641 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.5 ' H ' ' CD ' ' A' ' 76' ' ' GLU . 2.3 mp0 -50.05 -40.84 46.41 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.795 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 27.7 m-20 -62.39 -22.03 65.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.505 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -93.64 -24.82 17.75 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.663 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 13.2 mtp -69.14 -29.57 67.63 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.535 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.406 ' O ' ' CB ' ' A' ' 84' ' ' LEU . 6.5 t -65.56 -45.74 68.11 Favored Pre-proline 0 CA--C 1.535 0.372 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.505 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -76.33 -63.87 0.03 OUTLIER 'Trans proline' 0 N--CA 1.498 1.749 0 C-N-CA 120.903 1.069 . . . . 0.0 111.563 178.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 4.2 mt -47.19 -46.73 24.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.439 179.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.499 ' O ' ' N ' ' A' ' 86' ' ' THR . . . -68.38 -64.13 3.25 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 111.015 -0.834 . . . . 0.0 111.015 -179.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.406 ' CB ' ' O ' ' A' ' 80' ' ' VAL . 65.3 tp -41.9 -28.18 0.15 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.03 0.443 . . . . 0.0 109.88 179.751 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.465 ' CD1' ' C ' ' A' ' 85' ' ' TYR . 0.6 OUTLIER -76.85 -43.6 35.54 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.029 179.663 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.499 ' N ' ' O ' ' A' ' 83' ' ' GLY . 0.3 OUTLIER -61.56 -43.95 97.92 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.164 -179.57 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -73.62 -58.17 4.65 Favored Glycine 0 CA--C 1.527 0.808 0 C-N-CA 120.9 -0.667 . . . . 0.0 111.466 -179.455 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -51.14 -48.61 61.77 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-O 121.052 0.453 . . . . 0.0 109.943 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.455 HD22 ' CZ ' ' A' ' 85' ' ' TYR . 23.3 tp -54.85 -63.39 1.17 Allowed 'General case' 0 C--O 1.211 -0.927 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.814 179.593 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.588 ' O ' ' HB2' ' A' ' 94' ' ' ALA . . . -37.86 -42.87 0.64 Allowed 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 120.568 -0.453 . . . . 0.0 111.522 -179.497 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 90.8 mt -63.38 -56.98 11.87 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -178.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -72.62 -53.85 10.73 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.346 0.593 . . . . 0.0 111.33 -178.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . 0.606 ' O ' ' N ' ' A' ' 95' ' ' TRP . 30.7 t-105 -51.86 -33.31 35.85 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.152 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.588 ' HB2' ' O ' ' A' ' 90' ' ' ALA . . . -60.01 72.11 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 120.611 -0.436 . . . . 0.0 109.89 179.228 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.694 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 22.2 p-90 -99.42 -15.91 0.19 Allowed Pre-proline 0 CA--C 1.538 0.505 0 N-CA-C 112.581 0.586 . . . . 0.0 112.581 -179.113 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.694 ' CD ' ' N ' ' A' ' 95' ' ' TRP . 49.3 Cg_exo -58.87 -31.14 94.79 Favored 'Trans proline' 0 N--CA 1.497 1.717 0 C-N-CA 120.645 0.897 . . . . 0.0 113.808 -179.731 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.494 ' CD ' ' N ' ' A' ' 96' ' ' PRO . 89.0 Cg_exo -56.99 -13.91 12.99 Favored 'Trans proline' 0 N--CA 1.499 1.825 0 C-N-CA 120.642 0.895 . . . . 0.0 113.654 -179.152 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 1.1 pp -90.05 29.96 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 C-N-CA 120.453 -0.499 . . . . 0.0 110.779 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.585 ' CD2' ' O ' ' A' ' 96' ' ' PRO . 42.6 m-85 -50.37 -40.09 48.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.213 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.598 ' CD1' ' N ' ' A' ' 100' ' ' PHE . 0.1 OUTLIER -70.05 -58.84 3.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.318 -179.311 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -55.56 -14.82 7.42 Favored Glycine 0 CA--C 1.522 0.489 0 N-CA-C 110.847 -0.901 . . . . 0.0 110.847 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.493 ' HB1' ' CE2' ' A' ' 25' ' ' PHE . . . -59.76 -12.14 6.63 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.587 0.232 . . . . 0.0 111.203 -179.662 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 -94.78 10.3 35.7 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 121.005 -0.278 . . . . 0.0 110.862 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 16.6 mt-30 -117.21 -175.35 2.78 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.732 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.495 ' CE ' ' CZ3' ' A' ' 155' ' ' TRP . 17.5 mmt -74.78 -18.31 60.49 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.094 0.473 . . . . 0.0 109.78 179.662 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.613 ' O ' ' N ' ' A' ' 108' ' ' ALA . . . -74.23 -14.77 80.39 Favored Glycine 0 CA--C 1.524 0.653 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.355 -179.702 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' TRP . . . . . 0.606 ' NE1' ' OD1' ' A' ' 151' ' ' ASN . 0.0 OUTLIER -41.6 -14.96 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.252 0 CA-C-O 120.749 0.309 . . . . 0.0 110.879 -179.468 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.752 ' HB2' ' OD1' ' A' ' 151' ' ' ASN . . . -62.49 -17.57 59.9 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.983 0.421 . . . . 0.0 110.172 179.53 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.52 HD13 ' O ' ' A' ' 106' ' ' GLY . 6.8 mp -47.5 -30.7 3.65 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.358 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.416 ' HB2' ' CZ3' ' A' ' 95' ' ' TRP . . . -57.81 -63.98 1.06 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.935 -179.72 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.691 ' O ' HG23 ' A' ' 115' ' ' VAL . 1.9 p30 -57.82 -54.34 48.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.764 -179.224 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.54 ' N ' ' CG ' ' A' ' 111' ' ' ASP . 38.1 tp -52.84 -41.49 64.31 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.506 -0.316 . . . . 0.0 111.727 -178.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.403 HD23 ' HA ' ' A' ' 113' ' ' LEU . 57.2 mt -70.33 -62.12 1.51 Allowed 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.616 0.599 . . . . 0.0 112.616 -178.333 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.0 pp -59.0 -29.84 67.53 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 120.431 -0.508 . . . . 0.0 111.066 -178.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.691 HG23 ' O ' ' A' ' 111' ' ' ASP . 38.8 t -65.12 -60.61 2.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.221 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.498 ' O ' ' OG1' ' A' ' 120' ' ' THR . 9.8 p -68.81 -22.29 64.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.954 -179.55 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.405 ' O ' ' CB ' ' A' ' 121' ' ' ALA . . . -65.34 -62.66 4.69 Favored Glycine 0 CA--C 1.525 0.693 0 C-N-CA 120.903 -0.665 . . . . 0.0 111.496 -179.474 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.595 ' O ' HG23 ' A' ' 122' ' ' THR . 9.6 p -73.24 -37.5 52.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 C-N-CA 120.957 -0.297 . . . . 0.0 111.233 -179.531 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.524 ' O ' ' OG1' ' A' ' 123' ' ' THR . . . -67.02 -60.86 2.27 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.596 -0.442 . . . . 0.0 111.145 -179.393 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.498 ' OG1' ' O ' ' A' ' 116' ' ' SER . 1.6 m -60.36 -53.23 60.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.412 -179.455 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.405 ' CB ' ' O ' ' A' ' 117' ' ' GLY . . . -51.83 -42.38 62.5 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.916 -0.314 . . . . 0.0 111.044 -179.391 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.595 HG23 ' O ' ' A' ' 118' ' ' VAL . 35.6 p -71.55 -40.15 70.19 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.769 -179.09 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.524 ' OG1' ' O ' ' A' ' 119' ' ' ALA . 0.1 OUTLIER -54.77 -49.29 71.24 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 120.761 0.315 . . . . 0.0 110.897 -179.143 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.9 pp -84.11 -20.21 32.93 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.202 -0.454 . . . . 0.0 112.089 -178.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -90.17 -71.19 0.63 Allowed 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.821 0.675 . . . . 0.0 112.821 -178.331 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 41.6 m0 -80.46 -57.13 3.73 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 -177.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . 0.578 ' CG ' ' HB2' ' A' ' 134' ' ' ALA . 10.4 m170 -55.48 -23.57 26.53 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.826 -0.35 . . . . 0.0 111.54 -178.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.77 -39.56 87.89 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.756 -0.377 . . . . 0.0 110.666 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 98.7 t -90.6 -49.54 13.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.942 -179.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . 0.552 ' OG ' HG22 ' A' ' 67' ' ' VAL . 1.9 p -114.06 109.34 49.63 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.468 -179.661 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . 0.629 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 71.4 Cg_exo -69.68 -35.91 12.01 Favored 'Trans proline' 0 C--N 1.311 -1.418 0 C-N-CA 121.38 1.386 . . . . 0.0 112.422 179.472 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.629 ' CD ' ' N ' ' A' ' 131' ' ' PRO . 29.8 Cg_exo -56.28 -40.64 83.41 Favored 'Trans proline' 0 N--CA 1.495 1.58 0 C-N-CA 121.374 1.383 . . . . 0.0 111.679 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -51.89 -44.54 63.79 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.265 179.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.578 ' HB2' ' CG ' ' A' ' 127' ' ' HIS . . . -58.65 -22.64 57.28 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.511 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 7.7 tpt85 -79.32 -29.42 42.35 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.535 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 12.8 mt -79.01 -28.96 43.42 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.389 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.477 ' O ' ' CD1' ' A' ' 140' ' ' TYR . 13.2 mt -93.74 -18.64 21.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.091 179.686 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.54 ' C ' ' CD1' ' A' ' 138' ' ' TYR . 0.3 OUTLIER -37.43 -52.19 2.46 Favored Pre-proline 0 CA--C 1.537 0.461 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.715 -179.764 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.404 ' HD2' ' N ' ' A' ' 138' ' ' TYR . 5.6 Cg_endo -62.65 1.54 1.01 Allowed 'Trans proline' 0 N--CA 1.499 1.797 0 C-N-CA 121.734 1.622 . . . . 0.0 113.38 -179.281 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.477 ' CD1' ' O ' ' A' ' 137' ' ' LEU . 0.1 OUTLIER -80.0 -13.7 59.13 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-O 120.921 0.391 . . . . 0.0 111.53 -179.679 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.586 HD23 HD12 ' A' ' 144' ' ' LEU . 74.8 mt -57.64 -34.05 68.93 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.072 179.099 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -53.45 -47.2 69.91 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 179.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' TRP . . . . . 0.434 ' CE2' HD12 ' A' ' 52' ' ' ILE . 8.8 t-105 -63.37 -44.2 95.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.74 179.523 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.586 HD12 HD23 ' A' ' 141' ' ' LEU . 25.3 mt -55.19 -54.97 36.61 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.334 -0.547 . . . . 0.0 110.281 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.534 ' O ' HG23 ' A' ' 149' ' ' VAL . . . -64.68 -23.57 67.3 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.636 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 25.9 t80 -61.35 -59.16 5.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.771 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -64.33 -50.38 68.0 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.005 -179.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 10.9 m -52.62 -55.83 19.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.904 0.383 . . . . 0.0 110.769 -179.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.534 HG23 ' O ' ' A' ' 145' ' ' ALA . 80.9 t -58.25 -35.05 51.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.726 -179.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.432 ' O ' HG23 ' A' ' 154' ' ' VAL . 4.8 tp -54.7 -58.11 8.82 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.471 -179.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . 0.763 HD22 ' N ' ' A' ' 152' ' ' TYR . 0.2 OUTLIER -56.4 -58.89 6.08 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-O 120.988 0.423 . . . . 0.0 110.783 179.94 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . 0.763 ' N ' HD22 ' A' ' 151' ' ' ASN . 50.5 t80 -47.42 -39.65 16.03 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.83 -179.383 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 31.5 t80 -72.12 -35.83 69.25 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.401 -179.53 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.432 HG23 ' O ' ' A' ' 150' ' ' LEU . 45.1 t -59.15 -47.04 91.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 C-N-CA 120.791 -0.364 . . . . 0.0 111.395 -179.291 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' TRP . . . . . 0.495 ' CZ3' ' CE ' ' A' ' 105' ' ' MET . 22.9 m95 -79.95 -28.68 39.63 Favored 'General case' 0 N--CA 1.464 0.225 0 C-N-CA 119.818 -0.753 . . . . 0.0 111.521 -179.279 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.41 -21.66 61.23 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.461 -0.495 . . . . 0.0 110.164 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -83.57 -40.06 19.58 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.918 -179.668 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 18.2 t30 -90.53 -24.24 20.69 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.084 -179.587 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 63.69 148.33 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.34 -179.754 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -95.13 -170.08 36.46 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 111.31 -0.716 . . . . 0.0 111.31 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 69.1 mtt180 -80.6 39.17 0.46 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.69 0.281 . . . . 0.0 110.771 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 32.8 mtt180 -63.92 153.63 36.38 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.66 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -72.7 177.21 41.49 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 110.97 -0.852 . . . . 0.0 110.97 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -96.58 -3.35 59.7 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 111.035 -0.826 . . . . 0.0 111.035 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -160.69 170.9 19.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.784 0.326 . . . . 0.0 110.641 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 89.6 mtt180 -101.7 -132.29 0.27 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.305 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.608 ' N ' HD12 ' A' ' 167' ' ' LEU . 8.8 mp -89.28 -171.9 3.42 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.884 0.373 . . . . 0.0 110.63 -179.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -163.49 125.59 2.5 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.329 179.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 . . . . . 0 C--O 1.22 -0.455 0 CA-C-O 117.943 -1.027 . . . . 0.0 110.572 -179.959 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' PKA . . . . . 0.517 'CL ' ' C15' ' A' ' 201' ' ' PKA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.537 ' SD ' ' N ' ' A' ' 1' ' ' MET . 9.3 mmm . . . . . 0 CA--C 1.529 0.148 0 N-CA-C 110.451 -0.203 . . . . 0.0 110.451 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -75.51 39.36 0.62 Allowed 'Trans proline' 0 N--CA 1.493 1.488 0 C-N-CA 121.778 1.652 . . . . 0.0 112.034 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -56.98 -42.48 80.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.715 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.8 t 53.61 179.31 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.463 -179.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.559 ' O ' HG23 ' A' ' 9' ' ' VAL . 0.7 OUTLIER -79.58 116.84 20.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.275 -179.826 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.585 ' N ' ' CD ' ' A' ' 7' ' ' PRO . 0.9 OUTLIER -60.84 -33.62 15.03 Favored Pre-proline 0 CA--C 1.533 0.306 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.144 -179.759 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.585 ' CD ' ' N ' ' A' ' 6' ' ' VAL . 24.2 Cg_exo -73.34 -62.64 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 121.613 1.542 . . . . 0.0 111.518 179.282 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.708 ' O ' HG23 ' A' ' 12' ' ' THR . . . -50.78 -36.51 37.29 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.849 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.559 HG23 ' O ' ' A' ' 5' ' ' TRP . 56.0 t -68.27 -62.17 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.511 -179.442 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -55.6 -47.73 75.42 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 111.484 -0.646 . . . . 0.0 111.484 -179.33 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.434 ' N ' HD12 ' A' ' 11' ' ' LEU . 8.5 mp -64.84 -30.86 71.88 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 121.177 -0.209 . . . . 0.0 110.968 -179.514 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.708 HG23 ' O ' ' A' ' 8' ' ' ALA . 6.1 p -74.47 -22.95 58.84 Favored 'General case' 0 C--N 1.333 -0.135 0 C-N-CA 120.569 -0.453 . . . . 0.0 110.016 179.439 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 52.5 mt -80.18 -34.77 37.24 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.213 179.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.415 ' N ' ' HD2' ' A' ' 15' ' ' PRO . 11.9 t -43.63 -55.21 9.05 Favored Pre-proline 0 CA--C 1.536 0.423 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.45 -179.722 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.415 ' HD2' ' N ' ' A' ' 14' ' ' VAL . 13.8 Cg_endo -58.92 -21.92 60.26 Favored 'Trans proline' 0 N--CA 1.498 1.754 0 C-N-CA 120.672 0.915 . . . . 0.0 112.303 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 5.7 t -62.08 -30.59 71.1 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.825 -179.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 71.5 mt -71.62 -57.1 4.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.817 0.342 . . . . 0.0 110.893 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -61.16 -36.97 93.18 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 111.287 -0.725 . . . . 0.0 111.287 -179.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -75.44 -25.94 66.9 Favored Glycine 0 CA--C 1.521 0.461 0 N-CA-C 110.694 -0.962 . . . . 0.0 110.694 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 62.0 t80 -75.54 -60.62 2.23 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.528 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 3.9 ttt -70.16 -22.29 62.99 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.17 179.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -69.47 -62.31 3.97 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.825 -0.91 . . . . 0.0 110.825 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.496 ' O ' HG22 ' A' ' 26' ' ' VAL . . . -68.55 -21.28 64.56 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.831 -0.348 . . . . 0.0 110.635 -179.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 40.2 t80 -47.45 -24.0 0.73 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.013 0.435 . . . . 0.0 109.984 179.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 25.6 t80 -69.72 -52.26 27.07 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.966 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.496 HG22 ' O ' ' A' ' 23' ' ' ALA . 36.0 m -72.14 -15.89 18.2 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.894 -179.736 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -59.82 -28.88 67.85 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.258 -179.388 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -123.39 -59.39 0.19 Allowed Glycine 0 CA--C 1.524 0.643 0 N-CA-C 111.199 -0.76 . . . . 0.0 111.199 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 27.7 tp10 -53.92 -28.99 40.18 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.745 0.307 . . . . 0.0 110.686 -179.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -73.78 -40.98 43.73 Favored Glycine 0 CA--C 1.526 0.754 0 N-CA-C 111.134 -0.786 . . . . 0.0 111.134 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 85.6 mt -62.98 -33.2 74.9 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.881 0.372 . . . . 0.0 110.482 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 18.6 mmm-85 -81.0 -40.01 24.98 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.35 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . 0.489 ' O ' ' N ' ' A' ' 36' ' ' GLY . 0.0 OUTLIER -56.11 -40.41 73.67 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.802 179.624 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 91.4 t80 -44.5 -42.11 6.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.518 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -60.27 -29.32 68.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.145 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.489 ' N ' ' O ' ' A' ' 33' ' ' TRP . . . -84.86 -76.72 1.19 Allowed Glycine 0 CA--C 1.524 0.602 0 N-CA-C 110.437 -1.065 . . . . 0.0 110.437 179.679 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.582 ' O ' HD12 ' A' ' 37' ' ' LEU . 0.3 OUTLIER -95.65 166.94 11.58 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.791 0.329 . . . . 0.0 110.221 179.277 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.415 ' N ' ' CD ' ' A' ' 38' ' ' GLN . 3.7 mp0 -81.54 113.02 19.29 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.483 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.49 ' C ' ' H ' ' A' ' 41' ' ' SER . 8.9 mtpt -122.18 146.63 47.25 Favored Pre-proline 0 N--CA 1.464 0.265 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.05 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.623 ' C ' ' H ' ' A' ' 42' ' ' TRP . 85.5 Cg_endo -74.13 30.19 0.33 Allowed 'Trans proline' 0 C--N 1.309 -1.503 0 C-N-CA 121.28 1.32 . . . . 0.0 111.386 179.406 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.49 ' H ' ' C ' ' A' ' 39' ' ' LYS . 53.7 p -52.37 -0.1 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.94 179.565 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . 0.623 ' H ' ' C ' ' A' ' 40' ' ' PRO . 1.2 p90 -75.72 -14.0 60.32 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.398 -0.521 . . . . 0.0 110.758 -178.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.481 ' O ' ' C ' ' A' ' 44' ' ' PRO . 30.5 m-70 -74.59 140.32 75.13 Favored Pre-proline 0 C--N 1.328 -0.359 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 178.759 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.481 ' C ' ' O ' ' A' ' 43' ' ' HIS . 51.9 Cg_exo -32.55 131.54 0.1 OUTLIER 'Trans proline' 0 N--CA 1.492 1.439 0 C-N-CA 121.204 1.27 . . . . 0.0 111.346 -179.343 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.431 ' O ' ' N ' ' A' ' 47' ' ' TRP . 5.8 Cg_exo -54.82 162.94 4.45 Favored 'Trans proline' 0 C--N 1.311 -1.402 0 CA-C-N 118.791 0.604 . . . . 0.0 111.676 -179.191 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.462 ' O ' ' CB ' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -45.47 -17.73 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.202 -179.482 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.599 ' CD1' ' N ' ' A' ' 48' ' ' THR . 1.6 p-90 -63.74 -48.6 76.35 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.851 -0.34 . . . . 0.0 111.587 -179.03 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.599 ' N ' ' CD1' ' A' ' 47' ' ' TRP . 1.1 m -90.16 -27.45 19.57 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.555 -178.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.703 ' O ' HG23 ' A' ' 52' ' ' ILE . 0.1 OUTLIER -83.39 -45.92 13.15 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.473 -0.491 . . . . 0.0 112.029 -178.733 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.615 ' C ' ' H ' ' A' ' 52' ' ' ILE . . . -40.94 -28.92 0.23 Allowed Pre-proline 0 N--CA 1.465 0.281 0 N-CA-C 111.892 0.33 . . . . 0.0 111.892 -179.057 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.409 ' HD2' ' N ' ' A' ' 50' ' ' ALA . 17.6 Cg_exo -54.03 7.36 0.03 OUTLIER 'Trans proline' 0 C--N 1.312 -1.359 0 CA-C-N 119.126 0.724 . . . . 0.0 112.78 178.501 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.703 HG23 ' O ' ' A' ' 49' ' ' LEU . 8.1 pt -55.19 -31.35 26.05 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.133 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 178.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.403 ' O ' ' CB ' ' A' ' 57' ' ' TYR . 72.8 m95 -80.98 -22.21 39.7 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.124 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -69.92 -52.12 20.78 Favored Glycine 0 CA--C 1.527 0.828 0 N-CA-C 109.987 -1.245 . . . . 0.0 109.987 178.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.617 HG23 ' N ' ' A' ' 56' ' ' LEU . 9.3 t -67.23 -50.2 61.58 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 179.321 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.617 ' N ' HG23 ' A' ' 55' ' ' THR . 90.4 mt -58.4 -33.77 70.01 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 120.655 -0.418 . . . . 0.0 109.89 179.389 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.403 ' CB ' ' O ' ' A' ' 53' ' ' TRP . 3.6 t80 -59.16 -55.93 28.7 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 179.42 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 34.6 t -48.01 -50.33 27.95 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.347 -0.541 . . . . 0.0 109.88 179.339 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -55.63 -52.59 63.28 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.57 179.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.4 ' O ' ' CB ' ' A' ' 64' ' ' SER . 16.2 mtm -55.09 -37.68 67.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.036 -179.715 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -62.87 -41.2 99.92 Favored Glycine 0 CA--C 1.523 0.55 0 N-CA-C 111.216 -0.754 . . . . 0.0 111.216 -179.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -68.61 -60.25 2.55 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.695 0.283 . . . . 0.0 110.869 -179.487 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.475 ' O ' HG23 ' A' ' 67' ' ' VAL . . . -55.48 -56.58 22.83 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 110.749 -0.94 . . . . 0.0 110.749 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.477 ' O ' ' NE1' ' A' ' 68' ' ' TRP . 92.7 p -45.77 -49.53 14.87 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.004 0.43 . . . . 0.0 110.473 179.699 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 73.5 t80 -58.16 -34.4 70.26 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.835 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 96.2 mt -74.25 -39.13 49.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.882 -179.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.475 HG23 ' O ' ' A' ' 63' ' ' GLY . 37.4 t -56.98 -58.17 6.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.616 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . 0.578 ' O ' ' N ' ' A' ' 73' ' ' GLY . 1.0 OUTLIER -60.82 -45.04 96.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.692 -179.837 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 2.7 mmmt -56.65 -25.73 54.25 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.02 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 23.5 tp10 -82.41 -63.06 1.45 Allowed 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.827 -0.349 . . . . 0.0 111.317 -179.359 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.743 ' C ' HD12 ' A' ' 71' ' ' LEU . 3.3 pp -62.93 -7.12 4.58 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.777 -0.369 . . . . 0.0 111.023 -179.478 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.659 ' N ' HD12 ' A' ' 71' ' ' LEU . . . 108.45 71.69 0.73 Allowed Glycine 0 CA--C 1.527 0.791 0 N-CA-C 111.402 -0.679 . . . . 0.0 111.402 179.697 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.578 ' N ' ' O ' ' A' ' 68' ' ' TRP . . . 42.15 -174.03 0.01 OUTLIER Glycine 0 CA--C 1.525 0.698 0 N-CA-C 111.748 -0.541 . . . . 0.0 111.748 179.496 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 63.4 t80 -69.33 111.42 5.22 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.372 -0.414 . . . . 0.0 110.432 -179.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.477 ' OG1' ' N ' ' A' ' 76' ' ' GLU . 1.7 t -140.0 -178.6 5.52 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.538 -179.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.477 ' N ' ' OG1' ' A' ' 75' ' ' THR . 96.3 mt-10 -55.51 -23.24 25.09 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.632 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -79.97 -18.84 49.34 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.664 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -94.09 -24.42 17.59 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.927 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 13.1 mtp -62.19 -26.98 68.65 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.813 -0.355 . . . . 0.0 110.439 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 10.8 t -68.49 -52.99 18.4 Favored Pre-proline 0 CA--C 1.535 0.386 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.953 -179.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -66.42 -59.53 0.13 Allowed 'Trans proline' 0 N--CA 1.497 1.733 0 C-N-CA 120.97 1.113 . . . . 0.0 111.77 179.29 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.445 HD21 ' CZ2' ' A' ' 68' ' ' TRP . 1.2 mt -55.27 -51.49 66.47 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.492 179.714 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -57.82 -51.08 60.22 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 111.153 -0.779 . . . . 0.0 111.153 -179.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.427 ' O ' ' CB ' ' A' ' 88' ' ' GLN . 44.3 tp -60.15 -29.74 68.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.834 0.349 . . . . 0.0 110.61 -179.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 11.6 t80 -71.25 -43.51 67.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.627 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 1.5 m -67.29 -48.03 68.86 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.888 -179.625 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -68.75 -57.27 8.14 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 111.162 -0.775 . . . . 0.0 111.162 -179.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.443 HE21 ' HB2' ' A' ' 92' ' ' ASN . 53.1 tp60 -52.13 -46.01 65.19 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.826 0.346 . . . . 0.0 110.711 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 11.7 tp -66.12 -31.94 73.1 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.94 -179.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.79 ' O ' ' HB2' ' A' ' 94' ' ' ALA . . . -64.4 -65.64 0.65 Allowed 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 120.272 -0.571 . . . . 0.0 111.183 -179.547 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.431 HD12 ' N ' ' A' ' 92' ' ' ASN . 2.8 pp -67.65 -36.96 81.72 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 -178.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.454 HD22 ' HA2' ' A' ' 117' ' ' GLY . 34.7 t30 -75.03 -59.13 2.88 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 -178.768 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . 0.62 ' O ' ' N ' ' A' ' 95' ' ' TRP . 0.0 OUTLIER -69.95 -17.15 63.3 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 120.681 -0.408 . . . . 0.0 111.499 -178.576 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.79 ' HB2' ' O ' ' A' ' 90' ' ' ALA . . . -49.0 83.23 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 120.739 -0.385 . . . . 0.0 110.206 179.512 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.696 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 34.8 p-90 -101.42 -15.75 0.18 Allowed Pre-proline 0 CA--C 1.536 0.419 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 -179.278 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.696 ' CD ' ' N ' ' A' ' 95' ' ' TRP . 32.0 Cg_exo -60.24 -27.79 85.58 Favored 'Trans proline' 0 N--CA 1.495 1.564 0 C-N-CA 120.484 0.79 . . . . 0.0 113.126 179.654 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.52 ' CD ' ' N ' ' A' ' 96' ' ' PRO . 97.2 Cg_exo -58.96 -17.53 37.93 Favored 'Trans proline' 0 N--CA 1.496 1.671 0 C-N-CA 120.592 0.861 . . . . 0.0 113.127 -179.81 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.531 ' O ' ' N ' ' A' ' 101' ' ' GLY . 1.2 pp -82.24 17.26 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 121.105 0.479 . . . . 0.0 110.304 179.699 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -40.22 -31.7 0.14 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.789 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -80.85 -30.32 35.67 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.246 -179.36 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.531 ' N ' ' O ' ' A' ' 98' ' ' ILE . . . -83.66 -11.97 78.67 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 111.372 -0.691 . . . . 0.0 111.372 -179.742 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -63.55 -33.06 74.77 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.673 0.273 . . . . 0.0 111.033 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -75.91 9.65 2.29 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.98 -179.654 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . 0.416 ' C ' ' N ' ' A' ' 106' ' ' GLY . 5.3 mt-30 -126.09 158.83 34.45 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.748 0.308 . . . . 0.0 110.574 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 6.7 mmt -48.79 -18.91 0.31 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.097 0.475 . . . . 0.0 110.348 179.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.593 ' O ' ' N ' ' A' ' 108' ' ' ALA . . . -66.51 -14.59 62.59 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 111.351 -0.7 . . . . 0.0 111.351 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' TRP . . . . . 0.526 ' CZ2' ' ND2' ' A' ' 151' ' ' ASN . 0.0 OUTLIER -42.33 -14.52 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.287 0 CA-C-O 120.561 0.22 . . . . 0.0 111.137 -179.368 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.593 ' N ' ' O ' ' A' ' 106' ' ' GLY . . . -64.78 -24.1 67.45 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.092 0.472 . . . . 0.0 110.321 179.686 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 6.6 mt -49.98 -27.99 6.2 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.59 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.24 -58.51 7.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.733 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.708 ' O ' HG23 ' A' ' 115' ' ' VAL . 1.0 OUTLIER -59.2 -52.32 66.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.558 -179.422 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.538 ' N ' ' CG ' ' A' ' 111' ' ' ASP . 57.4 tp -55.07 -43.17 73.66 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.43 -179.137 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.402 HD23 ' HA ' ' A' ' 113' ' ' LEU . 51.6 mt -67.12 -61.55 1.87 Allowed 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 -178.487 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.0 pp -60.94 -34.04 74.12 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.337 -0.545 . . . . 0.0 111.413 -178.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.708 HG23 ' O ' ' A' ' 111' ' ' ASP . 40.7 t -59.87 -56.82 14.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.763 179.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.491 ' O ' ' OG1' ' A' ' 120' ' ' THR . 41.5 t -72.09 -22.54 61.34 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.54 -179.208 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.454 ' HA2' HD22 ' A' ' 92' ' ' ASN . . . -64.98 -62.74 4.7 Favored Glycine 0 CA--C 1.526 0.75 0 C-N-CA 120.938 -0.648 . . . . 0.0 111.674 -179.357 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.535 ' O ' HG23 ' A' ' 122' ' ' THR . 10.3 p -73.01 -37.62 53.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 C-N-CA 121.08 -0.248 . . . . 0.0 111.408 -179.476 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.527 ' O ' ' OG1' ' A' ' 123' ' ' THR . . . -65.53 -60.24 3.14 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.684 -0.406 . . . . 0.0 111.149 -179.344 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.491 ' OG1' ' O ' ' A' ' 116' ' ' SER . 1.9 m -60.43 -52.77 63.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.673 -179.237 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -54.6 -39.93 68.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.601 -0.272 . . . . 0.0 111.417 -179.166 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.535 HG23 ' O ' ' A' ' 118' ' ' VAL . 22.9 p -71.48 -39.11 71.09 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.994 -0.283 . . . . 0.0 111.728 -179.195 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.527 ' OG1' ' O ' ' A' ' 119' ' ' ALA . 0.1 OUTLIER -58.46 -49.44 77.33 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.782 -0.367 . . . . 0.0 111.08 -179.286 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.2 pp -79.97 -20.48 45.47 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.581 -179.057 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -87.42 -70.88 0.59 Allowed 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 112.515 0.561 . . . . 0.0 112.515 -178.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' TRP . . . . . 0.469 ' N ' ' CD1' ' A' ' 126' ' ' TRP . 32.0 m0 -83.57 -57.36 3.27 Favored 'General case' 0 N--CA 1.465 0.275 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -177.687 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . 0.496 ' CG ' ' HB2' ' A' ' 134' ' ' ALA . 7.0 m170 -54.52 -22.68 13.68 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.642 -0.423 . . . . 0.0 111.419 -178.672 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 17.1 ttt-85 -66.35 -39.62 89.28 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.877 -0.329 . . . . 0.0 111.137 -179.563 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 21.5 t -96.18 -49.77 11.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.149 -179.543 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . 0.467 ' HB2' HG22 ' A' ' 67' ' ' VAL . 16.8 m -114.72 110.35 46.84 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.699 -179.661 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . 0.64 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 77.7 Cg_exo -75.19 -33.11 4.64 Favored 'Trans proline' 0 C--N 1.31 -1.479 0 C-N-CA 121.73 1.62 . . . . 0.0 112.871 179.544 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.64 ' CD ' ' N ' ' A' ' 131' ' ' PRO . 53.1 Cg_exo -52.97 -49.91 15.92 Favored 'Trans proline' 0 N--CA 1.497 1.687 0 C-N-CA 121.587 1.525 . . . . 0.0 112.572 -179.536 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -53.27 -38.98 63.55 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.908 0.385 . . . . 0.0 110.666 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.496 ' HB2' ' CG ' ' A' ' 127' ' ' HIS . . . -56.18 -28.06 56.79 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.596 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 11.4 tpp180 -75.98 -29.66 58.3 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.653 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 54.3 mt -72.43 -35.74 68.39 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.878 0.37 . . . . 0.0 110.118 179.627 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.589 ' O ' ' N ' ' A' ' 140' ' ' TYR . 6.2 mt -82.46 -36.81 26.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.211 179.571 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.519 ' C ' ' H ' ' A' ' 140' ' ' TYR . 0.8 OUTLIER -21.04 -45.48 0.04 OUTLIER Pre-proline 0 N--CA 1.467 0.399 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.811 -179.725 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.559 ' N ' ' O ' ' A' ' 137' ' ' LEU . 5.5 Cg_exo -66.08 14.33 0.11 Allowed 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 120.986 1.124 . . . . 0.0 112.001 179.593 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.771 ' CE2' HD11 ' A' ' 144' ' ' LEU . 3.7 p90 -93.25 -14.64 26.78 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.197 0.522 . . . . 0.0 110.341 179.684 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.656 ' CD1' ' CE1' ' A' ' 140' ' ' TYR . 5.9 mp -58.79 -30.63 67.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.268 178.578 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -60.92 -45.37 94.91 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.983 179.562 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' TRP . . . . . 0.475 ' CE2' HD12 ' A' ' 52' ' ' ILE . 7.7 t-105 -60.33 -49.57 77.06 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 179.415 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.771 HD11 ' CE2' ' A' ' 140' ' ' TYR . 11.9 mt -51.37 -54.61 24.75 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.743 179.322 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.616 ' O ' HG23 ' A' ' 149' ' ' VAL . . . -59.72 -24.79 64.29 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.792 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 23.0 t80 -65.1 -59.16 4.42 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.741 -0.383 . . . . 0.0 110.711 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -67.18 -43.41 82.24 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.622 -0.431 . . . . 0.0 110.633 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 5.2 m -57.3 -55.13 38.79 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.579 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.616 HG23 ' O ' ' A' ' 145' ' ' ALA . 91.2 t -59.19 -31.66 46.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.59 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -58.33 -53.94 52.6 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.796 -0.362 . . . . 0.0 110.068 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . 0.634 HD21 ' C21' ' A' ' 201' ' ' PKA . 8.3 m120 -64.16 -53.37 50.49 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.939 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 31.5 t80 -51.4 -37.53 48.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.867 -179.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 90.8 t80 -67.93 -42.68 80.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.949 -179.692 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 86.7 t -63.61 -38.27 81.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 C-N-CA 120.945 -0.302 . . . . 0.0 110.79 -179.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' TRP . . . . . . . . . . . . . 4.8 m0 -64.06 -45.96 86.49 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.536 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 7.5 mpt_? -70.62 -34.31 71.97 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.954 -179.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -74.64 -37.79 62.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.111 -179.314 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . 0.476 ' O ' ' ND2' ' A' ' 158' ' ' ASN . 0.6 OUTLIER -84.45 -23.42 29.95 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.918 -179.745 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 9.4 p 52.33 -160.1 0.11 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.342 -179.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 165.56 80.19 0.04 OUTLIER Glycine 0 CA--C 1.525 0.694 0 N-CA-C 111.102 -0.799 . . . . 0.0 111.102 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 24.4 ttm180 -98.44 -56.58 2.42 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.771 0.32 . . . . 0.0 110.552 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 67.1 mtt85 -76.96 147.04 37.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.611 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 169.94 165.52 27.44 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 111.064 -0.815 . . . . 0.0 111.064 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -90.88 48.26 3.0 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.904 -0.878 . . . . 0.0 110.904 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 5.7 t -92.77 123.3 35.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.783 0.325 . . . . 0.0 110.61 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 8.4 mtp180 -141.57 -141.67 0.14 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.165 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.794 ' C ' HD22 ' A' ' 167' ' ' LEU . 0.0 OUTLIER -173.76 -10.08 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.834 -0.347 . . . . 0.0 111.217 179.781 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.504 ' N ' HD22 ' A' ' 167' ' ' LEU . . . -43.71 117.13 1.09 Allowed 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.912 -0.315 . . . . 0.0 110.416 179.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 . . . . . 0 C--O 1.22 -0.464 0 CA-C-O 117.985 -1.007 . . . . 0.0 110.64 -179.938 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' PKA . . . . . 0.634 ' C21' HD21 ' A' ' 151' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 56.3 mmm . . . . . 0 CA--C 1.528 0.129 0 CA-C-O 120.546 0.212 . . . . 0.0 110.442 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_exo -39.86 125.85 1.66 Allowed 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 121.819 1.679 . . . . 0.0 112.123 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.546 ' CD ' ' H ' ' A' ' 3' ' ' GLU . 10.3 mp0 -49.71 -52.12 33.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.806 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.407 ' C ' ' O ' ' A' ' 3' ' ' GLU . 34.8 t -38.99 116.78 0.61 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.544 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.688 ' O ' HG23 ' A' ' 9' ' ' VAL . 0.7 OUTLIER -63.97 116.93 6.33 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.282 -179.816 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.594 ' N ' ' CD ' ' A' ' 7' ' ' PRO . 0.9 OUTLIER -62.36 -35.76 22.72 Favored Pre-proline 0 CA--C 1.534 0.35 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.43 -179.715 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.594 ' CD ' ' N ' ' A' ' 6' ' ' VAL . 35.2 Cg_exo -65.99 -64.59 0.05 OUTLIER 'Trans proline' 0 C--N 1.306 -1.665 0 C-N-CA 121.668 1.579 . . . . 0.0 111.827 179.624 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.761 ' O ' HG22 ' A' ' 12' ' ' THR . . . -51.65 -32.76 30.63 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.973 -179.706 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.688 HG23 ' O ' ' A' ' 5' ' ' TRP . 58.5 t -69.87 -61.37 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.94 0.4 . . . . 0.0 111.304 -179.447 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -57.89 -43.36 94.85 Favored Glycine 0 CA--C 1.528 0.853 0 N-CA-C 111.215 -0.754 . . . . 0.0 111.215 -179.545 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 8.1 mp -65.92 -62.95 1.21 Allowed 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 111.544 0.202 . . . . 0.0 111.544 -179.166 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.761 HG22 ' O ' ' A' ' 8' ' ' ALA . 6.9 t -54.38 -20.55 7.57 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.449 -0.5 . . . . 0.0 110.572 -179.395 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.431 ' O ' ' C ' ' A' ' 14' ' ' VAL . 17.6 mt -78.79 -38.12 39.17 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.779 0.324 . . . . 0.0 110.371 179.611 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.432 ' N ' ' HD2' ' A' ' 15' ' ' PRO . 28.1 t -35.55 -56.72 1.01 Allowed Pre-proline 0 CA--C 1.534 0.342 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.63 -179.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.432 ' HD2' ' N ' ' A' ' 14' ' ' VAL . 15.4 Cg_endo -54.6 -32.59 75.46 Favored 'Trans proline' 0 N--CA 1.498 1.772 0 C-N-CA 120.475 0.783 . . . . 0.0 112.501 -179.488 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.421 ' N ' ' O ' ' A' ' 13' ' ' LEU . 2.3 t -45.05 -25.96 0.39 Allowed 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 120.396 -0.522 . . . . 0.0 110.341 -179.586 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 74.5 mt -72.85 -53.69 10.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.128 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -68.61 -34.48 78.69 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 111.594 -0.602 . . . . 0.0 111.594 -179.399 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -75.14 -29.61 60.21 Favored Glycine 0 CA--C 1.517 0.184 0 N-CA-C 110.651 -0.98 . . . . 0.0 110.651 -179.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 36.9 t80 -74.79 -60.71 2.16 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.506 -0.478 . . . . 0.0 110.64 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 9.4 ttt -69.7 -22.85 63.38 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.809 -179.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -73.59 -63.23 2.8 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 111.081 -0.808 . . . . 0.0 111.081 -179.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.482 ' O ' HG22 ' A' ' 26' ' ' VAL . . . -63.83 -23.49 67.38 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.424 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 76.2 t80 -47.83 -23.5 0.76 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.936 0.398 . . . . 0.0 109.95 179.235 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 46.8 t80 -69.49 -52.65 24.56 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.703 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.482 HG22 ' O ' ' A' ' 23' ' ' ALA . 31.1 m -71.14 -16.2 19.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.864 -179.685 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 2.4 tmt_? -58.04 -46.38 85.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.79 0.328 . . . . 0.0 110.568 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -100.73 -60.51 0.81 Allowed Glycine 0 CA--C 1.526 0.749 0 N-CA-C 110.916 -0.873 . . . . 0.0 110.916 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -49.84 -31.69 12.51 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.753 0.311 . . . . 0.0 110.546 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -68.7 -53.6 19.26 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 110.826 -0.91 . . . . 0.0 110.826 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 71.2 mt -51.24 -38.68 53.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.831 0.348 . . . . 0.0 110.51 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 20.1 mmm-85 -75.13 -46.85 31.7 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.035 -179.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 4.8 m95 -47.12 -39.35 13.17 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 120.853 -0.339 . . . . 0.0 110.269 -179.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 77.6 t80 -53.33 -26.11 17.63 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.312 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -75.89 -16.38 60.05 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.377 179.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -111.37 -76.47 0.83 Allowed Glycine 0 CA--C 1.523 0.568 0 N-CA-C 110.727 -0.949 . . . . 0.0 110.727 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.795 ' C ' HD12 ' A' ' 37' ' ' LEU . 3.6 pp -95.27 165.41 12.4 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 110.245 -0.28 . . . . 0.0 110.245 179.708 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.414 ' N ' HD12 ' A' ' 37' ' ' LEU . 77.0 mm-40 -75.55 113.08 12.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.93 0.395 . . . . 0.0 111.624 -179.121 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.538 ' C ' ' H ' ' A' ' 41' ' ' SER . 0.7 OUTLIER -129.59 135.48 27.61 Favored Pre-proline 0 CA--C 1.536 0.424 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 179.313 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.536 ' C ' ' H ' ' A' ' 42' ' ' TRP . 43.1 Cg_endo -70.39 25.54 0.19 Allowed 'Trans proline' 0 N--CA 1.496 1.671 0 C-N-CA 120.386 0.724 . . . . 0.0 111.617 179.582 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.538 ' H ' ' C ' ' A' ' 39' ' ' LYS . 2.9 t -53.54 -2.28 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.154 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . 0.692 ' CH2' ' NE2' ' A' ' 43' ' ' HIS . 48.4 p-90 -77.49 -16.12 58.91 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.365 -0.534 . . . . 0.0 110.708 -179.367 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.692 ' NE2' ' CH2' ' A' ' 42' ' ' TRP . 6.9 m-70 -65.6 147.16 98.84 Favored Pre-proline 0 C--N 1.33 -0.267 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 178.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.474 ' C ' ' O ' ' A' ' 43' ' ' HIS . 53.0 Cg_exo -31.45 114.39 0.05 OUTLIER 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 121.762 1.642 . . . . 0.0 111.441 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.598 ' O ' ' N ' ' A' ' 47' ' ' TRP . 33.1 Cg_exo -41.89 154.24 0.11 Allowed 'Trans proline' 0 C--N 1.308 -1.555 0 CA-C-N 118.796 0.606 . . . . 0.0 111.844 -179.356 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.443 ' O ' ' CB ' ' A' ' 50' ' ' ALA . 3.0 ppt_? -40.19 -16.77 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.034 -179.83 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.622 ' CD1' ' N ' ' A' ' 48' ' ' THR . 0.7 OUTLIER -60.81 -50.41 73.56 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.77 -0.372 . . . . 0.0 111.005 -179.175 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.622 ' N ' ' CD1' ' A' ' 47' ' ' TRP . 0.9 OUTLIER -90.34 -27.24 19.51 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.621 -178.922 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.712 ' O ' HG23 ' A' ' 52' ' ' ILE . 0.1 OUTLIER -83.13 -51.97 7.03 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.524 -0.47 . . . . 0.0 111.867 -178.659 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.613 ' C ' ' H ' ' A' ' 52' ' ' ILE . . . -39.96 -29.57 0.21 Allowed Pre-proline 0 C--O 1.234 0.281 0 N-CA-C 111.88 0.326 . . . . 0.0 111.88 -178.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.404 ' HD2' ' N ' ' A' ' 50' ' ' ALA . 33.7 Cg_exo -53.19 4.5 0.03 OUTLIER 'Trans proline' 0 C--N 1.312 -1.379 0 CA-C-N 119.179 0.742 . . . . 0.0 112.439 178.158 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.712 HG23 ' O ' ' A' ' 49' ' ' LEU . 8.1 pt -52.49 -33.45 17.84 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.174 0 CA-C-O 121.101 0.477 . . . . 0.0 109.961 179.214 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.439 ' O ' ' CB ' ' A' ' 57' ' ' TYR . 72.6 m95 -79.72 -23.38 42.37 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.45 -179.002 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -71.76 -46.22 39.52 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 110.12 -1.192 . . . . 0.0 110.12 179.08 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 5.9 m -68.36 -52.22 35.66 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 179.321 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.413 HD23 ' HA ' ' A' ' 56' ' ' LEU . 96.0 mt -60.02 -28.72 67.97 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.887 179.438 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.512 ' C ' ' CD1' ' A' ' 57' ' ' TYR . 0.4 OUTLIER -63.76 -51.53 64.43 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 179.454 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 5.8 p -53.98 -50.73 65.91 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.152 179.467 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.71 -42.03 87.7 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.329 179.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.517 ' SD ' ' OG1' ' A' ' 12' ' ' THR . 11.3 mtm -59.27 -40.87 87.41 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.926 179.579 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -58.83 -45.09 95.47 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 110.526 -1.03 . . . . 0.0 110.526 179.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.481 ' N ' ' CD1' ' A' ' 62' ' ' TYR . 2.9 m-30 -62.15 -60.0 4.23 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 121.06 -0.256 . . . . 0.0 110.951 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.475 ' O ' HG23 ' A' ' 67' ' ' VAL . . . -54.04 -60.89 7.76 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 110.986 -0.845 . . . . 0.0 110.986 -179.593 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.521 ' O ' ' CD1' ' A' ' 68' ' ' TRP . 56.0 p -45.5 -48.27 14.09 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.012 0.434 . . . . 0.0 110.465 179.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 57.6 t80 -56.47 -41.05 75.91 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.945 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 79.4 mt -67.8 -43.44 86.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.952 -179.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.496 ' CG1' ' CZ3' ' A' ' 68' ' ' TRP . 21.5 t -52.54 -56.33 7.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.86 -179.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . 0.609 ' CE2' HD11 ' A' ' 82' ' ' LEU . 1.0 OUTLIER -66.29 -46.85 75.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.089 -179.391 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.07 -24.46 40.0 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.947 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -81.19 -62.1 1.76 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.348 -179.455 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.2 pp -69.3 -2.15 9.99 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.46 -179.101 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.491 ' O ' ' O ' ' A' ' 73' ' ' GLY . . . 108.4 71.13 0.71 Allowed Glycine 0 CA--C 1.527 0.817 0 N-CA-C 111.572 -0.611 . . . . 0.0 111.572 179.557 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.591 ' N ' ' O ' ' A' ' 68' ' ' TRP . . . 42.03 -173.53 0.01 OUTLIER Glycine 0 CA--C 1.525 0.701 0 N-CA-C 111.94 -0.464 . . . . 0.0 111.94 179.286 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 57.6 t80 -69.81 111.21 5.4 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.203 -0.498 . . . . 0.0 111.009 -179.523 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.516 ' OG1' ' N ' ' A' ' 76' ' ' GLU . 1.3 t -139.4 -175.44 4.18 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.226 179.664 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.516 ' N ' ' OG1' ' A' ' 75' ' ' THR . 73.4 mt-10 -52.92 -24.4 9.18 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.086 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -79.92 -17.71 52.39 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.001 -179.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.531 ' O ' HD12 ' A' ' 82' ' ' LEU . . . -96.78 -15.6 21.26 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.04 -179.495 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 7.0 mtp -70.05 -28.27 65.32 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.484 -0.326 . . . . 0.0 110.885 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 5.1 t -70.47 -54.99 8.02 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.758 -179.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -62.93 -54.61 1.08 Allowed 'Trans proline' 0 N--CA 1.498 1.764 0 C-N-CA 120.993 1.129 . . . . 0.0 111.802 179.324 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.609 HD11 ' CE2' ' A' ' 68' ' ' TRP . 1.5 mt -61.05 -55.91 27.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.533 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -53.33 -60.32 8.34 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 111.084 -0.807 . . . . 0.0 111.084 -179.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.6 tt -48.54 -40.82 28.34 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.781 0.324 . . . . 0.0 110.631 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.4 ' O ' ' CB ' ' A' ' 89' ' ' LEU . 11.0 t80 -63.02 -36.15 82.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.597 -179.747 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.74 -63.05 1.14 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.197 -179.556 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -60.11 -55.59 29.39 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 111.378 -0.689 . . . . 0.0 111.378 -179.547 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.423 ' O ' ' CB ' ' A' ' 92' ' ' ASN . 6.5 tp-100 -50.84 -47.25 60.28 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.652 0.263 . . . . 0.0 111.029 -179.669 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.4 ' CB ' ' O ' ' A' ' 85' ' ' TYR . 11.4 tp -65.3 -28.83 69.59 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.98 0.419 . . . . 0.0 110.313 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.789 ' O ' ' HB2' ' A' ' 94' ' ' ALA . . . -64.7 -65.57 0.66 Allowed 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 120.429 -0.509 . . . . 0.0 111.404 -179.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.3 pp -71.59 -26.11 62.46 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -178.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.423 ' CB ' ' O ' ' A' ' 88' ' ' GLN . 19.1 t-20 -83.53 -57.23 3.32 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.68 -0.408 . . . . 0.0 111.75 -178.847 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . 0.621 ' O ' ' N ' ' A' ' 95' ' ' TRP . 0.0 OUTLIER -72.08 -20.58 61.63 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.693 -0.403 . . . . 0.0 111.091 -178.851 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.789 ' HB2' ' O ' ' A' ' 90' ' ' ALA . . . -46.94 85.31 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.115 0 C-N-CA 120.703 -0.399 . . . . 0.0 110.207 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.707 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 34.4 p-90 -99.77 -16.9 0.2 Allowed Pre-proline 0 CA--C 1.537 0.445 0 CA-C-N 116.2 -0.455 . . . . 0.0 112.119 -179.653 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.707 ' CD ' ' N ' ' A' ' 95' ' ' TRP . 50.1 Cg_exo -55.15 -36.61 93.49 Favored 'Trans proline' 0 N--CA 1.496 1.639 0 C-N-CA 120.424 0.749 . . . . 0.0 113.106 179.483 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.469 ' HD2' ' N ' ' A' ' 96' ' ' PRO . 26.7 Cg_exo -39.74 -29.5 0.29 Allowed 'Trans proline' 0 N--CA 1.491 1.364 0 CA-C-N 118.979 0.671 . . . . 0.0 113.261 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 1.1 pt -83.87 26.45 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 121.109 0.48 . . . . 0.0 110.341 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.444 ' N ' ' O ' ' A' ' 96' ' ' PRO . 11.1 t80 -40.82 -43.52 2.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.794 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -81.53 -42.8 19.66 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.859 -179.699 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -61.09 -7.01 7.94 Favored Glycine 0 CA--C 1.527 0.791 0 N-CA-C 111.21 -0.756 . . . . 0.0 111.21 -179.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -76.01 -7.32 54.38 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 121.015 -0.274 . . . . 0.0 110.884 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 39.7 ptt85 -89.34 2.04 54.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.77 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 9.4 mt-30 -119.47 164.34 15.92 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.492 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.586 ' O ' ' NE1' ' A' ' 155' ' ' TRP . 0.0 OUTLIER -52.44 -17.46 1.22 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.296 179.78 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.577 ' O ' ' N ' ' A' ' 108' ' ' ALA . . . -68.11 -15.34 67.33 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 111.058 -0.817 . . . . 0.0 111.058 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' TRP . . . . . 0.416 ' CD1' ' C ' ' A' ' 107' ' ' TRP . 0.0 OUTLIER -44.87 -11.71 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.726 0.298 . . . . 0.0 110.802 -179.727 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.577 ' N ' ' O ' ' A' ' 106' ' ' GLY . . . -66.99 -23.28 65.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.998 0.428 . . . . 0.0 110.485 179.765 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 8.3 mp -52.44 -29.82 26.43 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.023 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -55.87 -64.02 0.99 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.396 179.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.748 ' O ' HG23 ' A' ' 115' ' ' VAL . 1.6 p30 -55.62 -52.46 63.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.917 -179.418 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.586 ' N ' ' OD1' ' A' ' 111' ' ' ASP . 8.1 tp -55.55 -40.88 72.47 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.884 -0.327 . . . . 0.0 111.714 -178.66 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 50.5 mt -68.68 -61.36 1.85 Allowed 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.678 -0.409 . . . . 0.0 111.912 -178.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.5 pp -57.95 -34.51 69.98 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 120.361 -0.536 . . . . 0.0 111.122 -178.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.748 HG23 ' O ' ' A' ' 111' ' ' ASP . 41.0 t -59.96 -54.52 33.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.912 179.745 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.443 ' O ' ' OG1' ' A' ' 120' ' ' THR . 58.7 m -71.68 -24.01 61.75 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.573 -179.286 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -65.22 -63.05 4.39 Favored Glycine 0 CA--C 1.527 0.821 0 C-N-CA 120.824 -0.703 . . . . 0.0 111.762 -179.32 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.566 ' O ' HG23 ' A' ' 122' ' ' THR . 8.0 p -71.78 -37.87 63.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 O-C-N 122.834 -0.215 . . . . 0.0 111.429 -179.404 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.491 ' O ' ' OG1' ' A' ' 123' ' ' THR . . . -66.22 -60.85 2.4 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.623 -0.431 . . . . 0.0 111.192 -179.171 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.443 ' OG1' ' O ' ' A' ' 116' ' ' SER . 3.0 m -59.1 -54.28 48.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.408 -179.241 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.411 ' O ' ' CB ' ' A' ' 125' ' ' ALA . . . -52.31 -40.35 61.74 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.414 -179.24 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.566 HG23 ' O ' ' A' ' 118' ' ' VAL . 33.4 p -73.71 -35.53 65.12 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 111.918 0.34 . . . . 0.0 111.918 -178.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.491 ' OG1' ' O ' ' A' ' 119' ' ' ALA . 0.1 OUTLIER -59.94 -48.51 81.41 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.821 -0.352 . . . . 0.0 110.947 -179.458 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.6 pp -83.79 -19.98 34.09 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.616 -179.011 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.411 ' CB ' ' O ' ' A' ' 121' ' ' ALA . . . -87.66 -68.03 0.78 Allowed 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -178.606 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' TRP . . . . . 0.44 ' N ' ' CD1' ' A' ' 126' ' ' TRP . 38.0 m0 -85.22 -57.44 3.08 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 112.762 0.653 . . . . 0.0 112.762 -177.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . 0.494 ' CD2' ' N ' ' A' ' 127' ' ' HIS . 8.5 m170 -54.37 -22.46 12.32 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.903 -0.319 . . . . 0.0 111.374 -178.58 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.409 ' C ' ' CD ' ' A' ' 128' ' ' ARG . 0.0 OUTLIER -70.84 -48.49 53.66 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.877 -0.329 . . . . 0.0 111.058 -179.665 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 44.2 t -80.82 -49.83 17.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.207 -179.471 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 5.7 t -129.85 115.6 17.94 Favored Pre-proline 0 CA--C 1.532 0.281 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.827 -179.487 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . 0.565 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 82.7 Cg_exo -72.12 -43.34 1.16 Allowed 'Trans proline' 0 N--CA 1.491 1.371 0 C-N-CA 121.294 1.329 . . . . 0.0 113.077 179.436 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.565 ' CD ' ' N ' ' A' ' 131' ' ' PRO . 68.8 Cg_exo -36.91 -48.82 1.5 Allowed 'Trans proline' 0 N--CA 1.497 1.684 0 C-N-CA 121.038 1.159 . . . . 0.0 112.099 -179.392 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -54.94 -34.98 63.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.042 0.448 . . . . 0.0 110.028 179.568 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.554 ' N ' ' O ' ' A' ' 131' ' ' PRO . . . -61.64 -22.36 65.2 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.316 179.609 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 12.1 tpp180 -77.69 -34.58 52.83 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.844 -179.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 29.9 mt -73.9 -33.52 64.04 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.63 -0.428 . . . . 0.0 109.922 179.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.586 ' O ' ' N ' ' A' ' 139' ' ' PRO . 10.1 mt -80.16 -40.37 27.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.276 -0.42 . . . . 0.0 109.973 179.315 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.493 ' O ' ' CD1' ' A' ' 138' ' ' TYR . 1.1 t80 -23.02 -40.61 0.03 OUTLIER Pre-proline 0 CA--C 1.534 0.335 0 CA-C-N 115.251 -0.886 . . . . 0.0 112.0 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.586 ' N ' ' O ' ' A' ' 137' ' ' LEU . 3.0 Cg_exo -70.59 13.51 0.35 Allowed 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 121.037 1.158 . . . . 0.0 112.237 179.698 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.766 ' CE2' HD11 ' A' ' 144' ' ' LEU . 2.6 p90 -94.18 -14.81 25.21 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-O 121.27 0.557 . . . . 0.0 110.438 179.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.64 ' CD1' ' CE1' ' A' ' 140' ' ' TYR . 5.2 mp -56.41 -27.8 57.55 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.266 178.805 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -63.78 -46.43 85.28 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.002 179.451 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' TRP . . . . . 0.515 ' CE2' HD12 ' A' ' 52' ' ' ILE . 13.6 t-105 -59.61 -46.82 87.84 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 179.572 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.766 HD11 ' CE2' ' A' ' 140' ' ' TYR . 10.8 mt -52.48 -52.34 54.82 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.263 -0.575 . . . . 0.0 109.871 179.625 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.657 ' O ' HG23 ' A' ' 149' ' ' VAL . . . -64.14 -21.76 66.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.664 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 13.5 t80 -66.09 -63.0 1.18 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.828 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -68.9 -36.48 78.08 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.882 -179.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . 0.498 ' O ' ' OD1' ' A' ' 151' ' ' ASN . 14.8 m -63.32 -50.01 71.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.735 0.302 . . . . 0.0 110.684 -179.828 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.657 HG23 ' O ' ' A' ' 145' ' ' ALA . 88.3 t -65.84 -30.69 50.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.567 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 1.4 tp -60.53 -52.9 63.22 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.9 -0.32 . . . . 0.0 110.209 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . 0.498 ' OD1' ' O ' ' A' ' 148' ' ' THR . 0.8 OUTLIER -64.53 -44.04 92.12 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.905 -179.959 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . 0.495 ' N ' ' ND2' ' A' ' 151' ' ' ASN . 26.0 t80 -56.64 -44.51 81.37 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.653 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . 0.428 ' CD2' ' OD2' ' A' ' 157' ' ' ASP . 20.5 t80 -59.08 -55.07 39.85 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.574 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 64.8 t -57.35 -46.09 85.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.75 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' TRP . . . . . 0.586 ' NE1' ' O ' ' A' ' 105' ' ' MET . 5.1 m0 -48.07 -52.06 21.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.818 0.342 . . . . 0.0 110.173 179.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . 0.435 ' HA ' ' HE ' ' A' ' 156' ' ' ARG . 0.0 OUTLIER -64.7 -52.2 58.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.685 -179.83 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . 0.428 ' OD2' ' CD2' ' A' ' 153' ' ' TYR . 80.0 m-20 -50.02 -48.14 52.76 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.854 -179.689 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 29.2 t-20 -67.83 -30.88 70.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.777 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 31.4 t -73.67 157.69 36.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.699 -179.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -162.36 -169.42 25.71 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 111.013 -0.835 . . . . 0.0 111.013 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 39.4 mtm105 -141.61 -107.08 0.14 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.745 0.307 . . . . 0.0 110.47 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 85.8 mtt180 -92.86 149.58 21.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.589 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -166.11 -70.04 0.03 OUTLIER Glycine 0 CA--C 1.526 0.746 0 N-CA-C 110.941 -0.864 . . . . 0.0 110.941 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 68.04 95.98 0.04 OUTLIER Glycine 0 CA--C 1.525 0.678 0 N-CA-C 111.183 -0.767 . . . . 0.0 111.183 179.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 2.3 p -97.27 115.25 27.28 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.753 0.311 . . . . 0.0 110.538 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 38.5 ttm-85 -86.83 42.23 1.01 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.703 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.501 ' C ' ' H ' ' A' ' 169' ' ' GLU . 2.2 mp -139.37 179.32 6.61 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.93 0.395 . . . . 0.0 110.743 -179.684 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.49 ' HB3' ' O ' ' A' ' 167' ' ' LEU . . . 69.41 -38.86 0.41 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.884 179.725 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . 0.501 ' H ' ' C ' ' A' ' 167' ' ' LEU . 42.6 mm-40 . . . . . 0 C--O 1.219 -0.505 0 CA-C-O 117.963 -1.018 . . . . 0.0 110.655 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' PKA . . . . . 0.534 'CL ' ' C15' ' A' ' 201' ' ' PKA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.425 ' O ' ' N ' ' A' ' 3' ' ' GLU . 5.1 mmt . . . . . 0 CA--C 1.528 0.115 0 N-CA-C 110.406 -0.22 . . . . 0.0 110.406 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_exo -48.81 89.99 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 121.687 1.591 . . . . 0.0 112.147 179.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.425 ' N ' ' O ' ' A' ' 1' ' ' MET . 20.8 mt-10 -66.55 -16.75 64.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.457 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.1 t 62.65 -162.55 0.28 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.919 179.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.711 ' CE2' ' CE3' ' A' ' 68' ' ' TRP . 0.4 OUTLIER -55.38 117.87 3.93 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.595 -179.738 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.638 ' N ' ' CD ' ' A' ' 7' ' ' PRO . 1.0 OUTLIER -64.26 -33.32 8.96 Favored Pre-proline 0 C--N 1.328 -0.329 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 179.662 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.638 ' CD ' ' N ' ' A' ' 6' ' ' VAL . 18.9 Cg_exo -72.78 -67.12 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 121.855 1.703 . . . . 0.0 111.867 179.613 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.711 ' O ' HG23 ' A' ' 12' ' ' THR . . . -47.74 -41.89 24.12 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.319 -179.537 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.468 ' O ' ' OG1' ' A' ' 12' ' ' THR . 74.7 t -67.94 -62.41 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -178.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -53.78 -47.53 64.74 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 111.567 -0.613 . . . . 0.0 111.567 -179.163 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.415 ' N ' ' CD1' ' A' ' 11' ' ' LEU . 7.6 mp -65.34 -30.53 71.37 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.533 0.206 . . . . 0.0 111.105 -179.519 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.711 HG23 ' O ' ' A' ' 8' ' ' ALA . 6.6 p -76.14 -25.18 55.08 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.749 -0.381 . . . . 0.0 110.786 -179.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.425 ' O ' ' C ' ' A' ' 14' ' ' VAL . 9.3 mt -81.72 -36.3 28.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.673 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.428 ' N ' ' HD2' ' A' ' 15' ' ' PRO . 4.9 t -37.08 -55.08 1.74 Allowed Pre-proline 0 CA--C 1.535 0.398 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.784 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.428 ' HD2' ' N ' ' A' ' 14' ' ' VAL . 19.3 Cg_endo -60.98 -47.82 11.84 Favored 'Trans proline' 0 N--CA 1.5 1.868 0 C-N-CA 120.678 0.919 . . . . 0.0 112.125 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.9 m -46.01 -22.14 0.19 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.662 -179.556 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 83.9 mt -71.02 -55.9 7.32 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.85 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -74.84 -21.57 78.33 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 111.157 -0.777 . . . . 0.0 111.157 -179.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -69.79 -52.69 18.71 Favored Glycine 0 CA--C 1.522 0.483 0 N-CA-C 110.573 -1.011 . . . . 0.0 110.573 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 68.9 t80 -71.14 -57.88 4.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.721 0.296 . . . . 0.0 110.595 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 8.1 tpp -59.95 -25.69 65.39 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.278 -179.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -82.55 -62.98 1.81 Allowed Glycine 0 CA--C 1.525 0.718 0 C-N-CA 120.839 -0.696 . . . . 0.0 111.485 -179.421 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.582 ' O ' HG22 ' A' ' 26' ' ' VAL . . . -59.6 -15.64 20.14 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.798 -0.361 . . . . 0.0 110.659 -179.371 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 61.6 t80 -46.7 -26.19 0.88 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.981 0.42 . . . . 0.0 110.389 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 70.5 t80 -67.73 -50.65 56.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.661 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.603 HG21 'CL ' ' A' ' 201' ' ' PKA . 31.3 m -72.57 -21.03 19.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.671 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -61.24 -41.09 96.28 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.381 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -110.17 -73.44 0.74 Allowed Glycine 0 CA--C 1.525 0.702 0 N-CA-C 111.034 -0.826 . . . . 0.0 111.034 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.422 ' O ' ' CD ' ' A' ' 29' ' ' GLU . 13.0 tm-20 -46.01 -26.51 0.74 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.753 0.311 . . . . 0.0 110.57 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -65.28 -53.25 33.96 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 111.185 -0.766 . . . . 0.0 111.185 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 24.7 mt -48.5 -28.93 3.66 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.916 0.389 . . . . 0.0 110.211 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 82.8 mtt180 -84.1 -53.75 5.32 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.567 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . 0.637 ' CZ3' HD21 ' A' ' 37' ' ' LEU . 0.0 OUTLIER -44.74 -35.92 2.92 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.19 -0.459 . . . . 0.0 109.96 179.949 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.443 ' O ' ' O ' ' A' ' 37' ' ' LEU . 2.8 t80 -64.42 -46.62 82.42 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.938 179.558 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -51.18 -22.88 2.86 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.124 179.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -90.59 -73.9 1.27 Allowed Glycine 0 CA--C 1.524 0.614 0 N-CA-C 110.569 -1.013 . . . . 0.0 110.569 179.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.637 HD21 ' CZ3' ' A' ' 33' ' ' TRP . 0.6 OUTLIER -96.2 167.23 11.32 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 120.791 0.329 . . . . 0.0 110.238 179.171 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -77.57 116.09 17.86 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.963 0.411 . . . . 0.0 111.55 -178.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.496 ' C ' ' H ' ' A' ' 41' ' ' SER . 8.0 mtpt -128.93 149.12 71.54 Favored Pre-proline 0 CA--C 1.532 0.275 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.562 179.385 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.656 ' C ' ' H ' ' A' ' 42' ' ' TRP . 93.5 Cg_endo -74.05 20.2 0.41 Allowed 'Trans proline' 0 C--N 1.308 -1.564 0 C-N-CA 121.199 1.266 . . . . 0.0 111.022 179.304 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.496 ' H ' ' C ' ' A' ' 39' ' ' LYS . 11.9 p -49.28 -0.67 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.212 179.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . 0.656 ' H ' ' C ' ' A' ' 40' ' ' PRO . 1.8 p90 -75.56 -15.53 60.36 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.568 -0.453 . . . . 0.0 110.662 -179.076 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.455 ' O ' ' C ' ' A' ' 44' ' ' PRO . 3.6 m-70 -62.7 147.28 93.38 Favored Pre-proline 0 C--N 1.329 -0.3 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 179.095 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.474 ' O ' ' O ' ' A' ' 45' ' ' PRO . 6.7 Cg_endo -32.76 120.42 0.1 OUTLIER 'Trans proline' 0 N--CA 1.493 1.46 0 C-N-CA 121.483 1.455 . . . . 0.0 110.837 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.474 ' O ' ' O ' ' A' ' 44' ' ' PRO . 1.5 Cg_endo -37.89 160.99 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.398 0 C-N-CA 120.342 0.694 . . . . 0.0 111.997 -178.411 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.632 ' O ' ' HB3' ' A' ' 50' ' ' ALA . 7.1 ppt_? -49.37 -22.83 1.23 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.277 -0.874 . . . . 0.0 112.134 -178.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.585 ' CD1' ' N ' ' A' ' 48' ' ' THR . 1.2 p-90 -58.94 -41.5 87.55 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.93 0.715 . . . . 0.0 112.93 -178.487 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.585 ' N ' ' CD1' ' A' ' 47' ' ' TRP . 0.9 OUTLIER -88.86 -43.44 11.21 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.477 0.547 . . . . 0.0 112.477 -177.6 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.666 ' O ' HG23 ' A' ' 52' ' ' ILE . 44.1 tp -82.81 -51.59 7.52 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.134 -0.626 . . . . 0.0 112.471 -178.051 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.632 ' HB3' ' O ' ' A' ' 46' ' ' ARG . . . -41.74 -28.92 0.27 Allowed Pre-proline 0 N--CA 1.466 0.358 0 C-N-CA 120.22 -0.592 . . . . 0.0 111.46 -179.138 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.426 ' HD2' ' N ' ' A' ' 50' ' ' ALA . 23.2 Cg_exo -53.05 4.06 0.03 OUTLIER 'Trans proline' 0 C--N 1.312 -1.364 0 CA-C-N 118.847 0.624 . . . . 0.0 112.123 177.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.666 HG23 ' O ' ' A' ' 49' ' ' LEU . 7.1 pt -48.44 -29.61 2.55 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.177 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 179.054 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 6.5 m0 -58.97 -45.44 90.54 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.465 -0.788 . . . . 0.0 110.89 -179.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -68.84 -42.53 78.48 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 110.901 -0.879 . . . . 0.0 110.901 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.48 ' O ' ' OG ' ' A' ' 58' ' ' SER . 51.9 m -59.04 -56.31 23.93 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.798 0.332 . . . . 0.0 110.709 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 70.4 mt -67.32 -30.45 70.29 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.665 -179.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.493 ' C ' ' CD1' ' A' ' 57' ' ' TYR . 13.7 t80 -60.8 -36.31 78.7 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.132 179.572 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.48 ' OG ' ' O ' ' A' ' 55' ' ' THR . 7.7 p -74.07 -57.92 3.64 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.047 179.587 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -48.53 -52.29 23.29 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.022 179.645 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 70.6 mtm -55.09 -47.88 74.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.072 179.608 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -46.82 -59.56 5.44 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 110.717 -0.953 . . . . 0.0 110.717 179.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 3.4 m-30 -51.84 -52.18 51.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.924 0.392 . . . . 0.0 110.116 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.501 ' O ' HG23 ' A' ' 67' ' ' VAL . . . -47.83 -46.76 25.33 Favored Glycine 0 CA--C 1.522 0.53 0 N-CA-C 110.487 -1.045 . . . . 0.0 110.487 179.674 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.537 ' O ' ' NE1' ' A' ' 68' ' ' TRP . 1.1 t -60.53 -45.04 95.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.793 0.33 . . . . 0.0 110.577 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.416 ' HA ' ' CZ2' ' A' ' 68' ' ' TRP . 84.6 t80 -48.55 -45.85 38.19 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 179.58 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 37.9 mt -72.27 -26.06 24.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.136 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.501 HG23 ' O ' ' A' ' 63' ' ' GLY . 55.8 t -65.21 -59.94 3.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 C-N-CA 120.584 -0.446 . . . . 0.0 111.09 -179.673 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . 0.711 ' CE3' ' CE2' ' A' ' 5' ' ' TRP . 0.0 OUTLIER -67.51 -33.83 75.88 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 119.9 -0.72 . . . . 0.0 110.563 -179.753 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 5.8 mmmt -69.56 -23.41 63.56 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.517 -0.473 . . . . 0.0 111.035 -179.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 19.9 tp10 -80.95 -55.61 4.67 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.941 -0.304 . . . . 0.0 111.226 -179.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.6 pp -77.04 -11.77 59.85 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.93 -0.308 . . . . 0.0 111.184 -179.301 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.491 ' O ' ' O ' ' A' ' 73' ' ' GLY . . . 107.0 87.29 1.93 Allowed Glycine 0 CA--C 1.527 0.835 0 N-CA-C 111.604 -0.598 . . . . 0.0 111.604 179.398 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.596 ' N ' ' O ' ' A' ' 68' ' ' TRP . . . 41.56 -173.82 0.01 OUTLIER Glycine 0 CA--C 1.525 0.714 0 N-CA-C 111.797 -0.521 . . . . 0.0 111.797 179.207 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 82.7 t80 -79.94 113.39 18.07 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.841 0.353 . . . . 0.0 110.548 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.548 ' OG1' ' N ' ' A' ' 76' ' ' GLU . 0.0 OUTLIER -141.89 -178.85 5.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.626 -179.86 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.548 ' N ' ' OG1' ' A' ' 75' ' ' THR . 31.8 mt-10 -54.93 -20.12 8.23 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.623 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 76.0 m-20 -83.1 -18.57 39.1 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.921 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -93.32 -20.21 20.61 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.862 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 11.7 mtp -69.01 -27.22 65.49 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.846 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 5.9 t -67.56 -46.9 47.3 Favored Pre-proline 0 CA--C 1.536 0.432 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.534 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -75.18 -61.65 0.04 OUTLIER 'Trans proline' 0 N--CA 1.499 1.845 0 C-N-CA 121.106 1.204 . . . . 0.0 111.656 178.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 4.6 mt -52.33 -50.66 61.84 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.363 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.406 ' O ' ' N ' ' A' ' 86' ' ' THR . . . -61.93 -64.04 4.27 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 111.262 -0.735 . . . . 0.0 111.262 -179.705 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 40.3 tp -46.83 -29.61 2.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.823 0.344 . . . . 0.0 110.233 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.423 ' CD1' ' C ' ' A' ' 85' ' ' TYR . 1.1 t80 -75.27 -37.68 60.82 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.033 179.744 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.406 ' N ' ' O ' ' A' ' 83' ' ' GLY . 0.8 OUTLIER -67.91 -48.92 64.63 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.094 -179.648 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -69.15 -58.04 7.06 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 111.492 -0.643 . . . . 0.0 111.492 -179.507 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 34.0 tp60 -51.45 -49.23 62.14 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-O 120.991 0.424 . . . . 0.0 110.414 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.427 ' O ' ' C ' ' A' ' 90' ' ' ALA . 27.3 tp -54.65 -62.62 1.54 Allowed 'General case' 0 C--O 1.212 -0.869 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 179.525 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.696 ' O ' ' HB2' ' A' ' 94' ' ' ALA . . . -38.24 -42.81 0.72 Allowed 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 120.537 -0.465 . . . . 0.0 111.426 -179.683 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 92.1 mt -63.16 -56.81 13.57 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 -178.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 15.8 m-20 -72.24 -54.63 9.02 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 121.431 0.634 . . . . 0.0 111.058 -178.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . 0.61 ' O ' ' N ' ' A' ' 95' ' ' TRP . 16.6 t-105 -52.75 -30.0 30.23 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.049 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.696 ' HB2' ' O ' ' A' ' 90' ' ' ALA . . . -60.38 71.8 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 121.084 0.469 . . . . 0.0 109.753 179.376 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.71 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 23.8 p-90 -98.49 -17.18 0.2 Allowed Pre-proline 0 CA--C 1.537 0.478 0 CA-C-N 115.852 -0.613 . . . . 0.0 112.336 -179.255 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.71 ' CD ' ' N ' ' A' ' 95' ' ' TRP . 52.6 Cg_exo -53.4 -39.84 80.31 Favored 'Trans proline' 0 N--CA 1.497 1.684 0 C-N-CA 120.556 0.837 . . . . 0.0 113.341 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.457 ' HD2' ' N ' ' A' ' 96' ' ' PRO . 31.7 Cg_exo -36.52 -34.94 0.17 Allowed 'Trans proline' 0 N--CA 1.491 1.327 0 CA-C-N 119.143 0.73 . . . . 0.0 113.185 -179.727 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -79.58 24.27 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 121.024 0.44 . . . . 0.0 110.386 179.696 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.537 ' N ' ' O ' ' A' ' 96' ' ' PRO . 27.0 t80 -44.31 -34.93 2.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.666 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -86.19 -42.97 13.39 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.893 -179.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -61.42 -9.59 18.12 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 111.07 -0.812 . . . . 0.0 111.07 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -61.55 -13.27 20.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.748 0.309 . . . . 0.0 110.935 -179.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 25.3 ptt180 -90.68 4.56 51.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.809 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 12.1 mt-30 -115.28 154.2 29.53 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.435 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -52.71 -18.26 1.73 Allowed 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 179.559 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.583 ' O ' ' N ' ' A' ' 108' ' ' ALA . . . -69.43 -15.96 71.01 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' TRP . . . . . 0.452 ' CD1' ' N ' ' A' ' 108' ' ' ALA . 0.1 OUTLIER -45.36 -11.67 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.9 0.381 . . . . 0.0 110.54 -179.865 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.583 ' N ' ' O ' ' A' ' 106' ' ' GLY . . . -59.32 -23.15 62.24 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.193 179.657 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 13.9 mt -53.7 -28.66 35.05 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.383 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -56.71 -61.37 2.48 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.862 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.716 ' O ' HG23 ' A' ' 115' ' ' VAL . 1.4 p30 -61.53 -52.29 65.08 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.785 -179.293 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.531 ' N ' ' CG ' ' A' ' 111' ' ' ASP . 56.1 tp -55.42 -38.41 68.93 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.716 -178.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.42 HD23 ' HA ' ' A' ' 113' ' ' LEU . 51.7 mt -71.4 -61.81 1.64 Allowed 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.36 0.504 . . . . 0.0 112.36 -178.611 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.6 pp -59.75 -32.84 70.95 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.213 -0.595 . . . . 0.0 110.95 -178.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.716 HG23 ' O ' ' A' ' 111' ' ' ASP . 41.3 t -61.7 -59.47 4.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.752 179.767 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.49 ' O ' ' OG1' ' A' ' 120' ' ' THR . 49.4 m -68.84 -22.1 64.25 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.428 -179.261 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -66.51 -62.58 4.49 Favored Glycine 0 CA--C 1.527 0.823 0 C-N-CA 121.039 -0.601 . . . . 0.0 111.934 -179.124 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.6 ' O ' HG23 ' A' ' 122' ' ' THR . 7.0 p -72.43 -36.91 56.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 C-N-CA 120.915 -0.314 . . . . 0.0 111.411 -179.23 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.531 ' O ' ' OG1' ' A' ' 123' ' ' THR . . . -67.41 -61.01 2.11 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.593 -0.443 . . . . 0.0 110.953 -179.362 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.49 ' OG1' ' O ' ' A' ' 116' ' ' SER . 2.8 m -58.64 -55.33 36.53 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.234 -179.584 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.419 ' O ' ' CB ' ' A' ' 125' ' ' ALA . . . -50.53 -41.95 54.45 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.304 -179.352 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.6 HG23 ' O ' ' A' ' 118' ' ' VAL . 38.9 p -73.32 -39.72 65.04 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 111.844 0.313 . . . . 0.0 111.844 -179.095 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.531 ' OG1' ' O ' ' A' ' 119' ' ' ALA . 0.1 OUTLIER -54.09 -50.28 67.17 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.91 -179.268 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.6 pp -84.11 -20.32 32.76 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.198 -0.455 . . . . 0.0 112.077 -178.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.419 ' CB ' ' O ' ' A' ' 121' ' ' ALA . . . -88.68 -70.68 0.63 Allowed 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 -178.47 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' TRP . . . . . 0.55 ' N ' ' CD1' ' A' ' 126' ' ' TRP . 18.6 m0 -83.93 -58.0 2.97 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 112.84 0.681 . . . . 0.0 112.84 -177.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 18.9 m170 -49.77 -22.23 1.35 Allowed 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.458 -0.497 . . . . 0.0 110.932 -179.128 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 1.4 tmt_? -73.44 -29.47 62.57 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.023 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 14.6 t -99.76 -49.85 11.07 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 CA-C-O 120.942 0.401 . . . . 0.0 110.763 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -115.56 105.83 51.36 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.202 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . 0.64 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 76.9 Cg_exo -72.77 -24.34 18.22 Favored 'Trans proline' 0 C--N 1.311 -1.398 0 C-N-CA 121.59 1.526 . . . . 0.0 112.686 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.64 ' CD ' ' N ' ' A' ' 131' ' ' PRO . 51.2 Cg_exo -66.21 -47.47 3.34 Favored 'Trans proline' 0 N--CA 1.496 1.627 0 C-N-CA 121.292 1.328 . . . . 0.0 112.084 179.624 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -50.41 -39.39 47.03 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.568 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -53.92 -23.48 13.02 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.404 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 11.0 tpp180 -78.25 -32.4 49.63 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.545 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 47.0 mt -72.77 -33.47 66.34 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.32 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.58 ' O ' ' N ' ' A' ' 140' ' ' TYR . 5.6 mt -84.09 -39.26 19.74 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.002 -0.545 . . . . 0.0 109.855 179.519 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.477 ' C ' ' O ' ' A' ' 137' ' ' LEU . 2.0 t80 -23.72 -43.67 0.05 OUTLIER Pre-proline 0 CA--C 1.534 0.338 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.82 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.516 ' N ' ' O ' ' A' ' 137' ' ' LEU . 3.4 Cg_exo -67.61 10.96 0.24 Allowed 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 120.984 1.123 . . . . 0.0 112.561 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.871 ' CE2' HD11 ' A' ' 144' ' ' LEU . 1.5 p90 -93.83 -14.88 25.65 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 121.083 0.468 . . . . 0.0 110.483 179.819 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.618 ' CD1' ' CE1' ' A' ' 140' ' ' TYR . 4.1 mp -53.63 -32.45 51.36 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 179.004 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -60.33 -52.46 65.17 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.217 179.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' TRP . . . . . 0.545 ' CE2' HD12 ' A' ' 52' ' ' ILE . 7.7 t-105 -53.08 -49.66 65.95 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 179.577 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.871 HD11 ' CE2' ' A' ' 140' ' ' TYR . 10.5 mt -49.99 -59.6 3.72 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.015 179.51 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.614 ' O ' HG23 ' A' ' 149' ' ' VAL . . . -58.73 -20.71 51.49 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.056 -179.684 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -67.18 -57.6 6.43 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.805 -0.358 . . . . 0.0 110.402 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -66.08 -47.4 74.38 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.216 179.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 7.1 m -55.68 -51.35 67.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.709 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.614 HG23 ' O ' ' A' ' 145' ' ' ALA . 90.7 t -64.68 -26.53 40.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 C-N-CA 120.895 -0.322 . . . . 0.0 110.278 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -60.72 -55.0 38.38 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.313 -0.555 . . . . 0.0 109.794 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . 0.495 ' ND2' ' OD2' ' A' ' 111' ' ' ASP . 1.9 m-80 -65.85 -39.89 91.19 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.694 -0.403 . . . . 0.0 110.357 179.429 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 29.3 t80 -56.05 -46.19 78.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.569 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . 0.408 ' O ' ' OD1' ' A' ' 157' ' ' ASP . 5.5 t80 -63.56 -44.66 93.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.479 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 79.5 t -57.74 -45.15 86.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.653 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' TRP . . . . . 0.588 ' O ' ' N ' ' A' ' 159' ' ' SER . 10.2 m0 -56.45 -56.98 14.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.518 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . 0.455 ' O ' ' O ' ' A' ' 159' ' ' SER . 0.9 OUTLIER -49.16 -38.71 26.4 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.589 -179.962 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . 0.408 ' OD1' ' O ' ' A' ' 153' ' ' TYR . 1.5 m-20 -75.41 -52.04 11.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.803 0.335 . . . . 0.0 110.675 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . 0.532 HD21 ' CB ' ' A' ' 37' ' ' LEU . 4.7 m120 -74.79 -6.12 47.2 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.648 -179.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . 0.588 ' N ' ' O ' ' A' ' 155' ' ' TRP . 7.6 t -149.03 131.52 15.75 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.808 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -175.32 71.51 0.09 OUTLIER Glycine 0 CA--C 1.526 0.759 0 N-CA-C 111.176 -0.77 . . . . 0.0 111.176 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 10.5 mtm-85 -95.17 90.38 5.87 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.752 0.31 . . . . 0.0 110.505 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 54.9 mtm180 -87.67 124.64 33.77 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.681 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 90.48 -165.5 31.2 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 111.128 -0.789 . . . . 0.0 111.128 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . 0.428 ' H ' ' H ' ' A' ' 165' ' ' SER . . . 176.48 11.76 0.02 OUTLIER Glycine 0 CA--C 1.525 0.707 0 N-CA-C 111.017 -0.833 . . . . 0.0 111.017 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . 0.428 ' H ' ' H ' ' A' ' 164' ' ' GLY . 3.5 t 63.27 -172.26 0.17 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.837 0.351 . . . . 0.0 110.569 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 83.4 mtt180 -89.23 173.41 8.42 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.656 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.78 HD22 ' N ' ' A' ' 167' ' ' LEU . 1.5 mm? -108.13 62.12 0.61 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.113 179.608 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -74.23 -0.84 18.17 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.676 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 . . . . . 0 C--O 1.219 -0.503 0 CA-C-O 118.008 -0.996 . . . . 0.0 110.473 179.852 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' PKA . . . . . 0.603 'CL ' HG21 ' A' ' 26' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.529 0.151 0 CA-C-O 120.74 0.305 . . . . 0.0 110.463 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -73.9 150.14 43.42 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 C-N-CA 122.095 1.863 . . . . 0.0 112.118 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -133.93 -30.94 1.18 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.291 179.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.6 p 73.36 133.8 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.694 179.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.69 ' CE2' ' CE3' ' A' ' 68' ' ' TRP . 0.3 OUTLIER -61.43 118.41 6.94 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.001 179.806 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.609 ' N ' ' CD ' ' A' ' 7' ' ' PRO . 0.9 OUTLIER -61.66 -35.5 22.96 Favored Pre-proline 0 CA--C 1.532 0.277 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 -179.914 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.609 ' CD ' ' N ' ' A' ' 6' ' ' VAL . 18.6 Cg_exo -70.83 -67.53 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.509 0 C-N-CA 121.686 1.59 . . . . 0.0 111.835 179.541 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.656 ' O ' HG23 ' A' ' 12' ' ' THR . . . -46.79 -40.27 13.37 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.202 -179.652 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.572 HG23 ' O ' ' A' ' 5' ' ' TRP . 73.8 t -65.24 -61.97 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 112.062 0.393 . . . . 0.0 112.062 -178.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -58.38 -49.49 75.81 Favored Glycine 0 CA--C 1.527 0.837 0 N-CA-C 111.269 -0.732 . . . . 0.0 111.269 -179.158 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 9.3 mp -58.87 -30.54 67.81 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.538 0.209 . . . . 0.0 110.755 -179.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.656 HG23 ' O ' ' A' ' 8' ' ' ALA . 7.5 p -78.66 -31.18 46.64 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 120.801 -0.36 . . . . 0.0 110.191 179.548 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.416 ' HA ' HD23 ' A' ' 13' ' ' LEU . 81.2 mt -73.53 -22.17 60.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.117 179.656 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.498 ' O ' ' N ' ' A' ' 16' ' ' SER . 9.7 t -58.22 -66.6 1.26 Allowed Pre-proline 0 CA--C 1.536 0.434 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.312 -179.798 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -45.49 -14.87 0.11 Allowed 'Trans proline' 0 N--CA 1.499 1.799 0 C-N-CA 120.778 0.985 . . . . 0.0 112.074 -179.625 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.498 ' N ' ' O ' ' A' ' 14' ' ' VAL . 1.1 t -76.17 -35.99 58.9 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.866 0.365 . . . . 0.0 110.6 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 8.9 mt -69.75 -45.12 68.8 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.172 -179.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -73.6 -48.86 16.25 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 111.631 -0.588 . . . . 0.0 111.631 -179.545 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -63.24 -30.16 76.67 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 111.18 -0.768 . . . . 0.0 111.18 -179.576 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 64.4 t80 -75.95 -60.77 2.18 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.838 -0.345 . . . . 0.0 111.107 -179.528 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 28.0 ttp -61.59 -21.31 64.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.908 0.385 . . . . 0.0 110.324 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.515 ' C ' ' CZ2' ' A' ' 95' ' ' TRP . . . -73.45 -62.9 2.92 Favored Glycine 0 CA--C 1.524 0.615 0 N-CA-C 111.135 -0.786 . . . . 0.0 111.135 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.94 -16.49 63.92 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.54 -179.752 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 42.8 t80 -49.93 -24.15 2.37 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 179.264 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 9.7 t80 -72.11 -53.41 12.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.862 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 16.4 m -72.09 -14.58 17.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.81 -179.668 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.64 -42.69 75.35 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.255 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -121.45 -49.86 0.26 Allowed Glycine 0 CA--C 1.525 0.709 0 N-CA-C 110.693 -0.963 . . . . 0.0 110.693 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -56.01 -32.03 63.61 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.887 0.375 . . . . 0.0 110.417 179.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -75.46 -58.23 3.96 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.874 -0.89 . . . . 0.0 110.874 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 11.0 mp -53.49 -21.89 7.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.903 0.382 . . . . 0.0 110.06 179.676 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 38.9 mtp180 -84.86 -54.98 4.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.526 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -48.52 -30.57 5.36 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.182 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 52.1 t80 -50.3 -40.02 47.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.877 0.37 . . . . 0.0 110.31 179.723 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -58.91 -17.42 24.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.393 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -100.44 -72.15 0.99 Allowed Glycine 0 CA--C 1.527 0.796 0 N-CA-C 111.003 -0.839 . . . . 0.0 111.003 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.575 ' O ' HD12 ' A' ' 37' ' ' LEU . 0.3 OUTLIER -95.45 167.08 11.54 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.838 0.352 . . . . 0.0 110.828 179.861 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.51 ' NE2' ' H ' ' A' ' 38' ' ' GLN . 2.4 mp0 -81.62 113.38 19.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.126 -179.673 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 15.4 mtpt -129.05 160.19 64.91 Favored Pre-proline 0 CA--C 1.531 0.248 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.718 179.489 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.595 ' C ' ' H ' ' A' ' 42' ' ' TRP . 56.3 Cg_endo -82.55 30.48 0.53 Allowed 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 121.806 1.671 . . . . 0.0 111.381 179.356 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -51.12 -1.29 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.486 -179.896 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . 0.673 ' CH2' ' NE2' ' A' ' 43' ' ' HIS . 43.6 p-90 -76.38 -11.3 59.87 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.331 -0.548 . . . . 0.0 110.326 -179.247 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.673 ' NE2' ' CH2' ' A' ' 42' ' ' TRP . 5.6 m80 -63.71 133.16 95.44 Favored Pre-proline 0 C--N 1.328 -0.354 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 178.352 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.538 ' HG2' HD23 ' A' ' 49' ' ' LEU . 30.2 Cg_endo -34.94 149.82 0.03 OUTLIER 'Trans proline' 0 N--CA 1.496 1.622 0 C-N-CA 121.034 1.156 . . . . 0.0 111.464 -179.158 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -53.68 151.1 26.3 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 120.896 1.064 . . . . 0.0 111.823 -179.48 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.58 ' C ' ' HE ' ' A' ' 46' ' ' ARG . 0.0 OUTLIER -52.4 -17.71 1.31 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.997 -179.812 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.56 ' CD1' ' N ' ' A' ' 48' ' ' THR . 0.8 OUTLIER -49.71 -48.68 49.67 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.876 -0.33 . . . . 0.0 111.608 -179.105 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.56 ' N ' ' CD1' ' A' ' 47' ' ' TRP . 12.9 t -91.79 -27.47 17.98 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 -179.496 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.823 ' O ' HG23 ' A' ' 52' ' ' ILE . 0.2 OUTLIER -77.73 -56.77 4.24 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 112.243 0.46 . . . . 0.0 112.243 -178.05 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.587 ' C ' ' H ' ' A' ' 52' ' ' ILE . . . -38.3 -33.78 0.25 Allowed Pre-proline 0 C--O 1.235 0.337 0 C-N-CA 120.771 -0.372 . . . . 0.0 111.431 -179.03 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.43 ' HD2' ' N ' ' A' ' 50' ' ' ALA . 34.4 Cg_exo -53.69 4.93 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.613 0 C-N-CA 120.355 0.703 . . . . 0.0 112.773 178.816 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.823 HG23 ' O ' ' A' ' 49' ' ' LEU . 10.5 pt -54.08 -35.65 29.57 Favored 'Isoleucine or valine' 0 C--O 1.232 0.169 0 CA-C-O 121.248 0.547 . . . . 0.0 109.542 179.157 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.421 ' O ' ' CB ' ' A' ' 57' ' ' TYR . 62.3 m95 -73.17 -22.95 60.38 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.244 -0.889 . . . . 0.0 111.35 -179.285 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -70.49 -48.15 38.33 Favored Glycine 0 CA--C 1.527 0.812 0 N-CA-C 110.481 -1.048 . . . . 0.0 110.481 179.503 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 11.0 m -65.75 -55.28 18.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.969 0.414 . . . . 0.0 109.909 179.58 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.562 ' O ' ' SD ' ' A' ' 60' ' ' MET . 94.8 mt -56.71 -36.29 69.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.954 179.463 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.548 ' C ' ' CD1' ' A' ' 57' ' ' TYR . 0.4 OUTLIER -54.76 -52.03 63.84 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 179.109 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 3.1 m -52.23 -47.26 65.8 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 178.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -56.26 -46.24 79.74 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.343 179.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.562 ' SD ' ' O ' ' A' ' 56' ' ' LEU . 0.0 OUTLIER -61.87 -40.74 96.44 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.334 179.926 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -52.46 -52.89 34.69 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 110.641 -0.984 . . . . 0.0 110.641 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.46 ' CD1' ' N ' ' A' ' 62' ' ' TYR . 1.1 m-85 -65.78 -40.86 92.38 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.925 0.393 . . . . 0.0 110.376 179.762 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.46 ' O ' HG23 ' A' ' 67' ' ' VAL . . . -54.19 -52.55 43.13 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 110.342 -1.103 . . . . 0.0 110.342 179.644 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.587 ' O ' ' CD1' ' A' ' 68' ' ' TRP . 1.0 OUTLIER -56.47 -44.56 80.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.86 0.362 . . . . 0.0 110.42 179.684 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.45 ' HA ' ' CZ2' ' A' ' 68' ' ' TRP . 85.4 t80 -48.45 -47.35 38.27 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.674 -0.41 . . . . 0.0 110.083 179.651 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 53.3 mt -70.7 -25.95 27.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.041 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.46 HG23 ' O ' ' A' ' 63' ' ' GLY . 68.8 t -66.02 -58.79 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 C-N-CA 120.582 -0.447 . . . . 0.0 111.578 -179.41 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . 0.69 ' CE3' ' CE2' ' A' ' 5' ' ' TRP . 0.0 OUTLIER -71.79 -27.8 63.18 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 119.656 -0.818 . . . . 0.0 110.69 -179.643 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 9.4 mmmt -72.25 -24.2 61.33 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.468 -0.493 . . . . 0.0 110.352 179.658 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -82.31 -59.18 2.63 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.949 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.5 pp -71.67 -16.77 62.26 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.02 -179.548 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.5 ' O ' ' O ' ' A' ' 73' ' ' GLY . . . 108.39 94.53 2.34 Favored Glycine 0 CA--C 1.527 0.826 0 N-CA-C 111.703 -0.559 . . . . 0.0 111.703 179.459 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.585 ' N ' ' O ' ' A' ' 68' ' ' TRP . . . 42.02 -174.1 0.01 OUTLIER Glycine 0 CA--C 1.525 0.704 0 N-CA-C 111.799 -0.52 . . . . 0.0 111.799 179.198 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 32.4 t80 -87.22 113.21 22.75 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.547 -0.327 . . . . 0.0 110.595 -179.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.528 ' OG1' ' N ' ' A' ' 76' ' ' GLU . 0.8 OUTLIER -142.13 -177.41 5.22 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.686 -179.909 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.528 ' N ' ' OG1' ' A' ' 75' ' ' THR . 29.5 mt-10 -51.78 -23.14 4.27 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.796 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -79.72 -24.58 41.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.939 -179.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.446 ' O ' HD12 ' A' ' 82' ' ' LEU . . . -90.33 -20.59 22.7 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.003 -179.836 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 14.9 mtp -69.49 -28.66 66.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.806 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.416 ' O ' ' CB ' ' A' ' 84' ' ' LEU . 5.9 t -67.16 -50.77 39.01 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.507 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.4 ' HD2' ' N ' ' A' ' 80' ' ' VAL . 14.7 Cg_endo -69.52 -60.45 0.07 OUTLIER 'Trans proline' 0 N--CA 1.499 1.846 0 C-N-CA 121.065 1.177 . . . . 0.0 111.81 179.031 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.446 HD12 ' O ' ' A' ' 78' ' ' ALA . 1.3 mt -53.37 -51.95 60.84 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.614 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -62.84 -63.33 4.7 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 111.383 -0.687 . . . . 0.0 111.383 -179.485 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.416 ' CB ' ' O ' ' A' ' 80' ' ' VAL . 52.6 tp -45.87 -31.64 2.23 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.749 0.309 . . . . 0.0 110.647 -179.845 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 7.0 t80 -67.96 -58.51 4.42 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.274 -179.729 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 3.5 m -61.89 -60.35 3.77 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.841 -179.754 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -45.56 -57.11 6.04 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 111.112 -0.795 . . . . 0.0 111.112 -179.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 11.1 tp-100 -58.94 -32.85 69.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.759 0.314 . . . . 0.0 110.679 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.445 ' O ' ' CD1' ' A' ' 93' ' ' TRP . 11.8 tp -67.73 -36.59 80.85 Favored 'General case' 0 C--O 1.222 -0.379 0 C-N-CA 120.685 -0.406 . . . . 0.0 110.306 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.856 ' O ' ' HB2' ' A' ' 94' ' ' ALA . . . -65.81 -59.91 3.41 Favored 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 120.268 -0.573 . . . . 0.0 110.379 179.833 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.416 ' N ' HD23 ' A' ' 91' ' ' LEU . 7.9 mt -55.31 -53.89 50.44 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.786 -0.643 . . . . 0.0 112.21 -179.085 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -75.2 -60.83 2.12 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -177.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . 0.611 ' O ' ' N ' ' A' ' 95' ' ' TRP . 0.0 OUTLIER -63.78 -11.74 29.4 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.192 0.441 . . . . 0.0 112.192 -177.688 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.856 ' HB2' ' O ' ' A' ' 90' ' ' ALA . . . -54.12 80.5 0.0 OUTLIER 'General case' 0 CA--C 1.528 0.126 0 C-N-CA 120.399 -0.521 . . . . 0.0 109.76 179.224 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.689 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 14.6 p-90 -101.22 -15.23 0.18 Allowed Pre-proline 0 CA--C 1.534 0.338 0 CA-C-N 116.208 -0.451 . . . . 0.0 112.086 -179.312 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.689 ' CD ' ' N ' ' A' ' 95' ' ' TRP . 64.8 Cg_exo -64.12 -12.65 33.48 Favored 'Trans proline' 0 N--CA 1.498 1.768 0 C-N-CA 120.875 1.05 . . . . 0.0 113.558 179.634 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.621 ' CD ' ' N ' ' A' ' 96' ' ' PRO . 51.2 Cg_exo -85.33 -8.79 8.55 Favored 'Trans proline' 0 N--CA 1.502 1.978 0 C-N-CA 120.753 0.968 . . . . 0.0 113.519 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.416 ' O ' ' N ' ' A' ' 101' ' ' GLY . 1.5 pp -84.18 18.62 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 C-N-CA 120.608 -0.437 . . . . 0.0 110.932 -179.661 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.565 ' CD1' ' O ' ' A' ' 96' ' ' PRO . 2.7 m-30 -39.85 -34.12 0.25 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.211 179.673 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.457 ' O ' ' NE ' ' A' ' 103' ' ' ARG . 0.9 OUTLIER -76.36 -45.08 33.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.745 -179.902 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.416 ' N ' ' O ' ' A' ' 98' ' ' ILE . . . -65.98 -9.98 49.36 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 110.97 -0.852 . . . . 0.0 110.97 -179.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -78.35 -7.17 56.98 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.749 0.309 . . . . 0.0 110.724 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.457 ' NE ' ' O ' ' A' ' 100' ' ' PHE . 1.2 ptp180 -79.16 -14.8 58.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.867 -179.769 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . 0.407 ' C ' ' N ' ' A' ' 106' ' ' GLY . 1.4 pt20 -125.82 172.58 9.74 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.826 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.493 ' N ' ' SD ' ' A' ' 105' ' ' MET . 0.0 OUTLIER -49.37 -16.88 0.21 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.457 179.822 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.437 ' C ' ' N ' ' A' ' 108' ' ' ALA . . . -60.6 -15.79 41.84 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 111.1 -0.8 . . . . 0.0 111.1 -179.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' TRP . . . . . 0.481 ' CD1' ' N ' ' A' ' 108' ' ' ALA . 0.0 OUTLIER -50.48 -14.46 0.18 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.848 0.356 . . . . 0.0 110.432 -179.779 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.481 ' N ' ' CD1' ' A' ' 107' ' ' TRP . . . -61.11 -17.55 53.3 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.212 179.621 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 6.0 mp -56.67 -28.56 60.96 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.671 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -58.71 -62.63 1.72 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.845 0.355 . . . . 0.0 110.672 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.691 ' O ' HG23 ' A' ' 115' ' ' VAL . 4.4 p-10 -57.29 -53.67 55.53 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.358 -179.429 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 29.9 tp -54.45 -43.13 71.37 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.773 -179.034 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 53.7 mt -67.54 -61.3 1.96 Allowed 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.584 0.587 . . . . 0.0 112.584 -178.387 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.9 pp -61.09 -34.36 74.82 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 120.445 -0.502 . . . . 0.0 111.572 -178.555 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.691 HG23 ' O ' ' A' ' 111' ' ' ASP . 48.1 t -61.49 -58.0 9.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.383 -0.372 . . . . 0.0 111.385 -179.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 23.4 p -71.9 -23.59 61.51 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.603 -179.091 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -64.61 -62.14 5.31 Favored Glycine 0 CA--C 1.525 0.67 0 C-N-CA 120.842 -0.694 . . . . 0.0 111.472 -179.389 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.6 ' O ' HG23 ' A' ' 122' ' ' THR . 9.8 p -70.71 -37.18 68.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 111.874 0.324 . . . . 0.0 111.874 -179.336 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.512 ' O ' ' OG1' ' A' ' 123' ' ' THR . . . -67.96 -60.91 2.14 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.545 -0.462 . . . . 0.0 111.63 -179.087 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 6.4 m -59.47 -51.84 68.16 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.909 0.385 . . . . 0.0 111.464 -179.299 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -53.92 -43.37 69.71 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.272 -179.203 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.6 HG23 ' O ' ' A' ' 118' ' ' VAL . 38.0 p -71.13 -30.81 66.95 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 111.971 0.36 . . . . 0.0 111.971 -179.135 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.512 ' OG1' ' O ' ' A' ' 119' ' ' ALA . 0.1 OUTLIER -64.72 -48.79 73.32 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 120.851 -0.34 . . . . 0.0 111.074 -179.141 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.8 pp -82.79 -19.92 36.8 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.763 -0.375 . . . . 0.0 111.531 -179.021 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -88.93 -69.59 0.7 Allowed 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.594 0.591 . . . . 0.0 112.594 -178.689 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' TRP . . . . . 0.445 ' N ' ' CD1' ' A' ' 126' ' ' TRP . 36.9 m0 -83.14 -57.53 3.23 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 -177.751 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . 0.47 ' CD2' ' N ' ' A' ' 127' ' ' HIS . 10.0 m170 -52.12 -22.18 3.95 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.418 -0.513 . . . . 0.0 111.06 -178.661 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 2.8 tmt_? -71.07 -43.39 67.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.504 -0.317 . . . . 0.0 111.225 -179.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 14.9 t -86.92 -49.6 14.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 C-N-CA 120.922 -0.311 . . . . 0.0 111.054 -179.523 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 7.5 m -120.11 110.83 35.92 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.434 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . 0.627 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 73.6 Cg_exo -71.34 -33.78 10.68 Favored 'Trans proline' 0 N--CA 1.491 1.345 0 C-N-CA 121.373 1.382 . . . . 0.0 112.387 179.488 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.627 ' CD ' ' N ' ' A' ' 131' ' ' PRO . 37.1 Cg_exo -55.36 -39.09 92.91 Favored 'Trans proline' 0 N--CA 1.495 1.595 0 C-N-CA 121.31 1.34 . . . . 0.0 111.75 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -55.91 -34.66 65.78 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.334 179.772 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.403 ' HB2' ' CG ' ' A' ' 127' ' ' HIS . . . -64.83 -24.97 67.71 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.38 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 13.5 tpt180 -77.12 -29.12 54.59 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.362 179.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 18.4 mt -74.9 -41.05 60.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.379 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.574 ' O ' ' N ' ' A' ' 140' ' ' TYR . 5.0 mt -78.82 -35.49 44.06 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.152 179.624 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.481 ' C ' ' O ' ' A' ' 137' ' ' LEU . 2.0 t80 -23.4 -44.75 0.05 OUTLIER Pre-proline 0 CA--C 1.535 0.372 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.853 -179.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.515 ' N ' ' O ' ' A' ' 137' ' ' LEU . 1.7 Cg_endo -67.91 12.6 0.21 Allowed 'Trans proline' 0 C--N 1.309 -1.5 0 C-N-CA 121.188 1.259 . . . . 0.0 112.57 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.865 ' CE2' HD11 ' A' ' 144' ' ' LEU . 1.7 p90 -93.41 -14.2 27.08 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-O 121.008 0.432 . . . . 0.0 110.633 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.492 HD22 ' CE1' ' A' ' 140' ' ' TYR . 4.1 mm? -53.37 -38.64 63.54 Favored 'General case' 0 C--N 1.333 -0.122 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 178.754 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -54.99 -46.58 75.14 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.549 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' TRP . . . . . 0.627 ' CE2' HD12 ' A' ' 52' ' ' ILE . 9.5 t-105 -59.21 -49.36 78.16 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.773 -0.455 . . . . 0.0 109.773 179.807 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.865 HD11 ' CE2' ' A' ' 140' ' ' TYR . 12.2 mt -51.89 -54.5 28.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.086 179.722 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.628 ' O ' HG23 ' A' ' 149' ' ' VAL . . . -60.5 -27.01 67.26 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.536 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -60.99 -64.56 0.91 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.533 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.4 ' HB1' ' C20' ' A' ' 201' ' ' PKA . . . -63.83 -49.14 74.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.694 -179.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 73.8 m -51.21 -47.22 62.33 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.911 -179.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.628 HG23 ' O ' ' A' ' 145' ' ' ALA . 53.3 t -65.24 -34.47 70.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.882 -179.738 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 1.7 tp -57.15 -55.56 33.22 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.837 0.351 . . . . 0.0 110.307 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -58.12 -57.12 14.22 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.413 179.697 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 18.5 t80 -46.76 -47.26 20.8 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.589 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 43.6 t80 -55.79 -42.98 76.38 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.611 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 89.1 t -66.53 -40.42 86.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.826 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' TRP . . . . . 0.515 ' C ' ' HE ' ' A' ' 156' ' ' ARG . 8.8 m0 -58.61 -39.74 81.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.801 -179.707 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . 0.515 ' HE ' ' C ' ' A' ' 155' ' ' TRP . 0.0 OUTLIER -79.29 -45.93 18.75 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.504 -179.885 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -64.19 -50.11 69.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.445 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -79.72 -12.39 59.8 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.524 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 92.6 p 49.19 98.36 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.597 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -71.13 -89.01 0.11 Allowed Glycine 0 CA--C 1.524 0.619 0 N-CA-C 110.804 -0.918 . . . . 0.0 110.804 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 13.8 mtm180 -70.39 80.5 0.55 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.828 0.347 . . . . 0.0 110.346 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 43.8 ttt180 -67.9 139.36 56.47 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.594 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 103.22 -72.51 0.28 Allowed Glycine 0 CA--C 1.526 0.738 0 N-CA-C 111.111 -0.795 . . . . 0.0 111.111 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 66.79 -109.52 2.95 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 110.809 -0.917 . . . . 0.0 110.809 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 48.0 t -67.04 153.06 44.59 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.875 0.369 . . . . 0.0 110.566 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . 0.462 ' O ' ' O ' ' A' ' 167' ' ' LEU . 93.0 mtt180 -44.27 159.28 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.675 -179.88 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.462 ' O ' ' O ' ' A' ' 166' ' ' ARG . 2.2 mp 54.02 161.58 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.779 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -158.01 -46.28 0.06 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.674 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 15.1 tt0 . . . . . 0 C--O 1.219 -0.522 0 CA-C-O 118.006 -0.997 . . . . 0.0 110.373 -179.797 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 201' ' ' PKA . . . . . 0.523 'CL ' ' C15' ' A' ' 201' ' ' PKA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.547 ' O ' ' SD ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.888 0.375 . . . . 0.0 110.552 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.43 ' CD ' ' N ' ' A' ' 1' ' ' MET . 41.0 Cg_endo -76.66 155.94 35.53 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 C-N-CA 122.299 1.999 . . . . 0.0 112.01 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 -74.61 -47.51 31.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.64 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.1 p -176.59 132.64 0.21 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.494 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.663 ' CE2' ' CE3' ' A' ' 68' ' ' TRP . 0.4 OUTLIER -67.14 118.0 9.95 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.287 -179.86 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.626 ' N ' ' CD ' ' A' ' 7' ' ' PRO . 0.9 OUTLIER -64.61 -32.79 7.52 Favored Pre-proline 0 CA--C 1.534 0.335 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 179.743 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.626 ' CD ' ' N ' ' A' ' 6' ' ' VAL . 23.8 Cg_exo -72.61 -67.02 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 121.888 1.726 . . . . 0.0 112.156 179.654 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.696 ' O ' HG23 ' A' ' 12' ' ' THR . . . -50.93 -38.24 49.09 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.541 -0.3 . . . . 0.0 111.278 -179.565 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.559 HG23 ' O ' ' A' ' 5' ' ' TRP . 75.5 t -67.63 -62.25 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.756 -179.14 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -56.74 -47.61 84.16 Favored Glycine 0 CA--C 1.527 0.79 0 N-CA-C 111.743 -0.543 . . . . 0.0 111.743 -179.192 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.414 ' N ' ' CD1' ' A' ' 11' ' ' LEU . 7.7 mp -64.02 -30.91 71.95 Favored 'General case' 0 C--N 1.326 -0.433 0 O-C-N 122.921 -0.164 . . . . 0.0 111.052 -179.498 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.696 HG23 ' O ' ' A' ' 8' ' ' ALA . 7.5 p -74.96 -25.15 58.66 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.621 -0.432 . . . . 0.0 110.129 179.549 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.454 ' O ' ' CB ' ' A' ' 16' ' ' SER . 9.4 mt -80.65 -32.26 36.21 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.133 179.563 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.42 ' N ' ' HD2' ' A' ' 15' ' ' PRO . 17.9 t -44.65 -53.29 15.5 Favored Pre-proline 0 CA--C 1.536 0.414 0 CA-C-N 115.894 -0.593 . . . . 0.0 111.237 -179.806 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.42 ' HD2' ' N ' ' A' ' 14' ' ' VAL . 18.6 Cg_endo -62.56 -7.53 10.97 Favored 'Trans proline' 0 N--CA 1.499 1.82 0 C-N-CA 120.591 0.861 . . . . 0.0 111.882 179.582 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.454 ' CB ' ' O ' ' A' ' 13' ' ' LEU . 3.7 t -77.69 -26.37 50.15 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.543 -179.866 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 15.9 mt -76.73 -49.66 15.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.85 -179.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -77.79 -29.27 55.21 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 111.329 -0.708 . . . . 0.0 111.329 -179.652 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -76.72 -37.49 34.3 Favored Glycine 0 CA--C 1.523 0.539 0 N-CA-C 110.877 -0.889 . . . . 0.0 110.877 -179.829 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 77.9 t80 -72.85 -55.81 6.12 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.875 0.369 . . . . 0.0 110.295 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 32.5 ttp -69.81 -22.09 63.34 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.464 179.768 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.462 ' C ' ' CZ2' ' A' ' 95' ' ' TRP . . . -69.99 -63.38 3.33 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 111.159 -0.776 . . . . 0.0 111.159 -179.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.496 ' O ' HG22 ' A' ' 26' ' ' VAL . . . -68.86 -20.77 64.29 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 120.999 -0.281 . . . . 0.0 110.793 -179.623 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 56.5 t80 -47.27 -25.15 0.88 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.872 0.367 . . . . 0.0 110.479 179.706 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.426 ' CZ ' ' HB3' ' A' ' 102' ' ' ALA . 24.8 t80 -67.55 -55.55 13.01 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.797 -179.871 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.496 HG22 ' O ' ' A' ' 23' ' ' ALA . 27.5 m -68.08 -16.79 21.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.867 -179.663 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 3.3 ttm180 -60.5 -41.13 93.68 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.037 -179.613 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -104.74 -74.32 0.96 Allowed Glycine 0 CA--C 1.525 0.686 0 N-CA-C 111.393 -0.683 . . . . 0.0 111.393 -179.57 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.412 ' OE1' ' CZ ' ' A' ' 25' ' ' PHE . 22.8 tt0 -44.38 -33.02 1.51 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.641 0.258 . . . . 0.0 110.965 -179.515 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -63.38 -51.61 53.27 Favored Glycine 0 CA--C 1.526 0.757 0 N-CA-C 111.222 -0.751 . . . . 0.0 111.222 -179.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.638 HD21 ' NH2' ' A' ' 46' ' ' ARG . 83.6 mt -49.43 -47.24 48.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.728 0.299 . . . . 0.0 110.851 -179.829 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 67.8 mtm180 -68.79 -49.38 59.1 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.86 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -45.13 -43.61 9.92 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.429 -179.717 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 75.9 t80 -46.11 -45.13 16.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.802 -179.656 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -57.42 -25.91 60.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.811 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -87.64 -73.8 1.28 Allowed Glycine 0 CA--C 1.526 0.74 0 N-CA-C 110.901 -0.88 . . . . 0.0 110.901 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.566 ' O ' HD12 ' A' ' 37' ' ' LEU . 0.3 OUTLIER -95.89 167.63 11.13 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.873 0.368 . . . . 0.0 110.673 179.838 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.524 ' NE2' ' C ' ' A' ' 38' ' ' GLN . 0.0 OUTLIER -81.74 114.76 20.61 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.778 -179.725 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.509 ' C ' ' H ' ' A' ' 41' ' ' SER . 11.0 mtpt -128.77 148.78 70.04 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.076 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.631 ' C ' ' H ' ' A' ' 42' ' ' TRP . 93.2 Cg_endo -72.71 19.49 0.33 Allowed 'Trans proline' 0 C--N 1.308 -1.566 0 C-N-CA 121.445 1.43 . . . . 0.0 110.968 179.293 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.509 ' H ' ' C ' ' A' ' 39' ' ' LYS . 15.7 t -49.63 -1.7 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.386 -0.824 . . . . 0.0 110.972 179.781 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . 0.631 ' H ' ' C ' ' A' ' 40' ' ' PRO . 2.3 p90 -76.53 -15.21 59.93 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.744 -0.382 . . . . 0.0 110.369 -179.472 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.489 ' O ' ' C ' ' A' ' 44' ' ' PRO . 23.0 m80 -65.05 143.55 98.9 Favored Pre-proline 0 C--N 1.328 -0.353 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 179.071 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.489 ' C ' ' O ' ' A' ' 43' ' ' HIS . 68.6 Cg_exo -31.26 125.45 0.08 OUTLIER 'Trans proline' 0 N--CA 1.492 1.422 0 C-N-CA 121.441 1.427 . . . . 0.0 111.319 -179.461 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.6 ' O ' ' N ' ' A' ' 47' ' ' TRP . 11.4 Cg_endo -45.92 151.35 1.44 Allowed 'Trans proline' 0 C--N 1.31 -1.488 0 C-N-CA 120.22 0.614 . . . . 0.0 111.883 -178.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.735 ' NE ' ' H ' ' A' ' 46' ' ' ARG . 0.0 OUTLIER -38.66 -18.16 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.595 -179.008 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.6 ' N ' ' O ' ' A' ' 45' ' ' PRO . 0.0 OUTLIER -60.58 -37.54 81.68 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.705 0.288 . . . . 0.0 111.696 -179.05 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.585 ' N ' ' CD1' ' A' ' 47' ' ' TRP . 1.0 OUTLIER -91.01 -44.88 9.04 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 -178.399 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.68 HD23 ' O8 ' ' A' ' 201' ' ' PKA . 27.6 tp -83.02 -50.74 8.22 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -177.61 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.643 ' C ' ' H ' ' A' ' 52' ' ' ILE . . . -41.22 -28.46 0.24 Allowed Pre-proline 0 C--O 1.234 0.27 0 C-N-CA 120.141 -0.623 . . . . 0.0 111.516 -179.021 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.418 ' HD2' ' N ' ' A' ' 50' ' ' ALA . 22.3 Cg_exo -53.63 5.16 0.03 OUTLIER 'Trans proline' 0 C--N 1.313 -1.317 0 CA-C-N 118.955 0.663 . . . . 0.0 112.085 177.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.673 HG23 ' O ' ' A' ' 49' ' ' LEU . 7.2 pt -49.37 -29.27 3.73 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.144 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 178.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.605 ' O ' ' CD1' ' A' ' 57' ' ' TYR . 2.8 m0 -66.06 -45.91 79.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.799 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -59.34 -60.26 9.14 Favored Glycine 0 CA--C 1.527 0.82 0 N-CA-C 111.593 -0.603 . . . . 0.0 111.593 -179.609 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.734 HG23 ' H ' ' A' ' 56' ' ' LEU . 5.3 t -56.21 -60.71 3.11 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 121.033 -0.267 . . . . 0.0 111.329 -179.279 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.734 ' H ' HG23 ' A' ' 55' ' ' THR . 82.6 mt -50.82 -44.68 59.23 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 120.59 -0.444 . . . . 0.0 110.478 -179.744 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.605 ' CD1' ' O ' ' A' ' 53' ' ' TRP . 3.7 m-30 -50.93 -46.96 61.08 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 75.7 m -57.89 -42.15 84.05 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.187 -0.46 . . . . 0.0 109.911 179.584 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.78 -37.24 86.65 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.203 179.627 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 41.5 mtt -67.69 -49.18 64.07 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.462 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -52.09 -48.57 52.27 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 111.108 -0.797 . . . . 0.0 111.108 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -60.97 -56.69 18.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.868 0.366 . . . . 0.0 110.512 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.486 ' O ' HG23 ' A' ' 67' ' ' VAL . . . -49.55 -48.47 35.11 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.504 -1.038 . . . . 0.0 110.504 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.523 ' O ' ' NE1' ' A' ' 68' ' ' TRP . 1.2 t -57.7 -44.92 86.22 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.667 0.27 . . . . 0.0 110.707 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.451 ' HA ' ' CZ2' ' A' ' 68' ' ' TRP . 87.3 t80 -50.79 -44.52 58.9 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 179.301 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 69.9 mt -70.79 -25.16 25.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.787 179.598 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.486 HG23 ' O ' ' A' ' 63' ' ' GLY . 77.9 t -68.8 -59.04 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.155 0 C-N-CA 120.69 -0.404 . . . . 0.0 111.192 -179.67 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . 0.663 ' CE3' ' CE2' ' A' ' 5' ' ' TRP . 0.0 OUTLIER -67.65 -28.1 67.43 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 119.973 -0.691 . . . . 0.0 110.646 -179.666 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -73.22 -28.18 62.02 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.532 -0.467 . . . . 0.0 110.526 -179.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 32.0 tp10 -76.85 -59.99 2.54 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.79 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.447 HD11 ' O ' ' A' ' 73' ' ' GLY . 3.3 pp -69.11 -22.14 63.99 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.717 -179.744 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.497 ' O ' ' O ' ' A' ' 73' ' ' GLY . . . 110.68 97.58 2.43 Favored Glycine 0 CA--C 1.526 0.775 0 N-CA-C 111.585 -0.606 . . . . 0.0 111.585 179.586 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.557 ' N ' ' O ' ' A' ' 68' ' ' TRP . . . 41.88 -173.86 0.01 OUTLIER Glycine 0 CA--C 1.523 0.557 0 N-CA-C 111.667 -0.573 . . . . 0.0 111.667 179.389 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 51.5 t80 -87.54 111.64 21.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.819 0.342 . . . . 0.0 110.741 -179.606 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.576 ' OG1' ' N ' ' A' ' 76' ' ' GLU . 0.8 OUTLIER -141.73 -174.03 3.95 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.672 179.73 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.576 ' N ' ' OG1' ' A' ' 75' ' ' THR . 46.1 mt-10 -47.98 -44.29 30.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.174 -179.768 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -60.49 -24.4 65.26 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.502 -179.239 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -91.09 -25.34 19.68 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.82 -0.352 . . . . 0.0 111.234 -179.424 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 12.5 mtp -66.79 -27.78 67.86 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.814 -0.354 . . . . 0.0 111.354 -179.283 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.403 ' N ' ' HD2' ' A' ' 81' ' ' PRO . 4.7 t -68.72 -50.89 22.78 Favored Pre-proline 0 C--N 1.328 -0.335 0 C-N-CA 120.673 -0.411 . . . . 0.0 110.364 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.403 ' HD2' ' N ' ' A' ' 80' ' ' VAL . 15.5 Cg_endo -69.43 -62.38 0.05 OUTLIER 'Trans proline' 0 N--CA 1.498 1.764 0 C-N-CA 120.955 1.103 . . . . 0.0 111.616 179.007 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.0 mt -52.12 -52.45 51.45 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.271 179.592 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.504 ' O ' ' N ' ' A' ' 86' ' ' THR . . . -60.46 -63.88 4.61 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 111.367 -0.693 . . . . 0.0 111.367 -179.549 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 59.3 tp -43.15 -38.74 2.56 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.9 0.381 . . . . 0.0 110.114 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 6.3 t80 -68.22 -34.33 76.05 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.242 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.504 ' N ' ' O ' ' A' ' 83' ' ' GLY . 1.3 m -70.42 -57.97 4.23 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.917 -179.683 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -62.51 -49.23 75.64 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 111.463 -0.655 . . . . 0.0 111.463 -179.591 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.416 ' O ' ' CB ' ' A' ' 92' ' ' ASN . 51.6 tp60 -57.26 -45.54 83.91 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.739 0.304 . . . . 0.0 110.952 -179.583 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 11.6 tp -65.4 -29.12 69.79 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.475 -179.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.781 ' O ' ' HB2' ' A' ' 94' ' ' ALA . . . -67.04 -66.08 0.6 Allowed 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.393 -0.523 . . . . 0.0 111.176 -179.723 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.2 pp -67.64 -29.79 69.19 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 -178.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.416 ' CB ' ' O ' ' A' ' 88' ' ' GLN . 11.1 t-20 -84.12 -54.52 4.77 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 -178.441 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . 0.609 ' O ' ' N ' ' A' ' 95' ' ' TRP . 0.0 OUTLIER -76.57 -12.53 60.04 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.516 -0.474 . . . . 0.0 111.491 -178.478 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.781 ' HB2' ' O ' ' A' ' 90' ' ' ALA . . . -55.69 78.73 0.0 OUTLIER 'General case' 0 C--O 1.231 0.129 0 C-N-CA 120.448 -0.501 . . . . 0.0 109.852 179.174 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.708 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 44.1 p-90 -93.11 -16.87 0.21 Allowed Pre-proline 0 CA--C 1.533 0.302 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -179.444 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.708 ' CD ' ' N ' ' A' ' 95' ' ' TRP . 46.5 Cg_exo -55.66 -34.49 90.6 Favored 'Trans proline' 0 N--CA 1.495 1.576 0 C-N-CA 120.422 0.748 . . . . 0.0 113.021 179.502 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.555 ' C ' ' H ' ' A' ' 99' ' ' PHE . 33.6 Cg_exo -44.08 -30.84 3.58 Favored 'Trans proline' 0 N--CA 1.492 1.386 0 CA-C-N 118.969 0.668 . . . . 0.0 112.994 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.577 ' O ' ' N ' ' A' ' 101' ' ' GLY . 1.3 pp -72.61 20.22 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 121.076 0.465 . . . . 0.0 110.059 179.66 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.555 ' H ' ' C ' ' A' ' 97' ' ' PRO . 0.8 OUTLIER -39.72 -36.67 0.44 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.889 -179.968 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.401 ' O ' ' CG ' ' A' ' 103' ' ' ARG . 1.6 m-85 -85.98 -21.0 28.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.045 -179.518 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.577 ' N ' ' O ' ' A' ' 98' ' ' ILE . . . -89.16 -5.45 72.97 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 111.153 -0.779 . . . . 0.0 111.153 -179.718 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.426 ' HB3' ' CZ ' ' A' ' 25' ' ' PHE . . . -73.16 -11.26 60.47 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.778 0.323 . . . . 0.0 110.753 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.401 ' CG ' ' O ' ' A' ' 100' ' ' PHE . 5.4 ptp180 -94.94 11.61 31.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.586 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -123.97 162.62 23.02 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.63 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 21.2 mmm -57.18 -17.13 9.83 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.234 179.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.589 ' O ' ' N ' ' A' ' 108' ' ' ALA . . . -70.42 -15.01 72.48 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 111.214 -0.755 . . . . 0.0 111.214 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' TRP . . . . . 0.444 ' CD1' ' N ' ' A' ' 108' ' ' ALA . 0.1 OUTLIER -43.14 -12.51 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.521 0.2 . . . . 0.0 111.113 -179.468 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.589 ' N ' ' O ' ' A' ' 106' ' ' GLY . . . -63.01 -23.44 67.46 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-O 121.132 0.491 . . . . 0.0 110.075 179.417 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 54.6 mt -52.71 -29.45 26.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.107 179.726 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -56.19 -60.76 3.04 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.548 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.713 ' O ' HG23 ' A' ' 115' ' ' VAL . 1.2 p30 -57.46 -51.24 70.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.323 -179.673 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.601 HD13 ' O ' ' A' ' 112' ' ' LEU . 0.2 OUTLIER -55.29 -40.26 70.85 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.474 -178.944 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 11.3 mt -70.18 -61.51 1.75 Allowed 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 -178.655 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.4 pp -58.38 -30.55 66.88 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 120.292 -0.563 . . . . 0.0 110.866 -179.052 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.713 HG23 ' O ' ' A' ' 111' ' ' ASP . 38.7 t -65.49 -55.78 18.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.264 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 4.9 m -71.45 -24.57 62.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.4 -179.009 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.411 ' O ' ' CB ' ' A' ' 121' ' ' ALA . . . -68.02 -62.49 4.2 Favored Glycine 0 CA--C 1.527 0.794 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.051 -179.218 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.559 ' O ' HG23 ' A' ' 122' ' ' THR . 8.5 p -70.62 -36.93 67.64 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 O-C-N 122.738 -0.272 . . . . 0.0 111.572 -179.14 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.526 ' O ' ' OG1' ' A' ' 123' ' ' THR . . . -66.67 -60.54 2.61 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.493 -0.483 . . . . 0.0 111.201 -179.288 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 1.9 m -61.56 -53.68 53.11 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.334 -179.446 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.411 ' CB ' ' O ' ' A' ' 117' ' ' GLY . . . -50.12 -42.41 50.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.411 -0.358 . . . . 0.0 111.152 -179.494 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.559 HG23 ' O ' ' A' ' 118' ' ' VAL . 27.7 p -70.65 -39.32 73.69 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.64 -179.28 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.526 ' OG1' ' O ' ' A' ' 119' ' ' ALA . 0.2 OUTLIER -55.29 -52.2 64.23 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.921 0.391 . . . . 0.0 111.197 -179.312 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.7 pp -80.49 -20.33 43.91 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.752 -178.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -86.06 -73.88 0.44 Allowed 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -178.179 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' TRP . . . . . 0.571 ' N ' ' CD1' ' A' ' 126' ' ' TRP . 15.7 m0 -84.88 -57.37 3.14 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 112.762 0.653 . . . . 0.0 112.762 -177.444 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . 0.492 ' CD2' ' N ' ' A' ' 127' ' ' HIS . 9.7 m170 -47.71 -22.12 0.48 Allowed 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.686 -0.405 . . . . 0.0 111.121 -179.027 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 19.2 ttt85 -72.59 -40.84 66.25 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.063 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 86.4 t -88.37 -50.01 13.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.788 0.328 . . . . 0.0 111.076 -179.514 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 6.0 m -115.69 105.28 51.98 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.502 -179.734 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . 0.631 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 73.5 Cg_exo -70.98 -36.43 7.58 Favored 'Trans proline' 0 C--N 1.312 -1.364 0 C-N-CA 121.557 1.505 . . . . 0.0 112.726 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.631 ' CD ' ' N ' ' A' ' 131' ' ' PRO . 32.4 Cg_exo -55.8 -35.48 93.72 Favored 'Trans proline' 0 N--CA 1.496 1.675 0 C-N-CA 121.678 1.585 . . . . 0.0 111.946 -179.847 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -62.6 -43.2 99.41 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.66 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -50.47 -24.77 3.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.764 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 14.9 ttp180 -80.93 -28.39 35.78 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.786 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 26.7 mt -72.84 -39.18 66.75 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.779 -0.368 . . . . 0.0 110.068 179.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.583 ' O ' ' N ' ' A' ' 139' ' ' PRO . 4.8 mt -81.04 -35.78 31.38 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 179.126 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.473 ' C ' ' O ' ' A' ' 137' ' ' LEU . 14.3 t80 -24.23 -38.9 0.03 OUTLIER Pre-proline 0 CA--C 1.534 0.356 0 CA-C-N 115.368 -0.833 . . . . 0.0 112.118 -179.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.583 ' N ' ' O ' ' A' ' 137' ' ' LEU . 5.8 Cg_exo -66.62 5.54 0.73 Allowed 'Trans proline' 0 C--N 1.31 -1.479 0 C-N-CA 120.897 1.065 . . . . 0.0 112.771 179.508 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.756 ' CE2' HD11 ' A' ' 144' ' ' LEU . 2.5 p90 -88.62 -14.55 37.22 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 120.54 -0.464 . . . . 0.0 111.074 -179.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.463 HD22 ' CE1' ' A' ' 140' ' ' TYR . 4.1 mm? -53.55 -33.45 54.72 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 178.568 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -60.63 -50.01 75.21 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.473 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' TRP . . . . . 0.462 ' CH2' ' HB2' ' A' ' 147' ' ' ALA . 8.8 t-105 -55.13 -46.1 75.62 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.226 -0.443 . . . . 0.0 109.844 179.74 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.756 HD11 ' CE2' ' A' ' 140' ' ' TYR . 9.3 mt -53.35 -55.96 20.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.267 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.605 ' O ' HG23 ' A' ' 149' ' ' VAL . . . -62.86 -18.85 63.5 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.94 -179.786 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -69.45 -63.34 1.09 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.682 -179.725 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.462 ' HB2' ' CH2' ' A' ' 143' ' ' TRP . . . -60.37 -47.42 86.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.414 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 89.0 m -53.93 -49.67 68.14 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.495 179.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.605 HG23 ' O ' ' A' ' 145' ' ' ALA . 45.0 t -62.42 -28.54 44.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.594 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.447 ' O ' HG23 ' A' ' 154' ' ' VAL . 0.9 OUTLIER -63.53 -54.85 29.81 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.704 -0.398 . . . . 0.0 110.415 -179.598 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . 0.612 ' ND2' ' H ' ' A' ' 152' ' ' TYR . 1.4 p-10 -67.47 -54.65 18.37 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.96 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . 0.612 ' H ' ' ND2' ' A' ' 151' ' ' ASN . 15.6 t80 -50.5 -43.26 55.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.681 -179.69 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . 0.481 ' C ' ' CD1' ' A' ' 153' ' ' TYR . 17.5 t80 -61.86 -43.75 98.22 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.188 179.72 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.447 HG23 ' O ' ' A' ' 150' ' ' LEU . 49.4 t -60.27 -35.25 60.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.597 179.801 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' TRP . . . . . 0.519 ' O ' ' N ' ' A' ' 159' ' ' SER . 8.1 m0 -62.99 -53.32 55.86 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.413 179.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . 0.436 ' CZ ' ' OH ' ' A' ' 152' ' ' TYR . 0.5 OUTLIER -64.73 -31.61 72.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.414 -179.899 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -71.33 -52.59 17.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.678 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 22.3 m-20 -83.92 -12.27 55.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.646 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . 0.519 ' N ' ' O ' ' A' ' 155' ' ' TRP . 10.9 m 53.44 24.78 4.18 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.447 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 85.22 -105.62 2.91 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.784 -0.926 . . . . 0.0 110.784 -179.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 73.9 mtt85 -94.19 -111.78 0.12 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.757 0.313 . . . . 0.0 110.441 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.403 ' O ' ' CG ' ' A' ' 162' ' ' ARG . 25.1 ptt-85 -82.37 128.45 34.24 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 120.869 -0.333 . . . . 0.0 110.443 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -91.02 79.74 1.35 Allowed Glycine 0 CA--C 1.524 0.613 0 N-CA-C 110.946 -0.862 . . . . 0.0 110.946 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -147.15 34.28 1.31 Allowed Glycine 0 CA--C 1.526 0.719 0 N-CA-C 111.202 -0.759 . . . . 0.0 111.202 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 24.0 p -89.06 169.85 11.15 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.784 0.326 . . . . 0.0 110.634 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . 0.554 ' C ' HD13 ' A' ' 167' ' ' LEU . 11.0 mmp_? -107.16 178.81 4.44 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.536 179.805 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.853 HD13 ' N ' ' A' ' 167' ' ' LEU . 0.0 OUTLIER -150.8 -179.92 7.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.619 179.656 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -167.77 47.83 0.05 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.378 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 33.8 mm-40 . . . . . 0 C--O 1.221 -0.425 0 CA-C-O 118.011 -0.995 . . . . 0.0 110.573 179.946 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 201' ' ' PKA . . . . . 0.68 ' O8 ' HD23 ' A' ' 49' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.484 ' C ' ' SD ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.183 0 CA-C-O 120.888 0.375 . . . . 0.0 110.518 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -70.82 120.87 7.4 Favored 'Trans proline' 0 C--N 1.303 -1.823 0 C-N-CA 122.528 2.152 . . . . 0.0 112.228 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -55.98 -25.22 43.08 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.451 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.0 m 65.39 175.09 0.21 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.501 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.645 ' O ' HG23 ' A' ' 9' ' ' VAL . 2.2 t-105 -57.25 119.84 7.09 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.001 0.429 . . . . 0.0 110.038 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.497 HG12 ' N ' ' A' ' 7' ' ' PRO . 3.0 t -56.69 -69.45 0.44 Allowed Pre-proline 0 CA--C 1.537 0.471 0 CA-C-N 115.717 -0.674 . . . . 0.0 112.285 -178.375 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.497 ' N ' HG12 ' A' ' 6' ' ' VAL . 18.1 Cg_endo -46.3 -53.49 5.87 Favored 'Trans proline' 0 N--CA 1.494 1.519 0 C-N-CA 120.349 0.699 . . . . 0.0 112.343 -178.618 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.579 ' HB2' ' OG ' ' A' ' 64' ' ' SER . . . -49.14 -43.92 42.16 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.595 -0.442 . . . . 0.0 111.195 -179.74 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.645 HG23 ' O ' ' A' ' 5' ' ' TRP . 63.3 t -60.85 -60.97 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.775 -179.04 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -58.05 -53.95 41.42 Favored Glycine 0 CA--C 1.527 0.808 0 N-CA-C 111.369 -0.692 . . . . 0.0 111.369 -179.398 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 9.0 mp -54.53 -31.36 56.2 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.605 0.241 . . . . 0.0 110.775 -179.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.576 HG23 ' O ' ' A' ' 8' ' ' ALA . 8.9 p -79.03 -24.39 43.66 Favored 'General case' 0 C--N 1.333 -0.145 0 C-N-CA 120.783 -0.367 . . . . 0.0 110.41 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.423 ' HA ' HD23 ' A' ' 13' ' ' LEU . 41.3 mt -76.84 -26.48 54.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.152 179.49 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.486 ' O ' ' N ' ' A' ' 16' ' ' SER . 13.7 t -52.05 -64.22 1.64 Allowed Pre-proline 0 CA--C 1.536 0.42 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.593 -179.519 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_endo -44.6 -16.29 0.11 Allowed 'Trans proline' 0 N--CA 1.497 1.726 0 C-N-CA 120.941 1.094 . . . . 0.0 112.137 -179.434 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.486 ' N ' ' O ' ' A' ' 14' ' ' VAL . 0.5 OUTLIER -75.49 -29.12 59.46 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.641 -179.915 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 81.7 mt -68.22 -56.17 9.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.002 -179.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -66.96 -38.55 92.89 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 111.558 -0.617 . . . . 0.0 111.558 -179.362 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -74.12 -26.2 69.2 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 111.378 -0.689 . . . . 0.0 111.378 -179.433 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.441 ' CB ' ' O ' ' A' ' 16' ' ' SER . 34.3 t80 -78.0 -60.7 2.26 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.78 -0.368 . . . . 0.0 110.998 -179.665 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 19.9 tpp -71.53 -21.26 61.93 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.34 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.422 ' C ' ' CZ2' ' A' ' 95' ' ' TRP . . . -75.51 -53.59 5.92 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 111.302 -0.719 . . . . 0.0 111.302 -179.802 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.625 ' O ' HG22 ' A' ' 26' ' ' VAL . . . -73.56 -20.81 60.53 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.963 0.411 . . . . 0.0 110.461 -179.702 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.43 ' O ' ' CD1' ' A' ' 24' ' ' TYR . 27.2 t80 -51.08 -23.9 3.49 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.862 179.298 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 52.1 t80 -71.27 -55.46 8.02 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.02 -179.779 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.625 HG22 ' O ' ' A' ' 23' ' ' ALA . 34.6 m -58.46 -26.06 29.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 C-N-CA 120.599 -0.441 . . . . 0.0 110.306 -179.796 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.519 ' O ' ' CD1' ' A' ' 31' ' ' LEU . 0.0 OUTLIER -87.95 -15.08 37.53 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.338 179.851 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -101.33 -71.66 0.94 Allowed Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.835 -0.906 . . . . 0.0 110.835 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.403 ' OE2' ' O ' ' A' ' 29' ' ' GLU . 3.3 tm-20 -76.88 -36.89 56.39 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.739 0.304 . . . . 0.0 110.567 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -51.3 -36.12 36.38 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 110.89 -0.884 . . . . 0.0 110.89 -179.79 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.519 ' CD1' ' O ' ' A' ' 27' ' ' ARG . 86.3 mt -55.35 -32.17 62.34 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.737 0.303 . . . . 0.0 110.348 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.434 ' O ' ' N ' ' A' ' 35' ' ' ALA . 37.6 ttm180 -81.28 -48.96 11.33 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.252 179.728 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . 0.565 ' CZ3' HD21 ' A' ' 37' ' ' LEU . 0.0 OUTLIER -44.76 -36.13 3.05 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 179.473 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 26.6 t80 -55.66 -40.52 72.36 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.287 179.452 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.434 ' N ' ' O ' ' A' ' 32' ' ' ARG . . . -53.29 -26.96 20.46 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.169 179.784 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -90.37 -72.32 1.25 Allowed Glycine 0 CA--C 1.524 0.615 0 N-CA-C 110.921 -0.872 . . . . 0.0 110.921 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.565 HD21 ' CZ3' ' A' ' 33' ' ' TRP . 0.3 OUTLIER -96.1 167.64 11.09 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 120.947 0.404 . . . . 0.0 110.88 179.614 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 43.8 mm-40 -84.79 122.93 29.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.241 -179.256 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.508 ' C ' ' H ' ' A' ' 41' ' ' SER . 16.0 mtpt -129.28 153.34 80.47 Favored Pre-proline 0 N--CA 1.464 0.24 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.048 179.443 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.637 ' C ' ' H ' ' A' ' 42' ' ' TRP . 56.8 Cg_endo -73.17 26.23 0.3 Allowed 'Trans proline' 0 C--N 1.31 -1.47 0 C-N-CA 121.549 1.499 . . . . 0.0 111.372 179.417 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.508 ' H ' ' C ' ' A' ' 39' ' ' LYS . 1.5 t -50.13 -0.65 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.105 179.689 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . 0.637 ' H ' ' C ' ' A' ' 40' ' ' PRO . 44.6 p-90 -76.27 -15.07 60.08 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.517 -0.473 . . . . 0.0 111.144 -178.875 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.454 ' O ' ' C ' ' A' ' 44' ' ' PRO . 0.3 OUTLIER -82.07 143.13 48.75 Favored Pre-proline 0 C--N 1.329 -0.292 0 C-N-CA 120.157 -0.617 . . . . 0.0 109.419 178.622 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.454 ' C ' ' O ' ' A' ' 43' ' ' HIS . 52.2 Cg_exo -33.88 143.04 0.06 OUTLIER 'Trans proline' 0 C--N 1.311 -1.41 0 C-N-CA 121.399 1.4 . . . . 0.0 111.717 -179.463 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -69.49 169.91 17.47 Favored 'Trans proline' 0 C--N 1.313 -1.29 0 C-N-CA 120.595 0.864 . . . . 0.0 111.322 179.748 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.471 HH11 ' N ' ' A' ' 47' ' ' TRP . 0.0 OUTLIER -47.7 -17.9 0.12 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.771 -179.149 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.599 ' CD1' ' N ' ' A' ' 48' ' ' THR . 1.4 p-90 -61.81 -45.05 95.5 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 120.151 -0.62 . . . . 0.0 111.159 -179.188 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.599 ' N ' ' CD1' ' A' ' 47' ' ' TRP . 1.2 m -91.43 -33.79 15.1 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.983 -178.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.751 ' O ' HG23 ' A' ' 52' ' ' ILE . 0.2 OUTLIER -83.28 -43.86 15.58 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 112.686 0.624 . . . . 0.0 112.686 -177.936 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.591 ' C ' ' H ' ' A' ' 52' ' ' ILE . . . -40.34 -30.26 0.24 Allowed Pre-proline 0 N--CA 1.468 0.427 0 C-N-CA 120.857 -0.337 . . . . 0.0 111.818 -178.699 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.408 ' HD2' ' N ' ' A' ' 50' ' ' ALA . 33.6 Cg_exo -53.76 4.53 0.04 OUTLIER 'Trans proline' 0 C--N 1.312 -1.382 0 CA-C-N 119.163 0.737 . . . . 0.0 112.547 178.498 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.751 HG23 ' O ' ' A' ' 49' ' ' LEU . 44.0 pt -53.52 -32.42 20.51 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 C-N-CA 120.515 -0.474 . . . . 0.0 109.779 179.52 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.457 ' O ' ' CB ' ' A' ' 57' ' ' TYR . 60.9 m95 -78.94 -23.08 44.87 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.267 -179.145 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -68.54 -45.47 67.24 Favored Glycine 0 CA--C 1.527 0.793 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 178.773 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 16.5 m -69.27 -58.45 4.02 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-O 120.991 0.424 . . . . 0.0 110.0 179.408 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 96.6 mt -54.55 -28.62 46.99 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.033 179.511 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.521 ' C ' ' CD1' ' A' ' 57' ' ' TYR . 0.6 OUTLIER -63.51 -58.98 5.27 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 179.523 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 11.0 m -46.16 -49.29 17.01 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.406 -0.518 . . . . 0.0 109.909 179.515 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.55 -51.49 69.65 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.856 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 12.3 mtm -55.81 -35.59 66.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.78 -179.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -61.88 -49.31 77.05 Favored Glycine 0 CA--C 1.522 0.491 0 N-CA-C 110.59 -1.004 . . . . 0.0 110.59 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -56.83 -60.27 3.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.817 0.341 . . . . 0.0 110.501 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.539 ' O ' HG23 ' A' ' 67' ' ' VAL . . . -52.21 -49.74 49.15 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 110.66 -0.976 . . . . 0.0 110.66 179.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.58 ' O ' ' CE2' ' A' ' 68' ' ' TRP . 1.4 t -48.1 -54.24 13.87 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.108 0.48 . . . . 0.0 110.396 179.617 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 59.0 t80 -51.28 -41.48 60.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.51 179.834 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 84.9 mt -67.72 -45.58 84.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.329 -179.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.789 HG22 ' OG ' ' A' ' 130' ' ' SER . 39.0 t -50.72 -55.81 5.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 C-N-CA 121.043 -0.263 . . . . 0.0 111.277 -179.327 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . 0.585 ' O ' ' N ' ' A' ' 73' ' ' GLY . 0.7 OUTLIER -59.97 -52.56 64.89 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.686 -179.542 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 24.3 mmtt -53.64 -22.67 9.22 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.993 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 43.0 tp10 -79.6 -62.46 1.68 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.441 -179.312 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.0 pp -71.22 -1.17 11.72 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.2 -179.297 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 104.43 64.98 0.68 Allowed Glycine 0 CA--C 1.526 0.778 0 N-CA-C 111.43 -0.668 . . . . 0.0 111.43 179.51 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.585 ' N ' ' O ' ' A' ' 68' ' ' TRP . . . 51.75 -174.46 0.15 Allowed Glycine 0 CA--C 1.525 0.679 0 N-CA-C 111.325 -0.71 . . . . 0.0 111.325 179.661 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 89.8 t80 -76.62 110.72 11.42 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.86 0.362 . . . . 0.0 110.604 -179.784 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.591 ' OG1' ' N ' ' A' ' 76' ' ' GLU . 0.0 OUTLIER -139.17 -174.94 4.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.13 179.804 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.591 ' N ' ' OG1' ' A' ' 75' ' ' THR . 3.1 pt-20 -50.55 -21.62 1.61 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.839 -179.838 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -83.95 -18.47 37.16 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.105 -179.538 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -89.32 -18.25 27.32 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.874 -0.33 . . . . 0.0 110.838 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 15.4 mtp -69.32 -27.4 65.35 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.871 -0.332 . . . . 0.0 110.573 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 5.0 t -67.73 -47.94 43.26 Favored Pre-proline 0 CA--C 1.535 0.4 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.582 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -71.83 -58.12 0.08 OUTLIER 'Trans proline' 0 N--CA 1.498 1.786 0 C-N-CA 121.187 1.258 . . . . 0.0 112.087 179.277 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 13.0 mt -60.08 -53.4 58.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.985 0.421 . . . . 0.0 110.678 -179.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -55.86 -55.19 30.28 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 111.268 -0.733 . . . . 0.0 111.268 -179.537 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.404 ' O ' ' CB ' ' A' ' 88' ' ' GLN . 33.0 tp -61.01 -24.23 66.0 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.687 0.279 . . . . 0.0 110.936 -179.702 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -74.7 -56.49 4.74 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.884 -179.685 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.415 HG23 ' N ' ' A' ' 87' ' ' GLY . 14.2 t -66.13 -38.35 87.97 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.799 -0.361 . . . . 0.0 110.977 -179.64 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.415 ' N ' HG23 ' A' ' 86' ' ' THR . . . -68.77 -57.26 8.14 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.932 -0.867 . . . . 0.0 110.932 -179.843 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.45 ' O ' ' CB ' ' A' ' 92' ' ' ASN . 36.3 tp60 -58.09 -40.5 81.28 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.859 0.362 . . . . 0.0 110.149 179.756 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 12.3 tp -67.37 -30.54 70.35 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.292 179.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.826 ' O ' ' HB2' ' A' ' 94' ' ' ALA . . . -66.95 -66.09 0.6 Allowed 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 120.13 -0.628 . . . . 0.0 110.944 -179.746 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.0 pp -66.51 -29.68 69.83 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.389 0.514 . . . . 0.0 112.389 -178.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.582 ' C ' HD22 ' A' ' 92' ' ' ASN . 0.2 OUTLIER -85.2 -62.2 1.59 Allowed 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.551 -0.46 . . . . 0.0 111.815 -178.827 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . 0.631 ' O ' ' N ' ' A' ' 95' ' ' TRP . 0.0 OUTLIER -64.57 -17.57 64.08 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.552 -0.459 . . . . 0.0 110.834 -179.007 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.826 ' HB2' ' O ' ' A' ' 90' ' ' ALA . . . -48.76 83.81 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 179.313 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.698 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 23.2 p-90 -100.95 -16.13 0.19 Allowed Pre-proline 0 CA--C 1.535 0.377 0 CA-C-N 116.107 -0.497 . . . . 0.0 112.334 -179.235 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.698 ' CD ' ' N ' ' A' ' 95' ' ' TRP . 37.2 Cg_exo -60.65 -31.52 92.21 Favored 'Trans proline' 0 N--CA 1.495 1.582 0 CA-C-N 119.067 0.703 . . . . 0.0 112.718 179.691 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.518 ' CD ' ' N ' ' A' ' 96' ' ' PRO . 83.8 Cg_exo -56.76 -16.92 21.23 Favored 'Trans proline' 0 N--CA 1.496 1.647 0 C-N-CA 120.803 1.002 . . . . 0.0 113.15 -179.775 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.423 ' O ' ' N ' ' A' ' 101' ' ' GLY . 1.1 pp -88.34 20.36 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 C-N-CA 120.713 -0.395 . . . . 0.0 110.732 -179.718 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.597 ' CD2' ' O ' ' A' ' 96' ' ' PRO . 29.7 m-85 -39.36 -36.96 0.4 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.326 179.649 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.557 ' CD1' ' N ' ' A' ' 100' ' ' PHE . 0.5 OUTLIER -76.71 -43.87 35.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.697 179.948 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.423 ' N ' ' O ' ' A' ' 98' ' ' ILE . . . -62.23 -11.28 32.29 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 111.083 -0.807 . . . . 0.0 111.083 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -62.17 -38.47 89.17 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.637 0.256 . . . . 0.0 111.198 -179.615 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.16 17.97 2.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.078 -179.607 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 11.5 mt-30 -124.4 160.15 28.81 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.888 0.375 . . . . 0.0 110.638 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.547 ' N ' ' SD ' ' A' ' 105' ' ' MET . 0.0 OUTLIER -51.12 -17.06 0.57 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.416 179.813 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.601 ' O ' ' N ' ' A' ' 108' ' ' ALA . . . -75.48 -14.13 82.27 Favored Glycine 0 CA--C 1.529 0.919 0 CA-C-N 115.938 -0.573 . . . . 0.0 111.722 -179.554 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' TRP . . . . . 0.617 ' CD1' ' CZ2' ' A' ' 155' ' ' TRP . 0.0 OUTLIER -36.62 -21.84 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.417 0 CA-C-O 120.529 0.204 . . . . 0.0 111.366 -179.165 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.601 ' N ' ' O ' ' A' ' 106' ' ' GLY . . . -63.35 -16.67 61.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.669 0.271 . . . . 0.0 111.168 -179.322 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 6.2 mp -54.5 -32.95 58.95 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.776 -179.632 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.442 ' O ' HD23 ' A' ' 114' ' ' LEU . . . -55.82 -62.33 1.76 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.858 0.361 . . . . 0.0 111.138 -179.628 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.689 ' O ' HG23 ' A' ' 115' ' ' VAL . 3.8 p-10 -58.92 -54.43 47.24 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.033 -0.53 . . . . 0.0 112.005 -179.155 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 34.3 tp -55.76 -44.36 77.59 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 -178.56 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 52.1 mt -64.24 -60.68 2.9 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.254 0.465 . . . . 0.0 112.254 -178.482 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.442 HD23 ' O ' ' A' ' 110' ' ' ALA . 2.3 pp -62.89 -35.32 79.64 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.494 -0.483 . . . . 0.0 111.68 -178.565 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.689 HG23 ' O ' ' A' ' 111' ' ' ASP . 27.2 t -57.91 -60.12 2.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.136 -179.687 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.488 ' O ' ' OG1' ' A' ' 120' ' ' THR . 4.5 m -74.18 -22.44 59.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.427 -0.352 . . . . 0.0 111.592 -178.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -62.93 -62.71 5.22 Favored Glycine 0 CA--C 1.526 0.721 0 C-N-CA 120.783 -0.723 . . . . 0.0 111.475 -179.418 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.593 ' O ' HG23 ' A' ' 122' ' ' THR . 8.6 p -75.58 -35.1 30.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 C-N-CA 121.035 -0.266 . . . . 0.0 111.046 -179.579 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.526 ' O ' ' OG1' ' A' ' 123' ' ' THR . . . -66.69 -60.4 2.73 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.635 -0.426 . . . . 0.0 110.56 -179.742 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.488 ' OG1' ' O ' ' A' ' 116' ' ' SER . 2.4 m -60.32 -54.57 44.15 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.408 -179.589 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.408 ' O ' ' CB ' ' A' ' 125' ' ' ALA . . . -51.25 -41.12 60.14 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.314 -179.153 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.593 HG23 ' O ' ' A' ' 118' ' ' VAL . 36.0 p -73.19 -29.95 63.2 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.625 -179.19 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.526 ' OG1' ' O ' ' A' ' 119' ' ' ALA . 0.2 OUTLIER -66.84 -49.89 64.3 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.714 -0.394 . . . . 0.0 110.864 -179.412 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.8 pp -81.44 -19.05 43.27 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.57 -179.04 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.408 ' CB ' ' O ' ' A' ' 121' ' ' ALA . . . -93.61 -65.28 1.0 Allowed 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.427 0.529 . . . . 0.0 112.427 -178.824 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 42.1 m0 -83.59 -56.98 3.42 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 113.056 0.762 . . . . 0.0 113.056 -177.802 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . 0.467 ' CG ' ' HB2' ' A' ' 134' ' ' ALA . 11.1 m170 -59.6 -25.62 64.77 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.586 -0.445 . . . . 0.0 111.569 -178.535 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 15.9 ttt180 -61.76 -41.17 97.34 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.31 -179.455 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 33.4 t -93.34 -48.88 13.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.517 -0.311 . . . . 0.0 110.964 -179.611 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . 0.789 ' OG ' HG22 ' A' ' 67' ' ' VAL . 2.1 p -113.07 107.94 53.63 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.884 -179.301 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . 0.646 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 73.8 Cg_exo -74.69 -26.52 11.49 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 C-N-CA 121.702 1.601 . . . . 0.0 112.741 179.355 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.646 ' CD ' ' N ' ' A' ' 131' ' ' PRO . 52.0 Cg_exo -62.09 -54.97 1.17 Allowed 'Trans proline' 0 N--CA 1.496 1.666 0 C-N-CA 121.357 1.372 . . . . 0.0 112.194 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.524 ' O ' ' N ' ' A' ' 136' ' ' LEU . . . -45.97 -46.07 16.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.879 0.371 . . . . 0.0 110.42 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.467 ' HB2' ' CG ' ' A' ' 127' ' ' HIS . . . -45.12 -27.31 0.57 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.109 179.816 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 10.1 tpp180 -76.3 -30.7 57.85 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.299 179.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.524 ' N ' ' O ' ' A' ' 133' ' ' ALA . 36.6 mt -74.16 -24.9 59.47 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 179.303 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.573 ' O ' ' N ' ' A' ' 140' ' ' TYR . 3.7 mt -89.81 -33.26 16.58 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.075 179.511 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.519 ' C ' ' CD1' ' A' ' 138' ' ' TYR . 0.5 OUTLIER -27.68 -51.13 0.23 Allowed Pre-proline 0 CA--C 1.536 0.416 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.554 179.727 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.432 ' HD2' ' N ' ' A' ' 138' ' ' TYR . 2.2 Cg_endo -58.76 4.69 0.11 Allowed 'Trans proline' 0 N--CA 1.497 1.687 0 C-N-CA 121.374 1.383 . . . . 0.0 112.689 -179.823 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.573 ' N ' ' O ' ' A' ' 137' ' ' LEU . 0.3 OUTLIER -90.66 -15.41 30.45 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.904 0.383 . . . . 0.0 110.724 179.764 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.467 HD23 HD12 ' A' ' 144' ' ' LEU . 97.6 mt -60.09 -36.5 77.55 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 178.872 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -56.61 -41.8 77.67 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.689 179.161 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' TRP . . . . . . . . . . . . . 7.5 t-105 -62.74 -43.66 98.22 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 115.771 -0.65 . . . . 0.0 109.472 179.227 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.467 HD12 HD23 ' A' ' 141' ' ' LEU . 22.0 mt -58.44 -37.59 75.73 Favored 'General case' 0 CA--C 1.521 -0.163 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.707 179.268 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.673 ' O ' HG23 ' A' ' 149' ' ' VAL . . . -73.28 -27.84 61.78 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.496 179.848 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 28.7 t80 -64.75 -62.32 1.64 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.781 -179.781 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.489 ' O ' ' OD1' ' A' ' 151' ' ' ASN . . . -64.15 -43.84 93.95 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.432 -0.507 . . . . 0.0 110.45 -179.815 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . 0.499 ' O ' ' OD1' ' A' ' 151' ' ' ASN . 52.4 m -57.89 -36.71 72.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.475 179.807 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.673 HG23 ' O ' ' A' ' 145' ' ' ALA . 39.3 t -74.65 -27.5 20.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.686 179.82 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.546 ' O ' HG23 ' A' ' 154' ' ' VAL . 0.7 OUTLIER -66.41 -52.64 44.45 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.426 -0.509 . . . . 0.0 110.209 -179.935 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . 0.499 ' OD1' ' O ' ' A' ' 148' ' ' THR . 8.1 p-10 -65.35 -43.42 90.93 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.25 -179.837 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . 0.455 ' C ' ' CD1' ' A' ' 152' ' ' TYR . 22.6 t80 -64.78 -42.44 95.09 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.988 -0.285 . . . . 0.0 111.006 -179.562 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 77.1 t80 -61.18 -41.16 96.29 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.181 -179.376 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.546 HG23 ' O ' ' A' ' 150' ' ' LEU . 42.9 t -75.44 -50.46 23.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.38 -179.348 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' TRP . . . . . 0.617 ' CZ2' ' CD1' ' A' ' 107' ' ' TRP . 0.1 OUTLIER -55.4 -29.4 58.45 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.826 -178.889 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . 0.418 ' HA ' HH11 ' A' ' 156' ' ' ARG . 0.1 OUTLIER -85.41 -45.93 11.4 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.952 -0.299 . . . . 0.0 110.625 -179.639 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -69.02 -44.02 73.58 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.897 -179.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 16.3 t30 -69.74 -10.22 57.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.79 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 27.0 t -62.22 -28.51 69.74 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.71 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 83.0 -162.01 40.32 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 110.842 -0.903 . . . . 0.0 110.842 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 83.0 mtt-85 -139.06 167.93 20.95 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.828 0.347 . . . . 0.0 110.526 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 89.3 mtt180 -89.05 141.83 28.16 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.7 -179.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 82.09 118.66 0.52 Allowed Glycine 0 CA--C 1.524 0.62 0 N-CA-C 111.106 -0.798 . . . . 0.0 111.106 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 160.15 -106.31 0.28 Allowed Glycine 0 CA--C 1.524 0.624 0 N-CA-C 111.223 -0.751 . . . . 0.0 111.223 179.824 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 9.5 p -56.43 159.14 3.84 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.891 0.377 . . . . 0.0 110.846 -179.744 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 43.9 ttp85 -139.74 128.03 22.62 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.453 179.853 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.756 HD22 ' N ' ' A' ' 167' ' ' LEU . 1.3 mm? -108.38 172.19 6.98 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.044 179.785 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -139.64 139.81 36.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.598 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 . . . . . 0 C--O 1.219 -0.511 0 CA-C-O 117.999 -1.001 . . . . 0.0 110.453 179.929 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 201' ' ' PKA . . . . . 0.521 'CL ' ' C15' ' A' ' 201' ' ' PKA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.492 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.903 0.382 . . . . 0.0 110.636 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_exo -62.09 -45.25 16.54 Favored 'Trans proline' 0 C--N 1.304 -1.765 0 C-N-CA 122.515 2.143 . . . . 0.0 112.266 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -166.53 -21.86 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.57 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 67.5 p -54.14 124.66 16.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.734 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.694 ' CE2' ' CE3' ' A' ' 68' ' ' TRP . 1.0 OUTLIER -76.57 117.81 18.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.898 179.748 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.576 ' N ' ' CD ' ' A' ' 7' ' ' PRO . 0.9 OUTLIER -60.52 -33.01 12.86 Favored Pre-proline 0 CA--C 1.534 0.362 0 C-N-CA 120.858 -0.337 . . . . 0.0 110.274 -179.653 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.576 ' CD ' ' N ' ' A' ' 6' ' ' VAL . 24.6 Cg_exo -73.14 -66.23 0.03 OUTLIER 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 121.517 1.478 . . . . 0.0 112.069 179.577 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.4 ' O ' ' OG1' ' A' ' 12' ' ' THR . . . -50.11 -36.58 30.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.261 -179.485 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.594 HG23 ' O ' ' A' ' 5' ' ' TRP . 78.7 t -69.53 -61.96 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.552 -179.292 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -56.11 -34.71 62.71 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 111.51 -0.636 . . . . 0.0 111.51 -179.347 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 6.9 mp -74.44 -30.29 61.83 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.57 0.224 . . . . 0.0 110.737 -179.532 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.4 ' OG1' ' O ' ' A' ' 8' ' ' ALA . 3.1 p -81.21 -21.02 39.9 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.876 0.37 . . . . 0.0 110.578 179.83 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.423 ' O ' ' N ' ' A' ' 16' ' ' SER . 69.8 mt -82.9 -38.12 23.3 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.517 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.403 ' N ' ' HD2' ' A' ' 15' ' ' PRO . 5.1 t -43.07 -58.9 3.55 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.717 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.403 ' HD2' ' N ' ' A' ' 14' ' ' VAL . 11.7 Cg_endo -56.8 -13.96 12.57 Favored 'Trans proline' 0 N--CA 1.497 1.71 0 C-N-CA 121.02 1.147 . . . . 0.0 111.789 179.718 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.423 ' N ' ' O ' ' A' ' 13' ' ' LEU . 1.9 t -79.52 -24.73 42.01 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.506 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 55.0 mt -74.24 -58.16 3.48 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.323 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -75.72 -23.24 73.13 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 110.685 -0.966 . . . . 0.0 110.685 179.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -70.38 -52.49 16.86 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 111.259 -0.736 . . . . 0.0 111.259 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 86.9 t80 -74.07 -55.14 6.47 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.682 0.277 . . . . 0.0 111.184 -179.597 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 16.2 ttm -62.97 -30.12 71.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.26 -179.365 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -72.76 -59.54 4.34 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 111.277 -0.729 . . . . 0.0 111.277 -179.669 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.553 ' O ' HG22 ' A' ' 26' ' ' VAL . . . -64.22 -16.43 62.0 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.784 -0.366 . . . . 0.0 110.62 -179.434 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 63.4 t80 -48.14 -23.99 1.0 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.104 179.56 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 48.5 t80 -72.08 -53.54 12.54 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.953 -179.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.553 HG22 ' O ' ' A' ' 23' ' ' ALA . 33.3 m -65.52 -16.32 20.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 C-N-CA 120.835 -0.346 . . . . 0.0 110.672 -179.777 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.458 ' O ' ' CD1' ' A' ' 31' ' ' LEU . 0.0 OUTLIER -56.57 -47.51 79.34 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.741 -179.813 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -105.51 -62.98 0.63 Allowed Glycine 0 CA--C 1.525 0.7 0 N-CA-C 111.191 -0.764 . . . . 0.0 111.191 -179.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 6.1 tm-20 -45.09 -33.89 2.36 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.722 0.296 . . . . 0.0 110.626 -179.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -71.66 -51.11 17.05 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 111.023 -0.831 . . . . 0.0 111.023 -179.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.458 ' CD1' ' O ' ' A' ' 27' ' ' ARG . 86.6 mt -57.61 -35.04 69.93 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.752 0.31 . . . . 0.0 110.609 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 62.8 mtp180 -76.07 -42.72 46.56 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.36 179.796 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -51.71 -40.61 60.46 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.372 179.845 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.506 ' C ' ' CD1' ' A' ' 34' ' ' TYR . 9.8 t80 -48.23 -40.6 24.96 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.67 -179.797 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -57.73 -24.95 59.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.449 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -95.55 -75.18 1.26 Allowed Glycine 0 CA--C 1.525 0.663 0 N-CA-C 110.974 -0.85 . . . . 0.0 110.974 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.569 ' O ' HD12 ' A' ' 37' ' ' LEU . 0.4 OUTLIER -95.79 167.54 11.21 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.971 0.415 . . . . 0.0 110.739 179.823 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 47.2 mm-40 -79.91 113.21 17.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.888 -179.568 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.419 ' C ' ' H ' ' A' ' 41' ' ' SER . 8.3 mtpt -128.86 150.72 75.86 Favored Pre-proline 0 CA--C 1.532 0.281 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.068 179.637 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.595 ' C ' ' H ' ' A' ' 42' ' ' TRP . 72.4 Cg_endo -75.7 23.8 0.43 Allowed 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 121.871 1.714 . . . . 0.0 111.636 179.526 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.494 ' HG ' ' HD2' ' A' ' 34' ' ' TYR . 98.1 p -51.66 -1.72 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.264 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . 0.695 ' CH2' ' NE2' ' A' ' 43' ' ' HIS . 55.7 p-90 -76.81 -14.2 59.93 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.397 -0.521 . . . . 0.0 110.558 -179.308 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.695 ' NE2' ' CH2' ' A' ' 42' ' ' TRP . 19.0 m80 -64.45 139.14 97.65 Favored Pre-proline 0 C--N 1.33 -0.267 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 178.438 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.48 ' C ' ' O ' ' A' ' 43' ' ' HIS . 71.2 Cg_exo -31.37 116.12 0.06 OUTLIER 'Trans proline' 0 N--CA 1.494 1.537 0 C-N-CA 121.215 1.276 . . . . 0.0 111.349 -179.771 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.596 ' O ' ' N ' ' A' ' 47' ' ' TRP . 38.5 Cg_exo -39.65 152.82 0.06 OUTLIER 'Trans proline' 0 C--N 1.308 -1.588 0 CA-C-N 118.776 0.599 . . . . 0.0 111.774 -179.194 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.467 ' O ' ' CB ' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -40.57 -17.74 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.726 -179.812 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.602 ' CD1' ' N ' ' A' ' 48' ' ' THR . 0.2 OUTLIER -60.12 -45.78 91.84 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.899 -0.32 . . . . 0.0 111.685 -179.247 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.602 ' N ' ' CD1' ' A' ' 47' ' ' TRP . 1.0 OUTLIER -91.21 -39.78 11.91 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 112.824 0.675 . . . . 0.0 112.824 -178.268 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.808 HD23 ' O8 ' ' A' ' 201' ' ' PKA . 31.5 tp -83.0 -39.67 20.98 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -177.097 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.634 ' C ' ' H ' ' A' ' 52' ' ' ILE . . . -40.43 -29.08 0.21 Allowed Pre-proline 0 N--CA 1.466 0.327 0 C-N-CA 120.069 -0.652 . . . . 0.0 111.569 -178.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.408 ' HD2' ' N ' ' A' ' 50' ' ' ALA . 25.2 Cg_exo -54.93 7.39 0.03 OUTLIER 'Trans proline' 0 C--N 1.312 -1.355 0 CA-C-N 119.058 0.699 . . . . 0.0 112.205 177.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.778 HG23 ' O ' ' A' ' 49' ' ' LEU . 11.6 pt -54.37 -35.19 29.98 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.203 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 178.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 63.0 m95 -81.79 -24.12 36.16 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.359 179.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -71.43 -47.07 37.23 Favored Glycine 0 CA--C 1.527 0.792 0 N-CA-C 110.36 -1.096 . . . . 0.0 110.36 179.275 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.612 HG23 ' N ' ' A' ' 56' ' ' LEU . 13.3 t -70.65 -48.15 56.38 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 179.408 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.612 ' N ' HG23 ' A' ' 55' ' ' THR . 93.5 mt -60.92 -27.9 68.54 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 178.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.46 ' C ' ' CD1' ' A' ' 57' ' ' TYR . 0.8 OUTLIER -65.94 -53.64 36.54 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 179.375 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -48.88 -47.56 42.89 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 178.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.11 -48.21 82.44 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.062 179.177 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 27.1 mtt -52.67 -50.55 63.02 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.876 179.652 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -48.37 -53.63 15.38 Favored Glycine 0 CA--C 1.522 0.526 0 N-CA-C 110.399 -1.081 . . . . 0.0 110.399 179.638 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.538 ' N ' ' CD1' ' A' ' 62' ' ' TYR . 1.4 m-30 -56.55 -50.31 72.25 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.8 0.333 . . . . 0.0 110.527 179.68 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -52.06 -54.13 27.42 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 110.475 -1.05 . . . . 0.0 110.475 179.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.617 ' CB ' ' HE1' ' A' ' 68' ' ' TRP . 1.4 t -54.88 -47.23 74.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.834 0.349 . . . . 0.0 110.281 179.672 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.449 ' O ' ' CG ' ' A' ' 69' ' ' LYS . 74.7 t80 -46.27 -45.17 17.04 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.647 -0.421 . . . . 0.0 109.899 179.69 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 59.0 mt -71.38 -27.1 27.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.902 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 73.6 t -67.34 -57.71 8.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 C-N-CA 120.732 -0.387 . . . . 0.0 111.6 -179.3 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . 0.694 ' CE3' ' CE2' ' A' ' 5' ' ' TRP . 0.0 OUTLIER -72.82 -24.61 60.93 Favored 'General case' 0 CA--C 1.528 0.11 0 C-N-CA 119.814 -0.754 . . . . 0.0 110.73 -179.654 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.449 ' CG ' ' O ' ' A' ' 65' ' ' TYR . 6.5 mmmt -76.73 -26.74 54.98 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.427 -0.509 . . . . 0.0 110.181 179.341 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 33.6 tp10 -79.96 -58.4 3.18 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.817 -179.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.462 HD21 ' HB2' ' A' ' 78' ' ' ALA . 2.2 pp -73.34 -21.72 60.48 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.878 -179.597 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.499 ' O ' ' O ' ' A' ' 73' ' ' GLY . . . 109.32 98.57 2.54 Favored Glycine 0 CA--C 1.528 0.844 0 C-N-CA 121.088 -0.577 . . . . 0.0 112.248 178.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.577 ' N ' ' O ' ' A' ' 68' ' ' TRP . . . 41.52 -173.99 0.01 OUTLIER Glycine 0 CA--C 1.525 0.691 0 N-CA-C 111.975 -0.45 . . . . 0.0 111.975 178.878 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 84.0 t80 -90.42 110.64 21.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.724 0.297 . . . . 0.0 110.483 -179.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.568 ' OG1' ' N ' ' A' ' 76' ' ' GLU . 0.8 OUTLIER -142.43 -173.6 3.9 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.909 0.385 . . . . 0.0 110.893 -179.839 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.568 ' N ' ' OG1' ' A' ' 75' ' ' THR . 26.0 mt-10 -53.27 -21.68 5.83 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.692 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 24.3 m-20 -79.67 -33.07 41.5 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.778 -179.796 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.462 ' HB2' HD21 ' A' ' 71' ' ' LEU . . . -87.02 -15.62 38.12 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.821 -179.785 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 8.1 mtp -70.99 -27.24 63.56 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.763 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.401 ' N ' ' HD2' ' A' ' 81' ' ' PRO . 8.4 t -66.85 -45.12 54.36 Favored Pre-proline 0 C--N 1.328 -0.331 0 C-N-CA 120.783 -0.367 . . . . 0.0 110.52 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.401 ' HD2' ' N ' ' A' ' 80' ' ' VAL . 12.4 Cg_endo -77.1 -61.7 0.03 OUTLIER 'Trans proline' 0 N--CA 1.499 1.816 0 C-N-CA 121.227 1.284 . . . . 0.0 111.799 178.814 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 12.7 mt -55.39 -44.41 76.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.759 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -65.92 -55.85 17.43 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.972 -0.851 . . . . 0.0 110.972 -179.792 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 60.3 tp -55.28 -21.87 16.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.812 0.339 . . . . 0.0 110.37 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 30.7 t80 -78.03 -51.89 9.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.063 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -61.84 -38.58 88.75 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.8 -0.36 . . . . 0.0 111.277 -179.059 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -73.67 -58.14 4.65 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 111.277 -0.729 . . . . 0.0 111.277 -179.571 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 5.0 tp-100 -53.45 -47.74 69.45 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-O 121.127 0.489 . . . . 0.0 109.778 179.714 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.445 ' O ' ' C ' ' A' ' 90' ' ' ALA . 19.5 tp -52.81 -66.02 0.46 Allowed 'General case' 0 C--O 1.211 -0.961 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.904 179.823 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.563 ' O ' ' HB2' ' A' ' 94' ' ' ALA . . . -38.17 -48.7 1.29 Allowed 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 120.267 -0.573 . . . . 0.0 111.771 -179.496 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 95.3 mt -55.22 -57.03 13.45 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 113.415 0.894 . . . . 0.0 113.415 -178.407 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.758 ' O ' HD22 ' A' ' 113' ' ' LEU . 4.8 m-20 -78.05 -53.42 7.43 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 121.284 0.564 . . . . 0.0 111.604 -178.223 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . 0.645 ' O ' ' N ' ' A' ' 95' ' ' TRP . 5.6 t-105 -52.13 -25.11 8.12 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.568 -179.679 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.563 ' HB2' ' O ' ' A' ' 90' ' ' ALA . . . -55.74 71.35 0.0 OUTLIER 'General case' 0 CA--C 1.528 0.133 0 CA-C-O 120.829 0.347 . . . . 0.0 110.675 -179.722 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.681 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 7.0 p-90 -101.62 -17.73 0.19 Allowed Pre-proline 0 CA--C 1.534 0.35 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.891 -179.784 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.681 ' CD ' ' N ' ' A' ' 95' ' ' TRP . 44.5 Cg_exo -61.16 -24.78 79.85 Favored 'Trans proline' 0 C--N 1.311 -1.396 0 C-N-CA 120.248 0.632 . . . . 0.0 112.412 179.034 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.529 ' CD ' ' N ' ' A' ' 96' ' ' PRO . 63.8 Cg_exo -59.82 -31.82 94.51 Favored 'Trans proline' 0 N--CA 1.493 1.474 0 C-N-CA 120.339 0.693 . . . . 0.0 112.803 179.547 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 1.4 pt -77.2 44.01 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 C-N-CA 120.342 -0.543 . . . . 0.0 110.259 179.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -61.57 -35.59 78.23 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.302 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -82.62 -20.01 37.2 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.399 179.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -87.28 -14.73 63.57 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.912 -0.875 . . . . 0.0 110.912 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -62.04 -34.18 75.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.783 0.325 . . . . 0.0 110.672 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 15.8 ptt180 -76.4 11.24 1.65 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.78 -179.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 14.8 mt-30 -121.89 154.56 36.93 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.564 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 6.0 mmt -51.49 -18.59 1.12 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.413 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.606 ' O ' ' N ' ' A' ' 108' ' ' ALA . . . -71.13 -14.98 74.19 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 111.18 -0.768 . . . . 0.0 111.18 179.874 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' TRP . . . . . 0.461 ' CD1' ' N ' ' A' ' 108' ' ' ALA . 0.1 OUTLIER -42.55 -14.12 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.683 0.278 . . . . 0.0 110.822 -179.498 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.606 ' N ' ' O ' ' A' ' 106' ' ' GLY . . . -58.49 -28.68 65.6 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 179.416 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 12.2 mt -47.02 -31.68 3.42 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.889 179.49 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -54.55 -60.47 3.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.39 179.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.715 ' O ' HG23 ' A' ' 115' ' ' VAL . 1.6 p30 -59.0 -53.68 55.72 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.76 -179.44 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.589 ' N ' ' OD1' ' A' ' 111' ' ' ASP . 40.5 tp -55.43 -39.81 70.72 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -178.414 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.758 HD22 ' O ' ' A' ' 92' ' ' ASN . 17.9 mt -70.47 -61.69 1.67 Allowed 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.124 0.416 . . . . 0.0 112.124 -178.506 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.9 pp -59.6 -34.02 72.21 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 120.339 -0.544 . . . . 0.0 111.064 -179.006 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.715 HG23 ' O ' ' A' ' 111' ' ' ASP . 42.3 t -61.68 -60.86 2.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.102 -179.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 13.0 m -68.0 -22.62 64.99 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.546 -178.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -66.35 -62.75 4.39 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 120.696 -0.764 . . . . 0.0 111.856 -179.252 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.602 ' O ' HG23 ' A' ' 122' ' ' THR . 9.1 p -72.46 -35.86 52.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 111.614 0.227 . . . . 0.0 111.614 -179.183 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.547 ' O ' ' OG1' ' A' ' 123' ' ' THR . . . -67.96 -61.31 1.92 Allowed 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.387 -0.525 . . . . 0.0 111.289 -179.326 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 8.1 m -59.64 -50.43 73.9 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.561 -0.291 . . . . 0.0 111.492 -179.184 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.447 ' O ' HD23 ' A' ' 124' ' ' LEU . . . -55.29 -40.49 71.13 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.79 0.329 . . . . 0.0 111.019 -179.461 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.602 HG23 ' O ' ' A' ' 118' ' ' VAL . 40.4 p -74.79 -33.44 62.24 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.803 -0.359 . . . . 0.0 111.713 -179.253 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.547 ' OG1' ' O ' ' A' ' 119' ' ' ALA . 0.2 OUTLIER -60.07 -56.48 21.15 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.559 -0.456 . . . . 0.0 110.784 -179.521 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.606 HD23 ' N ' ' A' ' 125' ' ' ALA . 0.6 OUTLIER -79.19 -20.16 49.07 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 -178.584 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.606 ' N ' HD23 ' A' ' 124' ' ' LEU . . . -91.17 -66.73 0.9 Allowed 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 112.789 0.663 . . . . 0.0 112.789 -178.818 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 43.4 m0 -83.0 -57.42 3.3 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -177.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . 0.57 ' CG ' ' HB2' ' A' ' 134' ' ' ALA . 11.5 m170 -55.69 -22.18 22.08 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.584 -0.446 . . . . 0.0 111.129 -179.004 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 19.2 ttt85 -69.66 -48.79 58.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.148 -179.624 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 10.3 t -81.39 -47.46 19.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.993 -179.453 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 61.0 p -116.28 104.98 51.39 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.51 -179.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . 0.639 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 57.2 Cg_exo -70.79 -29.43 18.99 Favored 'Trans proline' 0 C--N 1.31 -1.477 0 C-N-CA 121.537 1.491 . . . . 0.0 112.367 179.639 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.639 ' CD ' ' N ' ' A' ' 131' ' ' PRO . 41.4 Cg_exo -62.58 -42.81 24.51 Favored 'Trans proline' 0 N--CA 1.496 1.663 0 C-N-CA 121.391 1.394 . . . . 0.0 111.787 179.7 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -54.44 -41.52 69.5 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.311 179.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.57 ' HB2' ' CG ' ' A' ' 127' ' ' HIS . . . -57.18 -22.66 42.06 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.309 179.705 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 11.2 tpp180 -77.06 -31.7 56.32 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.61 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 82.8 mt -72.56 -43.54 63.3 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.857 0.361 . . . . 0.0 110.082 179.571 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.556 ' O ' ' N ' ' A' ' 140' ' ' TYR . 3.4 mt -75.31 -37.68 60.68 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.442 179.79 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.55 ' C ' ' H ' ' A' ' 140' ' ' TYR . 0.8 OUTLIER -19.4 -48.64 0.04 OUTLIER Pre-proline 0 N--CA 1.466 0.352 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.948 -179.608 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.527 ' N ' ' O ' ' A' ' 137' ' ' LEU . 1.6 Cg_endo -64.45 16.08 0.08 OUTLIER 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 120.968 1.112 . . . . 0.0 112.142 179.617 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.76 ' CE2' HD11 ' A' ' 144' ' ' LEU . 5.3 p90 -93.35 -15.17 26.01 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-O 121.153 0.501 . . . . 0.0 110.22 179.634 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.653 ' CD1' ' CE1' ' A' ' 140' ' ' TYR . 5.8 mp -57.43 -26.74 61.62 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.273 178.773 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -66.49 -48.93 68.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.08 179.651 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' TRP . . . . . 0.563 ' CZ2' HD12 ' A' ' 52' ' ' ILE . 12.0 t-105 -55.81 -48.7 74.96 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 179.499 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.76 HD11 ' CE2' ' A' ' 140' ' ' TYR . 8.8 mt -50.37 -56.58 10.76 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 120.444 -0.502 . . . . 0.0 109.968 179.714 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.514 ' O ' HG23 ' A' ' 149' ' ' VAL . . . -61.41 -18.28 58.09 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.709 -179.815 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 6.5 t80 -70.93 -65.04 0.79 Allowed 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.843 -0.343 . . . . 0.0 110.829 -179.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.494 ' O ' ' OD1' ' A' ' 151' ' ' ASN . . . -62.95 -40.23 97.03 Favored 'General case' 0 C--N 1.332 -0.154 0 C-N-CA 120.769 -0.372 . . . . 0.0 110.309 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 13.9 m -58.77 -49.83 76.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.46 179.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.514 HG23 ' O ' ' A' ' 145' ' ' ALA . 53.6 t -66.9 -29.38 46.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.334 179.831 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.445 ' O ' HG23 ' A' ' 154' ' ' VAL . 1.0 OUTLIER -58.33 -59.6 5.08 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.506 -0.478 . . . . 0.0 109.935 179.989 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . 0.494 ' OD1' ' O ' ' A' ' 147' ' ' ALA . 6.7 p-10 -60.6 -51.29 70.02 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.543 179.624 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . 0.665 ' CZ ' ' NE ' ' A' ' 156' ' ' ARG . 53.8 t80 -50.13 -34.74 23.18 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.283 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . 0.552 ' CE2' ' OD2' ' A' ' 157' ' ' ASP . 41.0 t80 -68.06 -46.07 72.09 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.529 179.826 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.445 HG23 ' O ' ' A' ' 150' ' ' LEU . 19.0 t -58.14 -36.8 58.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.305 179.797 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' TRP . . . . . 0.575 ' O ' ' N ' ' A' ' 159' ' ' SER . 15.3 m0 -65.57 -46.02 81.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.624 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . 0.665 ' NE ' ' CZ ' ' A' ' 152' ' ' TYR . 7.2 mpt_? -68.4 -29.27 67.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.579 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . 0.552 ' OD2' ' CE2' ' A' ' 153' ' ' TYR . 17.0 m-20 -72.3 -51.71 19.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.819 -179.78 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 -89.2 -40.02 13.15 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.602 -179.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . 0.575 ' N ' ' O ' ' A' ' 155' ' ' TRP . 23.0 t -115.78 -170.12 1.72 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.632 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 84.81 25.53 41.28 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 110.974 -0.851 . . . . 0.0 110.974 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 69.6 mtt180 -48.77 -24.92 1.58 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.766 0.317 . . . . 0.0 110.721 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 11.9 ttt85 -61.92 153.7 28.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.968 0.413 . . . . 0.0 110.616 -179.788 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -153.87 179.32 30.22 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 110.713 -0.955 . . . . 0.0 110.713 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -176.7 -90.98 0.08 OUTLIER Glycine 0 CA--C 1.525 0.709 0 N-CA-C 111.1 -0.8 . . . . 0.0 111.1 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . 0.561 ' OG ' ' N ' ' A' ' 166' ' ' ARG . 5.6 t -76.91 -174.32 3.04 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.705 0.288 . . . . 0.0 110.759 -179.853 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . 0.561 ' N ' ' OG ' ' A' ' 165' ' ' SER . 22.0 ttp180 83.52 137.09 0.06 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.319 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.772 HD22 ' N ' ' A' ' 167' ' ' LEU . 1.4 mm? -111.19 54.16 0.69 Allowed 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.401 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.522 ' HB2' ' HE ' ' A' ' 166' ' ' ARG . . . -50.47 -39.13 47.19 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.617 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 . . . . . 0 C--O 1.221 -0.431 0 CA-C-O 118.011 -0.995 . . . . 0.0 110.444 179.855 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 201' ' ' PKA . . . . . 0.808 ' O8 ' HD23 ' A' ' 49' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 37.9 mtt . . . . . 0 C--O 1.231 0.08 0 CA-C-O 120.689 0.28 . . . . 0.0 110.41 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -81.72 -15.15 9.76 Favored 'Trans proline' 0 N--CA 1.494 1.538 0 C-N-CA 121.84 1.693 . . . . 0.0 111.944 179.68 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -62.75 -26.56 68.76 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.481 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 4.3 m -177.99 145.22 0.37 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.522 179.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.569 ' O ' HG23 ' A' ' 9' ' ' VAL . 0.6 OUTLIER -65.68 117.03 7.53 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.354 -179.872 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.589 ' N ' ' CD ' ' A' ' 7' ' ' PRO . 0.9 OUTLIER -62.28 -37.52 37.86 Favored Pre-proline 0 CA--C 1.534 0.352 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.114 -179.999 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.589 ' CD ' ' N ' ' A' ' 6' ' ' VAL . 33.5 Cg_exo -63.68 -64.21 0.07 OUTLIER 'Trans proline' 0 C--N 1.307 -1.621 0 C-N-CA 121.704 1.603 . . . . 0.0 111.525 179.638 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.7 ' O ' HG23 ' A' ' 12' ' ' THR . . . -52.77 -38.84 61.64 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.695 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.569 HG23 ' O ' ' A' ' 5' ' ' TRP . 24.8 t -59.3 -62.02 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.848 -179.691 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -59.86 -56.67 23.48 Favored Glycine 0 CA--C 1.527 0.81 0 N-CA-C 111.516 -0.634 . . . . 0.0 111.516 -179.628 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 10.1 mp -50.15 -37.77 36.19 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.563 0.22 . . . . 0.0 110.888 -179.643 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.7 HG23 ' O ' ' A' ' 8' ' ' ALA . 35.9 p -75.57 -25.18 56.85 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.858 -0.337 . . . . 0.0 110.625 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.55 HD13 ' O ' ' A' ' 9' ' ' VAL . 4.1 mp -75.81 -25.11 56.06 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.196 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.2 t -54.54 -61.87 4.94 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.428 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -55.8 -46.16 33.67 Favored 'Trans proline' 0 N--CA 1.496 1.672 0 C-N-CA 120.662 0.908 . . . . 0.0 111.808 179.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.2 t -46.13 -28.37 1.2 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.236 -179.474 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 92.7 mt -70.2 -56.02 7.86 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.645 -0.422 . . . . 0.0 110.742 -179.705 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -68.0 -23.2 74.42 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 111.316 -0.714 . . . . 0.0 111.316 -179.659 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -69.93 -54.66 11.13 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 110.881 -0.888 . . . . 0.0 110.881 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 52.3 t80 -65.94 -60.29 2.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.833 0.349 . . . . 0.0 110.675 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 17.3 tpp -59.09 -27.67 65.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.04 -179.726 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -74.71 -62.91 2.71 Favored Glycine 0 CA--C 1.523 0.536 0 N-CA-C 111.011 -0.836 . . . . 0.0 111.011 -179.78 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.593 ' O ' HG22 ' A' ' 26' ' ' VAL . . . -55.48 -19.54 9.9 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.947 0.403 . . . . 0.0 109.994 -179.917 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 9.5 t80 -47.83 -24.39 0.98 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.409 179.713 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.466 ' CE2' ' O ' ' A' ' 99' ' ' PHE . 50.0 t80 -69.34 -48.32 61.74 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.417 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.593 HG22 ' O ' ' A' ' 23' ' ' ALA . 35.6 m -75.23 -16.37 15.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.634 -179.893 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -56.31 -47.28 79.01 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.834 -179.77 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -107.14 -42.2 1.55 Allowed Glycine 0 CA--C 1.525 0.7 0 N-CA-C 111.055 -0.818 . . . . 0.0 111.055 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.44 ' OE2' ' CZ3' ' A' ' 33' ' ' TRP . 16.8 tp10 -71.45 -29.63 65.09 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.701 0.286 . . . . 0.0 110.693 -179.845 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -73.99 -57.36 4.87 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.913 -0.875 . . . . 0.0 110.913 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 10.0 mp -56.83 -25.42 56.02 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.973 -0.381 . . . . 0.0 109.973 179.781 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 55.4 ttt180 -81.2 -49.89 10.24 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.088 -0.506 . . . . 0.0 109.989 179.432 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . 0.44 ' CZ3' ' OE2' ' A' ' 29' ' ' GLU . 0.2 OUTLIER -45.83 -39.94 9.14 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.688 179.252 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 42.2 t80 -47.37 -38.67 13.55 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.774 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -55.97 -35.18 66.43 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.262 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -84.31 -72.27 1.29 Allowed Glycine 0 CA--C 1.524 0.634 0 N-CA-C 110.804 -0.918 . . . . 0.0 110.804 179.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.587 ' O ' HD12 ' A' ' 37' ' ' LEU . 0.4 OUTLIER -96.67 167.89 10.85 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.798 0.333 . . . . 0.0 110.611 179.622 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 42.3 mm-40 -83.71 118.53 23.95 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.512 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.474 ' C ' ' H ' ' A' ' 41' ' ' SER . 15.0 mtpt -127.47 150.15 71.97 Favored Pre-proline 0 N--CA 1.465 0.277 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.255 -179.804 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.607 ' C ' ' H ' ' A' ' 42' ' ' TRP . 99.0 Cg_endo -72.61 17.23 0.37 Allowed 'Trans proline' 0 C--N 1.309 -1.509 0 C-N-CA 121.747 1.632 . . . . 0.0 111.045 179.177 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.474 ' H ' ' C ' ' A' ' 39' ' ' LYS . 95.1 p -49.28 -2.04 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.397 -0.82 . . . . 0.0 111.447 -179.861 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . 0.607 ' H ' ' C ' ' A' ' 40' ' ' PRO . 48.7 p-90 -77.19 -15.14 59.63 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.448 -0.501 . . . . 0.0 110.557 -179.381 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.587 ' CE1' ' CH2' ' A' ' 42' ' ' TRP . 6.9 m-70 -60.71 146.07 86.84 Favored Pre-proline 0 C--N 1.33 -0.265 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 178.587 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.455 ' C ' ' O ' ' A' ' 43' ' ' HIS . 9.7 Cg_endo -34.18 139.79 0.08 OUTLIER 'Trans proline' 0 C--N 1.309 -1.515 0 C-N-CA 121.377 1.385 . . . . 0.0 111.145 -179.645 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -59.94 163.18 14.4 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 C-N-CA 120.148 0.565 . . . . 0.0 112.003 -179.347 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.64 ' O ' ' HB3' ' A' ' 50' ' ' ALA . 1.6 ptm180 -46.19 -26.88 0.85 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.832 -179.066 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.597 ' CD1' ' N ' ' A' ' 48' ' ' THR . 1.4 p-90 -55.42 -46.23 76.68 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 120.805 -0.358 . . . . 0.0 111.872 -178.678 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.597 ' N ' ' CD1' ' A' ' 47' ' ' TRP . 1.1 m -91.41 -40.92 11.16 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -178.499 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.673 ' O ' HG23 ' A' ' 52' ' ' ILE . 15.5 tp -83.19 -47.43 11.59 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -177.188 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.649 ' C ' ' H ' ' A' ' 52' ' ' ILE . . . -43.41 -27.84 0.33 Allowed Pre-proline 0 N--CA 1.468 0.431 0 N-CA-C 112.141 0.422 . . . . 0.0 112.141 -179.141 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.433 ' HD2' ' N ' ' A' ' 50' ' ' ALA . 26.6 Cg_exo -53.41 6.46 0.03 OUTLIER 'Trans proline' 0 C--N 1.313 -1.309 0 CA-C-N 119.003 0.68 . . . . 0.0 112.476 178.214 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.673 HG23 ' O ' ' A' ' 49' ' ' LEU . 7.0 pt -51.85 -36.81 19.84 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.19 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 178.827 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.423 ' HE1' ' C13' ' A' ' 201' ' ' PKA . 66.1 m95 -80.74 -25.0 38.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.143 -179.752 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -73.1 -50.75 11.64 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 110.326 -1.109 . . . . 0.0 110.326 179.326 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.593 HG23 ' N ' ' A' ' 56' ' ' LEU . 6.8 t -66.28 -49.16 68.04 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.983 -0.287 . . . . 0.0 110.287 179.713 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.593 ' N ' HG23 ' A' ' 55' ' ' THR . 77.7 mt -60.33 -36.53 78.17 Favored 'General case' 0 CA--C 1.521 -0.16 0 C-N-CA 120.403 -0.519 . . . . 0.0 109.608 179.317 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.485 ' C ' ' CD1' ' A' ' 57' ' ' TYR . 0.8 OUTLIER -56.46 -48.29 77.38 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.61 179.334 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.7 p -55.87 -48.06 76.23 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.022 179.5 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.0 -38.82 80.09 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.315 179.558 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 22.2 mtt -63.16 -37.91 89.1 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.479 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -63.38 -47.02 91.28 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 111.245 -0.742 . . . . 0.0 111.245 -179.703 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 3.3 m-30 -61.49 -59.13 5.71 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.574 -179.662 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.448 ' O ' HG23 ' A' ' 67' ' ' VAL . . . -53.94 -60.06 8.95 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 111.02 -0.832 . . . . 0.0 111.02 -179.884 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.534 ' OG ' ' CH2' ' A' ' 126' ' ' TRP . 44.7 m -45.51 -48.47 14.12 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.001 0.429 . . . . 0.0 110.726 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 62.6 t80 -56.51 -41.45 76.74 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.697 -179.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 74.7 mt -65.43 -37.56 80.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.923 -179.694 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.571 HG22 ' CB ' ' A' ' 130' ' ' SER . 21.3 t -59.85 -60.83 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.721 -179.801 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . 0.576 ' O ' ' N ' ' A' ' 73' ' ' GLY . 0.7 OUTLIER -57.3 -41.51 79.96 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.655 -0.418 . . . . 0.0 110.325 179.933 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 13.9 mmmt -61.44 -24.77 66.77 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.498 179.622 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 17.7 tp10 -82.34 -62.47 1.61 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.187 -179.473 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.743 ' C ' HD12 ' A' ' 71' ' ' LEU . 3.4 pp -65.25 -8.88 19.7 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.831 -0.348 . . . . 0.0 111.377 -179.152 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.676 ' N ' HD12 ' A' ' 71' ' ' LEU . . . 108.87 76.43 0.93 Allowed Glycine 0 CA--C 1.527 0.801 0 C-N-CA 120.939 -0.648 . . . . 0.0 111.592 179.561 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.576 ' N ' ' O ' ' A' ' 68' ' ' TRP . . . 42.84 -174.03 0.01 OUTLIER Glycine 0 CA--C 1.524 0.595 0 N-CA-C 111.947 -0.461 . . . . 0.0 111.947 179.219 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 43.8 t80 -76.33 110.71 11.07 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.262 -0.469 . . . . 0.0 110.837 -179.671 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.573 HG23 ' H ' ' A' ' 77' ' ' ASP . 7.4 t -142.37 -178.21 5.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.428 179.743 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -46.8 -26.57 0.98 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.179 -179.66 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.573 ' H ' HG23 ' A' ' 75' ' ' THR . 51.7 m-20 -79.05 -28.78 43.21 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.268 -179.422 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.485 ' O ' HD12 ' A' ' 82' ' ' LEU . . . -86.4 -18.34 32.05 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.955 -0.298 . . . . 0.0 110.937 -179.681 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 9.1 mtp -68.96 -27.38 65.68 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.604 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.404 ' N ' ' HD2' ' A' ' 81' ' ' PRO . 7.0 t -68.37 -47.77 36.5 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.9 -179.832 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.404 ' HD2' ' N ' ' A' ' 80' ' ' VAL . 11.4 Cg_endo -72.03 -58.56 0.07 OUTLIER 'Trans proline' 0 N--CA 1.498 1.792 0 C-N-CA 121.113 1.208 . . . . 0.0 111.843 179.253 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.519 HD11 ' CE2' ' A' ' 68' ' ' TRP . 1.6 mt -57.07 -43.71 82.34 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.48 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -66.84 -63.77 3.67 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 111.142 -0.783 . . . . 0.0 111.142 -179.475 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 57.7 tp -49.66 -23.07 1.55 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.924 0.393 . . . . 0.0 110.137 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.462 ' CZ ' HD22 ' A' ' 89' ' ' LEU . 12.9 t80 -76.61 -48.58 18.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.54 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.44 -42.45 95.99 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.8 -0.36 . . . . 0.0 111.056 -179.442 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -70.05 -57.97 6.55 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 111.149 -0.78 . . . . 0.0 111.149 -179.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 36.5 tp60 -54.71 -47.52 73.64 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-O 121.012 0.434 . . . . 0.0 110.104 179.731 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.462 HD22 ' CZ ' ' A' ' 85' ' ' TYR . 17.4 tp -56.55 -65.04 0.68 Allowed 'General case' 0 C--O 1.21 -0.991 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.936 179.581 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.592 ' O ' ' HB2' ' A' ' 94' ' ' ALA . . . -37.86 -44.33 0.75 Allowed 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 120.407 -0.517 . . . . 0.0 111.649 -179.407 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 78.2 mt -60.97 -56.89 15.81 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 113.102 0.778 . . . . 0.0 113.102 -178.664 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 41.7 m-20 -75.9 -53.11 8.93 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.392 0.615 . . . . 0.0 111.697 -178.369 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . 0.628 ' O ' ' N ' ' A' ' 95' ' ' TRP . 9.8 t-105 -52.05 -33.68 40.07 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.055 -0.975 . . . . 0.0 111.594 -179.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.592 ' HB2' ' O ' ' A' ' 90' ' ' ALA . . . -57.03 72.3 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.892 0.377 . . . . 0.0 110.076 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.705 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 22.1 p-90 -97.47 -17.0 0.2 Allowed Pre-proline 0 CA--C 1.532 0.264 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.966 -179.387 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.705 ' CD ' ' N ' ' A' ' 95' ' ' TRP . 52.8 Cg_exo -60.14 -32.23 94.32 Favored 'Trans proline' 0 N--CA 1.493 1.493 0 C-N-CA 120.357 0.705 . . . . 0.0 112.635 179.387 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.484 ' CD ' ' N ' ' A' ' 96' ' ' PRO . 70.1 Cg_exo -50.35 -23.31 9.98 Favored 'Trans proline' 0 N--CA 1.493 1.458 0 C-N-CA 120.254 0.636 . . . . 0.0 112.443 179.785 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.588 ' O ' ' N ' ' A' ' 101' ' ' GLY . 1.1 pp -84.5 19.77 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 121.087 0.47 . . . . 0.0 110.135 179.531 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.466 ' O ' ' CE2' ' A' ' 25' ' ' PHE . 4.4 t80 -39.13 -35.41 0.23 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.843 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 30.6 m-85 -86.59 -25.79 24.79 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.82 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.588 ' N ' ' O ' ' A' ' 98' ' ' ILE . . . -82.8 -4.4 90.07 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 111.195 -0.762 . . . . 0.0 111.195 -179.886 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -72.24 -9.63 58.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.637 0.256 . . . . 0.0 111.081 -179.704 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 3.7 ptm180 -105.25 4.3 30.95 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.755 0.312 . . . . 0.0 110.779 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . 0.406 ' C ' ' N ' ' A' ' 106' ' ' GLY . 9.6 mt-30 -113.69 167.54 10.53 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.475 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.486 ' N ' ' SD ' ' A' ' 105' ' ' MET . 0.0 OUTLIER -49.64 -17.38 0.32 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.532 179.979 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.578 ' O ' ' N ' ' A' ' 108' ' ' ALA . . . -72.77 -15.12 78.0 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 111.37 -0.692 . . . . 0.0 111.37 -179.751 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' TRP . . . . . 0.665 ' CD1' ' CZ2' ' A' ' 155' ' ' TRP . 0.0 OUTLIER -38.15 -21.32 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 120.548 0.213 . . . . 0.0 111.239 -179.473 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.578 ' N ' ' O ' ' A' ' 106' ' ' GLY . . . -66.81 -16.15 64.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.912 0.387 . . . . 0.0 111.291 -179.531 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 13.5 mt -60.31 -36.79 78.73 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.479 -179.246 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -53.66 -63.59 1.1 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.967 0.413 . . . . 0.0 110.721 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.742 ' O ' HG23 ' A' ' 115' ' ' VAL . 5.6 p-10 -56.76 -60.69 3.2 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.826 -179.297 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 51.9 tp -49.83 -41.9 46.06 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -178.477 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.418 HD23 ' HA ' ' A' ' 113' ' ' LEU . 71.4 mt -68.49 -61.72 1.7 Allowed 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 -178.144 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.3 pp -59.76 -33.29 71.48 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 120.581 -0.448 . . . . 0.0 111.281 -178.723 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.742 HG23 ' O ' ' A' ' 111' ' ' ASP . 53.3 t -62.04 -60.93 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.148 -179.838 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.493 ' O ' ' OG1' ' A' ' 120' ' ' THR . 11.4 t -68.57 -22.12 64.49 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.1 -179.373 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -64.8 -62.92 4.58 Favored Glycine 0 CA--C 1.526 0.764 0 C-N-CA 120.883 -0.675 . . . . 0.0 111.742 -179.284 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.585 ' O ' HG23 ' A' ' 122' ' ' THR . 9.9 p -73.38 -36.57 49.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 C-N-CA 120.948 -0.301 . . . . 0.0 111.286 -179.389 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.536 ' O ' ' OG1' ' A' ' 123' ' ' THR . . . -67.41 -61.21 2.02 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.529 -0.469 . . . . 0.0 111.019 -179.462 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.493 ' OG1' ' O ' ' A' ' 116' ' ' SER . 2.0 m -59.27 -54.59 45.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.351 -179.431 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.437 ' O ' ' CB ' ' A' ' 125' ' ' ALA . . . -49.5 -45.89 47.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.854 -179.513 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.585 HG23 ' O ' ' A' ' 118' ' ' VAL . 40.9 p -69.75 -35.29 74.84 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.996 -179.06 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.536 ' OG1' ' O ' ' A' ' 119' ' ' ALA . 0.2 OUTLIER -58.2 -52.07 67.1 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.633 -0.427 . . . . 0.0 111.139 -179.218 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.7 pp -83.96 -19.73 34.11 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.705 -0.398 . . . . 0.0 111.721 -178.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.437 ' CB ' ' O ' ' A' ' 121' ' ' ALA . . . -88.02 -70.11 0.65 Allowed 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.584 0.587 . . . . 0.0 112.584 -178.796 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' TRP . . . . . 0.534 ' CH2' ' OG ' ' A' ' 64' ' ' SER . 35.9 m0 -83.23 -57.82 3.1 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 -177.702 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . 0.449 ' CD2' ' N ' ' A' ' 127' ' ' HIS . 12.3 m170 -52.22 -21.82 3.76 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.663 -0.415 . . . . 0.0 111.295 -178.825 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 28.3 ttt180 -70.05 -47.01 63.75 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.667 -179.337 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 4.1 t -94.44 -9.58 9.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 111.861 0.319 . . . . 0.0 111.861 -178.674 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . 0.571 ' CB ' HG22 ' A' ' 67' ' ' VAL . 0.8 OUTLIER -149.56 106.39 3.29 Favored Pre-proline 0 C--N 1.328 -0.368 0 C-N-CA 120.872 -0.331 . . . . 0.0 111.183 -179.364 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . 0.665 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 74.4 Cg_exo -76.05 -23.27 12.28 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 121.759 1.639 . . . . 0.0 112.656 179.058 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.665 ' CD ' ' N ' ' A' ' 131' ' ' PRO . 52.4 Cg_exo -65.89 -56.85 0.28 Allowed 'Trans proline' 0 N--CA 1.496 1.652 0 C-N-CA 121.322 1.348 . . . . 0.0 112.347 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -46.76 -40.73 14.07 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.64 -179.793 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -52.35 -24.39 7.54 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.533 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 6.1 tpt180 -76.93 -36.71 56.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.432 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 41.3 mt -67.19 -37.06 83.05 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.353 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.568 ' O ' ' N ' ' A' ' 140' ' ' TYR . 5.8 mt -81.86 -39.63 23.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.487 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.513 ' C ' ' H ' ' A' ' 140' ' ' TYR . 4.2 t80 -22.58 -43.57 0.04 OUTLIER Pre-proline 0 CA--C 1.532 0.274 0 O-C-N 123.664 0.602 . . . . 0.0 111.819 -179.601 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.552 ' N ' ' O ' ' A' ' 137' ' ' LEU . 6.3 Cg_exo -65.36 12.66 0.12 Allowed 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 120.852 1.034 . . . . 0.0 111.975 179.291 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.702 ' CE2' HD11 ' A' ' 144' ' ' LEU . 3.1 p90 -93.15 -14.42 27.21 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-O 120.892 0.377 . . . . 0.0 110.852 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.53 HD13 HD12 ' A' ' 144' ' ' LEU . 4.3 mm? -55.94 -33.48 64.77 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 178.536 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -56.21 -55.43 33.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.005 179.604 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' TRP . . . . . 0.655 ' CE2' HD12 ' A' ' 52' ' ' ILE . 10.8 t-105 -52.08 -50.49 61.46 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 179.643 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.702 HD11 ' CE2' ' A' ' 140' ' ' TYR . 13.3 mt -49.68 -54.92 15.83 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 120.348 -0.541 . . . . 0.0 109.91 179.599 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.643 ' O ' HG23 ' A' ' 149' ' ' VAL . . . -60.44 -21.35 62.19 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.852 -179.779 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.583 ' CE1' HD21 ' A' ' 49' ' ' LEU . 6.2 t80 -69.48 -63.18 1.12 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.837 -179.582 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.429 ' HB2' ' CH2' ' A' ' 143' ' ' TRP . . . -64.91 -33.4 75.94 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.728 -0.389 . . . . 0.0 110.436 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 68.9 m -67.13 -35.35 79.53 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.2 179.673 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.643 HG23 ' O ' ' A' ' 145' ' ' ALA . 43.5 t -79.5 -26.87 12.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.179 179.79 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.526 ' O ' HG23 ' A' ' 154' ' ' VAL . 0.8 OUTLIER -66.55 -48.7 68.83 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.827 -0.435 . . . . 0.0 109.827 179.747 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . 0.55 ' CG ' ' HE1' ' A' ' 107' ' ' TRP . 0.9 OUTLIER -72.92 -51.23 19.34 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.627 179.81 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . 0.414 ' CD1' ' C ' ' A' ' 152' ' ' TYR . 27.8 t80 -56.16 -43.31 78.22 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.855 -179.77 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . 0.437 ' CB ' ' O ' ' A' ' 149' ' ' VAL . 63.9 t80 -62.46 -54.38 40.98 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.299 -179.548 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.526 HG23 ' O ' ' A' ' 150' ' ' LEU . 72.7 t -60.44 -54.81 29.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.151 -179.291 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' TRP . . . . . 0.665 ' CZ2' ' CD1' ' A' ' 107' ' ' TRP . 0.4 OUTLIER -48.92 -37.6 20.36 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.206 -0.452 . . . . 0.0 109.978 -179.564 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -77.51 -28.98 52.23 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.296 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 12.5 t0 -75.44 -52.82 9.82 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.826 -179.595 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . 0.484 ' OD1' ' O ' ' A' ' 158' ' ' ASN . 48.9 t-20 -68.03 -31.28 70.85 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.731 -179.861 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 3.8 m -54.46 174.46 0.06 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.636 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 175.88 177.09 44.65 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 111.217 -0.753 . . . . 0.0 111.217 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 15.3 tpt85 -100.68 146.27 27.4 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.82 0.343 . . . . 0.0 110.253 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 66.9 ttp85 -75.15 125.2 28.45 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.664 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -147.93 35.04 1.2 Allowed Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.76 -0.936 . . . . 0.0 110.76 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 60.19 151.26 0.01 OUTLIER Glycine 0 CA--C 1.523 0.569 0 N-CA-C 110.774 -0.93 . . . . 0.0 110.774 -179.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -64.37 -12.45 42.79 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.825 0.345 . . . . 0.0 110.42 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -137.95 -122.67 0.13 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.026 179.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.583 ' N ' HD12 ' A' ' 167' ' ' LEU . 8.4 mp -92.87 -79.43 0.4 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.803 0.335 . . . . 0.0 110.205 179.77 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.414 ' HB3' ' O ' ' A' ' 167' ' ' LEU . . . 64.52 118.89 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.718 179.722 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 . . . . . 0 C--O 1.221 -0.426 0 CA-C-O 117.988 -1.006 . . . . 0.0 110.303 179.822 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 201' ' ' PKA . . . . . 0.495 'CL ' ' C15' ' A' ' 201' ' ' PKA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.563 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.085 0 CA-C-O 121.009 0.433 . . . . 0.0 110.472 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -66.4 -12.71 36.82 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 C-N-CA 122.679 2.252 . . . . 0.0 112.213 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.435 ' O ' ' C ' ' A' ' 4' ' ' SER . 47.4 mm-40 -43.22 -29.86 0.43 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.648 -179.887 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.435 ' C ' ' O ' ' A' ' 3' ' ' GLU . 32.5 p 36.59 87.98 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.539 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.629 ' O ' HG23 ' A' ' 9' ' ' VAL . 0.3 OUTLIER -66.97 117.51 9.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.239 -179.938 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.648 ' N ' ' CD ' ' A' ' 7' ' ' PRO . 1.0 OUTLIER -62.64 -33.73 12.4 Favored Pre-proline 0 C--N 1.328 -0.326 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 179.788 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.648 ' CD ' ' N ' ' A' ' 6' ' ' VAL . 21.6 Cg_exo -72.37 -66.97 0.03 OUTLIER 'Trans proline' 0 C--N 1.308 -1.557 0 C-N-CA 121.957 1.772 . . . . 0.0 111.895 179.516 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.647 ' O ' HG23 ' A' ' 12' ' ' THR . . . -49.65 -31.32 10.67 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.153 -179.683 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.629 HG23 ' O ' ' A' ' 5' ' ' TRP . 47.4 t -71.36 -62.2 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.425 -179.182 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -59.02 -43.82 96.67 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 111.262 -0.735 . . . . 0.0 111.262 -179.419 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 8.0 mp -61.87 -39.03 90.5 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.697 0.284 . . . . 0.0 110.637 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.647 HG23 ' O ' ' A' ' 8' ' ' ALA . 8.0 p -69.73 -28.48 65.84 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.786 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.427 ' O ' ' CB ' ' A' ' 16' ' ' SER . 10.7 mt -78.27 -33.38 49.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.669 -179.843 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.443 ' N ' ' HD2' ' A' ' 15' ' ' PRO . 20.3 t -42.0 -59.48 2.58 Favored Pre-proline 0 CA--C 1.535 0.38 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.561 -179.681 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.443 ' HD2' ' N ' ' A' ' 14' ' ' VAL . 17.1 Cg_endo -51.69 -9.46 0.4 Allowed 'Trans proline' 0 N--CA 1.5 1.869 0 C-N-CA 120.616 0.877 . . . . 0.0 112.317 -179.471 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.427 ' CB ' ' O ' ' A' ' 13' ' ' LEU . 3.1 t -79.35 -30.99 42.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.74 -179.865 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 16.6 mt -69.63 -54.44 13.95 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.998 -179.728 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -73.38 -38.55 52.75 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 111.632 -0.587 . . . . 0.0 111.632 -179.374 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -68.94 -29.84 72.42 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 111.066 -0.813 . . . . 0.0 111.066 -179.546 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.412 ' CB ' ' O ' ' A' ' 16' ' ' SER . 64.0 t80 -78.73 -60.32 2.42 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.815 -0.354 . . . . 0.0 110.934 -179.672 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 23.8 ttm -64.88 -21.1 66.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.66 -179.805 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -79.09 -63.02 2.12 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 111.309 -0.716 . . . . 0.0 111.309 -179.628 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.559 ' O ' HG22 ' A' ' 26' ' ' VAL . . . -62.93 -22.19 66.6 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.594 -179.667 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 64.4 t80 -50.9 -23.91 3.19 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.989 0.424 . . . . 0.0 109.892 179.31 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.446 ' CD1' ' C ' ' A' ' 25' ' ' PHE . 25.4 t80 -67.08 -55.01 16.14 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.964 -179.84 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.559 HG22 ' O ' ' A' ' 23' ' ' ALA . 27.2 m -65.87 -22.13 30.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.966 -179.509 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.7 tmt_? -75.56 -17.54 60.03 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.698 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -116.06 -67.3 0.41 Allowed Glycine 0 CA--C 1.525 0.7 0 N-CA-C 111.239 -0.744 . . . . 0.0 111.239 -179.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -67.97 -29.72 68.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.751 0.31 . . . . 0.0 110.94 -179.69 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -69.27 -45.91 59.33 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 111.31 -0.716 . . . . 0.0 111.31 -179.737 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.405 ' N ' HD12 ' A' ' 31' ' ' LEU . 11.1 mp -60.34 -28.53 68.24 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.692 0.282 . . . . 0.0 110.677 -179.789 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 76.7 mtm180 -80.38 -43.03 21.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.829 0.347 . . . . 0.0 110.36 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . 0.466 ' O ' ' N ' ' A' ' 36' ' ' GLY . 0.2 OUTLIER -59.91 -27.2 66.54 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 179.751 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.487 ' C ' ' CD1' ' A' ' 34' ' ' TYR . 10.3 t80 -49.02 -37.02 19.33 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.894 179.496 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -70.87 -21.66 62.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.902 179.447 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.466 ' N ' ' O ' ' A' ' 33' ' ' TRP . . . -87.95 -76.89 1.28 Allowed Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.442 -1.063 . . . . 0.0 110.442 179.591 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.596 ' O ' HD12 ' A' ' 37' ' ' LEU . 0.4 OUTLIER -96.04 163.7 13.01 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 109.889 -0.411 . . . . 0.0 109.889 179.011 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.506 ' H ' ' CD ' ' A' ' 38' ' ' GLN . 11.2 mp0 -81.79 122.64 27.95 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.932 0.396 . . . . 0.0 111.432 -179.066 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 20.3 mtpt -119.02 160.01 42.58 Favored Pre-proline 0 C--N 1.332 -0.176 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.575 179.182 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -41.97 131.79 4.37 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 C-N-CA 122.023 1.815 . . . . 0.0 111.972 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.6 t -80.57 -2.53 46.67 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.021 -179.631 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 6.1 p90 -111.42 22.85 14.66 Favored 'General case' 0 N--CA 1.463 0.187 0 C-N-CA 120.959 -0.297 . . . . 0.0 110.845 -179.364 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.567 ' O ' ' CG ' ' A' ' 43' ' ' HIS . 1.7 p80 -90.27 122.92 66.92 Favored Pre-proline 0 CA--C 1.538 0.519 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.821 -179.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -105.44 -175.83 0.07 OUTLIER 'Trans proline' 0 N--CA 1.496 1.662 0 C-N-CA 120.933 1.089 . . . . 0.0 111.13 177.713 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -77.45 155.8 32.25 Favored 'Trans proline' 0 C--N 1.303 -1.839 0 C-N-CA 121.359 1.372 . . . . 0.0 110.698 178.659 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.504 ' O ' ' HB3' ' A' ' 50' ' ' ALA . 40.7 ptt85 -48.14 -32.28 6.73 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 112.2 0.444 . . . . 0.0 112.2 -178.693 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.499 ' CD1' ' N ' ' A' ' 48' ' ' THR . 0.0 OUTLIER -61.86 -17.0 54.85 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 120.618 -0.433 . . . . 0.0 111.551 -178.596 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.499 ' N ' ' CD1' ' A' ' 47' ' ' TRP . 8.9 m -92.39 -63.5 1.22 Allowed 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 -178.666 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.853 ' O ' HG23 ' A' ' 52' ' ' ILE . 2.1 mm? -85.02 -35.49 21.88 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 -177.657 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.565 ' C ' ' H ' ' A' ' 52' ' ' ILE . . . -39.87 -29.12 0.19 Allowed Pre-proline 0 N--CA 1.466 0.346 0 C-N-CA 120.14 -0.624 . . . . 0.0 111.849 -178.266 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.423 ' HD2' ' N ' ' A' ' 50' ' ' ALA . 95.5 Cg_exo -57.01 5.85 0.06 OUTLIER 'Trans proline' 0 C--N 1.313 -1.323 0 CA-C-N 119.114 0.719 . . . . 0.0 112.273 178.125 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.853 HG23 ' O ' ' A' ' 49' ' ' LEU . 33.5 pt -55.29 -31.37 26.65 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.295 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 179.514 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.459 ' O ' ' CB ' ' A' ' 57' ' ' TYR . 72.7 m95 -78.73 -22.81 45.98 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.892 -179.497 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -69.22 -48.23 47.52 Favored Glycine 0 CA--C 1.526 0.772 0 N-CA-C 110.064 -1.214 . . . . 0.0 110.064 178.754 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 14.5 m -66.77 -55.63 14.12 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.783 0.325 . . . . 0.0 110.142 179.431 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 86.1 mt -58.62 -26.98 64.26 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.44 179.713 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.526 ' C ' ' CD1' ' A' ' 57' ' ' TYR . 0.5 OUTLIER -64.98 -54.1 35.79 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 179.509 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 37.2 t -51.19 -50.49 58.92 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 179.126 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -56.6 -45.18 81.58 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.319 179.435 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 12.3 mtt -57.72 -49.03 77.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.365 179.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -51.49 -43.98 52.98 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 110.994 -0.842 . . . . 0.0 110.994 -179.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 3.2 m-30 -65.26 -56.3 13.54 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.762 0.315 . . . . 0.0 110.943 -179.456 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -52.06 -48.53 52.21 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.37 -1.092 . . . . 0.0 110.37 179.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.488 ' O ' ' CD1' ' A' ' 68' ' ' TRP . 1.7 t -58.83 -41.9 87.98 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.652 -0.274 . . . . 0.0 110.571 179.889 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.406 ' O ' ' CG ' ' A' ' 69' ' ' LYS . 14.5 t80 -54.58 -37.97 66.14 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 109.138 -0.689 . . . . 0.0 109.138 179.038 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 97.3 mt -73.34 -27.29 23.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.096 179.223 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 61.2 t -69.52 -61.69 1.58 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.252 0 C-N-CA 120.746 -0.382 . . . . 0.0 110.763 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . 0.516 ' CD1' ' N ' ' A' ' 68' ' ' TRP . 0.0 OUTLIER -57.9 -38.07 75.17 Favored 'General case' 0 C--O 1.221 -0.402 0 C-N-CA 119.388 -0.925 . . . . 0.0 109.622 179.758 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.406 ' CG ' ' O ' ' A' ' 65' ' ' TYR . 0.2 OUTLIER -58.39 -40.52 82.56 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.889 0.376 . . . . 0.0 110.458 179.956 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 55.8 tt0 -64.35 -41.67 96.64 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.344 -179.555 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.6 mt -78.78 -17.64 55.45 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.955 0.407 . . . . 0.0 111.053 -179.347 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 97.84 43.16 2.93 Favored Glycine 0 CA--C 1.526 0.771 0 N-CA-C 110.345 -1.102 . . . . 0.0 110.345 -178.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 96.98 -175.09 30.76 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 111.03 -0.828 . . . . 0.0 111.03 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -71.8 112.44 7.91 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.844 0.354 . . . . 0.0 110.533 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.433 ' OG1' ' N ' ' A' ' 76' ' ' GLU . 3.0 t -139.4 179.51 6.5 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.855 -179.801 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.433 ' N ' ' OG1' ' A' ' 75' ' ' THR . 5.0 mm-40 -54.56 -50.06 68.85 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.595 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -55.0 -16.11 2.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.454 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -95.56 -30.7 13.68 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.392 179.769 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 3.5 mtp -64.9 -27.06 68.6 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.495 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.427 ' O ' ' CB ' ' A' ' 84' ' ' LEU . 9.1 t -68.9 -49.64 25.67 Favored Pre-proline 0 CA--C 1.534 0.345 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.643 -179.694 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -72.13 -61.48 0.05 OUTLIER 'Trans proline' 0 N--CA 1.497 1.728 0 C-N-CA 121.127 1.218 . . . . 0.0 111.523 178.891 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.7 mt -51.3 -46.32 62.5 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.384 179.809 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.452 ' O ' ' N ' ' A' ' 86' ' ' THR . . . -67.6 -63.56 3.65 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.672 -0.971 . . . . 0.0 110.672 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.427 ' CB ' ' O ' ' A' ' 80' ' ' VAL . 56.9 tp -43.73 -24.75 0.14 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.892 0.377 . . . . 0.0 110.014 179.727 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.424 ' N ' ' C ' ' A' ' 83' ' ' GLY . 7.2 t80 -80.62 -40.48 25.59 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.442 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.452 ' N ' ' O ' ' A' ' 83' ' ' GLY . 0.7 OUTLIER -71.63 -39.07 70.65 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 120.599 -0.44 . . . . 0.0 110.854 -179.787 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -74.7 -56.92 4.74 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 110.758 -0.937 . . . . 0.0 110.758 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.454 ' O ' ' CB ' ' A' ' 92' ' ' ASN . 9.4 tp-100 -52.7 -43.88 65.93 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.723 0.296 . . . . 0.0 110.236 179.747 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 11.1 tp -67.59 -34.9 77.95 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.605 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.74 ' O ' ' HB2' ' A' ' 94' ' ' ALA . . . -59.73 -65.75 0.63 Allowed 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 120.279 -0.568 . . . . 0.0 111.343 -179.633 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.0 pp -70.71 -39.01 73.67 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -178.479 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.454 ' CB ' ' O ' ' A' ' 88' ' ' GLN . 36.7 t-20 -72.42 -50.33 27.14 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 -178.6 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . 0.622 ' O ' ' N ' ' A' ' 95' ' ' TRP . 0.0 OUTLIER -79.63 -16.63 55.45 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.536 -0.466 . . . . 0.0 111.832 -178.374 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.74 ' HB2' ' O ' ' A' ' 90' ' ' ALA . . . -52.02 81.83 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 120.31 -0.556 . . . . 0.0 109.965 179.336 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.704 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 33.8 p-90 -98.97 -16.14 0.19 Allowed Pre-proline 0 CA--C 1.537 0.451 0 N-CA-C 112.564 0.579 . . . . 0.0 112.564 -179.103 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.704 ' CD ' ' N ' ' A' ' 95' ' ' TRP . 36.6 Cg_exo -57.31 -31.5 91.09 Favored 'Trans proline' 0 N--CA 1.495 1.609 0 C-N-CA 120.526 0.818 . . . . 0.0 113.125 179.777 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.455 ' CD ' ' N ' ' A' ' 96' ' ' PRO . 80.4 Cg_exo -53.14 -20.28 13.87 Favored 'Trans proline' 0 N--CA 1.495 1.601 0 C-N-CA 120.352 0.701 . . . . 0.0 113.271 -179.873 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.463 ' O ' ' N ' ' A' ' 101' ' ' GLY . 1.3 pp -82.61 19.21 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 C-N-CA 120.586 -0.446 . . . . 0.0 110.469 -179.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -40.76 -41.48 1.56 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.933 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 2.5 p90 -85.5 -23.75 27.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.914 -179.698 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.463 ' N ' ' O ' ' A' ' 98' ' ' ILE . . . -78.82 -7.7 88.15 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 111.194 -0.762 . . . . 0.0 111.194 -179.851 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -80.14 -7.11 58.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.774 0.321 . . . . 0.0 110.729 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -74.36 -12.18 60.45 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.846 -179.727 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . 0.429 ' C ' ' N ' ' A' ' 106' ' ' GLY . 6.7 pt20 -117.39 164.62 14.59 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.804 -179.862 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 8.6 mmt -47.92 -17.15 0.1 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.536 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.595 ' O ' ' N ' ' A' ' 108' ' ' ALA . . . -62.09 -15.56 50.58 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' TRP . . . . . 0.512 ' C ' ' CD1' ' A' ' 107' ' ' TRP . 0.0 OUTLIER -44.04 -12.62 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.758 0.313 . . . . 0.0 110.725 -179.687 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.595 ' N ' ' O ' ' A' ' 106' ' ' GLY . . . -65.27 -28.52 69.4 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.363 179.743 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.413 HD13 ' O ' ' A' ' 106' ' ' GLY . 9.1 mp -45.76 -26.43 0.65 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.231 179.842 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -60.82 -63.97 1.12 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.595 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.704 ' O ' HG23 ' A' ' 115' ' ' VAL . 4.1 p30 -57.66 -50.75 72.15 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.464 -179.614 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.438 ' N ' ' OD1' ' A' ' 111' ' ' ASP . 53.2 tp -55.14 -44.27 74.92 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.875 -0.33 . . . . 0.0 111.587 -178.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 54.2 mt -66.7 -61.39 1.99 Allowed 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -178.515 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.3 pp -61.51 -32.64 72.67 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 120.567 -0.453 . . . . 0.0 111.842 -178.391 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.704 HG23 ' O ' ' A' ' 111' ' ' ASP . 46.0 t -63.32 -54.44 32.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.24 -179.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.447 ' O ' ' OG1' ' A' ' 120' ' ' THR . 28.9 t -72.46 -24.12 61.15 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.316 -179.059 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -66.2 -62.66 4.49 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 120.944 -0.646 . . . . 0.0 111.749 -179.278 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.588 ' O ' HG23 ' A' ' 122' ' ' THR . 7.5 p -71.79 -38.48 65.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 C-N-CA 120.961 -0.296 . . . . 0.0 111.709 -179.246 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.527 ' O ' ' OG1' ' A' ' 123' ' ' THR . . . -64.54 -60.92 2.58 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.697 -0.401 . . . . 0.0 111.221 -179.286 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.447 ' OG1' ' O ' ' A' ' 116' ' ' SER . 2.1 m -60.28 -55.16 37.12 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.56 -179.275 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -51.11 -40.65 58.95 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.204 -179.268 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.588 HG23 ' O ' ' A' ' 118' ' ' VAL . 30.9 p -72.25 -35.54 68.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.3 -179.363 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.527 ' OG1' ' O ' ' A' ' 119' ' ' ALA . 0.2 OUTLIER -58.28 -50.66 72.81 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.812 0.339 . . . . 0.0 111.148 -179.221 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.6 pp -82.42 -20.19 37.54 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.669 -178.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -88.12 -72.72 0.52 Allowed 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 -178.511 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 43.7 m0 -81.83 -57.93 3.21 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 112.662 0.616 . . . . 0.0 112.662 -177.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . 0.533 ' CD2' ' N ' ' A' ' 127' ' ' HIS . 5.3 m170 -53.18 -22.23 6.28 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.63 -0.428 . . . . 0.0 111.14 -178.823 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 14.0 ttt180 -76.31 -30.49 57.74 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.146 -179.61 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 73.8 t -95.64 -49.9 12.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.769 0.319 . . . . 0.0 111.29 -179.422 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 67.7 p -117.6 109.23 41.99 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.511 -179.707 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . 0.657 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 50.5 Cg_exo -71.68 -18.13 29.04 Favored 'Trans proline' 0 N--CA 1.493 1.461 0 C-N-CA 121.458 1.439 . . . . 0.0 112.584 179.638 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.657 ' CD ' ' N ' ' A' ' 131' ' ' PRO . 54.3 Cg_exo -74.43 -35.57 3.68 Favored 'Trans proline' 0 N--CA 1.496 1.653 0 C-N-CA 121.262 1.308 . . . . 0.0 112.0 179.365 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -63.49 -39.64 94.97 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.348 179.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -57.33 -26.56 61.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.2 179.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 15.9 tpt180 -77.66 -31.09 52.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.373 179.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 20.5 mt -75.5 -25.83 57.63 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.261 -0.427 . . . . 0.0 109.849 179.506 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.486 ' O ' ' N ' ' A' ' 140' ' ' TYR . 68.6 mt -92.47 -23.81 19.01 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.165 179.505 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.518 ' C ' ' CD1' ' A' ' 138' ' ' TYR . 0.3 OUTLIER -35.43 -50.19 1.33 Allowed Pre-proline 0 CA--C 1.535 0.395 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.977 179.715 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.439 ' HD2' ' N ' ' A' ' 138' ' ' TYR . 0.9 OUTLIER -61.28 4.89 0.2 Allowed 'Trans proline' 0 N--CA 1.496 1.667 0 C-N-CA 121.64 1.56 . . . . 0.0 112.958 -179.471 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.486 ' N ' ' O ' ' A' ' 137' ' ' LEU . 0.1 OUTLIER -88.88 -14.32 37.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.0 0.429 . . . . 0.0 110.562 179.657 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.538 HD23 HD12 ' A' ' 144' ' ' LEU . 97.5 mt -60.02 -33.6 72.22 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.685 178.582 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -57.15 -41.39 79.06 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.584 179.304 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' TRP . . . . . 0.431 ' CE2' HD12 ' A' ' 52' ' ' ILE . 8.6 t-105 -66.11 -43.64 86.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.591 179.24 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.538 HD12 HD23 ' A' ' 141' ' ' LEU . 30.0 mt -59.08 -41.97 89.27 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.174 179.765 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.619 ' O ' HG23 ' A' ' 149' ' ' VAL . . . -72.65 -23.4 60.9 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.419 179.855 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 24.4 t80 -65.91 -57.11 8.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.804 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.4 ' HB1' ' C20' ' A' ' 201' ' ' PKA . . . -68.08 -43.37 78.69 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 120.91 -0.316 . . . . 0.0 110.886 -179.727 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 63.6 m -58.99 -45.68 90.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.831 0.348 . . . . 0.0 110.754 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.619 HG23 ' O ' ' A' ' 145' ' ' ALA . 69.4 t -68.49 -29.43 43.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.632 -179.885 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.464 ' O ' HG23 ' A' ' 154' ' ' VAL . 1.6 tp -62.51 -47.09 85.44 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.293 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . 0.596 ' ND2' ' N ' ' A' ' 152' ' ' TYR . 0.3 OUTLIER -69.27 -37.2 77.77 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.568 179.934 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . 0.596 ' N ' ' ND2' ' A' ' 151' ' ' ASN . 26.0 t80 -64.15 -48.82 74.53 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.593 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 31.1 t80 -59.27 -43.51 92.49 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.872 -179.864 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.464 HG23 ' O ' ' A' ' 150' ' ' LEU . 75.8 t -61.7 -36.04 71.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.81 -179.757 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' TRP . . . . . . . . . . . . . 8.0 m0 -64.44 -59.19 4.63 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.74 -179.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . 0.411 ' NE ' ' CZ ' ' A' ' 152' ' ' TYR . 3.3 mpt_? -60.62 -51.29 70.05 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.829 -179.571 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 31.3 t0 -53.82 -43.79 69.7 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.791 -179.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 16.5 t-20 -76.18 -31.41 58.48 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.55 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 86.2 p -128.65 116.44 19.58 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.439 179.671 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . 0.476 ' O ' ' O ' ' A' ' 161' ' ' ARG . . . -93.09 130.41 10.32 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 110.999 -0.841 . . . . 0.0 110.999 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . 0.476 ' O ' ' O ' ' A' ' 160' ' ' GLY . 46.9 mtt180 45.67 -177.22 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.826 0.346 . . . . 0.0 110.742 179.872 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 34.9 ttp180 -94.66 129.8 41.39 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.504 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -79.67 -169.17 37.96 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 110.827 -0.909 . . . . 0.0 110.827 179.805 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 71.3 -123.82 10.63 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.809 -0.916 . . . . 0.0 110.809 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 6.0 t 63.4 158.34 0.08 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.759 0.314 . . . . 0.0 110.512 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . 0.407 HH11 ' HB3' ' A' ' 166' ' ' ARG . 4.1 ttm105 -80.35 -70.63 0.51 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.336 -0.393 . . . . 0.0 109.977 179.882 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 3.8 mp -141.73 -113.94 0.12 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.351 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -91.59 107.09 18.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.578 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 . . . . . 0 C--O 1.219 -0.525 0 CA-C-O 117.974 -1.013 . . . . 0.0 110.525 -179.98 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 201' ' ' PKA . . . . . 0.535 'CL ' ' C15' ' A' ' 201' ' ' PKA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.644 ' N ' ' CD ' ' A' ' 2' ' ' PRO . 1.6 mmt . . . . . 0 CA--C 1.53 0.179 0 CA-C-O 120.511 0.196 . . . . 0.0 110.99 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.644 ' CD ' ' N ' ' A' ' 1' ' ' MET . 52.5 Cg_exo -60.42 139.12 84.88 Favored 'Trans proline' 0 N--CA 1.495 1.602 0 C-N-CA 121.602 1.535 . . . . 0.0 112.13 -179.823 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.4 ' O ' ' CB ' ' A' ' 4' ' ' SER . 92.1 mt-10 -145.54 -25.63 0.47 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.459 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.4 ' CB ' ' O ' ' A' ' 3' ' ' GLU . 1.3 p 73.98 137.56 0.06 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.379 -179.814 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.712 ' O ' HG23 ' A' ' 9' ' ' VAL . 1.3 t-105 -60.2 109.12 0.9 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.096 -179.881 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.576 ' N ' ' CD ' ' A' ' 7' ' ' PRO . 0.9 OUTLIER -62.23 -40.43 66.78 Favored Pre-proline 0 CA--C 1.533 0.313 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.479 -179.479 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.576 ' CD ' ' N ' ' A' ' 6' ' ' VAL . 25.1 Cg_exo -61.24 -60.29 0.24 Allowed 'Trans proline' 0 C--N 1.306 -1.66 0 C-N-CA 121.627 1.551 . . . . 0.0 111.874 179.904 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.722 ' O ' HG23 ' A' ' 12' ' ' THR . . . -56.88 -32.94 66.37 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.42 -179.465 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.712 HG23 ' O ' ' A' ' 5' ' ' TRP . 55.3 t -67.22 -62.03 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 C-N-CA 120.897 -0.321 . . . . 0.0 111.397 -179.263 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -57.52 -41.23 93.33 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 111.354 -0.698 . . . . 0.0 111.354 -179.509 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 7.7 mp -69.64 -30.14 67.78 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 121.043 -0.263 . . . . 0.0 110.758 -179.641 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.722 HG23 ' O ' ' A' ' 8' ' ' ALA . 4.8 p -74.81 -25.24 58.89 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.842 -0.343 . . . . 0.0 110.406 179.802 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.441 ' O ' ' CB ' ' A' ' 16' ' ' SER . 6.4 mp -81.48 -33.79 31.74 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.023 179.688 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.416 ' N ' ' HD2' ' A' ' 15' ' ' PRO . 7.9 t -40.25 -60.66 1.4 Allowed Pre-proline 0 CA--C 1.535 0.366 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.061 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.416 ' HD2' ' N ' ' A' ' 14' ' ' VAL . 10.5 Cg_endo -51.49 -17.15 4.14 Favored 'Trans proline' 0 N--CA 1.499 1.8 0 C-N-CA 120.949 1.099 . . . . 0.0 112.091 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.441 ' CB ' ' O ' ' A' ' 13' ' ' LEU . 4.0 t -70.0 -33.3 71.86 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.886 0.374 . . . . 0.0 110.512 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 27.9 mt -72.11 -55.17 7.77 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.336 179.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -60.75 -46.36 94.63 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 110.857 -0.897 . . . . 0.0 110.857 179.784 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -65.35 -29.45 75.28 Favored Glycine 0 CA--C 1.526 0.756 0 N-CA-C 111.051 -0.82 . . . . 0.0 111.051 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 31.9 t80 -74.23 -59.98 2.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.696 0.284 . . . . 0.0 110.66 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 6.7 ttp -63.31 -22.47 66.9 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.621 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.479 ' C ' ' CZ2' ' A' ' 95' ' ' TRP . . . -77.2 -62.65 2.41 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 111.093 -0.803 . . . . 0.0 111.093 -179.874 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.41 ' O ' HG22 ' A' ' 26' ' ' VAL . . . -64.51 -17.54 63.99 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.006 0.431 . . . . 0.0 110.314 179.891 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 41.4 t80 -48.91 -24.73 1.58 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.143 179.634 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 33.9 t80 -67.64 -54.72 17.31 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.761 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.41 HG22 ' O ' ' A' ' 23' ' ' ALA . 22.2 m -71.64 -17.2 19.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.761 -179.724 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -62.17 -39.84 94.0 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.623 -179.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -114.65 -72.42 0.55 Allowed Glycine 0 CA--C 1.525 0.681 0 N-CA-C 110.824 -0.91 . . . . 0.0 110.824 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -45.92 -28.23 1.07 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.82 0.343 . . . . 0.0 110.431 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -68.26 -45.16 71.91 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 84.2 mt -54.95 -36.43 65.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.887 0.375 . . . . 0.0 110.274 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 56.2 mtp180 -77.69 -50.53 12.26 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.637 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . 0.422 ' O ' ' N ' ' A' ' 36' ' ' GLY . 0.6 OUTLIER -46.73 -30.68 2.52 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 116.3 -0.409 . . . . 0.0 109.909 -179.996 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 37.7 t80 -47.75 -33.62 7.33 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.424 179.723 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -74.9 -30.64 61.35 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.263 179.731 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.422 ' N ' ' O ' ' A' ' 33' ' ' TRP . . . -77.72 -77.39 0.83 Allowed Glycine 0 CA--C 1.524 0.64 0 N-CA-C 110.793 -0.923 . . . . 0.0 110.793 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.56 ' O ' HD12 ' A' ' 37' ' ' LEU . 0.4 OUTLIER -96.45 166.23 11.8 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 120.791 0.329 . . . . 0.0 110.739 179.712 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.597 HE21 ' C ' ' A' ' 39' ' ' LYS . 2.3 tm0? -83.17 113.41 20.63 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.767 -179.739 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.597 ' C ' HE21 ' A' ' 38' ' ' GLN . 7.8 mtpt -97.24 157.28 35.16 Favored Pre-proline 0 CA--C 1.532 0.267 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 179.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.428 ' O ' ' CD2' ' A' ' 43' ' ' HIS . 2.9 Cg_exo -49.79 139.85 31.35 Favored 'Trans proline' 0 N--CA 1.495 1.568 0 C-N-CA 120.924 1.083 . . . . 0.0 112.104 -178.714 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 6.0 t -80.86 -2.83 49.02 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.841 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 4.5 p90 -114.27 15.96 18.01 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.256 -179.257 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.59 ' CD2' ' O ' ' A' ' 43' ' ' HIS . 0.4 OUTLIER -88.68 119.67 70.06 Favored Pre-proline 0 CA--C 1.537 0.459 0 CA-C-N 116.742 -0.208 . . . . 0.0 111.484 -179.684 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.462 ' CG ' HD23 ' A' ' 49' ' ' LEU . 65.4 Cg_endo -102.77 152.42 0.26 Allowed 'Trans proline' 0 N--CA 1.491 1.367 0 C-N-CA 120.763 0.975 . . . . 0.0 111.049 178.47 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.481 ' O ' ' N ' ' A' ' 47' ' ' TRP . 2.0 Cg_endo -47.85 135.47 22.94 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 C-N-CA 120.615 0.877 . . . . 0.0 111.088 179.877 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.486 ' C ' ' HE ' ' A' ' 46' ' ' ARG . 0.0 OUTLIER -41.87 -18.43 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.904 -0.589 . . . . 0.0 112.258 -178.879 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.564 ' CD1' ' N ' ' A' ' 48' ' ' THR . 0.2 OUTLIER -53.91 -47.44 71.15 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 112.508 0.559 . . . . 0.0 112.508 -178.412 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.564 ' N ' ' CD1' ' A' ' 47' ' ' TRP . 4.7 t -90.43 -32.65 16.32 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 113.256 0.836 . . . . 0.0 113.256 -178.124 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.757 ' O ' HG23 ' A' ' 52' ' ' ILE . 0.2 OUTLIER -83.63 -46.32 12.48 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.808 0.669 . . . . 0.0 112.808 -177.658 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.6 ' C ' ' H ' ' A' ' 52' ' ' ILE . . . -39.08 -30.98 0.21 Allowed Pre-proline 0 C--O 1.235 0.305 0 C-N-CA 120.614 -0.435 . . . . 0.0 111.73 -178.391 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.413 ' HD2' ' N ' ' A' ' 50' ' ' ALA . 39.7 Cg_exo -53.53 5.55 0.03 OUTLIER 'Trans proline' 0 C--N 1.311 -1.417 0 CA-C-N 118.99 0.675 . . . . 0.0 112.456 178.253 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.757 HG23 ' O ' ' A' ' 49' ' ' LEU . 9.9 pt -53.34 -34.86 23.3 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.201 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 179.114 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.454 ' O ' ' CB ' ' A' ' 57' ' ' TYR . 72.6 m95 -78.83 -23.24 45.19 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.151 -179.415 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -68.96 -45.12 64.33 Favored Glycine 0 CA--C 1.527 0.797 0 N-CA-C 109.909 -1.276 . . . . 0.0 109.909 179.047 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 6.2 m -68.8 -56.89 6.58 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 179.282 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 95.8 mt -57.32 -26.0 60.25 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.094 179.733 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.543 ' C ' ' CD1' ' A' ' 57' ' ' TYR . 0.5 OUTLIER -66.27 -54.65 22.37 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 179.482 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 61.5 m -51.13 -53.85 30.59 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.539 -0.464 . . . . 0.0 109.92 179.369 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -54.51 -41.07 69.2 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.485 179.772 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 10.1 mtt -62.45 -58.2 8.46 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.354 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -42.31 -41.99 4.17 Favored Glycine 0 CA--C 1.521 0.445 0 N-CA-C 110.641 -0.984 . . . . 0.0 110.641 179.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -63.55 -57.64 9.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.896 0.379 . . . . 0.0 110.412 179.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -52.1 -57.0 14.11 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 110.682 -0.967 . . . . 0.0 110.682 179.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.455 ' O ' ' CD1' ' A' ' 68' ' ' TRP . 0.3 OUTLIER -46.26 -51.64 14.09 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.927 0.394 . . . . 0.0 110.176 179.574 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 70.6 t80 -49.84 -41.07 44.24 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.447 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 40.9 mt -69.63 -44.68 79.3 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.023 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.465 ' CG1' ' CZ3' ' A' ' 68' ' ' TRP . 23.3 t -53.83 -58.61 3.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 120.962 0.411 . . . . 0.0 110.815 -179.722 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . 0.526 ' O ' ' N ' ' A' ' 73' ' ' GLY . 1.5 m95 -64.06 -39.48 94.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.196 -179.526 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 4.9 mmmt -63.0 -23.96 67.69 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.847 0.356 . . . . 0.0 110.543 179.804 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -83.0 -62.67 1.53 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.08 -179.47 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.743 ' C ' HD12 ' A' ' 71' ' ' LEU . 3.6 pp -64.92 -9.29 20.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.179 -179.487 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.646 ' N ' HD12 ' A' ' 71' ' ' LEU . . . 106.05 81.99 1.49 Allowed Glycine 0 CA--C 1.525 0.707 0 C-N-CA 121.071 -0.585 . . . . 0.0 111.783 179.335 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.526 ' N ' ' O ' ' A' ' 68' ' ' TRP . . . 42.03 -174.13 0.01 OUTLIER Glycine 0 CA--C 1.526 0.722 0 N-CA-C 111.933 -0.467 . . . . 0.0 111.933 179.097 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 69.8 t80 -76.98 110.8 11.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.871 0.367 . . . . 0.0 110.884 -179.718 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.539 ' OG1' ' N ' ' A' ' 76' ' ' GLU . 1.1 t -142.05 -173.66 3.88 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.326 179.781 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.539 ' N ' ' OG1' ' A' ' 75' ' ' THR . 9.1 mm-40 -49.25 -34.71 15.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.779 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -69.64 -24.29 63.61 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.027 -179.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.485 ' O ' HD12 ' A' ' 82' ' ' LEU . . . -91.53 -24.22 19.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.861 0.362 . . . . 0.0 110.642 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 9.2 mtp -63.05 -26.72 68.98 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.576 179.861 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 6.8 t -70.41 -53.9 9.54 Favored Pre-proline 0 CA--C 1.536 0.405 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.838 -179.617 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -64.34 -56.32 0.46 Allowed 'Trans proline' 0 N--CA 1.498 1.753 0 C-N-CA 121.053 1.169 . . . . 0.0 112.097 179.551 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.504 HD11 ' CZ2' ' A' ' 68' ' ' TRP . 1.2 mt -61.41 -46.56 89.64 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.911 0.386 . . . . 0.0 110.569 -179.896 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -61.03 -53.96 40.7 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 111.241 -0.743 . . . . 0.0 111.241 -179.64 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 54.9 tp -62.69 -26.58 68.73 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.885 0.374 . . . . 0.0 110.603 -179.707 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 20.9 t80 -68.65 -50.88 47.67 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.783 -179.732 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 9.7 t -70.98 -33.82 70.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.268 -179.468 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -70.52 -57.2 6.8 Favored Glycine 0 CA--C 1.523 0.587 0 N-CA-C 110.947 -0.861 . . . . 0.0 110.947 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.428 ' O ' ' CB ' ' A' ' 92' ' ' ASN . 1.8 tp-100 -59.51 -40.54 87.42 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.818 0.342 . . . . 0.0 110.397 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.405 ' O ' ' CD1' ' A' ' 93' ' ' TRP . 11.4 tp -66.52 -34.91 78.98 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.41 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.766 ' O ' ' HB2' ' A' ' 94' ' ' ALA . . . -64.52 -65.73 0.64 Allowed 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 120.254 -0.578 . . . . 0.0 111.489 -179.398 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.6 pp -66.42 -34.48 78.04 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.714 0.635 . . . . 0.0 112.714 -178.493 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.428 ' CB ' ' O ' ' A' ' 88' ' ' GLN . 7.5 t-20 -82.04 -57.6 3.33 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 -178.461 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . 0.6 ' O ' ' N ' ' A' ' 95' ' ' TRP . 0.0 OUTLIER -69.94 -17.04 63.3 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 111.838 0.31 . . . . 0.0 111.838 -178.265 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.766 ' HB2' ' O ' ' A' ' 90' ' ' ALA . . . -52.51 82.95 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.14 0 C-N-CA 120.349 -0.54 . . . . 0.0 110.068 179.637 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.702 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 30.8 p-90 -99.32 -16.31 0.19 Allowed Pre-proline 0 CA--C 1.535 0.375 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 -179.449 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.702 ' CD ' ' N ' ' A' ' 95' ' ' TRP . 48.8 Cg_exo -58.91 -32.92 98.31 Favored 'Trans proline' 0 N--CA 1.495 1.579 0 C-N-CA 120.692 0.928 . . . . 0.0 112.977 179.393 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.466 ' CD ' ' N ' ' A' ' 96' ' ' PRO . 66.4 Cg_exo -49.41 -18.55 2.37 Favored 'Trans proline' 0 N--CA 1.495 1.559 0 C-N-CA 120.389 0.726 . . . . 0.0 112.971 -179.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.549 ' O ' ' N ' ' A' ' 101' ' ' GLY . 1.1 pp -92.06 20.97 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.934 0.397 . . . . 0.0 110.466 179.758 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 10.3 t80 -40.41 -48.42 2.73 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.488 179.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -77.5 -19.73 55.41 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.546 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.549 ' N ' ' O ' ' A' ' 98' ' ' ILE . . . -78.34 -15.17 81.35 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 110.892 -0.883 . . . . 0.0 110.892 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -67.73 -12.95 61.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.772 0.32 . . . . 0.0 110.468 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.413 HH11 ' HB2' ' A' ' 103' ' ' ARG . 0.0 OUTLIER -81.56 -8.44 59.72 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.467 179.998 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . 0.523 ' O ' ' N ' ' A' ' 106' ' ' GLY . 19.1 pt20 -123.87 173.8 7.95 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.838 179.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.55 ' N ' ' SD ' ' A' ' 105' ' ' MET . 0.0 OUTLIER -42.83 -17.02 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.125 -179.748 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.523 ' N ' ' O ' ' A' ' 104' ' ' GLN . . . -63.34 -16.84 58.74 Favored Glycine 0 CA--C 1.527 0.836 0 C-N-CA 121.324 -0.465 . . . . 0.0 111.979 -179.233 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' TRP . . . . . 0.686 ' CD1' ' CH2' ' A' ' 155' ' ' TRP . 0.0 OUTLIER -51.11 -15.87 0.4 Allowed 'General case' 0 C--N 1.329 -0.314 0 O-C-N 122.626 -0.338 . . . . 0.0 110.554 -179.581 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.492 ' O ' ' OD1' ' A' ' 111' ' ' ASP . . . -76.2 -25.05 54.78 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.855 0.359 . . . . 0.0 110.621 -179.825 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 84.2 mt -59.24 -29.72 67.73 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.923 -179.716 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.417 ' O ' HD23 ' A' ' 114' ' ' LEU . . . -54.1 -62.02 1.92 Allowed 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.728 -0.389 . . . . 0.0 110.502 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.68 ' O ' HG23 ' A' ' 115' ' ' VAL . 5.5 p-10 -62.02 -53.73 51.42 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.108 -0.496 . . . . 0.0 112.024 -179.432 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 31.8 tp -52.95 -45.13 67.57 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 -178.458 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.404 ' HA ' HD23 ' A' ' 113' ' ' LEU . 60.3 mt -67.67 -61.7 1.76 Allowed 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.624 0.601 . . . . 0.0 112.624 -178.322 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.417 HD23 ' O ' ' A' ' 110' ' ' ALA . 2.9 pp -58.62 -35.1 71.94 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 120.157 -0.617 . . . . 0.0 111.251 -178.736 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.68 HG23 ' O ' ' A' ' 111' ' ' ASP . 37.2 t -58.86 -59.27 3.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.963 179.801 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.494 ' O ' ' OG1' ' A' ' 120' ' ' THR . 5.6 t -70.45 -22.34 62.71 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.658 -179.009 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -64.93 -62.84 4.62 Favored Glycine 0 CA--C 1.526 0.778 0 C-N-CA 120.963 -0.637 . . . . 0.0 111.84 -179.058 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.529 ' O ' HG23 ' A' ' 122' ' ' THR . 8.9 p -72.16 -37.51 59.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 C-N-CA 120.975 -0.29 . . . . 0.0 111.39 -179.404 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.51 ' O ' ' OG1' ' A' ' 123' ' ' THR . . . -67.07 -60.21 2.81 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.338 -0.545 . . . . 0.0 111.038 -179.549 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.494 ' OG1' ' O ' ' A' ' 116' ' ' SER . 3.3 m -57.92 -56.46 21.75 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.754 0.311 . . . . 0.0 111.393 -179.638 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -50.68 -41.15 55.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.305 -179.302 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.529 HG23 ' O ' ' A' ' 118' ' ' VAL . 31.4 p -73.53 -30.16 62.92 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.855 -0.338 . . . . 0.0 111.817 -179.144 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.51 ' OG1' ' O ' ' A' ' 119' ' ' ALA . 0.2 OUTLIER -64.96 -49.04 71.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.942 0.401 . . . . 0.0 110.759 -179.559 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.0 pp -81.59 -20.18 40.38 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.488 -179.274 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -90.8 -67.04 0.88 Allowed 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 -178.552 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 34.8 m0 -83.73 -57.15 3.34 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 112.962 0.727 . . . . 0.0 112.962 -177.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . 0.492 ' CD2' ' N ' ' A' ' 127' ' ' HIS . 9.1 m170 -55.88 -22.21 24.24 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.715 -0.394 . . . . 0.0 111.707 -178.565 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 33.5 ttt-85 -72.91 -47.25 47.37 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.783 -0.367 . . . . 0.0 111.178 -179.592 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 64.3 t -79.47 -41.49 22.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.168 -179.449 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -130.2 118.22 18.23 Favored Pre-proline 0 CA--C 1.536 0.405 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.578 -179.543 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . 0.647 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 70.9 Cg_exo -75.26 -26.6 10.36 Favored 'Trans proline' 0 N--CA 1.493 1.476 0 C-N-CA 121.238 1.292 . . . . 0.0 112.857 179.276 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.647 ' CD ' ' N ' ' A' ' 131' ' ' PRO . 53.8 Cg_exo -60.4 -55.22 1.6 Allowed 'Trans proline' 0 N--CA 1.497 1.73 0 C-N-CA 121.517 1.478 . . . . 0.0 112.492 -179.731 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -46.28 -37.36 7.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.857 0.361 . . . . 0.0 110.315 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.427 ' HB2' ' CG ' ' A' ' 127' ' ' HIS . . . -57.57 -29.45 64.45 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.366 179.894 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 25.5 ttp180 -74.44 -30.47 61.91 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.319 179.788 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 48.5 mt -73.28 -28.91 62.38 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 179.405 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.519 ' O ' ' N ' ' A' ' 140' ' ' TYR . 5.7 mt -86.45 -31.01 21.61 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.413 179.614 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.462 ' C ' ' H ' ' A' ' 140' ' ' TYR . 1.5 t80 -31.52 -49.72 0.45 Allowed Pre-proline 0 CA--C 1.538 0.506 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.508 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.429 ' HD2' ' N ' ' A' ' 138' ' ' TYR . 4.1 Cg_endo -62.65 7.42 0.15 Allowed 'Trans proline' 0 N--CA 1.498 1.764 0 C-N-CA 121.526 1.484 . . . . 0.0 112.807 -179.689 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.519 ' N ' ' O ' ' A' ' 137' ' ' LEU . 0.1 OUTLIER -93.08 -14.41 27.32 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 121.013 0.435 . . . . 0.0 111.096 179.806 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.581 HD23 HD12 ' A' ' 144' ' ' LEU . 97.7 mt -59.73 -26.53 65.72 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.16 -0.473 . . . . 0.0 109.942 178.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -64.38 -39.3 93.6 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 179.256 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' TRP . . . . . 0.509 ' CE2' HD12 ' A' ' 52' ' ' ILE . 10.5 t-105 -67.19 -42.45 84.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.521 179.115 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.581 HD12 HD23 ' A' ' 141' ' ' LEU . 17.9 mt -58.73 -45.66 89.13 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.226 179.8 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.603 ' O ' HG23 ' A' ' 149' ' ' VAL . . . -70.35 -23.29 62.78 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.27 179.715 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 33.8 t80 -64.83 -64.34 0.89 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.776 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -64.96 -43.82 91.4 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.977 -179.571 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 37.4 m -56.89 -49.86 74.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.804 -179.781 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.603 HG23 ' O ' ' A' ' 145' ' ' ALA . 90.5 t -68.57 -31.78 52.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.935 -179.56 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 1.9 tp -57.07 -46.46 82.48 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.983 0.42 . . . . 0.0 109.912 179.738 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . 0.601 ' OD1' ' NE1' ' A' ' 107' ' ' TRP . 7.3 t30 -70.08 -54.53 12.67 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.922 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 65.8 t80 -51.58 -39.09 57.25 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.4 -179.397 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . 0.578 ' CE1' ' OD2' ' A' ' 157' ' ' ASP . 53.2 t80 -68.22 -52.43 34.2 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.63 -179.08 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 86.6 t -65.16 -28.07 43.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.596 -178.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' TRP . . . . . 0.686 ' CH2' ' CD1' ' A' ' 107' ' ' TRP . 0.6 OUTLIER -78.32 -40.64 36.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.773 0.32 . . . . 0.0 110.445 -179.334 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . 0.402 ' HD2' ' N ' ' A' ' 156' ' ' ARG . 6.0 mpt_? -76.52 -23.22 53.67 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 110.051 -0.351 . . . . 0.0 110.051 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . 0.578 ' OD2' ' CE1' ' A' ' 153' ' ' TYR . 2.1 m-20 -79.53 -39.89 30.89 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.537 179.79 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . 0.583 ' OD1' ' N ' ' A' ' 159' ' ' SER . 43.1 p30 -86.82 -18.42 31.04 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.501 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . 0.583 ' N ' ' OD1' ' A' ' 158' ' ' ASN . 19.0 p 54.17 -157.39 0.19 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.734 179.837 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -172.68 -73.11 0.05 OUTLIER Glycine 0 CA--C 1.526 0.733 0 N-CA-C 110.864 -0.895 . . . . 0.0 110.864 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 41.4 ttm180 -160.79 90.92 0.87 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.8 0.334 . . . . 0.0 110.514 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 27.1 ttm180 -65.88 143.01 57.71 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.451 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -82.97 -171.52 47.46 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 111.061 -0.816 . . . . 0.0 111.061 -179.805 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -159.11 -167.76 20.24 Favored Glycine 0 CA--C 1.526 0.733 0 N-CA-C 110.869 -0.893 . . . . 0.0 110.869 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 3.1 t -79.74 -74.12 0.31 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.749 0.309 . . . . 0.0 110.596 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 75.3 mtm180 57.2 179.86 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.647 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.62 ' N ' HD12 ' A' ' 167' ' ' LEU . 8.9 mp 57.27 -102.93 0.16 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.488 -179.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -56.41 90.94 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.531 179.827 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.22 -0.496 0 CA-C-O 118.021 -0.99 . . . . 0.0 110.509 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 201' ' ' PKA . . . . . 0.524 'CL ' ' C15' ' A' ' 201' ' ' PKA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 81.4 mmm . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.971 0.415 . . . . 0.0 110.571 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -59.3 -69.81 0.04 OUTLIER 'Trans proline' 0 C--N 1.306 -1.677 0 C-N-CA 122.565 2.176 . . . . 0.0 112.275 179.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 19.6 pt-20 -167.71 -32.03 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.793 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 12.9 m -154.17 -178.43 7.1 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.89 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.564 ' O ' HG23 ' A' ' 9' ' ' VAL . 0.9 OUTLIER -88.87 116.8 27.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.148 -179.983 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.538 ' N ' ' CD ' ' A' ' 7' ' ' PRO . 0.9 OUTLIER -57.94 -45.1 99.81 Favored Pre-proline 0 CA--C 1.534 0.346 0 C-N-CA 120.855 -0.338 . . . . 0.0 110.297 -179.577 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.538 ' CD ' ' N ' ' A' ' 6' ' ' VAL . 20.6 Cg_exo -58.02 -65.36 0.1 OUTLIER 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 121.416 1.411 . . . . 0.0 111.646 179.559 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.69 ' O ' HG23 ' A' ' 12' ' ' THR . . . -45.32 -36.32 4.06 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.366 -179.701 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.564 HG23 ' O ' ' A' ' 5' ' ' TRP . 69.0 t -70.04 -62.59 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 C-N-CA 120.866 -0.334 . . . . 0.0 111.775 -178.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -57.23 -43.59 93.53 Favored Glycine 0 CA--C 1.527 0.822 0 C-N-CA 121.275 -0.488 . . . . 0.0 112.0 -179.051 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.437 ' N ' HD12 ' A' ' 11' ' ' LEU . 8.5 mp -67.13 -35.53 79.94 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.569 0.223 . . . . 0.0 111.324 -179.166 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.69 HG23 ' O ' ' A' ' 8' ' ' ALA . 10.6 p -69.66 -29.83 67.38 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.733 -0.387 . . . . 0.0 110.635 -179.9 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.445 ' O ' ' C ' ' A' ' 14' ' ' VAL . 6.0 mp -78.58 -32.13 47.53 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.738 -179.758 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.445 ' C ' ' O ' ' A' ' 13' ' ' LEU . 6.0 t -35.97 -55.91 1.23 Allowed Pre-proline 0 CA--C 1.534 0.35 0 C-N-CA 120.891 -0.323 . . . . 0.0 110.867 -179.704 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.403 ' HD2' ' N ' ' A' ' 14' ' ' VAL . 13.2 Cg_endo -61.03 -41.27 45.25 Favored 'Trans proline' 0 N--CA 1.5 1.87 0 C-N-CA 120.936 1.091 . . . . 0.0 112.026 179.644 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 7.8 t -45.54 -28.34 0.92 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.665 -179.57 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 87.4 mt -66.0 -57.89 6.75 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.72 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -64.55 -24.92 69.83 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 111.291 -0.724 . . . . 0.0 111.291 -179.738 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -77.32 -27.82 59.01 Favored Glycine 0 CA--C 1.518 0.256 0 N-CA-C 110.432 -1.067 . . . . 0.0 110.432 -179.709 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 19.7 t80 -76.08 -60.75 2.19 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.785 0.326 . . . . 0.0 110.617 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 48.6 ttm -73.17 -21.08 60.76 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.216 -179.673 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -79.39 -57.04 3.24 Favored Glycine 0 CA--C 1.526 0.769 0 C-N-CA 120.956 -0.64 . . . . 0.0 111.664 -179.478 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.616 ' O ' HG22 ' A' ' 26' ' ' VAL . . . -69.65 -26.74 64.54 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 120.59 -0.444 . . . . 0.0 110.794 -179.466 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 45.1 t80 -46.92 -23.89 0.52 Allowed 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.516 -0.474 . . . . 0.0 109.848 179.443 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.566 ' CD1' ' CE1' ' A' ' 99' ' ' PHE . 56.6 t80 -72.71 -54.99 7.49 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.086 -179.769 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.616 HG22 ' O ' ' A' ' 23' ' ' ALA . 29.1 m -57.15 -25.83 23.91 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.107 0 C-N-CA 120.392 -0.523 . . . . 0.0 110.291 -179.528 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.75 -37.38 81.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.709 179.592 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -101.07 -56.03 0.9 Allowed Glycine 0 CA--C 1.525 0.693 0 N-CA-C 111.447 -0.661 . . . . 0.0 111.447 -179.596 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 6.0 tm-20 -65.63 -34.72 78.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.603 0.24 . . . . 0.0 111.107 -179.589 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -71.74 -55.02 7.72 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 111.076 -0.81 . . . . 0.0 111.076 -179.775 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 11.0 mp -59.32 -28.33 66.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.744 0.307 . . . . 0.0 110.508 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 40.3 ttm180 -79.02 -52.79 7.75 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.814 0.34 . . . . 0.0 110.466 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -50.51 -33.74 22.63 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 179.87 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.427 ' CD1' ' C ' ' A' ' 34' ' ' TYR . 25.8 t80 -45.51 -35.2 3.7 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.216 179.641 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -56.42 -36.94 69.52 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.58 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -85.67 -66.26 1.42 Allowed Glycine 0 CA--C 1.525 0.657 0 N-CA-C 111.033 -0.827 . . . . 0.0 111.033 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.785 HD22 HD21 ' A' ' 158' ' ' ASN . 0.4 OUTLIER -96.49 167.2 11.3 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.843 0.354 . . . . 0.0 110.532 179.564 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 6.3 tt0 -90.05 113.58 25.31 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.635 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.581 ' NZ ' ' CH2' ' A' ' 107' ' ' TRP . 17.9 mtpt -125.65 156.23 71.18 Favored Pre-proline 0 C--N 1.331 -0.211 0 CA-C-N 116.174 -0.466 . . . . 0.0 109.862 179.727 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.574 ' C ' ' H ' ' A' ' 42' ' ' TRP . 62.8 Cg_endo -74.72 29.06 0.35 Allowed 'Trans proline' 0 C--N 1.305 -1.712 0 C-N-CA 121.984 1.789 . . . . 0.0 111.497 179.672 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.463 ' H ' ' C ' ' A' ' 39' ' ' LYS . 87.4 p -52.41 -1.85 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.139 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . 0.574 ' H ' ' C ' ' A' ' 40' ' ' PRO . 3.5 p90 -76.9 -11.8 59.87 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.798 -0.361 . . . . 0.0 110.928 -179.259 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.457 ' O ' ' C ' ' A' ' 44' ' ' PRO . 24.2 m80 -68.52 135.56 90.68 Favored Pre-proline 0 C--N 1.329 -0.295 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 179.097 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.457 ' C ' ' O ' ' A' ' 43' ' ' HIS . 74.6 Cg_exo -33.79 148.52 0.03 OUTLIER 'Trans proline' 0 N--CA 1.495 1.566 0 C-N-CA 121.312 1.341 . . . . 0.0 111.683 -179.69 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.469 ' O ' ' N ' ' A' ' 47' ' ' TRP . 5.0 Cg_exo -64.13 157.83 51.37 Favored 'Trans proline' 0 C--N 1.311 -1.432 0 C-N-CA 120.627 0.885 . . . . 0.0 111.475 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.562 ' O ' ' HB3' ' A' ' 50' ' ' ALA . 3.1 ptm180 -43.51 -18.51 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.59 -179.188 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.588 ' CD1' ' N ' ' A' ' 48' ' ' THR . 1.0 OUTLIER -64.7 -42.41 95.31 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.658 -0.417 . . . . 0.0 111.012 -179.469 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.588 ' N ' ' CD1' ' A' ' 47' ' ' TRP . 1.7 m -90.58 -34.34 15.53 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.438 -179.257 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.695 ' O ' HG23 ' A' ' 52' ' ' ILE . 0.1 OUTLIER -83.3 -56.31 3.84 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 120.454 -0.498 . . . . 0.0 112.05 -178.635 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.633 ' C ' ' H ' ' A' ' 52' ' ' ILE . . . -39.19 -29.23 0.17 Allowed Pre-proline 0 C--O 1.237 0.407 0 C-N-CA 120.745 -0.382 . . . . 0.0 111.44 -178.618 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.426 ' HD2' ' N ' ' A' ' 50' ' ' ALA . 35.1 Cg_exo -52.92 3.71 0.04 OUTLIER 'Trans proline' 0 C--N 1.313 -1.32 0 CA-C-N 118.852 0.626 . . . . 0.0 111.877 177.516 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.695 HG23 ' O ' ' A' ' 49' ' ' LEU . 5.7 pt -51.12 -45.23 30.3 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.233 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 178.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.534 ' N ' ' CG1' ' A' ' 52' ' ' ILE . 87.6 m95 -57.66 -23.41 51.22 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.789 -179.094 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -68.48 -45.33 68.6 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 109.411 -1.476 . . . . 0.0 109.411 178.399 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 6.0 m -69.1 -57.6 5.2 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 179.133 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.509 HD13 ' CE3' ' A' ' 143' ' ' TRP . 34.6 mt -48.52 -49.58 35.45 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 179.112 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 6.9 t80 -46.37 -58.48 3.69 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.696 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.431 ' O ' ' CE1' ' A' ' 62' ' ' TYR . 0.2 OUTLIER -48.05 -58.88 3.87 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.881 0.372 . . . . 0.0 110.686 -179.556 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.534 ' HB1' ' O ' ' A' ' 136' ' ' LEU . . . -51.68 -61.46 2.24 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.852 -179.893 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.433 ' SD ' ' C ' ' A' ' 56' ' ' LEU . 0.2 OUTLIER -46.1 -38.93 8.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.396 -179.957 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -56.6 -54.29 37.37 Favored Glycine 0 CA--C 1.522 0.493 0 N-CA-C 110.905 -0.878 . . . . 0.0 110.905 -179.859 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.6 ' N ' ' CD1' ' A' ' 62' ' ' TYR . 0.6 OUTLIER -55.85 -59.81 4.36 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.876 -0.33 . . . . 0.0 110.847 -179.814 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -48.33 -56.14 9.69 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 110.75 -0.94 . . . . 0.0 110.75 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.563 ' OG ' ' NE1' ' A' ' 68' ' ' TRP . 0.6 OUTLIER -45.6 -56.07 5.59 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.963 0.411 . . . . 0.0 111.025 179.967 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 59.7 t80 -47.51 -47.11 27.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.023 -179.723 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 53.6 mt -59.62 -40.01 81.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.009 -179.588 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.447 ' CG1' ' CZ3' ' A' ' 68' ' ' TRP . 43.0 t -57.74 -52.12 61.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 C-N-CA 120.862 -0.335 . . . . 0.0 110.849 -179.612 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . 0.563 ' NE1' ' OG ' ' A' ' 64' ' ' SER . 0.6 OUTLIER -64.19 -28.94 70.09 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 120.643 -0.423 . . . . 0.0 110.778 -179.978 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.06 -22.46 59.52 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.816 0.341 . . . . 0.0 110.374 179.828 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -81.35 -61.36 1.96 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.053 -179.72 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.8 pp -74.43 -20.67 59.95 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.788 -0.365 . . . . 0.0 111.209 -179.294 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.509 ' O ' ' O ' ' A' ' 73' ' ' GLY . . . 109.44 99.11 2.56 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 121.135 -0.555 . . . . 0.0 112.268 178.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.509 ' O ' ' O ' ' A' ' 72' ' ' GLY . . . 40.64 -173.55 0.01 OUTLIER Glycine 0 CA--C 1.525 0.671 0 N-CA-C 112.195 -0.362 . . . . 0.0 112.195 178.684 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 25.4 t80 -90.2 110.88 21.9 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.538 -0.331 . . . . 0.0 110.53 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.587 ' OG1' ' N ' ' A' ' 76' ' ' GLU . 0.1 OUTLIER -142.2 -177.43 5.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.592 179.796 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.587 ' N ' ' OG1' ' A' ' 75' ' ' THR . 35.8 mt-10 -47.92 -29.6 3.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.636 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -70.04 -27.57 64.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.895 -179.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.416 ' O ' HD12 ' A' ' 82' ' ' LEU . . . -95.64 -17.74 21.09 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.917 -179.798 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 25.9 mtp -68.7 -28.63 67.01 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.836 -0.346 . . . . 0.0 110.786 -179.859 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 9.1 t -66.78 -49.29 49.77 Favored Pre-proline 0 CA--C 1.533 0.292 0 C-N-CA 120.782 -0.367 . . . . 0.0 110.536 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -69.52 -59.7 0.08 OUTLIER 'Trans proline' 0 N--CA 1.497 1.692 0 C-N-CA 121.051 1.167 . . . . 0.0 111.61 179.094 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.431 HD11 ' CH2' ' A' ' 68' ' ' TRP . 5.0 mt -52.47 -52.4 54.49 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.411 179.836 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -58.37 -57.67 18.64 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 110.484 -1.046 . . . . 0.0 110.484 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.425 ' O ' ' CB ' ' A' ' 88' ' ' GLN . 57.0 tp -48.22 -32.98 7.86 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 179.534 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -74.56 -47.53 32.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.827 -179.823 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -60.08 -48.74 80.44 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.742 -0.383 . . . . 0.0 110.919 -179.597 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -70.73 -58.33 5.88 Favored Glycine 0 CA--C 1.527 0.822 0 N-CA-C 111.477 -0.649 . . . . 0.0 111.477 -179.611 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.425 ' CB ' ' O ' ' A' ' 84' ' ' LEU . 12.4 tp-100 -50.45 -40.66 51.27 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.092 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.419 ' O ' ' C ' ' A' ' 90' ' ' ALA . 50.6 tp -58.51 -65.84 0.59 Allowed 'General case' 0 C--O 1.215 -0.719 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.927 179.717 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.699 ' O ' ' HB2' ' A' ' 94' ' ' ALA . . . -38.56 -46.13 1.15 Allowed 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 120.349 -0.54 . . . . 0.0 111.622 -179.448 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 83.8 mt -57.86 -56.43 22.11 Favored 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 112.815 0.672 . . . . 0.0 112.815 -178.694 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -75.2 -57.07 4.12 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.185 0.517 . . . . 0.0 111.742 -178.396 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . 0.676 ' O ' ' N ' ' A' ' 95' ' ' TRP . 0.1 OUTLIER -53.92 -23.44 12.84 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.454 -0.793 . . . . 0.0 111.49 -179.468 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.699 ' HB2' ' O ' ' A' ' 90' ' ' ALA . . . -52.34 73.64 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.818 0.342 . . . . 0.0 110.757 -179.549 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.682 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 13.5 p-90 -101.96 -17.48 0.19 Allowed Pre-proline 0 CA--C 1.532 0.266 0 CA-C-N 116.279 -0.418 . . . . 0.0 112.127 -179.522 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.682 ' CD ' ' N ' ' A' ' 95' ' ' TRP . 39.5 Cg_exo -62.43 -24.81 75.76 Favored 'Trans proline' 0 N--CA 1.495 1.577 0 C-N-CA 120.404 0.736 . . . . 0.0 112.812 179.401 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.541 ' CD ' ' N ' ' A' ' 96' ' ' PRO . 92.5 Cg_exo -62.02 -26.94 78.93 Favored 'Trans proline' 0 N--CA 1.496 1.628 0 C-N-CA 120.496 0.798 . . . . 0.0 112.675 179.679 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 1.2 pp -72.79 17.49 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-O 121.086 0.47 . . . . 0.0 110.107 179.797 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.566 ' CE1' ' CD1' ' A' ' 25' ' ' PHE . 2.4 t80 -39.49 -31.65 0.1 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.191 -179.802 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.488 ' CE1' ' O ' ' A' ' 97' ' ' PRO . 3.4 p90 -84.69 -50.37 7.69 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.942 -0.303 . . . . 0.0 110.869 -179.633 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.417 ' N ' ' CD2' ' A' ' 100' ' ' PHE . . . -64.22 -4.58 12.48 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 111.171 -0.772 . . . . 0.0 111.171 -179.739 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -75.07 -14.17 60.56 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.643 0.258 . . . . 0.0 110.939 -179.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 4.3 ptm180 -86.68 5.35 36.49 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.915 -0.314 . . . . 0.0 110.677 -179.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -121.57 171.01 9.13 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.565 179.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 4.7 mmt -59.37 -17.68 32.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.419 179.737 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.588 ' O ' ' N ' ' A' ' 108' ' ' ALA . . . -69.46 -15.37 70.47 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 111.455 -0.658 . . . . 0.0 111.455 -179.571 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' TRP . . . . . 0.581 ' CH2' ' NZ ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -43.49 -13.86 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.749 0.309 . . . . 0.0 110.725 -179.604 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.588 ' N ' ' O ' ' A' ' 106' ' ' GLY . . . -57.96 -18.68 25.18 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.431 179.718 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 13.4 mt -54.45 -32.13 56.92 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.386 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.558 ' HB3' ' C22' ' A' ' 201' ' ' PKA . . . -52.85 -63.05 1.27 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.544 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.757 ' O ' HG23 ' A' ' 115' ' ' VAL . 0.9 OUTLIER -59.67 -57.79 11.38 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.495 -179.545 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.418 ' N ' ' OD1' ' A' ' 111' ' ' ASP . 50.8 tp -47.82 -41.72 24.43 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.115 -0.493 . . . . 0.0 112.025 -178.87 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.421 HD23 ' HA ' ' A' ' 113' ' ' LEU . 64.5 mt -71.84 -61.84 1.64 Allowed 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -178.14 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.439 ' CD2' ' O ' ' A' ' 110' ' ' ALA . 1.1 pp -57.22 -32.8 66.88 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 120.037 -0.665 . . . . 0.0 111.432 -178.178 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.757 HG23 ' O ' ' A' ' 111' ' ' ASP . 98.0 t -67.06 -51.36 54.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.84 0.353 . . . . 0.0 110.925 179.777 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 18.0 m -68.53 -27.72 66.35 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.393 -179.312 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -68.07 -59.96 6.0 Favored Glycine 0 CA--C 1.528 0.867 0 C-N-CA 121.045 -0.598 . . . . 0.0 111.899 -179.036 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.532 ' O ' HG23 ' A' ' 122' ' ' THR . 7.5 p -65.27 -38.51 82.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 -178.831 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.449 ' N ' HG13 ' A' ' 118' ' ' VAL . . . -71.12 -60.76 2.06 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.518 -0.473 . . . . 0.0 111.52 -178.687 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 43.7 m -52.23 -52.97 49.28 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.918 0.39 . . . . 0.0 110.975 -179.594 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -57.47 -50.91 71.51 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.115 -0.493 . . . . 0.0 112.226 -179.161 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.532 HG23 ' O ' ' A' ' 118' ' ' VAL . 40.0 p -64.75 -64.54 0.85 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.969 0.414 . . . . 0.0 111.745 -178.72 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.434 ' OG1' ' O ' ' A' ' 119' ' ' ALA . 0.2 OUTLIER -44.06 -41.31 5.41 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.892 -0.595 . . . . 0.0 112.295 -178.448 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.78 ' C ' HD12 ' A' ' 124' ' ' LEU . 1.5 pp -84.34 -19.93 32.87 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.393 -0.523 . . . . 0.0 111.643 -179.117 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -94.77 -71.3 0.67 Allowed 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 113.053 0.761 . . . . 0.0 113.053 -178.433 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' TRP . . . . . 0.467 ' N ' ' CD1' ' A' ' 126' ' ' TRP . 25.6 m0 -76.71 -57.09 4.06 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 -177.411 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . 0.502 ' CG ' ' HB2' ' A' ' 134' ' ' ALA . 18.1 m170 -48.79 -22.58 0.84 Allowed 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.558 -0.457 . . . . 0.0 111.332 -178.63 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 23.0 ttt180 -69.11 -48.1 63.41 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.838 -0.345 . . . . 0.0 111.06 -179.628 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 15.0 t -79.77 -49.33 19.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.962 -179.62 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . 0.455 ' O ' ' OG ' ' A' ' 130' ' ' SER . 0.4 OUTLIER -118.71 108.92 40.47 Favored Pre-proline 0 CA--C 1.532 0.258 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.673 -179.701 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . 0.654 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 82.1 Cg_exo -74.38 -32.52 6.33 Favored 'Trans proline' 0 C--N 1.311 -1.447 0 C-N-CA 121.577 1.518 . . . . 0.0 112.794 179.451 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.654 ' CD ' ' N ' ' A' ' 131' ' ' PRO . 27.5 Cg_exo -58.67 -44.43 36.66 Favored 'Trans proline' 0 N--CA 1.494 1.558 0 C-N-CA 121.706 1.604 . . . . 0.0 112.199 -179.82 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.413 ' O ' ' N ' ' A' ' 136' ' ' LEU . . . -50.24 -49.51 52.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.672 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.502 ' HB2' ' CG ' ' A' ' 127' ' ' HIS . . . -44.19 -23.07 0.08 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.665 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . 0.401 ' N ' ' O ' ' A' ' 133' ' ' ALA . 14.1 tpp180 -76.66 -37.11 56.82 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.17 -179.528 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.534 ' O ' ' HB1' ' A' ' 59' ' ' ALA . 9.4 mt -76.26 -22.13 55.5 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 179.777 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.547 ' O ' ' N ' ' A' ' 140' ' ' TYR . 0.7 OUTLIER -85.44 -43.64 13.43 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 179.147 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.559 ' C ' ' H ' ' A' ' 140' ' ' TYR . 0.2 OUTLIER -21.32 -50.66 0.06 OUTLIER Pre-proline 0 N--CA 1.466 0.341 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.871 179.71 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.434 ' N ' ' O ' ' A' ' 137' ' ' LEU . 17.2 Cg_exo -51.21 -3.33 0.07 OUTLIER 'Trans proline' 0 C--N 1.308 -1.598 0 C-N-CA 121.247 1.298 . . . . 0.0 112.051 179.824 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.674 ' CE2' HD11 ' A' ' 144' ' ' LEU . 1.9 p90 -83.45 -17.55 41.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.779 -179.836 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.402 HD12 ' CD1' ' A' ' 138' ' ' TYR . 93.4 mt -61.35 -36.59 80.61 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 179.154 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -56.95 -40.29 76.16 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 179.08 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' TRP . . . . . 0.55 ' CD1' ' C ' ' A' ' 143' ' ' TRP . 0.4 OUTLIER -63.54 -45.14 91.93 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.647 179.414 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.674 HD11 ' CE2' ' A' ' 140' ' ' TYR . 13.7 mt -60.81 -41.53 95.85 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 179.354 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.66 ' O ' HG23 ' A' ' 149' ' ' VAL . . . -70.42 -18.98 63.02 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.103 -0.499 . . . . 0.0 109.766 179.217 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -71.14 -63.09 1.17 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.823 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.415 ' HB1' ' C20' ' A' ' 201' ' ' PKA . . . -68.64 -31.74 71.09 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 120.607 -0.437 . . . . 0.0 110.583 -179.804 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 85.0 m -67.7 -45.48 74.99 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.851 -0.34 . . . . 0.0 110.217 179.772 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.66 HG23 ' O ' ' A' ' 145' ' ' ALA . 45.7 t -64.64 -33.71 64.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.047 179.731 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.485 ' O ' HG23 ' A' ' 154' ' ' VAL . 0.9 OUTLIER -60.59 -58.9 6.53 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.033 179.859 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . 0.467 ' OD1' ' HB2' ' A' ' 108' ' ' ALA . 11.1 t30 -55.8 -54.43 44.54 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.56 179.823 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 16.6 t80 -52.42 -34.36 48.1 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.649 -179.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . 0.583 ' CE2' ' OD2' ' A' ' 157' ' ' ASP . 59.4 t80 -66.53 -47.1 73.98 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.821 -179.729 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.485 HG23 ' O ' ' A' ' 150' ' ' LEU . 13.0 t -55.9 -42.16 69.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.659 -179.825 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' TRP . . . . . . . . . . . . . 16.5 m0 -62.5 -59.45 4.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.151 -179.657 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.63 -25.93 63.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.047 -179.43 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . 0.583 ' OD2' ' CE2' ' A' ' 153' ' ' TYR . 0.8 OUTLIER -86.74 -42.67 13.15 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.885 -0.326 . . . . 0.0 111.333 -179.393 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . 0.785 HD21 HD22 ' A' ' 37' ' ' LEU . 2.4 m-20 -78.02 -40.78 37.85 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.208 -179.43 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . 0.473 ' O ' ' OG ' ' A' ' 159' ' ' SER . 22.8 p -67.57 90.5 0.26 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.476 -179.893 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 161.92 58.42 0.02 OUTLIER Glycine 0 CA--C 1.526 0.719 0 N-CA-C 111.176 -0.769 . . . . 0.0 111.176 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 27.8 mmt180 -89.19 -49.48 6.71 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.849 0.357 . . . . 0.0 110.586 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 36.7 ttt180 -52.34 143.96 13.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.632 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -139.44 -95.65 0.31 Allowed Glycine 0 CA--C 1.525 0.66 0 N-CA-C 111.024 -0.83 . . . . 0.0 111.024 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -159.73 45.81 0.43 Allowed Glycine 0 CA--C 1.524 0.629 0 N-CA-C 110.845 -0.902 . . . . 0.0 110.845 179.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . 0.426 ' O ' ' O ' ' A' ' 166' ' ' ARG . 1.1 t 56.97 18.74 4.11 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.803 0.335 . . . . 0.0 110.502 -179.816 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . 0.433 ' C ' HD22 ' A' ' 167' ' ' LEU . 0.3 OUTLIER 48.88 -178.97 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.439 179.89 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.791 HD22 ' N ' ' A' ' 167' ' ' LEU . 2.0 mm? -107.49 31.35 5.49 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.795 179.661 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -48.73 -37.87 20.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.869 -179.771 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 66.9 mm-40 . . . . . 0 C--O 1.22 -0.497 0 CA-C-O 117.98 -1.01 . . . . 0.0 110.511 179.882 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 201' ' ' PKA . . . . . 0.558 ' C22' ' HB3' ' A' ' 110' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 42.0 mtt . . . . . 0 CA--C 1.529 0.145 0 CA-C-O 120.593 0.235 . . . . 0.0 110.495 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_exo -45.01 148.58 1.53 Allowed 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 121.997 1.798 . . . . 0.0 112.182 179.759 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.408 ' CD ' ' N ' ' A' ' 3' ' ' GLU . 4.5 mp0 -109.42 -20.26 12.97 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.416 179.853 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 22.7 t -79.84 65.67 5.07 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.485 179.822 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.668 ' CD2' ' CZ3' ' A' ' 68' ' ' TRP . 0.3 OUTLIER -49.31 119.75 3.56 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.624 -179.858 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.59 ' N ' ' CD ' ' A' ' 7' ' ' PRO . 0.9 OUTLIER -61.05 -32.66 11.44 Favored Pre-proline 0 C--N 1.329 -0.291 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 179.7 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.59 ' CD ' ' N ' ' A' ' 6' ' ' VAL . 22.7 Cg_exo -74.71 -67.81 0.02 OUTLIER 'Trans proline' 0 N--CA 1.492 1.423 0 C-N-CA 121.531 1.488 . . . . 0.0 111.953 179.168 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.656 ' O ' HG23 ' A' ' 12' ' ' THR . . . -48.13 -38.95 19.09 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.965 -0.294 . . . . 0.0 111.178 -179.569 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.512 HG23 ' O ' ' A' ' 5' ' ' TRP . 89.2 t -69.96 -62.21 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.802 -179.255 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -53.9 -50.94 52.65 Favored Glycine 0 CA--C 1.526 0.773 0 N-CA-C 111.486 -0.646 . . . . 0.0 111.486 -179.307 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 8.8 mp -58.47 -40.9 83.94 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.615 0.245 . . . . 0.0 111.134 -179.603 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.656 HG23 ' O ' ' A' ' 8' ' ' ALA . 18.2 p -69.39 -28.71 66.42 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.843 -0.343 . . . . 0.0 110.998 -179.643 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.418 HD13 ' O ' ' A' ' 9' ' ' VAL . 7.1 mp -80.2 -26.31 39.25 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.737 -179.737 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.402 ' N ' ' HD2' ' A' ' 15' ' ' PRO . 14.2 t -44.58 -60.15 3.26 Favored Pre-proline 0 CA--C 1.534 0.342 0 C-N-CA 120.89 -0.324 . . . . 0.0 110.934 -179.64 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.402 ' HD2' ' N ' ' A' ' 14' ' ' VAL . 9.7 Cg_endo -52.7 -20.65 13.01 Favored 'Trans proline' 0 N--CA 1.498 1.761 0 C-N-CA 121.025 1.15 . . . . 0.0 111.749 179.746 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.587 ' OG ' ' CE3' ' A' ' 53' ' ' TRP . 1.6 t -73.79 -27.39 61.11 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.857 -179.744 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 87.7 mt -73.77 -58.16 3.49 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.477 -179.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -68.95 -22.06 75.59 Favored Glycine 0 CA--C 1.523 0.539 0 N-CA-C 110.449 -1.06 . . . . 0.0 110.449 179.694 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -74.12 -39.1 45.96 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 110.517 -1.033 . . . . 0.0 110.517 179.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 67.4 t80 -70.82 -60.09 2.44 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.676 0.274 . . . . 0.0 110.668 179.797 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 16.2 ttm -67.27 -21.21 65.72 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.951 -179.703 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -81.42 -62.68 1.93 Allowed Glycine 0 CA--C 1.525 0.672 0 N-CA-C 111.43 -0.668 . . . . 0.0 111.43 -179.671 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.652 ' O ' HG22 ' A' ' 26' ' ' VAL . . . -64.88 -24.96 67.69 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.77 0.319 . . . . 0.0 111.129 -179.386 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 27.8 t80 -47.36 -23.2 0.54 Allowed 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 179.558 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.4 ' CE2' ' HB3' ' A' ' 102' ' ' ALA . 21.3 t80 -72.72 -51.21 20.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.916 -0.583 . . . . 0.0 111.25 -179.769 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.652 HG22 ' O ' ' A' ' 23' ' ' ALA . 34.9 m -62.79 -26.88 41.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 C-N-CA 120.541 -0.464 . . . . 0.0 110.522 -179.745 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -66.72 -24.9 66.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.223 179.799 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -106.03 -35.36 2.98 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 110.377 -1.089 . . . . 0.0 110.377 179.531 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.419 ' O ' ' N ' ' A' ' 32' ' ' ARG . 18.8 tt0 -84.95 -47.42 10.29 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.753 0.311 . . . . 0.0 110.227 179.644 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.459 ' N ' ' O ' ' A' ' 26' ' ' VAL . . . -48.39 -46.5 28.87 Favored Glycine 0 CA--C 1.523 0.567 0 N-CA-C 110.567 -1.013 . . . . 0.0 110.567 179.787 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.407 ' N ' HD12 ' A' ' 31' ' ' LEU . 10.5 mp -60.0 -25.12 65.02 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 179.612 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.452 ' O ' ' HB3' ' A' ' 35' ' ' ALA . 56.6 ttt180 -78.33 -50.96 10.84 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.131 179.344 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 11.9 m0 -47.26 -45.24 23.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.231 179.745 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 88.3 t80 -52.52 -23.99 7.29 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.438 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.452 ' HB3' ' O ' ' A' ' 32' ' ' ARG . . . -67.73 -42.16 82.31 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.696 -179.868 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -97.1 -68.83 0.97 Allowed Glycine 0 CA--C 1.525 0.683 0 N-CA-C 111.076 -0.809 . . . . 0.0 111.076 -179.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.777 ' C ' HD12 ' A' ' 37' ' ' LEU . 3.6 pp -90.52 166.2 13.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.875 0.369 . . . . 0.0 110.592 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 48.5 mm-40 -85.46 129.8 34.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.608 -179.16 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.409 ' HG3' HD11 ' A' ' 37' ' ' LEU . 14.2 mtpt -118.63 165.02 17.78 Favored Pre-proline 0 CA--C 1.532 0.25 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 179.013 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.498 ' C ' ' H ' ' A' ' 42' ' ' TRP . 2.8 Cg_endo -63.77 92.36 0.17 Allowed 'Trans proline' 0 C--N 1.307 -1.612 0 C-N-CA 122.164 1.909 . . . . 0.0 111.75 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.2 m -56.02 -1.68 0.05 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.324 -179.792 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . 0.501 ' C ' ' CD1' ' A' ' 42' ' ' TRP . 2.8 p90 -95.07 -9.24 34.29 Favored 'General case' 0 C--O 1.231 0.113 0 C-N-CA 120.295 -0.562 . . . . 0.0 110.772 -179.386 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.583 ' O ' ' ND1' ' A' ' 43' ' ' HIS . 0.9 OUTLIER -87.86 121.2 70.91 Favored Pre-proline 0 CA--C 1.537 0.471 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.813 -179.985 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -95.11 156.98 1.72 Allowed 'Trans proline' 0 N--CA 1.492 1.429 0 C-N-CA 120.844 1.029 . . . . 0.0 111.562 179.13 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.425 ' C ' ' N ' ' A' ' 47' ' ' TRP . 2.9 Cg_endo -43.01 140.3 3.22 Favored 'Trans proline' 0 C--N 1.306 -1.694 0 C-N-CA 121.511 1.474 . . . . 0.0 111.59 -179.764 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -45.82 -16.96 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.231 -179.528 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.593 ' CD1' ' N ' ' A' ' 48' ' ' THR . 0.3 OUTLIER -53.06 -49.66 65.92 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 120.407 -0.517 . . . . 0.0 111.818 -178.653 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.593 ' N ' ' CD1' ' A' ' 47' ' ' TRP . 6.6 t -91.29 -30.09 16.79 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 113.341 0.867 . . . . 0.0 113.341 -178.606 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.675 ' O ' HG23 ' A' ' 52' ' ' ILE . 0.1 OUTLIER -83.14 -43.01 16.69 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -177.999 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.639 ' C ' ' H ' ' A' ' 52' ' ' ILE . . . -40.8 -28.34 0.21 Allowed Pre-proline 0 N--CA 1.465 0.287 0 N-CA-C 111.934 0.346 . . . . 0.0 111.934 -179.107 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.417 ' HD2' ' N ' ' A' ' 50' ' ' ALA . 12.4 Cg_exo -54.48 8.28 0.03 OUTLIER 'Trans proline' 0 C--N 1.311 -1.401 0 CA-C-N 119.005 0.68 . . . . 0.0 112.533 178.352 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.675 HG23 ' O ' ' A' ' 49' ' ' LEU . 9.2 pt -55.62 -35.56 39.12 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 178.673 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.587 ' CE3' ' OG ' ' A' ' 16' ' ' SER . 3.5 m0 -55.11 -25.01 28.79 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.433 179.615 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -69.89 -61.51 4.3 Favored Glycine 0 CA--C 1.528 0.845 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.906 -179.371 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.49 ' CG2' ' N ' ' A' ' 56' ' ' LEU . 1.9 t -56.39 -46.69 79.99 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 120.729 -0.389 . . . . 0.0 110.706 -179.351 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.49 ' N ' ' CG2' ' A' ' 55' ' ' THR . 57.9 mt -62.31 -41.57 98.65 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.365 -0.534 . . . . 0.0 109.639 179.313 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.532 ' C ' ' CD1' ' A' ' 57' ' ' TYR . 4.2 t80 -56.69 -40.27 75.29 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.678 -179.707 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.431 ' OG ' ' N ' ' A' ' 59' ' ' ALA . 1.3 p -62.85 -53.63 51.26 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 179.62 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.669 ' HB1' ' O ' ' A' ' 136' ' ' LEU . . . -55.78 -62.3 1.79 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.503 179.713 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 36.5 mtm -51.72 -32.35 29.99 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.447 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -57.93 -56.06 27.22 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 111.19 -0.764 . . . . 0.0 111.19 -179.774 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.459 ' HB3' HD13 ' A' ' 136' ' ' LEU . 3.4 m-30 -65.46 -42.67 92.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.05 0.452 . . . . 0.0 110.301 -179.834 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -53.35 -56.27 20.4 Favored Glycine 0 CA--C 1.524 0.615 0 N-CA-C 110.44 -1.064 . . . . 0.0 110.44 179.68 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.582 ' O ' ' CD1' ' A' ' 68' ' ' TRP . 0.9 OUTLIER -54.97 -45.12 74.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.774 0.321 . . . . 0.0 110.539 179.815 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.438 ' HA ' ' CZ2' ' A' ' 68' ' ' TRP . 74.7 t80 -47.01 -47.21 22.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.019 0.438 . . . . 0.0 110.01 179.668 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 62.4 mt -70.56 -28.14 33.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.058 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 59.3 t -63.42 -59.22 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 C-N-CA 120.617 -0.433 . . . . 0.0 111.647 -179.399 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . 0.668 ' CZ3' ' CD2' ' A' ' 5' ' ' TRP . 0.0 OUTLIER -70.78 -29.56 65.8 Favored 'General case' 0 N--CA 1.462 0.152 0 C-N-CA 119.84 -0.744 . . . . 0.0 110.822 -179.327 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -70.89 -22.38 62.28 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.517 -0.473 . . . . 0.0 110.207 179.524 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -82.22 -60.75 2.1 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.924 -179.677 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.8 pp -72.92 -11.19 60.49 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.99 -179.395 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.515 ' O ' ' O ' ' A' ' 73' ' ' GLY . . . 104.86 92.57 2.27 Favored Glycine 0 CA--C 1.527 0.814 0 C-N-CA 121.163 -0.541 . . . . 0.0 112.149 179.101 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.586 ' N ' ' O ' ' A' ' 68' ' ' TRP . . . 40.94 -173.52 0.01 OUTLIER Glycine 0 CA--C 1.524 0.652 0 N-CA-C 111.973 -0.451 . . . . 0.0 111.973 179.009 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 42.9 t80 -86.98 110.18 19.87 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.85 0.357 . . . . 0.0 110.341 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.576 ' OG1' ' N ' ' A' ' 76' ' ' GLU . 0.1 OUTLIER -142.57 -174.12 4.05 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.788 -179.822 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.576 ' N ' ' OG1' ' A' ' 75' ' ' THR . 92.2 mt-10 -49.89 -24.43 2.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.884 179.881 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -78.63 -31.68 47.03 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.893 -179.804 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -85.8 -20.57 29.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.831 0.348 . . . . 0.0 110.716 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 8.3 mtp -65.43 -27.1 68.29 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.658 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.409 ' O ' ' CB ' ' A' ' 84' ' ' LEU . 6.9 t -69.4 -48.74 24.75 Favored Pre-proline 0 C--N 1.328 -0.33 0 C-N-CA 120.839 -0.345 . . . . 0.0 110.728 -179.768 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -71.23 -60.85 0.05 OUTLIER 'Trans proline' 0 N--CA 1.497 1.715 0 C-N-CA 120.961 1.107 . . . . 0.0 111.829 179.179 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 5.0 mt -57.6 -48.73 78.61 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.618 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -61.2 -61.45 6.91 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 110.938 -0.865 . . . . 0.0 110.938 -179.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.409 ' CB ' ' O ' ' A' ' 80' ' ' VAL . 33.2 tp -53.54 -24.05 12.37 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.902 0.382 . . . . 0.0 110.494 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 13.5 t80 -77.33 -47.99 18.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.433 179.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -66.71 -37.0 83.81 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.603 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -71.21 -57.44 6.18 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 110.612 -0.995 . . . . 0.0 110.612 179.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 49.3 tp60 -53.38 -45.29 69.2 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 179.61 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.424 ' O ' ' C ' ' A' ' 90' ' ' ALA . 24.3 tp -53.35 -66.14 0.44 Allowed 'General case' 0 C--O 1.21 -0.994 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.63 179.603 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.613 ' O ' ' HB2' ' A' ' 94' ' ' ALA . . . -38.65 -48.64 1.48 Allowed 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 120.637 -0.425 . . . . 0.0 111.85 -179.575 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 94.6 mt -55.04 -57.28 12.33 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 112.9 0.704 . . . . 0.0 112.9 -178.277 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -74.84 -55.88 5.35 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 121.316 0.579 . . . . 0.0 111.419 -178.717 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . 0.642 ' O ' ' N ' ' A' ' 95' ' ' TRP . 4.9 t-105 -53.19 -19.45 3.06 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.124 -0.943 . . . . 0.0 111.209 -179.781 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.613 ' HB2' ' O ' ' A' ' 90' ' ' ALA . . . -59.19 69.37 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.161 0 CA-C-O 120.992 0.425 . . . . 0.0 109.86 179.629 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.688 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 11.9 p-90 -101.95 -17.04 0.19 Allowed Pre-proline 0 CA--C 1.536 0.418 0 CA-C-N 115.729 -0.668 . . . . 0.0 112.142 -179.106 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.688 ' CD ' ' N ' ' A' ' 95' ' ' TRP . 31.9 Cg_exo -60.89 -30.57 90.28 Favored 'Trans proline' 0 N--CA 1.495 1.573 0 C-N-CA 120.383 0.722 . . . . 0.0 112.618 179.638 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.514 ' CD ' ' N ' ' A' ' 96' ' ' PRO . 91.8 Cg_exo -55.24 -27.55 57.42 Favored 'Trans proline' 0 N--CA 1.494 1.526 0 C-N-CA 120.495 0.796 . . . . 0.0 112.607 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 1.1 pp -76.79 22.73 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.152 0 CA-C-O 121.335 0.588 . . . . 0.0 109.933 179.537 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.504 ' H ' ' C ' ' A' ' 97' ' ' PRO . 2.4 t80 -39.53 -45.74 1.62 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.043 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.434 ' C ' ' H ' ' A' ' 102' ' ' ALA . 4.7 m-85 -83.11 -49.65 9.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.195 -179.361 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -54.81 -7.75 1.12 Allowed Glycine 0 CA--C 1.526 0.726 0 N-CA-C 111.372 -0.691 . . . . 0.0 111.372 -179.506 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.434 ' H ' ' C ' ' A' ' 100' ' ' PHE . . . -75.06 -13.43 60.49 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 121.079 -0.248 . . . . 0.0 110.964 -179.707 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -75.77 6.98 4.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.768 0.318 . . . . 0.0 110.82 -179.848 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -125.63 165.95 17.62 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.326 179.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 8.4 mmt -56.07 -17.12 6.15 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.924 0.392 . . . . 0.0 110.183 179.602 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.514 ' O ' ' N ' ' A' ' 108' ' ' ALA . . . -63.36 -15.85 57.44 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 110.611 -0.996 . . . . 0.0 110.611 179.718 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' TRP . . . . . 0.483 ' C ' ' CD1' ' A' ' 107' ' ' TRP . 0.0 OUTLIER -47.47 -11.8 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.762 0.315 . . . . 0.0 110.525 -179.776 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.514 ' N ' ' O ' ' A' ' 106' ' ' GLY . . . -63.58 -20.7 65.86 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-O 121.118 0.485 . . . . 0.0 109.816 179.432 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 7.1 mt -55.36 -30.76 60.95 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.717 179.491 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.433 ' O ' HD23 ' A' ' 114' ' ' LEU . . . -53.86 -61.87 2.02 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.548 179.718 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.722 ' O ' HG23 ' A' ' 115' ' ' VAL . 1.4 p30 -60.69 -57.97 10.46 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.769 -179.351 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.526 ' N ' ' OD1' ' A' ' 111' ' ' ASP . 9.1 tp -50.46 -38.12 41.96 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 -178.733 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.406 HD23 ' HA ' ' A' ' 113' ' ' LEU . 62.6 mt -72.7 -62.24 1.52 Allowed 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -178.409 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.433 HD23 ' O ' ' A' ' 110' ' ' ALA . 1.3 pp -58.29 -35.45 71.82 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 120.063 -0.655 . . . . 0.0 110.912 -178.724 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.722 HG23 ' O ' ' A' ' 111' ' ' ASP . 87.7 t -63.46 -52.66 55.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.746 -179.708 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 39.0 t -69.81 -32.31 70.69 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.428 -178.704 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -61.22 -59.96 9.13 Favored Glycine 0 CA--C 1.526 0.753 0 C-N-CA 121.05 -0.595 . . . . 0.0 111.924 -179.262 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.564 ' O ' HG23 ' A' ' 122' ' ' THR . 4.4 p -68.78 -38.05 78.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -178.789 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.503 ' O ' ' OG1' ' A' ' 123' ' ' THR . . . -65.99 -60.19 3.08 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.625 -0.43 . . . . 0.0 111.339 -178.746 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 28.1 m -59.73 -57.26 13.67 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.366 -179.285 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -49.07 -43.93 41.45 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.42 -179.29 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.564 HG23 ' O ' ' A' ' 118' ' ' VAL . 27.9 p -68.32 -38.06 81.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.511 -179.197 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.503 ' OG1' ' O ' ' A' ' 119' ' ' ALA . 0.1 OUTLIER -56.77 -49.81 74.18 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.845 0.355 . . . . 0.0 111.134 -179.191 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.6 pp -83.76 -19.82 34.45 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.886 -178.745 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -86.48 -71.32 0.55 Allowed 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -178.433 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' TRP . . . . . 0.456 ' N ' ' CD1' ' A' ' 126' ' ' TRP . 37.0 m0 -85.01 -57.23 3.18 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 112.767 0.654 . . . . 0.0 112.767 -177.881 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . 0.514 ' CD2' ' N ' ' A' ' 127' ' ' HIS . 8.7 m170 -50.4 -23.97 2.74 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.874 -0.33 . . . . 0.0 111.549 -178.7 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 40.4 ttt-85 -76.34 -37.08 57.82 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.918 -0.313 . . . . 0.0 110.99 -179.721 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 60.2 t -83.94 -48.88 16.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.783 0.325 . . . . 0.0 110.88 -179.575 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -128.2 112.82 19.9 Favored Pre-proline 0 CA--C 1.532 0.274 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.573 -179.624 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . 0.625 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 67.1 Cg_exo -70.71 -34.28 11.67 Favored 'Trans proline' 0 N--CA 1.492 1.423 0 C-N-CA 121.092 1.195 . . . . 0.0 112.307 179.473 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.625 ' CD ' ' N ' ' A' ' 131' ' ' PRO . 32.3 Cg_exo -56.34 -35.0 95.56 Favored 'Trans proline' 0 N--CA 1.495 1.607 0 C-N-CA 121.52 1.48 . . . . 0.0 111.877 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -63.66 -38.68 92.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.321 179.865 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -54.51 -25.39 25.36 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.194 -0.457 . . . . 0.0 109.994 179.697 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 9.5 tpt85 -77.37 -29.82 53.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.002 179.63 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.669 ' O ' ' HB1' ' A' ' 59' ' ' ALA . 79.1 mt -80.02 -31.34 39.64 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.829 179.362 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.579 ' O ' ' N ' ' A' ' 140' ' ' TYR . 0.7 OUTLIER -79.39 -44.61 21.13 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 179.344 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.548 ' C ' ' H ' ' A' ' 140' ' ' TYR . 0.4 OUTLIER -19.97 -51.24 0.05 OUTLIER Pre-proline 0 N--CA 1.466 0.327 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.913 179.916 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.457 ' N ' ' O ' ' A' ' 137' ' ' LEU . 16.9 Cg_exo -53.08 -1.69 0.09 OUTLIER 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 121.11 1.207 . . . . 0.0 112.015 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.657 ' CE2' HD11 ' A' ' 144' ' ' LEU . 2.2 p90 -84.24 -19.5 33.82 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 120.919 0.39 . . . . 0.0 110.638 -179.781 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 95.6 mt -59.98 -49.92 75.79 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.63 -0.428 . . . . 0.0 109.986 179.253 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -45.55 -44.92 13.15 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 179.37 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' TRP . . . . . 0.575 ' C ' ' CD1' ' A' ' 143' ' ' TRP . 0.3 OUTLIER -58.34 -48.74 79.59 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.423 179.37 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.657 HD11 ' CE2' ' A' ' 140' ' ' TYR . 16.1 mt -55.46 -46.7 76.78 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.32 -0.552 . . . . 0.0 109.59 179.567 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.563 ' O ' HG23 ' A' ' 149' ' ' VAL . . . -63.44 -20.91 65.97 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.902 179.3 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -68.99 -62.91 1.18 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.504 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.452 ' HB1' ' C20' ' A' ' 201' ' ' PKA . . . -67.8 -45.61 74.28 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 120.57 -0.452 . . . . 0.0 110.414 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 19.2 m -52.28 -60.29 3.39 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.756 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.563 HG23 ' O ' ' A' ' 145' ' ' ALA . 93.2 t -54.16 -41.64 52.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 C-N-CA 120.878 -0.329 . . . . 0.0 110.798 -179.725 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 3.5 tp -50.39 -56.05 13.1 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.819 0.342 . . . . 0.0 110.548 -179.679 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . 0.414 ' ND2' ' CB ' ' A' ' 108' ' ' ALA . 9.8 t30 -61.7 -54.76 38.24 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.672 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . 0.443 ' CZ ' ' NE ' ' A' ' 156' ' ' ARG . 40.5 t80 -46.36 -38.09 8.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.616 -179.702 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 32.0 t80 -65.9 -53.39 40.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.699 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 62.8 t -49.22 -48.13 18.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 C-N-CA 120.614 -0.435 . . . . 0.0 110.365 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' TRP . . . . . . . . . . . . . 13.5 m0 -53.67 -55.56 24.99 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.363 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . 0.443 ' NE ' ' CZ ' ' A' ' 152' ' ' TYR . 0.7 OUTLIER -54.79 -52.14 63.55 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.362 179.949 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -49.19 -46.89 46.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.743 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . 0.478 ' O ' ' ND2' ' A' ' 158' ' ' ASN . 1.7 t30 -79.2 -12.92 59.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.73 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . 0.532 ' OG ' ' N ' ' A' ' 160' ' ' GLY . 1.6 t 57.73 -95.4 0.05 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.603 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . 0.532 ' N ' ' OG ' ' A' ' 159' ' ' SER . . . 85.43 16.33 64.51 Favored Glycine 0 CA--C 1.525 0.705 0 N-CA-C 111.102 -0.799 . . . . 0.0 111.102 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 15.5 mmt180 -56.74 -55.07 38.92 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.772 0.32 . . . . 0.0 110.66 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.54 ' CD ' ' H ' ' A' ' 162' ' ' ARG . 0.0 OUTLIER -91.17 125.13 35.86 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.618 -179.958 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 95.22 -95.8 1.91 Allowed Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.896 -0.882 . . . . 0.0 110.896 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -170.67 -106.92 0.19 Allowed Glycine 0 CA--C 1.523 0.552 0 N-CA-C 110.873 -0.891 . . . . 0.0 110.873 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 40.0 m -73.03 -24.5 60.73 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.866 0.365 . . . . 0.0 110.426 179.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 19.5 ttp180 63.36 140.41 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.552 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.776 HD22 ' N ' ' A' ' 167' ' ' LEU . 1.6 mm? -108.72 63.64 0.61 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.108 179.739 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -43.97 93.58 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.728 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . 0.461 ' N ' ' O ' ' A' ' 167' ' ' LEU . 27.8 mm-40 . . . . . 0 C--O 1.22 -0.479 0 CA-C-O 117.943 -1.027 . . . . 0.0 110.689 179.822 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 201' ' ' PKA . . . . . 0.5 'CL ' ' C15' ' A' ' 201' ' ' PKA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 29.3 mtt . . . . . 0 CA--C 1.529 0.156 0 N-CA-C 110.404 -0.221 . . . . 0.0 110.404 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_exo -41.33 124.95 2.45 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 121.593 1.529 . . . . 0.0 112.129 179.758 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 52.3 tt0 -80.96 -63.4 1.41 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.354 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 79.9 p -102.14 154.44 19.0 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.439 179.707 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.436 ' CE2' ' CD2' ' A' ' 68' ' ' TRP . 0.5 OUTLIER -60.1 116.2 4.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.234 -179.931 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.633 ' N ' ' CD ' ' A' ' 7' ' ' PRO . 1.0 OUTLIER -63.8 -36.56 22.04 Favored Pre-proline 0 C--N 1.328 -0.328 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 179.875 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.633 ' CD ' ' N ' ' A' ' 6' ' ' VAL . 15.0 Cg_exo -70.09 -68.23 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 121.987 1.792 . . . . 0.0 112.251 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.655 ' HB2' ' OG ' ' A' ' 64' ' ' SER . . . -47.41 -42.8 22.88 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.538 -179.35 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.462 ' O ' ' OG1' ' A' ' 12' ' ' THR . 60.6 t -65.1 -62.51 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 111.852 0.316 . . . . 0.0 111.852 -179.126 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -53.92 -40.03 64.14 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 111.462 -0.655 . . . . 0.0 111.462 -179.355 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.673 ' HG ' HG22 ' A' ' 86' ' ' THR . 6.7 mp -68.61 -28.7 67.15 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.646 0.26 . . . . 0.0 110.862 -179.575 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.462 ' OG1' ' O ' ' A' ' 9' ' ' VAL . 2.2 p -81.25 -24.0 37.63 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.844 -0.342 . . . . 0.0 110.901 -179.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 84.6 mt -81.4 -33.39 32.28 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.517 -0.31 . . . . 0.0 110.695 -179.845 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.421 ' N ' ' HD2' ' A' ' 15' ' ' PRO . 3.9 t -47.11 -57.89 8.35 Favored Pre-proline 0 CA--C 1.535 0.373 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.907 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.421 ' HD2' ' N ' ' A' ' 14' ' ' VAL . 11.6 Cg_endo -56.66 -30.9 85.58 Favored 'Trans proline' 0 N--CA 1.498 1.754 0 C-N-CA 121.169 1.246 . . . . 0.0 112.3 -179.857 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.1 t -67.84 -27.16 66.46 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.694 -179.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 96.2 mt -69.54 -58.16 4.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.861 -179.687 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -68.92 -20.27 74.36 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 110.816 -0.913 . . . . 0.0 110.816 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -71.02 -46.07 46.57 Favored Glycine 0 CA--C 1.522 0.502 0 N-CA-C 110.909 -0.876 . . . . 0.0 110.909 -179.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -74.44 -59.64 2.64 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.737 0.303 . . . . 0.0 110.796 -179.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 1.1 tpt -60.9 -26.78 67.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.108 -179.509 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -79.26 -59.84 2.64 Favored Glycine 0 CA--C 1.527 0.8 0 N-CA-C 111.602 -0.599 . . . . 0.0 111.602 -179.462 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.617 ' O ' HG22 ' A' ' 26' ' ' VAL . . . -61.35 -17.13 52.4 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.812 0.339 . . . . 0.0 110.843 -179.264 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 28.7 t80 -50.01 -24.0 2.37 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.935 0.398 . . . . 0.0 110.223 179.69 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.582 ' CE2' ' HB3' ' A' ' 102' ' ' ALA . 53.9 t80 -69.38 -48.6 60.67 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.904 -179.775 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.624 HG21 'CL ' ' A' ' 201' ' ' PKA . 27.6 m -72.12 -19.52 19.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.805 -179.624 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.55 -44.38 86.97 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.764 -179.751 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -102.37 -43.9 1.94 Allowed Glycine 0 CA--C 1.525 0.711 0 N-CA-C 111.503 -0.639 . . . . 0.0 111.503 -179.472 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -73.78 -24.62 59.87 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.95 -0.3 . . . . 0.0 111.019 -179.605 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -81.33 -58.77 2.52 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 111.24 -0.744 . . . . 0.0 111.24 -179.659 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 10.3 mp -51.69 -29.05 16.73 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.853 -0.339 . . . . 0.0 110.122 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 33.3 ttt180 -82.55 -47.84 11.69 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.217 179.52 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -49.09 -27.67 3.57 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.294 -0.412 . . . . 0.0 109.921 179.748 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.52 ' C ' ' CD1' ' A' ' 34' ' ' TYR . 9.0 t80 -46.83 -43.31 18.42 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.241 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -54.37 -24.4 19.42 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.489 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -96.09 -72.6 1.13 Allowed Glycine 0 CA--C 1.525 0.706 0 N-CA-C 110.986 -0.845 . . . . 0.0 110.986 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.585 ' O ' HD12 ' A' ' 37' ' ' LEU . 0.4 OUTLIER -95.95 166.87 11.57 Favored 'General case' 0 N--CA 1.462 0.173 0 C-N-CA 120.863 -0.335 . . . . 0.0 110.431 179.546 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 31.2 tp60 -85.92 118.67 25.55 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.947 -179.471 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 7.6 mtpt -105.13 162.28 20.23 Favored Pre-proline 0 CA--C 1.535 0.392 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.73 179.7 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.426 ' O ' ' ND1' ' A' ' 43' ' ' HIS . 8.2 Cg_exo -53.05 139.5 61.47 Favored 'Trans proline' 0 N--CA 1.494 1.503 0 C-N-CA 121.369 1.379 . . . . 0.0 112.408 -179.353 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 35.9 t -81.71 -2.81 51.87 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.69 179.632 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 2.6 p90 -112.41 20.25 16.86 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.656 -0.247 . . . . 0.0 110.98 -179.213 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.536 ' O ' ' CG ' ' A' ' 43' ' ' HIS . 2.0 p-80 -88.65 117.2 68.08 Favored Pre-proline 0 CA--C 1.535 0.375 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.369 -179.66 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.48 ' CG ' HD23 ' A' ' 49' ' ' LEU . 85.6 Cg_endo -99.35 -175.19 0.16 Allowed 'Trans proline' 0 N--CA 1.489 1.248 0 C-N-CA 120.836 1.024 . . . . 0.0 111.13 178.457 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.479 ' O ' ' N ' ' A' ' 47' ' ' TRP . 3.0 Cg_endo -80.3 140.97 14.07 Favored 'Trans proline' 0 C--N 1.302 -1.893 0 C-N-CA 121.573 1.515 . . . . 0.0 111.62 179.665 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.442 ' O ' ' HB3' ' A' ' 50' ' ' ALA . 23.6 ptt180 -41.2 -18.57 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.725 -0.671 . . . . 0.0 112.557 -178.758 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.586 ' CD1' ' N ' ' A' ' 48' ' ' THR . 0.4 OUTLIER -58.7 -48.58 80.64 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 112.48 0.548 . . . . 0.0 112.48 -178.335 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.586 ' N ' ' CD1' ' A' ' 47' ' ' TRP . 5.1 t -89.72 -34.3 16.27 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 113.196 0.813 . . . . 0.0 113.196 -178.019 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.913 ' O ' HG23 ' A' ' 52' ' ' ILE . 0.3 OUTLIER -82.71 -49.33 9.89 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.212 -0.595 . . . . 0.0 112.263 -178.016 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.587 ' C ' ' H ' ' A' ' 52' ' ' ILE . . . -40.37 -32.17 0.3 Allowed Pre-proline 0 CA--C 1.534 0.348 0 C-N-CA 120.425 -0.51 . . . . 0.0 111.835 -178.922 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.407 ' HD2' ' N ' ' A' ' 50' ' ' ALA . 81.6 Cg_exo -54.24 4.26 0.04 OUTLIER 'Trans proline' 0 C--N 1.316 -1.182 0 CA-C-N 119.052 0.697 . . . . 0.0 112.342 178.23 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.913 HG23 ' O ' ' A' ' 49' ' ' LEU . 46.9 pt -54.24 -30.75 21.11 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.113 0 CA-C-O 121.167 0.508 . . . . 0.0 110.066 179.662 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.428 ' CE2' HD11 ' A' ' 52' ' ' ILE . 52.9 m95 -80.1 -23.41 41.27 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.898 -179.44 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -70.85 -45.0 54.66 Favored Glycine 0 CA--C 1.523 0.585 0 N-CA-C 109.916 -1.274 . . . . 0.0 109.916 178.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 5.3 m -68.52 -51.8 39.07 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 179.294 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 94.5 mt -60.8 -26.53 67.36 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.044 179.586 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.543 ' C ' ' CD1' ' A' ' 57' ' ' TYR . 0.4 OUTLIER -65.61 -56.72 10.69 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 179.615 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 40.3 t -52.2 -44.01 64.5 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.775 -0.37 . . . . 0.0 110.288 179.784 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.76 -47.15 82.14 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.789 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 30.3 mtm -60.47 -35.65 76.38 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.563 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -64.53 -43.15 97.0 Favored Glycine 0 CA--C 1.523 0.538 0 N-CA-C 110.815 -0.914 . . . . 0.0 110.815 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -63.18 -53.41 53.63 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.466 ' O ' HG23 ' A' ' 67' ' ' VAL . . . -57.32 -37.08 79.31 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 179.032 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.655 ' OG ' ' HB2' ' A' ' 8' ' ' ALA . 23.3 t -62.33 -44.62 96.08 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 179.278 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.4 ' HA ' ' CE3' ' A' ' 68' ' ' TRP . 21.1 t80 -54.16 -44.06 71.12 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 179.155 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 65.7 mt -65.05 -30.52 50.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.603 179.625 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.466 HG23 ' O ' ' A' ' 63' ' ' GLY . 73.1 t -65.49 -58.8 5.46 Favored 'Isoleucine or valine' 0 C--O 1.233 0.186 0 C-N-CA 120.501 -0.479 . . . . 0.0 111.125 -179.711 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . 0.631 ' N ' ' CD1' ' A' ' 68' ' ' TRP . 0.0 OUTLIER -56.17 -37.17 69.21 Favored 'General case' 0 CA--C 1.528 0.104 0 C-N-CA 119.96 -0.696 . . . . 0.0 110.119 -179.78 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 16.5 mmmt -73.17 -21.62 60.66 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.416 -0.514 . . . . 0.0 110.917 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 15.8 tp10 -76.83 -40.64 47.14 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 -178.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.612 HD12 ' N ' ' A' ' 72' ' ' GLY . 0.5 OUTLIER -105.03 -0.11 27.1 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 120.32 -0.552 . . . . 0.0 111.44 -179.506 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.612 ' N ' HD12 ' A' ' 71' ' ' LEU . . . 96.3 84.62 1.71 Allowed Glycine 0 CA--C 1.525 0.662 0 C-N-CA 120.992 -0.623 . . . . 0.0 111.628 179.222 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.578 ' N ' ' O ' ' A' ' 68' ' ' TRP . . . 44.81 -173.88 0.01 OUTLIER Glycine 0 CA--C 1.525 0.691 0 N-CA-C 111.652 -0.579 . . . . 0.0 111.652 179.31 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 77.7 t80 -81.71 110.46 17.06 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.875 0.369 . . . . 0.0 110.651 -179.663 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.503 ' OG1' ' N ' ' A' ' 76' ' ' GLU . 2.6 t -142.65 -173.77 3.97 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.646 179.849 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.503 ' N ' ' OG1' ' A' ' 75' ' ' THR . 22.0 mt-10 -51.97 -24.56 6.68 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.649 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.451 ' H ' HG23 ' A' ' 75' ' ' THR . 30.9 m-20 -79.29 -24.69 42.72 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.901 -179.752 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -93.28 -16.83 24.3 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.838 0.352 . . . . 0.0 111.031 -179.663 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 14.1 mtp -69.54 -30.46 68.28 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.871 -179.782 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.42 ' N ' ' HD2' ' A' ' 81' ' ' PRO . 6.3 t -68.16 -46.57 40.29 Favored Pre-proline 0 CA--C 1.533 0.291 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.749 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.42 ' HD2' ' N ' ' A' ' 80' ' ' VAL . 13.4 Cg_endo -71.76 -61.18 0.05 OUTLIER 'Trans proline' 0 N--CA 1.498 1.786 0 C-N-CA 120.841 1.027 . . . . 0.0 111.916 179.397 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.715 ' O ' HG23 ' A' ' 86' ' ' THR . 8.4 mt -56.22 -51.9 66.4 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 121.014 0.435 . . . . 0.0 109.906 179.54 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -52.03 -53.96 28.09 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 111.167 -0.773 . . . . 0.0 111.167 -179.79 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.494 HD21 HD11 ' A' ' 124' ' ' LEU . 29.6 tp -58.42 -33.09 69.28 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.554 0.216 . . . . 0.0 110.954 -179.512 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 31.1 t80 -68.42 -37.08 79.97 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.801 -0.36 . . . . 0.0 110.86 -179.645 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.715 HG23 ' O ' ' A' ' 82' ' ' LEU . 5.1 p -68.44 -58.73 3.89 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.742 -0.383 . . . . 0.0 110.747 -179.46 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.428 ' N ' ' OG1' ' A' ' 86' ' ' THR . . . -58.69 -57.46 19.76 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 111.268 -0.733 . . . . 0.0 111.268 -179.799 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 54.1 tp60 -50.6 -55.36 16.66 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-O 120.88 0.371 . . . . 0.0 110.922 -179.758 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.424 ' O ' ' C ' ' A' ' 90' ' ' ALA . 26.3 tp -47.88 -66.27 0.43 Allowed 'General case' 0 C--O 1.209 -1.051 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.06 -179.731 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.476 ' O ' ' HB2' ' A' ' 94' ' ' ALA . . . -38.37 -50.51 1.5 Allowed 'General case' 0 C--N 1.319 -0.759 0 C-N-CA 120.633 -0.427 . . . . 0.0 112.026 -179.309 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 95.2 mt -53.64 -56.75 14.54 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 -178.312 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.411 ' O ' HD22 ' A' ' 113' ' ' LEU . 3.0 m120 -76.97 -53.7 7.51 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.275 0.559 . . . . 0.0 111.615 -178.312 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . 0.64 ' O ' ' N ' ' A' ' 95' ' ' TRP . 3.9 t-105 -53.11 -20.76 4.04 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.364 -0.835 . . . . 0.0 111.63 -179.595 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.476 ' HB2' ' O ' ' A' ' 90' ' ' ALA . . . -57.01 70.48 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 120.793 0.33 . . . . 0.0 110.608 -179.807 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.68 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 5.6 p-90 -102.38 -17.32 0.19 Allowed Pre-proline 0 CA--C 1.537 0.472 0 CA-C-N 116.051 -0.522 . . . . 0.0 112.036 -179.543 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.68 ' CD ' ' N ' ' A' ' 95' ' ' TRP . 32.5 Cg_exo -63.28 -24.2 72.06 Favored 'Trans proline' 0 N--CA 1.495 1.614 0 C-N-CA 120.629 0.886 . . . . 0.0 112.831 179.466 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.558 ' CD ' ' N ' ' A' ' 96' ' ' PRO . 97.3 Cg_exo -62.93 -24.87 74.14 Favored 'Trans proline' 0 N--CA 1.495 1.563 0 C-N-CA 120.833 1.022 . . . . 0.0 112.832 179.856 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 1.1 pp -78.58 22.53 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 121.015 0.436 . . . . 0.0 110.1 179.751 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.445 ' H ' ' C ' ' A' ' 97' ' ' PRO . 2.5 t80 -40.21 -42.78 1.55 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.531 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -86.23 -33.1 20.83 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.724 -179.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -68.46 -5.12 41.8 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 111.231 -0.748 . . . . 0.0 111.231 -179.716 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.582 ' HB3' ' CE2' ' A' ' 25' ' ' PHE . . . -74.63 -9.45 58.58 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.74 0.305 . . . . 0.0 110.908 -179.76 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.488 ' C ' ' CD ' ' A' ' 103' ' ' ARG . 0.0 OUTLIER -88.56 -11.73 44.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.828 -179.792 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -109.7 -178.92 3.67 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.914 0.387 . . . . 0.0 110.801 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.66 ' N ' ' SD ' ' A' ' 105' ' ' MET . 0.0 OUTLIER -55.45 -23.0 22.99 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.123 -179.826 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -62.22 -15.42 51.0 Favored Glycine 0 CA--C 1.528 0.847 0 CA-C-N 116.193 -0.458 . . . . 0.0 112.08 -179.287 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' TRP . . . . . 0.688 ' CD1' ' CZ2' ' A' ' 155' ' ' TRP . 0.0 OUTLIER -48.75 -18.98 0.31 Allowed 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 116.812 0.306 . . . . 0.0 110.972 -179.329 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -70.8 -23.76 62.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.991 0.424 . . . . 0.0 110.647 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 7.5 mt -54.21 -28.68 42.46 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.635 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -53.29 -63.01 1.29 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.087 0.47 . . . . 0.0 110.334 179.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.699 ' O ' HG23 ' A' ' 115' ' ' VAL . 2.1 p30 -62.26 -53.38 56.06 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.838 -0.619 . . . . 0.0 112.039 -179.376 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.611 HD13 ' O ' ' A' ' 112' ' ' LEU . 0.2 OUTLIER -53.49 -40.46 65.36 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.268 0.47 . . . . 0.0 112.268 -178.194 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.45 HD23 ' HA ' ' A' ' 113' ' ' LEU . 61.4 mt -71.4 -61.69 1.68 Allowed 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.281 0.475 . . . . 0.0 112.281 -178.479 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.5 pp -58.3 -33.67 69.71 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 120.15 -0.62 . . . . 0.0 110.9 -178.759 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.699 HG23 ' O ' ' A' ' 111' ' ' ASP . 41.2 t -62.16 -60.91 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.462 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 57.3 p -68.87 -22.24 64.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.474 -178.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -66.17 -62.22 4.85 Favored Glycine 0 CA--C 1.526 0.723 0 C-N-CA 120.952 -0.642 . . . . 0.0 111.549 -179.27 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.588 ' O ' HG23 ' A' ' 122' ' ' THR . 10.0 p -71.12 -37.54 67.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 C-N-CA 120.872 -0.331 . . . . 0.0 111.694 -179.258 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.508 ' O ' ' OG1' ' A' ' 123' ' ' THR . . . -68.39 -60.64 2.29 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.564 -0.454 . . . . 0.0 111.522 -179.204 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 3.7 m -58.7 -51.73 68.7 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.892 0.377 . . . . 0.0 111.372 -179.34 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.442 ' O ' HD23 ' A' ' 124' ' ' LEU . . . -55.58 -39.7 71.04 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.381 -179.384 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.588 HG23 ' O ' ' A' ' 118' ' ' VAL . 36.2 p -75.01 -28.94 60.7 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.638 -0.425 . . . . 0.0 111.601 -179.279 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.508 ' OG1' ' O ' ' A' ' 119' ' ' ALA . 0.1 OUTLIER -65.11 -54.55 28.23 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.631 -0.428 . . . . 0.0 110.717 -179.669 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.56 HD23 ' N ' ' A' ' 125' ' ' ALA . 0.6 OUTLIER -79.45 -19.73 49.16 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.576 -0.449 . . . . 0.0 111.73 -179.043 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.56 ' N ' HD23 ' A' ' 124' ' ' LEU . . . -88.33 -68.28 0.77 Allowed 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 -179.083 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' TRP . . . . . 0.4 ' N ' ' CD1' ' A' ' 126' ' ' TRP . 41.8 m0 -84.17 -57.23 3.26 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -177.87 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . 0.505 ' CD2' ' N ' ' A' ' 127' ' ' HIS . 7.1 m170 -54.69 -22.11 12.83 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.581 -0.448 . . . . 0.0 111.289 -178.718 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 26.8 ttt180 -68.34 -42.98 78.49 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.863 -0.335 . . . . 0.0 110.821 -179.694 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 23.2 t -87.51 -49.64 14.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.807 -179.796 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 26.6 p -116.23 108.32 46.03 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.523 -179.793 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . 0.642 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 79.5 Cg_exo -74.22 -25.71 13.3 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 121.554 1.503 . . . . 0.0 112.663 179.471 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.642 ' CD ' ' N ' ' A' ' 131' ' ' PRO . 51.4 Cg_exo -63.16 -43.31 19.28 Favored 'Trans proline' 0 N--CA 1.495 1.609 0 C-N-CA 121.371 1.38 . . . . 0.0 111.961 179.797 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -54.83 -38.75 67.78 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.251 179.771 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.426 ' HB2' ' CG ' ' A' ' 127' ' ' HIS . . . -55.06 -26.28 36.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.256 179.813 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 13.4 tpp180 -76.07 -32.23 59.16 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.248 179.658 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.401 HD23 ' HA ' ' A' ' 136' ' ' LEU . 95.9 mt -72.53 -26.78 61.88 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 179.314 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.512 ' O ' ' N ' ' A' ' 140' ' ' TYR . 2.6 mt -88.69 -29.25 20.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.376 179.757 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.516 ' C ' ' CD1' ' A' ' 138' ' ' TYR . 0.4 OUTLIER -33.59 -49.3 0.75 Allowed Pre-proline 0 CA--C 1.537 0.458 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.381 -179.819 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.416 ' HD2' ' N ' ' A' ' 138' ' ' TYR . 3.9 Cg_exo -60.96 4.96 0.17 Allowed 'Trans proline' 0 N--CA 1.494 1.535 0 C-N-CA 121.402 1.401 . . . . 0.0 112.591 -179.688 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.512 ' N ' ' O ' ' A' ' 137' ' ' LEU . 0.1 OUTLIER -90.07 -16.65 29.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.709 0.29 . . . . 0.0 111.125 179.88 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.55 HD23 HD12 ' A' ' 144' ' ' LEU . 94.8 mt -58.42 -26.19 63.0 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 178.831 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -63.41 -42.3 98.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.628 179.266 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' TRP . . . . . 0.444 ' CE2' HD12 ' A' ' 52' ' ' ILE . 12.3 t-105 -66.72 -38.72 87.27 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.7 179.387 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.55 HD12 HD23 ' A' ' 141' ' ' LEU . 18.0 mt -62.55 -37.64 86.93 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 120.539 -0.465 . . . . 0.0 110.035 179.616 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.598 ' O ' HG23 ' A' ' 149' ' ' VAL . . . -76.91 -25.92 53.52 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.389 179.746 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 26.4 t80 -64.28 -57.96 7.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.744 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -70.4 -49.38 49.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.794 -179.74 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 99.2 m -51.38 -47.46 62.86 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.906 -179.667 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.598 HG23 ' O ' ' A' ' 145' ' ' ALA . 94.2 t -69.54 -34.06 59.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.176 -179.502 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -56.18 -52.9 62.71 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.917 0.389 . . . . 0.0 110.383 -179.683 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . 0.494 ' OD1' ' NE1' ' A' ' 107' ' ' TRP . 3.4 t30 -63.88 -51.25 65.41 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.843 -179.841 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 58.9 t80 -56.27 -29.8 61.6 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.454 -179.282 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . 0.436 ' O ' ' CG ' ' A' ' 157' ' ' ASP . 55.8 t80 -73.02 -52.58 13.84 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.827 -0.349 . . . . 0.0 111.296 -179.464 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.486 ' O ' ' OD1' ' A' ' 157' ' ' ASP . 54.3 t -65.1 -32.44 58.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.593 -179.353 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' TRP . . . . . 0.688 ' CZ2' ' CD1' ' A' ' 107' ' ' TRP . 0.2 OUTLIER -73.4 -42.14 62.46 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.177 -178.559 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . 0.437 ' HE ' ' C ' ' A' ' 155' ' ' TRP . 0.0 OUTLIER -77.61 -57.04 4.03 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.855 -0.338 . . . . 0.0 110.751 -179.753 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . 0.579 ' OD1' ' N ' ' A' ' 158' ' ' ASN . 39.7 p-10 -48.24 -36.31 13.66 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.962 -0.295 . . . . 0.0 110.76 -179.688 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . 0.579 ' N ' ' OD1' ' A' ' 157' ' ' ASP . 8.7 t-20 -89.03 -22.34 23.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.773 -179.715 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . 0.446 ' O ' ' O ' ' A' ' 158' ' ' ASN . 8.7 t 53.83 165.51 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.726 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 160.16 98.53 0.14 Allowed Glycine 0 CA--C 1.524 0.656 0 N-CA-C 110.731 -0.948 . . . . 0.0 110.731 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 26.7 ttt85 -166.9 -33.12 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.833 0.349 . . . . 0.0 110.728 -179.642 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 62.2 mtt85 -74.98 140.5 43.69 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.757 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -74.39 2.61 45.05 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 111.208 -0.757 . . . . 0.0 111.208 -179.687 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 105.97 -149.96 16.8 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 111.077 -0.809 . . . . 0.0 111.077 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 4.9 t -78.17 -159.57 0.17 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.844 0.354 . . . . 0.0 110.686 -179.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . 0.48 ' C ' HD12 ' A' ' 167' ' ' LEU . 16.4 mmt85 -66.62 -95.28 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.366 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.48 HD12 ' C ' ' A' ' 166' ' ' ARG . 7.6 mp -113.12 -75.73 0.6 Allowed 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.294 179.89 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . 59.04 111.08 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.554 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.22 -0.481 0 CA-C-O 117.97 -1.014 . . . . 0.0 110.564 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 201' ' ' PKA . . . . . 0.624 'CL ' HG21 ' A' ' 26' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 stop_ save_